PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jung, Y; Park, J; Kim, HL; Sim, JE; Youn, DH; Kang, J; Lim, S; Jeong, MY; Yang, WM; Lee, SG; Ahn, KS; Um, JY				Jung, Yunu; Park, Jinbong; Kim, Hye-Lin; Sim, Jung-Eun; Youn, Dong-Hyun; Kang, JongWook; Lim, Seona; Jeong, Mi-Young; Yang, Woong Mo; Lee, Seok-Geun; Ahn, Kwang Seok; Um, Jae-Young			Vanillic acid attenuates obesity via activation of the AMPK pathway and thermogenic factors in vivo and in vitro	FASEB JOURNAL			English	Article						brown adipose tissue; adipogenesis; thermogenesis; lipogenesis; mitochondria	BROWN ADIPOSE-TISSUE; NF-KAPPA-B; PROTEIN-KINASE; ENERGY-EXPENDITURE; HEPATIC STEATOSIS; UPSTREAM KINASE; GLUCOSE-UPTAKE; UNITED-STATES; 3T3-L1 CELLS; PLATYCODIN D	Energy expenditure is a target gaining recent interest for obesity treatment. The antiobesity effect of vanillic acid (VA), a well-known flavoring agent, was investigated in vivo and in vitro. High-fat diet (HFD)-induced obese mice and genetically obese db/db mice showed significantly decreased body weights after VA administration. Two major adipogenic markers, peroxisome proliferator activated receptor gamma (PPAR gamma) and CCAAT/enhancer-binding protein alpha (C/EBP alpha), were reduced while the key factor of energy metabolism, AMPK alpha, was increased in the white adipose tissue and liver tissue of VA-treated mice. Furthermore, VA inhibited lipid accumulation and reduced hepatotoxic/inflammatory markers in liver tissues of mice and HepG2 hepatocytes. VA treatment also decreased differentiation of 3T3-L1 adipocytes by regulating adipogenic factors including PPAR gamma and C/EBP alpha. AMPK alpha small interfering RNA was used to examine whether AMPK was associated with the actions of VA. In AMPK alpha-nulled 3T3-L1 cells, the inhibitory action of VA on PPAR gamma and C/EBP alpha was attenuated. Furthermore, in brown adipose tissues of mice and primary cultured brown adipocytes, VA increased mitochondria- and thermogenesis-related factors such as uncoupling protein 1 and PPAR gamma-coactivator 1-alpha. Taken together, our results suggest that VA has potential as an AMPK alpha- and thermogenesis-activating antiobesity agent.	[Jung, Yunu; Park, Jinbong; Kim, Hye-Lin; Youn, Dong-Hyun; Kang, JongWook; Jeong, Mi-Young; Yang, Woong Mo; Lee, Seok-Geun; Ahn, Kwang Seok; Um, Jae-Young] Kyung Hee Univ, Coll Korean Med, Seoul, South Korea; [Jung, Yunu; Park, Jinbong; Kim, Hye-Lin; Youn, Dong-Hyun; Kang, JongWook; Jeong, Mi-Young; Yang, Woong Mo; Lee, Seok-Geun; Ahn, Kwang Seok; Um, Jae-Young] Kyung Hee Univ, Basic Res Lab Comorbid Regulat, Seoul, South Korea; [Jung, Yunu; Youn, Dong-Hyun; Kang, JongWook; Lim, Seona] Kyung Hee Univ, Dept Sci Korean Med, Seoul, South Korea; [Sim, Jung-Eun] Kyung Hee Univ, Grad Sch, Dept Biol Sci Korean Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Um, JY (corresponding author), Kyung Hee Univ, Dept Pharmacol, Coll Korean Med, 26 Kyungheedae Ro, Seoul 02447, South Korea.	jyum@khu.ac.kr	Yang, Woong Mo/AAH-9185-2020; jung, yunu/HGC-7295-2022; Lee, Seok-Geun/B-3408-2011; Park, Jinbong/AAU-5204-2020	Lee, Seok-Geun/0000-0002-0060-5777; Park, Jinbong/0000-0002-5984-5855; Yang, Woong Mo/0000-0001-5308-2386	National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2015R1A4A1042399]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP; NRF-2015R1A4A1042399). The authors declare no conflicts of interest.	Aljada A, 2001, J CLIN ENDOCR METAB, V86, P3250, DOI 10.1210/jc.86.7.3250; Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Baumruk F, 1999, FEBS LETT, V444, P206, DOI 10.1016/S0014-5793(99)00053-8; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Brondani LD, 2012, ARQ BRAS ENDOCRINOL, V56, P215, DOI 10.1590/S0004-27302012000400001; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Calixto-Campos C, 2015, J NAT PROD, V78, P1799, DOI 10.1021/acs.jnatprod.5b00246; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chakrabarti P, 2010, ENDOCRINOLOGY, V151, P2408, DOI 10.1210/en.2010-0316; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Crowley VEE, 2002, NAT REV DRUG DISCOV, V1, P276, DOI 10.1038/nrd770; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feldstein AE, 2010, SEMIN LIVER DIS, V30, P391, DOI 10.1055/s-0030-1267539; Fenzl A, 2014, HORM MOL BIOL CLIN I, V19, P25, DOI 10.1515/hmbci-2014-0022; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; GALVEZ MC, 1994, Z LEBENSM UNTERS FOR, V199, P29, DOI 10.1007/BF01192948; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grishko V, 2005, FREE RADICAL BIO MED, V38, P755, DOI 10.1016/j.freeradbiomed.2004.11.023; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Itoh A, 2009, BIOL PHARM BULL, V32, P1215, DOI 10.1248/bpb.32.1215; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jeong MY, 2015, INT J OBESITY, V39, P456, DOI 10.1038/ijo.2014.155; Kim HL, 2015, J AGR FOOD CHEM, V63, P7721, DOI 10.1021/acs.jafc.5b01908; Kim HL, 2014, FOOD FUNCT, V5, P2961, DOI 10.1039/c4fo00470a; Kim HL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/423741; Kim SJ, 2010, MOLECULES, V15, P7208, DOI 10.3390/molecules15107208; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lee H, 2011, LIFE SCI, V89, P388, DOI 10.1016/j.lfs.2011.07.006; Lee H, 2010, PHYTOTHER RES, V24, pS161, DOI 10.1002/ptr.3054; Lee JN, 2017, MOL CELL TOXICOL, V13, P125, DOI 10.1007/s13273-017-0013-x; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; Lopez-Velazquez JA, 2012, J LIPIDS, V2012, DOI 10.1155/2012/139875; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Martin-Sanz P, 2010, WORLD J GASTROENTERO, V16, P1430, DOI 10.3748/wjg.v16.i12.1430; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Palou A, 1998, INT J BIOCHEM CELL B, V30, P7, DOI 10.1016/S1357-2725(97)00065-4; Park J, 2017, MOL CELL TOXICOL, V13, P1, DOI 10.1007/s13273-017-0001-1; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Polvani S, 2016, WORLD J GASTROENTERO, V22, P2441, DOI 10.3748/wjg.v22.i8.2441; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sindhu G, 2015, ENVIRON TOXICOL PHAR, V39, P392, DOI 10.1016/j.etap.2014.12.008; Sinha AK, 2008, INT J FOOD SCI NUTR, V59, P299, DOI 10.1080/09687630701539350; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tateya Sanshiro, 2013, Front Endocrinol (Lausanne), V4, P93, DOI 10.3389/fendo.2013.00093; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wright SK, 2017, MOL CARCINOGEN, V56, P149, DOI 10.1002/mc.22479; Xing YF, 2010, BIOCHEM BIOPH RES CO, V396, P691, DOI 10.1016/j.bbrc.2010.04.163; Yao HR, 2011, AM J TRANSL RES, V3, P284; Youn DH, 2017, ONCOTARGET, V8, P9500, DOI 10.18632/oncotarget.13430; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang CF, 2016, MOL CELL TOXICOL, V12, P45, DOI 10.1007/s13273-016-0007-0; Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	73	42	44	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1388	1402		10.1096/fj.201700231RR	http://dx.doi.org/10.1096/fj.201700231RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29141998				2022-12-26	WOS:000427246000022
J	Yang, XN; Niu, YY; Liu, Y; Yang, Y; Wang, J; Cheng, XY; Liang, H; Wang, HS; Hu, YM; Lu, XY; Zhu, MX; Xu, TL; Tian, Y; Yu, Y				Yang, Xiao-Na; Niu, You-Ya; Liu, Yan; Yang, Yang; Wang, Jin; Cheng, Xiao-Yang; Liang, Hong; Wang, Heng-Shan; Hu, You-Min; Lu, Xiang-Yang; Zhu, Michael X.; Xu, Tian-Le; Tian, Yun; Yu, Ye			The nonproton ligand of acid-sensing ion channel 3 activates mollusk-specific FaNaC channels via a mechanism independent of the native FMRFamide peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); ion channel; ligand-binding protein; neuropeptide; small molecule; 2-guanidine-4-methylquinazoline (GMQ); FMRFamide (Phe-Met-Arg-Phe-NH2) peptides; FMRFamide peptide-gated sodium channel (FaNaC); acid-sensing ion channels (ASIC)	GATED NA+ CHANNEL; SODIUM-CHANNEL; MODULATION; AMILORIDE; CONTRIBUTES; EXPRESSION; CLONING; NEURONS; DOMAIN; ASIC3	The degenerin/epithelial sodium channel (DEG/ENaC) superfamily of ion channels contains subfamilies with diverse functions that are fundamental to many physiological and pathological processes, ranging from synaptic transmission to epileptogenesis. The absence in mammals of some DEG/ENaCs subfamily orthologues such as FMRFamide peptide-activated sodium channels (FaNaCs), which have been identified only in mollusks, indicates that the various subfamilies diverged early in evolution. We recently reported that the nonproton agonist 2-guanidine-4-methylquinazoline (GMQ) activates acid-sensing ion channels (ASICs), a DEG/ENaC subfamily mainly in mammals, in the absence of acidosis. Here, we show that GMQ also could directly activate the mollusk-specific FaNaCs. Differences in ion selectivity and unitary conductance and effects of substitutions at key residues revealed that GMQ and FMRFamide activate FaNaCs via distinct mechanisms. The presence of two activation mechanisms in the FaNaC subfamily diverging early in the evolution of DEG/ENaCs suggested that dual gating is an ancient feature in this superfamily. Notably, the GMQ-gating mode is still preserved in the mammalian ASIC subfamily, whereas FMRFamide-mediated channel gating was lost during evolution. This implied that GMQ activation may be essential for the functions of mammalian DEG/ENaCs. Our findings provide new insights into the evolution of DEG/ENaCs and may facilitate the discovery and characterization of their endogenous agonists.	[Yang, Xiao-Na; Niu, You-Ya; Lu, Xiang-Yang; Zhu, Michael X.; Tian, Yun; Yu, Ye] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China; [Yang, Xiao-Na; Niu, You-Ya; Liu, Yan; Yang, Yang; Wang, Jin; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China; [Yang, Xiao-Na; Niu, You-Ya; Liu, Yan; Yang, Yang; Wang, Jin; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China; [Niu, You-Ya] Hunan Univ Med, Dept Cell Biol & Genet, Huaihua 418000, Peoples R China; [Cheng, Xiao-Yang; Xu, Tian-Le] Shanghai Jiao Tong Univ, Dept Anat Histol & Embryol, Discipline Neurosci, Sch Med, Shanghai 200025, Peoples R China; [Liang, Hong; Wang, Heng-Shan] Guangxi Normal Univ, Sch Chem & Pharm, State Key Lab Chem & Mol Engn Med Resources, Guilin 541004, Peoples R China; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Hunan Agricultural University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guangxi Normal University; University of Texas System; University of Texas Health Science Center Houston	Tian, Y; Yu, Y (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China.	tianyun@hunau.edu.cn; yuye@shsmu.edu.cn	Cheng, Xiaoyang/M-1257-2017; Pan, Ying-Ming/AAC-6424-2019; Cheng, Xiaoyang/N-9970-2019	Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; Yu, Ye/0000-0002-4054-8543	National Program on Key Basic Research Project of China [2014CB910300/02]; National Natural Science Foundation of China [31570832, 21431001, 31170787, 81760626, 31400707]; Guangxi Foundation for Distinguished Experts; National Excellent Young Scientist Foundation of China [31222018]; Innovation Program of Shanghai Municipal Education Commission [14YZ034]; Research Foundation of Education Bureau of Hunan Province, China [17A153]	National Program on Key Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Foundation for Distinguished Experts; National Excellent Young Scientist Foundation of China; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Research Foundation of Education Bureau of Hunan Province, China	This study was supported by National Program on Key Basic Research Project of China Grant 2014CB910300/02, National Natural Science Foundation of China Grants 31570832, 21431001, 31170787, 81760626, and 31400707, Guangxi Foundation for Distinguished Experts (2017), National Excellent Young Scientist Foundation of China Grant 31222018, Innovation Program of Shanghai Municipal Education Commission Grant 14YZ034, and Research Foundation of Education Bureau of Hunan Province, China Grant 17A153. The authors declare that they have no conflicts of interest with the contents of this article.	Alijevic O, 2012, J BIOL CHEM, V287, P36059, DOI 10.1074/jbc.M112.360487; Arias RL, 2008, NEUROBIOL DIS, V31, P334, DOI 10.1016/j.nbd.2008.05.008; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Assmann M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0084-2; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Cabo R, 2015, HISTOCHEM CELL BIOL, V143, P267, DOI 10.1007/s00418-014-1278-y; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Cottrell GA, 2005, PFLUG ARCH EUR J PHY, V450, P168, DOI 10.1007/s00424-005-1385-7; Delaunay A, 2012, P NATL ACAD SCI USA, V109, P13124, DOI 10.1073/pnas.1120350109; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Eastwood AL, 2012, PHYSIOLOGY, V27, P282, DOI 10.1152/physiol.00006.2012; Frey EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071733; Furukawa Y, 2006, PFLUG ARCH EUR J PHY, V451, P646, DOI 10.1007/s00424-005-1498-z; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Green KA, 2002, PFLUG ARCH EUR J PHY, V443, P813, DOI 10.1007/s00424-001-0750-4; Grunder S, 2015, NEUROPHARMACOLOGY, V94, P9, DOI 10.1016/j.neuropharm.2014.12.016; Grunder S, 2015, J EXP BIOL, V218, P551, DOI 10.1242/jeb.111666; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jeziorski MC, 2000, J PHYSIOL-LONDON, V526, P13, DOI 10.1111/j.1469-7793.2000.00013.x; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Kreple CJ, 2014, NAT NEUROSCI, V17, P1083, DOI 10.1038/nn.3750; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li WG, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-88; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Marra S, 2016, EMBO J, V35, P414, DOI 10.15252/embj.201592335; McClenaghan C, 2016, J GEN PHYSIOL, V147, P497, DOI 10.1085/jgp.201611601; Niu YY, 2016, J BIOL CHEM, V291, P7571, DOI 10.1074/jbc.M115.710251; Omerbasic D, 2015, NEUROPHARMACOLOGY, V94, P80, DOI 10.1016/j.neuropharm.2014.12.007; Perry SJ, 2001, J NEUROSCI, V21, P5559, DOI 10.1523/JNEUROSCI.21-15-05559.2001; Picloplichko VI, 2006, P NATL ACAD SCI USA, V103, P11376, DOI 10.1073/pnas.0600768103; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Smith RN, 2014, CHANNELS, V8, P49, DOI 10.4161/chan.26978; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zhainazarov AB, 1998, J PHYSIOL-LONDON, V513, P19, DOI 10.1111/j.1469-7793.1998.019by.x; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	56	8	9	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21662	21675		10.1074/jbc.M117.814707	http://dx.doi.org/10.1074/jbc.M117.814707			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29123030	hybrid, Green Published			2022-12-26	WOS:000419013000040
J	Ma, LJ; Liu, Y; Landry, NK; El-Achkar, TM; Lieske, JC; Wu, XR				Ma, Lijie; Liu, Yan; Landry, Nichole K.; El-Achkar, Tarek M.; Lieske, John C.; Wu, Xue-Ru			Point mutation in D8C domain of Tamm-Horsfall protein/uromodulin in transgenic mice causes progressive renal damage and hyperuricemia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; COTRANSPORTER NKCC2; URINARY SECRETION; MUTANT UROMODULIN; URATE TRANSPORT; UMOD GENE; URIC-ACID; NEPHROPATHY; PROTEIN; GLYCOPROTEIN	Hereditary mutations in Tamm-Horsfall protein (THP/uromodulin) gene cause autosomal dominant kidney diseases characterized by juvenile-onset hyperuricemia, gout and progressive kidney failure, although the disease pathogenesis remains unclear. Here we show that targeted expression in transgenic mice of a mutation within the domain of 8 cysteines of THP in kidneys' thick ascending limb (TAL) caused unfolded protein response in younger (1-month old) mice and apoptosis in older (12-month old) mice. While the young mice had urine concentration defects and polyuria, such defects progressively reversed in the older mice to marked oliguria, highly concentrated urine, fibrotic kidneys and reduced creatinine clearance. Both the young and the old transgenic mice had significantly higher serum uric acid and its catabolic product, allantoin, than age-matched wild-type mice. This THP mutation apparently caused primary defects in TAL by compromising the luminal translocation and reabsorptive functions of NKCC2 and ROMK and secondary responses in proximal tubules by upregulating NHE3 and URAT1. Our results strongly suggest that the progressive worsening of kidney functions reflects the accumulation of the deleterious effects of the misfolded mutant THP and the compensatory responses. Transgenic mice recapitulating human THP/uromodulin-associated kidney diseases could be used to elucidate their pathogenesis and test novel therapeutic strategies.	[Ma, Lijie; Liu, Yan; Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Ma, Lijie; Liu, Yan; Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Landry, Nichole K.; El-Achkar, Tarek M.] Indiana Univ Sch Med, Div Nephrol, Indianapolis, IN 46202 USA; [Landry, Nichole K.; El-Achkar, Tarek M.] Indianapolis VA, Indianapolis, IN USA; [Lieske, John C.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Wu, Xue-Ru] Vet Affairs New York Harbor Healthcare Syst, Manhattan Campus, New York, NY 10010 USA	New York University; New York University; Indiana University System; Indiana University Bloomington; Mayo Clinic	Wu, XR (corresponding author), NYU, Sch Med, Dept Urol, New York, NY 10016 USA.; Wu, XR (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.; Wu, XR (corresponding author), Vet Affairs New York Harbor Healthcare Syst, Manhattan Campus, New York, NY 10010 USA.	xue-ru.wu@med.nyu.edu	Lieske, John/ABA-4829-2020	Wu, Xue-Ru/0000-0001-6058-6291	United States National Institutes of Health [R01DK056903]; Mayo Clinic O'Brien Urology Research Center [U54DK100227]; Veterans Affairs Office of Research and Development (Biomedical Laboratory Research and Development Service) [1I01BX002049]; New York University School of Medicine; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056903, R01DK111651] Funding Source: NIH RePORTER; Veterans Affairs [IK6BX004479] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic O'Brien Urology Research Center; Veterans Affairs Office of Research and Development (Biomedical Laboratory Research and Development Service); New York University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by grants from the United States National Institutes of Health (R01DK056903), the Mayo Clinic O'Brien Urology Research Center (U54DK100227), and the Veterans Affairs Office of Research and Development (Biomedical Laboratory Research and Development Service; 1I01BX002049) and a grant-in-aid from the Goldstein Fund for Urological Research of the New York University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai N, 2012, CLIN EXP NEPHROL, V16, P89, DOI 10.1007/s10157-011-0532-z; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Bleyer AJ, 2016, CLIN J AM SOC NEPHRO, V11, P6, DOI 10.2215/CJN.12201115; Cameron JS, 2005, SEMIN NEPHROL, V25, P9, DOI 10.1016/j.semnephrol.2004.09.003; Capasso G, 2005, CURR PHARM DESIGN, V11, P4153, DOI 10.2174/138161205774913219; Castrop H, 2014, AM J PHYSIOL-RENAL, V307, pF991, DOI 10.1152/ajprenal.00432.2014; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; El-Achkar TM, 2012, AM J KIDNEY DIS, V59, P452, DOI 10.1053/j.ajkd.2011.10.054; Enomoto Atsushi, 2005, Clin Exp Nephrol, V9, P195, DOI 10.1007/s10157-005-0368-5; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Haas M, 1998, J BIOENERG BIOMEMBR, V30, P161, DOI 10.1023/A:1020521308985; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; HESSION C, 1987, SCIENCE, V237, P1479, DOI 10.1126/science.3498215; Iorember FM, 2014, PEDIATR NEPHROL, V29, P1151, DOI 10.1007/s00467-013-2563-z; Jennings P, 2007, J AM SOC NEPHROL, V18, P264, DOI 10.1681/ASN.2006020158; Khan SR, 2004, FRONT BIOSCI-LANDMRK, V9, P1450, DOI 10.2741/1347; Kottgen A, 2010, J AM SOC NEPHROL, V21, P337, DOI 10.1681/ASN.2009070725; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; KUMAR S, 1990, KIDNEY INT, V37, P1395, DOI 10.1038/ki.1990.128; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Lhotta K, 2010, KIDNEY BLOOD PRESS R, V33, P393, DOI 10.1159/000320681; Ma LJ, 2012, J BIOL CHEM, V287, P1290, DOI 10.1074/jbc.M111.283036; Moskowitz JL, 2013, CLIN J AM SOC NEPHRO, V8, P1349, DOI 10.2215/CJN.11151012; Muratsubaki H, 2006, ANAL BIOCHEM, V359, P161, DOI 10.1016/j.ab.2006.09.024; Mutig K, 2011, J BIOL CHEM, V286, P30200, DOI 10.1074/jbc.M111.222968; Palmer BF, 2011, SEMIN NEPHROL, V31, P542, DOI 10.1016/j.semnephrol.2011.09.009; Rafey MA, 2003, CURR OPIN NEPHROL HY, V12, P511, DOI 10.1097/00041552-200309000-00005; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Renigunta A, 2011, J BIOL CHEM, V286, P2224, DOI 10.1074/jbc.M110.149880; Schaeffer C, 2012, KIDNEY INT, V81, P769, DOI 10.1038/ki.2011.456; Scolari F, 2004, AM J KIDNEY DIS, V44, P987, DOI 10.1053/j.ajkd.2004.08.021; Scolari Francesco, 2003, Saudi J Kidney Dis Transpl, V14, P316; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Shlipak MG, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-2; SIKRI KL, 1979, BIOCHEM J, V181, P525, DOI 10.1042/bj1810525; Takiue Y, 2008, NUCLEOS NUCLEOT NUCL, V27, P596, DOI 10.1080/15257770802136065; Turner JJO, 2003, J CLIN ENDOCR METAB, V88, P1398, DOI 10.1210/jc.2002-021973; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Yang HR, 2004, FEBS LETT, V578, P236, DOI 10.1016/j.febslet.2004.10.092; Zhu XH, 2003, TRANSGENIC RES, V12, P155, DOI 10.1023/A:1022967505222; Zhu XH, 2002, AM J PHYSIOL-RENAL, V282, pF608, DOI 10.1152/ajprenal.00297.2001	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0186769	10.1371/journal.pone.0186769	http://dx.doi.org/10.1371/journal.pone.0186769			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145399	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800005
J	Lindquist, KJ; Sanford, T; Friedlander, TW; Paris, PL; Porten, SP				Lindquist, Karla J.; Sanford, Thomas; Friedlander, Terence W.; Paris, Pamela L.; Porten, Sima P.			Copy number gains at chr3p25 and chr11p11 are associated with lymph node involvement and survival in muscle-invasive bladder tumors	PLOS ONE			English	Article							GENE-EXPRESSION; RADICAL CYSTECTOMY; CANCER; CHEMOTHERAPY; PREDICTION; SIGNATURES; CARCINOMA; OUTCOMES; DISEASE	Patients with muscle-invasive bladder cancer (MIBC) have poorer prognoses if cancer has metastasized to the lymph nodes. Genomic markers of lymph node involvement (LNI) would be useful for treatment planning, especially if measured at the biopsy stage, but large-scale studies of tumor tissue at any stage are needed to discover robust markers of LNI. We performed a genome-wide query of copy number alterations (CNA) in 237 MIBC surgical tumor specimens from patients in The Cancer Genome Atlas who had radical cystectomy and lymphadenectomy without neoadjuvant treatment. Pathology reports were independently reviewed to confirm LNI, and copy number data was analyzed to confirm gene-level gains and losses while adjusting for tumor purity and ploidy. Using logistic regression and elastic net models, we identified the CNA most significantly associated with LNI. Multivariable logistic regression was used to describe these CNA associations while adjusting for clinical variables. Kaplan-Meier and Cox regression were used to describe their association with overall survival. Gains in 26 genes were identified as having strong associations with LNI. After adjusting for age, gender, race, pathological tumor stage, histology, and number of nodes examined, gains in 22 genes on chr3p25 or chr11p11 remained significantly associated with LNI (p<0.01) and improved model discrimination over clinical variables alone (p = 0.04). They were also associated with shorter overall survival (adjusted p = 0.02). These results suggest that a simple genomic test for gains in chr3p25 and chr11p11 could inform adjuvant treatment or clinical trial decisions if validated in external cohorts. Additional studies will also be needed to determine if these CNA are detectible in biopsy tissue and can inform clinical decisions at the preoperative stage.	[Lindquist, Karla J.; Sanford, Thomas; Paris, Pamela L.; Porten, Sima P.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Friedlander, Terence W.; Paris, Pamela L.] Univ Calif San Francisco, Dept Med, Div Hematol & Med Oncol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lindquist, KJ (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.	karla.lindquist@ucsf.edu		Sanford, Thomas/0000-0002-7123-9807; Lindquist, Karla/0000-0002-1971-2273	Marie Lundin Cancer Research Trust	Marie Lundin Cancer Research Trust	Funded by the Marie Lundin Cancer Research Trust to KJL, TS, TWF, PLP, SPP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2016, CANC FACTS FIGURES 2; Bruins HM, 2012, EUR UROL, V62, P671, DOI 10.1016/j.eururo.2012.04.050; Bruins HM, 2009, J UROLOGY, V182, P2182, DOI 10.1016/j.juro.2009.07.017; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cox dr, 1984, ANAL SURVIVAL DATA, DOI DOI 10.1201/9781315137438; Dancik Garrett, 2011, PLoS Curr, V3, pRRN1248, DOI 10.1371/currents.RRN1248; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Herr HW, 2004, J CLIN ONCOL, V22, P2781, DOI 10.1200/JCO.2004.11.024; Herr HW, 2001, J UROLOGY, V165, P62, DOI 10.1097/00005392-200101000-00015; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Hurle R, 2010, SURG ONCOL, V19, P208, DOI 10.1016/j.suronc.2009.05.004; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kassouf W, 2009, UROLOGY, V73, P147, DOI 10.1016/j.urology.2008.07.035; Laurberg JR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-638; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Maurer T, 2012, EUR UROL, V61, P1031, DOI 10.1016/j.eururo.2011.12.009; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mitra AP, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju290; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Park A, 2007, UROLOGY, V70, P257, DOI 10.1016/j.urology.2007.03.054; Perez CA, 2007, ONCOGENE, V26, P7363, DOI 10.1038/sj.onc.1210561; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; R Core Team, 2021, R LANGUAGE ENV STAT; Riester M, 2012, CLIN CANCER RES, V18, P1323, DOI 10.1158/1078-0432.CCR-11-2271; Seiler R, 2016, J UROLOGY, V196, P1036, DOI 10.1016/j.juro.2016.04.061; Smith SC, 2011, LANCET ONCOL, V12, P137, DOI 10.1016/S1470-2045(10)70296-5; StataCorp, 2009, STAT STAT SOFTW REL; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Vieweg J, 1999, J UROLOGY, V161, P72, DOI 10.1016/S0022-5347(01)62067-6; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Zehnder P, 2014, BJU INT, V113, P554, DOI 10.1111/bju.12520; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	43	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187975	10.1371/journal.pone.0187975	http://dx.doi.org/10.1371/journal.pone.0187975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140994	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400039
J	Wang, NN; Guo, J; Liu, FD; Wang, MX; Li, CT; Jia, LH; Zhai, LL; Wei, W; Bai, YL				Wang, Nannan; Guo, Jie; Liu, Fuding; Wang, Mingxia; Li, Chuntao; Jia, Lihong; Zhai, Lingling; Wei, Wei; Bai, Yinglong			Depot-specific inflammation with decreased expression of ATM2 in white adipose tissues induced by high-margarine/lard intake	PLOS ONE			English	Article							TRANS-FATTY-ACIDS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; DIET-INDUCED OBESE; CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; CHEMOKINE RECEPTORS; MOLECULAR-CLONING; GENE-EXPRESSION; KIDNEY-DISEASE	A high-fat diet has been recognized as an important risk factor of obesity, with variable impacts of different fatty acid compositions on the physiological process. To understand the effects of a high-margarine/lard diet, which is a major source of trans fatty acids (TFAs)/saturated fatty acids (SFAs), elaidic acid as a biomarker of margarine intake was used to screen affected adipokines on mature human adipocytes in vitro. Weaned male Wistar rats were fed a high-fat diet enriched with margarine/lard to generate obesity-prone (OP) and obesity-resistant (OR) models, which were then used to explore the inflammatory responses of depot-specific white adipose tissue. Adiposity, glucose and lipid metabolism parameters and macrophage cell markers were also compared in vivo. In the subcutaneous depot, a high-margarine diet induced elevated IL-6, MCP-1 and XCL1 expression levels in both MOP and M-OR groups. High-lard diet-fed rats displayed higher protein expression levels of MCP-1 and XCL1 compared with the control group. In the epididymal depot, significantly elevated IL-6 production was observed in M-OP rats, and high-lard diet-fed rats displayed elevated IL-6 and decreased XCL1 expression. In the retroperitoneal depot, a high-margarine diet caused higher IL-6 and MCP-1 expression levels, a high-lard diet caused elevated IL-6 expression in L-OP/L-OR rats, and elevated XCL1 expression was observed only in LOP rats. In general, CD206 mRNA levels were notably down-regulated by high-fat diet feeding in the above-mentioned depots. CD11c mRNA levels were slightly upregulated in the subcutaneous depot of OP rats fed a high-margarine/lard diet. In the epidydimal depot, higher expression levels of F4/80 and CD206 mRNA were observed only in high-margarine diet-fed OP rats. These results suggest that depot-specific inflammation with decreased expression of adipose tissue anti-inflammatory M2-type (ATM2) macrophages could be induced by high-margarine/lard intake.	[Wang, Nannan; Guo, Jie; Liu, Fuding; Wang, Mingxia; Jia, Lihong; Zhai, Lingling; Wei, Wei; Bai, Yinglong] China Med Univ, Sch Publ Hlth, Dept Child & Adolescent Hlth, Shenyang, Liaoning, Peoples R China; [Guo, Jie] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China; [Liu, Fuding] Huangshi Cent Hosp, Dept Publ Hlth, Edong Healthcare Grp, Huangshi, Hubei, Peoples R China; [Li, Chuntao] China Med Univ, Informat Ctr, Hosp 1, Shenyang, Liaoning, Peoples R China	China Medical University; Sun Yat Sen University; China Medical University	Bai, YL (corresponding author), China Med Univ, Sch Publ Hlth, Dept Child & Adolescent Hlth, Shenyang, Liaoning, Peoples R China.	ylbai@cmu.edu.cn	白, 英龙/AAF-6124-2020		National Natural Science Foundation Committee of China [81373018, 81172691]	National Natural Science Foundation Committee of China(National Natural Science Foundation of China (NSFC))	The present study was supported by grants from the National Natural Science Foundation Committee of China (No 81373018 and 81172691).	Albersen M, 2013, SEX MED-UK, V1, P3, DOI 10.1002/sm2.1; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Bai Y, 2015, OBES REV, V16, P127, DOI 10.1111/obr.12242; BELZUNG F, 1993, AM J PHYSIOL, V264, pR1111, DOI 10.1152/ajpregu.1993.264.6.R1111; Bendsen NT, 2011, EUR J CLIN NUTR, V65, P773, DOI 10.1038/ejcn.2011.34; Benoit B, 2013, NUTR RES, V33, P952, DOI 10.1016/j.nutres.2013.07.017; Blogowski W, 2012, J BIOL REG HOMEOS AG, V26, P607; Booth A, 2016, HORM MOL BIOL CLIN I, V26, P25, DOI 10.1515/hmbci-2015-0073; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Bueno AA, 2010, EUR J NUTR, V49, P235, DOI 10.1007/s00394-009-0069-z; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Casas-Agustench P, 2009, CLIN NUTR, V28, P39, DOI 10.1016/j.clnu.2008.10.008; Chacon MR, 2007, OBESITY, V15, P664, DOI 10.1038/oby.2007.578; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chu Y, 2010, ENDOCRINOLOGY, V151, P5669, DOI 10.1210/en.2010-0772; Comstock IA, 2017, FERTIL STERIL, V107, P740, DOI [10.1016/.fertnstert.2016.11.009, 10.1016/j.fertnstert.2016.11.009]; Dawczynski C, 2016, EXPERT REV CARDIOVAS, V14, P1001, DOI 10.1080/14779072.2016.1199956; Ellander A, 2015, EUR J LIPID SCI TECH, V117, P1370, DOI 10.1002/ejlt.201400513; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; Fenton JI, 2009, DIABETES OBES METAB, V11, P343, DOI 10.1111/j.1463-1326.2008.00974.x; Fox JC, 2015, ACS CHEM BIOL, V10, P2580, DOI 10.1021/acschembio.5b00542; Fu CP, 2012, CLIN CHIM ACTA, V413, P1647, DOI 10.1016/j.cca.2012.05.008; Gao MM, 2013, PHARM RES-DORDR, V30, P2940, DOI 10.1007/s11095-013-1125-1; Gayet-Boyer C, 2014, BRIT J NUTR, V112, P1914, DOI 10.1017/S0007114514002578; Ghosh Sagar, 2013, Front Biosci (Elite Ed), V5, P461; Giancarlo B, 1996, EUR J IMMUNOL, V26, P3238, DOI 10.1002/eji.1830261260; Ginter E, 2016, BRATISL MED J, V117, P251, DOI 10.4149/BLL_2016_048; Gomez-Hernandez A, 2013, CLIN INVEST ARTERIOS, V25, P27, DOI 10.1016/j.arteri.2012.11.003; Harris HR, 2017, CANCER RES, V77, P1179, DOI 10.1158/0008-5472.CAN-16-2273; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hodge AM, 2004, CANCER CAUSE CONTROL, V15, P11, DOI 10.1023/B:CACO.0000016568.25127.10; Hooper Lee, 2015, Cochrane Database Syst Rev, pCD011737, DOI 10.1002/14651858.CD011737; Huang H, 2001, BIOCHEM BIOPH RES CO, V281, P378, DOI 10.1006/bbrc.2001.4363; Hutcheson J, 2015, CYTOKINE, V75, P272, DOI 10.1016/j.cyto.2015.04.004; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Jen KLC, 2003, EXP BIOL MED, V228, P843, DOI 10.1177/15353702-0322807-10; Jung C, 2009, PEDIATR DIABETES, V10, P329, DOI 10.1111/j.1399-5448.2008.00486.x; Kalaitzidis RG, 2011, INT UROL NEPHROL, V43, P771, DOI 10.1007/s11255-011-9974-1; Kang YE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154003; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; KENNEDY J, 1995, J IMMUNOL, V155, P203; Khorramdelazad H, 2016, J NEUROIMMUNOL, V290, P70, DOI 10.1016/j.jneuroim.2015.11.021; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim D, 2014, DIABETOLOGIA, V57, P1456, DOI 10.1007/s00125-014-3237-5; Kremmyda LS, 2011, BIOMED PAP, V155, P195, DOI 10.5507/bp.2011.052; Lamacchia O, 2011, NEPHROL DIAL TRANSPL, V26, P892, DOI 10.1093/ndt/gfq522; Lei Y, 2012, MICROBES INFECT, V14, P262, DOI 10.1016/j.micinf.2011.10.003; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR382, DOI 10.1152/ajpregu.1999.276.2.R382; Li SY, 2008, OBESITY, V16, P811, DOI 10.1038/oby.2007.116; Lichtenstein A H, 2000, J Cardiopulm Rehabil, V20, P143, DOI 10.1097/00008483-200005000-00001; Lionetti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092753; Liu AD, 2015, BIOMED ENVIRON SCI, V28, P477, DOI 10.3967/bes2015.069; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Luo MY, 2016, OBESITY, V24, P1244, DOI 10.1002/oby.21463; Lytle LA, 2002, PUBLIC HEALTH NUTR, V5, P319, DOI 10.1079/PHN2002255; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR1306, DOI 10.1152/ajpregu.00463.2004; Mansour SG, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0490-0; Mayneris-Perxachs J, 2010, FOOD CHEM, V123, P296, DOI 10.1016/j.foodchem.2010.04.035; Mertens E, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010075; Micha R, 2010, AM J CLIN NUTR, V91, P883, DOI 10.3945/ajcn.2009.28877; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ordway D, 2007, J LEUKOCYTE BIOL, V82, P1221, DOI 10.1189/jlb.0607426; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pande G, 2012, J FOOD SCI, V77, pC1203, DOI 10.1111/j.1750-3841.2012.02935.x; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; de Heredia FP, 2012, P NUTR SOC, V71, P332, DOI 10.1017/S0029665112000092; Perusse L, 2000, AM J CLIN NUTR, V72, p1285S, DOI 10.1093/ajcn/72.5.1285s; Proenca ARG, 2014, BRAZ J MED BIOL RES, V47, P192, DOI 10.1590/1414-431X20132911; Rehm CD, 2016, JAMA-J AM MED ASSOC, V315, P2542, DOI 10.1001/jama.2016.7491; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rokling-Andersen MH, 2009, BRIT J NUTR, V102, P995, DOI 10.1017/S0007114509353210; Rumsaeng V, 1997, J IMMUNOL, V158, P1353; Saadatian-Elahi M, 2009, AM J CLIN NUTR, V89, P331, DOI 10.3945/ajcn.2008.26834; Sackmann-Sala L, 2012, OBESITY, V20, P101, DOI 10.1038/oby.2011.235; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Sheng XL, 2007, WORLD J GASTROENTERO, V13, P5944, DOI 10.3748/wjg.v13.i44.5944; Sindhu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133494; Skeaff CM, 2006, BRIT J NUTR, V96, P377, DOI 10.1079/BJN20061737; Skopkova M, 2007, OBESITY, V15, P2396, DOI 10.1038/oby.2007.285; Stender S, 2006, NEW ENGL J MED, V354, P1650, DOI 10.1056/NEJMc052959; Suburu Janel, 2013, Food Biosci, V4, P1; Tang Wenjing, 2013, Wei Sheng Yan Jiu, V42, P571; Tardy AL, 2011, NUTR RES REV, V24, P111, DOI 10.1017/S0954422411000011; Tschop M, 2001, EXP CLIN ENDOCR DIAB, V109, P307, DOI 10.1055/s-2001-17297; van den Berg SAA, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-24; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Vaughan RA, 2015, LIPIDS, V50, P1115, DOI 10.1007/s11745-015-4072-2; Wang QY, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000914; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wensveen FM, 2015, EUR J IMMUNOL, V45, P2446, DOI 10.1002/eji.201545502; Xu L, 2015, BIOMOLECULES, V5, P1563, DOI 10.3390/biom5031563; Xu ZG, 2005, CIRCULATION, V111, P1962, DOI 10.1161/01.CIR.0000161831.07637.63; Yamada M, 2010, J EPIDEMIOL, V20, P119, DOI 10.2188/jea.JE20090080; YOSHIDA T, 1995, FEBS LETT, V360, P155, DOI 10.1016/0014-5793(95)00093-O; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; Zong G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5796	104	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188007	10.1371/journal.pone.0188007	http://dx.doi.org/10.1371/journal.pone.0188007			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141038	Green Submitted, gold, Green Published			2022-12-26	WOS:000415260400043
J	Montoya-Tangarife, C; de la Barrera, F; Salazar, A; Inostroza, L				Montoya-Tangarife, Claudia; de la Barrera, Francisco; Salazar, Alejandro; Inostroza, Luis			Monitoring the effects of land cover change on the supply of ecosystem services in an urban region: A study of Santiago-Valparaiso Chile	PLOS ONE			English	Article							LANDSCAPE CHANGE; DRIVING FORCES; LATIN-AMERICA; PROVISION; DEMAND; QUANTIFICATION; CHALLENGES; STRATEGIES; FRAMEWORK; HERITAGE	Mankind's quest for well-being results in continuous pressure to transform landscapes, with said transformation driven by land use changes, urbanization, production activity, and protective measures in addition to climate variability and other environmental drivers. The relationship between anthropogenic landscape changes and the provision of ecosystem services (ES) is a topic of increasing interest in Latin America. In Chile, land cover changes due to increased urbanization and forestry, and expansion of agricultural land, in addition to conservation initiatives as a part of land planning, have been intensive in the last few decades. In this study, the effects of anthropogenic landscape changes on the supply of ES were analyzed for the urban region of Santiago-Valparaiso (Chile) using a method based on expert consultation and land cover change assessment. A pool of experts scored the potential of specific land covers to provide certain ES. The results enabled calculation and mapping of changes in the potential of the landscape to supply ES. The aforementioned changes over a period of 15 years were evaluated. The results indicate a tenuous balance between positive and negative changes to the supply of ES derived from land cover changes. Understanding and reporting how these processes occur in urban regions contributes to the conservation of valuable landscapes through spatial planning tools, especially in areas close to housing developments and sensitive ecosystems.	[Montoya-Tangarife, Claudia; Salazar, Alejandro] Pontificia Univ Catolica Chile, Inst Geog, Santiago, Chile; [de la Barrera, Francisco; Salazar, Alejandro] Pontificia Univ Catolica Chile, Ctr Desarrollo Urbano Sustentable, Santiago, Chile; [de la Barrera, Francisco] Univ Concepcion, Fac Arquitectura Urbanismo & Geog, Concepcion, Chile; [Inostroza, Luis] Ruhr Univ Bochum, Inst Geog, Bochum, Germany; [Inostroza, Luis] Univ Autonoma Chile, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Concepcion; Ruhr University Bochum; Universidad Autonoma de Chile	Montoya-Tangarife, C (corresponding author), Pontificia Univ Catolica Chile, Inst Geog, Santiago, Chile.	cmmontoya@uc.cl	Inostroza, Luis/N-1524-2014	Inostroza, Luis/0000-0002-6303-4529; de la Barrera, Francisco/0000-0002-6854-3197; Montoya Tangarife, Claudia/0000-0001-7085-2805; Salazar Burrows, Alejandro/0000-0003-1558-7898	CONICYT-FONDECYT project [1150422]; CONICYT-FONDAP [15110020]	CONICYT-FONDECYT project(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	This work has been funded by CONICYT-FONDECYT project 1150422 (to FD and AS), and CONICYT-FONDAP 15110020 (to FD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Hulkko T, 2016, ECOL INDIC, V66, P416, DOI 10.1016/j.ecolind.2016.02.013; Altamirano A, 2010, BOSQUE, V31, P53, DOI 10.4067/S0717-92002010000100007; [Anonymous], HYDROLOGICAL SCI J; Antrop M, 2006, LANDSCAPE URBAN PLAN, V75, P187, DOI 10.1016/j.landurbplan.2005.02.014; Armesto J, 2007, MEDITERRANEAN ENV CE, P184; Balvanera P, 2012, ECOSYST SERV, V2, P56, DOI 10.1016/j.ecoser.2012.09.006; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; Burkhard B., 2009, Landscape Online; Burkhard B, 2014, LANDSCAPE ONLINE, V34, P1, DOI [DOI 10.3097/LO.201434, 10.3097/lo.201434, 10.3097/LO.201434]; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; CONAF, 2013, MON CAMB CORR CART A; CONAF, 2001, MON ACT CAT US SUEL; Crespin SJ, 2016, ECOSYST SERV, V17, P5, DOI 10.1016/j.ecoser.2015.10.020; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; De La Barrera F, 2015, INVESTIGACION SERVIC, V50, P3; Delgado LE, 2015, ECOSYST SERV, V14, P24, DOI 10.1016/j.ecoser.2015.03.002; Eitelberg DA, 2016, GLOBAL ENVIRON CHANG, V40, P101, DOI 10.1016/j.gloenvcha.2016.06.014; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Forman R.T.T, 2008, URBAN REGIONS ECOLOG; Frank S, 2014, LANDSCAPE ECOL, V29, P1377, DOI 10.1007/s10980-014-9992-3; Furst C, 2014, LANDSCAPE ECOL, V29, P1435, DOI 10.1007/s10980-014-0052-9; Furst C, 2013, J ENVIRON MANAGE, V127, pS96, DOI 10.1016/j.jenvman.2012.09.020; Han J, 2017, J CLEAN PROD, V141, P1040, DOI 10.1016/j.jclepro.2016.09.177; Heilmayr R, 2016, APPL GEOGR, V75, P71, DOI 10.1016/j.apgeog.2016.07.014; Hendrychova M, 2016, APPL GEOGR, V74, P151, DOI 10.1016/j.apgeog.2016.07.009; Hermann A., 2011, Living Reviews in Landscape Research, V5, P1; Hermanns T, 2015, LAND-BASEL, V4, P778, DOI 10.3390/land4030778; Hidalgo R., 2005, REV INVI, V20, P104, DOI DOI 10.4067/1NVI.V20I54.330; INE, 2014, PROD EST DEM VIT; Inostroza L, 2008, CUAD INVEST URBANIST, V56, P122; Inostroza L, 2017, ECOSYST SERV, V26, P303, DOI 10.1016/j.ecoser.2017.07.004; Inostroza L, 2016, REG ENVIRON CHANGE, V16, P2071, DOI 10.1007/s10113-016-0935-1; Inostroza L, 2013, J ENVIRON MANAGE, V115, P87, DOI 10.1016/j.jenvman.2012.11.007; Konig H. J., 2010, Sustainability, V2, P1991, DOI 10.3390/su2071991; Kopperoinen L, 2014, LANDSCAPE ECOL, V29, P1361, DOI 10.1007/s10980-014-0014-2; Koschke L, 2012, ECOL INDIC, V21, P54, DOI 10.1016/j.ecolind.2011.12.010; Kroll F, 2012, LAND USE POLICY, V29, P521, DOI 10.1016/j.landusepol.2011.07.008; Paula BM, 2012, AGR ECOSYST ENVIRON, V154, P34, DOI 10.1016/j.agee.2011.07.010; Millennium Ecosystem Assessment (MEA), 2005, EC SERV HUM WELL BEI; Miranda A, 2017, REG ENVIRON CHANGE, V17, P285, DOI 10.1007/s10113-016-1010-7; Moran D, 2017, NAT ECOL EVOL, V1, DOI [10.1038/41559-016-0023, 10.1038/s41559-016-0023]; Moreira-Munoz A., 2014, SERIES PLANT VEGETAT, V9, P221; Mukul SA, 2017, ECOSSYTEM S IN PRESS; Nahuelhual L, 2014, ECOL INDIC, V40, P90, DOI 10.1016/j.ecolind.2014.01.005; Nahuelhual L, 2016, ECOL SOC, V21, DOI 10.5751/ES-08676-210324; Nunez D, 2006, ECOL ECON, V58, P606, DOI 10.1016/j.ecolecon.2005.08.010; Plieninger T, 2016, LAND USE POLICY, V57, P204, DOI 10.1016/j.landusepol.2016.04.040; Portman ME, 2013, APPL GEOGR, V45, P185, DOI 10.1016/j.apgeog.2013.09.011; Potschin M, 2013, LANDSCAPE ECOL, V28, P1053, DOI 10.1007/s10980-012-9756-x; Quense A., 2006, THESIS; Ramirez-Gomez SOI, 2015, ECOSYST SERV, V13, P93, DOI 10.1016/j.ecoser.2014.12.009; Ravetz J., 2000, ENVIRON IMPACT ASSES, V20, P31; Reyers B, 2013, FRONT ECOL ENVIRON, V11, P268, DOI 10.1890/120144; Rozas-Vasquez D, 2017, ENVIRON IMPACT ASSES, V62, P135, DOI 10.1016/j.eiar.2016.09.001; Salazar A., 2010, SCRIPTA NOVA, V14, P47; SCHULZ J, 2008, APPL GEOGR, V30, P436, DOI DOI 10.1016/J.APGE0G.2009.12.003; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Shoyama K, 2014, ECOSYST SERV, V8, P25, DOI 10.1016/j.ecoser.2014.02.004; Tengberg A, 2012, ECOSYST SERV, V2, P14, DOI 10.1016/j.ecoser.2012.07.006; Troy A, 2006, ECOL ECON, V60, P435, DOI 10.1016/j.ecolecon.2006.04.007; van Berkel DB, 2014, ECOL INDIC, V37, P163, DOI 10.1016/j.ecolind.2012.06.025; van Zanten BT, 2016, ECOSYST SERV, V17, P87, DOI 10.1016/j.ecoser.2015.11.011; Vigl LE, 2017, SCI TOTAL ENVIRON, V574, P422, DOI [10.1016/jscitotenv.2016.08.209, 10.1016/j.scitotenv.2016.08.209]; Vihervaara P, 2010, ECOL COMPLEX, V7, P410, DOI 10.1016/j.ecocom.2009.12.002; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Weng YC, 2007, LANDSCAPE URBAN PLAN, V81, P341, DOI 10.1016/j.landurbplan.2007.01.009; Wu JG, 2013, LANDSCAPE ECOL, V28, P999, DOI 10.1007/s10980-013-9894-9; Xu G., 2016, ECOL PROCESS, V5, P23, DOI [10.1186/s13717-016-0067-z, DOI 10.1186/s13717-016-0067-z]; Yeh CT, 2009, LANDSCAPE URBAN PLAN, V93, P151, DOI 10.1016/j.landurbplan.2009.07.002; Youlton C, 2010, CIENC INVESTIG AGRAR, V37, P113; Zamorano-Elgueta C, 2015, FOREST ECOL MANAG, V345, P10, DOI 10.1016/j.foreco.2015.02.025; Zewdie W, 2017, APPL GEOGR, V79, P167, DOI 10.1016/j.apgeog.2016.12.019	73	30	30	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188117	10.1371/journal.pone.0188117	http://dx.doi.org/10.1371/journal.pone.0188117			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136016	gold, Green Published, Green Submitted			2022-12-26	WOS:000415121200067
J	Yang, F; Lei, Q; Li, L; He, JC; Zeng, JJ; Luo, CX; Yeung, SCJ; Yang, RX				Yang, Fang; Lei, Qiao; Li, Lu; He, Jian Chang; Zeng, Jiajia; Luo, Chunxiang; Yeung, Sai-Ching Jim; Yang, Runxiang			Delivery of epirubicin via slow infusion as a strategy to mitigate chemotherapy-induced cardiotoxicity	PLOS ONE			English	Article							21-DAY CONTINUOUS-INFUSION; PHASE-II; PROSTATE-CANCER; PREVENTION; SCHEDULE	Background Continuous infusion of doxorubicin has been a strategy to reduce cardiotoxicity. Epirubicin is another anthracycline in common clinical use. However, evidence is lacking regarding whether this strategy can reduce cardiotoxicity of epirubicin without compromising antineoplastic efficacy. Design and methods Healthy rats were randomized into groups: epirubicin (8 mg/kg) delivered intraperitoneally via micro osmotic pumps (MOP), epirubicin (8 mg/kg) by intraperitoneal (IP) bolus injection, and placebo control. Blood samples were collected for analyzing biomarkers of myocardial injury and pharmacokinetics. At chosen times, sub-groups of animals were sacrificed for histopathology. A mouse breast cancer cell line (4T1), stably transfected with luciferase, was orthotopically allografted in female mice, and treated in three groups as described above for the rats. Tumor growth was monitored by measuring tumor size as well as bioluminescence. Results Delivery by IP bolus and by MOP achieved essentially the same area under the curve of epirubicin plasma concentration time profile. Blood biomarkers showed that the degree of myocardial injury in MOP group was lower than that of IP group. Histopathology showed that there was less eosinophilic enhancement, interstitial hemorrhage and necrotizing muscle atrophy in MOP group than IP group. In the orthotopic breast cancer allograft mouse model, the antineoplastic effect of epirubicin by MOP was not different from that by IP as measured by tumor weights or by in vivo bioluminescence. Conclusion Slow delivery of epirubicin by MOP reduced cardiotoxicity without compromising the antineoplastic effect compared to IP bolus delivery. These in vivo data support our previous clinical data that continuous intravenous infusion of epirubicin using micro infusion pumps over 48-96 hours had less cardiotoxicity than intravenous bolus injections. However, whether multiple doses of epirubicin given by MOP result in a lower magnitude of long term cardiomyopathy remains to be further investigated.	[Yang, Fang; Lei, Qiao; Zeng, Jiajia; Luo, Chunxiang; Yang, Runxiang] Kunming Med Univ, Affiliated Hosp 3, Dept Med Oncol 2, Kunming, Yunnan, Peoples R China; [Yang, Fang; Lei, Qiao; Zeng, Jiajia; Luo, Chunxiang; Yang, Runxiang] Yunnan Tumor Hosp, Dept Med Oncol 2, Kunming, Yunnan, Peoples R China; [Li, Lu] Nanchang Univ, Queen Mary Coll Med, Nanchang, Jiangxi, Peoples R China; [He, Jian Chang] Kunming Gen Hosp Chengdu Mil Command, Dept Pharm, Kunming, Yunnan, Peoples R China; [Yeung, Sai-Ching Jim] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA; [Yeung, Sai-Ching Jim] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA	Kunming Medical University; Nanchang University; Kunming General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yang, RX (corresponding author), Kunming Med Univ, Affiliated Hosp 3, Dept Med Oncol 2, Kunming, Yunnan, Peoples R China.; Yang, RX (corresponding author), Yunnan Tumor Hosp, Dept Med Oncol 2, Kunming, Yunnan, Peoples R China.	13888876721@163.com	Yeung, Sai-Ching/AAP-8079-2020; Yeung, Sai-Ching/AAI-6178-2021	Yeung, Sai-Ching/0000-0001-5170-0822	National Natural Science Foundation of China [81360393, 81560432]; Yunnan Health Department Science and Technology Plan Projects [2012WS0037]; Kunming Medical University Graduate Student Innovation Fund [2013 N06]; Yunnan Educational Scientific Research Fund Project [2013 J051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Health Department Science and Technology Plan Projects; Kunming Medical University Graduate Student Innovation Fund; Yunnan Educational Scientific Research Fund Project	This study was supported by the National Natural Science Foundation of China (81360393 and 81560432 to Dr. Runxiang Yang). Dr. Runxiang Yang was also supported by Yunnan Health Department Science and Technology Plan Projects (2012WS0037). Dr. Fang Yang was supported by Kunming Medical University Graduate Student Innovation Fund (2013 N06). Dr. Qiao Lei was supported by Yunnan Educational Scientific Research Fund Project (2013 J051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berruti A, 2005, ANTICANCER RES, V25, P4475; BERTAZZOLI C, 1979, CANCER TREAT REP, V63, P1877; Chao D, 1997, EUR J CANCER, V33, P1230, DOI 10.1016/S0959-8049(97)00097-X; Conway A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1407-6; DEVRIES EGE, 1987, J CLIN ONCOL, V5, P1445, DOI 10.1200/JCO.1987.5.9.1445; DEVRIES EGE, 1989, EUR J CANCER CLIN ON, V25, P1509, DOI 10.1016/0277-5379(89)90114-4; Gammella E, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00025; GREIDANUS J, 1988, EUR J CANCER CLIN ON, V24, P801, DOI 10.1016/0277-5379(88)90321-5; Lao J, 2013, J DRUG DELIV, V2013, DOI 10.1155/2013/456409; LEGHA SS, 1982, ANN INTERN MED, V96, P133, DOI 10.7326/0003-4819-96-2-133; LISO V, 1990, ACTA HAEMATOL-BASEL, V83, P116, DOI 10.1159/000205185; Qin JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9471; Simunek T, 2009, PHARMACOL REP, V61, P154; STROCCHI E, 1985, DRUG EXP CLIN RES, V11, P295; [谭慧 TAN Hui], 2010, [肿瘤防治研究, Cancer Research on Prevention and Treatment], V37, P342; Tan TC, 2015, COMPR PHYSIOL, V5, P1517, DOI 10.1002/cphy.c140059; Vejpongsa P, 2014, J AM COLL CARDIOL, V64, P938, DOI 10.1016/j.jacc.2014.06.1167; Yang RX, 2012, ARZNEIMITTELFORSCH, V62, P677, DOI 10.1055/s-0032-1331166; [杨润祥 Yang Runxiang], 2012, [肿瘤防治研究, Cancer Research on Prevention and Treatment], V39, P573; Yang RunXiang, 2009, Cancer Research on Prevention and Treatment, V36, P872	20	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0188025	10.1371/journal.pone.0188025	http://dx.doi.org/10.1371/journal.pone.0188025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131861	Green Submitted, gold, Green Published			2022-12-26	WOS:000414997800037
J	Chen, YF; Yuan, A; Cho, KH; Lu, YC; Kuo, MYP; Chen, JH; Chang, YC				Chen, Yi-Fang; Yuan, Ang; Cho, Kuan-Hung; Lu, Yi-Chien; Kuo, Mark Yen-Ping; Chen, Jyh-Horng; Chang, Yeun-Chung			Functional evaluation of therapeutic response of HCC827 lung cancer to bevacizumab and erlotinib targeted therapy using dynamic contrast-enhanced and diffusion-weighted MRI	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE INHIBITOR; PHASE-III TRIAL; EGFR MUTATIONS; 1ST-LINE THERAPY; TUMOR RESPONSE; ANTIANGIOGENIC AGENTS; ACQUIRED-RESISTANCE; MET AMPLIFICATION; GEFITINIB	This study aimed to investigate the therapeutic responses of lung cancer mice models with adenocarcinoma HCC827 (gefitinib sensitive) and HCC827R (gefitinib resistant) to the epidermal growth factor receptor-tyrosine kinase inhibitor erlotinib alone and in combination with the anti-angiogenesis agent bevacizumab using dynamic contrast enhanced (DCE) and diffusion-weighted MRI. In the HCC827 model, temporal changes in DCE-MRI derived parameters (K-trans, k(ep), and iAUC(90)) and apparent diffusion coefficient (ADC) were significantly correlated with tumor size. K-trans and iAUC(90) significantly decreased at week 2 in the groups receiving erlotinib alone and in combination with bevacizumab, whereas k(ep) decreased at week 1 and 2 in both treatment groups. In addition, there was a significant difference in iAUC(90) between the treatment groups at week 1. Compared to the control group of HCC827, there was a significant reduction in microvessel density and increased tumor apoptosis in the two treatment group. ADC value increased in the erlotinib alone group at week 1 and week 2, and in the erlotinib combined with bevacizumab group at week 2. Enlarged areas of central tumor necrosis were associated with a higher ADC value. However, progressive enlargement of the tumors but no significant differences in DCE parameters or ADC were noted in the HCC827R model. These results showed that both erlotinib alone and in combination with bevacizumab could effectively inhibit tumor growth in the gefitinib-sensitive lung cancer mice model, and that this was associated with decreased vascular perfusion, increased ADC percentage, decreased microvessel density, and increased tumor apoptosis with a two-week treatment cycle.	[Chen, Yi-Fang; Kuo, Mark Yen-Ping] Natl Taiwan Univ, Grad Inst Clin Dent, Taipei, Taiwan; [Yuan, Ang] Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei, Taiwan; [Cho, Kuan-Hung] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Miaoli, Taiwan; [Lu, Yi-Chien; Chang, Yeun-Chung] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Lu, Yi-Chien; Chang, Yeun-Chung] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chen, Jyh-Horng] Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Chang, YC (corresponding author), Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan.; Chang, YC (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	ycc5566@ntu.edu.tw		YUAN, ANG/0000-0002-5664-1339; CHANG, YEUN-CHUNG/0000-0001-9984-5713	National Taiwan University Hospital [NTUH99-S1274]; National Science Council, Execute Yuan, Taiwan, ROC [N5C98-2627-B-002-016, N5C99-2627-B-002-007, NSC100-2627-B-002-005]	National Taiwan University Hospital(National Taiwan University); National Science Council, Execute Yuan, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by National Taiwan University Hospital (NTUH99-S1274), and National Science Council, Execute Yuan, Taiwan, ROC (N5C98-2627-B-002-016, N5C99-2627-B-002-007, NSC100-2627-B-002-005.	[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bonekamp S, 2012, J MAGN RESON IMAGING, V35, P257, DOI 10.1002/jmri.22786; Braren R, 2011, J HEPATOL, V55, P1034, DOI 10.1016/j.jhep.2011.01.049; Chang YC, 2004, PHYS MED BIOL, V49, P3593, DOI 10.1088/0031-9155/49/16/007; Chang YC, 2012, J MAGN RESON IMAGING, V36, P387, DOI 10.1002/jmri.23660; Cheng JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063140; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Deng J, 2007, CANCER RES, V67, P11867, DOI 10.1158/0008-5472.CAN-07-1961; Dingemans AMC, 2011, ANN ONCOL, V22, P559, DOI 10.1093/annonc/mdq391; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Furugaki K, 2016, INT J CANCER, V138, P1024, DOI 10.1002/ijc.29848; Horn L, 2009, CLIN CANCER RES, V15, P5040, DOI 10.1158/1078-0432.CCR-09-0520; Jahangiri A, 2014, CANCER RES, V74, P3, DOI 10.1158/0008-5472.CAN-13-1742; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kurdziel Karen A, 2011, Imaging Med, V3, P445; Le Bihan D, 1991, Magn Reson Q, V7, P1; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Nahmias C, 2007, J NUCL MED, V48, P744, DOI 10.2967/jnumed.106.038513; Padhani AR, 2010, RADIOLOGY, V256, P348, DOI 10.1148/radiol.10091760; Padhani AR, 2000, BRIT J RADIOL, V73, P1031, DOI 10.1259/bjr.73.874.11271893; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Rogosin S, 2012, CLIN LUNG CANCER, V13, P326, DOI 10.1016/j.cllc.2011.12.001; Rosell R, 2017, LANCET RESP MED, V5, P435, DOI 10.1016/S2213-2600(17)30129-7; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sasaki H, 2006, LUNG CANCER, V54, P103, DOI 10.1016/j.lungcan.2006.06.003; Schnell CR, 2008, CANCER RES, V68, P6598, DOI 10.1158/0008-5472.CAN-08-1044; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Seto T, 2014, LANCET ONCOL, V15, P1236, DOI 10.1016/S1470-2045(14)70381-X; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sinkus R, 2012, EUR J CANCER, V48, P425, DOI 10.1016/j.ejca.2011.11.034; Slatore CG, 2010, AM J RESP CRIT CARE, V182, P1195, DOI 10.1164/rccm.2009-038ST; Subramanian J, 2010, CLIN LUNG CANCER, V11, P311, DOI 10.3816/CLC.2010.n.039; Thatcher N, 2005, P AACAR AN CA, DOI [10.1093/annonc/mda391, DOI 10.1093/ANNONC/MDA391]; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Turkbey B, 2010, RADIOLOGY, V255, P89, DOI 10.1148/radiol.09090475; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; WEIDNER N, 1995, AM J PATHOL, V147, P9	50	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187824	10.1371/journal.pone.0187824	http://dx.doi.org/10.1371/journal.pone.0187824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121075	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900083
J	Hu, XJ; Lau, CC				Hu, Xu-Jun; Lau, Chi-Chuen			Central conduction time in auditory brainstem response and ear advantage in dichotic listening across menstrual cycle	PLOS ONE			English	Article							COGNITIVE CONTROL; LANGUAGE LATERALIZATION; ASYMMETRY; HORMONES; REPLACEMENT; PHASE	The ovarian hormones fluctuate during the menstrual cycle in women. Such fluctuation of sex hormones, in particular estrogen, is believed to affect the central conduction time in auditory function as well as the language lateralization in cognitive function. However, findings are inconsistent. The underlying mechanisms are also unclear. This paper examined if there was any relation between the central conduction time and the language lateralization at different times during the menstrual cycle. Twenty young women with normal menstrual cycle were tested four times (5 to 7 days apart) across the menstrual cycle. The test battery included the electrophysiological measurement of auditory evoked response in brainstem and the speech performance in dichotic listening with monosyllables as stimulus pairs. The dichotic listening task was conducted under the non-forced, forced-right and forced-left attention. The central conduction time was defined by the time elapsed between two auditory elicited responses along the auditory pathway. The language lateralization in dichotic listening was expressed in ear advantage, which was the right-ear score minus the left-ear score. The results showed that the effects of test time were significant on both the central conduction time and the ear advantage under the forced-left attention. Overall, the interaural difference in the central conduction time correlates with the ear advantage (non-forced attention) at the beginning of the menstrual cycle. The change in central conduction time between two test times correlates significantly with the change in ear advantage under the non-forced and forced-left attention. Conclusively, the central conduction time depends on the time during the menstrual cycle, which in turn may affect the performance in dichotic listening.	[Hu, Xu-Jun] Zhejiang Chinese Med Univ, Coll Med Technol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University	Hu, XJ (corresponding author), Zhejiang Chinese Med Univ, Coll Med Technol, Hangzhou, Zhejiang, Peoples R China.	huxujun10@hotmail.com						Alexander GM, 2002, NEUROPSYCHOLOGIA, V40, P1293, DOI 10.1016/S0028-3932(01)00220-2; Avizheh S, 2015, AUD VEST RES, V24, P217; Batta Meenal, 2017, Int J Appl Basic Med Res, V7, P44, DOI 10.4103/2229-516X.198522; Bless JJ, 2015, LATERALITY, V20, P434, DOI 10.1080/1357650X.2014.997245; Bless JJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00042; Can H, 2012, J NEUROL SCI-TURK, V29, P676; Castelfranco AM, 2016, BRAIN RES, V1641, P11, DOI 10.1016/j.brainres.2016.02.015; COLEMAN JR, 1994, HEARING RES, V80, P209, DOI 10.1016/0378-5955(94)90112-0; Compton RJ, 2004, NEUROPSYCHOLOGIA, V42, P1496, DOI 10.1016/j.neuropsychologia.2004.03.006; Cowell PE, 2011, BRAIN COGNITION, V76, P256, DOI 10.1016/j.bandc.2011.03.010; ELKINDHIRSCH KE, 1992, HEARING RES, V64, P93, DOI 10.1016/0378-5955(92)90171-I; ELKINDHIRSCH KE, 1992, HEARING RES, V60, P143, DOI 10.1016/0378-5955(92)90016-G; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; Hjelmervik H, 2012, PSYCHONEUROENDOCRINO, V37, P1866, DOI 10.1016/j.psyneuen.2012.03.021; Hodgetts S, 2017, NEUROPSYCHOLOGY, V31, P319, DOI 10.1037/neu0000338; Hodgetts S, 2015, HORM BEHAV, V74, P194, DOI 10.1016/j.yhbeh.2015.06.019; Hu XJ, 2016, J INT ADV OTOL; Hu XJ, 2016, ACTA OTOLARYNGOLOGIC; Hugdahl K, 2003, ASYMMETRICAL BRAIN, P441; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P11, DOI 10.1111/j.1467-9450.2008.00676.x; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; Knudtson J, 2016, FEMALE REPROD ENDOCR, V8; Mann N, 2012, J CLIN DIAGN RES, V6, P1640, DOI 10.7860/JCDR/2012/4896.2621; Mead LA, 1996, NEUROPSYCHOLOGY, V10, P578; Natarajan N, 2014, INT J MED SCI PUBLIC, V3, P689; Resende LAD, 2000, ARQ NEURO-PSIQUIAT, V58, P418; Sanders G, 1998, NEUROPSYCHOLOGIA, V36, P869, DOI 10.1016/S0028-3932(98)00022-0; Serra A, 2003, ANN OTO RHINOL LARYN, V112, P549, DOI 10.1177/000348940311200612; Upadhayay N, 2014, INDIAN J OTOLARYNGOL, V66, pS133, DOI 10.1007/s12070-011-0378-4; van Wageningen H, 2010, CEREB CORTEX, V20, P798, DOI 10.1093/cercor/bhp145; Veale JF, 2014, LATERALITY, V19, P164, DOI 10.1080/1357650X.2013.783045; Wadnerkar MB, 2008, LATERALITY, V13, P297, DOI 10.1080/13576500701821106; Wideman L, 2013, SPORTS HEALTH, V5, P143, DOI 10.1177/1941738112469930; Wilson R H, 1996, J Am Acad Audiol, V7, P1	34	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187672	10.1371/journal.pone.0187672	http://dx.doi.org/10.1371/journal.pone.0187672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121103	gold, Green Submitted, Green Published			2022-12-26	WOS:000414769900064
J	Kamaliddin, C; Salnot, V; Leduc, M; Ezinmegnon, S; Broussard, C; Fievet, N; Deloron, P; Guillonneau, F; Bertin, GI				Kamaliddin, Claire; Salnot, Virginie; Leduc, Marjorie; Ezinmegnon, Sem; Broussard, Cedric; Fievet, Nadine; Deloron, Philippe; Guillonneau, Francois; Bertin, Gwladys I.			PFI1785w: A highly conserved protein associated with pregnancy associated malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM PARASITES; PLACENTAL MALARIA; VAR2CSA; ERYTHROCYTE; VACCINE; ANTIBODIES; BINDING	Pregnancy-associated malaria (PAM) is one of the severe forms of Plasmodium falciparum infection. The main antigen VAR2CSA is the target of vaccine development. However, the large size of VAR2CSA protein and its high degree of variability limit to the efficiency of the vaccination. Using quantitative mass spectrometry method, we detected and quantified proteotypic peptides from 5 predicted PAM associated proteins. Our results confirmed that PFI1785w is over-expressed in PAM samples. Then, we investigated PFI1785w variability among a set of parasite samples from various endemic areas. PFI1785w appear to be more conserved than VAR2CSA. PFB0115w, another PAM associated protein, seems also associated with the pathology. Further vaccination strategies could integrate other proteins in addition to the major VAR2CSA antigen to improve immune response to vaccination.	[Kamaliddin, Claire; Fievet, Nadine; Deloron, Philippe; Bertin, Gwladys I.] Univ Paris 05, MERIT, IRD, Sorbonne Paris Cite, Paris, France; [Kamaliddin, Claire; Fievet, Nadine; Deloron, Philippe; Bertin, Gwladys I.] DHU Risques & Grossesse, Lab Excellence GR Ex, Paris, France; [Salnot, Virginie; Leduc, Marjorie; Broussard, Cedric; Guillonneau, Francois] Univ Paris 05, Prote Facil 3P5, COMUE Sorbonne Paris Cite, Paris, France; [Ezinmegnon, Sem; Fievet, Nadine] Univ Abomey Calavi, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi	Bertin, GI (corresponding author), Univ Paris 05, MERIT, IRD, Sorbonne Paris Cite, Paris, France.; Bertin, GI (corresponding author), DHU Risques & Grossesse, Lab Excellence GR Ex, Paris, France.	gwladys.bertin@ird.fr	Kamaliddin, Claire/ABD-1836-2021	Kamaliddin, Claire/0000-0001-8198-6235; , Marjorie Leduc/0000-0002-4049-3976; Bertin, Gwladys/0000-0002-2218-9591; Guillonneau, Francois/0000-0003-1484-4696; Broussard, Cedric/0000-0001-9508-2341; Fievet, Nadine/0000-0003-2272-9794; Salnot, Virginie/0000-0002-7530-4493	Institut de Recherche pour le Developpement and Laboratoire d'Excellence GR-Ex, Paris, France [ANR-11-LABX-0051]; program Investissements d'avenir of the French National Research Agency [ANR-11-IDEX-0005-02]; ANR [13-JSV1-0004-01]	Institut de Recherche pour le Developpement and Laboratoire d'Excellence GR-Ex, Paris, France; program Investissements d'avenir of the French National Research Agency(French National Research Agency (ANR)); ANR(French National Research Agency (ANR))	The work was supported by Institut de Recherche pour le Developpement and Laboratoire d'Excellence GR-Ex, Paris, France, reference ANR-11-LABX-0051, that is funded by the program Investissements d'avenir of the French National Research Agency, reference ANR-11-IDEX-0005-02 to GIB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the ANR-funded RECIPAL project (13-JSV1-0004-01, coordination Valerie Briand) for the placenta.	Andrews KT, 2002, PARASITOL RES, V88, P715, DOI 10.1007/s00436-002-0624-5; Bertin GI, 2013, J INFECT DIS, V208, P1987, DOI 10.1093/infdis/jit377; Bigey P, 2011, J INFECT DIS, V204, P1125, DOI 10.1093/infdis/jir499; Bordbar B, 2014, INFECT GENET EVOL, V25, P81, DOI 10.1016/j.meegid.2014.04.010; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Francis SE, 2007, INFECT IMMUN, V75, P4838, DOI 10.1128/IAI.00635-07; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2007, MOL BIOCHEM PARASIT, V155, P57, DOI 10.1016/j.molbiopara.2007.05.010; Fried M, 2015, VACCINE, V33, P7483, DOI 10.1016/j.vaccine.2015.10.011; Gamain B, 2007, INT J PARASITOL, V37, P273, DOI 10.1016/j.ijpara.2006.11.011; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Goel S, 2015, NAT MED, V21, P314, DOI 10.1038/nm.3812; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Mayer C, 2012, J BIOL CHEM, V287, P7182, DOI 10.1074/jbc.M111.330779; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Ndam NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001855; Niang M, 2014, CELL HOST MICROBE, V16, P81, DOI 10.1016/j.chom.2014.06.004; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Pereira MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005831; Pitoiset F, 2015, EXPERT REV VACCINES, V14, P913, DOI 10.1586/14760584.2015.1046440; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tarr SJ, 2014, MOL BIOCHEM PARASIT, V196, P29, DOI 10.1016/j.molbiopara.2014.07.011; Thrane S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143071; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Warncke JD, 2016, MICROBIOL MOL BIOL R, V80, P905, DOI 10.1128/MMBR.00014-16	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187817	10.1371/journal.pone.0187817	http://dx.doi.org/10.1371/journal.pone.0187817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121643	Green Submitted, gold, Green Published			2022-12-26	WOS:000414769900081
J	Muir, E; Raze, M; Ellis, C; Burnside, E; Love, F; Heller, S; Elliot, M; Daniell, E; Dasgupta, D; Alves, N; Day, P; Fawcett, J; Keynes, R				Muir, Elizabeth; Raze, Mansoor; Ellis, Clare; Burnside, Emily; Love, Fiona; Heller, Simon; Elliot, Matthew; Daniell, Esther; Dasgupta, Debayan; Alves, Nuno; Day, Priscilla; Fawcett, James; Keynes, Roger			Trafficking and processing of bacterial proteins by mammalian cells: Insights from chondroitinase ABC	PLOS ONE			English	Article							SPINAL-CORD-INJURY; SULFATE PROTEOGLYCANS; FLUORESCENT PROTEIN; FUNCTIONAL RECOVERY; QUALITY-CONTROL; EXPRESSION; SECRETION; PATHWAY; BRAIN; GENE	Background There is very little reported in the literature about the relationship between modifications of bacterial proteins and their secretion by mammalian cells that synthesize them. We previously reported that the secretion of the bacterial enzyme Chondroitinase ABC by mammalian cells requires the strategic removal of at least three N-glycosylation sites. The aim of this study was to determine if it is possible to enhance the efficacy of the enzyme as a treatment for spinal cord injury by increasing the quantity of enzyme secreted or by altering its cellular location. Methodology/Principal findings To determine if the efficiency of enzyme secretion could be further increased, cells were transfected with constructs encoding the gene for chondroitinase ABC modified for expression by mammalian cells; these contained additional modifications of strategic N-glycosylation sites or alternative signal sequences to direct secretion of the enzyme from the cells. We show that while removal of certain specific N-glycosylation sites enhances enzyme secretion, N-glycosylation of at least two other sites, N-856 and N-773, is essential for both production and secretion of active enzyme. Furthermore, we find that the signal sequence directing secretion also influences the quantity of enzyme secreted, and that this varies widely amongst the cell types tested. Last, we find that replacing the 3' UTR on the cDNA encoding Chondroitinase ABC with that of beta-actin is sufficient to target the enzyme to the neuronal growth cone when transfected into neurons. This also enhances neurite outgrowth on an inhibitory substrate. Conclusion/Significance Some intracellular trafficking pathways are adversely affected by cryptic signals present in the bacterial gene sequence, whilst unexpectedly others are required for efficient secretion of the enzyme. Furthermore, targeting chondroitinase to the neuronal growth cone promotes its ability to increase neurite outgrowth on an inhibitory substrate. These findings are timely in view of the renewed prospects for gene therapy, and of direct relevance to strategies aimed at expressing foreign proteins in mammalian cells, in particular bacterial proteins.	[Muir, Elizabeth; Raze, Mansoor; Ellis, Clare; Burnside, Emily; Love, Fiona; Heller, Simon; Elliot, Matthew; Daniell, Esther; Dasgupta, Debayan; Alves, Nuno; Day, Priscilla; Keynes, Roger] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Alves, Nuno; Fawcett, James] Univ Cambridge, John Van Geest Ctr Brain Repair, Forvie Site, Cambridge, England	University of Cambridge; University of Cambridge	Muir, E (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	emml@cam.ac.uk		Fawcett, James/0000-0002-7990-4568; Dasgupta, Debayan/0000-0002-1064-0541; Elliot, Matthew/0000-0003-4111-9414; Love, Fiona M./0000-0002-7805-5234; Heller, Simon/0000-0001-7335-9266; Muir, Elizabeth/0000-0002-8821-5051	Wellcome Trust [RG61825]; Isaac Newton Trust [RG46400]	Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust	This study was supported by Wellcome Trust, https://wellcome.ac.uk, RG61825; and Isaac Newton Trust, http://www.newtontrust.cam.ac.uk/, RG46400.	Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Alves JN, 2014, J NEUROSCI METH, V227, P107, DOI 10.1016/j.jneumeth.2014.02.010; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BUNKER CA, 1988, GENE, V67, P279, DOI 10.1016/0378-1119(88)90404-0; Carter LM, 2008, J NEUROSCI, V28, P14107, DOI 10.1523/JNEUROSCI.2217-08.2008; Chen XR, 2014, BRAIN RES, V1543, P324, DOI 10.1016/j.brainres.2013.12.002; Clement JM, 1995, J BIOTECHNOL, V43, P169, DOI 10.1016/0168-1656(95)00127-1; Coulson-Thomas YA, 2008, J NEUROSCI METH, V171, P19, DOI 10.1016/j.jneumeth.2008.01.030; Curinga GM, 2007, J NEUROCHEM, V102, P275, DOI 10.1111/j.1471-4159.2007.04530.x; Dalton AC, 2014, PROTEIN SCI, V23, P517, DOI 10.1002/pro.2439; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Fontes CMGA, 1999, J BIOTECHNOL, V72, P95, DOI 10.1016/S0168-1656(99)00098-X; Garcia-Alias G, 2008, EXP NEUROL, V210, P331, DOI 10.1016/j.expneurol.2007.11.002; Gardner RT, 2013, J NEUROSCI, V33, P7175, DOI 10.1523/JNEUROSCI.5866-12.2013; Gartner T, 2008, VACCINE, V26, P1458, DOI 10.1016/j.vaccine.2007.12.056; Gherardini L, 2015, CEREB CORTEX, V25, P202, DOI 10.1093/cercor/bht217; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Hansen JK, 2010, J IMMUNOTHER, V33, P297, DOI 10.1097/CJI.0b013e3181cd1164; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; JOUANNEAU J, 1985, EUR J BIOCHEM, V146, P173, DOI 10.1111/j.1432-1033.1985.tb08635.x; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kanno H, 2014, J NEUROSCI, V34, P1838, DOI 10.1523/JNEUROSCI.2661-13.2014; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; Lee HJ, 2012, J NEUROTRAUM, V29, P1850, DOI 10.1089/neu.2011.2290; Mondello SE, 2015, EXP NEUROL, V267, P64, DOI 10.1016/j.expneurol.2015.02.028; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Muir EM, 2010, J BIOTECHNOL, V145, P103, DOI 10.1016/j.jbiotec.2009.11.002; Rutkowski DT, 2003, J BIOL CHEM, V278, P30365, DOI 10.1074/jbc.M302117200; Sagt CMJ, 2000, APPL ENVIRON MICROB, V66, P4940, DOI 10.1128/AEM.66.11.4940-4944.2000; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SMITHTHOMAS LC, 1994, J CELL SCI, V107, P1687; Tabakow P, 2014, CELL TRANSPLANT, V23, P1631, DOI 10.3727/096368914X685131; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Wilby MJ, 1999, J NEUROSCI, V19, P2301; Wilson RL, 2000, J IMMUNOL METHODS, V234, P137, DOI 10.1016/S0022-1759(99)00221-5; Zhang JX, 1997, BBA-MOL CELL RES, V1357, P215, DOI 10.1016/S0167-4889(97)00030-X; Zhao RR, 2011, J NEUROSCI METH, V201, P228, DOI 10.1016/j.jneumeth.2011.08.003	43	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0186759	10.1371/journal.pone.0186759	http://dx.doi.org/10.1371/journal.pone.0186759			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121057	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900012
J	Frohlich, J; Kubickova, S; Musilova, P; Cernohorska, H; Muskova, H; Vodicka, R; Rubes, J				Frohlich, Jan; Kubickova, Svatava; Musilova, Petra; Cernohorska, Halina; Muskova, Helena; Vodicka, Roman; Rubes, Jiri			Karyotype relationships among selected deer species and cattle revealed by bovine FISH probes	PLOS ONE			English	Article							MOLECULAR CYTOGENETIC ANALYSIS; MUNTJAC MUNTIACUS-REEVESI; IN-SITU HYBRIDIZATION; INDIAN MUNTJAC; CHROMOSOMAL EVOLUTION; X-CHROMOSOME; ANCESTRAL KARYOTYPE; TANDEM FUSIONS; BOVIDAE; CETARTIODACTYLA	The Cervidae family comprises more than fifty species divided into three subfamilies: Capreolinae, Cervinae and Hydropotinae. A characteristic attribute for the species included in this family is the great karyotype diversity, with the chromosomal numbers ranging from 2n = 6 observed in female Muntiacus muntjak vaginalis to 2n = 70 found in Mazama gouazoubira as a result of numerous Robertsonian and tandem fusions. This work reports chromosomal homologies between cattle (Bos taurus, 2n = 60) and nine cervid species using a combination of whole chromosome and region-specific paints and BAC clones derived from cattle. We show that despite the great diversity of karyotypes in the studied species, the number of conserved chromosomal segments detected by 29 cattle whole chromosome painting probes was 35 for all Cervidae samples. The detailed analysis of the X chromosomes revealed two different morphological types within Cervidae. The first one, present in the Capreolinae is a sub/metacentric X with the structure more similar to the bovine X. The second type found in Cervini and Muntiacini is an acrocentric X which shows rearrangements in the proximal part that have not yet been identified within Ruminantia. Moreover, we characterised four repetitive sequences organized in heterochromatic blocks on sex chromosomes of the reindeer (Rangifer tarandus). We show that these repeats gave no hybridization signals to the chromosomes of the closely related moose (Alces alces) and are therefore specific to the reindeer.	[Frohlich, Jan; Kubickova, Svatava; Musilova, Petra; Cernohorska, Halina; Muskova, Helena; Rubes, Jiri] Vet Res Inst, Cent European Inst Technol, Brno, Czech Republic; [Vodicka, Roman] Zoo Prague, Prague, Czech Republic	Czech Veterinary Research Institute	Frohlich, J (corresponding author), Vet Res Inst, Cent European Inst Technol, Brno, Czech Republic.	frohlich@vri.cz	Černohorská, Halina/GZM-9624-2022; Frohlich, Jan/AAI-4184-2021; Musilova, Petra/B-7380-2011; Kubickova, Svatava/GZL-5927-2022	Frohlich, Jan/0000-0002-8312-0483; Kubickova, Svatava/0000-0002-1006-9453	Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC [LQ1601]; Ministry of Agriculture of the Czech Republic [RO 0516]	Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC; Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601) and by the Ministry of Agriculture of the Czech Republic (RO 0516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601) and by the Ministry of Agriculture of the Czech Republic (RO 0516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors wish to thank Mr. Paul Veater (Bristol, UK) for proofreading the translated manuscript.	Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bonnet A, 2001, CHROMOSOME RES, V9, P673, DOI 10.1023/A:1012908508488; Bonnet-Garnier A, 2003, CHROMOSOME RES, V11, P649, DOI 10.1023/A:1025981508867; Burkin DJ, 1997, GENOMICS, V46, P143, DOI 10.1006/geno.1997.4998; Cernohorska H, 2012, CYTOGENET GENOME RES, V136, P188, DOI 10.1159/000336248; Cernohorska H, 2011, CYTOGENET GENOME RES, V132, P255, DOI 10.1159/000322483; Cernohorska H, 2015, CHROMOSOMA, V124, P235, DOI 10.1007/s00412-014-0494-5; Cernohorska H, 2013, CHROMOSOME RES, V21, P447, DOI 10.1007/s10577-013-9361-0; Chi J, 2005, CYTOGENET GENOME RES, V108, P310, DOI 10.1159/000081520; Chi JX, 2005, CHROMOSOMA, V114, P167, DOI 10.1007/s00412-005-0004-x; De Lorenzi L, 2015, CHROMOSOME RES, V23, P225, DOI 10.1007/s10577-014-9462-4; Dementyeva PV, 2010, CYTOGENET GENOME RES, V128, P229, DOI 10.1159/000298878; Dobigny G, 2005, CHROMOSOME RES, V13, P651, DOI 10.1007/s10577-005-1002-9; Duarte JMB, 2003, MAMMALIA, V67, P403, DOI 10.1515/mamm.2003.67.3.403; FONTANA F, 1990, BIOSYSTEMS, V24, P157, DOI 10.1016/0303-2647(90)90008-O; Frohlich J, 2016, J MAMM EVOL; GALLAGHER DS, 1992, J HERED, V83, P287, DOI 10.1093/oxfordjournals.jhered.a111215; Gallagher DS, 1999, CHROMOSOME RES, V7, P481, DOI 10.1023/A:1009254014526; Huang L, 2006, GENETICA, V127, P25, DOI 10.1007/s10709-005-2449-5; Huang L, 2006, GENOMICS, V87, P608, DOI 10.1016/j.ygeno.2005.12.008; Iannuzzi L, 2009, CYTOGENET GENOME RES, V126, P49, DOI 10.1159/000245906; Kubickova S, 2002, CHROMOSOME RES, V10, P571, DOI 10.1023/A:1020914702767; Kulemzina AI, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-68; Kulemzina AI, 2011, CHROMOSOME RES, V19, P531, DOI 10.1007/s10577-011-9201-z; Kulemzina AI, 2009, CHROMOSOME RES, V17, P419, DOI 10.1007/s10577-009-9032-3; Lee C, 1998, CHROMOSOMA, V107, P61, DOI 10.1007/s004120050281; Pauciullo A, 2006, VETMED, V51; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Piumi F, 1998, CYTOGENET CELL GENET, V81, P36, DOI 10.1159/000015004; Prakash B, 1996, CHROMOSOME RES, V4, P214, DOI 10.1007/BF02254962; Proskuryakova AA, 2017, GENES-BASEL, V8, DOI 10.3390/genes8090216; Robinson TJ, 1997, CYTOGENET CELL GENET, V77, P218, DOI 10.1159/000134580; Robinson TJ, 1998, CYTOGENET CELL GENET, V80, P179, DOI 10.1159/000014976; Ropiquet A, 2010, CHROMOSOME RES, V18, P277, DOI 10.1007/s10577-010-9115-1; Rubes J, 2012, CYTOGENET GENOME RES, V137, P194, DOI 10.1159/000338932; Rubes J, 2008, CHROMOSOME RES, V16, P935, DOI 10.1007/s10577-008-1250-6; RUBINI M, 1990, CYTOBIOS, V64, P155; SEABRIGH.M, 1971, LANCET, V2, P971; Slate J, 2002, GENETICS, V160, P1587; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Wilson D. E., 2005, MAMMAL SPECIES WORLD; WURSTER DH, 1970, SCIENCE, V168, P1364, DOI 10.1126/science.168.3937.1364; Yang F, 1997, CHROMOSOMA, V106, P37, DOI 10.1007/s004120050222; Yang F, 1997, CHROMOSOME RES, V5, P109, DOI 10.1023/A:1018466107822; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691	46	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187559	10.1371/journal.pone.0187559	http://dx.doi.org/10.1371/journal.pone.0187559			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112970	Green Published, Green Submitted, gold			2022-12-26	WOS:000414572100021
J	Davis, TL; Hoi, CSL; Rebay, I				Davis, Trevor L.; Hoi, Charlene S. L.; Rebay, Ilaria			Mutations that impair Eyes absent tyrosine phosphatase activity in vitro reduce robustness of retinal determination gene network output in Drosophila	PLOS ONE			English	Article							SINE-OCULIS; CONTAINING PROTEIN; VISUAL-SYSTEM; TRANSCRIPTION; PATHWAY; DEPHOSPHORYLATION; IDENTIFICATION; SPECIFICATION; MELANOGASTER; EXPRESSION	A limited collection of signaling networks and transcriptional effectors directs the full spectrum of cellular behaviors that comprise development. One mechanism to diversify regulatory potential is to combine multiple biochemical activities into the same protein. Exemplifying this principle of modularity, Eyes absent (Eya), originally identified as a transcriptional co-activator within the retinal determination gene network (RDGN), also harbors tyrosine and threonine phosphatase activities. Although mounting evidence argues for the importance of Eya's phosphatase activities to mammalian biology, genetic rescue experiments in Drosophila have shown that the tyrosine phosphatase function is dispensable for normal development. In this study, we repeated these rescue experiments in genetically sensitized backgrounds in which the dose of one or more RDGN factor was reduced. Heterozygosity for sine oculis or dachshund, both core RDGN members, compromised the ability of phosphatase-dead eya, but not of the control wild type eya transgene, to rescue the retinal defects and reduced viability associated with eya loss. We speculate that Eya's tyrosine phosphatase activity, although non-essential, confers robustness to RDGN output.	[Davis, Trevor L.; Hoi, Charlene S. L.; Rebay, Ilaria] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Davis, Trevor L.; Rebay, Ilaria] Univ Chicago, Comm Dev Regenerat & Stem Cell Biol, Chicago, IL 60637 USA; [Hoi, Charlene S. L.; Rebay, Ilaria] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Rebay, I (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.; Rebay, I (corresponding author), Univ Chicago, Comm Dev Regenerat & Stem Cell Biol, Chicago, IL 60637 USA.; Rebay, I (corresponding author), Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA.	irebay@uchicago.edu			National Institute of Health [R01 EY12549, T32 GM07197, T32 HD055164]; Genomics Core Facility through a University of Chicago Cancer Center Support Grant from the National Institute of Health [P30 CA014599]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055164] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012549] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genomics Core Facility through a University of Chicago Cancer Center Support Grant from the National Institute of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by R01 EY12549 from the National Institute of Health to I. R. and by the Genomics Core Facility through a University of Chicago Cancer Center Support Grant from the National Institute of Health P30 CA014599. C.H. was supported by T32 GM07197 from the National Institute of Health. T.L.D. was supported by T32 HD055164 from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessa J, 2002, GENE DEV, V16, P2415, DOI 10.1101/gad.1009002; Bonini NM, 1998, DEV BIOL, V196, P42, DOI 10.1006/dbio.1997.8845; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Borsani G, 1999, HUM MOL GENET, V8, P11, DOI 10.1093/hmg/8.1.11; Bui QT, 2000, GENETICS, V155, P709; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Davis TL, 2017, DEV BIOL, V421, P93, DOI 10.1016/j.ydbio.2016.12.005; EI-Hashash AHK, 2011, DEVELOPMENT, V138, P1395; Hayashi T, 2008, DEVELOPMENT, V135, P2787, DOI 10.1242/dev.006189; Housden BE, 2014, TRENDS BIOCHEM SCI, V39, P457, DOI 10.1016/j.tibs.2014.07.008; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Jin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058818; Krishnan N, 2009, J BIOL CHEM, V284, P16066, DOI 10.1074/jbc.C900032200; Lee MJ, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a005918; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Liu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042725; MARDON G, 1994, DEVELOPMENT, V120, P3473; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pappu KS, 2005, DEVELOPMENT, V132, P2895, DOI 10.1242/dev.01869; Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Rebay I, 2000, GENETICS, V154, P695; Rebay I, 2016, MOL CELL BIOL, V36, P668, DOI 10.1128/MCB.00976-15; Rhee DY, 2014, CELL REP, V8, P2031, DOI 10.1016/j.celrep.2014.08.038; SERIKAKU MA, 1994, GENETICS, V138, P1137; Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vivekanand P, 2006, ANNU REV GENET, V40, P139, DOI 10.1146/annurev.genet.40.110405.090555; Xiong WJ, 2009, DEV CELL, V16, P271, DOI 10.1016/j.devcel.2008.12.005; Xu PX, 1997, P NATL ACAD SCI USA, V94, P11974, DOI 10.1073/pnas.94.22.11974; Xu PX, 1997, DEVELOPMENT, V124, P219; Yan HJ, 2003, DEV BIOL, V263, P323, DOI 10.1016/j.ydbio.2003.08.003; Yuan B, 2014, J CLIN INVEST, V124, P3378, DOI 10.1172/JCI74085; Zhang TY, 2006, DEVELOPMENT, V133, P4881, DOI 10.1242/dev.02669; Zimmerman JE, 1997, GENOME RES, V7, P128, DOI 10.1101/gr.7.2.128	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187546	10.1371/journal.pone.0187546	http://dx.doi.org/10.1371/journal.pone.0187546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108015	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600040
J	Goh, CW; Lee, IC; Sundaram, JR; George, SE; Yusoff, P; Brush, MH; Sze, NSK; Shenolikar, S				Goh, Catherine Wenhui; Lee, Irene Chengjie; Sundaram, Jeyapriya Rajameenakshi; George, Simi Elizabeth; Yusoff, Permeen; Brush, Matthew Hayden; Sze, Newman Siu Kwan; Shenolikar, Shirish			Chronic oxidative stress promotes GADD34-mediated phosphorylation of the TAR DNA-binding protein TDP-43, a modification linked to neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; INITIATION-FACTOR 2; ENDOPLASMIC-RETICULUM; GROWTH ARREST; EIF2-ALPHA DEPHOSPHORYLATION; MAMMALIAN-CELLS; GADD34; RNA; TRANSLATION	Oxidative and endoplasmic reticulum (ER) stresses are hallmarks of the pathophysiology of ALS and other neurodegenerative diseases. In these stresses, different kinases phosphorylate eukaryotic initiation factor eIF2 alpha, enabling the translation of stress response genes; among these is GADD34, the protein product of which recruits the alpha-isoform of protein phosphatase 1 catalytic subunit (PP1 alpha) and eIF2 alpha to assemble a phosphatase complex catalyzing eIF2 alpha dephosphorylation and resumption of protein synthesis. Aberrations in this pathway underlie the aforementioned disorders. Previous observations indicating that GADD34 is induced by arsenite, a thiol-directed oxidative stressor, in the absence of eIF2 alpha phosphorylation suggest other roles for GADD34. Here, we report that arsenite-induced oxidative stress differs from thapsigargin-or tunicamycin-induced ER stress in promoting GADD34 transcription and the preferential translation of itsmRNAin the absence of eIF2 alpha phosphorylation. Arsenite also stabilized GADD34 protein, slowing its degradation. In response to oxidative stress, but not ER stress, GADD34 recruited TDP-43, and enhanced cytoplasmic distribution and cysteine modifications of TDP-43 promoted its binding to GADD34. Arsenite also recruited a TDP-43 kinase, casein kinase-1 epsilon (CK1 epsilon), to GADD34. Concomitant with TDP-43 aggregation and proteolysis after prolonged arsenite exposure, GADD34-boundCK1 epsilon catalyzed TDP-43 phosphorylations at serines 409/410, which were diminished or absent in GADD34(-/-) cells. Our findings highlight that the phosphatase regulator, GADD34, also functions as a kinase scaffold in response to chronic oxidative stress and recruits CK1 epsilon and oxidized TDP-43 to facilitate its phosphorylation, as seen in TDP-43 proteinopathies.	[Goh, Catherine Wenhui; Lee, Irene Chengjie; Sundaram, Jeyapriya Rajameenakshi; Yusoff, Permeen; Shenolikar, Shirish] Duke NUS Med Sch, Signature Res Program Neurosci & Behav Disorders, Singapore 169857, Singapore; [Lee, Irene Chengjie; Sundaram, Jeyapriya Rajameenakshi; George, Simi Elizabeth; Yusoff, Permeen; Shenolikar, Shirish] Duke NUS Med Sch, Signature Res Program Cardiovasc & Metab Disorder, Singapore 169857, Singapore; [Brush, Matthew Hayden] Oregon Hlth & Sci Univ, Ontol Dev Grp, Portland, OR 97239 USA; [Sze, Newman Siu Kwan] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Shenolikar, Shirish] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Shenolikar, Shirish] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	National University of Singapore; National University of Singapore; Oregon Health & Science University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Duke University; Duke University	Shenolikar, S (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.; Shenolikar, S (corresponding author), Duke NUS Med Sch Singapore, Signature Res Program Neurosci & Behav Disorders, 8 Coll Rd, Singapore 169857, Singapore.; Shenolikar, S (corresponding author), Duke NUS Med Sch Singapore, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore.	Shirish.Shenolikar@Duke-NUS.edu.sg	LEE, IRENE CHENG JIE/AAV-2915-2020; Sze, Siu Kwan/AAO-3342-2020	LEE, IRENE CHENG JIE/0000-0001-6862-6438; Sze, Siu Kwan/0000-0002-5652-1687	Duke-NUS graduate fellowship; Duke-NUS start-up funds by the Singapore Ministry of Health; A-Star/BMRC Translational and Clinical Research Partnership Award [ACP0113683]; National Medical Research Council Translational Clinical Research Flagship Award [NMRC/TCR/013-NNI/2014]	Duke-NUS graduate fellowship; Duke-NUS start-up funds by the Singapore Ministry of Health; A-Star/BMRC Translational and Clinical Research Partnership Award; National Medical Research Council Translational Clinical Research Flagship Award	This work was supported by a Duke-NUS graduate fellowship (to C. W. G.) and Duke-NUS start-up funds provided by the Singapore Ministry of Health (to S. S.). Additional support was provided by A-Star/BMRC Translational and Clinical Research Partnership Award ACP0113683 and National Medical Research Council Translational Clinical Research Flagship Award NMRC/TCR/013-NNI/2014 (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Becker LA, 2017, NATURE, V544, P367, DOI 10.1038/nature22038; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brush MH, 2008, MOL CELL BIOL, V28, P6989, DOI 10.1128/MCB.00724-08; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Carlomagno Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090452; Chambers JE, 2015, ELIFE, V4, DOI 10.7554/eLife.04872; Chen RM, 2015, ELIFE, V4, DOI 10.7554/eLife.04871; Choksi DK, 2014, HUM MOL GENET, V23, P1025, DOI 10.1093/hmg/ddt498; Choy MS, 2015, CELL REP, V11, P1885, DOI 10.1016/j.celrep.2015.05.043; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; De Conti L, 2015, NUCLEIC ACIDS RES, V43, P8990, DOI 10.1093/nar/gkv814; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hasegawa T, 1999, BBA-GEN SUBJECTS, V1428, P161, DOI 10.1016/S0304-4165(99)00060-4; Hasegawa T, 2000, BIOCHEM BIOPH RES CO, V267, P593, DOI 10.1006/bbrc.1999.1991; Hasegawa T, 2000, BIOCHEM J, V352, P795, DOI 10.1042/0264-6021:3520795; Hung WJ, 2003, MOL CELL BIOL, V23, P3477, DOI 10.1128/MCB.23.10.3477-3486.2003; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kametani F, 2009, BIOCHEM BIOPH RES CO, V382, P405, DOI 10.1016/j.bbrc.2009.03.038; Kim HJ, 2017, NEURON, V96, P285, DOI 10.1016/j.neuron.2017.07.029; Lee IC, 2018, CELL DEATH DIFFER, V25, P255, DOI 10.1038/cdd.2017.152; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Patterson AD, 2006, MOL CELL BIOL, V26, P1644, DOI 10.1128/MCB.26.5.1644-1653.2006; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Reid DW, 2016, MOL CELL BIOL, V36, P1868, DOI 10.1128/MCB.00190-16; Reid DW, 2014, CELL, V158, P1362, DOI 10.1016/j.cell.2014.08.012; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Shelkovnikova TA, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.199; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Somalinga BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035818; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Wang LJ, 2014, HUM MOL GENET, V23, P2629, DOI 10.1093/hmg/ddt658; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Watanabe R, 2007, INT J MOL MED, V19, P475; Wu DY, 2002, J BIOL CHEM, V277, P27706, DOI 10.1074/jbc.M200955200; Zhang HM, 2010, MOL CELL PROTEOMICS, V9, P635, DOI 10.1074/mcp.M900314-MCP200; Zhou W, 2011, J BIOL CHEM, V286, P21687, DOI 10.1074/jbc.M110.212787	64	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					163	176		10.1074/jbc.M117.814111	http://dx.doi.org/10.1074/jbc.M117.814111			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29109149	Green Published, hybrid			2022-12-26	WOS:000419453200015
J	Cook, JD; Ng, SY; Lloyd, M; Eddington, S; Sun, H; Nathans, J; Bok, D; Radu, RA; Travis, GH				Cook, Jeremy D.; Ng, Sze Yin; Lloyd, Marcia; Eddington, Shannan; Sun, Hui; Nathans, Jeremy; Bok, Dean; Radu, Roxana A.; Travis, Gabriel H.			Peropsin modulates transit of vitamin A from retina to retinal pigment epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); gene knock-out; membrane; photoreceptor; retina; retinal metabolism; retinoid-binding protein; retinol; vitamin A	BINDING-PROTEIN; VISUAL CYCLE; KNOCKOUT MICE; MULLER CELLS; LIGHT; ACYLTRANSFERASE; RHODOPSIN; RPE65; PHOTORECEPTORS; CHROMOPHORE	Peropsin is a non-visual opsin in both vertebrate and invertebrate species. In mammals, peropsin is present in the apical microvilli of retinal pigment epithelial (RPE) cells. These structures interdigitate with the outer segments of rod and cone photoreceptor cells. RPE cells play critical roles in the maintenance of photoreceptors, including the recycling of visual chromophore for the opsin visual pigments. Here, we sought to identify the function of peropsin in the mouse eye. To this end, we generated mice with a null mutation in the peropsin gene (Rrh). These mice exhibited normal retinal histology, normal morphology of outer segments and RPE cells, and no evidence of photoreceptor degeneration. Biochemically, Rrh(-/-) mice had approximate to 2-fold higher vitamin A (all-trans-retinol (all-trans-ROL)) in the neural retina following a photobleach and 5-fold lower retinyl esters in the RPE. This phenotype was similar to those reported in mice that lack interphotoreceptor retinoid-binding protein (IRBP) or cellular retinol-binding protein, suggesting that peropsin plays a role in the movement of all-trans-ROL from photoreceptors to the RPE. We compared the phenotypes in mice lacking both peropsin and IRBP with those of mice lacking peropsin or IRBP alone and found that the retinoid phenotype was similarly severe in each of these knock-out mice. We conclude that peropsin controls all-trans-ROL movement from the retina to the RPE or may regulate all-trans-ROL storage within the RPE. We propose that peropsin affects light-dependent regulation of all-trans-ROL uptake from photoreceptors into RPE cells through an as yet undefined mechanism.	[Cook, Jeremy D.; Ng, Sze Yin; Lloyd, Marcia; Eddington, Shannan; Sun, Hui; Bok, Dean; Radu, Roxana A.; Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Sun, Hui] Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet Neurosci & Ophthalmol, Baltimore, MD 21205 USA; [Nathans, Jeremy] Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Bok, Dean] Univ Calif Los Angeles, Ophthalmol, Los Angeles, CA 90024 USA; [Bok, Dean] Univ Calif Los Angeles, Ophthalmol & Neurobiol, Los Angeles, CA 90024 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Ophthalmol & Biol Chem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Travis, GH (corresponding author), Univ Calif Los Angeles, Sch Med, Stein Eye Inst, 100 Stein Plaza Driveway, Los Angeles, CA 90095 USA.	travis@jsei.ucla.edu	Radu, Roxana A./K-8924-2019; Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493; Nathans, Jeremy/0000-0001-8106-5460; Radu, Roxana/0000-0002-5064-6403	NEI, National Institutes of Health [R01-EY011713, R01-EY024379, R01-EY025002, P30-EY000331]; Howard Hughes Medical Institute; Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY000331, R01EY025002, R01EY011713, R01EY024379] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI, National Institutes of Health Grants R01-EY011713 and R01-EY024379 (to G. H. T.) and R01-EY025002 (to R. A. R.); the Howard Hughes Medical Institute (to J. N.); NEI, National Institutes of Health Core Grant P30-EY000331; and a Research to Prevent Blindness unrestricted grant (to the Jules Stein Eye Institute). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Hao WS, 2000, METHOD ENZYMOL, V316, P413; Huang J, 2009, MOL VIS, V15, P223; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kang SW, 2015, GEN COMP ENDOCR, V211, P106, DOI 10.1016/j.ygcen.2014.11.020; Kaschula CH, 2006, EXP EYE RES, V82, P111, DOI 10.1016/j.exer.2005.05.010; KATZ ML, 1987, BIOCHIM BIOPHYS ACTA, V924, P432, DOI 10.1016/0304-4165(87)90157-7; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kaylor JJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00018-4; Kaylor JJ, 2014, P NATL ACAD SCI USA, V111, P7302, DOI 10.1073/pnas.1319142111; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kojima D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026388; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LIOU GI, 1982, VISION RES, V22, P1457, DOI 10.1016/0042-6989(82)90210-3; Liou GI, 1998, J NEUROSCI, V18, P4511; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MACDONALD PN, 1988, BIOCHEM BIOPH RES CO, V156, P157, DOI 10.1016/S0006-291X(88)80818-0; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Montell C, 2012, TRENDS NEUROSCI, V35, P356, DOI 10.1016/j.tins.2012.03.004; Nagata T, 2010, J COMP PHYSIOL A, V196, P51, DOI 10.1007/s00359-009-0493-9; Nieto PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026417; OZAKI K, 1983, BIOPHYS J, V44, P127, DOI 10.1016/S0006-3495(83)84285-4; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PANDEY S, 1994, EXP EYE RES, V58, P605, DOI 10.1006/exer.1994.1055; PEPE IM, 1992, J PHOTOCH PHOTOBIO B, V13, P5, DOI 10.1016/1011-1344(92)80035-T; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; SAARI JC, 1989, J BIOL CHEM, V264, P8636; Saari JC, 2002, INVEST OPHTH VIS SCI, V43, P1730; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sun H, 1997, P NATL ACAD SCI USA, V94, P9893, DOI 10.1073/pnas.94.18.9893; Toh PPC, 2016, EXP DERMATOL, V25, P1002, DOI 10.1111/exd.13226; Tsukamoto H, 2010, PHOTOCH PHOTOBIO SCI, V9, P1435, DOI 10.1039/c0pp00168f; Van Gelder RN, 2016, ANNU REV VIS SCI, V2, P153, DOI 10.1146/annurev-vision-111815-114558; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wright CB, 2015, PROG MOL BIOL TRANSL, V134, P433, DOI 10.1016/bs.pmbts.2015.06.009; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	49	10	10	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21407	21416		10.1074/jbc.M117.812701	http://dx.doi.org/10.1074/jbc.M117.812701			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29109151	Green Published, hybrid			2022-12-26	WOS:000419013000017
J	Oh, JH; Chen, SJ; Varshavsky, A				Oh, Jang-Hyun; Chen, Shun-Jia; Varshavsky, Alexander			A reference-based protein degradation assay without global translation inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aptamer; protein degradation; Saccharomyces cerevisiae; ubiquitin; yeast; assay; chase; degradation; reference; GID; Mdh2; Gid4; tetracycline	END RULE PATHWAY; N-TERMINAL ACETYLATION; E3 UBIQUITIN LIGASE; STRUCTURAL BASIS; QUALITY-CONTROL; IN-VIVO; COTRANSLATIONAL UBIQUITINATION; SUBSTRATE RECOGNITION; CELLULAR-PROTEINS; GID COMPLEX	Although it is widely appreciated that the use of global translation inhibitors, such as cycloheximide, in protein degradation assays may result in artefacts, these inhibitors continue to be employed, owing to the absence of robust alternatives. We describe here the promoter reference technique (PRT), an assay for protein degradation with two advantageous features: a reference protein and a gene-specific inhibition of translation. In PRT assays, one measures, during a chase, the ratio of a test protein to a long-lived reference protein, a dihydrofolate reductase (DHFR). The test protein and DHFR are coexpressed, in the yeast Saccharomyces cerevisiae, on a low-copy plasmid from two identical P-TDH3 promoters containing additional, previously developed DNA elements. Once transcribed, these elements form 5-RNA aptamers that bind to the added tetracycline, which represses translation of aptamer-containing mRNAs. The selectivity of repression avoids a global inhibition of translation. This selectivity is particularly important if a component of a relevant proteolytic pathway (e.g. a specific ubiquitin ligase) is itself short-lived. We applied PRT to the Pro/N-end rule pathway, whose substrates include the short-lived Mdh2 malate dehydrogenase. Mdh2 is targeted for degradation by the Gid4 subunit of the GID ubiquitin ligase. Gid4 is also a metabolically unstable protein. Through analyses of short-lived Mdh2 as a target of short-lived Gid4, we illustrate the advantages of PRT over degradation assays that lack a reference and/or involve cycloheximide. In sum, PRT avoids the use of global translation inhibitors during a chase and also provides a built-in reference protein.	[Oh, Jang-Hyun; Chen, Shun-Jia; Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	avarsh@caltech.edu		Chen, Shun-Jia/0000-0002-5489-4930; Varshavsky, Alexander/0000-0002-4011-258X	National Institutes of Health [1R01GM031530, 1R01DK039520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 1R01GM031530 and 1R01DK039520 (to A. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksnes H, 2016, TRENDS BIOCHEM SCI, V41, P746, DOI 10.1016/j.tibs.2016.07.005; Arnold L, 2015, MOL BIOL CELL, V26, P843, DOI 10.1091/mbc.E14-09-1342; Ausubel FM, 2010, CURRENT PROTOCOLS MO; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1991, P NATL ACAD SCI USA, V88, P1090, DOI 10.1073/pnas.88.4.1090; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bojkowska K, 2011, CHEM BIOL, V18, P805, DOI 10.1016/j.chembiol.2011.03.014; Brower CS, 2013, MOL CELL, V50, P161, DOI 10.1016/j.molcel.2013.02.009; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Bursac S, 2012, P NATL ACAD SCI USA, V109, P20467, DOI 10.1073/pnas.1218535109; Butko MT, 2012, NAT NEUROSCI, V15, P1742, DOI 10.1038/nn.3246; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Cha-Molstad H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00085-7; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Chen SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aal3655; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Christiano R, 2014, CELL REP, V9, P1959, DOI 10.1016/j.celrep.2014.10.065; Cohen I, 2014, JOVE-J VIS EXP, DOI 10.3791/52021; Cui Y, 2011, EMBO J, V30, P2675, DOI 10.1038/emboj.2011.155; Davey NE, 2016, MOL CELL, V64, P12, DOI 10.1016/j.molcel.2016.09.006; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Dissmeyer N, 2018, NEW PHYTOL, V218, P929, DOI 10.1111/nph.14619; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Fan KT, 2016, J PROTEOME RES, V15, P851, DOI 10.1021/acs.jproteome.5b00772; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Fraenkel D. G., 2011, YEAST INTERMEDIARY M; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gandin V, 2014, TRANSLATION, V2, DOI 10.4161/trla.28109; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Green DR, 2011, MEANS END APOPTOSIS; Ha SW, 2016, J BIOL CHEM, V291, P9827, DOI 10.1074/jbc.M116.716175; Holm L, 2013, AM J PHYSIOL-ENDOC M, V304, pE895, DOI 10.1152/ajpendo.00579.2012; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kim I, 2013, MOL CELL PROTEOMICS, V12, P3370, DOI 10.1074/mcp.O113.031708; Kim MK, 2016, P NATL ACAD SCI USA, V113, P12438, DOI 10.1073/pnas.1612620113; Kotter P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp578; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Li L, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010025, 10.1074/mcp.M111.014209]; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Lu D, 2014, J CELL BIOL, V207, P23, DOI 10.1083/jcb.201402041; Lucas X, 2017, CURR OPIN STRUC BIOL, V44, P101, DOI 10.1016/j.sbi.2016.12.015; Lykke-Andersen J, 2014, J CELL BIOL, V204, P467, DOI 10.1083/jcb.201311103; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; Maurer MJ, 2016, G3-GENES GENOM GENET, V6, P1853, DOI 10.1534/g3.116.027953; McShane E, 2016, CELL, V167, P803, DOI 10.1016/j.cell.2016.09.015; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; Meszaros B, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aak9982; Nie MH, 2015, J BIOL CHEM, V290, P22678, DOI 10.1074/jbc.M115.673038; Oh JH, 2017, P NATL ACAD SCI USA, V114, pE4370, DOI 10.1073/pnas.1705898114; Omnus DJ, 2011, MOL BIOL CELL, V22, P2754, DOI 10.1091/mbc.E11-04-0282; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Piatkov K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067952; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Shi Q, 2015, DEV CELL, V35, P483, DOI 10.1016/j.devcel.2015.10.014; Stein BJ, 2016, STRUCTURE, V24, P232, DOI 10.1016/j.str.2015.12.008; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Terweij M, 2013, G3-GENES GENOM GENET, V3, P1261, DOI 10.1534/g3.113.006213; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Vittal V, 2015, J BIOL CHEM, V290, P21244, DOI 10.1074/jbc.R115.675165; Wadas B, 2016, J BIOL CHEM, V291, P20976, DOI 10.1074/jbc.M116.747956; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Yu HQ, 2016, J BIOL CHEM, V291, P14526, DOI 10.1074/jbc.M116.727578; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922	84	11	11	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21457	21465		10.1074/jbc.M117.814236	http://dx.doi.org/10.1074/jbc.M117.814236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29122887	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000419013000021
J	Suh, JH; Lai, L; Nam, D; Kim, J; Jo, J; Taffet, GE; Kim, E; Kaelber, JT; Lee, HK; Entman, ML; Cooke, JP; Reineke, EL				Suh, Ji Ho; Lai, Li; Nam, Deokhwa; Kim, Jong; Jo, Juyeon; Taffet, George E.; Kim, Eunah; Kaelber, Jason T.; Lee, Hyun-Kyoung; Entman, Mark L.; Cooke, John P.; Reineke, Erin L.			Steroid receptor coactivator-2 (SRC-2) coordinates cardiomyocyte paracrine signaling to promote pressure overload-induced angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; cardiac hypertrophy; cardiomyocyte; gene expression; hypoxia; transcription coactivator; transcription regulation	TRANSCRIPTION FACTOR GATA4; CARDIAC-HYPERTROPHY; HEART-FAILURE; REGULATOR; GROWTH; INHIBITION; ACTIVATION; TRANSITION; VENTRICLE; PROTEIN	Pressure overload-induced cardiac stress induces left ventricular hypertrophy driven by increased cardiomyocyte mass. The increased energetic demand and cardiomyocyte size during hypertrophy necessitate increased fuel and oxygen delivery and stimulate angiogenesis in the left ventricular wall. We have previously shown that the transcriptional regulator steroid receptor coactivator-2 (SRC-2) controls activation of several key cardiac transcription factors and that SRC-2 loss results in extensive cardiac transcriptional remodeling. Pressure overload in mice lacking SRC-2 induces an abrogated hypertrophic response and decreases sustained cardiac function, but the cardiomyocyte-specific effects of SRC-2 in these changes are unknown. Here, we report that cardiomyocyte-specific loss of SRC-2 (SRC-2 CKO) results in a blunted hypertrophy accompanied by a rapid, progressive decrease in cardiac function. We found that SRC-2 CKO mice exhibit markedly decreased left ventricular vasculature in response to transverse aortic constriction, corresponding to decreased expression of the angiogenic factor VEGF. Of note, SRC-2 knockdown in cardiomyocytes decreased VEGF expression and secretion to levels sufficient to blunt in vitro tube formation and proliferation of endothelial cells. During pressure overload, both hypertrophic and hypoxic signals can stimulate angiogenesis, both of which stimulated SRC-2 expression in vitro. Furthermore, SRC-2 coactivated the transcription factors GATA-binding protein 4 (GATA-4) and hypoxia-inducible factor (HIF)-1 and -2 in response to angiotensin II and hypoxia, respectively, which drive VEGF expression. These results suggest that SRC-2 coordinates cardiomyocyte secretion of VEGF downstream of the two major angiogenic stimuli occurring during pressure overload bridging both hypertrophic and hypoxia-stimulated paracrine signaling.	[Suh, Ji Ho; Nam, Deokhwa; Kim, Eunah; Reineke, Erin L.] Houston Methodist Res Inst, Ctr Bioenerget, 6670 Bertner Ave,R11-213, Houston, TX 77030 USA; [Lai, Li; Cooke, John P.] Houston Methodist Res Inst, Dept Cardiovasc Sci, 6670 Bertner Ave,R11-213, Houston, TX 77030 USA; [Kim, Jong] Univ Houston, Houston, TX 77004 USA; [Jo, Juyeon; Lee, Hyun-Kyoung] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat & Neurosci, Houston, TX 77030 USA; [Jo, Juyeon; Lee, Hyun-Kyoung] Texas Childrens Hosp, Neurol Res Inst, Houston, TX 77030 USA; [Taffet, George E.; Entman, Mark L.] Baylor Coll Med, Dept Med, Div Cardiovasc Sci, Houston, TX 77030 USA; [Kaelber, Jason T.] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Kaelber, Jason T.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Reineke, EL (corresponding author), Houston Methodist Res Inst, Ctr Bioenerget, 6670 Bertner Ave,R11-213, Houston, TX 77030 USA.	elreineke@houstonmethodist.org		Lai, Li/0000-0002-5731-2705; Lee, Hyun Kyoung/0000-0001-5793-4398; Kaelber, Jason/0000-0001-9426-1030	National Institutes of Health [R00-HL118159, R01-HL089792]; Souki Mitochondrial Project Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL118159, R01HL089792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Souki Mitochondrial Project Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R00-HL118159 (to E. L. R.), R01-HL089792 (to M. L. E.), and the Souki Mitochondrial Project Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bajgelman MC, 2015, VIROLOGY, V476, P106, DOI 10.1016/j.virol.2014.12.009; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Biscetti F, 2008, DIABETES, V57, P1394, DOI 10.2337/db07-0765; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Demidenko ZN, 2011, CELL CYCLE, V10, P1557, DOI 10.4161/cc.10.10.15789; el Azzouzi H, 2015, TRENDS ENDOCRIN MET, V26, P502, DOI 10.1016/j.tem.2015.06.008; Guo J, 2015, EUR HEART J, V36, P2530, DOI 10.1093/eurheartj/ehv294; Haghikia A, 2014, CARDIOVASC RES, V102, P281, DOI 10.1093/cvr/cvu034; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Katanasaka Y, 2016, INT HEART J, V57, P672, DOI 10.1536/ihj.16-404; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Li YH, 2003, ULTRASOUND MED BIOL, V29, P1281, DOI 10.1016/S0301-5629(03)00986-4; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Oka T, 2014, CIRC RES, V114, P565, DOI 10.1161/CIRCRESAHA.114.300507; Park AM, 2010, HYPERTENSION, V56, P1145, DOI 10.1161/HYPERTENSIONAHA.110.160515; Reineke EL, 2014, J BIOL CHEM, V289, P17721, DOI 10.1074/jbc.M113.539908; Reineke EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053395; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Shang YL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001527; Taffet GE, 1996, AM J PHYSIOL-HEART C, V270, pH2204; Walsh K, 2007, J CLIN INVEST, V117, P3176, DOI 10.1172/JCI34126	25	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21643	21652		10.1074/jbc.M117.804740	http://dx.doi.org/10.1074/jbc.M117.804740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29127200	hybrid, Green Published			2022-12-26	WOS:000419013000038
J	Li, Y; Roberts, J; AkhavanAghdam, Z; Hao, N				Li, Yang; Roberts, Julie; AkhavanAghdam, Zohreh; Hao, Nan			Mitogen-activated protein kinase (MAPK) dynamics determine cell fate in the yeast mating response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell fate decision; single-cell analysis; yeast mating response; mitogen-activated protein kinase (MAPK); differentiation; pheromone; cell signaling; imaging	SACCHAROMYCES-CEREVISIAE; SIGNALING DYNAMICS; GENE-EXPRESSION; SPECIFICITY; GROWTH; DIFFERENTIATION; FEEDBACK; PATHWAY; PHOSPHORYLATION; PROLIFERATION	In the yeast Saccharomyces cerevisiae, the exposure to mating pheromone activates a prototypic mitogen-activated protein kinase (MAPK) cascade and triggers a dose-dependent differentiation response. Whereas a high pheromone dose induces growth arrest and formation of a shmoo-like morphology in yeast cells, lower pheromone doses elicit elongated cell growth. Previous population-level analysis has revealed that the MAPK Fus3 plays an important role in mediating this differentiation switch. To further investigate how Fus3 controls the fate decision process at the single-cell level, we developed a specific translocation-based reporter for monitoring Fus3 activity in individual live cells. Using this reporter, we observed strikingly different dynamic patterns of Fus3 activation in single cells differentiated into distinct fates. Cells committed to growth arrest and shmoo formation exhibited sustained Fus3 activation. In contrast, most cells undergoing elongated growth showed either a delayed gradual increase or pulsatile dynamics of Fus3 activity. Furthermore, we found that chemically perturbing Fus3 dynamics with a specific inhibitor could effectively redirect the mating differentiation, confirming the causative role of Fus3 dynamics in driving cell fate decisions. MAPKs mediate proliferation and differentiation signals in mammals and are therapeutic targets in many cancers. Our results highlight the importance of MAPK dynamics in regulating single-cell responses and open up the possibility that MAPK signaling dynamics could be a pharmacological target in therapeutic interventions.	[Li, Yang; Roberts, Julie; AkhavanAghdam, Zohreh; Hao, Nan] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hao, N (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	nhao@ucsd.edu	Hao, Nan/O-3462-2016	Hao, Nan/0000-0003-2857-4789; AkhavanAghdam, Zohreh/0000-0003-3307-7541; Paxman, Julie/0000-0001-7259-247X; Li, Yang/0000-0001-5714-0416	National Institutes of Health [R01 GM111458]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111458, T32GM007240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM111458. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AkhavanAghdam Z, 2016, ELIFE, V5, DOI 10.7554/eLife.18458; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Conlon P, 2016, P NATL ACAD SCI USA, V113, pE5896, DOI 10.1073/pnas.1610081113; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; Dixit G, 2014, MOL CELL, V55, P85, DOI 10.1016/j.molcel.2014.05.019; Doncic A, 2015, CELL, V160, P1182, DOI 10.1016/j.cell.2015.02.032; Doncic A, 2013, MOL CELL, V50, P856, DOI 10.1016/j.molcel.2013.04.014; Durandau E, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0163-z; Erdman S, 2001, GENETICS, V159, P919; Hansen AS, 2015, NAT PROTOC, V10, P1181, DOI 10.1038/nprot.2015.079; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hao N, 2012, MOL BIOL CELL, V23, P3899, DOI 10.1091/mbc.E12-04-0333; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; Houser JR, 2012, YEAST, V29, P519, DOI 10.1002/yea.2932; Kim J, 2012, GENE DEV, V26, P1110, DOI 10.1101/gad.187260.112; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Patterson JC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001275; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Shao B, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005671; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Wang X, 2006, BIOPHYS J, V90, P1961, DOI 10.1529/biophysj.105.073874; Ydenberg CA, 2009, J CELL BIOL, V184, P409, DOI 10.1083/jcb.200809066; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	36	13	14	1	98	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20354	20361		10.1074/jbc.AC117.000548	http://dx.doi.org/10.1074/jbc.AC117.000548			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29123025	hybrid, Green Published			2022-12-26	WOS:000418267000001
J	Pawlowska, S; Nakielski, P; Pierini, F; Piechocka, IK; Zembrzycki, K; Kowalewski, TA				Pawlowska, Sylwia; Nakielski, Pawel; Pierini, Filippo; Piechocka, Izabela K.; Zembrzycki, Krzysztof; Kowalewski, Tomasz A.			Lateral migration of electrospun hydrogel nanofilaments in an oscillatory flow	PLOS ONE			English	Article							SHEAR-INDUCED MIGRATION; POISEUILLE FLOW; INERTIAL MIGRATION; POLYMER-SOLUTIONS; ACTIN-FILAMENTS; FLEXIBLE FIBERS; RIGID SPHERES; DYNAMICS; DNA; FLUID	The recent progress in bioengineering has created great interest in the dynamics and manipulation of long, deformable macromolecules interacting with fluid flow. We report experimental data on the cross-flow migration, bending, and buckling of extremely deformable hydrogel nanofilaments conveyed by an oscillatory flow into a microchannel. The changes in migration velocity and filament orientation are related to the flow velocity and the filament's initial position, deformation, and length. The observed migration dynamics of hydrogel filaments qualitatively confirms the validity of the previously developed worm-like bead-chain hydrodynamic model. The experimental data collected may help to verify the role of hydrodynamic interactions in molecular simulations of long molecular chains dynamics.	[Pawlowska, Sylwia; Nakielski, Pawel; Pierini, Filippo; Piechocka, Izabela K.; Zembrzycki, Krzysztof; Kowalewski, Tomasz A.] Polish Acad Sci, Inst Fundamental Technol Res, Dept Biosyst & Soft Matter, Warsaw, Poland	Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Pawlowska, S; Kowalewski, TA (corresponding author), Polish Acad Sci, Inst Fundamental Technol Res, Dept Biosyst & Soft Matter, Warsaw, Poland.	spaw@ippt.pan.pl; tkowale@ippt.pan.pl	Kowalewski, Tomasz Aleksander/F-2055-2011; Pawłowska, Sylwia/HIK-1653-2022; Nakielski, Pawel/A-2077-2013; Pierini, Filippo/B-5328-2019; Piechocka, Izabela Katarzyna/L-3079-2014	Kowalewski, Tomasz Aleksander/0000-0002-3664-9659; Nakielski, Pawel/0000-0001-6194-701X; Pierini, Filippo/0000-0002-6526-4141; Piechocka, Izabela Katarzyna/0000-0002-2877-3924	Polish National Science Center (NCN) [2015/17/N/ST8/02012]; EC structural funds of the Center for Preclinical Research and Technology (CePT), POIG [02.02.00-17-024/08-00]; EC structural funds of the Biocentrum Ochota [POIG.02.03.00-00-003/09-00]	Polish National Science Center (NCN); EC structural funds of the Center for Preclinical Research and Technology (CePT), POIG; EC structural funds of the Biocentrum Ochota	This work was supported by Polish National Science Center (NCN), grant no. 2015/17/N/ST8/02012. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by the Polish National Science Center (NCN, grant no. 2015/17/N/5T8/02012). The experiments were performed using apparatus available thanks to the EC structural funds in framework of the Center for Preclinical Research and Technology (CePT), POIG Nr. 02.02.00-17-024/08-00. The computational resources were made available thanks to the EC structural funds in framework of the Biocentrum Ochota, POIG.02.03.00-00-003/09-00.	Bloom KS, 2008, CHROMOSOMA, V117, P103, DOI 10.1007/s00412-007-0138-0; Broedersz CP, 2014, REV MOD PHYS, V86, P995, DOI 10.1103/RevModPhys.86.995; CHAKRABORTY K, 2013, J CHEM PHYS, V139, DOI DOI 10.1063/1.4769980; CHAN PCH, 1979, J FLUID MECH, V92, P131, DOI 10.1017/S0022112079000562; CHAUDHURY K, 2016, PHYS REV E, V93, DOI DOI 10.1063/1.2176587; CHELAKKOT R, 2010, EPL-EUROPHYS LETT, V91, P17060, DOI DOI 10.1017/S0022112006000243; Chen YL, 2014, RSC ADV, V4, P17908, DOI 10.1039/c4ra00837e; Chen YJ, 2014, P NATL ACAD SCI USA, V111, P17396, DOI 10.1073/pnas.1415685111; Chen YL, 2005, MACROMOLECULES, V38, P6680, DOI 10.1021/ma050238d; Chun B, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2176587; Corbin EA, 2013, BIOMED MICRODEVICES, V15, P311, DOI 10.1007/s10544-012-9730-z; DEPABLO JJ, 1992, AICHE J, V38, P273, DOI 10.1002/aic.690380213; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Doyle PS, 2000, PHYS REV LETT, V84, P4769, DOI 10.1103/PhysRevLett.84.4769; Elbaum M, 1996, PHYS REV LETT, V76, P4078, DOI 10.1103/PhysRevLett.76.4078; Fahraeus R, 1929, PHYSIOL REV, V9, P241, DOI 10.1152/physrev.1929.9.2.241; Farutin A, 2016, SOFT MATTER, V12, P7307, DOI 10.1039/c6sm00819d; GAUTHIER F J, 1972, Biorheology, V9, P205; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Gerashchenko S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.038304; Gittes F, 1996, BIOPHYS J, V70, P418, DOI 10.1016/S0006-3495(96)79585-1; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Graham MD, 2011, ANNU REV FLUID MECH, V43, P273, DOI 10.1146/annurev-fluid-121108-145523; Guo ZJ, 2008, J PHYS CHEM B, V112, P16163, DOI 10.1021/jp806260h; Harasim M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.108302; Herczynski R, 2016, ARCH MECH, V68, P81; HILLER W, 1987, EXP FLUIDS, V5, P141, DOI 10.1007/BF00776185; HLADKY SB, 2014, FLUIDS BARRIERS CNS, V11, P17060, DOI DOI 10.1007/S10544-012-9730-Z; HO BP, 1974, J FLUID MECH, V65, P365, DOI 10.1017/S0022112074001431; Izmitli A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2831777; Jendrejack RM, 2004, J CHEM PHYS, V120, P2513, DOI 10.1063/1.1637331; Jo K, 2009, LAB CHIP, V9, P2348, DOI 10.1039/b902292a; Kantsler V, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.038103; Kirchenbuechler I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6060; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; KUEI S, 2015, NEW J PHYS, V17, DOI DOI 10.1088/0953-8984/19/28/285224; Lamour G, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-16; Lang PS, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022606; LeDuc P, 1999, NATURE, V399, P564, DOI 10.1038/21148; Lei YM, 2017, PROG NEUROBIOL, V157, P230, DOI 10.1016/j.pneurobio.2015.12.007; Lopez HM, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4905920; Ma HB, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2011367; Murrell MP, 2012, P NATL ACAD SCI USA, V109, P20820, DOI 10.1073/pnas.1214753109; Nakielski P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129816; Noding B, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.088101; Pal K, 2009, DES MONOMERS POLYM, V12, P197, DOI 10.1163/156855509X436030; Perez A, 2012, ACCOUNTS CHEM RES, V45, P196, DOI 10.1021/ar2001217; Quennouz N, 2015, J FLUID MECH, V769, P387, DOI 10.1017/jfm.2015.115; Reddig S, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3656070; Sadlej K, 2010, INT J HEAT FLUID FL, V31, P996, DOI 10.1016/j.ijheatfluidflow.2010.02.021; Saintillan D, 2006, J FLUID MECH, V557, P297, DOI 10.1017/S0022112006000243; Schroeder CM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.018301; SEGRE G, 1962, J FLUID MECH, V14, P136, DOI 10.1017/S0022112062001111; SEGRE G, 1961, NATURE, V189, P209, DOI 10.1038/189209a0; Slowicka AM, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3678852; SLOWICKA AM, 2013, EUR PHYS J E, V36, P17060, DOI DOI 10.1063/1.1637331; Smith DE, 1999, SCIENCE, V283, P1724, DOI 10.1126/science.283.5408.1724; Steinhauser D, 2012, ACS MACRO LETT, V1, P541, DOI 10.1021/mz3000539; Sunyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046107; SZYMCZAK P, 2007, J PHYS-CONDENS MAT, V19, DOI DOI 10.1103/PHYSREVLETT.96.038304; Teixeira RE, 2005, MACROMOLECULES, V38, P581, DOI 10.1021/ma048077l; Tornberg AK, 2004, J COMPUT PHYS, V196, P8, DOI 10.1016/j.jcp.2003.10.017; Truong NP, 2015, EXPERT OPIN DRUG DEL, V12, P129, DOI 10.1517/17425247.2014.950564; Vezeridis PS, 2006, BIOCHEM BIOPH RES CO, V348, P1082, DOI 10.1016/j.bbrc.2006.07.146; Wandersman E, 2010, SOFT MATTER, V6, P5715, DOI 10.1039/c0sm00132e; Wang JH, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4769980; Wen Q, 2012, SOFT MATTER, V8, P8039, DOI 10.1039/c2sm25364j; Wiig H, 2012, PHYSIOL REV, V92, P1005, DOI 10.1152/physrev.00037.2011	68	10	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187815	10.1371/journal.pone.0187815	http://dx.doi.org/10.1371/journal.pone.0187815			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141043	Green Submitted, Green Published, gold			2022-12-26	WOS:000415260400031
J	Shimizu, JF; Pereira, CM; Bittar, C; Batista, MN; Campos, GRF; da Silva, S; Cintra, ACO; Zothner, C; Harris, M; Sampaio, SV; Aquino, VH; Rahal, P; Jardim, ACG				Shimizu, Jacqueline Farinha; Pereira, Carina Machado; Bittar, Cintia; Batista, Mariana Nogueira; Fernandes Campos, Guilherme Rodrigues; da Silva, Suely; Oliveira Cintra, Adelia Cristina; Zothner, Carsten; Harris, Mark; Sampaio, Suely Vilela; Aquino, Victor Hugo; Rahal, Paula; Gomes Jardim, Ana Carolina			Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; REPLICATION IN-VITRO; PHOSPHOLIPASES A(2); ANTIVIRAL STRATEGIES; ISOLATED SUBUNITS; CROTOXIN COMPLEX; CORE PROTEIN; SNAKE-VENOM; INHIBITORS; INFECTION	Hepatitis C virus (HCV) is one of the main causes of liver disease and transplantation worldwide. Current therapy is expensive, presents additional side effects and viral resistance has been described. Therefore, studies for developing more efficient antivirals against HCV are needed. Compounds isolated from animal venoms have shown antiviral activity against some viruses such as Dengue virus, Yellow fever virus and Measles virus. In this study, we evaluated the effect of the complex crotoxin (CX) and its subunits crotapotin (CP) and phospholipase A(2) (PLA(2)-CB) isolated from the venom of Crotalus durissus terrificus on HCV life cycle. Huh 7.5 cells were infected with HCVcc JFH-1 strain in the presence or absence of these toxins and virus was titrated by focus formation units assay or by qPCR. Toxins were added to the cells at different time points depending on the stage of virus life cycle to be evaluated. The results showed that treatment with PLA(2)-CB inhibited HCV entry and replication but no effect on HCV release was observed. CX reduced virus entry and release but not replication. By treating cells with CP, an antiviral effect was observed on HCV release, the only stage inhibited by this compound. Our data demonstrated the multiple antiviral effects of toxins from animal venoms on HCV life cycle.	[Shimizu, Jacqueline Farinha; Pereira, Carina Machado; Bittar, Cintia; Batista, Mariana Nogueira; Fernandes Campos, Guilherme Rodrigues; da Silva, Suely; Rahal, Paula; Gomes Jardim, Ana Carolina] Sao Paulo State Univ, IBILCE, Genom Study Lab, Sao Paulo, Brazil; [Shimizu, Jacqueline Farinha; da Silva, Suely; Aquino, Victor Hugo] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Lab Virol, Sao Paulo, Brazil; [Oliveira Cintra, Adelia Cristina; Sampaio, Suely Vilela] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Lab Toxinol, Sao Paulo, Brazil; [Zothner, Carsten; Harris, Mark] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Zothner, Carsten; Harris, Mark] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Gomes Jardim, Ana Carolina] Univ Fed Uberlandia, ICBIM, Inst Biomed Sci, Lab Virol, Uberlandia, MG, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Leeds; University of Leeds; Universidade Federal de Uberlandia	Jardim, ACG (corresponding author), Sao Paulo State Univ, IBILCE, Genom Study Lab, Sao Paulo, Brazil.; Jardim, ACG (corresponding author), Univ Fed Uberlandia, ICBIM, Inst Biomed Sci, Lab Virol, Uberlandia, MG, Brazil.	jardim@ufu.br	Aquino, Victor Hugo/C-1922-2012; Rahal, Paula/D-3871-2012; Jardim, Ana Carolina/H-3615-2012; Bittar, Cintia/A-5042-2015; Vilela, Suely/D-7429-2012	Aquino, Victor Hugo/0000-0003-1910-0776; Rahal, Paula/0000-0001-5693-6148; Jardim, Ana Carolina/0000-0002-6348-7923; Bittar, Cintia/0000-0002-2048-4589; Vilela, Suely/0000-0003-3274-180X; Rodrigues Fernandes Campos, Guilherme/0000-0003-1118-8486; Farinha Shimizu, Jacqueline/0000-0002-9844-7745	Royal Society [NA 150195]; FAPEMIG [APQ-00587-14, SICONV 793988/2013]; FAPESP (Sao Paulo Research Foundation) [2011/00313-3, 2012/01403-9, 2013/03897-1]; CAPES (Coordination for the Improvement of Higher Education Personnel); CNPQ (National Council for Scientific and Technological Development) [45021/2014-4]; Wellcome Trust Investigator Award [096670]	Royal Society(Royal Society of London); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wellcome Trust Investigator Award(Wellcome Trust)	This work was supported by the Royal Society (Newton Advanced Fellowship: NA 150195 to ACGJ), FAPEMIG (grants: APQ-00587-14 and SICONV 793988/2013 to ACGJ), FAPESP (Sao Paulo Research Foundation grants: 2011/00313-3 to ACGJ, 2012/01403-9 to CB, and 2013/03897-1 to JFS), CAPES (Coordination for the Improvement of Higher Education Personnel) to JFS, and CNPQ (National Council for Scientific and Technological Development grant 45021/2014-4) to ACGJ. Research in the MH laboratory is funded by a Wellcome Trust Investigator Award (grant reference 096670). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRD SD, 1985, BIOCHEMISTRY-US, V24, P7054, DOI 10.1021/bi00346a005; Ayoub WS, 2015, CLIN LIVER DIS, V19, P619, DOI 10.1016/j.cld.2015.06.003; Bailey P, 2001, Emerg Med (Fremantle), V13, P28, DOI 10.1046/j.1442-2026.2001.00174.x; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Blaising J, 2013, BIOCHIMIE, V95, P96, DOI 10.1016/j.biochi.2012.07.016; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x; BON C, 1982, TOXICON, V20, P105, DOI 10.1016/0041-0101(82)90173-8; BREITHAUPT H, 1976, TOXICON, V14, P221, DOI 10.1016/0041-0101(76)90010-6; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Cecilio AB, 2013, TOXINS, V5, P1780, DOI 10.3390/toxins5101780; Ciesek S, 2009, HEPATOLOGY, V50, P1638, DOI 10.1002/hep.23281; Dabbouseh NM, 2013, NAT REV GASTRO HEPAT, V10, P268, DOI 10.1038/nrgastro.2013.17; FAURE G, 1988, BIOCHEMISTRY-US, V27, P730, DOI 10.1021/bi00402a036; Faure G, 2012, TOXICON, V60, P531, DOI 10.1016/j.toxicon.2012.05.009; Faure G, 2011, J MOL BIOL, V412, P176, DOI 10.1016/j.jmb.2011.07.027; Fenard D, 1999, J CLIN INVEST, V104, P611, DOI 10.1172/JCI6915; FERREIRA SH, 1965, BRIT J PHARM CHEMOTH, V24, P163, DOI 10.1111/j.1476-5381.1965.tb02091.x; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Goldwasser J, 2011, J HEPATOL, V55, P963, DOI 10.1016/j.jhep.2011.02.011; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; HENDON RA, 1971, P NATL ACAD SCI USA, V68, P1560, DOI 10.1073/pnas.68.7.1560; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Jardim ACG, 2015, ANTIVIR RES, V115, P39, DOI 10.1016/j.antiviral.2014.12.018; Jin H, 2008, HEPATOL RES, V38, P909, DOI 10.1111/j.1872-034X.2008.00352.x; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Krawczyk M, 2009, BIOL CHEM, V390, P351, DOI 10.1515/BC.2009.040; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Meenakshisundaram R., 2009, AIDS RES THER, V6, P25, DOI DOI 10.1186/1742-6405-6-25; Muller VDM, 2012, TOXICON, V59, P507, DOI 10.1016/j.toxicon.2011.05.021; Menjon Muller VD., 2014, J VIROL ANTIVIR RES, V3; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112351; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Park IW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075648; Pearlman BL, 2012, LANCET INFECT DIS, V12, P717, DOI 10.1016/S1473-3099(12)70060-9; Petricevich VL, 2003, TOXICON, V42, P143, DOI 10.1016/S0041-0101(03)00124-7; Popescu Costin-Ioan, 2014, Biology (Basel), V3, P892, DOI 10.3390/biology3040892; Rojas A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31777; Sampaio SC, 2010, TOXICON, V55, P1045, DOI 10.1016/j.toxicon.2010.01.011; Santos KF, 2007, ACTA CRYSTALLOGR F, V63, P287, DOI 10.1107/S1744309107006719; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Slotta KH, 1938, BER DTSCH CHEM GES, V71, P1076, DOI 10.1002/cber.19380710527; Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x; Stankiewicz-Drogon A, 2010, J MED CHEM, V53, P3117, DOI 10.1021/jm901741p; Sugawara E, 2014, ANTIMICROB AGENTS CH, V58, P7250, DOI 10.1128/AAC.03728-14; Syed GH, 2011, HEPATOLOGY, V54, P1936, DOI 10.1002/hep.24619; Talwani R, 2012, DRUG TODAY, V48, P219, DOI 10.1358/dot.2012.48.3.1740457; Thompson AJ, 2011, CURR OPIN VIROL, V1, P599, DOI 10.1016/j.coviro.2011.10.001; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wandeler G, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14093; Wyles DL, 2007, J VIROL, V81, P3005, DOI 10.1128/JVI.02083-06; Wyles DL, 2009, ANTIMICROB AGENTS CH, V53, P2660, DOI 10.1128/AAC.01546-08; Xiao F, 2014, GUT, P1; Yan R, 2011, PEPTIDES, V32, P11, DOI 10.1016/j.peptides.2010.10.008; Zhang S, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0320-4; Zona L, 2014, VIRUSES-BASEL, V6, P875, DOI 10.3390/v6020875	62	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187857	10.1371/journal.pone.0187857	http://dx.doi.org/10.1371/journal.pone.0187857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141010	gold, Green Published			2022-12-26	WOS:000415260400034
J	Wang, MM; Ong, LLS; Dauwels, J; Asada, HH				Wang, Mengmeng; Ong, Lee-Ling Sharon; Dauwels, Justin; Asada, H. Harry			Automated tracking and quantification of angiogenic vessel formation in 3D microfluidic devices	PLOS ONE			English	Article							CENTERLINE EXTRACTION; ENDOTHELIAL-CELLS; IDENTIFICATION; MICROSCOPY; BEHAVIORS; MIGRATION; GUIDANCE; IMAGES; MODEL; VEGF	Angiogenesis, the growth of new blood vessels from pre-existing vessels, is a critical step in cancer invasion. Better understanding of the angiogenic mechanisms is required to develop effective antiangiogenic therapies for cancer treatment. We culture angiogenic vessels in 3D microfluidic devices under different Sphingosin-1-phosphate (S1P) conditions and develop an automated vessel formation tracking system (AVFTS) to track the angiogenic vessel formation and extract quantitative vessel information from the experimental time-lapse phase contrast images. The proposed AVFTS first preprocesses the experimental images, then applies a distance transform and an augmented fast marching method in skeletonization, and finally implements the Hungarian method in branch tracking. When applying the AVFTS to our experimental data, we achieve 97.3% precision and 93.9% recall by comparing with the ground truth obtained from manual tracking by visual inspection. This system enables biologists to quantitatively compare the influence of different growth factors. Specifically, we conclude that the positive S1P gradient increases cell migration and vessel elongation, leading to a higher probability for branching to occur. The AVFTS is also applicable to distinguish tip and stalk cells by considering the relative cell locations in a branch. Moreover, we generate a novel type of cell lineage plot, which not only provides cell migration and proliferation histories but also demonstrates cell phenotypic changes and branch information.	[Wang, Mengmeng; Dauwels, Justin] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore, Singapore; [Wang, Mengmeng; Ong, Lee-Ling Sharon; Asada, H. Harry] Singapore MIT Alliance Res & Technol, Singapore, Singapore; [Asada, H. Harry] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); Massachusetts Institute of Technology (MIT)	Wang, MM (corresponding author), Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore, Singapore.; Wang, MM; Ong, LLS (corresponding author), Singapore MIT Alliance Res & Technol, Singapore, Singapore.	mwang009@e.ntu.edu.sg; sharon.ong@smart.mit.edu		Ong, Lee Ling/0000-0002-4120-163X	National Research Foundation Singapore through Singapore MIT Alliance for Research and Technology's BioSystems and Micromechanics Inter-Disciplinary Research programme	National Research Foundation Singapore through Singapore MIT Alliance for Research and Technology's BioSystems and Micromechanics Inter-Disciplinary Research programme(National Research Foundation, SingaporeSingapore-MIT Alliance for Research & Technology Centre (SMART))	This research was supported by the National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's BioSystems and Micromechanics Inter-Disciplinary Research programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2010, ADV PATTERN RECOGNIT, P331, DOI 10.1007/978-1-84996-098-4_7; Adanja I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022263; Amat F, 2014, NAT METHODS, V11, P951, DOI [10.1038/NMETH.3036, 10.1038/nmeth.3036]; Angulo J, 2007, CELL MOL BIOL, V53, P22, DOI 10.1170/T784; Angulo J, 2005, Proceedings of the Fifth IASTED International Conference on Visualization, Imaging, and Image Processing, P51; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Bouix S, 2005, MED IMAGE ANAL, V9, P209, DOI 10.1016/j.media.2004.06.026; Burkard  R., 2009, ASSIGNMENT PROBLEMS; Carlier A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002724; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Das SK, 2008, BIOMICROFLUIDICS, V2, DOI 10.1063/1.2988313; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Debeir O, 2005, IEEE T MED IMAGING, V24, P697, DOI 10.1109/TMI.2005.846851; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Ebert D., 2002, P S DATA VISUALISATI, P251; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Farahat WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037333; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt Holger, 2008, P68, DOI 10.1007/978-0-387-78632-2_6; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Gonzalez R.C, 2007, DIGITAL IMAGE PROCES, V3rd; Gonzalez R. C., 2009, DIGITAL IMAGE PROCES, DOI 10.1117/1.3115362; Haeger A, 2015, TRENDS CELL BIOL, V25, P556, DOI 10.1016/j.tcb.2015.06.003; Haralock R. M., 1991, COMPUTER ROBOT VISIO; Hassouna MS, 2005, PROC CVPR IEEE, P458; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kanade T., 2011, 2011 IEEE WORKSH APP, P374; KIMMEL R, 1995, P SOC PHOTO-OPT INS, V2356, P137, DOI 10.1117/12.198602; Lim SH, 2013, INTEGR BIOL-UK, V5, P1474, DOI 10.1039/c3ib40082d; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; Lumsdaine A, 2002, BOOST GRAPH LIB USER; Michaels JG, 1991, APPL DISCRETE MATH; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Murphy D.B., 2002, FUNDAMENTALS LIGHT M; Nguyen DHT, 2013, P NATL ACAD SCI USA, V110, P6712, DOI 10.1073/pnas.1221526110; Ong LLS, 2014, MED IMAGE ANAL, V18, P211, DOI 10.1016/j.media.2013.10.008; Otsu N, 1975, AUTOMATICA, V11, P23, DOI [DOI 10.1109/TSMC.1979.4310076, 10.1109/TSMC.1979.4310076, 10.1109/tsmc.1979.4310076]; Palagyi K, 1998, PATTERN RECOGN LETT, V19, P613, DOI 10.1016/S0167-8655(98)00031-2; Parsa H, 2011, P NATL ACAD SCI USA, V108, P5133, DOI 10.1073/pnas.1007508108; PAWELETZ N, 1989, CRIT REV ONCOL HEMAT, V9, P197, DOI 10.1016/S1040-8428(89)80002-2; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Progatzky F, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0001; Schiegg M, 2014, BIOINFORMATICS; Schuermann A, 2014, SEMIN CELL DEV BIOL, V31, P106, DOI 10.1016/j.semcdb.2014.04.037; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; Siekmann AF, 2013, EXP CELL RES, V319, P1255, DOI 10.1016/j.yexcr.2013.01.019; Song Y, 2010, LEUKEMIA, V24, P153, DOI 10.1038/leu.2009.191; Strzodka R, 2004, P EG IEEE TCVG S VIS, P221, DOI DOI 10.2312/VISSYM/VISSYM04/221-230; Suman R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22032; Wan M, 2002, IEEE T MED IMAGING, V21, P1450, DOI 10.1109/TMI.2002.806409; Wang MM, 2015, INT CONF ACOUST SPEE, P942, DOI 10.1109/ICASSP.2015.7178108; Wood L, 2011, INT J ROBOT RES, V30, P659, DOI 10.1177/0278364910394690; Yan TQ, 2012, COMM COM INF SC, V304, P251; Yi-Chun Lin, 2012, 2012 4th International Conference on Computational Intelligence, Communication Systems and Networks (CICSyN 2012), P278, DOI 10.1109/CICSyN.2012.59; Zattara EE, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0104-2; Zhao FJ, 2016, MED BIOL ENG COMPUT, V54, P511, DOI 10.1007/s11517-015-1337-0; Zhou Y, 1999, IEEE T VIS COMPUT GR, V5, P196, DOI 10.1109/2945.795212	62	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0186465	10.1371/journal.pone.0186465	http://dx.doi.org/10.1371/journal.pone.0186465			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136008	gold, Green Submitted, Green Published			2022-12-26	WOS:000415121200005
J	Wassermann, M; Raisch, L; Lyons, JA; Natusch, DJD; Richter, S; Wirth, M; Preeprem, P; Khoprasert, Y; Ginting, S; Mackenstedt, U; Jakel, T				Wassermann, Marion; Raisch, Lisa; Lyons, Jessica Ann; Natusch, Daniel James Deans; Richter, Sarah; Wirth, Mareike; Preeprem, Piyarat; Khoprasert, Yuvaluk; Ginting, Sulaiman; Mackenstedt, Ute; Jaekel, Thomas			Examination of Sarcocystis spp. of giant snakes from Australia and Southeast Asia confirms presence of a known pathogen - Sarcocystis nesbitti	PLOS ONE			English	Article							SINGAPORENSIS ZAMAN; PYTHON; RAT; MORPHOLOGY; PHYLOGENY; EVOLUTION; INFECTION; OUTBREAK; SPOROZOA; MALAYSIA	We examined Sarcocystis spp. in giant snakes from the Indo-Australian Archipelago and Australia using a combination of morphological (size of sporocyst) and molecular analyses. We amplified by PCR nuclear 18S rDNA from single sporocysts in order to detect mixed infections and unequivocally assign the retrieved sequences to the corresponding parasite stage. Sarcocystis infection was generally high across the study area, with 78 (68%) of 115 examined pythons being infected by one or more Sarcocystis spp. Among 18 randomly chosen, sporocyst-positive samples (11 from Southeast Asia, 7 from Northern Australia) the only Sarcocystis species detected in Southeast Asian snakes was S. singaporensis (in reticulated pythons), which was absent from all Australian samples. We distinguished three different Sarcocystis spp. in the Australian sample set; two were excreted by scrub pythons and one by the spotted python. The sequence of the latter is an undescribed species phylogenetically related to S. lacertae. Of the two Sarcocystis species found in scrub pythons, one showed an 18S rRNA gene sequence similar to S. zamani, which is described from Australia for the first time. The second sequence was identical/similar to that of S. nesbitti, a known human pathogen that was held responsible for outbreaks of disease among tourists in Malaysia. The potential presence of S. nesbitti in Australia challenges the current hypothesis of a snake-primate life cycle, and would have implications for human health in the region. Further molecular and biological characterizations are required to confirm species identity and determine whether or not the Australian isolate has the same zoonotic potential as its Malaysian counterpart. Finally, the absence of S. nesbitti in samples from reticulated pythons (which were reported to be definitive hosts), coupled with our phylogenetic analyses, suggest that alternative snake hosts may be responsible for transmitting this parasite in Malaysia.	[Wassermann, Marion; Raisch, Lisa; Richter, Sarah; Wirth, Mareike; Mackenstedt, Ute; Jaekel, Thomas] Univ Hohenheim, Div Parasitol, Dept Zool, Stuttgart, Germany; [Lyons, Jessica Ann] Resource Evaluat & Dev, Bamaga, Qld, Australia; [Natusch, Daniel James Deans] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Preeprem, Piyarat; Khoprasert, Yuvaluk; Jaekel, Thomas] Plant Protect Res & Dev Off, Dept Agr, Bangkok, Thailand; [Ginting, Sulaiman] Islamic Univ North Sumatra, Medan, Indonesia	University Hohenheim; University of Sydney; Ministry of Agriculture & Cooperatives - Thailand	Jakel, T (corresponding author), Univ Hohenheim, Div Parasitol, Dept Zool, Stuttgart, Germany.; Jakel, T (corresponding author), Plant Protect Res & Dev Off, Dept Agr, Bangkok, Thailand.	thom.jaekel@t-online.de	Wassermann, Marion/AAE-7238-2021; Jäkel, Thomas/ABH-2236-2020	Jäkel, Thomas/0000-0001-8039-5054; Wassermann, Marion/0000-0002-6622-9997; Lyons, Jessica A./0000-0002-7579-447X	German Federal Ministry of Economic Cooperation and Development (BMZ) [2002.2156.4]; Holsworth Wildlife Research Endowment; Skyrail Rainforest Foundation; Australian Research Council	German Federal Ministry of Economic Cooperation and Development (BMZ); Holsworth Wildlife Research Endowment; Skyrail Rainforest Foundation; Australian Research Council(Australian Research Council)	The study was carried out with funding from the German Federal Ministry of Economic Cooperation and Development (BMZ) (Project No. 2002.2156.4; http://www.bmz.de; TJ for German International Cooperation). The Holsworth Wildlife Research Endowment (http://www.eqt.com.au), the Skyrail Rainforest Foundation (http://www.skyrailfoundation.org) and the Australian Research Council (http://www.arc.gov.au) provided funding for the Australian sampling (to DN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2015, PARASITOL RES, V114, P3175, DOI 10.1007/s00436-015-4564-2; AbuBakar S, 2013, EMERG INFECT DIS, V19, P1989, DOI 10.3201/eid1912.120530; Arness MK, 1999, AM J TROP MED HYG, V61, P548, DOI 10.4269/ajtmh.1999.61.548; BEAVER PC, 1981, J PARASITOL, V67, P241, DOI 10.2307/3280645; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Daulay H. B., 2001, JURNAL TEKNOLOGI, V34, P51; Dubey J. P., 2015, Sarcocystosis of animals and humans; Duff A, 2004, MAMMALS WORLD CHECKL; Esposito DH, 2014, CLIN INFECT DIS, V59, P1401, DOI 10.1093/cid/ciu622; Fayer R, 2015, CLIN MICROBIOL REV, V28, P295, DOI 10.1128/CMR.00113-14; Furlan E, 2016, CONSERV GENET RESOUR; Greiner EC, 2006, REPTILE MED SURG, P343; HAFNER U, 1984, ZBL BAKT-INT J MED M, V256, P296, DOI 10.1016/S0174-3031(84)80005-0; Hafner U, 1987, THESIS; Headland TN, 2011, P NATL ACAD SCI USA, V108, pE1470, DOI 10.1073/pnas.1115116108; Holmdahl OJM, 1999, MOL PHYLOGENET EVOL, V11, P27, DOI 10.1006/mpev.1998.0556; Italiano Claire M, 2014, PLoS Negl Trop Dis, V8, pe2876, DOI 10.1371/journal.pntd.0002876; Jakel T, 1997, J WILDLIFE DIS, V33, P860; Jakel T, 2006, CROP PROT, V25, P773, DOI 10.1016/j.cropro.2005.10.008; Lau YL, 2014, AM J TROP MED HYG, V90, P361, DOI 10.4269/ajtmh.12-0678; Lau YL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-257; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; MANDOUR AM, 1969, J PROTOZOOL, V16, P353, DOI 10.1111/j.1550-7408.1969.tb02281.x; More G, 2014, PARASITOLOGY, V141, P646, DOI 10.1017/S0031182013001960; Moretti S, 2008, NUCLEIC ACIDS RES, V36, pW10, DOI 10.1093/nar/gkn278; Morrison DA, 2004, INT J PARASITOL, V34, P501, DOI 10.1016/j.ijpara.2003.11.006; Morrison DA, 2009, TRENDS PARASITOL, V25, P375, DOI 10.1016/j.pt.2009.05.010; Odening K, 1998, SYST PARASITOL, V41, P209, DOI 10.1023/A:1006090232343; Paperna I, 1996, FOLIA PARASIT, V43, P13; Poulsen CS, 2014, J CLIN MICROBIOL, V52, P3524, DOI 10.1128/JCM.00955-14; Rawlings LH, 2008, BIOL J LINN SOC, V93, P603, DOI 10.1111/j.1095-8312.2007.00904.x; Rawlings LH, 2003, MOL PHYLOGENET EVOL, V27, P36, DOI 10.1016/S1055-7903(02)00396-2; RZEPCZYK C, 1976, Z PARASITENKD, V50, P137, DOI 10.1007/BF00380518; RZEPCZYK C M, 1974, International Journal for Parasitology, V4, P447, DOI 10.1016/0020-7519(74)90058-7; Shahari S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1883-9; SHINE R, 1990, HERPETOLOGICA, V46, P283; Shine R, 1998, FUNCT ECOL, V12, P248, DOI 10.1046/j.1365-2435.1998.00179.x; Slapeta JR, 2003, MOL PHYLOGENET EVOL, V27, P464, DOI 10.1016/S1055-7903(03)00018-6; Slapeta JR, 2002, PARASITOL RES, V88, P810, DOI 10.1007/s00436-002-0657-9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tappe D, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.21.20816; Tian M, 2012, VET PARASITOL, V183, P373, DOI 10.1016/j.vetpar.2011.07.034; Verma SK, 2016, PARASITOL RES, V115, P1767, DOI 10.1007/s00436-016-4914-8; Volf J, 1999, FOLIA PARASITOL PRAH; Watthanakaiwan V, 2015, P 53 KAS U ANN C 201; Yang ZQ, 2005, PARASITOL INT, V54, P75, DOI 10.1016/j.parint.2004.12.004; ZAMAN V, 1975, Z PARASITENKD, V47, P169, DOI 10.1007/BF00418200; ZAMAN V, 1976, Southeast Asian Journal of Tropical Medicine and Public Health, V7, P112	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187984	10.1371/journal.pone.0187984	http://dx.doi.org/10.1371/journal.pone.0187984			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131856	Green Published, gold, Green Submitted			2022-12-26	WOS:000414997800034
J	Dimasuay, KG; Gong, L; Rosario, F; McBryde, E; Spelman, T; Glazier, J; Rogerson, SJ; Beeson, JG; Jansson, T; Devenish, RJ; Boeuf, P				Dimasuay, Kris Genelyn; Gong, Lan; Rosario, Fredrick; McBryde, Emma; Spelman, Tim; Glazier, Jocelyn; Rogerson, Stephen J.; Beeson, James G.; Jansson, Thomas; Devenish, Rodney J.; Boeuf, Philippe			Impaired placental autophagy in placental malaria	PLOS ONE			English	Article							FETAL-GROWTH RESTRICTION; TRANSPORTER; PREGNANCY; RAB7; TROPHOBLAST; ASSOCIATION; DEGRADATION; MATURATION; MEMBRANE; PATHWAY	Background Placental malaria is a major cause of low birthweight, principally due to impaired fetal growth. Intervillositis, a local inflammatory response to placental malaria, is central to the pathogenesis of poor fetal growth as it impairs transplacental amino acid transport. Given the link between inflammation and autophagy, we investigated whether placental malaria-associated intervillositis increased placental autophagy as a potential mechanism in impaired fetal growth. Methods We examined placental biopsies collected after delivery from uninfected women (n = 17) and from women with Plasmodium falciparum infection with (n = 14) and without (n = 7) intervillositis. Western blotting and immunofluorescence staining coupled with advanced image analysis were used to quantify the expression of autophagic markers (LC3-II, LC3-I, Rab7, ATG4B and p62) and the density of autophagosomes (LC3-positive puncta) and lysosomes (LAMP1-positive puncta). Results Placental malaria with intervillositis was associated with higher LC3-II: LC3-I ratio, suggesting increased autophagosome formation. We found higher density of autophagosomes and lysosomes in the syncytiotrophoblast of malaria-infected placentas with intervillositis. However, there appear to be no biologically relevant increase in LC3B/LAMP1 colocalization and expression of Rab7, a molecule involved in autophagosome/lysosome fusion, was lower in placental malaria with intervillositis, indicating a block in the later stage of autophagy. ATG4B and p62 expression showed no significant difference across histological groups suggesting normal autophagosome maturation and loading of cargo proteins into autophagosomes. The density of autophagosomes and lysosomes in the syncytiotrophoblast was negatively correlated with placental amino acid uptake. Conclusions Placental malaria-associated intervillositis is associated with dysregulated autophagy that may impair transplacental amino acid transport, possibly contributing to poor fetal growth.	[Dimasuay, Kris Genelyn; McBryde, Emma; Spelman, Tim; Beeson, James G.; Boeuf, Philippe] Burnet Inst, Melbourne, Vic, Australia; [Dimasuay, Kris Genelyn; Rogerson, Stephen J.; Beeson, James G.; Boeuf, Philippe] Univ Melbourne, Peter Doherty Inst, Dept Med, Parkville, Vic, Australia; [Gong, Lan; Devenish, Rodney J.] Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia; [Gong, Lan; Devenish, Rodney J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Rosario, Fredrick; Jansson, Thomas] Univ Colorado, Dept Obstet & Gynecol, Anschutz Med Campus, Aurora, CO USA; [McBryde, Emma; Spelman, Tim; Rogerson, Stephen J.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic, Australia; [Glazier, Jocelyn] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Fac Biol Med & Hlth, St Marys Hosp, Manchester, Lancs, England; [Gong, Lan] Univ New South Wales, St George & Sutherland Clin Sch, Sydney, NSW, Australia; [McBryde, Emma] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia	Burnet Institute; University of Melbourne; Monash University; Monash University; University of Colorado System; University of Colorado Anschutz Medical Campus; Royal Melbourne Hospital; University of Manchester; University of New South Wales Sydney; James Cook University	Boeuf, P (corresponding author), Burnet Inst, Melbourne, Vic, Australia.; Boeuf, P (corresponding author), Univ Melbourne, Peter Doherty Inst, Dept Med, Parkville, Vic, Australia.	philippe.boeuf@burnet.edu.au	Gong, Lan/O-7886-2019; Rosario, Fredrick Joseph/I-2835-2019; McBryde, Emma/D-2220-2018	Gong, Lan/0000-0003-3136-1565; Dimasuay, Kris Genelyn/0000-0001-9229-4824; McBryde, Emma/0000-0002-9570-9172	Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne; National Institutes of Health [RHD68370]; Australian National Health and Medical Research Council [1092789]; Australian National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme; Victoria State Government Operational Infrastructure Support grant	Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne(University of Melbourne); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme; Victoria State Government Operational Infrastructure Support grant	This work was supported by the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne [Henry and Rachael Ackman Travelling Scholarship to KGD]; the National Institutes of Health [RHD68370 to TJ] and the Australian National Health and Medical Research Council [program grant 1092789 to JGB and SJR]. The Burnet Institute is supported by the Australian National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme, and a Victoria State Government Operational Infrastructure Support grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; AGRAWAL V, 2015, SCI REP UK, V5; Altman BJ, 2009, AUTOPHAGY, V5, P569, DOI 10.4161/auto.5.4.8254; Ao X, 2014, CELL DEATH DIFFER, V21, P348, DOI 10.1038/cdd.2013.187; Bains M, 2011, NEUROSCI LETT, V488, P112, DOI 10.1016/j.neulet.2010.09.018; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Bildirici I, 2012, PLACENTA, V33, P591, DOI 10.1016/j.placenta.2012.04.011; Boeuf P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003153; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cao B, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12650; Chandrasiri UP, 2014, J INFECT DIS; Chandrasiri UP, 2014, J INFECT DIS, V209, P1663, DOI 10.1093/infdis/jit803; Conroy AL, 2013, CELL HOST MICROBE, V13, P215, DOI 10.1016/j.chom.2013.01.010; Conroy AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028540; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Curtis S, 2013, J MATERN-FETAL NEO M, V26, P339, DOI 10.3109/14767058.2012.733764; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dimasuay KG, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0759-3; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Glazier JD, 1997, PEDIATR RES, V42, P514, DOI 10.1203/00006450-199710000-00016; Gong Jin-Sung, 2014, Clin Exp Reprod Med, V41, P97, DOI 10.5653/cerm.2014.41.3.97; Guerra F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030034; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Hung TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040957; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Keelan JA, 2015, NANOMEDICINE-UK, V10, P2229, DOI [10.2217/NNM.15.48, 10.2217/nnm.15.48]; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Liu PF, 2014, AUTOPHAGY, V10, P1454, DOI 10.4161/auto.29556; MAHENDRAN D, 1993, PEDIATR RES, V34, P661; Mijaljica D, 2012, INT J MOL SCI, V13, P3618, DOI 10.3390/ijms13033618; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Oh SY, 2008, REPROD SCI, V15, P912, DOI 10.1177/1933719108319159; Orr ME, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt217; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rosario FJ, 2013, J PHYSIOL-LONDON, V591, P609, DOI 10.1113/jphysiol.2012.238014; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003; Signorelli P, 2011, PLACENTA, V32, P482, DOI 10.1016/j.placenta.2011.03.005; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Walker PGT, 2014, LANCET GLOB HEALTH, V2, pE460, DOI 10.1016/S2214-109X(14)70256-6; WHO, 2004, LOW BIRTHW COUNTR RE; WHO, 2014, CONTR MAL CONTR MAT; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102	52	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187291	10.1371/journal.pone.0187291	http://dx.doi.org/10.1371/journal.pone.0187291			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125872	gold, Green Published, Green Accepted			2022-12-26	WOS:000414866000011
J	Kyek, M; Kaufmann, PH; Lindner, R				Kyek, Martin; Kaufmann, Peter H.; Lindner, Robert			Differing long term trends for two common amphibian species (Bufo bufo and Rana temporaria) in alpine landscapes of Salzburg, Austria	PLOS ONE			English	Article							CONSERVATION; DECLINE; POPULATIONS	This study focuses on the population trends of two widespread European anuran species: the common toad (Bufo bufo) and the common frog (Rana temporaria). The basis of this study is data gathered over two decades of amphibian fencing alongside roads in the Austrian state of Salzburg. Different statistical approaches were used to analyse the data. Overall average increase or decrease of each species was estimated by calculating a simple average locality index. In addition the statistical software TRIM was used to verify these trends as well as to categorize the data based on the geographic location of each migration site. The results show differing overall trends for the two species: the common toad being stable and the common frog showing a substantial decline over the last two decades. Further analyses based on geographic categorization reveal the strongest decrease in the alpine range of the species. Drainage and agricultural intensification are still ongoing problems within alpine areas, not only in Salzburg. Particularly in respect to micro-climate and the availability of spawning places these changes appear to have a greater impact on the habitats of the common frog than the common toad. Therefore we consider habitat destruction to be the main potential reason behind this dramatic decline. We also conclude that the substantial loss of biomass of a widespread species such as the common frog must have a severe, and often overlooked, ecological impact.	[Kyek, Martin; Kaufmann, Peter H.; Lindner, Robert] Haus Nat, Museum Nat & Tech, Museumspl 5, Salzburg, Austria		Kaufmann, PH (corresponding author), Haus Nat, Museum Nat & Tech, Museumspl 5, Salzburg, Austria.	peter.kaufmann@hausdernatur.at		Kaufmann, Peter/0000-0002-2611-5071	state government of Salzburg; European Union; state-government of Salzburg; European Agricultural Fund for Rural Development; city of Salzburg	state government of Salzburg; European Union(European Commission); state-government of Salzburg; European Agricultural Fund for Rural Development; city of Salzburg	Even though the installation and administration of amphibian fences was funded by the state government of Salzburg together with the European Union, the authors received no specific funding for the analyses published in this work.; We would like to thank all the many volunteers who offered their time and work to maintain amphibian fences over the last twenty or more years. Without their relentless commitment neither systematic amphibian conservation nor this study would have been possible. For the erection and the technical service of the amphibian fences we furthermore thank the local road maintenance staff as well as the community governments and the members of the "Berg- und Naturwacht Salzburg" (nature wardens). We also would like to thank the state-government of Salzburg (especially Mag. Maria Jerabek) for the continuous support and funding of amphibian protection in Salzburg. The maintenance of the annual amphibian fences has been co-financed by the European Agricultural Fund for Rural Development. We also want to thank two anonymous referees as well as Norbert Teufelbauer, who helped to considerably improve the manuscript, and Chris Taylor, who proofread the text and improved our English. Finally we want to thank the city of Salzburg for financial support regarding the publication fees.	Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; [Anonymous], 2004, DATA BIRD; [Anonymous], LANDNUTZUNG BIOL VIE; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Beebee TJC, 2013, CONSERV BIOL, V27, P657, DOI 10.1111/cobi.12063; Beniston M, 2002, THEORETICAL APPL CLI, P29; Biek R, 2002, CONSERV BIOL, V16, P728, DOI 10.1046/j.1523-1739.2002.00433.x; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Bonardi A, 2001, BIOL CONSERV, V144, P2328; Bonardi A, 2012, FROGLOG, V101, P22; Carrier JA, 2003, BIOL CONSERV, V111, P395, DOI 10.1016/S0006-3207(02)00308-7; COOKE AS, 1972, J ZOOL, V167, P161; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gaston KJ, 2007, PROG PHYS GEOG, V31, P213, DOI 10.1177/0309133307076488; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Gollmann B, 2014, HDB REPTILIEN AMPHIB, P305; GOLLMANN G., 2007, ROTE LISTEN GEFAHRDE, V14/2, P37; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; IUCN, IUCN RED LIST THREAT; Jehle R, 1997, STAPFIA 51, P73; Jochimsen DM, 2004, LIT REV EFFECTS ROAD; Jolivet R, 2013, IMPACT ROAD MITIGATI; Klepsch R, 2011, AMPHIBIENSCHUTZ STRA, V25, P1; Kyek M, 1999, ENZY AMPHIBIANS, P242; Kyek M, 1992, THESIS; Kyek M, 1995, LOBF MITTEILUNGEN, V1, P34; Kyek M, 2006, NATURSCHUTZ BEITRAGE; Loman J, 2007, BIOL CONSERV, V135, P46, DOI 10.1016/j.biocon.2006.09.017; Meyer AH, 1998, P ROY SOC B-BIOL SCI, V265, P523, DOI 10.1098/rspb.1998.0326; Pannekoek, 2005, TRIM 3 MANUAL TRENDS; Petrovan SO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161943; Schluepmann Martin, 2011, P787; Schmidt Benedikt R., 2011, Zeitschrift fuer Feldherpetologie, V18, P129; Seefeldner E., 1961, SALZBURG SEINE LANDS; Sinsch U., 2009, HDB REPTILIEN AMPHIB, P191; Sztatecsny M, 2009, ECO MONT, V1, P19, DOI 10.1553/ecomont2s19; Sztatecsny M, 2011, HERPETOL J, V21, P87; Wagner N, 2013, DELATTINIA, V39, P195; Weddeling K, 2011, HDB REPTILIEN AMPHIB, P582	39	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187148	10.1371/journal.pone.0187148	http://dx.doi.org/10.1371/journal.pone.0187148			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121054	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900023
J	Andres-Colas, N; Van Der Straeten, D				Andres-Colas, Nuria; Van Der Straeten, Dominique			Optimization of non-denaturing protein extraction conditions for plant PPR proteins	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; ARABIDOPSIS-THALIANA; RNA; MITOCHONDRIA; RECOGNITION; FERTILITY; SUBSTRATE; VECTORS; COMPLEX; SYSTEM	Pentatricopeptide repeat proteins are one of the major protein families in flowering plants, containing around 450 members. They participate in RNA editing and are related to plant growth, development and reproduction, as well as to responses to ABA and abiotic stresses. Their characteristics have been described in silico; however, relatively little is known about their biochemical properties. Different types of PPR proteins, with different tasks in RNA editing, have been suggested to interact in an editosome to complete RNA editing. Other non-PPR editing factors, such as the multiple organellar RNA editing factors and the organelle RNA recognition motif-containing protein family, for example, have also been described in plants. However, while evidence on protein interactions between non-PPR RNA editing proteins is accumulating, very few PPR protein interactions have been reported; possibly due to their high instability. In this manuscript, we aimed to optimize the conditions for non denaturing protein extraction of PPR proteins allowing in vivo protein analyses, such as interaction assays by co-immunoprecipitation. The unusually high protein degradation rate, the aggregation properties and the high pl, as well as the ATP-dependence of some PPR proteins, are key aspects to be considered when extracting PPR proteins in a non-denatured state. During extraction of PPR proteins, the use of proteasome and phosphatase inhibitors is critical. The use of the ATP-cofactor reduces considerably the degradation of PPR proteins. A short centrifugation step to discard cell debris is essential to avoid PPR precipitation; while in some cases, addition of a reductant is needed, probably caused by the pl/pH context. This work provides an easy and rapid optimized non-denaturing total protein extraction protocol from plant tissue, suitable for polypeptides of the PPR family.	[Andres-Colas, Nuria; Van Der Straeten, Dominique] Univ Ghent, Dept Biol, Lab Funct Plant Biol, Ghent, Belgium	Ghent University	Van Der Straeten, D (corresponding author), Univ Ghent, Dept Biol, Lab Funct Plant Biol, Ghent, Belgium.	Dominique.VanDerStraeten@ugent.be	Van Der Straeten, Dominique/E-7385-2016	Van Der Straeten, Dominique/0000-0002-7755-1420	Research Foundation Flanders (FWO) [G.0C84.14N]; Ghent University	Research Foundation Flanders (FWO)(FWO); Ghent University(Ghent University)	This work was supported by Research Foundation Flanders (FWO) (project G.0C84.14N). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r D.V.D.S. gratefully acknowledges Ghent University and the Research Foundation Flanders (FWO) for financial support (project G.0084.14N). N.A.-C. and D.V.D.S. acknowledge Maria Helena S. Goldman for the N. benthamiana seeds, helpful suggestions regarding experimental design and data interpretation, and critical reading of the manuscript.	Andres-Colas N, 2017, P NATL ACAD SCI USA, V114, P8883, DOI 10.1073/pnas.1705815114; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Colcombet J, 2013, RNA BIOL, V10, P1557, DOI 10.4161/rna.26128; Coquille S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6729; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; Glass F, 2015, MOL PLANT, V8, P1466, DOI 10.1016/j.molp.2015.05.008; Hartel B, 2013, PLANT MOL BIOL, V81, P337, DOI 10.1007/s11103-012-0003-2; Hegeman CE, 2005, PLANT J, V42, P124, DOI 10.1111/j.1365-313X.2005.02360.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hooper CM, 2017, NUCLEIC ACIDS RES, V45, pD1064, DOI 10.1093/nar/gkw1041; Hu J, 2012, PLANT CELL, V24, P109, DOI 10.1105/tpc.111.093211; Ichinose M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010005; Jaedicke K, 2012, P NATL ACAD SCI USA, V109, P12231, DOI 10.1073/pnas.1120203109; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Klenova E, 2002, METHODS, V26, P254, DOI 10.1016/S1046-2023(02)00029-4; Kobayashi T, 2016, METHODS MOL BIOL, V1469, P147, DOI 10.1007/978-1-4939-4931-1_11; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Kun W, 2010, PLANT MOL BIOL REP, V29, P739; Law YS, 2015, PLANT PHYSIOL, V169, P1344, DOI 10.1104/pp.15.01115; Liu JM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01825; Liu Y, 2010, PLANT J, V63, P749, DOI 10.1111/j.1365-313X.2010.04280.x; Irigoyen ML, 2014, PLANT CELL, V26, P712, DOI 10.1105/tpc.113.122234; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Magori S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002124; Manavski N, 2012, PLANT CELL, V24, P3087, DOI 10.1105/tpc.112.099051; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Pukac LA, 1997, BIOTECHNIQUES, V23, P385, DOI 10.2144/97233bm08; Saha D, 2007, PLANT PHYSIOL BIOCH, V45, P521, DOI 10.1016/j.plaphy.2007.03.026; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Singh R, 2012, PLANT PHYSIOL, V160, P477, DOI 10.1104/pp.112.200071; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Sun T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005028; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Sung TY, 2010, PLANT J, V63, P499, DOI 10.1111/j.1365-313X.2010.04258.x; Takenaka M, 2007, METHOD ENZYMOL, V424, P439, DOI 10.1016/S0076-6879(07)24020-0; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Tan SC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/574398; Uyttewaal M, 2008, PLANT CELL, V20, P3331, DOI 10.1105/tpc.107.057208; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Yagi Y, 2013, RNA BIOL, V10, P1419, DOI 10.4161/rna.24908; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Zhou X, 2012, J CELL BIOL, V196, P203, DOI 10.1083/jcb.201108098; Zhu Q, 2014, MOL PLANT, V7, P290, DOI 10.1093/mp/sst102; Zhu Q, 2012, PLANT J, V71, P836, DOI 10.1111/j.1365-313X.2012.05036.x	47	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187753	10.1371/journal.pone.0187753	http://dx.doi.org/10.1371/journal.pone.0187753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112961	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100036
J	Raz, V; Riaz, M; Tatum, Z; Kielbasa, SM; 't Hoen, PAC				Raz, Vered; Riaz, Muhammad; Tatum, Zuotian; Kielbasa, Szymon M.; 't Hoen, Peter A. C.			The distinct transcriptomes of slow and fast adult muscles are delineated by noncoding RNAs	FASEB JOURNAL			English	Article						skeletal muscles; fiber type; mRNA processing; RNAseq; noncoding RNA	FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; TARGET GENES; FIBER TYPES; PROTEIN; DIFFERENTIATION; MECHANISMS; EXPRESSION; COOPERATION; HOMEOSTASIS	Adult muscles have a vast adaptation capacity, enabling function switches in response to altered conditions. During intensive physical activity, disease, or aging, adult skeletal muscles change and adjust their functions. The competence to adjust varies among muscles. Muscle-specific molecular mechanisms in healthy and normal conditions could designate changes in physiologic and pathologic conditions. We generated deep mRNA-sequencing data in adult fast and slow mouse muscles, and applying paired analysis, we identified that the muscle specific signatures are composed of half of the muscle transcriptome. The fast muscles showed a more compact gene network that is concordant with homogenous myofiber typing, compared with the pattern in the slow muscle. The muscle-specific mRNA landscape did not correlate with alternative spicing, alternative polyadenylation, or the expression of muscle transcription factor gene networks. However, we found significant correlation between the differentially expressed noncoding RNAs, microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) and their target genes. More than 25% of the genes expressed in amuscle-specific fashion were found to be targets of muscle specific miRNAs and lncRNAs. We suggest that muscle-specific miRNAs and lncRNAs contribute to the establishment of muscle-specific transcriptomes in adult muscles.	[Raz, Vered; Riaz, Muhammad; Tatum, Zuotian; 't Hoen, Peter A. C.] Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands; [Kielbasa, Szymon M.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Bioinformat Ctr Expertise, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Raz, V (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands.	v.raz@lumc.nl	Kiełbasa, Szymon M./K-2792-2019; Kiełbasa, Szymon/G-1636-2018; Hoen, Peter A 't/D-3950-2018	Kiełbasa, Szymon/0000-0003-2805-6535; Hoen, Peter A 't/0000-0003-4450-3112; raz, vered/0000-0003-3152-1952	AFM-Telethon [21160]	AFM-Telethon(Association Francaise contre les Myopathies)	The authors thank Raz Yotam (Leiden University Medical Centre) for muscle histology staining and image quantification advice, and Maaike van Putten (Leiden University Medical Centre) for advice on muscle myofiber staining. The authors thank the Leiden Genome Technology Center and the Sequencing Analysis Support Core (Leiden University Medical Center) for RNAseq and quality control assessment of the RNAseq. The study was partly funded by AFM-Telethon 21160. The authors declare no conflicts of interest.	Abbassi-Daloii T, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0007-x; Aoi W, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00290; Bajan Sarah, 2014, Microrna, V3, P10; Barber TD, 2002, GENOMICS, V79, P278, DOI 10.1006/geno.2002.6703; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490; Cheng AW, 2014, BLOOD, V124, P598, DOI 10.1182/blood-2013-12-542209; Conerly ML, 2016, DEV CELL, V36, P375, DOI 10.1016/j.devcel.2016.01.021; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; de Klerk E, 2012, NUCLEIC ACIDS RES, V40, P9089, DOI 10.1093/nar/gks655; Flynn JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013535; Fu LN, 2014, CELL RES, V24, P141, DOI 10.1038/cr.2013.165; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GAUTHIER GF, 1966, J CELL BIOL, V28, P333, DOI 10.1083/jcb.28.2.333; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Horak M, 2016, DEV BIOL, V410, P1, DOI 10.1016/j.ydbio.2015.12.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes SM, 1997, MECH DEVELOP, V61, P151, DOI 10.1016/S0925-4773(96)00631-4; Jelier R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-291; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Katz Y, 2015, BIOINFORMATICS, V31, P2400, DOI 10.1093/bioinformatics/btv034; Koebis M, 2011, GENES CELLS, V16, P961, DOI 10.1111/j.1365-2443.2011.01542.x; Larsen M, 2015, EUR J HUM GENET, V23, P808, DOI 10.1038/ejhg.2014.191; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Li N, 2013, NAT PROTOC, V8, P1155, DOI 10.1038/nprot.2013.065; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Mankodi A, 2003, ANN NEUROL, V54, P760, DOI 10.1002/ana.10763; Martinet C, 2016, DEVELOPMENT, V143, P962, DOI 10.1242/dev.131771; Merrell AJ, 2016, NAT REV MOL CELL BIO, V17, P413, DOI 10.1038/nrm.2016.24; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Neguembor MV, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-8; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Porter JD, 2001, P NATL ACAD SCI USA, V98, P12062, DOI 10.1073/pnas.211257298; Purves-Smith FM, 2014, EXERC SPORT SCI REV, V42, P45, DOI 10.1249/JES.0000000000000012; Rahimov F, 2012, P NATL ACAD SCI USA, V109, P16234, DOI 10.1073/pnas.1209508109; Raz Y, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00236; Riaz M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006031; Riaz M, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0064-4; ROBINSON MD, 2010, GENOME BIOL, V11; Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422; Sakakibara I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004386; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098; Wang B, 2017, J AM SOC NEPHROL, V28, P2632, DOI 10.1681/ASN.2016111213; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xia Z., 2014, NAT COMMUN, V5	58	16	17	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1579	1590		10.1096/fj.201700861R	http://dx.doi.org/10.1096/fj.201700861R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29141996				2022-12-26	WOS:000427246000036
J	Schwartz, NU; Linzer, RW; Truman, JP; Gurevich, M; Hannun, YA; Senkal, CE; Obeid, LM				Schwartz, Nicholas U.; Linzer, Ryan W.; Truman, Jean-Philip; Gurevich, Mikhail; Hannun, Yusuf A.; Senkal, Can E.; Obeid, Lina M.			Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F	FASEB JOURNAL			English	Article						sphingolipid; CerS; mitochondria; neuropathy; CMT2F	LONGEVITY ASSURANCE GENES; OXIDATIVE STRESS; ANIMAL-MODELS; DISEASE; CELL; AUTOPHAGY; MOTOR; HEAT-SHOCK-PROTEIN-27; SPHINGOLIPIDS; SYNTHASES	Charcot-Marie-Tooth (CMT) disease is the most commonly inherited neurologic disorder, but its molecular mechanisms remain unclear. One variant of CMT, 2F, is characterized by mutations in heat shock protein 27 (Hsp27). As bioactive sphingolipids have been implicated in neurodegenerative diseases, we sought to determine if their dysregulation is involved in CMT. Here, we show that Hsp27 knockout mice demonstrated decreases in ceramide in peripheral nerve tissue and that the disease-associated Hsp27 S135F mutant demonstrated decreases in mitochondrial ceramide. Given that Hsp27 is a chaperone protein, we examined its role in regulating ceramide synthases (CerSs), an enzyme family responsible for catalyzing generation of the sphingolipid ceramide. We determined that CerSs colocalized with Hsp27, and upon the presence of S135F mutants, CerS1 lost its colocalization with mitochondria suggesting that decreased mitochondrial ceramides result from reduced mitochondrial CerS localization rather than decreased CerS activity. Mitochondria in mutant cells appeared larger with increased interconnectivity. Furthermore, mutant cell lines demonstrated decreased mitochondrial respiratory function and increased autophagic flux. Mitochondrial structural and functional changes were recapitulated by blocking ceramide generation pharmacologically. These results suggest that mutant Hsp27 decreases mitochondrial ceramide levels, producing structural and functional changes in mitochondria leading to neuronal degeneration.	[Schwartz, Nicholas U.] SUNY Stony Brook, Dept Neurobiol & Behav, Sch Med, Stony Brook, NY 11794 USA; [Linzer, Ryan W.; Truman, Jean-Philip; Hannun, Yusuf A.; Senkal, Can E.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Sch Med, Stony Brook, NY 11794 USA; [Gurevich, Mikhail] SUNY Stony Brook, Dept Pharmacol, Sch Med, Stony Brook, NY 11794 USA; [Gurevich, Mikhail] SUNY Stony Brook, Sch Med, Dept Orthopaed, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Obeid, LM (corresponding author), SUNY Stony Brook, Med Ctr, Hlth Sci Ctr, L-4,179, Stony Brook, NY 11794 USA.	lina.obeid@stonybrookmedicine.edu	Gurevich, Mikhail/AAO-2831-2020	Gurevich, Mikhail/0000-0002-4928-9939	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM062887]; Veterans Affairs Merit Award [5I01BX000156-08]; NIH National Cancer Institute [P01CA097132]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887, R01GM097741] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; Veterans Affairs Merit Award(US Department of Veterans Affairs); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. Chiara Luberto (Stony Brook University) for overall advice. The authors also thank the Stony Brook Lipidomics Core for measurement and analysis of sphingolipids, the Stony Brook Proteomics Core for proteomic measurement and analysis of samples, and Dr. Ashley Snider (Stony Brook University) for assistance in managing mice. Peter Dong (University of Pennsylvania, Philadelphia, PA, USA) and Dr. Tanvir Khan (Stony Brook University) assisted in training for DRG dissection. The research in this manuscript was supported by the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant GM062887 and Veterans Affairs Merit Award 5I01BX000156-08 (to L.M.O.), NIH National Cancer Institute Grant P01CA097132 (to Y.A.H. and L.M.O.). The authors declare no conflicts of interest.	Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Almeida-Souza L, 2011, J NEUROSCI, V31, P15320, DOI 10.1523/JNEUROSCI.3266-11.2011; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Atkinson D, 2017, NEUROLOGY, V88, P533, DOI 10.1212/WNL.0000000000003595; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Bouhy D, 2013, ANN NEUROL, V74, P391, DOI 10.1002/ana.23987; Chen R, 2011, FOLIA BIOL-PRAGUE, V57, P87; Crowe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077383; d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P603, DOI 10.1001/archneur.1968.00470360025002; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fleming MS, 2015, ELIFE, V4, DOI 10.7554/eLife.06828; Haidar M, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00143; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harel T, 2014, CLIN GENET, V86, P422, DOI 10.1111/cge.12393; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Henriques A, 2015, HUM MOL GENET, V24, P7390, DOI 10.1093/hmg/ddv439; Hernandez-Corbacho MJ, 2015, J BIOL CHEM, V290, P25356, DOI 10.1074/jbc.M115.658658; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Kim JY, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9475981; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Lee J, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0154-y; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lee SM, 2011, J CELL SCI, V124, P3319, DOI 10.1242/jcs.087114; Liu J, 2009, LIFE SCI, V84, P267, DOI 10.1016/j.lfs.2008.12.008; Luigetti M, 2010, J NEUROL SCI, V298, P114, DOI 10.1016/j.jns.2010.09.008; MACMILLAN JC, 1994, CLIN GENET, V45, P128; Matsumoto T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126229; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Mielke MM, 2012, NEUROLOGY, V79, P633, DOI 10.1212/WNL.0b013e318264e380; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; MORELL P, 1970, J BIOL CHEM, V245, P342; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Neusch C, 2007, EUR J NEUROL, V14, P575, DOI 10.1111/j.1468-1331.2006.01688.x; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Patwardhan GA, 2016, J BIOENERG BIOMEMBR, V48, P153, DOI 10.1007/s10863-015-9602-3; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Piccinini M, 2010, MOL NEUROBIOL, V41, P314, DOI 10.1007/s12035-009-8096-6; Rodriguez GE, 2012, ARQ NEURO-PSIQUIAT, V70, P45, DOI 10.1590/S0004-282X2012000100010; Sanderson TH, 2015, MOL CELL NEUROSCI, V64, P116, DOI 10.1016/j.mcn.2014.12.007; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002; Shen L, 2016, CELL SIGNAL, V28, P1086, DOI 10.1016/j.cellsig.2016.05.008; Smith HL, 2015, SEMIN CELL DEV BIOL, V40, P142, DOI 10.1016/j.semcdb.2015.03.003; Sridevi P, 2010, EXP CELL RES, V316, P78, DOI 10.1016/j.yexcr.2009.09.027; Srivastava AK, 2012, NEUROBIOL DIS, V47, P163, DOI 10.1016/j.nbd.2012.03.035; Sundaram K, 2016, BIOCHEM J, V473, P743, DOI 10.1042/BJ20150586; Tang BS, 2005, ARCH NEUROL-CHICAGO, V62, P1201, DOI 10.1001/archneur.62.8.1201; Teramoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066001; Timmerman V, 2014, GENES-BASEL, V5, P13, DOI 10.3390/genes5010013; Tirodkar TS, 2015, J BIOL CHEM, V290, P13157, DOI 10.1074/jbc.M114.631325; Toth ME, 2013, CELL STRESS CHAPERON, V18, P759, DOI 10.1007/s12192-013-0428-9; Venkataraman K, 2002, FEBS LETT, V528, P3, DOI 10.1016/S0014-5793(02)03248-9; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Xie WL, 2012, J NEUROCHEM, V122, P404, DOI 10.1111/j.1471-4159.2012.07769.x; Xu HB, 2014, EUR J CLIN MICROBIOL, V33, P347, DOI 10.1007/s10096-013-1962-1; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	66	15	17	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1716	1728		10.1096/fj.201701067R	http://dx.doi.org/10.1096/fj.201701067R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29133339	Green Published			2022-12-26	WOS:000427246000047
J	Gasparotto, J; Girardi, CS; Somensi, N; Ribeiro, CT; Moreira, JCF; Michels, M; Sonai, B; Rocha, M; Steckert, AV; Barichello, T; Quevedo, J; Dal-Pizzol, F; Gelain, DP				Gasparotto, Juciano; Girardi, Carolina S.; Somensi, Nauana; Ribeiro, Camila T.; Moreira, Jose C. F.; Michels, Monique; Sonai, Beatriz; Rocha, Mariane; Steckert, Amanda V.; Barichello, Tatiana; Quevedo, Joao; Dal-Pizzol, Felipe; Gelain, Daniel P.			Receptor for advanced glycation end products mediates sepsis-triggered amyloid-beta accumulation, Tau phosphorylation, and cognitive impairment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ALZHEIMERS-DISEASE; CECAL LIGATION; ANIMAL-MODEL; MOUSE MODEL; SYSTEMIC INFLAMMATION; OXIDATIVE STRESS; RAGE; BRAIN; PROTEIN	Patients recovering from sepsis have higher rates of CNS morbidities associated with long-lasting impairment of cognitive functions, including neurodegenerative diseases. However, the molecular etiology of these sepsis-induced impairments is unclear. Here, we investigated the role of the receptor for advanced glycation end products (RAGE) in neuroinflammation, neurodegeneration-associated changes, and cognitive dysfunction arising after sepsis recovery. Adult Wistar rats underwent cecal ligation and perforation (CLP), and serum and brain (hippocampus and prefrontal cortex) samples were obtained at days 1, 15, and 30 after the CLP. We examined these samples for systemic and brain inflammation; amyloid-beta peptide (A beta) and Ser-202-phosphorylated Tau (p-Tau(Ser-202)) levels; and RAGE, RAGE ligands, and RAGE intracellular signaling. Serum markers associated with the acute proinflammatory phase of sepsis (TNF alpha, IL-1 beta, and IL-6) rapidly increased and then progressively decreased during the 30-day period post-CLP, concomitant with a progressive increase in RAGE ligands (S100B, N epsilon-[carboxymethyl]lysine, HSP70, and HMGB1). In the brain, levels of RAGE and Toll-like receptor 4, glial fibrillary acidic protein and neuronal nitric-oxide synthase, and A beta and p-Tau(Ser-202) also increased during that time. Of note, intracerebral injection of RAGE antibody into the hippocampus at days 15, 17, and 19 post-CLP reduced A beta and p-Tau(Ser-202) accumulation, Akt/mechanistic target of rapamycin signaling, levels of ionized calcium-binding adapter molecule 1 and glial fibrillary acidic protein, and behavioral deficits associated with cognitive decline. These results indicate that brain RAGE is an essential factor in the pathogenesis of neurological disorders following acute systemic inflammation.	[Gasparotto, Juciano; Girardi, Carolina S.; Somensi, Nauana; Ribeiro, Camila T.; Moreira, Jose C. F.; Gelain, Daniel P.] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Ctr Estudos Estresse Oxidat, BR-90035003 Porto Alegre, RS, Brazil; [Michels, Monique; Sonai, Beatriz; Rocha, Mariane; Dal-Pizzol, Felipe] Univ Extremo Sul Catarinense Criciuma, Inst Nacl Ciencia & Tecnol Translac Med, Lab Fisiopatol Expt, BR-88806000 Criciuma, SC, Brazil; [Steckert, Amanda V.; Barichello, Tatiana; Quevedo, Joao] Univ Extremo Sul Catarinense Criciuma, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Neurociencias, BR-88806000 Criciuma, SC, Brazil; [Steckert, Amanda V.; Barichello, Tatiana; Quevedo, Joao] Univ Texas Hlth Sci Ctr Houston, Translat Psychiat Program, Houston, TX 77030 USA; [Steckert, Amanda V.; Barichello, Tatiana; Quevedo, Joao] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Psychiat & Behav Sci, Ctr Excellence Mood Disorders, Houston, TX 77030 USA; [Steckert, Amanda V.; Barichello, Tatiana; Quevedo, Joao] Univ Texas Grad Sch Biomed Sci Houston, Neurosci Grad Program, Houston, TX 77030 USA	Universidade Federal do Rio Grande do Sul; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Gelain, DP (corresponding author), Univ Fed Rio Grande do Sul, ICBS, Dept Bioquim, Rua Ramiro Barcelos,2600 Anexo, BR-90035003 Porto Alegre, RS, Brazil.	daniel.gelain@ufrgs.br	Gasparotto, Juciano/K-3239-2013; Girardi, Carolina/M-8804-2019; MICHELS, MONIQUE/U-3967-2019; de Quevedo, João Luciano/E-5491-2013; Gelain, Daniel Pens/I-5144-2013; Barichello, Tatiana/E-2725-2013; moreira, jose claudio/AAO-6400-2021	Gasparotto, Juciano/0000-0003-2545-7288; MICHELS, MONIQUE/0000-0001-8440-1976; de Quevedo, João Luciano/0000-0003-3114-6611; Gelain, Daniel Pens/0000-0001-5254-0509; Saibro Girardi, Carolina/0000-0002-1685-011X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina; Propesq/UFRGS; Fundacao CAPES, Instituto Cerebro e Mente; UNESC	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina; Propesq/UFRGS; Fundacao CAPES, Instituto Cerebro e Mente(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UNESC	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to D. P. G., J. C. F. M., J. Q., and F. D.-P.), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (to D. P. G. and J. C. F. M.), Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (to J. Q. and F. D.-P.), Propesq/UFRGS (to D. P. G. and J. C. F. M.), Fundacao CAPES, Instituto Cerebro e Mente (to J. Q.) and UNESC (to T. B., J. Q., and F. D.-P.). The authors declare that they have no conflicts of interest with the contents of this article.	Annane D, 2015, LANCET RESP MED, V3, P61, DOI 10.1016/S2213-2600(14)70246-2; Asati V, 2016, EUR J MED CHEM, V109, P314, DOI 10.1016/j.ejmech.2016.01.012; Barichello T, 2007, BRAZ J MED BIOL RES, V40, P831, DOI 10.1590/S0100-879X2007000600013; Barichello T, 2006, CRIT CARE MED, V34, P886, DOI 10.1097/01.CCM.0000201880.50116.12; Barichello T, 2005, CRIT CARE MED, V33, P1671, DOI 10.1097/01.CCM.0000170192.54682.C1; Barichello T, 2005, CRIT CARE MED, V33, P221, DOI 10.1097/01.CCM.0000150741.12906.BD; Barichello T, 2007, CRIT CARE MED, V35, P2186, DOI 10.1097/01.CCM.0000281452.60683.96; Batkulwar KB, 2015, PROTEOMICS, V15, P245, DOI 10.1002/pmic.201400169; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candela P, 2010, J ALZHEIMERS DIS, V22, P849, DOI 10.3233/JAD-2010-100462; Capetillo-Zarate E, 2011, AM J PATHOL, V179, P2551, DOI 10.1016/j.ajpath.2011.07.045; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Cho HJ, 2009, FASEB J, V23, P2639, DOI 10.1096/fj.08-126383; Creagh-Brown BC, 2010, INTENS CARE MED, V36, P1644, DOI 10.1007/s00134-010-1952-z; Cunningham C, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0117-2; Dal-Pizzol F, 2006, AM J RESP CRIT CARE, V173, P84, DOI 10.1164/rccm.200507-1118OC; Dal-Pizzol F, 2013, MOL NEUROBIOL, V48, P62, DOI 10.1007/s12035-013-8433-7; Dal-Pizzol F, 2012, MOL MED, V18, P1357, DOI 10.2119/molmed.2012.00317; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Dent Paul, 2014, Cancer Biol Ther, V15, P245, DOI 10.4161/cbt.27541; DUMOULIN GC, 1985, BRAIN RES, V340, P261, DOI 10.1016/0006-8993(85)90922-9; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Galasko D, 2014, NEUROLOGY, V82, P1536, DOI 10.1212/WNL.0000000000000364; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Goedert M, 1998, BIOCHEM SOC T, V26, P463, DOI 10.1042/bst0260463; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Gouras GK, 2014, NEURODEGENER DIS, V13, P142, DOI 10.1159/000354776; Guillot F, 2016, J ALZHEIMERS DIS, V51, P1157, DOI 10.3233/JAD-150926; GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hong Y, 2016, NEUROCHEM RES, V41, P1192, DOI 10.1007/s11064-015-1814-8; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kamat PK, 2014, MOL NEUROBIOL, V50, P852, DOI 10.1007/s12035-014-8699-4; Kuhla A, 2013, BRIT J SURG, V100, P1229, DOI 10.1002/bjs.9188; Lee JY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0310-z; Li XH, 2012, NEUROBIOL AGING, V33, P1400, DOI 10.1016/j.neurobiolaging.2011.02.003; Lukic IK, 2008, ANN NY ACAD SCI, V1126, P76, DOI 10.1196/annals.1433.059; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Lutterloh EC, 2007, EXPERT OPIN PHARMACO, V8, P1193, DOI 10.1517/14656566.8.9.1193; Maiese K, 2016, BRIT J CLIN PHARMACO, V82, P1245, DOI 10.1111/bcp.12804; Michels Monique, 2015, Intensive Care Med Exp, V3, P30, DOI 10.1186/s40635-015-0066-x; Michels M, 2015, BRAIN BEHAV IMMUN, V43, P54, DOI 10.1016/j.bbi.2014.07.002; Multhaup G, 2015, J BIOL CHEM, V290, P23515, DOI 10.1074/jbc.R115.677211; Nalivaeva NN, 2013, FEBS LETT, V587, P2046, DOI 10.1016/j.febslet.2013.05.010; [National Research Council (U.S.) Institute for Laboratory Animal Research (U.S.) & National Academies Press (U.S.).], 2011, COMM UPD GUID CAR US; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Opp MR, 2015, BRAIN BEHAV IMMUN, V50, P259, DOI 10.1016/j.bbi.2015.07.023; Origlia N, 2008, J NEUROSCI, V28, P3521, DOI 10.1523/JNEUROSCI.0204-08.2008; Pan WH, 2011, CURR PHARM DESIGN, V17, P3729, DOI 10.2174/138161211798220918; Paxinos G., 2005, RAT BRAIN STEREOTAXI, P181; Ritter C, 2004, CRIT CARE MED, V32, P342, DOI 10.1097/01.CCM.0000109454.13145.CA; Ritter C, 2003, INTENS CARE MED, V29, P1782, DOI 10.1007/s00134-003-1789-9; Roesler R, 1999, NEUROBIOL LEARN MEM, V72, P252, DOI 10.1006/nlme.1999.3910; Sabbagh MN, 2011, ALZ DIS ASSOC DIS, V25, P206, DOI 10.1097/WAD.0b013e318204b550; Schwalm MT, 2014, MOL NEUROBIOL, V49, P380, DOI 10.1007/s12035-013-8526-3; Semmler A, 2007, EXP NEUROL, V204, P733, DOI 10.1016/j.expneurol.2007.01.003; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Sharshar T, 2003, LANCET, V362, P1799, DOI 10.1016/S0140-6736(03)14899-4; Shi S, 2016, J ALZHEIMERS DIS, V50, P859, DOI 10.3233/JAD-150963; Simic G, 2002, LANCET NEUROL, V1, P276, DOI 10.1016/S1474-4422(02)00130-8; Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Tobon-Velasco JC, 2014, CNS NEUROL DISORD-DR, V13, P1615, DOI 10.2174/1871527313666140806144831; van Zoelen MAD, 2008, CRIT CARE, V12, DOI 10.1186/cc6187; van Zoelen MAD, 2009, J INFECT DIS, V200, P765, DOI 10.1086/604730; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Widmann CN, 2014, LANCET NEUROL, V13, P630, DOI 10.1016/S1474-4422(14)70017-1; Wilson JX, 2003, CAN J NEUROL SCI, V30, P98, DOI 10.1017/S031716710005335X; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Xia P, 2016, EUR J PHARMACOL, V779, P102, DOI 10.1016/j.ejphar.2016.03.017; Yarlagadda Atmaram, 2009, Psychiatry (Edgmont), V6, P18; Yende S, 2016, CRIT CARE MED, V44, P1461, DOI 10.1097/CCM.0000000000001658; Yu Y, 2015, CELL MOL NEUROBIOL, V35, P71, DOI 10.1007/s10571-014-0101-6; Zilka N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-47; Zuo L, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/604658	82	66	70	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					226	244		10.1074/jbc.M117.786756	http://dx.doi.org/10.1074/jbc.M117.786756			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29127203	hybrid, Green Published			2022-12-26	WOS:000419453200020
J	Bozler, J; Kacsoh, BZ; Bosco, G				Bozler, Julianna; Kacsoh, Balint Z.; Bosco, Giovanni			Nematocytes: Discovery and characterization of a novel anculeate hemocyte in Drosophila falleni and Drosophila phalerata	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSE; INNATE IMMUNITY; HEMATOPOIESIS; EVOLUTION; SYSTEM; CELLS	Immune challenges, such as parasitism, can be so pervasive and deleterious that they constitute an existential threat to a species' survival. In response to these ecological pressures, organisms have developed a wide array of novel behavioral, cellular, and molecular adaptations. Research into these immune defenses in model systems has resulted in a revolutionary understanding of evolution and functional biology. As the field has expanded beyond the limited number of model organisms our appreciation of evolutionary innovation and unique biology has widened as well. With this in mind, we have surveyed the hemolymph of several nonmodel species of Drosophila. Here we identify and describe a novel hemocyte, type-II nematocytes, found in larval stages of numerous Drosophila species. Examined in detail in Drosophila falleni and Drosophila phalerata, we find that these remarkable cells are distinct from previously described hemocytes due to their anucleate state (lacking a nucleus) and unusual morphology. Type-II nematocytes are long, narrow cells with spindle-like projections extending from a cell body with high densities of mitochondria and microtubules, and exhibit the ability to synthesize proteins. These properties are unexpected for enucleated cells, and together with our additional characterization, we demonstrate that these type-II nematocytes represent a biological novelty. Surprisingly, despite the absence of a nucleus, we observe through live cell imaging that these cells remain motile with a highly dynamic cellular shape. Furthermore, these cells demonstrate the ability to form multicellular structures, which we suggest may be a component of the innate immune response to macro-parasites. In addition, live cell imaging points to a large nucleated hemocyte, type-I nematocyte, as the progenitor cell, leading to enucleation through a budding or asymmetrical division process rather than nuclear ejection: This study is the first to report such a process of enucleation. Here we describe these cells in detail for the first time and examine their evolutionary history in Drosophila.	[Bozler, Julianna; Kacsoh, Balint Z.; Bosco, Giovanni] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH 03755 USA	Dartmouth College	Bozler, J (corresponding author), Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH 03755 USA.	Julianna.E.Bozler.GR@Dartmouth.edu	Kacsoh, Balint/AAF-2165-2019	Kacsoh, Balint/0000-0001-9171-0611; Bozler, Julianna/0000-0002-6275-3409	National Institutes of Health [1DP1MH110234]; Dartmouth College; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH110234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dartmouth College; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institutes of Health, Pioneer grant: 1DP1MH110234, (GB) and the Dartmouth College Alumni Research Award (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1976, AM J PATHOL, V84, P164; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; BERNSTEIN C, 1987, OIKOS, V49, P236, DOI 10.2307/3566033; COHEN WD, 1982, PROTOPLASMA, V113, P23, DOI 10.1007/BF01283036; de Back DZ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00009; Dzierzak E, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011601; EDMONDSON PW, 1963, BRIT J EXP PATHOL, V44, P72; Hebiguchi M, 2008, INT J HEMATOL, V88, P498, DOI 10.1007/s12185-008-0200-6; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Janssen A, 1987, J NETH ZOOL, V38, P61; Kacsoh BZ, 2014, PARASITOLOGY, V141, P697, DOI 10.1017/S0031182013001431; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lu J, 2010, PEPTIDES, V31, P44, DOI 10.1016/j.peptides.2009.09.028; Markus R, 2015, J INNATE IMMUN, V7, P340, DOI 10.1159/000369618; Migliaccio AR, 2010, HAEMATOL-HEMATOL J, V95, P1985, DOI 10.3324/haematol.2010.033225; Mueller RL, 2008, ZOOLOGY, V111, P218, DOI 10.1016/j.zool.2007.07.010; Nappi AJ, 2000, NITRIC OXIDE-BIOL CH, V4, P423, DOI 10.1006/niox.2000.0294; Polilov AA, 2012, ARTHROPOD STRUCT DEV, V41, P29, DOI 10.1016/j.asd.2011.09.001; RIZKI MOHAMMED TAHIR MIRZA, 1957, J MORPH, V100, P437, DOI 10.1002/jmor.1051000303; RIZKI MTM, 1959, J BIOPHYS BIOCHEM CY, V5, P235, DOI 10.1083/jcb.5.2.235; RIZKI MTM, 1953, J EXP ZOOL, V123, P397, DOI 10.1002/jez.1401230302; Russo J, 1996, PARASITOLOGY, V112, P135, DOI 10.1017/S0031182000065173; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Sloboda RD, 2007, CELL MOTIL CYTOSKEL, V64, P446, DOI 10.1002/cm.20195; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; WIGGLESWORTH VB, 1959, ANNU REV ENTOMOL, V4, P1, DOI 10.1146/annurev.en.04.010159.000245; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188133	10.1371/journal.pone.0188133	http://dx.doi.org/10.1371/journal.pone.0188133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141015	Green Submitted, Green Published, gold			2022-12-26	WOS:000415260400062
J	Padula, MC; Schaer, M; Scariati, E; Mutlu, AK; Zoller, D; Schneider, M; Eliez, S				Padula, Maria Carmela; Schaer, Marie; Scariati, Elisa; Mutlu, A. Kadir; Zoller, Daniela; Schneider, Maude; Eliez, Stephan			Quantifying indices of short-and long-range white matter connectivity at each cortical vertex	PLOS ONE			English	Article							22Q11.2 DELETION SYNDROME; CARDIO-FACIAL SYNDROME; SURFACE-BASED ANALYSIS; VELOCARDIOFACIAL SYNDROME; PSYCHIATRIC-DISORDERS; CINGULATE CORTEX; HUMAN CONNECTOME; FIBER TRACKING; GREY-MATTER; BRAIN	Several neurodevelopmental diseases are characterized by impairments in cortical morphology along with altered white matter connectivity. However, the relationship between these two measures is not yet clear. In this study, we propose a novel methodology to compute and display metrics of white matter connectivity at each cortical point. After co-registering the extremities of the tractography streamlines with the cortical surface, we computed two measures of connectivity at each cortical vertex: the mean tracts' length, and the proportion of short-and long-range connections. The proposed measures were tested in a clinical sample of 62 patients with 22q11.2 deletion syndrome (22q11DS) and 57 typically developing individuals. Using these novel measures, we achieved a fine-grained visualization of the white matter connectivity patterns at each vertex of the cortical surface. We observed an intriguing pattern of both increased and decreased short-and long-range connectivity in 22q11DS, that provides novel information about the nature and topology of white matter alterations in the syndrome. We argue that the method presented in this study opens avenues for additional analyses of the relationship between cortical properties and patterns of underlying structural connectivity, which will help clarifying the intrinsic mechanisms that lead to altered brain structure in neurodevelopmental disorders.	[Padula, Maria Carmela; Schaer, Marie; Scariati, Elisa; Zoller, Daniela; Schneider, Maude; Eliez, Stephan] Univ Geneva, Dev Imaging & Psychopathol Lab, Sch Med, Geneva, Switzerland; [Mutlu, A. Kadir] Neuroelect Res Flanders, Leuven, Netherlands; [Zoller, Daniela] Ecole Polytech Fed Lausanne, Inst Bioengn, Med Image Proc Lab, Lausanne, Switzerland; [Eliez, Stephan] Univ Geneva, Dept Genet Med & Dev, Sch Med, Geneva, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Padula, MC (corresponding author), Univ Geneva, Dev Imaging & Psychopathol Lab, Sch Med, Geneva, Switzerland.	Maria.Padula@unige.ch	Zöller, Daniela/D-7452-2019	Zöller, Daniela/0000-0002-7049-0696; Schaer, Marie/0000-0001-8479-6365; Schneider, Maude/0000-0001-7147-8915	Swiss National Science Foundation [324730 121996, 324730 144260, 324730_121996, 324730_144260]; National Center of Competence in Research (NCCR) synapsy [51NF40 158776, 51NF40_158776]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) synapsy(Swiss National Science Foundation (SNSF))	This work have been funded by grants from the Swiss National Science Foundation to prof. Stephan Eliez [grant number: 324730 121996 and 324730 144260], and by the National Center of Competence in Research (NCCR) synapsy [grant number 51NF40 158776]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work have been funded by grants from the Swiss National Science Foundation to prof. Stephan Eliez [grant number: 324730_121996 and 324730_144260], and by the National Center of Competence in Research (NCCR) synapsy [grant number 51NF40_158776].	ARIKUNI T, 1994, NEUROSCI RES, V21, P19, DOI 10.1016/0168-0102(94)90065-5; Avants BB, 2010, NEUROIMAGE, V50, P1004, DOI 10.1016/j.neuroimage.2010.01.041; Bammer R, 2003, EUR J RADIOL, V45, P223, DOI 10.1016/S0720-048X(02)00311-X; Bearden CE, 2009, CEREB CORTEX, V19, P115, DOI 10.1093/cercor/bhn064; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Bozzali M, 2011, NEUROIMAGE, V54, P2045, DOI 10.1016/j.neuroimage.2010.08.069; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Caspers S, 2013, NEUROIMAGE, V80, P18, DOI 10.1016/j.neuroimage.2013.04.003; Catani M, 2011, BIOL PSYCHIAT, V70, P1143, DOI 10.1016/j.biopsych.2011.06.013; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Smedt B, 2009, DEV DISABIL RES REV, V15, P4, DOI 10.1002/ddrr.44; Eckert MA, 2006, NEUROIMAGE, V32, P1001, DOI 10.1016/j.neuroimage.2006.05.014; Eliez S, 2000, AM J PSYCHIAT, V157, P409, DOI 10.1176/appi.ajp.157.3.409; Englander ZA, 2013, NEUROIMAGE-CLIN, V2, P440, DOI 10.1016/j.nicl.2013.03.006; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gao JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085005; Glaser B, 2002, J PEDIATR-US, V140, P753, DOI 10.1067/mpd.2002.124774; Gothelf D, 2008, DEV DISABIL RES REV, V14, P59, DOI 10.1002/ddrr.9; Gothelf D, 2007, SCHIZOPHR RES, V96, P72, DOI 10.1016/j.schres.2007.07.021; Gothelf D, 2011, J PSYCHIATR RES, V45, P322, DOI 10.1016/j.jpsychires.2010.07.008; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Greve DN, 2014, NEUROIMAGE, V92, P225, DOI 10.1016/j.neuroimage.2013.12.021; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2003, NEUROIMAGE, V19, P545, DOI 10.1016/S1053-8119(03)00142-3; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Huang H, 2015, CEREB CORTEX, V25, P1389, DOI 10.1093/cercor/bht335; Huang H, 2011, J NEUROSCI METH, V197, P324, DOI 10.1016/j.jneumeth.2011.02.017; Im K, 2014, NEUROIMAGE, V86, P182, DOI 10.1016/j.neuroimage.2013.08.011; Kates WR, 2001, BIOL PSYCHIAT, V49, P677, DOI 10.1016/S0006-3223(00)01002-7; Kunwar A, 2012, SCHIZOPHR RES, V137, P20, DOI 10.1016/j.schres.2012.01.032; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Nie JX, 2012, CEREB CORTEX, V22, P2831, DOI 10.1093/cercor/bhr361; O'Donnell LJ, 2013, NEUROIMAGE, V80, P283, DOI 10.1016/j.neuroimage.2013.04.066; Oguz I, 2009, LECT NOTES COMPUT SC, V5636, P651, DOI 10.1007/978-3-642-02498-6_54; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ottet MC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00402; Ottet MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058429; Ouyang Minhui, 2016, Proc SPIE Int Soc Opt Eng, V9788; Ouyang MH, 2017, NEUROSCI BIOBEHAV R, V83, P109, DOI 10.1016/j.neubiorev.2017.10.007; Padula MC, 2017, NEUROIMAGE-CLIN, V16, P142, DOI 10.1016/j.nicl.2017.07.023; Padula MC, 2017, HUM BRAIN MAPP, V38, P2177, DOI 10.1002/hbm.23512; Phillips OR, 2013, BRAIN CONNECT, V3, P146, DOI 10.1089/brain.2012.0111; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pugliese L, 2009, NEUROIMAGE, V47, P427, DOI 10.1016/j.neuroimage.2009.05.014; Radoeva PD, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-38; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Sandini C, BIOL PSYCHI IN PRESS; Savadjiev P, 2014, MED IMAGE ANAL, V18, P1349, DOI 10.1016/j.media.2014.06.013; Scariati E, 2016, J NEURAL TRANSM, V123, P823, DOI 10.1007/s00702-016-1548-z; Scariati E, 2014, BRAIN TOPOGR, V27, P808, DOI 10.1007/s10548-014-0356-8; Schaer M, 2006, PSYCHIAT RES-NEUROIM, V146, P1, DOI 10.1016/j.pscychresns.2005.10.002; Schaer M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00750; Schaer M, 2009, SCHIZOPHR RES, V115, P182, DOI 10.1016/j.schres.2009.09.016; Schaer M, 2009, DEV MED CHILD NEUROL, V51, P746, DOI 10.1111/j.1469-8749.2009.03281.x; Schmitt JE, 2015, BIOL PSYCHIAT, V78, P135, DOI 10.1016/j.biopsych.2014.10.025; Schneider M, 2014, AM J PSYCHIAT, V171, P627, DOI 10.1176/appi.ajp.2013.13070864; Schonberg T, 2006, NEUROIMAGE, V30, P1100, DOI 10.1016/j.neuroimage.2005.11.015; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Shprintzen RJ, 2008, DEV DISABIL RES REV, V14, P3, DOI 10.1002/ddrr.2; Shukla DK, 2011, NEUROPSYCHOLOGIA, V49, P1378, DOI 10.1016/j.neuropsychologia.2011.02.022; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Srivastava S, 2012, HUM BRAIN MAPP, V33, P213, DOI 10.1002/hbm.21206; Swillen A, 1999, CHILD NEUROPSYCHOL, V5, P230, DOI 10.1076/0929-7049(199912)05:04;1-R;FT230; Thomas C, 2011, CORTEX, V47, P863, DOI 10.1016/j.cortex.2010.07.006; Thomason ME, 2011, ANNU REV CLIN PSYCHO, V7, P63, DOI 10.1146/annurev-clinpsy-032210-104507; Tozer DJ, 2012, NEUROIMAGE, V59, P3094, DOI 10.1016/j.neuroimage.2011.10.088; Tucholka A, 2012, NEUROIMAGE, V63, P1443, DOI 10.1016/j.neuroimage.2012.06.019; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zoller D, 2017, SCHIZOPHR RES	84	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187493	10.1371/journal.pone.0187493	http://dx.doi.org/10.1371/journal.pone.0187493			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29141024	Green Submitted, Green Published, gold			2022-12-26	WOS:000415260400025
J	Javarone, MA; Marinazzo, D				Javarone, Marco Alberto; Marinazzo, Daniele			Evolutionary dynamics of group formation	PLOS ONE			English	Article							GROUP-SIZE; TRADE-OFFS; CONSEQUENCES; EMERGENCE; SELECTION; FISSION; CHOICE; GAMES	Group formation is a quite ubiquitous phenomenon across different animal species, whose individuals cluster together forming communities of diverse size. Previous investigations suggest that, in general, this phenomenon might have similar underlying reasons across the interested species, despite genetic and behavioral differences. For instance improving the individual safety (e.g. from predators), and increasing the probability to get food resources. Remarkably, the group size might strongly vary from species to species, e.g. shoals of fishes and herds of lions, and sometimes even within the same species, e.g. tribes and families in human societies. Here we build on previous theories stating that the dynamics of group formation may have evolutionary roots, and we explore this fascinating hypothesis from a purely theoretical perspective, with a model using the framework of Evolutionary Game Theory. In our model we hypothesize that homogeneity constitutes a fundamental ingredient in these dynamics. Accordingly, we study a population that tries to form homogeneous groups, i.e. composed of similar agents. The formation of a group can be interpreted as a strategy. Notably, agents can form a group (receiving a 'group payoff'), or can act individually (receiving an 'individual payoff'). The phase diagram of the modeled population shows a sharp transition between the 'group phase' and the 'individual phase', characterized by a critical 'individual payoff'. Our results then support the hypothesis that the phenomenon of group formation has evolutionary roots.	[Javarone, Marco Alberto] Univ Hertfordshire, Sch Comp Sci, Hatfield AL10 9AB, Herts, England; [Javarone, Marco Alberto] Univ Cagliari, Dept Math & Comp Sci, I-09123 Cagliari, Italy; [Marinazzo, Daniele] Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, Ghent, Belgium; [Marinazzo, Daniele] Univ Elect Sci & Technol China, Chengdu Brain Sci Inst, Clin Hosp, MOE Key Lab Neuroinformat, Chengdu, Sichuan, Peoples R China	University of Hertfordshire; University of Cagliari; Ghent University; University of Electronic Science & Technology of China	Javarone, MA (corresponding author), Univ Hertfordshire, Sch Comp Sci, Hatfield AL10 9AB, Herts, England.; Javarone, MA (corresponding author), Univ Cagliari, Dept Math & Comp Sci, I-09123 Cagliari, Italy.	marcojavarone@gmail.com	Marinazzo, Daniele/H-4793-2019; Javarone, Marco/AFU-9191-2022	Marinazzo, Daniele/0000-0002-9803-0122; Javarone, Marco/0000-0003-0514-9544	H WiMUST project [645141]; National Group of Mathematical Physics (GNFM-INdAM); Faculty of Psychology and Educational Sciences of Ghent University	H WiMUST project; National Group of Mathematical Physics (GNFM-INdAM); Faculty of Psychology and Educational Sciences of Ghent University	MAJ would like to acknowledge support by the H2020-645141 WiMUST project, the National Group of Mathematical Physics (GNFM-INdAM), and the mobility funds of the Faculty of Psychology and Educational Sciences of Ghent University.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alcock J., 2013, ANIMAL BEHAV EVOLUTI; Antonioni A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025555; Couzin I, 2007, NATURE, V445, P715, DOI 10.1038/445715a; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Curry O, 2013, HUM NATURE-INT BIOS, V24, P336, DOI 10.1007/s12110-013-9174-z; David-Barrett T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1151; Dizard J. E., 1990, THE MINIMAL FAMILY; Du WB, 2009, PHYSICA A, V388, P4509, DOI 10.1016/j.physa.2009.07.012; Dunbar R, 2016, PSYCHOLOGY, P1; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Frewen T.A., 2011, COPING COMPLEXITY MO, P299; Frey E, 2010, PHYSICA A, V389, P4265, DOI 10.1016/j.physa.2010.02.047; Galam S, 2000, PHYSICA A, V287, P644, DOI 10.1016/S0378-4371(00)00399-X; GALAM S, 1991, EUR J SOC PSYCHOL, V21, P49, DOI 10.1002/ejsp.2420210105; GERARD JF, 1995, J THEOR BIOL, V176, P511, DOI 10.1006/jtbi.1995.0217; Gracia-Lazaro C, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042808; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Guillen MF, 2000, ACAD MANAGE J, V43, P362, DOI 10.2307/1556400; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; Hofmann HA, 2014, TRENDS ECOL EVOL, V29, P581, DOI 10.1016/j.tree.2014.07.008; Ioannou CC, 2012, SCIENCE, V337, P1212, DOI 10.1126/science.1218919; Javarone M. A., 2016, EPJ; Javarone M. A., 2017, SOURCE CODE; Javarone MA, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/07/073404; Javarone MA, 2016, EPL-EUROPHYS LETT, V114, DOI 10.1209/0295-5075/114/38001; Johnson KVA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25267; Johnson S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108702; Julia P. C., 2009, NEW J PHYS, V11; Kao AB, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003762; Kao AB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3305; Korstjens AH, 2006, BEHAV ECOL SOCIOBIOL, V60, P683, DOI 10.1007/s00265-006-0212-2; Lee J, 2002, STRATEGIC MANAGE J, V23, P727, DOI 10.1002/smj.250; Lehmann J., 2009, P ROY SOC LOND B BIO; Meenakshi JV, 2002, J POLICY MODEL, V24, P539, DOI 10.1016/S0161-8938(02)00129-1; Michod RE, 2006, P NATL ACAD SCI USA, V103, P9113, DOI 10.1073/pnas.0601080103; Miller N, 2013, P NATL ACAD SCI USA, V110, P5263, DOI 10.1073/pnas.1217513110; Moreira JA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01521; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Perc M., 2013, J R SOC INTERFACE, V80, P10; Perc M, 2017, PHYS REP, V687, P1, DOI 10.1016/j.physrep.2017.05.004; Perc M, 2013, CHAOS SOLITON FRACT, V56, P1, DOI 10.1016/j.chaos.2013.06.002; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Stewart AJ, 2016, P NATL ACAD SCI USA, V113, pE7003, DOI 10.1073/pnas.1608990113; Sueur C, 2011, J THEOR BIOL, V273, P156, DOI 10.1016/j.jtbi.2010.12.035; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Szabo G, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022820; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/58004; Szolnoki A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1299; Tehrani JJ, 2009, EVOL HUM BEHAV, V30, P286, DOI 10.1016/j.evolhumbehav.2009.03.002; Traulsen A, 2009, UNDERST COMPLEX SYST, P253, DOI 10.1007/978-3-642-01284-6_12; Wang Z, 2016, PHYS REP, V664, P1, DOI 10.1016/j.physrep.2016.10.006	57	16	16	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187960	10.1371/journal.pone.0187960	http://dx.doi.org/10.1371/journal.pone.0187960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136020	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200051
J	Marouli, E; Kanoni, S; Mamakou, V; Hackinger, S; Southam, L; Prins, B; Rentari, A; Dimitriou, M; Zengini, E; Gonidakis, F; Kolovou, G; Kontaxakis, V; Rallidis, L; Tentolouris, N; Thanopoulou, A; Lamnissou, K; Dedoussis, G; Zeggini, E; Deloukas, P				Marouli, Eirini; Kanoni, Stavroula; Mamakou, Vasiliki; Hackinger, Sophie; Southam, Lorraine; Prins, Bram; Rentari, Angela; Dimitriou, Maria; Zengini, Eleni; Gonidakis, Fragiskos; Kolovou, Genovefa; Kontaxakis, Vassilis; Rallidis, Loukianos; Tentolouris, Nikolaos; Thanopoulou, Anastasia; Lamnissou, Klea; Dedoussis, George; Zeggini, Eleftheria; Deloukas, Panagiotis			Evaluating the glucose raising effect of established loci via a genetic risk score	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; TYPE-2; HERITABILITY; POPULATION; PROVIDE	Recent genome-wide association studies have identified several single nucleotide polymorphisms (SNPs) associated with glucose levels. We tested the hypothesis here whether the cumulative effect of glucose raising SNPs, assessed via a score, is associated with glucose levels. A total of 1,434 participants of Greek descent from the THISEAS study and 1,160 participants form the GOMAP study were included in this analysis. We developed a genetic risk score (GRS), based on the known glucose-raising loci, in order to investigate the cumulative effect of known glucose loci on glucose levels. In the THISEAS study, the GRS score was significantly associated with increased glucose levels (mmol/L) (beta +/- SE: 0.024 +/- 0.004, P = 8.27e-07). The effect of the genetic risk score was also significant in the GOMAP study (beta +/- SE: 0.011 +/- 0.005, P = 0.031). In the meta-analysis of the two studies both scores were significantly associated with higher glucose levels GRS: beta +/- SE: 0.019 +/- 0.003, P = 1.41e-09. Also, variants at the SLC30A8, PROX1, MTNR1B, ADRA2A, G6PC2, LPIN3 loci indicated nominal evidence for association with glucose levels (p < 0.05). We replicate associations of the established glucose raising variants in the Greek population and confirm directional consistency of effects (binomial sign test p = 6.96e-05). We also demonstrate that the cumulative effect of the established glucose loci yielded a significant association with increasing glucose levels.	[Marouli, Eirini; Kanoni, Stavroula; Deloukas, Panagiotis] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Mamakou, Vasiliki; Zengini, Eleni] Dromokaiteio Psychiat Hosp, Athens, Greece; [Hackinger, Sophie; Southam, Lorraine; Prins, Bram; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Cambridge, England; [Southam, Lorraine] Wellcome Trust Ctr Human Genet, Oxford, England; [Rentari, Angela; Dimitriou, Maria; Dedoussis, George] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens, Greece; [Zengini, Eleni] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Gonidakis, Fragiskos] Natl & Kapodistrian Univ Athens, Med Sch, Eginit Hosp, Psychiat Dept 1, Athens, Greece; [Kolovou, Genovefa] Onassis Cardiac Surg Ctr, Dept Cardiol, Athens, Greece; [Kontaxakis, Vassilis] Natl & Kapodistrian Univ Athens, Med Sch, Eginit Hosp, Early Psychosis Unit,Dept Psychiat 1, Athens, Greece; [Rallidis, Loukianos] Natl & Kapodistrian Univ Athens, Dept Cardiol 2, Med Sch, Attikon Hosp, Athens, Greece; [Tentolouris, Nikolaos] Natl & Kapodistrian Univ Athens, Med Sch, Laiko Gen Hosp, Dept Propaedeut & Internal Med 1, Athens, Greece; [Thanopoulou, Anastasia] Natl & Kapodistrian Univ Athens, Med Sch, Hippokration Gen Hosp, Diabet Ctr,Dept Internal Med 2, Athens, Greece; [Lamnissou, Klea] Natl & Kapodistrian Univ Athens, Div Genet & Biotechnol, Dept Biol, Athens, Greece; [Deloukas, Panagiotis] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia	University of London; Queen Mary University London; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; Harokopio University Athens; University of Sheffield; National & Kapodistrian University of Athens; Onassis Cardiac Surgery Center; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; University Hospital Attikon; Laiko General Hospital; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; King Abdulaziz University	Marouli, E (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	marouli@qmul.ac.uk	Anastasia, Thanopoulou/AAV-6559-2021; Kanoni, Stavroula/AAN-7161-2021; Dedoussis, George/AAN-7252-2021; gonidakis, fragiskos/AAC-5296-2020; TENTOLOURIS, NIKOLAOS/AAH-6231-2019; Thanopoulou, Anastasia/ABH-2579-2020	Kanoni, Stavroula/0000-0002-1691-9615; Dedoussis, George/0000-0002-7798-6221; TENTOLOURIS, NIKOLAOS/0000-0003-0615-2534; Deloukas, Panos/0000-0001-9251-070X; Prins, Bram/0000-0001-5774-034X	Wellcome Trust [098051]; research grant (PENED) from Greek General Secretary of Research and Technology; National Institute for Health Research; British Heart Foundation [RG/14/5/30893] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); research grant (PENED) from Greek General Secretary of Research and Technology; National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This work was funded by the Wellcome Trust [098051]. Recruitment for THISEAS was partially funded by a research grant (PENED 2003) from the Greek General Secretary of Research and Technology. PD's work forms part of the research themes contributing to the translational research portfolio of Barts Cardiovascular Biomedical Research Unit which is supported and funded by the National Institute for Health Research.; This work was funded by the Wellcome Trust [098051].; Recruitment for THISEAS was partially funded by a research grant (PENED 2003) from the Greek General Secretary of Research and Technology.; PD's work forms part of the research themes contributing to the translational research portfolio of Barts Cardiovascular Biomedical Research Unit which is supported and funded by the National Institute for Health Research	Barker A, 2011, DIABETES, V60, P1805, DOI 10.2337/db10-1575; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dimitriou M, 2016, PUBLIC HEALTH NUTR, V19, P1081, DOI 10.1017/S1368980015002244; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Grant RW, 2009, DIABETES CARE, V32, P1107, DOI 10.2337/dc08-2171; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Lyssenko V, 2013, DIABETES CARE, V36, pS120, DOI 10.2337/dcS13-2009; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nolte IM, 2017, EUR J HUM GENET, V25, P877, DOI 10.1038/ejhg.2017.50; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasmussen-Torvik LJ, 2011, DIABETES, V60, P331, DOI 10.2337/db10-0839; Santaguida P L, 2005, Evid Rep Technol Assess (Summ), P1; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Snell-Bergeon JK, 2012, DIABETES TECHNOL THE, V14, pS51, DOI 10.1089/dia.2012.0031; Theodoraki EV, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-28; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yan J, 2016, DIABETOLOGIA, V59, P1458, DOI 10.1007/s00125-016-3939-y; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0186669	10.1371/journal.pone.0186669	http://dx.doi.org/10.1371/journal.pone.0186669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125842	Green Published, Green Accepted, gold			2022-12-26	WOS:000414866000003
J	Iqbal, E; Mallah, R; Rhodes, D; Wu, HH; Romero, A; Chang, N; Dzahini, O; Pandey, C; Broadbent, M; Stewart, R; Dobson, RJB; Ibrahim, ZM				Iqbal, Ehtesham; Mallah, Robbie; Rhodes, Daniel; Wu, Honghan; Romero, Alvin; Chang, Nynn; Dzahini, Olubanke; Pandey, Chandra; Broadbent, Matthew; Stewart, Robert; Dobson, Richard J. B.; Ibrahim, Zina M.			ADEPt, a semantically-enriched pipeline for extracting adverse drug events from free-text electronic health records	PLOS ONE			English	Article							CLINICAL TEXT; OUTPATIENTS; INFORMATION; CHALLENGE; SYSTEM	Adverse drug events (ADEs) are unintended responses to medical treatment. They can greatly affect a patient's quality of life and present a substantial burden on healthcare. Although Electronic health records (EHRs) document a wealth of information relating to ADEs, they are frequently stored in the unstructured or semi-structured free-text narrative requiring Natural Language Processing (NLP) techniques to mine the relevant information. Here we present a rule-based ADE detection and classification pipeline built and tested on a large Psychiatric corpus comprising 264k patients using the de-identified EHRs of four UK-based psychiatric hospitals. The pipeline uses characteristics specific to Psychiatric EHRs to guide the annotation process, and distinguishes: a) the temporal value associated with the ADE mention (whether it is historical or present), b) the categorical value of the ADE (whether it is assertive, hypothetical, retrospective or a general discussion) and c) the implicit contextual value where the status of the ADE is deduced from surrounding indicators, rather than explicitly stated. We manually created the rulebase in collaboration with clinicians and pharmacists by studying ADE mentions in various types of clinical notes. We evaluated the open-source Adverse Drug Event annotation Pipeline (ADEPt) using 19 ADEs specific to antipsychotics and antidepressants medication. The ADEs chosen vary in severity, regularity and persistence. The average F-measure and accuracy achieved by our tool across all tested ADEs were 0.83 and 0.83 respectively. In addition to annotation power, the ADEPT pipeline presents an improvement to the state of the art context-discerning algorithm, ConText.	[Iqbal, Ehtesham; Rhodes, Daniel; Wu, Honghan; Pandey, Chandra; Dobson, Richard J. B.; Ibrahim, Zina M.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, Crespigny Pk, London, England; [Mallah, Robbie; Dzahini, Olubanke] South London & Maudsley NHS Fdn Trust, Dept Pharm, London, England; [Romero, Alvin; Chang, Nynn] South London & Maudsley NHS Fdn Trust, SLaM BioResource Mental Hlth, London, England; [Romero, Alvin; Chang, Nynn] Kings Coll London, London, England; [Pandey, Chandra; Broadbent, Matthew; Stewart, Robert; Dobson, Richard J. B.; Ibrahim, Zina M.] South London & Maudsley NHS Fdn, NIHR Biomed Res Ctr Mental Hlth, London, England; [Pandey, Chandra; Broadbent, Matthew; Stewart, Robert; Dobson, Richard J. B.; Ibrahim, Zina M.] South London & Maudsley NHS Fdn, Biomed Res Unit Dementia, London, England; [Stewart, Robert] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Hlth Serv & Populat Res, London, England; [Dobson, Richard J. B.; Ibrahim, Zina M.] UCL, UCL Inst Hlth Informat, Farr Inst Hlth Informat Res, London, England; [Dobson, Richard J. B.; Ibrahim, Zina M.] Univ Coll London Hosp, NIHR Biomed Res Ctr, London, England	University of London; King's College London; South London & Maudsley NHS Trust; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Dobson, RJB; Ibrahim, ZM (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, Crespigny Pk, London, England.; Dobson, RJB; Ibrahim, ZM (corresponding author), South London & Maudsley NHS Fdn, NIHR Biomed Res Ctr Mental Hlth, London, England.; Dobson, RJB; Ibrahim, ZM (corresponding author), South London & Maudsley NHS Fdn, Biomed Res Unit Dementia, London, England.; Dobson, RJB; Ibrahim, ZM (corresponding author), UCL, UCL Inst Hlth Informat, Farr Inst Hlth Informat Res, London, England.; Dobson, RJB; Ibrahim, ZM (corresponding author), Univ Coll London Hosp, NIHR Biomed Res Ctr, London, England.	richard.j.dobson@kcl.ac.uk; zina.ibrahim@kcl.ac.uk	Wu, Honghan/AAT-6084-2020; Stewart, Robert/B-1667-2010; Dzahini, Olubanke/HDM-6742-2022; dobson, richard/C-9269-2011	Stewart, Robert/0000-0002-4435-6397; Dzahini, Olubanke/0000-0003-3878-2143; Iqbal, Ehtesham/0000-0001-9477-9745; Rhodes, Daniel/0000-0002-2021-4773; Ibrahim, Zina/0000-0001-6203-2727; Wu, Honghan/0000-0002-0213-5668; dobson, richard/0000-0003-4224-9245	National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Farr Institute of Health Informatics Research at UCL; Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research; Wellcome Trust [MR/K006584/1]	National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London(General Electric); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Farr Institute of Health Informatics Research at UCL; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; Wellcome Trust(Wellcome Trust)	This paper represents independent research funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. This research was supported by researchers at the National Institute for Health Research University College London Hospitals Biomedical Research Centre, and by awards establishing the Farr Institute of Health Informatics Research at UCL Partners, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (grant MR/K006584/1).; This paper represents independent research funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. This research was supported by researchers at the National Institute for Health Research University College London Hospitals Biomedical Research Centre, and by awards establishing the Farr Institute of Health Informatics Research at UCL Partners, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (grant MR/K006584/1).	Albright D, 2013, J AM MED INFORM ASSN, V20, P922, DOI 10.1136/amiajnl-2012-001317; [Anonymous], 2007, PREVENTING MEDICATIO; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Cai RC, 2017, ARTIF INTELL MED, V76, P7, DOI 10.1016/j.artmed.2017.01.004; Canada A, 2017, NUCL ACIDS RES; Chapman WW, 2008, INT J MED ELSEVIER; Chu D, 2007, BIONLP 2007 BIOL TRA, P81, DOI 10.3115/1572392.1572408; Cohen R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-10; Cunningham H, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P168; Cunningham H., 2011, TEXT PROCESSING GATE; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Forster AJ, 2003, ANN INTERN MED AMM C; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Haerian K, 2010, ELECT HLTH RECORD PH; Han L, 2017, J AM MED INFORM ASS; Hazlehurst B, 2009, VACCINE; Honigman B, 2001, J AM MED INFORM ASSN, V8, P254, DOI 10.1136/jamia.2001.0080254; Iqbal E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134208; Koeling R., 2011, INT WORKSH HLTH TEXT, P43; Korkontzelos I, 2016, J BIOMED INFORM, V62, P148, DOI 10.1016/j.jbi.2016.06.007; Kuhn M, 2016, NUCLEIC ACIDS RES, V44, pD1075, DOI 10.1093/nar/gkv1075; Nikfarjam A, 2015, J AM MED INFORM ASSN, V22, P671, DOI 10.1093/jamia/ocu041; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Roberts A, 2009, J BIOMED INFORM, V42, P950, DOI 10.1016/j.jbi.2008.12.013; Sarker A, 2015, J BIOMED INFORM, V53, P196, DOI 10.1016/j.jbi.2014.11.002; Savova GK, 2007, CONSTRUCTING EVALUAT; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Thakker D, 2009, GATE JAPE GRAMMAR TU, P1; Uzuner O, 2011, J AM MED INFORM ASSN, V18, P552, DOI 10.1136/amiajnl-2011-000203; Uzuner O, 2010, J AM MED INFORM ASSN, V17, P519, DOI 10.1136/jamia.2010.004200; Wang XY, 2010, J BIOMED INFORM, V43, P595, DOI 10.1016/j.jbi.2010.03.011; Wang YM, 2009, PROCEEDINGS OF THE 2009 INTERNATIONAL CONFERENCE ON PUBLIC ECONOMICS AND MANAGEMENT ICPEM 2009, VOL 2, P18, DOI 10.3115/1667884.1667888; Warrer P, 2015, J RES; Xu H, 2010, J AM MED INFORM ASSN, V17, P19, DOI 10.1197/jamia.M3378; Xu R, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-17	36	18	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187121	10.1371/journal.pone.0187121	http://dx.doi.org/10.1371/journal.pone.0187121			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121053	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900022
J	Miwa, S; Shirai, T; Yamamoto, N; Hayashi, K; Takeuchi, A; Tada, K; Kajino, Y; Inatani, H; Higuchi, T; Abe, K; Taniguchi, Y; Tsuchiya, H				Miwa, Shinji; Shirai, Toshiharu; Yamamoto, Norio; Hayashi, Katsuhiro; Takeuchi, Akihiko; Tada, Kaoru; Kajino, Yoshitomo; Inatani, Hiroyuki; Higuchi, Takashi; Abe, Kensaku; Taniguchi, Yuta; Tsuchiya, Hiroyuki			Risk factors for postoperative deep infection in bone tumors	PLOS ONE			English	Article							SURGICAL SITE INFECTION; GIANT-CELL TUMOR; ENDOPROSTHETIC RECONSTRUCTION; LONG BONES; SURGERY; COMPLICATIONS; MEGAPROSTHESES; RESECTIONS; CURETTAGE; SARCOMA	Background Postoperative deep infection after bone tumor surgery remains a serious complication. Although there are numerous reports about risk factors for postoperative deep infection in general surgery, there is only a small number of reports about those for bone tumor surgery. This retrospective study aimed to identify risk factors for postoperative deep infection after bone tumor resection. Methods We reviewed data of 681 patients (844 bone tumors) who underwent surgery. Associations between variables, including age, recurrent tumor, pathological fracture, surgical site (pelvis/other), chemotherapy, biological reconstruction, augmentation of artificial bone or bone cement, the use of an implant, intraoperative blood loss, operative time, additional surgery for complications, and postoperative deep infection were evaluated. Results The rate of postoperative deep infection was 3.2% (27/844 tumors). A pelvic tumor (odds ratio [OR]: 3.4, 95% confidence interval [CI]: 1.0-11.3) and use of an implant (OR: 9.3, 95% CI: 1.9-45.5) were associated with an increased risk of deep infection. Conclusions This retrospective study showed that pelvic tumor and use of an implant were independent risk factors for deep infection. This information will help surgeons prepare an adequate surgical plan for patients with bone tumors.	[Miwa, Shinji; Shirai, Toshiharu; Yamamoto, Norio; Hayashi, Katsuhiro; Takeuchi, Akihiko; Tada, Kaoru; Kajino, Yoshitomo; Inatani, Hiroyuki; Higuchi, Takashi; Abe, Kensaku; Taniguchi, Yuta; Tsuchiya, Hiroyuki] Kanazawa Univ, Dept Orthopaed Surg, Sch Med, Kanazawa, Ishikawa, Japan; [Shirai, Toshiharu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto, Japan	Kanazawa University; Kyoto Prefectural University of Medicine	Miwa, S (corresponding author), Kanazawa Univ, Dept Orthopaed Surg, Sch Med, Kanazawa, Ishikawa, Japan.	smiwa001@yahoo.co.jp	Hayashi, K/C-4685-2015; Miwa, Shinji/AAI-9309-2020; Takeuchi, Akihiko/AAJ-1563-2020	Hayashi, K/0000-0001-8665-2154; Miwa, Shinji/0000-0002-5962-8287; Takeuchi, Akihiko/0000-0002-4071-5620	 [16K20042]		This work was supported by Grant-in-Aid for Young Japanese Scientist (B) 16K20042.	Ahn DK, 2013, ASIAN SPINE J, V7, P8, DOI 10.4184/asj.2013.7.1.8; Angelini A, 2014, CLIN ORTHOP RELAT R, V472, P349, DOI 10.1007/s11999-013-3250-x; Aponte-Tinao LA, 2016, CLIN ORTHOP RELAT R, V474, P669, DOI 10.1007/s11999-015-4353-3; Bus MPA, 2017, CLIN ORTHOP RELAT R, V475, P686, DOI 10.1007/s11999-016-4805-4; Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528; Capanna R, 2015, CLIN ORTHOP RELAT R, V473, P820, DOI 10.1007/s11999-014-3736-1; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Demura S, 2009, SPINE, V34, P635, DOI 10.1097/BRS.0b013e31819712ca; Dierselhuis EF, 2016, J BONE JOINT SURG AM, V98, P303, DOI 10.2106/JBJS.O.00472; DIETZ FR, 1991, J BONE JOINT SURG AM, V73A, P1200, DOI 10.2106/00004623-199173080-00009; Farfalli G L, 2015, Musculoskelet Surg, V99, P237, DOI 10.1007/s12306-015-0379-7; Gaur AH, 2005, CANCER-AM CANCER SOC, V104, P602, DOI 10.1002/cncr.21212; Gradl G, 2014, J BONE JOINT SURG AM, V96A, P223, DOI 10.2106/JBJS.L.01514; Hardes J, 2010, J SURG ONCOL, V101, P389, DOI 10.1002/jso.21498; Healey JH, 2013, CLIN ORTHOP RELAT R, V471, P2028, DOI 10.1007/s11999-013-2893-y; Hillmann A, 2003, ARCH ORTHOP TRAUM SU, V123, P340, DOI 10.1007/s00402-003-0543-7; Hoffman RM, CANCER; Kabirian N, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.00618; Lozano-Calderon SA, 2016, J SURG ONCOL, V113, P811, DOI 10.1002/jso.24234; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Mankin HJ, 1982, CANCER, V168, P252; MCDONALD DJ, 1990, CANCER, V65, P1509, DOI 10.1002/1097-0142(19900401)65:7<1509::AID-CNCR2820650710>3.0.CO;2-I; Morris CD, 2003, ANN SURG ONCOL, V10, P778, DOI 10.1245/ASO.2003.07.023; Ozaki T, 1996, ACTA ORTHOP SCAND, V67, P333, DOI 10.3109/17453679609002326; Peel T, 2014, EJSO-EUR J SURG ONC, V40, P1087, DOI 10.1016/j.ejso.2014.02.241; Pugely AJ, 2015, J ARTHROPLASTY, V30, P47, DOI 10.1016/j.arth.2015.01.063; Rutkowski P, 2015, ANN SURG ONCOL, V22, P2860, DOI 10.1245/s10434-015-4634-9; Shirai T, 2011, ACTA BIOMATER, V7, P1928, DOI 10.1016/j.actbio.2010.11.036; Sprowson AP, 2016, BONE JOINT J, V98B, P1534, DOI 10.1302/0301-620X.98611.34693; Tsuchiya H, 2006, ANTICANCER RES, V26, P447; Tsuchiya H, 2005, J BONE JOINT SURG BR, V87B, P218, DOI 10.1302/0301-620X.87B2.15325; Tsuchiya H, 2012, J ORTHOP SCI, V17, P595, DOI 10.1007/s00776-012-0247-3; Verdegaal SHM, 2012, J BONE JOINT SURG AM, V94A, P1201, DOI 10.2106/JBJS.J.01498; Zhen W, 2004, J BONE JOINT SURG BR, V86B, P212, DOI 10.1302/0301-620X.86B2.14362	34	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187438	10.1371/journal.pone.0187438	http://dx.doi.org/10.1371/journal.pone.0187438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121658	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900039
J	Mukoswa, GM; Charalambous, S; Nelson, G				Mukoswa, Grace Musanse; Charalambous, Salome; Nelson, Gill			The association between social capital and HIV treatment outcomes in South Africa	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS HIV; ANTIRETROVIRAL THERAPY; HEALTH; NETWORKS; PEOPLE; MORTALITY	Background HIV treatment has reduced morbidity and mortality. By 2012, it was estimated that 60.4% of eligible South Africans accessed antiretroviral treatment; however, treatment adherence and retention remain the greatest challenges. There is a growing belief that social capital, seen as "the features of social organization that facilitate cooperation for mutual benefit", is important in promoting HIV treatment retention. The aim of this study was to establish whether social capital is associated with HIV treatment outcomes. Methods and findings This was a cross-sectional analysis of data from a cohort study that investigated how patient outcomes were linked to clinical characteristics, and included exploratory factor and logistic regression analysis. Data from 943 patients were analyzed. Outcomes for the analysis were visit non-adherence, unsuppressed viral load, and treatment failure. Sixteen percent of patients (n = 118) had unsuppressed viral loads; 19% (n = 179) were non-adherent; and 32% (n = 302) experienced treatment failure. Social capital had two dimensions that were described by two factors. There was no association between either factor and visit non-adherence. Social capital factor 1 was marginally associated with lower risks of unsuppressed viral load and treatment failure at 12 months (OR = 0.78; 95% CI = 0.58-1.03 and OR = 0.76; 95% CI = 0.62-0.93, respectively); but not with visit non-adherence (OR = 0.93; 95% CI = 0.71-1.22). After controlling for confounders, the odds of both unsuppressed viral load and treatment failure decreased with an increase in social capital factor 1. Conclusion This study suggests that social capital, in terms of the number of groups to which an HIV-infected person belongs, the diversity of the groups, availability of child support, and time available for community projects, is protective against poor HIV treatment outcomes. Implementers and policy makers in the areas of HIV treatment and prevention need to consider the inclusion of social capital in the design of HIV/AIDS treatment program.	[Mukoswa, Grace Musanse; Charalambous, Salome; Nelson, Gill] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Charalambous, Salome] Aurum Inst, Johannesburg, South Africa	University of Witwatersrand	Mukoswa, GM (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.	gmukoswa@yahoo.fr	Nelson, Gill/AAC-3074-2020	Nelson, Gill/0000-0001-7815-3718; Charalambous, Salome/0000-0001-7143-1009	School of Public Health, University of the Witwatersrand	School of Public Health, University of the Witwatersrand	Grace Mukoswa acknowledges the support of the School of Public Health, University of the Witwatersrand where this study was conducted in partial fulfillment of the requirements for the MSc in the field of Epidemiology and Biostatistics. The authors thank Jonathan Levin and Nicola Christofides, Wits School of Public Health for advice on statistical methods and interpretation.	Campbell C, 2002, AIDS CARE, V14, P41, DOI 10.1080/09540120220097928; Cattell V, 2001, SOC SCI MED, V52, P1501, DOI 10.1016/S0277-9536(00)00259-8; Cene CW, 2011, J GEN INTERN MED, V26, P737, DOI 10.1007/s11606-011-1646-4; Charalambous S, 2016, AIDS, V30, P1099, DOI 10.1097/QAD.0000000000001014; Churchyard G J, 2014, SAMJ, S. Afr. med. j., V104, P234; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; Grootaert Christiaan, 2004, WORLD BANK WORKING P; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Odek WO, 2014, WORK, V47, P145, DOI 10.3233/WOR-2012-1469; Odek WO, 2014, AIDS CARE, V26, P1042, DOI 10.1080/09540121.2014.902421; Oksanen T, 2011, AM J PUBLIC HEALTH, V101, P1742, DOI 10.2105/AJPH.2011.300166; Pronyk PM, 2008, SOC SCI MED, V67, P1559, DOI 10.1016/j.socscimed.2008.07.022; Pronyk PM, 2008, SOC SCI MED, V66, P1999, DOI 10.1016/j.socscimed.2008.01.023; Putnam R., 1993, AM PROSPECT, V13, P35, DOI DOI 10.1287/mnsc.1120.1644; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sapp AL, 2003, CANCER-AM CANCER SOC, V98, P1749, DOI 10.1002/cncr.11717; Schneider H, 2008, CHP MONOGRAPHS JOHAN, V93; Simbayi L, 2014, S AFRICAN NATL HIV P; Stigma GE., 1963, STIGMA NOTES MANAGEM; Stuber J, 2008, SOC SCI MED, V67, P351, DOI 10.1016/j.socscimed.2008.03.023; Webel A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-188; WHO UNAIDS UNICEF, 2012, GLOB HIV AIDS RESP E; Wouters E, 2009, AIDS CARE, V21, P411, DOI 10.1080/09540120802242077	23	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0184140	10.1371/journal.pone.0184140	http://dx.doi.org/10.1371/journal.pone.0184140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121656	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900005
J	Yoshioka, N; Deguchi, M; Hagiya, H; Kagita, M; Tsukamoto, H; Takao, M; Yoshida, H; Yamamoto, N; Akeda, Y; Nabetani, Y; Maeda, I; Hidaka, Y; Tomono, K				Yoshioka, Nori; Deguchi, Matsuo; Hagiya, Hideharu; Kagita, Masanori; Tsukamoto, Hiroko; Takao, Miyuki; Yoshida, Hisao; Yamamoto, Norihisa; Akeda, Yukihiro; Nabetani, Yoshiko; Maeda, Ikuhiro; Hidaka, Yoh; Tomono, Kazunori			Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations	PLOS ONE			English	Article							ANTI-HBS; VIRUS; PERSISTENCE; IMMUNOGENICITY; PROTECTION; INFECTION; PERSONNEL; FAILURE	Background Health care workers (HCWs) are frequently exposed to hepatitis B virus (HBV) infection. The efficacy and safety of immunization with the hepatitis B (HB) vaccine are well recognized, but the durability of immunity and need for booster doses in those with secondary vaccine response failure remains controversial. Methods This was a retrospective cohort study performed at Osaka University Hospital, Japan. We examined antibodies against HB surface antigen (anti-HBs) titers annually after immunization for previously non-immunized HCWs. Primary responders were categorized by their sero-positive durations as short responders (those whose anti-HBs titers declined to negative range within 3 years), and long responders (those who retained positive anti-HBs levels for 3 years and more). We re-immunized short responders with either single or 3-dose boosters, the long responders with a single booster when their titers dropped below protective levels, and examined their sero-protection rates over time thereafter. Results From 2001 to 2012, data of 264 HCWs with a median age of 25.3 were collected. The rate of anti-HBs positivity after primary vaccination were 93.0% after three doses (n = 229), 54.5% after two doses (n = 11), and 4.2% after a single dose (n = 24). Of 213 primary responders, the anti-HBs levels of 95 participants (44.6%) fell below the protective levels, including 46 short responders and 49 long responders. HCWs with higher initial anti-HBs titers after primary vaccination had significantly longer durations of sero-positivity. For short responders, 3-dose booster vaccination induced a longer duration of anti-HBs positivity compared to a single-dose booster, whereas for long responders, a single-dose booster alone could induce prolonged anti-HBs positivity. Conclusion Our preliminary data suggested that it may be useful to differentiate HB vaccine responders based on their primary response durations to maintain protective levels of anti-HBs efficiently. A randomized, prospective, large-scale study is warranted to support our findings.	[Yoshioka, Nori; Deguchi, Matsuo; Hagiya, Hideharu; Yoshida, Hisao; Yamamoto, Norihisa; Akeda, Yukihiro; Nabetani, Yoshiko; Tomono, Kazunori] Osaka Univ Hosp, Div Infect Control & Prevent, Suita, Osaka, Japan; [Yoshioka, Nori; Deguchi, Matsuo; Kagita, Masanori; Tsukamoto, Hiroko; Takao, Miyuki; Maeda, Ikuhiro; Hidaka, Yoh] Osaka Univ Hosp, Lab Clin Investigat, Suita, Osaka, Japan; [Nabetani, Yoshiko] Osaka Univ Hosp, Nursing Dept, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Yoshioka, N (corresponding author), Osaka Univ Hosp, Div Infect Control & Prevent, Suita, Osaka, Japan.; Yoshioka, N (corresponding author), Osaka Univ Hosp, Lab Clin Investigat, Suita, Osaka, Japan.	yoshioka@hp-infect.med.osaka-u.ac.jp		Yoshioka, Nori/0000-0003-3395-9712				Averhoff F, 1998, AM J PREV MED, V15, P1, DOI 10.1016/S0749-3797(98)00003-8; Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6; Barash C, 1999, ARCH INTERN MED, V159, P1481, DOI 10.1001/archinte.159.13.1481; Bennett RG, 1996, J AM GERIATR SOC, V44, P699, DOI 10.1111/j.1532-5415.1996.tb01835.x; BOND WW, 1981, LANCET, V1, P550; Boot HJ, 2009, J HEPATOL, V50, P426, DOI 10.1016/j.jhep.2008.07.040; Das K, 2003, WORLD J GASTROENTERO, V9, P1132; DENIS F, 1984, J INFECT DIS, V149, P1019, DOI 10.1093/infdis/149.6.1019; Durlach R, 2003, INFECT CONT HOSP EP, V24, P773, DOI 10.1086/502132; FitzSimons D, 2013, VACCINE, V31, P584, DOI 10.1016/j.vaccine.2012.10.101; Floreani A, 2004, VACCINE, V22, P607, DOI 10.1016/j.vaccine.2003.09.001; Gara N, 2015, CLIN INFECT DIS, V60, P505, DOI 10.1093/cid/ciu867; Hennig BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001898; Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578; Lu CY, 2004, HEPATOLOGY, V40, P1415, DOI 10.1002/hep.20490; McMahon BJ, 2005, ANN INTERN MED, V142, P333, DOI 10.7326/0003-4819-142-5-200503010-00008; McMahon BJ, 2009, J INFECT DIS, V200, P1390, DOI 10.1086/606119; Meireles LC, 2015, WORLD J HEPATOL, V7, P2127, DOI 10.4254/wjh.v7.i18.2127; Mendy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058029; O'Halloran JA, 2011, J CLIN VIROL, V52, P151, DOI 10.1016/j.jcv.2011.06.020; PASKO MT, 1990, AM J PUBLIC HEALTH, V80, P590, DOI 10.2105/AJPH.80.5.590; Peces R, 2001, NEPHRON, V89, P172, DOI 10.1159/000046064; Schillie S, 2013, MMWR RECOMM REP, V62, P1; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; SEEFF LB, 1978, ANN INTERN MED, V88, P285, DOI 10.7326/0003-4819-88-3-285; Stramer SL, 2011, NEW ENGL J MED, V364, P236, DOI 10.1056/NEJMoa1007644; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Ujiie M, 2016, LANCET INFECT DIS, V16, P1325, DOI 10.1016/S1473-3099(16)30463-7; Umemura T, 2008, CLIN INFECT DIS, V47, pE52, DOI 10.1086/590968; Yu AS, 2006, INFECT DIS CLIN N AM, V20, P27, DOI 10.1016/j.idc.2006.01.004	30	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187661	10.1371/journal.pone.0187661	http://dx.doi.org/10.1371/journal.pone.0187661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121107	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900061
J	Liu, YY; Chiang, CH; Hung, SC; Chian, CF; Tsai, CL; Chen, WC; Zhang, HB				Liu, Yung-Yang; Chiang, Chi-Huei; Hung, Shih-Chieh; Chian, Chih-Feng; Tsai, Chen-Liang; Chen, Wei-Chih; Zhang, Haibo			Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury	PLOS ONE			English	Article							MARROW STROMAL CELLS; ISCHEMIA; DEXAMETHASONE; SURVIVAL; DELIVERY; INCREASE	Background Hypoxia preconditioning has been proven to be an effective method to enhance the therapeutic action of mesenchymal stem cells (MSCs). However, the beneficial effects of hypoxic MSCs in ischemia/reperfusion (I/R) lung injury have yet to be investigated. In this study, we hypothesized that the administration of hypoxic MSCs would have a positive therapeutic impact on I/R lung injury at molecular, cellular, and functional levels. Methods I/R lung injury was induced in isolated and perfused rat lungs. Hypoxic MSCs were administered in perfusate at a low (2.5x10(5) cells) and high (1 x10(6) cells) dose. Rats ventilated with a low tidal volume of 6 ml/kg served as controls. Hemodynamics, lung injury indices, inflammatory responses and activation of apoptotic pathways were determined. Results I/R induced permeability pulmonary edema with capillary leakage and increased levels of reactive oxygen species (ROS), pro-inflammatory cytokines, adhesion molecules, cytosolic cytochrome C, and activated MAPK, NF-kappa B, and apoptotic pathways. The administration of a low dose of hypoxic MSCs effectively attenuated I/R pathologic lung injury score by inhibiting inflammatory responses associated with the generation of ROS and anti-apoptosis effect, however this effect was not observed with a high dose of hypoxic MSCs. Mechanistically, a low dose of hypoxic MSCs down-regulated P38 MAPK and NF-kappa B signaling but upregulated glutathione, prostaglandin E2, IL-10, mitochondrial cytochrome C and Bcl-2. MSCs infused at a low dose migrated into interstitial and alveolar spaces and bronchial trees, while MSCs infused at a high dose aggregated in the microcirculation and induced pulmonary embolism. Conclusions Hypoxic MSCs can quickly migrate into extravascular lung tissue and adhere to other inflammatory or structure cells and attenuate I/R lung injury through anti-oxidant, anti-inflammatory and anti-apoptotic mechanisms. However, the dose of MSCs needs to be optimized to prevent pulmonary embolism and thrombosis.	[Liu, Yung-Yang; Chiang, Chi-Huei; Chen, Wei-Chih] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan; [Liu, Yung-Yang; Chiang, Chi-Huei; Chen, Wei-Chih] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan; [Liu, Yung-Yang; Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei, Taiwan; [Chiang, Chi-Huei] Natl Def Med Ctr, Triserv Gen Hosp, Dept Med, Taipei, Taiwan; [Hung, Shih-Chieh] China Med Univ, Chinese Med Univ Hosp, Grad Inst Clin Med Sci, Integrat Stem Cell Ctr, Taichung, Taiwan; [Hung, Shih-Chieh] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Hung, Shih-Chieh] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan; [Hung, Shih-Chieh] Taipei Vet Gen Hosp, Therapeut & Res Ctr Musculoskeletal Tumor, Taipei, Taiwan; [Chian, Chih-Feng; Tsai, Chen-Liang] Natl Def Med Ctr, Triserv Gen Hosp, Div Pulm & Crit Care Med, Internal Med Dept, Taipei, Taiwan; [Zhang, Haibo] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Zhang, Haibo] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; China Medical University Taiwan; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Defense Medical Center; Tri-Service General Hospital; University of Toronto; University of Toronto	Chiang, CH (corresponding author), Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan.; Chiang, CH (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan.; Chiang, CH (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Med, Taipei, Taiwan.	chiang1990@gmail.com		Tsai, Chen-Liang/0000-0001-9783-5423	Taipei Veterans General Hospital [101DHA0100665, 101DHA0100079, 100DHA0100130, 99DHA0100412]; National Science Council, Taiwan [NSC99-2314-B-075-034-MY2, NSC 101-2314-B-075-054-MY3]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Taipei Veterans General Hospital (101DHA0100665, 101DHA0100079, 100DHA0100130 and 99DHA0100412) and the National Science Council (NSC99-2314-B-075-034-MY2 and NSC 101-2314-B-075-054-MY3), Taiwan.	Agnelli G, 2010, NEW ENGL J MED, V363, P266, DOI 10.1056/NEJMra0907731; Chailakhyan RK, 2014, B EXP BIOL MED+, V157, P138, DOI 10.1007/s10517-014-2509-x; Chambers DC, 2017, STEM CELL TRANSL MED, V6, P1152, DOI 10.1002/sctm.16-0372; Chang DM, 1997, AM J RESP CRIT CARE, V156, P1230, DOI 10.1164/ajrccm.156.4.9702095; Chiang CH, 1997, J APPL PHYSIOL, V83, P583, DOI 10.1152/jappl.1997.83.2.583; Chiang CH, 1999, AM J RESP CRIT CARE, V160, P1319, DOI 10.1164/ajrccm.160.4.9811079; Chiang CH, 2001, CLIN SCI, V101, P285, DOI 10.1042/CS20000302; Chiang CH, 2006, CHINESE J PHYSIOL, V49, P266; Chiang CH, 2011, INTENS CARE MED, V37, P1360, DOI 10.1007/s00134-011-2251-z; Chiang CH, 2011, TRANSL RES, V158, P17, DOI 10.1016/j.trsl.2011.02.002; Chistiakov DA, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-92; Cui LL, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt544; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Gotts JE, 2011, CRIT CARE CLIN, V27, P719, DOI 10.1016/j.ccc.2011.04.004; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Huang WH, 2014, CARDIOVASC RES, V101, P266, DOI 10.1093/cvr/cvt250; Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Lan YW, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0081-6; Laubach VE, 2016, CURR OPIN ORGAN TRAN, V21, P246, DOI 10.1097/MOT.0000000000000304; Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Lee SH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-16; Lu HL, 2008, INJURY, V39, P1062, DOI 10.1016/j.injury.2007.10.022; Manning E, 2010, HUM GENE THER, V21, P713, DOI 10.1089/hum.2009.147; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PROCKOP DJ, 1997, SCIENCE, V276, P71, DOI [DOI 10.1126/SCIENCE.276.5309.71, 10.1126/science.276.5309.71]; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Sack MN, 2006, CARDIOVASC RES, V72, P210, DOI 10.1016/j.cardiores.2006.07.010; Souidi N, 2013, CURR OPIN ORGAN TRAN, V18, P34, DOI 10.1097/MOT.0b013e32835c2a05; Sun CK, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-118; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Zhang W, 2014, BIOMED RES INT, V2014; Zhang Z, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0543-0	40	43	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187637	10.1371/journal.pone.0187637	http://dx.doi.org/10.1371/journal.pone.0187637			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117205	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600053
J	Ognibene, M; Cangelosi, D; Morini, M; Segalerba, D; Bosco, MC; Sementa, AR; Eva, A; Varesio, L				Ognibene, Marzia; Cangelosi, Davide; Morini, Martina; Segalerba, Daniela; Bosco, Maria Carla; Sementa, Angela Rita; Eva, Alessandra; Varesio, Luigi			Immunohistochemical analysis of PDK1, PHD3 and HIF-1 alpha expression defines the hypoxic status of neuroblastoma tumors	PLOS ONE			English	Article							RISK NEUROBLASTOMA; PROLYL HYDROXYLASE; CANCER; GROWTH; STRATIFICATION; PROLIFERATION; ANGIOGENESIS; INHIBITION; METABOLISM; ACTIVATION	Neuroblastoma (NB) is the most common solid tumor during infancy and the first cause of death among the preschool age diseases. The availability of several NB genomic profiles improves the prognostic ability, but the outcome prediction for this pathology remains imperfect. We previously produced a novel prognostic gene signature based on the response of NB cells to hypoxia, a condition of tumor microenvironment strictly connected with cancer aggressiveness. Here we attempted to further define the expression of hypoxia-modulated specific genes, looking at their protein level in NB specimens, considering in particular the hypoxia inducible factor-1 alpha (HIF-1 alpha), the mitochondrial pyruvate dehydrogenase kinase 1 (PDK1), and the HIF-prolyl hydroxylase domain 3 (PHD3). The evaluation of expression was performed by Western blot and immunocytochemistry on NB cell lines and by immunohistochemistry on tumor specimens. Stimulation of both HIF-1 alpha and PDK1 and inhibition of PHD3 expression were observed in NB cell lines cultured under prolonged hypoxic conditions as well as in most of the tumors with poor outcome. Our results indicate that the immunohistochemistry analysis of the protein expression of PDK1, PHD3, and HIF-1 alpha defines the hypoxic status of NB tumors and can be used as a simple and relevant tool to stratify high risk patients.	[Ognibene, Marzia; Cangelosi, Davide; Morini, Martina; Segalerba, Daniela; Bosco, Maria Carla; Eva, Alessandra; Varesio, Luigi] Giannina Gaslini Inst, Lab Mol Biol, Genoa, Italy; [Sementa, Angela Rita] Giannina Gaslini Inst, Dept Pathol, Genoa, Italy; [Ognibene, Marzia] Giannina Gaslini Inst, Lab Oncol, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Ognibene, M; Eva, A (corresponding author), Giannina Gaslini Inst, Lab Mol Biol, Genoa, Italy.; Ognibene, M (corresponding author), Giannina Gaslini Inst, Lab Oncol, Genoa, Italy.	marziaognibene@gaslini.org; alessandraeva@gaslini.org	Cangelosi, Davide/K-2627-2016; Bosco, Maria Carla/J-7928-2016; Morini, Martina/K-3725-2018; Segalerba, Daniela/AAB-2023-2020; Ognibene, Marzia/AAA-7275-2020; Eva, Alessandra/J-8268-2016; Sementa, Angela Rita/ABH-4686-2020	Cangelosi, Davide/0000-0002-6010-5619; Bosco, Maria Carla/0000-0003-1857-7193; Morini, Martina/0000-0003-2569-4515; Segalerba, Daniela/0000-0002-3232-5497; Ognibene, Marzia/0000-0003-3698-9319; Eva, Alessandra/0000-0003-2949-078X; 	Italian Association for Cancer Research [AIRC-IG10565]; Associazione Italiana per la Lotta al Neuroblastoma	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Lotta al Neuroblastoma(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Association for Cancer Research (AIRC-IG10565) and by the Associazione Italiana per la Lotta al Neuroblastoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applebaum MA, 2016, ONCOTARGET, V7, P76816, DOI 10.18632/oncotarget.12713; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Bordow SB, 1998, J CLIN ONCOL, V16, P3286, DOI 10.1200/JCO.1998.16.10.3286; Brodeur G. M., 2006, PRINCIPLES PRACTICE, P933; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cangelosi D, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1194-3; Cangelosi D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S5-S4; Cangelosi D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S12; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chesney J, 2014, ONCOTARGET, V5, P6670, DOI 10.18632/oncotarget.2213; De Preter K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r84; De Preter K, 2010, CLIN CANCER RES, V16, P1532, DOI 10.1158/1078-0432.CCR-09-2607; Doroshow JH, 2010, J CLIN ONCOL, V28, P4869, DOI 10.1200/JCO.2010.31.1472; Dougherty J, 1995, P 12 INT C MACH LEAR, P115; Edsjo A, 2007, SEMIN CANCER BIOL, V17, P248, DOI 10.1016/j.semcancer.2006.04.005; Fardin P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-185; Fardin P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-474; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Fujiwara S, 2013, BRIT J CANCER, V108, P170, DOI 10.1038/bjc.2012.527; Hatzimichael E, 2010, EUR J HAEMATOL, V84, P47, DOI 10.1111/j.1600-0609.2009.01344.x; Henze AT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6582; Herrmann A, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2014.52; Huang CC, 2015, DIS MODEL MECH, V8, P1247, DOI 10.1242/dmm.021667; Hur H, 2013, INT J ONCOL, V42, P44, DOI 10.3892/ijo.2012.1687; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lin Q, 2010, CANCER BIOL THER, V9, P949, DOI 10.4161/cbt.9.12.12347; Liu QL, 2013, ARCH MED SCI, V9, P589, DOI 10.5114/aoms.2013.36987; Liu T, 2017, ONCOL REP, V37, P193, DOI 10.3892/or.2016.5253; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mazzocco K, 2015, PEDIATR BLOOD CANCER, V62, P1725, DOI 10.1002/pbc.25552; Meitar D, 1996, J CLIN ONCOL, V14, P405, DOI 10.1200/JCO.1996.14.2.405; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Oberthuer A, 2015, CLIN CANCER RES, V21, P1904, DOI 10.1158/1078-0432.CCR-14-0817; Peurala E, 2012, BREAST CANCER RES TR, V133, P179, DOI 10.1007/s10549-011-1750-5; Poomthavorn P, 2009, ENDOCR-RELAT CANCER, V16, P991, DOI 10.1677/ERC-08-0340; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; STILLER CA, 1992, INT J CANCER, V52, P538, DOI 10.1002/ijc.2910520407; Thiele CJ, 1999, HUMAN CELL CULTURE, V1, P21; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; van Noesel MM, 2004, GENE, V325, P1, DOI 10.1016/j.gene.2003.09.042; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; von Stedingk K, 2015, INT J CANCER, V137, P868, DOI 10.1002/ijc.29461; Weinstein JL, 2003, ONCOLOGIST, V8, P278, DOI 10.1634/theoncologist.8-3-278; Zhang W, 2015, INT J BIOL SCI, V11, P1390, DOI 10.7150/ijbs.13325	56	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187206	10.1371/journal.pone.0187206	http://dx.doi.org/10.1371/journal.pone.0187206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117193	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600028
J	Pfister, R; Ihle, P; Mews, B; Kohnen, E; Wahner, M; Karbach, U; Aslan, H; Hopp, HW; Schneider, CA				Pfister, Roman; Ihle, Peter; Mews, Birgit; Kohnen, Elisabeth; Waehner, Marcus; Karbach, Ute; Aslan, Hasan; Hoepp, Hans-Wilhelm; Schneider, Christian Alfons			Feasibility of including patients with migration background in a structured heart failure management programme: A prospective case-control study exemplarily on Turkish migrants	PLOS ONE			English	Article							EUROPEAN-SOCIETY; PRIMARY-CARE; HEALTH-CARE; ASSOCIATION; SERVICES; QUALITY	Aims Structured management programmes deliver optimized care in heart failure patients and improve outcome. We examined the feasibility of including patients with migration background speaking little or no German in a heart failure management programme. Methods and results After adaption of script material and staff to Turkish language we aimed to recruit 300 Turkish and 300 German (control group) patients within 18 months using the operational basis of a local heart failure management programme for screening, contact and inclusion. Of 488 and 1,055 eligible Turkish and German patients identified through screening, 165 Turkish (34%) and 335 German (32%) patients consented on participation (p = 0.46). General practitioners contributed significantly more of the Turkish (84%) than of the German patients (16%, p<0.001). Contact attempts by programme staff were significantly less successful in Turkish (52%) than in German patients (60%, p = 0.005) due to significantly higher rate of missing phone numbers (36% vs 25%), invalid address data (28% vs 7%) and being unreachable by phone more frequently (39% vs 26%, all p<0.001). Consent rate was significantly higher in successfully contacted Turkish (63%) compared to German patients (50%, p<0.001). Conclusion The inclusion of Turkish minority patients into a heart failure management programme is feasible with higher consent rate than in Germans. However, effort is high due to inherent logistic adaptions and barriers in identification and contacting of patients.	[Pfister, Roman] Univ Cologne, Dept Internal Med 3, Heart Ctr, Cologne, Germany; [Pfister, Roman; Mews, Birgit; Kohnen, Elisabeth; Waehner, Marcus; Hoepp, Hans-Wilhelm; Schneider, Christian Alfons] HerzNetzKoln2, Cologne, Germany; [Ihle, Peter] Univ Cologne, PMV Forsch Grp, Cologne, Germany; [Karbach, Ute] Inst Med Sociol Hlth Serv Res & Rehabil Sci, Cologne, Germany; [Schneider, Christian Alfons] Kardiol Pan Klin, Cologne, Germany	University of Cologne; University of Cologne	Pfister, R (corresponding author), Univ Cologne, Dept Internal Med 3, Heart Ctr, Cologne, Germany.; Pfister, R (corresponding author), HerzNetzKoln2, Cologne, Germany.	roman.pfister@uk-koeln.de	Karbach, Ute/AAX-2844-2020	Karbach, Ute/0000-0003-3479-9474	European Union and the Department of Health, Emancipation, Nursing and Ageing of the County Nordrhein-Westfalen [005-GW02-037A-C]	European Union and the Department of Health, Emancipation, Nursing and Ageing of the County Nordrhein-Westfalen	This work was supported by the European Union and the Department of Health, Emancipation, Nursing and Ageing of the County Nordrhein-Westfalen [Nr: 005-GW02-037A-C] to HWH. The funder played no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The researchers were independent from the funders.	Berens EM, 2015, GESUNDHEITSWESEN; Bungartz J, 2011, BUNDESGESUNDHEITSBLA, V54, P1179, DOI 10.1007/s00103-011-1365-3; Corrao G, 2015, INT J CARDIOL, V181, P81, DOI 10.1016/j.ijcard.2014.12.004; Correa-De-Araujo R, 2006, WOMEN HEALTH ISS, V16, P44, DOI 10.1016/j.whi.2005.04.003; de Graaff FM, 2009, BMC PALLIAT CARE, V8; Dickson VV, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001561; Fiscella K, 2002, MED CARE, V40, P52, DOI 10.1097/00005650-200201000-00007; Guder G, 2015, EUR J HEART FAIL, V17, P442, DOI 10.1002/ejhf.252; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Juenger J, 2002, HEART, V87, P235, DOI 10.1136/heart.87.3.235; Maggioni AP, 2016, EUR J HEART FAIL; McDonagh TA, 2011, EUR J HEART FAIL, V13, P235, DOI 10.1093/eurjhf/hfq221; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Neumann T, 2009, DTSCH ARZTEBL INT, V106, P269, DOI 10.3238/arztebl.2009.0269; Quan H, 2006, CAN MED ASSOC J, V174, P787, DOI 10.1503/cmaj.050674; Razum O, 2004, DTSCH ARZTEBLATT, V101, P2882; Reiss K, 2014, EUR J PUBLIC HEALTH, V24, P721, DOI 10.1093/eurpub/cku046; Sproston KA, 2001, ETHNIC HEALTH, V6, P189, DOI 10.1080/13557850120078116; Takeda A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002752.pub3; Uslu S, 2014, GESUNDHEITSWESEN, V76, P366, DOI 10.1055/s-0033-1357199; Vivo RP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001134; Wu JR, 2010, J CARD FAIL, V16, P142, DOI 10.1016/j.cardfail.2009.10.017; Yilmaz-Aslan Y, 2013, Z GERONTOL GERIATR, V46, P346, DOI 10.1007/s00391-012-0406-3	23	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187358	10.1371/journal.pone.0187358	http://dx.doi.org/10.1371/journal.pone.0187358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM0ME	29117200	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600035
J	Zhang, MW; Wang, H; Yi, Y; Ding, JF; Zhu, M; Li, CY; Guo, WS; Feng, CN; Zhu, XK				Zhang, Mingwei; Wang, Hui; Yi, Yuan; Ding, Jinfeng; Zhu, Min; Li, Chunyan; Guo, Wenshan; Feng, Chaonian; Zhu, Xinkai			Effect of nitrogen levels and nitrogen ratios on lodging resistance and yield potential of winter wheat (Triticum aestivum L.)	PLOS ONE			English	Article							SPRING WHEAT; GROWTH; CULTIVARS; GRAIN; SEMIDWARF; WEIGHT; LIGNIN; BARLEY; GENES; STEM	Lodging is one of the constraints that limit wheat yields and quality due to the unexpected bending or breaking stems on wheat (Triticum aestivum L.) production worldwide. In addition to choosing lodging resistance varieties, husbandry practices also have a significant effect on lodging. Nitrogen management is one of the most common and efficient methods. A field experiment with Yangmai 20 as research material (a widely-used variety) was conducted to study the effects of different nitrogen levels and ratios on culm morphological, anatomical characters and chemical components and to explore the nitrogen application techniques for lodging tolerance and high yield. Results showed that some index of basal internodes, such as stem wall thickness, filling degree, lignin content, cellulose content, water-soluble carbohydrate (WSC) and WSC/N ratio, were positively and significantly correlated with culm lodging-resistant index (CLRI). As the increase of nitrogen level and basal nitrogen ratio, the basal internodes became slender and fragile with the thick stem wall, while filling degree, chemical components and the strength of the stem decreased gradually, which significantly increased the lodging risk. The response of grain yield to nitrogen doses was quadratic and grain yield reached the highest at the nitrogen ratio of 50%:10%:20%:20% (the ratio of nitrogen amount applied before sowing, at tillering stage, jointing stage and booting stage respectively, abbreviated as 5:1:2:2). These results suggested that for Yangmai 20, the planting density of 180x10(4)ha(-1), nitrogen level of 225 kg ha(-1), and the ratio of 5: 1: 2: 2 effectively increased lodging resistance and grain yield. This combination of planting density and nitrogen level and ratio could effectively relieve the contradiction between high-yielding and anti-lodging.	[Zhang, Mingwei; Yi, Yuan; Ding, Jinfeng; Zhu, Min; Li, Chunyan; Guo, Wenshan; Feng, Chaonian; Zhu, Xinkai] Yangzhou Univ, Lab Crop Genet & Physiol Jiangsu Prov, Coinnovat Ctr Modern Prod Technol Grain Crops, Wheat Res Inst, Yangzhou, Jiangsu, Peoples R China; [Wang, Hui] Lixiahe Insitute Agr Sci Jiangsu, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Feng, CN; Zhu, XK (corresponding author), Yangzhou Univ, Lab Crop Genet & Physiol Jiangsu Prov, Coinnovat Ctr Modern Prod Technol Grain Crops, Wheat Res Inst, Yangzhou, Jiangsu, Peoples R China.	fengchaonian@hotmail.com; xkzhu@yzu.edu.cn			National Key Research and Development Program of China [2016YFD0300405]; Jiangsu Province Agricultural Science and Technology Independent Innovation Funds [CX(15)1002]; Special Fund for Agro-scientific Research in the Public Interest [201503130]; Priority Academic Program Development of Jiangsu Higher Education Institutions; University Scientific and Technological Innovation Team of Jiangsu Province; Science and Technology Innovation Team and Outstanding Talents Support Program of Yangzhou University	National Key Research and Development Program of China; Jiangsu Province Agricultural Science and Technology Independent Innovation Funds; Special Fund for Agro-scientific Research in the Public Interest; Priority Academic Program Development of Jiangsu Higher Education Institutions; University Scientific and Technological Innovation Team of Jiangsu Province; Science and Technology Innovation Team and Outstanding Talents Support Program of Yangzhou University	This work was supported by the grants from the National Key Research and Development Program of China (2016YFD0300405), Jiangsu Province Agricultural Science and Technology Independent Innovation Funds (CX(15)1002), Special Fund for Agro-scientific Research in the Public Interest (201503130), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the University Scientific and Technological Innovation Team of Jiangsu Province, and Science and Technology Innovation Team and Outstanding Talents Support Program of Yangzhou University.	Acreche MM, 2011, FIELD CROP RES, V122, P40, DOI 10.1016/j.fcr.2011.02.004; ALI AA, 1993, MENOFIYA J AGR RES, V18, P2225; ALLAN RE, 1986, CROP SCI, V26, P707, DOI 10.2135/cropsci1986.0011183X002600040014x; Baucher M, 1998, CRIT REV PLANT SCI, V17, P125, DOI 10.1016/S0735-2689(98)00360-8; Berry PM, 2007, EUPHYTICA, V154, P165, DOI 10.1007/s10681-006-9284-3; Berry PM, 2000, FIELD CROP RES, V67, P59, DOI 10.1016/S0378-4290(00)00084-8; Berry PM, 2004, ADV AGRON, V84, P217, DOI 10.1016/S0065-2113(04)84005-7; Berry PM, 2003, J AGRON CROP SCI, V189, P390, DOI 10.1046/j.0931-2250.2003.00062.x; Chem A, 1980, OFFICIAL METHODS ANA; Chen XiaoGuang, 2011, Acta Agronomica Sinica, V37, P1616, DOI 10.3724/SP.J.1006.2011.01616; Cheng S., 2012, WHEAT SO CHINA; CHERNEY JH, 1985, CROP SCI, V25, P1113, DOI 10.2135/cropsci1985.0011183X002500060051x; CROOK MJ, 1995, J EXP BOT, V46, P931, DOI 10.1093/jxb/46.8.931; FISCHER RA, 1987, FIELD CROP RES, V17, P245, DOI 10.1016/0378-4290(87)90038-4; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; Foulkes MJ, 2011, J EXP BOT, V62, P469, DOI 10.1093/jxb/erq300; He ZH, 2014, J CEREAL SCI, V59, P235, DOI 10.1016/j.jcs.2013.07.012; Hobbs P. R., 1998, INCREASING WHEAT YIE; JEDEL PE, 1991, AGRON J, V83, P158, DOI 10.2134/agronj1991.00021962008300010036x; Kheiralla KA, 1993, PRESSESS SCI PO, V53, P135; KNAPP JS, 1987, CROP SCI, V27, P1201, DOI 10.2135/cropsci1987.0011183X002700060022x; Kong EY, 2013, CROP J, V1, P43, DOI 10.1016/j.cj.2013.07.012; LAUDE H. H., 1956, AGRON JOUR, V48, P452; Li JinCai, 2005, Acta Agronomica Sinica, V31, P662; MIRALLES DJ, 1995, FIELD CROP RES, V43, P55, DOI 10.1016/0378-4290(95)00041-N; NEENAN M, 1975, J AGR SCI, V85, P495, DOI 10.1017/S0021859600062377; Niu LY, 2012, FIELD CROP RES, V139, P1, DOI 10.1016/j.fcr.2012.10.014; Peake AS, 2016, CROP PASTURE SCI, V67, P907, DOI 10.1071/CP16052; Peake AS, 2014, FIELD CROP RES, V158, P1, DOI 10.1016/j.fcr.2013.12.001; Peng DL, 2014, FIELD CROP RES, V157, P1, DOI 10.1016/j.fcr.2013.11.015; Pinthis M. J., 1973, Advances in Agronomy, V25, P209; Sylvester-Bradley R., 1997, Aspects of Applied Biology, P103; Tripathi SC, 2003, FIELD CROP RES, V84, P271, DOI 10.1016/S0378-4290(03)00095-9; Wei FengZhen, 2008, Acta Agronomica Sinica, V34, P1080, DOI 10.3724/SP.J.1006.2008.01080; WEIBEL R. O., 1964, AGRON J, V56, P487; Xue GP, 2009, CROP PASTURE SCI, V60, P51, DOI 10.1071/CP08073; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zuber U, 1999, J AGRON CROP SCI, V182, P17, DOI 10.1046/j.1439-037x.1999.00251.x	38	45	47	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187543	10.1371/journal.pone.0187543	http://dx.doi.org/10.1371/journal.pone.0187543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117250	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600043
J	Fukuda, T; Naganuma, M; Sugimoto, S; Nanki, K; Mizuno, S; Mutaguchi, M; Nakazato, Y; Inoue, N; Ogata, H; Iwao, Y; Kanal, T				Fukuda, Tomohiro; Naganuma, Makoto; Sugimoto, Shinya; Nanki, Kosaku; Mizuno, Shinta; Mutaguchi, Makoto; Nakazato, Yoshihiro; Inoue, Nagamu; Ogata, Haruhiko; Iwao, Yasushi; Kanal, Takanori			The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; 1ST COURSE; REMISSION; MESALAZINE; EFFICACY; CORTICOSTEROIDS; AZATHIOPRINE; OUTCOMES	Background 5-Aminosalicylic acids (5-ASA) are effective for ulcerative colitis (UC) as a maintenance therapy. It is not clear when and how to reduce a dose of 5-ASA after inducing remission. We aimed to investigate the clinical characteristics and evaluate the risk factors of relapse for UC patients receiving 5-ASA. Methods The medical records of prospectively registered UC patients who received oral 5-ASA as maintenance therapy between January and December 31, 2014, were investigated. The patients' clinical characteristics in a 2-year follow-up were compared between a relapse group and a remission group. Results Of 527 UC patients receiving only oral 5-ASA, 390 (74.0%) maintained remission and 137 (26.0%) relapsed during the follow-up period. Multivariable analysis indicated that a shorter duration of disease remission (p < 0.001, OR: 1.24, 95% Cl: 1.12-1.38) was statistically significant for each comparison between the remission and relapse groups among all the patients. Risk factors for clinical relapse were a shorter duration of disease remission (p < 0.001, OR: 1.17, 95% C: 1.04-1.33) in the high-dose 5-ASA group and a shorter duration of disease remission (p=0.003, OR: 1.45, 95% C: 1.13-1.89) and a history of steroid use (p= 0.048, OR: 4.73, 95% C: 1.01-22.2) in the low-dose group. Conclusions A dose reduction of 5-ASA might be cautiously selected in UC patients with a history of steroid use and a shorter duration of disease remission.	[Fukuda, Tomohiro; Naganuma, Makoto; Sugimoto, Shinya; Nanki, Kosaku; Mizuno, Shinta; Mutaguchi, Makoto; Kanal, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Nakazato, Yoshihiro; Ogata, Haruhiko] Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Tokyo, Japan; [Inoue, Nagamu; Iwao, Yasushi] Kele Univ, Sch Med, Ctr Prevent Med, Tokyo, Japan	Keio University; Keio University	Kanal, T (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan.	takagast@z2.keio.jp	Sugimoto, Shinya/X-6548-2018	Kanai, Takanori/0000-0002-1466-4532; Nanki, Kosaku/0000-0003-4232-0523; Sugimoto, Shinya/0000-0002-1560-1605	Grants-in-Aid for Scientific Research [15K08974] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arai M, 2016, J CROHNS COLITIS, V10, P1303, DOI 10.1093/ecco-jcc/jjw104; ARDIZZONE S, 1995, J CLIN GASTROENTEROL, V21, P287, DOI 10.1097/00004836-199512000-00007; Ardizzone S, 2006, GUT, V55, P47, DOI 10.1136/gut.2005.068809; Ardizzone S, 2011, CLIN GASTROENTEROL H, V9, P483, DOI 10.1016/j.cgh.2010.12.028; Bello C, 2011, J CROHNS COLITIS, V5, P196, DOI 10.1016/j.crohns.2010.12.011; Bressler B, 2015, GASTROENTEROLOGY, V148, P1035, DOI 10.1053/j.gastro.2015.03.001; Feagan BG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000543.pub3; Feagan BG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000544.pub3; Fockens P, 1995, EUR J GASTROEN HEPAT, V7, P1025, DOI 10.1097/00042737-199511000-00003; Froslie KF, 2007, GASTROENTEROLOGY, V133, P412, DOI 10.1053/j.gastro.2007.05.051; Garcia-Planella E, 2012, DIGEST LIVER DIS, V44, P206, DOI 10.1016/j.dld.2011.10.004; Gisbert JP, 2009, ALIMENT PHARM THER, V30, P126, DOI 10.1111/j.1365-2036.2009.04023.x; Hanauer SB, 2004, GASTROENTEROLOGY, V126, P1582, DOI 10.1053/j.gastro.2004.02.071; Khan N, 2013, DIGEST DIS SCI, V58, P2963, DOI 10.1007/s10620-013-2748-0; Khan N, 2013, INFLAMM BOWEL DIS, V19, P1123, DOI 10.1097/MIB.0b013e318280b1b8; Meijer B, 2016, WORLD J GASTROENTERO, V22, P9012, DOI 10.3748/wjg.v22.i40.9012; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Paoluzi OA, 2005, ALIMENT PHARM THER, V21, P1111, DOI 10.1111/j.1365-2036.2005.02458.x; Parente F, 2010, AM J GASTROENTEROL, V105, P1150, DOI 10.1038/ajg.2009.672; Rubin DT, 2016, J CROHNS COLITIS, V10, P925, DOI 10.1093/ecco-jcc/jjw049; Sandborn WJ, 2009, GASTROENTEROLOGY, V137, P1250, DOI 10.1053/j.gastro.2009.06.061; Sutherland L., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000544; Zeisler B, 2013, J PEDIATR GASTR NUTR, V56, P12, DOI 10.1097/MPG.0b013e31826ac41a	23	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187737	10.1371/journal.pone.0187737	http://dx.doi.org/10.1371/journal.pone.0187737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108025	gold, Green Published, Green Submitted			2022-12-26	WOS:000414424600067
J	Sato, Y; Ohtsubo, H; Nihei, N; Kaneko, T; Sato, Y; Adachi, SI; Kondo, S; Nakamura, M; Mizunoya, W; Iida, H; Tatsumi, R; Rada, C; Yoshizawa, F				Sato, Yusuke; Ohtsubo, Hideaki; Nihei, Naohiro; Kaneko, Takane; Sato, Yoriko; Adachi, Shin-Ichi; Kondo, Shinji; Nakamura, Mako; Mizunoya, Wataru; Iida, Hiroshi; Tatsumi, Ryuichi; Rada, Cristina; Yoshizawa, Fumiaki			Apobec2 deficiency causes mitochondrial defects and mitophagy in skeletal muscle	FASEB JOURNAL			English	Article						mitochondria; myopathy; APOBEC	RNA-EDITING ENZYME; CYTIDINE DEAMINASE AID; POLYPEPTIDE 2 APOBEC2; MESSENGER-RNA; MUSCULAR-DYSTROPHIES; RETINA REGENERATION; DNA DEMETHYLATION; MULLER GLIA; FIBER-TYPE; AUTOPHAGY	Apobec2 is a member of the activation-induced deaminase/apolipoprotein B mRNA editing enzyme catalytic polypeptide cytidine deaminase family expressed in differentiated skeletal and cardiac muscle. We previously reported that Apobec2 deficiency in mice leads to a shift in muscle fiber type, myopathy, and diminished muscle mass. However, the mechanisms of myopathy caused by Apobec2 deficiency and its physiologic functions are unclear. Here we show that, although Apobec2 localizes to the sarcomeric Z-lines in mouse tissue and cultured myotubes, the sarcomeric structure is not affected in Apobec2-deficient muscle. In contrast, electron microscopy reveals enlarged mitochondria and mitochondria engulfed by autophagic vacuoles, suggesting that Apobec2 deficiency causes mitochondrial defects leading to increased mitophagy in skeletal muscle. Indeed, Apobec2 deficiency results in increased reactive oxygen species generation and depolarized mitochondria, leading to mitophagy as a defensive response. Furthermore, the exercise capacity of Apobec2(-/-) mice is impaired, implying Apobec2 deficiency results in ongoing muscle dysfunction. The presence of rimmed vacuoles in myofibers from 10-mo-old mice suggests that the chronic muscle damage impairs normal autophagy. We conclude that Apobec2 deficiency causes mitochondrial defects that increase muscle mitophagy, leading to myopathy and atrophy. Our findings demonstrate that Apobec2 is required for mitochondrial homeostasis to maintain normal skeletal muscle function.	[Sato, Yusuke; Nihei, Naohiro; Adachi, Shin-Ichi; Kondo, Shinji; Yoshizawa, Fumiaki] Utsunomiya Univ, Dept Agrobiol & Bioresources, 350 Minemachi, Utsunomiya, Tochigi 3218505, Japan; [Ohtsubo, Hideaki; Kaneko, Takane; Nakamura, Mako; Mizunoya, Wataru; Iida, Hiroshi; Tatsumi, Ryuichi] Kyushu Univ, Dept Anim & Marine Bioresource Sci, Fukuoka, Japan; [Sato, Yoriko; Yoshizawa, Fumiaki] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Tokyo, Japan; [Rada, Cristina] MRC, Lab Mol Biol, Cambridge, England	Utsunomiya University; Kyushu University; Tokyo University of Agriculture & Technology; MRC Laboratory Molecular Biology	Sato, Y (corresponding author), Utsunomiya Univ, Dept Agrobiol & Bioresources, 350 Minemachi, Utsunomiya, Tochigi 3218505, Japan.	ysato@cc.utsunomiya-u.ac.jp	Mizunoya, Wataru/W-1674-2019	Mizunoya, Wataru/0000-0002-2258-1964; Nakamura, Mako/0000-0002-6129-7560; Kondo, Shinji/0000-0002-9097-6394	Ministry of Education, Science, Sports and Culture of Japan [25850218]; Morinaga Hoshikai; Nakatomi Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [17H03908] Funding Source: KAKEN; Medical Research Council [MC_U105178806] Funding Source: researchfish; MRC [MC_U105178806] Funding Source: UKRI	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Morinaga Hoshikai; Nakatomi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Dr. Ichizo Nishino (National Center of Neurology Psychiatry, Tokyo, Japan) and Dr. Tomotake Kanki (Niigata University, Niigata, Japan) for technical advice and helpful discussions on mitophagy and myopathy, and Yuhei Fujita, Dr. Kunio Sugahara (Utsunomiya University), and Dr. Yoshihide Ikeuchi (Kyushu University) for their kind support and helpful suggestions. The authors acknowledge the original contribution of their late colleague Michael Neuberger. This work was supported by Grants-in-Aid for Scientific Research (Grant 25850218) from the Ministry of Education, Science, Sports and Culture of Japan; Morinaga Hoshikai; Nakatomi Foundation; and The Uehara Memorial Foundation. The authors declare no conflicts of interest.	Anant S, 2001, AM J PHYSIOL-CELL PH, V281, pC1904, DOI 10.1152/ajpcell.2001.281.6.C1904; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Duran RV, 2012, CELL CYCLE, V11, P4107, DOI 10.4161/cc.22632; Etard C, 2010, J CELL BIOL, V189, P527, DOI 10.1083/jcb.200912125; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; JOST JP, 1993, P NATL ACAD SCI USA, V90, P4684, DOI 10.1073/pnas.90.10.4684; Krzysiak TC, 2012, BIOCHEMISTRY-US, V51, P2008, DOI 10.1021/bi300021s; Lada AG, 2011, BIOCHEMISTRY-MOSCOW+, V76, P131, DOI 10.1134/S0006297911010135; Landes T, 2010, EMBO REP, V11, P459, DOI 10.1038/embor.2010.50; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2014, GENE, V539, P263, DOI 10.1016/j.gene.2014.01.003; Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004; Nishino Ichizo, 2003, Curr Neurol Neurosci Rep, V3, P64, DOI 10.1007/s11910-003-0040-y; Okuyama S, 2012, INT J CANCER, V130, P1294, DOI 10.1002/ijc.26114; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Powell C, 2014, J BIOL CHEM, V289, P28924, DOI 10.1074/jbc.M114.603043; Powell C, 2013, P NATL ACAD SCI USA, V110, P19814, DOI 10.1073/pnas.1312009110; Powell C, 2012, J NEUROSCI, V32, P1096, DOI 10.1523/JNEUROSCI.5603-11.2012; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Sato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1748, DOI 10.1271/bbb.90085; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Suzuki T, 2002, J BIOCHEM, V131, P647, DOI 10.1093/oxfordjournals.jbchem.a003147; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Vonica A, 2011, DEV BIOL, V350, P13, DOI 10.1016/j.ydbio.2010.09.016; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhang TM, 2016, J BIOL CHEM, V291, P21616, DOI 10.1074/jbc.M116.733410	61	15	17	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1428	1439		10.1096/fj.201700493R	http://dx.doi.org/10.1096/fj.201700493R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127187	Green Published, hybrid			2022-12-26	WOS:000427246000025
J	Bansal, M; Moharir, SC; Sailasree, SP; Sirohi, K; Sudhakar, C; Sarathi, DP; Lakshmi, BJ; Buono, M; Kumar, S; Swarup, G				Bansal, Megha; Moharir, Shivranjani C.; Sailasree, S. Purnima; Sirohi, Kapil; Sudhakar, Cherukuri; Sarathi, D. Partha; Lakshmi, B. Jyothi; Buono, Mario; Kumar, Satish; Swarup, Ghanshyam			Optineurin promotes autophagosome formation by recruiting the autophagy-related Atg12-5-16L1 complex to phagophores containing the Wipi2 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GLAUCOMA-ASSOCIATED MUTANT; RETINAL GANGLION-CELLS; SELECTIVE AUTOPHAGY; MYOSIN-VI; DAMAGED MITOCHONDRIA; TRANSFERRIN RECEPTOR; MAMMALIAN AUTOPHAGY; LC3 LIPIDATION; ATG PROTEINS	Autophagy is a quality-control mechanism that helps to maintain cellular homeostasis by removing damaged proteins and organelles through lysosomal degradation. During autophagy, signaling events lead to the formation of a cup-shaped structure called the phagophore that matures into the autophagosome. Recruitment of the autophagy-associated Atg12-5-16L1 complex to Wipi2-positive phagophores is crucial for producing microtubule-associated protein 1 light chain 3-II (LC3-II), which is required for autophagosome formation. Here, we explored the role of the autophagy receptor optineurin (Optn) in autophagosome formation. Fibroblasts from Optn knock-out mouse showed reduced LC3-II formation and a lower number of autophagosomes and autolysosomes during both basal and starvation- induced autophagy. However, the number of Wipi2-positive phagophores was not decreased in Optn-deficient cells. We also found that the number of Atg12/16L1-positive puncta and recruitment of the Atg12-5-16L1 complex to Wipi2-positive puncta are reduced in Optn-deficient cells. Of note, Optn was recruited to Atg12-5-16L1-positive puncta, and interacted with Atg5 and also with Atg12-5 conjugate. A disease-associated Optn mutant, E478G, defective in ubiquitin binding, was also defective in autophagosome formation and recruitment to the Atg12-5-16L1-positive puncta. Moreover, we noted that Optn phosphorylation at Ser-177 was required for autophagosome formation but not for Optn recruitment to the phagophore. These results suggest that Optn potentiates LC3-II production and maturation of the phagophore into the autophagosome, by facilitating the recruitment of the Atg12-5-16L1 complex to Wipi2-positive phagophores.	[Bansal, Megha; Moharir, Shivranjani C.; Sailasree, S. Purnima; Sirohi, Kapil; Sudhakar, Cherukuri; Sarathi, D. Partha; Lakshmi, B. Jyothi; Kumar, Satish; Swarup, Ghanshyam] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Buono, Mario] Univ Oxford, MRC Mol Hematol Unit, Oxford OX3 9DS, England; [Sirohi, Kapil] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Oxford; National Jewish Health	Swarup, G (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	gshyam@ccmb.res.in	Sirohi, Kapil/N-6676-2019; Sirohi, Kapil/GVT-2867-2022	Sirohi, Kapil/0000-0001-5039-2848; Sirohi, Kapil/0000-0001-5039-2848; Moharir, Shivranjani/0000-0001-8713-4543; Swarup, Ghanshyam/0000-0002-8098-0509	Council of Scientific and Industrial Research, Government of India [BSC-0115, BSC-0208]; Dept. of Science and Technology, Government of India [SR/S2/JCB-41/2010]; Council of Scientific and Industrial Research, New Delhi, India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Dept. of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research, Government of India Grants BSC-0115 and BSC-0208 (to G. S.). G. S. is grateful to the Dept. of Science and Technology, Government of India for J C Bose National Fellowship Grant SR/S2/JCB-41/2010. M. Bansal and S. C. M are recipients of a Research Fellowship from the Council of Scientific and Industrial Research, New Delhi, India. The authors declare that they have no conflict of interest with the content of this article.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bansal M, 2015, IUBMB LIFE, V67, P120, DOI 10.1002/iub.1355; Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; Chalasani ML, 2009, OPHTHALMIC RES, V42, P176, DOI 10.1159/000232400; Chalasani MLS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095758; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Fracchiolla D, 2016, ELIFE, V5, DOI 10.7554/eLife.18544; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Ito H, 2011, ACTA NEUROPATHOL, V122, P223, DOI 10.1007/s00401-011-0842-y; Kachaner D, 2012, CELL CYCLE, V11, P2808, DOI 10.4161/cc.20946; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Ktistakis NT, 2016, TRENDS CELL BIOL, V26, P624, DOI 10.1016/j.tcb.2016.03.006; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Levine B, 2015, J CLIN INVEST, V125, P14, DOI 10.1172/JCI73938; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Minegishi Y, 2016, PROG RETIN EYE RES, V55, P149, DOI 10.1016/j.preteyeres.2016.08.002; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moore AS, 2016, P NATL ACAD SCI USA, V113, pE3349, DOI 10.1073/pnas.1523810113; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Nakamura S, 2017, J CELL SCI, V130, P1209, DOI 10.1242/jcs.196352; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda NN, 2013, EMBO REP, V14, P206, DOI 10.1038/embor.2012.208; Osawa T, 2011, NEUROPATHOLOGY, V31, P569, DOI 10.1111/j.1440-1789.2011.01199.x; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Shen WC, 2015, AUTOPHAGY, V11, P685, DOI 10.4161/auto.36098; Shen XA, 2011, J BIOL CHEM, V286, P3618, DOI 10.1074/jbc.M110.175810; Shim MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep33830; Sirohi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138289; Sirohi K, 2013, AUTOPHAGY, V9, P510, DOI 10.4161/auto.23458; Slobodkin MR, 2013, ESSAYS BIOCHEM, V55, P51, DOI [10.1042/bse0550051, 10.1042/BSE0550051]; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Sundaramoorthy V, 2015, HUM MOL GENET, V24, P3830, DOI 10.1093/hmg/ddv126; Tooze Sharon A, 2015, Methods Mol Biol, V1270, P155, DOI 10.1007/978-1-4939-2309-0_12; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; von Muhlinen N, 2010, AUTOPHAGY, V6, P288, DOI 10.4161/auto.6.2.11118; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Ying HY, 2012, INT REV CEL MOL BIO, V294, P223, DOI 10.1016/B978-0-12-394305-7.00005-7; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	61	45	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					132	147		10.1074/jbc.M117.801944	http://dx.doi.org/10.1074/jbc.M117.801944			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29133525	hybrid, Green Published			2022-12-26	WOS:000419453200013
J	Glidden, MD; Aldabbagh, K; Phillips, NB; Carr, K; Chen, YS; Whittaker, J; Phillips, M; Wickramasinghe, NP; Rege, N; Swain, M; Peng, Y; Yang, YW; Lawrence, MC; Yee, VC; Ismail-Beigi, F; Weiss, MA				Glidden, Michael D.; Aldabbagh, Khadijah; Phillips, Nelson B.; Carr, Kelley; Chen, Yen-Shan; Whittaker, Jonathan; Phillips, Manijeh; Wickramasinghe, Nalinda P.; Rege, Nischay; Swain, Mamuni; Peng, Yi; Yang, Yanwu; Lawrence, Michael C.; Yee, Vivien C.; Ismail-Beigi, Faramarz; Weiss, Michael A.			An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; RECEPTOR-BINDING; IGF-I; SECRETORY EXPRESSION; MINI-PROINSULIN; LIGAND-BINDING; CROSS-LINKING; STABILITY; DESIGN; FIBRILLATION	Thermal degradation of insulin complicates its delivery and use. Previous efforts to engineer ultra-stable analogs were confounded by prolonged cellular signaling in vivo, of unclear safety and complicating mealtime therapy. We therefore sought an ultra-stable analog whose potency and duration of action on intravenous bolus injection in diabetic rats are indistinguishable from wild-type (WT) insulin. Here, we describe the structure, function, and stability of such an analog, a 57-residue single-chain insulin (SCI) with multiple acidic substitutions. Cell-based studies revealed native-like signaling properties with negligible mitogenic activity. Its crystal structure, determined as a novel zinc-free hexamer at 2.8 angstrom, revealed a native insulin fold with incomplete or absent electron density in the C domain; complementary NMR studies are described in the accompanying article. The stability of the analog (Delta G(U) 5.0(+/-0.1) kcal/mol at 25 degrees C) was greater than that of WT insulin (3.3(+/-0.1) kcal/mol). On gentle agitation, the SCI retained full activity for >140 days at 45 degrees C and >48 h at 75 degrees C. These findings indicate that marked resistance to thermal inactivation in vitro is compatible with native duration of activity in vivo. Further, whereas WT insulin forms large and heterogeneous aggregates above the standard 0.6 mM pharmaceutical strength, perturbing the pharmacokinetic properties of concentrated formulations, dynamic light scattering, and size-exclusion chromatography revealed only limited SCI self-assembly and aggregation in the concentration range 1-7 mM. Such a combination of favorable biophysical and biological properties suggests that SCIs could provide a global therapeutic platform without a cold chain.	[Glidden, Michael D.; Aldabbagh, Khadijah; Phillips, Nelson B.; Carr, Kelley; Chen, Yen-Shan; Whittaker, Jonathan; Phillips, Manijeh; Wickramasinghe, Nalinda P.; Rege, Nischay; Swain, Mamuni; Yang, Yanwu; Yee, Vivien C.; Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Glidden, Michael D.; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Peng, Yi] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Walter & Eliza Hall Institute; University of Melbourne	Weiss, MA (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	weissma@iu.edu	Wickramasinghe, Nalinda P/F-9465-2010; Lawrence, Michael C/A-5357-2009	Lawrence, Michael/0000-0003-1999-0801; Wickramasinghe, Nalinda P./0000-0002-8700-2775	National Institutes of Health [R01 DK040949, R01 DK069764]; Australian National Health and Medical Research Council [APP1058233]; Victorian State Government Operational Infrastructure Support; Australian NHMRC Independent Research Institutes Infrastructure Support Scheme; Sanofi (Germany); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069764, R01DK040949, F30DK112644, F30DK104618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian NHMRC Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); Sanofi (Germany)(Sanofi-Aventis); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work, a contribution of the Cleveland Center for Membrane and Structural Biology and CWRU Institute for the Science of Origins, was supported in part by National Institutes of Health Grants R01 DK040949 and R01 DK069764 (to M.A.W.), Australian National Health and Medical Research Council Project Grant APP1058233 (to M.C.L.), Victorian State Government Operational Infrastructure Support, and funding from the Australian NHMRC Independent Research Institutes Infrastructure Support Scheme, both to his institution. M.A.W. has equity in Thermalin Diabetes, LLC (Cleveland, OH), where he serves as Chief Innovation Officer; he has also been a consultant to Merck Research Laboratories and DEKA Research & Development Corp. N.B.P. and F.I.-B. are consultants to Thermalin Diabetes, LLC. Part of M.C.L.'s research is funded by Sanofi (Germany). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Barlocco Daniela, 2003, Curr Opin Investig Drugs, V4, P1240; BENTLEY GA, 1992, J MOL BIOL, V228, P1163, DOI 10.1016/0022-2836(92)90323-C; Bode BW, 2011, ENDOCR PRACT, V17, P271, DOI 10.4158/EP10260.RA; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1993, Pharm Biotechnol, V5, P315; Brange J., 1997, PROTEIN DELIVERY PHY, P343; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Chan SJ, 2000, AM ZOOL, V40, P213; CHU YC, 1992, J PROTEIN CHEM, V11, P571, DOI 10.1007/BF01025035; CUTFIELD J, 1981, H-S Z PHYSIOL CHEM, V362, P755, DOI 10.1515/bchm2.1981.362.1.755; Cyranoski D, 2009, NATURE, V458, P561, DOI 10.1038/458561b; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Eby EL, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000074; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frikke-Schmidt H, 2015, DIABETES, V64, P1057, DOI 10.2337/db14-0914; Gallagher EJ, 2013, DIABETES, V62, P3553, DOI 10.2337/db13-0249; GALLOWAY JA, 1992, DIABETES CARE, V15, P666, DOI 10.2337/diacare.15.5.666; Ginter E, 2013, ADV EXP MED BIOL, V771, P42; Glidden MD, 2018, J BIOL CHEM, V293, P69, DOI 10.1074/jbc.M117.808667; Goldin A. A., 2002, SOFTWARE PARTICLE SI; HILL CP, 1991, BIOCHEMISTRY-US, V30, P917, DOI 10.1021/bi00218a006; Hua QX, 2008, J BIOL CHEM, V283, P14703, DOI 10.1074/jbc.M800313200; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; HUANG XF, 1994, J BIOL CHEM, V269, P20838; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; JOHNSON IS, 1983, SCIENCE, V219, P632, DOI 10.1126/science.6337396; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kjeldsen T, 2000, APPL MICROBIOL BIOT, V54, P277, DOI 10.1007/s002530000402; Kjeldsen T, 1999, BIOTECHNOL APPL BIOC, V29, P79; Kjeldsen T, 2001, Biotechnol Genet Eng Rev, V18, P89; Knudsen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051972; KOBAYASHI M, 1989, DIABETES RES CLIN PR, V7, P25, DOI 10.1016/0168-8227(89)90040-5; KRISTENSEN C, 1995, BIOCHEM J, V305, P981, DOI 10.1042/bj3050981; Landreh M, 2012, FEBS J, V279, P4589, DOI 10.1111/febs.12045; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Listov-Saabye N, 2009, J APPL TOXICOL, V29, P470, DOI 10.1002/jat.1428; Mansur M, 2005, BIOTECHNOL LETT, V27, P339, DOI 10.1007/s10529-005-1007-7; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; NAKAGAWA SH, 1989, J BIOL CHEM, V264, P272; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Niu CH, 1998, J PHARM SCI, V87, P1331, DOI 10.1021/js9800782; OHARA T, 1989, J BIOL CHEM, V264, P20625; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Pace C.N., 2000, PROTEINS, V41, P1; PAKULA AA, 1990, NATURE, V344, P363, DOI 10.1038/344363a0; Pandyarajan V, 2016, J BIOL CHEM, V291, P12978, DOI 10.1074/jbc.M115.708347; Pandyarajan V, 2014, J BIOL CHEM, V289, P23367, DOI 10.1074/jbc.M114.588277; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Phillips Nelson B, 2012, J Diabetes Sci Technol, V6, P277; Phillips NB, 2010, J BIOL CHEM, V285, P11755, DOI 10.1074/jbc.C110.105825; Poon K, 2010, DRUG HEALTHC PATIENT, V2, P213, DOI 10.2147/DHPS.S7301; Poon R.Y.C., 2015, CELL CYCLE CONTROL, DOI [10.1016/B978-0-12-801238-3.98748-8, DOI 10.1016/B978-0-12-801238-3.98748-8]; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Reutrakul Sirimon, 2012, J Diabetes Sci Technol, V6, P412; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Saker F, 1998, AM J PHYSIOL-ENDOC M, V274, pE984, DOI 10.1152/ajpendo.1998.274.6.E984; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sciacca Laura, 2012, Front Endocrinol (Lausanne), V3, P21, DOI 10.3389/fendo.2012.00021; Segal AR, 2016, ENDOCRIN METAB CLIN, V45, P845, DOI 10.1016/j.ecl.2016.06.009; Setter SM, 2000, ANN PHARMACOTHER, V34, P1423; Shabanpoor F, 2009, VITAM HORM, V80, P1, DOI 10.1016/S0083-6729(08)00601-8; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Stammberger I, 2006, INT J TOXICOL, V25, P25, DOI 10.1080/10915810500488379; STEINER DF, 1978, DIABETES, V27, P145, DOI 10.2337/diab.27.1.S145; STEINER DF, 1967, SCIENCE, V157, P697, DOI 10.1126/science.157.3789.697; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Sunga AJ, 2008, FEMS YEAST RES, V8, P870, DOI 10.1111/j.1567-1364.2008.00410.x; Svendsen AM, 2014, BIOCHEM J, V457, P69, DOI 10.1042/BJ20130490; Vinther TN, 2013, PROTEIN SCI, V22, P296, DOI 10.1002/pro.2211; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Wang Y, 2001, BIOTECHNOL BIOENG, V73, P74, DOI 10.1002/1097-0290(20010405)73:1<74::AID-BIT1038>3.0.CO;2-V; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Waugh D. F., 1957, J CELL COMP PHYSL, V49, P20; Weiss M., 2013, J HLTH SPEC, V1, P59, DOI DOI 10.4103/1658-600X.114683; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; Zaykov AN, 2016, NAT REV DRUG DISCOV, V15, P425, DOI 10.1038/nrd.2015.36; Zaykov AN, 2014, ACS CHEM BIOL, V9, P683, DOI 10.1021/cb400792s; Zhou C, 2016, J PHARM SCI-US, V105, P551, DOI 10.1016/j.xphs.2015.10.023	103	19	21	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					47	68		10.1074/jbc.M117.808626	http://dx.doi.org/10.1074/jbc.M117.808626			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29114035	Green Published, hybrid			2022-12-26	WOS:000419453200004
J	Tian, H; Tackmann, NR; Jin, AW; Zheng, JN; Zhang, YP				Tian, Hui; Tackmann, Nicole R.; Jin, Aiwen; Zheng, Junnian; Zhang, Yanping			Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MDM2; MDMX; Mouse; p53; Ubiquitin E3	UBIQUITIN LIGASE ACTIVITY; ACTIVITY IN-VIVO; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; DNA-DAMAGE; ACETYLATION; DEGRADATION; ACTIVATION; PATHWAY; PROTEIN	The MDM2 RING domain harbors E3 ubiquitin ligase activity critical for regulating the degradation of tumor suppressor p53, which controls many cellular pathways. The MDM2 RING domain also is required for an interaction with MDMX. Mice containing a substitution in the MDM2 RING domain, MDM2(C462A), disrupting MDM2 E3 function and the MDMX interaction, die during early embryogenesis that can be rescued by p53 deletion. To investigate whether MDM2(C462A), which retains p53 binding, has p53-suppressing activity, we generated Mdm2(C462A/C462A);p53(ER/-) mice, in which we replaced the endogenous p53 alleles with an inducible p53(ER/-) allele, and compared survival with that of similarly generated Mdm2(-/-);p53(ER/-) mice. Adult Mdm2-null mice died approximate to 7 days after tamoxifen-induced p53 activation, indicating that in the absence of MDM2, MDMX cannot suppress p53. Surprisingly, Mdm2(C462A/C462A);p53(ER/-) mice died approximate to 5 days after tamoxifen injection, suggesting that p53 activity is higher in the presence of MDM2(C462A) than in the absence of MDM2. Indeed, in MDM2(C462A)-expressing mouse tissues and embryonic fibroblasts, p53 exhibited higher transcriptional activity than in those expressing no MDM2 or no MDM2 and MDMX. This observation indicated that MDM2(C462A) not only is unable to suppress p53 but may have gained the ability to enhance p53 activity. We also found that p53 acetylation, a measure of p53 transcriptional activity, was higher in the presence of MDM2(C462A) than in the absence of MDM2. These results reveal an unexpected role of MDM2(C462A) in enhancing p53 activity and suggest the possibility that compounds targeting MDM2 RING domain function could produce even more robust p53 activation.	[Tian, Hui; Tackmann, Nicole R.; Jin, Aiwen; Zhang, Yanping] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Dept Radiat Oncol, 450 West Dr, Chapel Hill, NC 27514 USA; [Tackmann, Nicole R.] Univ North Carolina Chapel Hill, Sch Med, Curriculum Genet & Mol Biol, 450 West Dr, Chapel Hill, NC 27514 USA; [Tian, Hui; Zheng, Junnian; Zhang, Yanping] Xuzhou Med Univ, Inst Canc, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou 221002, Jiangsu, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Xuzhou Medical University	Zhang, YP (corresponding author), Univ North Carolina Chapel Hill, Dept Radiat Oncol, 450 West Dr, Chapel Hill, NC 27514 USA.; Zhang, YP (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27514 USA.	ypzhang@med.unc.edu	, Histology Research Core Facility/ABF-6317-2021		National Institutes of Health [CA127770, CA100302, CA167637]; Natural Science Foundation of China [81272207]; NIGMS, National Institutes of Health [5T32 GM007092]; NATIONAL CANCER INSTITUTE [R01CA127770, R01CA212407, R01CA100302, R01CA167637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA127770, CA100302, and CA167637; Natural Science Foundation of China Grant 81272207 (to Y. Z.); and NIGMS, National Institutes of Health Grant 5T32 GM007092 (to N. R. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Clegg HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038212; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Farhang Ghahremani M, 2013, CELL DEATH DIFFER, V20, P888, DOI 10.1038/cdd.2013.12; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Leslie PL, 2015, J BIOL CHEM, V290, P12941, DOI 10.1074/jbc.M115.644435; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; LUNA RMD, 1995, NATURE, V378, P203; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Sabbatini P, 2002, DNA CELL BIOL, V21, P519, DOI 10.1089/104454902320219077; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tollini LA, 2014, CANCER CELL, V26, P235, DOI 10.1016/j.ccr.2014.06.006; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang XJ, 2011, CELL CYCLE, V10, P4225, DOI 10.4161/cc.10.24.18662; Wang XJ, 2011, J BIOL CHEM, V286, P23725, DOI 10.1074/jbc.M110.213868; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1	42	6	8	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21614	21622		10.1074/jbc.RA117.000122	http://dx.doi.org/10.1074/jbc.RA117.000122			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29123033	Green Published, hybrid			2022-12-26	WOS:000419013000035
J	Zhang, LP; Turner, B; Ribbeck, K; Ten Hagen, KG				Zhang, Liping; Turner, Bradley; Ribbeck, Katharina; Ten Hagen, Kelly G.			Loss of the mucosal barrier alters the progenitor cell niche via Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; glycosylation; interleukin 6 (IL-6); mucin; mucus; JAK; STAT; Tango1; niche; peritrophic membrane; progenitor cell; mucous membrane; O-glycosylation; Upd3	INTESTINAL STEM-CELLS; N-ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; COLITIS-ASSOCIATED CANCER; ADULT DROSOPHILA MIDGUT; PORCINE GASTRIC MUCIN; O-GLYCOSYLATION; EXPRESSION ANALYSIS; PERITROPHIC MATRIX; COLORECTAL-CANCER; UDP-GALNAC	The mucous barrier of our digestive tract is the first line of defense against pathogens and damage. Disruptions in this barrier are associated with diseases such as Crohn's disease, colitis, and colon cancer, but mechanistic insights into these processes and diseases are limited. We have previously shown that loss of a conserved O-glycosyltransferase (PGANT4) in Drosophila results in aberrant secretion of components of the peritrophic/mucous membrane in the larval digestive tract. Here, we show that loss of PGANT4 disrupts the mucosal barrier, resulting in epithelial expression of the IL-6-like cytokine Upd3, leading to activation of JAK/STAT signaling, differentiation of cells that form the progenitor cell niche, and abnormal proliferation of progenitor cells. This niche disruption could be recapitulated by overexpressing upd3 and rescued by deleting upd3, highlighting a crucial role for this cytokine. Moreover, niche integrity and cell proliferation in pgant4-deficient animals could be rescued by overexpression of the conserved cargo receptor Tango1 and partially rescued by supplementation with exogenous mucins or treatment with antibiotics. Our findings help elucidate the paracrine signaling events activated by a compromised mucosal barrier and provide a novel in vivo screening platform for mucin mimetics and other strategies to treat diseases of the oral mucosa and digestive tract.	[Zhang, Liping; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Sect, NIH, Bethesda, MD 20892 USA; [Turner, Bradley; Ribbeck, Katharina] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Massachusetts Institute of Technology (MIT)	Ten Hagen, KG (corresponding author), Bldg 30,Rm 426,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov			Intramural Research Program of NIDCR, National Institutes of Health [Z01-DE-000713]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000713] Funding Source: NIH RePORTER	Intramural Research Program of NIDCR, National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of NIDCR, National Institutes of Health, Grant Z01-DE-000713 (to K. G. T. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arike L, 2016, J MOL BIOL, V428, P3221, DOI 10.1016/j.jmb.2016.02.010; Arndt S, 2007, ONCOL REP, V18, P885; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bergstrom K, 2016, GASTROENTEROLOGY, V151, P152, DOI 10.1053/j.gastro.2016.03.039; Caldara M, 2012, CURR BIOL, V22, P2325, DOI 10.1016/j.cub.2012.10.028; Celli J, 2005, BIOMACROMOLECULES, V6, P1329, DOI 10.1021/bm0493990; Chaudhury NMA, 2015, J DENT RES, V94, P1660, DOI 10.1177/0022034515609070; Chaudhury NMA, 2016, MOL CELL PROTEOMICS, V15, P1048, DOI 10.1074/mcp.M115.052993; Corfield AP, 2015, BBA-GEN SUBJECTS, V1850, P236, DOI 10.1016/j.bbagen.2014.05.003; Dutzan N, 2017, IMMUNITY, V46, P133, DOI 10.1016/j.immuni.2016.12.010; Fox DT, 2009, CELL STEM CELL, V5, P290, DOI 10.1016/j.stem.2009.06.003; Gao N, 2016, AM J PHYSIOL-GASTR L, V311, pG74, DOI 10.1152/ajpgi.00060.2016; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Guo Z, 2013, J CELL BIOL, V201, P945, DOI 10.1083/jcb.201302049; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Harvey NM, 2011, BIOMACROMOLECULES, V12, P1041, DOI 10.1021/bm101369d; Hu YH, 2013, G3-GENES GENOM GENET, V3, P1607, DOI 10.1534/g3.113.007021; Jiang HQ, 2011, EXP CELL RES, V317, P2780, DOI 10.1016/j.yexcr.2011.07.020; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Kobayashi S, 2003, BIOCHEM BIOPH RES CO, V308, P306, DOI 10.1016/S0006-291X(03)01362-7; Kramer JR, 2015, P NATL ACAD SCI USA, V112, P12574, DOI 10.1073/pnas.1516127112; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Larsson JMH, 2011, INFLAMM BOWEL DIS, V17, P2299, DOI 10.1002/ibd.21625; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Lohmann N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai9044; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; Mathur D, 2010, SCIENCE, V327, P210, DOI 10.1126/science.1181958; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Schwartz DM, 2016, NAT REV RHEUMATOL, V12, P25, DOI 10.1038/nrrheum.2015.167; Slattery ML, 2013, MOL CARCINOGEN, V52, P155, DOI 10.1002/mc.21841; Syed ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003041; TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555; Takashima S, 2012, STEM CELL REV REP, V8, P597, DOI 10.1007/s12015-012-9351-1; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Tian AG, 2015, J CELL BIOL, V208, P807, DOI 10.1083/jcb.201409025; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wang SW, 2014, INT J ONCOL, V44, P1032, DOI 10.3892/ijo.2014.2259; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zeng XK, 2015, CELL REP, V10, P1226, DOI 10.1016/j.celrep.2015.01.051; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111; Zhou F, 2013, DEV BIOL, V373, P383, DOI 10.1016/j.ydbio.2012.10.023; Zhou J, 2015, DEV BIOL, V399, P189, DOI 10.1016/j.ydbio.2014.12.017	56	16	16	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21231	21242		10.1074/jbc.M117.809848	http://dx.doi.org/10.1074/jbc.M117.809848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29127201	Green Published, hybrid			2022-12-26	WOS:000419013000002
J	Prioreschi, A; Wrottesley, SV; Cohen, E; Reddy, A; Said-Mohamed, R; Twine, R; Tollman, SM; Kahn, K; Dunger, DB; Norris, SA				Prioreschi, Alessandra; Wrottesley, Stephanie V.; Cohen, Emmanuel; Reddy, Ankita; Said-Mohamed, Rihlat; Twine, Rhian; Tollman, Stephen M.; Kahn, Kathleen; Dunger, David B.; Norris, Shane A.			Examining the relationships between body image, eating attitudes, BMI, and physical activity in rural and urban South African young adult females using structural equation modeling	PLOS ONE			English	Article							OBESITY; DISSATISFACTION; ADOLESCENTS; TRANSITION; OVERWEIGHT; DISORDERS; DYNAMICS; PROFILE; HEALTH; WOMEN	The persistence of food insecurity, malnutrition, increasing adiposity, and decreasing physical activity, heightens the need to understand relationships between body image satisfaction, eating attitudes, BMI and physical activity levels in South Africa. Females aged 18-23 years were recruited from rural (n = 509) and urban (n = 510) settings. Body image satisfaction was measured using Stunkard's silhouettes, and the 26-item Eating Attitudes questionnaire (EAT-26) was used to evaluate participants' risk of disordered eating. Minutes per week of moderate to vigorous physical activity (MVPA) was assessed using the Global Physical Activity Questionnaire (GPAQ). Significant linear correlates were included in a series of regressions run separately for urban and rural participants. Structural equation modeling (SEM) was used to test the relationships between variables. Urban females were more likely to be overweight and obese than rural females (p = 0.02), and had a greater desire to be thinner (p = 0.02). In both groups, being overweight or obese was positively associated with a desire to be thinner (p<0.01), and negatively associated with a desire to be fatter (p<0.01). Having a disordered eating attitude was associated with body image dissatisfaction in the urban group (beta = 1.27, p<0.01, CI: 0.38; 2.16), but only with a desire to be fatter in the rural group (beta = 0.63, p = 0.04, CI: 0.03; 1.23). In the SEM model, body image dissatisfaction was associated with disordered eating (beta = 0.63), as well as higher MVPA participation (p<0.01). These factors were directly associated with a decreased risk of disordered eating attitude, and with a decreased desire to be thinner. Findings indicate a shift in both settings towards more Westernised ideals. Physical activity may provide a means to promote a healthy body image, while reducing the risk of disordered eating. Given the high prevalence of overweight and obesity in both rural and urban women, this study provides insights for future interventions aimed at decreasing adiposity in a healthy way.	[Prioreschi, Alessandra; Wrottesley, Stephanie V.; Cohen, Emmanuel; Reddy, Ankita; Said-Mohamed, Rihlat; Dunger, David B.; Norris, Shane A.] Univ Witwatersrand, Fac Hlth Sci, MRC WITS Dev Pathways Hlth Res Unit, Dept Paediat,Sch Clin Med, Johannesburg, South Africa; [Twine, Rhian; Tollman, Stephen M.; Kahn, Kathleen] Univ Witwatersrand, Fac Hlth Sci, MRC WITS Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth, Johannesburg, South Africa; [Tollman, Stephen M.; Kahn, Kathleen] INDEPTH Network, Accra, Ghana; [Tollman, Stephen M.; Kahn, Kathleen] Umea Univ, Umea Ctr Global Hlth Res, Umea, Sweden; [Dunger, David B.] Univ Cambridge, MRL Wellcome Trust, MRC Inst Metab Sci, NIHR Cambridge Comprehens Biomed Res Ctr,Dept Paed, Cambridge, England	University of Witwatersrand; University of Witwatersrand; INDEPTH Network; Umea University; University of Cambridge	Prioreschi, A (corresponding author), Univ Witwatersrand, Fac Hlth Sci, MRC WITS Dev Pathways Hlth Res Unit, Dept Paediat,Sch Clin Med, Johannesburg, South Africa.	Alessandra.Prioreschi@wits.ac.za	Wrottesley, Stephanie/L-5462-2019; Cohen, Emmanuel/ABE-1916-2021; Norris, Shane/C-4664-2014	Cohen, Emmanuel/0000-0001-5643-1473; Norris, Shane/0000-0001-7124-3788; Tollman, Stephen/0000-0003-0744-7588; Reddy, Ankita/0000-0003-4986-8719; Dunger, Professor David/0000-0002-2566-9304; Prioreschi, Alessandra/0000-0002-6913-0706; SAID MOHAMED, Rihlat/0000-0003-1592-5412; Wrottesley, Stephanie/0000-0002-5419-2920; Twine, Rhian/0000-0002-0766-6556; Kahn, Kathleen/0000-0003-3339-3931	UK DfID/MRC African Research Leader Scheme; Wellcome Trust (UK); DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa; Medical Research, South Africa; Wellcome Trust, UK [058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z, 085477/B/08/Z]; Claude Leon Foundation; Medical Research Council [G1001333, MC_UU_12012/5/B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10012, NF-SI-0508-10274] Funding Source: researchfish; MRC [G1001333] Funding Source: UKRI	UK DfID/MRC African Research Leader Scheme; Wellcome Trust (UK)(Wellcome Trust); DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa; Medical Research, South Africa; Wellcome Trust, UK(Wellcome Trust); Claude Leon Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge the following funders: The UK DfID/MRC African Research Leader Scheme (Norris and Dunger) and the Wellcome Trust (UK) to SAN funded the research. The MRC/Wits Rural Public Health and Health Transitions Research Unit and Agincourt health and socio-demographic surveillance system have been supported by the DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa to AP, and Medical Research, South Africa, and the Wellcome Trust, UK (grants 058893/Z/99/A to SMT; 069683/Z/02/Z; 085477/Z/08/Z; 085477/B/08/Z to SMT). Opinions expressed and conclusions arrived at, are those of the authors and are not to be attributed to the CoE in Human Development. Claude Leon Foundation also supported the work of AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, J PSYCHIAT, DOI DOI 10.4172/1994-8220.1000101; Benkeser R M, 2012, Ghana Med J, V46, P66; Bhatnagar R., 2014, AM J ED RES, V2, P683, DOI [10.12691/education-2-8-18, DOI 10.12691/EDUCATION-2-8-18, 10.12691/ education- 2-8-18]; Blachno M, 2016, PSYCHIATR POL, V50, P55, DOI 10.12740/PP/34810; Bove CF, 2006, WOMEN HEALTH, V44, P57, DOI 10.1300/J013v44n01_04; Bucchianeri MM, 2013, BODY IMAGE, V10, P1, DOI 10.1016/j.bodyim.2012.09.001; Chisuwa N, 2010, APPETITE, V54, P5, DOI 10.1016/j.appet.2009.11.008; Cohen E, 2013, SOC SCI MED, V96, P24, DOI 10.1016/j.socscimed.2013.07.004; DAVIS C, 1994, PSYCHOL MED, V24, P957, DOI 10.1017/S0033291700029044; Draper CE, 2015, CHILD CARE HLTH DEV, V41, P654, DOI 10.1111/cch.12241; Filmer D, 2012, DEMOGRAPHY, V49, P359, DOI 10.1007/s13524-011-0077-5; Gitau TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109709; Hausenblas HA, 2006, PSYCHOL HEALTH, V21, P33, DOI 10.1080/14768320500105270; Hidaka BH, 2012, J AFFECT DISORDERS, V140, P205, DOI 10.1016/j.jad.2011.12.036; Holmqvist K, 2010, EUR EAT DISORD REV, V18, P133, DOI 10.1002/erv.965; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Knoll LJ, 2015, PSYCHOL SCI, V26, P583, DOI 10.1177/0956797615569578; Labadarios D, 2011, B WORLD HEALTH ORGAN, V89, P891, DOI 10.2471/BLT.11.089243; le Grange D, 1998, AM J PSYCHIAT, V155, P250; Mchiza ZJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2324-y; Mchiza ZJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-433; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Mvo Z, 1999, Curationis, V22, P27; Organisation WH, GLOBAL RECOMMENDATIO; Pedro TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154784; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Pradeilles R, 2015, PUBLIC HEALTH NUTR, V18, P2998, DOI 10.1017/S1368980015000415; Puoane T, 2005, S AFR J CLIN NUTR, V18, P6; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Senekal M, 2001, S AFR J PSYCHOL, V31, P45, DOI 10.1177/008124630103100108; Sharan P, 2015, INDIAN J PSYCHIAT, V57, pS286, DOI 10.4103/0019-5545.161493; Shisana O, 2014, S AFRICAN NATL HLTH; Sorsdahl K, 2011, J EPIDEMIOL COMMUN H, V65, P426, DOI 10.1136/jech.2009.091462; Steyn NP, 2000, ASIA PAC J CLIN NUTR, V9, P53, DOI 10.1046/j.1440-6047.2000.00137.x; Szabo Christopher Paul, 2006, Afr Health Sci, V6, P201; Szabo Christopher Paul, 2004, World Psychiatry, V3, P41; Townsend MS, 2001, J NUTR, V131, P1738, DOI 10.1093/jn/131.6.1738; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40; Van Laar, 2007, SCI AGR RURAL DEV LO; Van Son GE, 2006, BRIT J PSYCHIAT, V189, P562, DOI 10.1192/bjp.bp.106.021378; Van Vonderen K. E., 2012, AM COMMUNICATION J, V14, P41; Vandenberg RJ, 2006, ORGAN RES METHODS, V9, P194, DOI 10.1177/1094428105285506; Vorster HH, 2010, HEALTH SA GESONDHEID, V15, DOI 10.4102/hsag.v15i1.435; Weinstein A, 2015, J BEHAV ADDICT, V4, P22, DOI 10.1556/JBA.4.2015.1.6; Wurwarg J., 2014, J INT AFF, V67, P75	48	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187508	10.1371/journal.pone.0187508	http://dx.doi.org/10.1371/journal.pone.0187508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145423	gold, Green Published, Green Submitted			2022-12-26	WOS:000415378800017
J	Butler, WE				Butler, William E.			Wavelet brain angiography suggests arteriovenous pulse wave phase locking	PLOS ONE			English	Article							CROSS-CORRELATION ANALYSIS; INTRACRANIAL-PRESSURE; SIGNAL ANALYSIS; IN-VIVO; FLOW; ULTRASOUND; MICROSCOPE; AMPLITUDE; INJURY; CT	When a stroke volume of arterial blood arrives to the brain, the total blood volume in the bony cranium must remain constant as the proportions of arterial and venous blood vary, and by the end of the cardiac cycle an equivalent volume of venous blood must have been ejected. I hypothesize the brain to support this process by an extraluminally mediated exchange of information between its arterial and venous circulations. To test this I introduce wavelet angiography methods to resolve single moving vascular pulse waves (PWs) in the brain while simultaneously measuring brain pulse motion. The wavelet methods require angiographic data acquired at significantly faster rate than cardiac frequency. I obtained these data in humans from brain surface optical angiograms at craniotomy and in piglets from ultrasound angiograms via cranial window. I exploit angiographic time of flight to resolve arterial from venous circulation. Initial wavelet reconstruction proved unsatisfactory because of angiographic motion alias from brain pulse motion. Testing with numerically simulated cerebral angiograms enabled the development of a vascular PW cine imaging method based on cross-correlated wavelets of mixed high frequency and high temporal resolution respectively to attenuate frequency and motion alias. Applied to the human and piglet data, the method resolves individual arterial and venous PWs and finds them to be phase locked each with separate phase relations to brain pulse motion. This is consistent with arterial and venous PW coordination mediated by pulse motion and points to a testable hypothesis of a function of cerebrospinal fluid in the ventricles of the brain.	[Butler, William E.] Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Butler, WE (corresponding author), Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA.	wbutler@mgh.harvard.edu		Butler, William/0000-0002-4249-565X	Center for Integration of Medicine and Innovative Technology [a0K300000022wE4000840]; Center for Integration of Medicine and Innovative Technology (CIMIT) [a0K300000022wE4000840]	Center for Integration of Medicine and Innovative Technology; Center for Integration of Medicine and Innovative Technology (CIMIT)	Center for Integration of Medicine and Innovative Technology http://www.cimit.org/ grant #a0K300000022wE4000840 funded about 2% of the work, the remainder had no funding.; Benjamin I. Rapoport contributed an early Fourier-based version of the pulsation image phase reconstruction algorithm that inspired the development of the wavelet-based one. In addition, he contributed the brightness-hue model for rendering complex-valued data. Saad Khan helped create and implement the piglet cranial window ultrasound model. Kenneth Kwong performed the piglet MRI imaging. Pankaj K. Agarwalla, Paul H. Chapman, Patricia K. Donahoe, Ann Christine Duhaime, Bernard Kinane, Elizabeth G. Shannon, Victor Solo, Ralph Weissleder and Ziv Williams commented on versions of the manuscript. There was an earlier version of the manuscript that contained only the piglet data. James Baish and Lance Munn provided criticisms of it that prompted me to gather the human data and redirect the argument. The piglet cranial window studies were funded by Center for Integration of Medicine and Innovative Technology (CIMIT) grant a0K300000022wE4000840.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Ashmead J., 2012, QUANTA, V1, P1, DOI [10.12743/quanta.v1i1.5, DOI 10.12743/QUANTA.V1I1.5]; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Bernstein MA, 2004, HDB MRI PULSE SEQUEN, P443; Bhadelia RA, 1997, NEURORADIOLOGY, V39, P258, DOI 10.1007/s002340050404; Butler WE, PLOS ONE; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; Daubechies I., 1992, 10 LECT WAVELETS; Gabor D., 1946, J I ENG ELECT 3, V93, P442, DOI [10.1049/ji-3-2.1946.0075, DOI 10.1049/JI-3-2.1946.0075]; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; GOUPILLAUD P, 1984, GEOEXPLORATION, V23, P85, DOI 10.1016/0016-7142(84)90025-5; Hamberg LM, 1996, AM J NEURORADIOL, V17, P639; Hardesty DA, 2014, J CLIN NEUROSCIENCE; Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6; HYVARINEN L, 1980, ACTA OPHTHALMOL, V58, P528; Kachelriess M, 2000, MED PHYS, V27, P1881, DOI 10.1118/1.1286552; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Kim DJ, 2015, ACTA NEUROCHIR, V157, P633, DOI 10.1007/s00701-015-2353-4; Kim MH, 1998, ACT NEUR S, V71, P343; Klimenko S, 2002, GEN RELATIVITY QUANT; Kotelnikov V., 1933, P 1 ALL UN C TECHN R, P736; Kulkarni AV, 2009, J PEDIATR-US, V155, P254, DOI 10.1016/j.jpeds.2009.02.048; Kuroiwa T, 2001, MINIM INVAS NEUROSUR, V44, P240, DOI 10.1055/s-2001-19929; Lassen N., 1979, TRACER KINETIC METHO; Lawton MT, 2011, 7 ANEURYSMS TENETS T; Markl M, 2012, J MAGN RESON IMAGING, V36, P1015, DOI 10.1002/jmri.23632; Martin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075335; Meairs S, 2007, PROG BIOPHYS MOL BIO, V93, P354, DOI 10.1016/j.pbiomolbio.2006.07.019; Mizuno-Matsumoto Y, 2005, BRAIN TOPOGR, V17, P237, DOI 10.1007/s10548-005-6032-2; MORLET J, 1982, GEOPHYSICS, V47, P203, DOI 10.1190/1.1441328; Nyquist H., 1928, T AM I ELECT ING, V47, P617, DOI [10.1109/T-AIEE.1928.5055024, DOI 10.1109/T-AIEE.1928.5055024]; Provost J, 2014, PHYS MED BIOL, V59, pL1, DOI 10.1088/0031-9155/59/19/L1; Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982; Serroukh A, 2012, ELECTRON J APPL STAT, V5, P289, DOI 10.1285/i20705948v5n2p289; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Tomita M, 2008, MICROCIRCULATION, V15, P163, DOI 10.1080/10739680701567089; Unser M, 2000, P IEEE, V88, P569, DOI 10.1109/5.843002; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Zaidi HA, 2014, OPER NEUROSURG, V10, P246, DOI 10.1227/NEU.0000000000000318; Zou R, 2008, J NEUROS-PEDIATR, V2, P83, DOI 10.3171/PED/2008/2/7/083	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187014	10.1371/journal.pone.0187014	http://dx.doi.org/10.1371/journal.pone.0187014			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140981	gold, Green Published, Green Submitted			2022-12-26	WOS:000415260400014
J	Proll, MJ; Neuhoff, C; Schellander, K; Uddin, MJ; Cinar, MU; Sahadevan, S; Qu, XQ; Islam, MA; Poirier, M; Muller, MA; Drosten, C; Tesfaye, D; Tholen, E; Grosse-Brinkhaus, C				Proell, Maren Julia; Neuhoff, Christiane; Schellander, Karl; Uddin, Muhammad Jasim; Cinar, Mehmet Ulas; Sahadevan, Sudeep; Qu, Xueqi; Islam, Md. Aminul; Poirier, Mikhael; Mueller, Marcel A.; Drosten, Christian; Tesfaye, Dawit; Tholen, Ernst; Grosse-Brinkhaus, Christine			Transcriptome profile of lung dendritic cells after in vitro porcine reproductive and respiratory syndrome virus (PRRSV) infection	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; ALVEOLAR MACROPHAGES; MOLECULAR CHARACTERIZATION; VIRAL-INFECTION; LELYSTAD VIRUS; RNA-SEQ; ACTIVATION; ARTERIVIRUS; POPULATIONS; DISEASE	The porcine reproductive and respiratory syndrome (PRRS) is an infectious disease that leads to high financial and production losses in the global swine industry. The pathogenesis of this disease is dependent on a multitude of factors, and its control remains problematic. The immune system generally defends against infectious diseases, especially dendritic cells (DCs), which play a crucial role in the activation of the immune response after viral infections. However, the understanding of the immune response and the genetic impact on the immune response to PRRS virus (PRRSV) remains incomplete. In light of this, we investigated the regulation of the host immune response to PRRSV in porcine lung DCs using RNA-sequencing (RNA-Seq). Lung DCs from two different pig breeds (Pietrain and Duroc) were collected before (0 hours) and during various periods of infection (3, 6, 9, 12, and 24 hours post infection (hpi)). RNA-Seq analysis revealed a total of 20,396 predicted porcine genes, which included breed-specific differentially expressed immune genes. Pietrain and Duroc infected lung DCs showed opposite gene expression courses during the first time points post infection. Duroc lung DCs reacted more strongly and distinctly than Pietrain lung DCs during these periods (3, 6, 9, 12 hpi). Additionally, cluster analysis revealed time-dependent co-expressed groups of genes that were involved in immune-relevant pathways. Key clusters and pathways were identified, which help to explain the biological and functional background of lung DCs post PRRSV infection and suggest IL-1 beta 1 as an important candidate gene. RNA-Seq was also used to characterize the viral replication of PRRSV for each breed. PRRSV was able to infect and to replicate differently in lung DCs between the two mentioned breeds. These results could be useful in investigations on immunity traits in pig breeding and enhancing the health of pigs.	[Proell, Maren Julia; Neuhoff, Christiane; Schellander, Karl; Islam, Md. Aminul; Poirier, Mikhael; Tesfaye, Dawit; Tholen, Ernst; Grosse-Brinkhaus, Christine] Univ Bonn, Inst Anim Sci, Dept Anim Breeding & Husb, Bonn, Germany; [Uddin, Muhammad Jasim] Univ Queensland, Sch Vet Sci, Gatton Campus, Gatton, Australia; [Cinar, Mehmet Ulas] Erciyes Univ, Dept Anim Sci, Fac Agr, Kayseri, Turkey; [Sahadevan, Sudeep] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Qu, Xueqi] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Lab Gene & Cell Engn, Shenzhen, Peoples R China; [Mueller, Marcel A.; Drosten, Christian] Charite, Inst Virol, Helmut Ruska Haus, Berlin, Germany	University of Bonn; University of Queensland; Erciyes University; University of Copenhagen; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Neuhoff, C (corresponding author), Univ Bonn, Inst Anim Sci, Dept Anim Breeding & Husb, Bonn, Germany.	cneu@itz.uni-bonn.de	Müller, Marcel A./O-2425-2019; Uddin, Muhammad Jasim/N-3866-2013; Große-Brinkhaus, Christine/AAF-6712-2020; Ertan, Asli/AAE-6201-2021; Islam, Aminul/AAE-9484-2019; Uddin, Muhammad Jasim/P-8497-2019	Müller, Marcel A./0000-0003-2242-5117; Große-Brinkhaus, Christine/0000-0002-6190-4463; Islam, Aminul/0000-0003-1979-9652; Uddin, Muhammad Jasim/0000-0002-6732-5534; Uddin, Dr. Md. Jashim/0000-0002-3243-3455	State of North Rhine Westphalia of Germany; program "Umweltvertragliche und Standortgerechte Landwirtschaft (USL)" [17-02.04.01-6/13]	State of North Rhine Westphalia of Germany; program "Umweltvertragliche und Standortgerechte Landwirtschaft (USL)"	This work was financially supported by the State of North Rhine Westphalia of Germany with the program "Umweltvertragliche und Standortgerechte Landwirtschaft (USL)" with the grant no. 17-02.04.01-6/13.	Abada PB, 2012, MOL PHARMACOL, V82, P510, DOI 10.1124/mol.112.079822; ABBAS AK, 2012, CELLULAR MOL IMMUNOL, DOI DOI 10.1016/J.VETMIC.2013.07.022; Ait-Ali T, 2011, IMMUNOGENETICS, V63, P437, DOI 10.1007/s00251-011-0518-8; Alberts B, 2008, MOL BIOL CELL, p[921, 1417]; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Badaoui B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091918; Bagga S, 2014, METHODS MOL BIOL, V1170, P165, DOI 10.1007/978-1-4939-0888-2_10; Balasuriya U. B. R., 2013, VET MICROBIOL, P456; Beura LK, 2010, J VIROL, V84, P1574, DOI 10.1128/JVI.01326-09; BI J, 2014, MEDIAT INFLAMM, P22717, DOI DOI 10.1155/2014/403515; Brockmeier SL, 2002, POLYMICROBIAL DIS; Chen XX, 2014, VET MICROBIOL, V170, P48, DOI 10.1016/j.vetmic.2014.01.031; Chen Z, 2010, VIROLOGY, V398, P87, DOI 10.1016/j.virol.2009.11.033; CONZELMANN KK, 1993, VIROLOGY, V193, P329, DOI 10.1006/viro.1993.1129; De Baere MI, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-47; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dwivedi V, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-45; Flori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022717; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Grayson MH, 2007, J IMMUNOL, V179, P1438, DOI 10.4049/jimmunol.179.3.1438; Halbur PG, 1998, J ANIM BREED GENET, V115, P181, DOI 10.1111/j.1439-0388.1998.tb00341.x; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; Hu Rui, 2011, BMC Proc, V5 Suppl 4, pS10, DOI 10.1186/1753-6561-5-S4-S10; Huang YW, 2010, VIRUS RES, V154, P141, DOI 10.1016/j.virusres.2010.07.020; Islam MS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3249-2; JANEWAY CA, 2001, IMMUNOBIOLOGY IMMUNE, DOI DOI 10.1126/SCISIGNAL.3105CM1; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kindt TJ, 2007, KUBY IMMUNOLOGY, p[1, 302, 447]; Li HX, 2010, J GEN VIROL, V91, P2947, DOI 10.1099/vir.0.025205-0; Lopez A., 2001, THOMSONS SPECIAL VET, P178; Loving CL, 2007, IMMUNOLOGY, V120, P217, DOI 10.1111/j.1365-2567.2006.02493.x; Lunney JK, 2016, ANNU REV ANIM BIOSCI, V4, P129, DOI 10.1146/annurev-animal-022114-111025; Lunney JK, 2010, VIRUS RES, V154, P161, DOI 10.1016/j.virusres.2010.08.004; MacPherson G, 2012, EXPLORING IMMUNOLOGY, p[1, 99]; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Miller LC, 2010, ADV VIROL, V2010, DOI 10.1155/2010/864181; Murphy K, 2017, JANEWAY'S IMMUNOBIOLOGY, 9TH EDITION, P1; Nauwynck HJ, 1999, J GEN VIROL, V80, P297, DOI 10.1099/0022-1317-80-2-297; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Park JY, 2008, J MICROBIOL BIOTECHN, V18, P1709; Pejsak Z, 1997, COMP IMMUNOL MICROB, V20, P345, DOI 10.1016/S0147-9571(97)00010-6; Petry DB, 2005, J ANIM SCI, V83, P1494; Rodriguez-Gomez Irene M, 2013, World J Virol, V2, P146, DOI 10.5501/wjv.v2.i4.146; Ross JW, 2003, BIOL REPROD, V69, P1251, DOI 10.1095/biolreprod.103.015842; Schmid MA, 2011, BLOOD, V118, P4829, DOI 10.1182/blood-2011-03-344960; SEO H, 2012, BIOL REPROD, V87, DOI DOI 10.1095/BIOLREPROD.103.015842; Sorensen V, 2006, DIS SWINE, V9th, P149; Stumbles PA, 2003, APMIS, V111, P741, DOI 10.1034/j.1600-0463.2003.11107806.x; Tizard I, 2013, VET IMMUNOLOGY, P1; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uddin MJ, 2011, INT J IMMUNOGENET, V38, P121, DOI 10.1111/j.1744-313X.2010.00985.x; Vanhee M, 2009, VET RES, V40, DOI 10.1051/vetres/2009046; Wang R, 2013, VET MICROBIOL, V166, P493, DOI 10.1016/j.vetmic.2013.07.022; Wang X, 2007, ARCH VIROL, V152, P289, DOI 10.1007/s00705-006-0857-1; WEBER A, 2010, SCI SIGNAL, V3, DOI DOI 10.1038/NRI3024; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wolf JBW, 2013, MOL ECOL RESOUR, V13, P559, DOI 10.1111/1755-0998.12109; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Zentralverband der Deutschen Schweineproduktion ZDS, 2003, RICHTL STAT MASTL SC; Zhang K, 2013, VIROLOGY, V442, P156, DOI 10.1016/j.virol.2013.04.007; Zhao W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000726; Zhou A, 2012, CELL SIGNAL, V24, P973, DOI 10.1016/j.cellsig.2012.01.004; Zhou P, 2011, INT J BIOL SCI, V7, P947, DOI 10.7150/ijbs.7.947; Zimmerman J., 2012, DIS SWINE, V10, P461	68	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187735	10.1371/journal.pone.0187735	http://dx.doi.org/10.1371/journal.pone.0187735			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140992	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400027
J	Ng, YP; Rashid, A; O'Brien, F				Ng, Yin Ping; Rashid, Abdul; O'Brien, Finian			Determining the effectiveness of a video-based contact intervention in improving attitudes of Penang primary care nurses towards people with mental illness	PLOS ONE			English	Article							HEALTH-CARE; INTERGROUP CONTACT; STIGMATIZING ATTITUDES; CLINICIAN ATTITUDES; NEGATIVE ATTITUDES; PUBLIC STIGMA; DISCRIMINATION; PROFESSIONALS; DEPRESSION; SYMPTOMS	Background Mental illness-related stigma is common, and is associated with poorer outcomes in people with mental illness. This study evaluated the attitudes of primary care nurses towards people with mental illness and its associated factors; and the effectiveness of a short video-based contact intervention (VBCI) in improving these attitudes using a Malay version of the 15-item Opening Minds Stigma Scale for Healthcare Providers (OMS-HC-15-M). Methods A 5-minute VBCI was developed comprising elements of psychoeducation and interviews of people with mental illness and the people they interact with, relating to experience of mental illness and recovery. A pre-post cross-sectional study was conducted on 206 randomly selected primary care nurses in Penang, Malaysia. The OMS-HC-15-M questionnaire was administered before and immediately after participants viewed the VBCI. The difference in mean pre-post VBCI scores using paired t-tests, effect size and standardised response mean (SRM) were obtained. Factors correlating to attitudes were obtained using univariate and multivariate regression analyses. Results Differences in pre-post VBCI score were statistically significant (p<0.001) with a 14% score reduction, a moderate effect size and SRM at 0.97 (0.85-0.11) and 1.1 (0.97-1.2) respectively. By factoring in the Minimal Detectable Change statistic of 7.76, the VBCI produced a significant improvement of attitudes in 30% of the participants. Factors associated with less stigmatising attitudes at baseline were previous psychiatry-related training, desiring psychiatric training, and positive contact with people with mental illness. Conclusions This is the first study in Malaysia to show that a brief VBCI is effective in improving attitudes of primary care nurses towards people with mental illness in the immediate term. Further studies are needed to determine if these results can be sustained in the longer term and generalizable to other health care professionals. Qualitative studies are warranted to provide insight to the factors correlating to these attitudes. (300 words)	[Ng, Yin Ping; O'Brien, Finian] Penang Med Coll, Dept Psychiat, George Town, Malaysia; [Rashid, Abdul] Penang Med Coll, Dept Publ Hlth, George Town, Malaysia		Ng, YP (corresponding author), Penang Med Coll, Dept Psychiat, George Town, Malaysia.	ng.yp@pmc.edu.my	Ng, Wing Yin/HHN-1743-2022	rashid, abdul/0000-0003-1520-8480				Allport G. W., 1954, NATURE PREJUDICE; Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Arnold Maggie, 2008, Nurs Older People, V20, P28; Ashencaen Crabtree S, 2003, J Psychiatr Ment Health Nurs, V10, P713, DOI 10.1046/j.1365-2850.2003.00665.x; Atkin K, 2005, INT J GERIATR PSYCH, V20, P1081, DOI 10.1002/gps.1414; Awani A., 2015, ASTRO; Azma B Nur, 2014, INT J COLLABORATIVE, V6; Baker JA, 2005, J ADV NURS, V49, P522, DOI 10.1111/j.1365-2648.2004.03325.x; Bjorkman T, 2008, SCAND J CARING SCI, V22, P170, DOI 10.1111/j.1471-6712.2007.00509.x; Borges TL, 2016, J AM PSYCHIAT NURSES, V22, P378, DOI 10.1177/1078390316655207; Brown SA, 2008, PSYCHIATR REHABIL J, V32, P89, DOI 10.2975/32.2.2008.89.94; Chambers M, 2010, INT J NURS STUD, V47, P350, DOI 10.1016/j.ijnurstu.2009.08.008; Cheang SI, 2014, PSYCH J, V3, P222, DOI 10.1002/pchj.61; Cheung T, 2015, INT J ENV RES PUB HE, V12, P11072, DOI 10.3390/ijerph120911072; Chong S. T., 2013, ASIAN SOCIAL SCI, V9, P1, DOI [DOI 10.5539/ASS.V9N6P1, DOI 10.5539/ass.v9n6p1]; Clement S, 2015, PSYCHOL MED, V45, P11, DOI 10.1017/S0033291714000129; Corrigan PW, 2012, PSYCHIAT SERV, V63, P963, DOI 10.1176/appi.ps.201100529; Corrigan PW, 2005, PSYCHIAT SERV, V56, P544, DOI 10.1176/appi.ps.56.5.544; Couture Shannon M., 2003, J MENTAL HLTH, V12, P291, DOI [10.1080/09638231000118276, DOI 10.1080/09638231000118276]; DESFORGES DM, 1991, J PERS SOC PSYCHOL, V60, P531, DOI 10.1037/0022-3514.60.4.531; Fernandez A, 2016, ACAD PSYCHIATR, V40, P905, DOI 10.1007/s40596-016-0592-1; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Gabbidon J, 2013, PSYCHIAT RES, V206, P81, DOI 10.1016/j.psychres.2012.09.028; Giandinoto Jo-Ann, 2014, Br J Nurs, V23, P728, DOI 10.12968/bjon.2014.23.13.728; Gillies D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007193.pub2; Goffman, 1963, STIGMA NOTES MANAGEM; Gong YH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07109; Goodwin J, 2014, PERSPECT PSYCHIATR C, V50, P224, DOI 10.1111/ppc.12044; Graves RE, 2011, SCHIZOPHR RES, V130, P271, DOI 10.1016/j.schres.2011.04.019; Gronholm PC, 2017, SOC PSYCH PSYCH EPID, V52, P249, DOI 10.1007/s00127-017-1341-9; Gurugopinath S, 2016, P 8 INT C COMM SYST, P1; GUYATT GH, 1989, J CLIN EPIDEMIOL, V42, P403, DOI 10.1016/0895-4356(89)90128-5; Haddad M, 2005, J CLIN NURS, V14, P976, DOI 10.1111/j.1365-2702.2005.01196.x; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hanafiah AN, 2015, INT J MENT HEALTH SY, V9, DOI 10.1186/s13033-015-0002-1; Hansson L, 2013, INT J SOC PSYCHIATR, V59, P48, DOI 10.1177/0020764011423176; Haque A, 2010, PSYCHOL HEALTH MED, V15, P127, DOI 10.1080/13548501003615266; Hawke LD, 2014, INT J SOC PSYCHIATR, V60, P741, DOI 10.1177/0020764013513443; Henderson C, 2014, LANCET PSYCHIAT, V1, P467, DOI 10.1016/S2215-0366(14)00023-6; Hopkins W., 1997, NEW VIEW STAT EFFECT; [IfPH IPH], 2015, MOHSIKU5215RR IPH IF; ISLAM MR, 1993, PERS SOC PSYCHOL B, V19, P700, DOI 10.1177/0146167293196005; Jones PS, 2001, NURS RES, V50, P300, DOI 10.1097/00006199-200109000-00008; Jorm AF, 2008, ACTA PSYCHIAT SCAND, V118, P315, DOI 10.1111/j.1600-0447.2008.01251.x; Kassam A, 2010, ACTA PSYCHIAT SCAND, V122, P153, DOI 10.1111/j.1600-0447.2010.01562.x; Kassam A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-62; Kassam SP. Aliya, 2013, QUANTITATIVE ANAL ME; Khan TM, 2011, IRAN J PUBLIC HEALTH, V40, P50; Knaak S, 2014, CAN J PSYCHIAT S1, V59, P26; Knaak S HL, 2013, STIGMA OM THATS JUST; Knaak S, 2015, BORDER PERS DIS EMOT, V2, DOI 10.1186/s40479-015-0030-0; Lauber C, 2006, ACTA PSYCHIAT SCAND, V113, P51, DOI 10.1111/j.1600-0447.2005.00718.x; Lauber C, 2007, INT REV PSYCHIATR, V19, P157, DOI 10.1080/09540260701278903; LIANG MH, 1990, MED CARE, V28, P632, DOI 10.1097/00005650-199007000-00008; Link BG, 2004, SCHIZOPHRENIA BULL, V30, P511, DOI 10.1093/oxfordjournals.schbul.a007098; LINK BG, 1987, AM J SOCIOL, V92, P1461, DOI 10.1086/228672; Luong AS Dorothy, 2013, PROGR PLACE; Martensson G, 2014, J PSYCHIATR MENT HLT, V21, P782, DOI 10.1111/jpm.12145; Middha B, 2002, ISSS'02: 15TH INTERNATIONAL SYMPOSIUM ON SYSTEM SYNTHESIS, P2, DOI 10.1109/ISSS.2002.1227143; Minas H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-317; Mittal D, 2014, PSYCHIATR REHABIL J, V37, P297, DOI 10.1037/prj0000095; Modgill G, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-120; Mohamad M.S., 2012, ASIAN SOCIAL SCI, V8, P74, DOI 10.5539/ass.v8n9p74; Ndetei DM, 2011, AFR J PSYCHIATRY, V14, P225, DOI [10.4314/ajpsy.v14i3.6, http://dx.doi.org/10.4314/ajpsy.v14i3.6]; Ng J., 2013, THE STORY OF A LENG; Ning Audrey Tan Xiang, 2011, JBI Libr Syst Rev, V9, P1132; Ohler MC, 2010, CAN J NURS RES, V42, P66; Oranye NO, 2016, CONTEMP NURSE, V52, P555, DOI 10.1080/10376178.2016.1194726; Patten SB, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-120; Pescosolido BA, 2007, PSYCHIAT SERV, V58, P613, DOI 10.1176/appi.ps.58.5.613; Pettigrew TF, 2008, EUR J SOC PSYCHOL, V38, P922, DOI 10.1002/ejsp.504; Pettigrew TF, 2011, INT J INTERCULT REL, V35, P271, DOI 10.1016/j.ijintrel.2011.03.001; Plummer SE, 2000, PSYCHOL MED, V30, P1233, DOI 10.1017/S0033291799002597; Razali SM, 2014, J MENT HEALTH, V23, P176, DOI 10.3109/09638237.2014.910644; Reilly S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036468; Ross CA, 2009, J PSYCHIATR MENT HLT, V16, P558, DOI 10.1111/j.1365-2850.2009.01399.x; Rusch N, 2014, BRIT J PSYCHIAT, V205, P257, DOI 10.1192/bjp.bp.114.145755; Stefanovics E, 2015, PSYCHIAT Q; Stuart Heather, 2014, Can J Psychiatry, V59, pS13; Suhaimi S N Mohamad Mohd, 2014, PERTANIKA J SOCIAL S, V21, P1; Tanaka G, 2003, PSYCHIAT CLIN NEUROS, V57, P595, DOI 10.1046/j.1440-1819.2003.01173.x; Tay Sim-Eng Clara, 2004, J Psychosoc Nurs Ment Health Serv, V42, P40; Thornicroft G, 2015, LANCET LONDON ENGLAN; van der Kluit Maria Johanna, 2011, Issues Ment Health Nurs, V32, P519, DOI 10.3109/01612840.2011.571360; West K, 2014, J SOC PSYCHOL, V154, P217, DOI 10.1080/00224545.2014.888327; ZamZam Ruzanna, 2009, Int J Ment Health Syst, V3, P13, DOI 10.1186/1752-4458-3-13	86	11	11	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187861	10.1371/journal.pone.0187861	http://dx.doi.org/10.1371/journal.pone.0187861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM4OL	29131841	gold, Green Published, Green Submitted			2022-12-26	WOS:000414997800028
J	Tavallali, P; Razavi, M; Brady, S				Tavallali, Peyman; Razavi, Marianne; Brady, Sean			A non-linear data mining parameter selection algorithm for continuous variables	PLOS ONE			English	Article							POSSIBLE REGRESSIONS; ARTERIAL STIFFNESS; RIDGE-REGRESSION; HEART; SQUARES	In this article, we propose a new data mining algorithm, by which one can both capture the non-linearity in data and also find the best subset model. To produce an enhanced subset of the original variables, a preferred selection method should have the potential of adding a supplementary level of regression analysis that would capture complex relationships in the data via mathematical transformation of the predictors and exploration of synergistic effects of combined variables. The method that we present here has the potential to produce an optimal subset of variables, rendering the overall process of model selection more efficient. This algorithm introduces interpretable parameters by transforming the original inputs and also a faithful fit to the data. The core objective of this paper is to introduce a new estimation technique for the classical least square regression framework. This new automatic variable transformation and model selection method could offer an optimal and stable model that minimizes the mean square error and variability, while combining all possible subset selection methodology with the inclusion variable transformations and interactions. Moreover, this method controls multicollinearity, leading to an optimal set of explanatory variables.	[Tavallali, Peyman; Razavi, Marianne] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Brady, Sean] Principium Consulting LLC, Pasadena, CA USA	California Institute of Technology	Tavallali, P (corresponding author), CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA.	ptavalla@caltech.edu			National Heart Lung, and Blood Institute (NHLBI); Boston University [N01-HC-25195]	National Heart Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University	We would like to thank Dr. Niema M. Pahlevan and Prof. Morteza Gharib for giving us the permission to use the Framingham Heart Study data in this paper. The Framingham Heart Study is conducted and supported by the National Heart Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or conclusions of the Framingham Heart Study or the NHLBI.	Association AH, 2015, HEART DIS STROK STAT; Barber RF, 2015, ANN STAT, V43, P2055, DOI 10.1214/15-AOS1337; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Candes E, 2007, ANN STAT, V35, P2313, DOI 10.1214/009053606000001523; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dawber TR, 1951, AM J PUBLIC HEALTH N, V41, P279, DOI 10.2105/ajph.41.3.279; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Efroymson M. A., 1960, MATH METHODS DIGITAL, P191; Friedman J., 2001, SPRINGER SERIES STAT, V1; FURNIVAL GM, 1971, TECHNOMETRICS, V13, P403, DOI 10.2307/1266801; Furnival GM, 2000, TECHNOMETRICS, V42, P69, DOI 10.2307/1271435; Garcia CB, 2015, J APPL STAT, V42, P648, DOI 10.1080/02664763.2014.980789; GARSIDE MJ, 1965, ROY STAT SOC C-APP, V14, P196; Geerts BF, 2011, BRIT J CLIN PHARMACO, V71, P316, DOI 10.1111/j.1365-2125.2010.03798.x; Greupner J, 2012, J AM COLL CARDIOL, V59, P1897, DOI 10.1016/j.jacc.2012.01.046; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; MacKay D. J. C., 2003, INFORM THEORY INFERE; Mallows C., 1964, CENTR REG M I MATH S, V5; MALLOWS CL, 1995, TECHNOMETRICS, V37, P362, DOI 10.2307/1269729; MALLOWS CL, 1967, TECHNOMETRICS, V9, P190; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Montgomery D.C., 2015, INTRO LINEAR REGRESS; MORGAN JA, 1972, TECHNOMETRICS, V14, P317, DOI 10.2307/1267424; Olusegun A.M., 2015, AM J THEOR APPL STAT, V4, P414, DOI [10.11648/j.ajtas.20150405.22, DOI 10.11648/J.AJTAS.20150405.22]; Safar ME, 2000, J HYPERTENS, V18, P1527, DOI 10.1097/00004872-200018110-00001; SCHATZOFF M, 1968, TECHNOMETRICS, V10, P769, DOI 10.2307/1267458; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; STONE M, 1990, J ROY STAT SOC B MET, V52, P237; Trefethen L. N., 1997, NUMERICAL LINEAR ALG, V50; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187676	10.1371/journal.pone.0187676	http://dx.doi.org/10.1371/journal.pone.0187676			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131829	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000414997800020
J	Yahara, M; Kitamura, A; Kinjo, M				Yahara, Masao; Kitamura, Akira; Kinjo, Masataka			U6 snRNA expression prevents toxicity in TDP-43-knockdown cells	PLOS ONE			English	Article							RNA DEPLETION; TDP-43 LOSS; ALS; AGGREGATION	Depletion of amyotrophic lateral sclerosis (ALS)-associated transactivation response (TAR) RNA/DNA-binding protein 43 kDa (TDP-43) alters splicing efficiency of multiple transcripts and results in neuronal cell death. TDP-43 depletion can also disturb expression levels of small nuclear RNAs (snRNAs) as spliceosomal components. Despite this knowledge, the relationship between cell death and alteration of snRNA expression during TDP-43 depletion remains unclear. Here, we knocked down TDP-43 in murine neuroblastoma Neuro2A cells and found a time lag between efficient TDP-43 depletion and appearance of cell death, suggesting that several mechanisms mediate between these two events. The amount of U6 snRNA was significantly decreased during TDP-43 depletion prior to increase of cell death, whereas that of U1, U2, and U4 snRNAs was not. Downregulation of U6 snRNA led to cell death, whereas transient exogenous expression of U6 snRNA counteracted the effect of TDP-43 knockdown on cell death, and slightly decreased the mis-splicing rate of Dnajc5 and Sortilin 1 transcripts, which are assisted by TDP-43. These results suggest that regulation of the U6 snRNA expression level by TDP-43 is a key factor in the increase in cell death upon TDP-43 loss-of-function.	[Yahara, Masao; Kitamura, Akira; Kinjo, Masataka] Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido, Japan	Hokkaido University	Kinjo, M (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido, Japan.	kinjo@sci.hokudai.ac.jp	Kinjo, Masataka/F-5267-2011	Kinjo, Masataka/0000-0001-8889-8369; Kitamura, Akira/0000-0001-8357-8593	Japan Society for Promotion of Science (JSPS) [26440090]; Japan Agency for Medical Research and Development (AMED); Nakabayashi Trust; Japan Amyotrophic Lateral Sclerosis Association (JALSA, Tokyo, Japan); Akiyama Life Science Foundation (Sapporo, Japan); Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Nakabayashi Trust; Japan Amyotrophic Lateral Sclerosis Association (JALSA, Tokyo, Japan); Akiyama Life Science Foundation (Sapporo, Japan); Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering	A.K. was supported by a Japan Society for Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) (#26440090); by a grant for Development of Systems and Technologies for Advanced Measurement and Analysis from the Japan Agency for Medical Research and Development (AMED); by a grant-in-aid of The Nakabayashi Trust for ALS Research (Tokyo, Japan); by a grant-in-aid of Japan Amyotrophic Lateral Sclerosis Association (JALSA, Tokyo, Japan) for ALS research; and by a grant of The Akiyama Life Science Foundation (Sapporo, Japan). M.K. was partially supported by a grant-in-aid of Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering.	Anthony K, 2010, BRAIN RES, V1338, P67, DOI 10.1016/j.brainres.2010.03.008; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; De Conti L, 2015, NUCLEIC ACIDS RES, V43, P8990, DOI 10.1093/nar/gkv814; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Huang YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073890; Iguchi Y, 2013, BRAIN, V136, P1371, DOI 10.1093/brain/awt029; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Ishiguro T, 2017, REGULATORY ROLE RNA, V94, P108; Ishihara T, 2013, HUM MOL GENET, V22, P4136, DOI 10.1093/hmg/ddt262; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kitamura A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19230; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Liu Y, 2014, NEUROSCIENCE, V281, P88, DOI 10.1016/j.neuroscience.2014.09.043; Mills JD, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.030; Mroczek S, 2013, WIRES RNA, V4, P581, DOI 10.1002/wrna.1181; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Schwenk BM, 2016, EMBO J, V35, P2350, DOI 10.15252/embj.201694221; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tsuiji H, 2013, EMBO MOL MED, V5, P221, DOI 10.1002/emmm.201202303; Vogt M., 2013, BIO-PROTOCOL, V3, pe398, DOI DOI 10.21769/BioProtoc.398; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wu L-SS, 2016, GENESIS, V48, P56; Xia Q, 2016, EMBO J, V35, P121, DOI 10.15252/embj.201591998; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187813	10.1371/journal.pone.0187813	http://dx.doi.org/10.1371/journal.pone.0187813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125873	gold, Green Published, Green Submitted			2022-12-26	WOS:000414866000025
J	Ban, EZ; Lye, MS; Chong, PP; Yap, YY; Ying, S; Lim, C; Rahman, HA				Ban, Eng-Zhuan; Lye, Munn-Sann; Chong, Pei Pei; Yap, Yoke-Yeow; Ying, Siew; Lim, Crystale; Rahman, Hejar Abdul			Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; DNA EXCISION-REPAIR; GASTRIC-CANCER RISK; LUNG-CANCER; P53 MUTATIONS; SALTED FISH; GENETIC POLYMORPHISMS; ASP/ASP GENOTYPE; XRCC1; INTEGRINS	Background 8-oxoG, a common DNA lesion resulting from reactive oxygen species (ROS), has been shown to be associated with cancer initiation. hOGG1 DNA glycosylase is the primary enzyme responsible for excision of 8-oxoG through base excision repair (BER). Integrins are members of a family of cell surface receptors that mediate the cell-cell and extracellular matrix (ECM) interactions. Integrins are involved in almost every aspect of carcinogenesis, from cell differentiation, cell proliferation, metastasis to angiogenesis. Loss of ITGA2 expression was associated with enhanced tumor intravasation and metastasis of breast and colon cancer. XPD gene encodes DNA helicase enzyme that is involved in nucleotide excision repair (NER). It is shown in previous research that XPD homozygous wildtype Lys/Lys genotype was associated with higher odds of NPC. Methods We conducted a 1 to N case-control study involving 300 nasopharyngeal carcinoma (NPC) cases and 533 controls matched by age, gender and ethnicity to investigate the effect of hOGG1 Ser326Cys, ITGA2 C807T and XPD Lys751Gln polymorphisms on NPC risk. Linkage disequilibrium and haplotype analysis were conducted to explore the association of allele combinations with NPC risk. Restriction fragment length polymorphism (RFLP-PCR) was used for DNA genotyping. Results No significant association was observed between hOGG1 Ser326Cys and ITGA2 C807T polymorphisms with NPC risk after adjustment for age, gender, ethnicity, cigarette smoking, alcohol and salted fish consumption. Lys/Lys genotype of XPD Lys751Gln polymorphism was associated with increased NPC risk (OR = 1.60, 95% CI = 1.06-2.43). Subjects with history of smoking (OR = 1.81, 95% CI = 1.26-2.60), and salted fish consumption before age of 10 (OR = 1.77, 95% CI = 1.30-2.42) were observed to have increased odds of NPC. The odds of developing NPC of CGC haplotype was significantly higher compared to reference AGC haplotype (OR = 2.20, 95% CI = 1.06-4.58). Conclusion The allele combination of CGC from hOGG1, ITGA2 and XPD polymorphisms was significantly associated with increased odds of NPC.	[Ban, Eng-Zhuan; Lye, Munn-Sann; Rahman, Hejar Abdul] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Community Hlth, Serdang, Malaysia; [Chong, Pei Pei] Univ Putra Malaysia, Dept Biomed Sci, Fac Med & Hlth Sci, Serdang, Malaysia; [Yap, Yoke-Yeow] Univ Putra Malaysia, Dept Otorhinolaryngol, Fac Med & Hlth Sci, Serdang, Malaysia; [Lim, Crystale] UCSI Univ, Fac Sci Appl, Cheras, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; UCSI University	Lye, MS (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Community Hlth, Serdang, Malaysia.	lyems9@yahoo.com	Chong, Pei Pei/AAP-4227-2021; Chong, Pei pei/G-1367-2018; Lim, Crystale Siew Ying/W-1295-2019	Chong, Pei Pei/0000-0002-8229-3593; Chong, Pei pei/0000-0002-8229-3593; Lim, Crystale Siew Ying/0000-0002-0517-0610	Ministry of Science, Technology and Innovation (MOSTI) [04-11-08-625FR]	Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was supported by the Science Fund, Ministry of Science, Technology and Innovation (MOSTI; Project code: 04-11-08-625FR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to all hospital staff involved as well as the data enumerators, research assistants and participants who assisted in this study. This study was funded by the Ministry of Science, Technology and Innovation (MOSTI; Project code: 04-11-08-625FR).	Abdulrahman W, 2013, P NATL ACAD SCI USA, V110, pE633, DOI 10.1073/pnas.1213981110; Anderson Luke R, 2014, Biophys Rev, V6, P191, DOI 10.1007/s12551-013-0123-1; Ariffin OZ, 2011, NCR REPORT 2007; Armstrong RW, 1998, INT J CANCER, V77, P228, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;228::AID-IJC11&gt;3.0.CO;2-7; Banescu C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/213790; Boiteux S, 2000, ARCH BIOCHEM BIOPHYS, V377, P1, DOI 10.1006/abbi.2000.1773; Chen J, 2011, WORLD J GASTROENTERO, V17, P2860, DOI 10.3748/wjg.v17.i23.2860; Chen S, 2002, CARCINOGENESIS, V23, P599; CHENG KC, 1992, J BIOL CHEM, V267, P166; Cheng YJ, 1999, CANCER CAUSE CONTROL, V10, P201, DOI 10.1023/A:1008893109257; Cho EY, 2003, CANCER EPIDEM BIOMAR, V12, P1100; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; CHOW WH, 1993, INT J CANCER, V55, P538, DOI 10.1002/ijc.2910550403; Clezardin P, 1998, CELL MOL LIFE SCI, V54, P541, DOI 10.1007/s000180050182; Court M, 2008, COURT LAB CALCULATOR; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Department of Statistics, 2016, POP AG SEX ETHN GROU; Diggs DL, 2011, J ENVIRON SCI HEAL C, V29, P324, DOI 10.1080/10590501.2011.629974; Ding W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135128; Elahi A, 2002, CARCINOGENESIS, V23, P1229, DOI 10.1093/carcin/23.7.1229; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Garmy-Susini Barbara, 2008, Lymphatic Research and Biology, V6, P155, DOI 10.1089/lrb.2008.1011; Gerger A, 2009, INT J COLORECTAL DIS, V24, P159, DOI 10.1007/s00384-008-0587-9; Hildesheim A, 2001, CANCER EPIDEM BIOMAR, V10, P1145; Hou SM, 2003, ENVIRON MOL MUTAGEN, V41, P37, DOI 10.1002/em.10128; Huang CG, 2012, MOL BIOL REP, V39, P709, DOI 10.1007/s11033-011-0789-z; Ke YB, 2009, ARCH TOXICOL, V83, P663, DOI 10.1007/s00204-009-0421-3; Kritzik M, 1998, BLOOD, V92, P2382, DOI 10.1182/blood.V92.7.2382; Kuper J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001954; Laantri N, 2011, MOL CARCINOGEN, V50, P732, DOI 10.1002/mc.20754; Laine JP, 2006, METHOD ENZYMOL, V408, P246, DOI 10.1016/S0076-6879(06)08015-3; Langsenlehner U, 2006, BREAST CANCER RES TR, V97, P67, DOI 10.1007/s10549-005-9089-4; Lee A. W. M., 1997, Hong Kong Medical Journal, V3, P355; Lin CH, 2012, J EPIDEMIOL, V22, P537, DOI 10.2188/jea.JE20120048; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Long XD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-400; Lye MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130530; Ma L, 2012, CANCER SCI, V103, P1215, DOI 10.1111/j.1349-7006.2012.02290.x; Mechanic LE, 2005, CARCINOGENESIS, V26, P597, DOI 10.1093/carcin/bgh344; Moorthy B, 2015, TOXICOL SCI, V145, P5, DOI 10.1093/toxsci/kfv040; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Ni M, 2012, EUR J GASTROEN HEPAT, V24, P683, DOI 10.1097/MEG.0b013e328351d1c0; NING JP, 1990, J NATL CANCER I, V82, P291, DOI 10.1093/jnci/82.4.291; Ning Y, 2005, CANCER RES, V65, P9280, DOI 10.1158/0008-5472.CAN-05-0407; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pan HJ, 2009, BREAST CANCER RES TR, V118, P197, DOI 10.1007/s10549-008-0179-y; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Robertson JH, 2009, CLIN EXP METASTAS, V26, P769, DOI 10.1007/s10585-009-9276-5; SANCAR A, 1994, SCIENCE, V266, P1954, DOI 10.1126/science.7801120; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Seker H, 2001, CANCER RES, V61, P7430; SMITH ML, 1995, ONCOGENE, V10, P1053; Smith ML, 2002, MUTAGENESIS, V17, P149, DOI 10.1093/mutage/17.2.149; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; van Gijssel HE, 2004, MUTAT RES-FUND MOL M, V547, P55, DOI 10.1016/j.mrfmmm.2003.11.010; Varner JA, 1996, CURR OPIN CELL BIOL, V8, P724, DOI 10.1016/S0955-0674(96)80115-3; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WANG XW, 1995, CANCER RES, V55, P6012; Wang XW, 1996, GENE DEV, V10, P1219, DOI 10.1101/gad.10.10.1219; Xie H, 2013, BREAST, V22, P707, DOI 10.1016/j.breast.2012.12.016; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; YU MC, 1986, CANCER RES, V46, P956; Yuan T, 2012, DIGEST DIS SCI, V57, P2451, DOI 10.1007/s10620-012-2192-6; Zhou W, 2003, CANCER EPIDEM BIOMAR, V12, P359	71	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187200	10.1371/journal.pone.0187200	http://dx.doi.org/10.1371/journal.pone.0187200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121049	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900025
J	Armenta, BM; Stroebe, K; Scheibe, S; Postmes, T; Van Yperen, NW				Armenta, Bibiana M.; Stroebe, Katherine; Scheibe, Susanne; Postmes, Tom; Van Yperen, Nico W.			Feeling younger and identifying with older adults: Testing two routes to maintaining well-being in the face of age discrimination	PLOS ONE			English	Article							SOCIAL IDENTITY; SUBJECTIVE AGE; PERCEIVED DISCRIMINATION; PERVASIVE DISCRIMINATION; GROUP IDENTIFICATION; SELF-PERCEPTIONS; HEALTH; RESPONSES; CONSEQUENCES; ATTRIBUTIONS	Integrating the social identity and aging literatures, this work tested the hypothesis that there are two independent, but simultaneous, responses by which adults transitioning into old age can buffer themselves against age discrimination: an individual response, which entails adopting a younger subjective age when facing discrimination, and a collective response, which involves increasing identification with the group of older adults. In three experimental studies with a total number of 488 older adults (50 to 75 years of age), we manipulated age discrimination in a job application scenario and measured the effects of both responses on perceived health and self-esteem. Statistical analyses include individual study results as well as a meta-analysis on the combined results of the three studies. Findings show consistent evidence only for the individual response, which was in turn associated with well-being. Furthermore, challenging previous research, the two responses (adopting a younger subjective age and increasing group identification) were not only theoretically, but also empirically distinct. This research complements prior research by signaling the value of considering both responses to discrimination as complementary rather than mutually exclusive.	[Armenta, Bibiana M.; Stroebe, Katherine; Scheibe, Susanne; Postmes, Tom; Van Yperen, Nico W.] Univ Groningen, Dept Psychol, Groningen, Netherlands	University of Groningen	Armenta, BM (corresponding author), Univ Groningen, Dept Psychol, Groningen, Netherlands.	b.a.armenta.gutierrez@rug.nl	Armenta, Bibiana/R-1225-2018; Postmes, Tom/A-9004-2010; Van Yperen, Nico W./C-2341-2012; Scheibe, Susanne/G-6017-2012	Armenta, Bibiana/0000-0002-8427-4185; Postmes, Tom/0000-0002-8029-7398; Van Yperen, Nico W./0000-0003-2116-8841; Scheibe, Susanne/0000-0003-1001-6199	Netherlands Organization for Scientific Research (NWO) [022.003.040]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by a grant from the Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl/), project number 022.003.040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armenta BM, 2017, PERS SOC PSYCHOL B, V43, P418, DOI 10.1177/0146167216688202; Becker JC, 2015, J SOC ISSUES, V71, P497, DOI 10.1111/josi.12125; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bohannon J, 2011, SCIENCE, V334, P307, DOI 10.1126/science.334.6054.307; Branscombe NR, 1999, J PERS SOC PSYCHOL, V77, P135, DOI 10.1037/0022-3514.77.1.135; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Clarke LH, 2008, AGEING SOC, V28, P653, DOI 10.1017/S0144686X07007003; Cohen J.E., 1988, STAT POWER ANAL BEHA; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Derks B, 2007, EUR J SOC PSYCHOL, V37, P470, DOI 10.1002/ejsp.375; Derks B, 2011, PSYCHOL SCI, V22, P1243, DOI 10.1177/0956797611417258; Derks B, 2007, SOC ISS POLICY REV, V1, P217, DOI 10.1111/j.1751-2409.2007.00008.x; Desmette D., 2008, CAREER DEV INT, V13, P168, DOI [10.1108/13620430810860567, DOI 10.1108/13620430810860567]; Diehl MK, 2010, J GERONTOL B-PSYCHOL, V65, P340, DOI 10.1093/geronb/gbp110; Doosje B, 1998, J PERS SOC PSYCHOL, V75, P872, DOI 10.1037/0022-3514.75.4.872; Dovidio J, 1996, STEREOTYPES STEREOTY, P276, DOI DOI 10.1177/1368430204046142; Freund A.M., 2003, HDB PSYCHOL; Garstka TA, 2004, PSYCHOL AGING, V19, P326, DOI 10.1037/0882-7974.19.2.326; Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x; Haslam SA, 2005, BRIT J SOC PSYCHOL, V44, P355, DOI 10.1348/014466605X37468; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Heckhausen J, 1997, DEV PSYCHOL, V33, P176, DOI 10.1037/0012-1649.33.1.176; HECKHAUSEN J, 1993, DEV PSYCHOL, V29, P539, DOI 10.1037/0012-1649.29.3.539; Helmer C, 1999, J GERONTOL B-PSYCHOL, V54, pS84, DOI 10.1093/geronb/54B.2.S84; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jetten J, 2001, PERS SOC PSYCHOL B, V27, P1204, DOI 10.1177/0146167201279012; Jetten J., 2012, SOCIAL CURE IDENTITY; Jetten J, 2014, SOC ISS POLICY REV, V8, P103, DOI 10.1111/sipr.12003; Kaufman G, 2002, J AGING STUD, V16, P169, DOI 10.1016/S0890-4065(02)00042-7; Kotter-Gruhn D, 2015, PSYCHOL HEALTH, V30, P1470, DOI 10.1080/08870446.2015.1061130; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P875, DOI 10.1177/1948550617693058; Levy BR, 2003, J GERONTOL B-PSYCHOL, V58, pP203, DOI 10.1093/geronb/58.4.P203; LOGAN JR, 1992, SOC FORCES, V71, P451, DOI 10.2307/2580019; Major B, 2003, PERS SOC PSYCHOL B, V29, P772, DOI 10.1177/0146167203029006009; Meade AW, 2012, PSYCHOL METHODS, V17, P437, DOI 10.1037/a0028085; MONTEPARE JM, 1989, PSYCHOL AGING, V4, P73, DOI 10.1037/0882-7974.4.1.73; Montepare JM, 2009, INT J BEHAV DEV, V33, P42, DOI 10.1177/0165025408095551; Moor C, 2006, INT J AGING HUM DEV, V63, P241, DOI 10.2190/AKRY-UM4K-PB1V-PBHF; North MS, 2012, PSYCHOL BULL, V138, P982, DOI 10.1037/a0027843; Posthuma RA, 2009, J MANAGE, V35, P158, DOI 10.1177/0149206308318617; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Reynolds KJ, 2000, GROUP DYN-THEOR RES, V4, P275, DOI DOI 10.1037/1089-2699.4.4.275; RODIN J, 1980, J SOC ISSUES, V36, P12, DOI 10.1111/j.1540-4560.1980.tb02019.x; Schmitt MT, 2014, PSYCHOL BULL, V140, P921, DOI 10.1037/a0035754; Schmitt MT, 2002, PERS SOC PSYCHOL B, V28, P197, DOI 10.1177/0146167202282006; Schmitt MT, 2002, PERS SOC PSYCHOL B, V28, P620, DOI 10.1177/0146167202288006; Schmitt MT, 2003, EUR J SOC PSYCHOL, V33, P297, DOI 10.1002/ejsp.147; Stephan Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119293; Stephan Y, 2013, J GERONTOL B-PSYCHOL, V68, P1, DOI 10.1093/geronb/gbs037; Steverink N, 2001, J GERONTOL B-PSYCHOL, V56, pP364, DOI 10.1093/geronb/56.6.P364; Stroebe K, 2015, J SOC ISSUES, V71, P633, DOI 10.1111/josi.12132; Stroebe K, 2011, BRIT J SOC PSYCHOL, V50, P484, DOI 10.1348/014466610X523057; Stroebe K, 2009, EUR J SOC PSYCHOL, V39, P576, DOI 10.1002/ejsp.557; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; TAYLOR DM, 1984, BRIT J SOC PSYCHOL, V23, P291, DOI 10.1111/j.2044-8309.1984.tb00644.x; Teuscher U, 2009, INT J BEHAV DEV, V33, P22, DOI 10.1177/0165025408099487; van Zomeren M, 2008, PSYCHOL BULL, V134, P504, DOI 10.1037/0033-2909.134.4.504; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; von Hippel C, 2013, PSYCHOL AGING, V28, P17, DOI 10.1037/a0029825; Weiss D, 2013, PSYCHOL AGING, V28, P1140, DOI 10.1037/a0033811; Weiss D, 2012, PSYCHOL AGING, V27, P153, DOI 10.1037/a0024887; Weiss D, 2012, PSYCHOL AGING, V27, P173, DOI 10.1037/a0024819; Weiss D, 2009, PSYCHOL AGING, V24, P729, DOI 10.1037/a0016339; Westerhof GJ, 2005, J GERONTOL B-PSYCHOL, V60, pS129, DOI 10.1093/geronb/60.3.S129; WRIGHT SC, 1990, J PERS SOC PSYCHOL, V58, P994, DOI 10.1037/0022-3514.58.6.994	66	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187805	10.1371/journal.pone.0187805	http://dx.doi.org/10.1371/journal.pone.0187805			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM0ME	29117257	gold, Green Submitted, Green Published			2022-12-26	WOS:000414659600076
J	Draper, JP; Waits, LP; Adams, JR; Seals, CL; Steury, TD				Draper, John P.; Waits, Lisette P.; Adams, Jennifer R.; Seals, Christopher L.; Steury, Todd D.			Genetic health and population monitoring of two small black bear (Ursus americanus) populations in Alabama, with a regional perspective of genetic diversity and exchange	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; MICROSATELLITE ANALYSIS; EXTINCTION RISK; MARK-RECAPTURE; R-PACKAGE; SIZE; PROGRAM; INFERENCE; SOFTWARE; ABUNDANCE	One of the major concerns in conservation today is the loss of genetic diversity which is a frequent consequence of population isolation and small population sizes. Fragmentation of populations and persecution of carnivores has posed a substantial threat to the persistence of free ranging carnivores in North America since the arrival of European settlers. Black bears have seen significant reductions in range size from their historic extent, which is most pronounced in the southeastern United States and even more starkly in Alabama where until recently bears were reduced to a single geographically isolated population in the Mobile River Basin. Recently a second population has naturally re-established itself in northeastern Alabama. We sought to determine size, genetic diversity and genetic connectivity for these two populations in relation to other regional populations. Both populations of black bears in Alabama had small population sizes and had moderate to low genetic diversity, but showed different levels of connectivity to surrounding populations of bears. The Mobile River Basin population had a small population size at only 86 individuals (76-124, 95% C.I.), the lowest genetic diversity of compared populations (richness = 2.33, Ho and He = 0.33), and showed near complete genetic isolation from surrounding populations across multiple tests. The newly recolonizing population in northeastern Alabama had a small but growing population doubling in 3 years (34 individuals 26-43, 95% C.I.), relatively moderate genetic diversity compared to surrounding populations (richness = 3.32, Ho = 0.53, He = 0.65), and showed a high level of genetic connectivity with surrounding populations.	[Draper, John P.; Seals, Christopher L.; Steury, Todd D.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA; [Waits, Lisette P.; Adams, Jennifer R.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA	Auburn University System; Auburn University; Idaho; University of Idaho	Draper, JP (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.	jpd0019@auburn.edu	Adams, Jennifer R/H-1780-2011	Draper, John/0000-0003-2005-6039; Waits, Lisette/0000-0002-1323-0812; Steury, Todd/0000-0001-6754-8319	Alabama Department of Conservation and National Resources [T-3-9]	Alabama Department of Conservation and National Resources	This study was supported by grant number T-3-9, from Alabama Department of Conservation and National Resources to TDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Balkenhol N, 2015, LANDSCAPE GENETICS; Bellemain E, 2004, MOL ECOL NOTES, V4, P519, DOI 10.1111/j.1471-8286.2004.00711.x; Bouzat JL, 2009, CONSERV GENET, V10, P191, DOI 10.1007/s10592-008-9547-8; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Charlesworth D, 1987, ANN REV ECOL EVOL SY, V18; De Barba M, 2010, MOL ECOL RESOUR, V10, P659, DOI 10.1111/j.1755-0998.2009.02818.x; De Barba M, 2014, CONSERV GENET RESOUR, V6, P821, DOI 10.1007/s12686-014-0257-x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards AS, 2002, STATUS BLACK BEAR SW; ENNIS S, 1994, ANIM GENET, V25, P425, DOI 10.1111/j.1365-2052.1994.tb00533.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Goudet J., 2002, FSTAT; Graham SE, 2016, GENETIC STRUCTURE DI; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hollander M., 1973, NONPARAMETRIC STAT M; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Hooker MJ, 2015, URSUS, V26, P107, DOI 10.2192/URSUS-D-14-00025; Howell AH, 1921, BIPLOGICAL SURVEY AL, p29 ; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kasbohm JW, 1994, TAXONOMY BLACK BEARS; Kendall Katherine C., 2008, P141; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; MacKay Paula, 2008, P183; McCarthy TM, 2009, URSUS, V20, P30, DOI 10.2192/07GR013R.1; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Miller B, 1999, ANIM CONSERV, V2, P59, DOI 10.1111/j.1469-1795.1999.tb00049.x; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Miller CR, 2002, GENETICS, V160, P357; Mladenoff DJ, 1997, BIOSCIENCE, V47, P21, DOI 10.2307/1313003; Murphy MA, 2002, CONSERV GENET, V3, P435, DOI 10.1023/A:1020503330767; Noyce KV, 2011, BEHAV ECOL SOCIOBIOL, V65, P823, DOI 10.1007/s00265-010-1086-x; Ohnishi N, 2007, CONSERV GENET, V8, P1331, DOI 10.1007/s10592-006-9281-z; Onorato DP, 2004, J MAMMAL, V85, P140, DOI 10.1644/1545-1542(2004)085<0140:PPWAMO>2.0.CO;2; PAETKAU D, 1995, MOL ECOL, V4, P519, DOI 10.1111/j.1365-294X.1995.tb00248.x; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pelton Michael R., 1997, P31; Pennell MW, 2013, MOL ECOL RESOUR, V13, P154, DOI 10.1111/1755-0998.12019; Pillay M, 1999, CROP SCI, V39, P1881, DOI 10.2135/cropsci1999.3961881x; Pritchard J. K., 2009, DOCUMENTATION STRUCT, P1; Pritchard JK, 2000, GENETICS, V155, P945; Puckett EE, 2015, MOL BIOL EVOL, V32, P2338, DOI 10.1093/molbev/msv114; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Reed DH, 2005, CONSERV BIOL, V19, P563, DOI 10.1111/j.1523-1739.2005.00444.x; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Rstudio Team, 2015, RSTUDIO INT DEV R; Sachs L., 1997, ANGEW STAT, P11, DOI [10.1007/978-3-662-05746-9_2, DOI 10.1007/978-3-662-05746-9_2, 10.1007/978-3-662-05746-9]; Scheick BK, 2014, URSUS, V25, P24, DOI 10.2192/URSUS-D-12-00020.1; Servheen C., 1990, MONOGRAPH, V32; Settlage KE, 2008, J WILDLIFE MANAGE, V72, P1035, DOI 10.2193/2006-472; Settlage KE, 2005, EFFICACY DNA SAMPLIN; Silvano AL, 2007, BLACK BEAR PROVISION; Society IB, 2010, SOM PRACT ASP COND L, V47, p725 ; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Triant DA, 2004, CONSERV GENET, V5, P647, DOI 10.1007/s10592-003-1861-6; U. S. Fish and Wildlife Service, 1998, FED REGISTER, V63, p67613 ; United States Census Bureau, US CENS QUICK FACTS; Waits JL, 2000, ANIM CONSERV, V3, P191, DOI 10.1017/S1367943000000901; Waits L, 1998, URSUS-SERIES, V10, P307; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2005, MOL ECOL, V14, P3335, DOI 10.1111/j.1365-294X.2005.02673.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White GC, 2008, ENVIRON ECOL STAT, V15, P89, DOI 10.1007/s10651-007-0030-3; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	80	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0186701	10.1371/journal.pone.0186701	http://dx.doi.org/10.1371/journal.pone.0186701			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117263	Green Submitted, gold, Green Published			2022-12-26	WOS:000414659600013
J	Castaneda, CA; Wolfson, NA; Leng, KR; Kuo, YM; Andrews, AJ; Fierke, CA				Castaneda, Carol Ann; Wolfson, Noah A.; Leng, Katherine R.; Kuo, Yin-Ming; Andrews, Andrew J.; Fierke, Carol A.			HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme turnover; histone; histone acetylation; histone deacetylase (HDAC); nucleosome; peptides; protein complex; non-natural amino acid incorporation	NUCLEOSOME CORE PARTICLE; DEACETYLASE 8; CRYSTAL-STRUCTURE; RECOMBINANT HISTONES; LYSINE ACETYLATION; PROTEIN; ASSAY; SPECIFICITY; INHIBITORS; COMPLEXES	Histone deacetylases (HDACs) catalyze deacetylation of acetyl-lysine residues within proteins. To date, HDAC substrate specificity and selectivity have been largely estimated using peptide substrates. However, it is unclear whether peptide substrates accurately reflect the substrate selectivity of HDAC8 toward full-length proteins. Here, we compare HDAC8 substrate selectivity in the context of peptides, full-length proteins, and protein-nucleic acid complexes. We demonstrate that HDAC8 catalyzes deacetylation of tetrameric histone (H3/H4) substrates with catalytic efficiencies that are 40-300-fold higher than those for corresponding peptide substrates. Thus, we conclude that additional contacts with protein substrates enhance catalytic efficiency. However, the catalytic efficiency decreases for larger multiprotein complexes. These differences in HDAC8 substrate selectivity for peptides and full-length proteins suggest that HDAC8 substrate preference is based on a combination of short- and long-range interactions. In summary, this work presents detailed kinetics for HDAC8-catalyzed deacetylation of singly-acetylated, full-length protein substrates, revealing that HDAC8 substrate selectivity is determined by multiple factors. These insights provide a foundation for understanding recognition of full-length proteins by HDACs.	[Castaneda, Carol Ann; Fierke, Carol A.] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA; [Wolfson, Noah A.; Fierke, Carol A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Leng, Katherine R.; Fierke, Carol A.] Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA; [Kuo, Yin-Ming; Andrews, Andrew J.] Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fox Chase Cancer Center	Fierke, CA (corresponding author), Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.; Andrews, AJ (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Andrew.Andrews@fccc.edu; fierke@umich.edu		Fierke, Carol/0000-0002-1481-0579	National Science Foundation; National Institutes of Health [5-R01-GM-040602]; University of Michigan Chemistry-Biology Interface (CBI) Training Program, National Institutes of Health [5T32GM008597]; Rackham Graduate School; Cellular Biotechnology Training Program [T32-GM008353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353, R01GM040602, T32GM008597] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Chemistry-Biology Interface (CBI) Training Program, National Institutes of Health; Rackham Graduate School; Cellular Biotechnology Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Science Foundation predoctoral fellowship (to N. A. W.), National Institutes of Health Grant 5-R01-GM-040602 (to C. A. F.), University of Michigan Chemistry-Biology Interface (CBI) Training Program, National Institutes of Health Grant 5T32GM008597 (to C. A. C.), Rackham Graduate School (to C. A. C.), and the Cellular Biotechnology Training Program T32-GM008353 (to N. A. W. and K. R. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam N, 2016, STRUCTURE, V24, P458, DOI 10.1016/j.str.2016.02.002; Buggy JJ, 2000, BIOCHEM J, V350, P199, DOI 10.1042/0264-6021:3500199; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cole KE, 2011, J AM CHEM SOC, V133, P12474, DOI 10.1021/ja205972n; D'Mello SR, 2009, DRUG NEWS PERSPECT, V22, P513, DOI [10.1358/dnp.2009.22.9.1437959, 10.1358/dnp.2009.9.1428871]; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Decroos C, 2015, BIOCHEMISTRY-US, V54, P2126, DOI 10.1021/acs.biochem.5b00010; Dose A, 2016, ANGEW CHEM INT EDIT, V55, P1192, DOI 10.1002/anie.201508174; Dowling DP, 2010, BIOCHEMISTRY-US, V49, P5048, DOI 10.1021/bi1005046; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; Fenichel MP, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv165; Gantt ML, 2016, BIOCHEMISTRY-US, V55, P820, DOI 10.1021/acs.biochem.5b01327; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Gantt SL, 2010, J BIOL CHEM, V285, P6036, DOI 10.1074/jbc.M109.033399; Gao JX, 2009, BIOCHEM BIOPH RES CO, V379, P1, DOI 10.1016/j.bbrc.2008.11.135; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gober IN, 2016, J AM CHEM SOC, V138, P9452, DOI 10.1021/jacs.6b02836; Gurard-Levin ZA, 2008, BIOCHEMISTRY-US, V47, P6242, DOI 10.1021/bi800053v; Gurard-Levin ZA, 2010, ACS CHEM BIOL, V5, P863, DOI 10.1021/cb100088g; Gurard-Levin ZA, 2009, CHEMBIOCHEM, V10, P2159, DOI 10.1002/cbic.200900417; Hedstrom L, 2010, ENCY LIFE SCI; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Huang XY, 2011, ANAL BIOCHEM, V414, P278, DOI 10.1016/j.ab.2011.04.001; Izzo A, 2010, BRIEF FUNCT GENOMICS, V9, P429, DOI 10.1093/bfgp/elq024; Joshi P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.26; Kaiser FJ, 2014, HUM MOL GENET, V23, P2888, DOI 10.1093/hmg/ddu002; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kuo YM, 2015, BIOCHEM J, V472, P239, DOI 10.1042/BJ20150654; Kuo YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054896; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Lee H, 2006, MOL CELL BIOL, V26, P5259, DOI 10.1128/MCB.01971-05; Li GY, 2011, J NEUROL SCI, V304, P1, DOI 10.1016/j.jns.2011.02.017; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marek M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003645; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; Olson DE, 2014, ACS CHEM BIOL, V9, P2210, DOI 10.1021/cb500492r; Poole RM, 2014, DRUGS, V74, P1543, DOI 10.1007/s40265-014-0275-8; Riester D, 2007, BIOCHEM BIOPH RES CO, V357, P439, DOI 10.1016/j.bbrc.2007.03.158; Saha A, 2013, BIOORGAN MED CHEM, V21, P4201, DOI 10.1016/j.bmc.2013.05.002; Shahian T, 2012, METHODS MOL BIOL, V833, P337, DOI 10.1007/978-1-61779-477-3_20; Smith BC, 2007, J BIOL CHEM, V282, P37256, DOI 10.1074/jbc.M707878200; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Toro TB, 2015, PROTEIN SCI, V24, P2020, DOI 10.1002/pro.2813; Van den Wyngaert I, 2000, FEBS LETT, V478, P77, DOI 10.1016/S0014-5793(00)01813-5; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Wegener D, 2003, ANAL BIOCHEM, V321, P202, DOI 10.1016/S0003-2697(03)00426-3; Wegener D, 2003, CHEM BIOL, V10, P61, DOI 10.1016/S1074-5521(02)00305-8; Whitehead L, 2011, BIOORGAN MED CHEM, V19, P4626, DOI 10.1016/j.bmc.2011.06.030; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Wolfson NA, 2014, ANAL BIOCHEM, V456, P61, DOI 10.1016/j.ab.2014.03.012; Wolfson NA, 2013, BIOPOLYMERS, V99, P112, DOI 10.1002/bip.22135; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	66	20	20	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21568	21577		10.1074/jbc.M117.811026	http://dx.doi.org/10.1074/jbc.M117.811026			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29109148	hybrid, Green Published			2022-12-26	WOS:000419013000031
J	Francischini, FJB; de Campos, JB; Alves-Pereira, A; Viana, JPG; Grinter, CC; Clough, SJ; Zucchi, MI				Francischini, Fabricio J. B.; de Campos, Jaqueline Bueno; Alves-Pereira, Alessandro; Gomes Viana, Joao Paulo; Grinter, Christopher C.; Clough, Steven J.; Zucchi, Maria I.			Morphological and molecular characterization of Brazilian populations of Diatraea saccharalis (Fabricius, 1794) (Lepidoptera: Crambidae) and the evolutionary relationship among species of Diatraea Guilding	PLOS ONE			English	Article							SPODOPTERA-FRUGIPERDA LEPIDOPTERA; MITOCHONDRIAL-DNA VARIATION; SUGARCANE BORER; MOTHS LEPIDOPTERA; R-PACKAGE; GENETICS; NOCTUIDAE; VARIABILITY; DIVERSITY; GENITALIA	The sugarcane borer or corn stalk borer, Diatraea Guilding is polyphagous insect pest of many important crops such as corn, sorghum and sugarcane. Losses arising from the attack of Diatraea species have been a serious problem, which may cause loss in sugarcane production around 0.25% in sugar, 0.20% in alcohol and 0.77% of body weight for every 1% infestation and up to 21% in corn production fields. In Brazil, the most commonly reported species are Diatraea saccharalis (Fabricius, 1794) and Diatraea impersonatella (Walker, 1863) (= D. flavipennella). However, multiple other species of Diatraea have been identified in Brazil according to the literature. Currently, little information exists on the presence of the other species causing injury to sugarcane and corn. The objectives of this study were to improve the accuracy of species assignment, evaluate the population genetic structure, and address many of the outstanding questions of systematics and evolution of Brazilian populations of D. saccharalis. To address these main questions, classical taxonomic methods were used, focused on morphological characterization of the reproductive organs, especially the male genitalia. In addition, genetic studies were performed using simple sequence repeats (SSR) and a fragment of cytochrome C oxidase subunit I (COI) gene. The data and findings from this research will contribute to the understanding of evolutionary aspects of insect pests in order to develop more effective and sustainable population management practices.	[Francischini, Fabricio J. B.; de Campos, Jaqueline Bueno; Alves-Pereira, Alessandro; Gomes Viana, Joao Paulo] Univ Estadual Campinas, Inst Biol, Dept Genet & Mol Biol, Campinas, SP, Brazil; [Grinter, Christopher C.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA; [Clough, Steven J.] Univ Illinois, Dept Crop Sci, USDA ARS, Urbana, IL 61801 USA; [Zucchi, Maria I.] APTA, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; California Academy of Sciences; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Zucchi, MI (corresponding author), APTA, Piracicaba, SP, Brazil.	mizucchi@apta.sp.gov.br	Zucchi, Maria Imaculada/D-2637-2012; Francischini, Fabricio/AAZ-9542-2020; Alves-Pereira, Alessandro/I-6595-2012; Zucchi, Maria Imaculada/AAC-8157-2019; Viana, João Paulo JPGV Gomes/K-1178-2012	Zucchi, Maria Imaculada/0000-0002-4863-1843; Alves-Pereira, Alessandro/0000-0002-3012-6355; Zucchi, Maria Imaculada/0000-0002-4863-1843; Viana, João Paulo JPGV Gomes/0000-0002-9217-9604	Sao Paulo Research Foundation (FAPESP) [2012/50848-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) AUXPE-BioComputacional [23038.010032/2013-14, 33762013]; National Council for Scientific and Technological Development of Brazil (CNPq) [310446/2015-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) AUXPE-BioComputacional(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank the Sao Paulo Research Foundation (FAPESP) for the financial support (#2012/50848-3). FJBF received funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) AUXPE-BioComputacional 33762013 grant number: 23038.010032/2013-14. MIZ thanks the National Council for Scientific and Technological Development of Brazil (CNPq) for a productivity grant (#310446/2015-5).	Almeida JR, 1936, REV AGR PIRACICABA, V11, P257; Arnqvist G, 1997, BIOL J LINN SOC, V60, P365; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; BARTON NH, 1984, ANNU REV ECOL SYST, V15, P133, DOI 10.1146/annurev.es.15.110184.001025; Bleszynski S., 1969, PESTS SUGAR CANE, P11; BOGDANOWICZ SM, 1993, ANN ENTOMOL SOC AM, V86, P710, DOI 10.1093/aesa/86.6.710; BOX H. E., 1950, Proceedings of the Hawaiian Entomological Society, V14, P41; BOX HAROLD E., 1931, BULL ENT RES [LONDON], V22, P1, DOI 10.1017/S0007485300029709; BOX HE, 1951, B ENTOMOL RES, V42, P379, DOI 10.1017/S0007485300025402; Box HE, 1960, P INT SOC SUG CANE T, V10, P870; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; BROWER AVZ, 1991, EVOLUTION, V45, P1281, DOI 10.1111/j.1558-5646.1991.tb04393.x; Brown B, 1999, MOL PHYLOGENET EVOL, V13, P463, DOI 10.1006/mpev.1999.0662; Caixeta DF, 2010, THESIS; CHAPCO W, 1992, HEREDITY, V69, P547, DOI 10.1038/hdy.1992.170; Cirelli Kátia Resende Netto, 2003, Rev. Bras. entomol., V47, P89, DOI 10.1590/S0085-56262003000100014; Cruz FZ, 1976, ESPECIES DIATRAEA GU; De Freitas MDRT, 2006, FLA ENTOMOL, V89, P539, DOI 10.1653/0015-4040(2006)89[539:TPODFL]2.0.CO;2; DEBACH P, 1974, P323; Dinardo-Miranda LL, 2008, CANA DE ACUCAR, P349; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dyar Harrison G., 1911, Entomological News Philadelphia, V22; DYAR HARRISON G., 1927, PROC U S NATION MM, V71, P1; Elias-Gutierrez Manuel, 2008, Zootaxa, V1839, P1; Elton C., 1958; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferreira ME, 1998, INTRO USO MARCADORES; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gepts P, 2004, PLANT PHYSIOL, V134, P1295, DOI 10.1104/pp.103.038885; Goldstein D, 1999, MICROSATELLITES EVOL; Gomez LA, 1995, SERIE DIVULGATIVA CE; Goyes P. C., 2008, CARACTERIZACION MORF; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hartl Daniel L., 1997; Hayward KJ, 1943, BRASIL ACUCAREIRO, V11, P69; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holloway TE, 1928, USDA TECHNICAL B, V41; Jombart, 2020, HIERFSTAT ESTIMATION; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Joyce AL, 2016, ECOLOGY EVOLUTION, P1; Joyce AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110036; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Lange CL, 2004, B ENTOMOL RES, V94, P457, DOI 10.1079/BER2004320; Leite NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113286; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; LONG WH, 1972, ANNU REV ENTOMOL, V17, P149, DOI 10.1146/annurev.en.17.010172.001053; Lopes DA, 2014, ACTA SCI-AGRON, V36, P189, DOI 10.4025/actasciagron.v36i2.16211; MARTIN A, 1990, EVOLUTION, V44, P1066, DOI 10.2307/2409567; Martinelli S, 2007, B ENTOMOL RES, V97, P225, DOI 10.1017/S0007485307004944; Martinelli S, 2006, J ECON ENTOMOL, V99, P519, DOI 10.1603/0022-0493-99.2.519; Mendonca AF, 1996, PRAGAS CANA DE ACUCA; MIKKOLA K, 1992, SYST ENTOMOL, V17, P145, DOI 10.1111/j.1365-3113.1992.tb00327.x; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Myers JG, 1935, ECOLOGICAL DISTRIBUT; Myers JG, 1932, ORIGINAL HABITAT HOS; Nascimento JB, 2015, DIVERSIDADE GENETICA; NEI M, 1974, GENETICS, V76, P379; Nei M., 1975, MOL POPULATION GENET; Neto MSR, 2014, ANALISE ESTRUTURAL A; Cortes AMP, 2010, J INSECT PHYSIOL, V56, P1624, DOI 10.1016/j.jinsphys.2010.06.005; Pashley D.P., 1989, Systematics Association Special Volume Series, P103; PASHLEY DP, 1990, ANN ENTOMOL SOC AM, V83, P1048, DOI 10.1093/aesa/83.6.1048; Passoa S. C., 2014, LEPINTERCEPT IDENTIF; Patwardhan A., 2014, J PHYLOGENETICS EVOL, DOI [10.4172/2329-9002.1000131, DOI 10.4172/2329-9002.1000131]; Pavinato VAC, 2013, GENET MOL RES, V12, P1631, DOI 10.4238/2013.May.14.3; Pavinato VAC, 1794, THESIS; Peairs B, 1980, AGRONOMIA CONSTARRIC, V4, P123; Peterson Merrill A., 1998, P263; Powell JA, 2009, ENCY INSECTS, P1132; Riley DR, 2005, SOUTHWEST ENTOMOL, V30, P35; Risco SH, 1975, OBSERVACIONES RELACI; ROBINSON G S, 1976, Entomologist's Gazette, V27, P127; Rock J, 2008, ANTARCT SCI, V20, P253, DOI 10.1017/S0954102008001120; RODRIGUEZDELBOSQUE LA, 1988, FLA ENTOMOL, V71, P176, DOI 10.2307/3495365; Roe RM, 1981, 20 USDA ARS ARMS; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schilthuizen M., 2003, NETHERLANDS ENTOMOLO, V14, P9; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCUDDER GGE, 1971, ANNU REV ENTOMOL, V16, P379, DOI 10.1146/annurev.en.16.010171.002115; Shere-Kharwar A, 2013, INDIAN J L SCI, V2, P35; Shere-Kharwar A, 2012, LIFE SCI B, P123; Silva-Brandao KL, 2015, J ECON ENTOMOL, V108, P307, DOI 10.1093/jee/tou040; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Simpson GG, 1949, TEMPO MODE EVOLUTION; Sneath Pha R. R., 1973, NUMERICAL TAXONOMY; Solis MA, 2016, ZOOKEYS, P73, DOI 10.3897/zookeys.565.6797; Sosa-Gomez DR, 2004, GENET MOL BIOL, V27, P378, DOI 10.1590/S1415-47572004000300012; Stireman JO, 2005, EVOLUTION, V59, P2573, DOI 10.1554/05-222.1; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1980, GENETICS, V94, P1011; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tischendorf L, 2003, LANDSCAPE ECOL, V18, P41, DOI 10.1023/A:1022908109982; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Vialatte A, 2005, P ROY SOC B-BIOL SCI, V272, P1075, DOI 10.1098/rspb.2004.3033; Walker F., 1863, LIST SPECIMENS LE 27; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; ZEHNDER GW, 1992, ANN ENTOMOL SOC AM, V85, P234, DOI 10.1093/aesa/85.2.234	103	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0186266	10.1371/journal.pone.0186266	http://dx.doi.org/10.1371/journal.pone.0186266			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145390	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800003
J	Fiume, E; Coen, O; Xu, WJ; Lepiniec, L; Magnani, E				Fiume, Elisa; Coen, Olivier; Xu, Wenjia; Lepiniec, Loic; Magnani, Enrico			Developmental patterning of sub-epidermal cells in the outer integument of Arabidopsis seeds	PLOS ONE			English	Article							PROTEIN; FERTILIZATION; THALIANA; GORDITA; GENES	The seed, the reproductive unit of angiosperms, is generally protected by the seed coat. The seed coat is made of one or two integuments, each comprising two epidermal cells layers and, in some cases, extra sub-epidermal cell layers. The thickness of the seed-coat affects several aspects of seed biology such as dormancy, germination and mortality. In Arabidopsis, the inner integument displays one or two sub-epidermal cell layers that originate from periclinal cell divisions of the innermost epidermal cell layer. By contrast, the outer integument was considered to be two-cell layered. Here, we show that sub-epidermal chalazal cells grow in between the epidermal outer integument cell layers to create an incomplete three-cell layered outer integument. We found that the MADS box transcription factor TRANSPARENT TESTA 16 represses growth of the chalaza and formation of sub-epidermal outer integument cells. Finally, we demonstrate that sub-epidermal cells of the outer and inner integument respond differently to the repressive mechanism mediated by FERTILIZATION INDEPENDENT SEED Polycomb group proteins and to fertilization signals. Our data suggest that integument cell origin rather than sub-epidermal cell position underlies different responses to fertilization.	[Fiume, Elisa; Coen, Olivier; Xu, Wenjia; Lepiniec, Loic; Magnani, Enrico] Univ Paris Saclay, CNRS, AgroParisTech, Inst Jean Pierre Bourgin,INRA, Versailles, France; [Coen, Olivier] Univ Paris Saclay, Univ Paris Sud, Ecole Doctorale Sci Vegetal 567, Bat 360, Orsay, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Magnani, E (corresponding author), Univ Paris Saclay, CNRS, AgroParisTech, Inst Jean Pierre Bourgin,INRA, Versailles, France.	enrico.magnani@inra.fr	Lepiniec, Loic/G-5808-2012	Lepiniec, Loic/0000-0002-5845-3323; Magnani, Enrico/0000-0002-2959-3714; XU, Wenjia/0000-0003-1945-4451	Marie Curie SEEDNET EU-CIG [E321710]; Labex Saclay Plant Sciences-SPS [ANR-10-LABX-0040-SPS]	Marie Curie SEEDNET EU-CIG; Labex Saclay Plant Sciences-SPS	The projec twas supported by the Marie Curie SEEDNET EU-CIG no E321710 and Labex Saclay Plant Sciences-SPS (ANR-10-LABX-0040-SPS) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coen O, 2017, DEVELOPMENT, V144, P1490, DOI 10.1242/dev.146274; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Ehlers K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165075; Endress PK, 2011, ANN BOT-LONDON, V107, P1465, DOI 10.1093/aob/mcr120; Erdmann R, 2010, PLANT J, V63, P914, DOI 10.1111/j.1365-313X.2010.04290.x; Figueiredo DD, 2016, ELIFE, V5, DOI 10.7554/eLife.20542; Fiume E, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2017.1339000; Gardarin A, 2010, SEED SCI RES, V20, P243, DOI 10.1017/S0960258510000255; Haughn G, 2005, TRENDS PLANT SCI, V10, P472, DOI 10.1016/j.tplants.2005.08.005; Kasahara RD, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600554; KELLY KM, 1992, PLANT GROWTH REGUL, V11, P201, DOI 10.1007/BF00024559; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Mizzotti C, 2012, PLANT J, V70, P409, DOI 10.1111/j.1365-313X.2011.04878.x; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; NOODEN LD, 1985, PLANT PHYSIOL, V79, P543, DOI 10.1104/pp.79.2.543; Oliva M, 2016, J EXP BOT, V67, P6111, DOI 10.1093/jxb/erw373; Prasad K, 2010, PLANT J, V62, P203, DOI 10.1111/j.1365-313X.2010.04139.x; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Roszak P, 2011, P NATL ACAD SCI USA, V108, P20826, DOI 10.1073/pnas.1117111108; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; Xu WJ, 2016, PLANT CELL, V28, P1343, DOI 10.1105/tpc.16.00041	23	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188148	10.1371/journal.pone.0188148	http://dx.doi.org/10.1371/journal.pone.0188148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141031	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400066
J	Morell, CM; Fiorotto, R; Meroni, M; Raizner, A; Torsello, B; Cadamuro, M; Spagnuolo, G; Kaffe, E; Sutti, S; Albano, E; Strazzabosco, M				Morell, Carola M.; Fiorotto, Romina; Meroni, Marica; Raizner, Aileen; Torsello, Barbara; Cadamuro, Massimiliano; Spagnuolo, Gaia; Kaffe, Eleanna; Sutti, Salvatore; Albano, Emanuele; Strazzabosco, Mario			Notch signaling and progenitor/ductular reaction in steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; DUCTULAR REACTION; MOUSE-LIVER; INSULIN-RESISTANCE; HEPATOCYTES; MICE; REGENERATION; CELLS; FIBROSIS; REPAIR	Background and objective Persistent hepatic progenitor cells (HPC) activation resulting in ductular reaction (DR) is responsible for pathologic liver repair in cholangiopathies. Also, HPC/DR expansion correlates with fibrosis in several chronic liver diseases, including steatohepatitis. Increasing evidence indicates Notch signaling as a key regulator of HPC/DR response in biliary and more in general liver injuries. Therefore, we aimed to investigate the role of Notch during HPC/DR activation in a mouse model of steatohepatitis. Methods Steatohepatitis was generated using methionine-choline deficient (MCD) diet. For hepatocyte lineage tracing, R26R-YFP mice were infected with AAV8-TBG-Cre. Results MCD diet promoted a strong HPC/DR response that progressively diffused in the lobule, and correlated with increased fibrosis and TGF-beta 1 expression. Notch signaling was unchanged in laser-capture microdissected HPC/DR, whereas Notch receptors were down regulated in hepatocytes. However, in-vivo lineage tracing experiments identified discrete hepatocytes showing Notch-1 activation and expressing (the Notch-dependent) Sox9. Stimulation of AML-12 hepatocyte-cell line with immobilized Jag1 induced Sox9 and down-regulated albumin and BSEP expression. TGF-beta 1 treatment in primary hepatic stellate cells (HSC) induced Jag1 expression. In MCD diet-fed mice, alpha SMA-positive HSC were localized around Sox9 expressing hepatocytes, suggesting that Notch activation in hepatocytes was promoted by TGF-beta 1 stimulated HSC. In-vivo Notch inhibition reduced HPC response and fibrosis progression. Conclusion Our data suggest that Notch signaling is an important regulator of DR and that in steatohepatitis, hepatocytes exposed to Jag1-positive HSC, contribute to pathologic DR by undergoing Notch-mediated differentiation towards an HPC-like phenotype. Given the roles of Notch in fibrosis and liver cancer, these data suggest mesenchymal expression of Jag1 as an alternative therapeutic target.	[Morell, Carola M.; Fiorotto, Romina; Meroni, Marica; Torsello, Barbara; Cadamuro, Massimiliano; Spagnuolo, Gaia; Strazzabosco, Mario] Univ Milano Bicocca, Dept Med & Surg, Int Ctr Digest Hlth, Monza, Italy; [Fiorotto, Romina; Raizner, Aileen; Kaffe, Eleanna; Strazzabosco, Mario] Yale Univ, Ctr Liver, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA; [Sutti, Salvatore; Albano, Emanuele] Univ A Avogadro East Piedmont, Dept Hlth Sci, Novara, Italy; [Morell, Carola M.] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Anne McLaren Lab, Cambridge, England; [Meroni, Marica] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Raizner, Aileen] Montefiore Med Ctr, Dept Pediat, Bronx, NY USA	University of Milano-Bicocca; Yale University; University of Eastern Piedmont Amedeo Avogadro; University of Cambridge; University of Milan; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Strazzabosco, M (corresponding author), Univ Milano Bicocca, Dept Med & Surg, Int Ctr Digest Hlth, Monza, Italy.; Strazzabosco, M (corresponding author), Yale Univ, Ctr Liver, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA.	mario.strazzabosco@yale.edu	Cadamuro, Massimiliano/AAC-6169-2022; meroni, marica/K-8621-2018; Sutti, Salvatore/X-5716-2019	Cadamuro, Massimiliano/0000-0002-0899-7613; meroni, marica/0000-0002-4161-4178; Sutti, Salvatore/0000-0002-0192-8199; Morell, Carola Maria/0000-0001-9140-8068; STRAZZABOSCO, MARIO/0000-0002-1995-6331	Italian Ministry of Education and University [PRIN 2009ARYX4T_005]; CARIPLO [2011-0470]; National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01DK079005, P30 DK034989]; Mario Strazzabosco; NICHD; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096096, P30DK034989, R01DK079005] Funding Source: NIH RePORTER	Italian Ministry of Education and University(Ministry of Education, Universities and Research (MIUR)); CARIPLO(Fondazione Cariplo); National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mario Strazzabosco; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Italian Ministry of Education and University (PRIN 2009ARYX4T_005), by CARIPLO 2011-0470, by the National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK079005 and P30 DK034989-Silvio O. Conte Digestive Diseases Research Core. All funding received by Mario Strazzabosco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The rat anti-mouse K19 antibody (TROMA-III) developed by Kemler R. and the N2ICD (c651.6DbHN clone) developed by Artavanis-Tsakonas S. were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242	Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Dill MT, 2013, HEPATOLOGY, V57, P1607, DOI 10.1002/hep.26165; Dill MT, 2012, HEPATOLOGY; Fabris L, 2007, AM J PATHOL, V171, P641, DOI 10.2353/ajpath.2007.070073; Fabris L, 2017, AM J PHYSIOL-GASTR L, V313, pG102, DOI 10.1152/ajpgi.00452.2016; Fabris L, 2011, SEMIN LIVER DIS, V31, P11, DOI 10.1055/s-0031-1272832; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Fiorotto R, 2013, J HEPATOL, V59, P124, DOI 10.1016/j.jhep.2013.02.025; Flores AN, 2014, NAT REV UROL, V11, P499, DOI 10.1038/nrurol.2014.195; Geisler F, 2014, HEPATOLOGY; HEDLEY DW, 1983, J HISTOCHEM CYTOCHEM, V31, P1333, DOI 10.1177/31.11.6619538; Huntzicker EG, 2014, HEPATOLOGY; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Morell CM, 2014, J HEPATOL, V60, P885, DOI 10.1016/j.jhep.2013.11.028; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Pritchett J, 2012, HEPATOLOGY, V56, P1108, DOI 10.1002/hep.25758; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078; Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X; Roskams T, 1998, SEMIN DIAGN PATHOL, V15, P259; Sekiya S, 2014, AM J PATHOL, V184, P1468, DOI 10.1016/j.ajpath.2014.01.005; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Strazzabosco M, 2012, J HEPATOL, V56, P1159, DOI 10.1016/j.jhep.2011.09.022; Svegliati-Baroni G, 2011, GUT, V60, P108, DOI 10.1136/gut.2010.219741; Tanimizu N, 2014, J BIOL CHEM, V289, P7589, DOI 10.1074/jbc.M113.517243; Villanueva A, 2012, GASTROENTEROLOGY, V143, P1660, DOI 10.1053/j.gastro.2012.09.002; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Zender S, 2013, CANCER CELL, V23, P784, DOI 10.1016/j.ccr.2013.04.019; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	38	16	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187384	10.1371/journal.pone.0187384	http://dx.doi.org/10.1371/journal.pone.0187384			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140985	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400023
J	Rubio, AAV; Castro-Arellano, I; Mills, JN; List, R; Avila-Flores, R; Suzan, G				Rubio, Andre A. V.; Castro-Arellano, Ivan; Mills, James N.; List, Rurik; Avila-Flores, Rafael; Suzan, Gerardo			Is species richness driving intra- and interspecific interactions and temporal activity overlap of a hantavirus host? An experimental test	PLOS ONE			English	Article							SIN NOMBRE VIRUS; DEER MICE; SEASONAL-VARIATION; NICHE SEGREGATION; UNITED-STATES; BIODIVERSITY; TRANSMISSION; POPULATIONS; INFECTIONS; PREVALENCE	High species diversity of the potential animal host community for a zoonotic pathogen may reduce pathogen transmission among the most competent host, a phenomenon called the "dilution effect", but the mechanisms driving this effect have been little studied. One proposed mechanism is "encounter reduction" where host species of low-competency decrease contact rates between infected and susceptible competent hosts, especially in directly transmitted diseases. We conducted an experiment in outdoor enclosures in northwestern Mexico where we manipulated rodent assemblages to assess the effect of species richness on the frequency of intra-and interspecific interactions and activity patterns of a hantavirus reservoir host (North American deermouse; Peromyscus maniculatus). Trials consisted of three treatments of rodent assemblages that differed in species richness, but had equal abundance of deermice; treatment 1 consisted of only deermice, treatment 2 included deermice and one non-competent host species, and treatment 3 included two non-competent host species in addition to deermice. To measure interactions and temporal activity, we strategically deployed foraging stations and infrared cameras. We did not find differences in the frequency of intraspecific interactions of deermice among treatments, but there were significantly more interspecific interactions between deermouse and non-competent hosts in treatment 2 than treatment 3, which is explained by the identity of the non-competent host species. In addition, there were differences in activity patterns between rodent species, and also between deermice from treatment 1 and treatment 2. These results indicate that at least at a small-scale analysis, the co-occurrence with other species in the study area does not influence the frequency of intraspecific interactions of deermice, and that deermice may be changing their activity patterns to avoid a particular non-competent host species (Dipodomys merriami). In conclusion, in this deermouse-hantavirus system a potential dilution effect would not be through intraspecific encounter reduction in the most competent hantavirus host. To identify variables of host assemblages that can influence pathogen transmission, we highlight the need to address the identity of species and the composition of assemblages, not only host species richness or diversity.	[Rubio, Andre A. V.; Suzan, Gerardo] Univ Nacl Autonoma Mexico, Dept Etol Fauna Silvestre & Anim Lab, Fac Med Vet Zootecnia, Mexico City, DF, Mexico; [Castro-Arellano, Ivan] Texas State Univ, Biol Dept, San Marcos, TX USA; [Mills, James N.] Emory Univ, Populat Biol Ecol & Evolut Program, Atlanta, GA 30322 USA; [List, Rurik] Univ Autonoma Metropolitana, Area Invest Biol Conservac, Lerma, Estado De Mexic, Mexico; [Avila-Flores, Rafael] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Biol, Villahermosa, Tabasco, Mexico; [Rubio, Andre A. V.] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile	Universidad Nacional Autonoma de Mexico; Texas State University System; Texas State University San Marcos; Emory University; Universidad Autonoma Metropolitana - Mexico; Universidad Juarez Autonoma de Tabasco; Universidad de Chile	Rubio, AAV (corresponding author), Univ Nacl Autonoma Mexico, Dept Etol Fauna Silvestre & Anim Lab, Fac Med Vet Zootecnia, Mexico City, DF, Mexico.; Rubio, AAV (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile.	andre.rubio@gmail.com	Rubio, André V./M-5307-2015	Rubio, André V./0000-0001-7297-9535; Suzan, Gerardo/0000-0003-2508-6376	Consejo Nacionalde Ciencia y Tecnologia (Mexico) [179482]; Becas-Chile PhD Scholarship	Consejo Nacionalde Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Becas-Chile PhD Scholarship	Funding for the study was provided by Consejo Nacionalde Ciencia y Tecnologia (Mexico) project no. 179482 (AVR, ICA, RAF, GS). AVR was supported by Becas-Chile PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Avila B, 2016, ACTA OECOL, V70, P67, DOI 10.1016/j.actao.2015.12.001; Bagamian KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047731; Bagamian KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037254; Calisher CH, 1999, EMERG INFECT DIS, V5, P126, DOI 10.3201/eid0501.990115; Cantoni G, 2001, TROP MED INT HEALTH, V6, P811, DOI 10.1046/j.1365-3156.2001.00788.x; Carver S, 2011, OECOLOGIA, V166, P713, DOI 10.1007/s00442-010-1882-z; Castro-Arellano I, 2010, METHODS ECOL EVOL, V1, P311, DOI 10.1111/j.2041-210X.2010.00031.x; Castro-Arellano I, 2009, J TROP ECOL, V25, P593, DOI 10.1017/S0266467409990186; CHILDS JE, 1994, J INFECT DIS, V169, P1271, DOI 10.1093/infdis/169.6.1271; Civitello DJ, 2015, P NATL ACAD SCI USA, V112, P8667, DOI 10.1073/pnas.1506279112; Clay CA, 2009, ECOHEALTH, V6, P250, DOI 10.1007/s10393-009-0240-2; Clay CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006467; Dearing MD, 2009, J WILDLIFE DIS, V45, P430, DOI 10.7589/0090-3558-45.2.430; Dizney L, 2016, ANIM BEHAV, V111, P341, DOI 10.1016/j.anbehav.2015.11.006; Dizney L, 2013, ANIM BEHAV, V86, P911, DOI 10.1016/j.anbehav.2013.08.003; Escutenaire S, 2000, VIRUS RES, V67, P91, DOI 10.1016/S0168-1702(00)00136-2; Falkenberg JC, 1998, J MAMMAL, V79, P558, DOI 10.2307/1382986; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; FLAKE LD, 1973, J MAMMAL, V54, P636, DOI 10.2307/1378963; Fuller CA, 1996, CAN J ZOOL, V74, P750, DOI 10.1139/z96-085; Hantsch L, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00103.1; HEALEY MC, 1967, ANNU REV ECOL SYST, V48, P377; Huang ZYX, 2016, PARASITOLOGY, V143, P1075, DOI 10.1017/S0031182016000536; Huang ZYX, 2014, PARASITOLOGY, V141, P981, DOI 10.1017/S0031182013002357; Johnson PTJ, 2015, ECOL LETT, V18, P1119, DOI 10.1111/ele.12479; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Khalil H, 2014, VECTOR-BORNE ZOONOT, V14, P537, DOI 10.1089/vbz.2013.1562; Kilpatrick AM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0131; Knust B, 2013, EMERG INFECT DIS, V19, P1934, DOI 10.3201/eid1912.131217; Kovach W. L, 2011, ORIANA CIRCULAR STAT; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; LANDRY SO, 1970, Q REV BIOL, V45, P351, DOI 10.1086/406647; Luis AD, 2016, 101 ESA ANN M FLOR; McDonald PJ, 2015, BIOL CONSERVATION, V19; Milazzo ML, 2012, EMERG INFECT DIS, V18, P571, DOI 10.3201/eid1804.111028; Mills JN, 2010, VECTOR-BORNE ZOONOT, V10, P563, DOI 10.1089/vbz.2009.0018; Mills JN, 2005, ARCH VIROL, P45; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Moreno-Torres K, 2014, SW NATURALIST, V59, P590; O'Regan SM, 2015, AM NAT, V186, P480, DOI 10.1086/682721; Ostfeld RS, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1676; Padula P, 2004, J VIROL, V78, P11972, DOI 10.1128/JVI.78.21.11972-11979.2004; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Rendall AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086592; Rubio AV, 2015, MAMM BIOL, V80, P491, DOI 10.1016/j.mambio.2015.06.004; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; WATSON GS, 1962, BIOMETRIKA, V49, P57; YANAGIHARA R, 1990, REV INFECT DIS, V12, P449	53	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188060	10.1371/journal.pone.0188060	http://dx.doi.org/10.1371/journal.pone.0188060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141047	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400051
J	Abdullaev, AA; Salakhutdinov, IB; Egamberdiev, SS; Khurshut, EE; Rizaeva, SM; Ulloa, M; Abdurakhmonov, IY				Abdullaev, Alisher A.; Salakhutdinov, Ilkhom B.; Egamberdiev, Sharof S.; Khurshut, Ernest E.; Rizaeva, Sofiya M.; Ulloa, Mauricio; Abdurakhmonov, Ibrokhim Y.			Genetic diversity, linkage disequilibrium, and association mapping analyses of Gossypium barbadense L. germplasm	PLOS ONE			English	Article							FIBER QUALITY TRAITS; MARKER-ASSISTED SELECTION; UPLAND COTTON; HIRSUTUM L.; POPULATION-STRUCTURE; SSR MARKERS; P-VALUES; YIELD; QTL; LOCI	Limited polymorphism and narrow genetic base, due to genetic bottleneck through historic domestication, highlight a need for comprehensive characterization and utilization of existing genetic diversity in cotton germplasm collections. In this study, 288 worldwide Gossypium barbadense L. cotton germplasm accessions were evaluated in two diverse environments (Uzbekistan and USA). These accessions were assessed for genetic diversity, population structure, linkage disequilibrium (LD), and LD-based association mapping (AM) of fiber quality traits using 108 genome-wide simple sequence repeat (SSR) markers. Analyses revealed structured population characteristics and a high level of intra-variability (67.2%) and moderate interpopulation differentiation (32.8%). Eight percent and 4.3% of markers revealed LD in the genome of the G. barbadense at critical values of r(2) >= 0.1 and r(2) >= 0.2, respectively. The LD decay was on average 24.8 cM at the threshold of r(2) >= 0.05. LD retained on average distance of 3.36 cM at the threshold of r(2) >= 0.1. Based on the phenotypic evaluations in the two diverse environments, 100 marker loci revealed a strong association with major fiber quality traits using mixed linear model (MLM) based association mapping approach. Fourteen marker loci were found to be consistent with previously identified quantitative trait loci (QTLs), and 86 were found to be new unreported marker loci. Our results provide insights into the breeding history and genetic relationship of G. barbadense germplasm and should be helpful for the improvement of cotton cultivars using molecular breeding and omics-based technologies.	[Abdullaev, Alisher A.; Salakhutdinov, Ilkhom B.; Egamberdiev, Sharof S.; Khurshut, Ernest E.; Abdurakhmonov, Ibrokhim Y.] Acad Sci Uzbek, Ctr Genom & Bioinformat, Tashkent, Uzbekistan; [Abdullaev, Alisher A.; Rizaeva, Sofiya M.] Acad Sci Uzbek, Inst Genet & Plant Expt Biol, Tashkent, Uzbekistan; [Ulloa, Mauricio] USDA ARS, Cropping Syst Res Lab, Lubbock, TX 79401 USA	Academy of Sciences of Uzbekistan; Center of Genomics & Bioinformatics; Academy of Sciences of Uzbekistan; Institute of Genetics & Experimental Biology of Plants; United States Department of Agriculture (USDA)	Abdurakhmonov, IY (corresponding author), Acad Sci Uzbek, Ctr Genom & Bioinformat, Tashkent, Uzbekistan.	genomics@uzsci.net	Abdurakhmonov, Ibrokhim Y./F-5588-2015; Salakhutdinov, Ilkhom/AAA-5027-2021; Salakhutdinov, Ilkhom B/T-7215-2018; Abdullaev, Alisher/ABC-7149-2021; Khurshut, Ernest/AAH-3231-2020	Abdurakhmonov, Ibrokhim Y./0000-0001-9563-0686; Salakhutdinov, Ilkhom/0000-0003-1159-6500; Salakhutdinov, Ilkhom B/0000-0003-1159-6500; Abdullaev, Alisher/0000-0002-8268-7699; Khurshut, Ernest/0000-0003-0278-8746	Academy of Sciences of Uzbekistan; Committee for Coordination Science and Technology Development of Uzbekistan [FA-F5-T030]; Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) [UZB-TA-31017]; U.S. Civilian Research and Development Foundation (CRDF) [UZB-TA-31017]; Uzbekistan Government, Ministry of Foreign Economic Relations, Trade and Investments of Uzbekistan	Academy of Sciences of Uzbekistan; Committee for Coordination Science and Technology Development of Uzbekistan; Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS); U.S. Civilian Research and Development Foundation (CRDF); Uzbekistan Government, Ministry of Foreign Economic Relations, Trade and Investments of Uzbekistan	This work was supported by the Academy of Sciences of Uzbekistan, and Committee for Coordination Science and Technology Development of Uzbekistan have provided research grant fund under the project No. FA-F5-T030 to IYA and the Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) and U.S. Civilian Research and Development Foundation (CRDF) provided an international cooperative grant No. UZB-TA-31017 to IYA and MU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Academy of Sciences of Uzbekistan, and Committee for Coordination Science and Technology Development of Uzbekistan for basic science (FA-F5-T030). We greatly acknowledge the Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA)-Agricultural Research Service (ARS) and U.S. Civilian Research and Development Foundation (CRDF) for international cooperative grants UZB-TA-31017, which were devoted to study G. barbadense germplasm resources. We thank Uzbekistan Government, Ministry of Foreign Economic Relations, Trade and Investments of Uzbekistan for capacity funding of the Center of Genomics and Bioinformatics, Uzbekistan. We greatly acknowledge the Uzbek and US partner laboratories for the assistance with molecular mapping experiments described in this work. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the US Department of Agriculture. The US Department of Agriculture is an equal opportunity provider and employer.	Abdallah JM, 2003, GENET SEL EVOL, V35, P513, DOI [10.1186/1297-9686-35-6-513, 10.1051/gse:2003037]; Abdellatif K. F., 2012, Journal of Crop Science and Biotechnology, V15, P93, DOI 10.1007/s12892-011-0120-5; Abdurakhmonov IY, 2008, GENOMICS, V92, P478, DOI 10.1016/j.ygeno.2008.07.013; Abdurakhmonov I.Y., 2014, WORLD COTTON GERMPLA; Abdurakhmonov IY, 2009, GENETICA, V136, P401, DOI 10.1007/s10709-008-9337-8; Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Abdurakhmonov IY, 2016, COTTON INDIA 2015 16, P36; Adawy S. S., 2007, Journal of Applied Sciences Research, P1581; Ademe MS, 2017, MOL GENET G IN PRESS; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Asif M, 2008, PAK J BOT, V40, P1209; BADIGANNAVAR A, 2010, THESIS; Blenda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045739; Bolek Y, 2005, PLANT SCI, V168, P1581, DOI 10.1016/j.plantsci.2005.02.008; Bolek Y, 2016, COTTON RESEARCH, P123, DOI 10.5772/64593; Boopathi N. M., 2008, Journal of Cotton Research and Development, V22, P135; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Cai CP, 2014, J INTEGR PLANT BIOL, V56, P51, DOI 10.1111/jipb.12124; Campbell BT, 2010, CROP SCI, V50, P1161, DOI 10.2135/cropsci2009.09.0551; Campbell BT, 2005, EUPHYTICA, V144, P69, DOI 10.1007/s10681-005-4336-7; Chakraborty R., 1981, Genetics, V96, P721; Chee Peng W., 2009, V3, P283, DOI 10.1007/978-0-387-70810-2_12; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; CULP TW, 1973, CROP SCI, V13, P686, DOI 10.2135/cropsci1973.0011183X001300060030x; D'hoop BB, 2010, THEOR APPL GENET, V121, P1151, DOI 10.1007/s00122-010-1379-5; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; EBERHART SA, 1966, CROP SCI, V6, P36, DOI 10.2135/cropsci1966.0011183X000600010011x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fan L, 2012, BOTANY, P211; Fang DD, 2013, EUPHYTICA, V191, P391, DOI 10.1007/s10681-013-0886-2; Fang L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-838; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frelichowski JE, 2006, MOL GENET GENOMICS, V275, P479, DOI 10.1007/s00438-006-0106-z; Goodman SN, 2005, CLIN TRIALS, V2, P282, DOI 10.1191/1740774505cn098oa; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Goodman SN, 2001, EPIDEMIOLOGY, V12, P295, DOI 10.1097/00001648-200105000-00006; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Gupta PK, 2014, ADV GENET, V85, P109, DOI 10.1016/B978-0-12-800271-1.00002-0; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; Hardy OJ, 2003, MOL ECOL, V12, P1577, DOI 10.1046/j.1365-294X.2003.01835.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; He DH, 2007, EUPHYTICA, V153, P181, DOI 10.1007/s10681-006-9254-9; Hinze LL, 2016, J HERED, V107, P274, DOI 10.1093/jhered/esw004; Holsinger KE, 2002, EEB ARTIC, V1, P1, DOI DOI 10.1046/J.1365-294X.2002.01512.X; Holsinger KE, 2007, HICKORY PACKAGE ANAL, P1; Hutchinson J., 1945, MEM COTTON RES STATI, V25, P80; Iqbal MA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00086; Islam MS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3249-2; Jenkins J.N., 1993, TRADITIONAL CROP BRE, P61; Jenkins JN, 2012, EUPHYTICA, V183, P49, DOI 10.1007/s10681-011-0470-6; Jia YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095882; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Kalivas A, 2011, GENET MOL RES, V10, P208, DOI 10.4238/vol10-1gmr998; Kantartzi SK, 2008, PLANT BREEDING, V127, P173, DOI 10.1111/j.1439-0523.2008.01490.x; Karademir E, 2010, NOT BOT HORTI AGROBO, V38, P111; Katki HA, 2008, AM J EPIDEMIOL, V168, P384, DOI 10.1093/aje/kwn148; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Lacape JM, 2007, MOL BREEDING, V19, P45, DOI 10.1007/s11032-006-9042-1; Lacape JM, 2005, J HERED, V96, P441, DOI 10.1093/jhered/esi052; Li YC, 2007, GENETICS, V176, P1811, DOI 10.1534/genetics.106.068890; Liang QZ, 2013, CHINESE SCI BULL, V58, P3233, DOI 10.1007/s11434-013-5807-1; Lin Z, 2005, PLANT BREEDING, V124, P180, DOI 10.1111/j.1439-0523.2004.01039.x; Liu CX, 2013, J GENET, V92, P175, DOI 10.1007/s12041-013-0238-y; Liu GZ, 2015, EUPHYTICA, V205, P637, DOI 10.1007/s10681-015-1450-z; Liu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057531; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu S, 2000, CROP SCI, V40, P1459, DOI 10.2135/cropsci2000.4051459x; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; McGowan J. A., 1960, THESIS; McRae AF, 2002, GENETICS, V160, P1113; Mei HX, 2014, EUPHYTICA, V197, P237, DOI 10.1007/s10681-014-1063-y; Mei HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082193; Meredith WR, 1994, P 7 ANN COTT INC ENG, P256; Mohlke KL, 2001, GENOME RES, V11, P1221, DOI 10.1101/gr.173201; Muhammad Saeed, 2014, Australian Journal of Crop Science, V8, P338; Murray J., 1910, REPORTS SCI EXPEDITI, P17; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Niles GA, 1984, COTTON, V24, P201, DOI DOI 10.2134/AGR0NM0N0GR24.C7; Oraguzie N. C., 2007, Association mapping in plants, P11, DOI 10.1007/978-0-387-36011-9_2; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Paterson AH., 1999, COTTON ORIGIN HIST T, P415; Paterson Andrew H., 2009, V3, P483, DOI 10.1007/978-0-387-70810-2_20; PERCY RG, 1990, THEOR APPL GENET, V79, P529, DOI 10.1007/BF00226164; Percy Richard G., 2009, V3, P53, DOI 10.1007/978-0-387-70810-2_3; Pillay M, 1999, CROP SCI, V39, P1881, DOI 10.2135/cropsci1999.3961881x; Pritchard JK, 2000, GENETICS, V155, P945; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Qin HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118073; Reddy UK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41285; REYNOLDS J, 1983, GENETICS, V105, P767; Rungis D, 2005, AUST J AGR RES, V56, P301, DOI 10.1071/AR04190; Shappley Z. W., 1998, Journal of Cotton Science, V2, P153; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shen XL, 2006, THEOR APPL GENET, V113, P1539, DOI 10.1007/s00122-006-0401-4; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; Simongulyan NG., 1987, GENETICS BREEDING SE, P18; Song XL, 2005, GENOME, V48, P378, DOI 10.1139/G04-126; Soto-Cerda BJ, 2012, GENETIC DIVERSITY IN PLANTS, P29; Steel RGD, 1980, PRINCIPLES PROCEDURE; STEPHENS SG, 1975, AM ANTIQUITY, V40, P406, DOI 10.2307/279327; Stich B, 2006, MOL BREEDING, V17, P217, DOI 10.1007/s11032-005-5296-2; Stich B, 2005, THEOR APPL GENET, V111, P723, DOI 10.1007/s00122-005-2057-x; Storey JD, 2003, ANAL GENE EXPRESSION, P272; Thiyagu K, 2011, WORLD COTT RES C TEC, P104; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tuttle JR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1708-9; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Ulloa M., 2007, Technical crops, P1; Ulloa M, 2009, J COTTON SCI, V13, P246; Wang FR, 2011, EUPHYTICA, V181, P41, DOI 10.1007/s10681-011-0378-1; Wang Juan, 2007, Acta Agronomica Sinica, V33, P1915; Wang XQ, 2013, GENET MOL RES, V12, P3353, DOI 10.4238/2013.September.4.1; Wang XQ, 2011, GENET MOL RES, V10, P3620, DOI 10.4238/2011.December.8.5; Wang XiaQing, 2013, Australian Journal of Crop Science, V7, P1252; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WENDEL JF, 1992, AM J BOT, V79, P1291, DOI 10.2307/2445058; Whitt Sr, 2003, METH MOL B, V236, P123; Wright S., 1978, EVOLUTION GENETIC PO; Wu JX, 2009, EUPHYTICA, V165, P231, DOI 10.1007/s10681-008-9748-8; Wu ZD, 2005, J COTTON SCI, V9, P166; Wurschum T, 2012, HEREDITY, V108, P332, DOI 10.1038/hdy.2011.78; Xu HM, 2006, GENET RESOUR CROP EV, V53, P515, DOI 10.1007/s10722-004-2032-4; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhang TZ, 2003, THEOR APPL GENET, V106, P262, DOI 10.1007/s00122-002-1101-3; Zhang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135430; Zhang ZS, 2005, EUPHYTICA, V144, P91, DOI 10.1007/s10681-005-4629-x; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhao YL, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027370; Zhao YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113967; Zhao YL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4074-y	139	14	15	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188125	10.1371/journal.pone.0188125	http://dx.doi.org/10.1371/journal.pone.0188125			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136656	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200068
J	Jamaludin, FA; Ab-Kadir, MZA; Izadi, M; Azis, N; Jasni, J; Abd-Rahman, MS				Jamaludin, Farah Adilah; Ab-Kadir, Mohd Zainal Abidin; Izadi, Mahdi; Azis, Norhafiz; Jasni, Jasronita; Abd-Rahman, Muhammad Syahmi			Effects of RTV coating on the electrical performance of polymer insulator under lightning impulse voltage condition	PLOS ONE			English	Article								Located near the equator, Malaysia is a country with one of the highest lightning densities in the world. Lightning contributes to 70% of the power outages in Malaysia and affects power equipment, automated network systems, causes data losses and monetary losses in the nation. Therefore, consideration of insulator evaluation under lightning impulses can be crucial to evaluate and attempt to overcome this issue. This paper presents a new approach to increase the electrical performance of polymer insulators using a Room Temperature Vulcanisation (RTV) coating. The evaluation involves three different settings of polymer insulator, namely uncoated, RTV type 1, and RTV type 2 upper surface coatings. All the insulators were tested under three different conditions as dry, clean wet and salty under different impulse polarities using the even-rising test method. The voltage breakdown for each test was recorded. From the experiment, it was found that the effectiveness of the RTV coating application became apparent when tested under salty or polluted conditions. It increased the voltage withstand capabilities of the polymer insulator up to 50% from the basic uncoated insulator. Under dry and clean conditions, the RTV coating provided just a slight increase of the breakdown voltage. The increase in voltage breakdown capability decreased the probability of surface discharge and dry band arcing that could cause degradation of the polymeric material housing. The RTV type 1 coating was found to be more effective when performing under a lightning impulse. The findings might help the utility companies improve the performance of their insulators in order to increase power system reliability.	[Jamaludin, Farah Adilah; Ab-Kadir, Mohd Zainal Abidin; Izadi, Mahdi; Azis, Norhafiz; Jasni, Jasronita; Abd-Rahman, Muhammad Syahmi] Univ Putra Malaysia, Fac Engn, Ctr Electromagnet & Lightning Protect Res CELP, Serdang, Selangor, Malaysia	Universiti Putra Malaysia	Jamaludin, FA (corresponding author), Univ Putra Malaysia, Fac Engn, Ctr Electromagnet & Lightning Protect Res CELP, Serdang, Selangor, Malaysia.	farahad31@gmail.com	azis, norhafiz/AAD-8684-2020; Kadir, Zainal/B-6629-2009; Jasni, Jasronita/AAD-8703-2020; Izadi/AAN-5413-2021	azis, norhafiz/0000-0002-9669-569X; Kadir, Zainal/0000-0001-7263-2953; Jasni, Jasronita/0000-0002-9617-8609; Izadi, Mahdi/0000-0002-8348-4404				[Anonymous], 2010, 60507 IEC; Chandima G, 2012, IEEE C SUST UT DEV E; Charalampidis P, 2014, IEEE T DIELECT EL IN, V21, P740, DOI 10.1109/TDEI.2013.004015; Cherney EA, 1999, IEEE T DIELECT EL IN, V6, P605, DOI 10.1109/94.798117; Chinnusamy M., 2009, INT C POW SYST, P25; Fernando MARM, 2000, IEEE T POWER DELIVER, V15, P355, DOI 10.1109/61.847273; Gao HF, 2007, IEEE T POWER DELIVER, V22, P1117, DOI 10.1109/TPWRD.2007.893432; Homma H, 2000, IEEE T POWER DELIVER, V15, P1298, DOI 10.1109/61.891518; IEEE Standards, 2004, IEEE GUID IMPR LIGHT; Joseph V. V, 2012, TRACKING EROSION SIL, V19, P91; Krytian L. C, 2009, INT S HIGH VOLT; Maciej K, 2005, IEEE ELECTR INSUL M, V2, P14; Maciej K, 2005, IEEE ELECTR INSUL M, V21, P28; Marungsri B, 2006, IEEE T DIELECT EL IN, V13, P129, DOI 10.1109/TDEI.2006.1593411; Mohd Zainal Abidin A. K, 2012, INT C LIGHTN PROT IC; Ramirez I, 2012, C ELECT INSUL DIEL P, P794, DOI 10.1109/CEIDP.2012.6378900; RIZK FAM, 1975, P I ELECTR ENG, V122, P449, DOI 10.1049/piee.1975.0124; Rowland SM, 2010, IEEE T DIELECT EL IN, V17, P375, DOI 10.1109/TDEI.2010.5448091; Sendilkumar S, 2010, INT REV ELECTR ENG-I, V5, P2461; Shuji S, 2005, INT POW ENG C MAY 8; Siderakis K, 2008, ELECTR POW SYST RES, V78, P248, DOI 10.1016/j.epsr.2007.02.013; Stanislaw M. G., 2005, IEEE ELECTR INSUL M, V21, P5; Suwarno, 2012, PROCEEDINGS OF 2012 IEEE INTERNATIONAL CONFERENCE ON CONDITION MONITORING AND DIAGNOSIS (IEEE CMD 2012), P1143, DOI 10.1109/CMD.2012.6416361; Wei XX, 2014, IEEE ELECTR INSUL M, V30, P42, DOI 10.1109/MEI.2014.6749572	24	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187892	10.1371/journal.pone.0187892	http://dx.doi.org/10.1371/journal.pone.0187892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136025	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200041
J	Kim, SY; Sim, S; Choi, HG				Kim, So Young; Sim, Songyong; Choi, Hyo Geun			High stress, lack of sleep, low school performance, and suicide attempts are associated with high energy drink intake in adolescents	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; CAFFEINE INTAKE; RISK; BEVERAGES; INGESTION; PATTERNS; HEALTH; COFFEE; MOOD	Objective Although an association between energy drinks and suicide has been suggested, few prior studies have considered the role of emotional factors including stress, sleep, and school performance in adolescents. This study aimed to evaluate the association of energy drinks with suicide, independent of possible confounders including stress, sleep, and school performance. Methods In total, 121,106 adolescents with 13-18 years olds from the 2014 and 2015 Korea Youth Risk Behavior Web-based Survey were surveyed for age, sex, region of residence, economic level, paternal and maternal education level, sleep time, stress level, school performance, frequency of energy drink intake, and suicide attempts. Subjective stress levels were classified into severe, moderate, mild, a little, and no stress. Sleep time was divided into 6 groups: < 6 h; 6 <= h <= 7; 7 <= h <= 8; 8 <= h < 9; and >= 9 h. School performance was classified into 5 levels: A (highest), B (middle, high), C (middle), D (middle, low), and E (lowest). Frequency of energy drink consumption was divided into 3 groups: >= 3, 1-2, and 0 times a week. The associations of sleep time, stress level, and school performance with suicide attempts and the frequency of energy drink intake were analyzed using multiple and ordinal logistic regression analysis, respectively, with complex sampling. The relationship between frequency of energy drink intake and suicide attempts was analyzed using multiple logistic regression analysis with complex sampling. Results Higher stress levels, lack of sleep, and low school performance were significantly associated with suicide attempts (each P < 0.001). These variables of high stress level, abnormal sleep time, and low school performance were also proportionally related with higher energy drink intake (P < 0.001). Frequent energy drink intake was significantly associated with suicide attempts in multiple logistic regression analyses (AOR for frequency of energy intake >= 3 times a week = 3.03, 95% CI = 2.64-3.49, P < 0.001). Conclusion Severe stress, inadequate sleep, and low school performance were related with more energy drink intake and suicide attempts in Korean adolescents. Frequent energy drink intake was positively related with suicide attempts, even after adjusting for stress, sleep time, and school performance.	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea; [Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860, 2017R1C1B1007696]; Hallym University Sacred Heart Hospital [HURF-2016-38]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860 and 2017R1C1B1007696) from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azagba S, 2014, PREV MED, V62, P54, DOI 10.1016/j.ypmed.2014.01.019; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Bonsignore A, 2014, FORENSIC SCI MED PAT, V10, P448, DOI 10.1007/s12024-014-9571-6; Chan CYS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132457; Childs E, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12148; Jackson DAE, 2013, CLIN TOXICOL, V51, P557, DOI 10.3109/15563650.2013.820311; Jin MJ, 2016, KOREAN J FAM MED, V37, P111, DOI 10.4082/kjfm.2016.37.2.111; Johnson SJ, 2016, APPETITE, V96, P588, DOI 10.1016/j.appet.2015.10.007; Keaver L, 2017, PUBLIC HEALTH NUTR, V20, P1534, DOI 10.1017/S1368980017000362; Kelly Caitlin K., 2016, Journal of Caffeine Research, V6, P73, DOI 10.1089/jcr.2015.0027; Landolt HP, 2004, NEUROPSYCHOPHARMACOL, V29, P1933, DOI 10.1038/sj.npp.1300526; Lee JW, 2015, EUR J PEDIATR, V174, P1671, DOI 10.1007/s00431-015-2581-x; Lohsoonthorn V, 2013, SLEEP BREATH, V17, P1017, DOI 10.1007/s11325-012-0792-1; Lucas M, 2014, WORLD J BIOL PSYCHIA, V15, P377, DOI 10.3109/15622975.2013.795243; McKetin R, 2015, DRUG ALCOHOL DEPEN, V151, P15, DOI 10.1016/j.drugalcdep.2015.01.047; Ogawa N, 2007, PSYCHIAT CLIN NEUROS, V61, P263, DOI 10.1111/j.1440-1819.2007.01652.x; Orbeta RL, 2006, J ADOLESCENT HEALTH, V38, P451, DOI 10.1016/j.jadohealth.2005.05.014; Owens JA, 2014, NUTR REV, V72, P65, DOI 10.1111/nure.12150; Park C, 2016, J AFFECT DISORDERS, V194, P16, DOI 10.1016/j.jad.2016.01.021; Park SM, 2016, INT C NUMER SIMUL, P87, DOI 10.1109/NUSOD.2016.7547042; Pelkonen Mirjami, 2003, Paediatr Drugs, V5, P243, DOI 10.2165/00148581-200305040-00004; Pettit ML, 2011, J AM COLL HEALTH, V59, P335, DOI 10.1080/07448481.2010.510163; Reid Jessica L, 2017, Prev Med Rep, V5, P65; Reid JL, 2015, CAN J PUBLIC HEALTH, V106, pE101, DOI 10.17269/cjph.106.4684; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Robins MT, 2016, ALCOHOL, V54, P1, DOI 10.1016/j.alcohol.2016.05.001; Roehrs T, 2008, SLEEP MED REV, V12, P153, DOI 10.1016/j.smrv.2007.07.004; Sanchez Sixto E, 2013, Health (Irvine Calif), V5, P26; Shilo Lotan, 2002, Sleep Med, V3, P271, DOI 10.1016/S1389-9457(02)00015-1; Silva AC, 2014, CNS NEUROL DISORD-DR, V13, P937, DOI 10.2174/1871527313666140612123656	31	26	27	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187759	10.1371/journal.pone.0187759	http://dx.doi.org/10.1371/journal.pone.0187759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29135989	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200032
J	Chaber, R; Gurgul, A; Wrobel, G; Haus, O; Tomon, A; Kowalczyk, J; Szmatola, T; Jasielczuk, I; Rybka, B; Ryczan-Krawczyk, R; Duszenko, E; Stapor, S; Ciebiera, K; Paszek, S; Potocka, N; Arthur, CJ; Zawlik, I				Chaber, Radoslaw; Gurgul, Artur; Wrobel, Grazyna; Haus, Olga; Tomon, Anna; Kowalczyk, Jerzy; Szmatola, Tomasz; Jasielczuk, Igor; Rybka, Blanka; Ryczan-Krawczyk, Renata; Duszenko, Ewa; Stapor, Sylwia; Ciebiera, Krzysztof; Paszek, Sylwia; Potocka, Natalia; Arthur, Christopher J.; Zawlik, Izabela			Whole-genome DNA methylation characteristics in pediatric precursor B cell acute lymphoblastic leukemia (BCP ALL)	PLOS ONE			English	Article							CHILDHOOD; HYPERMETHYLATION; GENES; RISK	In addition to genetic alterations, epigenetic abnormalities have been shown to underlie the pathogenesis of acute lymphoblastic leukemia (ALL)-the most common pediatric cancer. The purpose of this study was to characterize the whole genome DNA methylation profile in children with precursor B-cell ALL (BCP ALL) and to compare this profile with methylation observed in normal bone marrow samples. Additional efforts were made to correlate the observed methylation patterns with selected clinical features. We assessed DNA methylation from bone marrow samples obtained from 38 children with BCP ALL at the time of diagnosis along with 4 samples of normal bone marrow cells as controls using Infinium MethylationEPIC BeadChip Array. Patients were diagnosed and stratified into prognosis groups according to the BFM ALL IC 2009 protocol. The analysis of differentially methylated sites across the genome as well as promoter methylation profiles allowed clear separation of the leukemic and control samples into two clusters. 86.6% of the promoter-associated differentially methylated sites were hypermethylated in BCP ALL. Seven sites were found to correlate with the BFM ALL IC 2009 high risk group. Amongst these, one was located within the gene body of the MBP gene and another was within the promoter region-PSMF1 gene. Differentially methylated sites that were significantly related with subsets of patients with ETV6-RUNX1 fusion and hyperdiploidy. The analyzed translocations and change of genes' sequence context does not affect methylation and methylation seems not to be a mechanism for the regulation of expression of the resulting fusion genes.	[Chaber, Radoslaw; Tomon, Anna] Univ Rzeszow, Inst Nursing & Hlth Sci, Fac Med, Rzeszow, Poland; [Gurgul, Artur; Szmatola, Tomasz; Jasielczuk, Igor] Natl Res Inst Anim Prod, Lab Genom, Balice, Poland; [Wrobel, Grazyna; Rybka, Blanka; Ryczan-Krawczyk, Renata] Med Univ Wroclaw, Dept Paediat Bone Marrow Transplantat Oncol & Hem, Wroclaw, Poland; [Haus, Olga] Nicolaus Copernicus Univ Torun, Dept Clin Genet, Coll Med Bydgoszcz, Fac Med, Torun, Poland; [Kowalczyk, Jerzy] Med Univ Lublin, Dept Pediat Hematol Oncol & Bone Marrow Transplan, Lublin, Poland; [Duszenko, Ewa; Stapor, Sylwia] Med Univ, Dept Hematol, Wroclaw, Poland; [Ciebiera, Krzysztof] Univ Warsaw, Inst Informat, Warsaw, Poland; [Paszek, Sylwia; Potocka, Natalia; Zawlik, Izabela] Univ Rzeszow, Ctr Innovat Res Med & Nat Sci, Lab Mol Biol, Fac Med, Rzeszow, Poland; [Arthur, Christopher J.] Univ Bristol, Sch Chem, Bristol, Avon, England; [Zawlik, Izabela] Univ Rzeszow, Inst Expt & Clin Med, Dept Genet, Rzeszow, Poland	University of Rzeszow; National Research Institute of Animal Production; Wroclaw Medical University; Nicolaus Copernicus University; Medical University of Lublin; Wroclaw Medical University; University of Warsaw; University of Rzeszow; University of Bristol; University of Rzeszow	Zawlik, I (corresponding author), Univ Rzeszow, Ctr Innovat Res Med & Nat Sci, Lab Mol Biol, Fac Med, Rzeszow, Poland.; Zawlik, I (corresponding author), Univ Rzeszow, Inst Expt & Clin Med, Dept Genet, Rzeszow, Poland.	izazawlik@yahoo.com	Gurgul, Artur/M-9480-2015; Jasielczuk, Igor/AAR-4103-2021; Jasielczuk, Igor/M-8660-2015; Arthur, Christopher J/F-9710-2011; Kowalczyk, Jerzy/AAU-3336-2020; Chaber, Radosław/ABB-9222-2020; Chaber, Radoslaw/AAY-5993-2020	Gurgul, Artur/0000-0001-5979-144X; Jasielczuk, Igor/0000-0001-8583-3850; Jasielczuk, Igor/0000-0001-8583-3850; Chaber, Radoslaw/0000-0002-6862-9142; Wrobel, Grazyna/0000-0003-4374-6083; Szmatola, Tomasz/0000-0003-1588-4198; Potocka, Natalia/0000-0002-5505-3922; Paszek, Sylwia/0000-0002-7865-2661; RYCZAN- KRAWCZYK, RENATA/0000-0002-4936-4951; Zawlik, Izabela/0000-0001-7992-9100; Kowalczyk, Jerzy/0000-0003-3080-0845; Arthur, Christopher/0000-0001-7577-8472; Rybka, Blanka/0000-0002-4216-0673	National Science Centre, Poland [2011/01/B/NZ4/03345]	National Science Centre, Poland(National Science Centre, Poland)	This study was supported by the grant of the National Science Centre, Poland, https://www.ncn.gov.pl/, grant no. 2011/01/B/NZ4/03345. The funding was received by author IZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almamun M, 2014, EPIGENETICS-US, V9, P1588, DOI 10.4161/15592294.2014.983379; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann AK, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26251; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Borssen M, 2016, PEDIATR BLOOD CANCER, V63, P1185, DOI 10.1002/pbc.25958; Borssen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065373; Boultwood J, 2007, BRIT J HAEMATOL, V138, P3, DOI 10.1111/j.1365-2141.2007.06604.x; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Campbell M, RANDOMIZED TRIAL BFM; Chatterton Z, 2014, EPIGENETICS-US, V9, P459, DOI 10.4161/epi.27585; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Figueroa ME, 2013, J CLIN INVEST, V123, P3099, DOI 10.1172/JCI66203; Florean C, 2011, EPIGENOMICS-UK, V3, P581, DOI [10.2217/EPI.11.73, 10.2217/epi.11.73]; Gabriel AS, 2015, EPIGENETICS-US, V10, P717, DOI 10.1080/15592294.2015.1061174; Han S, 2010, HUM IMMUNOL, V71, P727, DOI 10.1016/j.humimm.2010.04.004; Hunger SP, 2011, PEDIATR BLOOD CANCER, V56, P984, DOI 10.1002/pbc.22996; Iacobucci I, 2017, J CLIN ONCOL, V35, P975, DOI 10.1200/JCO.2016.70.7836; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanwar VS, 2017, PEDIATRIC ACUTE LYMP; Lu ML, 1996, P NATL ACAD SCI USA, V93, P8977, DOI 10.1073/pnas.93.17.8977; McCloskey SM, 2008, HEMATOL ONCOL, V26, P73, DOI 10.1002/hon.848; Milani L, 2010, BLOOD, V115, P1214, DOI 10.1182/blood-2009-04-214668; Moorman AV, 2012, BLOOD REV, V26, P123, DOI 10.1016/j.blre.2012.01.001; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Mullighan CG, 2012, J CLIN INVEST, V122, P3407, DOI 10.1172/JCI61203; Nordlund J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r105; Nordlund J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034513; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; Roman-Gomez J, 2006, LEUKEMIA, V20, P1445, DOI 10.1038/sj.leu.2404257; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schulze I, 2016, BLOOD, V127, P1575, DOI 10.1182/blood-2015-07-655928; Silverman LB, 2009, ONCOLOGY INFANCY CHI, P297, DOI 10.1016/B978-1-4160-3431-5.00010-8; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Takeuchi S, 2011, LEUKEMIA RES, V35, P1345, DOI 10.1016/j.leukres.2011.04.015; Teachey DT, 2013, BRIT J HAEMATOL, V162, P606, DOI 10.1111/bjh.12442; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Teschendorff AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008274; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vadakedath S, 2016, J MOL BIOMARK DIAGN, V2; Vilas-Zornoza A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017012; Wang MX, 2010, INT J CLIN EXP PATHO, V3, P265; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Wong NC, 2012, EPIGENETICS-US, V7, P535, DOI 10.4161/epi.20193	45	9	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187422	10.1371/journal.pone.0187422	http://dx.doi.org/10.1371/journal.pone.0187422			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125853	Green Published, gold, Green Submitted			2022-12-26	WOS:000414866000014
J	Kabunga, NS; Ghosh, S; Webb, P				Kabunga, Nassul S.; Ghosh, Shibani; Webb, Patrick			Does ownership of improved dairy cow breeds improve child nutrition? A pathway analysis for Uganda	PLOS ONE			English	Article							ANIMAL-SOURCE FOODS; DEVELOPING-COUNTRIES; INCOME COUNTRIES; MILK; INTERVENTIONS; PROGRAMS; IMPACTS; UNDERNUTRITION; CONSUMPTION; LIVESTOCK	The promotion of livestock production is widely believed to support enhanced diet quality and child nutrition, but the empirical evidence for this causal linkage remains narrow and ambiguous. This study examines whether adoption of improved dairy cow breeds is linked to farm-level outcomes that translate into household-level benefits including improved child nutrition outcomes in Uganda. Using nationwide data from Uganda's National Panel Survey, propensity score matching is used to create an unbiased counterfactual, based on observed characteristics, to assess the net impacts of improved dairy cow adoption. All estimates were tested for robustness and sensitivity to variations in observable and unobservable confounders. Results based on the matched samples showed that households adopting improved dairy cows significantly increased milk yield-by over 200% on average. This resulted in higher milk sales and milk intakes, demonstrating the potential of this agricultural technology to both integrate households into modern value chains and increase households' access to animal source foods. Use of improved dairy cows increased household food expenditures by about 16%. Although undernutrition was widely prevalent in the study sample and in matched households, the adoption of improved dairy cows was associated with lower child stunting in adopter household. In scale terms, results also showed that holding larger farms tends to support adoption, but that this also stimulates the household's ability to achieve gains from adoption, which can translate into enhanced nutrition.	[Kabunga, Nassul S.] IFPRI, Kampala, Uganda; [Ghosh, Shibani; Webb, Patrick] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA	CGIAR; International Food Policy Research Institute (IFPRI); Tufts University	Kabunga, NS (corresponding author), IFPRI, Kampala, Uganda.	n.kabunga@cgiar.org	Webb, Patrick/P-3420-2017	Webb, Patrick/0000-0002-9857-3354; Kabunga, Nassul/0000-0002-7563-0299	Feed the Future Innovation Lab for Nutrition - United States Agency for International Development (USAID); United States Agency for International Development through the Feed the Future Innovation Lab for Nutrition [USAID] [AID-OAA-L-1-00005]	Feed the Future Innovation Lab for Nutrition - United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); United States Agency for International Development through the Feed the Future Innovation Lab for Nutrition [USAID](United States Agency for International Development (USAID))	Support for this study was provided by the Feed the Future Innovation Lab for Nutrition, which is funded by the United States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the United States Agency for International Development through the Feed the Future Innovation Lab for Nutrition [USAID grant number AID-OAA-L-1-00005]. The authors gratefully acknowledge the invaluable support of Dr. Todd Benson and Dr. Jeffrey Griffiths. We are grateful to the editor and the reviewers for making important contributions to this article. Participants and contributors to this work at the several workshops, seminars and conferences are also highly appreciated. Part of this work was presented at the Agricultural Economics Society Conference, AgroParisTech, Paris, France 9-11 April 2014. We thank the Uganda Bureau of Statistics for making the data available.	Abadie A, 2004, STATA J, V4, P290, DOI 10.1177/1536867X0400400307; Alderman H., 1994, Agricultural commercialization, economic development, and nutrition., P239; [Anonymous], 2012, UG DEM HLTH SURV 201; Babatunde RO, 2010, FOOD POLICY, V35, P303, DOI 10.1016/j.foodpol.2010.01.006; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; de Beer H, 2012, ECON HUM BIOL, V10, P299, DOI 10.1016/j.ehb.2011.08.003; Dixit P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066175; Dror DK, 2011, FOOD NUTR BULL, V32, P227, DOI 10.1177/156482651103200307; FEDER G, 1985, ECON DEV CULT CHANGE, V33, P255, DOI 10.1086/451461; Fiedler JL, 2012, FOOD NUTR BULL, V33, pS242, DOI 10.1177/15648265120333S214; Garcia O, 2008, MILK PRODUCTION UGAN; Gereffi, 2016, DAIRY VALUE CHAINS E; Gerosa S, 2012, MILK AVAILABILITY TR; Grube MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122534; Hoddinott J., 2012, Reshaping agriculture for nutrition and health: an IFPRI 2020 book, P13; Hoppe C, 2006, ANNU REV NUTR, V26, P131, DOI 10.1146/annurev.nutr.26.010506.103757; Ichino A, 2008, J APPL ECONOMET, V23, P305, DOI 10.1002/jae.998; Kabunga NS, 2012, AGR ECON-BLACKWELL, V43, P473, DOI 10.1111/j.1574-0862.2012.00597.x; Leroy JL, 2007, J NUTR, V137, P2311, DOI 10.1093/jn/137.10.2311; Leroy JL, 2011, STAT SOFTWARE COMPON; Leuven E, PSMATCH2 STATA MODUL; MAAIF, 2010, STAT ABSTR; Masset E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8222; Mbowa S, 2012, DAIRY SECTOR REFORM; Meinzen-Dick R, 2012, LEV AGR IMPR NUTR HL; Menon P, 2013, FOOD NUTR BULL, V34, pS195, DOI 10.1177/15648265130343S206; Miller LC, 2016, PAEDIATR INT CHILD H, V36, P91, DOI 10.1080/20469047.2015.1133517; Mosites EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136686; Nicholson C.F., 2003, DAIRY COW OWNERSHIP; Nicholson CF, 2004, J AGR ECON, V55, P175, DOI 10.1111/j.1477-9552.2004.tb00092.x; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Rawlins R, 2014, FOOD POLICY, V44, P202, DOI 10.1016/j.foodpol.2013.12.003; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Shapiro MJ, 2017, FASEB J, V31; Uganda Bureau of Statistics (UBOS), 2017, UG DEM HLTH SURV 201; Uganda Bureau of Statistics (UBOS), 2007, UG NAT HOUS SURV 200; VONBRAUN J, 1995, FOOD POLICY, V20, P187, DOI 10.1016/0306-9192(95)00013-5; Wambugu S., 2011, PRODUCTIVITY TRENDS; Webb P, 2014, FOOD NUTR BULL, V35, P126, DOI 10.1177/156482651403500113; WHO, 2006, WHO CHILD GROWTH STA; Wiley AS, 2009, ANN HUM BIOL, V36, P125, DOI 10.1080/03014460802680466; Wong M., 2009, S S EXCHANGE SHARING; Zhang ZY, 2016, FOOD NUTR BULL, V37, P303, DOI 10.1177/0379572116647823	46	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187816	10.1371/journal.pone.0187816	http://dx.doi.org/10.1371/journal.pone.0187816			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM2XM	29125871	gold, Green Published, Green Submitted			2022-12-26	WOS:000414866000026
J	Schimunek, L; Serve, R; Teuben, MPJ; Stormann, P; Auner, B; Woschek, M; Pfeifer, R; Horst, K; Simon, TP; Kalbitz, M; Sturm, R; Pape, HC; Hildebrand, F; Marzi, I; Relja, B				Schimunek, Lukas; Serve, Rafael; Teuben, Michel P. J.; Stoermann, Philipp; Auner, Birgit; Woschek, Mathias; Pfeifer, Roman; Horst, Klemens; Simon, Tim-P.; Kalbitz, Miriam; Sturm, Ramona; Pape, Hans-C.; Hildebrand, Frank; Marzi, Ingo; Relja, Borna			Early decreased TLR2 expression on monocytes is associated with their reduced phagocytic activity and impaired maturation in a porcine polytrauma model	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-SUIS; ZOONOTIC AGENT; DR EXPRESSION; SEVERE INJURY; CLASS-I; TRAUMA; CARE; SEPSIS	In their post-traumatic course, trauma patients suffering from multiple injuries have a high risk for immune dysregulation, which may contribute to post-injury complications and late mortality. Monocytes as specific effector cells of the innate immunity play a crucial role in inflammation. Using their Pattern Recognition Receptors (PRRs), notably Toll-Like Receptors (TLR), the monocytes recognize pathogens and/or pathogen-associated molecular patterns (PAMPs) and organize their clearance. TLR2 is the major receptor for particles of gram-positive bacteria, and initiates their phagocytosis. Here, we investigated the phagocytizing capability of monocytes in a long-term porcine severe trauma model (polytrauma, PT) with regard to their TLR2 expression. Polytrauma consisted of femur fracture, unilateral lung contusion, liver laceration, hemorrhagic shock with subsequent resuscitation and surgical fracture fixation. After induction of PT, peripheral blood was withdrawn before (-1 h) and directly after trauma (0 h), as well as 3.5 h, 5.5 h, 24 h and 72 h later. CD14(+) monocytes were identified and the expression levels of H(S) LA-DR and TLR2 were investigated by flow cytometry. Additionally, the phagocytizing activity of monocytes by applying S. aureus particles labelled with pHrodo fluorescent reagent was also assessed by flow cytometry. Furthermore, blood samples from 10 healthy pigs were exposed to a TLR2-neutralizing antibody and subsequently to S. aureus particles. Using flow cytometry, phagocytizing activity was determined. P below 0.05 was considered significant. The number of CD14(+) monocytes of all circulating leukocytes remained constant during the observational time period, while the percentage of CD14(+) H(S) LA-DR+ monocytes significantly decreased directly, 3.5 h and 5.5 h after trauma. The percentage of TLR2(+) expressing cells out of all monocytes significantly decreased directly, 3.5 h and 5.5 h after trauma. The percentage of phagocytizing monocytes decreased immediately and remained lower during the first 3.5 h after trauma, but increased after 24 h. Antagonizing TLR2 significantly decreased the phagocytizing activity of monocytes. Both, decreased percentage of activated as well as TLR2 expressing monocytes persisted as long as the reduced phagocytosis was observed. Moreover, neutralizing TLR2 led to a reduced capability of phagocytosis as well. Therefore, we assume that reduced TLR2 expression may be responsible for the decreased phagocytizing capacity of circulating monocytes in the early post-traumatic phase.	[Schimunek, Lukas; Serve, Rafael; Stoermann, Philipp; Auner, Birgit; Woschek, Mathias; Sturm, Ramona; Marzi, Ingo; Relja, Borna] Goethe Univ, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany; [Teuben, Michel P. J.; Pfeifer, Roman; Pape, Hans-C.] Univ Zurich, Univ Hosp Zurich, Dept Orthopaed Trauma Surg, Zurich, Switzerland; [Horst, Klemens; Hildebrand, Frank] Rhein Westfal TH Aachen, Dept Orthopaed Trauma, Aachen, Germany; [Simon, Tim-P.] Rhein Westfal TH Aachen, Dept Intens Care & Intermediate Care, Aachen, Germany; [Kalbitz, Miriam] Univ Ulm, Dept Orthoped Trauma Hand Plast & Reconstruct Sur, Ulm, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Zurich; University Zurich Hospital; RWTH Aachen University; RWTH Aachen University; Ulm University	Relja, B (corresponding author), Goethe Univ, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany.	info@bornarelja.com	Relja, Borna/B-6642-2016	Relja, Borna/0000-0002-5625-8823; Pape, Hans-Christoph/0000-0002-2059-4980	Arbeitsgemeinschaft fur Osteosynthesefragen (AO) Foundation [5-14-14P]	Arbeitsgemeinschaft fur Osteosynthesefragen (AO) Foundation	Project no. 5-14-14P was supported by the Arbeitsgemeinschaft fur Osteosynthesefragen (AO) Foundation.	Adib-Conquy M, 2003, AM J RESP CRIT CARE, V168, P158, DOI 10.1164/rccm.200209-1077OC; AYALA A, 1992, CYTOKINE, V4, P66, DOI 10.1016/1043-4666(92)90039-T; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Bossaert L, 2010, RESUSCITATION, V81, pE175, DOI 10.1016/j.resuscitation.2010.09.001; BROOKS CF, 1988, IMMUNOLOGY, V63, P303; Castillo JS, 2012, REV PANAM SALUD PUBL, V32, P343, DOI 10.1590/S1020-49892012001100004; Chamorro S, 2004, IMMUNOBIOLOGY, V209, P57, DOI 10.1016/j.imbio.2004.02.002; Dominguez-Punaro MD, 2010, INFECT IMMUN, V78, P5074, DOI 10.1128/IAI.00698-10; Fairbairn L, 2013, J IMMUNOL, V190, P6389, DOI 10.4049/jimmunol.1300365; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Freeman SA, 2014, IMMUNOL REV, V262, P193, DOI 10.1111/imr.12212; Hanzelmann D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12304; Heftrig D, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/2608349; HERSHMAN MJ, 1990, BRIT J SURG, V77, P204, DOI 10.1002/bjs.1800770225; Hornef MW, 2008, CURR OPIN INFECT DIS, V21, P304, DOI 10.1097/QCO.0b013e3282f88ba3; Horst K, 2016, SCI REP-UK, V6, DOI 10.1038/srep39659; Humphreys H, 2012, SURG-J R COLL SURG E, V10, P357, DOI 10.1016/j.surge.2012.05.003; Islam MN, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.13; Keel M, 1996, J TRAUMA, V41, P430, DOI 10.1097/00005373-199609000-00008; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lendemans S, 2007, J TRAUMA, V63, P740, DOI 10.1097/01.ta.0000240451.42238.d1; Liu CH, 2009, VET MICROBIOL, V136, P266, DOI 10.1016/j.vetmic.2008.11.016; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; McHoney M, 2006, PEDIATR SURG INT, V22, P330, DOI 10.1007/s00383-006-1657-0; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Perez-Barcena J, 2010, ANN SURG, V251, P521, DOI 10.1097/SLA.0b013e3181cc8f84; Raymond CR, 2005, VET IMMUNOL IMMUNOP, V107, P235, DOI 10.1016/j.vetimm.2005.05.008; Relja B, 2015, J MOL MED, V93, P1391, DOI 10.1007/s00109-015-1320-0; Reuven EM, 2014, BBA-BIOMEMBRANES, V1838, P1586, DOI 10.1016/j.bbamem.2014.01.020; Rouget C, 2016, MINERVA ANESTESIOL; Seshadri A, 2017, CRIT CARE MED, V45, P1523, DOI 10.1097/CCM.0000000000002577; Shah P, 2013, J BIOL CHEM, V288, P12345, DOI 10.1074/jbc.M113.449983; Sirijatuphat Rujipas, 2014, Journal of the Medical Association of Thailand, V97, pS20; Sturm R, 2017, IMMUNOBIOLOGY, V222, P301, DOI 10.1016/j.imbio.2016.09.010; Subcommittee A, 2013, J TRAUMA ACUTE CARE, V74, P1363; Tsujimoto H, 2006, CLIN IMMUNOL, V119, P180, DOI 10.1016/j.clim.2006.01.004; Turner JD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002817; Vester H, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0180-y; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Worlein JM, 2011, AM J PRIMATOL, V73, P98; Wutzler S, 2013, CHIRURG, V84, P753, DOI 10.1007/s00104-013-2477-0; Zhang NZ, 2011, J VIROL, V85, P11709, DOI 10.1128/JVI.05040-11; Zheng H, 2011, J NEUROIMMUNOL, V234, P71, DOI 10.1016/j.jneuroim.2011.02.005; Ziegler-Heitbrock L, 2014, CELL IMMUNOL, V289, P135, DOI 10.1016/j.cellimm.2014.03.019; ZIEGLERHEITBROCK HWL, 1994, SCAND J IMMUNOL, V40, P509, DOI 10.1111/j.1365-3083.1994.tb03497.x	52	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187404	10.1371/journal.pone.0187404	http://dx.doi.org/10.1371/journal.pone.0187404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125848	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000414866000013
J	Fang, X; Fang, B; Wang, CF; Xia, T; Bottai, M; Fang, F; Cao, Y				Fang, Xin; Fang, Bo; Wang, Chunfang; Xia, Tian; Bottai, Matteo; Fang, Fang; Cao, Yang			Relationship between fine particulate matter, weather condition and daily non-accidental mortality in Shanghai, China: A Bayesian approach	PLOS ONE			English	Article							AIR-POLLUTION MORTALITY; CASE-CROSSOVER ANALYSIS; ISCHEMIC-HEART-DISEASE; SHORT-TERM EXPOSURE; HOSPITAL ADMISSIONS; TIME-SERIES; RESPIRATORY MORTALITY; CORONARY-OCCLUSION; AMBIENT PARTICLES; COLD WEATHER	There are concerns that the reported association of ambient fine particulate matter (PM2.5) with mortality might be a mixture of PM2.5 and weather conditions. We evaluated the effects of extreme weather conditions and weather types on mortality as well as their interactions with PM2.5 concentrations in a time series study. Daily non-accidental deaths, individual demographic information, daily average PM2.5 concentrations and meteorological data between 2012 and 2014 were obtained from Shanghai, China. Days with extreme weather conditions were identified. Six synoptic weather types (SWTs) were generated. The generalized additive model was set up to link the mortality with PM2.5 and weather conditions. Parameter estimation was based on Bayesian methods using both the Jeffreys' prior and an informative normal prior in a sensitivity analysis. We estimate the percent increase in non-accidental mortality per 10 mu g/m(3) increase in PM2.5 concentration and constructed corresponding 95% credible interval (CrI). In total, 336,379 non-accidental deaths occurred during the study period. Average daily deaths were 307. The results indicated that per 10 mu g/m(3) increase in daily average PM2.5 concentration alone corresponded to 0.26-0.35% increase in daily non-accidental mortality in Shanghai. Statistically significant positive associations between PM2.5 and mortality were found for favorable SWTs when considering the interaction between PM2.5 and SWTs. The greatest effect was found in hot dry SWT (percent increase = 1.28, 95% CrI: 0.72, 1.83), followed by warm humid SWT (percent increase = 0.64, 95% CrI: 0.15, 1.13). The effect of PM2.5 on non-accidental mortality differed under specific extreme weather conditions and SWTs. Environmental policies and actions should take into account the interrelationship between the two hazardous exposures.	[Fang, Xin; Bottai, Matteo; Cao, Yang] Karolinska Inst, Inst Environm Med, Unit Biostat, Stockholm, Sweden; [Fang, Bo; Wang, Chunfang] Shanghai Municipal Ctr Dis Control & Prevent, Div Vital Stat, Shanghai, Peoples R China; [Fang, Bo] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai, Peoples R China; [Xia, Tian] Shanghai Municipal Ctr Dis Control & Prevent, Inst Hlth Informat, Shanghai, Peoples R China; [Fang, Fang] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Cao, Yang] Orebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden	Karolinska Institutet; Shanghai Center for Disease Control & Prevention; Fudan University; Shanghai Center for Disease Control & Prevention; Karolinska Institutet; Orebro University	Fang, X (corresponding author), Karolinska Inst, Inst Environm Med, Unit Biostat, Stockholm, Sweden.	xin.fang@ki.se	Cao, Yang/C-6185-2008; Cao, Yang/HGD-6463-2022	Cao, Yang/0000-0002-3552-9153; Fang, Fang/0000-0002-3310-6456	Karolinska Institutet [C62400032, C62412022]	Karolinska Institutet(Karolinska Institutet)	This work was funded by the Karolinska Institutet Research Assistant Grant (C62400032) and Junior Faculty Grant (C62412022). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Agency EE European Environment Agency], 2015, ANN SAF REV 2014, P42; Alessandrini ER, 2016, AM J EPIDEMIOL, V184, P744, DOI 10.1093/aje/kww078; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; ANDERSON TW, 1979, CAN MED ASSOC J, V121, P1580; ANDERSON TW, 1970, LANCET, V1, P291; Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; Austin E, 2012, ENVIRON INT, V45, P112, DOI 10.1016/j.envint.2012.04.003; BAKERBLOCKER A, 1982, AM J PUBLIC HEALTH, V72, P261, DOI 10.2105/AJPH.72.3.261; Ballester F, 2003, J EPIDEMIOL COMMUN H, V57, P759, DOI 10.1136/jech.57.10.759; Basagana X, 2011, EPIDEMIOLOGY, V22, P765, DOI 10.1097/EDE.0b013e31823031c5; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Bean WB, 1938, AM HEART J, V16, P701, DOI 10.1016/S0002-8703(38)90952-4; Boldo E, 2006, EUR J EPIDEMIOL, V21, P449, DOI 10.1007/s10654-006-9014-0; BORWANKER J, 1971, ANN MATH STAT, V42, P1241, DOI 10.1214/aoms/1177693237; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; BUECHLEY RW, 1972, ENVIRON RES, V5, P85, DOI 10.1016/0013-9351(72)90022-9; Cakmak S, 2016, ENVIRON POLLUT, V214, P589, DOI 10.1016/j.envpol.2016.04.067; Cao JJ, 2012, ENVIRON HEALTH PERSP, V120, P373, DOI 10.1289/ehp.1103671; Chan AB, 2009, IEEE 12 INT NAT C CO; Chen R., 2017, AM J RESP CRIT CARE; Cheng CSQ, 2007, WATER AIR SOIL POLL, V182, P131, DOI 10.1007/s11270-006-9327-3; Cheng S., 1991, P MIDDLE STAT DIV AA, V24, P5; D'Ippoliti D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-37; Dai LZ, 2014, ENVIRON HEALTH PERSP, V122, P837, DOI 10.1289/ehp.1307568; Dockery D W, 1999, Res Rep Health Eff Inst, P1; Dominici F, 2003, INT STAT REV, V71, P243; Dominici F, 2000, BIOMETRICS, V56, P546, DOI 10.1111/j.0006-341X.2000.00546.x; Donaldson GC, 1997, J EPIDEMIOL COMMUN H, V51, P643, DOI 10.1136/jech.51.6.643; DOUGLAS AS, 1991, SCOT MED J, V36, P76, DOI 10.1177/003693309103600304; Eng H, 1998, J Cardiovasc Risk, V5, P89, DOI 10.1097/00043798-199804000-00004; [Europe WHOROf World Health Organization], 2003, EUR WHOROF; Fong YY, 2010, BIOSTATISTICS, V11, P397, DOI 10.1093/biostatistics/kxp053; Franklin M, 2007, J EXPO SCI ENV EPID, V17, P279, DOI 10.1038/sj.jes.7500530; Gelman A, 2009, STAT SCI, V24, P178, DOI [10.1214/09-STS284D, DOI 10.1214/09-STS284D]; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GILKS WR, 1992, J R STAT SOC C-APPL, V41, P337; Gilks WR., 2003, ADAPTIVE METROPOLIS; Goldberg MS, 2008, OCCUP ENVIRON MED, V65, P659, DOI 10.1136/oem.2007.034934; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Hoxie HJ, 1940, AM HEART J, V19, P475, DOI 10.1016/S0002-8703(40)90059-X; Huq S, 2007, ENVIRON URBAN, V19, P3, DOI 10.1177/0956247807078058; IBRAHIM JG, 1991, J AM STAT ASSOC, V86, P981, DOI 10.2307/2290514; Idrovo AJ, 2011, ENVIRON HEALTH PERSP, V119, pA332, DOI 10.1289/ehp.1103768; [Inspection and Quarantine of China General Administration of Quality Supervision Ministry of Environmental Protection of China], 2012, GEN ADM QUAL SUP INS; ISAACS N, 1993, AUST J PUBLIC HEALTH, V17, P68; Jakovljevic D, 1996, STROKE, V27, P1774, DOI 10.1161/01.STR.27.10.1774; Janssen NAH, 2000, J AIR WASTE MANAGE, V50, P1133, DOI 10.1080/10473289.2000.10464159; KALKSTEIN LS, 1987, J CLIM APPL METEOROL, V26, P717, DOI 10.1175/1520-0450(1987)026<0717:AEOTCP>2.0.CO;2; Kass RE, 1996, J AM STAT ASSOC, V91, P1343, DOI 10.2307/2291752; Kass RE, 1998, AM STAT, V52, P93, DOI 10.2307/2685466; KATSOUYANNI K, 1993, ARCH ENVIRON HEALTH, V48, P235, DOI 10.1080/00039896.1993.9940365; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; Keatinge WR, 2000, BRIT MED J, V321, P670, DOI 10.1136/bmj.321.7262.670; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Kelsall JE, 1997, AM J EPIDEMIOL, V146, P750; Klein Tank AM, 2009, GUIDELINES ANAL EXTR; Kloog I, 2013, EPIDEMIOLOGY, V24, P555, DOI 10.1097/EDE.0b013e318294beaa; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; Kruschke J.K., 2014, DOING BAYESIAN DATA, DOI DOI 10.1016/B978-0-12-405888-0.09999-2; Liang X, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2015.0257; Lippmann Morton, 2013, Res Rep Health Eff Inst, P5; Luo K, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111082; Moolgavkar SH, 2000, INHAL TOXICOL, V12, P75, DOI 10.1080/089583700750019512; Nakai S, 1999, INT J BIOMETEOROL, V43, P124, DOI 10.1007/s004840050127; Nawahda A, 2012, WATER AIR SOIL POLL, V223, P3445, DOI 10.1007/s11270-012-1123-7; Nayha S, 1981, Scand J Soc Med Suppl, V21, P1; Nayha Simo, 2002, Int J Circumpolar Health, V61, P373; Ou CQ, 2014, BIOMED ENVIRON SCI, V27, P917, DOI 10.3967/bes2014.132; Pham TH, GEN ADDITIVE MIXED M; PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892; Pope CA, 1996, ENVIRON HEALTH PERSP, V104, P414, DOI 10.2307/3432686; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Rainham DGC, 2005, INT J ENVIRON HEAL R, V15, P347, DOI 10.1080/09603120500289119; Ren CZ, 2006, INT J BIOMETEOROL, V51, P87, DOI 10.1007/s00484-006-0054-7; Roberts S, 2004, ENVIRON RES, V96, P328, DOI 10.1016/j.envres.2004.01.015; Samet J, 1998, ENVIRON RES, V77, P9, DOI 10.1006/enrs.1997.3821; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Samoli E, 2013, ENVIRON HEALTH PERSP, V121, P932, DOI 10.1289/ehp.1206124; SAS Institute Inc, 2016, SAS STAT 14 2 USERS; SCHWARTZ J, 1994, CAN J STAT, V22, P471, DOI 10.2307/3315405; Schwartz J, 2000, ENVIRON HEALTH PERSP, V108, P563, DOI 10.2307/3454620; Schwartz J, 1999, EPIDEMIOLOGY, V10, P17, DOI 10.1097/00001648-199901000-00005; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shanghai Bureau of Statistics, 2015, SOC DEV STAT B 2014; Stafoggia M, 2008, AM J EPIDEMIOL, V167, P1476, DOI 10.1093/aje/kwn074; Stokes M, 2014, P SAS GLOB FOR 2014; Sun Q H, 2016, Zhonghua Yu Fang Yi Xue Za Zhi, V50, P544, DOI 10.3760/cma.j.issn.0253-9624.2016.06.014; Tan JG, 2004, INT J BIOMETEOROL, V48, P157, DOI 10.1007/s00484-003-0193-z; Tan JG, 2010, INT J BIOMETEOROL, V54, P75, DOI 10.1007/s00484-009-0256-x; Theobald CM, 1997, GENET SEL EVOL, V29, P57, DOI 10.1051/gse:19970104; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Vandentorren S, 2006, EUR J PUBLIC HEALTH, V16, P583, DOI 10.1093/eurpub/ckl063; Vaneckova P, 2008, INT J BIOMETEOROL, V52, P439, DOI 10.1007/s00484-007-0138-z; Vanos JK, 2015, AIR QUAL ATMOS HLTH, V8, P307, DOI 10.1007/s11869-014-0266-7; Vanos JK, 2014, ENVIRON POLLUT, V185, P322, DOI 10.1016/j.envpol.2013.11.007; Vanos JK, 2013, ENVIRON RES, V126, P66, DOI 10.1016/j.envres.2013.08.003; VUORI I, 1987, ANN CLIN RES, V19, P156; WHO, 2006, HLTH RISKS PART MATT; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization (WHO), 2013, REV EV HLTH ASP AIR; WYNDHAM CH, 1978, S AFR MED J, V53, P1051; Yang Y, 2015, SCI TOTAL ENVIRON, V508, P178, DOI 10.1016/j.scitotenv.2014.11.070; Yao L, 2015, INT J ENV RES PUB HE, V12, P12264, DOI 10.3390/ijerph121012264; Zanobetti A, 2014, ENVIRON INT, V71, P13, DOI 10.1016/j.envint.2014.05.023; Zanobetti A, 2009, ENVIRON HEALTH PERSP, V117, P898, DOI 10.1289/ehp.0800108; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382	107	11	13	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187933	10.1371/journal.pone.0187933	http://dx.doi.org/10.1371/journal.pone.0187933			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121092	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900098
J	Shamim, HM; Minami, Y; Tanaka, D; Ukimori, S; Murray, JM; Ueno, M				Shamim, Hossain Mohammad; Minami, Yukako; Tanaka, Daiki; Ukimori, Shinobu; Murray, Johanne M.; Ueno, Masaru			Fission yeast strains with circular chromosomes require the 9-1-1 checkpoint complex for the viability in response to the anti-cancer drug 5-fluorodeoxyuridine	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; CELL-CYCLE; THYMIDYLATE SYNTHETASE; DNA-REPLICATION; RIBOSOMAL-RNA; 5-FLUOROURACIL; CLAMP; INHIBITION; MAINTENANCE; MECHANISM	Thymidine kinase converts 5-fluorodeoxyuridine to 5-fluorodeoxyuridine monophosphate, which causes disruption of deoxynucleotide triphosphate ratios. The fission yeast Schizosaccharomyces pombe does not express endogenous thymidine kinase but 5-fluorodeoxyuridine inhibits growth when exogenous thymidine kinase is expressed. Unexpectedly, we found that 5-fluorodeoxyuridine causes S phase arrest even without thymidine kinase expression. DNA damage checkpoint proteins such as the 9-1-1 complex were required for viability in the presence of 5-fluorodeoxyuridine. We also found that strains with circular chromosomes, due to loss of pot1(+), which have higher levels of replication stress, were more sensitive to loss of the 9-1-1 complex in the presence of 5-fluorodeoxyuridine. Thus, our results suggest that strains carrying circular chromosomes exhibit a greater dependence on DNA damage checkpoints to ensure viability in the presence of 5-fluorodeoxyuridine compared to stains that have linear chromosomes.	[Shamim, Hossain Mohammad; Minami, Yukako; Tanaka, Daiki; Ukimori, Shinobu; Ueno, Masaru] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima, Japan; [Murray, Johanne M.] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton, E Sussex, England	Hiroshima University; University of Sussex	Ueno, M (corresponding author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima, Japan.	scmueno@hiroshima-u.ac.jp	Ueno, Masaru/G-3990-2019	Hossain, Mohammad Shamim/0000-0001-8892-0124	MEXT/JSPS KAKENHI [17K07502]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); MRC [G1001668, G0901011]; BBSRC [BB/K019805/1]; Biotechnology and Biological Sciences Research Council [BB/C510291/1, BB/K019805/1] Funding Source: researchfish; Medical Research Council [G0901011] Funding Source: researchfish; Worldwide Cancer Research [10-0273] Funding Source: researchfish; Grants-in-Aid for Scientific Research [17K07502] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MU is supported by: MEXT/JSPS KAKENHI Grant Number 17K07502 and Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and Development (AMED). JMM is supported by: MRC Project Grants G1001668 and G0901011 and BBSRC project grant BB/K019805/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Daber RD, 2012, EUR J MED GENET, V55, P381, DOI 10.1016/j.ejmg.2012.02.004; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; DIASIO RB, 1989, CLIN PHARMACOKINET, V16, P215, DOI 10.2165/00003088-198916040-00002; DOONG SL, 1988, J BIOL CHEM, V263, P4467; Furuya K, 2010, MOL CELL, V40, P606, DOI 10.1016/j.molcel.2010.10.026; GHOSHAL K, 1994, CANCER RES, V54, P632; GISSELSSON D, 2001, ATLAS GENETICS CYTOG; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; Huehls AM, 2011, CANCER RES, V71, P4944, DOI 10.1158/0008-5472.CAN-11-0814; Jain D, 2010, NATURE, V467, P223, DOI 10.1038/nature09374; KANAMARU R, 1986, CANCER CHEMOTH PHARM, V17, P43, DOI 10.1007/BF00299864; Khair L, 2010, CELL CYCLE, V9, P2237, DOI 10.4161/cc.9.11.11920; Kiely J, 2000, GENETICS, V154, P599; Lo AWI, 2002, NEOPLASIA, V4, P531, DOI 10.1038/sj.neo.7900267; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; McClintock B, 1941, GENETICS, V26, P234; MEGNET R, 1966, EXPERIENTIA, V22, P151, DOI 10.1007/BF01897701; MITCHISON JM, 1971, EXP CELL RES, V69, P244, DOI 10.1016/0014-4827(71)90337-5; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nakayashiki T, 2013, J BACTERIOL, V195, P1226, DOI 10.1128/JB.02145-12; Nanbu T, 2013, MOL CELL BIOL, V33, P1175, DOI 10.1128/MCB.01713-12; PATTON JR, 1993, BIOCHEMISTRY-US, V32, P8939, DOI 10.1021/bi00085a027; Pitt CW, 2010, NUCLEIC ACIDS RES, V38, P6968, DOI 10.1093/nar/gkq580; RANDERATH K, 1983, RECENT RES CANCER, V84, P283; Sabatinos SA, 2012, MOL CELL BIOL, V32, P4986, DOI 10.1128/MCB.01060-12; Sakamoto K, 2015, INT J ONCOL, V46, P2327, DOI 10.3892/ijo.2015.2974; SANTI DV, 1987, BIOCHEMISTRY-US, V26, P8599, DOI 10.1021/bi00400a016; SANTI DV, 1974, BIOCHEMISTRY-US, V13, P471, DOI 10.1021/bi00700a012; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; SOMMER H, 1974, BIOCHEM BIOPH RES CO, V57, P689, DOI 10.1016/0006-291X(74)90601-9; Sugawara N., 1988, THESIS; Takahashi K, 2011, MOL CELL BIOL, V31, P495, DOI 10.1128/MCB.00613-10; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Trombetta D, 2009, GENE CHROMOSOME CANC, V48, P993, DOI 10.1002/gcc.20700; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Venclovas C, 2002, PROTEIN SCI, V11, P2403, DOI 10.1110/ps.0214302; Wang X, 2008, MOL CELL, V31, P463, DOI 10.1016/j.molcel.2008.05.028; Wilson PM, 2014, NAT REV CLIN ONCOL, V11, P282, DOI 10.1038/nrclinonc.2014.51; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zollino M, 2012, EUR J MED GENET, V55, P374, DOI 10.1016/j.ejmg.2012.03.009; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100	43	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187775	10.1371/journal.pone.0187775	http://dx.doi.org/10.1371/journal.pone.0187775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121084	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000414769900074
J	Shi, JJ; Chen, FE; Cai, YF; Fan, SC; Cai, J; Chen, RJ; Kan, HD; Lu, YH; Zhao, ZH				Shi, Jingjin; Chen, Fei'er; Cai, Yunfei; Fan, Shichen; Cai, Jing; Chen, Renjie; Kan, Haidong; Lu, Yihan; Zhao, Zhuohui			Validation of a light-scattering PM2.5 sensor monitor based on the long-term gravimetric measurements in field tests	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; INDOOR AIR; PM10; MORTALITY; OUTDOOR; HEALTH; CHINA; EXPOSURES; LEVEL; URBAN	Background Portable direct-reading instruments by light-scattering method are increasingly used in airborne fine particulate matter (PM2.5) monitoring. However, there are limited calibration studies on such instruments by applying the gravimetric method as reference method in field tests. Methods An 8-month sampling was performed and 96 pairs of PM2.5 data by both the gravimetric method and the simultaneous light-scattering real-time monitoring (QT-50) were obtained from July, 2015 to February, 2016 in Shanghai. Temperature and relative humidity (RH) were recorded. Mann-Whitney U nonparametric test and Spearman correlation were used to investigate the differences between the two measurements. Multiple linear regression (MLR) model was applied to set up the calibration model for the light-scattering device. Results The average PM2.5 concentration (median) was 48.1 mu g/m(3) (min-max 10.4-95.8 mu g/m(3)) by the gravimetric method and 58.1 mu g/m(3) (19.2-315.9 mu g/m(3)) by the light-scattering method, respectively. By time trend analyses, they were significantly correlated with each other (Spearman correlation coefficient 0.889, P<0.01). By MLR, the calibration model for the light-scattering instrument was Y(calibrated) = 57.45 + 0.47 x X(the QT - 50 measurements) - 0.53 x RH - 0.41 x Temp with both RH and temperature adjusted. The 10-fold cross-validation R-2 and the root mean squared error of the calibration model were 0.79 and 11.43 mu g/m(3), respectively. Conclusion Light-scattering measurements of PM2.5 by QT-50 instrument overestimated the concentration levels and were affected by temperature and RH. The calibration model for QT-50 instrument was firstly set up against the gravimetric method with temperature and RH adjusted.	[Shi, Jingjin; Chen, Fei'er; Cai, Jing; Chen, Renjie; Kan, Haidong; Zhao, Zhuohui] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai 200032, Peoples R China; [Shi, Jingjin] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, China Welf Inst, Shanghai, Peoples R China; [Cai, Yunfei] Shanghai Environm Monitoring Ctr, Shanghai, Peoples R China; [Fan, Shichen] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Cai, Jing; Chen, Renjie; Kan, Haidong; Zhao, Zhuohui] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ,Shanghai Key Lab Meteorol & Hlth, Key Lab Hlth Technol Assessment,Natl Hlth & Famil, Shanghai, Peoples R China; [Chen, Renjie; Kan, Haidong] Fudan Univ, Shanghai Key Lab Particle Pollut & Prevent LAP3, Shanghai, Peoples R China; [Lu, Yihan] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai, Peoples R China	Fudan University; Shanghai Jiao Tong University; Emory University; Rollins School Public Health; Fudan University; Fudan University; Fudan University	Zhao, ZH (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai 200032, Peoples R China.; Zhao, ZH (corresponding author), Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ,Shanghai Key Lab Meteorol & Hlth, Key Lab Hlth Technol Assessment,Natl Hlth & Famil, Shanghai, Peoples R China.	zhzhao@fudan.edu.cn	Kan, Haidong/AGU-0328-2022	zhao, zhuohui/0000-0001-8596-0278	National Key R&D Program of China [2017YFC0702701, 2016YFC0207400]; State Key Basic Research Program (973) project [20150553404]; Ministry of Environmental Protection of China [201409080]; Shanghai 3-Year Public Health Action Plan [GWTD2015S04]	National Key R&D Program of China; State Key Basic Research Program (973) project; Ministry of Environmental Protection of China; Shanghai 3-Year Public Health Action Plan	The study was supported by National Key R&D Program of China (2017YFC0702701), National Key R&D Program of China (2016YFC0207400), the State Key Basic Research Program (973) project (20150553404), Public Scientific Research Project of Ministry of Environmental Protection of China (No. 201409080) and Shanghai 3-Year Public Health Action Plan (GWTD2015S04).	Alexandrova OA, 2003, ATMOS ENVIRON, V37, P421, DOI 10.1016/S1352-2310(02)00803-8; Austin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137789; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Challoner A, 2014, BUILD ENVIRON, V80, P159, DOI 10.1016/j.buildenv.2014.05.032; Chan LY, 2002, ATMOS ENVIRON, V36, P5831, DOI 10.1016/S1352-2310(02)00687-8; Chang LT, 2001, J AIR WASTE MANAGE, V51, P1414, DOI 10.1080/10473289.2001.10464375; Chartier R, 2016, INDOOR AIR; Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425; Chen RJ, 2011, SCI TOTAL ENVIRON, V409, P4934, DOI 10.1016/j.scitotenv.2011.08.058; Gao ML, 2015, ENVIRON POLLUT, V199, P56, DOI 10.1016/j.envpol.2015.01.013; Holstius DM, 2014, ATMOS MEAS TECH, V7, P1121, DOI 10.5194/amt-7-1121-2014; Koehler Kirsten A, 2015, Curr Environ Health Rep, V2, P399, DOI 10.1007/s40572-015-0070-z; Li MM, 2012, SCI TOTAL ENVIRON, V414, P525, DOI 10.1016/j.scitotenv.2011.10.054; Liu D, 2017, J AEROSOL SCI; McNamara ML, 2011, AEROSOL AIR QUAL RES, V11, P316, DOI 10.4209/aaqr.2010.08.0072; Meng X, 2016, ENVIRON POLLUT, V208, P177, DOI 10.1016/j.envpol.2015.09.042; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Ramachandran G, 2003, AEROSOL SCI TECH, V37, P33, DOI 10.1080/02786820300889; Schwartz J, 2004, OCCUP ENVIRON MED, V61, P956, DOI 10.1136/oem.2003.008250; Sloan CD, 2016, J AIR WASTE MANAGE, V66, P53, DOI 10.1080/10962247.2015.1108942; Sousan S, 2016, AEROSOL SCI TECHNOLO, V50; Tasic V, 2012, ATMOS ENVIRON, V54, P358, DOI 10.1016/j.atmosenv.2012.02.030; Wallace LA, 2011, J EXPO SCI ENV EPID, V21, P49, DOI 10.1038/jes.2010.15; Wang Y, 2015, AEROSOL SCI TECH, V49, P1063, DOI 10.1080/02786826.2015.1100710; Wong CM, 2008, ENVIRON HEALTH PERSP, V116, P1195, DOI 10.1289/ehp.11257; Wu CF, 2005, J EXPO ANAL ENV EPID, V15, P99, DOI 10.1038/sj.jea.7500351; Yanosky JD, 2002, ATMOS ENVIRON, V36, P107, DOI 10.1016/S1352-2310(01)00422-8; Zhu Y, 2011, J OCCUP ENVIRON HYG, V8, P662, DOI 10.1080/15459624.2011.617234	28	26	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0185700	10.1371/journal.pone.0185700	http://dx.doi.org/10.1371/journal.pone.0185700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121101	Green Submitted, gold, Green Published			2022-12-26	WOS:000414769900008
J	Lee, D; See, S; Song, MK; Lee, HK; Park, S; Jin, YW				Lee, Dalnim; See, Songwon; Song, Min Kyoung; Lee, Hyang Ki; Park, Sunhoo; Jin, Young Woo			Factors associated with the risk perception and purchase decisions of Fukushima-related food in South Korea	PLOS ONE			English	Article							CONSUMER AWARENESS; SAFETY; ATTITUDES; VALUATION; ACCIDENT; ISSUES	Following the Fukushima nuclear power plant accident, the risk level perceived by Koreans on the radioactive contamination of Japanese food that is being distributed in Korea remains high. Many of these perceptions are based on subjective risk perception rather than an objective measure with scientific evidence, which makes communicating risks more difficult; therefore, it is critical to understand factors associated with risk perception for effective risk communication. In this study, we identified variables that are associated with buying tendencies and opinions about the regulatory policy of Japanese seafood after the accident. A survey was conducted with 1045 adults aged over 20 years in Korea. The majority (68.8%) responded that they would not purchase Japanese seafood when radioactivity levels in the food were non-detectable. Moreover, 82.2% responded that the current levels of import restrictions on Japanese seafood must be maintained. Despite many concerns regarding the exposure to radiation and the effects from food products following the Fukushima accident, the opportunities to encounter and to collect correct information remain limited and average radioactive knowledge scores were low (3.63 out of 9). Of the various characteristics associated with purchase decisions and agreement on the current import restraints of Japanese seafood, trust levels in the government and the mass media for providing information on radioactivity were major factors that influenced risk perception. While the scope of this study was limited to seafood, it is very closely tied to daily lives, where we revealed differences about risk perceptions and agreement on import restraints of Japanese seafood per a complex mixture of individual characteristics and the surrounding environment. These results provide useful information to understand the risk perception of the potential radioactive contamination of food and to predict the public's responses to food consumption and import restraint policies due to nuclear accidents in neighboring countries.	[Lee, Dalnim; See, Songwon; Park, Sunhoo; Jin, Young Woo] Korea Inst Radiol & Med Sci, Natl Radiat Emergency Med Ctr, Seoul, South Korea; [Song, Min Kyoung; Lee, Hyang Ki] Consumers Union Korea, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences	Jin, YW (corresponding author), Korea Inst Radiol & Med Sci, Natl Radiat Emergency Med Ctr, Seoul, South Korea.	ywjin@kirams.re.kr			Ministry of Food and Drug Safety (Imported Fishery Products Inspection); Korea Institute of Radiological and Medical Sciences (KIRAMS) - Ministry of Science and ICT, Republic of Korea [1711045572/50445-2016]	Ministry of Food and Drug Safety (Imported Fishery Products Inspection)(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Korea Institute of Radiological and Medical Sciences (KIRAMS) - Ministry of Science and ICT, Republic of Korea	This study was supported by the Ministry of Food and Drug Safety (Imported Fishery Products Inspection) and a grant of the Korea Institute of Radiological and Medical Sciences (KIRAMS), funded by the Ministry of Science and ICT, Republic of Korea (No. 1711045572/50445-2016) to Young Woo Jin. The funders had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Badrie N, 2006, FOOD CONTROL, V17, P370, DOI 10.1016/j.foodcont.2005.01.003; Brewer MS, 2008, J FOOD SAFETY, V28, P1, DOI 10.1111/j.1745-4565.2007.00091.x; Costa-Font M, 2008, FOOD POLICY, V33, P99, DOI 10.1016/j.foodpol.2007.07.002; Ergonul B, 2013, FOOD CONTROL, V32, P461, DOI 10.1016/j.foodcont.2013.01.018; FAO (Food and Agriculture Organization), 2016, STAT WORLD FISH AQ 2, DOI 10.18356/8e4e0ebf-en; Hosono H., 2013, AGR IMPLICATIONS FUK, P187, DOI DOI 10.1007/978-4-431-54328-2_17; Hosono H, 2015, FOOD SECURITY FOOD S, P319; Jung H., 2013, YONHAPNEWS      1001; Kim J., 2013, KOREA TIMES; Kim K, 2014, BIOELECTROMAGNETICS, V35, P235, DOI 10.1002/bem.21836; Kim NH, 2015, FOOD CONTROL, V50, P304, DOI 10.1016/j.foodcont.2014.09.008; Kimura A. H., 2013, International Journal of Sociology of Agriculture and Food, V20, P11; Knight A, 2004, J CONSUM AFF, V38, P107, DOI 10.1111/j.1745-6606.2004.tb00467.x; Kung YW, 2012, RISK ANAL, V32, P1535, DOI 10.1111/j.1539-6924.2011.01760.x; McKendree MG, 2013, CONSUMER PERCEPTIONS, P1; Miles T., 2015, REUTERS; Ministry of Food and Drug Safety, 2013, GOVT BANS IMP ALL MA; Peterson H, 2014, 2014 ANN M JUL 27 29; Sawada M, 2014, APPETITE, V80, P225, DOI 10.1016/j.appet.2014.05.018; Taylor AW, 2012, FOOD CONTROL, V25, P476, DOI 10.1016/j.foodcont.2011.11.003; The voice of Seoul, 2013, THE VOICE OF SEOUL; Wakatsuki Y., 2014, CNN	22	9	9	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187655	10.1371/journal.pone.0187655	http://dx.doi.org/10.1371/journal.pone.0187655			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117237	Green Submitted, Green Published, gold			2022-12-26	WOS:000414659600056
J	Erdogan, H; Vandemeulebroucke, A; Nauser, T; Bounds, PL; Koppenol, WH				Erdogan, Huriye; Vandemeulebroucke, An; Nauser, Thomas; Bounds, Patricia L.; Koppenol, Willem H.			Jumpstarting the cytochrome P450 catalytic cycle with a hydrated electron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; electron transfer; isotope effect; kinetics; oxidation-reduction (redox)	PSEUDOMONAS-PUTIDA CYTOCHROME-P-450; COMPOUND-I FORMATION; KINETIC CHARACTERIZATION; HYDROGEN-PEROXIDE; P450CAM; HYDROXYLATION; CAMPHOR; ACTIVATION; REDUCTION; SUBSTRATE	Cytochrome P450cam (CYP101Fe(3+)) regioselectively hydroxylates camphor. Possible hydroxylating intermediates in the catalytic cycle of this well-characterized enzyme have been proposed on the basis of experiments carried out at very low temperatures and shunt reactions, but their presence has not yet been validated at temperatures above 0 degrees C during a normal catalytic cycle. Here, we demonstrate that it is possible to mimic the natural catalytic cycle of CYP101Fe(3+) by using pulse radiolysis to rapidly supply the second electron of the catalytic cycle to camphor-bound CYP101[FeO2](2+). Judging by the appearance of an absorbance maximum at 440 nm, we conclude that CYP101[FeOOH](2+) (compound 0) accumulates within 5 s and decays rapidly to CYP101Fe(3+), with a k(440 nm) of 9.6 x 10(4) s(-1). All processes are complete within 40 s at 4 degrees C. Importantly, no transient absorbance bands could be assigned to CYP101[FeO(2+)por(center dot+)] (compound 1) or CYP101[FeO2+] (compound 2). However, indirect evidence for the involvement of compound 1 was obtained from the kinetics of formation and decay of a tyrosyl radical. 5-Hydroxycamphor was formed quantitatively, and the catalytic activity of the enzyme was not impaired by exposure to radiation during the pulse radiolysis experiment. The rapid decay of compound 0 enabled calculation of the limits for the Gibbs activation energies for the conversions of compound 0 compound 1 compound 2 CYP101Fe(3+), yielding a G(double dagger) of 45, 39, and 39 kJ/mol, respectively. At 37 degrees C, the steps from compound 0 to the iron(III) state would take only 4 s. Our kinetics studies at 4 degrees C complement the canonical mechanism by adding the dimension of time.	[Erdogan, Huriye; Nauser, Thomas; Bounds, Patricia L.; Koppenol, Willem H.] Swiss Fed Inst Technol, Inst Inorgan, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland; [Vandemeulebroucke, An] Swiss Fed Inst Technol, Inst Organ Chem, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland; [Erdogan, Huriye] Ilko Argem Biyoteknol Merkezi, Teknopk Istanbul,Sanayi Mah,Teknopk Bulvari, TR-34906 Pendik Istanbul, Turkey; [Vandemeulebroucke, An] F Hoffmann La Roche Ltd, Roche Pharma Res & Early Dev, Chem Biol, Grenzacherstr 124,065-210, CH-4070 Basel, Switzerland; [Bounds, Patricia L.] Fdn Res Informat Technol Soc, Zeughausstr 43, CH-8004 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Roche Holding	Koppenol, WH (corresponding author), Swiss Fed Inst Technol, Inst Inorgan, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.	koppenol@inorg.chem.ethz.ch	Erdogan, Huriye/AAV-7170-2020; Dagdas, Huriye Erdogan/AAH-6098-2019; Koppenol, Willem Hendrik/H-2991-2013	Erdogan, Huriye/0000-0003-0057-5579; Koppenol, Willem Hendrik/0000-0002-1620-6594	ETH Zurich [ETH-3810-3]	ETH Zurich(ETH Zurich)	This work was supported by the ETH Zurich, Grant ETH-3810-3. The authors declare that they have no conflicts of interest with the contents of this article.	ATKINS WM, 1988, BIOCHEMISTRY-US, V27, P1610, DOI 10.1021/bi00405a033; BIELSKI BHJ, 1985, J PHYS CHEM REF DATA, V14, P1041, DOI 10.1063/1.555739; BRAAMS R, 1966, RADIAT RES, V27, P319, DOI 10.2307/3571952; Collins D. P., 2010, HDB PORPHYRIN SCI, P299; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Davydov R, 2013, BIOCHEMISTRY-US, V52, P667, DOI 10.1021/bi301527c; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; de Visser SP, 2004, J AM CHEM SOC, V126, P8362, DOI 10.1021/ja048528h; DEBEY P, 1979, BIOCHEM BIOPH RES CO, V86, P953, DOI 10.1016/0006-291X(79)90210-9; Denisov I. G., 2015, CYTOCHROME P450 STRU, P69, DOI [10.1007/978-3-319-12108-6_3, DOI 10.1007/978-3-319-12108-6_3]; Denisov IG, 2001, J BIOL CHEM, V276, P11648, DOI 10.1074/jbc.M010219200; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; EGAWA T, 1994, BIOCHEM BIOPH RES CO, V201, P1464, DOI 10.1006/bbrc.1994.1868; Franke A, 2015, CHEM-EUR J, V21, P15201, DOI 10.1002/chem.201501886; GEORGE P, 1952, NATURE, V169, P612, DOI 10.1038/169612a0; GETOFF N, 1992, Amino Acids (Vienna), V2, P195, DOI 10.1007/BF00805942; GRIFFIN BW, 1972, BIOCHEMISTRY-US, V11, P4740, DOI 10.1021/bi00775a017; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Gunsalus I C, 1978, Methods Enzymol, V52, P166; Harada K, 2008, J AM CHEM SOC, V130, P432, DOI 10.1021/ja077902l; HASINOFF BB, 1985, BIOCHIM BIOPHYS ACTA, V829, P1, DOI 10.1016/0167-4838(85)90060-3; Hsieh CH, 2017, BIOCHEMISTRY-US, V56, P3347, DOI 10.1021/acs.biochem.7b00338; Kawakami N, 2015, J PORPHYR PHTHALOCYA, V19, P329, DOI 10.1142/S1088424615500145; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; KOBAYASHI K, 1987, J BIOL CHEM, V262, P5445; Koppenol WH, 2007, J AM CHEM SOC, V129, P9686, DOI 10.1021/ja071546p; Kuznetsov VY, 2006, BIOCHEMISTRY-US, V45, P11934, DOI 10.1021/bi0611154; LIPSCOMB JD, 1980, BIOCHEMISTRY-US, V19, P3590, DOI 10.1021/bi00556a027; Mahmoudi L, 2016, BIOCHEMISTRY-US, V55, P2849, DOI 10.1021/acs.biochem.6b00019; Masoudian S, 2011, INDIAN J CHEM A, V50, P1002; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; PETERSON JA, 1972, ARCH BIOCHEM BIOPHYS, V149, P197, DOI 10.1016/0003-9861(72)90315-3; Plata RE, 2015, J AM CHEM SOC, V137, P3811, DOI 10.1021/ja5111392; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; Prasad B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061897; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; SCHULER RH, 1980, J PHYS CHEM-US, V84, P2088, DOI 10.1021/j100453a020; Schunemann V, 2000, FEBS LETT, V479, P149, DOI 10.1016/S0014-5793(00)01886-X; Shaik S, 2010, CHEM REV, V110, P949, DOI 10.1021/cr900121s; Spolitak T, 2005, J BIOL CHEM, V280, P20300, DOI 10.1074/jbc.M501761200; Spolitak T, 2006, J INORG BIOCHEM, V100, P2034, DOI 10.1016/j.jinorgbio.2006.09.026; Vandemeulebroucke A, 2015, BIOCHEMISTRY-US, V54, P6692, DOI 10.1021/acs.biochem.5b00939; Yuan XT, 2009, BIOCHEMISTRY-US, V48, P9140, DOI 10.1021/bi901258m	43	8	8	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21481	21489		10.1074/jbc.M117.813683	http://dx.doi.org/10.1074/jbc.M117.813683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29109145	Green Published, hybrid			2022-12-26	WOS:000419013000023
J	Righetti, L; Rolli, E; Galaverna, G; Suman, M; Bruni, R; Dall'Asta, C				Righetti, Laura; Rolli, Enrico; Galaverna, Gianni; Suman, Michele; Bruni, Renato; Dall'Asta, Chiara			Plant organ cultures as masked mycotoxin biofactories: Deciphering the fate of zearalenone in micropropagated durum wheat roots and leaves	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CELL-SUSPENSION CULTURES; ARABIDOPSIS-THALIANA; BETA-ZEARALENOL; METABOLISM; AFLATOXIN; TRANSFORMATION; SEEDLINGS; MODEL; WATER	"Masked mycotoxins" senso strictu are conjugates of mycotoxins resulting from metabolic pathways activated by the interplay between pathogenic fungi and infected plants. Zearalenone, an estrogenic mycotoxin produced by Fusarium spp, was the first masked mycotoxin ever described in the literature, but its biotransformation has been studied to a lesser extent if compared to other compounds such as deoxynivalenol. We presented herein the first application of organ and tissue culture techniques to study the metabolic fate of zearalenone in durum wheat, using an untargeted HR-LCMS approach. A complete, quick absorption of zearalenone by uninfected plant organs was noticed, and its biotransformation into a large spectrum of phase I and phase II metabolites has been depicted. Therefore, wheat organ tissue cultures can be effectively used as a biocatalytic tool for the production of masked mycotoxins, as well as a replicable model for the investigation of the interplay between mycotoxins and wheat physiology.	[Righetti, Laura; Galaverna, Gianni; Bruni, Renato; Dall'Asta, Chiara] Univ Parma, Dept Food & Drug, Parma, Italy; [Rolli, Enrico] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy; [Suman, Michele] Barilla GRFlli SpA, Adv Lab Res, Parma, Italy	University of Parma; University of Parma	Dall'Asta, C (corresponding author), Univ Parma, Dept Food & Drug, Parma, Italy.	chiara.dallasta@unipr.it	Galaverna, Gianni/GNW-5335-2022; Righetti, Laura/Y-6208-2019; Dall'Asta, Chiara/C-3173-2008	Galaverna, Gianni/0000-0001-9042-2378; Righetti, Laura/0000-0003-4238-0665; Dall'Asta, Chiara/0000-0003-0716-8394				Berthiller F, 2007, Mycotoxin Res, V23, P68, DOI 10.1007/BF02946028; Berthiller F, 2006, FOOD ADDIT CONTAM, V23, P1194, DOI 10.1080/02652030600778728; Berthiller F, 2005, J AGR FOOD CHEM, V53, P3421, DOI 10.1021/jf047798g; Berthiller F, 2013, MOL NUTR FOOD RES, V57, P165, DOI 10.1002/mnfr.201100764; Berthiller F, 2009, ANAL BIOANAL CHEM, V395, P1243, DOI 10.1007/s00216-009-2874-x; Buerstmayr H, 2015, WORLD MYCOTOXIN J, V8, P591, DOI 10.3920/WMJ2015.1889; Card ML, 2012, J AGR FOOD CHEM, V60, P8264, DOI 10.1021/jf3014074; Cirlini M, 2014, TOXINS, V6, P81, DOI 10.3390/toxins6010081; Cruciani Gabriele, 2013, Drug Discov Today Technol, V10, pe155, DOI 10.1016/j.ddtec.2012.11.001; Dall'Erta A, 2013, CHEM RES TOXICOL, V26, P305, DOI 10.1021/tx300438c; De Boevre M, 2014, WORLD MYCOTOXIN J, V7, P305, DOI 10.3920/WMJ2014.1717; Dellafiora L, 2016, TOXICON, V111, P139, DOI 10.1016/j.toxicon.2016.01.053; Dellafiora L, 2015, FOOD CHEM TOXICOL, V86, P65, DOI 10.1016/j.fct.2015.09.009; Drzymala SS, 2015, ANAL BIOANAL CHEM, V407, P3489, DOI 10.1007/s00216-015-8541-5; EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2015.4359; Ehrlich V.A., 2015, ALTEX, V32, P201; Emidio ES, 2017, CHEMOSPHERE, V169, P146, DOI 10.1016/j.chemosphere.2016.11.042; ENGELHARDT G, 1988, NATURWISSENSCHAFTEN, V75, P309, DOI 10.1007/BF00367324; EVERETT DJ, 1987, J TOXICOL ENV HEALTH, V20, P435, DOI 10.1080/15287398709530995; Fink-Gremmels J, 2007, ANIM FEED SCI TECH, V137, P326, DOI 10.1016/j.anifeedsci.2007.06.008; Frizzell C, 2011, TOXICOL LETT, V206, P210, DOI 10.1016/j.toxlet.2011.07.015; GAREIS M, 1990, J VET MED B, V37, P236, DOI 10.1111/j.1439-0450.1990.tb01052.x; Hariprasad P, 2015, ENVIRON SCI POLLUT R, V22, P6246, DOI 10.1007/s11356-014-3851-2; Hariprasad P, 2013, FOOD CHEM, V138, P1908, DOI 10.1016/j.foodchem.2012.11.093; Hartmann N, 2008, ENVIRON SCI TECHNOL, V42, P5455, DOI 10.1021/es8007326; Hildebrand A. A., 2012, TOXICOL LETT, V192, P379; Hildebrand Andreas A, 2012, Mycotoxin Res, V28, P1, DOI 10.1007/s12550-011-0109-4; HOWES AW, 1991, MYCOPATHOLOGIA, V113, P25, DOI 10.1007/BF00436382; Koppen R, 2012, J AGR FOOD CHEM, V60, P11733, DOI 10.1021/jf3037775; Macherius A, 2012, ENVIRON SCI TECHNOL, V46, P10797, DOI 10.1021/es3028378; Malchi T, 2014, ENVIRON SCI TECHNOL, V48, P9325, DOI 10.1021/es5017894; Malekinejad H, 2006, VET J, V172, P96, DOI 10.1016/j.tvjl.2005.03.004; Marsik P, 2017, ENVIRON POLLUT, V220, P383, DOI 10.1016/j.envpol.2016.09.074; Meng F. J., 1992, Progress in plant growth regulation. Proceedings of the 14th international conference on plant growth substances, Amsterdam, 21-26 July, 1991., P291; Meng-Reiterer J, 2016, TOXINS, V8, DOI 10.3390/toxins8120364; Meng-Reiterer J, 2015, ANAL BIOANAL CHEM, V407, P8019, DOI 10.1007/s00216-015-8975-9; MERTZ D, 1980, J AGR FOOD CHEM, V28, P963, DOI 10.1021/jf60231a003; MERTZ D, 1981, J AGR FOOD CHEM, V29, P1168, DOI 10.1021/jf00108a017; Molina-Molina JM, 2014, FOOD CHEM TOXICOL, V74, P233, DOI 10.1016/j.fct.2014.10.008; Nathanail AV, 2015, J AGR FOOD CHEM, V63, P7862, DOI 10.1021/acs.jafc.5b02697; Nathanail AV, 2015, ANAL BIOANAL CHEM, V407, P4745, DOI 10.1007/s00216-015-8676-4; Paris MPK, 2014, J AGR FOOD CHEM, V62, P1181, DOI 10.1021/jf405627d; Patterson AD, 2010, CHEM RES TOXICOL, V23, P851, DOI 10.1021/tx100020p; Pirselova B, 2011, MOL BIOL REP, V38, P3437, DOI 10.1007/s11033-010-0453-z; RAO GJ, 1982, PLANT SOIL, V66, P121, DOI 10.1007/BF02203410; Repka V, 2014, EUR J PLANT PATHOL, V138, P787, DOI 10.1007/s10658-013-0351-z; RUHLAND M, 1994, NATURWISSENSCHAFTEN, V81, P453, DOI 10.1007/BF01136647; Snigdha M, 2015, CHEMOSPHERE, V119, P524, DOI 10.1016/j.chemosphere.2014.07.033; Vendl O, 2009, ANAL BIOANAL CHEM, V395, P1347, DOI 10.1007/s00216-009-2873-y; zearalenol, 2014, EUR J PLANT PATHOLOL, V138, P787; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030	51	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187247	10.1371/journal.pone.0187247	http://dx.doi.org/10.1371/journal.pone.0187247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145415	gold, Green Published, Green Submitted			2022-12-26	WOS:000415378800013
J	Schaudinn, C; Dittmann, C; Jurisch, J; Laue, M; Gunday-Tureli, N; Blume-Peytavi, U; Vogt, A; Rancan, F				Schaudinn, Christoph; Dittmann, Christin; Jurisch, Jana; Laue, Michael; Guenday-Tuereli, Nazende; Blume-Peytavi, Ulrike; Vogt, Annika; Rancan, Fiorenza			Development, standardization and testing of a bacterial wound infection model based on ex vivo human skin	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BIOFILMS; CELLS; EAR; PIG	Current research on wound infections is primarily conducted on animal models, which limits direct transferability of these studies to humans. Some of these limitations can be overcome by using-otherwise discarded-skin from cosmetic surgeries. Superficial wounds are induced in fresh ex vivo skin, followed by intradermal injection of Pseudomonas aeruginosa under the wound. Subsequently, the infected skin is incubated for 20 hours at 37 degrees C and the CFU/wound are determined. Within 20 hours, the bacteria count increased from 10(7) to 10(9) bacteria per wound, while microscopy revealed a dense bacterial community in the collagen network of the upper wound layers as well as numerous bacteria scattered in the dermis. At the same time, IL-1alpha and IL-1beta amounts increased in all infected wounds, while-due to bacteria-induced cell lysis-the IL-6 and IL-8 concentrations rose only in the uninfected samples. High-dosage ciprofloxacin treatment resulted in a decisive decrease in bacteria, but consistently failed to eradicate all bacteria. The main benefits of the ex vivo wound model are the use of healthy human skin, a quantifiable bacterial infection, a measureable donor-dependent immune response and a good repeatability of the results. These properties turn the ex vivo wound model into a valuable tool to examine the mechanisms of host-pathogen interactions and to test antimicrobial agents.	[Schaudinn, Christoph; Dittmann, Christin; Laue, Michael] Robert Koch Inst, Adv Light & Electron Microscopy, Berlin, Germany; [Jurisch, Jana; Blume-Peytavi, Ulrike; Vogt, Annika; Rancan, Fiorenza] Charite, Clin Res Ctr Hair & Skin Sci, Berlin, Germany; [Jurisch, Jana; Blume-Peytavi, Ulrike; Vogt, Annika; Rancan, Fiorenza] Humboldt Univ, Freie Univ Berlin, Berlin, Germany; [Jurisch, Jana; Blume-Peytavi, Ulrike; Vogt, Annika; Rancan, Fiorenza] Charite, Berlin Inst Hlth, Berlin, Germany; [Guenday-Tuereli, Nazende] MJR PharmJet GmbH, Uberherrn, Germany	Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schaudinn, C (corresponding author), Robert Koch Inst, Adv Light & Electron Microscopy, Berlin, Germany.	schaudinnc@rki.de		Vogt, Annika/0000-0001-9134-8413; Gunday-Tureli, Nazende/0000-0002-6310-4785; Blume-Peytavi, Ulrike/0000-0003-3528-3752; Rancan, Fiorenza/0000-0003-3903-3240	 [KF2928204MD4]		We hereby disclose that the authors CS and ML are employees of the federal Robert Koch Institute of Germany, JJ, UBP, AV and FR are employees of the Charite Universitatsmedizin of the city of Berlin, and NGT is an employee of the private company MJR PharmJet GmbH. Each of the above mentioned institutions/company received an equal part of the federal funding grant [KF2928204MD4], which was granted to the authors CS, NGT and FR. The funders provided support in the form of research materials and salaries for authors [Robert Koch Institute: CS, ML - Charite: UBP, AV, FR - MJR PharmJet GmbH: NGT grant salary support [KF2928204MD4]: CD, JJ]. However, any of the funders had an additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AHN ST, 1990, ANN PLAS SURG, V24, P17, DOI 10.1097/00000637-199001000-00004; Berthet A, 2017, ARCH TOXICOL; Boxman ILA, 1996, ARCH DERMATOL RES, V288, P391, DOI 10.1007/BF02507108; Contassot E, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13590; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; DIENER B, 1973, INFECT IMMUN, V7, P212, DOI 10.1128/IAI.7.2.212-217.1973; Doge N, 2016, EUR J PHARM BIOPHARM; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Grice EA, 2012, ADV EXP MED BIOL, V946, P55, DOI 10.1007/978-1-4614-0106-3_4; Hassett DJ, 1996, J BACTERIOL, V178, P3996, DOI 10.1128/jb.178.14.3996-4003.1996; HAUSER C, 1986, J IMMUNOL, V136, P3317; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Konrat K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157663; LaFayette SL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500199; Natsuaki Y, 2014, NAT IMMUNOL, V15, P1064, DOI 10.1038/ni.2992; Okuda J, 2011, J INFECT CHEMOTHER, V17, P782, DOI 10.1007/s10156-011-0257-7; Olivas AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044326; Percival SL, 2015, ADV WOUND CARE, V4, P373, DOI 10.1089/wound.2014.0557; Rancan F, 2017, EUR J PHARM BIOPHARM, V116, P4, DOI 10.1016/j.ejpb.2016.11.017; Rancan F, 2014, J CONTROL RELEASE, V176, P115, DOI 10.1016/j.jconrel.2013.12.022; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Surgeons ASoP, 2015, PLAST SURG STAT; Thompson BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117491; Wall GM, 2009, PEDIATR INFECT DIS J, V28, P141, DOI 10.1097/INF.0b013e31818b0c9c; Wang H., 2010, J CYST FIBROS, V9, pS41, DOI 10.1016/S1569-1993(10)60158-0; Wang JF, 2001, COMPARATIVE MED, V51, P341	29	32	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186946	10.1371/journal.pone.0186946	http://dx.doi.org/10.1371/journal.pone.0186946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140982	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400013
J	Tian, T; Mijiti, P; Huang, BX; Zhang, FD; Ainiwaer, A; Sang, GY; Zhang, ZL; Mahan, Y; Tuo, XQ; Gong, Z; Dai, JH				Tian Tian; Mijiti, Peierdun; Huang Bingxue; Zhang Fadong; Ainiwaer, Abidan; Sang Guoyao; Zhang Zhanlin; Mahan, Yeledan; Tuo Xiaoqin; Gong Zheng; Dai Jianghong			Prevalence and risk factors of anal human papillomavirus infection among HIV-negative men who have sex with men in Urumqi city of Xinjiang Uyghur Autonomous Region, China	PLOS ONE			English	Article							AGE-SPECIFIC PREVALENCE; HPV INFECTION; CANCER; IDENTITIES; DIAGNOSIS; ASSAY	Background Infection with human papillomavirus (HPV) is the most common sexually transmitted infection among men who have sex with men (MSM). Study on prevalence and risk factors of anal HPV infection among HIV-negative MSM in Northwestern China was rare. Methods We performed a cross-sectional study of HPV prevalence using anal swab specimens among HIV-negative MSM in Urumqi city of Xinjiang Uyghur Autonomous Region, China between April 1st and October 30th in 2016. Prevalence of any anal HPV infection, high-risk and low-risk HPV infection was estimated. Risk factors associated with any anal HPV infection was analyzed using univariate and multivariate logistic regression models. Results Among 538 potential participants, 500(92.9%) were recruited in this study. The genotyping results of anal HPV infection were available for all. Of them, 259 (51.8%), 190 (38.0%) and 141(28.2%) were positive for at least one of the targeted 37 HPV genotypes, high-risk HPV genotypes, and any low-risk HPV genotypes. The most prevalent anal HPV genotype was HPV 6(11.8%), followed by HPV 16(11.2%), HPV 11(10.8%), HPV 51(7.0%) and HPV 18 (5.4%). Among those infected with at least one of the targeted 37 anal HPV genotypes, 75 (29.0%), 155(59.8%) and 191(73.7%) were infected with 2-valent, quadrivalent and 9-valent HPV vaccine-covered genotypes. Receptive anal intercourse in the past year was the only predictor of any anal HPV infection in multivariate logistic regression model. Conclusion Prevalence of any anal HPV infection and high-risk HPV infection among HIV-negative MSM in Urumqi city of Xinjiang is high. The majority of genotypes detected in our study were covered by quadrivalent and 9-valent HPV vaccines. Regular anal exams and early HPV vaccination among MSM may be considered in future HPV prevention programs in Xinjiang, China.	[Tian Tian; Mijiti, Peierdun; Huang Bingxue; Ainiwaer, Abidan; Zhang Zhanlin; Mahan, Yeledan; Tuo Xiaoqin; Gong Zheng; Dai Jianghong] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Urumqi, Xinjiang, Peoples R China; [Zhang Fadong] Toutunhe Dist Gen Hosp, Surg Dept, Urumqi, Xinjiang, Peoples R China; [Sang Guoyao] Xinjiang Med Univ, Affiliated Hosp 1, Clin Lab, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Dai, JH (corresponding author), Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Urumqi, Xinjiang, Peoples R China.	438263678@qq.com		Tian, Tian/0000-0002-6103-1666	Natural Science Foundation of China [81560539]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (grant number 81560539) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benevolo M, 2016, EXPERT REV ANTI-INFE, V14, P465, DOI 10.1586/14787210.2016.1174065; Blas MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139524; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Cobos C, 2014, INT REV IMMUNOL, V33, P383, DOI 10.3109/08830185.2014.911857; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Guimaraes MDC, 2011, JAIDS-J ACQ IMM DEF, V57, pS217, DOI 10.1097/QAI.0b013e31821e9994; Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822; Fox P, 2009, CURR OPIN HIV AIDS, V4, P64, DOI 10.1097/COH.0b013e32831a6fe0; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Geskus RB, 2016, AIDS, V30, P37, DOI 10.1097/QAD.0000000000000874; Giuliano AR, 2010, GYNECOL ONCOL, V117, pS15, DOI 10.1016/j.ygyno.2010.01.026; Glick SN, 2014, J INFECT DIS, V209, P369, DOI 10.1093/infdis/jit441; Goldstone S, 2011, J INFECT DIS, V203, P66, DOI 10.1093/infdis/jiq016; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Hubbard RA, 2003, ARCH PATHOL LAB MED, V127, P940; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2009, HUM PAP REV HUM CA B, V100B, P255; Jaspal R, 2012, CULT HEALTH SEX, V14, P767, DOI 10.1080/13691058.2012.693626; Jaspal R, 2010, BRIT J SOC PSYCHOL, V49, P849, DOI 10.1348/014466609X485025; Li XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21368; Li ZK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127355; Liu SS, 2010, J CLIN MICROBIOL, V48, P758, DOI 10.1128/JCM.00989-09; Machalek DA, 2012, SEX HEALTH, V9, P527, DOI 10.1071/SH12043; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Molijn A, 2005, J CLIN VIROL, V32, pS43, DOI 10.1016/j.jcv.2004.12.004; Muller EE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1706-9; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Pan SW, 2016, JAIDS-J ACQ IMM DEF, V73, P463, DOI 10.1097/QAI.0000000000001127; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Phanuphak N, 2013, JAIDS-J ACQ IMM DEF, V63, P472, DOI 10.1097/QAI.0b013e3182918a5a; Ren XQ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2641259; Sonnex C, 1999, SEX TRANSM INFECT, V75, P317, DOI 10.1136/sti.75.5.317; Supindham T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124499; Tao PP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/938780; van Doorn L J, 2001, Expert Rev Mol Diagn, V1, P394; van Rijn VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092208; Wong OGW, 2012, J CLIN MICROBIOL, V50, P1691, DOI 10.1128/JCM.05933-11; Zhang DZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100793; Zou HC, 2016, HUM VACC IMMUNOTHER, V12, P1551, DOI 10.1080/21645515.2015.1099771	39	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187928	10.1371/journal.pone.0187928	http://dx.doi.org/10.1371/journal.pone.0187928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141014	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400038
J	de Souza, SSA; Catta-Preta, CM; Alves, JMP; Cavalcanti, DP; Teixeira, MMG; Camargo, EP; De Souza, W; Silva, R; Motta, MCM				de Souza, Silvana Sant' Anna; Catta-Preta, Carolina Moura; Alves, Joao Marcelo P.; Cavalcanti, Danielle P.; Teixeira, Marta M. G.; Camargo, Erney P.; De Souza, Wanderley; Silva, Rosane; Motta, Maria Cristina M.			Expanded repertoire of kinetoplast associated proteins and unique mitochondrial DNA arrangement of symbiont-bearing trypanosomatids	PLOS ONE			English	Article							CRITHIDIA-FASCICULATA; PHYLOGENETIC INFERENCE; ENDOSYMBIONT; STRIGOMONAS; REPLICATION; ANGOMONAS; BACTERIUM; GENOME; ORGANIZATION; METABOLISM	In trypanosomatids, the kinetoplast is the portion of the single mitochondrion that is connected to the basal body and contains the kDNA, a network composed by circular and interlocked DNA. The kDNA packing is conducted by Kinetoplast Associated Proteins (KAPs), which are similar to eukaryotic histone H1. In symbiont-harboring trypanosomatids (SHTs) such as Angomonas deanei and Strigomonas culicis, a beta-proteobacterium co-evolves with the host in a mutualistic relationship. The prokaryote confers nutritional benefits to the host and affects its cell structure. Atomic force microscopy showed that the topology of isolated kDNA networks is quite similar in the two SHT species. Ultrastructural analysis using high-resolution microscopy techniques revealed that the DNA fibrils are more compact in the kinetoplast region that faces the basal body and that the presence of the symbiotic bacterium does not interfere with kDNA topology. However, RT-PCR data revealed differences in the expression of KAPs in wild-type protozoa as compared to aposymbiotic cells. Immunolocalization showed that different KAPs present distinct distributions that are coincident in symbiont-bearing and in symbiont-free cells. Although KAP4 and KAP7 are shared by all trypanosomatid species, the expanded repertoire of KAPs in SHTs can be used as phylogenetic markers to distinguish different genera.	[de Souza, Silvana Sant' Anna; Catta-Preta, Carolina Moura; De Souza, Wanderley; Motta, Maria Cristina M.] Univ Fed Rio de Janeiro, Lab Ultraestrutura Celular Hertha Meyer, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [de Souza, Silvana Sant' Anna; Silva, Rosane] Univ Fed Rio de Janeiro, Lab Metab Macromol Firmino Torres de Castro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [de Souza, Silvana Sant' Anna; Catta-Preta, Carolina Moura; De Souza, Wanderley; Motta, Maria Cristina M.] Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Alves, Joao Marcelo P.; Teixeira, Marta M. G.; Camargo, Erney P.] Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, Sao Paulo, Brazil; [Cavalcanti, Danielle P.] Inst Nacl Metrol Qualidade & Tecnol Inmetro, Lab Microbiol, Rio De Janeiro, Brazil; [Catta-Preta, Carolina Moura] Univ York, Ctr Immunol & Infect, Dept Biol, York, N Yorkshire, England	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); University of York - UK	Motta, MCM (corresponding author), Univ Fed Rio de Janeiro, Lab Ultraestrutura Celular Hertha Meyer, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.; Motta, MCM (corresponding author), Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil.; Alves, JMP (corresponding author), Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, Sao Paulo, Brazil.	jotajj@usp.br; motta@biof.ufrj.br	Alves, Joao M.P./G-8927-2011; Camargo, Erney/A-6765-2009; Cavalcanti, Danielle P/C-5959-2015; Teixeira, Marta M G/B-1115-2009; Silva, Rosane/U-6913-2019; Motta, Maria Cristina M/I-3140-2014; Silva, Rosane/C-1427-2013	Alves, Joao M.P./0000-0001-5914-2087; Camargo, Erney/0000-0003-0011-5871; Silva, Rosane/0000-0002-2998-6999; Silva, Rosane/0000-0002-2998-6999; Catta-Preta, Carolina/0000-0001-8983-3487	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [2039906 E-26/2014, E-26/010.003015/2014]; Conselho Nacional de Pesquisa (CNPq) [306619/2014-8, 483202/2011-8, 471291/2012-9, 443139/2016-4]; FAPERJ; CNPq	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge support from the following: Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Program Scientist of Rio de Janeiro State, Process number: 2039906 E-26/2014, Validation: 2014-2017, $2,900 reais per month, to MCM Motta (money used to buy all reagents, culture medium and imported chemicals); Conselho Nacional de Pesquisa (CNPq), Program: Productivity in Research, Process number: 306619/2014-8, Validation: 2014-2018, $1,100 reais per month, to MCM Motta (money used to support the group research, buy reagents, chemical, etc); Conselho Nacional de Pesquisa (CNPq), Program: Universal public call for Sciences, Process number: 483202/2011-8, Validation: 2011-2012, $20,000 reais - total amount for the period, to R Silva (money used to support the group research, buy reagents, chemical, etc); Conselho Nacional de Pesquisa (CNPq), Program: Universal public call for Sciences, Process number: 471291/2012-9, Validation: 2012-2014, $20,000 reais - total amount for the period, to R Silva (money used to support the group research, buy reagents, chemical, etc); Conselho Nacional de Pesquisa (CNPq), Program: public call for the maintenance of multi-user equipments (CENABIO plataform), Process number: 443139/2016-4, Validation: 01/2017-12/2017, $108,000 reais - total amount for the period, to W De Souza (money used for the repair and maintenance of microscopy equipment); and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Program: public call for the maintenance of equipments, Process number: E-26/010.003015/2014, Validation: 2014-2017, $815.061,00 reais - total amount for the period, to W De Souza (money used for the maintenance of high resolution microscopy equipment).; We would like to thank to FAPERJ and CNPq for financial support.	Alves JMP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-190; Alves JMP, 2013, GENOME BIOL EVOL, V5, P338, DOI 10.1093/gbe/evt012; Alves JMP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023518; Andrade ID, 2011, MICROBIOL-SGM, V157, P2818, DOI 10.1099/mic.0.049247-0; Avliyakulov NK, 2004, EUKARYOT CELL, V3, P518, DOI 10.1128/EC.3.2.518-526.2004; Azevedo-Martins AC, 2014, PARASITOLOGY, V27, P1; Beck K, 2013, EUKARYOT CELL, V12, P970, DOI 10.1128/EC.00352-12; Catta-Preta CMC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00520; Cavalcanti DP, 2011, MICRON, V42, P553, DOI 10.1016/j.micron.2011.01.009; Cavalcanti DP, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-120; Cavalcanti DP, 2008, HISTOCHEM CELL BIOL, V130, P1177, DOI 10.1007/s00418-008-0450-7; CHANG KP, 1975, J PROTOZOOL, V22, P271, DOI 10.1111/j.1550-7408.1975.tb05866.x; CHANG KP, 1974, SCIENCE, V183, P531, DOI 10.1126/science.183.4124.531; Catta-Preta CMC, 2016, J EUKARYOT MICROBIOL, V63, P794, DOI 10.1111/jeu.12326; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fampa P, 2003, INT J PARASITOL, V33, P1019, DOI 10.1016/S0020-7519(03)00124-3; FREYMULLER E, 1981, J PROTOZOOL, V28, P175, DOI 10.1111/j.1550-7408.1981.tb02829.x; Gadelha C, 2005, EUKARYOT CELL, V4, P516, DOI 10.1128/EC.4.3.516-525.2005; Hines JC, 1998, MOL BIOCHEM PARASIT, V94, P41, DOI 10.1016/S0166-6851(98)00048-6; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jensen RE, 2012, ANNU REV MICROBIOL, V66, P473, DOI 10.1146/annurev-micro-092611-150057; Klein CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079786; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; Loyola-Machado AC, 2017, PROTIST, V168, P253, DOI 10.1016/j.protis.2017.02.001; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; Lukes J, 2001, MOL BIOCHEM PARASIT, V117, P179, DOI 10.1016/S0166-6851(01)00348-6; Motta MCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060209; Manchester T, 2013, PARASITOLOGY, V140, P1422, DOI 10.1017/S0031182013001029; Motta Maria Cristina M., 2010, Open Parasitology Journal, V4, P139; Motta MCM, 2008, CURR PHARM DESIGN, V14, P847, DOI 10.2174/138161208784041051; Mundim MH, 1977, J PROTOZOOL, V24, P239; Nabhan AR, 2012, BRIEF BIOINFORM, V13, P122, DOI 10.1093/bib/bbr014; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; de Souza FSP, 2010, MOL BIOCHEM PARASIT, V172, P90, DOI 10.1016/j.molbiopara.2010.03.014; PEREZMORGA DL, 1993, CELL, V74, P703, DOI 10.1016/0092-8674(93)90517-T; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SCHMID MB, 1990, CELL, V63, P451, DOI 10.1016/0092-8674(90)90438-K; SOUTOPADRON T, 1978, J HISTOCHEM CYTOCHEM, V26, P349, DOI 10.1177/26.5.77871; St John JC, 2010, HUM REPROD UPDATE, V16, P488, DOI 10.1093/humupd/dmq002; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Teixeira MMG, 2011, PROTIST, V162, P503, DOI 10.1016/j.protis.2011.01.001; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Trikin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005586; Votypka J, 2014, PROTIST, V165, P825, DOI 10.1016/j.protis.2014.09.002; WARREN LG, 1960, J PARASITOL, V46, P529, DOI 10.2307/3274932; Xu CW, 1996, MOL CELL BIOL, V16, P564; XU CX, 1993, P NATL ACAD SCI USA, V90, P1786, DOI 10.1073/pnas.90.5.1786	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187516	10.1371/journal.pone.0187516	http://dx.doi.org/10.1371/journal.pone.0187516			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131838	Green Submitted, Green Published, gold			2022-12-26	WOS:000414997800015
J	Datta, A; Kuhn, I; Ahmad, M; Michalski, S; Auge, H				Datta, Arunava; Kuehn, Ingolf; Ahmad, Mustaqeem; Michalski, Stefan; Auge, Harald			Processes affecting altitudinal distribution of invasive Ageratina adenophora in western Himalaya: The role of local adaptation and the importance of different life-cycle stages	PLOS ONE			English	Article							CROFTONWEED EUPATORIUM-ADENOPHORUM; PHENOTYPIC PLASTICITY; GENETIC-VARIATION; RANGE; POPULATIONS; ASTERACEAE; SELECTION; PLANTS; WEED; GERMINATION	The spread of invasive plants along elevational gradients is considered a threat to fragile mountain ecosystems, but it can also provide the opportunity to better understand some of the basic processes driving the success of invasive species. Ageratina adenophora (Asteraceae) is an invasive plant of global importance and has a broad distribution along elevational gradients in the Western Himalayas. Our study aimed at understanding the role of evolutionary processes (e.g. local adaptation and clinal differentiation) and different life history stages in shaping the distribution pattern of the invasive plant along an elevational gradient in the Western Himalaya. We carried out extensive distributional surveys, established a reciprocal transplant experiment with common gardens at three elevational levels, and measured a suite of traits related to germination, growth, reproduction and phenology. Our results showed a lack of local adaptation, and we did not find any evidence for clinal differentiation in any measured trait except a rather weak signal for plant height. We found that seed germination was the crucial life-cycle transition in determining the lower range limit while winter mortality of plants shaped the upper range limit in our study area, thus explaining the hump shaped distribution pattern. Differences in trait values between gardens for most traits indicated a high degree of phenotypic plasticity. Possible causes such as apomixis, seed dispersal among sites, and pre-adaptation might have confounded evolutionary processes to act upon. Our results suggest that the success and spread of Ageratina adenophora are dependent on different life history stages at different elevations that are controlled by abiotic conditions.	[Datta, Arunava; Kuehn, Ingolf; Michalski, Stefan; Auge, Harald] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Theodor Lieser Str 4, Halle, Germany; [Kuehn, Ingolf] Martin Luther Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, Kirchtor 1, Halle, Germany; [Kuehn, Ingolf; Auge, Harald] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, Leipzig, Germany; [Ahmad, Mustaqeem] CSIR, Inst Himalayan Bioresource Technol, High Altitude Biol, Palampur, Himachal Prades, India	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Datta, A (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Theodor Lieser Str 4, Halle, Germany.	arunava.datta@ufz.de	Datta, Arunava/AAE-9404-2022; Kühn, Ingolf/B-9756-2009; Ahmad, Mustaqeem/P-7367-2019; Auge, Harald/D-4802-2015; Datta, Arunava/AFD-8448-2022; Michalski, Stefan G/O-5774-2015	Datta, Arunava/0000-0002-3134-491X; Kühn, Ingolf/0000-0003-1691-8249; Ahmad, Mustaqeem/0000-0002-8454-3891; Auge, Harald/0000-0001-7432-8453; Datta, Arunava/0000-0002-3134-491X; Michalski, Stefan G/0000-0002-8969-7355	German Academic Exchange Service -DAAD [91541146]	German Academic Exchange Service -DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	The research was carried as a result of PhD project grant awarded to the 1st author, Arunava Datta, by German Academic Exchange Service -DAAD(91541146). Additional research expenses were covered by Department of Community Ecology Helmholtz Centre for Environmental Research - UFZ, Germany and CSIR-Institute of Himalayan Bioresource Technology,lndia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeli T, 2014, J BIOGEOGR, V41, P239, DOI 10.1111/jbi.12215; Alexander JM, 2012, J ECOL, V100, P771, DOI 10.1111/j.1365-2745.2011.01951.x; Alexander JM, 2009, ECOLOGY, V90, P612, DOI 10.1890/08-0453.1; Annapurna C, 2003, CURR SCI INDIA, V85, P197; [Anonymous], 2004, DIVERS DISTRIB, V10, P377; AULD BA, 1975, WEED RES, V15, P27, DOI 10.1111/j.1365-3180.1975.tb01092.x; Baker H. G., 1965, The genetics of colonizing species., P147; Baker HG, 1974, EVOLUTION WEEDS, P1; Bala S., 2014, BIOLIFE, V2, P679; Becker T, 2005, PERSPECT PLANT ECOL, V7, P173, DOI 10.1016/j.ppees.2005.09.006; Bone E, 2001, GENETICA, V112, P165, DOI 10.1023/A:1013378014069; Bossdorf O, 2008, DIVERS DISTRIB, V14, P676, DOI 10.1111/j.1472-4642.2008.00471.x; Colautti RI, 2015, MOL ECOL, V24, P1999, DOI 10.1111/mec.13162; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Easton LC, 2009, ENVIRON EXP BOT, V65, P137; Ebeling SK, 2011, J PLANT ECOL-UK, V4, P209, DOI 10.1093/jpe/rtr007; Feng YL, 2007, ACTA OECOL, V31, P40, DOI 10.1016/j.actao.2006.03.009; Geng YP, 2007, BIOL INVASIONS, V9, P245, DOI 10.1007/s10530-006-9029-1; Haider S, 2012, OECOLOGIA, V170, P89, DOI 10.1007/s00442-012-2291-2; Hao JH, 2011, BIOL INVASIONS, V13, P571, DOI 10.1007/s10530-010-9850-4; Hargreaves AL, 2014, AM NAT, V183, P157, DOI 10.1086/674525; Hereford J, 2010, AM J BOT, V97, P298, DOI 10.3732/ajb.0900224; HUISMAN J, 1993, J VEG SCI, V4, P37, DOI 10.2307/3235732; Jansen F, 2013, J VEG SCI, V24, P1108, DOI 10.1111/jvs.12050; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KHONGLAM A, 1980, P INDIAN AS-PLANT SC, V89, P237; Konarzewski TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049000; Lamarque LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074239; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Li H, 2008, WEED SCI, V56, P196, DOI 10.1614/WS-07-104.1; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lu HF, 2008, WEED SCI, V56, P42, DOI 10.1614/WS-06-210.1; Lu ZJ, 2006, WEED SCI, V54, P1068, DOI 10.1614/WS-06-040R1.1; McDougall KL, 2011, MT RES DEV, V31, P380, DOI 10.1659/MRD-JOURNAL-D-11-00082.1; Montague JL, 2008, J EVOLUTION BIOL, V21, P234, DOI 10.1111/j.1420-9101.2007.01456.x; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; Muniappan R, 2009, BIOLOGICAL CONTROL OF TROPICAL WEEDS USING ARTHROPODS, P63, DOI 10.1017/CBO9780511576348.004; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Normand S, 2014, ECOGRAPHY, V37, P1149, DOI 10.1111/ecog.01490; Normand S, 2009, GLOBAL ECOL BIOGEOGR, V18, P437, DOI 10.1111/j.1466-8238.2009.00451.x; Noyes RD., 2007, FUNC PLANT SCI BIOTE, V1, P207; Oduor AMO, 2016, J ECOL, V104, P957, DOI 10.1111/1365-2745.12578; OSMOND CB, 1987, BIOSCIENCE, V37, P38, DOI 10.2307/1310176; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Pauchard A, 2009, FRONT ECOL ENVIRON, V7, P479, DOI 10.1890/080072; Pysek P, 2011, P NATL ACAD SCI USA, V108, P439, DOI 10.1073/pnas.1017682108; RCore Team, 2020, R LANG ENV STAT COMP; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Ross CA, 2009, BIOL INVASIONS, V11, P441, DOI 10.1007/s10530-008-9261-y; Seipel T, 2016, PERSPECT PLANT ECOL, V20, P46, DOI 10.1016/j.ppees.2016.04.001; Sekar K. C., 2015, Indian Forester, V141, P520; Sexton JP, 2011, P NATL ACAD SCI USA, V108, P11704, DOI 10.1073/pnas.1100404108; Steinger T, 2000, OECOLOGIA, V123, P475, DOI 10.1007/s004420000342; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Tripathi RS, 2012, CABI INVASIVE SER, P43, DOI 10.1079/9781845939076.0043; TRIPATHI R S, 1981, Proceedings of the Indian National Science Academy Part B Biological Sciences, V47, P458; Vellend M, 2007, TRENDS ECOL EVOL, V22, P481, DOI 10.1016/j.tree.2007.02.017; Wan FH, 2010, SCI CHINA LIFE SCI, V53, P1291, DOI 10.1007/s11427-010-4080-7; Wang R, 2006, DIVERS DISTRIB, V12, P397, DOI 10.1111/j.1366-9516.2006.00250.x; Wang R, 2011, NEW PHYTOL, V191, P828, DOI 10.1111/j.1469-8137.2011.03720.x; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344; Wieneke S, 2004, GLOBAL CHANGE BIOL, V10, P1389, DOI 10.1111/j.1365-2486.2004.00813.x; Zhao XJ, 2013, J PLANT ECOL, V6, P316, DOI 10.1093/jpe/rts036; Zhong Sheng, 2007, Acta Prataculturae Sinica, V16, P81; Zhou Meng, 2009, Yingyong Shengtai Xuebao, V20, P1643; Zhu L, 2007, LANDSCAPE ECOL, V22, P1143, DOI 10.1007/s10980-007-9096-4	70	28	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187708	10.1371/journal.pone.0187708	http://dx.doi.org/10.1371/journal.pone.0187708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125852	Green Published, gold, Green Submitted			2022-12-26	WOS:000414866000019
J	Gronewold, J; Dahlmann, C; Jager, M; Hermann, DM				Gronewold, Janine; Dahlmann, Christian; Jaeger, Marcus; Hermann, Dirk M.			Identification of hospitalized elderly patients at risk for adverse in-hospital outcomes in a university orthopedics and trauma surgery environment	PLOS ONE			English	Article							CASE-MIX SYSTEM; EMERGENCY-DEPARTMENT; FUNCTIONAL DECLINE; SCREENING TOOL; OLDER-ADULTS; CARE; SENIORS; LENGTH; STAY; ADMISSION	Background As a consequence of demographic changes, hospitals are confronted with increasing numbers of elderly patients, who are at high risk of adverse events during hospitalization. Geriatric risk screening followed by comprehensive geriatric assessment (CGA) and treatment has been requested by geriatric societies and task forces to identify patients at risk. Since empirical evidence on factors predisposing to adverse hospital events is scarce, we now prospectively evaluated implications of geriatric risk screening followed by CGA in a university hospital department of orthopedics and trauma surgery. Methods Three hundred and eighty-one patients >= 75 years admitted to the Department of Orthopedics and Trauma Surgery of the University Hospital Essen received Identification of Seniors at Risk (ISAR) Screening followed by CGA via a geriatric liaison service in case of positive screening results. Associations between ISAR, CGA, comorbid risk factors and diseases, length of hospital stay, number of nursing and physiotherapy hours, and falls during hospital stay were analyzed. Results Of 381 ISAR screenings, 327 (85.8%) were positive, confirming a high percentage of patients at risk of adverse events. Of these, 300 CGAs revealed 82.7% abnormal results, indicating activities of daily living impairment combined with cognitive, emotional or mobility disturbances. Abnormal CGA resulted in a longer hospital stay (14.0 +/- 10.3 days in ISAR +/CGA abnormal compared with 7.6 +/- 7.0 days in ISAR+/CGA normal and 8.1 +/- 5.4 days in ISAR-, both p<0.001), increased nursing hours (3.4 +/- 1.1 hours/day in ISAR+/CGA abnormal compared with 2.5 +/- 1.0 hours/day in ISAR+/CGA normal and 2.2 +/- 0.8 hours/day in ISAR-, both p<0.001), and increased falls (7.3% in ISAR+/CGA abnormal, 0% in ISAR+/CGA normal, 1.9% in ISAR-). Physiotherapy hours were only significantly increased in ISAR+/CGA abnormal (3.0 +/- 2.7 hours) compared with in ISAR+/CGA normal (1.6 +/- 1.4 hours, p<0.001) whereas the comparison with ISAR-(2.4 +/- 2.4 hours) did not reach significance (p = 0.368). In multivariable regressions, the CGA domains activities of daily living impairment (assessed by Barthel-Index) and signs of depression (assessed by geriatric depression scale) predicted longer length of hospital stay. High ISAR score, and impairment in activities of daily living and cognition (assessed by mini-mental state examination and clock-drawing test) predicted increased nursing hours, and impairment in activities of daily living and mobility predicted increased physiotherapy hours. Conclusions An abnormal geriatric screening and assessment is associated with longer hospital stay, more nursing and physiotherapy hours, and more falls.	[Gronewold, Janine; Hermann, Dirk M.] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany; [Dahlmann, Christian] Univ Duisburg Essen, Univ Hosp Essen, Dept Nursing Res, Essen, Germany; [Jaeger, Marcus] Univ Duisburg Essen, Univ Hosp Essen, Dept Orthoped & Trauma Surg, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Hermann, DM (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany.	dirk.hermann@uk-essen.de	Hermann, Dirk/GZB-9350-2022; Hermann, Dirk M./AAT-3652-2021; Hermann, Dirk M/AAP-5538-2020	Hermann, Dirk M./0000-0003-0198-3152; Jager, Marcus/0000-0001-9516-1058				Alarcon T, 1999, AGE AGEING, V28, P429, DOI 10.1093/ageing/28.5.429; Asomaning N, 2014, J EMERG NURS, V40, P357, DOI 10.1016/j.jen.2013.08.014; Australian New Zealand Soc Geriatr, 2009, AUSTRALAS J AGEING, V28, P153, DOI 10.1111/j.1741-6612.2009.00380.x; Beaton K, 2013, CLIN INTERV AGING, V8, P485, DOI 10.2147/CIA.S42528; Bertozzi B, 1996, AGING CLIN EXP RES, V8, P170, DOI 10.1007/BF03339673; Campbell SE, 2004, AGE AGEING, V33, P110, DOI 10.1093/ageing/afh036; Conroy S, 2016, EUR GERIATR MED, V7, P315, DOI 10.1016/j.eurger.2016.03.011; Dendukuri N, 2004, J AM GERIATR SOC, V52, P290, DOI 10.1111/j.1532-5415.2004.52073.x; Di Bari M, 2012, J GERONTOL A-BIOL, V67, P544, DOI 10.1093/gerona/glr209; Di Iorio A, 1999, AGING CLIN EXP RES, V11, P150, DOI 10.1007/BF03399656; Dunstan EJ, 1996, AGE AGEING, V25, P102, DOI 10.1093/ageing/25.2.102; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; Findlay P, 2000, FACTORS AFFECTING DU; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HOGAN DB, 1987, CAN MED ASSOC J, V136, P713; Inouye SK, 2000, J AM GERIATR SOC, V48, P1697; Ivemeyer D, 2006, DEMENZTESTS PRAXIS W; Jette DU, 2009, PHYS THER, V89, P1158, DOI 10.2522/ptj.20080338; MAGUIRE PA, 1986, BRIT MED J, V292, P1251, DOI 10.1136/bmj.292.6530.1251; MAHONEY F I, 1965, Md State Med J, V14, P61; McCusker J, 2001, J AM GERIATR SOC, V49, P1272, DOI 10.1046/j.1532-5415.2001.49254.x; McCusker J, 1999, J AM GERIATR SOC, V47, P1229, DOI 10.1111/j.1532-5415.1999.tb05204.x; Mion LC, 2001, J AM GERIATR SOC, V49, P1379, DOI 10.1046/j.1532-5415.2001.49270.x; Mueller M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-295; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; NARAIN P, 1988, J AM GERIATR SOC, V36, P775, DOI 10.1111/j.1532-5415.1988.tb04259.x; Perlado F, 1999, AGE AGEING, V28, P581, DOI 10.1093/ageing/28.6.581; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rock BD, 1996, SOC WORK HEALTH CARE, V22, P21, DOI 10.1300/J010v22n03_02; Rosted E, 2014, DAN MED J, V61; SANDERS AB, 1992, ANN EMERG MED, V21, P830, DOI 10.1016/S0196-0644(05)81030-3; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; SHULMAN KI, 1993, INT J GERIATR PSYCH, V8, P487, DOI 10.1002/gps.930080606; Singler K, 2014, GERONTOLOGY, V60, P413, DOI 10.1159/000358825; SPAITE DW, 1990, ANN EMERG MED, V19, P1418, DOI 10.1016/S0196-0644(05)82611-3; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; Suffoletto B, 2016, EMERG MED J, V33, P4, DOI 10.1136/emermed-2014-203936; Sutton M, 2008, INT J CLIN PRACT, V62, P1900, DOI 10.1111/j.1742-1241.2008.01930.x; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Vetrano DL, 2014, EUR J INTERN MED, V25, P56, DOI 10.1016/j.ejim.2013.08.709; Warburton Rebecca N, 2004, Int J Health Care Qual Assur Inc Leadersh Health Serv, V17, P339, DOI 10.1108/09526860410557598; Ziere G, 2006, BRIT J CLIN PHARMACO, V61, P218, DOI 10.1111/j.1365-2125.2005.02543.x	42	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187801	10.1371/journal.pone.0187801	http://dx.doi.org/10.1371/journal.pone.0187801			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM2XM	29125861	Green Published, gold, Green Submitted			2022-12-26	WOS:000414866000024
J	Hsu, CY; Liu, PH; Ho, SY; Huang, YH; Lee, YH; Chiou, YY; Hsieh, TH; Fang, T; Tsai, YJ; Hou, MC; Huo, TI				Hsu, Chia-Yang; Liu, Po-Hong; Ho, Shu-Yein; Huang, Yi-Hsiang; Lee, Yun-Hsuan; Chiou, Yi-You; Hsieh, Ting-Hui; Fang, Tom; Tsai, Ya-Ju; Hou, Ming-Chih; Huo, Teh-Ia			Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study	PLOS ONE			English	Article							LIVER-CANCER SYSTEM; PERFORMANCE STATUS; NATURAL-HISTORY; SURVIVAL; MANAGEMENT; DETERMINANTS; REGORAFENIB; CIRRHOSIS; MODEL	Background The recently proposed nomogram of Barcelona Clinic Liver Cancer (BCLC) lacks predictive accuracy for patients with stage D hepatocellular carcinoma (HCC). Tumor burden is crucial in prognostic prediction but is not included in the criteria of stage D HCC. This study aims to develop a nomogram with tumor burden as the core element for BCLC stage D patients. Methods A total of 386 patients were randomly grouped into derivation and validation sets (1: 1 ratio). The multivariate Cox proportional hazards model was used to select factors with significant prognostic effect and generate the nomogram. Concordance indices and calibration plots were used to evaluate the performance of nomogram. Results Overall survival of study patients was significantly associated with tumor burden as well as hepatitis B, serum a-fetoprotein level, cirrhosis and performance status in multivariate Cox regression (all p< 0.05). Beta-coefficients of these variables in derivation set were used to generate the nomogram. Each patient was assigned with a total nomogram point that predicted individualized 6-month and 1-year survival. The derivation and validation sets had a c-index of 0.759 (95% confidence interval [CI]: 0.552-0.923) and 0.741 (95% CI: 0.529-0.913), respectively. The calibration plots were close to the 45-degree line for 6month and 1-year survival prediction for all quarters of patients in both derivation and validation sets. Conclusion Tumor burden is significantly associated with the outcome for patients with stage D HCC. The tumor burden-incorporated nomogram may serve as a feasible and easy-to-use tool in predicting survival on an individual level.	[Hsu, Chia-Yang; Liu, Po-Hong; Ho, Shu-Yein; Huang, Yi-Hsiang; Lee, Yun-Hsuan; Hou, Ming-Chih; Huo, Teh-Ia] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Hsu, Chia-Yang; Liu, Po-Hong; Ho, Shu-Yein; Lee, Yun-Hsuan; Chiou, Yi-You; Hou, Ming-Chih; Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Hsu, Chia-Yang] Univ Nevada, Sch Med, Dept Internal Med, Reno, NV 89557 USA; [Liu, Po-Hong] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Huang, Yi-Hsiang] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei, Taiwan; [Chiou, Yi-You] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Hsieh, Ting-Hui; Fang, Tom] Gastroenterol Consultants, Reno, NV USA; [Tsai, Ya-Ju] Renown Reg Med Ctr, Reno, NV USA; [Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Harvard University; Harvard T.H. Chan School of Public Health; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Huo, TI (corresponding author), Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan.; Huo, TI (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.; Huo, TI (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei, Taiwan.	tihuo@vghtpe.gov.tw	Liu, Po-Hong/HGB-9015-2022; Liu, Po-Hong/G-8459-2015	Huang, Yi-Hsiang/0000-0001-5241-5425; Liu, Po-Hong/0000-0001-6205-3704	Center of Excellence for Cancer Research at Taipei Veterans General Hospital, Taiwan [MOHW106-TDU-B-211-144-003]; Taipei Veterans General Hospital, Taiwan [V106C-021, V105A-011, VN106-11]	Center of Excellence for Cancer Research at Taipei Veterans General Hospital, Taiwan; Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This study was supported by grants from the Center of Excellence for Cancer Research at Taipei Veterans General Hospital (MOHW106-TDU-B-211-144-003), Taiwan, from Taipei Veterans General Hospital (V106C-021, V105A-011, VN106-11), Taiwan.	Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Bruix J, 2013, EUR J CANCER, V49, P3412, DOI 10.1016/j.ejca.2013.05.028; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cantarini MC, 2006, AM J GASTROENTEROL, V101, P91, DOI 10.1111/j.1572-0241.2006.00364.x; Chen S., 2017, BIOMED RES INT, V2017, P1, DOI DOI 10.1155/2017/3524307; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hsu CY, 2016, LIVER INT, V36, P1717, DOI 10.1111/liv.13175; Hsu CY, 2016, LIVER INT, V36, P1498, DOI 10.1111/liv.13114; Hsu CY, 2015, J CLIN GASTROENTEROL, V49, P878, DOI 10.1097/MCG.0000000000000300; Hsu CY, 2013, HEPATOLOGY, V57, P112, DOI 10.1002/hep.25950; Hsu CY, 2010, J HEPATOL, V53, P108, DOI 10.1016/j.jhep.2010.01.038; Huo TI, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-146; Huo TI, 2009, LIVER INT, V29, P767, DOI 10.1111/j.1478-3231.2008.01908.x; Khalaf N, 2017, CLIN GASTROENTEROL H, V15, P273, DOI 10.1016/j.cgh.2016.07.033; Kudo M, 2013, DIGEST DIS, V31, P490, DOI 10.1159/000355259; Lee YH, 2014, J CLIN GASTROENTEROL, V48, P734, DOI 10.1097/MCG.0b013e3182a8a254; Lee YH, 2013, HEPATOL INT, V7, P645, DOI 10.1007/s12072-012-9375-2; Liu PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155588; Liu PH, 2014, ANN SURG ONCOL, V21, P1825, DOI 10.1245/s10434-014-3510-3; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Luo CP, 2017, EUR J CANCER, V71, P117, DOI 10.1016/j.ejca.2016.09.040; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Ruzzenente A, 2009, J GASTROINTEST SURG, V13, P1313, DOI 10.1007/s11605-009-0903-x; Sanoff HK, 2017, J ONCOL PRACT, V13, pE197, DOI 10.1200/JOP.2016.017814; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Zhou YM, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-108	32	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0188031	10.1371/journal.pone.0188031	http://dx.doi.org/10.1371/journal.pone.0188031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125877	Green Published, Green Submitted, gold			2022-12-26	WOS:000414866000038
J	Lanini, S; Minosse, C; Vairo, F; Garbuglia, A; Di Bari, V; Agresta, A; Rezza, G; Puro, V; Pendenza, A; Loffredo, MR; Scognamiglio, P; Zumla, A; Panella, V; Ippolito, G; Capobianchi, MR				Lanini, Simone; Minosse, Claudia; Vairo, Francesco; Garbuglia, Annarosa; Di Bari, Virginia; Agresta, Alessandro; Rezza, Giovanni; Puro, Vincenzo; Pendenza, Alessio; Loffredo, Maria Rosaria; Scognamiglio, Paola; Zumla, Alimuddin; Panella, Vincenzo; Ippolito, Giuseppe; Capobianchi, Maria Rosaria		Grp Laziale Sorveglianza Epatiti V	A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016-March 2017	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; REGION	The hepatitis A virus (HAV) is mainly transmitted through the faecal-oral route. In industrialized countries HAV infection generally occurs as either sporadic cases in travelers from endemic areas, local outbreak within closed/semi-closed population and as foodborne community outbreak. Recently, an increasing number of HAV infection clusters have been reported among young men-who-have-sex-with-men (MSM). The Lazio Regional Service for the epidemiology and control for infectious diseases (SeRESMI) has noticed an increase of acute hepatitis A (AHA) since September 2016. Temporal analysis carried out with a discrete Poisson model using surveillance data between January 2016 and March 2017 evidenced an ongoing outbreak of AHA that started at the end of August. Molecular investigation carried out on 130 out of 513 cases AHA reported until March 2017 suggests that this outbreak is mainly supported by an HAV variant which is currently spreading within MSM communities across Europe (VRD_521_2016). The report confirms that AHA is an emerging issue among MSM. In addition through the integration of standard (case based) surveillance with molecular investigation we could discriminate, temporally concomitant but epidemiologically unrelated, clusters due to different HAV variants. As suggested by the WHO, in countries with low HAV circulation, vaccination programmes should be tailored on the local epidemiological patterns to prevent outbreaks among high risk groups and eventual spillover of the infection in the general population.	[Lanini, Simone; Minosse, Claudia; Vairo, Francesco; Garbuglia, Annarosa; Di Bari, Virginia; Agresta, Alessandro; Puro, Vincenzo; Scognamiglio, Paola; Ippolito, Giuseppe; Capobianchi, Maria Rosaria] Natl Inst Infect Dis Lazzaro Spallanzani, Dipartimento Epidemiol Ric Preclin & Diagnost Ava, Rome, Italy; [Rezza, Giovanni] Ist Super Sanita, Dept Infect Dis, Rome, Italy; [Pendenza, Alessio] Azienda Sanit Locale Roma 1, Dipartimento Prevenz UOS Controllo Malattie & Ges, Rome, Italy; [Loffredo, Maria Rosaria] Azienda Sanit Locale Roma 3, Serv Igiene & Sanita Pubbl Profilassi Malattie In, Rome, Italy; [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England; [Panella, Vincenzo] UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Panella, Vincenzo] Direz Reg Salute & Polit Sociali, Rome, Italy	IRCCS Lazzaro Spallanzani; Istituto Superiore di Sanita (ISS); University of London; University College London; University of London; University College London	Ippolito, G (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani, Dipartimento Epidemiol Ric Preclin & Diagnost Ava, Rome, Italy.	giuseppe.ippolito@inmi.it	Lanini, Simone/C-7523-2012; Minosse, Claudia/H-7874-2018; Agresta, Alessandro/J-8306-2018; rezza, giovanni/D-4393-2016; Scognamiglio, Paola/B-4754-2017; ZUMLA, Alimuddin/ABA-8208-2020; Minosse, Claudia/N-7805-2019	Lanini, Simone/0000-0002-6743-4001; Minosse, Claudia/0000-0001-7833-9539; Agresta, Alessandro/0000-0001-8890-0342; rezza, giovanni/0000-0003-0268-6790; Scognamiglio, Paola/0000-0002-7938-6457; ZUMLA, Alimuddin/0000-0002-5111-5735; Minosse, Claudia/0000-0001-7833-9539; Ippolito, Giuseppe/0000-0002-1076-2979; PERNO, CARLO FEDERICO/0000-0002-0825-5388; puro, vincenzo/0000-0003-0291-4490	Directorate of Health and Social Welfare, Lazio Region; Ricerca Corrente - Italian Ministry of Health; Local Public Health Units (ASL)	Directorate of Health and Social Welfare, Lazio Region; Ricerca Corrente - Italian Ministry of Health(Ministry of Health, Italy); Local Public Health Units (ASL)	This intervention and the study were funded by Directorate of Health and Social Welfare, Lazio Region (http://www.regione.lazio.it/ Organigramma/key.do?code=UNOR_DSS00008&type=dir), the Local Public Health Units (ASL) and Ricerca Corrente - Italian Ministry of Health (http://www.salute.gov.it/portale/home.html).	[Anonymous], 2012, Wkly Epidemiol Rec, V87; [Anonymous], 2012, OFFICIAL J EUROPEAN; [Anonymous], 2015, CDC EPIDEMIOLOGY PRE; Beebeejaun K, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.5.30454; Bordi L, 2012, J CLIN VIROL, V54, P26, DOI 10.1016/j.jcv.2012.01.009; Bruni R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149642; Capobianchi MR, 2014, MICROBES INFECT, V16, P362, DOI 10.1016/j.micinf.2014.01.003; Chironna M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-271; European Centre for Disease Prevention and Control, 2016, HEP VIR EU EEA 1975; European Centre for Disease Prevention and Control, 2017, HEP OUTBR EU EEA MOS; European Centre for Disease Prevention and Control, 2016, HEP VIR EU EEA 1975; European Centre for Disease Prevention and Control, 2015, SEX TRANSM INF EUR 2; Field N, 2014, LANCET INFECT DIS, V14, P341, DOI 10.1016/S1473-3099(13)70324-4; Freidl GS, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.8.30468; Gossner C. M., 2015, EURO SURVEILL, V20; Gozlan Y, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.29.30575; Kulldorf M, 2015, USER GUIDE; La Rosa G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-419; Lopalco PL, 2005, J VIRAL HEPATITIS, V12, P315, DOI 10.1111/j.1365-2893.2005.00593.x; Mellou K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116939; Vaughan G, 2014, INFECT GENET EVOL, V21, P227, DOI 10.1016/j.meegid.2013.10.023; Werber D, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.5.30457	22	32	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0185428	10.1371/journal.pone.0185428	http://dx.doi.org/10.1371/journal.pone.0185428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125835	Green Published, gold, Green Submitted			2022-12-26	WOS:000414866000001
J	Lei, MG; Gupta, RK; Lee, CY				Lei, Mei G.; Gupta, Ravi Kr.; Lee, Chia Y.			Proteomics of Staphylococcus aureus biofilm matrix in a rat model of orthopedic implant-associated infection	PLOS ONE			English	Article							UNIVERSAL STRESS-PROTEIN; MOONLIGHTING PROTEINS; ESCHERICHIA-COLI; IMMUNE-RESPONSE; BINDING PROTEIN; IDENTIFICATION; RECOGNITION; THIOREDOXIN; CANDIDATES; VIRULENCE	The matrix proteins of Staphylococcus aureus biofilm have not been well defined. Previous efforts to identify these proteins were performed using in vitro systems. Here we use a proteomic approach to identify biofilm matrix proteins directly from infected bone implants using a rat model of orthopedic implant-associated S. aureus infection. Despite heavy presence of host proteins, a total of 28 and 105 S. aureus proteins were identified during acute infection and chronic infection, respectively. Our results show that biofilm matrix contains mostly intracellular cytoplasmic proteins and, to a much less extent, extracellular and cell surface-associated proteins. Significantly, leukocidins were identified in the biofilm matrix during chronic infection, suggesting S. aureus is actively attacking the host immune system even though they are protected within the biofilm. The presence of two surface-associated proteins, Ebh and SasF, in the infected bone tissue during acute infection was confirmed by immunohistochemistry. In addition, a large number of host proteins were found differentially expressed in response to S. aureus biofilm formed on bone implants.	[Lei, Mei G.; Gupta, Ravi Kr.; Lee, Chia Y.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Lee, CY (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	clee2@uams.edu	Gupta, Ravi/AAS-3639-2021	Gupta, Ravi/0000-0002-1230-8382; Lee, Chia/0000-0002-2503-5467	National Institute of Allergy and Infectious Diseases [AI112028]; National Institutes of Health [S100D018445, P20GM103625, S10OD018445]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI112028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103625] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018445] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by grant AI112028 from the National Institute of Allergy and Infectious Diseases. We thank UAMS core facilities, which are supported in part by National Institutes of Health grants S100D018445 and P20GM103625.; We thank Olaf Schneewind and Simon Foster for anti-Ebh antisera and Timothy Foster for anti-SasF antisera. We thank Tammy Kielian for help with preparing bone tissues for thin sections. We thank UAMS core facilities, which are supported in part by National Institutes of Health grants S10OD018445 and P20GM103625. This work is supported by grant AI112028 from the National Institute of Allergy and Infectious Diseases.	Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; Alonzo F, 2014, MICROBIOL MOL BIOL R, V78, P199, DOI 10.1128/MMBR.00055-13; Bannerman DD, 2004, CLIN DIAGN LAB IMMUN, V11, P463, DOI 10.1128/CDLI.11.3.463-472.2004; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580; Bose JL, 2013, APPL ENVIRON MICROB, V79, P2218, DOI 10.1128/AEM.00136-13; Bose JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042244; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Cheng AG, 2014, J BACTERIOL, V196, P971, DOI 10.1128/JB.01366-13; Clarke SR, 2002, INFECT IMMUN, V70, P6680, DOI 10.1128/IAI.70.12.6680-6687.2002; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; den Reijer PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145722; Enany S, 2013, MICROBIOL RES, V168, P504, DOI 10.1016/j.micres.2013.03.004; Foulston L, 2014, MBIO, V5, DOI 10.1128/mBio.01667-14; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Gil C, 2014, INFECT IMMUN, V82, P1017, DOI 10.1128/IAI.01419-13; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Glowalla E, 2009, INFECT IMMUN, V77, P2719, DOI 10.1128/IAI.00617-08; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Junecko J.M., 2012, WORLD J CLIN INFECT, V2, P63, DOI [10.5495/wjcid.v2.i4.63, DOI 10.5495/WJCID.V2.I4.63]; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Liu WT, 2007, MICROB PATHOGENESIS, V42, P2, DOI 10.1016/j.micpath.2006.09.002; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Malachowa N, 2011, INFECT IMMUN, V79, P342, DOI 10.1128/IAI.00736-10; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Muthukrishnan G, 2011, J PROTEOME RES, V10, P2064, DOI 10.1021/pr200029r; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NYSTROM T, 1994, MOL MICROBIOL, V11, P537, DOI 10.1111/j.1365-2958.1994.tb00334.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Paharik AE, 2016, MICROBIOL SPECTR, V4, DOI [10.1128/microbiolspec.VMBF-0022-2015, DOI 10.1128/microbiolspec.VMBF-0022-2015]; Pasztor L, 2010, J BIOL CHEM, V285, P36794, DOI 10.1074/jbc.M110.167312; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Sassi M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01584-14; Scherr TD, 2015, MBIO, V6, DOI 10.1128/mBio.01021-15; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Sheldon JR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00041; Spaan AN, 2015, CELL HOST MICROBE, V18, P363, DOI 10.1016/j.chom.2015.08.001; Speziale P, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00171; SUGAI M, 1990, J BACTERIOL, V172, P6494, DOI 10.1128/jb.172.11.6494-6498.1990; Uziel O, 2004, J BACTERIOL, V186, P326, DOI 10.1128/JB.186.2.326-334.2004; Wang WF, 2016, MOL BIOSYST, V12, P1420, DOI 10.1039/c5mb00550g; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11; Zarnowski R, 2016, NAT PROTOC, V11, P2320, DOI 10.1038/nprot.2016.132	53	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187981	10.1371/journal.pone.0187981	http://dx.doi.org/10.1371/journal.pone.0187981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121106	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900107
J	Nzuza, S; Zondi, S; Owira, PMO				Nzuza, Sanelisiwe; Zondi, Sindiswa; Owira, Peter M. O.			Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo	PLOS ONE			English	Article							BETA-CELL DYSFUNCTION; INSULIN-RESISTANCE; OXIDATIVE STRESS; ANTIRETROVIRAL THERAPY; MOLECULAR-MECHANISMS; REGULATING ENZYMES; GLUCOSE; HYPERGLYCEMIA; HESPERIDIN; INFECTION	Background Insulin resistance, glucose intolerance and overt diabetes are known metabolic complications associated with chronic use of HIV-Protease Inhibitors. Naringin is a grapefruit-derived flavonoid with anti-diabetic, anti-dyslipidemia, anti-inflammatory and anti-oxidant activities. Objectives The study investigated the protective effects of naringin on glucose intolerance and impaired insulin secretion and signaling in vivo. Methods Male Wistar rats were divided into six groups (n = 6) and were daily orally treated with distilled water {3.0 ml/kg body weight (BW)}, atazanavir (133 mg/kg BW), saquinavir (333 mg/kg BW) with or without naringin (50 mg/kg BW), respectively for 56 days. Body weights and water consumption were recorded daily. Glucose tolerance tests were carried out on day 55 of the treatment and thereafter, the rats were sacrificed by halothane overdose. Results Atazanavir (ATV)- or saquinavir (SQV)-treated rats exhibited significant weight loss, polydipsia, elevated Fasting blood glucose (FBG), reduced Fasting Plasma Insulin (FPI) and expression of phosphorylated, Insulin Receptor Substrate-1 (IRS-1) and Akt proteins, hepatic and pancreatic glucokinase levels, and also increasing pancreatic caspase-3 and -9 as well as UCP2 protein expressions compared to controls, respectively. These effects were completely reversed by naringin treatment. Conclusion Naringin prevents PI-induced glucose intolerance and impairment of insulin signaling and as nutritional supplement it could therefore alleviate metabolic complications associated with antiretroviral therapy.	[Nzuza, Sanelisiwe; Zondi, Sindiswa; Owira, Peter M. O.] Univ KwaZulu Natal, Mol & Clin Pharmacol Res Lab, Dept Pharmacol, Discipline Pharmaceut Sci,Sch Hlth Sci, Durban, South Africa	University of Kwazulu Natal	Owira, PMO (corresponding author), Univ KwaZulu Natal, Mol & Clin Pharmacol Res Lab, Dept Pharmacol, Discipline Pharmaceut Sci,Sch Hlth Sci, Durban, South Africa.	owirap@ukzn.ac.za						Achenbach CJ, 2011, FUTURE VIROL, V6, P157, DOI 10.2217/FVL.10.89; Adamson C.S., 2012, MOL BIOL INT, V2012; Adebiyi OO, 2016, HUMAN EXPT TOXICOLOG; Alam MA, 2013, NUTRIENTS, V5, P637, DOI 10.3390/nu5030637; Arai S, 2013, AM J CRIT CARE, V22, P328, DOI 10.4037/ajcc2013533; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cade WT, 2008, HIV MED, V9, P96, DOI 10.1111/j.1468-1293.2007.00524.x; Chandra S, 2009, EXP BIOL MED, V234, P442, DOI 10.3181/0811-RM-317; Cheng MS, 2004, J CELL BIOCHEM, V92, P1234, DOI 10.1002/jcb.20150; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Flint OP, 2009, TOXICOL PATHOL, V37, P65, DOI 10.1177/0192623308327119; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; Ge HS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/323246; Gupta AK, 2007, NEOPLASIA, V9, P271, DOI 10.1593/neo.07124; Hayanga JA, 2016, EUR J NUTR, V55, P631, DOI 10.1007/s00394-015-0883-4; Hruz PW, 2006, AM J INFECT DIS, V2, P187, DOI 10.3844/ajidsp.2006.187.192; Hruz PW, 2011, BEST PRACT RES CL EN, V25, P459, DOI 10.1016/j.beem.2010.10.017; Hruz PW, 2008, CURR OPIN HIV AIDS, V3, P660, DOI 10.1097/COH.0b013e3283139134; Hughes Peter J, 2011, P T, V36, P332; James J S, 1995, AIDS Treat News, P1; Jeon SM, 2004, CLIN NUTR, V23, P1025, DOI 10.1016/j.clnu.2004.01.006; Jung UJ, 2004, J NUTR, V134, P2499, DOI 10.1093/jn/134.10.2499; Kalra S, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-2; Kim RJ, 2006, OBESITY, V14, P994, DOI 10.1038/oby.2006.114; Lagathu C, 2007, ANTIVIR THER, V12, P489; Loonam CR, 2012, NUTR RES REV, V25, P267, DOI 10.1017/S0954422411000138; Luzi L, 2003, AM J PHYSIOL-ENDOC M, V284, pE274, DOI 10.1152/ajpendo.00391.2001; Mahmoud AM, 2012, J DIABETES COMPLICAT, V26, P483, DOI 10.1016/j.jdiacomp.2012.06.001; McPherson PAC, 2012, J PHYSIOL BIOCHEM, V68, P141, DOI 10.1007/s13105-011-0112-4; Miura M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008664; Nolte LA, 2001, DIABETES, V50, P1397, DOI 10.2337/diabetes.50.6.1397; Nzuza S, 2016, MOL CELL ENDOCRINOL, V437, P1, DOI 10.1016/j.mce.2016.07.041; Richmond SR, 2010, BBA-MOL CELL BIOL L, V1801, P559, DOI 10.1016/j.bbalip.2010.01.007; Schutt M, 2000, DIABETOLOGIA, V43, P1145, DOI 10.1007/s001250051505; Seo HJ, 2003, LIFE SCI, V73, P933, DOI 10.1016/S0024-3205(03)00358-8; Shen W, 2012, J AGR FOOD CHEM, V60, P9609, DOI 10.1021/jf3032556; Spollett G. R., 2006, Diabetes Spectrum, V19, P163, DOI 10.2337/diaspect.19.3.163; THIEBAUD D, 1982, DIABETES, V31, P957, DOI 10.2337/diacare.31.11.957; Vinayagam R, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0057-7; Vyas AK, 2010, J BIOL CHEM, V285, P36395, DOI 10.1074/jbc.M110.176321; Xulu S, 2012, J CARDIOVASC PHARM, V59, P133, DOI 10.1097/FJC.0b013e31823827a4; Yeong MMK, 2010, PEDIATR INFECT DIS J, V29, P678, DOI 10.1097/INF.0b013e3181d95b37; Youngren JF, 2007, CELL MOL LIFE SCI, V64, P873, DOI 10.1007/s00018-007-6359-9; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	46	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0183355	10.1371/journal.pone.0183355	http://dx.doi.org/10.1371/journal.pone.0183355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121676	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900003
J	Sakata, N; Yamaguchi, Y; Chen, Y; Shimoda, M; Yoshimatsu, G; Unno, M; Sumi, S; Ohki, R				Sakata, Naoaki; Yamaguchi, Yohko; Chen, Yu; Shimoda, Masayuki; Yoshimatsu, Gumpei; Unno, Michiaki; Sumi, Shoichiro; Ohki, Rieko			Pleckstrin homology-like domain family A, member 3 (PHLDA3) deficiency improves islets engraftment through the suppression of hypoxic damage	PLOS ONE			English	Article							DIABETES-MELLITUS; CELLS; TRANSPLANTATION; PANCREAS; MARKERS; IMPACT; LIVER; MASS	Islet transplantation is a useful cell replacement therapy that can restore the glycometabolic function of severe diabetic patients. It is known that many transplanted islets failed to engraft, and thus, new approaches for overcoming graft loss that may improve the outcome of future clinical islet transplantations are necessary. Pleckstrin homology-like domain family A, member 3 (PHLDA3) is a known suppressor of neuroendocrine tumorigenicity, yet deficiency of this gene increases islet proliferation, prevents islet apoptosis, and improves their insulin-releasing function without causing tumors. In this study, we examined the potential use of PHLDA3-deficient islets in transplantation. We observed that: 1) transplanting PHLDA3-deficient islets into diabetic mice significantly improved their glycometabolic condition, 2) the improved engraftment of PHLDA3-deficient islets resulted from increased cell survival during early transplantation, and 3) Akt activity was elevated in PHLDA3-deficient islets, especially under hypoxic conditions. Thus, we determined that PHLDA3-deficient islets are more resistant against stresses induced by islet isolation and transplantation. We conclude that use of islets with suppressed PHLDA3 expression could be a novel and promising treatment for improving engraftment and consequent glycemic control in islet transplantation.	[Sakata, Naoaki; Yoshimatsu, Gumpei; Unno, Michiaki] Tohoku Univ, Dept Surg, Aoba Ku, Sendai, Miyagi, Japan; [Yamaguchi, Yohko; Chen, Yu; Ohki, Rieko] Natl Canc Ctr, Div Rare Canc Res, Chuo Ku, Tokyo, Japan; [Shimoda, Masayuki] Natl Ctr Global Hlth & Med, Dept Pancreat Islet Cell Transplantat, Res Inst, Shinjuku Ku, Tokyo, Japan; [Sumi, Shoichiro] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Organ & Tissue Reconstruct, Sakyo Ku, Kyoto, Japan	Tohoku University; National Cancer Center - Japan; National Center for Global Health & Medicine - Japan; Kyoto University	Sakata, N (corresponding author), Tohoku Univ, Dept Surg, Aoba Ku, Sendai, Miyagi, Japan.	n-sakata@surg1.med.tohoku.ac.jp	Sakata, Naoaki/H-4738-2019; Unno, Michiaki/A-8633-2010; Unno, Michiaki/AAX-5246-2020	Sakata, Naoaki/0000-0002-3495-4270; Unno, Michiaki/0000-0002-2145-6416; Unno, Michiaki/0000-0002-2145-6416	Ministry of Education, Culture, Sports, Science and Technology of Japan [26462053, 15K19869, 26430133]; Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare; Institute for Frontier Medical Sciences, Kyoto University, Japan; Grants-in-Aid for Scientific Research [17K19692] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare; Institute for Frontier Medical Sciences, Kyoto University, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research (C) (26462053, NS) and Grant-in-Aid for Encouragement of Young Scientists (B) (15K19869, NS), Grant-in-Aid for Scientific Research (C) (#26430133) (R.O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare (R.O.), Cooperative Research Program of Institute for Frontier Medical Sciences, Kyoto University, Japan (to R.O.); URL: https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-26462053/, https://kaken.nii.ac.jp/ja/grant/ KAKENHI-PROJECT-15K19869/, https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-26430133/.	Bassi R, 2011, CURR DIABETES REP, V11, P355, DOI 10.1007/s11892-011-0211-1; Chang H, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5125836; Citro A, 2013, CURR DIABETES REP, V13, P733, DOI 10.1007/s11892-013-0401-0; Elghazi L, 2009, TRENDS ENDOCRIN MET, V20, P243, DOI 10.1016/j.tem.2009.03.002; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Fiorina P, 2005, DIABETES CARE, V28, P1303, DOI 10.2337/diacare.28.6.1303; Fiorina P, 2003, J AM SOC NEPHROL, V14, P2150, DOI 10.1097/01.ASN.0000077339.20759.A3; Fornoni A, 2008, DIABETOLOGIA, V51, P298, DOI 10.1007/s00125-007-0889-4; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Hata T, 2015, AM J TRANSPLANT; Johansson H, 2006, AM J TRANSPLANT, V6, P305, DOI 10.1111/j.1600-6143.2005.01186.x; Kaida A, 2012, BIOCHEM BIOPH RES CO, V421, P855, DOI 10.1016/j.bbrc.2012.04.102; Kanak MA, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/451035; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Konagaya S, 2016, BBA-GEN SUBJECTS, V1860, P2008, DOI 10.1016/j.bbagen.2016.05.012; Liu Y, 2010, DIABETOLOGIA, V53, P2600, DOI 10.1007/s00125-010-1882-x; Massumi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164457; Mattsson G, 2002, PANCREATOLOGY, V2, P155, DOI 10.1159/000055906; Miladpour B, 2016, J ENDOCRINOL INVEST; Morozov VA, 2017, VIRUS RES, V227, P34, DOI 10.1016/j.virusres.2016.08.012; Ohki R, 2014, P NATL ACAD SCI USA, V111, pE2404, DOI 10.1073/pnas.1319962111; Porciuncula A, 2016, DIFFERENTIATION; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sakata N, 2006, PANCREAS, V32, P249, DOI 10.1097/01.mpa.0000203959.31877.8c; Sakata N, 2009, TRANSPLANTATION, V87, P825, DOI 10.1097/TP.0b013e318199c7d2; Sakata N, 2009, ISLETS, V1, P26, DOI 10.4161/isl.1.1.8563; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Stiegler P, 2010, TRANSPL P, V42, P1618, DOI 10.1016/j.transproceed.2009.11.047; Van de Velde S, 2011, P NATL ACAD SCI USA, V108, P16876, DOI 10.1073/pnas.1114228108; Walters SN, 2013, J MOL ENDOCRINOL, V51, P225, DOI 10.1530/JME-13-0016; Wang SH, 2012, CURR NEUROVASC RES, V9, P20, DOI 10.2174/156720212799297137; Xin Y, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0145838, 10.1371/journal.pone.0160613]; Xing BH, 2016, J PHARMACOL SCI, V131, P93, DOI 10.1016/j.jphs.2016.04.014; Yang KC, 2010, BIOCHEM BIOPH RES CO, V393, P818, DOI 10.1016/j.bbrc.2010.02.089; Yang KC, 2008, XENOTRANSPLANTATION, V15, P407, DOI 10.1111/j.1399-3089.2008.00503.x	36	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187927	10.1371/journal.pone.0187927	http://dx.doi.org/10.1371/journal.pone.0187927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121094	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900096
J	Yamakawa, GR; Lengkeek, C; Salberg, S; Spanswick, SC; Mychasiuk, R				Yamakawa, Glenn R.; Lengkeek, Connor; Salberg, Sabrina; Spanswick, Simon C.; Mychasiuk, Richelle			Behavioral and pathophysiological outcomes associated with caffeine consumption and repetitive mild traumatic brain injury (RmTBI) in adolescent rats	PLOS ONE			English	Article							SEX-DIFFERENCES; HIPPOCAMPAL NEUROGENESIS; RECEPTOR ANTAGONISTS; GENE-EXPRESSION; ENERGY DRINKS; CONCUSSION; CHILDREN; MODEL; IMPAIRMENT; SLEEP	Given that caffeine consumption is exponentially rising in adolescents and they are at increased risk for repetitive mild traumatic brain injury (RmTBI), we sought to examine the pathophysiological outcomes associated with early life caffeine consumption and RmTBI. Adolescent male and female Sprague Dawley rats received either caffeine in the drinking water or normal water and were then randomly assigned to 3 mild injuries using our lateral impact device or 3 sham procedures. Following injury induction, behavioral outcomes were measured with a test battery designed to examine symptoms consistent with clinical manifestation of PCS (balance and motor coordination, anxiety, short-term working memory, and depressive-like behaviours). In addition, pathophysiological outcomes were examined with histological measures of volume and cellular proliferation in the dentate gyrus, as well as microglia activation in the ventromedial hypothalamus. Finally, modifications to expression of 12 genes (Adora2a, App, Aqp4, Bdnf, Bmall, Clock, Cry, Gfap, Orxl, Orx2, Per, Tau), in the prefrontal cortex, hippocampus, and/or the hypothalamus were assessed. We found that chronic caffeine consumption in adolescence altered normal developmental trajectories, as well as recovery from RmTBI. Of particular importance, many of the outcomes exhibited sex-dependent responses whereby the sex of the animal modified response to caffeine, RmTBI, and the combination of the two. These results suggest that caffeine consumption in adolescents at high risk for RmTBI should be monitored.	[Yamakawa, Glenn R.; Lengkeek, Connor; Salberg, Sabrina; Spanswick, Simon C.; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada	University of Calgary	Mychasiuk, R (corresponding author), Univ Calgary, Dept Psychol, Calgary, AB, Canada.	rmmychas@ucalgary.ca		Yamakawa, Glenn/0000-0003-3079-6532	University of Calgary; Alberta Children's Hospital Research Institute; O'Brien Summer Studentship Foundation	University of Calgary; Alberta Children's Hospital Research Institute; O'Brien Summer Studentship Foundation	Financial support from the Integrated Concussion Research Program at the University of Calgary, the Alberta Children's Hospital Research Institute, and the O'Brien Summer Studentship Foundation. No Grant Numbers Available.; The authors would like to thank the Integrated Concussion Research Program at the University of Calgary, the Alberta Children's Hospital Research Institute, and the O'Brien Summer Studentship Foundation for their financial support. The authors would also like to thank Melinda Wang and Rose Tobias for their technical support.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Aepli A, 2015, BRAIN SCI, V5, P441, DOI 10.3390/brainsci5040441; Araujo LF, 2016, J ALZHEIMERS DIS, V53, P451, DOI 10.3233/JAD-160116; Ardais A, 2014, NEUROSCIENCE, V270; Ballesteros-Yanez Inmaculada, 2012, J Caffeine Res, V2, P90, DOI 10.1089/jcr.2012.0011; Behrens M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10209; Benedetti MD, 2000, NEUROLOGY, V55, P1350, DOI 10.1212/WNL.55.9.1350; Bloms LP, 2016, J STRENGTH COND RES, V30, P1855, DOI 10.1519/JSC.0000000000001280; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broshek D, 2012, J NEUROSURG, V102, P856; Brothers HM, 2010, NEUROSCI LETT, V480, P97, DOI 10.1016/j.neulet.2010.06.013; Burke TM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5125; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Cognato GP, 2010, J NEUROCHEM, V112, P453, DOI 10.1111/j.1471-4159.2009.06465.x; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Daisuke I, 1998, MOL BRAIN RES, V57, P1; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Endesfelder S, 2014, FREE RADICAL BIO MED, V67, P221, DOI 10.1016/j.freeradbiomed.2013.09.026; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Ghoneim FM, 2015, INT J CLIN EXP PATHO, V8, P7710; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Han ME, 2007, BIOCHEM BIOPH RES CO, V356, P976, DOI 10.1016/j.bbrc.2007.03.086; Han ME, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-110; Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6; Hehar H, 2016, NEUROSCIENCE, V332, P61, DOI 10.1016/j.neuroscience.2016.06.039; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kolb B, 2003, P NATL ACAD SCI USA, V100, P10523, DOI 10.1073/pnas.1834271100; Lakhan SE, 2012, BRAIN BEHAV, V2, P661, DOI 10.1002/brb3.78; Landolt HP, 2004, NEUROPSYCHOPHARMACOL, V29, P1933, DOI 10.1038/sj.npp.1300526; LATINI R, 1980, J PHARM PHARMACOL, V32, P596, DOI 10.1111/j.2042-7158.1980.tb13010.x; Lohsoonthorn V, 2013, SLEEP BREATH, V17, P1017, DOI 10.1007/s11325-012-0792-1; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; McCrory C, 2017, J NUTR EDUC BEHAV, V49, P304, DOI 10.1016/j.jneb.2016.11.013; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nowak D, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080768; Oike H, 2011, BIOCHEM BIOPH RES CO, V410, P654, DOI 10.1016/j.bbrc.2011.06.049; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Perlaki G, 2011, BRAIN IMAGING BEHAV, V5, P274, DOI 10.1007/s11682-011-9131-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pintor A, 2004, J NEUROCHEM, V89, P152, DOI 10.1111/j.1471-4159.2003.02306.x; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Qin  Y., 2016, BEHAV BRAIN RES; Qosa H, 2012, J ALZHEIMERS DIS, V31, P151, DOI 10.3233/JAD-2012-120319; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Rivera-Oliver M, 2014, LIFE SCI, V101, P1, DOI 10.1016/j.lfs.2014.01.083; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schallert T, 2002, PHARM CEREBRAL ISCHE, P201; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Sherman H, 2011, INT J BIOCHEM CELL B, V43, P829, DOI 10.1016/j.biocel.2011.02.008; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001; Van Batenburg-Eddes T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00457; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Vila-Luna S, 2012, NEUROSCIENCE, V202, P384, DOI 10.1016/j.neuroscience.2011.11.053; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Whishaw I. Q., 2004, BEHAV LAB RAT HDB TE; Wright D, NEUROBIOLOGY D UNPUB; Wright D, 2017, ANN CLIN TRANSLATION; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xu K, 2006, J NEUROSCI, V26, P535, DOI 10.1523/JNEUROSCI.3008-05.2006; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yamakawa GR, 2017, EXP NEUROL, V295, P55, DOI 10.1016/j.expneurol.2017.06.001; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	82	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187218	10.1371/journal.pone.0187218	http://dx.doi.org/10.1371/journal.pone.0187218			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108016	Green Submitted, gold, Green Published			2022-12-26	WOS:000414424600019
J	Noborn, F; Toledo, AG; Nasir, W; Nilsson, J; Dierker, T; Kjellen, L; Larson, G				Noborn, Fredrik; Toledo, Alejandro Gomez; Nasir, Waqas; Nilsson, Jonas; Dierker, Tabea; Kjellen, Lena; Larson, Goran			Expanding the chondroitin glycoproteome of Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caenorhabditis elegans (C; elegans); chondroitin; glycosaminoglycan; mass spectrometry (MS); proteoglycan; proteoglycan structure	SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; CORE PROTEIN; IDENTIFICATION; BIOSYNTHESIS; HEPARAN; MS/MS; GLYCOSAMINOGLYCANS; GLYCOPEPTIDES; MORPHOGENESIS	Chondroitin sulfate proteoglycans (CSPGs) are important structural components of connective tissues in essentially all metazoan organisms. In vertebrates, CSPGs are involved also in more specialized processes such as neurogenesis and growth factor signaling. In invertebrates, however, knowledge of CSPGs core proteins and proteoglycan-related functions is relatively limited, even for Caenorhabditis elegans. This nematode produces large amounts of non-sulfated chondroitin in addition to low-sulfated chondroitin sulfate chains. So far, only nine core proteins (CPGs) have been identified, some of which have been shown to be involved in extracellular matrix formation. We recently introduced a protocol to characterize proteoglycan core proteins by identifying CS-glycopeptides with a combination of biochemical enrichment, enzymatic digestion, and nano-scale liquid chromatography MS/MS analysis. Here, we have used this protocol to map the chondroitin glycoproteome in C. elegans, resulting in the identification of 15 novel CPG proteins in addition to the nine previously established. Three of the newly identified CPGs displayed homology to vertebrate proteins. Bioinformatics analysis of the primary protein sequences revealed that the CPG proteins altogether contained 19 unique functional domains, including Kunitz and endostatin domains, suggesting direct involvement in protease inhibition and axonal migration, respectively. The analysis of the core protein domain organization revealed that all chondroitin attachment sites are located in unstructured regions. Our results suggest that CPGs display a much greater functional and structural heterogeneity than previously appreciated and indicate that specialized proteoglycan-mediated functions evolved early in metazoan evolution.	[Noborn, Fredrik; Toledo, Alejandro Gomez; Nasir, Waqas; Nilsson, Jonas; Larson, Goran] Univ Gothenburg, Inst Biomed, Dept Clin Chem & Transfus Med, SE-41345 Gothenburg, Sweden; [Dierker, Tabea; Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	University of Gothenburg; Uppsala University	Larson, G (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Biomed, Bruna Straket 16, SE-41345 Gothenburg, Sweden.	goran.larson@clinchem.gu.se	Larson, Göran/AAF-3404-2019	Nilsson, Jonas/0000-0001-5263-2454; Larson, Goran/0000-0002-2616-0366	Swedish Research Council [8266]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Swedish Research Council Grant 8266 (to G. L.) and by governmental grants to the Sahlgrenska University Hospital (to G. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Bartolomucci A, 2011, ENDOCR REV, V32, P755, DOI 10.1210/er.2010-0027; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dierker T, 2016, SCI REP-UK, V6, DOI 10.1038/srep34662; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Halim A, 2014, J PROTEOME RES, V13, P6024, DOI 10.1021/pr500898r; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Izumikawa T, 2016, J BIOL CHEM, V291, P23294, DOI 10.1074/jbc.M116.757328; Kelley M, 2015, ELIFE, V4, DOI 10.7554/eLife.06565; King SL, 2017, BLOOD ADV, V1, P429, DOI 10.1182/bloodadvances.2016002121; KJELLEN L, 1989, BIOCHEM J, V263, P105, DOI 10.1042/bj2630105; Kramerova IA, 2000, DEVELOPMENT, V127, P5475; Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Lawrence R, 2012, NAT CHEM BIOL, V8, P197, DOI 10.1038/nchembio.766; Le Jan S, 2012, ARTERIOSCL THROM VAS, V32, P1255, DOI 10.1161/ATVBAHA.111.240622; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Mizumoto S, 2013, J BIOL CHEM, V288, P10953, DOI 10.1074/jbc.R112.437038; Nasir W, 2016, J PROTEOME RES, V15, P2826, DOI 10.1021/acs.jproteome.6b00417; Noborn F, 2016, SCI REP-UK, V6, DOI 10.1038/srep34537; Noborn F, 2015, MOL CELL PROTEOMICS, V14, P41, DOI 10.1074/mcp.M114.043703; Olson SK, 2006, J CELL BIOL, V173, P985, DOI 10.1083/jcb.200603003; Olson SK, 2012, J CELL BIOL, V198, P731, DOI 10.1083/jcb.201206008; Pedersen ME, 2013, SCIENCE, V341, P1404, DOI 10.1126/science.1242528; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Siebert JR, 2011, J NEUROCHEM, V119, P176, DOI 10.1111/j.1471-4159.2011.07370.x; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Wilson IBH, 2004, CELL MOL LIFE SCI, V61, P794, DOI 10.1007/s00018-003-3278-2; Yu J, 2016, CHEM-EUR J, V22, P1114, DOI 10.1002/chem.201503659	38	18	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					379	389		10.1074/jbc.M117.807800	http://dx.doi.org/10.1074/jbc.M117.807800			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29138239	hybrid, Green Published			2022-12-26	WOS:000419453200032
J	Rodarte, EM; Ramos, MA; Davalos, AJ; Moreira, DC; Moreno, DS; Cardenas, EI; Rodarte, AI; Petrova, Y; Molina, S; Rendon, LE; Sanchez, E; Breaux, K; Tortoriello, A; Manllo, J; Gonzalez, EA; Tuvim, MJ; Dickey, BF; Burns, AR; Heidelberger, R; Adachi, R				Rodarte, Elsa M.; Ramos, Marco A.; Davalos, Alfredo J.; Moreira, Daniel C.; Moreno, David S.; Cardenas, Eduardo I.; Rodarte, Alejandro I.; Petrova, Youlia; Molina, Sofia; Rendon, Luis E.; Sanchez, Elizabeth; Breaux, Keegan; Tortoriello, Alejandro; Manllo, John; Gonzalez, Erika A.; Tuvim, Michael J.; Dickey, Burton F.; Burns, Alan R.; Heidelberger, Ruth; Adachi, Roberto			Munc13 proteins control regulated exocytosis in mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergy; exocytosis; immunoglobulin E (IgE); mast cell; SNARE proteins; Munc13; anaphylaxis	READILY RELEASABLE POOL; CAPACITANCE MEASUREMENTS; FUSION-COMPETENCE; IL-6 PRODUCTION; TNF-ALPHA; GRANULES; DEGRANULATION; SECRETION; TRYPTASE; GENE	Mast cells (MCs) are involved in host defenses against pathogens and inflammation. Stimulated MCs release substances stored in their granules via regulated exocytosis. In other cell types, Munc13 (mammalian homolog of Caenorhabditis elegans uncoordinated gene 13) proteins play essential roles in regulated exocytosis. Here, we found that MCs express Munc13-2 and -4, and we studied their roles using global and conditional knock-out (KO) mice. In a model of systemic anaphylaxis, we found no difference between WT and Munc13-2 KO mice, but global and MC-specific Munc13-4 KO mice developed less hypothermia. This protection correlated with lower plasma histamine levels and with histological evidence of defective MC degranulation but not with changes in MC development, distribution, numbers, or morphology. In vitro assays revealed that the defective response in Munc13-4-deficient MCs was limited to regulated exocytosis, leaving other MC secretory effector responses intact. Single cell capacitance measurements in MCs from mouse mutants differing in Munc13-4 expression levels in their MCs revealed that as levels of Munc13-4 decrease, the rate of exocytosis declines first, and then the total amount of exocytosis decreases. A requirement for Munc13-2 in MC exocytosis was revealed only in the absence of Munc13-4. Electrophysiology and EM studies uncovered that the number of multigranular compound events (i.e. granule-to-granule homotypic fusion) was severely reduced in the absence of Munc13-4. We conclude that although Munc13-2 plays a minor role, Munc13-4 is essential for regulated exocytosis in MCs, and that this MC effector response is required for a full anaphylactic response.	[Rodarte, Elsa M.; Ramos, Marco A.; Davalos, Alfredo J.; Moreira, Daniel C.; Moreno, David S.; Cardenas, Eduardo I.; Rodarte, Alejandro I.; Petrova, Youlia; Molina, Sofia; Rendon, Luis E.; Sanchez, Elizabeth; Breaux, Keegan; Tortoriello, Alejandro; Manllo, John; Gonzalez, Erika A.; Tuvim, Michael J.; Dickey, Burton F.; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA; [Rodarte, Elsa M.; Davalos, Alfredo J.; Moreira, Daniel C.; Moreno, David S.; Cardenas, Eduardo I.; Rodarte, Alejandro I.; Molina, Sofia; Tortoriello, Alejandro; Gonzalez, Erika A.] Tecnol Monterrey, Escuela Med & Ciencias Salud Monterrey, Nuevo Leon 64710, Mexico; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77204 USA; [Heidelberger, Ruth] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston	Adachi, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	radachi@mdanderson.org		Cardenas, Eduardo/0000-0001-5973-5675; Adachi, Roberto/0000-0002-0146-0768; Rodarte, Elsa M./0000-0001-7138-0790; Moreno McNeill, David/0000-0003-0049-1770; Tuvim, Michael/0000-0001-8126-7716; Heidelberger, Ruth/0000-0002-8033-2050	National Institutes of Health [AI093533, HL129795, CA016672, EY007551, EY018239]; Cancer Prevention Research Institute of Texas [RP110166]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018239, P30EY007551] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097000, R01HL129795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grants AI093533, HL129795, CA016672, EY007551, and EY018239 and the Cancer Prevention Research Institute of Texas Grant RP110166. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi R, 2012, J BIOL CHEM, V287, P20047, DOI 10.1074/jbc.M112.360388; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Beil WJ, 1996, INT ARCH ALLERGY IMM, V109, P383, DOI 10.1159/000237267; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; Betz A, 1997, J BIOL CHEM, V272, P2520; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; BROCK TA, 1988, AM J PHYSIOL, V255, pC667, DOI 10.1152/ajpcell.1988.255.5.C667; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Bulfone-Paus S, 2017, TRENDS IMMUNOL, V38, P657, DOI 10.1016/j.it.2017.01.008; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Cairns JA, 1996, J IMMUNOL, V156, P275; Camacho M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15293; Chen ZX, 2013, J NEUROSCI, V33, P8336, DOI 10.1523/JNEUROSCI.5128-12.2013; Dernick G, 2007, FRONT NEUROENG, V1, P315; DETOLEDO GA, 1990, J CELL BIOL, V110, P1033, DOI 10.1083/jcb.110.4.1033; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Dudenhoffer-Pfeifer M, 2013, TRAFFIC, V14, P798, DOI 10.1111/tra.12074; Dwyer DF, 2016, NAT IMMUNOL, V17, P878, DOI 10.1038/ni.3445; FAWCETT DW, 1954, J EXP MED, V100, P217, DOI 10.1084/jem.100.2.217; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; FINKELSTEIN A, 1986, ANNU REV PHYSIOL, V48, P163, DOI 10.1146/annurev.ph.48.030186.001115; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gimborn K, 2005, J IMMUNOL, V174, P507, DOI 10.4049/jimmunol.174.1.507; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Gupta AA, 1996, J IMMUNOL, V157, P2123; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Higashio H, 2008, J IMMUNOL, V180, P4774, DOI 10.4049/jimmunol.180.7.4774; Higashio H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22539; Hogan AD, 1997, METHODS, V13, P43, DOI 10.1006/meth.1997.0494; Jahn R, 2004, ANN NY ACAD SCI, V1014, P170, DOI 10.1196/annals.1294.018; Kaeser PS, 2017, CURR OPIN NEUROBIOL, V43, P63, DOI 10.1016/j.conb.2016.12.012; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kasai H, 2012, PHYSIOL REV, V92, P1915, DOI 10.1152/physrev.00007.2012; Kim K, 2012, BIOCHEM J, V446, P383, DOI 10.1042/BJ20120057; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Kochel TJ, 2015, PROSTAG OTH LIPID M, V116, P99, DOI 10.1016/j.prostaglandins.2014.11.003; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Lai Y, 2017, NEURON, V95, P591, DOI 10.1016/j.neuron.2017.07.004; LEALBERUMEN I, 1994, J IMMUNOL, V152, P5468; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Liu XX, 2016, ELIFE, V5, DOI 10.7554/eLife.13696; Lorentz A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00143; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Makabe-Kobayashi Y, 2002, J ALLERGY CLIN IMMUN, V110, P298, DOI 10.1067/mai.2002.125977; Marshall JS, 1996, J CLIN INVEST, V97, P1122, DOI 10.1172/JCI118506; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Melicoff E, 2009, J BIOL CHEM, V284, P19445, DOI 10.1074/jbc.M109.002550; Michelassi F, 2017, NEURON, V95, P577, DOI 10.1016/j.neuron.2017.07.015; Oberhauser AF, 1996, P NATL ACAD SCI USA, V93, P14349, DOI 10.1073/pnas.93.25.14349; Olszewski MB, 2007, J IMMUNOL, V178, P5701, DOI 10.4049/jimmunol.178.9.5701; Olszewski MB, 2006, EUR J IMMUNOL, V36, P997, DOI 10.1002/eji.200535323; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Pivot-Pajot C, 2008, J IMMUNOL, V180, P6786, DOI 10.4049/jimmunol.180.10.6786; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; ROYET JP, 1991, PROG NEUROBIOL, V37, P433, DOI 10.1016/0301-0082(91)90009-P; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Shin OH, 2010, NAT STRUCT MOL BIOL, V17, P280, DOI 10.1038/nsmb.1758; Singh RK, 2013, FEBS J, V280, P892, DOI 10.1111/febs.12081; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Song Y, 1998, KIDNEY INT, V53, P1689, DOI 10.1046/j.1523-1755.1998.00942.x; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Woo SS, 2017, MOL BIOL CELL, V28, P792, DOI 10.1091/mbc.E16-08-0617; Xu JJ, 2017, ELIFE, V6, DOI 10.7554/eLife.22567; Yang XY, 2015, NAT STRUCT MOL BIOL, V22, P547, DOI 10.1038/nsmb.3038; Yu YY, 2016, EUR J PHARMACOL, V780, P115, DOI 10.1016/j.ejphar.2016.03.038	83	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					345	358		10.1074/jbc.M117.816884	http://dx.doi.org/10.1074/jbc.M117.816884			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29141910	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000419453200029
J	Shanker, S; Schaefer, GK; Barnhart, BK; Wallace-Kneale, VL; Chang, D; Coyle, TJ; Metzler, DA; Huang, J; Lawton, JA				Shanker, Sreejesh; Schaefer, Grace K.; Barnhart, Benjamin K.; Wallace-Kneale, Vicki L.; Chang, Dorsin; Coyle, Thomas J.; Metzler, David A.; Huang, Jeffrey; Lawton, Jeffrey A.			The virulence-associated protein HsvA from the fire blight pathogen Erwinia amylovora is a polyamine amidinotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; polyamine; protein structure; virulence factor; X-ray crystallography; amidinotransferase; fire blight	L-ARGININEGLYCINE AMIDINOTRANSFERASE; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; HOG KIDNEY; BIOSYNTHESIS; TRANSAMIDINASE; PURIFICATION; IDENTIFICATION; PHASEOLOTOXIN; HOMOARGININE	Studies of virulence determinants in the bacterial phytopathogen Erwinia amylovora, the cause of devastating fire blight disease in apple and pear, have shown that HsvA, a putative amidinotransferase enzyme located in the Hrp pathogenicity island, is required for systemic infection in apple. However, the mechanism by which HsvA contributes to virulence is unclear. To investigate the role of HsvA in virulence, we carried out a series of biochemical and structural studies to characterize the amidinotransferase activity of HsvA. We found that HsvA displays a preference for linear aliphatic polyamines as the amidino acceptor substrate, especially for spermidine and putrescine (K-m values of 33 m and 3.9 mm, respectively). The three-dimensional structure, determined at 2.30 resolution using X-ray crystallography, revealed that the overall architecture of HsvA is similar to that of the human arginine-glycine amidinotransferase in the creatine biosynthesis pathway. The active site is located in the core of the protein at the base of a long, narrow substrate access channel. Specific amino acids near the entrance of the channel may serve as major determinants of the substrate specificity, including a glutamate residue at the rim of the channel entrance that appears to be positioned to interact with the distal primary amine in the putrescine substrate as well as the internal and distal amines in the spermidine substrate. These results suggest potential in vivo functions for HsvA as a virulence factor in fire blight and may also provide a basis for strategies to control fire blight by inhibiting HsvA activity.	[Shanker, Sreejesh] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Schaefer, Grace K.; Barnhart, Benjamin K.; Wallace-Kneale, Vicki L.; Chang, Dorsin; Coyle, Thomas J.; Metzler, David A.; Huang, Jeffrey; Lawton, Jeffrey A.] Eastern Univ, Dept Chem, 1300 Eagle Rd, St Davids, PA 19087 USA	Baylor College of Medicine	Lawton, JA (corresponding author), Eastern Univ, Dept Chem, 1300 Eagle Rd, St Davids, PA 19087 USA.	jlawton@eastern.edu			Cottrell College Science Award from the Research Corporation for Science Advancement [7714]; HBE Foundation; VWR Charitable Foundation; Eastern University Office of the Provost; Eastern University Department of Chemistry	Cottrell College Science Award from the Research Corporation for Science Advancement; HBE Foundation; VWR Charitable Foundation; Eastern University Office of the Provost; Eastern University Department of Chemistry	This work was supported in part by Cottrell College Science Award 7714 from the Research Corporation for Science Advancement (to J. A. L.) and funding from the HBE Foundation, the VWR Charitable Foundation, the Eastern University Office of the Provost, and the Eastern University Department of Chemistry. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baron-Sola A, 2013, MICROBIOLOGYOPEN, V2, P447, DOI 10.1002/mbo3.78; Bartolomeo Maria Paola, 2006, J Biomol Tech, V17, P131; Bonn WG, 2000, FIRE BLIGHT, P37, DOI 10.1079/9780851992945.0037; CONCONI F, 1965, J BIOL CHEM, V240, P2461; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FEISTNER GJ, 1993, ORG MASS SPECTROM, V28, P163, DOI 10.1002/oms.1210280307; FEISTNER GJ, 1994, BIOL MASS SPECTROM, V23, P793, DOI 10.1002/bms.1200231212; Fritsche E, 1997, EUR J BIOCHEM, V247, P483, DOI 10.1111/j.1432-1033.1997.00483.x; Fritsche E, 1998, BIOCHEMISTRY-US, V37, P17664, DOI 10.1021/bi981949p; GRAZI E, 1968, J BIOL CHEM, V243, P538; Hernandez-Guzman G, 2001, MOL PLANT MICROBE IN, V14, P545, DOI 10.1094/MPMI.2001.14.4.545; Humm A, 1997, EMBO J, V16, P3373, DOI 10.1093/emboj/16.12.3373; Humm A, 1997, BIOL CHEM, V378, P193; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; Jimenez-Bremont JF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00095; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jung YG, 2003, FEMS MICROBIOL LETT, V219, P285, DOI 10.1016/S0378-1097(03)00019-3; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Lee GT, 2002, PHYTOCHEMISTRY, V61, P781, DOI 10.1016/S0031-9422(02)00401-6; Li M, 2016, FEBS OPEN BIO, V6, P603, DOI 10.1002/2211-5463.12071; Malnoy M, 2012, ANNU REV PHYTOPATHOL, V50, P475, DOI 10.1146/annurev-phyto-081211-172931; MARKISCH U, 1990, J BASIC MICROB, V30, P425, DOI 10.1002/jobm.3620300611; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Molnar-Perl I, 2011, J CHROMATOGR B, V879, P1241, DOI 10.1016/j.jchromb.2011.01.027; Muenchhoff J, 2012, FEBS J, V279, P805, DOI 10.1111/j.1742-4658.2012.08472.x; Muenchhoff J, 2010, FEBS J, V277, P3844, DOI 10.1111/j.1742-4658.2010.07788.x; National Agricultural Statistics Service, 2016, NONC FRUITS NUTS 201; Norelli JL, 2003, PLANT DIS, V87, P756, DOI 10.1094/PDIS.2003.87.7.756; Ogasawara Y, 2016, BIOORG MED CHEM LETT, V26, P3662, DOI 10.1016/j.bmcl.2016.05.090; Oh CS, 2005, MOL PLANT PATHOL, V6, P125, DOI 10.1111/j.1364-3703.2005.00269.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rambaut A., 2014, FIGTREE PHYLOGENETIC; Shirai H, 2006, PROTEINS, V64, P1010, DOI 10.1002/prot.20863; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; SRIVENUGOPAL KS, 1980, BIOCHEM J, V189, P553, DOI 10.1042/bj1890553; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Walker J B, 1979, Adv Enzymol Relat Areas Mol Biol, V50, P177; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106	45	4	4	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21366	21380		10.1074/jbc.M117.815951	http://dx.doi.org/10.1074/jbc.M117.815951			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29123034	Green Published, hybrid			2022-12-26	WOS:000419013000013
J	Richardsen, E; Andersen, S; Al-Saad, S; Rakaee, M; Nordby, Y; Pedersen, MI; Ness, N; Grindstad, T; Movik, I; Donnem, T; Bremnes, R; Busund, LT				Richardsen, Elin; Andersen, Sigve; Al-Saad, Samer; Rakaee, Mehrdad; Nordby, Yngve; Pedersen, Mona Irene; Ness, Nora; Grindstad, Thea; Movik, Ingeborg; Donnem, Tom; Bremnes, Roy; Busund, Lill-Tove			Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; TUMOR-GROWTH FRACTION; ANDROGEN-DEPRIVATION; MONOCLONAL-ANTIBODY; CANCER; EXPRESSION; TISSUE; RECURRENCE; MIB-1; KI67	The tumor proliferation index marker Ki-67 is strongly associated with tumor cell proliferation, growth and progression, and is widely used in routine clinicopathological investigation. Prostate cancer is a complex multifaceted and biologically heterogeneous disease, and overtreatment of localized, low volume indolent tumors, is evident. Here, we aimed to assess Ki-67 expression and related outcomes of 535 patients treated with radical prostatectomy. The percentage of tumor epithelial cells expressing Ki-67 was determined by immunohistochemical assay, both digital image analysis and visual scoring by light microscope were used for quantification. The association of Ki-67 and prostate cancer was evaluated, as well as its prognostic value. There was a positive correlation between high expression of Ki-67 and Gleason score > 7 (p < 0.001) as well as tumor size (>= 20 mm, p = 0.03). In univariate analyses, a high expression of Ki-67 in tumor epithelium was significantly associated with biochemical failure (BF) (digital scoring, p = 0.014) and (visual scoring, p = 0.004). In the multivariate analyses, a high level of Ki-67 was an independent poor prognostic factor for biochemical failure-free survival (BFFS) (Visual scoring, Ki67, p = 0.012, HR:1.50, CI95% 1.10-2.06). In conclusion, high Ki-67 expression is an independent negative prognostic marker for biochemical failure. Our findings support the role of Ki-67 as a significant, poor prognostic factor for in prostate cancer outcome.	[Richardsen, Elin; Al-Saad, Samer; Rakaee, Mehrdad; Pedersen, Mona Irene; Ness, Nora; Grindstad, Thea; Movik, Ingeborg; Busund, Lill-Tove] UiT Arctic Univ Norway, Dept Med Biol, Translat Canc Res Grp, Tromso, Norway; [Richardsen, Elin; Al-Saad, Samer; Busund, Lill-Tove] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway; [Andersen, Sigve; Nordby, Yngve; Donnem, Tom; Bremnes, Roy] UiT Arctic Univ Norway, Dept Med Biol, Translat Canc Res Grp, Tromso, Norway; [Andersen, Sigve; Donnem, Tom; Bremnes, Roy] Univ Hosp North Norway, Dept Oncol, Tromso, Norway; [Nordby, Yngve] Univ Hosp North Norway, Dept Urol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway	Richardsen, E (corresponding author), UiT Arctic Univ Norway, Dept Med Biol, Translat Canc Res Grp, Tromso, Norway.; Richardsen, E (corresponding author), Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway.	elin-ri@live.no	Rakaee, Mehrdad/GMX-0729-2022	Rakaee, Mehrdad/0000-0002-9080-0153	Norwegian Cancer Society; Northern Health Administration, UiT Arctic University of Norway	Norwegian Cancer Society(Norwegian Cancer Society); Northern Health Administration, UiT Arctic University of Norway	This study was supported by grants from Norwegian Cancer Society (www.kreftforeningen. no) and The Northern Health Administration (www.helse-nord.no), UiT Arctic University of Norway (www.uit.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN S, 2014, BMC UROL, V14, P14, DOI DOI 10.1002/IJC.24174; BARBARESCHI M, 1994, AM J CLIN PATHOL, V102, P171, DOI 10.1093/ajcp/102.2.171; Bettencourt MC, 1996, J UROLOGY, V156, P1064, DOI 10.1016/S0022-5347(01)65703-3; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Cooperberg MR, 2015, JAMA-J AM MED ASSOC, V314, P80, DOI 10.1001/jama.2015.6036; Cowen D, 2002, CLIN CANCER RES, V8, P1148; Desmeules P, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0294-0; Edge SB, 2010, AJCC CANC STAGING MA; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Epstein JI, 2016, EUR UROL, V69, P428, DOI 10.1016/j.eururo.2015.06.046; Fisher G, 2013, BRIT J CANCER, V108, P271, DOI 10.1038/bjc.2012.598; GERDES J, 1984, J IMMUNOL, V133, P1710; GRINDSTAD T, 2016, SCI REP, V9, P33114, DOI DOI 10.1038/SJ.BJC.6602678; Havelund BM, 2013, APPL IMMUNOHISTO M M, V21, P298, DOI 10.1097/PAI.0b013e31826f4475; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Johannessen AL, 2006, PATHOL ONCOL RES, V12, P143, DOI 10.1007/BF02893360; Kankuri M, 2006, ANTICANCER RES, V26, P3825; Leonardo E, 2007, APPL IMMUNOHISTO M M, V15, P220, DOI 10.1097/01.pai.0000213122.66096.f0; Li SY, 2013, AM J SURG PATHOL, V37, P14, DOI 10.1097/PAS.0b013e31826731b5; Lowrance William T, 2009, Rev Urol, V11, P117; MAZEROLLES C, 1994, HISTOPATHOLOGY, V25, P563, DOI 10.1111/j.1365-2559.1994.tb01375.x; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Mesko S, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/717080; Munstedt K, 2004, CANCER INVEST, V22, P185, DOI 10.1081/CNV-120030206; Ness N, 2014, PROSTATE, V74, P1452, DOI 10.1002/pros.22862; Nordby Y, 2015, PROSTATE, V75, P1682, DOI 10.1002/pros.23048; Pascale M, 2016, RADIOL ONCOL, V50, P313, DOI 10.1515/raon-2016-0033; Pollack A, 2004, J CLIN ONCOL, V22, P2133, DOI 10.1200/JCO.2004.09.150; Potosky AL, 2014, J CLIN ONCOL, V32, P1324, DOI 10.1200/JCO.2013.52.5782; Richardsen E, 2015, AM J PATHOL, V185, P2722, DOI 10.1016/j.ajpath.2015.06.013; Rubio J, 2005, EUR UROL, V48, P745, DOI 10.1016/j.eururo.2005.06.014; Scholzen T, 2002, J PATHOL, V196, P135, DOI 10.1002/path.1016; Shariat SF, 2008, CURR OPIN UROL, V18, P279, DOI 10.1097/MOU.0b013e3282f9b3e5; Tollefson MK, 2014, MAYO CLIN PROC, V89, P308, DOI 10.1016/j.mayocp.2013.12.001; Tolonen TT, 2011, BJU INT, V108, P1430, DOI 10.1111/j.1464-410X.2011.10253.x; Vis AN, 2002, J PATHOL, V197, P148, DOI 10.1002/path.1084; WOLTERS R, 2010, BJU INT, V106, P280, DOI DOI 10.1111/J.1464-410X.2011.10253.X; Zellweger T, 2009, INT J CANCER, V124, P2116, DOI 10.1002/ijc.24174	38	32	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186852	10.1371/journal.pone.0186852	http://dx.doi.org/10.1371/journal.pone.0186852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141018	Green Published, gold			2022-12-26	WOS:000415260400011
J	Wang, ZH				Wang, Zhenhong			Process strengths determine the forms of the relationship between plant species richness and primary productivity	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ECOSYSTEM FUNCTION; FIELD EXPERIMENTS; TREE DIVERSITY; BIODIVERSITY; COMPETITION; DISTURBANCE; COEXISTENCE; BIOMASS; EQUIVALENCE	The current rates of biodiversity loss have exceeded the rates observed during the earth's major extinction events, which spurs the studies of the ecological relationships between biodiversity and ecosystem functions, stability, and services to determine the consequences of biodiversity loss. Plant species richness-productivity relationship (SRPR) is crucial to the understanding of these relationships in plants. Most ecologists have reached a widespread consensus that the loss of plant diversity undoubtedly impairs ecosystem functions, and have proposed many processes to explain the SRPR. However, none of the available studies has satisfactorily described the forms and mechanisms clarifying the SRPR. Observed results of the SRPR forms are inconsistent, and studies have long debated the ecological processes explaining the SRPR. Here, I have developed a simple model that combines the positive and/or negative effects of sixteen ecological processes on the SRPR and models that describe the dynamics of complementary-selection effect, density effect, and the interspecific competitive stress influenced by other ecological processes. I can regulate the strengths of the effects of these ecological processes to derive the asymptotic, positive, humped, negative, and irregular forms of the SRPR, and verify these forms using the observed data. The results demonstrated that the different strengths of the ecological processes determine the forms of the SRPR. The forms of the SRPR can change with variations in the strengths of the ecological processes. The dynamic characteristics of the complementary-selection effect, density effect, and the interspecific competitive stress on the SRPR are diverse, and are dependent on the strengths and variation of the ecological processes. This report explains the diverse forms of the SRPR, clarifies the integrative effects of the different ecological processes on the SRPR, and deepens our understanding of the interactions that occur among these ecological processes.	[Wang, Zhenhong] Changan Univ, Sch Environm Sci & Engn, Xian, Shaanxi, Peoples R China; [Wang, Zhenhong] Changan Univ, Minist Educ, Key Lab Subsurface Hydrol & Ecol Effects Arid Reg, Xian, Shaanxi, Peoples R China	Chang'an University; Chang'an University	Wang, ZH (corresponding author), Changan Univ, Sch Environm Sci & Engn, Xian, Shaanxi, Peoples R China.; Wang, ZH (corresponding author), Changan Univ, Minist Educ, Key Lab Subsurface Hydrol & Ecol Effects Arid Reg, Xian, Shaanxi, Peoples R China.	w_zhenhong@126.com		wang, zhenhong/0000-0002-7829-8834	National Natural Science Foundation of China [40861015]; Foundation of State Key Laboratory of Soil Erosion and Dryland Forming on Loess Plateau [10501-161]; Fundamental Research Funds for the Central Universities [310829173601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of State Key Laboratory of Soil Erosion and Dryland Forming on Loess Plateau; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (No. 40861015) to Zhenhong Wang, the Foundation of State Key Laboratory of Soil Erosion and Dryland Forming on Loess Plateau (No. 10501-161) to Zhenhong Wang, and the Fundamental Research Funds for the Central Universities (No. 310829173601) to Zhenhong Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by grants from the Fundamental Research Funds for the Central Universities (No. 310829173601) and the National Natural Science Foundation of China (No. 40861015). We thank Dr. John A. Gamon, anonymous reviewers, and Axios Review for their constructive comments.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; BELSKY JA, 1992, J VEG SCI, V3, P187, DOI 10.2307/3235679; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Chisholm RA, 2013, J ECOL, V101, DOI 10.1111/1365-2745.12132; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Craven D, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0277; Downing AL, 2005, ECOLOGY, V86, P701, DOI 10.1890/03-0239; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; GARCIA LV, 1993, J VEG SCI, V4, P417, DOI 10.2307/3235601; GOLDBERG DE, 1983, AM J BOT, V70, P1098, DOI 10.2307/2442821; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hodapp D, 2016, ECOLOGY, V97, P1463, DOI 10.1890/15-0730.1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes AR, 2007, ECOL LETT, V10, P849, DOI 10.1111/j.1461-0248.2007.01075.x; Huston M A, 2000, Science, V289, P1255; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; Huston MA, 2014, ECOLOGY, V95, P2382, DOI 10.1890/13-1397.1; Jiang L, 2007, OIKOS, V116, P324, DOI 10.1111/j.2006.0030-1299.15371.x; Jiang XiaoLei, 2004, Acta Prataculturae Sinica, V13, P8; Jiang Y.X., 2002, BIODIVERSITY FORMATI; Jucker T, 2016, J ECOL, V104, P388, DOI 10.1111/1365-2745.12522; Kessler M, 2014, J ECOL, V102, P1623, DOI 10.1111/1365-2745.12299; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Lasky JR, 2014, ECOL LETT, V17, P1158, DOI 10.1111/ele.12322; Liang JJ, 2015, P NATL ACAD SCI USA, V112, P5738, DOI 10.1073/pnas.1409853112; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Matsinos YG, 2002, ECOL MODEL, V149, P71, DOI 10.1016/S0304-3800(01)00515-4; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Mishra BP, 2004, BIODIVERS CONSERV, V13, P421, DOI 10.1023/B:BIOC.0000006509.31571.a0; Nuttle T, 2013, ECOL MONOGR, V83, P3, DOI 10.1890/11-2263.1; Partel M, 1996, OIKOS, V75, P111, DOI 10.2307/3546327; Perrings C, 2011, FRONT ECOL ENVIRON, V9, P512, DOI 10.1890/100212; Rees M, 2013, ECOL LETT, V16, P291, DOI 10.1111/ele.12037; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Rychtecka T, 2014, NATURWISSENSCHAFTEN, V101, P637, DOI 10.1007/s00114-014-1198-7; Salo T, 2009, MAR ECOL PROG SER, V396, P261, DOI 10.3354/meps08325; Sammul M, 2000, OECOLOGIA, V125, P18, DOI 10.1007/PL00008887; Sammul M, 2006, OIKOS, V112, P138, DOI 10.1111/j.0030-1299.2006.13378.x; Schulze E.D., 1993, BIODIVERSITY ECOSYST; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Song Y.C., 2001, VEGETATION ECOLOGY; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Stevens MHH, 1999, ECOLOGY, V80, P455, DOI 10.1890/0012-9658(1999)080[0455:PDDSRA]2.0.CO;2; Stevens MHH, 2002, ECOL LETT, V5, P420, DOI 10.1046/j.1461-0248.2002.00333.x; Szwagrzyk J, 2007, J VEG SCI, V18, P555, DOI 10.1111/j.1654-1103.2007.tb02569.x; Thompson K, 2005, FUNCT ECOL, V19, P355, DOI [10.1111/j.0269-8463.2005.00936.x, 10.1111/j.1365-2435.2005.00936.x]; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Turnbull LA, 2013, ECOL LETT, V16, P116, DOI 10.1111/ele.12056; Vila M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053530; Wang ZH, 2010, PLANT ECOL, V209, P205, DOI 10.1007/s11258-009-9680-6; Wang Zhenhong, 2006, Yingyong Shengtai Xuebao, V17, P1583; Wardle DA, 2001, OECOLOGIA, V129, P620, DOI 10.1007/s004420100753; Weis JJ, 2007, ECOLOGY, V88, P929, DOI 10.1890/06-0943; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Willig MR, 2011, SCIENCE, V333, P1709, DOI 10.1126/science.1212453; Yachi S, 2007, ECOL LETT, V10, P54, DOI 10.1111/j.1461-0248.2006.00994.x; Zunzunegui M, 2012, PLANT SOIL, V354, P299, DOI 10.1007/s11104-011-1066-6	75	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0185884	10.1371/journal.pone.0185884	http://dx.doi.org/10.1371/journal.pone.0185884			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140995	Green Submitted, Green Published, gold			2022-12-26	WOS:000415260400003
J	Dunham, J; van de Vis, R; Bauer, J; Wubben, J; van Driel, N; Laman, JD; 't Hart, BA; Kap, YS				Dunham, Jordon; van de Vis, Reinofke; Bauer, Jan; Wubben, Jacqueline; van Driel, Nikki; Laman, Jon D.; 't Hart, Bert A.; Kap, Yolanda S.			Severe oxidative stress in an acute inflammatory demyelinating model in the rhesus monkey	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; INCOMPLETE FREUNDS-ADJUVANT; MULTIPLE-SCLEROSIS LESIONS; NONHUMAN PRIMATE MODELS; INNATE IMMUNE-SYSTEM; MITOCHONDRIAL DYSFUNCTION; RESPIRATORY BURST; TISSUE-INJURY; NEURODEGENERATION	Oxidative stress is increasingly implicated as a co-factor of tissue injury in inflammatory/demyelinating disorders of the central nervous system (CNS), such as multiple sclerosis (MS). While rodent experimental autoimmune encephalomyelitis (EAE) models diverge from human demyelinating disorders with respect to limited oxidative injury, we observed that in a non-human primate (NHP) model for MS, namely EAE in the common marmoset, key pathological features of the disease were recapitulated, including oxidative tissue injury. Here, we investigated the presence of oxidative injury in another NHP EAE model, i.e. in rhesus macaques, which yields an acute demyelinating disease, which may more closely resemble acute disseminated encephalomyelitis (ADEM) than MS. Rhesus monkey EAE diverges from marmoset EAE by abundant neutrophil recruitment into the CNS and destructive injury to white matter. This difference prompted us to investigate to which extent the oxidative pathway features elicited in MS and marmoset EAE are reflected in the acute rhesus monkey EAE model. The rhesus EAE brain was characterized by widespread demyelination and active lesions containing numerous phagocytic cells and to a lesser extent T cells. We observed induction of the oxidative stress pathway, including injury, with a predilection of p22phox expression in neutrophils and macrophages/microglia. In addition, changes in iron were observed. These results indicate that pathogenic mechanisms in the rhesus EAE model may differ from the marmoset EAE and MS brain due to the neutrophil involvement, but may in the end lead to similar induction of oxidative stress and injury.	[Dunham, Jordon; van de Vis, Reinofke; Wubben, Jacqueline; van Driel, Nikki; 't Hart, Bert A.; Kap, Yolanda S.] Biomed Primate Res Ctr, Dept Immunobiol, Rijswijk, Netherlands; [Dunham, Jordon; Laman, Jon D.; 't Hart, Bert A.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Bauer, Jan] Med Univ, Brain Res Inst, Dept Neuroimmunol, Vienna, Austria	University of Groningen	Kap, YS (corresponding author), Biomed Primate Res Ctr, Dept Immunobiol, Rijswijk, Netherlands.	kap@bprc.nl	Bauer, Jan/F-5429-2011	Bauer, Jan/0000-0001-5802-8047	Marie Curie Fellowship, ITN Neurokine [316722]	Marie Curie Fellowship, ITN Neurokine	The authors have no financial disclosures. The salary of Jordon Dunham was funded by A Marie Curie Fellowship, ITN Neurokine 316722.	BABIOR BM, 1994, ENVIRON HEALTH PERSP, V102, P53, DOI 10.2307/3432214; Barrett MJ, 2004, J NEUROSCI RES, V78, P420, DOI 10.1002/jnr.20249; Brok HPM, 2001, IMMUNOL REV, V183, P173, DOI 10.1034/j.1600-065x.2001.1830114.x; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Dunham J, 2017, J NEUROPATH EXP NEUR, V76, P467, DOI 10.1093/jnen/nlx034; FINKEL TH, 1987, J BIOL CHEM, V262, P12589; Flynn JM, 2013, FREE RADICAL BIO MED, V62, P4, DOI 10.1016/j.freeradbiomed.2013.05.027; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gandhi R, 2010, J NEUROIMMUNOL, V221, P7, DOI 10.1016/j.jneuroim.2009.10.015; Ghezzi A, 2004, NEUROL SCI, V25, pS336, DOI 10.1007/s10072-004-0336-y; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Haanstra KG, 2015, J IMMUNOL, V194, P1454, DOI 10.4049/jimmunol.1402563; Haanstra KG, 2013, J NEUROIMMUNE PHARM, V8, P1251, DOI 10.1007/s11481-013-9487-z; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; Hartung HP, 2001, NEUROLOGY, V56, P1257, DOI 10.1212/WNL.56.10.1257; Jagessar SA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0378-5; Kap YS, 2016, DRUG DISCOV TODAY, V21, P1200, DOI 10.1016/j.drudis.2016.03.014; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Kuhlmann T, 2008, ACTA NEUROPATHOL, V115, P275, DOI 10.1007/s00401-007-0320-8; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Mayo L, 2012, IMMUNOL REV, V248, P170, DOI 10.1111/j.1600-065X.2012.01135.x; Meguro R, 2007, ARCH HISTOL CYTOL, V70, P1, DOI 10.1679/aohc.70.1; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Popescu BFG, 2012, ANNU REV PATHOL-MECH, V7, P185, DOI 10.1146/annurev-pathol-011811-132443; Schuh C, 2014, ACTA NEUROPATHOL, V128, P247, DOI 10.1007/s00401-014-1263-5; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Stephenson E, 2014, NAT REV NEUROL, V10, P459, DOI 10.1038/nrneurol.2014.118; 't Hart BA, 2005, J NEUROIMMUNOL, V168, P1, DOI 10.1016/j.jneuroim.2005.05.017; 't Hart BA, 2011, TRENDS MOL MED, V17, P119, DOI 10.1016/j.molmed.2010.11.006; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; van Beek J, 2005, J IMMUNOL, V174, P2353, DOI 10.4049/jimmunol.174.4.2353; van Horssen J, 2008, FREE RADICAL BIO MED, V45, P1729, DOI 10.1016/j.freeradbiomed.2008.09.023; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Vargas DL, 2017, J INVESTIG MED; Vincent AM, 2007, EXP NEUROL, V208, P216, DOI 10.1016/j.expneurol.2007.07.017; Witte ME, 2014, TRENDS MOL MED, V20, P179, DOI 10.1016/j.molmed.2013.11.007; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	39	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188013	10.1371/journal.pone.0188013	http://dx.doi.org/10.1371/journal.pone.0188013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136024	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200056
J	Ioannou, A; Varotsis, C				Ioannou, Aristos; Varotsis, Constantinos			Modifications of hemoglobin and myoglobin by Maillard reaction products (MRPs)	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MODEL SYSTEMS; NONENZYMATIC GLYCATION; LIGAND-BINDING; SERUM-ALBUMIN; ACRYLAMIDE; TRANSITION; PH; CONFORMATION; SPECTROSCOPY	High performance liquid chromatography (HPLC) coupled with a Fraction Collector was employed to isolate Maillard reaction products (MRPs) formed in model systems comprising of asparagine and monosaccharides in the 60-180 degrees C range. The primary MRP which is detected at 60 E C is important for Acrylamide content and color/aroma development in foods and also in the field of food biotechnology for controlling the extent of the Maillard reaction with temperature. The discrete fractions of the reaction products were reacted with Hemoglobin (Hb) and Myoglobin (Mb) at physiological conditions and the reaction adducts were monitored by UV-vis and Attenuated Total Reflection-Fourier transform infrared (FTIR) spectrophotometry. The UV-vis kinetic profiles revealed the formation of a Soret transition characteristic of a low-spin six-coordinated species and the ATR-FTIR spectrum of the HbMRP and Mb-MRP fractions showed modifications in the protein Amide I and II vibrations. The UV-vis and the FTIR spectra of the Hb-MRPs indicate that the six-coordinated species is a hemichrome in which the distal E7 Histidine is coordinated to the heme Fe and blocks irreversibly the ligand binding site. Although the Mb-MRPs complex is a six-coordinated species, the 1608 cm(-1) FTIR band characteristic of a hemichrome was not observed.	[Ioannou, Aristos; Varotsis, Constantinos] Cyprus Univ Technol, Dept Environm Sci & Technol, Limassol, Cyprus	Cyprus University of Technology	Varotsis, C (corresponding author), Cyprus Univ Technol, Dept Environm Sci & Technol, Limassol, Cyprus.	c.varotsis@cut.ac.cy		Ioannou, Aristos/0000-0003-1884-0529	European Regional Development Fund; Republic of Cyprus through Research Promotion Foundation [YGEIA/TROFH/0311(BIE)/04]	European Regional Development Fund(European Commission); Republic of Cyprus through Research Promotion Foundation	Financial support by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation (Grant YGEIA/TROFH/0311(BIE)/04) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Ajandouz EH, 2001, J FOOD SCI, V66, P926, DOI 10.1111/j.1365-2621.2001.tb08213.x; Alizadeh-Rahrovi J, 2015, J BIOL PHYS, V41, P349, DOI 10.1007/s10867-015-9383-2; Amrein TM, 2006, J AGR FOOD CHEM, V54, P10253, DOI 10.1021/jf0625860; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; BANDEKAR J, 1992, BIOCHIM BIOPHYS ACTA, V1120, P123, DOI 10.1016/0167-4838(92)90261-B; Banerjee S, 2017, INT J BIOL MACROMOL, V95, P1159, DOI 10.1016/j.ijbiomac.2016.11.006; Banerjee S, 2016, SPECTROCHIM ACTA A, V155, P1, DOI 10.1016/j.saa.2015.10.022; Banerjee S, 2014, INT J BIOL MACROMOL, V66, P311, DOI 10.1016/j.ijbiomac.2014.02.034; Bath A, 2002, O REV BIOPHYS, V35, P369; Benjakul S, 2005, FOOD CHEM, V93, P189, DOI 10.1016/j.foodchem.2004.10.019; Chen QY, 2005, BIOPHYS J, V88, P2057, DOI 10.1529/biophysj.104.046136; Deli G, 2013, NEUROENDOCRINOLOGY, V98, P267, DOI 10.1159/000358728; DOU Y, 1995, J BIOL CHEM, V270, P15993, DOI 10.1074/jbc.270.27.15993; DOUSSEAU F, 1990, BIOCHEMISTRY-US, V29, P8771, DOI 10.1021/bi00489a038; Garidel P., 2006, BIOPROCESS INT, V1, P48; Gul A, 2009, J DIABETES COMPLICAT, V23, P343, DOI 10.1016/j.jdiacomp.2008.04.001; Hegde AH, 2013, INT J BIOL MACROMOL, V52, P133, DOI 10.1016/j.ijbiomac.2012.09.015; Hidalgo FJ, 2010, J AGR FOOD CHEM, V58, P10512, DOI 10.1021/jf102026c; Iannuzzi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080768; Ioannou A., 2016, J PHYS CHEM BIOPHYSI, V6, P210, DOI [10.4172/2161-0398.1000210, DOI 10.4172/2161-0398.1000210]; Ioannou A, 2017, J MOL STRUCT, V1141, P634, DOI 10.1016/j.molstruc.2017.04.011; JAYARAMAN V, 1995, SCIENCE, V269, P1843, DOI 10.1126/science.7569921; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lertittikul W, 2007, FOOD CHEM, V100, P669, DOI 10.1016/j.foodchem.2005.09.085; Little RR, 2013, CLIN CHIM ACTA, V418, P63, DOI 10.1016/j.cca.2012.12.026; LITVINKO N M, 1989, Prikladnaya Biokhimiya i Mikrobiologiya, V25, P847; Litvinov RI, 2012, BIOPHYS J, V103, P1020, DOI 10.1016/j.bpj.2012.07.046; Lu Z, 2007, J FLUORESC, V17, P580, DOI 10.1007/s10895-007-0220-2; Nass N, 2007, Z GERONTOL GERIATR, V40, P349, DOI 10.1007/s00391-007-0484-9; Pan T, 2014, J INNOV OPT HEAL SCI, V7, DOI 10.1142/S1793545813500600; Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149; Riccio A, 2002, P NATL ACAD SCI USA, V99, P9801, DOI 10.1073/pnas.132182099; Robinson VL, 2003, BIOCHEMISTRY-US, V42, P10113, DOI 10.1021/bi030059t; RODGERS KR, 1994, SCIENCE, V265, P1697, DOI 10.1126/science.8085153; Schalkwijk CG, 2004, DIABETES-METAB RES, V20, P369, DOI 10.1002/dmrr.488; Sen S, 2007, MOL CELL BIOCHEM, V301, P251, DOI 10.1007/s11010-007-9418-5; SHAPIRO R, 1980, J BIOL CHEM, V255, P3120; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Stadler RH, 2002, NATURE, V419, P449, DOI 10.1038/419449a; Stadler RH, 2004, J AGR FOOD CHEM, V52, P5550, DOI 10.1021/jf0495486; Sugawara Y, 2003, ACTA PHYSIOL SCAND, V179, P49, DOI 10.1046/j.1365-201X.2003.01142.x; Sugiyama K, 2011, United States patent US, Patent No. [8,021,887, 8021887]; Vergara A, 2008, METHOD ENZYMOL, V436, P425, DOI 10.1016/S0076-6879(08)36024-8; Yaylayan VA, 2003, J AGR FOOD CHEM, V51, P1753, DOI 10.1021/jf0261506; You Y, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2358-6; Zyzak DV, 2003, J AGR FOOD CHEM, V51, P4782, DOI 10.1021/jf034180i	47	11	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188095	10.1371/journal.pone.0188095	http://dx.doi.org/10.1371/journal.pone.0188095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136023	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200063
J	Umeda, K; Tanaka, S; Ihara, F; Yamagishi, J; Suzuki, Y; Nishikawa, Y				Umeda, Kousuke; Tanaka, Sachi; Ihara, Fumiaki; Yamagishi, Junya; Suzuki, Yutaka; Nishikawa, Yoshifumi			Transcriptional profiling of Toll-like receptor 2-deficient primary murine brain cells during Toxoplasma gondii infection	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FACTOR-XIII; CHRONIC NEURODEGENERATION; PROSTAGLANDIN E-2; MICROGLIAL CELLS; GENE-EXPRESSION; CUTTING EDGE; GTPASES; MOUSE; TLR2	Background Toxoplasma gondii is capable of persisting in the brain, although it is efficiently eliminated by cellular immune responses in most other sites. While Toll-like receptor 2 (TLR2) reportedly plays important roles in protective immunity against the parasite, the relationship between neurological disorders induced by T. gondii infection and TLR2 function in the brain remains controversial with many unknowns. In this study, primary cultured astrocytes, microglia, neurons, and peritoneal macrophages obtained from wild-type and TLR2-deficient mice were exposed to T. gondii tachyzoites. To characterize TLR2-dependent functional pathways activated in response to T. gondii infection, gene expression of different cell types was profiled by RNA sequencing. Results During T. gondii infection, a total of 611, 777, 385, and 1105 genes were upregulated in astrocytes, microglia, neurons, and macrophages, respectively, while 163, 1207, 158, and 1274 genes were downregulated, respectively, in a TLR2-dependent manner. Overrepresented Gene Ontology (GO) terms for TLR2-dependently upregulated genes were associated with immune and stress responses in astrocytes, immune responses and developmental processes in microglia, metabolic processes and immune responses in neurons, and metabolic processes and gene expression in macrophages. Overrepresented GO terms for downregulated genes included ion transport and behavior in astrocytes, cell cycle and cell division in microglia, metabolic processes in neurons, and response to stimulus, signaling and cell motility in macrophages. Conclusions To our knowledge, this is the first transcriptomic study of TLR2 function across different cell types during T. gondii infection. Results of RNA-sequencing demonstrated roles for TLR2 varied by cell type during T. gondii infection. Our findings facilitate understanding of the detailed relationship between TLR2 and T. gondii infection, and elucidate mechanisms underlying neurological changes during infection.	[Umeda, Kousuke; Ihara, Fumiaki; Nishikawa, Yoshifumi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan; [Tanaka, Sachi] Shinshu Univ, Fac Agr, Dept Agr & Life Sci, Div Anim Sci, Minamiminowa, Nagano, Japan; [Yamagishi, Junya] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	Obihiro University of Agriculture & Veterinary Medicine; Shinshu University; Hokkaido University; University of Tokyo	Nishikawa, Y (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan.	nisikawa@obihiro.ac.jp		nishikawa, yoshifumi/0000-0001-5005-6377	Japan Society for the Promotion of Science (JSPS) [2011/LS003]; JSPS KAKENHI [JP24880006, JP17K17570, JP15K15118, JP17K19538]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Japan Society for the Promotion of Science (JSPS), http://www.jsps.go.jp/english/, through the Funding Program for Next Generation World Leading Researchers (NEXT Program), initiated by the Council for Science and Technology Policy (2011/LS003) (YN) and JSPS KAKENHI (Grant-in-Aid for Research Activity Start-up JP24880006 [ST], Grant-in-Aid for Young Scientists (B) JP17K17570 [KU], Grant-in-Aid for Exploratory Research JP15K15118 [YN] and Challenging Research (Exploratory) JP17K19538 [YN]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ANGULO JA, 1990, J NEUROCHEM, V54, P1889, DOI 10.1111/j.1471-4159.1990.tb04887.x; Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; Bacaj T, 2013, NEURON, V80, P947, DOI 10.1016/j.neuron.2013.10.026; Bjornsen LP, 2014, J NEUROCHEM, V128, P641, DOI 10.1111/jnc.12509; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; BOARD PG, 1993, BLOOD REV, V7, P229, DOI 10.1016/0268-960X(93)90010-2; Cabral CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005447; Choa H, 2006, BIOORGAN MED CHEM, V14, P6486, DOI 10.1016/j.bmc.2006.06.030; Conseil V, 1999, ANTIMICROB AGENTS CH, V43, P1358, DOI 10.1128/AAC.43.6.1358; Contreras-Ochoa CO, 2012, PARASITOL RES, V110, P2089, DOI 10.1007/s00436-012-2836-7; Crack PJ, 2007, IMMUNOL CELL BIOL, V85, P476, DOI 10.1038/sj.icb.7100103; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Dellacasa-Lindberg I, 2011, INFECT IMMUN, V79, P3046, DOI 10.1128/IAI.01042-10; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; FISCHER HG, 1993, J NEUROIMMUNOL, V42, P87, DOI 10.1016/0165-5728(93)90215-K; FRESHMAN MM, 1966, P SOC EXP BIOL MED, V123, P862, DOI 10.3181/00379727-123-31625; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; GHOSH SK, 1991, J BIOL CHEM, V266, P15293; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Hilgenberg Lutz G W, 2007, J Vis Exp, P562, DOI 10.3791/562; Hill RD, 2012, INFECT IMMUN, V80, P968, DOI 10.1128/IAI.05421-11; Holst FGE, 1999, AM J TROP MED HYG, V60, P99, DOI 10.4269/ajtmh.1999.60.99; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Jin S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29424; Jones J, 2003, AM FAM PHYSICIAN, V67, P2131; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lagal V, 2010, CELL MICROBIOL, V12, P1792, DOI 10.1111/j.1462-5822.2010.01509.x; Luder CGK, 1999, EXP PARASITOL, V93, P23, DOI 10.1006/expr.1999.4421; LUFT BJ, 1983, LANCET, V1, P781; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Melzer TC, 2010, J NEUROPARASITOLOGY, V1; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; Neuner R, 2009, MECH DEVELOP, V126, P240, DOI 10.1016/j.mod.2008.10.010; Oosterhoff JK, 2003, ONCOGENE, V22, P2920, DOI 10.1038/sj.onc.1206397; Pasterkamp RJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-98; Peng BW, 2008, PARASITOL RES, V102, P1043, DOI 10.1007/s00436-007-0873-4; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Pittman KJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-806; Sanecka A, 2012, VIRULENCE, V3, P678, DOI 10.4161/viru.22833; Seiradake E, 2011, EMBO J, V30, P4479, DOI 10.1038/emboj.2011.346; Skariah S, 2010, PARASITOL RES, V107, P253, DOI 10.1007/s00436-010-1899-6; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sridharan J, 2012, MECH DEVELOP, V129, P136, DOI 10.1016/j.mod.2012.05.002; Stenzel W, 2008, AM J PATHOL, V172, P132, DOI 10.2353/ajpath.2008.070567; Sugitani K, 2012, NEUROCHEM INT, V61, P423, DOI 10.1016/j.neuint.2012.06.004; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Tanaka S, 2013, INFECT IMMUN, V81, P3609, DOI 10.1128/IAI.00439-13; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Weiss LM, 2000, FRONT BIOSCI-LANDMRK, V5, pD391, DOI 10.2741/Weiss; Wilhelmsen K, 2012, INNATE IMMUN-LONDON, V18, P602, DOI 10.1177/1753425911429336; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yoshida E, 2004, MOL BRAIN RES, V131, P33, DOI 10.1016/j.molbrainres.2004.08.023; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhao H, 2012, CELL HOST MICROBE, V12, P705, DOI 10.1016/j.chom.2012.10.010	62	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187703	10.1371/journal.pone.0187703	http://dx.doi.org/10.1371/journal.pone.0187703			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136637	Green Submitted, gold, Green Published			2022-12-26	WOS:000415121200028
J	Hald, J; Poulsen, PB; Qvist, I; Holm, L; Wedell-Wedellsborg, D; Dybro, L; Frost, L				Hald, Jonas; Poulsen, Peter Bo; Qvist, Ina; Holm, Lisbeth; Wedell-Wedellsborg, Dorte; Dybro, Lars; Frost, Lars			Opportunistic screening for atrial fibrillation in a real-life setting in general practice in Denmark - The Atrial Fibrillation Found On Routine Detection (AFFORD) non-interventional study	PLOS ONE			English	Article							PREVALENCE; RISK; ELECTROCARDIOGRAM; STROKE; HEART; AGE	Atrial fibrillation (AF) is a chronic disease with an incidence increasing steeply by age and affecting more than 11 million patients in Europe and the United States. Diagnosing AF is essential for the prevention of stroke by oral anticoagulation. Opportunistic screening for AF in patients >= 65 years of age is recommended by the European and Danish Societies of Cardiology. The study aim was to examine the detection rate of AF in consecutively screened patients in the primary care setting in Denmark. In an open, non-interventional, cluster, multicenter, cross-sectional, observational study patients >= 65 years of age entering consecutively into general practice clinics were invited to nurse-assisted opportunistic screening for AF. The General Practice (GP) clinics participating were randomized to patient inclusion in three age groups: 65-74, 75-84, and >= 85 years respectively. All patients underwent pulse palpation followed by 12-led electrocardiogram in case of irregular pulse. Two cardiologists validated all electrocardiogram examinations. Forty-nine general practice clinics recruited in total 970 patients split into three age groups; 480 patients (65-74 years), 372 (75-84 years), and 118 patients >= 85 years of age. Co-morbidities increased by age with hypertension being most frequent. Eighty-seven patients (9%) were detected with an irregular pulse, representing 4.4%, 10.5% and 22.9%, respectively in the three age groups. Assessment of electrocardiograms by the GP showed suspicion of AF in 13 patients with final verification of electrocardiograms by cardiologists revealing 10 AF-patients. The highest detection rate of AF was found in the >= 85 age group (3.39%) followed by the 65-74 age group (0.83%) and the 75-84 age group (0.54%). Opportunistic screening of AF in primary care is feasible and do result in the detection of new AF-patients. Close collaboration with cardiologists is advisable to avoid false positive screening results.	[Hald, Jonas; Holm, Lisbeth] Laegerne Odingarden GP Clin, Viborg, Denmark; [Poulsen, Peter Bo; Wedell-Wedellsborg, Dorte] Pfizer Denmark, Hlth & Value, Ballerup, Denmark; [Qvist, Ina; Frost, Lars] Univ Res Clin Innovat Patient Pathways, Reg Hosp Silkeborg, Dept Cardiol, Silkeborg, Denmark; [Dybro, Lars] Pfizer Denmark, Internal Med, Ballerup, Denmark; [Frost, Lars] Aarhus Univ Hosp, Dept Clin Med, Aarhus, Denmark	Pfizer; Pfizer; Aarhus University	Poulsen, PB (corresponding author), Pfizer Denmark, Hlth & Value, Ballerup, Denmark.	peterbo.poulsen@pfizer.com	Frost, Lars/Q-9295-2019; Frost, Lars/V-3982-2017; Qvist, Ina/R-1663-2016	Frost, Lars/0000-0001-9215-9796; Frost, Lars/0000-0001-9215-9796; Qvist, Ina/0000-0002-9756-4587; Poulsen, Peter Bo/0000-0002-5279-4637	Pfizer Denmark Aps.	Pfizer Denmark Aps.	JH and LH were paid by Pfizer Denmark Aps. for their work as investigator in the study, as well as their work as a member of the study steering committee. IQ and LF were paid by Pfizer Denmark Aps. for their work as members of the study steering committee. DWW was a paid contractor to Pfizer Denmark Aps. for her work as the CRO project leader role of the study and work as a member of the study steering committee. PBP and LD are full-time employees of Pfizer Denmark Aps. and were both members of the study steering committee.	Bilato C, 2009, AM J CARDIOL, V104, P1092, DOI 10.1016/j.amjcard.2009.05.058; Camm AJ, 2012, EUR HEART J, V33; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; CAMM AJ, 1980, AM HEART J, V99, P598, DOI 10.1016/0002-8703(80)90733-4; CAMPBELL A, 1974, BRIT HEART J, V36, P1005; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; Daniel WW, BIOSTATISTICS FDN AN, p18C; Danish Statistics, FOLK2 FOLK 1 JAN EFT; Deif B, 2013, INT J CARDIOL, V164, P371, DOI 10.1016/j.ijcard.2012.08.002; Fitzmaurice DA, 2007, BRIT MED J, V335, P383, DOI 10.1136/bmj.39280.660567.55; Freedman B, 2017, CIRCULATION, V135, P1851, DOI 10.1161/CIRCULATIONAHA.116.026693; Gill PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026710; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; HILL JD, 1987, J ROY COLL GEN PRACT, V37, P172; Hjertekarsygdomme i, 2014, HJERT 2011 INC PRAEV; Gomez-Doblas JJ, 2014, REV ESP CARDIOL, V67, P259, DOI [10.1016/j.rec.2013.07.014, 10.1016/j.recesp.2013.07.015]; Kirchhof P., 2016, EUR HEART J; Koch MB., 2014, HJERTEKARSYGDOMME 20; Levitt G, 1939, AM HEART J, V18, P692, DOI 10.1016/S0002-8703(39)90848-3; Lowres N, 2013, THROMB HAEMOSTASIS, V110, P213, DOI 10.1160/TH13-02-0165; Mairesse GH, 2017, EUROPACE, P1; Moran PS, 2016, VALUE HEALTH, V19, P985, DOI 10.1016/j.jval.2016.07.007; Moran PS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009586.pub2; Morgan S, 2002, BRIT J GEN PRACT, V52, P373; Naing L, SAMPLE SIZE CALCULAT; Sanmartin M, 2013, REV ESP CARDIOL, V66, P34, DOI 10.1016/j.recesp.2012.05.012; Savelieva I, 2008, CLIN CARDIOL, V31, P55, DOI 10.1002/clc.20138; Schmidt M, 2016, INT J CARDIOL, V225, P30, DOI 10.1016/j.ijcard.2016.09.071; Sudlow M, 1998, BRIT MED J, V317, P327, DOI 10.1136/bmj.317.7154.327; Svennberg E, 2015, CIRCULATION, V131, P2176, DOI 10.1161/CIRCULATIONAHA.114.014343; Taggar JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152086; Tawfik A, 2016, CLIN PHARMACOL-ADV A, V8, P93, DOI 10.2147/CPAA.S105165; Wheeldon NM, 1998, HEART, V79, P50, DOI 10.1136/hrt.79.1.50	33	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0188086	10.1371/journal.pone.0188086	http://dx.doi.org/10.1371/journal.pone.0188086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131836	gold, Green Published, Green Submitted			2022-12-26	WOS:000414997800045
J	Gough, CS; Fairlamb, GM; Bell, P; Nachman, RJ; Audsley, N; Isaac, RE				Gough, Caroline S.; Fairlamb, Grace M.; Bell, Petra; Nachman, Ronald J.; Audsley, Neil; Isaac, R. Elwyn			Peptidergic control in a fruit crop pest: The spotted-wing drosophila, Drosophila suzukii	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; INSECT NEUROPEPTIDES; FMRFAMIDE RECEPTOR; MOLECULAR-CLONING; PK/PBAN FAMILY; PHORMIA-REGINA; MELANOGASTER; CONTRACTIONS; MANAGEMENT; PROGRAMS	Neuropeptides play an important role in the regulation of feeding in insects and offer potential targets for the development of new chemicals to control insect pests. A pest that has attracted much recent attention is the highly invasive Drosophila suzukii, a polyphagous pest that can cause serious economic damage to soft fruits. Previously we showed by mass spectrometry the presence of the neuropeptide myosuppressin (TDVDHVFLRFamide) in the nerve bundle suggesting that this peptide is involved in regulating the function of the crop, which in adult dipteran insects has important roles in the processing of food, the storage of carbohydrates and the movement of food into the midgut for digestion. In the present study antibodies that recognise the C-terminal RFamide epitope of myosuppressin stain axons in the crop nerve bundle and reveal peptidergic fibres covering the surface of the crop. We also show using an in vitro bioassay that the neuropeptide is a potent inhibitor (EC50 of 2.3 nM) of crop contractions and that this inhibition is mimicked by the non-peptide myosuppressin agonist, benzethonium chloride (Bztc). Myosuppressin also inhibited the peristaltic contractions of the adult midgut, but was a much weaker agonist (EC50 = 5.7 mu M). The oral administration of Bztc (5 mM) in a sucrose diet to adult female D. suzukii over 4 hours resulted in less feeding and longer exposure to dietary Bztc led to early mortality. We therefore suggest that myosuppressin and its cognate receptors are potential targets for disrupting feeding behaviour of adult D. suzukii.	[Gough, Caroline S.; Fairlamb, Grace M.; Bell, Petra; Isaac, R. Elwyn] Univ Leeds, Sch Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Nachman, Ronald J.] USDA, Insect Control & Cotton Dis Res Unit, Southern Plains Agr Res Ctr, College Stn, TX USA; [Audsley, Neil] FERA Sci, York, N Yorkshire, England	University of Leeds; United States Department of Agriculture (USDA); Food & Environment Research Agency	Isaac, RE (corresponding author), Univ Leeds, Sch Biol, Fac Biol Sci, Leeds, W Yorkshire, England.	r.e.isaac@leeds.ac.uk		Isaac, Richard/0000-0003-4792-6559; Fairlamb, Grace/0000-0003-0175-6005; Audsley, Neil/0000-0002-7972-8656	European Union Horizon programme [634361]; European Union 7th Framework research and innovation programme [613678]	European Union Horizon programme; European Union 7th Framework research and innovation programme	This study was supported by the European Union's Horizon 2020 (CSG, REI) and 7th Framework research and innovation programmes (REI, NA) under grant agreement 634361 and 613678, respectively. FERA Science provided support in the form of a salary for NA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This study was supported by the European Union's Horizon 2020 (CSG, REI) and 7th Framework research and innovation programmes (REI, NA) under grant agreement 634361 y 613678, respectively. FERA Science provided support in the form of a salary for NA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altstein M, 2004, J MOL NEUROSCI, V22, P147, DOI 10.1385/JMN:22:1-2:147; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Audsley N, 2009, GEN COMP ENDOCR, V162, P93, DOI 10.1016/j.ygcen.2008.08.003; Audsley N, 2015, INSECT BIOCHEM MOLEC, V67, P27, DOI 10.1016/j.ibmb.2015.07.014; Audsley N, 2015, PEPTIDES, V68, P33, DOI 10.1016/j.peptides.2014.08.006; Barney R, 2006, J SURFACTANTS DETERG, V9, P137, DOI 10.1007/s11743-006-0382-y; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bendena WG, 2010, ADV EXP MED BIOL, V692, P166; Bolda M.P., 2010, AGR RESOUR EC UPDATE, V13, P5, DOI DOI 10.1016/J.JFF.2015.04.027; Bruck DJ, 2011, PEST MANAG SCI, V67, P1375, DOI 10.1002/ps.2242; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Cazzamali G, 2002, P NATL ACAD SCI USA, V99, P12073, DOI 10.1073/pnas.192442799; CHEN AC, 1975, J INSECT PHYSIOL, V21, P529, DOI 10.1016/0022-1910(75)90158-4; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cuthbertson Andrew G S, 2014, Insects, V5, P488, DOI 10.3390/insects5020488; De Ros G, 2015, J BERRY RES, V5, P89, DOI 10.3233/JBR-150092; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; Diepenbrock LM, 2016, CROP PROT, V81, P76, DOI 10.1016/j.cropro.2015.12.012; Duttlinger A, 2002, PEPTIDES, V23, P1953, DOI 10.1016/S0196-9781(02)00179-1; Egerod K, 2003, P NATL ACAD SCI USA, V100, P9808, DOI 10.1073/pnas.1632197100; Gade G, 2003, PEST MANAG SCI, V59, P1063, DOI 10.1002/ps.755; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Hariton A, 2009, PEPTIDES, V30, P1034, DOI 10.1016/j.peptides.2009.02.005; Haselton AT, 2004, J MED ENTOMOL, V41, P684, DOI 10.1603/0022-2585-41.4.684; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Kaminski S, 2002, J NEUROGENET, V16, P125, DOI 10.1080/01677060213156; LANGE AB, 1995, P NATL ACAD SCI USA, V92, P9250, DOI 10.1073/pnas.92.20.9250; Liscia A, 2012, J INSECT PHYSIOL, V58, P356, DOI 10.1016/j.jinsphys.2011.12.010; MASLER EP, 1993, ARCH INSECT BIOCHEM, V22, P87, DOI 10.1002/arch.940220109; Mazzi D, 2017, INSECTS, V8, DOI 10.3390/insects8010018; MCCORMICK J, 1993, J COMP NEUROL, V338, P279, DOI 10.1002/cne.903380210; Meeusen T, 2002, P NATL ACAD SCI USA, V99, P15363, DOI 10.1073/pnas.252339599; Mispelon M, 2003, PEPTIDES, V24, P1599, DOI 10.1016/j.peptides.2003.10.011; Nachman RJ, 1996, PEPTIDES, V17, P313, DOI 10.1016/0196-9781(95)02097-7; Nachman RJ, 2014, ACS SYM SER, V1172, P83; Peller CR, 2009, J INSECT PHYSIOL, V55, P834, DOI 10.1016/j.jinsphys.2009.05.011; Richer S, 2000, J COMP NEUROL, V421, P136; Stoffolano JG, 2013, ANNU REV ENTOMOL, V58, P205, DOI 10.1146/annurev-ento-120811-153653; Van Timmeren S, 2013, CROP PROT, V54, P126, DOI 10.1016/j.cropro.2013.08.003; Zhang QR, 2011, P NATL ACAD SCI USA, V108, P16922, DOI 10.1073/pnas.1113863108	40	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0188021	10.1371/journal.pone.0188021	http://dx.doi.org/10.1371/journal.pone.0188021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125862	Green Published, gold			2022-12-26	WOS:000414866000035
J	Nichols, IS; Jones, MI; Okere, C; Ananaba, G; Bush, B; Gray, C; Brager, A; Ehlen, JC; Paul, K				Nichols, India S.; Jones, Mary I.; Okere, Chuma; Ananaba, Godwin; Bush, Brittany; Gray, Cloe; Brager, Allison; Ehlen, J. Christopher; Paul, Ketema			Nitrergic neurons of the dorsal raphe nucleus encode information about stress duration	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DORSOLATERAL PERIAQUEDUCTAL GRAY; CENTRAL-NERVOUS-SYSTEM; NADPH-DIAPHORASE; NONSYNAPTIC COMMUNICATION; RAT-BRAIN; MODELS; EXPRESSION; EXPOSURE; ANXIETY	Nitrergic neurons of the dorsal raphe nucleus (DRN) may play a role in physiological stress responses. The caudal lateral wings (CLW) are unique compared to other rostral-caudal DRN sub-regions because they contain distinct nitric oxide (NO) synthase (NOS) populations that are independent of tryptophan hydroxylase (TPH). NOS neurons in the CLW are also highly activated during acute restraint stress. However, the effects of acute stress duration on NOS activation in the CLW are unclear. Here NADPH-d, an index of NOS activity, is used to show that sub-regions of the DRN have differential NOS activation in response to 6 hours of restraint stress in rats. We report increased NOS activity through 6 hours of restraint in the caudal lateral wings and ventromedial sub-regions. These data suggest that, NOS neurons may play a dynamic role in the response to stress duration.	[Nichols, India S.; Jones, Mary I.; Okere, Chuma; Ananaba, Godwin] Clark Atlanta Univ, Dept Biol Sci, Atlanta, GA 30314 USA; [Nichols, India S.; Bush, Brittany; Gray, Cloe; Brager, Allison; Ehlen, J. Christopher; Paul, Ketema] Morehouse Sch Med, Dept Neurobiol, Atlanta, GA 30310 USA; [Nichols, India S.; Paul, Ketema] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Brager, Allison] Walter Reed Army Inst Res, Behav Biol Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA	Clark Atlanta University; Morehouse School of Medicine; University of California System; University of California Los Angeles; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Paul, K (corresponding author), Morehouse Sch Med, Dept Neurobiol, Atlanta, GA 30310 USA.; Paul, K (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	Ketema.Paul@ucla.edu	Ehlen, Christopher/GXV-9278-2022		NIH: MBRS-RISE [5R25GM060414, NIH-R01 NS078410]; NIH [5R25GM060414, NS078410]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078410] Funding Source: NIH RePORTER	NIH: MBRS-RISE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part from the NIH: MBRS-RISE grant #5R25GM060414 and NIH-R01 NS078410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by NIH grant #NS078410 and NIH grant #5R25GM060414.	Ayers NA, 1996, BRAIN RES, V707, P127, DOI 10.1016/0006-8993(95)01362-8; Beijamini V, 2006, BEHAV BRAIN RES, V170, P52, DOI 10.1016/j.bbr.2006.01.025; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Cassano WJ, 2001, NEUROENDOCRINOLOGY, V74, P167, DOI 10.1159/000054683; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; MATSUMOTO T, 1993, NEUROSCI LETT, V155, P61, DOI 10.1016/0304-3940(93)90673-9; Morris BJ, 1997, NEUROPHARMACOLOGY, V36, P1589, DOI 10.1016/S0028-3908(97)00159-7; Okere CO, 2006, BRAIN RES, V1119, P174, DOI 10.1016/j.brainres.2006.08.058; Okere CO, 2006, NEUROSCI LETT, V404, P288, DOI 10.1016/j.neulet.2006.05.065; Okere CO, 2006, BRAIN RES, P1086; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; Shepherd GMG, 2003, CEREBELLUM, V2, P110, DOI 10.1080/14734220310011407; Shepherd MR, 2002, PNAS, V99; Sjakste N, 2005, EUR J PHARMACOL, V513, P193, DOI 10.1016/j.ejphar.2005.03.014; Smalls SL, 2012, NEUROSCI LETT, V511, P23, DOI 10.1016/j.neulet.2012.01.025; Spiacci A, 2008, PHARMACOL BIOCHEM BE, V88, P247, DOI 10.1016/j.pbb.2007.08.008; Spiacci A, 2012, NEUROSCIENCE, V227, P350, DOI 10.1016/j.neuroscience.2012.09.061; Vasudeva RK, 2011, J CHEM NEUROANAT, V41, P281, DOI 10.1016/j.jchemneu.2011.05.008; Vasudeva RK, 2014, J CHEM NEUROANAT, P57; Vazquez-Palacios G, 2000, PHYSIOL BEHAV, V71, P23, DOI 10.1016/S0031-9384(00)00285-7; Vizi ES, 2000, PHARMACOL REV, V52, P63; Vizi ES, 2004, NEUROCHEM INT, V45, P443, DOI 10.1016/j.neuint.2003.11.016; Waselus M, 2006, J CHEM NEUROANAT, V31, P233, DOI 10.1016/j.jchemneu.2006.01.007; WOOD J, 1994, NEUROPHARMACOLOGY, V33, P1235, DOI 10.1016/0028-3908(94)90022-1; Xu ZQD, 1997, J CHEM NEUROANAT, V13, P169, DOI 10.1016/S0891-0618(97)00043-4	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187071	10.1371/journal.pone.0187071	http://dx.doi.org/10.1371/journal.pone.0187071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125838	Green Published, gold, Green Submitted			2022-12-26	WOS:000414866000004
J	Conley, JM; Radhakrishnan, S; Valentino, SA; Tantama, M				Conley, Jason M.; Radhakrishnan, Saranya; Valentino, Stephen A.; Tantama, Mathew			Imaging extracellular ATP with a genetically-encoded, ratiometric fluorescent sensor	PLOS ONE			English	Article							INTERCELLULAR CALCIUM WAVES; FIND-ME SIGNAL; APOPTOTIC CELLS; LIVING CELLS; RELEASE; ACTIVATION; RECEPTOR; PROTEIN; MECHANISMS; EXPRESSION	Extracellular adenosine triphosphate (ATP) is a key purinergic signal that mediates cell-to-cell communication both within and between organ systems. We address the need for a robust and minimally invasive approach to measuring extracellular ATP by re-engineering the ATeam ATP sensor to be expressed on the cell surface. Using this approach, we image real-time changes in extracellular ATP levels with a sensor that is fully genetically-encoded and does not require an exogenous substrate. In addition, the sensor is ratiometric to allow for reliable quantitation of extracellular ATP fluxes. Using live-cell microscopy, we characterize sensor performance when expressed on cultured Neuro2A cells, and we measure both stimulated release of ATP and its clearance by ectonucleotidases. Thus, this proof-of-principle demonstrates a first-generation sensor to report extracellular ATP dynamics that may be useful for studying purinergic signaling in living specimens.	[Conley, Jason M.; Radhakrishnan, Saranya; Valentino, Stephen A.; Tantama, Mathew] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Conley, Jason M.; Radhakrishnan, Saranya; Valentino, Stephen A.; Tantama, Mathew] Purdue Univ, Purdue Inst Integrat Neuroscie, W Lafayette, IN 47907 USA; [Radhakrishnan, Saranya; Tantama, Mathew] Purdue Univ, Purdue Interdisciplinary Life Sci Grad Program, W Lafayette, IN 47907 USA; [Tantama, Mathew] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Tantama, M (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.; Tantama, M (corresponding author), Purdue Univ, Purdue Inst Integrat Neuroscie, W Lafayette, IN 47907 USA.; Tantama, M (corresponding author), Purdue Univ, Purdue Interdisciplinary Life Sci Grad Program, W Lafayette, IN 47907 USA.; Tantama, M (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.	mtantama@purdue.edu	Radhakrishnan, Saranya/GPC-8327-2022	Tantama, Mathew/0000-0002-4072-7680; Radhakrishnan, Saranya/0000-0001-5500-7611	National Institutes of Health [R21 NS092010, R21 EY026425]; NATIONAL EYE INSTITUTE [R21EY026425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS092010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M.T. acknowledges support from National Institutes of Health grants R21 NS092010 and R21 EY026425.; We thank Kyle Harvey for assistance with confocal microscopy. M.T. acknowledges support from National Institutes of Health grants R21 NS092010 and R21 EY026425.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Bao Y, 2014, J BIOL CHEM, V289, P26794, DOI 10.1074/jbc.M114.572495; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Bastid J, 2015, CANCER IMMUNOL RES, V3, P254, DOI 10.1158/2326-6066.CIR-14-0018; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Bodin P, 1996, J CARDIOVASC PHARM, V27, P872, DOI 10.1097/00005344-199606000-00015; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Brown P, 2002, J PHYSIOL-LONDON, V540, P851; Burma NE, 2017, NAT MED, V23, P355, DOI 10.1038/nm.4281; Burnstock G, 2013, PURINERG SIGNAL, V9, P541, DOI 10.1007/s11302-013-9381-4; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Charlton SJ, 1996, BRIT J PHARMACOL, V118, P704, DOI 10.1111/j.1476-5381.1996.tb15457.x; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Choi HW, 2010, COMPUTATIONAL MODELING IN BIOMECHANICS, P49, DOI 10.1007/978-90-481-3575-2_2; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; COLOMA MJ, 1992, J IMMUNOL METHODS, V152, P89, DOI 10.1016/0022-1759(92)90092-8; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; Danquah W, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8463; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Fields RD, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00032; Garcia GJM, 2011, SUBCELL BIOCHEM, V55, P51, DOI 10.1007/978-94-007-1217-1_3; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gomez-Villafuertes R, 2015, SCI REPORTS, P5; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; Gutierrez-Martin Y, 2011, J BIOL CHEM, V286, P11370, DOI 10.1074/jbc.M110.139410; Hayashi Seiji, 2004, Sci STKE, V2004, ppl14, DOI 10.1126/stke.2582004pl14; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Iglesias RM, 2012, NEUROCHEM RES, V37, P1355, DOI 10.1007/s11064-012-0720-6; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Inoue M, 2015, NAT METHODS, V12, P64, DOI [10.1038/NMETH.3185, 10.1038/nmeth.3185]; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kurishita Y, 2012, J AM CHEM SOC, V134, P18779, DOI 10.1021/ja308754g; Lakshmi S, 2006, NEUROSCIENCE, V141, P179, DOI 10.1016/j.neuroscience.2006.03.074; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Ledderose C, 2014, J BIOL CHEM, V289, P25936, DOI 10.1074/jbc.M114.575308; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; Liemburg-Apers DC, 2011, PHARM RES-DORDR, V28, P2745, DOI 10.1007/s11095-011-0492-8; Loo JM, 2015, CELL, V160, P393, DOI 10.1016/j.cell.2014.12.018; Lorenz V, 2007, NEUROSCI LETT, V420, P6, DOI 10.1016/j.neulet.2007.04.004; Lou NH, 2016, P NATL ACAD SCI USA, V113, P1074, DOI 10.1073/pnas.1520398113; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; Lu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13824; Macdonald Christopher L, 2008, Front Neuroeng, V1, P1, DOI 10.3389/neuro.16.001.2008; Mansfield KJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/830374; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Masgrau R, 2009, NEUROPHARMACOLOGY, V56, P598, DOI 10.1016/j.neuropharm.2008.10.015; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Morciano G, 2017, NAT PROTOC, V12, P1542, DOI 10.1038/nprot.2017.052; Murphy PS, 2017, CELL DEATH DIFFER, V24, P559, DOI 10.1038/cdd.2016.159; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pougnet JT, 2014, NEURON, V83, P417, DOI 10.1016/j.neuron.2014.06.005; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Rajendran M, 2016, BIOL BULL-US, V231, P73, DOI 10.1086/689592; Ralevic V, 1998, PHARMACOL REV, V50, P413; Reigada D, 2017, PURINERG SIGNAL, V13, P75, DOI 10.1007/s11302-016-9541-4; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Tan ZB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13772; Tantama M, 2013, NATURE COMMUNICATION, P4; Tantama M, 2011, J AM CHEM SOC, V133, P10034, DOI 10.1021/ja202902d; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; Torres A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002160; Trouillon R, 2013, ANAL CHEM, V85, P4822, DOI 10.1021/ac4008682; Vishnu N, 2014, MOL BIOL CELL, V25, P368, DOI 10.1091/mbc.E13-07-0433; von Schack D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017670; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Wu JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6262; Yaginuma H, 2014, SCI REPORTS, P4; Zhang Y, 2008, ANAL CHEM, V80, P9316, DOI 10.1021/ac801701w; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	92	31	32	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187481	10.1371/journal.pone.0187481	http://dx.doi.org/10.1371/journal.pone.0187481			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121644	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900041
J	Fink, AM; Dean, C; Piano, MR; Carley, DW				Fink, Anne M.; Dean, Caron; Piano, Mariann R.; Carley, David W.			The pedunculopontine tegmentum controls renal sympathetic nerve activity and cardiorespiratory activities in nembutal-anesthetized rats	PLOS ONE			English	Article							BAROREFLEX-EVOKED SYMPATHOINHIBITION; ROSTRAL VENTROLATERAL MEDULLA; CHRONIC KIDNEY-DISEASE; REM-SLEEP; ARTERIAL-PRESSURE; NUCLEUS; NEURONS; MICROINJECTION; STIMULATION; ACTIVATION	Elevated renal sympathetic nerve activity (RSNA) accompanies a variety of complex disorders, including obstructive sleep apnea, heart failure, and chronic kidney disease. Understanding pathophysiologic renal mechanisms is important for determining why hypertension is both a common sequelae and a predisposing factor of these disorders. The role of the brainstem in regulating RSNA remains incompletely understood. The pedunculopontine tegmentum (PPT) is known for regulating behaviors including alertness, locomotion, and rapid eye movement sleep. Activation of PPT neurons in anesthetized rats was previously found to increase splanchnic sympathetic nerve activity and blood pressure, in addition to altering breathing. The present study is the first investigation of the PPT and its potential role in regulating RSNA. Microinjections of DL-homocysteic acid (DLH) were used to probe the PPT in 100-mu m increments in Nembutal-anesthetized rats to identify effective sites, defined as locations where changes in RSNA could be evoked. A total of 239 DLH microinjections were made in 18 rats, which identified 20 effective sites (each confirmed by the ability to evoke a repeatable sympathoexcitatory response). Peak increases in RSNA occurred within 10-20 seconds of PPT activation, with RSNA increasing by 104.5 +/- 68.4% (mean +/- standard deviation) from baseline. Mean arterial pressure remained significantly elevated for 30 seconds, increasing from 101.6 +/- 18.6 mmHg to 135.9 +/- 36.4 mmHg. DLH microinjections also increased respiratory rate and minute ventilation. The effective sites were found throughout the rostal-caudal extent of the PPT with most located in the dorsal regions of the nucleus. The majority of PPT locations tested with DLH microinjections did not alter RSNA (179 sites), suggesting that the neurons that confer renal sympathoexcitatory functions comprise a small component of the PPT. The study also underscores the importance of further investigation to determine whether sympathoexcitatory PPT neurons contribute to adverse renal and cardiovascular consequences of diseases such as obstructive sleep apnea and heart failure.	[Fink, Anne M.; Carley, David W.] Univ Illinois, Ctr Narcolepsy Sleep & Hlth Res, Chicago, IL 60607 USA; [Fink, Anne M.; Piano, Mariann R.; Carley, David W.] Univ Illinois, Dept Biobehav Hlth Sci, Chicago, IL 60607 USA; [Dean, Caron] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Dean, Caron] Zablocki VA Med Ctr, Milwaukee, WI USA; [Carley, David W.] Univ Illinois, Dept Bioengn, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical College of Wisconsin; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Fink, AM (corresponding author), Univ Illinois, Ctr Narcolepsy Sleep & Hlth Res, Chicago, IL 60607 USA.; Fink, AM (corresponding author), Univ Illinois, Dept Biobehav Hlth Sci, Chicago, IL 60607 USA.	afink2@uic.edu			National Institute for Nursing Research [K99NR014369]; NATIONAL INSTITUTE OF NURSING RESEARCH [R00NR014369] Funding Source: NIH RePORTER	National Institute for Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by the National Institute for Nursing Research (K99NR014369). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeseun GA, 2010, CURR HYPERTENS REP, V12, P378, DOI 10.1007/s11906-010-0135-1; Andresen MC, 2001, ANN NY ACAD SCI, V940, P132; Brozoski DT, 2009, AUTON NEUROSCI-BASIC, V150, P82, DOI 10.1016/j.autneu.2009.05.243; Brozoski DT, 2005, BRAIN RES, V1059, P197, DOI 10.1016/j.brainres.2005.08.030; Campos RR, 2015, EXP PHYSIOL, V100, P496, DOI 10.1113/expphysiol.2014.079855; Cano G, 2004, J COMP NEUROL, V471, P462, DOI 10.1002/cne.20040; Cleary DR, 2012, J NEUROSCI METH, V209, P337, DOI 10.1016/j.jneumeth.2012.06.029; Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research ( ILAR) Division on Earth and Life Studies ( DELS) and National Research Council, 2011, GUIDE CARE USE LAB A; Datta S, 2001, AM J PHYSIOL-REG I, V280, pR752, DOI 10.1152/ajpregu.2001.280.3.R752; Dean C, 2011, AM J PHYSIOL-REG I, V300, pR771, DOI 10.1152/ajpregu.00391.2010; DIBONA GF, 1995, HYPERTENSION, V25, P531, DOI 10.1161/01.HYP.25.4.531; DiBona GF, 1999, AM J PHYSIOL-REG I, V276, pR539, DOI 10.1152/ajpregu.1999.276.2.R539; Dick TE, 2004, AM J PHYSIOL-REG I, V286, pR1121, DOI 10.1152/ajpregu.00485.2003; Fink AM, 2014, SLEEP, V37, P715, DOI 10.5665/sleep.3576; GILLIN JC, 1993, PROG BRAIN RES, V98, P379; GROFOVA I, 1991, ANAT EMBRYOL, V184, P275, DOI 10.1007/BF01673262; JACKY JP, 1980, J APPL PHYSIOL, V49, P319, DOI 10.1152/jappl.1980.49.2.319; Kannan A, 2014, WORLD J CARDIOL, V6, P814, DOI 10.4330/wjc.v6.i8.814; Kishi T, 2012, J CARDIOL, V59, P117, DOI 10.1016/j.jjcc.2011.12.006; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Kubin L, 2001, ARCH ITAL BIOL, V139, P147; Kumar NN, 2009, J HYPERTENS, V27, P1001, DOI 10.1097/HJH.0b013e3283282e5c; LYDIC R, 1993, AM J PHYSIOL, V264, pR544, DOI 10.1152/ajpregu.1993.264.3.R544; MACHADO BH, 1992, BRAIN RES, V576, P131, DOI 10.1016/0006-8993(92)90618-J; Malpas SC, 1998, PROG NEUROBIOL, V56, P65, DOI 10.1016/S0301-0082(98)00030-6; Markou N, 2006, LUNG, V184, P43, DOI 10.1007/s00408-005-2563-2; Mavanur M, 2010, INDIAN J MED RES, V131, P277; Mena-Segovia J, 2009, J COMP NEUROL, V515, P397, DOI 10.1002/cne.22065; Murakami M, 2014, BIOL PHARM BULL, V37, P834, DOI 10.1248/bpb.b14-00012; ODonnell C, 1996, AM J RESP CRIT CARE, V154, P1763, DOI 10.1164/ajrccm.154.6.8970368; Padley JR, 2007, CIRC RES, V100, P284, DOI 10.1161/01.RES.0000257370.63694.73; Paxinos G., RAT BRAIN STEREOTAXI, VSeventh; Pienaar IS, 2013, EXP NEUROL, V248, P213, DOI 10.1016/j.expneurol.2013.06.008; Rye DB, 1997, SLEEP, V20, P757, DOI 10.1093/sleep/20.9.757; Saponjic J, 2003, RESP PHYSIOL NEUROBI, V138, P223, DOI 10.1016/j.resp.2003.08.002; Saponjic Jasna, 2005, Sleep Breath, V9, P82, DOI 10.1007/s11325-005-0010-5; SCHERERSINGLER U, 1983, J NEUROSCI METH, V9, P229, DOI 10.1016/0165-0270(83)90085-7; Seagard JL, 2004, AM J PHYSIOL-HEART C, V286, pH992, DOI 10.1152/ajpheart.00870.2003; SELLDEN H, 1987, ACTA PHYSIOL SCAND, V130, P15, DOI 10.1111/j.1748-1716.1987.tb08106.x; Topchiy I, 2010, RESP PHYSIOL NEUROBI, V173, P64, DOI 10.1016/j.resp.2010.06.006; Torterolo P, 2002, BRAIN RES, V944, P1, DOI 10.1016/S0006-8993(02)02475-7; Van Dort CJ, 2015, P NATL ACAD SCI USA, V112, P584, DOI 10.1073/pnas.1423136112; Vincent SR, 2000, J CHEM NEUROANAT, V18, P23, DOI 10.1016/S0891-0618(99)00048-4; YASUI Y, 1990, BRAIN RES, V517, P19, DOI 10.1016/0006-8993(90)91002-X; Ye DW, 2012, J HUAZHONG U SCI-MED, V32, P216, DOI 10.1007/s11596-012-0038-2; Yoshimoto M, 2011, SLEEP, V34, P1093, DOI 10.5665/SLEEP.1168; Yousif N, 2016, EUR J NEUROL, V23, P668, DOI 10.1111/ene.12947; Zhang CZ, 2016, NEUROSCI LETT, V629, P79, DOI 10.1016/j.neulet.2016.06.063	48	11	11	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187956	10.1371/journal.pone.0187956	http://dx.doi.org/10.1371/journal.pone.0187956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121095	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900103
J	Cunha, MLR; Meijers, JCM; Rosendaal, FR; Vlieg, AV; Reitsma, PH; Middeldorp, S				Cunha, Marisa L. R.; Meijers, Joost C. M.; Rosendaal, Frits R.; Vlieg, Astrid van Hylckama; Reitsma, Pieter H.; Middeldorp, Saskia			Whole exome sequencing in thrombophilic pedigrees to identify genetic risk factors for venous thromboembolism	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; AFRICAN-AMERICANS; COMMON VARIANTS; LIPID-LEVELS; METAANALYSIS; CONTRIBUTE; HEART; COAGULATION; FIBRINOGEN	Background Family studies have shown a strong heritability component for venous thromboembolism (VTE), but established genetic risk factors are present in only half of VTE patients. Aim To identify genetic risk factors in two large families with unexplained hereditary VTE. Methods We performed whole exome sequencing in 10 affected relatives of two unrelated families with an unexplained tendency for VTE. We prioritized variants shared by all affected relatives from both families, and evaluated these in the remaining affected and unaffected individuals. We prioritized variants based on 3 different filter strategies: variants within candidate genes, rare variants across the exome, and SNPs present in patients with familial VTE and with low frequency in the general population. We used whole exome sequencing data available from 96 unrelated VTE cases with a positive family history of VTE from an affected sib study (the GIFT study) to identify additional carriers and compared the risk-allele frequencies with the general population. Variants found in only one individual were also retained for further analysis. Finally, we assessed the association of these variants with VTE in a population-based case-control study (the MEGA study) with 4,291 cases and 4,866 controls. Results Six variants remained as putative disease-risk candidates. These variants are located in 6 genes spread among 3 different loci: 2p21 (PLEKHH2 NM_172069:c.31051>C, LRPPRC rs372371276, SRBD1 rs34959371), 5q35.2 (UNC5A NM_133369.2:c.1869+23C>A), and 17q25.1 (GPRC5Crs142232982, RAB37 rs556450784). In GIFT, additional carriers were identified only for the variants located in the 2p21 locus. In MEGA, additional carriers for several of these variants were identified in both cases and controls, without a difference in prevalence; no carrier of the UNC5A variant was present. Conclusion Despite sequencing of several individuals from two thrombophilic families resulting in 6 candidate variants, we were unable to confirm their relevance as novel thrombophilic defects.	[Cunha, Marisa L. R.; Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, Amsterdam, Netherlands; [Cunha, Marisa L. R.; Middeldorp, Saskia] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Meijers, Joost C. M.] Sanquin, Dept Plasma Prot, Amsterdam, Netherlands; [Rosendaal, Frits R.; Vlieg, Astrid van Hylckama] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [Vlieg, Astrid van Hylckama; Reitsma, Pieter H.] Leiden Univ, Dept Thrombosis & Hemostasis, Med Ctr, Leiden, Netherlands; [Reitsma, Pieter H.] Leiden Univ, Einthoven Lab Expt Vasc Med, Med Ctr, Leiden, Netherlands; [Cunha, Marisa L. R.] AstraZeneca, Personalised Healthcare & Biomarkers, Cambridge, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; AstraZeneca	Middeldorp, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.	s.middeldorp@amc.uva.nl	Middeldorp, Saskia/ABI-8197-2020; Meijers, J.C.M./S-5981-2019	Middeldorp, Saskia/0000-0002-1006-6420; Meijers, J.C.M./0000-0002-4198-6780; Cunha, Marisa/0000-0001-6473-7368	Rembrandt Institute of Cardiovascular Science, Amsterdam/Leiden, The Netherlands	Rembrandt Institute of Cardiovascular Science, Amsterdam/Leiden, The Netherlands	This work was funded by a grant (2010) from the Rembrandt Institute of Cardiovascular Science, Amsterdam/Leiden, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkuraya FS, 2016, HUM GENET, V135, P615, DOI 10.1007/s00439-016-1664-8; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnold M, 2015, BIOINFORMATICS, V31, P1334, DOI 10.1093/bioinformatics/btu779; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bezemer ID, 2009, ARCH INTERN MED, V169, P610, DOI 10.1001/archinternmed.2008.589; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101; Chaney JL, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005531; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chen Z, 2013, HUM MOL GENET, V22, P2529, DOI 10.1093/hmg/ddt087; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; Cunha MLR, 2015, THROMB HAEMOSTASIS, V114, P920, DOI 10.1160/TH15-05-0411; Danik JS, 2009, CIRC-CARDIOVASC GENE, V2, P134, DOI 10.1161/CIRCGENETICS.108.825273; de Visser MCH, 2013, J THROMB HAEMOST, V11, P1474, DOI 10.1111/jth.12313; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Fernandez-Cadenas I, 2015, J ATHEROSCLER THROMB; Fleiss J, 2003, M STAT METHODS RATES; Francini E, 2014, EXPERT REV ANTICANC, P1; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Germain M, 2011, PLOS ONE, P6; Germain M, 2015, AM J HUM GENET, V96, P532, DOI 10.1016/j.ajhg.2015.01.019; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Greenland S, 2003, EPIDEMIOLOGY, V14, P300, DOI 10.1097/00001648-200305000-00009; Greliche N, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-36; Hart AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042646; Heit JA, 2012, J THROMB HAEMOST, V10, P1521, DOI 10.1111/j.1538-7836.2012.04810.x; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Konstantinides S V, 2014, ARTERIOSCLER THROMB, P2363; Larsen TB, 2003, EPIDEMIOLOGY, V14, P328, DOI 10.1097/00001648-200305000-00013; Lee EJ, 2017, BLOOD ADV, V1, P1224, DOI 10.1182/bloodadvances.2017005249; Lopez S, 2014, MITOCHONDRION, V18, P34, DOI 10.1016/j.mito.2014.09.004; Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Middeldorp S., 2013, HEMA, V7, P375; Morange PE, 2015, THROMB HAEMOSTASIS, V114, P910, DOI 10.1160/TH15-05-0410; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 2014, EUR J INTERN MED, V25, P25, DOI 10.1016/j.ejim.2013.09.005; Reitsma PH, 2007, J THROMB HAEMOST, V5, P264, DOI 10.1111/j.1538-7836.2007.02502.x; Reitsma PH, 2012, ARTERIOSCL THROM VAS, V32, P563, DOI 10.1161/ATVBAHA.111.242818; Renteria ME, 2013, TWIN RES HUM GENET, V16, P767, DOI 10.1017/thg.2013.30; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sabater-Lleal M, 2013, CIRCULATION, V128, P1310, DOI 10.1161/CIRCULATIONAHA.113.002251; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Simeoni I, 2016, BLOOD, V127, P2791, DOI 10.1182/blood-2015-12-688267; Smith JG, 2012, CIRC-CARDIOVASC GENE, V5, P647, DOI 10.1161/CIRCGENETICS.112.962787; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Su JJ, 2016, ONCOTARGET, V7, P76882, DOI 10.18632/oncotarget.12349; Tang WH, 2013, GENET EPIDEMIOL, V37, P512, DOI 10.1002/gepi.21731; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Teupser D, 2010, CIRC-CARDIOVASC GENE, V3, P331, DOI 10.1161/CIRCGENETICS.109.907873; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Wichers IM, 2009, THROMB HAEMOSTASIS, V101, P465, DOI 10.1160/TH08-06-0405; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wirth KE, 2014, EPIDEMIOLOGY, V25, P444, DOI 10.1097/EDE.0000000000000037; Yu B, 2013, GENET EPIDEMIOL, V37, P840, DOI 10.1002/gepi.21752; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zoller B, 2014, CIRC-CARDIOVASC GENE, V7, P296, DOI 10.1161/CIRCGENETICS.113.000341; Zoller B, 2017, THROMB RES, V149, P82, DOI 10.1016/j.thromres.2016.10.014; Zoller B, 2011, CIRCULATION, V124, P1012, DOI 10.1161/CIRCULATIONAHA.110.965020	73	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187699	10.1371/journal.pone.0187699	http://dx.doi.org/10.1371/journal.pone.0187699			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117201	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600068
J	Zhang, JJ; Chen, H; Chen, MJ; Wang, H; Wang, Q; Song, XX; Hao, HB; Feng, ZY				Zhang, Jinjing; Chen, Hui; Chen, Mingjie; Wang, Hong; Wang, Qian; Song, Xiaoxia; Hao, Haibo; Feng, Zhiyong			Kojic acid-mediated damage responses induce mycelial regeneration in the basidiomycete Hypsizygus marmoreus	PLOS ONE			English	Article							FRUITING BODY FORMATION; REACTIVE OXYGEN; ASPERGILLUS-ORYZAE; GENE; GROWTH; BIOSYNTHESIS; PROTEIN; INJURY	Mechanical damage can induce fruiting body production in fungi. In this study, the antioxidant kojic acid (KA) was found to enhance injured mycelial regeneration and increase fruiting body production in Hypsizygus marmoreus. KA reduced the level of reactive oxygen species (ROS), which are harmful to mycelia when excessively generated by mechanical damage. Moreover, KA increased catalase and superoxide dismutase activities and glutathione and ascorbic acid contents by up-regulating antioxidant gene expression. These results suggest that KA promotes mycelial regeneration in response to damage by activating a "stress signal" and enhances the ability of H. marmoreus to resist oxidative damage by invoking the antioxidant system. In addition, KA increased the content of extracellular ATP, which serves as a "stress signal" in response to injury, and modulated ROS signaling, decreasing NADPH oxidase gene expression and ROS levels in the mycelial-regeneration stage. KA treatment also up-regulated the MAPK, Ca2+ and oxylipin pathways, suggesting their involvement in the damage response. Furthermore, laccase and cellulase activities were stimulated by KA at different developmental stages. These results demonstrate that KA regulates gene expression and activates pathways for mycelial wound healing, regeneration of damaged mycelia and reproductive structure formation in the basidiomycete H. marmoreus.	[Zhang, Jinjing; Chen, Hui; Chen, Mingjie; Wang, Hong; Wang, Qian; Song, Xiaoxia; Hao, Haibo; Feng, Zhiyong] Shanghai Acad Agr Sci, Minist Agr, Key Lab Appl Mycol Resources & Utilizat, Natl Res Ctr Edible Fungi Biotechnol & Engn, Shanghai, Peoples R China; [Zhang, Jinjing; Chen, Hui; Chen, Mingjie; Wang, Hong; Wang, Qian; Song, Xiaoxia; Hao, Haibo; Feng, Zhiyong] Shanghai Acad Agr Sci, Inst Edible Fungi, Shanghai Key Lab Agr Genet & Breeding, Shanghai, Peoples R China; [Chen, Hui] Hefei Univ Technol, Sch Food Sci & Engn, Microbial Resources & Applicat Lab, Hefei, Anhui, Peoples R China; [Hao, Haibo; Feng, Zhiyong] Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Academy of Agricultural Sciences; Shanghai Academy of Agricultural Sciences; Hefei University of Technology; Nanjing Agricultural University	Chen, H; Feng, ZY (corresponding author), Shanghai Acad Agr Sci, Minist Agr, Key Lab Appl Mycol Resources & Utilizat, Natl Res Ctr Edible Fungi Biotechnol & Engn, Shanghai, Peoples R China.; Chen, H; Feng, ZY (corresponding author), Shanghai Acad Agr Sci, Inst Edible Fungi, Shanghai Key Lab Agr Genet & Breeding, Shanghai, Peoples R China.; Chen, H (corresponding author), Hefei Univ Technol, Sch Food Sci & Engn, Microbial Resources & Applicat Lab, Hefei, Anhui, Peoples R China.; Feng, ZY (corresponding author), Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	huichen_js@aliyun.com; feng_zy@yahoo.com	Gulliver, Aaron/K-7925-2012	Gulliver, Aaron/0000-0001-9919-0323	National Natural Science Foundation of China [31601802, 31401932]; Youth Talent Development Plan of Shanghai Municipal Agricultural System of China [20160111]; Project of Science and Technology Commission of Shanghai Municipality [13391912202]; Shanghai Municipal Agricultural Commission Development Program of China [20130510]; Shanghai Modern edible fungi-industry Technology Research System [201709]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Talent Development Plan of Shanghai Municipal Agricultural System of China; Project of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Agricultural Commission Development Program of China; Shanghai Modern edible fungi-industry Technology Research System	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31601802 and 31401932), the Youth Talent Development Plan of Shanghai Municipal Agricultural System of China (Grant No. 20160111), the Project of Science and Technology Commission of Shanghai Municipality (No.13391912202) and the Shanghai Municipal Agricultural Commission Development Program of China (Grant No. 20130510). Additional funding was provided by the earmarked fund for Shanghai Modern edible fungi-industry Technology Research System (201709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Aguirre J, 2006, MED MYCOL, V44, pS101, DOI 10.1080/13693780600900080; Bayram O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002816; BENTLEY R, 1957, METHOD ENZYMOL, V3, P238, DOI 10.1016/S0076-6879(57)03381-9; Bentley R, 2006, NAT PROD REP, V23, P1046, DOI 10.1039/b603758p; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; BOURBONNAIS R, 1988, BIOCHEM J, V255, P445, DOI 10.1042/bj2550445; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; Chang PK, 2011, TOXINS, V3, P82, DOI 10.3390/toxins3010082; de Oliveira S, 2014, J IMMUNOL, V192, P5710, DOI 10.4049/jimmunol.1302902; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Fester T, 2005, MYCORRHIZA, V15, P373, DOI 10.1007/s00572-005-0363-4; Gfeller A, 2011, PLANT PHYSIOL, V156, P1797, DOI 10.1104/pp.111.181008; Gomes AJ, 2001, BRAZ J MED BIOL RES, V34, P1487, DOI 10.1590/S0100-879X2001001100018; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gyongyosi N, 2013, FREE RADICAL BIO MED, V58, P134, DOI 10.1016/j.freeradbiomed.2012.12.016; Heil M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030537; HENIS Y, 1965, PHYTOPATHOLOGY, V55, P87; Hernandez-Onate MA, 2015, CURR GENET, V61, P359, DOI 10.1007/s00294-014-0467-5; Hernandez-Onate MA, 2012, P NATL ACAD SCI USA, V109, P14918, DOI 10.1073/pnas.1209396109; Juvvadi PR, 2007, BIOCHEM J, V405, P533, DOI 10.1042/BJ20061678; Kim JH, 2012, INT J MOL SCI, V13, P13867, DOI 10.3390/ijms131113867; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; Krengel U, 2015, SCIENCE, V6218, P125; Kues U, 2000, APPL MICROBIOL BIOT, V54, P141, DOI 10.1007/s002530000396; LEONARD TJ, 1973, MYCOLOGIA, V65, P809, DOI 10.2307/3758520; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lichius A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042565; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marui J, 2011, J BIOSCI BIOENG, V112, P40, DOI 10.1016/j.jbiosc.2011.03.010; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Medina-Castellanos E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00659; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Mohammadpour M, 2013, INT WOUND J, V10, P260, DOI 10.1111/j.1742-481X.2012.00971.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller WH, 1998, MICROBIOL-UK, V144, P1721, DOI 10.1099/00221287-144-7-1721; Nohynek GJ, 2004, FOOD CHEM TOXICOL, V42, P93, DOI 10.1016/j.fct.2003.08.008; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Ren A, 2016, ENV MICROBIOL; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Srivastava PK, 2012, ECOTOX ENVIRON SAFE, V83, P79, DOI 10.1016/j.ecoenv.2012.06.009; Suguimoto HH, 2001, FEMS MICROBIOL LETT, V194, P235, DOI 10.1111/j.1574-6968.2001.tb09475.x; Sun SJ, 2011, CURR MICROBIOL, V62, P871, DOI 10.1007/s00284-010-9794-z; Terabayashi Y, 2010, FUNGAL GENET BIOL, V47, P953, DOI 10.1016/j.fgb.2010.08.014; Terashita T, 1998, J WOOD SCI, V44, P234, DOI 10.1007/BF00521969; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wu Q, 2015, J PLANT PHYSIOL, V175, P174, DOI 10.1016/j.jplph.2014.09.017; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Zhang JJ, 2015, MICROBIOL RES, V179, P54, DOI 10.1016/j.micres.2015.06.005; Zhang JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123025; Zorov DB, 2005, BIOCHEMISTRY-MOSCOW+, V70, P215, DOI 10.1007/s10541-005-0103-6	51	8	9	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187351	10.1371/journal.pone.0187351	http://dx.doi.org/10.1371/journal.pone.0187351			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117227	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600033
J	Boonyarittichaikij, R; Verbrugghe, E; Dekeukeleire, D; De Beelde, R; Rouffaer, LO; Haesendonck, R; Strubbe, D; Mattheus, W; Bertrand, S; Pasmans, F; Bonte, D; Verheyen, K; Lens, L; Martel, A				Boonyarittichaikij, R.; Verbrugghe, E.; Dekeukeleire, D.; De Beelde, R.; Rouffaer, L. O.; Haesendonck, R.; Strubbe, D.; Mattheus, W.; Bertrand, S.; Pasmans, F.; Bonte, D.; Verheyen, K.; Lens, L.; Martel, A.			Salmonella Typhimurium DT193 and DT99 are present in great and blue tits in Flanders, Belgium	PLOS ONE			English	Article							WILD BIRDS; PASSERINE BIRDS; AVIAN WILDLIFE; HOST; INFECTION; SEROTYPES; VIRULENCE; EPIDEMIC; TRANSMISSION; RESISTANCE	Endemic infections with the common avian pathogen Salmonella enterica subspecies enterica serovar Typhimurium (Salmonella Typhimurium) may incur a significant cost on the host population. In this study, we determined the potential of endemic Salmonella infections to reduce the reproductive success of blue (Cyanistes caeruleus) and great (Parus major) tits by correlating eggshell infection with reproductive parameters. The fifth egg of each clutch was collected from nest boxes in 19 deciduous forest fragments. Out of the 101 sampled eggs, 7 Salmonella Typhimurium isolates were recovered. The low bacterial prevalence was reflected by a similarly low serological prevalence in the fledglings. In this study with a relatively small sample size, presence of Salmonella did not affect reproductive parameters (egg volume, clutch size, number of nestlings and number of fledglings), nor the health status of the fledglings. However, in order to clarify the impact on health and reproduction a larger number of samples have to be analyzed. Phage typing showed that the isolates belonged to the definitive phage types (DT) 193 and 99, and multi-locus variable number tandem repeat analysis (MLVA) demonstrated a high similarity among the tit isolates, but distinction to human isolates. These findings suggest the presence of passerine-adapted Salmonella strains in free-ranging tit populations with host pathogen co-existence.	[Boonyarittichaikij, R.; Verbrugghe, E.; Rouffaer, L. O.; Haesendonck, R.; Pasmans, F.; Martel, A.] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Salisburylaan 133, Merelbeke, Belgium; [Boonyarittichaikij, R.] Mahidol Univ, Fac Vet Sci, Dept Clin Sci & Publ Hlth, Phuttamonthon, Nakhon Pathom, Thailand; [Dekeukeleire, D.; De Beelde, R.; Strubbe, D.; Bonte, D.; Lens, L.] Univ Ghent, Dept Biol, Terr Ecol Unit, KL Ledeganckstr 35, Ghent, Belgium; [De Beelde, R.; Verheyen, K.] Univ Ghent, Dept Forest & Water Management, Forest & Nat Lab, Gontrode, Belgium; [Strubbe, D.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Univ Sparken 15, Copenhagen, Denmark; [Mattheus, W.; Bertrand, S.] Sci Inst Publ Hlth, NRC Salmonella & Shigella Bacterial Dis Div, Juliette Wytsmanstr 14, Brussels, Belgium	Ghent University; Mahidol University; Ghent University; Ghent University; University of Copenhagen	Boonyarittichaikij, R (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Salisburylaan 133, Merelbeke, Belgium.; Boonyarittichaikij, R (corresponding author), Mahidol Univ, Fac Vet Sci, Dept Clin Sci & Publ Hlth, Phuttamonthon, Nakhon Pathom, Thailand.	Roschong.Boonyarittichaikij@UGent.be	Pasmans, Frank/D-3667-2014; Strubbe, Diederik/J-4299-2015	Lens, Luc/0000-0002-0241-2215; Strubbe, Diederik/0000-0002-2613-4985; Verheyen, Kris/0000-0002-2067-9108	UGent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB); Marie Sklodowska-Curie Action (H-MSCA-IF) [706318]; Danish National Research Foundation [DNRF96]; Research Foundation Flanders (FWO) [12E6616N, 11L7514N]	UGent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB); Marie Sklodowska-Curie Action (H-MSCA-IF); Danish National Research Foundation(Danmarks Grundforskningsfond); Research Foundation Flanders (FWO)(FWO)	Financial support for this research was provided via the UGent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB). D.S. is currently funded by a Marie Sklodowska-Curie Action (H2020-MSCA-IF-2015, 706318) and acknowledges the Danish National Research Foundation for support to CMEC (grant number DNRF96). E.V. and L.O.R are supported by the Research Foundation Flanders (FWO grant 12E6616N and 11L7514N, respectively).; Financial support for this research was provided via the UGent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB). We would like to thank Bram Sercu, Irene Van Schrojenstein Lantman and Pieter Vantieghem for helping with the fieldwork. D.S. is currently funded by a Marie Sklodowska-Curie Action (H2020-MSCA-IF-2015, 706318) and acknowledges the Danish National Research Foundation for support to CMEC (grant number DNRF96). E.V. and L.O.R are supported by the Research Foundation Flanders (FWO grant 12E6616N and 11L7514N, respectively).	Alley MR, 2002, NEW ZEAL VET J, V50, P170; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Andres S, 2013, ZOONOSES PUBLIC HLTH, V60, P355, DOI 10.1111/j.1863-2378.2012.01542.x; Bates D, 2014, ARXIV140658232014; Baumler AJ, 1998, J BACTERIOL, V180, P1446; Bolton DJ, 2013, INT J FOOD MICROBIOL, V160, P298, DOI 10.1016/j.ijfoodmicro.2012.11.001; Brichta-Harhay DM, 2011, APPL ENVIRON MICROB, V77, P1783, DOI 10.1128/AEM.01885-10; Brunelle BW, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-202; CIZEK A, 1994, J VET MED B, V41, P320, DOI 10.1111/j.1439-0450.1994.tb00234.x; Cox NA, 2000, POULTRY SCI, V79, P1571, DOI 10.1093/ps/79.11.1571; Daoust PY, 2000, CAN VET J, V41, P54; Evangelopoulou G, 2013, VET WORLD, V6, P703, DOI 10.14202/vetworld.2013.703-708; FADDOUL GP, 1965, AVIAN DIS, V9, P377, DOI 10.2307/1588367; FAHEY KJ, 1987, AUST VET J, V64, P203, DOI 10.1111/j.1751-0813.1987.tb15182.x; Fallacara DM, 2001, AVIAN DIS, V45, P128, DOI 10.2307/1593019; Giovannini S, 2013, VET PATHOL, V50, P597, DOI 10.1177/0300985812465328; Gregg M, 2008, FIELD EPIDEMIOLOGY, V3rd; Haesendonck R, 2016, VET MICROBIOL, V195, P101, DOI 10.1016/j.vetmic.2016.09.017; Hamer SA, 2012, ZOONOSES PUBLIC HLTH, V59, P355, DOI 10.1111/j.1863-2378.2012.01462.x; HAMPTON MD, 1995, J APPL BACTERIOL, V78, P402, DOI 10.1111/j.1365-2672.1995.tb03425.x; Hernandez J, 2003, EMERG INFECT DIS, V9, P753; Hernandez SM, 2012, APPL ENV MICROBIOLOG; Hopkins K L, 2010, Euro Surveill, V15, P19580; Horvath L, 2016, OPEN FORUM INFECT DI; Hughes LA, 2010, LETT APPL MICROBIOL, V51, P477, DOI 10.1111/j.1472-765X.2010.02918.x; James TY, 2015, ECOL EVOL, V5, P4079, DOI 10.1002/ece3.1672; Kapperud G, 1998, AM J EPIDEMIOL, V147, P774, DOI 10.1093/oxfordjournals.aje.a009522; Kingsley RA, 2000, INFECT IMMUN, V68, P2720, DOI 10.1128/IAI.68.5.2720-2727.2000; Klemm EJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.23, 10.1038/nmicrobiol.2015.23]; Lawson B, 2011, APPL ENVIRON MICROB, V77, P8139, DOI 10.1128/AEM.00131-11; Lindstedt BA, 2004, J MICROBIOL METH, V59, P163, DOI 10.1016/j.mimet.2004.06.014; Middleton DMRL, 2014, J WILDLIFE DIS, V50, P655, DOI 10.7589/2013-10-277; Monack DM, 2012, CURR OPIN MICROBIOL, V15, P100, DOI 10.1016/j.mib.2011.10.013; Parsons BN, 2013, AVIAN PATHOL, V42, P443, DOI 10.1080/03079457.2013.822469; Pasmans F, 2004, J CLIN MICROBIOL, V42, P2000, DOI 10.1128/JCM.42.5.2000-2002.2004; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Pioz M, 2008, CAN J ZOOL, V86, P1111, DOI 10.1139/Z08-089; R Core Team, 2015, LANG ENV STAT COMP F; Rabsch W, 2002, INFECT IMMUN, V70, P2249, DOI 10.1128/IAI.70.5.2249-2255.2002; Refsum T, 2003, J WILDLIFE DIS, V39, P64, DOI 10.7589/0090-3558-39.1.64; Refsum T, 2002, APPL ENVIRON MICROB, V68, P5595, DOI 10.1128/AEM.68.11.5595-5599.2002; Rouffaer LO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155366; Stefanie R.E., 2017, PLANT ECOLO IN PRESS; Tizard I, 2004, SALMONELLOSIS WILD B; Tizard T, 2004, SEMINARS AVIAN EXOTI; Trupschuch S, 2010, INT J MED MICROBIOL, V300, P279, DOI 10.1016/j.ijmm.2010.02.001; Uzzau S, 2000, EPIDEMIOL INFECT, V125, P229, DOI 10.1017/S0950268899004379; Wuyts V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084055; Wybo I, 2004, ACTA CLIN BELG, V59, P152, DOI 10.1179/acb.2004.022; 2016, EFSA J, V14	50	3	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187640	10.1371/journal.pone.0187640	http://dx.doi.org/10.1371/journal.pone.0187640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112955	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100027
J	Contreras, I; Oviedo, S; Vettoretti, M; Visentin, R; Vehi, J				Contreras, Ivan; Oviedo, Silvia; Vettoretti, Martina; Visentin, Roberto; Vehi, Josep			Personalized blood glucose prediction: A hybrid approach using grammatical evolution and physiological models	PLOS ONE			English	Article							IN-SILICO; TYPE-1; INSULIN; UNIVERSITY; SENSORS	The large patient variability in human physiology and the effects of variables such as exercise or meals challenge current prediction modeling techniques. Physiological models are very precise but they are typically complex and specific physiological knowledge is required. In contrast, data-based models allow the incorporation of additional inputs and accurately capture the relationship between these inputs and the outcome, but at the cost of losing the physiological meaning of the model. In this work, we designed a hybrid approach comprising physiological models for insulin and grammatical evolution, taking into account the clinical harm caused by deviations from the target blood glucose by using a penalizing fitness function based on the Clarke error grid. The prediction models were built using data obtained over 14 days for 100 virtual patients generated by the UVA/Padova T1D simulator. Midterm blood glucose was predicted for the 100 virtual patients using personalized models and different scenarios. The results obtained were promising; an average of 98.31% of the predictions fell in zones A and B of the Clarke error grid. Midterm predictions using personalized models are feasible when the configuration of grammatical evolution explored in this study is used. The study of new alternative models is important to move forward in the development of alarm-and-control applications for the management of type 1 diabetes and the customization of the patient's treatments. The hybrid approach can be adapted to predict shortterm blood glucose values to detect continuous glucose-monitoring sensor errors and to estimate blood glucose values when the continuous glucose-monitoring system fails to provide them.	[Contreras, Ivan; Oviedo, Silvia; Vehi, Josep] Univ Girona, Inst Informat & Aplicac, Parc Cient & Tecnol, Girona, Spain; [Vettoretti, Martina; Visentin, Roberto] Univ Padua, Dept Informat Engn, Padua, Italy	Universitat de Girona; University of Padua	Contreras, I (corresponding author), Univ Girona, Inst Informat & Aplicac, Parc Cient & Tecnol, Girona, Spain.	ivancontrerasfd@gmail.com	Contreras, Ivan/L-6083-2017; Visentin, Roberto/J-4715-2016; Vehi, Josep/D-6602-2013; Vettoretti, Martina/AAC-4748-2019; Contreras, Ivan/N-2850-2019	Contreras, Ivan/0000-0001-6896-818X; Visentin, Roberto/0000-0002-5848-5990; Vehi, Josep/0000-0001-6884-9789; Contreras, Ivan/0000-0001-6896-818X; Vettoretti, Martina/0000-0002-5020-1818	Spanish Ministry of Science and Innovation [DPI 2013-46982-C2-2-R, DPI2016-78831-C2-2-R]; People program (Marie Sklodowska-Curie Actions) of the European Union Seventh Framework Programme (FP7) [600388]; Spanish Government [ES-2014-068289]; Agencia per a la Competitivitat de LEmpresa (ACCIO)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); People program (Marie Sklodowska-Curie Actions) of the European Union Seventh Framework Programme (FP7); Spanish Government(Spanish GovernmentEuropean Commission); Agencia per a la Competitivitat de LEmpresa (ACCIO)	This work was partly supported by the Spanish Ministry of Science and Innovation (grants DPI 2013-46982-C2-2-R and DPI2016-78831-C2-2-R), the People program (Marie Sklodowska-Curie Actions) of the European Union Seventh Framework Programme (FP7/2007-2013) with agreement (No. 600388) (TECNIOspring programme) of the REA and the Agencia per a la Competitivitat de LEmpresa (ACCIO), and by the Spanish Government through contract ES-2014-068289.	Bailey Timothy S, 2015, J Diabetes Sci Technol, V9, P209, DOI 10.1177/1932296814559746; Balakrishnan NP, 2012, IEEE ENG MED BIO, P1250, DOI 10.1109/EMBC.2012.6346164; Botwey RH, 2014, IEEE ENG MED BIO, P4843, DOI 10.1109/EMBC.2014.6944708; Buckingham B, 2010, DIABETES CARE, V33, P1013, DOI 10.2337/dc09-2303; Cescon M, 2015, BIOMED SIGNAL PROCES, V22, P99, DOI 10.1016/j.bspc.2014.09.012; CLARKE WL, 1987, DIABETES CARE, V10, P622, DOI 10.2337/diacare.10.5.622; Cobelli C, 2011, DIABETES, V60, P2672, DOI 10.2337/db11-0654; Contreras I., 2016, XIV MEDITERRANEAN CO; Contreras I., 2016, J INTELL FUZZY SYST; Dassau E, 2010, DIABETES CARE, V33, P1249, DOI 10.2337/dc09-1487; Del Favero S, 2012, IEEE T BIO-MED ENG, V59, P1281, DOI 10.1109/TBME.2012.2185234; Edelman Steven V, 2017, J Diabetes Sci Technol, V11, P160, DOI 10.1177/1932296816667749; Estrada GC, 2010, P AMER CONTR CONF, P2015; Facchinetti A, 2015, MED BIOL ENG COMPUT, V53, P1259, DOI 10.1007/s11517-014-1226-y; de Canete JF, 2012, COMPUT METH PROG BIO, V106, P55, DOI 10.1016/j.cmpb.2011.11.006; Fernandez M, 2007, COMPUT BIOL MED, V37, P611, DOI 10.1016/j.compbiomed.2006.05.008; Fong S, 2013, EXPERT SYST APPL, V40, P7354, DOI 10.1016/j.eswa.2013.07.035; Georga EI, 2013, IEEE J BIOMED HEALTH, V17, P71, DOI 10.1109/TITB.2012.2219876; Georga EI, 2012, IEEE ENG MED BIO, P2889, DOI 10.1109/EMBC.2012.6346567; Ghosh S, 2014, COMPUT BIOL MED, V46, P51, DOI 10.1016/j.compbiomed.2013.12.014; Hidalgo JI, 2014, P 2014 C COMP GEN EV, P1305; Hinshaw L, 2013, DIABETES, V62, P2223, DOI 10.2337/db12-1759; Hovorka R, 2004, PHYSIOL MEAS, V25, P905, DOI 10.1088/0967-3334/25/4/010; Hidalgo JI, 2014, APPL SOFT COMPUT, V20, P40, DOI 10.1016/j.asoc.2013.11.006; Leal Y., 2016, POSTER PRESENTED AT, DOI [10.1089/dia.2016.2526, DOI 10.1089/DIA.2016.2526]; Lu YH, 2010, IEEE T BIO-MED ENG, V57, P1839, DOI 10.1109/TBME.2010.2047504; Man Chiara Dalla, 2014, J Diabetes Sci Technol, V8, P26; Novara C, 2015, PROC 19TH WORLD CONG, P1; O'Neill M, 2003, IEEE T EVOLUT COMPUT, V5, P349; Oviedo S, 2016, INT J NUMER METHOD B; Ryan C., 1998, Genetic Programming. First European Workshop, EuroGP'98. Proceedings, P83, DOI 10.1007/BFb0055930; Toffanin C, 2017, IEEE TRANS BIOMED EN, P1; Vettoretti M, 2015, IEEE ENG MED BIO, P2363, DOI 10.1109/EMBC.2015.7318868; Vettoretti M, 2017, J DIABETES SCI TECHN; Vettoretti M, 2017, IEEE TRANS BIOMED EN, P1; Visentin R, 2016, IEEE T BIO-MED ENG, V63, P2416, DOI 10.1109/TBME.2016.2535241; Visentin R, 2016, DIABETES TECHNOL THE, V18, P574, DOI 10.1089/dia.2016.0128; Visentin R, 2015, DIABETES TECHNOL THE, V17, P1, DOI 10.1089/dia.2014.0192; Visentin R, 2014, DIABETES TECHNOL THE, V16, P428, DOI 10.1089/dia.2013.0377; Wang YQ, 2013, DIABETES TECHNOL THE, V15, P792, DOI 10.1089/dia.2013.0104; Wilinska ME, 2005, IEEE T BIO-MED ENG, V52, P3, DOI 10.1109/TBME.2004.839639; Zarkogianni K, 2015, MED BIOL ENG COMPUT, V53, P1333, DOI 10.1007/s11517-015-1320-9; Zarkogianni K., 2013, P 13 IEEE INT C BIOI, P1, DOI [10.1109/BIBE.2013.6701604, DOI 10.1109/BIBE.2013.6701604]; Zecchin C, 2014, COMPUT METH PROG BIO, V113, P144, DOI 10.1016/j.cmpb.2013.09.016	44	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187754	10.1371/journal.pone.0187754	http://dx.doi.org/10.1371/journal.pone.0187754			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112978	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100037
J	Ampomah, PB; Moraes, LA; Lukman, HM; Lim, LHK				Ampomah, Patrick B.; Moraes, Leonardo A.; Lukman, Hakim M.; Lim, Lina H. K.			Formyl peptide receptor 2 is regulated by RNA mimics and viruses through an IFN-beta-STAT3-dependent pathway	FASEB JOURNAL			English	Article						FPR2; IRF3; innate immunity; IFN signaling	TOLL-LIKE RECEPTORS; DOUBLE-STRANDED-RNA; INFLUENZA-A VIRUS; EPITHELIAL-CELLS; INNATE IMMUNITY; LIPOXIN A(4); IFN-BETA; INFLAMMATION; REPLICATION; RECOGNITION	The regulation of host factors is a key strategy employed by viruses to suppress host defense systems and enhance their propagation; however, the mechanisms that underlie this regulation is still unclear. Formyl peptide receptor 2 (FPR2) recognizes numerous proinflammatory and anti-inflammatory stimuli, and emerging reports indicate elevated levels of FPR2 in several disease conditions. Although studies have implicated FPR2 in a myriad of inflammatory conditions, how viruses exploit this cell-surface receptor to facilitate disease progression remains unknown. In this study, we show that the activation of TLR3 and TLR7 induces the up-regulation of FPR2. We provide evidence that signal transducer and activator of transcription 3 (STAT3) phosphorylation is critical for the induction of FPR2 by double-stranded RNA, but not single-stranded RNA viral mimetics. Use of bone marrow-derived macrophages (BMDMs) from IFN-alpha beta receptor-deficient mice revealed that signaling via the type I IFN-STAT3 pathway is essential for FPR2 induction. We demonstrate that virus infection with enterovirus 71 and H1N1 PR8 influenza virus results in increased FPR2 expression. Inhibition of STAT3 phosphorylation in virus-infected cells repressed the induction of FPR2, which led to a reduction in viral loads. Finally, the absence of FPR2 in murine BMDMs resulted in lower viral loads, which suggests that FPR2 may be important for virus replication. Altogether, our study provides novel insights into how RNA viruses may hijack the immune system to facilitate their replication and survival. Identification of these regulatory elements may be useful in designing therapeutics for inflammatory disease conditions that are associated with elevated levels of FPR2.	[Ampomah, Patrick B.; Moraes, Leonardo A.; Lukman, Hakim M.; Lim, Lina H. K.] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Ampomah, Patrick B.; Moraes, Leonardo A.; Lukman, Hakim M.; Lim, Lina H. K.] Natl Univ Singapore, Immunol Program, Life Sci Inst, Singapore, Singapore	National University of Singapore; National University of Singapore	Lim, LHK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Ctr Life Sci,NUS Immunol Program, Level 3,28 Med Dr 03-06J, Singapore 117456, Singapore.	linalim@nus.edu.sg			Singapore National Medical Research Council [NMRC/CBRG/056/2014]; NUS-SINGA graduate scholarship	Singapore National Medical Research Council(National Medical Research Council, Singapore); NUS-SINGA graduate scholarship	The authors thank Dr. Mauro Perretti (William Harvey Research Institute, London, United Kingdom) and Dr. Magnus Back (Karolinska Institutet, Solna, Sweden) for kindly providing FPR2-deficient mice. The authors thank Dr. Sylvie Alonso and Pei Xuan Lee of the National University of Singapore (NUS) Immunology Program for IFN-alpha b receptordeficient mice. The authors also thank Dr. Esther Koh and Dr. Paul Hutchinson (Life Sciences Institute) for their help and assistance. This study was supported by the Singapore National Medical Research Council (Grant NMRC/CBRG/056/2014; to L.H.K.L.). P.B.A. was supported by a NUS-SINGA graduate scholarship. The authors declare no conflicts of interest.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; [Anonymous], 2013, PAND INFL PREP RESP; Arora S, 2016, CELL DEATH DIFFER, V23, P1243, DOI 10.1038/cdd.2016.19; Bist P, 2013, J IMMUNOL, V191, P4375, DOI 10.4049/jimmunol.1301504; Boehme KW, 2004, J VIROL, V78, P7867, DOI 10.1128/JVI.78.15.7867-7873.2004; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; Bozinovski S, 2014, J THORAC DIS, V6, P1548, DOI 10.3978/j.issn.2072-1439.2014.08.08; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cattaneo F, 2013, INT J MOL SCI, V14, P7193, DOI 10.3390/ijms14047193; Chen KQ, 2006, J BIOL CHEM, V281, P3651, DOI 10.1074/jbc.M508125200; Courtin N, 2017, ANTIVIR RES, V143, P252, DOI 10.1016/j.antiviral.2017.05.001; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Fierro IM, 2003, J IMMUNOL, V170, P2688, DOI 10.4049/jimmunol.170.5.2688; FIORE S, 1992, J BIOL CHEM, V267, P16168; Fitzgerald DC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-130; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gobbetti T, 2014, P NATL ACAD SCI USA, V111, P18685, DOI 10.1073/pnas.1410938111; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hinkle P. M., 2010, J NEUROIMMUNOL, V300, P25; Hsiao HM, 2014, J IMMUNOL, V193, P4980, DOI 10.4049/jimmunol.1400313; Iribarren P, 2005, FASEB J, V19, P2032, DOI 10.1096/fj.05-4578fje; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Iwasaki A., 2012, NAT REV IMMUNOL, V100, P130; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Jeon SG, 2007, J ALLERGY CLIN IMMUN, V120, P803, DOI 10.1016/j.jaci.2007.05.030; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Koltsida O, 2013, EMBO MOL MED, V5, P762, DOI 10.1002/emmm.201201891; Li L, 2015, CELL REP, V10, P654, DOI 10.1016/j.celrep.2015.01.011; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Nacionales DC, 2007, ARTHRITIS RHEUM, V56, P3770, DOI 10.1002/art.23023; Okemoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071932; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Reuter S, 2012, J IMMUNOL, V188, P5123, DOI 10.4049/jimmunol.1101618; Sen N, 2012, P NATL ACAD SCI USA, V109, P600, DOI 10.1073/pnas.1114232109; Sheikh F, 2014, J LEUKOCYTE BIOL, V96, P591, DOI 10.1189/jlb.2A0414-191R; Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15; Sordi R, 2013, INT IMMUNOPHARMACOL, V17, P283, DOI 10.1016/j.intimp.2013.06.010; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tcherniuk S, 2016, J INFECT DIS, V214, P237, DOI 10.1093/infdis/jiw127; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; UNAIDS, UNAIDS WORLD AIDS DA; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Waris G, 2005, J VIROL, V79, P1569, DOI 10.1128/JVI.79.3.1569-1580.2005; Waris G, 2002, J VIROL, V76, P2721, DOI 10.1128/JVI.76.6.2721-2729.2002; Xiang Y, 2016, AM J CANCER RES, V6, P2599; Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138	54	18	18	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1468	1478		10.1096/fj.201700584RR	http://dx.doi.org/10.1096/fj.201700584RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127186				2022-12-26	WOS:000427246000028
J	Miao, YL; Zhou, CY; Cui, ZK; Zhang, MQ; ShiYang, XY; Lu, YJ; Xiong, B				Miao, Yilong; Zhou, Changyin; Cui, Zhaokang; Zhang, Mianqun; ShiYang, Xiayan; Lu, Yajuan; Xiong, Bo			Postovulatory aging causes the deterioration of porcine oocytes via induction of oxidative stress	FASEB JOURNAL			English	Article						oocyte quality; fertilization capacity; organelle arrangement; cortical granule; ovastacin	LYSOZYME-LIKE PROTEIN; MOUSE EGGS; MEIOTIC MATURATION; CORTICAL GRANULES; HUMAN SPERMATOZOA; MEIOSIS; FERTILIZATION; ACTIVATION; OVASTACIN; DYNAMICS	Negative effects of postovulatory aging on fertilization ability and subsequent embryo development have been reported in rodents; however, the molecular and cellular changes during this process have not been fully defined. Here, we used porcine oocytes, a model that is physiologically and developmentally similar to humans, to explore the molecular mechanisms that underlie how postovulatory aging affects oocyte quality and fertilization capacity. We found that postovulatory aging caused the morphologic change of porcine oocytes by exhibiting the incompact expansion of cumulus cells and an increased occurrence of fragmentation. Aging also impaired oocyte quality by disrupting organelle structures, including the spindle assembly, actin polymerization, and mitochondrial integrity. Moreover, postovulatory aging led to the abnormal distribution of cortical granules and ovastacin, which, in turn, resulted in defective sperm binding and consequently compromised fertilization potential. Of note, we observed that postovulatory aging induced oxidative stress with a high level of reactive oxygen species and apoptotic rate in oocytes, thereby resulting in the deterioration of critical factors in the maintenance of oocyte quality and fertilization capacity. Taken together, our findings demonstrate that postovulatory aging perturbs a variety of molecular and cellular changes in porcine oocytes by inducing oxidative stress.-Miao, Y., Zhou, C., Cui, Z., Zhang, M., ShiYang, X., Lu, Y., Xiong, B. Postovulatory aging causes the deterioration of porcine oocytes via induction of oxidative stress.	[Miao, Yilong; Zhou, Changyin; Cui, Zhaokang; Zhang, Mianqun; ShiYang, Xiayan; Lu, Yajuan; Xiong, Bo] Nanjing Agr Univ, Coll Anim Sci & Technol, 1 Weigang, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Xiong, B (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, 1 Weigang, Nanjing, Jiangsu, Peoples R China.	xiongbo@njau.edu.cn			National Natural Science Foundation of China [31571545]; Natural Science Foundation of Jiangsu Province [BK20150677]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The authors thank Dr. Jurrien Dean (National Institute of Diabetes and Digestive and Kidney Diseases, U.S. National Institutes of Health, Bethesda, MD, USA) for providing Abs. This work was supported by the National Natural Science Foundation of China (Grant 31571545) and the Natural Science Foundation of Jiangsu Province (Grant BK20150677). The authors declare no conflicts of interest.	Burkart AD, 2012, J CELL BIOL, V197, P37, DOI 10.1083/jcb.201112094; Dai XX, 2017, HUM REPROD, V32, P598, DOI 10.1093/humrep/dew362; Dai XX, 2016, BBA-MOL CELL RES, V1863, P2934, DOI 10.1016/j.bbamcr.2016.09.017; Diaz H, 2004, ZYGOTE, V12, P95, DOI 10.1017/S0967199404002680; Diaz H., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P211; DODSON MG, 1989, J IN VITRO FERTIL EM, V6, P101, DOI 10.1007/BF01130735; DUCIBELLA T, 1990, BIOL REPROD, V43, P870, DOI 10.1095/biolreprod43.5.870; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Field CM, 2011, CURR BIOL, V21, pR825, DOI 10.1016/j.cub.2011.07.043; GAO Y, 2016, SCI REP UK, V6; Goud PT, 1999, MOL HUM REPROD, V5, P227, DOI 10.1093/molehr/5.3.227; Herrero MB, 2005, DEV BIOL, V284, P126, DOI 10.1016/j.ydbio.2005.05.008; LONGO FJ, 1981, BIOL REPROD, V25, P399, DOI 10.1095/biolreprod25.2.399; Lord T, 2013, REPRODUCTION, V146, pR217, DOI 10.1530/REP-13-0111; Lord T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106450; Lu YJ, 2017, NUCLEIC ACIDS RES, V45, P9388, DOI 10.1093/nar/gkx563; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Miao YL, 2017, CELL CYCLE, V16, P536, DOI 10.1080/15384101.2017.1282583; ROTSZTEJN DA, 1991, SEMIN REPROD ENDOCR, V9, P272, DOI 10.1055/s-2007-1019419; SAITO H, 1993, HORM RES, V39, P28, DOI 10.1159/000182754; SATHANATHAN AH, 1994, MICROSC RES TECHNIQ, V27, P145, DOI 10.1002/jemt.1070270208; Schatten H, 2009, ENVIRON MOL MUTAGEN, V50, P620, DOI 10.1002/em.20493; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; Swann K, 2008, INT J DEV BIOL, V52, P585, DOI 10.1387/ijdb.072530ks; SZOLLOSI D, 1971, AM J ANAT, V130, P209, DOI 10.1002/aja.1001300207; Tarin JJ, 1999, BIOL REPROD, V61, P1347, DOI 10.1095/biolreprod61.5.1347; Wang H, 2017, ONCOTARGET, V8, P38631, DOI 10.18632/oncotarget.16219; Wang T, 2017, AGING-US, V9, P1552, DOI 10.18632/aging.101252; Xiong B, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006580; Xu Z, 1997, BIOL REPROD, V57, P743, DOI 10.1095/biolreprod57.4.743; Zhang MQ, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12396; Zhang MQ, 2017, ONCOTARGET, V8, P1593, DOI 10.18632/oncotarget.13684; Zhang T, 2016, AGING-US, V8, P685, DOI 10.18632/aging.100911	34	44	45	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1328	1337		10.1096/fj.201700908R	http://dx.doi.org/10.1096/fj.201700908R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29109171	Green Published			2022-12-26	WOS:000427246000017
J	Page, MM; Skovso, S; Cen, HN; Chiu, AP; Dionne, DA; Hutchinson, DF; Lim, GE; Szabat, M; Flibotte, S; Sinha, S; Nislow, C; Rodrigues, B; Johnson, JD				Page, Melissa M.; Skovso, Sos; Cen, Haoning; Chiu, Amy P.; Dionne, Derek A.; Hutchinson, Daria F.; Lim, Gareth E.; Szabat, Marta; Flibotte, Stephane; Sinha, Sunita; Nislow, Corey; Rodrigues, Brian; Johnson, James D.			Reducing insulin via conditional partial gene ablation in adults reverses diet-induced weight gain	FASEB JOURNAL			English	Article						obesity; adipose tissue; Ptrf/Cavin; high-fat diet; innate immunity	ADIPOSE-TISSUE; CAVEOLIN-1 EXPRESSION; INDUCED OBESITY; MICE LACKING; RECEPTOR; HYPERINSULINEMIA; RESISTANCE; CONTRIBUTES; RESTRICTION; SENSITIVITY	Excess circulating insulin is associated with obesity in humans and in animal models. However, the physiologic causality of hyperinsulinemia in adult obesity has rightfully been questioned because of the absence of clear evidence that weight loss can be induced by acutely reversing diet-induced hyperinsulinemia. Herein, we describe the consequences of inducible, partial insulin gene deletion in a mouse model in which animals have already been made obese by consuming a high-fat diet. A modest reduction in insulin production/secretion was sufficient to cause significant weight loss within 5 wk, with a specific effect on visceral adipose tissue. This result was associated with a reduction in the protein abundance of the lipodystrophy gene polymerase I and transcript release factor (Ptrf; Cavin) in gonadal adipose tissue. RNAseq analysis showed that reduced insulin and weight loss also associated with a signature of reduced innate immunity. This study demonstrates that changes in circulating insulin that are too fine to adversely affect glucose homeostasis nonetheless exert control over adiposity.	[Page, Melissa M.; Skovso, Sos; Cen, Haoning; Dionne, Derek A.; Hutchinson, Daria F.; Lim, Gareth E.; Szabat, Marta; Johnson, James D.] Univ British Columbia, Life Sci Inst, Diabet Res Grp, Dept Cellular & Physiol Sci, Vancouver, BC, Canada; [Chiu, Amy P.; Flibotte, Stephane; Sinha, Sunita; Nislow, Corey; Rodrigues, Brian] Univ British Columbia, Pharmaceut Sci, Vancouver, BC, Canada; [Page, Melissa M.] Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium; [Lim, Gareth E.] Univ Montreal, CRCHUM, Montreal, PQ, Canada	University of British Columbia; University of British Columbia; Universite Catholique Louvain; Universite de Montreal	Johnson, JD (corresponding author), Univ British Columbia, Vancouver, BC V6T 1Z3, Canada.	james.d.johnson@ubc.ca	Cen, Haoning Howard/GSN-3597-2022; Lim, Gareth/G-9143-2017	Cen, Haoning Howard/0000-0001-8045-1335; Rodrigues, Brian/0000-0002-0129-4261; Page, Melissa/0000-0001-5750-8962; Lim, Gareth/0000-0003-3850-3757; Flibotte, Stephane/0000-0001-9613-7666	Canadian Foundation for Innovation; British Columbia Knowledge Development Foundation; UBC Faculty of Dentistry; Canadian Institutes of Health Research; Canadian Diabetes Association; Canadian Diabetes Association Doctoral Student Research Award; Benzon Foundation Fellowship; Juvenile Diabetes Research Foundation; Michael Smith Foundation for Health Research Postdoctoral Fellowship Awards	Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Foundation; UBC Faculty of Dentistry; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Canadian Diabetes Association Doctoral Student Research Award; Benzon Foundation Fellowship; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Michael Smith Foundation for Health Research Postdoctoral Fellowship Awards	The authors thank Farnaz Taghizadeh and Xiaoke (Betty) Hu [both with the University of British Columbia (UBC)] for assistance with islet isolations, perifusions, and animal work; the UBC Sequencing and Bioinformatics Consortium for RNA sequencing; the UBC Centre for High-Throughput Phenogenomics for micro-CT imaging; and John Schipilow and Dr. Nancy Ford (UBC) for technical support and assistance. The Centre is supported by the Canadian Foundation for Innovation, British Columbia Knowledge Development Foundation, and the UBC Faculty of Dentistry. Financial support was provided by an operating grant from the Canadian Institutes of Health Research; Canadian Diabetes Association postdoctoral fellowship awards (to M.M.P. and M.S.); a Canadian Diabetes Association Doctoral Student Research Award (to A.P.C.); a Benzon Foundation Fellowship (to S.S.); and the Juvenile Diabetes Research Foundation and Michael Smith Foundation for Health Research Postdoctoral Fellowship Awards (to G.E.L.). The authors declare no conflicts of interest.	Alemzadeh R, 1998, J CLIN ENDOCR METAB, V83, P1911, DOI 10.1210/jc.83.6.1911; Alemzadeh R, 2008, METABOLISM, V57, P1597, DOI 10.1016/j.metabol.2008.06.017; Azizi PM, 2015, MOL BIOL CELL, V26, P740, DOI 10.1091/mbc.E14-08-1307; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; BJORNTORP P, 1978, J LIPID RES, V19, P316; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Boothe T, 2016, MOL METAB, V5, P366, DOI 10.1016/j.molmet.2016.01.009; Boucher J, 2016, DIABETES, V65, P2201, DOI 10.2337/db16-0212; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Briand N, 2014, DIABETES, V63, P4032, DOI 10.2337/db13-1961; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Cheverud JM, 2011, OBESITY, V19, P160, DOI 10.1038/oby.2010.141; Christian M, 2015, ADIPOCYTE, V4, P50, DOI 10.4161/adip.29853; Cohen AW, 2005, DIABETES, V54, P679, DOI 10.2337/diabetes.54.3.679; Czech MP, 2013, DIABETOLOGIA, V56, P949, DOI 10.1007/s00125-013-2869-1; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Ebana Y, 2007, J HUM GENET, V52, P220, DOI 10.1007/s10038-006-0102-5; Gray SL, 2010, ENDOCRINOLOGY, V151, P4178, DOI 10.1210/en.2010-0102; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; Lawson HA, 2011, MAMM GENOME, V22, P197, DOI 10.1007/s00335-010-9313-3; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Lustig RH, 2006, INT J OBESITY, V30, P331, DOI 10.1038/sj.ijo.0803074; Lustig RH, 2016, OBESITY, V24, P453, DOI 10.1002/oby.21371; Ma YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26242; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Nasteska D, 2014, DIABETES, V63, P2332, DOI 10.2337/db13-1563; Nolan CJ, 2015, DIABETES, V64, P673, DOI 10.2337/db14-0694; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Schwingshackl L, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-130; Softic S, 2016, DIABETES, V65, P2187, DOI 10.2337/db16-0213; Svensson Marcus, 2006, Expert Rev Clin Immunol, V2, P759, DOI 10.1586/1744666X.2.5.759; Szabat M, 2010, DIABETOLOGIA, V53, P1680, DOI 10.1007/s00125-010-1758-0; Szabat M, 2016, CELL METAB, V23, P179, DOI 10.1016/j.cmet.2015.10.016; Templeman NM, 2017, CELL REP, V20, P451, DOI 10.1016/j.celrep.2017.06.048; Templeman NM, 2017, J ENDOCRINOL, V232, pR173, DOI [10.1530/JOE-16-0449, 10.1530/joe-16-0449]; Templeman NM, 2015, DIABETOLOGIA, V58, P2392, DOI 10.1007/s00125-015-3676-7; Vetterli L, 2016, J BIOL CHEM, V291, P13063, DOI 10.1074/jbc.M115.707448; Wharton S, 2016, CAN J DIABETES, V40, P184, DOI 10.1016/j.jcjd.2015.07.005; World Health Organization, 2000, WHO TECHN REP SER, V894; Xue B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017386; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zhu Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6793	53	23	23	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1196	1206		10.1096/fj.201700518R	http://dx.doi.org/10.1096/fj.201700518R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29122848	hybrid, Green Published			2022-12-26	WOS:000427246000008
J	Lee, S; Rivera, OC; Kelleher, SL				Lee, Sooyeon; Rivera, Olivia C.; Kelleher, Shannon L.			Zinc transporter 2 interacts with vacuolar ATPase and is required for polarization, vesicle acidification, and secretion in mammary epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell polarity; mammary gland; secretion; vacuolar ATPase; vesicles; zinc; acidification; lactation; zinc transporter	H+-ATPASE; PLASMA-MEMBRANE; PROTON PUMPS; GLAND DEVELOPMENT; BREAST-MILK; PTEN; POLARITY; ACTIVATION; PROLACTIN; PROTEIN	An important feature of the mammary gland is its ability to undergo profound morphological, physiological, and intracellular changes to establish and maintain secretory function. During this process, key polarity proteins and receptors are recruited to the surface of mammary epithelial cells (MECs), and the vesicle transport system develops and matures. However, the intracellular mechanisms responsible for the development of secretory function in these cells are unclear. The vesicular zinc (Zn2+) transporter ZnT2 is critical for appropriate mammary gland architecture, and ZnT2 deletion is associated with cytoplasmic Zn2+ accumulation, loss of secretory function and lactation failure. The underlying mechanisms are important to understand as numerous mutations and non-synonymous genetic variation in ZnT2 have been detected in women that result in severe Zn2+ deficiency in exclusively breastfed infants. Here we found that ZnT2 deletion in lactating mice and cultured MECs resulted in Zn2+-mediated degradation of phosphatase and tensin homolog (PTEN), which impaired intercellular junction formation, prolactin receptor trafficking, and alveolar lumen development. Moreover, ZnT2 directly interacted with vacuolar H+-ATPase (V-ATPase), and ZnT2 deletion impaired vesicle biogenesis, acidification, trafficking, and secretion. In summary, our findings indicate that ZnT2 and V-ATPase interact and that this interaction critically mediates polarity establishment, alveolar development, and secretory function in the lactating mammary gland. Our observations implicate disruption in ZnT2 function as a modifier of secretory capacity and lactation performance.	[Lee, Sooyeon; Rivera, Olivia C.; Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Surg, Hershey, PA 17033 USA; [Kelleher, Shannon L.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Lee, Sooyeon] Stanford Univ, Sch Med, Dept Med, Div Endocrinol, Stanford, CA 94305 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University	Kelleher, SL (corresponding author), Univ Massachusetts, 883 Broadway, Lowell, MA 01854 USA.	shannon_kelleher@uml.edu		Rivera, Olivia/0000-0001-6953-253X; Lee, Sooyeon/0000-0002-1076-3314	Penn State Hershey Department of Surgery; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002016, UL1TR002014] Funding Source: NIH RePORTER	Penn State Hershey Department of Surgery; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by intramural funds from the Penn State Hershey Department of Surgery (to S. L. K.). The authors declare that they have no conflicts of interest with the contents of this article.	AINSCOUGH EW, 1980, AM J CLIN NUTR, V33, P1314, DOI 10.1093/ajcn/33.6.1314; Alam S, 2015, J MAMMARY GLAND BIOL, V20, P159, DOI 10.1007/s10911-015-9338-z; Berglund FM, 2013, ONCOGENE, V32, P4417, DOI 10.1038/onc.2012.459; BLAKEBOROUGH P, 1983, BIOCHEM J, V209, P505, DOI 10.1042/bj2090505; Bostanci Z, 2015, REPROD TOXICOL, V54, P84, DOI 10.1016/j.reprotox.2014.07.076; Bray K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3487; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Chakraborti S, 2010, LANGMUIR, V26, P3506, DOI 10.1021/la903118c; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chandler P, 2016, MOL CANCER, V15, DOI 10.1186/s12943-015-0486-y; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Collaco AM, 2013, AM J PHYSIOL-CELL PH, V305, pC981, DOI 10.1152/ajpcell.00067.2013; Pozzi CMC, 2015, FOOD CHEM, V166, P492, DOI 10.1016/j.foodchem.2014.06.040; Cowland JB, 2016, IMMUNOL REV, V273, P11, DOI 10.1111/imr.12440; Crivellato E, 2010, ANAT REC, V293, P1115, DOI 10.1002/ar.21146; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Dorea JG, 2002, J AM COLL NUTR, V21, P84, DOI 10.1080/07315724.2002.10719198; Druso JE, 2016, J BIOL CHEM, V291, P8886, DOI 10.1074/jbc.M115.694349; Dupont J, 2002, J CLIN INVEST, V110, P815, DOI [10.1172/JCI200213829, 10.1172/JCI0213829]; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fukao Y, 2011, PLANT SIGNAL BEHAV, V6, P1253, DOI 10.4161/psb.6.9.16529; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; HARTMANN PE, 1978, J PHYSIOL-LONDON, V275, P1, DOI 10.1113/jphysiol.1978.sp012173; HARZER G, 1982, AM J CLIN NUTR, V35, P981, DOI 10.1093/ajcn/35.5.981; Hennigar SR, 2015, J NUTR, V145, P1999, DOI 10.3945/jn.115.214122; Hennigar SR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08033; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Jager Richard, 2008, BMC Res Notes, V1, P29, DOI 10.1186/1756-0500-1-29; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kelleher SL, 2011, ADV NUTR, V2, P101, DOI 10.3945/an.110.000232; Kelleher SL, 2003, J NUTR, V133, P3378, DOI 10.1093/jn/133.11.3378; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; Langlois MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015742; Lasry I, 2014, J BIOL CHEM, V289, P7275, DOI 10.1074/jbc.M113.533786; Lavialle F, 2000, BBA-BIOMEMBRANES, V1464, P83, DOI 10.1016/S0005-2736(99)00251-5; Lavoie N, 2011, J NEUROSCI, V31, P18251, DOI 10.1523/JNEUROSCI.4164-11.2011; Lee S, 2015, J BIOL CHEM, V290, P13064, DOI 10.1074/jbc.M115.637439; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liu FM, 2015, STEM CELL RES, V15, P376, DOI 10.1016/j.scr.2015.08.001; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; McCormick NH, 2012, AM J PHYSIOL-CELL PH, V303, pC291, DOI 10.1152/ajpcell.00443.2011; Melnik VI, 2001, NEUROCHEM RES, V26, P549, DOI 10.1023/A:1010973214930; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; Miletta MC, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/259189; Moore H.-P. H., 2002, Archives of Physiology and Biochemistry, V110, P16, DOI 10.1076/apab.110.1.16.903; MORTON JA, 1994, PEDIATRICS, V93, P802; Nagaoka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065127; Nagaoka K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1678; Naik HB, 2009, AM J PHYSIOL-CELL PH, V297, pC979, DOI 10.1152/ajpcell.00577.2008; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Noatynska A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130083; Oakes SR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1411; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Pamarthy S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.347; Pang MF, 2016, ONCOGENE, V35, P748, DOI 10.1038/onc.2015.133; Peixoto EBMI, 2006, CELL BIOL INT, V30, P101, DOI 10.1016/j.cellbi.2005.08.004; Piela Z, 1998, CUTIS, V61, P197; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Roignot J., 2013, COLD SPRING HARBOR P, V5; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Semba RD, 1999, CLIN DIAGN LAB IMMUN, V6, P671, DOI 10.1128/CDLI.6.5.671-674.1999; Seo YA, 2014, J BIOL CHEM, V289, P23653, DOI 10.1074/jbc.M113.531145; Shinde SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10689; Shore AN, 2016, DEV BIOL, V409, P202, DOI 10.1016/j.ydbio.2015.10.023; SINGH H, 1989, J DAIRY RES, V56, P249, DOI 10.1017/S0022029900026467; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stelwagen K, 1999, MOL CELL ENDOCRINOL, V156, P55, DOI 10.1016/S0303-7207(99)00145-8; Stiernet P, 2006, J BIOL CHEM, V281, P22142, DOI 10.1074/jbc.M513224200; Tanguy E, 2016, J NEUROCHEM, V137, P904, DOI 10.1111/jnc.13577; Tarasenko AS, 2010, J MOL NEUROSCI, V41, P358, DOI 10.1007/s12031-010-9351-z; Triplett AA, 2005, GENESIS, V43, P1, DOI 10.1002/gene.20149; Truchet S, 2009, ANIMAL, V3, P1733, DOI 10.1017/S1751731109990589; Wagner Kay-Uwe, 1997, Genes and Function, V1, P233; Wang JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4415; Wang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091160; Watkin H, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-6; Whyte J, 2010, J CELL SCI, V123, P3316, DOI 10.1242/jcs.065243; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Xie YQ, 2016, ONCOL LETT, V12, P375, DOI 10.3892/ol.2016.4636; Xu R, 2010, CELL CYCLE, V9, P4315, DOI 10.4161/cc.9.21.13578; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]; Zhou J, 2009, NAT CELL BIOL, V11, P1177, DOI 10.1038/ncb1009-1177; Zimmermann B, 2003, J EXP BIOL, V206, P1867, DOI 10.1242/jeb.00376	101	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21598	21613		10.1074/jbc.M117.794461	http://dx.doi.org/10.1074/jbc.M117.794461			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29114036	Green Published, hybrid			2022-12-26	WOS:000419013000034
J	Carneiro, SR; Fagundes, MD; do Rosario, PDO; Neves, LMT; Souza, GD; Pinheiro, MDN				Carneiro, Saul Rassy; Fagundes, Marcela de Araujo; Oliveira do Rosario, Pricila de Jesus; Tomazi Neves, Laura Maria; Souza, Givago da Silva; Nascimento Pinheiro, Maria da Conceicao			Five-year survival and associated factors in women treated for cervical cancer at a reference hospital in the Brazilian Amazon	PLOS ONE			English	Article							QUALITY-OF-LIFE; PROGNOSTIC-FACTORS; STAGE; CARCINOMA; TRENDS; IMPACT; STATE	Cervical cancer (CC) is the most common type of cancer in women and is the third leading cause of death in most developing countries, causing more than 288,000 deaths in women worldwide each year. The most favourable survival rate is in developed countries, since CC mortality has recently declined in those countries. The purpose of this study was to determine the survival rate and associated factors of CC patients at a reference hospital in the Amazon region. The patient sample included records of 339 patients with cervical cancer who had been hospitalized in Bele A m, Para A, Brazil from January 2005 to December 2010; the socioeconomic and clinical data were collected between June and September 2016. A survival rate of approximately 84% was observed, and it was found that disease stage (p < 0.01), metastasis (p < 0.01) and readmission (p < 0.01) had significant influences on patient outcome. The impact of these factors on the general survival rate was higher in the Amazon region compared with other regions of Brazil, and the primary survival factors were associated with earlier stages of the disease. However, more national studies are needed on this subject. Our findings may contribute to the development of regional strategies for the prevention of cervical cancer, a reduction in its incidence and mortality rate, an increase in survival time and an improvement in the quality of life of these women.	[Carneiro, Saul Rassy; Fagundes, Marcela de Araujo; Oliveira do Rosario, Pricila de Jesus] Univ Fed Para, Hosp Univ Joao de Barros Barreto, Belem, Para, Brazil; [Carneiro, Saul Rassy; Souza, Givago da Silva; Nascimento Pinheiro, Maria da Conceicao] Univ Fed Para, Nucleo Med Trop, Belem, Para, Brazil; [Tomazi Neves, Laura Maria] Univ Fed Para, Fac Fisioterapia & Terapia Ocupac, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para	Carneiro, SR (corresponding author), Univ Fed Para, Hosp Univ Joao de Barros Barreto, Belem, Para, Brazil.; Carneiro, SR (corresponding author), Univ Fed Para, Nucleo Med Trop, Belem, Para, Brazil.	saul@ufpa.br	Souza, Givago/W-6393-2019; Carneiro, Saul/HGV-1549-2022	Souza, Givago/0000-0002-4525-3971; Carneiro, Saul/0000-0002-6825-0239	Pro-Reitoria de Pesquisa e Pos-Graduacao - UFPA	Pro-Reitoria de Pesquisa e Pos-Graduacao - UFPA	This work was supported by Pro-Reitoria de Pesquisa e Pos-Graduacao - UFPA.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; American Cancer Society, 2016, CERV CANC STAG; Ashing-Giwa KT, 2010, GYNECOL ONCOL, V118, P35, DOI 10.1016/j.ygyno.2010.02.027; Bifulco G, 2012, GYNECOL ONCOL, V124, P444, DOI 10.1016/j.ygyno.2011.11.033; Bustamante-Teixeira Maria Teresa, 2002, Cad. Saúde Pública, V18, P579, DOI 10.1590/S0102-311X2002000300003; Schneider IJC, 2009, CAD SAUDE PUBLICA, V25, P1285, DOI 10.1590/S0102-311X2009000600011; do Carmo CC, 2011, REV SAUDE PUBL, V45, P661, DOI 10.1590/S0034-89102011005000029; Donze J, 2014, J HOSP MED, V9, P310, DOI 10.1002/jhm.2173; Donze J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7171; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ibfelt EH, 2013, BRIT J CANCER, V109, P2489, DOI 10.1038/bjc.2013.558; Instituto Nacional de Cancer Jose A Alencar Gomes da Silva. INCA D Instituto Nacional de Cancer, 2016, EST 2016; Lee E, 2013, STAT METHODS SURVIVA; Lorin L, 2015, EUR J OBSTET GYN R B, V191, P1, DOI 10.1016/j.ejogrb.2015.04.007; Mendis S, 2014, GLOBAL STATUS REPORT; Nakagawa JT, 2011, ACTA PAUL ENFERM, V24, P631, DOI 10.1590/S0103-21002011000500006; Nowakowski A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155849; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Gonzaga CMR, 2013, CAD SAUDE PUBLICA, V29, P599, DOI 10.1590/S0102-311X2013000300017; Rudtanasudjatum K, 2011, INT J GYNECOL OBSTET, V115, P183, DOI 10.1016/j.ijgo.2011.06.011; Sales L., 2015, 14 SALES L MULHERES; Schlichte MJ, 2015, J CLIN MED, V4, P918, DOI 10.3390/jcm4050918; Shrivastava S, 2013, J CANCER RES THER, V9, P672, DOI 10.4103/0973-1482.126480; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Teke F, 2014, ASIAN PAC J CANCER P, V15, P2815, DOI 10.7314/APJCP.2014.15.6.2815; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Vesco KK, 2011, ANN INTERN MED, V155, P698, DOI 10.7326/0003-4819-155-10-201111150-00377	27	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187579	10.1371/journal.pone.0187579	http://dx.doi.org/10.1371/journal.pone.0187579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145414	gold, Green Submitted, Green Published			2022-12-26	WOS:000415378800019
J	de Andrade, LGM; Contti, MM; Nga, HS; Bravin, AM; Takase, HM; Viero, RM; da Silva, TN; Chagas, KD; Palma, LMP				de Andrade, Luis Gustavo Modelli; Contti, Mariana Moraes; Nga, Hong Si; Bravin, Ariane Moyses; Takase, Henrique Mochida; Viero, Rosa Marlene; da Silva, Trycia Nunes; Chagas, Kelem De Nardi; Pereira Palma, Lilian Monteiro			Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice	PLOS ONE			English	Article							COMPLEMENT INHIBITOR ECULIZUMAB; PROPHYLACTIC ECULIZUMAB; INVASIVE ASPERGILLOSIS; RENAL-TRANSPLANTATION; SYNDROME RECURRENCE; AHUS; MUTATIONS; IMPACT	Introduction The treatment of choice for Atypical Hemolytic Uremic Syndrome (aHUS) is the monoclonal antibody eculizumab. The objective of this study was to assess the efficacy and safety of eculizumab in a cohort of kidney transplant patients suffering from aHUS. Methods Description of the prospective cohort of all the patients primarily treated with eculizumab after transplantation and divided into the therapeutic (onset of aHUS after transplantation) and prophylactic use (patients with previous diagnosis of aHUS undergoing kidney transplantation). Results Seven cases were outlined: five of therapeutic use and two, prophylactic. From the five cases of therapeutic use, there was improvement of the thrombotic microangiopathy in the 48 hours following the start of the drug and no patient experienced relapse during an average follow-up of 21 months in the continuous use of eculizumab (minimum of 6 and maximum of 42 months). One patient died at 6 months, due to Aspergillus infection. From the two cases of prophylactic use, one patient experienced relapsed thrombotic microangiopathy after 4 months and another patient remained asymptomatic after 16 months of follow-up, both on chronic treatment. Discussion The therapeutic use of eculizumab showed to be effective, with improvement of the microangiopathy parameters and persisting up to the end of the follow-up, without relapses. The additional risk of immunosuppression, leading to opportunistic infections, was well tolerated. The prophylactic use showed to be effective and safe; however, the doses and intervals should be individualized in order to avoid relapsed microangiopathy, especially in patients with factor H mutation.	[de Andrade, Luis Gustavo Modelli; Contti, Mariana Moraes; Nga, Hong Si; Bravin, Ariane Moyses; Takase, Henrique Mochida; Viero, Rosa Marlene; da Silva, Trycia Nunes; Chagas, Kelem De Nardi; Pereira Palma, Lilian Monteiro] Univ Sao Paulo State, Dept Internal Med, UNESP, Botucatu, SP, Brazil; [da Silva, Trycia Nunes] Hosp Estadual Bauru, Dept Internal Med, Bauru, SP, Brazil; [Chagas, Kelem De Nardi] Univ Sao Paulo, Dept Internal Med, Sao Paulo, SP, Brazil; [Pereira Palma, Lilian Monteiro] Univ Estadual Campinas, Dept Internal Med, UNICAMP, Campinas, SP, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	de Andrade, LGM (corresponding author), Univ Sao Paulo State, Dept Internal Med, UNESP, Botucatu, SP, Brazil.	landrade@fmb.unesp.br	Palma, Lilian Monteiro Pereira/U-6672-2018; de Andrade, Luis Gustavo Modelli/I-4146-2013	Palma, Lilian Monteiro Pereira/0000-0002-0334-8470; Modelli de Andrade, Luis Gustavo/0000-0002-0230-0766				Barbour T, 2012, NEPHROL DIAL TRANSPL, V27, P2673, DOI 10.1093/ndt/gfs279; Barnett ANR, 2013, CLIN TRANSPLANT, V27, pE216, DOI 10.1111/ctr.12102; Bresin E, 2006, CLIN J AM SOC NEPHRO, V1, P88, DOI 10.2215/CJN.00050505; Bresin E, 2013, J AM SOC NEPHROL, V24, P475, DOI 10.1681/ASN.2012090884; Campistol JM, 2013, NEFROLOGIA, V33, P27, DOI 10.3265/Nefrologia.pre2012.Nov.11781; Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; Cheshire C., 2014, PRESCRIBING INFORM; Coppo R, 2016, PEDIATR NEPHROL, V31, P759, DOI 10.1007/s00467-015-3278-0; Cugno M, 2014, J THROMB HAEMOST, V12, P1440, DOI 10.1111/jth.12615; Fehrman-Ekholm I, 2014, AUSTIN J NEPHROL HYP, V1, P1019; Fernandez-de Larrea C, 2010, TRANSPLANTATION, V89, P903, DOI 10.1097/TP.0b013e3181ccd80d; Heylen L, 2015, CLIN INFECT DIS, V60, P1505, DOI 10.1093/cid/civ103; Kasapoglu Umut, 2015, Ann Transplant, V20, P714; Kozel TR, 1996, CLIN MICROBIOL REV, V9, P34, DOI 10.1128/CMR.9.1.34; Krid S, 2012, AM J TRANSPLANT, V12, P1938, DOI 10.1111/j.1600-6143.2012.04051.x; Le Quintrec M, 2013, AM J TRANSPLANT, V13, P663, DOI 10.1111/ajt.12077; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Licht C, 2015, KIDNEY INT, V87, P1061, DOI 10.1038/ki.2014.423; Loirat C, 2016, PEDIATR NEPHROL, V31, P15, DOI 10.1007/s00467-015-3076-8; Mallett A, 2015, INTERN MED J, V45, P1054, DOI 10.1111/imj.12864; Matar D, 2014, TRANSPLANTATION, V98, P1205, DOI 10.1097/TP.0000000000000200; Nester CM, 2015, MOL IMMUNOL, V67, P31, DOI 10.1016/j.molimm.2015.03.246; Noris M, 2013, CURR OPIN NEPHROL HY, V22, P704, DOI 10.1097/MNH.0b013e328365b3fe; Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Nurnberger J, 2009, NEW ENGL J MED, V360, P542, DOI 10.1056/NEJMc0808527; Palma LMP, 2016, J BLOOD MED, V7, P39, DOI 10.2147/JBM.S36249; Riddell A, 2016, CLIN NEPHROL, V86, P200, DOI 10.5414/CN108808; Saland JM, 2009, J AM SOC NEPHROL, V20, P940, DOI 10.1681/ASN.2008080906; Sheerin NS, 2016, QJM-INT J MED, V109, P27, DOI 10.1093/qjmed/hcv082; Singh N, 2009, AM J TRANSPLANT, V9, pS180, DOI 10.1111/j.1600-6143.2009.02910.x; Vellanki VS, 2014, RENAL FAILURE, V36, P631, DOI 10.3109/0886022X.2014.882712; Verhave JC, 2014, NEPHROL DIAL TRANSPL, V29, P131, DOI 10.1093/ndt/gfu235; Woodward L, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0537-5; Zimmerhackl LB, 2010, NEW ENGL J MED, V362, P1746, DOI 10.1056/NEJMc1001060; Zuber J, 2012, AM J TRANSPLANT, V12, P3337, DOI 10.1111/j.1600-6143.2012.04252.x; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214; Zuber J, 2011, NAT REV NEPHROL, V7, P23, DOI 10.1038/nrneph.2010.155	38	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188155	10.1371/journal.pone.0188155	http://dx.doi.org/10.1371/journal.pone.0188155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136640	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200071
J	Frelat, R; Lindegren, M; Denker, TS; Floeter, J; Fock, HO; Sguotti, C; Stabler, M; Otto, SA; Mollmann, C				Frelat, Romain; Lindegren, Martin; Denker, Tim Spaanheden; Floeter, Jens; Fock, Heino O.; Sguotti, Camilla; Staebler, Moritz; Otto, Saskia A.; Moellmann, Christian			Community ecology in 3D: Tensor decomposition reveals spatio-temporal dynamics of large ecological communities	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; CLIMATE-CHANGE; ATLANTIC; OSCILLATION; MANAGEMENT; ORDINATION; SEQUENCE; MODEL; SHIFT; ARRAY	Understanding spatio-temporal dynamics of biotic communities containing large numbers of species is crucial to guide ecosystem management and conservation efforts. However, traditional approaches usually focus on studying community dynamics either in space or in time, often failing to fully account for interlinked spatio-temporal changes. In this study, we demonstrate and promote the use of tensor decomposition for disentangling spatio-temporal community dynamics in long-term monitoring data. Tensor decomposition builds on traditional multivariate statistics (e.g. Principal Component Analysis) but extends it to multiple dimensions. This extension allows for the synchronized study of multiple ecological variables measured repeatedly in time and space. We applied this comprehensive approach to explore the spatio-temporal dynamics of 65 demersal fish species in the North Sea, a marine ecosystem strongly altered by human activities and climate change. Our case study demonstrates how tensor decomposition can successfully (i) characterize the main spatiotemporal patterns and trends in species abundances, (ii) identify sub-communities of species that share similar spatial distribution and temporal dynamics, and (iii) reveal external drivers of change. Our results revealed a strong spatial structure in fish assemblages persistent over time and linked to differences in depth, primary production and seasonality. Furthermore, we simultaneously characterized important temporal distribution changes related to the low frequency temperature variability inherent in the Atlantic Multidecadal Oscillation. Finally, we identified six major sub-communities composed of species sharing similar spatial distribution patterns and temporal dynamics. Our case study demonstrates the application and benefits of using tensor decomposition for studying complex community data sets usually derived from large-scale monitoring programs.	[Frelat, Romain; Floeter, Jens; Sguotti, Camilla; Otto, Saskia A.; Moellmann, Christian] Univ Hamburg, Ctr Earth Syst Res & Sustainabil CEN, Inst Hydrobiol & Fisheries Sci, KlimaCampus Hamburg,Grosse Elbstr 133, Hamburg, Germany; [Lindegren, Martin; Denker, Tim Spaanheden] Tech Univ Denmark, Natl Inst Aquat Resources, Ctr Ocean Life, Bygning 202, Lyngby, Denmark; [Fock, Heino O.] Thunen Inst Sea Fisheries, Palmaille 9, Hamburg, Germany; [Staebler, Moritz] Leibniz Ctr Trop Marine Ecol, Fahrenheitstr 6, Bremen, Germany	University of Hamburg; Technical University of Denmark; Johann Heinrich von Thunen Institute; Leibniz Zentrum fur Marine Tropenforschung (ZMT)	Frelat, R (corresponding author), Univ Hamburg, Ctr Earth Syst Res & Sustainabil CEN, Inst Hydrobiol & Fisheries Sci, KlimaCampus Hamburg,Grosse Elbstr 133, Hamburg, Germany.	romain.frelat@uni-hamburg.de	Romain, Frelat/G-9930-2018; Möllmann, Christian/C-4788-2011; Möllmann, Christian/M-8006-2019	Romain, Frelat/0000-0002-8631-4398; Möllmann, Christian/0000-0001-9161-6342; Stabler, Moritz/0000-0002-9987-2532; Lindegren, Martin/0000-0002-9185-951X; Dencker, Tim Spaanheden/0000-0001-7804-0828	European Union's Horizon research and innovation programme [675997]; Centre for Ocean Life; VKR center of excellence; VILLUM research grant [13159]; German Science Foundation; Villum Fonden [00007178, 00013159] Funding Source: researchfish	European Union's Horizon research and innovation programme; Centre for Ocean Life; VKR center of excellence; VILLUM research grant; German Science Foundation(German Research Foundation (DFG)); Villum Fonden(Villum Fonden)	This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 675997 (ITN MARmaED). ML received support from the Centre for Ocean Life, a VKR center of excellence, as well as a VILLUM research grant (#13159). The study is a contribution to the University of Hamburg Center of Excellence on "Integrated Climate System Analysis and Prediction" (CliSAP) funded by the German Science Foundation (to CM). The results of this publication reflect only the author's view and the Commission is not responsible for any use that may be made of the information it contains.	Beare DJ, 2004, MAR ECOL PROG SER, V284, P269, DOI 10.3354/meps284269; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Benjamini Y, 2001, ANN STAT, V29, P1165; Bro R, 2006, CRIT REV ANAL CHEM, V36, P279, DOI 10.1080/10408340600969965; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cichocki A, 2015, IEEE SIGNAL PROC MAG, V32, P145, DOI 10.1109/MSP.2013.2297439; DAAN N, 1990, NETH J SEA RES, V26, P343, DOI 10.1016/0077-7579(90)90096-Y; Daan N, 2006, INT COUNC EXPL SEA A, V20, P10; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Edwards M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057212; Emeis KC, 2015, J MARINE SYST, V141, P18, DOI 10.1016/j.jmarsys.2014.03.012; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Engelhard GH, 2015, ENVIRON CONSERV, V42, P227, DOI 10.1017/S0376892915000077; Engelhard GH, 2011, ICES J MAR SCI, V68, P580, DOI 10.1093/icesjms/fsq183; Fung T, 2012, ICES J MAR SCI, V69, P235, DOI 10.1093/icesjms/fsr206; Gauch Jr HG, 1982, MULTIVARIATE ANAL CO; Giordani P, 2014, J STAT SOFTW, V57; Goberville E, 2014, J MARINE SYST, V129, P189, DOI 10.1016/j.jmarsys.2013.05.008; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Harshman R. A., 1970, FDN PARAFAC PROCEDUR, P1; Heo MS, 1998, COMMUN STAT-SIMUL C, V27, P843, DOI 10.1080/03610919808813512; ICES, 2015, SER ICES SURV PROT; Jones PD, 1997, INT J CLIMATOL, V17, P1433, DOI 10.1002/(SICI)1097-0088(19971115)17:13<1433::AID-JOC203>3.0.CO;2-P; Kauppi JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127231; Kenny AJ, 2009, PROG OCEANOGR, V81, P132, DOI 10.1016/j.pocean.2009.04.007; Kide SO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141566; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY, V24; Leibovici D, 1998, LINEAR ALGEBRA APPL, V269, P307, DOI 10.1016/S0024-3795(97)81516-9; Leibovici DG, 2011, INT J IMAGE DATA FUS, V2, P105, DOI 10.1080/19479832.2010.542893; Leibovici DG, 2010, J STAT SOFTW, V34, P1; Lindegren M, 2012, GLOBAL CHANGE BIOL, V18, P3491, DOI 10.1111/j.1365-2486.2012.02799.x; Lindegren M, 2009, P NATL ACAD SCI USA, V106, P14722, DOI 10.1073/pnas.0906620106; Ros-Santaella JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112382; Maritorena S, 2010, REMOTE SENS ENVIRON, V114, P1791, DOI 10.1016/j.rse.2010.04.002; McNeice GW, 2001, GEOPHYSICS, V66, P158, DOI 10.1190/1.1444891; Mendes S, 2016, J APPL STAT, V4763, P1; Mollmann C, 2014, ICES J MAR SCI, V71, P1187, DOI 10.1093/icesjms/fst123; Morup M, 2011, WIRES DATA MIN KNOWL, V1, P24, DOI 10.1002/widm.1; Nunez-Riboni I, 2015, J MARINE SYST, V151, P15, DOI 10.1016/j.jmarsys.2015.06.003; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Ovaskainen O, 2016, MAKE MORE OUT COMMUN, P561, DOI [10.1111/ele.12757, DOI 10.1111/ELE.12757]; Pecuchet L, 2017, GLOBAL ECOL BIOGEOGR, V26, P812, DOI 10.1111/geb.12587; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; R Core Team, 2021, R LANGUAGE ENV STAT; Sparrevohn CR, 2013, FISH OCEANOGR, V22, P400, DOI 10.1111/fog.12030; Stabler M, 2016, ECOL MODEL, V331, P17, DOI 10.1016/j.ecolmodel.2016.01.020; THIOULOUSE J, 1987, ACTA OECOL-OEC GEN, V8, P463; Thioulouse J, 2004, ECOLOGY, V85, P272, DOI 10.1890/02-0605; Thioulouse J, 2011, ANN APPL STAT, V5, P2300, DOI 10.1214/10-AOAS372; Thorson JT, 2017, ICES J MAR SCI, V74, P1311, DOI 10.1093/icesjms/fsw193; Thorson JT, 2016, GLOBAL ECOL BIOGEOGR, V25, P1144, DOI 10.1111/geb.12464; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Weinert M, 2016, ESTUAR COAST SHELF S, V175, P157, DOI 10.1016/j.ecss.2016.03.024	57	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188205	10.1371/journal.pone.0188205	http://dx.doi.org/10.1371/journal.pone.0188205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136658	gold, Green Published, Green Submitted			2022-12-26	WOS:000415121200077
J	Rasero, J; Amoroso, N; La Rocca, M; Tangaro, S; Bellotti, R; Stramaglia, S				Rasero, Javier; Amoroso, Nicola; La Rocca, Marianna; Tangaro, Sabina; Bellotti, Roberto; Stramaglia, Sebastiano		Alzheimer's Dis Neuroimag	Multivariate regression analysis of structural MRI connectivity matrices in Alzheimer's disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ORBITOFRONTAL CORTEX; CORTICAL NETWORKS; BRAIN NETWORKS; CONVERSION; DEMENTIA; ATROPHY; CONNECTOME; PREDICTION; PATTERNS	Alzheimer's disease (AD) is the most common form of dementia among older people and increasing longevity ensures its prevalence will rise even further. Whether AD originates by disconnecting a localized brain area and propagates to the rest of the brain across disease-severity progression is a question with an unknown answer. An important related challenge is to predict whether a given subject, with a mild cognitive impairment (MCI), will convert or not to AD. Here, our aim is to characterize the structural connectivity pattern of MCI and AD subjects using the multivariate distance matrix regression (MDMR) analysis, and to compare it to those of healthy subjects. MDMR is a technique developed in genomics that has been recently applied to functional brain network data, and here applied to identify brain nodes with different connectivity patterns, in controls and patients, because of brain atrophy. We address this issue at the macroscale by looking to differences in individual structural MRI brain networks, obtained from MR images according to a recently proposed definition of connectivity which measures the image similarity between patches at different locations in the brain. In particular, using data from ADNI, we selected four groups of subjects (all of them matched by age and sex): HC (healthy control participants), ncMCI (mild cognitive impairment not converting to AD), cMCI (mild cognitive impairment converting to AD) and AD. Next, we built structural MRI brain networks and performed group comparison for all the pairs of groups. Our results were three-fold: (i) considering the comparison of HC with the three other groups, the number of significant brain regions was 4 for ncMCI, 290 for cMCI and 74 for AD, out of a total of 549 regions; hence, in terms of the structural MRI connectivity here adopted, cMCI subjects have the maximal altered pattern w.r.t. healthy conditions. (ii) Eight and seven nodes were significant for the comparisons AD-ncMCI and AD-cMCI, respectively; six nodes, among them, were significant in both comparisons and these nodes form a connected brain region (corresponding to hippocampus, amygdala, Parahippocampal Gyrus, Planum Polare, Frontal Orbital Cortex, Temporal Pole and subcallosal cortex) showing reduced strength of connectivity in the MCI stages; (iii) The connectivity maps of cMCI and ncMCI subjects significantly differ from the connectome of healthy subjects in three regions all corresponding to Frontal Orbital Cortex.	[Rasero, Javier] Hosp Univ Cruces, Biocruces Hlth Res Inst, E-48903 Baracaldo, Spain; [Rasero, Javier; Amoroso, Nicola; La Rocca, Marianna; Bellotti, Roberto; Stramaglia, Sebastiano] Univ Aldo Moro, Dipartimento Fis, Via Orabona 4, I-70126 Bari, Italy; [Rasero, Javier; Amoroso, Nicola; La Rocca, Marianna; Tangaro, Sabina; Bellotti, Roberto; Stramaglia, Sebastiano] Ist Nazl Fis Nucl, Sez Bari, Via Orabona 4, I-70126 Bari, Italy; [Bellotti, Roberto; Stramaglia, Sebastiano] Univ Aldo Moro, TIRES Ctr Innovat Technol Signal Detect & Proc, Bari, Italy	Hospital Universitario Cruces; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro	Stramaglia, S (corresponding author), Univ Aldo Moro, Dipartimento Fis, Via Orabona 4, I-70126 Bari, Italy.; Stramaglia, S (corresponding author), Ist Nazl Fis Nucl, Sez Bari, Via Orabona 4, I-70126 Bari, Italy.; Stramaglia, S (corresponding author), Univ Aldo Moro, TIRES Ctr Innovat Technol Signal Detect & Proc, Bari, Italy.	sebastiano.stramaglia@ba.infn.it	La Rocca, Marianna/ABG-1214-2021; Tangaro, Sabina/AAN-6617-2020; Blanco, Leire/O-5114-2017; Daparte, Javier Raspero/ABC-7280-2020; stramaglia, sebastiano/H-7582-2015	La Rocca, Marianna/0000-0002-2254-1583; Tangaro, Sabina/0000-0002-1372-3916; Daparte, Javier Raspero/0000-0003-1661-2856; Bellotti, Roberto/0000-0003-3198-2708; stramaglia, sebastiano/0000-0002-5873-8564	Doctoral Research Staff Improvement Programme; Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd.; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Doctoral Research Staff Improvement Programme; Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); Eurolmmun; F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	JR's grant was funded from the Minister of Education, Language Policy and Culture (Basque Government) under Doctoral Research Staff Improvement Programme. The other authors received no specific funding for this work. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. None of these companies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health Grant U01 AG024904) and DOD ADNI(Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Amoroso N, 2015, PHYS MED BIOL, V60, P8851, DOI 10.1088/0031-9155/60/22/8851; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bellotti R, 2012, EUR PHYS J PLUS, V127, DOI 10.1140/epjp/i2012-12145-4; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P175, DOI 10.1016/j.jalz.2014.12.002; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Cheng B, 2015, BRAIN IMAGING BEHAV, V9, P913, DOI 10.1007/s11682-015-9356-x; Ciftci K, 2011, ANN BIOMED ENG, V39, P1493, DOI 10.1007/s10439-011-0258-9; Daniel BM, 2016, MDMR MULTIVARIATE DI; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; Derflinger S, 2011, J ALZHEIMERS DIS, V25, P347, DOI 10.3233/JAD-2011-110041; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012853; Dinomais M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162889; Duan HQ, 2017, BRAIN RES, V1655, P77, DOI 10.1016/j.brainres.2016.11.019; Eskildsen SF, 2013, NEUROIMAGE, V65, P511, DOI 10.1016/j.neuroimage.2012.09.058; Geslani DM, 2005, DEMENT GERIATR COGN, V19, P383, DOI 10.1159/000084709; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kumfor F, 2013, BRAIN, V136, P2992, DOI 10.1093/brain/awt185; La Rocca M, 2017, SPRINGER PROC PHYS, V191, P189, DOI 10.1007/978-3-319-47810-4_15; Leung KK, 2013, NEUROLOGY, V80, P648, DOI 10.1212/WNL.0b013e318281ccd3; Li H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082450; Lindberg O, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00032; Liu MX, 2016, IEEE T BIO-MED ENG, V63, P1473, DOI 10.1109/TBME.2015.2496233; Liu MX, 2016, IEEE T MED IMAGING, V35, P1463, DOI 10.1109/TMI.2016.2515021; Liu MX, 2015, HUM BRAIN MAPP, V36, P1847, DOI 10.1002/hbm.22741; Liu YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055246; Lo A, 2015, P NATL ACAD SCI USA, V112, P13892, DOI 10.1073/pnas.1518285112; Mattis PJ, 2016, NEUROLOGY, V87, P1925, DOI 10.1212/WNL.0000000000003285; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Ritter Kerstin, 2015, Alzheimers Dement (Amst), V1, P206, DOI 10.1016/j.dadm.2015.01.006; Rozzini L, 2007, INT J GERIATR PSYCH, V22, P1217, DOI 10.1002/gps.1816; Schmidtke K, 2008, INT PSYCHOGERIATR, V20, P96, DOI 10.1017/S1041610207005509; Shehzad Z, 2014, NEUROIMAGE, V93, P74, DOI 10.1016/j.neuroimage.2014.02.024; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Suk HI, 2014, NEUROIMAGE, V101, P569, DOI 10.1016/j.neuroimage.2014.06.077; Teipel S, 2015, LANCET NEUROL, V14, P1037, DOI 10.1016/S1474-4422(15)00093-9; Tijms BM, 2015, SCHIZOPHR RES, V168, P1, DOI 10.1016/j.schres.2015.08.025; Tijms BM, 2014, BRAIN CONNECT, V4, P337, DOI 10.1089/brain.2013.0209; Tijms BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058921; Tijms BM, 2012, CEREB CORTEX, V22, P1530, DOI 10.1093/cercor/bhr221; Van Hoesen GW, 2000, CEREB CORTEX, V10, P243, DOI 10.1093/cercor/10.3.243; Wang H, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.448; Wee CY, 2013, HUM BRAIN MAPP, V34, P3411, DOI 10.1002/hbm.22156; Westman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022506; Wimo A, 1997, INT J GERIATR PSYCH, V12, P841, DOI 10.1002/(SICI)1099-1166(199708)12:8<841::AID-GPS652>3.3.CO;2-I; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zhang S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010386.pub2; Zhang YD, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00066	61	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187281	10.1371/journal.pone.0187281	http://dx.doi.org/10.1371/journal.pone.0187281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29135998	gold, Green Submitted, Green Published			2022-12-26	WOS:000415121200017
J	Syed, S; Schober, J; Blanco, A; Zustiak, SP				Syed, Sana; Schober, Joseph; Blanco, Alexandra; Zustiak, Silviya Petrova			Morphological adaptations in breast cancer cells as a function of prolonged passaging on compliant substrates	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX; MECHANICAL MEMORY; FOCAL ADHESION; STIFFNESS; PROLIFERATION; ACTIVATION; COMPLEXITY; RESPONSES; DYNAMICS	Standard tissue culture practices involve propagating cells on tissue culture polystyrene (TCP) dishes, which are flat, 2-dimensional (2D) and orders of magnitude stiffer than most tissues in the body. Such simplified conditions lead to phenotypical cell changes and altered cell behaviors. Hence, much research has been focused on developing novel biomaterials and culture conditions that more closely emulate in vivo cell microenvironments. In particular, biomaterial stiffness has emerged as a key property that greatly affects cell behaviors such as adhesion, morphology, proliferation and motility among others. Here we ask whether cells that have been conditioned to TCP, would still show significant dependence on substrate stiffness if they are first pre-adapted to a more physiologically relevant environment. We used two commonly utilized breast cancer cell lines, namely MDA-MB-231 and MCF-7, and examined the effect of prolonged cell culturing on polyacrylamide substrates of varying compliance. We followed changes in cell adhesion, proliferation, shape factor, spreading area and spreading rate. After pre-adaptation, we noted diminished differences in cell behaviors when comparing between soft (1 kPa) and stiff (103 kPa) gels as well as rigid TCP control. Prolonged culturing of cells on complaint substrates further influenced responses of pre-adapted cells when transferred back to TCP. Our results have implications for the study of stiffness-dependent cell behaviors and indicate that cell pre-adaptation to the substrate needs consideration.	[Syed, Sana; Blanco, Alexandra; Zustiak, Silviya Petrova] St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA; [Schober, Joseph] Southern Illinois Univ Edwardsville, Dept Pharmaceut Sci, Edwardsville, IL USA	Saint Louis University; Washington University (WUSTL); Southern Illinois University System; Southern Illinois University Edwardsville	Zustiak, SP (corresponding author), St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA.	szustiak@slu.edu		Blanco, Alexandra/0000-0001-5090-7565	Saint Louis University	Saint Louis University	This work was supported by start-up funds provided to Dr. Zustiak by Saint Louis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by start-up funds provided to Dr. Zustiak by Saint Louis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestrini JL, 2012, INTEGR BIOL-UK, V4, P410, DOI 10.1039/c2ib00149g; Barcus CE, 2016, ONCOTARGET, V7, P48093, DOI 10.18632/oncotarget.10137; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bioptechs, 2015, DELT T PETR DISH; Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9; Carrel A, 1924, PHYSIOL REV, V4, P1; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Domura R, 2017, J MATER CHEM B, V5, P2588, DOI 10.1039/c7tb00207f; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Fusco S, 2015, ACTA BIOMATER, V23, P63, DOI 10.1016/j.actbio.2015.05.008; Geiger B, 2009, NATURE REV MOL CELL, V10; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gilbert PM, 2017, CELLULAR ADAPTATION; Heo S-J, 2015, SCI REPORTS, P5; Hoesel B, COMPLEXITY NF SIGNAL; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Ishihara S, 2013, EXP CELL RES, V319, P2916, DOI 10.1016/j.yexcr.2013.09.018; Kaushik S, 2016, CANCER METAST REV, V35, P655, DOI 10.1007/s10555-016-9650-0; Kirkpatrick CJ, 2007, BIOMATERIALS, V28, P5193, DOI 10.1016/j.biomaterials.2007.08.012; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Lee MYK, 2010, J VASC RES, V47, P287, DOI 10.1159/000265563; Lee MYK, 2009, MOL IMMUNOL, V46, P1050, DOI 10.1016/j.molimm.2008.09.027; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Li JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03910; Liao HH, 2014, CYTOTECHNOLOGY, V66, P229, DOI 10.1007/s10616-013-9560-8; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mason B. N., 2012, ENG BIOMATERIALS REG, P19, DOI DOI 10.1007/978-1-4614-1080-5_2; Masters JRW, 2000, NAT REV MOL CELL BIO, V1, P233, DOI 10.1038/35043102; Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929; Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1; Nisenholz N, 2014, SOFT MATTER, V10, P7234, DOI 10.1039/c4sm00780h; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/nmat2441, 10.1038/NMAT2441]; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Rianna C, 2017, EUR BIOPHYS J BIOPHY, V46, P309, DOI 10.1007/s00249-016-1168-4; Sazonova OV, 2011, BIOPHYS J, V101, P622, DOI 10.1016/j.bpj.2011.06.051; Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108; Sero JE, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145644; Shi Q, 2004, DNA CELL BIOL, V23, P502, DOI 10.1089/1044549041562294; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Stowers RS, 2017, CELL MOL BIOENG, V10, P114, DOI 10.1007/s12195-016-0468-1; Syed S, 2015, JOVE-J VIS EXP, DOI 10.3791/52643; Talele NP, 2015, STEM CELL REP, V4, P1016, DOI 10.1016/j.stemcr.2015.05.004; Tilghman RW, 2012, MATRIX RIGIDITY REGU, V7, DOI DOI 10.1371/J0URNAL.P0NE.0037231; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Tse J. R., 2001, PREPARATION HYDROGEL; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/nmat3889, 10.1038/NMAT3889]; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zustiak S, 2014, BIOTECHNOL BIOENG, V111, P396, DOI 10.1002/bit.25097; Zustiak SP, 2010, BIOMACROMOLECULES, V11, P1348, DOI 10.1021/bm100137q; Zustiak SP, 2015, MACROMOL BIOSCI, V15, P589, DOI 10.1002/mabi.201400507	59	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187853	10.1371/journal.pone.0187853	http://dx.doi.org/10.1371/journal.pone.0187853			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136040	gold, Green Submitted, Green Published			2022-12-26	WOS:000415121200038
J	Xu, JY; Hu, J; Yu, P; Wang, WW; Hu, XX; Hou, JS; Fang, SL; Liu, XQ				Xu, Jieyun; Hu, Jing; Yu, Pei; Wang, Weiwang; Hu, Xingxue; Hou, Jinsong; Fang, Silian; Liu, Xiqiang			Perioperative risk factors for postoperative pneumonia after major oral cancer surgery: A retrospective analysis of 331 cases	PLOS ONE			English	Article							PULMONARY COMPLICATIONS; RESPIRATORY COMPLICATIONS; SURGICAL-PATIENTS; NECK-SURGERY; HEAD; MORTALITY; ANESTHESIA; MORBIDITY; OUTCOMES	Objective Postoperative pneumonia (POP) is common and results in prolonged hospital stays, higher costs, increased morbidity and mortality. However, data on the incidence and risk factors of POP after oral and maxillofacial surgery are rare. This study aims to identify perioperative risk factors for POP after major oral cancer (OC) surgery. Methods Perioperative data and patient records of 331 consecutive subjects were analyzed in the period of April 2014 to March 2016. We individually traced each OC patient for a period to discharge from the hospital or 45 days after surgery, whichever occur later. Results The incidence of POP after major OC surgery with free flap construction or major OC surgery was 11.6% or 4.5%, respectively. Patient-related risk factors for POP were male sex, T stage, N stage, clinical stage and preoperative serum albumin level. Among the investigated procedure-related variables, incision grade, mandibulectomy, free flap reconstruction, tracheotomy, intraoperative blood loss, and the length of the operation were shown to be associated with the development of POP. Postoperative hospital stay was also significantly related to increased incidence of POP. Using a multivariable logistic regression model, we identified male sex, preoperative serum albumin level, operation time and postoperative hospital stay as independent risk factors for POP. Conclusion Several perioperative risk factors can be identified that are associated with POP. At-risk oral cancer patients should be subjected to intensified postoperative pulmonary care.	[Xu, Jieyun; Hu, Jing; Yu, Pei; Wang, Weiwang; Hou, Jinsong; Liu, Xiqiang] Sun Yat Sen Univ, Guanghua Sch Stomatol, Hosp Stomatol, Dept Oral Maxillofacial Head & Neck Oncol, Guangzhou, Guangdong, Peoples R China; [Xu, Jieyun; Hu, Jing; Yu, Pei; Wang, Weiwang; Hou, Jinsong; Liu, Xiqiang] Guangdong Prov Key Lab Stomatol, Guangzhou, Guangdong, Peoples R China; [Hu, Xingxue] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA; [Hu, Xingxue] Ohio State Univ, Coll Dent, Div Gen Practice & Mat Sci, Columbus, OH 43210 USA; [Fang, Silian] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Harvard University; Forsyth Institute; University System of Ohio; Ohio State University; Sun Yat Sen University	Liu, XQ (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Hosp Stomatol, Dept Oral Maxillofacial Head & Neck Oncol, Guangzhou, Guangdong, Peoples R China.; Liu, XQ (corresponding author), Guangdong Prov Key Lab Stomatol, Guangzhou, Guangdong, Peoples R China.; Fang, SL (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China.	fangsilian@126.com; liuxiq@mail.sysu.edu.cn			National Natural Science Foundation of China [81372885, 81772889, 81702699]; Major Special Research Collaborative Innovation of Guangzhou [201604020160]; China Postdoctoral Science Foundation [2017M612826]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Special Research Collaborative Innovation of Guangzhou; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The present study was supported by grants from the National Natural Science Foundation of China (81372885, 81772889, 81702699), the Major Special Research Collaborative Innovation of Guangzhou (201604020160), and the China Postdoctoral Science Foundation (2017M612826).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailawadi G, 2017, J THORAC CARDIOV SUR, V153, P1384, DOI 10.1016/j.jtcvs.2016.12.055; Akutsu Y, 2008, DIGEST SURG, V25, P93, DOI 10.1159/000121903; Chen P, 2014, ARCH GERONTOL GERIAT, V59, P186, DOI 10.1016/j.archger.2014.03.007; Chughtai Morad, 2017, J Clin Med Res, V9, P466, DOI 10.14740/jocmr3002w; Correa RD, 2014, J BRAS PNEUMOL, V40, P643, DOI 10.1590/S1806-37132014000600008; Damian D, 2016, J CLIN ANESTH, V28, P12, DOI 10.1016/j.jclinane.2015.08.007; Dillon JK, 2011, HEAD NECK-J SCI SPEC, V33, P112, DOI 10.1002/hed.21411; Dupont H, 2003, INTENS CARE MED, V29, P179, DOI 10.1007/s00134-002-1603-0; Guay J, 2014, ANESTH ANALG, V119, P716, DOI 10.1213/ANE.0000000000000339; Hausman MS, 2015, ANESTH ANALG, V120, P1405, DOI 10.1213/ANE.0000000000000574; Li L, 2016, J ORAL MAXIL SURG, V74, P415, DOI 10.1016/j.joms.2015.08.018; Ligh CA, 2016, J PLAST SURG HAND SU, V50, P85, DOI 10.3109/2000656X.2015.1106407; Liu YT, 2017, FRONT MED-PRC, V11, P239, DOI 10.1007/s11684-017-0509-8; Loeffelbein DJ, 2016, J CRANIO MAXILL SURG, V44, P952, DOI 10.1016/j.jcms.2016.05.007; Longo WE, 1998, ANN SURG, V228, P64, DOI 10.1097/00000658-199807000-00010; McMahon JD, 2013, BRIT J ORAL MAX SURG, V51, P689, DOI 10.1016/j.bjoms.2013.04.015; Molena D, 2014, SEMIN THORAC CARDIOV, V26, P287, DOI 10.1053/j.semtcvs.2014.12.002; Moolchandani K, 2017, J CLIN DIAGN RES, V11, pDC1, DOI 10.7860/JCDR/2017/23717.9247; Patil Harsha V, 2017, J Nat Sci Biol Med, V8, P46, DOI 10.4103/0976-9668.198360; Petrar S, 2012, LARYNGOSCOPE, V122, P1057, DOI 10.1002/lary.23228; Poelaert J, 2014, J THORAC CARDIOV SUR, V148, P1622, DOI 10.1016/j.jtcvs.2014.05.085; Sabate S, 2014, CURR OPIN ANESTHESIO, V27, P201, DOI 10.1097/ACO.0000000000000045; Sachdev G, 2012, SURG CLIN N AM, V92, P321, DOI 10.1016/j.suc.2012.01.013; Schwam ZG, 2015, LARYNGOSCOPE, V125, P1869, DOI 10.1002/lary.25328; Semenov YR, 2012, LARYNGOSCOPE, V122, P1994, DOI 10.1002/lary.23446; Shah JP, 2009, ORAL ONCOL, V45, P394, DOI 10.1016/j.oraloncology.2008.05.017; Silberstein JL, 2012, BJU INT, V110, P1276, DOI 10.1111/j.1464-410X.2012.11103.x; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; Sok M, 2002, EUR J CARDIO-THORAC, V22, P23, DOI 10.1016/S1010-7940(02)00244-0; Trinh VQ, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/6019416; Tusman G, 2012, CURR OPIN ANESTHESIO, V25, P1, DOI 10.1097/ACO.0b013e32834dd1eb; Yeung JK, 2013, LARYNGOSCOPE, V123, P2996, DOI 10.1002/lary.24241; Yoo SH, 2016, J CANCER RES CLIN, V142, P1343, DOI 10.1007/s00432-016-2141-4	33	12	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188167	10.1371/journal.pone.0188167	http://dx.doi.org/10.1371/journal.pone.0188167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135994	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200075
J	Ahlman, MA; Vigneault, DM; Sandfort, V; Maass-Moreno, R; Dave, J; Sadek, A; Mallek, MB; Selwaness, MAF; Herscovitch, P; Mehta, NN; Bluemke, DA				Ahlman, Mark A.; Vigneault, Davis M.; Sandfort, Veit; Maass-Moreno, Roberto; Dave, Jenny; Sadek, Ahmed; Mallek, Marissa B.; Selwaness, Mariana A. F.; Herscovitch, Peter; Mehta, Nehal N.; Bluemke, David A.			Internal tissue references for (18)Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUE INFLAMMATION; STANDARDIZED UPTAKE VALUES; F-18-FDG PET/CT; DAL-PLAQUE; FDG; DISEASE; QUANTIFICATION; ASSOCIATION; DALCETRAPIB; PROTOCOLS	Introduction (18)Fluorodeoxyglucose (FDG) positron emission tomography (PET) uptake in the artery wall correlates with active inflammation. However, in part due to the low spatial resolution of PET, variation in the apparent arterial wall signal may be influenced by variation in blood FDG activity that cannot be fully corrected for using typical normalization strategies. The purpose of this study was to evaluate the ability of the current common methods to normalize for blood activity and to investigate alternative methods for more accurate quantification of vascular inflammation. Materials and methods The relationship between maximum FDG aorta wall activity and mean blood activity was evaluated in 37 prospectively enrolled subjects aged 55 years or more, treated for hyperlipidemia. Target maximum aorta standardized uptake value (SUV) and mean background reference tissue activity (blood, spleen, liver) were recorded. Target-to-background ratios (TBR) and arterial maximum activity minus blood activity were calculated. Multivariable regression was conducted, predicting uptake values based on variation in background reference and target tissue FDG uptake; adjusting for gender, age, lean body mass (LBM), blood glucose, blood pool activity, and glomerular filtration rate (GFR), where appropriate. Results Blood pool activity was positively associated with maximum artery wall SUV (beta = 5.61, P < 0.0001) as well as mean liver (beta = 6.23, P < 0.0001) and spleen SUV (beta = 5.20, P < 0.0001). Artery wall activity divided by blood activity (TBRBlood) or subtraction of blood activity did not remove the statistically significant relationship to blood activity. Blood pool activity was not related to TBRliver and TBRspleen (beta = -0.36, P = NS and beta = -0.58, P = NS, respectively) Conclusions In otherwise healthy individuals treated for hyperlipidemia, blood FDG activity is associated with artery wall activity. However, variation in blood activity may mask artery wall signal reflective of inflammation, which requires normalization. Blood-based TBR and subtraction do not sufficiently adjust for blood activity. Warranting further investigation, background reference tissues with cellular uptake such as the liver and spleen may better adjust for variation in blood activity to improve assessment of vascular activity.	[Ahlman, Mark A.; Vigneault, Davis M.; Sandfort, Veit; Maass-Moreno, Roberto; Mallek, Marissa B.; Selwaness, Mariana A. F.; Bluemke, David A.] NIH, Radiol & Imaging Sci, Bldg 10, Bethesda, MD 20892 USA; [Vigneault, Davis M.] Univ Oxford, Dept Engn, Inst Biomed Engn, Oxford, England; [Vigneault, Davis M.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Dave, Jenny; Sadek, Ahmed; Mehta, Nehal N.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Herscovitch, Peter] NIH, PET Res Dept, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; University of Oxford; Tufts University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA	Ahlman, MA (corresponding author), NIH, Radiol & Imaging Sci, Bldg 10, Bethesda, MD 20892 USA.	mark.ahlman@nih.gov	Mehta, Nehal N/W-4669-2019; Vigneault, Davis/AAX-9750-2020; Bluemke, David/GYU-8169-2022	Mehta, Nehal N/0000-0003-4939-5130; Vigneault, Davis/0000-0003-3798-9812; Bluemke, David/0000-0002-8323-8086	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research is funded by the National Institutes of Health intramural research program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele JT, 2010, RADIOLOGY, V254, P917, DOI 10.1148/radiol.09090768; Ahn SS, 2017, J NUCL MED, V58, P507, DOI 10.2967/jnumed.116.180729; Athyros VG, 2004, J CLIN PATHOL, V57, P728, DOI 10.1136/jcp.2003.012989; Brazy PC, 1989, KIDNEY INT, V35; Bucerius J, 2016, EUR J NUCL MED MOL I, V43, P780, DOI 10.1007/s00259-015-3259-3; Bucerius J, 2014, EUR J NUCL MED MOL I, V41, P369, DOI 10.1007/s00259-013-2569-6; Chen WG, 2015, J NUCL MED, V56, P503, DOI 10.2967/jnumed.115.154385; Delgado RI, 2014, J NUCL MED, V55, P80, DOI 10.2967/jnumed.113.119511; Dellavedova L, 2016, EUR J NUCL MED MOL I, V43, P340, DOI 10.1007/s00259-015-3148-9; Derlin T, 2011, ANN NUCL MED, V25, P586, DOI 10.1007/s12149-011-0503-1; Fayad ZA, 2011, LANCET, V378, P1547, DOI 10.1016/S0140-6736(11)61383-4; Fayad ZA, 2011, AM HEART J, V162, P214, DOI 10.1016/j.ahj.2011.05.006; Gholami S, 2015, J NUCL CARDIOL, V22, P468, DOI 10.1007/s12350-015-0069-8; Huet P, 2015, J NUCL MED, V56, P552, DOI 10.2967/jnumed.114.142596; Kim EJ, 2014, CIRC-CARDIOVASC IMAG, V7, P455, DOI 10.1161/CIRCIMAGING.113.001093; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mani V, 2014, INT J CARDIOVAS IMAG, V30, P571, DOI 10.1007/s10554-014-0370-7; Minamimoto R, 2007, ANN NUCL MED, V21, P217, DOI 10.1007/s12149-007-0012-4; Muratore F, 2016, BEST PRACT RES CL RH, V30, P688, DOI 10.1016/j.berh.2016.09.010; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Qiao HT, 2008, COMPUT BIOL MED, V38, P1171, DOI 10.1016/j.compbiomed.2008.09.006; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rudd JHF, 2008, J NUCL MED, V49, P871, DOI 10.2967/jnumed.107.050294; Rudd JHF, 2010, J AM COLL CARDIOL, V55, P2527, DOI 10.1016/j.jacc.2009.12.061; Sandfort V, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003621; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Tawakol A, 2013, J AM COLL CARDIOLOGY; Tawakol A., 2017, LANCET; van den Hoff Jorg, 2015, J Nucl Med, V56, P1635, DOI 10.2967/jnumed.115.161570; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; ZASADNY KR, 1993, RADIOLOGY, V189, P847, DOI 10.1148/radiology.189.3.8234714	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187995	10.1371/journal.pone.0187995	http://dx.doi.org/10.1371/journal.pone.0187995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131857	Green Submitted, Green Published, gold			2022-12-26	WOS:000414997800036
J	Yun, KW; Choi, EH; Lee, HJ				Yun, Ki Wook; Choi, Eun Hwa; Lee, Hoan Jong			Genetic diversity of pneumococcal surface protein A in invasive pneumococcal isolates from Korean children, 1991-2016	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; SEROTYPE DISTRIBUTION; ELICIT PROTECTION; PSPA SEQUENCE; UNITED-STATES; OTITIS-MEDIA; IMMUNIZATION; ANTIBODIES; DISEASE	Pneumococcal surface protein A (PspA) is an important virulence factor of pneumococci and has been investigated as a primary component of a capsular serotype-independent pneumococcal vaccine. Thus, we sought to determine the genetic diversity of PspA to explore its potential as a vaccine candidate. Among the 190 invasive pneumococcal isolates collected from Korean children between 1991 and 2016, two (1.1%) isolates were found to have no pspA by multiple polymerase chain reactions. The full length pspA genes from 185 pneumococcal isolates were sequenced. The length of pspA varied, ranging from 1,719 to 2,301 base pairs with 55.7-100% nucleotide identity. Based on the sequences of the clade-defining regions, 68.7% and 49.7% were in PspA family 2 and clade 3/family 2, respectively. PspA clade types were correlated with genotypes using multilocus sequence typing and divided into several subclades based on diversity analysis of the N-terminal a-helical regions, which showed nucleotide sequence identities of 45.7-100% and amino acid sequence identities of 23.1-100%. Putative antigenicity plots were also diverse among individual clades and subclades. The differences in antigenicity patterns were concentrated within the N-terminal 120 amino acids. In conclusion, the N-terminal a-helical domain, which is known to be the major immunogenic portion of PspA, is genetically variable and should be further evaluated for antigenic differences and cross-reactivity between various PspA types from pneumococcal isolates.	[Yun, Ki Wook; Choi, Eun Hwa; Lee, Hoan Jong] Seoul Natl Univ, Dept Pediat, Coll Med, Seoul, South Korea; [Yun, Ki Wook; Choi, Eun Hwa; Lee, Hoan Jong] Seoul Natl Univ, Dept Pediat, Childrens Hosp, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Lee, HJ (corresponding author), Seoul Natl Univ, Dept Pediat, Coll Med, Seoul, South Korea.; Lee, HJ (corresponding author), Seoul Natl Univ, Dept Pediat, Childrens Hosp, Seoul, South Korea.	hoanlee@snu.ac.kr			National Research Foundation (NRF) of Korea - Ministry of Education, Science, and Technology [20110023092]	National Research Foundation (NRF) of Korea - Ministry of Education, Science, and Technology	HJL is the recipient of a Grant of the the Basic Science Research Program through the National Research Foundation (NRF,http://www.nrf.re.kr) of Korea, which is funded by the Ministry of Education, Science, and Technology (20110023092). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barocchi MA, 2007, VACCINE, V25, P2963, DOI 10.1016/j.vaccine.2007.01.065; Beall B, 2000, J CLIN MICROBIOL, V38, P3663, DOI 10.1128/JCM.38.10.3663-3669.2000; Beddows S, 1999, J VIROL, V73, P1740, DOI 10.1128/JVI.73.2.1740-1745.1999; Brandileone MCC, 2004, VACCINE, V22, P3890, DOI 10.1016/j.vaccine.2004.04.009; Cho EY, 2016, J KOREAN MED SCI, V31, P1082, DOI 10.3346/jkms.2016.31.7.1082; Cho EY, 2014, DIAGN MICR INFEC DIS, V78, P481, DOI 10.1016/j.diagmicrobio.2013.12.016; Coral MCV, 2001, EMERG INFECT DIS, V7, P832; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Eun BW, 2010, DIAGN MICR INFEC DIS, V68, P345, DOI 10.1016/j.diagmicrobio.2010.07.008; Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006; Heeg C, 2007, VACCINE, V25, P1030, DOI 10.1016/j.vaccine.2006.09.061; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Kim L, 2016, CLIN MICROBIOL REV, V29, P525, DOI 10.1128/CMR.00058-15; MCDANIEL LS, 1994, MICROB PATHOGENESIS, V17, P323, DOI 10.1006/mpat.1994.1078; McDaniel LS, 1998, INFECT IMMUN, V66, P4748, DOI 10.1128/IAI.66.10.4748-4754.1998; Melin MM, 2008, CLIN VACCINE IMMUNOL, V15, P1555, DOI 10.1128/CVI.00177-08; Mollerach M, 2004, EPIDEMIOL INFECT, V132, P177, DOI 10.1017/S0950268803001626; Moore CE, 2014, J INFECT DIS, V210, P1001, DOI 10.1093/infdis/jiu213; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Pimenta FC, 2006, J CLIN MICROBIOL, V44, P2838, DOI 10.1128/JCM.00156-06; Roche H, 2003, INFECT IMMUN, V71, P1033, DOI 10.1128/IAI.71.3.1033-1041.2003; Rolo D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-80; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Vadesilho CFM, 2014, CLIN VACCINE IMMUNOL, V21, P940, DOI 10.1128/CVI.00239-14; White P, 1999, ORL J OTO-RHINO-LARY, V61, P206, DOI 10.1159/000027672; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yamamoto M, 1998, J IMMUNOL, V161, P4115; Yatim MM, 2013, J MICROBIOL IMMUNOL, V46, P180, DOI 10.1016/j.jmii.2012.04.004; Yun KW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134055; Yun KW, 2011, J KOREAN MED SCI, V26, P971, DOI 10.3346/jkms.2011.26.8.971; 김경호, 2005, Clinical and Experimental Pediatrics, V48, P1206	32	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0183968	10.1371/journal.pone.0183968	http://dx.doi.org/10.1371/journal.pone.0183968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131872	Green Submitted, gold, Green Published			2022-12-26	WOS:000414997800001
J	Feve, K; Foissac, S; Pinton, A; Mompart, F; Esquerre, D; Faraut, T; Yerle, M; Piquet, J				Feve, Katia; Foissac, Sylvain; Pinton, Alain; Mompart, Florence; Esquerre, Diane; Faraut, Thomas; Yerle, Martine; Piquet, Juliette			Identification of a t(3;4)(p1.3;q1.5) translocation breakpoint in pigs using somatic cell hybrid mapping and high-resolution mate-pair sequencing	PLOS ONE			English	Article							ISOLATED ECTOPIA LENTIS; RECIPROCAL TRANSLOCATION; ADAMTSL4; MUTATION; GENE; CHROMOSOMES; HYBRIDIZATION; CYTOGENETICS; POPULATIONS; BIOGENESIS	Reciprocal translocations are the most frequently occurring constitutional structural rear-rangements in mammalian genomes. In phenotypically normal pigs, an incidence of 1/200 is estimated for such rearrangements. Even if constitutional translocations do not necessarily induce defects and diseases, they are responsible for significant economic losses in domestic animals due to reproduction failures. Over the last 30 years, advances in molecular and cytogenetic technologies have led to major improvements in the resolution of the characterization of translocation events. Characterization of translocation breakpoints helps to decipher the mechanisms that lead to such rearrangements and the functions of the genes that are involved in the translocation. Here, we describe the fine characterization of a reciprocal translocation t(3;4)(p1.3;q1.5) detected in a pig line. The breakpoint was identified at the base-pair level using a positional cloning and chromosome walking strategy in somatic cell hybrids that were generated from an animal that carries this translocation. We show that this translocation occurs within the ADAMTSL4 gene and results in a loss of expression in homozygous carriers. In addition, by taking this translocation as a model, we used a whole-genome next-generation mate-pair sequencing approach on pooled individuals to evaluate this strategy for high-throughput screening of structural rearrangements.	[Feve, Katia; Foissac, Sylvain; Pinton, Alain; Mompart, Florence; Esquerre, Diane; Faraut, Thomas; Yerle, Martine; Piquet, Juliette] Univ Toulouse, INRA, INPT, ENVT,GenPhySE, Castanet Tolosan, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Piquet, J (corresponding author), Univ Toulouse, INRA, INPT, ENVT,GenPhySE, Castanet Tolosan, France.	juliette.riquet@inra.fr	Pinton, Alain/AAQ-1648-2020	Pinton, Alain/0000-0002-0809-7180; Foissac, Sylvain/0000-0002-2631-5356	French National Research Agency (ANR) [ANR-08-GENM-038]; INRA (Institut National de le Recherche Agronomique); INRA	French National Research Agency (ANR)(French National Research Agency (ANR)); INRA (Institut National de le Recherche Agronomique); INRA	This experiment was partly supported by the French National Research Agency (ANR), program "PIG_FEED" (ANR-08-GENM-038), and by INRA (Institut National de le Recherche Agronomique). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Aragon-Martin JA, 2010, HUM MUTAT, V31, pE1622, DOI 10.1002/humu.21305; Benet J, 2005, CYTOGENET GENOME RES, V111, P281, DOI 10.1159/000086901; Buchner DA, 2003, GENE, V307, P23, DOI 10.1016/S0378-1119(03)00423-2; Chandra A, 2013, OPHTHALMIC GENET, V34, P78, DOI 10.3109/13816810.2012.710707; Chen W, 2008, GENOME RES, V18, P1143, DOI 10.1101/gr.076166.108; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Dubail J, 2015, MATRIX BIOL, V44-46, P24, DOI 10.1016/j.matbio.2015.03.001; Ducos A, 2008, CYTOGENET GENOME RES, V120, P26, DOI 10.1159/000118738; Ducos A, 1998, J HERED, V89, P136, DOI 10.1093/jhered/89.2.136; Ducos A, 2002, GENET SEL EVOL, V34, P389, DOI [10.1051/gse:2002014, 10.1186/1297-9686-34-3-389]; Ducos A, 2000, GENET SEL EVOL, V32, P589, DOI 10.1051/gse:2000139; DUTRILLAUX B, 1971, CR ACAD SCI D NAT, V273, P587; Fiegler H, 2003, J MED GENET, V40, P664, DOI 10.1136/jmg.40.9.664; FORD CE, 1980, HEREDITAS, V92, P145; Gabriel LAR, 2012, INVEST OPHTH VIS SCI, V53, P461, DOI 10.1167/iovs.10-5955; GELLIN J, 1981, CYTOGENET CELL GENET, V30, P59, DOI 10.1159/000131590; Gilbert H., 2017, ANIMAL, P1; HENRICSON B, 1964, HEREDITAS-GENETISK A, V52, P166; Hubmacher D, 2015, MATRIX BIOL, V47, P34, DOI 10.1016/j.matbio.2015.05.004; Hubmacher D, 2014, INVEST OPHTH VIS SCI, V55, P7934, DOI 10.1167/iovs.14-15453; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Murphy SJ, 2012, DNA RES, P1; Neuhann TM, 2015, AM J MED GENET A, V167, P2376, DOI 10.1002/ajmg.a.37157; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Nielsen K, 2000, J MED GENET, V37, P858, DOI [10.1136/jmp.37.11.858, DOI 10.1136/JMG.37.11.858]; Reinstein E, 2016, MOL GENET METAB, V117, P38, DOI 10.1016/j.ymgme.2015.11.011; Rodriguez A, 2010, THERIOGENOLOGY, V74, P67, DOI 10.1016/j.theriogenology.2009.12.020; ROHRER GA, 1994, GENETICS, V136, P231; Roukos V, 2014, NAT CELL BIOL, V16, P293, DOI 10.1038/ncb2941; Rubes J, 2009, CYTOGENET GENOME RES, V126, P34, DOI 10.1159/000245905; SEABRIGH.M, 1971, LANCET, V2, P971; Sindi SS, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r22; VANDYKE DL, 1983, AM J HUM GENET, V35, P301; YERLE M, 1992, CYTOGENET CELL GENET, V59, P48, DOI 10.1159/000133198; Yerle M, 1996, CYTOGENET CELL GENET, V73, P194, DOI 10.1159/000134338; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293	38	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187617	10.1371/journal.pone.0187617	http://dx.doi.org/10.1371/journal.pone.0187617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121641	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900057
J	Guo, Y; Duan, JL; Liu, LJ; Sun, Y; Tang, P; Lv, YY; Xu, L; Jonas, JB				Guo, Yin; Duan, Jia Li; Liu, Li Juan; Sun, Ying; Tang, Ping; Lv, Yan Yun; Xu, Liang; Jonas, Jost B.			High myopia in Greater Beijing School Children in 2016	PLOS ONE			English	Article							REFRACTIVE-ERROR; VISUAL IMPAIRMENT; SOUTHERN CHINA; PREVALENCE; EYE; URBAN	Purpose To assess prevalence and associated factors of myopia and high myopia in schoolchildren in Greater Beijing. Methods The school-based, cross-sectional Greater Beijing School Children Myopia study was carried out in the year 2016 in 54 schools randomly selected from 15 districts in Beijing. Non-cycloplegic auto-refractometry of the right eyes was performed. Results The study included 35,745 (99.4%) out of 35,968 eligible pupils with a mean age of 12.6 +/- 3.4 years (range 6-18 years). Prevalence of myopia defined as myopic refractive error of >=-0.50 diopters (D), >=-1D, >=-6D, >=-8D and >=-10D was 70.9%(95% confidence intervals (CI): 70.5,71.4), 60.9% (95% CI: 60.4,61.4), 8.6%(95% CI: 8.4,8.9), 2.2%(95% CI: 2.0,2.4), and 0.3% (95% CI: 0.3,0.4), respectively. The frequency of high myopia (>=-6D, >=-8D, >=-10D) increased from 1.5% (95% CI: 1.0,2.0), 0.4% (95% CI: 0.1,0.6) and 0.1% (95% CI: 0.00,0.02), respectively in 10-year-olds to 19.4% (95% CI: 17.3,21.6), 5.2% (95% CI: 4.0,6.4) and 0.9% (95% CI: 0.4,1.5), respectively, in 18-year-olds. Mean refractive error in the 18-year-olds was -3.74 +/- 2.56D (median:-3.63D; range:-19.6D to + 6.25D). Higher prevalence of high myopia (>=-6D and >=-8D) was correlated (all P<0.001) with older age (OR: 1.18, and 1.15, respectively), female gender (OR: 1.44 and 1.40, respectively), higher body mass index (OR: 1.02 and 1.03, respectively), taller body height (OR: 1.03 and 1.02, respectively), urban region of habitation (OR: 1.26 and 1.33, respectively) and higher school type (OR: 1.57 and 2.22, respectively). Prevalence of severe high myopia (>=-10D) was associated only with older age (P<0.001; OR: 1.44; 95% CI: 1.31, 1.59) but not with any education-related parameter such as higher school type (P = 0.48), urban region of habitation (P = 0.07) or female gender (P = 0.37). Conclusion In this most recent survey, prevalence of high myopia (>=-6D: 19.4%; >=-8D: 5.2%; >=-10D: 0.9%) in 18-year-old school children was higher than in previous surveys from mainland China. In contrast to minor high myopia and moderate high myopia (defined as myopic refractive error of <-10D), severe high myopia (myopic refractive error >=-10D) was not strongly correlated with educational parameters.	[Guo, Yin; Tang, Ping; Lv, Yan Yun] Capital Med Univ, Beijing Tongren Hosp, Tongren Eye Care Ctr, Beijing, Peoples R China; [Guo, Yin; Liu, Li Juan; Xu, Liang] Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Guo, Yin; Liu, Li Juan; Xu, Liang] Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Visual Sci Key Lab, Beijing, Peoples R China; [Duan, Jia Li; Sun, Ying] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Seegartenklin Heidelberg, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.; Xu, L (corresponding author), Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Visual Sci Key Lab, Beijing, Peoples R China.; Jonas, JB (corresponding author), Heidelberg Univ, Seegartenklin Heidelberg, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany.	xlbio1@163.com; Jost.Jonas@medma.uni-heidelberg.de	Guo, Yin/ABC-2134-2020	Guo, Yin/0000-0003-3806-3771; Jonas, Jost/0000-0003-2972-5227	National Natural Science Foundation of China [81400431]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81400431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; Fotedar R, 2007, AM J OPHTHALMOL, V144, P307, DOI 10.1016/j.ajo.2007.03.041; Guo K, 2015, INVEST OPHTH VIS SCI, V56, P1769, DOI 10.1167/iovs.14-15737; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; Hu YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117482; Jonas JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154554; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Lin LL, 2004, ANN ACAD MED SINGAP, V33, P27; Lin Z, 2014, INVEST OPHTH VIS SCI, V55, P5711, DOI 10.1167/iovs.13-13693; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Ohno-Matsui K, 2015, AM J OPHTHALMOL, V159, P877, DOI 10.1016/j.ajo.2015.01.022; Sun J, 2012, INVEST OPHTH VIS SCI, V53, P7504, DOI 10.1167/iovs.11-8343; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Wu LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120764; Xiang F, 2012, OPHTHALMOLOGY, V119, P1478, DOI 10.1016/j.ophtha.2012.01.017; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; You QS, 2014, ACTA OPHTHALMOL, V92, pE398, DOI 10.1111/aos.12299; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	21	22	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187396	10.1371/journal.pone.0187396	http://dx.doi.org/10.1371/journal.pone.0187396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121045	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900033
J	Kalbitz, M; Amann, EM; Bosch, B; Palmeri, A; Schultze, A; Pressmar, J; Weber, B; Wepler, M; Gebhard, F; Schrezenmeier, H; Brenner, R; Huber-Lang, M				Kalbitz, Miriam; Amann, Elisa Maria; Bosch, Belinda; Palmeri, Annette; Schultze, Anke; Pressmar, Jochen; Weber, Birte; Wepler, Martin; Gebhard, Florian; Schrezenmeier, Hubert; Brenner, Rolf; Huber-Lang, Markus			Experimental blunt chest trauma-induced myocardial inflammation and alteration of gap-junction protein connexin 43	PLOS ONE			English	Article							ACUTE LUNG INJURY; EXTRACELLULAR HISTONES; CARDIAC INJURY; CIRCULATING HISTONES; RECEPTOR STIMULATION; PRIMARY BLAST; C5A RECEPTOR; SEPSIS; MEDIATORS; CARDIOMYOPATHY	Objective Severe blunt chest trauma in humans is associated with high mortality rates. Whereas lung tissue damage and lung inflammation after blunt chest trauma have extensively been investigated, the traumatic and posttraumatic effects on the heart remain poorly understood. Therefore, the purpose of this study was to define cardiac injury patterns in an experimental blunt chest trauma model in rats. Methods Experimental blunt chest trauma was induced by a blast wave in rats, with subsequent analysis of its effects on the heart. The animals were subjected either to a sham or trauma procedure. Systemic markers for cardiac injury were determined after 24 h and 5 days. Postmortem analysis of heart tissue addressed structural injury and inflammation 24 h and 5 days after trauma. Results Plasma levels of extracellular histones were elevated 24 h and 5 days after blunt chest trauma compared to sham-treated animals. In the heart, up-regulation of interleukin-1 beta 24 h after trauma and increased myeloperoxidase activity 24 h and 5 days after trauma were accompanied by reduced complement C5a receptor-1 expression 24 h after trauma. Histological analysis revealed extravasation of erythrocytes and immunohistochemical analysis alteration of the pattern of the gap-junction protein connexin 43. Furthermore, a slight reduction of a-actinin and desmin expression in cardiac tissue was found after trauma together with a minor increase in sarcoplasmatic/endoplasmatic reticlulum calcium-ATPase (SERCA) expression. Conclusions The clinically highly relevant rat model of blast wave-induced blunt chest trauma is associated with cardiac inflammation and structural alterations in cardiac tissue.	[Kalbitz, Miriam; Bosch, Belinda; Pressmar, Jochen; Weber, Birte; Gebhard, Florian] Univ Ulm, Dept Traumatol Hand Plast & Reconstruct Surg, Ctr Surg, Ulm, Germany; [Amann, Elisa Maria; Schrezenmeier, Hubert] Univ Ulm, Inst Clin Transfus Med & Immunogenet Ulm, German Red Cross Blood Transfus Serv Baden Wurtte, Ulm, Germany; [Amann, Elisa Maria; Schrezenmeier, Hubert] Univ Ulm, Univ Hosp Ulm, Ulm, Germany; [Palmeri, Annette; Schultze, Anke; Huber-Lang, Markus] Univ Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany; [Wepler, Martin] Univ Ulm, Inst Anaesthesiol Pathophysiol & Proc Engn, Ulm, Germany; [Brenner, Rolf] Univ Ulm, Dept Orthoped, Div Biochem Joint & Connect Tissue Dis, Ulm, Germany	Ulm University; Ulm University; Ulm University; Ulm University; Ulm University; Ulm University	Kalbitz, M (corresponding author), Univ Ulm, Dept Traumatol Hand Plast & Reconstruct Surg, Ctr Surg, Ulm, Germany.	miriam.kalbitz@uniklinik-ulm.de	Wepler, Martin/GWC-0127-2022; Huber-Lang, Markus/AAJ-2209-2020	Weber, Birte/0000-0001-7779-9816	Deutsche Forschungsgemeinschaft [CRC 1149, SFB1149]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors declare no commercial or financial conflicts of interest related to the studies. This work is supported by Deutsche Forschungsgemeinschaft grant CRC 1149 and SFB1149 to FG and MH-L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by Deutsche Forschungsgemeinschaft grant CRC 1149.	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Agullo-Pascual E, 2014, FEBS LETT, V588, P1322, DOI 10.1016/j.febslet.2014.02.008; Alhamdi Y, 2015, CRIT CARE MED, V43, P2094, DOI 10.1097/CCM.0000000000001162; Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; Asimaki A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008008; Atefi G, 2011, FASEB J, V25, P2500, DOI 10.1096/fj.11-183236; Bertinchant JP, 1999, J TRAUMA, V47, P474, DOI 10.1097/00005373-199909000-00007; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Burk AM, 2012, SHOCK, V37, P348, DOI 10.1097/SHK.0b013e3182471795; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Crown LA, 1997, AM FAM PHYSICIAN, V55, P2467; EISENACH JC, 1986, ANESTHESIOLOGY, V64, P364, DOI 10.1097/00000542-198603000-00011; Elie MC, 2006, MT SINAI J MED, V73, P542; Fattahi F, 2015, IMMUNOL RES, V61, P177, DOI 10.1007/s12026-015-8628-2; GANDEVIA SC, 1978, J PHYSIOL-LONDON, V276, P369, DOI 10.1113/jphysiol.1978.sp012240; Glukhov AV, 2012, CIRCULATION, V125, P1835, DOI 10.1161/CIRCULATIONAHA.111.047274; Guo RF, 2003, FASEB J, V17, P1889, DOI 10.1096/fj.03-0009fje; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Guy RJ, 1998, J TRAUMA, V45, P983, DOI 10.1097/00005373-199812000-00001; Hoesel LM, 2007, J IMMUNOL, V178, P7902, DOI 10.4049/jimmunol.178.12.7902; Huber S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0052-4; Irwin RJ, 1997, J TRAUMA, V43, P650, DOI 10.1097/00005373-199710000-00015; Jain SK, 2003, CIRC RES, V92, P1138, DOI 10.1161/01.RES.0000074883.66422.C5; Kalbitz M, 2016, FASEB J; Kalbitz M, 2015, FASEB J, V29, P2185, DOI 10.1096/fj.14-268730; Knoferl MW, 2004, SHOCK, V22, P51, DOI 10.1097/01.shk.0000127684.64611.5c; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; Kretschmer SBM, 2016, FUTURE MED CHEM, V8, P149, DOI 10.4155/fmc.15.174; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P1389, DOI 10.1097/TA.0b013e318270d595; Lausevic Z, 2008, CAN J SURG, V51, P97; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; NIRGIOTIS J G, 1990, Journal of Emergency Medicine, V8, P617, DOI 10.1016/0736-4679(90)90459-9; Perl M, 2007, AM J RESP CRIT CARE, V176, P591, DOI 10.1164/rccm.200611-1743OC; Poursharifi P, 2013, CELL SIGNAL, V25, P910, DOI 10.1016/j.cellsig.2012.12.010; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Rocksen D, 2012, INJURY, V43, P632, DOI 10.1016/j.injury.2010.10.002; Rudiger A, 2013, CURR VASC PHARMACOL, V11, P187; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seely AJE, 2002, ANN SURG, V235, P550, DOI 10.1097/00000658-200204000-00014; Skinner DL, 2015, INJURY, V46, P66, DOI 10.1016/j.injury.2014.08.051; van den Berg CW, 2014, J IMMUNOL, V192, P1787, DOI 10.4049/jimmunol.1301920; Vetter C, 2010, PHYSIOL RES, V59, P35, DOI 10.33549/physiolres.931654; Xia Y, 2009, ACTA PHARMACOL SIN, V30, P928, DOI 10.1038/aps.2009.92; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Zhang YX, 2012, FREE RADICAL BIO MED, V53, P1531, DOI 10.1016/j.freeradbiomed.2012.07.010	50	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187270	10.1371/journal.pone.0187270	http://dx.doi.org/10.1371/journal.pone.0187270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121655	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900026
J	Ahn, SG; Bae, SJ; Yoon, C; Cha, YJ; Lee, HW; Lee, SA; Jeong, J				Ahn, Sung Gwe; Bae, Soong June; Yoon, Changik; Cha, Yoon Jin; Lee, Hak Woo; Lee, Seung Ah; Jeong, Joon			Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay	PLOS ONE			English	Article							CLINICAL-PRACTICE; GENE-EXPRESSION; THERAPY; CHEMOTHERAPY; WOMEN; DECISIONS	Aim The 21-gene recurrence score (RS) predicts a clinical benefit of chemotherapy for individuals with ER-positive/HER2-negative breast cancer. Using in vitro chemoresponse assay, we compared the chemosensitivity according to RS in these patients. Method Among the patients with Oncotype Dx assay, we identified 63 patients who had chemotherapy response assays to doxorubicin based on adenosine triphosphate. The degree of chemosensitivity to doxorubicin was translated into the cell death rate (CDR). The RS was also dichotomized with a cutoff of 26. Results Of 63 patients, 34 (54%), 17 (27%), and 12 patients (19%) had a low, intermediate, and high RS, respectively. The mean CDR differed significantly according to categorized RS, with 17.3 10.8 in the low RS group vs. 23.6 16.3 in the intermediate RS group vs. 28.8 12.6 in the high RS group (P=0.024, One-way ANOVA test). The mean CDR was significantly higher in the higher RS (26>) group compared with the lower RS (<26) group (P=0.025, the Student's t-test), as well as in the high RS (>30) group compared with the low RS (<18) group (P=0.012, the Student's t-test). Also, continuous RS and CDR correlated positively (Pearson's R =0.337; P =0.007). High RS demonstrated the odds ratio (OR =26.33; 95% CI =1.69-410.0) for predicting tumors with chemosensitivity on the multivariate analysis. Conclusions The chemosensitivity measured by in vitro chemoresponse assay was different according to the RS. Our findings support that tumors with high RS has the chemosensitivity even though they are luminal/HER2-negative tumors.	[Ahn, Sung Gwe; Bae, Soong June; Yoon, Changik; Lee, Hak Woo; Jeong, Joon] Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea; [Cha, Yoon Jin] Yonsei Univ, Gangnam Severance Hosp, Dept Pathol, Coll Med, Seoul, South Korea; [Lee, Seung Ah] CHA Univ, Dept Surg, CHA Bundang Med Ctr, Seongnam, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University	Jeong, J (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea.	gsjjoon@yuhs.ac	, 정준/I-2133-2019	, 정준/0000-0003-0397-0005; Bae, Soong June/0000-0002-0012-9694; Yoon, Chang Ik/0000-0002-7273-8886; Ahn, Sung Gwe/0000-0002-8778-9686; Cha, Yoon Jin/0000-0002-5967-4064	Basic Science Research Program through the NRF - Ministry of Science, ICT, & Future Planning [NRF-2015R1C1A1A02037104]; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1520120]	Basic Science Research Program through the NRF - Ministry of Science, ICT, & Future Planning; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by the Basic Science Research Program through the NRF, funded by the Ministry of Science, ICT, & Future Planning (NRF-2015R1C1A1A02037104), and grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1520120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ahn SG, 2014, JPN J CLIN ONCOL, V44, P624, DOI 10.1093/jjco/hyu057; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Dowsett M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1798; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Harris LN, 2016, J CLIN ONCOL, V34, P1134, DOI 10.1200/JCO.2015.65.2289; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; HD Bear WW, 2016, CANC RES, V77; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Sharma S, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-19; Soran Atilla, 2016, Breast Dis, V36, P65, DOI 10.3233/BD-150199; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Yardley DA, 2015, BREAST CANCER RES TR, V154, P89, DOI 10.1007/s10549-015-3599-5	17	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187679	10.1371/journal.pone.0187679	http://dx.doi.org/10.1371/journal.pone.0187679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117208	gold, Green Submitted, Green Published			2022-12-26	WOS:000414659600061
J	Li, S; Yuan, HF; Pan, JF; Fan, WS; Zhu, L; Yan, ZQ; Guo, CG				Li, Shuo; Yuan, Hengfeng; Pan, Jianfeng; Fan, Wenshuai; Zhu, Liang; Yan, Zuoqin; Guo, Changan			The treatment of femoral neck fracture using VEGF-loaded nanographene coated internal fixation screws	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BONE REPAIR; GRAPHENE OXIDE; VESSEL; ANGIOGENESIS; TOMOGRAPHY; DELIVERY; HEAD	Purpose Previous studies have proved that vascular endothelial growth factor (VEGF) has a dual role in the promotion of new bone formation and blood vessel repair during fracture healing. However, how to introduce VEGF to a fracture site safely and effectively is still a challenge. This study aimed to prepare a VEGF-loaded nanographene coated internal fixation screw and to evaluate its effects in the treatment of femoral neck fracture. Methods Nanographene coated screws were prepared by direct liquid-phase exfoliation of the graphite method, and the surface characteristics were observed through scanning electron microscopy (SEM). VEGF was loaded on nanographene coatings through physical adsorption, and the VEGF controlled release was examined by ELISA. Then a canine femoral neck fracture model was built to examine both the angiogenic and osteogenic properties of the VEGF-loaded coated screws. X-ray, micro-CT-based microangiography, and histopathologic evaluation were used to assess the fracture healing progress. Results The results demonstrated that nanographene could load VEGF effectively, and the accumulative release of VEGF clearly increased during the entire testing period (9 days) without burst release. In canine fracture models, the results of X-ray, microangiography, and histopathologic examination proved that the speed of fracture healing, new bone formation area, and revascularization of the fractured femoral heads in the VEGF-loaded coated screws groups were significantly higher than in the control groups. Conclusion Our study proved that VEGF-loaded nanographene coated screws were effective in the treatment of femoral neck fracture and prevention of avascular necrosis of femoral head.	[Li, Shuo; Yuan, Hengfeng; Pan, Jianfeng; Fan, Wenshuai; Zhu, Liang; Yan, Zuoqin; Guo, Changan] Fudan Univ, Dept Orthoped, Shanghai, Peoples R China	Fudan University	Guo, CG (corresponding author), Fudan Univ, Dept Orthoped, Shanghai, Peoples R China.	caguozsyygk@gmail.com	Li, Shuo/GXV-6545-2022; Yan, Zuoqin/AAZ-2059-2020		Science and Technology Commission of Shanghai Municipality [124119a7500]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The study was funded by Science and Technology Commission of Shanghai Municipality-124119a7500.	Bachiller F G, CLIN ORTHOP RELAT RE, P87; Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Clarkin CE, 2013, CELL BIOCHEM FUNCT, V31, P1, DOI 10.1002/cbf.2911; Davidovitch RI, 2010, J TRAUMA, V68, P236, DOI 10.1097/TA.0b013e3181c428ce; Ehlinger M, 2011, ORTHOP TRAUMATOL-SUR, V97, P79, DOI 10.1016/j.otsr.2010.06.014; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; Gothard D, 2014, EUR CELLS MATER, V28, P166, DOI 10.22203/eCM.v028a13; Grabherr S, 2008, MICROSC RES TECHNIQ, V71, P551, DOI 10.1002/jemt.20585; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Hu K, 2016, J CLIN INVEST, V126, P509, DOI 10.1172/JCI82585; Isner JM, 1996, LANCET, V348, P370, DOI 10.1016/S0140-6736(96)03361-2; Keramaris NC, 2008, INJURY, V39, pS45, DOI 10.1016/S0020-1383(08)70015-9; Kim J, 2013, J BIOMED MATER RES A, V101, P3520, DOI 10.1002/jbm.a.34659; Kumar MN, 2014, ORTHOPEDICS, V37, pE563, DOI 10.3928/01477447-20140528-57; La WG, 2013, SMALL, V9, DOI 10.1002/smll.201300571; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c; Li N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01604; Li T, 2016, ACS APPL MATER INTER, V8, P31311, DOI 10.1021/acsami.6b09915; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; Nyangoga H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017336; Papakostidis C, 2015, INJURY, V46, P459, DOI 10.1016/j.injury.2014.12.025; Ramanathan T, 2008, NAT NANOTECHNOL, V3, P327, DOI 10.1038/nnano.2008.96; Stegen S, 2015, BONE, V70, P19, DOI 10.1016/j.bone.2014.09.017; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8; Takahashi Y, 1996, CLIN CANCER RES, V2, P1679; Yuan HF, 2015, INT ORTHOP, V39, P1417, DOI 10.1007/s00264-015-2709-7; Zhang XY, 2016, SMALL, V12, P3578, DOI 10.1002/smll.201600618; Zhao DW, 2016, MICROSURG, V36, P426, DOI 10.1002/micr.30029	30	3	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187447	10.1371/journal.pone.0187447	http://dx.doi.org/10.1371/journal.pone.0187447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117211	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600040
J	McGovern, AM; Androga, GO; Knight, DR; Watson, MW; Elliott, B; Foster, NF; Chang, BJ; Riley, TV				McGovern, Alan M.; Androga, Grace O.; Knight, Daniel R.; Watson, Mark W.; Elliott, Briony; Foster, Niki F.; Chang, Barbara J.; Riley, Thomas V.			Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027	PLOS ONE			English	Article							INFECTION; STRAINS; PATHOGENICITY; SURVEILLANCE; POPULATIONS; SEQUENCE; REVEALS; PATIENT; CALVES; PIGS	Virulence of Clostridium difficile is primarily attributed to the large clostridial toxins A and B while the role of binary toxin (CDT) remains unclear. The prevalence of human strains of C. difficile possessing only CDT genes (A(-)B(-)CDT(+)) is generally low (< 5%), however, this genotype is commonly found in neonatal livestock both in Australia and elsewhere. Zoonotic transmission of C. difficile has been suggested previously. Most human diagnostic tests will not detect A(-)B(-)CDT(+) strains of C. difficile because they focus on detection of toxin A and/or B. We performed a prospective investigation into the prevalence and genetic characteristics of A(-)B(-)CDT(+) C. difficile in symptomatic humans. All glutamate dehydrogenase or toxin B gene positive faecal specimens from symptomatic inpatients over 30 days (n = 43) were cultured by enrichment, and C. difficile PCR ribotypes (RTs) and toxin gene profiles determined. From 39 culture-positive specimens, 43 C. difficile isolates were recovered, including two A(-)B(-)CDT(+) isolates. This corresponded to an A(-)B(-)CDT(+) prevalence of 2/35 (5.7%) isolates possessing at least one toxin, 2/10 (20%) A(-)B(-) isolates, 2/3 CDT+ isolates and 1/28 (3.6%) presumed true CDI cases. No link to Australian livestock-associated C. difficile was found. Neither A(-)B(-)CDT(+) isolate was the predominant A(-)B(-)CDT(+) strain found in Australia, RT 033, nor did they belong to toxinotype Xl. Previous reports infrequently describe A(-)B(-)CDT(+) C. difficile in patients and strain collections but the prevalence of human A(-)B(-)CDT(+) C. difficile is rarely investigated. This study highlights the occurrence of A(-)B(-)CDT(+) strains of C. difficile in symptomatic patients, warranting further investigations of its role in human infection.	[McGovern, Alan M.; Androga, Grace O.; Knight, Daniel R.; Chang, Barbara J.] Univ Western Australia, Sch Biomed Sci, Perth, WA, Australia; [Androga, Grace O.; Foster, Niki F.; Riley, Thomas V.] PathWest Lab Med, Dept Microbiol, Perth, WA, Australia; [Watson, Mark W.] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia; [Elliott, Briony; Riley, Thomas V.] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia; [Riley, Thomas V.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia	University of Western Australia; Murdoch University; Edith Cowan University; Murdoch University	Riley, TV (corresponding author), PathWest Lab Med, Dept Microbiol, Perth, WA, Australia.; Riley, TV (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia.; Riley, TV (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia.	thomas.riley@uwa.edu.au	Knight, Daniel R./F-2522-2014	Knight, Daniel R./0000-0002-9480-4733; Riley, Thomas/0000-0002-1351-3740; Chang, Barbara/0000-0002-6077-1646; Androga, Grace O/0000-0002-8787-2375	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank Alere-Australia, for the provision of materials required for this study. This publication made use of the Clostridium difficile Multi Locus Sequence Typing website (https://pubmlst.org/cdifficiele/) developed by Keith Jolley and sited at the University of Oxford (Jolley & Maiden 2010, BMC Bioinformatics, 11:595). The development of this site has been funded by the Wellcome Trust. Results from this study were presented at the 41st Annual Scientific Meeting of the Australian Society for Microbiology, July 2016; Perth, Australia (Abstr A243).	Androga GO, 2015, J CLIN MICROBIOL, V53, P3702, DOI 10.1128/JCM.01810-15; Androga GO, 2015, J CLIN MICROBIOL, V53, P973, DOI 10.1128/JCM.03297-14; Behroozian AA, 2013, INFECT CONT HOSP EP, V34, P961, DOI 10.1086/671728; Carman RJ, 2012, J CLIN MICROBIOL, V50, P1425, DOI 10.1128/JCM.05600-11; Carter GP, 2007, J BACTERIOL, V189, P7290, DOI 10.1128/JB.00731-07; Carter GP, 2015, MBIO, V6, DOI 10.1128/mBio.00551-15; Collins DA, 2016, ANAEROBE, V37, P34, DOI 10.1016/j.anaerobe.2015.11.007; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Eckert C., 2015, New Microbes and New Infections, V3, P12, DOI 10.1016/j.nmni.2014.10.003; Elliott B, 2014, GENOME BIOL EVOL, V6, P3159, DOI 10.1093/gbe/evu248; Geric B, 2003, J CLIN MICROBIOL, V41, P5227, DOI 10.1128/JCM.41.11.5227-5232.2003; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Grandesso S, 2016, NEW MICROBIOL, V39, P235; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; HAMMOND GA, 1995, MICROB PATHOGENESIS, V19, P203, DOI 10.1016/S0882-4010(95)90263-5; Hell M, 2011, INFECTION, V39, P461, DOI 10.1007/s15010-011-0167-8; Janezic S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167101; KATO N, 1991, J CLIN MICROBIOL, V29, P33, DOI 10.1128/JCM.29.1.33-37.1991; Knight DR, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.11.017; Knight DR, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02138; Knight DR, 2015, APPL ENVIRON MICROB, V81, P119, DOI 10.1128/AEM.03032-14; Knight DR, 2014, J CLIN MICROBIOL, V52, P3856, DOI 10.1128/JCM.01225-14; Knight DR, 2013, APPL ENVIRON MICROB, V79, P2630, DOI 10.1128/AEM.03951-12; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; Moono P, 2016, ANAEROBE, V37, P62, DOI 10.1016/j.anaerobe.2015.11.012; Nagaro KJ, 2013, ANTIMICROB AGENTS CH, V57, P5266, DOI 10.1128/AAC.00580-13; Rupnik M, 2016, J CLIN MICROBIOL, V54, P13, DOI 10.1128/JCM.02083-15; Schneeberg A, 2013, J MED MICROBIOL, V62, P1190, DOI 10.1099/jmm.0.056473-0; Spigaglia P, 2016, ANAEROBE, V37, P29, DOI 10.1016/j.anaerobe.2015.11.002; van den Berg RJ, 2005, J MED MICROBIOL, V54, P173, DOI 10.1099/jmm.0.45825-0; Wroblewski D, 2009, J CLIN MICROBIOL, V47, P2142, DOI 10.1128/JCM.02498-08; Zidaric V, 2012, APPL ENVIRON MICROB, V78, P8515, DOI 10.1128/AEM.02185-12	34	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187658	10.1371/journal.pone.0187658	http://dx.doi.org/10.1371/journal.pone.0187658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117204	gold, Green Submitted, Green Published			2022-12-26	WOS:000414659600057
J	Konerman, MA; Lu, DX; Zhang, YW; Thomson, M; Zhu, J; Verma, A; Liu, DT; Talaat, N; Balis, U; Higgins, PDR; Lok, ASF; Waljee, AK				Konerman, Monica A.; Lu, Dongxia; Zhang, Yiwei; Thomson, Mary; Zhu, Ji; Verma, Aashesh; Liu, Doting; Talaat, Nizar; Balis, Ulysses; Higgins, Peter D. R.; Lok, Anna S. F.; Waljee, Akbar K.			Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C	PLOS ONE			English	Article							DISEASE PROGRESSION; PREDICTIVE MODELS	Objective Assessing risk of adverse outcomes among patients with chronic liver disease has been challenging due to non-linear disease progression. We previously developed accurate prediction models for fibrosis progression and clinical outcomes among patients with advanced chronic hepatitis C (CHC). The primary aim of this study was to validate fibrosis progression and clinical outcomes models among a heterogeneous patient cohort. Design Adults with CHC with >= 3 years follow-up and without hepatic decompensation, hepatocellular carcinoma (HCC), liver transplant (LT), HBV or HIV co-infection at presentation were analyzed (N = 1007). Outcomes included: 1) fibrosis progression 2) hepatic decompensation 3) HCC and 4) LT-free survival. Predictors included longitudinal clinical and laboratory data. Machine learning methods were used to predict outcomes in 1 and 3 years. Results The external cohort had a median age of 49.4 years (IQR 44.3-54.3); 61% were male, 80% white, and 79% had genotype 1. At presentation, 73% were treatment naive and 31% had cirrhosis. Fibrosis progression occurred in 34% over a median of 4.9 years (IQR 3.2-7.6). Clinical outcomes occurred in 22% over a median of 4.4 years (IQR 3.2-7.6). Model performance for fibrosis progression was limited due to small sample size. The area under the receiver operating characteristic curve (AUROC) for 1 and 3-year risk of clinical outcomes was 0.78 (95% CI 0.73-0.83) and 0.76 (95% Cl 0.69-0.81). Conclusion Accurate assessments for risk of clinical outcomes can be obtained using routinely collected data across a heterogeneous cohort of patients with CHC. These methods can be applied to predict risk of progression in other chronic liver diseases.	[Konerman, Monica A.; Lu, Dongxia; Zhang, Yiwei; Thomson, Mary; Zhu, Ji; Liu, Doting; Talaat, Nizar; Higgins, Peter D. R.; Lok, Anna S. F.; Waljee, Akbar K.] Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA; [Verma, Aashesh] Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI USA; [Balis, Ulysses] Univ Michigan Hlth Syst, Div Pathol, Ann Arbor, MI USA; [Waljee, Akbar K.] VA Ann Arbor Hlth Serv Res & Dev, Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Konerman, MA (corresponding author), Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA.	konerman@med.umich.edu	Tincopa, Monica/AAK-7187-2021; zhu, ji/HDM-1538-2022; Waljee, Akbar K/G-2067-2010	Waljee, Akbar K/0000-0003-1964-8790; Balis, Ulysses/0000-0002-4168-1477	National Institutes of Health [T32DK062708]; MSLD Advanced/Transplant Hepatology Fellowship; NIH [R01 GM097117]; United States (U.S.) Department of Veterans Affairs Health Services Research and Development Service [CDA 11-217]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSLD Advanced/Transplant Hepatology Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States (U.S.) Department of Veterans Affairs Health Services Research and Development Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in part by the National Institutes of Health T32DK062708 training grant and the MSLD Advanced/Transplant Hepatology Fellowship (MAK). Dr. Higgins is supported by the NIH R01 GM097117. Dr. Waljee's research is funded by a Career Development Award (CDA 11-217) from the United States (U.S.) Department of Veterans Affairs Health Services Research and Development Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua S, 2015, ANN INTERNAL MED; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; El-Serag HB, 2016, HEPATOLOGY, V64, P130, DOI 10.1002/hep.28535; Friedman J., 1998, ANN STAT, V28, P2000; Goossens N, 2014, CLIN LIVER DIS, V18, P147, DOI 10.1016/j.cld.2013.09.007; Kanwal F, 2014, HEPATOLOGY, V60, P98, DOI 10.1002/hep.27095; Konerman MA, 2014, ALIMENT PHARM THER, V40, P863, DOI 10.1111/apt.12921; Konerman MA, 2016, J VIRAL HEPATITIS; Konerman MA, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.50; Konerman MA, 2015, HEPATOLOGY, V61, P1832, DOI 10.1002/hep.27750; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lee WM, 2004, CONTROL CLIN TRIALS, V25, P472, DOI 10.1016/j.cct.2004.08.003; Menze BH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-213; Neff Guy W, 2011, Gastroenterol Hepatol (N Y), V7, P661; Schapire RE, 2003, LECT NOTES STAT, V171, P149, DOI 10.1007/978-0-387-21579-2_9; Sinn DH, 2008, LIVER INT, V28, P1363, DOI 10.1111/j.1478-3231.2008.01860.x; Therapeutics J., 2013, FULL PRESCRIBING INF; WALJEE AK, 2014, CLIN TRANSL GASTROEN, V5; Waljee AK, 2013, BMJ OPEN, P3; Waljee AK, 2010, AM J GASTROENTEROL, V105, P1224, DOI 10.1038/ajg.2010.173; World Health Organization, TOP 10 CAUS DEATH	22	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187344	10.1371/journal.pone.0187344	http://dx.doi.org/10.1371/journal.pone.0187344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108017	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600026
J	Burstein, O; Franko, M; Gale, E; Handelsman, A; Barak, S; Motsan, S; Shamir, A; Toledano, R; Simhon, O; Hirshler, Y; Chen, G; Doron, R				Burstein, Or; Franko, Motty; Gale, Eyal; Handelsman, Assaf; Barak, Segev; Motsan, Shai; Shamir, Alon; Toledano, Roni; Simhon, Omri; Hirshler, Yafit; Chen, Gang; Doron, Ravid			Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ANIMAL-MODELS; NEUROTROPHIC FACTOR; MAJOR DEPRESSION; DOPAMINE RELEASE; HERBAL TREATMENT; REMISSION RATES; MILD STRESS; ALCOHOL; ANTIDEPRESSANT	Anhedonia is defined as a diminished ability to obtain pleasure from otherwise positive stimuli. Anxiety and mood disorders have been previously associated with dysregulation of the reward system, with anhedonia as a core element of major depressive disorder (MDD). The aim of the present study was to investigate whether stress-induced anhedonia could be prevented by treatments with escitalopram or novel herbal treatment (NHT) in an animal model of depression. Unpredictable chronic mild stress (UCMS) was administered for 4 weeks on ICR outbred mice. Following stress exposure, animals were randomly assigned to pharmacological treatment groups (i.e., saline, escitalopram or NHT). Treatments were delivered for 3 weeks. Hedonic tone was examined via ethanol and sucrose preferences. Biological indices pertinent to MDD and anhedonia were assessed: namely, hippocampal brain-derived neurotrophic factor (BDNF) and striatal dopamine receptor D2 (Drd2) mRNA expression levels. The results indicate that the UCMS-induced reductions in ethanol or sucrose preferences were normalized by escitalopram or NHT. This implies a resemblance between sucrose and ethanol in their hedonic-eliciting property. On a neurobiological aspect, UCMS-induced reduction in hippocampal BDNF levels was normalized by escitalopram or NHT, while UCMS-induced reduction in striatal Drd2 mRNA levels was normalized solely by NHT. The results accentuate the association of stress and anhedonia, and pinpoint a distinct effect for NHT on striatal Drd2 expression.	[Burstein, Or; Franko, Motty; Motsan, Shai; Toledano, Roni; Simhon, Omri; Doron, Ravid] Acad Coll Tel Aviv Yaffo, Sch Behav Sci, Tel Aviv, Israel; [Burstein, Or; Gale, Eyal; Hirshler, Yafit; Doron, Ravid] Open Univ, Dept Educ & Psychol, Raanana, Israel; [Handelsman, Assaf; Barak, Segev] Tel Aviv Univ, Sch Psychol Sci, Tel Aviv, Israel; [Handelsman, Assaf; Barak, Segev] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Shamir, Alon] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Shamir, Alon] Mazor Mental Hlth Ctr, Akko, Israel; [Chen, Gang] Nanjing Univ Chinese Med, Ctr Translat Syst Biol & Neurosci, Nanjing, Jiangsu, Peoples R China; [Chen, Gang] Nanjing Univ Chinese Med, Key Lab Integrat Biomed Brain Dis, Nanjing, Jiangsu, Peoples R China	Open University Israel; Tel Aviv University; Tel Aviv University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Doron, R (corresponding author), Acad Coll Tel Aviv Yaffo, Sch Behav Sci, Tel Aviv, Israel.; Doron, R (corresponding author), Open Univ, Dept Educ & Psychol, Raanana, Israel.	raviddor@mta.ac.il	Barak, Segev/ABG-4080-2020	Barak, Segev/0000-0002-3143-6777; Burstein, Or/0000-0003-2638-8018	Israel Science Foundation (ISF) [738/11]; National Institute for Psychobiology in Israel (NIPI) [7-2011-12]; Open University of Israel	Israel Science Foundation (ISF)(Israel Science Foundation); National Institute for Psychobiology in Israel (NIPI); Open University of Israel	Funding for this study was provided by the Israel Science Foundation (ISF, http://www.isf.org.il, Grant 738/11), by the National Institute for Psychobiology in Israel (NIPI, http://www.psychobiology.org.il, Grant 7-2011-12) and by the Open University of Israel research fund (http://www.openu.ac.il) (all funds received by R.D.); the ISF, NIPI and the Open University of Israel had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2011, COMMUNICATION; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Becker HC, 2013, CURR TOP BEHAV NEURO, V13, P355, DOI 10.1007/7854_2012_203; Belzung C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-9; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; Bessa JM, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.39; Bjornebekk A, 2007, NEUROREPORT, V18, P1039; Blum K., 2014, ANHEDONIA COMPREHENS, P179, DOI [10.1007/978-94-017-8591-4_9, DOI 10.1007/978-94-017-8591-4_9]; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Carnicella S, 2014, ALCOHOL, V48, P243, DOI 10.1016/j.alcohol.2014.01.006; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Chen ACH, 2001, BIOL PSYCHIAT, V49, P753, DOI 10.1016/S0006-3223(00)01114-8; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chourbaji S, 2011, NEUROSCI BIOBEHAV R, V35, P599, DOI 10.1016/j.neubiorev.2010.07.003; Cicero TJ, 1979, BIOCH PHARM ETHANOL, P533; Clayton AH, 2002, J CLIN PSYCHIAT, V63, P357, DOI 10.4088/JCP.v63n0414; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Der-Avakian A, 2012, TRENDS NEUROSCI, V35, P68, DOI 10.1016/j.tins.2011.11.005; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Doron R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091455; Doron R, 2014, LIFE SCI, V94, P151, DOI 10.1016/j.lfs.2013.10.025; Doron R, 2012, LIFE SCI, V90, P995, DOI 10.1016/j.lfs.2012.05.014; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Dziedzicka-Wasylewska M, 1997, BEHAV PHARMACOL, V8, P607, DOI 10.1097/00008877-199711000-00017; Ebert D, 1996, PSYCHOPHARMACOLOGY, V126, P91, DOI 10.1007/BF02246416; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Grant KA, 2003, PHARMACOL THERAPEUT, V100, P235, DOI 10.1016/j.pharmthera.2003.08.004; HRUSKA RE, 1988, J NEUROCHEM, V50, P1929, DOI 10.1111/j.1471-4159.1988.tb02499.x; Jansen K, 2016, ACTA PSYCHIAT SCAND, V134, P281, DOI 10.1111/acps.12551; Kasch KL, 2002, J ABNORM PSYCHOL, V111, P589, DOI 10.1037//0021-843X.111.4.589; KATZ RJ, 1982, PHARMACOL BIOCHEM BE, V16, P965, DOI 10.1016/0091-3057(82)90053-3; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Keane H., 2009, Critical Public Health, V19, P135, DOI 10.1080/09581590802350957; Keltner NL, 2002, PERSPECT PSYCHIATR C, V38, P111; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Klimke A, 1999, PSYCHIAT RES-NEUROIM, V90, P91, DOI 10.1016/S0925-4927(99)00009-8; Larisch R, 1997, NEUROIMAGE, V5, P251, DOI 10.1006/nimg.1997.0267; Licinio J, 2009, ARCH GEN PSYCHIAT, V66, P488, DOI 10.1001/archgenpsychiatry.2009.38; Loas G, 1996, J AFFECT DISORDERS, V41, P39, DOI 10.1016/0165-0327(96)00065-1; Lutz CM, 2012, LABORATORY MOUSE, P37, DOI 10.1016/B978-0-12-382008-2.00003-9; Malone DA, 2009, BIOL PSYCHIAT, V65, P267, DOI 10.1016/j.biopsych.2008.08.029; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; Molendijk ML, 2014, MOL PSYCHIATR, V19, P791, DOI 10.1038/mp.2013.105; Moraga-Amaro R, 2014, J PHYSIOL-PARIS, V108, P240, DOI 10.1016/j.jphysparis.2014.08.005; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nollet M., 2013, CURR PROTOC PHARM; Oswald LM, 2005, NEUROPSYCHOPHARMACOL, V30, P821, DOI 10.1038/sj.npp.1300667; Overstreet DH, 2005, NEUROSCI BIOBEHAV R, V29, P739, DOI 10.1016/j.neubiorev.2005.03.015; Owens MJ, 2001, BIOL PSYCHIAT, V50, P345, DOI 10.1016/S0006-3223(01)01145-3; Palm S, 2011, ALCOHOL, V45, P607, DOI 10.1016/j.alcohol.2010.11.005; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Pardo M, 2015, PSYCHOPHARMACOLOGY, V232, P2377, DOI 10.1007/s00213-015-3872-7; Paredes RG, 2004, PROG NEUROBIOL, V73, P179, DOI 10.1016/j.pneurobio.2004.05.001; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; Pizzagalli DA, 2014, ANNU REV CLIN PSYCHO, V10, P393, DOI 10.1146/annurev-clinpsy-050212-185606; Quesseveur G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.30; Sanchez C, 2003, PSYCHOPHARMACOLOGY, V167, P353, DOI 10.1007/s00213-002-1364-z; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Smith JW, 1996, BR J PHARM, V118; Smith JW, 1996, EUR NEUROPSYCHOPHARM, V6, pS4; Spanagel R, 2003, BEST PRACT RES CL GA, V17, P507, DOI 10.1016/S1521-6918(03)00031-3; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Surget A, 2009, EXPT ANIMAL MODELS N, P79; Thase ME, 2005, J CLIN PSYCHIAT, V66, P974, DOI 10.4088/JCP.v66n0803; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; Timofeeva E, 2013, SUCROSE PROPERTIES B, P75; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Vrieze E, 2014, J AFFECT DISORDERS, V155, P35, DOI 10.1016/j.jad.2013.10.020; Willner P, 2005, J AFFECT DISORDERS, V86, P37, DOI 10.1016/j.jad.2004.12.010; WILLNER P, 1984, PSYCHOPHARMACOLOGY, V83, P1, DOI 10.1007/BF00427414; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; WISE RA, 1995, PSYCHOPHARMACOLOGY, V120, P10, DOI 10.1007/BF02246140; Yoneyama N, 2008, ALCOHOL, V42, P149, DOI 10.1016/j.alcohol.2007.12.006; YOSHIMOTO K, 1992, ALCOHOL, V9, P17, DOI 10.1016/0741-8329(92)90004-T; Zhang Y, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv006; Zhu XZ, 2011, BEHAV BRAIN RES, V223, P329, DOI 10.1016/j.bbr.2011.04.052; Zipori D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02177-2	89	23	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188043	10.1371/journal.pone.0188043	http://dx.doi.org/10.1371/journal.pone.0188043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29141007	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400047
J	Stroffolini, T; Sagnelli, E; Andriulli, A; Colloredo, G; Furlan, C; Gaeta, GB; Morisco, F; Pirisi, M; Rosina, F; Sagnelli, C; Smedile, A; Almasio, PL				Stroffolini, Tommaso; Sagnelli, Evangelista; Andriulli, Angelo; Colloredo, Guido; Furlan, Caterina; Gaeta, Giovanni Battista; Morisco, Filomena; Pirisi, Mario; Rosina, Floriano; Sagnelli, Caterina; Smedile, Antonina; Almasio, Piero Luigi		EPACRON Study Grp	Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis	PLOS ONE			English	Article							LIVER-DISEASE; MULTICENTER PREVALENCE; INFECTION; CONSUMPTION; CLASSIFICATION; PROGRESSION; DIAGNOSIS; SEVERITY; FIBROSIS; CARRIERS	Background The joint effect of the interaction of alcohol intake, hepatitis B virus (HBV) and hepatitis C virus (HCV) on the risk of cirrhosis is still unexplored because a large sample size is required for this investigation. Objective Evaluation of interaction of HBV, HCV and alcohol abuse on the risk of cirrhosis. Design We analysed 12,262 consecutive patients with chronic liver disease of various aetiologies referring to 95 Italian liver units in 2001 or 2014. To evaluate the interaction between alcohol abuse, HBV infection, and HCV infection, patients unexposed to either factors were used as reference category. Adjustment for BMI and age was done by multiple logistic regression analysis. Results Females were older than males (p<0.01) and less frequently showed HBV and alcoholic aetiology (p<0.01). In both sexes, an overtime increasing age and an increasing proportion of subjects with liver cirrhosis was observed, reflecting a better survival (0.01). An additive interaction is observed in females: the O.R. generated by the simultaneous presence of HBV, HCV, and alcohol (5.09; 95% C.I. 1.06-24.56) exceeds the sum (4.14) of the O.R. generated by a single exposure (O.R. = 0.72 for HBsAg positivity, OR = 1.34 for anti-HCV positivity, and O.R. = 2.08 for alcohol intake). No interaction is observed in male sex. Conclusions The observed gender difference suggests that the simultaneous presence of HBV/HCV coinfection and risky alcohol intake enhances the mechanism of liver damage to a greater extent in females than in males.	[Stroffolini, Tommaso; Furlan, Caterina] Policlin Umberto 1, Dept Trop & Infect Dis, Rome, Italy; [Sagnelli, Evangelista; Sagnelli, Caterina] Campania Univ Luigi Vanvitelli, Dept Mental Hlth & Publ Med, Naples, Italy; [Andriulli, Angelo] Casa Sollievo Sofferenza Hosp, IRCCS, Div Gastroenterol, San Giovanni Rotondo, Italy; [Colloredo, Guido] San Pietro Hosp, Dept Internal Med, Ponte San Pietro, Italy; [Gaeta, Giovanni Battista] Campania Univ Luigi Vanvitelli, Dept Mental & Phys Hlth & Prevent Med, Infect Dis, Naples, Italy; [Morisco, Filomena] Univ Naples Federico II, Dept Clin Med & Surg, Gastroenterol Unit, Naples, Italy; [Pirisi, Mario] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; [Rosina, Floriano] Hosp G Garibaldi Catania, Liver Unit, Catania, Italy; [Smedile, Antonina] Univ Turin, Dept Med Sci, Liver Physiopathol Lab, Turin, Italy; [Almasio, Piero Luigi] Univ Palermo, Biomed Dept Internal Med & Special DiBiMIS, Palermo, Italy	Sapienza University Rome; University Hospital Sapienza Rome; Universita della Campania Vanvitelli; IRCCS Casa Sollievo Della Sofferenza; Universita della Campania Vanvitelli; University of Naples Federico II; University of Eastern Piedmont Amedeo Avogadro; University of Turin; University of Palermo	Almasio, PL (corresponding author), Univ Palermo, Biomed Dept Internal Med & Special DiBiMIS, Palermo, Italy.	piero.almasio@unipa.it	Pirisi, Mario/ABF-2102-2020; Gaeta, Giovanni/AAQ-4294-2021; Morisco, Filomena/AHI-0851-2022; Sagnelli, Caterina/AAD-4950-2022	Sagnelli, Caterina/0000-0002-6413-7810; Pirisi, Mario/0000-0001-9740-0155; Crisanti, Andrea/0000-0002-2406-4426	Gilead Sciences	Gilead Sciences(Gilead Sciences)	The unrestricted grant offered by Gilead Sciences was used exclusively for the overheads of the study. Author who received the funding is Professor Piero Luigi Almasio. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PC, 1998, GASTROENTEROLOGY, V114, P319, DOI 10.1016/S0016-5085(98)70483-4; Aloman C, 2007, GASTROENTEROLOGY, V132, P698, DOI 10.1053/j.gastro.2006.11.016; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Bissell DM, 1999, HEPATOLOGY, V29, P988, DOI 10.1002/hep.510290351; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Corrao G, 1998, HEPATOLOGY, V27, P914, DOI 10.1002/hep.510270404; Di Marco V, 1999, HEPATOLOGY, V30, P257, DOI 10.1002/hep.510300109; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Gaeta GB, 2003, J HEPATOL, V39, P1036, DOI 10.1016/S0168-8278(03)00470-7; Gaiani S, 1997, J HEPATOL, V27, P979, DOI 10.1016/S0168-8278(97)80140-7; Lin S, 2017, VIRUSES, V18; Loguercio C, 2003, FREE RADICAL BIO MED, V34, P1, DOI 10.1016/S0891-5849(02)01167-X; MCMAHON BJ, 1990, ARCH INTERN MED, V150, P1051, DOI 10.1001/archinte.150.5.1051; Ostapowicz G, 1998, HEPATOLOGY, V27, P1730, DOI 10.1002/hep.510270637; PARES A, 1990, HEPATOLOGY, V12, P1295, DOI 10.1002/hep.1840120608; Pianko S, 2000, J GASTROEN HEPATOL, V15, P798, DOI 10.1046/j.1440-1746.2000.02083.x; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Sagnelli E, 2000, HEPATOLOGY, V32, P1106, DOI 10.1053/jhep.2000.19288; Sagnelli E, 2005, J MED VIROL, V75, P522, DOI 10.1002/jmv.20313; Sagnelli E, 2016, DIGEST LIVER DIS, V48, P1066, DOI 10.1016/j.dld.2016.05.014; Stroffolini T, 2006, J VIRAL HEPATITIS, V13, P351, DOI 10.1111/j.1365-2893.2005.00690.x; Stroffolini T, 2015, J MED VIROL, V87, P1899, DOI 10.1002/jmv.24243; Stroffolini T, 2010, LIVER INT, V30, P867, DOI 10.1111/j.1478-3231.2010.02261.x; TAAL BG, 1983, HEPATO-GASTROENTEROL, V30, P178; Zarski JP, 1998, J HEPATOL, V28, P27, DOI 10.1016/S0168-8278(98)80198-0	27	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0185710	10.1371/journal.pone.0185710	http://dx.doi.org/10.1371/journal.pone.0185710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140988	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400002
J	Fujishima, H; Fumoto, S; Shibata, T; Nishiki, K; Tsukamoto, Y; Etoh, T; Moriyama, M; Shiraishi, N; Inomata, M				Fujishima, Hajime; Fumoto, Shoichi; Shibata, Tomotaka; Nishiki, Kohei; Tsukamoto, Yoshiyuki; Etoh, Tsuyoshi; Moriyama, Masatsugu; Shiraishi, Norio; Inomata, Masafumi			A 17-molecule set as a predictor of complete response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer	PLOS ONE			English	Article							PERIOPERATIVE CHEMOTHERAPY; TRIMODALITY THERAPY; GENE-EXPRESSION; FLUOROURACIL; SENSITIVITY; CARCINOMA; SURGERY; CHEMORADIOTHERAPY; CHEMOSENSITIVITY; PHARMACOGENOMICS	Background Recently, neoadjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil (NAC-DCF) was identified as a novel strong regimen with a high rate of pathological complete response (pCR) in advanced esophageal cancer in Japan. Predicting pCR will contribute to the therapeutic strategy and the prevention of surgical invasion. However, a predictor of pCR after NAC-DCF has not yet been developed. The aim of this study was to identify a novel predictor of pCR in locally advanced esophageal cancer treated with NAC-DCF. Patients and methods A total of 32 patients who received NAC-DCF followed by esophagectomy between June 2013 and March 2016 were enrolled in this study. We divided the patients into the following 2 groups: pCR group (9 cases) and non-pCR group (23 cases), and compared gene expressions between these groups using DNA microarray data and KeyMolnet. Subsequently, a validation study of candidate molecular expression was performed in 7 additional cases. Results Seventeen molecules, including transcription factor E2F, T-cell-specific transcription factor, Src (known as "proto-oncogene tyrosine-protein kinase of sarcoma-), interferon regulatory factor 1, thymidylate synthase, cyclin B, cyclin-dependent kinase (CDK) 4, CDK, caspase-1, vitamin D receptor, histone deacetylase, MAPK/ERK kinase, bcl-2-associated X protein, runt-related transcription factor 1, PR domain zinc finger protein 1, platelet-derived growth factor receptor, and interleukin 1, were identified as candidate molecules. The molecules were mainly associated with pathways, such as transcriptional regulation by SMAD, RB/E2F, and STAT. The validation study indicated that 12 of the 17 molecules (71%) matched the trends of molecular expression. Conclusions A 17-molecule set that predicts pCR after NAC-DCF for locally advanced esophageal cancer was identified.	[Fujishima, Hajime; Shibata, Tomotaka; Etoh, Tsuyoshi; Inomata, Masafumi] Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, Oita, Japan; [Fumoto, Shoichi; Nishiki, Kohei] Oita Nakamura Hosp, Dept Surg, Oita, Japan; [Tsukamoto, Yoshiyuki; Moriyama, Masatsugu] Oita Univ, Dept Mol Pathol, Fac Med, Oita, Japan; [Shiraishi, Norio] Oita Univ, Fac Med, Comprehens Surg Community Med, Oita, Japan	Oita University; Oita University; Oita University	Fujishima, H (corresponding author), Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, Oita, Japan.	hajime-f@oita-u.ac.jp		Fujishima, Hajime/0000-0002-0858-8967	Grants-in-Aid for Scientific Research [15K08405, 15K10106] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adenis A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-413; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Ando T, 2008, DIS ESOPHAGUS, V21, P15, DOI 10.1111/j.1442-2050.2007.00700.x; Bancewicz J, 2002, LANCET, V359, P1727; Batchu RB, 2014, PHARMACEUTICALS, V7, P46, DOI 10.3390/ph7010046; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Empuku S, 2016, MOL CLIN ONCOL, V4, P733, DOI 10.3892/mco.2016.806; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fumoto S, 2008, INT J ONCOL, V32, P413; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058453; Hara H, 2013, CANCER SCI, V104, P1455, DOI 10.1111/cas.12274; Harpole DH, 2001, CLIN CANCER RES, V7, P562; Hato SV, 2017, ONCOTARGET; Hiyoshi Y, 2017, WORLD J SURG, V41, P480, DOI 10.1007/s00268-016-3649-0; Huang RW, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-170; Japan Esophageal Soc, 2017, ESOPHAGUS-TOKYO, V14, P37, DOI 10.1007/s10388-016-0556-2; Japan Esophageal Soc, 2017, ESOPHAGUS-TOKYO, V14, P1, DOI 10.1007/s10388-016-0551-7; Joshi MBM, 2005, CLIN CANCER RES, V11, P2215; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kitagawa Y, 2015, ASIAN J ENDOSC SURG, V8, P114, DOI 10.1111/ases.12185; Kurtyka CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096357; Kuzuhara T, 2007, J CANCER RES CLIN, V133, P287, DOI 10.1007/s00432-006-0169-6; Li L, 2015, ONCOL REP, V34, P2325, DOI 10.3892/or.2015.4211; Liu JK, 2015, BRAIN RES, V1610, P1, DOI 10.1016/j.brainres.2015.03.044; McLeod HL, 2001, ANNU REV PHARMACOL, V41, P101, DOI 10.1146/annurev.pharmtox.41.1.101; Molena D, 2014, DIS ESOPHAGUS, V27, P355, DOI 10.1111/dote.12126; Mori R, 2008, ONCOL REP, V20, P1345, DOI 10.3892/or_00000150; Nakano J, 2006, BRIT J CANCER, V95, P607, DOI 10.1038/sj.bjc.6603297; Nomura M, 2015, CANCER CHEMOTH PHARM, V76, P357, DOI 10.1007/s00280-015-2806-8; Ojima T, 2016, ANTICANCER RES, V36, P829; Reed MF, 2007, J SURG RES, V142, P364, DOI 10.1016/j.jss.2007.03.038; Romano G, 2016, ONCOTARGET, V7, P22077, DOI 10.18632/oncotarget.7895; Satoh J, 2009, NEUROPATH APPL NEURO, V35, P16, DOI 10.1111/j.1365-2990.2008.00947.x; Satoh J, 2007, NEUROSCI LETT, V422, P30, DOI 10.1016/j.neulet.2007.05.056; Satoh J, 2015, J CENT NERV SYST DIS, V7, P1, DOI [10.4137/JCNSNSD.S23210, 10.4137/JCNSD.S23210]; Smit JK, 2013, RADIOTHER ONCOL, V107, P434, DOI 10.1016/j.radonc.2013.03.027; Sohda M, 2014, ANTICANCER RES, V34, P909; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Sun ZF, 2006, CANCER EPIDEM BIOMAR, V15, P2063, DOI 10.1158/1055-9965.EPI-06-0505; Tanaka Y, 2012, ASIAN J ENDOSC SURG, V5, P179, DOI [10.1111/j.1758-5910.2012.00147.x, 10.1111/j.1758-5910.2012.00131.x]; Wang W, 2014, THORAC CANCER, V5, P139, DOI 10.1111/1759-7714.12061; Wang Y, 2007, CANCER RES, V67, P2535, DOI 10.1158/0008-5472.CAN-06-3530; Watanabe M, 2014, ANN SURG ONCOL, V21, P2838, DOI 10.1245/s10434-014-3684-8; Wendling J, 2003, MOL PHARMACOL, V64, P707, DOI 10.1124/mol.64.3.707; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597	46	8	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188098	10.1371/journal.pone.0188098	http://dx.doi.org/10.1371/journal.pone.0188098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136005	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200065
J	Talsness, CE; Penders, J; Jansen, EHJM; Damoiseaux, J; Thijsl, C; Mommers, M				Talsness, Chris E.; Penders, John; Jansen, Eugene H. J. M.; Damoiseaux, Jan; Thijsl, Carel; Mommers, Monique			Influence of vitamin D on key bacterial taxa in infant microbiota in the KOALA Birth Cohort Study	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; IMMUNE-SYSTEM; DISEASE; ASTHMA	Vitamin D has immunomodulatory properties giving it the potential to affect microbial colonization of the intestinal tract. We investigated whether maternal vitamin D supplemention, maternal plasma 25-hydroxyvitamin D concentration, or direct supplementation of the infant influences key bacterial taxa within microbiota of one month old infants. Infant and maternal vitamin D supplement use was ascertained via questionnaires. Maternal plasma 25-hydroxyvitamin D was determined at approximately the 36th week of pregnancy. In 913 one month old infants in the prospective KOALA Birth Cohort Study, fecal Bifidobacterium spp., Escherichia coli, Clostridium difficile, Bacteroides fragilis group, Lactobacillus spp. and total bacteria were quantified with real-time polymerase chain reaction assays targeting 16S rRNA gene sequences. The association between vitamin D exposure and prevalence or abundance of a specific bacterial group or species was analyzed using logistic or linear regression, respectively. There was a statistically significant negative linear trend between counts of Bifidobacterium spp. and levels of maternal vitamin D supplementation and maternal 25-hydroxyvitamin D quintiles, respectively. In addition, a positive linear trend between quintile groups and B. fragilis group counts was observed. Lower counts of C. difficile were associated with vitamin D supplementation of breast fed infants whose mothers were more likely to adhere to an alternative lifestyle in terms of, e.g., dietary habits. These data suggest that vitamin D influences the abundance of several key bacterial taxa within the infant microbiota. Given that intestinal microbiotic homeostasis may be an important factor in the prevention of immune mediated diseases and that vitamin D status is a modifiable factor, further investigation of the impact of postnatal vitamin D supplementation should be conducted in older infants.	[Talsness, Chris E.; Thijsl, Carel; Mommers, Monique] Maastricht Univ, CAPHRI, Dept Epidemiol, Maastricht, Netherlands; [Penders, John] Maastricht Univ, Med Ctr, CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Jansen, Eugene H. J. M.] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, Bilthoven, Netherlands; [Damoiseaux, Jan] Maastricht Univ, Lab Clin Immunol, Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Netherlands National Institute for Public Health & the Environment; Maastricht University	Mommers, M (corresponding author), Maastricht Univ, CAPHRI, Dept Epidemiol, Maastricht, Netherlands.	monique.mommers@maastrichtuniversity.nl	Damoiseaux, Jan/B-8993-2009; Penders, John/A-1280-2011; Thijs, Carel/H-8340-2019	Damoiseaux, Jan/0000-0003-4007-6985; Penders, John/0000-0001-9146-5919; Thijs, Carel/0000-0001-6646-5458	Royal Friesland Foods; Triodos Foundation; Phoenix Foundation; Raphael Foundation; lona Foundation; Foundation for the Advancement of Heilpedagogie; Louis Bolk Institute; Dutch Asthma Foundation [3.2.03.48]; Dutch Ministry of Public Health, Welfare and Sport	Royal Friesland Foods; Triodos Foundation; Phoenix Foundation; Raphael Foundation; lona Foundation; Foundation for the Advancement of Heilpedagogie; Louis Bolk Institute; Dutch Asthma Foundation; Dutch Ministry of Public Health, Welfare and Sport	Recruitment of participants and collection of biosamples for this study was supported by Royal Friesland Foods (http://www.frieslandcampina.com/english/), Triodos Foundation (http://www:triodos.com/en/about-triodos-bank/who-we-are/triodos-foundation/), Phoenix Foundation, Raphael Foundation (http://www.raphaelsitchting.nI/), lona Foundation (http://www.iona.nI/), the Foundation for the Advancement of Heilpedagogie (http://www.. heilpedagogie.nI/), and the Louis Bolk Institute (http://www.louisbolk.org/); microbial analyses were co-financed by the Dutch Asthma Foundation (grant 3.2.03.48) (now Lung Foundation https://www.longfonds.nI/); plasma vitamin D measurements were supported by the Dutch Ministry of Public Health, Welfare and Sport (http://www.government.nI/ministries/vws). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2004, J STEROID BIOCHEM, V89-90, P437, DOI 10.1016/j.jsbmb.2004.03.013; [Anonymous], 2002, GEZOND HLTH GUIDE DU, V32, P34; Bischoff SC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-24; Chun RF, 2008, J ENDOCRINOL, V198, P261, DOI 10.1677/JOE-08-0170; Cremers E, 2011, THORAX, V66, P474, DOI 10.1136/thx.2010.151985; Kaplan JL, 2011, PEDIATR RES, V69, P465, DOI 10.1203/PDR.0b013e318217638a; Kosiewicz MM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00180; Kummeling I, 2005, PEDIATR ALLERGY IMMU, V16, P679, DOI 10.1111/j.1399-3038.2005.00333.x; Lagishetty V, 2010, J STEROID BIOCHEM, V121, P228, DOI 10.1016/j.jsbmb.2010.02.004; Lagishetty V, 2010, ENDOCRINOLOGY, V151, P2423, DOI 10.1210/en.2010-0089; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Mai V, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-49; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; Peelen E, 2013, EUR J CLIN MICROBIOL, V32, P61, DOI 10.1007/s10096-012-1714-7; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Schwalfenberg GK, 2011, MOL NUTR FOOD RES, V55, P96, DOI 10.1002/mnfr.201000174; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Tedjo DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126685; Thacher TD, 2011, MAYO CLIN PROC, V86, P50, DOI 10.4065/mcp.2010.0567; Vassallo MF, 2010, J ALLERGY CLIN IMMUN, V126, P217, DOI 10.1016/j.jaci.2010.06.011; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Weiss ST, 2011, J ALLERGY CLIN IMMUN, V127, P1128, DOI 10.1016/j.jaci.2011.02.025; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	32	37	37	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0188011	10.1371/journal.pone.0188011	http://dx.doi.org/10.1371/journal.pone.0188011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121673	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900108
J	Boessenecker, RW; Ahmed, E; Geisler, JH				Boessenecker, Robert W.; Ahmed, Erum; Geisler, Jonathan H.			New records of the dolphin Albertocetus meffordorum (Odontoceti: Xenorophidae) from the lower Oligocene of South Carolina: Encephalization, sensory anatomy, postcranial morphology, and ontogeny of early odontocetes	PLOS ONE			English	Article							CETACEA MYSTICETI; NORTH-CAROLINA; BALEEN WHALE; NEW-ZEALAND; BODY-SIZE; ORIGIN; EOCENE; MIOCENE; ARCHAEOCETI; PLIOCENE	We report five new specimens of xenorophid dolphins from North and South Carolina. Four of the specimens represent the xenorophid Albertocetus meffordorum, previously only known from the holotype skull. The other is a fragmentary petrosal from the upper Oligocene Belgrade Formation that we refer to Echovenatorsp, indicating at least two xenorophids from that unit. Two of the Albertocetus meffordorum specimens are from the lower Oligocene Ashley Formation: 1) a partial skeleton with neurocranium, fragmentary mandible, ribs, vertebrae, and chevrons, and 2) an isolated braincase. The partial vertebral column indicates that Albertocetus retained the ancestral morphology and locomotory capabilities of basilosaurid archaeocetes, toothed mysticetes, and physeteroids, and caudal vertebrae that are as wide as tall suggest that the caudal peduncle, which occurs in all extant Cetacea, was either wide or lacking. CT data from the isolated braincase were used to generate a digital endocast of the cranial cavity. The estimated EQ of this specimen is relatively high for an Oligocene odontocete, and other aspects of the brain, such as its anteroposterior length and relative size of the temporal lobe, are intermediate in morphology between those of extant cetaceans and terrestrial artiodactyls. Ethmoturbinals are also preserved, and are similar in morphology and number to those described for the Miocene odontocete Squalodon. These fossils extend the temporal range of Albertocetus meffordorum into the early Oligocene, its geographic range into South Carolina, and expand our paleobiological understanding of the Xenorophidae.	[Boessenecker, Robert W.] Coll Charleston, Dept Geol & Environm Geosci, Charleston, SC 29401 USA; [Boessenecker, Robert W.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Ahmed, Erum; Geisler, Jonathan H.] New York Inst Technol, Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA	College of Charleston; University of California System; University of California Berkeley; New York Institute Technology	Boessenecker, RW (corresponding author), Coll Charleston, Dept Geol & Environm Geosci, Charleston, SC 29401 USA.; Boessenecker, RW (corresponding author), Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA.	boesseneckerrw@cofc.edu		Geisler, Jonathan/0000-0002-4880-1152	National Science Foundation [DEB 0640361, EAR 1349607]; Division Of Earth Sciences [1349607] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Science Foundation DEB 0640361 JHG and National Science Foundation EAR 1349607 JHG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Fernandez G, 2014, J VERTEBR PALEONTOL, V34, P195, DOI 10.1080/02724634.2013.799069; [Anonymous], 1970, INVESTIGATIONS CETAC; Bianucci G, 2010, PALAEONTOLOGY, V53, P1077, DOI 10.1111/j.1475-4983.2010.00995.x; Boessenecker R. W., 2015, ZOOLOGICAL J LINNEAN, V2015, P1, DOI DOI 10.7717/PEERJ.1129; Boessenecker RW, 2015, PEERJ, V3, DOI 10.7717/peerj.1129; Boessenecker RW, 2015, LETHAIA, V48, P326, DOI 10.1111/let.12108; Bouetel V, 2006, GEODIVERSITAS, V28, P319; BREATHNACH AS, 1955, J ANAT, V89, P532; Buchholtz EA, 2001, J ZOOL, V253, P175, DOI 10.1017/S0952836901000164; Chen Ing, 2011, Taiwania, V56, P177; Churchill M, 2016, CURR BIOL, V26, P2144, DOI 10.1016/j.cub.2016.06.004; Dart RA, 1923, P ZOOL SOC LOND, V1923, P615; DEMERE TA, 1982, J PALEONTOL, V56, P1480; Denison R.E., 1993, SE GEOLOGY, V33, P53; Edwards L.E., 1997, 97145 US GEOL SURV, V97, P1; Ekdale EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021311; El Adli JJ, 2014, ZOOL J LINN SOC-LOND, V170, P400, DOI 10.1111/zoj.12108; Fierstine Harry L., 2009, Palaeo Ichthyologica, V11, P43; Fitzgerald EMG, 2010, ZOOL J LINN SOC-LOND, V158, P367, DOI 10.1111/j.1096-3642.2009.00572.x; Fordyce R. Ewan, 2002, Smithsonian Contributions to Paleobiology, V93, P185; Fordyce R. Ewan, 1994, Proceedings of the San Diego Society of Natural History, V29, P147; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Galatius A, 2003, CAN J ZOOL, V81, P1851, DOI 10.1139/Z03-181; Geisler JH, 2014, NATURE, V508, P383, DOI 10.1038/nature13086; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; Gingerich PD, 1998, ADV VERT PALEOBIOL, P423; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; Gingerich Philip, 2015, Contributions from the Museum of Paleontology University of Michigan, V32, P1; Gingerich PD, 2016, J MAMM EVOL, V23, P17, DOI 10.1007/s10914-015-9304-y; Gingerich PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004366; Godfrey SJ, 2016, J PALEONTOL, V90, P154, DOI 10.1017/jpa.2016.4; Godfrey SJ, 2013, ANAT REC, V296, P257, DOI 10.1002/ar.22637; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris WB, 2000, SEDIMENT GEOL, V134, P49, DOI 10.1016/S0037-0738(00)00013-0; Hazel J. E., 1977, US GEOL SURV PROF F, P71; Hulbert RC, 1998, J PALEONTOL, V72, P907, DOI 10.1017/S0022336000027232; Jacobsen AR, 2009, GEOL Q, V53, P373; Katuna MP, 1997, SEDIMENT GEOL, V108, P181, DOI 10.1016/S0037-0738(96)00053-X; Kier PM, 1997, SMITHSONIAN CONTRIBU, V83, P1; Kojima T., 1951, Scientific Reports of the Whales Research Institute Tokyo, V6, P49; Lambert O, 2014, J VERTEBR PALEONTOL, V34, P987, DOI 10.1080/02724634.2014.858050; Loch C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116557; Marino L, 2004, ANAT REC PART A, V281A, P1247, DOI 10.1002/ar.a.20128; Marino Lori, 2000, Journal of Mammalian Evolution, V7, P81, DOI 10.1023/A:1009417831601; Marx FG, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150476; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Montgomery SH, 2013, EVOLUTION, V67, P3339, DOI 10.1111/evo.12197; Moore K.L., 2014, MOORE CLIN ORIENTED, V7th ed.; Moran MM, 2015, J MAMM EVOL, V22, P93, DOI 10.1007/s10914-014-9256-7; Oelschlager HHA, 2009, ENCY MARINE MAMMALS, P133; Omura H., 1962, Scientific Reports of the Whales Research Institute Tokyo, VNo. 16, P35; Omura H, 1984, SCI REPORTS WHALES R, V35, P183; Omura H., 1957, SCI REPORTS WHALES R, V12, P11; Orliac MJ, 2012, P ROY SOC B-BIOL SCI, V279, P3670, DOI 10.1098/rspb.2012.1156; Park T, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0060; PILLERI G, 1972, INVESTIGATIONS CETAC, V4, P44; Prothero D.R., 2001, SPECIAL PUBLICATIONS, V91, P184; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; Riabinin A. N., 1938, Problems of Paleontology Moscow, V4, P137; Ridgway SH, 2016, BRAIN BEHAV EVOLUT, V88, P235, DOI 10.1159/000454797; Sanders AE, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.890107; Gutstein CS, 2009, J MAMMAL, V90, P504, DOI 10.1644/07-MAMM-A-081.1; Tanaka Y., 2015, PALAEONTOL ELECTRON, P1; THEWISSEN JGM, 1994, SCIENCE, V263, P210, DOI 10.1126/science.263.5144.210; Thewissen JGM, 2001, NATURE, V413, P277, DOI 10.1038/35095005; Uhen MD, 2008, J SYST PALAEONTOL, V6, P433, DOI 10.1017/S1477201908002472; Uhen MD., 2004, U MICHIGAN PAP PALEO, V34, P1; van Netten HH, 2010, GEOIMPULSE, V88, P169; Walsh BM, 2011, ANAT REC, V294, P394, DOI DOI 10.1002/AR.21340; Ward LW, 1978, US GEOLOGICAL SURV F, V1457-F, pF1; Weems R.E., 2016, S C GEOL, V49, P1; Weems RE, 2002, GEOL SOC AM BULL, V114, P24, DOI 10.1130/0016-7606(2002)114<0024:SATSOT>2.0.CO;2; YAMADA M, 1954, SCI REPORTS WHALES R, V9, P59	74	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0186476	10.1371/journal.pone.0186476	http://dx.doi.org/10.1371/journal.pone.0186476			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117197	gold, Green Submitted, Green Published			2022-12-26	WOS:000414659600008
J	Davis, T; Goldwater, MB; Ireland, ME; Gaylord, N; Van Allen, J				Davis, Tyler; Goldwater, Micah B.; Ireland, Molly E.; Gaylord, Nicholas; Van Allen, Jason			Can you catch Ebola from a stork bite? Inductive reasoning influences generalization of perceived zoonosis risk	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; CATEGORY-BASED INDUCTION; MECHANICAL TURK; SIMILARITY; DIVERSITY; EMERGENCE; CATEGORIZATION; DETERMINANTS; PERCEPTIONS; EXPERTISE	Emerging zoonoses are a prominent global health threat. Human beliefs are central to drivers of emerging zoonoses, yet little is known about how people make inferences about risk in such scenarios. We present an inductive account of zoonosis risk perception, suggesting that beliefs about the range of animals able to transmit diseases to each other influence how people generalize risks to other animals and health behaviors. Consistent with our account, in Study 1, we find that participants who endorse higher likelihoods of cross-species disease transmission have stronger intentions to report animal bites. In Study 2, using real-world descriptions of Ebola virus from the WHO and CDC, we find that communications conveying a broader range of animals as susceptible to the virus increase intentions to report animal bites and decrease perceived safety of wild game meat. These results suggest that inductive reasoning principles may be harnessed to modulate zoonosis risk perception and combat emerging infectious diseases.	[Davis, Tyler; Ireland, Molly E.; Van Allen, Jason] Texas Tech Univ, Dept Psychol Sci, Lubbock, TX 79409 USA; [Goldwater, Micah B.] Univ Sydney, Sch Psychol, Sydney, NSW, Australia	Texas Tech University System; Texas Tech University; University of Sydney	Davis, T (corresponding author), Texas Tech Univ, Dept Psychol Sci, Lubbock, TX 79409 USA.	tyler.h.davis@ttu.edu			Texas Tech University	Texas Tech University	This research was funded by start-up funds to T.D., from Texas Tech University. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bingham GM, 2010, PREV VET MED, V93, P211, DOI 10.1016/j.prevetmed.2009.09.019; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Castillo-Chavez C, 2015, LANCET GLOB HEALTH, V3, pE354, DOI 10.1016/S2214-109X(15)00068-6; Center for Disease Control and Prevention, 2016, EB VIR DIS; Centers for Disease Control and Prevention, 2016, QUEST ANSW EB PETS O; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Cui B, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4364-y; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis T., 2013, BATS PHYLOGENY EVOLU, P1; Decker DJ, 2010, ILAR J, V51, P255, DOI 10.1093/ilar.51.3.255; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; FAZIO RH, 1978, PERS SOC PSYCHOL B, V4, P48, DOI 10.1177/014616727800400109; Gbogbo F, 2017, ZOONOSES PUBLIC HLTH; Glasman LR, 2006, PSYCHOL BULL, V132, P778, DOI 10.1037/0033-2909.132.5.778; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Hayes BK, 2010, WIRES COGN SCI, V1, P278, DOI 10.1002/wcs.44; Heit E, 2005, PSYCHON B REV, V12, P340, DOI 10.3758/BF03196382; Heit E, 2001, COGNITIVE PSYCHOL, V43, P243, DOI 10.1006/cogp.2001.0757; Heit E., 1998, RATIONAL MODELS COGN, V024, P248; Heymann DL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1499; Janes CR, 2012, LANCET, V380, P1884, DOI 10.1016/S0140-6736(12)61725-5; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kamins AO, 2015, ECOHEALTH, V12, P104, DOI 10.1007/s10393-014-0977-0; Li FH, 2009, THINK REASONING, V15, P388, DOI 10.1080/13546780903343227; LOPEZ A, 1995, MEM COGNITION, V23, P374, DOI 10.3758/BF03197238; Lopez A, 1997, COGNITIVE PSYCHOL, V32, P251, DOI 10.1006/cogp.1997.0651; McDonald J, 1996, COGNITION, V59, P199, DOI 10.1016/0010-0277(95)00702-4; MEDIN DL, 1993, PSYCHOL REV, V100, P254, DOI 10.1037/0033-295X.100.2.254; Medin DL, 2003, PSYCHON B REV, V10, P517, DOI 10.3758/BF03196515; Medin DL, 2002, PSYCHOL LEARN MOTIV, V41, P1, DOI 10.1016/S0079-7421(02)80003-2; Nemeroff C, IMAGINING IMPOSSIBLE, P1; NEMEROFF CJ, 1995, HEALTH PSYCHOL, V14, P147, DOI 10.1037/0278-6133.14.2.147; Newman S.H., 2011, FAO ANIMAL PRODUCTIO; OSHERSON DN, 1990, PSYCHOL REV, V97, P185, DOI 10.1037/0033-295X.97.2.185; Pinheiro J, 2001, MIXED EFFECTS MODELS; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Proffitt JB, 2000, J EXP PSYCHOL LEARN, V26, P811, DOI 10.1037/0278-7393.26.4.811; Rhodes M, 2008, COGNITION, V108, P543, DOI 10.1016/j.cognition.2008.03.002; RIPS LJ, 1975, J VERB LEARN VERB BE, V14, P665, DOI 10.1016/S0022-5371(75)80055-7; Rivero MR, 2017, ZOONOSES PUBLIC HLTH; Ross N, 2003, COGNITIVE DEV, V18, P25, DOI 10.1016/S0885-2014(02)00142-9; ROZIN P, 1992, J APPL SOC PSYCHOL, V22, P1081, DOI 10.1111/j.1559-1816.1992.tb00943.x; ROZIN P, 1990, PSYCHOL SCI, V1, P383, DOI 10.1111/j.1467-9280.1990.tb00246.x; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Shafto P, 2003, J EXP PSYCHOL LEARN, V29, P641, DOI 10.1037/0278-7393.29.4.641; Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; SLOMAN SA, 1993, COGNITIVE PSYCHOL, V25, P231, DOI 10.1006/cogp.1993.1006; Slovic P., 2016, PERCEPTION RISK; Stewart N, 2015, JUDGM DECIS MAK, V10, P479; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789	57	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0186969	10.1371/journal.pone.0186969	http://dx.doi.org/10.1371/journal.pone.0186969			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM0ME	29117192	Green Submitted, gold, Green Published			2022-12-26	WOS:000414659600021
J	Martin, JL; Gadegbeku, B; Wu, D; Viallon, V; Laumon, B				Martin, Jean-Louis; Gadegbeku, Blandine; Wu, Dan; Viallon, Vivian; Laumon, Bernard			Cannabis, alcohol and fatal road accidents	PLOS ONE			English	Article							DRIVING PERFORMANCE; TRAFFIC ACCIDENTS; ATTRIBUTABLE RISK; INTOXICATION; CRASHES; CULPABILITY; MARIJUANA; FRANCE	Introduction This research aims to estimate the relative risks of responsibility for a fatal accident linked to driving under the influence of cannabis or alcohol, the prevalence of these influences among drivers and the corresponding attributable risk ratios. A secondary goal is to estimate the same items for three other groups of illicit drugs (amphetamines, cocaine and opiates), and to compare the results to a similar study carried out in France between 2001 and 2003. Methodology Police procedures for fatal accidents in Metropolitan France during 2011 were analyzed and 300 characteristics encoded to provide a database of 4,059 drivers. Information on alcohol and four groups of illicit drugs derived from tests for positivity and potential confirmation through blood analysis. The study compares drivers responsible for causing the accident, that is to say having directly contributed to its occurrence, to drivers involved in an accident for which they were not responsible, and who can be assimilated to drivers in general. Results The proportion of persons driving under the influence of alcohol is estimated at 2.1% (95% CI: 1.4-2.8) and under the influence of cannabis at 3.4% (2.9%-3.9%). Drivers under the influence of alcohol are 17.8 times (12.1-26.1) more likely to be responsible for a fatal accident, and the proportion of fatal accidents which would be prevented if no drivers ever exceeded the legal limit for alcohol is estimated at 27.7% (26.0%-29.4%). Drivers under the influence of cannabis multiply their risk of being responsible for causing a fatal accident by 1.65 (1.16-2.34), and the proportion of fatal accidents which would be prevented if no drivers ever drove under the influence of cannabis is estimated at 4.2% (3.7%-4.8%). An increased risk linked to opiate use has also been found to be significant, but with low prevalence, requiring caution in interpreting this finding. Other groups of narcotics have even lower prevalence, and the associated extra risks cannot be assessed. Conclusion Almost a decade separates the present study from a similar one previously conducted in France, and there have been numerous developments in the intervening years. Even so, the prevalence of drivers responsible for causing fatal accidents under the influence of alcohol or narcotics has stayed remarkably stable, as have the proportion of fatal accidents which could in theory be prevented if no drivers ever exceeded the legal limits. The overall number of deaths from traffic accidents has dropped sharply during this period, and the number of victims attributable to alcohol and/or cannabis declined proportionally. Alcohol remains the main problem in France. It is just as important to note that one in two drivers considered to be under the influence of cannabis was also under the influence of alcohol. With risks cumulating between the two, it is particularly important to point out the danger of consuming them together.	[Martin, Jean-Louis; Gadegbeku, Blandine; Wu, Dan; Viallon, Vivian; Laumon, Bernard] Univ Claude Bernard Lyon 1, Lfsttar, UMR T 9405, UMRESTTE, Bron, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Gustave-Eiffel	Martin, JL (corresponding author), Univ Claude Bernard Lyon 1, Lfsttar, UMR T 9405, UMRESTTE, Bron, France.	jean-louis.martin@ifsttar.fr	Martin, Jean-Louis/X-6588-2019; Gadegbeku, Blandine/AAE-3618-2019	Martin, Jean-Louis/0000-0002-3426-9601; Gadegbeku, Blandine/0000-0001-6720-206X	Agence Nationale pour la Recherche [ANR-11-VPTT-0007]; Ministry of the Interior, Delegation a la Securite eta la Circulation Routieres [2200868646]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ministry of the Interior, Delegation a la Securite eta la Circulation Routieres	The work was supported by the following: Agence Nationale pour la Recherche, grant: ANR-11-VPTT-0007, url: http://www.agence-nationale-recherche.fr/en/anr-funded-project/?? solr=run & Ministry of the Interior, Delegation a la Securite eta la Circulation Routieres, grant 2200868646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Wahlberg AE, 2007, J SAFETY RES, V38, P453, DOI 10.1016/j.jsr.2007.01.013; Asbridge M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e536; Battistella G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052545; Beck F., 2015, DROGUES CHIFFRES CLE; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Berghaus G, 1995, ALCOHOL, DRUGS AND TRAFFIC SAFETY - T'95, VOLS 1 AND 2, P403; Borkenstein R., 1964, ROLE DRINKING DRIVER; Brubacher J, 2014, INT J EPIDEMIOL, V43, P270, DOI 10.1093/ije/dyt142; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Carnis L, 2013, ACCIDENT ANAL PREV, V51, P301, DOI 10.1016/j.aap.2012.11.022; Davis G. A., 1993, TRANSPORT RES REC, V1401, P43; Dufournet M, J CAUSAL IN IN PRESS; Elvik R, 2013, ACCIDENT ANAL PREV, V60, P254, DOI 10.1016/j.aap.2012.06.017; Focant N., 2016, BOIRE CONDUIRE FAISO; Gjerde H, 2011, ACCIDENT ANAL PREV, V43, P1197, DOI 10.1016/j.aap.2010.12.034; Haight F. A., 1973, ACCIDENT ANAL PREV, V5, P111, DOI [10.1016/0001-4575(73)90019-5, DOI 10.1016/0001-4575(73)90019-5]; Hartman RL, 2013, CLIN CHEM, V59, P478, DOI 10.1373/clinchem.2012.194381; Hours M, 2008, ACCIDENT ANAL PREV, V40, P1789, DOI 10.1016/j.aap.2008.06.017; Huestis MA, 2005, CLIN CHEM, V51, P2289, DOI 10.1373/clinchem.2005.056838; Keall MD, 2004, ACCIDENT ANAL PREV, V36, P49, DOI 10.1016/S0001-4575(02)00114-8; Kelly E, 2004, DRUG ALCOHOL REV, V23, P319, DOI 10.1080/09595230412331289482; Laumon B, 2005, BRIT MED J, V331, P1371, DOI 10.1136/bmj.38648.617986.1F; Laumon B., 2011, STUPEFIANTS ACCIDENT; Lenguerrand E, 2008, ACCIDENT ANAL PREV, V40, P861, DOI 10.1016/j.aap.2007.09.027; Li MC, 2012, EPIDEMIOL REV, V34, P65, DOI 10.1093/epirev/mxr017; Longo MC, 2000, ACCIDENT ANAL PREV, V32, P623, DOI 10.1016/S0001-4575(99)00110-4; MOSKOWITZ H, 1985, ACCIDENT ANAL PREV, V17, P323, DOI 10.1016/0001-4575(85)90034-X; Orriols L, 2016, BRIT J CLIN PHARMACO, V82, P1625, DOI 10.1111/bcp.13075; Orriols L, 2012, J CLIN PSYCHIAT, V73, P1088, DOI 10.4088/JCP.11m07624; Ramaekers JG, 2000, HUM PSYCHOPHARM CLIN, V15, P551, DOI 10.1002/1099-1077(200010)15:7<551::AID-HUP236>3.0.CO;2-P; Robbe H, 1998, HUM PSYCHOPHARM CLIN, V13, pS70, DOI 10.1002/(SICI)1099-1077(1998110)13:2+<S70::AID-HUP50>3.0.CO;2-R; Rogeberg O, 2016, ADDICTION, V111, P1348, DOI 10.1111/add.13347; Ronen A, 2008, ACCIDENT ANAL PREV, V40, P926, DOI 10.1016/j.aap.2007.10.011; Ronen A, 2010, ACCIDENT ANAL PREV, V42, P1855, DOI 10.1016/j.aap.2010.05.006; Rothman K., 1998, MODERN EPIDEMIOLOGY; Schnabel E, 2010, METAANALYSIS EMPIRIC; Sewell RA, 2009, AM J ADDICTION, V18, P185, DOI 10.1080/10550490902786934; Stubig T, 2012, ALCOHOL, V46, P681, DOI 10.1016/j.alcohol.2012.07.002; Viallon V, 2013, ACCIDENT ANAL PREV, V52, P250, DOI 10.1016/j.aap.2012.12.024; Zador PL, 2000, RELATIVE RISK FATAL	40	49	49	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187320	10.1371/journal.pone.0187320	http://dx.doi.org/10.1371/journal.pone.0187320			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM0ME	29117206	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600032
J	Schwartz, CJ; Lee, J; Amasino, R				Schwartz, C. J.; Lee, Joohyun; Amasino, Richard			Variation in shade-induced flowering in Arabidopsis thaliana results from FLOWERING LOCUS Tallelic variation	PLOS ONE			English	Article							AMBIENT-TEMPERATURE; PHYTOCHROME-B; EXPRESSION; CONSTANS; VERNALIZATION; RESPONSES; TWILIGHT; TIME	Plants have evolved developmental mechanisms to ensure reproduction when in sub-optimal local environments. The shade-avoidance syndrome is one such mechanism that causes plants to elongate and accelerate flowering. Plants sense shade via the decreased red:far-red (R:FR) ratio that occurs in shade. We explored natural variation in flowering behavior caused by a decrease in the R:FR ratio of Arabidopsis thaliana accessions. A survey of accessions revealed that most exhibit a vigorous rapid-flowering response in a FR enriched environment. However, a subset of accessions appeared to be compromised in the accelerated-flowering component of the shade-avoidance response. The genetic basis of the muted response to FR enrichment was studied in three accessions (FI-1, Hau-O, and Mir-0). For all three accessions, the reduced FR flowering-time effect mapped to the FLOWERING LOCUS T (F7) region, and the FTalleles from these accessions are expressed at a lower level in FR-enriched light compared to alleles from accessions that respond robustly to FR enrichment. In the Mir-0 accession, a second genomic region, which includes CONSTANTS (CO), also influenced flowering in FR-enriched conditions. We have demonstrated that variation in the degree of precocious flowering in shaded conditions (low R:FR ratio) results from allelic variation at FT.	[Schwartz, C. J.; Lee, Joohyun; Amasino, Richard] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [Schwartz, C. J.] Sunrise Genet Inc, Hempgene Div, Ft Collins, CO 80522 USA; [Lee, Joohyun] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Amherst	Schwartz, CJ; Amasino, R (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.; Schwartz, CJ (corresponding author), Sunrise Genet Inc, Hempgene Div, Ft Collins, CO 80522 USA.	cj.schwart@sunrisegenetics.com; amasino@biochem.wisc.edu		Schwartz, CJ/0000-0001-9295-8504; Lee, Joohyun/0000-0003-1696-8991	Frontiers in Integrative Biological Research program grant [EF-0425759]	Frontiers in Integrative Biological Research program grant	This work was supported by a Frontiers in Integrative Biological Research program grant EF-0425759 to Richard Amasino.	Adams S, 2009, PLANT J, V60, P257, DOI 10.1111/j.1365-313X.2009.03962.x; Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; CASAL JJ, 1990, NEW PHYTOL, V116, P565, DOI 10.1111/j.1469-8137.1990.tb00540.x; Domagalska MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014012; Fan CM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-9; Filiault DL, 2008, P NATL ACAD SCI USA, V105, P3157, DOI 10.1073/pnas.0712174105; Frankilin KA, 2008, PHOTOMORPHOGENESIS N; Franklin KA, 2005, INT J DEV BIOL, V49, P653, DOI 10.1387/ijdb.051989kf; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim JJ, 2012, PLANT PHYSIOL, V159, P461, DOI 10.1104/pp.111.192369; Kim SY, 2008, PLANT PHYSIOL, V148, P269, DOI 10.1104/pp.108.122606; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee J, 2015, P NATL ACAD SCI USA, V112, P2269, DOI 10.1073/pnas.1423585112; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Linkosalo T, 2006, TREE PHYSIOL, V26, P1249, DOI 10.1093/treephys/26.10.1249; Maloof JN, 2000, SEMIN CELL DEV BIOL, V11, P523, DOI 10.1006/scdb.2000.0198; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Osnato M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1810; Porri A, 2010, DEVELOPMENT, V139, P2190; Rantanen M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00271; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Schwartz C, 2009, GENETICS, V183, P723, DOI 10.1534/genetics.109.104984; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; Strange A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019949; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Turnbull C, 2011, J EXP BOT, V62, P4399, DOI 10.1093/jxb/err191; Wang Jing, 2012, PLoS ONE, V7, pe47127, DOI 10.1371/journal.pone.0047127; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428; Wollenberg AC, 2008, PLANT PHYSIOL, V148, P1681, DOI 10.1104/pp.108.125468; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928	41	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187768	10.1371/journal.pone.0187768	http://dx.doi.org/10.1371/journal.pone.0187768			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117199	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600074
J	Sugasini, D; Subbaiah, PV				Sugasini, Dhavamani; Subbaiah, Papasani V.			Rate of acyl migration in lysophosphatidylcholine (LPC) is dependent upon the nature of the acyl group. Greater stability of sn-2 docosahexaenoyl LPC compared to the more saturated LPC species	PLOS ONE			English	Article							HYDROLYSIS PRODUCTS; HEPATIC SECRETION; LIPASE ACTIVITY; FATTY-ACIDS; LC-MS/MS; PLASMA; SEPARATION; BRAIN; PHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPIDS	Several previous studies reported that sn-2 acyl lysophosphatidylcholines (LPCs) undergo rapid isomerization due to acyl migration, especially at physiological pH and temperature. However, these studies have been carried out using mostly sn-2 palmitoyl LPC, whereas the naturally occurring sn-2 LPCs are predominantly unsaturated. In this study, we investigated the acyl migration in four naturally occurring sn-2 acyl LPCs (sn-2 16:0, sn-2 18:1, sn-2 20:4, and sn-2 22:6) stored at various temperatures in aqueous or organic solvents, employing LC/MS to analyze the isomer composition. At 37 degrees C and pH 7.4, the order of acyl migration rates (from sn-2 to sn-1) in aqueous buffer was 16:0 LPC> 18:1 LPC> 20:4 LPC> 22:6 LPC. The rate of isomerization of sn-2 16:0 LPC was 2-5 times greater than that of sn-2 22:6 under these conditions. Complexing the LPCs to serum albumin accelerated the acyl migration of all species, but sn-2 22:6 LPC was least affected by the presence of albumin. The migration rates were lower at lower temperatures (22 degrees C, 4 degrees C, and -20 degrees C), but the differences between the LPC species persisted. All the sn-2 acyl LPCs were more stable in organic solvent (chloroform: methanol, 2:1 v/v), but the effect of the acyl groups on acyl migration was evident in the solvent also, at all temperatures. Storage of sn-2 22:6 LPC at-20 degrees C for 4 weeks in the organic solvent resulted in about 10% isomerization, compared to 55% isomerization for sn-2 16:0. These results show that the sn-2 polyunsaturated LPCs can be stored at-20 degrees C or below for several days without appreciable isomerization. Furthermore, they demonstrate that the sn-2 polyunsaturated LPCs generated in vivo are much more stable under physiological conditions than previously assumed.	[Sugasini, Dhavamani; Subbaiah, Papasani V.] Univ Illinois, Dept Med, Sect Endocrinol, Chicago, IL 60607 USA; [Sugasini, Dhavamani; Subbaiah, Papasani V.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Subbaiah, Papasani V.] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Subbaiah, PV (corresponding author), Univ Illinois, Dept Med, Sect Endocrinol, Chicago, IL 60607 USA.; Subbaiah, PV (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.; Subbaiah, PV (corresponding author), Jesse Brown VA Med Ctr, Chicago, IL 60612 USA.	psubbaia@uic.edu	Subbaiah, Papasani/U-1104-2019	Subbaiah, Papasani/0000-0002-9376-8582; Dhavamani, Dr.Sugasini/0000-0001-9077-9940	National Institutes of Health, National Center for Complementary and Integrative Health [R21 AT008457]; Veterans Administration Merit Review award [101 BX00190]; Office of the Director, National Institutes of Health [S10 OD 010660]; National Center for Complementary & Integrative Health [R21AT008457] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Complementary and Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit Review award(US Department of Veterans Affairs); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported National Institutes of Health, National Center for Complementary and Integrative Health R21 AT008457 (PVS); Veterans Administration Merit Review award 101 BX00190 (PVS) and the Office of the Director, National Institutes of Health S10 OD 010660 (PVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlercreutz D, 2001, J AM OIL CHEM SOC, V78, P1007, DOI 10.1007/s11746-001-0379-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boswinkel G, 1996, J AM OIL CHEM SOC, V73, P707, DOI 10.1007/BF02517944; BRINDLEY DN, 1993, J NUTR BIOCHEM, V4, P442, DOI 10.1016/0955-2863(93)90061-Z; CREER MH, 1985, LIPIDS, V20, P922, DOI 10.1007/BF02534778; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; DEHAAS GH, 1965, BIOCHIM BIOPHYS ACTA, V106, P315, DOI 10.1016/0005-2760(65)90040-8; Dong J, 2010, METABOLOMICS, V6, P478, DOI 10.1007/s11306-010-0215-x; Hachem M, 2015, MOL NEUROBIOL, P1; Kielbowicz G, 2012, TALANTA, V94, P22, DOI 10.1016/j.talanta.2012.01.018; Koistinen KM, 2015, ANAL BIOANAL CHEM, V407, P5091, DOI 10.1007/s00216-014-8453-9; Lagarde M, 2015, PROSTAG LEUKOTR ESS, V92, P63, DOI 10.1016/j.plefa.2014.01.005; Lagarde M, 2001, J MOL NEUROSCI, V16, P201, DOI 10.1385/JMN:16:2-3:201; LANDS WEM, 1963, J BIOL CHEM, V238, P898; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; MARINETTI GV, 1962, J LIPID RES, V3, P1; Nakanishi H, 2010, J BIOCHEM, V147, P245, DOI 10.1093/jb/mvp171; Hung DN, 2011, INFLAMMATION, V34, P147, DOI 10.1007/s10753-010-9218-z; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; SARNEY DB, 1994, J AM OIL CHEM SOC, V71, P93, DOI 10.1007/BF02541478; SEKAS G, 1985, J LAB CLIN MED, V105, P190; Subbaiah PV, 2016, BBA-MOL CELL BIOL L, V1861, P723, DOI 10.1016/j.bbalip.2016.05.002; Subbaiah PV, 2004, J LIPID RES, V45, P2245, DOI 10.1194/jlr.M400197-JLR200; Sugasini D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11766-0; THIES F, 1992, J NEUROCHEM, V59, P1110, DOI 10.1111/j.1471-4159.1992.tb08353.x; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yang P, 2015, BBA-MOL CELL BIOL L, V1851, P1327, DOI 10.1016/j.bbalip.2015.07.003; Yang P, 2014, LIPIDS, V49, P987, DOI 10.1007/s11745-014-3944-1	29	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187826	10.1371/journal.pone.0187826	http://dx.doi.org/10.1371/journal.pone.0187826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117232	gold, Green Submitted, Green Published			2022-12-26	WOS:000414659600078
J	Woldemichael, T; Rosania, GR				Woldemichael, Tehetina; Rosania, Gus R.			The physiological determinants of drug induced lysosomal stress resistance	PLOS ONE			English	Article							RENAL TUBULAR-ACIDOSIS; MUCOLIPIDOSIS TYPE-IV; CELL-DEATH; H+-ATPASE; V-ATPASE; MEMBRANE PERMEABILIZATION; CHLORIDE CHANNELS; VACUOLAR ATPASE; PROTON PUMP; GENE	Many weakly basic, lipophilic drugs accumulate in lysosomes and exert complex, pleiotropic effects on organelle structure and function. Thus, modeling how perturbations of lysosomal physiology affect the maintenance of lysosomal ion homeostasis is necessary to elucidate the key factors which determine the toxicological effects of lysosomotropic agents, in a cell type dependent manner. Accordingly, a physiologically-based mathematical modeling and simulation approach was used to explore the dynamic, multi-parameter phenomenon of lysosomal stress. With this approach, parameters that are either directly involved in lysosomal ion transportation or lysosomal morphology were transiently altered to investigate their downstream effects on lysosomal physiology reflected by the changes they induce in lysosomal pH, chloride, and membrane potential. In addition, combinations of parameters were simultaneously altered to assess which parameter was most critical for recovery of normal lysosomal physiology. Lastly, to explore the relationship between organelle morphology and induced stress, we investigated the effects of parameters controlling organelle geometry on the restoration of normal lysosomal physiology following a transient perturbation. Collectively, our results indicate a key, interdependent role of V-ATPase number and membrane proton permeability in lysosomal stress tolerance. This suggests that the cell type dependent regulation of V-ATPase subunit expression and turnover, together with the proton permeability properties of the lysosomal membrane, is critical to understand the differential sensitivity or resistance of different cell types to the toxic effects of lysosomotropic drugs.	[Woldemichael, Tehetina] Univ Michigan, Coll Literature Sci & Arts, Biophys Program, Ann Arbor, MI 48109 USA; [Rosania, Gus R.] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, 428 Church St, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rosania, GR (corresponding author), Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, 428 Church St, Ann Arbor, MI 48109 USA.	grosania@umich.edu			National Institutes of Health grant [R01GM078200]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078200] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01GM078200 to GRR (https://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2013, P NATL ACAD SCI USA, V110, P17247, DOI 10.1073/pnas.1305000110; Ashoor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082481; Bach G, 2010, BIOCHEM SOC T, V38, P1432, DOI 10.1042/BST0381432; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Berkovic SE, 2008, AM J HUM GENET, V82, P673, DOI 10.1016/j.ajhg.2007.12.019; Bourdenx M, 2016, AUTOPHAGY, V12, P472, DOI 10.1080/15548627.2015.1136769; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Boyle J., 2008, BIOCH MOL BIOL ED, V36, P317, DOI DOI 10.1002/BMB.20192; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bruns H, 2012, J IMMUNOL, V189, P4069, DOI 10.4049/jimmunol.1201538; BUTLER JD, 1993, BIOCHEM BIOPH RES CO, V196, P154, DOI 10.1006/bbrc.1993.2228; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Deng D, 2009, BBA-BIOMEMBRANES, V1788, P470, DOI 10.1016/j.bbamem.2008.11.018; Dielschneider RF, 2016, LEUKEMIA, V30, P1290, DOI 10.1038/leu.2016.4; Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106; Emanuel R, 2014, ARTERIOSCL THROM VAS, V34, P1942, DOI 10.1161/ATVBAHA.114.303342; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; GAMBALE F, 1994, EUR BIOPHYS J BIOPHY, V22, P399, DOI 10.1007/BF00180161; Goldman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023835; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Grabe M, 2000, BIOPHYS J, V78, P2798, DOI 10.1016/S0006-3495(00)76823-8; Graham RM, 2014, ONCOTARGET, V5, P1162, DOI 10.18632/oncotarget.1699; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; Hosogi S, 2014, J CELL MOL MED, V18, P1124, DOI 10.1111/jcmm.12257; Ishida Y, 2013, J GEN PHYSIOL, V141, P705, DOI 10.1085/jgp.201210930; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Kiselyov K, 2011, CELL CALCIUM, V50, P288, DOI 10.1016/j.ceca.2011.04.009; KNAPP PE, 1990, J CELL SCI, V95, P433; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Li XR, 2013, J PHYSIOL-LONDON, V591, P4389, DOI 10.1113/jphysiol.2013.258301; Logan R, 2014, J PHARM SCI-US, V103, P3287, DOI 10.1002/jps.24087; Logan R, 2012, EXPERT OPIN DRUG MET, V8, P943, DOI 10.1517/17425255.2012.691165; Lu SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173771; Luellmann-Rauch Renate, 2005, P1; Manchon JFM, 2016, AGING-US, V8, P3507, DOI 10.18632/aging.101144; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; Morissette G, 2008, TOXICOL APPL PHARM, V228, P364, DOI 10.1016/j.taap.2007.12.031; Nilsson C, 2006, APOPTOSIS, V11, P1149, DOI 10.1007/s10495-006-7108-5; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Nyman JKE, 2010, CALCIFIED TISSUE INT, V87, P273, DOI 10.1007/s00223-010-9395-7; OHKUMA S, 1981, J CELL BIOL, V90, P656, DOI 10.1083/jcb.90.3.656; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Padman BS, 2013, AUTOPHAGY, V9, P1862, DOI 10.4161/auto.26557; Pangrazio A, 2006, J BONE MINER RES, V21, P1098, DOI 10.1359/JBMR.060403; Parks A, 2016, TOXICOL APPL PHARM, V305, P55, DOI 10.1016/j.taap.2016.06.006; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Petersen NHT, 2013, CANCER CELL, V24, P379, DOI 10.1016/j.ccr.2013.08.003; Quarello P, 2004, J BONE MINER RES, V19, P1194, DOI 10.1359/JBMR.040407; Repnik U, 2014, MITOCHONDRION, V19, P49, DOI 10.1016/j.mito.2014.06.006; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Samie MA, 2014, J LIPID RES, V55, P995, DOI 10.1194/jlr.R046896; Sardiello M, 2009, CELL CYCLE, V8, P4021, DOI 10.4161/cc.8.24.10263; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Shayman JA, 2013, BBA-MOL CELL BIOL L, V1831, P602, DOI 10.1016/j.bbalip.2012.08.013; Siintola E, 2007, AM J HUM GENET, V81, P136, DOI 10.1086/518902; Slaugenhaupt SA, 1999, AM J HUM GENET, V65, P773, DOI 10.1086/302549; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; STRAUSBAUCH P, 1989, J LEUKOCYTE BIOL, V46, P441, DOI 10.1002/jlb.46.5.441; SWANSON J, 1987, J CELL BIOL, V104, P1217, DOI 10.1083/jcb.104.5.1217; TAPPER H, 1990, BIOCHEM J, V272, P407, DOI 10.1042/bj2720407; VANDYKE RW, 1993, AM J PHYSIOL, V265, pC901, DOI 10.1152/ajpcell.1993.265.4.C901; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; von Schwarzenberg K, 2013, J BIOL CHEM, V288, P1385, DOI 10.1074/jbc.M112.412007; Vruchte DT, 2004, J BIOL CHEM, V279, P26167, DOI 10.1074/jbc.M311591200; Wang WY, 2015, P NATL ACAD SCI USA, V112, pE1373, DOI 10.1073/pnas.1419669112; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200; Yang QQ, 2006, J AM SOC NEPHROL, V17, P1858, DOI 10.1681/ASN.2005121277; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004; Zhang GJ, 2000, J MEMBRANE BIOL, V175, P53, DOI 10.1007/s002320001054; Zhang LS, 2009, ACTA BIOCH BIOPH SIN, V41, P437, DOI 10.1093/abbs/gmp031; Zhao H, 2005, RADIAT RES, V164, P250, DOI 10.1667/RR3436.1	82	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187627	10.1371/journal.pone.0187627	http://dx.doi.org/10.1371/journal.pone.0187627			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117253	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600051
J	Zhang, HC; Chen, SY; Liu, J; Zhou, Z; Wu, TS				Zhang, Hancui; Chen, Shuyu; Liu, Jun; Zhou, Zhen; Wu, Tianshu			An incremental anomaly detection model for virtual machines	PLOS ONE			English	Article							SELF-ORGANIZING MAPS; SYSTEM	Self-Organizing Map (SOM) algorithm as an unsupervised learning method has been applied in anomaly detection due to its capabilities of self-organizing and automatic anomaly prediction. However, because of the algorithm is initialized in random, it takes a long time to train a detection model. Besides, the Cloud platforms with large scale virtual machines are prone to performance anomalies due to their high dynamic and resource sharing characters, which makes the algorithm present a low accuracy and a low scalability. To address these problems, an Improved Incremental Self-Organizing Map (IISOM) model is proposed for anomaly detection of virtual machines. In this model, a heuristic-based initialization algorithm and a Weighted Euclidean Distance (WED) algorithm are introduced into SOM to speed up the training process and improve model quality. Meanwhile, a neighborhood based searching algorithm is presented to accelerate the detection time by taking into account the large scale and high dynamic features of virtual machines on cloud platform. To demonstrate the effectiveness, experiments on a common benchmark KDD Cup dataset and a real dataset have been performed. Results suggest that IISOM has advantages in accuracy and convergence velocity of anomaly detection for virtual machines on cloud platform.	[Zhang, Hancui; Chen, Shuyu] Chongqing Univ, Coll Software Engn, Chongqing, Peoples R China; [Wu, Tianshu] Chongqing Univ, Coll Comp Sci, Chongqing, Peoples R China; [Liu, Jun] Chongqing Univ Posts & Telecommun, Coll Software Engn, Chongqing, Peoples R China; [Zhou, Zhen] Southwest Minzu Univ, Sch Comp Sci & Technol, Chengdu, Sichuan, Peoples R China	Chongqing University; Chongqing University; Chongqing University of Posts & Telecommunications; Southwest Minzu University	Zhang, HC (corresponding author), Chongqing Univ, Coll Software Engn, Chongqing, Peoples R China.	zhc_813@126.com	Jun, LIU/HIK-1509-2022	Jun, LIU/0000-0001-8122-1443	National Natural Science Foundation of China [61272399, 61572090]; Science and Technology Research Project of Chongqing Municipal Education Committee [KJ1704081]; Research Fund for the Doctoral Program of Higher Education of China [20110191110038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Project of Chongqing Municipal Education Committee; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The work of this paper is supported by National Natural Science Foundation of China (Grant No.61272399 and No.61572090), the Science and Technology Research Project of Chongqing Municipal Education Committee (Grant No. KJ1704081) and Research Fund for the Doctoral Program of Higher Education of China (Grant No.20110191110038).	Abdelsamea MM, 2015, NEUROCOMPUTING, V149, P820, DOI 10.1016/j.neucom.2014.07.052; Calero JMA, 2015, IEEE T SERV COMPUT, V8, P65, DOI 10.1109/TSC.2014.2302810; Chalasani R, 2015, NEUROCOMPUTING, V147, P3, DOI 10.1016/j.neucom.2013.12.059; Chavez-Arroyo R, 2015, APPL THERM ENG, V75, P1201, DOI 10.1016/j.applthermaleng.2014.03.002; Chengwei Wang, 2011, 2011 IFIP/IEEE International Symposium on Integrated Network Management (IM 2011), P385, DOI 10.1109/INM.2011.5990537; Chin Y.-J., 1999, CIRCUITS SYST VIDEO, V9, P438, DOI DOI 10.1109/76.754773; Cho Y, 2014, CLUSTER COMPUT, V17, P1215, DOI 10.1007/s10586-014-0391-y; Deep K, 2007, IEEE C EVOL COMPUTAT, P2796, DOI 10.1109/CEC.2007.4424825; Delgado S, 2015, BIOINFORMATICS, V31, P736, DOI 10.1093/bioinformatics/btu708; Dollar P, 2012, IEEE T PATTERN ANAL, V34, P743, DOI 10.1109/TPAMI.2011.155; Fritzke B, 1999, KOHONEN MAPS, P131, DOI 10.1016/B978-044450270-4/50010-3; Guan Q, 2013, SYM REL DIST SYST, P205, DOI 10.1109/SRDS.2013.29; Guan T, 2015, ACM T INTEL SYST TEC, V7, DOI 10.1145/2795234; Gunarathne T, 2011, CONCURR COMP-PRACT E, V23, P2338, DOI 10.1002/cpe.1780; He J, 2004, P IEEE INT JOINT C N; Hoz E D L, 2014, KNOWL-BASED SYST, V71, P322, DOI DOI 10.1016/J.KNOSYS.2014.08.013; Hoz E D L, 2015, NEUROCOMPUTING, V164, P71, DOI DOI 10.1016/J.NEUC0M.2014.09.083; Huang DW, 2015, NEURAL NETWORKS, V63, P208, DOI 10.1016/j.neunet.2014.12.003; Ji R, 2016, PATTERN RECOGNITION; Ji RR, 2014, IEEE T GEOSCI REMOTE, V52, P1811, DOI 10.1109/TGRS.2013.2255297; Jin H, 2015, INT J PARALLEL PROG, V43, P403, DOI 10.1007/s10766-013-0286-1; Juan A, 2000, COMP 4 INITIALIZATIO, P842; Junior AHS, 2014, NEUROCOMPUTING, V147, P31; Kiviluoto K., 1996, IEEE INT C NEUR NETW; Kiziloren T, 2009, REV BRASILEIRA CIRUR, V14, P355; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kohonen T., 1997, SELF ORGANIZING MAPS; Koikkalainen P., 1994, ECAI 94. 11th European Conference on Artificial Intelligence. Proceedings, P211; Koikkalainen P, 1990, P 1990 INT JOINT C N; Kourki M, 2014, J GEOPHYS ENG, V11; Kubota R, 2007, IEICE T INF SYST, VE90D, P382, DOI 10.1093/ietisy/e90-d.1.382; Laaksonen J, 1999, IEE CONF PUBL, P174, DOI 10.1049/cp:19991104; Lennard C, 2015, CLIM DYNAM, V44, P861, DOI 10.1007/s00382-014-2169-6; Li JX, 2013, FUTURE GENER COMP SY, V29, P330, DOI 10.1016/j.future.2011.08.001; Liu J, 2016, MATH PROBL ENG, V1, P1, DOI DOI 10.1038/NENERGY.2016.89; Liu JC, 2008, INT J SECUR APPL, V2, P89, DOI 10.1109/ISA.2008.12; Meschino GJ, 2015, NEUROCOMPUTING, V147, P47, DOI 10.1016/j.neucom.2014.02.059; Milojicic D, 2011, IEEE INTERNET COMPUT, V15, P11, DOI 10.1109/MIC.2011.44; Paschalidis IC, 2010, ACM T SENSOR NETWORK, V7, DOI 10.1145/1824766.1824773; Peter B, 2009, USENIX WRKSHP HOT TO; Polani D, 1999, KOHONEN MAPS, P157, DOI 10.1016/B978-044450270-4/50012-7; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Russo T, 2014, PLOS ONE, V9; Rzhetsky A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000061; Sani Y, 2009, IEEE ST CONF RES DEV, P89, DOI 10.1109/SCORED.2009.5443289; Shanahan HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102642; Skupin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058779; Song Y, 2015, J CENT SOUTH UNIV, V22, P601, DOI 10.1007/s11771-015-2561-3; Tan YM, 2012, INT CON DISTR COMP S, P285, DOI 10.1109/ICDCS.2012.65; Tylman W., 2008, P INT C DEP COMP SYS, P211; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Vesanto J., 1999, Intelligent Data Analysis, V3, P111, DOI 10.1016/S1088-467X(99)00013-X; Wang GP, 2015, INT J SECUR APPL, V9, P227, DOI 10.14257/ijsia.2015.9.6.22; Wang H, 2009, BIOMEDICAL ENG INFOR; Wei BC, 2015, MULTIMEDIA SYST, V21, P381, DOI 10.1007/s00530-014-0364-2; Wu ST, 2007, IEEE T NEURAL NETWOR, V18, P385, DOI 10.1109/TNN.2006.887556; Xu ZB, 2015, FRONT COMPUT SCI-CHI, V9, P34, DOI 10.1007/s11704-014-3460-8; Yazar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108490; Zhang Y, 2015, SIGNAL PROCESS, V112, P17, DOI 10.1016/j.sigpro.2014.08.029; Zhao JP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085054, 10.1371/journal.pone.0108005]; Zhou Z, 2015, INT J GRID DISTRIB, V8, P275, DOI 10.14257/ijgdc.2015.8.3.27	61	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187488	10.1371/journal.pone.0187488	http://dx.doi.org/10.1371/journal.pone.0187488			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117245	gold, Green Published, Green Submitted			2022-12-26	WOS:000414659600041
J	Animaw, W; Seyoum, Y				Animaw, Worku; Seyoum, Yeshaneh			Increasing prevalence of diabetes mellitus in a developing country and its related factors	PLOS ONE			English	Article							HEALTH	Background All countries, irrespective of their developmental stage, face an increasing burden of non-communicable diseases including diabetes mellitus. There is substantial evidence of the existence of the gap in the level of diabetes mellitus and its complications prevention and control measures in developing countries. This study aimed to assess the prevalence of diabetes mellitus in urban and rural dwellers in a low-income country from both younger and older population and to identify factors related. Methods This is a community based comparative cross-sectional study conducted in a low-income country, Ethiopia. The sample size was determined by EPI-Info for two populations; the WHO's STEP-wise approach for non-communicable diseases surveillance in developing countries was employed for sampling, study variable selection and data collection procedures. Fasting blood glucose levels were measured by finger pricking after overnight fasting. Data entry was done by EPI-data computer program version 3.1 and then processed by SPSS version 20. Bivariate and multivariate logistic regression tests were used to assess the associations between diabetes status of individuals and its potential predictor variables. P-value < 0.05 was considered as statistically significant level. Result The study was conducted on 1405 individuals with age range of 18-97 years old. The mean fasting blood glucose level for study participants was 91.16mg/dl; while it was 94.73mg/dl for urban and 87.71mg/dl for rural dwellers. The prevalence of diabetes mellitus was 3.3%; while it was 2.0% for rural and (4.6%) for urban dwellers. Both the mean blood glucose level and the prevalence of diabetes mellitus were significantly higher for urban residents than rural. More than three-fourths of diabetic cases were newly diagnosed by this study. Urban dwellers, centrally obese, overweight, and hypertensive individuals have higher odds of getting diabetes mellitus. Conclusions and recommendations High prevalence of diabetes mellitus involving both old and young population was documented. Most diabetic cases were suddenly diagnosed during this survey. The problem is noticeably alarming, attention should be given to the control and prevention of diabetes mellitus and related complications.	[Animaw, Worku; Seyoum, Yeshaneh] Bahir Dar Univ, Sch Nursing, Coll Med & Hlth Sci, Bahir Dar, Ethiopia	Bahir Dar University	Animaw, W (corresponding author), Bahir Dar Univ, Sch Nursing, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	workimaw@gmail.com		TEMESGEN, WORKU ANIMAW/0000-0002-4119-998X				Abebe SM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-97; Admassu G, 2009, ETHIOPIAN J REPROD H, V3; Adugna A., 2014, AMHARA DEMOGRAPHY HL; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Campbell RK, 2009, J AM PHARM ASSOC, V49, pS3, DOI 10.1331/JAPhA.2009.09077; Central America Diabetes Initiative (CAMDI), 2006, SURV DIAB HYP CHRON; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fauci A, 2008, HARRISONS PRINCIPLES, V1; Giday A, 2010, ETHIOP J HEALTH DEV, V24, P145; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Jones T. L. E., 2013, South Sudan Medical Journal, V6, P60; Kim JH, 2014, DIABETES CARE, V37, P671, DOI 10.2337/dc13-1784; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Motala A, 2003, J CARDIOVASCULAR RIS, V10; Rahim M, 2002, I GEN PRACTICE COMMU; WHO, 2021, WHO STEPWISE APPR SU; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2010, STEPW APPR SURV STEP; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 2017, WHO STEPSWISE APPR N; World Health Organization (WHO), 2002, WORLD HEALTH REPORT	24	79	80	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187670	10.1371/journal.pone.0187670	http://dx.doi.org/10.1371/journal.pone.0187670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112962	Green Published, Green Submitted, gold			2022-12-26	WOS:000414572100032
J	Yang, W; Hosford, SR; Traphagen, NA; Shee, K; Demidenko, E; Liu, S; Miller, TW				Yang, Wei; Hosford, Sarah R.; Traphagen, Nicole A.; Shee, Kevin; Demidenko, Eugene; Liu, Stephanie; Miller, Todd W.			Autophagy promotes escape from phosphatidylinositol 3-kinase inhibition in estrogen receptor-positive breast cancer	FASEB JOURNAL			English	Article						PI3K; GDC-0941; chloroquine; ER; BH3-only proteins	ADVANCED SOLID TUMORS; PHASE-I TRIAL; MONITORING AUTOPHAGY; BH3-ONLY PROTEINS; FEEDBACK LOOP; HYDROXYCHLOROQUINE; PUMA; RESISTANT; APOPTOSIS; CELLS	Hyperactivation of the PI3K pathway has been implicated in resistance to antiestrogen therapies in estrogen receptor a (ER)-positive breast cancer, prompting the development of therapeutic strategies to inhibit this pathway. Autophagy has tumor-promoting and -suppressing roles and has been broadly implicated in resistance to anticancer therapies, including antiestrogens. Chloroquine (CQ) is an antimalarial and amebicidal drug that inhibits autophagy in mammalian cells and human tumors. Herein, we observed that CQ inhibited proliferation and autophagy in ER+ breast cancer cells. PI3K inhibition with GDC-0941 (pictilisib) induced autophagy. Inhibition of autophagy using CQ or RNA interference potentiated PI3K inhibitor-induced apoptosis. Combined inhibition of PI3K and autophagy effectively induced mitochondrial membrane depolarization, which required the BH3-only proapoptotic proteins Bim and PUMA. Treatment with GDC-0941, CQ, or the combination, significantly suppressed the growth of ER+ breast cancer xenografts in mice. In an antiestrogen-resistant xenograft model, GDC-0941 synergized with CQ to provide partial, but durable, tumor regression. These findings warrant clinical evaluation of therapeutic strategies to target ER, PI3K, and autophagy for the treatment of ER+ breast cancer.	[Yang, Wei; Hosford, Sarah R.; Traphagen, Nicole A.; Shee, Kevin; Liu, Stephanie; Miller, Todd W.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Dept Mol & Syst Biol, One Med Ctr Dr,HB 7936, Lebanon, NH 03756 USA; [Demidenko, Eugene] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Community & Family Med, Lebanon, NH 03756 USA; [Miller, Todd W.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Comprehens Breast Program, Lebanon, NH 03756 USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center	Miller, TW (corresponding author), Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Dept Mol & Syst Biol, One Med Ctr Dr,HB 7936, Lebanon, NH 03756 USA.	todd.w.miller@dartmouth.edu	Shee, Kevin/V-6803-2019	Shee, Kevin/0000-0001-5378-7650	American Cancer Society [RSG-13-292-01-TBE]; U.S. National Institutes of Health, National Cancer Institute [P30CA023108]; NATIONAL CANCER INSTITUTE [R01CA200994, R01CA211869, P30CA023108, F30CA216966] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the following Norris Cotton Cancer Center Shared Resources for assistance: Flow Cytometry, Microscopy, Pathology, and the Center for Comparative Medicine and Research. This work was supported by the American Cancer Society (Grant RSG-13-292-01-TBE to T.W.M.) and U.S. National Institutes of Health, National Cancer Institute (Grant P30CA023108 to Dartmouth College, Norris Cotton Cancer Center Support). The authors declare no conflicts of interest.	Amente S, 2011, NUCLEIC ACIDS RES, V39, P9498, DOI 10.1093/nar/gkr638; Barnard RA, 2014, AUTOPHAGY, V10, P1415, DOI 10.4161/auto.29165; Baselga J, 2016, CANC RES S, V76; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chude CI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061279; Cook KL, 2014, CLIN CANCER RES, V20, P3222, DOI 10.1158/1078-0432.CCR-13-3227; Cook KL, 2012, CANCER RES, V72, P3337, DOI 10.1158/0008-5472.CAN-12-0269; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Demidenko E., 2013, MIXED MODELS THEORY; Demidenko E, 2006, J R STAT SOC C-APPL, V55, P365, DOI 10.1111/j.1467-9876.2006.00541.x; Demidenko E, 2010, INT J RADIAT BIOL, V86, P164, DOI 10.3109/09553000903419304; Dillon LM, 2015, ONCOGENE, V34, P3968, DOI 10.1038/onc.2014.328; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Echeverry N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.124; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Garner F, 2016, CANC RES, V76; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Guo JYX, 2016, COLD SH Q B, V81, P73, DOI 10.1101/sqb.2016.81.030981; Happo L, 2012, J CELL SCI, V125, P1081, DOI 10.1242/jcs.090514; Hosford SR, 2017, CLIN CANCER RES, V23, P2795, DOI 10.1158/1078-0432.CCR-15-2764; Ji YH, 2015, CLIN LAB, V61, P1043, DOI 10.7754/Clin.Lab.2015.150144; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Krop IE, 2016, LANCET ONCOL, V17, P811, DOI 10.1016/S1470-2045(16)00106-6; Lamoureux F, 2013, CLIN CANCER RES, V19, P833, DOI 10.1158/1078-0432.CCR-12-3114; Lewis Matthew D, 2011, BMC Res Notes, V4, P262, DOI 10.1186/1756-0500-4-262; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Lui A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2490-z; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Mayer IA, 2017, CLIN CANCER RES, V23, P26, DOI 10.1158/1078-0432.CCR-16-0134; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Miller TW, 2009, CLIN CANCER RES, V15, P7266, DOI 10.1158/1078-0432.CCR-09-1665; Molenaar RJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014961; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Ni J, 2012, CANCER DISCOV, V2, P425, DOI 10.1158/2159-8290.CD-12-0003; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Rangwala R, 2014, AUTOPHAGY, V10, P1369, DOI 10.4161/auto.29118; Rosenfeld MR, 2014, AUTOPHAGY, V10, P1359, DOI 10.4161/auto.28984; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Tartarone A, 2012, NEW ENGL J MED, V366, P1739, DOI 10.1056/NEJMc1202719; Team RC., 2014, R LANGUAGE ENV STAT; Vaillant F, 2013, CANCER CELL, V24, P120, DOI 10.1016/j.ccr.2013.06.002; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang C, 2016, PHARMACOL RES, V105, P164, DOI 10.1016/j.phrs.2016.01.028; Wang YC, 2016, ONCOTARGET, V7, P19897, DOI 10.18632/oncotarget.7658; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Wolpin BM, 2014, ONCOLOGIST, V19, P637, DOI 10.1634/theoncologist.2014-0086; Yang W, 2016, CLIN CANCER RES, V22, P2250, DOI 10.1158/1078-0432.CCR-15-2276; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353	60	18	18	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1222	1235		10.1096/fj.201700477R	http://dx.doi.org/10.1096/fj.201700477R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127189	Green Published			2022-12-26	WOS:000427246000010
J	Sala, MA; Chen, C; Zhang, Q; Do-Umehara, HC; Wu, WJ; Misharin, AV; Waypa, GB; Fang, DY; Budinger, GRS; Liu, SW; Chandel, NS; Schumacker, PT; Sznajder, JI; Liu, J				Sala, Marc A.; Chen, Cong; Zhang, Qiao; Do-Umehara, Hanh Chi; Wu, Wenjiao; Misharin, Alexander V.; Waypa, Gregory B.; Fang, Deyu; Budinger, G. R. Scott; Liu, Shuwen; Chandel, Navdeep S.; Schumacker, Paul T.; Sznajder, Jacob I.; Liu, Jing			JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; ARTERY PRESSURE; FACTOR-I; JUN; ACTIVATION; EXPRESSION; MICE; UBIQUITINATION	The hypoxic response is a stress response triggered by low oxygen tension. Hypoxia-inducible factors (HIFs) play a prominent role in the pathobiology of hypoxia-associated conditions, including pulmonary hypertension (PH) and polycythemia. The c-Jun N-terminal protein kinase (JNK), a stress-activated protein kinase that consists of two ubiquitously expressed isoforms, JNK1 and JNK2, and a tissue-specific isoform, JNK3, has been shown to be activated by hypoxia. However, the physiological role of JNK1 and JNK2 in the hypoxic response remains elusive. Here, using genetic knockout cells and/or mice, we show that JNK2, but not JNK1, up-regulates the expression of HIF-1- and HIF-2 alpha and contributes to hypoxia-induced PH and polycythemia. Knockout or silencing of JNK2, but not JNK1, prevented the accumulation of HIF-1- in hypoxia-treated cells. Loss of JNK2 resulted in a decrease in HIF-1 and HIF-2 mRNAlevels under resting conditions and in response to hypoxia. Consequently, hypoxia-treated Jnk2 / mice had reduced erythropoiesis and were less prone to polycythemia because of decreased expression of the HIF target gene erythropoietin (Epo). Jnk2 / mice were also protected from hypoxia-induced PH, as indicated by lower right ventricular systolic pressure, a process that depends on HIF. Taken together, our results suggest that JNK2 is a positive regulator of HIFs and therefore may contribute to HIF-dependent pathologies.	[Sala, Marc A.; Chen, Cong; Zhang, Qiao; Do-Umehara, Hanh Chi; Wu, Wenjiao; Misharin, Alexander V.; Budinger, G. R. Scott; Chandel, Navdeep S.; Sznajder, Jacob I.; Liu, Jing] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Waypa, Gregory B.; Schumacker, Paul T.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Fang, Deyu] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Zhang, Qiao; Wu, Wenjiao; Liu, Shuwen] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou 510515, Guangdong, Peoples R China	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Southern Medical University - China	Liu, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA.	jing@northwestern.edu	Misharin, Alexander/AAD-6456-2019	Liu, Shuwen/0000-0001-6346-5006; Schumacker, Paul T/0000-0001-9591-2034	National Institutes of Health [R01 HL114763-01A1]; American Lung Association Senior Research Training Grant [RT-416649]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139, R01HL114763, P01HL071643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG049665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association Senior Research Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant R01 HL114763-01A1 (to J. L.) and American Lung Association Senior Research Training Grant RT-416649 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; ANTHONISEN NR, 1983, ANN INTERN MED, V99, P519, DOI 10.7326/0003-4819-99-4-519; Ball MK, 2014, AM J RESP CRIT CARE, V189, P314, DOI 10.1164/rccm.201302-0302OC; Barbera JA, 2003, EUR RESPIR J, V21, P892, DOI 10.1183/09031936.03.00115402; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; BERAN M, 1971, SCAND J HAEMATOL, V8, P5; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; COOPER R, 1991, CHEST, V99, P112, DOI 10.1378/chest.99.1.112; Cote C, 2007, EUR RESPIR J, V29, P923, DOI 10.1183/09031936.00137106; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cuttica MJ, 2010, RESP MED, V104, P1877, DOI 10.1016/j.rmed.2010.05.009; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dumitriu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012088; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; Fuchs SY, 1996, ONCOGENE, V13, P1531; Girgis RE, 2007, CLIN CHEST MED, V28, P219, DOI 10.1016/j.ccm.2006.11.006; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Gozal E, 1999, J NEUROCHEM, V73, P665, DOI 10.1046/j.1471-4159.1999.0730665.x; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Guma M, 2009, P NATL ACAD SCI USA, V106, P8760, DOI 10.1073/pnas.0902659106; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Incalzi RA, 1999, CIRCULATION, V99, P1600, DOI 10.1161/01.CIR.99.12.1600; Jin NJ, 2000, AM J RESP CELL MOL, V23, P593, DOI 10.1165/ajrcmb.23.5.3921; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KAMPF D, 1992, NEPHRON, V61, P393, DOI 10.1159/000186955; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Kunz M, 2001, CELL GROWTH DIFFER, V12, P137; LACOMBE C, 1988, J CLIN INVEST, V81, P620, DOI 10.1172/JCI113363; Leclerc Guy J, 2002, Cancer Cell Int, V2, P1, DOI 10.1186/1475-2867-2-1; Lee G, 2015, EUR J INTERN MED, V26, P297, DOI 10.1016/j.ejim.2015.03.007; Lee YJ, 1999, MOL CELL BIOCHEM, V202, P1, DOI 10.1023/A:1007059806016; LESLEY J, 1984, CELL IMMUNOL, V83, P14, DOI 10.1016/0008-8749(84)90220-X; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Luo FB, 2016, CELL PHYSIOL BIOCHEM, V39, P1051, DOI 10.1159/000447812; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McCloskey CA, 2004, SHOCK, V22, P380, DOI 10.1097/01.shk.0000140660.78744.bf; Mishra OP, 2004, NEUROSCIENCE, V123, P179, DOI 10.1016/j.neuroscience.2003.08.008; Nakamura A, 2000, RESPIRATION, V67, P502, DOI 10.1159/000067463; Nijboer CH, 2010, BRAIN BEHAV IMMUN, V24, P812, DOI 10.1016/j.bbi.2009.09.008; OU LC, 1980, J APPL PHYSIOL, V48, P857, DOI 10.1152/jappl.1980.48.5.857; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Park JY, 2016, BIOCHEM BIOPH RES CO, V469, P251, DOI 10.1016/j.bbrc.2015.11.111; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Shang LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010092; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Tournier Cathy, 2013, Genes Cancer, V4, P397, DOI 10.1177/1947601913486349; Tsuboi I, 2015, J CELL PHYSIOL, V230, P1534, DOI 10.1002/jcp.24899; Wang G L, 1996, Curr Opin Hematol, V3, P156; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wanner RM, 2000, BLOOD, V96, P1558, DOI 10.1182/blood.V96.4.1558.h8001558_1558_1565; WEITZENBLUM E, 1981, THORAX, V36, P752, DOI 10.1136/thx.36.10.752; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; YORK EL, 1980, AM REV RESPIR DIS, V121, P813; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhang DY, 2012, J BIOL CHEM, V287, P34361, DOI 10.1074/jbc.M112.365882; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhang Q, 2015, NAT IMMUNOL, V16, P458, DOI 10.1038/ni.3130	71	12	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					271	284		10.1074/jbc.RA117.000440	http://dx.doi.org/10.1074/jbc.RA117.000440			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29118187	hybrid, Green Published			2022-12-26	WOS:000419453200023
J	Ghosh, T; Varshney, A; Kumar, P; Kaur, M; Kumar, V; Shekhar, R; Devi, R; Priyanka, P; Khan, MM; Saxena, S				Ghosh, Tanushree; Varshney, Akhil; Kumar, Praveen; Kaur, Manpreet; Kumar, Vipin; Shekhar, Ritu; Devi, Raksha; Priyanka, Priyanka; Khan, Md Muntaz; Saxena, Sandeep			MicroRNA-874-mediated inhibition of the major G(1)/S phase cyclin, CCNE1, is lost in osteosarcomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell biology; cell cycle; cell proliferation; cyclin; microRNA (miRNA); microRNA mechanism; non-coding RNA; cyclin E1; oncogenesis	CELL-CYCLE; MESSENGER-RNAS; MIR-16 FAMILY; IN-VITRO; CANCER; PROLIFERATION; E1; OVEREXPRESSION; CONTRIBUTES; EXPRESSION	The tumor microenvironment is characterized by nutrient-deprived conditions in which the cancer cells have to adapt for survival. Serum starvation resembles the growth factor deprivation characteristic of the poorly vascularized tumor microenvironment and has aided in the discovery of key growth regulatory genes and microRNAs (miRNAs) that have a role in the oncogenic transformation. We report here that miR-874 down-regulates the major G(1)/S phase cyclin, cyclin E1 (CCNE1), during serum starvation. Because the adaptation of cancer cells to the tumor microenvironment is vital for subsequent oncogenesis, we tested for miR-874 and CCNE1 interdependence in osteosarcoma cells. We observed that miR-874 inhibits CCNE1 expression in primary osteoblasts, but in aggressive osteosarcomas, miR-874 is down-regulated, leading to elevated CCNE1 expression and appearance of cancer-associated phenotypes. We established that loss of miR-874-mediated control of cyclin E1 is a general feature of osteosarcomas. The down-regulation of CCNE1 by miR-874 is independent of E2F transcription factors. Restoration of miR-874 expression impeded S phase progression, suppressing aggressive growth phenotypes, such as cell invasion, migration, and xenograft tumors, in nude mice. In summary, we report that miR-874 inhibits CCNE1 expression during growth factor deprivation and that miR-874 down-regulation in osteosarcomas leads to CCNE1 up-regulation and more aggressive growth phenotypes.	[Ghosh, Tanushree; Varshney, Akhil; Kumar, Praveen; Kaur, Manpreet; Kumar, Vipin; Shekhar, Ritu; Devi, Raksha; Priyanka, Priyanka; Khan, Md Muntaz; Saxena, Sandeep] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Saxena, S (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	sandeep@nii.res.in		Varshney, Akhil/0000-0003-0759-0982; Devi, Raksha/0000-0003-3179-2891; Ghosh, Tanushree/0000-0002-0988-2367; Priyanka, Fnu/0000-0001-7933-3809				Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bar-Joseph Z, 2008, P NATL ACAD SCI USA, V105, P955, DOI 10.1073/pnas.0704723105; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11; Chen MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028203; D'Abaco GM, 2002, J CELL SCI, V115, P4607, DOI 10.1242/jcs.00161; Ekholm SV, 2001, MOL CELL BIOL, V21, P3256, DOI 10.1128/MCB.21.9.3256-3265.2001; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Golpour M, 2014, INT J MOL CELL MED, V3, P74; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Han JF, 2016, ONCOL REP, V36, P542, DOI 10.3892/or.2016.4810; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Iida H, 1997, BLOOD, V90, P3707, DOI 10.1182/blood.V90.9.3707; Zubillaga-Guerrero MI, 2015, INT J CLIN EXP MED, V8, P15999; Jiang BF, 2014, J GASTROENTEROL, V49, P1011, DOI 10.1007/s00535-013-0851-9; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lauvrak SU, 2013, BRIT J CANCER, V109, P2228, DOI 10.1038/bjc.2013.549; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Levin VA, 2010, J PROTEOME RES, V9, P179, DOI 10.1021/pr900392b; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lockwood WW, 2011, J MOL DIAGN, V13, P289, DOI 10.1016/j.jmoldx.2010.11.020; MCALLISTER RM, 1971, CANCER-AM CANCER SOC, V27, P397, DOI 10.1002/1097-0142(197102)27:2<397::AID-CNCR2820270224>3.0.CO;2-X; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Nohata N, 2013, BRIT J CANCER, V108, P1648, DOI 10.1038/bjc.2013.122; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Pautke C, 2004, ANTICANCER RES, V24, P3743; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Sheinerman KS, 2013, AGING-US, V5, P925, DOI 10.18632/aging.100624; Shtutman M, 2003, EXP CELL RES, V286, P22, DOI 10.1016/S0014-4827(03)00087-9; Suh EJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r121; Tashiro E, 2003, CANCER RES, V63, P424; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Tissier F, 2004, EUR J ENDOCRINOL, V150, P809, DOI 10.1530/eje.0.1500809; Wang F, 2009, BMB REP, V42, P725, DOI 10.5483/BMBRep.2009.42.11.725; Wang J, 2014, TUMOR BIOL, V35, P4859, DOI 10.1007/s13277-014-1637-2; Wang L, 2014, FEBS LETT, V588, P4527, DOI 10.1016/j.febslet.2014.09.035; Wolowiec D, 1996, BRIT J HAEMATOL, V95, P518, DOI 10.1046/j.1365-2141.1996.d01-1930.x; Yang R, 2017, CELL PHYSIOL BIOCHEM, V42, P126, DOI 10.1159/000477121; Yasui W, 1996, VIRCHOWS ARCH, V429, P13; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zhang FY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0187-x; Zhang RP, 2017, ONCOTARGET, V8, P26079, DOI 10.18632/oncotarget.15317; Zhang X, 2014, BIOCHEM BIOPH RES CO, V443, P1078, DOI 10.1016/j.bbrc.2013.12.095; Zhang XY, 2015, ONCOTARGET, V6, P1605, DOI 10.18632/oncotarget.2748; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492	48	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21264	21281		10.1074/jbc.M117.808287	http://dx.doi.org/10.1074/jbc.M117.808287			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29109143	Green Published, hybrid			2022-12-26	WOS:000419013000005
J	Wang, L; Tong, X; Gu, F; Zhang, L; Chen, W; Cheng, XW; Xie, LW; Chang, YS; Zhang, HB				Wang, Lu; Tong, Xin; Gu, Fang; Zhang, Lei; Chen, Wei; Cheng, Xiaowen; Xie, Liwei; Chang, Yongsheng; Zhang, Huabing			The KLF14 transcription factor regulates hepatic gluconeogenesis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gluconeogenesis; Kruppel-like factor 14 (KLF14); PGC-1; type 2 diabetes; peroxisome proliferator-activated receptor coactivator 1 (PPARGC1); diabetes; hepatocyte; glucose metabolism	DEPENDENT DIABETES-MELLITUS; INSULIN-RESISTANCE; PGC-1-ALPHA; METABOLISM; GLUCOSE; IDENTIFICATION; ASSOCIATION; GENERATION; HEALTH; FAMILY	Kruppel-like factor 14 (KLF14) is a member of the Cys(2)/His(2) zinc-finger DNA-binding proteins. Despite strong evidence showing that a polymorphism in the Klf14 gene is closely linked to the development of type 2 diabetes, the physiological and metabolic functions of KLF14 still remain unclear. In the present study, we investigated the role of KLF14 in the regulation of hepatic gluconeogenesis. Adenoviruses expressing KLF14 (Ad-Klf14) or KLF14-specific shRNAs (Ad-shKlf14) were injected into normal C57BL/6J, db/db diabetic, or high-fat diet-induced obese (DIO) mice. Gene expression, hepatic glucose production, glucose tolerance, and insulin resistance were tested in C57BL/6J, db/db, and DIO mice and primary hepatocytes. Our results demonstrate that KLF14 expression is induced in the livers of normal C57BL/6J mice upon fasting and significantly up-regulated in the livers of db/db mice, suggesting a physiological link between KLF14 and gluconeogenesis. Adenovirus-mediated overexpression of KLF14 in primary hepatocytes increased both the mRNA and protein levels of peroxisome proliferator-activated receptor- coactivator 1 (Pgc-1, also known as Ppargc1a), thereby stimulating cellular glucose production. Conversely, knockdown of KLF14 expression led to a reduction in PGC-1, subsequently inhibiting glucose output in primary hepatocytes. Finally, forced expression of KLF14 in the livers of normal mice increased the plasma glucose levels and impaired glucose tolerance; in contrast, KLF14 knockdown in diabetic mouse livers improved glucose tolerance. Taken together, our data strongly indicate that KLF14 modulates hepatic gluconeogenesis.	[Wang, Lu; Tong, Xin; Gu, Fang; Zhang, Huabing] Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei 230032, Anhui, Peoples R China; [Zhang, Lei; Chang, Yongsheng] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; [Zhang, Lei; Chang, Yongsheng] Peking Union Med Coll, Beijing 100005, Peoples R China; [Chen, Wei] Anhui Med Univ, Dept Gen Surg, Affiliated Hosp 1, Hefei 230032, Anhui, Peoples R China; [Cheng, Xiaowen] Anhui Med Univ, Dept Clin Lab, Affiliated Hosp 1, Hefei 230032, Anhui, Peoples R China; [Xie, Liwei] Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangzhou 510070, Guangdong, Peoples R China	Anhui Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Anhui Medical University; Anhui Medical University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Zhang, HB (corresponding author), Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei 230032, Anhui, Peoples R China.; Chang, YS (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China.; Chang, YS (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Xie, LW (corresponding author), Guangdong Inst Microbiol, 100 Xianlie Middle Rd,Bldg 58, Guangzhou 500070, Guangdong, Peoples R China.	liweixie1984@gmail.com; changy@ibms.pumc.edu.cn; slzhang1977@163.com		zhang, huabing/0000-0001-8402-7830	National Natural Science Foundation of China [81670517, 31371191]; Natural Science Foundation of Anhui Province [1408085MH153, 1508085MH175]; Anhui Provincial Excellent Young Talent Support Program [gxyqAD2017024]; Open Project of State Key Laboratory of Medical Molecular Biology (Peking Union Medical College, National Laboratory Special Fund) [2060204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Anhui Provincial Excellent Young Talent Support Program; Open Project of State Key Laboratory of Medical Molecular Biology (Peking Union Medical College, National Laboratory Special Fund)	This work was supported by National Natural Science Foundation of China Grants 81670517 and 31371191, Natural Science Foundation of Anhui Province Grants 1408085MH153 and 1508085MH175, Anhui Provincial Excellent Young Talent Support Program Grant gxyqAD2017024, and the Open Project of State Key Laboratory of Medical Molecular Biology (Peking Union Medical College, National Laboratory Special Fund 2060204). The authors declare that they have no conflicts of interest with the contents of this article.	Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Canto C, 2010, CELL METAB, V11, P6, DOI 10.1016/j.cmet.2009.12.003; Civelek M, 2011, NAT GENET, V43, P506, DOI 10.1038/ng.842; Cui Y, 2016, DIABETOLOGIA, V59, P2229, DOI 10.1007/s00125-016-4043-z; de Assuncao TM, 2014, J BIOL CHEM, V289, P15798, DOI 10.1074/jbc.M113.544346; DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313; GERICH JE, 1991, DIABETOLOGIA, V34, P607, DOI 10.1007/BF00400282; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Guo YH, 2015, J CLIN INVEST, V125, P3819, DOI 10.1172/JCI79048; Hanson RL, 2013, DIABETES, V62, P2984, DOI 10.2337/db12-1767; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nielsen T, 2011, DIABETOLOGIA, V54, P1052, DOI 10.1007/s00125-011-2054-3; Parker-Katiraee L, 2007, PLOS GENET, V3, P665, DOI 10.1371/journal.pgen.0030065; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Schmidt SF, 2011, GENE DEV, V25, P1453, DOI 10.1101/gad.2076411; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Yang M, 2015, CELL SIGNAL, V27, P2201, DOI 10.1016/j.cellsig.2015.07.019; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089552; Zhang HB, 2013, J HEPATOL, V58, P763, DOI 10.1016/j.jhep.2012.11.024	33	15	16	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21631	21642		10.1074/jbc.RA117.000184	http://dx.doi.org/10.1074/jbc.RA117.000184			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29123026	Green Published, hybrid			2022-12-26	WOS:000419013000037
J	Cao, Y; Ye, Q; Zhuang, MF; Xie, SW; Zhong, RH; Cui, JG; Zhou, JY; Zhu, Y; Zhang, TT; Cao, L				Cao, Yang; Ye, Qing; Zhuang, Mengfei; Xie, Shuwu; Zhong, Ruihua; Cui, Jingang; Zhou, Jieyun; Zhu, Yan; Zhang, Tingting; Cao, Lin			Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; EXPRESSION; STRATEGIES; RAPAMYCIN; TARGET; CELLS; AKT	Objective This study aimed to investigate the link between the inhibitory effect of ginsenoside Rg3 on the ectopic endometrium growth and the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway, a mechanism known to inhibit angiogenesis and induce ectopic endometrial cell apoptosis. Materials and methods A model of endometriosis was established by allotransplantation in rats. The rats were randomly divided into 5 groups: the ginsenoside Rg3 low-dose group (group A,5mg/kgBW/d of ginsenoside Rg3), the ginsenoside Rg3 high-dose group (group B, 10mg/kgBW/d of ginsenoside Rg3), the gestrinone group (group C, 0.5mg/kgBW/d of gestrinone), the control group (groupD, 10ml/kg BW/d of 0.5% CMC-Na) and the ovariectomized group (group E, 10ml/kgBW/d of 0.5% CMC-Na). Rats were executed after 21 days of continuous administration. The ectopic endometrium volume was measured and the inhibitory rate was calculated. The levels of serum estradiol (E-2) and progesterone (P) were detected by Electro-Chemiluminescence Immunoassay (ECLI). The protein expression of VEGF, VEGFR-2, pAkt, and p-mTOR inthe ectopic endometrium wastested by immunohistochemistry(IHC) and Western Blotting. The mRNA expression levels of VEGF, VEGFR-2, Akt, and mTOR were tested by Real-Time Polymerase Chain Reaction (PCR). The apoptosis rate of the ectopic endometrial cells was detected by Terminal Deoxynucleotidyl Transferase-mediated Digoxigenin-dUTP Nick-End Labeling Assay(TUNEL). Main results Tissue measurements revealed a dose-dependent inhibition effect of ginsenoside Rg3 on the growth of the ectopic endometrium in treated rats compared to controls. Immunohistochemical and Western Blotting assays confirmed that the expression of VEGF, p-Akt, and p-mTOR was down-regulated in ginsenoside Rg3 -treated lesions. Real-time PCR results also showed that the mRNA expression levels of VEGF, Akt, and mTOR in the ectopic endometrium were reduced. Conclusions The present study demonstrates, for the first time, that ginsenoside Rg3 suppresses angiogenesis in developing endometrial lesions. The ginsenoside Rg3 inhibitory effect on the growth of the ectopic endometrium in EMs rats might occur through the blocking of the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway, thus halting angiogenesis and promoting the apoptosis of ectopic endometrial cells.	[Cao, Yang; Zhuang, Mengfei; Zhang, Tingting] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Dept Gynecol, Shanghai, Peoples R China; [Ye, Qing] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Neurol, Shanghai, Peoples R China; [Xie, Shuwu; Zhong, Ruihua; Zhou, Jieyun; Zhu, Yan; Cao, Lin] Shanghai Inst Planned Parenthood Res, Dept Reprod Pharmacol, NPFPC Key Lab Contracept & Devices, Shanghai, Peoples R China; [Cui, Jingang] Shanghai Univ Tradit Chinese Med, Clin Res Inst Integrat Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Zhang, TT (corresponding author), Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Dept Gynecol, Shanghai, Peoples R China.; Zhu, Y (corresponding author), Shanghai Inst Planned Parenthood Res, Dept Reprod Pharmacol, NPFPC Key Lab Contracept & Devices, Shanghai, Peoples R China.	zhuyan0311@163.com; tingting185@aliyun.com	庄, 梦斐/GWV-0486-2022	zhang, tingting/0000-0002-1919-1471	National Natural Science Foundation of China [81302996]; Shanghai Municipal population and Family Planning commission [ZY3-CCCX-3-3019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal population and Family Planning commission	This project was supported by the National Natural Science Foundation of China (No. 81302996) and Shanghai Municipal population and Family Planning commission (No.ZY3-CCCX-3-3019). The funders provide only financial aid, and there was no individuals employed or contracted by the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang KK, 2013, INT J CLIN EXP PATHO, V6, P2030; Chen SH, 2011, CHINESE MED FRONTIER, V6, P26; Djokovic D, 2014, ACTA MEDICA PORT, V27, P489, DOI 10.20344/amp.5244; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Hull ML, 2003, J CLIN ENDOCR METAB, V88, P2889, DOI 10.1210/jc.2002-021912; Jie H, 2011, CHIN J NEW DRUGS, V20, P2415; JONES RC, 1984, ACTA ENDOCRINOL-COP, V106, P282, DOI 10.1530/acta.0.1060282; Kang ZC, 2013, BASIC CLIN PHARMACOL, V113, P221, DOI 10.1111/bcpt.12094; Kim JW, 2012, CANCER BIOL THER, V13, P504, DOI 10.4161/cbt.19599; Kodaman PH, 2015, OBSTET GYN CLIN N AM, V42, P87, DOI 10.1016/j.ogc.2014.10.005; Laschke MW, 2012, HUM REPROD UPDATE, V18, P682, DOI 10.1093/humupd/dms026; Leconte M, 2011, AM J PATHOL, V179, P880, DOI 10.1016/j.ajpath.2011.04.020; Liu JX, 2014, MAR DRUGS, V12, P2790, DOI 10.3390/md12052790; Liu SG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166658; Matsumoto T, 2015, AM J CLIN PATHOL, V144, P452, DOI 10.1309/AJCPZ5T2POOFMQVN; Matsuzaki S, 2001, FERTIL STERIL, V76, P712, DOI 10.1016/S0015-0282(01)02003-9; Matsuzaki S, 2015, HUM REPROD, V30, P1606, DOI 10.1093/humrep/dev108; Mayerhofer M, 2002, BLOOD, V100, P3767, DOI 10.1182/blood-2002-01-0109; de Carvalho MDR, 2015, REV BRAS GINECOL OBS, V37, P77, DOI [10.1590/SO100-720320140005199, 10.1590/S0100-720320140005199]; Steven L, 2013, AVMA GUIDELINES EUTH, V2013, P20; Wang NN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/546479; Wei W, 2010, EXPT METHODOLOGY PHA, P68; Yeo SG, 2013, INT J MED SCI, V10, P1199, DOI 10.7150/ijms.5169; Zhang H, 2010, MOL CELL ENDOCRINOL, V317, P31, DOI 10.1016/j.mce.2009.11.009	26	46	50	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186520	10.1371/journal.pone.0186520	http://dx.doi.org/10.1371/journal.pone.0186520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140979	gold, Green Published, Green Submitted			2022-12-26	WOS:000415260400007
J	Yadav, N; Chandra, H				Yadav, Niket; Chandra, Harish			Suppression of inflammatory and infection responses in lung macrophages by eucalyptus oil and its constituent 1,8-cineole: Role of pattern recognition receptors TREM-1 and NLRP3, the MAP kinase regulator MKP-1, and NF kappa B	PLOS ONE			English	Article							LPS; EXPRESSION; ACTIVATION; MICE; ANTIMICROBIALS; CYTOKINE; SIGNAL; SHOCK	Eucalyptus oil (EO) used in traditional medicine continues to prove useful for aroma therapy in respiratory ailments; however, there is a paucity of information on its mechanism of action and active components. In this direction, we investigated EO and its dominant constituent 1,8-cineole (eucalyptol) using the murine lung alveolar macrophage (AM) cell line MH-S. In an LPS-induced AM inflammation model, pre-treatment with EO significantly reduced (P <= 0.01 or 0.05) the pro-inflammatory mediators TNF-alpha, IL-1 (alpha and beta), and NO, albeit at a variable rate and extent; 1,8-cineole diminished IL-1 and IL-6. In a mycobacterial-infection AM model, EO pre-treatment or post-treatment significantly enhanced (P <= 0.01) the phagocytic activity and pathogen clearance. 1,8-cineole also significantly enhanced the pathogen clearance though the phagocytic activity was not significantly altered. EO or 1,8-cineole pre-treatment attenuated LPS-induced inflammatory signaling pathways at various levels accompanied by diminished inflammatory response. Among the pattern recognition receptors (PRRs) involved in LPS signaling, the TREM pathway surface receptor (TREM-1) was significantly downregulated. Importantly, the pre-treatments significantly downregulated (P <= 0.01) the intracellular PRR receptor NLRP3 of the inflammasome, which is consistent with the decrease in IL-1 beta secretion. Of the shared downstream signaling cascade for these PRR pathways, there was significant attenuation of phosphorylation of the transcription factor NF-kappa B and p38 (but increased phosphorylation of the other two MAP kinases, ERK1/2 and JNK1/2). 1,8-cineole showed a similar general trend except for an opposite effect on NF-kappa B and JNK1/2. In this context, either pre-treatment caused a significant downregulation of MKP-1 phosphatase, a negative regulator of MAPKs. Collectively, our results demonstrate that the anti-inflammatory activity of EO and 1,8-cineole is modulated via selective downregulation of the PRR pathways, including PRR receptors (TREM-1 and NLRP3) and common downstream signaling cascade partners (NF-kappa B, MAPKs, MKP-1). To our knowledge, this is the first report on the modulatory role of TREM-1 and NLRP3 inflammasome pathways and the MAPK negative regulator MKP-1 in context of the anti-inflammatory potential of EO and its constituent 1,8-cineole.	[Yadav, Niket; Chandra, Harish] Univ Cincinnati, Coll Med, Microbial Pathogenesis & Immunotoxicol Lab, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati	Chandra, H (corresponding author), Univ Cincinnati, Coll Med, Microbial Pathogenesis & Immunotoxicol Lab, Cincinnati, OH 45220 USA.	harish.chandra@uc.edu	chandra, Harish/GQB-5139-2022	Yadav, Niket/0000-0003-0544-2417	University of Cincinnati funds; Microbial Pathogenesis and Immunotoxicology Laboratory	University of Cincinnati funds; Microbial Pathogenesis and Immunotoxicology Laboratory	The study was supported in part by the University of Cincinnati funds. NY acknowledges the Microbial Pathogenesis and Immunotoxicology Laboratory for providing support for this research.; NY acknowledges the Microbial Pathogenesis and Immunotoxicology Laboratory for providing the opportunity and support for this research.	Alvarenga RFR, 2014, J NAT PROD, V77, P603, DOI 10.1021/np400872m; Angela E, 2010, ALTERN MED REV, V15, P33; Atochina-Vasserman EN, 2007, J IMMUNOL, V179, P8090, DOI 10.4049/jimmunol.179.12.8090; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bastos VPD, 2011, BASIC CLIN PHARMACOL, V108, P34, DOI 10.1111/j.1742-7843.2010.00622.x; Bode JG, 2012, CELL SIGNAL, V24, P1185, DOI 10.1016/j.cellsig.2012.01.018; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Camporese Alessandro, 2013, Infez Med, V21, P117; Cermelli C, 2008, CURR MICROBIOL, V56, P89, DOI 10.1007/s00284-007-9045-0; Chandra H, 2016, MOL IMMUNOL, V75, P168, DOI 10.1016/j.molimm.2016.05.020; Chandra H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083172; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chi HB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.141pe44; Frank EA, 2016, TOXICOL PATHOL, V44, P211, DOI 10.1177/0192623315620587; Gochman E, 2012, ACTA HISTOCHEM, V114, P827, DOI 10.1016/j.acthis.2012.02.004; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gurung P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14488; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Juergens UR, 2004, PULM PHARMACOL THER, V17, P281, DOI 10.1016/j.pupt.2004.06.002; Jun YS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/502727; Khan NM, 2017, FREE RADICAL BIO MED, V106, P288, DOI 10.1016/j.freeradbiomed.2017.02.041; Kim YH, 2005, IMMUNOL LETT, V99, P45, DOI 10.1016/j.imlet.2004.12.007; Kumar H.D., 2011, INT J RES AYURVEDA P, V2, P1527; Laird K, 2012, LETT APPL MICROBIOL, V54, P169, DOI 10.1111/j.1472-765X.2011.03190.x; Lind M, 2017, BIOMED PHARMACOTHER, V93, P370, DOI 10.1016/j.biopha.2017.06.036; Lioberas J, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00028; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Medina E, 2016, CURR TOP MICROBIOL, V398, P3, DOI 10.1007/82_2016_492; Moens U, 2013, GENES-BASEL, V4, P101, DOI 10.3390/genes4020101; Mulyaningsih, 2011, PHARM BIOL, V49, P893, DOI 10.3109/13880209.2011.553625; Murakami Y, 2007, J IMMUNOL, V178, P1144, DOI 10.4049/jimmunol.178.2.1144; Perez-Roses R, 2015, J AGR FOOD CHEM, V63, P1496, DOI 10.1021/jf504761m; Rantzsch U, 2009, EUR J MED RES, V14, P205, DOI 10.1186/2047-783X-14-S4-205; Santos FA, 2000, PHYTOTHER RES, V14, P240, DOI 10.1002/1099-1573(200006)14:4&lt;240::AID-PTR573&gt;3.0.CO;2-X; Sarkar S, 2016, CURR MED CHEM, V23, P1657, DOI 10.2174/0929867323666160418115540; Serafino A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-17; Silva J, 2003, J ETHNOPHARMACOL, V89, P277, DOI 10.1016/j.jep.2003.09.007; Subramani R, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0848-9; Tabuti JRS, 2010, J ETHNOPHARMACOL, V127, P130, DOI 10.1016/j.jep.2009.09.035; Tsai ML, 2011, BIOSCI BIOTECH BIOCH, V75, P1977, DOI 10.1271/bbb.110377; Tucsek Z, 2011, J LEUKOCYTE BIOL, V89, P105, DOI 10.1189/jlb.0610355; Vuong QV, 2015, CHEM BIODIVERS, V12, P907, DOI 10.1002/cbdv.201400327; Yadav N, 2017, IMMUNOBIOL; Yadav N, 2012, ALT MED STU, V2, pE13; Zhao CZ, 2014, INFLAMMATION, V37, P566, DOI 10.1007/s10753-013-9770-4; ZHAO X, 2015, J CIV STRUCT HEALTH, V5, P1	46	32	38	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188232	10.1371/journal.pone.0188232	http://dx.doi.org/10.1371/journal.pone.0188232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141025	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400071
J	Ismail, M; Soliman, A; Ghazal, M; Switala, AE; Gimel'farb, G; Barnes, GN; Khalil, A; El-Baz, A				Ismail, Marwa; Soliman, Ahmed; Ghazal, Mohammed; Switala, Andrew E.; Gimel'farb, Georgy; Barnes, Gregory N.; Khalil, Ashraf; El-Baz, Ayman			A fast stochastic framework for automatic MR brain images segmentation	PLOS ONE			English	Article							TISSUE SEGMENTATION; LEVEL SET; MODEL; INTEGRATION	This paper introduces a new framework for the segmentation of different brain structures (white matter, gray matter, and cerebrospinal fluid) from 3D MR brain images at different life stages. The proposed segmentation framework is based on a shape prior built using a subset of co-aligned training images that is adapted during the segmentation process based on first-and second-order visual appearance characteristics of MR images. These characteristics are described using voxel-wise image intensities and their spatial interaction features. To more accurately model the empirical grey level distribution of the brain signals, we use a linear combination of discrete Gaussians (LCDG) model having positive and negative components. To accurately account for the large inhomogeneity in infant MRIs, a higher-order Markov-Gibbs Random Field (MGRF) spatial interaction model that integrates third-and fourth-order families with a traditional second-order model is proposed. The proposed approach was tested and evaluated on 102 3D MR brain scans using three metrics: the Dice coefficient, the 95-percentile modified Hausdorff distance, and the absolute brain volume difference. Experimental results show better segmentation of MR brain images compared to current open source segmentation tools.	[Ismail, Marwa; Soliman, Ahmed; Ghazal, Mohammed; Switala, Andrew E.; El-Baz, Ayman] Univ Louisville, Bioengn Dept, Louisville, KY 40292 USA; [Ghazal, Mohammed; Khalil, Ashraf] Abu Dhabi Univ, Dept Elect & Comp Engn, Abu Dhabi, U Arab Emirates; [Gimel'farb, Georgy] Univ Auckland, Dept Comp Sci, Auckland, New Zealand; [Barnes, Gregory N.] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA	University of Louisville; Abu Dhabi University; University of Auckland; University of Louisville	El-Baz, A (corresponding author), Univ Louisville, Bioengn Dept, Louisville, KY 40292 USA.	ayman.elbaz@louisville.edu	El-Baz, Ayman/AAC-6689-2019; , CONTRACT_ADMIN/R-7014-2019; Soliman, Ahmed/I-1601-2013	El-Baz, Ayman/0000-0001-7264-1323; Ghazal, Mohammed/0000-0002-9045-6698; Soliman, Ahmed/0000-0002-1931-3416; Switala, Andrew/0000-0002-4438-3758; Khalil, Ashraf/0000-0003-1584-8525	University of Louisville 21st Century University Initiative on Big Data in Medicine	University of Louisville 21st Century University Initiative on Big Data in Medicine	This work has been supported by the University of Louisville 21st Century University Initiative on Big Data in Medicine.; This work has been supported by the University of Louisville 21st Century University Initiative on Big Data in Medicine.	Alansary A, 2016, IEEE J BIOMED HEALTH, V20, P925, DOI 10.1109/JBHI.2015.2415477; Altaye M, 2008, NEUROIMAGE, V43, P721, DOI 10.1016/j.neuroimage.2008.07.060; Anbeek P, 2008, PEDIATR RES, V63, P158, DOI 10.1203/PDR.0b013e31815ed071; Angelini ED, 2004, PROC SPIE, V5370, P526, DOI 10.1117/12.535860; [Anonymous], 2001, INT C MEDICAL IMAGE, DOI DOI 10.1007/3-540-45468-3_62; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Balafar MA, 2010, ARTIF INTELL REV, V33, P261, DOI 10.1007/s10462-010-9155-0; Barkovich AJ, 2005, J INHERIT METAB DIS, V28, P311, DOI 10.1007/s10545-005-5952-z; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; BESAG J, 1986, J R STAT SOC B, V48, P259; Bournan C, 1993, IEEE T IMAGE PROCESS, V2, P296, DOI 10.1109/83.236536; Bourouis S, 2010, INT J IMAGE GRAPH, V10, P135, DOI 10.1142/S0219467810003706; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; Chen H, 2016, VOXRESNET DEEP VOXEL; Cherel M, 2015, PROC SPIE, V9413, DOI 10.1117/12.2082209; Ciofolo C, 2009, MED IMAGE ANAL, V13, P456, DOI 10.1016/j.media.2009.02.008; Colliot O, 2006, PATTERN RECOGN, V39, P1401, DOI 10.1016/j.patcog.2006.02.022; Dai YK, 2013, NEUROINFORMATICS, V11, P211, DOI 10.1007/s12021-012-9164-z; de Brebisson Alexandre, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P20, DOI 10.1109/CVPRW.2015.7301312; del Fresno M, 2009, COMPUT MED IMAG GRAP, V33, P369, DOI 10.1016/j.compmedimag.2009.03.002; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Egekher V.S., 2012, MICCAI GRAND CHALLEN, P22; El-Baz A., 2015, STOCHASTIC MODELING; El-Baz A, 2012, IEEE T BIO-MED ENG, V59, P2019, DOI 10.1109/TBME.2012.2196434; Farag AA, 2006, IEEE T IMAGE PROCESS, V15, P952, DOI 10.1109/TIP.2005.863949; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Hall D, 2012, NEUROINFORMATICS, V10, P331, DOI 10.1007/s12021-012-9151-4; Han X, 2007, IEEE T MED IMAGING, V26, P479, DOI 10.1109/TMI.2007.893282; Huang A, 2009, IEEE T BIO-MED ENG, V56, P1838, DOI 10.1109/TBME.2009.2017509; Ismail M, 2016, I S BIOMED IMAGING, P6, DOI 10.1109/ISBI.2016.7493198; Ismail M, 2015, IEEE IMAGE PROC, P4327, DOI 10.1109/ICIP.2015.7351623; Janney JB, 2014, ADV INTELL SYST, V216, P111, DOI 10.1007/978-81-322-1299-7_11; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Ledig C, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P896, DOI 10.1109/ISBI.2012.6235693; Li L, 2014, UNIFYING ELECT ENG E, P1233; Liu JX, 2009, J NEUROSCI METH, V183, P255, DOI 10.1016/j.jneumeth.2009.05.011; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; Mahmood Q, 2015, IRBM, V36, P185, DOI 10.1016/j.irbm.2015.01.007; Makropoulos A, 2014, IEEE T MED IMAGING, V33, P1818, DOI 10.1109/TMI.2014.2322280; Mayer A, 2009, IEEE T MED IMAGING, V28, P1238, DOI 10.1109/TMI.2009.2013850; Mewes AUJ, 2006, PEDIATRICS, V118, P23, DOI 10.1542/peds.2005-2675; Miri S, 2008, LECT NOTES COMPUT SC, V5099, P67, DOI 10.1007/978-3-540-69905-7_8; Moeskops P, 2015, NEUROIMAGE, V118, P628, DOI 10.1016/j.neuroimage.2015.06.007; Morin J., 2012, P IEEE COMP SOC C CO, P44; Ng HP, 2006, 7TH IEEE SOUTHWEST SYMPOSIUM ON IMAGE ANALYSIS AND INTERPRETATION, P61; Ortiz A, 2011, ELECTRON LETT, V47, P585, DOI 10.1049/el.2011.0322; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pohl KA, 2006, NEUROIMAGE, V31, P228, DOI 10.1016/j.neuroimage.2005.11.044; Ruogu Fang, 2010, Proceedings of 2010 Western New York Image Processing Workshop (WNYIPW), P10, DOI 10.1109/WNYIPW.2010.5649772; Sabuncu MR, 2010, IEEE T MED IMAGING, V29, P1714, DOI 10.1109/TMI.2010.2050897; Serag A, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00002; Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066; Soliman A, 2017, IEEE T MED IMAGING, V36, P263, DOI 10.1109/TMI.2016.2606370; Song T, 2007, IEEE T NEURAL NETWOR, V18, P1424, DOI 10.1109/TNN.2007.891635; Song Z, 2007, LECT NOTES COMPUT SC, V4791, P883; Song Z, 2006, I S BIOMED IMAGING, P762; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van der Lijn F, 2012, IEEE T MED IMAGING, V31, P276, DOI 10.1109/TMI.2011.2168420; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Wang L, 2015, NEUROIMAGE, V108, P160, DOI 10.1016/j.neuroimage.2014.12.042; Wang L, 2013, LECT NOTES COMPUT SC, V8149, P703, DOI 10.1007/978-3-642-40811-3_88; Wang L, 2013, HUM BRAIN MAPP, V34, P956, DOI 10.1002/hbm.21486; Wang L, 2010, J NEUROSCI METH, V188, P316, DOI 10.1016/j.jneumeth.2010.03.004; Weber J, 2015, BILDVERARBEITUNG FUR DIE MEDIZIN 2015: ALGORITHMEN - SYSTEME - ANWENDUNGEN, P389, DOI 10.1007/978-3-662-46224-9_67; Weisenfeld NI, 2009, NEUROIMAGE, V47, P564, DOI 10.1016/j.neuroimage.2009.04.068; Xiao-hong Wang, 2014, Applied Mechanics and Materials, V536-537, P218, DOI 10.4028/www.scientific.net/AMM.536-537.218; Xue H, 2007, NEUROIMAGE, V38, P461, DOI 10.1016/j.neuroimage.2007.07.030; Zhang WL, 2015, NEUROIMAGE, V108, P214, DOI 10.1016/j.neuroimage.2014.12.061; Zhao M, 2015, APPL MATH, V9, P1971, DOI DOI 10.12785/amis/090437	72	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187391	10.1371/journal.pone.0187391	http://dx.doi.org/10.1371/journal.pone.0187391			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136034	gold, Green Published, Green Submitted			2022-12-26	WOS:000415121200018
J	Pyo, S; Lee, J; Cha, M; Jang, H				Pyo, Sujin; Lee, Jaewook; Cha, Mincheol; Jang, Huisu			Predictability of machine learning techniques to forecast the trends of market index prices: Hypothesis testing for the Korean stock markets	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; SUPPORT VECTOR MACHINES; MODELS	The prediction of the trends of stocks and index prices is one of the important issues to market participants. Investors have set trading or fiscal strategies based on the trends, and considerable research in various academic fields has been studied to forecast financial markets. This study predicts the trends of the Korea Composite Stock Price Index 200 (KOSPI 200) prices using nonparametric machine learning models: artificial neural network, support vector machines with polynomial and radial basis function kernels. In addition, this study states controversial issues and tests hypotheses about the issues. Accordingly, our results are inconsistent with those of the precedent research, which are generally considered to have high prediction performance. Moreover, Google Trends proved that they are not effective factors in predicting the KOSPI 200 index prices in our frameworks. Furthermore, the ensemble methods did not improve the accuracy of the prediction.	[Pyo, Sujin; Lee, Jaewook; Cha, Mincheol; Jang, Huisu] Seoul Natl Univ, Dept Ind Engn, Seoul, South Korea	Seoul National University (SNU)	Jang, H (corresponding author), Seoul Natl Univ, Dept Ind Engn, Seoul, South Korea.	gmltn7798@snu.ac.kr			National Research Foundation of Korea (NRF) grant - Korean government (MEST) [2016R1A2B3014030]	National Research Foundation of Korea (NRF) grant - Korean government (MEST)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2016R1A2B3014030). Jaewook Lee is a recipient of the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Da Z, 2011, J FINANC, V66, P1461, DOI 10.1111/j.1540-6261.2011.01679.x; Guresen E, 2011, EXPERT SYST APPL, V38, P10389, DOI 10.1016/j.eswa.2011.02.068; Huang W, 2005, COMPUT OPER RES, V32, P2513, DOI 10.1016/j.cor.2004.03.016; Kim KJ, 2003, NEUROCOMPUTING, V55, P307, DOI 10.1016/S0925-2312(03)00372-2; Kohzadi N, 1996, NEUROCOMPUTING, V10, P169, DOI 10.1016/0925-2312(95)00020-8; Kumar D, 2016, J COMPUT SCI-NETH, V17, P1, DOI 10.1016/j.jocs.2016.07.006; Ni LP, 2011, EXPERT SYST APPL, V38, P5569, DOI 10.1016/j.eswa.2010.10.079; Pai PF, 2005, OMEGA-INT J MANAGE S, V33, P497, DOI 10.1016/j.omega.2004.07.024; Preethi G, 2013, J THEOR APPL INF TEC, V46; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Qiu MY, 2016, CHAOS SOLITON FRACT, V85, P1, DOI 10.1016/j.chaos.2016.01.004; Vapnik V., 2013, NATURE STAT LEARNING; Wang Y., 2014, INT J BUSINESS INTEL, V9, P145; Youngohc Yoon, 1991, Proceedings of the Twenty-Fourth Annual Hawaii International Conference on System Sciences (Cat. No.91TH0350-9), P156, DOI 10.1109/HICSS.1991.184055; Zahedi J, 2015, PHYSICA A, V438, P178, DOI 10.1016/j.physa.2015.06.033	17	30	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188107	10.1371/journal.pone.0188107	http://dx.doi.org/10.1371/journal.pone.0188107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136004	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200066
J	Fischer-Huchzermeyer, S; Dombrowski, A; Wilke, G; Stahn, V; Streubel, A; Mautner, VF; Harder, A				Fischer-Huchzermeyer, Susan; Dombrowski, Anna; Wilke, Gordon; Stahn, Verena; Streubel, Anna; Mautner, Victor Felix; Harder, Anja			MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro	PLOS ONE			English	Article							TRANS-RETINOIC ACID; ALL-TRANS; NEUROFIBROMATOSIS TYPE-1; SCHWANN-CELLS; 13-CIS-RETINOIC ACID; REAL-TIME; EXPRESSION; CANCER; DIFFERENTIATION; NEUROBLASTOMA	Objective Neurofibromatosis type 1 (NF1) is a hereditary tumor syndrome characterized by an increased risk of malignant peripheral nerve sheath tumors (MPNST). Chemotherapy of MPNST is still insufficient. In this study, we investigated whether human tumor Schwann cells derived from NF1 associated MPNST respond to all-trans retinoic acid (ATRA). We analyzed effects of ATRA and MEK inhibitor (MEKi) combination therapy. Methods MPNST cell lines S462, T265, NSF1 were treated with ATRA and MEKi U0126 and PD0325901. We assessed cell viability, proliferation, migration, apoptosis and differentiation as well as mRNA expression of RAR and RXR subtypes and ATRA target genes such as CRABP2, CYP26A1, RARB and PDK1. We also analyzed CRABP2 methylation in cell lines and performed immunohistochemistry of human MPNST specimens. Results ATRA therapy reduced viability and proliferation in S462 and T265 cells, accompanied by differentiation, apoptosis and reduced migration. NSF1 cells which lacked RXRG expression did not respond to ATRA. We furthermore demonstrated that ATRA signaling was functional for common targets, and that mRNA expression of CRABP2 and its targets was raised by ATRA therapy, whereas alternative pathways via FABP5 were not induced. Finally, combination of ATRA and MEKi demonstrated additively reduced viability of T265 and S462 cells. Conclusions We observed therapeutic effects in two of three MPNST cell lines pronounced by combination therapy. These data point to a potentially successful treatment of MPNST by combined application of ATRA and MEK inhibitors such as U0126 or PD0325901.	[Fischer-Huchzermeyer, Susan; Stahn, Verena; Harder, Anja] Univ Hosp Munster, Inst Neuropathol, Munster, Germany; [Dombrowski, Anna] HELIOS Clin Berlin Buch, Clin Radiotherapy, Berlin, Germany; [Wilke, Gordon] Charite Univ Med Berlin, Dept Neuropathol, Berlin, Germany; [Streubel, Anna] HELIOS Clin Emil von Behring, Inst Pathol, Berlin, Germany; [Mautner, Victor Felix] Univ Hosp Hamburg Eppendorf, Clin & Polyclin Neurol, Hamburg, Germany; [Harder, Anja] Med Univ Brandenburg, Inst Pathol, Brandenburg, Germany	University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Harder, A (corresponding author), Univ Hosp Munster, Inst Neuropathol, Munster, Germany.; Harder, A (corresponding author), Med Univ Brandenburg, Inst Pathol, Brandenburg, Germany.	anja.harder@ukmuenster.de		Harder, nee Klose, Anja/0000-0002-3045-2222	Deutsche Krebshilfe e.V. [109523]; Nothing is forever e.V. [604242]; University of Muenster	Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); Nothing is forever e.V.; University of Muenster	The study was supported by grants of Deutsche Krebshilfe e.V. (AH, no. 109523, https://www.krehshilfe.de) and Nothing is forever e.V. (AH, no. 604242, http://www.nothing-is-forever.de/). We acknowledge support by Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge support by Open Access Publication Fund of University of Muenster.	Aass N, 2005, J CLIN ONCOL, V23, P4172, DOI 10.1200/JCO.2005.07.114; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Boorjian SA, 2007, J IMMUNOTHER, V30, P655, DOI 10.1097/CJI.0b013e31805449a8; Campos B, 2012, INT J CANCER, V131, P1963, DOI 10.1002/ijc.27446; Campos B, 2011, AM J PATHOL, V178, P1953, DOI 10.1016/j.ajpath.2011.01.051; Carroll SL, 2008, GLIA, V56, P1590, DOI 10.1002/glia.20776; Cimino G, 2006, CANCER RES, V66, P8903, DOI 10.1158/0008-5472.CAN-05-2726; Das BC, 2014, BIOORGAN MED CHEM, V22, P673, DOI 10.1016/j.bmc.2013.11.025; DELVA L, 1993, BLOOD, V82, P2175; Dombrowski A., 2010, CHILDR TUM FDN C BAL; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; DUCATMAN BS, 1986, CANCER-AM CANCER SOC, V57, P2006, DOI 10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; Emmerich D, 2014, EUR J HUM GENET; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Fenaux P, 1999, BLOOD, V94, P1192, DOI 10.1182/blood.V94.4.1192.416k07_1192_1200; Fischer S., 2012, GERMAN MED SCI; Fischer S, 2012, CHILDR TUM FDN C NEW; Fischer-Huchzermeyer S, 2014, THESIS; Fischer-Huchzermeyer S, 2017, AM J PATHOL, V187, P1623, DOI 10.1016/j.ajpath.2017.02.021; Frahm S, 2004, NEUROBIOL DIS, V16, P85, DOI 10.1016/j.nbd.2004.01.006; Fu YS, 2012, MOL ONCOL, V6, P48, DOI 10.1016/j.molonc.2011.11.004; Gachiani John, 2007, Neurosurg Focus, V22, pE13; Gupta A, 2008, EXP CELL RES, V314, P3663, DOI 10.1016/j.yexcr.2008.09.029; Gupta S, 2012, CLIN CANCER RES, V18, P280, DOI 10.1158/1078-0432.CCR-11-2165; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Harder A., 2007, ACTA NEUROPATHOL, V114, P307; Holtkamp N, 2006, CARCINOGENESIS, V27, P664, DOI 10.1093/carcin/bgi273; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Honecker F, 2014, J PROTEOMICS, V96, P300, DOI 10.1016/j.jprot.2013.11.010; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Imaizumi S, 1998, VIRCHOWS ARCH, V433, P435, DOI 10.1007/s004280050271; Jessen WJ, 2013, J CLIN INVEST, V123, P340, DOI 10.1172/JCI60578; Kashyap V, 2013, J CELL SCI, V126, P999, DOI 10.1242/jcs.119701; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kim EJ, 2002, J CELL PHYSIOL, V190, P92, DOI 10.1002/jcp.10045; Kluwe L, 1999, GENE CHROMOSOME CANC, V24, P283, DOI 10.1002/(SICI)1098-2264(199903)24:3<283::AID-GCC15>3.0.CO;2-K; Kourea HP, 1999, AM J PATHOL, V155, P1855, DOI 10.1016/S0002-9440(10)65504-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee PR, 2004, NEURON GLIA BIOL, V1, P135, DOI 10.1017/S1740925X04000274; LEGIUS E, 1994, GENE CHROMOSOME CANC, V10, P250, DOI 10.1002/gcc.2870100405; Liu RZ, 2011, AM J PATHOL, V178, P997, DOI 10.1016/j.ajpath.2010.11.075; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu M, 2005, ONCOGENE, V24, P4362, DOI 10.1038/sj.onc.1208661; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Maertens O, 2006, HUM MUTAT, V27, P1030, DOI 10.1002/humu.20389; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; Moniri MR, 2015, CYTOTECHNOLOGY, V67, P379, DOI 10.1007/s10616-014-9692-5; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nielsen GP, 1999, AM J PATHOL, V155, P1879, DOI 10.1016/S0002-9440(10)65507-1; Njar VCO, 2006, BIOORGAN MED CHEM, V14, P4323, DOI 10.1016/j.bmc.2006.02.041; Park GH, 2014, ONCOL REP, V32, P1347, DOI 10.3892/or.2014.3379; Rosenbaum T, 2000, J NEUROSCI RES, V61, P524, DOI 10.1002/1097-4547(20000901)61:5<524::AID-JNR7>3.3.CO;2-Q; Rutkowski JL, 2000, HUM MOL GENET, V9, P1059, DOI 10.1093/hmg/9.7.1059; Schlenk RF, 2016, ANN HEMATOL, V95, P1931, DOI 10.1007/s00277-016-2810-z; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; Spyra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021099; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Upadhyaya M, 2011, FRONT BIOSCI-LANDMRK, V16, P937, DOI 10.2741/3727; VAUTHEY JN, 1995, ANN SURG ONCOL, V2, P126, DOI 10.1007/BF02303627; Vo HP, 1998, ANTICANCER RES, V18, P217; WARRELL RP, 1993, NEW ENGL J MED, V329, P177, DOI 10.1056/NEJM199307153290307; Wiest V, 2003, HUM MUTAT, V22, P423, DOI 10.1002/humu.10272; Williams VC, 2009, PEDIATRICS, V123, P124, DOI 10.1542/peds.2007-3204	69	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187700	10.1371/journal.pone.0187700	http://dx.doi.org/10.1371/journal.pone.0187700			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131833	Green Published, Green Submitted, gold			2022-12-26	WOS:000414997800021
J	Liao, WY; Fugmann, SD				Liao, Wen-Yun; Fugmann, Sebastian D.			Lectins identify distinct populations of coelomocytes in Strongylocentrotus purpuratus	PLOS ONE			English	Article							PURPLE SEA-URCHIN; COMPLEMENT HOMOLOG; BINDING; GLYCOSYLATION; SUBPOPULATIONS; LOCALIZATION; MICROARRAYS; SYSTEM; TISSUE; MOUSE	Coelomocytes represent the immune cells of echinoderms, but detailed knowledge about their roles during immune responses is very limited. One major challenge for studying coelomocyte biology is the lack of reagents to identify and purify distinct populations defined by objective molecular markers rather than by morphology-based classifications that are subjective at times. Glycosylation patterns are known to differ significantly between cell types in vertebrates, and furthermore they can vary depending on the developmental stage and activation states within a given lineage. Thus fluorescently labeled lectins that recognize distinct glycan structures on cell surface proteins are routinely used to identify discrete cell populations in the vertebrate immune system. Here we now employed a panel of fifteen fluorescently- labeled lectins to determine differences in the glycosylation features on the surface of Strongylocentrotus purpuratus coelomocytes by fluorescence microscopy and flow cytometry. Eight of the lectins (succinylated wheat germ agglutinin, Len culinaris lectin, Pisum sativum agglutinin, Saphora japonica agglutinin, Solanum tuberosum lectin, Lycopersicon esculentum lectin, Datura stramonium lectin, Vicia villosa lectin) showed distinct binding patterns to fixed and live cells of three major coelomocyte classes: phagocytic cells, red spherule cells, and vibratile cells. Importantly, almost all lectins bound only to a subgroup of cells within each cell type. Lastly, we established fluorescently-labeled lectin-based fluorescence activated cell sorting as a strategy to purify distinct S. purpuratus coelomocyte (sub-) populations based on molecular markers. We anticipate that this will become a routine approach in future studies focused on dissecting the roles of different coelomocytes in echinoderm immunity.	[Liao, Wen-Yun; Fugmann, Sebastian D.] Chang Gung Univ, Dept Biomed Sci, Tao Yuan, Taiwan; [Fugmann, Sebastian D.] Chang Gung Univ, Grad Inst Biomed Sci, Div Microbiol, Tao Yuan, Taiwan; [Fugmann, Sebastian D.] Chang Gung Mem Hosp, Chang Gung Immunol Consortium, Tao Yuan, Taiwan; [Fugmann, Sebastian D.] Chang Gung Univ, Tao Yuan, Taiwan; [Fugmann, Sebastian D.] Chang Gung Mem Hosp, Dept Gen Surg, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Fugmann, SD (corresponding author), Chang Gung Univ, Dept Biomed Sci, Tao Yuan, Taiwan.; Fugmann, SD (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Div Microbiol, Tao Yuan, Taiwan.; Fugmann, SD (corresponding author), Chang Gung Mem Hosp, Chang Gung Immunol Consortium, Tao Yuan, Taiwan.; Fugmann, SD (corresponding author), Chang Gung Univ, Tao Yuan, Taiwan.; Fugmann, SD (corresponding author), Chang Gung Mem Hosp, Dept Gen Surg, Tao Yuan, Taiwan.	sdfugmann@mail.cgu.edu.tw			Ministry of Science and Technology Taiwan [NSC 102-2320-B-182-001-MY3]; Chang Gung Memorial Hospital [CMRPD1C0242, CMRPD1F0421, CORPD1F0051]	Ministry of Science and Technology Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by a grant of Ministry of Science and Technology Taiwan (NSC 102-2320-B-182-001-MY3, www.most.go.tw) to SDF and by grants of the Chang Gung Memorial Hospital (CMRPD1C0242, CMRPD1F0421, and CORPD1F0051) to SDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON RT, 1987, HISTOCHEM J, V19, P65, DOI 10.1007/BF01682750; Bard F, 2016, TRENDS CELL BIOL, V26, P379, DOI 10.1016/j.tcb.2015.12.004; BERTHEUSSEN K, 1978, EXP CELL RES, V111, P401, DOI 10.1016/0014-4827(78)90185-4; Brockton V, 2008, J CELL SCI, V121, P339, DOI 10.1242/jcs.012096; Buckley KM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00136; Clow LA, 2004, J EXP BIOL, V207, P2147, DOI 10.1242/jeb.01001; Delannoy CP, 2017, J PROTEOME RES, V16, P156, DOI 10.1021/acs.jproteome.6b00161; Engelmann P, 2016, DEV COMP IMMUNOL, V65, P41, DOI 10.1016/j.dci.2016.06.017; Gross PS, 2000, IMMUNOGENETICS, V51, P1034, DOI 10.1007/s002510000234; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HAKOMORI S, 1985, CANCER RES, V45, P2405; Ho ECH, 2016, IMMUNOL CELL BIOL, V94, P861, DOI 10.1038/icb.2016.51; Kletter D, 2013, MOL CELL PROTEOMICS, V12, P1026, DOI 10.1074/mcp.M112.026641; Majeske AJ, 2014, J IMMUNOL, V193, P5678, DOI 10.4049/jimmunol.1401681; MALMI R, 1988, HISTOCHEM J, V20, P276, DOI 10.1007/BF01745606; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; PORTER GA, 1990, EUR J CELL BIOL, V51, P85; REISNER Y, 1984, METHOD ENZYMOL, V108, P168; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; Sener E, 2015, FISH SHELLFISH IMMUN, V42, P34, DOI 10.1016/j.fsi.2014.10.020; Smith LC, 2010, ADV EXP MED BIOL, V708, P260; SMITH LC, 1992, MOL BIOL CELL, V3, P403, DOI 10.1091/mbc.3.4.403; Syed P, 2016, PROTEOMICS, V16, P1257, DOI 10.1002/pmic.201500404; Tao SC, 2008, GLYCOBIOLOGY, V18, P761, DOI 10.1093/glycob/cwn063; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099	25	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187987	10.1371/journal.pone.0187987	http://dx.doi.org/10.1371/journal.pone.0187987			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125863	Green Published, gold			2022-12-26	WOS:000414866000034
J	Cao, YY; Bian, XC; Chen, MX; Xia, LR; Zhang, JH; Zhu, FY; Wu, CF				Cao, Yun-Ying; Bian, Xiao-Chun; Chen, Mo-Xian; Xia, Li-Ru; Zhang, Jianhua; Zhu, Fu-Yuan; Wu, Chun-Fang			iTRAQ-based quantitative proteomic analysis in vernalization-treated faba bean (Vicia faba L.)	PLOS ONE			English	Article							RNA-BINDING PROTEIN; TRANSCRIPTION FACTOR; ARABIDOPSIS-THALIANA; COLD-ACCLIMATION; ANALYSIS REVEALS; CHILLING STRESS; LOW-PHYTATE; WHEAT; GENE; EXPRESSION	Vernalization is classically defined as the induction of flowering process by exposure of the plants to a prolonged cold condition. Normally, it is considered as a precondition of flowering. Vicia faba, commonly known as faba bean, belongs to family Fabaceae. It is one of the plant species that has been cultivated in the earliest human settlements. In this study, an iTRAQ-LC-MS/MS-based quantitative proteomic analysis has been conducted to compare the vernalized faba bean seedlings and its corresponding control. In total, 91 proteins from various functional categories were observed to be differentially accumulated in vernalized faba bean seedlings. Subsequent gene ontology analysis indicated that several biological processes or metabolic pathways including photosynthesis and phytic acid metabolism were differentially respond to vernalization in comparison to the control sample. Further investigation revealed that a family of proteins nominated as glycine-rich RNA-binding factor was accumulated in vernalized seedlings, indicating an extra layer of regulation by alternative splicing on transcript abundance in response to vernalization. These findings raise a possibility that these candidate proteins could be important to represent the responsive network under vernalization process. Therefore, we propose that the regulation of vernalization in faba bean not only occurs at the transcriptional level as previously reported, but also at the post-transcriptional level.	[Cao, Yun-Ying; Bian, Xiao-Chun; Wu, Chun-Fang] Jiangsu Yanjiang Inst Agr Sci, Nantong, Peoples R China; [Cao, Yun-Ying] Nantong Univ, Coll Life Sci, Nantong, Jiangsu, Peoples R China; [Cao, Yun-Ying; Zhu, Fu-Yuan] Nanjing Forestry Univ, Coll Biol & Environm, Nanjing, Jiangsu, Peoples R China; [Chen, Mo-Xian] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Xia, Li-Ru] Jiangsu Acad Agr Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Jianhua] Chinese Univ Hong Kong, Hong Kong Baptist Univ, Dept Biol, Shatin, Hong Kong, Peoples R China; [Zhang, Jianhua] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China	Jiangsu Academy of Agricultural Sciences; Nantong University; Nanjing Forestry University; Chinese University of Hong Kong, Shenzhen; Jiangsu Academy of Agricultural Sciences; Chinese University of Hong Kong; Hong Kong Baptist University; Chinese University of Hong Kong	Wu, CF (corresponding author), Jiangsu Yanjiang Inst Agr Sci, Nantong, Peoples R China.; Zhu, FY (corresponding author), Nanjing Forestry Univ, Coll Biol & Environm, Nanjing, Jiangsu, Peoples R China.	frankzhu300@gmail.com; jsyias@163.com	Cao, Yunying/AGY-6922-2022	Cao, Yunying/0000-0003-0806-8280; Zhang, Jianhua/0000-0002-3819-2437	Jiangsu Agricultural Science and Technology Innovation Fund [CX(13)5085]; Central Finance Agricultural Extension Project [TG(15)075]; Jiangsu Province [2015-NY-043]; Science and Technology Program of Nantong [MS12016044]; National Science Foundation of China [NSFC31701341]; China Postdoctoral Science Foundation [2017T100648]; Shenzhen Overseas Talents Innovation and Entrepreneurship Funding Scheme	Jiangsu Agricultural Science and Technology Innovation Fund; Central Finance Agricultural Extension Project; Jiangsu Province; Science and Technology Program of Nantong; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shenzhen Overseas Talents Innovation and Entrepreneurship Funding Scheme	This work was supported by the Jiangsu Agricultural Science and Technology Innovation Fund (CX(13)5085), the Central Finance Agricultural Extension Project (TG(15)075), the "Six Talent Peak" Funded Projects of Jiangsu Province (2015-NY-043), Science and Technology Program of Nantong (MS12016044), the National Science Foundation of China (NSFC31701341), the China Postdoctoral Science Foundation (2017T100648) and Shenzhen Overseas Talents Innovation and Entrepreneurship Funding Scheme (The Peacock Scheme).	Abid G, 2009, GENE, V439, P1, DOI 10.1016/j.gene.2009.03.007; Cai YC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/810209; Cho MR, 2007, B KOREAN CHEM SOC, V28, P427; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Dahiya S. S., 1998, Environment and Ecology, V16, P855; Dai F, 2009, BIOL PLANTARUM, V53, P257, DOI 10.1007/s10535-009-0048-5; Dezar CA, 2011, J EXP BOT, V62, P1061, DOI 10.1093/jxb/erq339; Drechsel G, 2013, PLANT CELL, V25, P3726, DOI 10.1105/tpc.113.115485; Fukao Y, 2011, PLANT PHYSIOL, V155, P1893, DOI 10.1104/pp.110.169730; Huang J, 2014, MOL BIOL REP, V41, P3839, DOI 10.1007/s11033-014-3250-2; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jensen ES, 2010, FIELD CROP RES, V115, P203, DOI 10.1016/j.fcr.2009.10.008; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Keller R, 1998, PLANT J, V16, P403, DOI 10.1046/j.1365-313x.1998.00309.x; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kim JY, 2010, J EXP BOT, V61, P2317, DOI 10.1093/jxb/erq058; Komor MA, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.AM2016-848; Landry EJ, 2015, AGRON J, V107, P574, DOI 10.2134/agronj14.0284; Lee JH, 2013, SCIENCE, V342, P628, DOI 10.1126/science.1241097; Liu Q, 2006, FOOD CHEM, V99, P470, DOI 10.1016/j.foodchem.2005.08.008; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; Mahfoozi S, 2006, FIELD CROP RES, V97, P182, DOI 10.1016/j.fcr.2005.09.012; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nomata T, 2004, PLANT CELL PHYSIOL, V45, P48, DOI 10.1093/pcp/pch005; Oatway L, 2001, FOOD REV INT, V17, P419, DOI 10.1081/FRI-100108531; Paina C, 2013, RNA SEQ APPROACH STU; Quesada V, 2005, INT J DEV BIOL, V49, P773, DOI 10.1387/ijdb.051995vq; Raboy V, 2001, TRENDS PLANT SCI, V6, P458, DOI 10.1016/S1360-1385(01)02104-5; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Rinalducci S, 2011, ELECTROPHORESIS, V32, P1807, DOI 10.1002/elps.201000663; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; Salekdeh GH, 2007, PROTEOMICS, V7, P2976, DOI 10.1002/pmic.200700181; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Shinozuka H, 2006, MOL GENET GENOMICS, V275, P399, DOI 10.1007/s00438-005-0095-3; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Stephen JR, 2003, GENE, V320, P177, DOI 10.1016/S0378-1119(03)00826-6; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Tanaka R, 2011, BBA-BIOENERGETICS, V1807, P968, DOI 10.1016/j.bbabio.2011.01.002; Thatcher SR, 2016, PLANT PHYSIOL, V170, P586, DOI 10.1104/pp.15.01267; Wang XY, 2016, J PROTEOMICS, V146, P14, DOI 10.1016/j.jprot.2016.06.007; Wang Y, 2012, PLANT CELL PHYSIOL, V53, P2073, DOI 10.1093/pcp/pcs146; Wilcox JR, 2000, CROP SCI, V40, P1601, DOI 10.2135/cropsci2000.4061601x; Yadav P. K., 2007, Progressive Agriculture, V7, P189; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Zhu FY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01926; Zhu FY, 2016, J PROTEOME RES, V15, P3528, DOI 10.1021/acs.jproteome.6b00258	51	4	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187436	10.1371/journal.pone.0187436	http://dx.doi.org/10.1371/journal.pone.0187436			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121109	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900038
J	Peterson, LM; Weckerly, FW				Peterson, Leah M.; Weckerly, Floyd W.			Male group size, female distribution and changes in sexual segregation by Roosevelt elk	PLOS ONE			English	Article							WHITE-TAILED DEER; MULE DEER; DENSITY-DEPENDENCE; FORAGING BEHAVIOR; RED DEER; SOCIAL SEGREGATION; MOUNTAIN UNGULATE; WOLF PREDATION; BIGHORN SHEEP; FOOD-INTAKE	Sexual segregation, or the differential use of space by males and females, is hypothesized to be a function of body size dimorphism. Sexual segregation can also manifest at small (social segregation) and large (habitat segregation) spatial scales for a variety of reasons. Furthermore, the connection between small-and large-scale sexual segregation has rarely been addressed. We studied a population of Roosevelt elk (Cervus elaphus roosevelti) across 21 years in north coastal California, USA, to assess small-and large-scale sexual segregation in winter. We hypothesized that male group size would associate with small-scale segregation and that a change in female distribution would associate with large-scale segregation. Variation in forage biomass might also be coupled to small and large-scale sexual segregation. Our findings were consistent with male group size associating with smallscale segregation and a change in female distribution associating with large-scale segregation. Females appeared to avoid large groups comprised of socially dominant males. Males appeared to occupy a habitat vacated by females because of a wider forage niche, greater tolerance to lethal risks, and, perhaps, to reduce encounters with other elk. Sexual segregation at both spatial scales was a poor predictor of forage biomass. Size dimorphism was coupled to change in sexual segregation at small and large spatial scales. Small scale segregation can seemingly manifest when all forage habitat is occupied by females and large scale segregation might happen when some forage habitat is not occupied by females.	[Peterson, Leah M.; Weckerly, Floyd W.] Texas State Univ, Dept Biol, San Marcos, TX 78666 USA	Texas State University System; Texas State University San Marcos	Weckerly, FW (corresponding author), Texas State Univ, Dept Biol, San Marcos, TX 78666 USA.	fw11@txstate.edu			California Department of Fish and Wildlife; Redwood National Park; Rocky Mountain Elk Foundation; Houston Safari Club; Alamo Safari Club; Granite Bay Safari Club; Save the Redwoods League; Texas State University	California Department of Fish and Wildlife; Redwood National Park; Rocky Mountain Elk Foundation; Houston Safari Club; Alamo Safari Club; Granite Bay Safari Club; Save the Redwoods League; Texas State University	FWW received funding from California Department of Fish and Wildlife, Redwood National Park, Rocky Mountain Elk Foundation, Houston Safari Club, Alamo Safari Club, Granite Bay Safari Club, Save the Redwoods League and Texas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this long-term study was provided by California Department of Fish and Wildlife, Redwood National Park, Rocky Mountain Elk Foundation, Houston Safari Club, Alamo Safari Club, Granite Bay Safari Club, Save the Redwoods League and Texas State University. We would like to thank the many students that participated in the field work: A. Duarte, J. Hunt, R. Keleher, N. Kolbe, M. Longoria, R. Luna, K. McFarland, M. O'Dell, K. Richardson, S. Robinson, S. Shelton, G. Street, and D. Wolcott. In addition, we would like to thank the coordinators and biologists of Redwood National and State Parks for their assistance in fieldwork and cooperation over the years. We would also like to thank A. Duarte and D. Wolcott for their reviews and advice while writing this article.	Aublet JF, 2009, OECOLOGIA, V159, P237, DOI 10.1007/s00442-008-1198-4; Bailey ED, 1960, THESIS; Barboza PS, 2000, J MAMMAL, V81, P473, DOI 10.1644/1545-1542(2000)081&lt;0473:SSIDDA&gt;2.0.CO;2; Bates D., 2014, LINEAR MIXED EFFECT; BERGER J, 1991, ANIM BEHAV, V41, P61, DOI 10.1016/S0003-3472(05)80503-2; Bleich V. C., 1997, WILDLIFE MONOGR, V134, P3; Bleich VC, 1999, J MAMMAL, V80, P283, DOI 10.2307/1383228; Bliss LM, 2016, CALIF FISH GAME, V102, P8; Bon R, 1996, BEHAV PROCESS, V38, P131, DOI 10.1016/S0376-6357(96)00029-0; Bonenfant C, 2004, P ROY SOC B-BIOL SCI, V271, P883, DOI 10.1098/rspb.2003.2661; Bonenfant C, 2007, ECOLOGY, V88, P3202, DOI 10.1890/07-0129.1; BOWDEN DC, 1995, J WILDLIFE MANAGE, V59, P840, DOI 10.2307/3801965; BOWYER RT, 1984, J MAMMAL, V65, P410, DOI 10.2307/1381087; Bowyer RT, 2004, J MAMMAL, V85, P1039, DOI 10.1644/BBL-002.1; Bowyer RT, 2004, J MAMMAL, V85, P498; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; Conradt L, 1998, P ROY SOC B-BIOL SCI, V265, P1359, DOI 10.1098/rspb.1998.0442; Conradt L, 2000, ANIM BEHAV, V59, P1049, DOI 10.1006/anbe.2000.1409; Daubenmire R., 1968, PLANT COMMUNITIES, P300; Gaillard JM, 2000, P ROY SOC B-BIOL SCI, V267, P471, DOI 10.1098/rspb.2000.1024; GROSS JE, 1993, ECOLOGY, V74, P778, DOI 10.2307/1940805; Harper J.A., 1967, WILDLIFE MONOGR, V16, P3; HEARD DC, 1992, AM NAT, V139, P190, DOI 10.1086/285320; Jacobson AR, 2004, ECOLOGY, V85, P1598, DOI 10.1890/02-0753; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kie JG, 1999, J MAMMAL, V80, P1004, DOI 10.2307/1383271; KOUTNIK DL, 1981, J MAMMAL, V62, P1, DOI 10.2307/1380472; Legendre P, 2000, J STAT COMPUT SIM, V67, P37, DOI 10.1080/00949650008812035; Loe LE, 2009, P ROY SOC B-BIOL SCI, V276, P2581, DOI 10.1098/rspb.2009.0224; Main MB, 1996, J WILDLIFE MANAGE, V60, P497, DOI 10.2307/3802067; Main MB, 1996, J MAMMAL, V77, P449, DOI 10.2307/1382821; McCullough D.R., 1979, GEORGE RESERVE DEER; McCullough DR, 1999, J MAMMAL, V80, P1130, DOI 10.2307/1383164; MCCULLOUGH DR, 1989, J WILDLIFE MANAGE, V53, P277, DOI 10.2307/3801123; Michelena P, 2008, APPL ANIM BEHAV SCI, V112, P81, DOI 10.1016/j.applanim.2007.06.020; Miquelle D. G., 1992, WILDLIFE MONOGR, V122, P3; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; OZOGA JJ, 1972, J WILDLIFE MANAGE, V36, P861, DOI 10.2307/3799441; Perez-Barberia FJ, 2005, ANIM BEHAV, V69, P827, DOI 10.1016/j.anbehav.2004.06.011; Perez-Barberia FJ, 2002, EVOLUTION, V56, P1276; Pinheiro J, 2001, MIXED EFFECTS MODELS; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Ruckstuhl KE, 1998, ANIM BEHAV, V56, P99, DOI 10.1006/anbe.1998.0745; Ruckstuhl KE, 2002, ANIM BEHAV, V64, P909, DOI 10.1006/anbe.2002.2015; Sokal R. R., 2012, BIOMETRY PRINCIPLES, V4; Starns HD, 2015, ECOL EVOL, V5, P109, DOI 10.1002/ece3.1327; Starns HD, 2014, J MAMMAL, V95, P925, DOI 10.1644/13-MAMM-A-313; Stauffer H. B., 2008, CONT BAYESIAN FREQUE; Stewart KM, 2015, ECOL EVOL, V5, P709, DOI 10.1002/ece3.1397; SULLIVAN GM, 1980, J RANGE MANAGE, V33, P174, DOI 10.2307/3898278; Townsend TW, 1981, AM MIDL NAT, V106, P99; Weckerly B, 2017, POPULATION ECOLOGY R, DOI [10.1371/journal.pone.0187829, DOI 10.1371/JOURNAL.PONE.0187829]; Weckerly F, 2004, AM MIDL NAT, V152, P386, DOI 10.1674/0003-0031(2004)152[0386:REDASS]2.0.CO;2; Weckerly FW, 2014, ARCTIC, V67, P189, DOI 10.14430/arctic4380; Weckerly FW, 2013, J MAMMAL, V94, P120, DOI 10.1644/12-MAMM-A-066.1; Weckerly Floyd W., 1998, Northwestern Naturalist, V79, P113, DOI 10.2307/3536841; Weckerly FW, 2001, J MAMMAL, V82, P414, DOI 10.1644/1545-1542(2001)082&lt;0414:ALMREL&gt;2.0.CO;2; Weckerly FW, 1999, CAN J ZOOL, V77, P1379, DOI 10.1139/cjz-77-9-1379; Weckerly FW, 2001, J MAMMAL, V82, P825, DOI 10.1644/1545-1542(2001)082<0825:SSIREC>2.0.CO;2; Weckerly FW, 1996, CALIF FISH GAME, V82, P175; WECKERLY FW, 1993, J WILDLIFE MANAGE, V57, P475, DOI 10.2307/3809272; WICKSTROM ML, 1984, J WILDLIFE MANAGE, V48, P1285, DOI 10.2307/3801789; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Wolcott DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124431; Xavier JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174850; Yearsley IM, 2005, ANIM BEHAV, V69, P257, DOI 10.1016/j.anbehav.2004.04.010	66	10	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187829	10.1371/journal.pone.0187829	http://dx.doi.org/10.1371/journal.pone.0187829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121076	Green Published, gold			2022-12-26	WOS:000414769900084
J	Rayan, A; Raiyn, J; Falah, M				Rayan, Anwar; Raiyn, Jamal; Falah, Mizied			Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity	PLOS ONE			English	Article							RECEPTOR; METABOLISM; INHIBITORS; EXTRACT	Cancer is considered one of the primary diseases that cause morbidity and mortality in millions of people worldwide and due to its prevalence, there is undoubtedly an unmet need to discover novel anticancer drugs. However, the traditional process of drug discovery and development is lengthy and expensive, so the application of in silico techniques and optimization algorithms in drug discovery projects can provide a solution, saving time and costs. A set of 617 approved anticancer drugs, constituting the active domain, and a set of 2,892 natural products, constituting the inactive domain, were employed to build predictive models and to index natural products for their anticancer bioactivity. Using the iterative stochastic elimination optimization technique, we obtained a highly discriminative and robust model, with an area under the curve of 0.95. Twelve natural products that scored highly as potential anticancer drug candidates are disclosed. Searching the scientific literature revealed that few of those molecules (Neoechinulin, Colchicine, and Piperolactam) have already been experimentally screened for their anticancer activity and found active. The other phytochemicals await evaluation for their anticancerous activity in wet lab.	[Rayan, Anwar; Raiyn, Jamal] Al Qasemi Acad Coll, QRC, Drug Discovery Informat Lab, Baka El Garbiah, Israel; [Rayan, Anwar] Galilee Soc, Inst Appl Res, Drug Discovery & Dev Lab, Shefa Amr, Israel; [Falah, Mizied] Bar Ilan Univ, Fac Med Galilee, Tel Aviv, Israel; [Falah, Mizied] Galilee Med Ctr, Nahariyya, Israel	Bar Ilan University; Western Galilee Hospital	Rayan, A (corresponding author), Al Qasemi Acad Coll, QRC, Drug Discovery Informat Lab, Baka El Garbiah, Israel.; Rayan, A (corresponding author), Galilee Soc, Inst Appl Res, Drug Discovery & Dev Lab, Shefa Amr, Israel.; Falah, M (corresponding author), Bar Ilan Univ, Fac Med Galilee, Tel Aviv, Israel.; Falah, M (corresponding author), Galilee Med Ctr, Nahariyya, Israel.	a_ayan@qsm.ac.il; mizied.falah@gmail.com			Al-Qasemi Academic College; Ministry of Science, Space and Technology	Al-Qasemi Academic College; Ministry of Science, Space and Technology	This work was funded by an unrestricted research grants from Al-Qasemi Academic College and the Ministry of Science, Space and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aswad M, 2017, INFLAMM RES; Avato P, 2017, ANTICANCER AGENTS ME; Cern A, 2017, J CONTROL RELEASE, V252, P18, DOI 10.1016/j.jconrel.2017.02.015; Choi YL, 2009, BIOORG MED CHEM LETT, V19, P3036, DOI 10.1016/j.bmcl.2009.04.020; Deeb O, 2013, CURR PHARM DESIGN, V19, P2237, DOI 10.2174/1381612811319120010; Frank A, 2017, INFLAMM RES, V66, P923, DOI 10.1007/s00011-017-1075-x; Glick M, 2002, P NATL ACAD SCI USA, V99, P703, DOI 10.1073/pnas.022418199; Glick M, 2000, PROTEINS, V38, P273, DOI 10.1002/(SICI)1097-0134(20000215)38:3<273::AID-PROT4>3.3.CO;2-9; Hann MM, 2004, CURR OPIN CHEM BIOL, V8, P255, DOI 10.1016/j.cbpa.2004.04.003; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heikamp K, 2013, J CHEM INF MODEL, V53, P1595, DOI 10.1021/ci4002712; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Joshi P, 2017, EUR J MED CHEM, V138, P273, DOI 10.1016/j.ejmech.2017.06.047; Kacergius T, 2017, MOL MED REP, V16, P949, DOI 10.3892/mmr.2017.6674; Kumar A, 2017, ANTI-CANCER DRUG, V28, P250, DOI 10.1097/CAD.0000000000000464; Kuramochi K, 2013, BIOSCI BIOTECH BIOCH, V77, P446, DOI 10.1271/bbb.120884; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lusci A, 2013, J CHEM INF MODEL, V53, P1563, DOI 10.1021/ci400187y; Majumder D, 2017, INT J BIOL MACROMOL, V104, P929, DOI 10.1016/j.ijbiomac.2017.06.100; Michaeli A, 2016, LETT DRUG DES DISCOV, V13, P646, DOI 10.2174/1570180813666160617103437; Mussa HY, 2011, J CHEM INF MODEL, V51, P4, DOI 10.1021/ci100022u; Ngo DC, 2015, MOL BIOL REP, V42, P819, DOI 10.1007/s11033-015-3857-y; Pappalardo M, 2017, MOL INFORM, V36, DOI 10.1002/minf.201700014; Pappalardo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109340; Rayan A, 2004, J MOL GRAPH MODEL, V22, P319, DOI 10.1016/j.jmgm.2003.12.012; Rayan A, 2013, EUR J MED CHEM, V65, P304, DOI 10.1016/j.ejmech.2013.04.059; Rayan A, 2010, LETT DRUG DES DISCOV, V7, P409, DOI 10.2174/157018010791306515; Rayan A, 2010, J CHEM INF MODEL, V50, P437, DOI 10.1021/ci9004354; Seelinger M, 2012, INT J ONCOL, V41, P1164, DOI 10.3892/ijo.2012.1538; Shahaf N, 2016, MOL INFORM, V35, P414, DOI 10.1002/minf.201501029; Shen M, 2004, J MED CHEM, V47, P2356, DOI 10.1021/jm030584q; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; ul-Haq Z, 2008, J CHEM INF MODEL, V48, P1092, DOI 10.1021/ci8000056; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wright GD, 2017, NAT PROD REP, V34, P694, DOI 10.1039/c7np00019g; Yao H, 2017, EXPERT OPIN DRUG DIS, V12, P121, DOI 10.1080/17460441.2016.1272757; Zaid H, 2016, FRONT BIOSCI-LANDMRK, V21, P597, DOI 10.2741/4409; Zatsepin M, 2016, J CHEM INF MODEL, V56, P1835, DOI 10.1021/acs.jcim.6b00070; Zeidan M, 2017, MOLECULES, V22, DOI 10.3390/molecules22091563	40	169	169	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187925	10.1371/journal.pone.0187925	http://dx.doi.org/10.1371/journal.pone.0187925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121120	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900095
J	Soliman, M; Andreeva, K; Nasraoui, O; Cooper, NGF				Soliman, Maha; Andreeva, Kalina; Nasraoui, Olfa; Cooper, Nigel G. F.			A causal mediation model of ischemia reperfusion injury in the retina	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; REGULATORY ELEMENT DATABASE; MIRNA-MESSENGER-RNA; ISCHEMIA/REPERFUSION INJURY; GENE-REGULATION; NETWORK MOTIFS; CANCER; RESOURCE; IDENTIFICATION; ANGIOGENESIS	The goal of this study is to develop a model that explains the relationship between microRNAs, transcription factors, and their co-target genes. This relationship was previously reported in gene regulatory loops associated with 24 hour (24h) and 7 day (7d) time periods following ischemia-reperfusion injury in a rat's retina. Using a model system of retinal ischemia- reperfusion injury, we propose that microRNAs first influence transcription factors, which in turn act as mediators to influence transcription of genes via triadic regulatory loops. Analysis of the relative contributions of direct and indirect regulatory influences on genes revealed that a substantial fraction of the regulatory loops (69% for 24 hours and 77% for 7 days) could be explained by causal mediation. Over 40% of the mediated loops in both time points were regulated by transcription factors only, while about 20% of the loops were regulated entirely by microRNAs. The remaining fractions of the mediated regulatory loops were cooperatively mediated by both microRNAs and transcription factors. The results from these analyses were supported by the patterns of expression of the genes, transcription factors, and microRNAs involved in the mediated loops in both post-ischemic time points. Additionally, network motif detection for the mediated loops showed a handful of time specific motifs related to ischemia-reperfusion injury in a rat's retina. In summary, the effects of microRNAs on genes are mediated, in large part, via transcription factors.	[Soliman, Maha; Andreeva, Kalina; Cooper, Nigel G. F.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Nasraoui, Olfa] Univ Louisville, Dept Comp Engn & Comp Sci, Louisville, KY 40292 USA; [Soliman, Maha; Andreeva, Kalina; Cooper, Nigel G. F.] 511 South Floyd, Louisville, KY USA; [Nasraoui, Olfa] 132 Eastern Pkwy, Louisville, KY USA	University of Louisville; University of Louisville	Cooper, NGF (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	nigel.cooper@louisville.edu	Nasraoui, Olfa/V-8973-2019		National Eye Institute [R01EY017594]; National Institute of General Medical Sciences [P20 GM103436]	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Eye Institute, R01EY017594, and the National Institute of General Medical Sciences, P20 GM103436.	Afshar AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100806; Akbari G., 2017, OXIDATIVE MED CELLUL, V2017, P11; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Andreeva K, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0201-4; Andreeva K, 2014, OPHTHALMOL EYE DIS, V6, P43, DOI 10.4137/OED.S17671; Awan A, 2007, IET SYST BIOL, V1, P292, DOI 10.1049/iet-syb:20060068; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bronwen LA, 2016, DATABASE; Cantini L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9878; Chi X., 2015, OXIDATIVE MED CELLUL, V2015; Chiu CC, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S12; Dunn LL, 2014, ANTIOXID REDOX SIGN, V20, P1723, DOI 10.1089/ars.2013.5675; Dvoriantchikova G, 2014, EXP EYE RES, V123, P1, DOI 10.1016/j.exer.2014.04.009; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Emmrich S, 2010, CELL CYCLE, V9, P2555, DOI 10.4161/cc.9.13.12061; Filen S, 2010, J IMMUNOL, V184, P4990, DOI 10.4049/jimmunol.0903106; Fu JH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-68; Fukunaga K, 2009, ADV EXP MED BIOL, V665, P130; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Gokulnath M, 2017, INT J BIOL MACROMOL, V94, P370, DOI 10.1016/j.ijbiomac.2016.10.026; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087446; Guzzi PH, 2015, EURASIP J BIOINFORM, DOI 10.1186/s13637-015-0023-8; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hsieh WT, 2015, BMC SYST BIOL, V9, DOI 10.1186/1752-0509-9-S1-S5; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hussain N, 2014, SAUDI J OPHTHALMOL, V28, P325, DOI 10.1016/j.sjopt.2014.02.004; Imai K, ADV SOCIAL SCI RES U, P129; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Jaeger M, 2005, J ARTIF INTELL RES, V24, P889, DOI 10.1613/jair.1657; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Jiang CJ, 2013, INT J NEUROSCI, V123, P684, DOI 10.3109/00207454.2013.817409; Jiang XJ, 2016, ANTICANCER RES, V36, P509; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kashtan N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031909; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Knight Richard A, 2012, JAKSTAT, V1, P111, DOI 10.4161/jkst.20078; Lai X., 2016, NUCLEIC ACIDS RES; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li H, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000247; Li Q, 2016, FEBS J, V283, P1720, DOI 10.1111/febs.13697; Li YS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1054; Lin Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09653; Liu ZC, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0094-2; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Martirosyan A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004715; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Moorthy K, 2014, CURR BIOINFORM, V9, P18, DOI 10.2174/1574893608999140109120957; Muniategui A, 2013, BRIEF BIOINFORM, V14, P263, DOI 10.1093/bib/bbs028; Naeem H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022519; Nicholson LB, 2014, OSLI RETINA, V45, P338, DOI 10.3928/23258160-20140605-01; Nyayanit D, 2015, RNA, V21, P307, DOI 10.1261/rna.046862.114; Ocone A, 2011, BIOINFORMATICS, V27, P2873, DOI 10.1093/bioinformatics/btr487; Parikh A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-163; Pearl J, 2014, PSYCHOL METHODS, V19, P459, DOI 10.1037/a0036434; Piriyapongsa J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-61; Portales-Casamar E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r207; Portales-Casamar E, 2009, NUCLEIC ACIDS RES, V37, pD54, DOI 10.1093/nar/gkn783; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Rice JJ, 2005, P NATL ACAD SCI USA, V102, P3173, DOI 10.1073/pnas.0500130102; Robbs BK, 2013, BBA-MOL CELL RES, V1833, P2016, DOI 10.1016/j.bbamcr.2013.04.003; Ryan C, 2011, METHODS MOL BIOL, V781, P353, DOI 10.1007/978-1-61779-276-2_17; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Takagi Y, 2002, J CEREBR BLOOD F MET, V22, P1311, DOI 10.1097/01.WCB.0000034148.72481.F4; Talat L, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/197675; Tingley D., MEDIATION R PACKAGE; Tran DH, 2010, BIOINFORMATION, V4, P371, DOI 10.6026/97320630004371; Tsuchiya M, 2015, WORLD J DIABETES, V6, P175, DOI 10.4239/wjd.v6.i1.175; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Wang SY, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055002; Wang Y., 2014, BIOMED RES INT, V2014; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wu Q, 2015, BIOMED REP, V3, P611, DOI 10.3892/br.2015.477; Xu XL, 2014, PHYSIOL GENOMICS, V46, P789, DOI 10.1152/physiolgenomics.00020.2014; Yan Z, 2012, NUCLEIC ACIDS RES; Yang J, 2015, EUR REV MED PHARMACO, V19, P825; Ye S, 2014, CELL BIOCHEM BIOPHYS, V70, P1849, DOI 10.1007/s12013-014-0142-y; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; Yu H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-61; Yu XP, 2008, NUCLEIC ACIDS RES, V36, P6494, DOI 10.1093/nar/gkn712; Zhan XH, 2010, J CEREBR BLOOD F MET, V30, P110, DOI 10.1038/jcbfm.2009.189; Zhang GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135339; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004; Zheng GY, 2008, BIOINFORMATICS, V24, P2416, DOI 10.1093/bioinformatics/btn439; Zhu DY, 2004, P NATL ACAD SCI USA, V101, P9453, DOI 10.1073/pnas.0401063101	94	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187426	10.1371/journal.pone.0187426	http://dx.doi.org/10.1371/journal.pone.0187426			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121052	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900036
J	Yeom, SK; Won, DO; Chi, SI; Seo, KS; Kim, HJ; Muller, KR; Lee, SW				Yeom, Seul-Ki; Won, Dong-Ok; Chi, Seong In; Seo, Kwang-Suk; Kim, Hyun Jeong; Mueller, Klaus-Robert; Lee, Seong-Whan			Spatio-temporal dynamics of multimodal EEG-fNIRS signals in the loss and recovery of consciousness under sedation using midazolam and propofol	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CORTICAL EFFECTIVE CONNECTIVITY; PATIENT-CONTROLLED SEDATION; TIME-FREQUENCY DYNAMICS; GENERAL-ANESTHESIA; NITROUS-OXIDE; ADULT VOLUNTEERS; BRAIN ACTIVITY; SLEEP; ELECTROENCEPHALOGRAM	On sedation motivated by the clinical needs for safety and reliability, recent studies have attempted to identify brain-specific signatures for tracking patient transition into and out of consciousness, but the differences in neurophysiological effects between 1) the sedative types and 2) the presence/absence of surgical stimulations still remain unclear. Here we used multimodal electroencephalography-functional near-infrared spectroscopy (EEG-fNIRS) measurements to observe electrical and hemodynamic responses during sedation simultaneously. Forty healthy volunteers were instructed to push the button to administer sedatives in response to auditory stimuli every 9-11 s. To generally illustrate brain activity at repetitive transition points at the loss of consciousness (LOC) and the recovery of consciousness (ROC), patient-controlled sedation was performed using two different sedatives (midazolam (MDZ) and propofol (PPF)) under two surgical conditions. Once consciousness was lost via sedatives, we observed gradually increasing EEG power at lower frequencies (< 15 Hz) and decreasing power at higher frequencies (> 15 Hz), as well as spatially increased EEG powers in the delta and lower alpha bands, and particularly also in the upper alpha rhythm, at the frontal and parieto-occipital areas over time. During ROC from unconsciousness, these spatio-temporal changes were reversed. Interestingly, the level of consciousness was switched on/off at significantly higher effect-site concentrations of sedatives in the brain according to the use of surgical stimuli, but the spatio-temporal EEG patterns were similar, regardless of the sedative used. We also observed sudden phase shifts in fronto-parietal connectivity at the LOC and the ROC as critical points. fNIRS measurement also revealed mild hemodynamic fluctuations. Compared with general anesthesia, our results provide insights into critical hallmarks of sedative-induced (un) consciousness, which have similar spatio-temporal EEG-fNIRS patterns regardless of the stage and the sedative used.	[Yeom, Seul-Ki; Won, Dong-Ok; Lee, Seong-Whan] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Chi, Seong In; Seo, Kwang-Suk; Kim, Hyun Jeong; Mueller, Klaus-Robert] Seoul Natl Univ, Dent Hosp, Dept Dent Anesthesiol, Seoul, South Korea; [Mueller, Klaus-Robert] Berlin Inst Technol, Machine Learning Grp, Berlin, Germany	Korea University; Seoul National University (SNU); Technical University of Berlin	Lee, SW (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.; Seo, KS (corresponding author), Seoul Natl Univ, Dent Hosp, Dept Dent Anesthesiol, Seoul, South Korea.	stone90@snu.ac.kr; sw.lee@korea.ac.kr	Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685; Seo, Kwang-Suk/0000-0001-5906-0639; Chi, Seong In/0000-0003-1282-8633; Yeom, Seul-Ki/0000-0002-3127-7219; Kim, Hyun Jeong/0000-0002-9265-7549	Institute for Information & Communications Technology Promotion (IITP) grant - Korea government [2017-0-00451]; MSIT (Ministry of Science and ICT), Korea, under SW Starlab support program [IITP-2015-1107]; Seoul National University Dental Hospital (SNUDH) Research Fund [01-2015-0007]	Institute for Information & Communications Technology Promotion (IITP) grant - Korea government; MSIT (Ministry of Science and ICT), Korea, under SW Starlab support program; Seoul National University Dental Hospital (SNUDH) Research Fund	This work was supported by Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korea government (No. 2017-0-00451, Development of BCI based Brain and Cognitive Computing Technology for Recognizing User's Intentions using Deep Learning) and MSIT (Ministry of Science and ICT), Korea, under the SW Starlab support program (IITP-2015-1107) supervised by the IITP and the Seoul National University Dental Hospital (SNUDH) Research Fund [01-2015-0007].	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; Anderson RE, 2004, BRIT J ANAESTH, V92, P167, DOI 10.1093/bja/aeh036; Andrillon T, 2011, J NEUROSCI, V31, P17821, DOI 10.1523/JNEUROSCI.2604-11.2011; Bentsen B, 2003, EUR J PAIN-LONDON, V7, P49, DOI 10.1016/S1090-3801(02)00051-4; Blankertz B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00198; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Brown TB, 2005, AM FAM PHYSICIAN, V71, P85; Canakci V, 2007, CLIN ORAL INVEST, V11, P377, DOI 10.1007/s00784-007-0126-z; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Ching SN, 2010, P NATL ACAD SCI USA, V107, P22665, DOI 10.1073/pnas.1017069108; CLARK DL, 1973, ANESTHESIOLOGY, V38, P564, DOI 10.1097/00000542-197306000-00011; Cope M, 1988, Adv Exp Med Biol, V222, P183; Curtin A, 2014, NEUROIMAGE, V85, P626, DOI 10.1016/j.neuroimage.2013.07.009; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; FAULCONER A, 1952, ANESTHESIOLOGY, V13, P361, DOI 10.1097/00000542-195207000-00004; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Gibbs FA, 1937, ARCH INTERN MED, V60, P154, DOI 10.1001/archinte.1937.00180010159012; Gugino LA, 2001, BRIT J ANAESTH, V87, P421, DOI 10.1093/bja/87.3.421; Guzeldemir E, 2008, J PERIODONTOL, V79, P2247, DOI [10.1902/jop.2008.080152, 10.1902/jop.2008.080152 ]; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hudetz AG, 2012, BRAIN CONNECT, V2, P291, DOI 10.1089/brain.2012.0107; Hughes CG, 2012, CLIN PHARMACOL-ADV A, V4, P53, DOI 10.2147/CPAA.S26582; Imas OA, 2005, NEUROSCI LETT, V387, P145, DOI 10.1016/j.neulet.2005.06.018; Izzetoglu K, 2004, INT J HUM-COMPUT INT, V17, P211, DOI 10.1207/s15327590ijhc1702_6; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; KIERSEY D K, 1951, Br J Anaesth, V23, P141, DOI 10.1093/bja/23.3.141; Kocsis L, 2006, PHYS MED BIOL, V51, pN91, DOI 10.1088/0031-9155/51/5/N02; Koskinen M, 2005, CLIN NEUROPHYSIOL, V116, P2069, DOI 10.1016/j.clinph.2005.06.004; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Laureys S, 2005, BOUNDARIES CONSCIOUS, V150; Lee U, 2011, ANESTHESIOLOGY, V114, P872, DOI 10.1097/ALN.0b013e31821102c9; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Leon-Dominguez U, 2014, NEUROIMAGE, V85, P616, DOI 10.1016/j.neuroimage.2013.07.023; Li ST, 2000, ANESTHESIOLOGY, V93, P1225, DOI 10.1097/00000542-200011000-00015; Liu J, 1997, ANESTH ANALG, V84, P185, DOI 10.1097/00000539-199701000-00033; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lovell AT, 1999, ANESTH ANALG, V88, P554, DOI 10.1097/00000539-199903000-00017; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Mason KP, 2002, RADIOLOGY, V225, P457, DOI 10.1148/radiol.2252011786; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; MOULD DR, 1995, CLIN PHARMACOL THER, V58, P35, DOI 10.1016/0009-9236(95)90070-5; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Ng JM, 2001, GASTROINTEST ENDOSC, V54, P8, DOI 10.1067/mge.2001.116110; Nicolaou N, 2014, BRIT J ANAESTH, V112, P529, DOI 10.1093/bja/aet350; Patel S, 2005, AM J GASTROENTEROL, V100, P2689, DOI 10.1111/j.1572-0241.2005.00320.x; Purdon PL, 2013, P NATL ACAD SCI USA, V110, pE1142, DOI 10.1073/pnas.1221180110; RAMPIL IJ, 1987, ANESTHESIOLOGY, V67, P139, DOI 10.1097/00000542-198707000-00033; Rodrigo MRC, 1999, BRIT J ORAL MAX SURG, V37, P472, DOI 10.1054/bjom.1999.0118; Ropcke H, 2001, ANESTHESIOLOGY, V94, P390; Rudrauf D, 2006, NEUROIMAGE, V31, P209, DOI 10.1016/j.neuroimage.2005.11.021; Sanikop Sheetal, 2011, J Oral Sci, V53, P341; Schnider TW, 1998, ANESTHESIOLOGY, V88, P1170, DOI 10.1097/00000542-199805000-00006; Schnider TW, 1999, ANESTHESIOLOGY, V90, P1502, DOI 10.1097/00000542-199906000-00003; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Song DJ, 2000, ANESTH ANALG, V91, P876, DOI 10.1097/00000539-200010000-00020; Stamatakis EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014224; Tagliazucchi E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00339; Thatcher RW, 2008, HUM BRAIN MAPP, V29, P1400, DOI 10.1002/hbm.20474; TINKER JH, 1977, ANESTHESIOLOGY, V46, P252, DOI 10.1097/00000542-197704000-00005; Tononi G, 2015, PHILOS T R SOC B, V370, P117, DOI 10.1098/rstb.2014.0167; Untergehrer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087498; Upton RN, 2005, ANESTHESIOLOGY, V103, P344, DOI 10.1097/00000542-200508000-00018; Veselis RA, 1997, ANESTHESIOLOGY, V87, P749, DOI 10.1097/00000542-199710000-00007; Vijayan S, 2013, J NEUROSCI, V33, P11070, DOI 10.1523/JNEUROSCI.5670-12.2013; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Voss L, 2007, BEST PRACT RES-CLIN, V21, P313, DOI 10.1016/j.bpa.2007.04.003; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Yeom SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111157; Yeom SK, 2013, PATTERN RECOGN, V46, P1159, DOI 10.1016/j.patcog.2012.10.023; Zomorodi K, 1998, ANESTHESIOLOGY, V89, P1418, DOI 10.1097/00000542-199812000-00020	78	16	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187743	10.1371/journal.pone.0187743	http://dx.doi.org/10.1371/journal.pone.0187743			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121108	Green Submitted, gold, Green Published			2022-12-26	WOS:000414769900069
J	Anestiadou, K; Nikoloudakis, N; Hagidimitriou, M; Katsiotis, A				Anestiadou, Katerina; Nikoloudakis, Nikolaos; Hagidimitriou, Marianna; Katsiotis, Andreas			Monumental olive trees of Cyprus contributed to the establishment of the contemporary olive germplasm	PLOS ONE			English	Article							OLEA-EUROPAEA L.; GENETIC DIVERSITY; CULTIVATED OLIVES; MICROSATELLITE MARKERS; MEDITERRANEAN BASIN; DOMESTICATION; WILD; ACCESSIONS; RAPD	Even though Cyprus was an important crossing point for the westward spread of olive, and one of the primary regions of domestication, its genetic recourses remain uncharted at a great extent. Throughout the centuries, a number of ancient olive trees remain in the same orchards, contributing to Cypriot oleiculture and society. In an attempt to explore this monumental genetic pool, a survey was conducted to identify centennial olive trees in rural provinces of Cyprus. Microsatellites were employed in order to study their genetic composition (including rootstocks when feasible) and to establish possible associations among genotypes. High numbers of specific alleles, suggestive of the distinctiveness of this germplasm, were detected, and both grafting and rootstock propagation was verified. Moreover, it was determined by Bayesian structural and network reticulate analysis that centennial olives can be divided in two discrete genetic clusters having intermediate admixed accessions. Furthermore, it was determined that all contemporary Cypriot cultivars, that were included in the present study, were highly affiliated exclusively to one genetic group, a strong evidence of selection among elite clones. The information acquired from the current study reveals the genetic rareness of this material and its contribution to the current olive germplasm.	[Anestiadou, Katerina; Nikoloudakis, Nikolaos; Katsiotis, Andreas] Cyprus Univ Technol, Dept Agr Sci Biotechnol & Food Sci, Limassol, Cyprus; [Hagidimitriou, Marianna] Agr Univ Athens, Dept Biotechnol, Athens, Greece	Cyprus University of Technology; Agricultural University of Athens	Katsiotis, A (corresponding author), Cyprus Univ Technol, Dept Agr Sci Biotechnol & Food Sci, Limassol, Cyprus.	andreas.katsiotis@cut.ac.cy	Nikoloudakis, Nikolaos/AAK-1396-2020	Nikoloudakis, Nikolaos/0000-0002-3935-8443; Katsiotis, Andreas/0000-0002-0329-3617				Baldoni L, 2006, ANN BOT-LONDON, V98, P935, DOI 10.1093/aob/mcl178; Baldoni L, 2009, MOL BREEDING, V24, P213, DOI 10.1007/s11032-009-9285-8; Banilas G, 2003, GENOME, V46, P370, DOI [10.1139/g03-011, 10.1139/G03-011]; Barazani O, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-146; Belaj A, 2010, SCI HORTIC-AMSTERDAM, V124, P323, DOI 10.1016/j.scienta.2010.01.010; Besnard G, 2013, ANN BOT-LONDON, V112, P1293, DOI 10.1093/aob/mct196; Besnard G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2833; Besnard G, 2001, THEOR APPL GENET, V102, P251, DOI 10.1007/s001220051642; Breton C, 2008, PLANT SCI, V175, P524, DOI 10.1016/j.plantsci.2008.05.025; Breton C, 2006, J BIOGEOGR, V33, P1916, DOI 10.1111/j.1365-2699.2006.01544.x; Breton C, 2009, CR BIOL, V332, P1059, DOI 10.1016/j.crvi.2009.08.001; Carrion Y, 2010, QUATERNARY SCI REV, V29, P952, DOI 10.1016/j.quascirev.2009.12.015; Chalak L, 2015, GENET RESOUR CROP EV, V62, P621, DOI 10.1007/s10722-014-0187-1; Charafi J, 2008, GENET RESOUR CROP EV, V55, P893, DOI 10.1007/s10722-007-9294-6; Cipriani G, 2002, THEOR APPL GENET, V104, P223, DOI 10.1007/s001220100685; Claros MG, 2000, EUPHYTICA, V116, P131, DOI 10.1023/A:1004011829274; Diez CM, 2015, NEW PHYTOL, V206, P436, DOI 10.1111/nph.13181; Diez CM, 2011, ANN BOT-LONDON, V108, P797, DOI 10.1093/aob/mcr194; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Erre P, 2010, GENET RESOUR CROP EV, V57, P41, DOI 10.1007/s10722-009-9449-8; Garcia-Diaz A, 2003, GENOME, V46, P377, DOI 10.1139/G03-017; GILL DE, 1995, ANNU REV ECOL SYST, V26, P423, DOI 10.1146/annurev.es.26.110195.002231; Gregoriou C, 1996, EUPHYTICA, V87, P173, DOI 10.1007/BF00023745; Hadjisavvas, 2012, PARALLEL LIVES ANCIE; Hagidimitriou M, 2005, J AM SOC HORTIC SCI, V130, P211, DOI 10.21273/JASHS.130.2.211; Haouane H, 2011, ACTA HORTIC, V918, P807; Haouane H, 2011, GENETICA, V139, P1083, DOI 10.1007/s10709-011-9608-7; Harris SA, 2002, TRENDS GENET, V18, P426, DOI 10.1016/S0168-9525(02)02689-6; Hosseini-Mazinani M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093146; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaniewski D, 2012, BIOL REV, V87, P885, DOI 10.1111/j.1469-185X.2012.00229.x; Kopelman NM, 2015, MOL ECOL RESOUR; Lavee S, 2013, SCI HORTIC-AMSTERDAM, V161, P333, DOI 10.1016/j.scienta.2013.07.002; Linos A, 2014, SCI HORTIC-AMSTERDAM, V175, P33, DOI 10.1016/j.scienta.2014.05.034; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Mekuria GT, 1999, J HORTIC SCI BIOTECH, V74, P309, DOI 10.1080/14620316.1999.11511114; Newton C, 2014, VEG HIST ARCHAEOBOT, V23, P567, DOI 10.1007/s00334-013-0412-4; Nikoloudakis N, 2003, J AM SOC HORTIC SCI, V128, P741, DOI 10.21273/JASHS.128.5.0741; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pineda-Krch M, 2004, J EVOLUTION BIOL, V17, P1167, DOI 10.1111/j.1420-9101.2004.00808.x; Pritchard JK, 2000, GENETICS, V155, P945; Rackham O., 1996, MAKING CRETAN LANDSC; Salimonti A, 2013, SCI HORTIC-AMSTERDAM, V162, P204, DOI 10.1016/j.scienta.2013.08.005; Sarri V, 2006, GENOME, V49, P1606, DOI 10.1139/G06-126; Terral JF, 2004, J BIOGEOGR, V31, P63, DOI 10.1046/j.0305-0270.2003.01019.x; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	49	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187697	10.1371/journal.pone.0187697	http://dx.doi.org/10.1371/journal.pone.0187697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112969	Green Submitted, Green Published, gold			2022-12-26	WOS:000414572100034
J	Knudsen, PK; Brandtzaeg, P; Hoiby, EA; Bohlin, J; Samuelsen, O; Steinbakk, M; Abrahamsen, TG; Muller, F; Gammelsrud, KW				Knudsen, Per Kristian; Brandtzaeg, Petter; Hoiby, E. Arne; Bohlin, Jon; Samuelsen, Orjan; Steinbakk, Martin; Abrahamsen, Tore G.; Mueller, Fredrik; Gammelsrud, Karianne Wiger			Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAINS; HORIZONTAL GENE-TRANSFER; CYSTIC-FIBROSIS; ANTIMICROBIAL RESISTANCE; TETRACYCLINE RESISTANCE; BETA-LACTAMASES; COLONIZATION; EPIDEMIOLOGY; IDENTIFICATION; CIPROFLOXACIN	We prospectively studied the consequences of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in a cohort of children with cystic fibrosis (CF) and a cohort of children with cancer compared to healthy children with no or low antibiotic exposure. The study was conducted in Norway in a low resistance prevalence setting. Sixty longitudinally collected faecal samples from children with CF (n = 32), 88 samples from children with cancer (n = 45) and 127 samples from healthy children (n = 70) were examined. A direct MIC-gradient strip method was used to detect resistant Enterobacteriaceae by applying Etest strips directly onto agar-plates swabbed with faecal samples. Whole genome sequencing (WGS) data were analysed to identify resistance mechanisms in 28 multidrug-resistant Escherichia coli isolates. The prevalence of resistance to third-generation cephalosporins, gentamicin and ciprofloxacin was low in all the study groups. At inclusion the prevalence of ampicillin-resistant E. coli and trimethoprim-sulfamethoxazole-resistant E. coli in the CF group compared to healthy controls was 58.6% vs. 28.4% (p = 0.005) and 48.3% vs. 14.9% (p = 0.001), respectively, with a similar prevalence at the end of the study. The prevalence of resistant enterobacteria was not significantly different in the children with cancer compared to the healthy children, not even at the end of the study when the children with cancer had been treated with repeated courses of broad-spectrum antibiotics. Children with cancer were mainly treated with intravenous antibiotics, while the CF group mainly received peroral treatment. Our observations indicate that the mode of administration of antibiotics and the general level of antimicrobial resistance in the community may have an impact on emergence of resistance in intestinal enterobacteria during antibiotic treatment. The WGS analyses detected acquired resistance genes and/or chromosomal mutations that explained the observed phenotypic resistance in all 28 multidrug- resistant E. coli isolates examined.	[Knudsen, Per Kristian; Brandtzaeg, Petter; Abrahamsen, Tore G.] Oslo Univ Hosp, Div Paediat & Adolescent Med, Dept Paediat Med, Oslo, Norway; [Knudsen, Per Kristian; Brandtzaeg, Petter; Abrahamsen, Tore G.; Mueller, Fredrik; Gammelsrud, Karianne Wiger] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Hoiby, E. Arne] Norwegian Inst Publ Hlth, Oslo, Norway; [Bohlin, Jon] Norwegian Inst Publ Hlth, Domain Infect Control & Environm Hlth, Dept Methodol Res & Anal, Oslo, Norway; [Samuelsen, Orjan] Univ Hosp North Norway, Dept Microbiol & Infect Control, Norwegian Natl Advisory Unit Detect Antimicrobial, Tromso, Norway; [Samuelsen, Orjan] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Pharm, Tromso, Norway; [Steinbakk, Martin] Norwegian Inst Publ Hlth, Domain Infect Control & Environm Hlth, Dept Antibiot Resistance & Infect Prevent, Oslo, Norway; [Mueller, Fredrik; Gammelsrud, Karianne Wiger] Oslo Univ Hosp, Div Lab Med, Dept Microbiol, Oslo, Norway; [Brandtzaeg, Petter] Maltrostveien 16, Oslo, Norway; [Hoiby, E. Arne] Dyna Brygge 5, Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; Norwegian Institute of Public Health (NIPH); University of Oslo	Knudsen, PK (corresponding author), Oslo Univ Hosp, Div Paediat & Adolescent Med, Dept Paediat Med, Oslo, Norway.; Knudsen, PK (corresponding author), Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.	p.k.knudsen@medisin.uio.no	Samuelsen, Ørjan/K-9068-2019	Samuelsen, Ørjan/0000-0002-5525-2614	Southern and Eastern Norway Regional Health Authority (Helse Sor-Ost) [2014071, HO-2006-188]; Norwegian Cancer Society [D-03071/002]; Oslo University Hospital; Norwegian Surveillance System for Antimicrobial Drug Resistance (NORM)	Southern and Eastern Norway Regional Health Authority (Helse Sor-Ost); Norwegian Cancer Society(Norwegian Cancer Society); Oslo University Hospital; Norwegian Surveillance System for Antimicrobial Drug Resistance (NORM)	The study was funded by grants from the Southern and Eastern Norway Regional Health Authority (Helse Sor-Ost), grant numbers 2014071 (awarded to PKK) and HO-2006-188 (awarded to KWG), www.helsesorost.no, the Norwegian Cancer Society, grant number D-03071/002 (awarded to KWG), www.kreftforeningen.no, Barnestiftelsen, Oslo University Hospital (awarded to PKK), www.oslo-universitetssykehus.no and the Norwegian Surveillance System for Antimicrobial Drug Resistance (NORM) (awarded to PKK) www.unn.no	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Blaser MJ, 2015, MANDELL DOUGLAS BENN, P310; BODET CA, 1985, ANTIMICROB AGENTS CH, V28, P437, DOI 10.1128/AAC.28.3.437; Boucher RC, 2015, HODSON GEDDESCYSTIC, P71; Bryce A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1697-6; BURMAN LG, 1992, ANTIMICROB AGENTS CH, V36, P989, DOI 10.1128/AAC.36.5.989; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; DALZELL AM, 1991, THORAX, V46, P239, DOI 10.1136/thx.46.4.239; de Man P, 2000, LANCET, V355, P973, DOI 10.1016/S0140-6736(00)90015-1; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; Doi Y, 2015, MANDELL DOUGLAS BENN, P263, DOI [DOI 10.1016/B978-1-4557-4801-3.00020-5, 10.1016/B978-1-4557-4801-3.00020-5Philadelphia, DOI 10.1016/B978-1-4557-4801-3.00020-5PHILADELPHIA]; Duytschaever G, 2013, J CYST FIBROS, V12, P780, DOI 10.1016/j.jcf.2013.06.006; Gammelsrud KW, 2016, J MICROBIOL METH, V129, P94, DOI 10.1016/j.mimet.2016.08.007; GIERINGER JH, 1986, CHEMOTHERAPY, V32, P418, DOI 10.1159/000238445; Gottig S, 2015, CLIN INFECT DIS, V60, P1808, DOI 10.1093/cid/civ191; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Holmes Alison H, 2016, Lancet, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Horcajada JP, 2002, J ANTIMICROB CHEMOTH, V49, P55, DOI 10.1093/jac/49.1.55; Huddleston JR, 2014, INFECT DRUG RESIST, V7, P167, DOI 10.2147/IDR.S48820; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Jorgensen SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173510; KALENIC S, 1993, J HOSP INFECT, V23, P35, DOI 10.1016/0195-6701(93)90128-M; Karami N, 2006, ANTIMICROB AGENTS CH, V50, P156, DOI 10.1128/AAC.50.1.156-161.2006; Karami N, 2007, J ANTIMICROB CHEMOTH, V60, P1142, DOI 10.1093/jac/dkm327; Knudsen PK, 2009, J CYST FIBROS, V8, P135, DOI 10.1016/j.jcf.2008.11.001; Kothari C, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-136; Kvakkestad KM, 2012, CHEMOTHERAPY, V58, P118, DOI 10.1159/000337058; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; LASSEN J, 1975, ACTA PATH MICRO IM B, V83, P525; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Leclercq R, 2013, CLIN MICROBIOL INFEC, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Literak I, 2011, ANTIMICROB AGENTS CH, V55, P3005, DOI 10.1128/AAC.01724-10; Macfarlane S, 2014, ENVIRON MICROBIOL, V16, P919, DOI 10.1111/1462-2920.12399; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Millar M, 2008, J CLIN MICROBIOL, V46, P560, DOI 10.1128/JCM.00832-07; Moore AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078822; NORM/NORM-VET, 2006, USAGE OF ANTIMICROBI; Nyberg SD, 2007, SCAND J INFECT DIS, V39, P514, DOI 10.1080/00365540701199790; Nyhlen A, 2002, CHEMOTHERAPY, V48, P71, DOI 10.1159/000057665; PREVOT MH, 1986, ANTIMICROB AGENTS CH, V30, P945, DOI 10.1128/AAC.30.6.945; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Raum E, 2008, CLIN MICROBIOL INFEC, V14, P41, DOI 10.1111/j.1469-0691.2007.01841.x; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Rodriguez-Bano J, 2008, J ANTIMICROB CHEMOTH, V62, P1142, DOI 10.1093/jac/dkn293; Saenz Y, 2003, J ANTIMICROB CHEMOTH, V51, P1001, DOI 10.1093/jac/dkg168; SCULLY BE, 1987, AM J MED, V82, P336; Skold O, 2001, VET RES, V32, P261, DOI 10.1051/vetres:2001123; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stoesser N, 2015, J CLIN MICROBIOL, V53, P2122, DOI 10.1128/JCM.00378-15; Stoesser N, 2013, J ANTIMICROB CHEMOTH, V68, P2234, DOI 10.1093/jac/dkt180; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Tracz DM, 2007, FEMS MICROBIOL LETT, V270, P265, DOI 10.1111/j.1574-6968.2007.00672.x; Turnidge J, 2005, LANCET, V365, P548; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang L, 2013, ANTIMICROB AGENTS CH, V57, P3659, DOI 10.1128/AAC.00670-13	64	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187618	10.1371/journal.pone.0187618	http://dx.doi.org/10.1371/journal.pone.0187618			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112974	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000414572100026
J	Hummel, C; Provenzale, A; van der Meer, J; Wijnhoven, S; Nolte, A; Poursanidis, D; Janss, G; Jurek, M; Andresen, M; Poulin, B; Kobler, J; Beierkuhnlein, C; Honrado, J; Razinkovas, A; Stritih, A; Bargmann, T; Ziemba, A; Bonet-Garcia, F; Adamescu, MC; Janssen, G; Hummel, H				Hummel, Christiaan; Provenzale, Antonello; van der Meer, Jaap; Wijnhoven, Sander; Nolte, Arno; Poursanidis, Dimitris; Janss, Guyonne; Jurek, Matthias; Andresen, Magnus; Poulin, Brigitte; Kobler, Johannes; Beierkuhnlein, Carl; Honrado, Joao; Razinkovas, Arturas; Stritih, Ana; Bargmann, Tessa; Ziemba, Alex; Bonet-Garcia, Francisco; Adamescu, Mihai Cristian; Janssen, Gerard; Hummel, Herman			Ecosystem services in European protected areas: Ambiguity in the views of scientists and managers?	PLOS ONE			English	Article							BIODIVERSITY; CONSERVATION; ECOLOGY; TRAITS; INDEX	Protected Areas are a key component of nature conservation. They can play an important role in counterbalancing the impacts of ecosystem degradation. For an optimal protection of a Protected Area it is essential to account for the variables underlying the major Ecosystem Services an area delivers, and the threats upon them. Here we show that the perception of these important variables differs markedly between scientists and managers of Protected Areas in mountains and transitional waters. Scientists emphasise variables of abiotic and biotic nature, whereas managers highlight socio-economic, cultural and anthropogenic variables. This indicates fundamental differences in perception. To be able to better protect an area it would be advisable to bring the perception of scientists and managers closer together. Intensified and harmonised communication across disciplinary and professional boundaries will be needed to implement and improve Ecosystem Service oriented management strategies in current and future Protected Areas.	[Hummel, Christiaan; Hummel, Herman] NIOZ Royal Netherlands Inst Sea Res, Dept Estuarine & Delta Syst, Yerseke, Netherlands; [Hummel, Christiaan; Hummel, Herman] Univ Utrecht, Yerseke, Netherlands; [Hummel, Christiaan; van der Meer, Jaap] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Provenzale, Antonello] CNR, Rome, Italy; [van der Meer, Jaap] NIOZ Royal Netherlands Inst Sea Res, Dept Coastal Syst, Texel, Netherlands; [van der Meer, Jaap] Univ Utrecht, Texel, Netherlands; [Wijnhoven, Sander] EcoAuthor, Heinkenszand, Netherlands; [Nolte, Arno; Ziemba, Alex] Deltares, Delft, Netherlands; [Poursanidis, Dimitris] Fdn Res & Technol, Iraklion, Greece; [Janss, Guyonne] CSIC, Estn Biol Donana, Almonte, Spain; [Jurek, Matthias; Andresen, Magnus] United Nations Environm, Vienna, Austria; [Poulin, Brigitte] Res Inst Conservat Mediterranean Wetlands, Tour Du Valat, Le Sambuc, France; [Kobler, Johannes] Umweltbundesamt, Vienna, Austria; [Beierkuhnlein, Carl] Univ Bayreuth, BayCEER, Bayreuth, Germany; [Honrado, Joao] Univ Porto, Fac Ciencias, InBIO CIBIO, Oporto, Portugal; [Razinkovas, Arturas] Klaipeda Univ, Marine Sci & Technol Ctr, Klaipeda, Lithuania; [Stritih, Ana] Swiss Fed Inst Technol, Zurich, Switzerland; [Bargmann, Tessa] Univ Bergen, Bergen, Norway; [Bonet-Garcia, Francisco] Univ Granada, Granada, Spain; [Adamescu, Mihai Cristian] Univ Bucharest, Bucharest, Romania; [Janssen, Gerard] Rijkswaterstaat, Leeuwarden, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Vrije Universiteit Amsterdam; Consiglio Nazionale delle Ricerche (CNR); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Deltares; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Bayreuth; Universidade do Porto; Klaipeda University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bergen; University of Granada; University of Bucharest	Hummel, C (corresponding author), NIOZ Royal Netherlands Inst Sea Res, Dept Estuarine & Delta Syst, Yerseke, Netherlands.; Hummel, C (corresponding author), Univ Utrecht, Yerseke, Netherlands.; Hummel, C (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	christiaan.hummel@nioz.nl	Beierkuhnlein, Carl/ABF-8797-2021; Bonet-García, Francisco/A-3551-2011; Wijnhoven, Sander/A-8866-2011; Poursanidis, Dimitris/M-8957-2013; Kobler, Johannes/E-7042-2012; Beierkuhnlein, Carl/ABF-9693-2021; Adamescu, Cristian Mihai/AFX-5768-2022; Adamescu, Cristian Mihai/AAM-6873-2020; Hummel, Herman/A-9610-2011; Janss, Guyonne F E/C-4157-2011; Honrado, Joao/L-8365-2013	Bonet-García, Francisco/0000-0002-4627-1442; Wijnhoven, Sander/0000-0001-5850-1383; Poursanidis, Dimitris/0000-0003-3228-280X; Beierkuhnlein, Carl/0000-0002-6456-4628; Adamescu, Cristian Mihai/0000-0002-3056-8444; Adamescu, Cristian Mihai/0000-0002-3056-8444; Hummel, Herman/0000-0001-6902-5773; Ziemba, Alexander/0000-0002-8293-6376; Stritih, Ana/0000-0001-5323-8176; Kobler, Johannes/0000-0003-0052-4245; Janss, Guyonne F E/0000-0003-4318-6602; Bargmann, Tessa/0000-0001-9096-7511; Honrado, Joao/0000-0001-8443-4276	European Union's Horizon research and innovation programme [641762]	European Union's Horizon research and innovation programme	This study was done in the frame of the EcoPotential project. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 641762. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was done in the frame of the EcoPotential project. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 641762. We would like to thank all PA managers, and scientists for their contribution to the tables by filling in the survey, and especially the PA manager of Samaria, Antonios Barnias, the PA manager of Gran Paradiso, Ramona Viterbi, and the scientist responsible for Samaria, Dr. Nektarios Chrysoulakis.	Adams J.S., 1992, MYTH WILD AFRICA CON; Agardy T, 2000, B MAR SCI, V66, P875; Atkins JP, 2011, MAR POLLUT BULL, V62, P215, DOI 10.1016/j.marpolbul.2010.12.012; Bagstad KJ, 2014, ECOL SOC, V19, DOI 10.5751/ES-06523-190264; Bishop K, 2004, SPEAKING COMMON LANG; Bonet-Garcia FJ, 2015, BIOL CONSERV, V187, P221, DOI 10.1016/j.biocon.2015.04.027; Bremner J, 2008, J EXP MAR BIOL ECOL, V366, P37, DOI 10.1016/j.jembe.2008.07.007; Carvalho-Santos C, 2015, HYDROLOGICAL PROCESS; Coad L., 2008, COSTS BENEFITS PROTE; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Draper MA, 2004, CULTURE ORG, V10; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fisher JA, 2014, ECOL ECON, V108, P257, DOI 10.1016/j.ecolecon.2014.11.004; Fitter A, 2010, ISS ENVIRON SCI TECH, V30, P1, DOI 10.1039/9781849731058-00001; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Haines-Young R., 2012, COMMON INT CLASSIFIC, P33; Hattam C, 2015, ECOL INDIC, V49, P61, DOI 10.1016/j.ecolind.2014.09.026; Hauck J, 2013, ENVIRON SCI POLICY, V25, P13, DOI 10.1016/j.envsci.2012.08.001; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Honrado JP, 2013, ENVIRON IMPACT ASSES, V40, P14, DOI 10.1016/j.eiar.2012.12.002; IBM, 2016, IBM SPSS STAT WINDOW; ISCBD Interim Secretariat of the Convention on Biological Diversity, 1994, UNEPCBD941 ISCBD; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lamarque P, 2011, REG ENVIRON CHANGE, V11, P791, DOI 10.1007/s10113-011-0214-0; Likert R, 1932, TECHNIQUE MEASUREMEN; Maes J, 2015, LANDSCAPE ECOL, V30, P517, DOI 10.1007/s10980-014-0083-2; McClanahan T, 2005, ENVIRON CONSERV, V32, P42, DOI 10.1017/S0376892904001791; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Nagendra H, 2015, INT J APPL EARTH OBS, V37, P124, DOI 10.1016/j.jag.2014.10.010; Nolte A, 2016, SYNTHESIS REPORT ANA; Norling K, 2007, MAR ECOL PROG SER, V332, P11, DOI 10.3354/meps332011; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Palmer M, 2004, SCIENCE, V304, P1251, DOI 10.1126/science.1095780; Parrish JD, 2003, BIOSCIENCE, V53, P851, DOI 10.1641/0006-3568(2003)053[0851:AWCWWS]2.0.CO;2; Paruelo JM, 2016, ECOL INDIC, V71, P145, DOI 10.1016/j.ecolind.2016.06.054; Petrosillo I, 2009, MAR POLLUT BULL, V58, P1454, DOI 10.1016/j.marpolbul.2009.06.013; Phillips, 2007, SHORT HIST INT SYST; Pomeroy RS, 2005, OCEAN COAST MANAGE, V48, P485, DOI 10.1016/j.ocecoaman.2005.05.004; Potts T, 2014, MAR POLICY, V44, P139, DOI 10.1016/j.marpol.2013.08.011; Ridder B, 2008, BIODIVERS CONSERV, V17, P781, DOI 10.1007/s10531-008-9316-5; Sil A, 2016, MT RES DEV, V36, P452, DOI 10.1659/MRD-JOURNAL-D-16-00035.1; TEEB, 2008, EC ECOSYSTEMS BIODIV; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Tornroos A, 2015, J SEA RES, V98, P49, DOI 10.1016/j.seares.2014.04.010; UNEP, 2016, MAR COAST EC HUM WEL; Upton C, 2008, ORYX, V42, P19, DOI 10.1017/S0030605307001044; Van der Biest K, 2014, ECOL INDIC, V37, P252, DOI 10.1016/j.ecolind.2013.04.006; Vassallo P, 2013, MAR POLLUT BULL, V75, P157, DOI 10.1016/j.marpolbul.2013.07.044; Vermaat JE, 2016, AMBIO, P1; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	55	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187143	10.1371/journal.pone.0187143	http://dx.doi.org/10.1371/journal.pone.0187143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29140983	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400017
J	Lei, FL; Li, SS; Mi, BB; Liu, DM; Yang, JM; Qu, PF; Zhang, R; Zhang, XF; Ying, J; Dang, SN; Yan, H				Lei, Fangliang; Li, Shanshan; Mi, Baibing; Liu, Danmeng; Yang, Jiaomei; Qu, Pengfei; Zhang, Ruo; Zhang, Xiaofeng; Ying, Jia; Dang, Shaonong; Yan, Hong			Association between birth season and physical development in children under 3 years old residing in low-income counties in western China	PLOS ONE			English	Article							PRENATAL VITAMIN-D; WEIGHT; HEIGHT; GROWTH; LENGTH; JAPAN; SIZE	Objective To explore the association between birth season and physical development and provide a necessary reference value to inform the implementation of public health services. Design Cross-sectional study. Setting Forty-five counties in ten provinces in western China in 2005. Subjects A sample of 13,387 children under 3 years old and their mothers were recruited using a stratified, multistage, cluster random sampling method. Results The results of the circular distribution analysis suggested that stunting and underweight exhibited time aggregation (Z = 32.57, P< 0.05; Z = 10.42, P< 0.05) among children under 3 years old. The Z -value for wasting, however, was not statistically significant (P> 0.05). The generalized linear mixed models showed that children born in the summer were less likely to exhibit stunting (OR: 0.74 similar to 0.97) than were children born in the winter after adjusting for confounders, but no significant differences were identified for the other seasons. In addition, among children aged 25 to 36 months, those born in the summer and autumn were less likely to exhibit stunting after adjusting for confounders than were children born in the winter, but the association between birth in spring and stunting was not statistically significant. Conclusions Stunting was associated with season of birth among children under 3 years old in lowincome counties in western China, especially children aged 25 to 36 months, and children born in the summer and autumn were less likely to exhibit stunting than were children born in the winter.	[Lei, Fangliang; Li, Shanshan; Mi, Baibing; Liu, Danmeng; Yang, Jiaomei; Zhang, Ruo; Dang, Shaonong] Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China; [Qu, Pengfei] Northwest Women & Childrens Hosp, Assisted Reprod Ctr, Xian, Shaanxi, Peoples R China; [Zhang, Xiaofeng] Luoyang Matern & Child Care Hosp, Luoyang, Henan, Peoples R China; [Ying, Jia] Putuo Ctr Dis Prevent & Control, Dept Dis Prevent & Control, Zhoushan, Zhejiang, Peoples R China; [Yan, Hong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China; [Yan, Hong] Nutr & Food Safety Engn Res Ctr Shaanxi Prov, Xian, Shaanxi, Peoples R China; [Yan, Hong] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Yan, H (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China.; Yan, H (corresponding author), Nutr & Food Safety Engn Res Ctr Shaanxi Prov, Xian, Shaanxi, Peoples R China.; Yan, H (corresponding author), Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China.	xjtu_yh.paper@aliyun.com	Shaonong, Dang/J-7421-2019; mi, baibing/ABO-1246-2022	Shaonong, Dang/0000-0002-6980-8169; mi, baibing/0000-0002-5208-7633	Chinese Ministry of Health (MOH); United Nations Children's Fund (UNICEF) [YH001]; National Natural Science Foundation of China [81230016]; Shaanxi Health and Family Planning Commission [Sxwsjswzfcght2016-013]	Chinese Ministry of Health (MOH); United Nations Children's Fund (UNICEF); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Health and Family Planning Commission	The study was sponsored the Chinese Ministry of Health (MOH), the United Nations Children's Fund (UNICEF) (grant number YH001); National Natural Science Foundation of China (grant number 81230016); and Shaanxi Health and Family Planning Commission (grant number Sxwsjswzfcght2016-013). The MOH and UNICEF selected the counties that were sampled in the present study, and these sponsors had no role in the design, analysis, interpretation of data, or composition of this article or the decision to submit the paper for publication.	Chen Mingxia, 2003, Wei Sheng Yan Jiu, V32, P249; DECASTRO JM, 1991, PHYSIOL BEHAV, V50, P243, DOI 10.1016/0031-9384(91)90527-U; Gloria-Bottini F, 2009, EARLY HUM DEV, V85, P439, DOI 10.1016/j.earlhumdev.2009.02.004; GloriaBottini F, 1997, HUM GENET, V101, P158, DOI 10.1007/s004390050606; GOLDEN MHN, 1994, EUR J CLIN NUTR, V48, pS58; Jensen CB, 2015, EARLY HUM DEV, V91, P361, DOI 10.1016/j.earlhumdev.2015.03.010; Koscinski K, 2004, AM J HUM BIOL, V16, P31, DOI 10.1002/ajhb.10232; Krenz-Niedbala M, 2011, AM J HUM BIOL, V23, P190, DOI 10.1002/ajhb.21101; Li C, 2015, J NUTR, V145, P1844, DOI 10.3945/jn.114.207795; Lund R., 2003, J AM             SEP; MATSUDA S, 1993, HUM BIOL, V65, P481; MATSUDA S, 1995, HUM BIOL, V67, P641; McGrath JJ, 2005, EARLY HUM DEV, V81, P609, DOI 10.1016/j.earlhumdev.2005.03.013; McGrath J, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-45; McMichael AJ, 2001, HUMAN FRONTIERS ENV, DOI [10.1017/CBO9781139106924, DOI 10.1017/CBO9781139106924]; Pomeroy E, 2014, AM J PHYS ANTHROPOL, V154, P115, DOI 10.1002/ajpa.22484; Qu Peng-fei, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P346; Robert R, 2000, KIMBERLEE GAUVREAU P; Schwekendiek D, 2009, HOMO, V60, P59, DOI 10.1016/j.jchb.2008.03.001; Sohn K, 2015, AM J PHYS ANTHROPOL, V157, P659, DOI 10.1002/ajpa.22763; Sun Jian-wei, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P1026; Torche F, 2010, ANN EPIDEMIOL, V20, P818, DOI 10.1016/j.annepidem.2010.08.005; Tucker JD, 2010, B WORLD HEALTH ORGAN, V88, P452, DOI 10.2471/BLT.09.070326; Waldie KE, 2000, EARLY HUM DEV, V60, P35, DOI 10.1016/S0378-3782(00)00102-X; Wang Yuying, 2007, Wei Sheng Yan Jiu, V36, P203; WATERLOW JC, 1994, EUR J CLIN NUTR, V48, pS72; Weber GW, 1998, NATURE, V391, P754, DOI 10.1038/35781; WHO, 2006, WHO CHILD GROWTH STA; Wohlfahrt J, 1998, LANCET, V352, P1990, DOI 10.1016/S0140-6736(05)61336-0; Xu X, 2001, EUR J CLIN NUTR, V55, P714, DOI 10.1038/sj.ejcn.1601212	30	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187029	10.1371/journal.pone.0187029	http://dx.doi.org/10.1371/journal.pone.0187029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136010	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200013
J	Deichmann, JL; Mulcahy, DG; Vanthomme, H; Tobi, E; Wynn, AH; Zimkus, BM; McDiarmid, RW				Deichmann, Jessica L.; Mulcahy, Daniel G.; Vanthomme, Hadrien; Tobi, Elie; Wynn, Addison H.; Zimkus, Breda M.; McDiarmid, Roy W.			How many species and under what names? Using DNA barcoding and GenBank data for west Central African amphibian conservation	PLOS ONE			English	Article							TROPICAL FORESTS; REED FROGS; TAXONOMY; BIODIVERSITY; SYSTEMATICS; MADAGASCAR; BIOGEOGRAPHY; INFORMATION; INVENTORY; DIVERSITY	Development projects in west Central Africa are proceeding at an unprecedented rate, often with little concern for their effects on biodiversity. In an attempt to better understand potential impacts of a road development project on the anuran amphibian community, we conducted a biodiversity assessment employing multiple methodologies (visual encounter transects, auditory surveys, leaf litter plots and pitfall traps) to inventory species prior to construction of a new road within the buffer zone of Moukalaba-Doudou National Park, Gabon. Because of difficulties in morphological identification and taxonomic uncertainty of amphibian species observed in the area, we integrated a DNA barcoding analysis into the project to improve the overall quality and accuracy of the species inventory. Based on morphology alone, 48 species were recognized in the field and voucher specimens of each were collected. We used tissue samples from specimens collected at our field site, material available from amphibians collected in other parts of Gabon and the Republic of Congo to initiate a DNA barcode library for west Central African amphibians. We then compared our sequences with material in GenBank for the genera recorded at the study site to assist in identifications. The resulting COI and 16S barcode library allowed us to update the number of species documented at the study site to 28, thereby providing a more accurate assessment of diversity and distributions. We caution that because sequence data maintained in GenBank are often poorly curated by the original submitters and cannot be amended by third-parties, these data have limited utility for identification purposes. Nevertheless, the use of DNA barcoding is likely to benefit biodiversity inventories and long-term monitoring, particularly for taxa that can be difficult to identify based on morphology alone; likewise, inventory and monitoring programs can contribute invaluable data to the DNA barcode library and the taxonomy of complex groups. Our methods provide an example of how non-taxonomists and parataxonomists working in understudied parts of the world with limited geographic sampling and comparative morphological material can use DNA barcoding and publicly available sequence data (GenBank) to rapidly identify the number of species and assign tentative names to aid in urgent conservation management actions and contribute to taxonomic resolution.	[Deichmann, Jessica L.; Vanthomme, Hadrien; Tobi, Elie] Natl Zool Pk, Ctr Conservat & Sustainabil, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [Mulcahy, Daniel G.] Smithsonian Inst, Natl Museum Amer Hist, Global Genome Initiat, Washington, DC 20560 USA; [Wynn, Addison H.] Smithsonian Inst, Natl Museum Amer Hist, Dept Vertebrate Zool, Div Amphibians & Reptiles, Washington, DC 20560 USA; [Zimkus, Breda M.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [McDiarmid, Roy W.] USGS, Patuxent Wildlife Res Ctr, Natl Museum Nat Hist, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History; Harvard University; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of the Interior; United States Geological Survey	Deichmann, JL (corresponding author), Natl Zool Pk, Ctr Conservat & Sustainabil, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA.	jessiedeichmann@gmail.com		Deichmann, Jessica/0000-0002-2198-3515	Shell Gabon; Smithsonian Institution's DNA Barcode Network; Smithsonian Conservation Biology Institute; National Museum of Natural History's Laboratories of Analytical Biology	Shell Gabon; Smithsonian Institution's DNA Barcode Network; Smithsonian Conservation Biology Institute(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); National Museum of Natural History's Laboratories of Analytical Biology	Shell Gabon funded the field work in the LMR study area. The Smithsonian Institution's DNA Barcode Network provided funding for all laboratory work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Smithsonian Conservation Biology Institute and the National Museum of Natural History's Laboratories of Analytical Biology provided in-kind support.	American Veterinary Medical Association (AVMA), 2013, AVMA GUID EUTH AN 20; [Anonymous], 2016, AMPHIBIAN SPECIES WO; Baldwin CC, 2009, ZOOTAXA, P1; Basset Y, 2004, J APPL ECOL, V41, P163, DOI 10.1111/j.1365-2664.2004.00878.x; Beaz-Hidalgo R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115813; Bell RC, 2017, MOL ECOL, V26, P5223, DOI 10.1111/mec.14260; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blackburn D.C., 2009, BREVIORA, V515, P1; Blackburn DC, 2008, MOL PHYLOGENET EVOL, V49, P806, DOI 10.1016/j.ympev.2008.08.015; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Bridge PD, 2003, NEW PHYTOL, V160, P43, DOI 10.1046/j.1469-8137.2003.00861.x; Burger M, 2006, B BIOL SOC WASH, V2, P297; Burger Marius, 2006, Bulletin of the Biological Society of Washington, V12, P297; Cameron S, 2006, SYST BIOL, V55, P844, DOI 10.1080/10635150600960079; Cerutti-Pereyra F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036479; Chambers EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154363; Channing A, 2013, ZOOTAXA, V3620, P301, DOI 10.11646/zootaxa.3620.3.1; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chapple DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077882; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Christy P, 2008, CHECKLIST AMPHIBIANS; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Cortes-Gomez AM, 2015, Univ. Sci., V20, P229, DOI 10.11144/Javeriana.SC20-2.efna; Dai LN, 2012, MOL ECOL RESOUR, V12, P437, DOI 10.1111/j.1755-0998.2012.03118.x; de Mendonca RS, 2011, EXP APPL ACAROL, V55, P1, DOI 10.1007/s10493-011-9453-5; de Queiroz Kevin, 2005, Proceedings of the California Academy of Sciences, V56, P196; Ernst R, 2008, ZOOTAXA, P58; Evans BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142823; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Frantine-Silva W, 2015, MOL ECOL RESOUR, V15, P1226, DOI 10.1111/1755-0998.12385; Fretey T, 2001, B SOC ZOOL FR, V126, P375; Fretey T, 2011, MUSEUM NATL HIST PAR; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; GAO (Government Accountability Office), 2014, NATL ENV POLICY ACT; Giam X, 2011, P ROYAL SOC LONDON B; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hocking DJ, 2014, HERPETOL CONSERV BIO, V9, P1; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hoffman EA, 2000, BIOL J LINN SOC, V70, P633, DOI 10.1006/bijl.1999.0421; Hurtado J, 2011, REV BIOL TROP, V59, P1455; IEA, 2019, WORLD EN OUTL; IUCN, IUCN RED LIST THREAT; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kim KC, 2006, ECOL RES, V21, P794, DOI 10.1007/s11284-006-0035-7; Krell FT, 2004, BIODIVERS CONSERV, V13, P795, DOI 10.1023/B:BIOC.0000011727.53780.63; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Krishnamurthy PK, 2012, BIODIVERS CONSERV, V21, P1901, DOI 10.1007/s10531-012-0306-2; Kurabayashi A., 2011, BMC EVOLUTIONARY BIO, V11, P1, DOI DOI 10.1186/1471-2148-11-175; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Larson J.C., 2015, HERPETOLOGICAL REV, V46, P57; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; Lotters S, 2005, HERPETOL J, V15, P149; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; MacGregor-Fors I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056794; Measey GJ, 2007, J BIOGEOGR, V34, P7, DOI 10.1111/j.1365-2699.2006.01589.x; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meier R, 2016, CLADISTICS, V32, P100, DOI 10.1111/cla.12115; Miller SE, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0339; Ohler A, 2016, PEERJ, V4, DOI 10.7717/peerj.1553; Okon EE, 2016, MULTINATIONAL ENTERP, P351; Oliver LA, 2015, MOL PHYLOGENET EVOL, V90, P176, DOI 10.1016/j.ympev.2015.05.001; Osti M, 2011, BIODIVERS CONSERV, V20, P1863, DOI 10.1007/s10531-011-0056-6; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pauwels Olivier S.G., 2007, Herpetozoa, V19, P135; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Perl RGB, 2014, AMPHIBIA-REPTILIA, V35, P197, DOI 10.1163/15685381-00002942; Pino-Del-Carpio A, 2014, BIOL CONSERV, V173, P74, DOI 10.1016/j.biocon.2013.11.020; Poynton JC, 2016, ZOOTAXA, V4098, P73, DOI 10.11646/zootaxa.4098.1.3; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rodrigues ASL, 2010, BIOSCIENCE, V60, P798, DOI 10.1525/bio.2010.60.10.6; Rodel MO, 2014, ZOOSYST EVOL, V90, P21, DOI 10.3897/zse.90.7120; Roelants K, 2005, SYST BIOL, V54, P111, DOI 10.1080/10635150590905894; Roelke CE, 2011, J HERPETOL, V45, P343, DOI 10.1670/10-092.1; Rossini BC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167203; Rubinoff D, 2006, CONSERV BIOL, V20, P1026, DOI 10.1111/j.1523-1739.2006.00372.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; San Mauro D, 2009, SYST BIOL, V58, P425, DOI 10.1093/sysbio/syp043; Schmiedel U, 2016, CONSERV BIOL, V30, P506, DOI 10.1111/cobi.12661; Sheil D, 2004, TRENDS ECOL EVOL, V19, P634, DOI 10.1016/j.tree.2004.09.019; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STEWART MM, 1974, COPEIA, P823; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Veith M, 2009, MOL PHYLOGENET EVOL, V51, P388, DOI 10.1016/j.ympev.2008.12.022; Vences M, 2004, J BIOGEOGR, V31, P593, DOI 10.1046/j.1365-2699.2003.01031.x; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Warkentin IG, 2009, CONSERV BIOL, V23, P1056, DOI 10.1111/j.1523-1739.2008.01165.x; Weigt Lee A, 2012, Methods Mol Biol, V858, P11, DOI 10.1007/978-1-61779-591-6_2; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; Zimkus BM, 2017, MOL PHYLOGENET EVOL, V106, P254, DOI 10.1016/j.ympev.2016.09.018; Zimkus BM, 2013, SALAMANDRA, V49, P159; Zimkus BM, 2010, SYST BIODIVERS, V8, P39, DOI 10.1080/14772000903543004	101	24	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187283	10.1371/journal.pone.0187283	http://dx.doi.org/10.1371/journal.pone.0187283			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131846	gold, Green Published, Green Submitted			2022-12-26	WOS:000414997800008
J	Duchartre, Y; Bachl, S; Kim, HN; Gang, EJ; Lee, S; Liu, HC; Shung, K; Xu, R; Kruse, A; Tachas, G; Bonig, H; Kim, YM				Duchartre, Yann; Bachl, Stefanie; Kim, Hye Na; Gang, Eun Ji; Lee, Solah; Liu, Hsiao-chuan; Shung, Kirk; Xu, Ruth; Kruse, Aaron; Tachas, George; Bonig, Halvard; Kim, Yong-Mi			Effects of CD49d-targeted antisense-oligonucleotide on alpha 4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; DRUG-RESISTANCE; NATALIZUMAB; BLOCKADE; ADHESION; ANTIBODY; DISEASE; VLA-4; MS	We recently demonstrated the effectiveness of blocking CD49d with anti-functional antibodies or small molecule inhibitors as a rational targeted approach to the treatment of acute leukemia in combination with chemotherapy. Antisense oligonucleotide promises to be no less specific than antibodies and inhibitors, but more interesting for pharmacokinetics and pharmacodynamics. We addressed this using the published CD49d antisense drug ATL1102. In vitro, we incubated/nucleofected the ALL cell line Kasumi-2 with ATL1102. In vivo, immunodeficient hosts were engrafted with primary ALL cells and treated with ATL1102. Changes in expression of CD49d mRNA and CD49d protein, and of cooperating gene products, including 131 integrin and CXCR4, as well as survival in the mouse experiments were quantified. We observed dose-dependent down-regulation of CD49d mRNA and protein levels and its partner integrin 131 cell surface protein level and, up-regulation of CXCR4 surface expression. The suppression was more pronounced after nucleofection than after incubation, where down-regulation was significant only at the higher doses. In vivo effects of ATL1102 were not sufficient to translate into "clinical" benefit in the leukemia model. In summary, anti sense oligonucleotides are successful tools for specifically modulating gene	[Duchartre, Yann; Bachl, Stefanie; Kim, Hye Na; Gang, Eun Ji; Lee, Solah; Xu, Ruth; Kruse, Aaron; Kim, Yong-Mi] Univ Southern Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dept Pediat,Div Hematol & Oncol, Los Angeles, CA 90033 USA; [Bachl, Stefanie; Bonig, Halvard] Goethe Univ, Inst Transfus Med & Immunohematol, Frankfurt, Germany; [Bachl, Stefanie; Bonig, Halvard] German Red Cross Blood Serv Baden Wurttemberg Hes, Frankfurt, Germany; [Liu, Hsiao-chuan; Shung, Kirk] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA USA; [Kruse, Aaron] Univ Southern Calif, Dept Pathol, Los Angeles, CA USA; [Tachas, George] Antisense Therapeut Ltd, Toorak, Vic, Australia; [Bonig, Halvard] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA	Children's Hospital Los Angeles; University of Southern California; Goethe University Frankfurt; University of Southern California; University of Southern California; University of Washington; University of Washington Seattle	Kim, YM (corresponding author), Univ Southern Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dept Pediat,Div Hematol & Oncol, Los Angeles, CA 90033 USA.	ymkim@chla.usc.edu	kim, y/AAR-6095-2020; Bönig, Halvard/AAG-3029-2021	Bönig, Halvard/0000-0003-0088-2675; Kim, Yong-Mi/0000-0003-3793-6438	NIH R01 funding [CA172896]	NIH R01 funding	This work was supported by NIH R01 funding (CA172896) for Yong-mi Kim. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SK, 1994, J BIOL CHEM, V269, P15961; BALZAC F, 1994, J CELL BIOL, V127, P557, DOI 10.1083/jcb.127.2.557; Bonig H, 2008, BLOOD, V111, P3439, DOI 10.1182/blood-2007-09-112052; Bonig H, 2009, STEM CELLS, V27, P836, DOI 10.1002/stem.9; Bonig H, 2009, EXP HEMATOL, V37, P402, DOI 10.1016/j.exphem.2008.10.017; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Hsieh YT, 2014, LEUKEMIA, V28, P2101, DOI 10.1038/leu.2014.182; Hsieh YT, 2013, BLOOD, V121, P1814, DOI 10.1182/blood-2012-01-406272; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jacamo R, 2014, BLOOD, V123, P2691, DOI 10.1182/blood-2013-06-511527; Juliano RL, 2016, NUCLEIC ACIDS RES, V44, P6518, DOI 10.1093/nar/gkw236; Karpova D, J TRANSL MED, V15, P2; Klemm L, 2009, CANCER CELL, V16, P232, DOI 10.1016/j.ccr.2009.07.030; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Limmroth V, 2014, NEUROLOGY, V83, P1780, DOI 10.1212/WNL.0000000000000926; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Park E, 2011, BLOOD, V118, P2191, DOI 10.1182/blood-2011-04-351239; Ramirez P, 2009, BLOOD, V114, P1340, DOI 10.1182/blood-2008-10-184721; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; Shishido S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00099; Tubridy N, 1999, NEUROLOGY, V53, P466, DOI 10.1212/WNL.53.3.466; Weber MS, CURR PHARM DES, V18, P209	24	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187684	10.1371/journal.pone.0187684	http://dx.doi.org/10.1371/journal.pone.0187684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117236	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600063
J	Lazzaroni, M; Marshall-Pescini, S; Cafazzo, S				Lazzaroni, Martina; Marshall-Pescini, Sarah; Cafazzo, Simona			Post-conflict opponent affiliation reduces victim re-aggression in a family group of captive arctic wolves (Canis lupus arctos)	PLOS ONE			English	Article							MACAQUES MACACA-FASCICULARIS; WILD OLIVE BABOONS; GRAY WOLVES; RELATIONSHIP QUALITY; SOCIAL ANXIETY; RECONCILIATION; BEHAVIOR; CONSOLATION; MANAGEMENT; RESOLUTION	Post-conflict affiliative interactions have been widely investigated in primates but not extensively in other species. Using the Post Conflict-Matched Control (PC-MC) comparison method, this study investigated the patterns of post-conflict opponent affiliation (POA) of a captive family group of 19 arctic wolves (Canis lupus arctos), investigating the correlation with various factors. We found that POAs occurred mainly in the non-feeding context and more often when the victim was dominant and the aggressor subordinate. Furthermore, POAs were more likely to have been initiated by the victim than the aggressor. Victims' stress related behaviours occurred more in PC than MC periods, and more after high vs. low intensity aggressions but they were not more likely to occur after conflicts between wolves with a stronger social bond and POAs did not reduce their rate of occurrence. Our results showed that re-aggression was twice less frequent when a friendly interaction occurred between the aggressor and the victim, and consistent with this, victims engaged in POAs more often than the aggressor. Overall, our results support the hypothesis that POAs in wolves may have been selected for as a mechanism to avoid conflict escalation, which could lead to social disruption and hence jeopardize cooperative activities. The high relatedness among individuals in the pack and the greater dependence of all members on cooperation in breeding and hunting may reduce the importance of 'relationship quality' as a mediating factor of POAs, although dominance relationships, which are directly linked to the risks of further conflicts, do play an important role.	[Lazzaroni, Martina; Marshall-Pescini, Sarah; Cafazzo, Simona] Univ Vienna, Med Univ Vienna, Univ Vet Med, Wolf Sci Ctr,Messerli Res Inst, Veterinaerpl 1, Vienna, Austria; [Lazzaroni, Martina; Marshall-Pescini, Sarah; Cafazzo, Simona] Univ Vienna, Med Univ Vienna, Univ Vet Med, Comparat Cognit,Messerli Res Inst, Veterinaerpl 1, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Cafazzo, S (corresponding author), Univ Vienna, Med Univ Vienna, Univ Vet Med, Wolf Sci Ctr,Messerli Res Inst, Veterinaerpl 1, Vienna, Austria.; Cafazzo, S (corresponding author), Univ Vienna, Med Univ Vienna, Univ Vet Med, Comparat Cognit,Messerli Res Inst, Veterinaerpl 1, Vienna, Austria.	simona.cafazzo@gmail.com		Marshall-Pescini, Sarah/0000-0002-5944-4701	Austrian Science Fund (FWF Der Wissenschaftsfonds) [M1400-819]; European Research Council under the European Union's Seventh Framework Program by ERC Grant [311870]; Doctoral Fellowship Programme of the Austrian Academy of Sciences	Austrian Science Fund (FWF Der Wissenschaftsfonds); European Research Council under the European Union's Seventh Framework Program by ERC Grant; Doctoral Fellowship Programme of the Austrian Academy of Sciences	This study was supported by funding from the Austrian Science Fund (FWF Der Wissenschaftsfonds, project number the project M1400-819 to Simone Cafazzo. Sarah Marshall Pescini was supported by the European Research Council under the European Union's Seventh Framework Program (http://ec.europa.eu/research/fp7/index_en.cfm) by ERC Grant Agreement n.[311870]. Martina Lazzaroni was supported by the Doctoral Fellowship Programme of the Austrian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arnold K, 2001, BEHAVIOUR, V138, P649, DOI 10.1163/156853901316924520; Arnold K, 2007, PRIMATES PERSPECTIVE, P592; Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; AURELI F, 1992, BEHAV ECOL SOCIOBIOL, V31, P329; AURELI F, 1989, AM J PRIMATOL, V19, P39, DOI 10.1002/ajp.1350190105; AURELI F, 1991, ETHOLOGY, V89, P101; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F, 2000, NATURAL CONFLICT RES, P3; Aureli Filippo, 2000, P199; Baan C, 2014, ANIM BEHAV, V90, P327, DOI 10.1016/j.anbehav.2014.01.033; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Bekoff M, 2002, BEHAV BRAIN SCI, V25, P26, DOI 10.1017/S0140525X02280012; Bloch G., 2002, WOLF MAGAZINE, V20; Cafazzo S, 2014, PHYSIOL BEHAV, V133, P223, DOI 10.1016/j.physbeh.2014.05.046; Cafazzo S, 2016, PEERJ, V4, DOI 10.7717/peerj.2707; Cassidy KA, 2017, BEHAV PROCESS, V136, P64, DOI 10.1016/j.beproc.2017.01.011; Cassidy KA, 2016, ANIM COGN, V19, P939, DOI 10.1007/s10071-016-0994-1; Cassidy KA, 2015, BEHAV ECOL, V26, P1352, DOI 10.1093/beheco/arv081; Castles DL, 1998, ETHOLOGY, V104, P126; Castles DL, 1999, ANIM BEHAV, V58, P1207, DOI 10.1006/anbe.1999.1250; Castles DL, 1998, ETHOLOGY, V104, P148; Cordoni G, 2008, ETHOLOGY, V114, P298, DOI 10.1111/j.1439-0310.2008.01474.x; CORDS M, 1992, ANIM BEHAV, V44, P57, DOI 10.1016/S0003-3472(05)80754-7; Das M, 1998, INT J PRIMATOL, V19, P53, DOI 10.1023/A:1020354826422; De Waal, 1989, PEACEMAKING PRIMATES; de Waal F.B.M., 1986, P341; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; DEVRIES H, 1993, BEHAVIOUR, V125, P157, DOI 10.1163/156853993X00218; DEWAAL FBM, 1988, ETHOLOGY, V78, P129; DEWAAL FBM, 1986, Q REV BIOL, V61, P459, DOI 10.1086/415144; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; DeWaal FBM, 1997, ANN NY ACAD SCI, V807, P317; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Fox MW., 1980, THE SOUL OF THE WOLF; Grafen A., 2002, MODERN STAT LIFE SCI; JARAM Van Hooff, 1987, MAN WOLF, P219; KAPPELER PM, 1992, ETHOLOGY, V92, P51; Koski SE, 2007, AM J PRIMATOL, V69, P158, DOI 10.1002/ajp.20338; Koyama NF, 2001, ETHOLOGY, V107, P975, DOI 10.1046/j.1439-0310.2001.00731.x; Kutsukake N, 2001, Anim Cogn, V4, P259, DOI 10.1007/s10071-001-0119-2; Kutsukake N, 2003, BEHAVIOUR, V140, P1153, DOI 10.1163/156853903322589687; Kutsukake N, 2008, ANIM BEHAV, V75, P1441, DOI 10.1016/j.anbehav.2007.09.018; LEHMAN N, 1992, BEHAV ECOL SOCIOBIOL, V30, P83; MacNulty DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112884; MacNulty DR, 2011, BEHAV ECOL; Majolo B., 2004, THESIS; Majolo B, 2006, INT J PRIMATOL, V27, P1383, DOI 10.1007/s10764-006-9079-3; Marshall-Pescini S., 2014, SOCIAL DOG BEHAV COG, P3; McFarland R, 2011, ETHOLOGY, V117, P928, DOI 10.1111/j.1439-0310.2011.01948.x; Mech L. David, 2003, P1; Mech LD, 2010, CAN FIELD NAT, V124, P215, DOI 10.22621/cfn.v124i3.1076; Mech LD, 1999, CAN J ZOOL, V77, P1192, DOI 10.1139/cjz-77-8-1192; Norscia I, 2011, J ETHOL, V29, P181, DOI 10.1007/s10164-010-0228-y; Orlaith NF, 2011, PLOS ONE, V6; Packard Jane M., 2003, P35; Packard Jane M., 2012, P1; Packard JM, 1980, POPULATION REGULATIO, P135; Palagi E, 2005, INT J PRIMATOL, V26, P279, DOI 10.1007/s10764-005-2925-x; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Palagi E, 2008, ANIM BEHAV, V76, P737, DOI 10.1016/j.anbehav.2008.04.016; Palagi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142150; Penate L, 2009, AM J PRIMATOL, V71, P895, DOI 10.1002/ajp.20721; Pinheiro J., 2016, PACKAGE NLME; R Core Team, 2021, R LANGUAGE ENV STAT; Romero T, 2009, AM J PRIMATOL, V71, P60, DOI 10.1002/ajp.20619; Schaffner Colleen M., 2000, P155; Schino G, 1998, BEHAVIOUR, V135, P343, DOI 10.1163/156853998793066302; Shizuka D, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0080; SIEGEL S, 1988, NONPARAMETRIC STAT; Stahler DR, 2013, J ANIM ECOL, V82, P222, DOI 10.1111/j.1365-2656.2012.02039.x; Thierry Bernard, 2000, P106; VANSCHAIK CP, 1988, BEHAVIOUR, V105, P77, DOI 10.1163/156853988X00458; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Verbeek P, 1997, INT J PRIMATOL, V18, P703, DOI 10.1023/A:1026391728909; Wahaj SA, 2001, ETHOLOGY, V107, P1057, DOI 10.1046/j.1439-0310.2001.00717.x; WATTS DP, 1995, ETHOLOGY, V100, P139; Weaver A, 2003, MAR MAMMAL SCI, V19, P836, DOI 10.1111/j.1748-7692.2003.tb01134.x; Webb CE, 2014, ANIM BEHAV, V90, P57, DOI 10.1016/j.anbehav.2014.01.014; Westlund K, 2000, AM J PRIMATOL, V52, P31; White AB., 2001, THESIS; Wittig RM, 2005, ETHOLOGY, V111, P736, DOI 10.1111/j.1439-0310.2005.01093.x; ZIMEN E, 1976, Z TIERPSYCHOL, V40, P300	88	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187450	10.1371/journal.pone.0187450	http://dx.doi.org/10.1371/journal.pone.0187450			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL7JU	29108020	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600029
J	Jules, J; Chen, W; Feng, X; Li, YP				Jules, Joel; Chen, Wei; Feng, Xu; Li, Yi-Ping			C/EBP transcription factor is regulated by the RANK cytoplasmic (IVVY538)-I-535 motif and stimulates osteoclastogenesis more strongly than c-Fos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; c-Fos; CCAAT; enhancer-binding protein (C; EBP); differentiation; NFAT transcription factor; osteoclast; transcription factor	NF-KAPPA-B; TNF-INDUCED OSTEOCLASTOGENESIS; FACTOR RBP-J; BONE-RESORPTION; RECEPTOR ACTIVATOR; NUCLEAR-FACTOR; EXTRACELLULAR ACIDIFICATION; PROTON PUMP; ESSENTIAL COMPONENT; LINEAGE COMMITMENT	Binding of receptor activator of NF-B ligand (RANKL) to its receptor RANK on osteoclast (OC) precursors up-regulates c-Fos and CCAAT/enhancer-binding protein- (C/EBP), two critical OC transcription factors. However, the effects of c-Fos and C/EBP on osteoclastogenesis have not been compared. Herein, we demonstrate that overexpression of c-Fos or C/EBP in OC precursors up-regulates OC genes and initiates osteoclastogenesis independently of RANKL. However, although C/EBP up-regulated c-Fos, c-Fos failed to up-regulate C/EBP in OC precursors. Consistently, C/EBP overexpression more strongly promoted OC differentiation than did c-Fos overexpression. RANK has a cytoplasmic (IVVY538)-I-535 (IVVY) motif that is essential for osteoclastogenesis, and we found that mutation of the IVVY motif blocked OC differentiation by partly inhibiting expression of C/EBP but not expression of c-Fos. We therefore hypothesized that C/EBP overexpression might rescue osteoclastogenesis in cells expressing the mutated IVVY motif. However, overexpression of C/EBP or c-Fos failed to stimulate osteoclastogenesis in the mutant cells. Notably, the IVVY motif mutation abrogated OC gene expression compared with a vector control, suggesting that the IVVY motif might counteract OC inhibitors during osteoclastogenesis. Consistently, the IVVY motif mutant triggered up-regulation of recombinant recognition sequence-binding protein at the J site (RBP-J) protein, a potent OC inhibitor. Mechanistically, C/EBP or c-Fos overexpression in the mutant cells failed to control the up-regulated RBP-J expression, leading to suppression of OC genes. Accordingly, RBP-J silencing in the mutant cells rescued osteoclastogenesis with C/EBP or c-Fos overexpression with C/EBP exhibiting a stronger osteoclastogenic effect. Collectively, our findings indicate that C/EBP is a stronger inducer of OC differentiation than c-Fos, partly via C/EBP regulation by the RANK (IVVY538)-I-535 motif.	[Jules, Joel; Chen, Wei; Feng, Xu; Li, Yi-Ping] Univ Alabama Birmingham, Dept Pathol, SHEL 815,1825 Univ Blvd, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Chen, W; Li, YP (corresponding author), Univ Alabama Birmingham, Dept Pathol, SHEL 815,1825 Univ Blvd, Birmingham, AL 35294 USA.	wechen@uabmc.edu; yipingli@uabmc.edu			National Institutes of Health [P30 AR046031, P30 NS0474666]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046031, R01AR047830, R01AR070135, R01AR044741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr. Jue Wangfor extensive reading and discussion of the manuscript. We appreciate the assistance of the Center for Metabolic Bone Disease at the University of Alabama at Birmingham (UAB) (supported by National Institutes of Health Grant P30 AR046031). We are also grateful for the assistance of the Small Animal Phenotyping Core, Metabolism Core, and Neuroscience Molecular Detection Core Laboratory at UAB (supported by National Institutes of Health GrantP30 NS0474666).	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Ashley JW, 2011, ASSAY DRUG DEV TECHN, V9, P40, DOI 10.1089/adt.2010.0307; Boggs K, 2009, CELL BIOL INT, V33, P318, DOI 10.1016/j.cellbi.2008.12.005; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen S, 2013, J BONE MINER RES, V28, P649, DOI 10.1002/jbmr.1770; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Chen W, 2014, P NATL ACAD SCI USA, V111, P8482, DOI 10.1073/pnas.1310617111; Chen W, 2013, P NATL ACAD SCI USA, V110, P7294, DOI 10.1073/pnas.1211383110; Das S, 2014, J MOL ENDOCRINOL, V53, P81, DOI 10.1530/JME-14-0077; Feng SM, 2009, BIOCHEM J, V417, P195, DOI 10.1042/BJ20081073; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI 10.1016/j.ajhg.2008.06.015; Horowitz MC, 2001, CYTOKINE GROWTH F R, V12, P9, DOI 10.1016/S1359-6101(00)00030-7; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Jules J, 2016, J BIOL CHEM, V291, P16390, DOI 10.1074/jbc.M115.674598; Jules J, 2015, J BIOL CHEM, V290, P23738, DOI 10.1074/jbc.M115.667535; Jules J, 2012, J BIOL CHEM, V287, P15728, DOI 10.1074/jbc.M111.296228; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Kim H, 2009, J CLIN INVEST, V119, P813, DOI 10.1172/JCI36809; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Li SS, 2014, J CLIN INVEST, V124, P5057, DOI 10.1172/JCI71882; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; LI YP, 1995, J BONE MINER RES, V10, P1197; Ma J, 2013, MOL BIOL REP, V40, P2097, DOI 10.1007/s11033-012-2268-6; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Rozenberg JM, 2014, ARTERIOSCL THROM VAS, V34, P2624, DOI 10.1161/ATVBAHA.114.304634; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Swarnkar G, 2015, P NATL ACAD SCI USA, V112, P154, DOI 10.1073/pnas.1415213112; Taguchi Y, 2009, GENES CELLS, V14, P1331, DOI 10.1111/j.1365-2443.2009.01351.x; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tian F, 2014, J BONE MINER RES, V29, P1564, DOI 10.1002/jbmr.2275; Wagner H, 2010, NAT REV RHEUMATOL, V6, P73, DOI 10.1038/nrrheum.2009.274; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Wu MR, 2017, P NATL ACAD SCI USA, V114, P10119, DOI 10.1073/pnas.1619294114; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Xu DR, 2004, BIOCHEM J, V383, P219, DOI 10.1042/BJ20040961; Yang DQ, 2012, J BONE MINER RES, V27, P1695, DOI 10.1002/jbmr.1623; Yang S, 2013, BONE RES, V1, P260, DOI 10.4248/BR201303005; Yang SY, 2007, GENE DEV, V21, P1803, DOI 10.1101/gad.1544107; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Zhao QX, 2007, FRONT BIOSCI-LANDMRK, V12, P2519, DOI 10.2741/2252	55	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1480	1492		10.1074/jbc.M116.736009	http://dx.doi.org/10.1074/jbc.M116.736009			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29122885	Green Published, hybrid			2022-12-26	WOS:000423515000031
J	Stober, VP; Johnson, CG; Majors, A; Lauer, ME; Cali, V; Midura, RJ; Wisniewski, HG; Aronica, MA; Garantziotis, S				Stober, Vandy P.; Johnson, Collin G.; Majors, Alana; Lauer, Mark E.; Cali, Valbona; Midura, Ronald J.; Wisniewski, Hans-Georg; Aronica, Mark A.; Garantziotis, Stavros			TNF-stimulated gene 6 promotes formation of hyaluronan-inter-alpha-inhibitor heavy chain complexes necessary for ozone-induced airway hyperresponsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED MURINE MODEL; SMOOTH-MUSCLE-CELLS; MORTALITY; PROTEIN; INFLAMMATION; HEALTH; LUNG; DEPOSITION; POLLUTION; ACTIVATION	Exposure to pollutants, such as ozone, exacerbates airway inflammation and hyperresponsiveness (AHR). TNF-stimulated gene 6 (TSG-6) is required to transfer inter-alpha-inhibitor heavy chains (HC) to hyaluronan (HA), facilitating HA receptor binding. TSG-6 is necessary for AHR in allergic asthma, because it facilitates the development of a pathological HA-HC matrix. However, the role of TSG-6 in acute airway inflammation is not well understood. Here, we hypothesized that TSG-6 is essential for the development ofHA-and ozone-induced AHR. TSG-6(-/-) and TSG-6(+/+) mice were exposed to ozone or short-fragment HA (sHA), and AHR was assayed via flexiVent. The AHR response to sHA was evaluated in the isolated tracheal ring assay in tracheal rings from TSG-6(-/-) or TSG-6(+/+), with or without the addition of exogenous TSG-6, and with or without inhibitors of Rho-associated, coiled-coil-containing protein kinase (ROCK), ERK, or PI3K. Smooth-muscle cells from mouse tracheas were assayed in vitro for signaling pathways. We found that TSG-6 deficiency protects against AHR after ozone (in vivo) or sHA (in vitro and in vivo) exposure. Moreover, TSG-6(-/-) tracheal ring non-responsiveness to sHA was reversed by exogenous TSG-6 addition. sHA rapidly activated RhoA, ERK, and Akt in airway smooth-muscle cells, but only in the presence of TSG-6. Inhibition of ROCK, ERK, or PI3K/Akt blocked sHA/TSG-6-mediated AHR. In conclusion, TSG-6 is necessary for AHR in response to ozone or sHA, in part because it facilitates rapid formation of HA-HC complexes. The sHA/TSG-6 effect is mediated by RhoA, ERK, and PI3K/Akt signaling.	[Stober, Vandy P.; Johnson, Collin G.; Garantziotis, Stavros] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Majors, Alana; Lauer, Mark E.; Cali, Valbona; Midura, Ronald J.; Aronica, Mark A.] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Wisniewski, Hans-Georg] Matrix Biol Inst, Edgewater, NJ 07020 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Cleveland Clinic Foundation	Garantziotis, S (corresponding author), NIEHS, NIH, MD CU-01,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	garantziotis@niehs.nih.gov	Garantziotis, Stavros/A-6903-2009	Garantziotis, Stavros/0000-0003-4007-375X; Johnson, Collin/0000-0002-5078-9551	Division of Intramural Research, NIEHS, National Institutes of Health [P01HL107147, HL103453, HL081064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, U10HL109250, P01HL103453, P01HL081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102605] Funding Source: NIH RePORTER	Division of Intramural Research, NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported partly through funds from the Division of Intramural Research, NIEHS, National Institutes of Health, by Grants P01HL107147 (to V.C. and R.M.) and HL103453 and HL081064 (to M.A.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adair JE, 2009, J BIOL CHEM, V284, P16922, DOI 10.1074/jbc.M808560200; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Bracke KR, 2010, AM J RESP CELL MOL, V42, P753, DOI 10.1165/rcmb.2008-0424OC; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020932; Cheng G, 2013, GLYCOBIOLOGY, V23, P43, DOI 10.1093/glycob/cws122; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Choi YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081773; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Foskett AM, 2014, AM J PHYSIOL-LUNG C, V306, pL120, DOI 10.1152/ajplung.00240.2013; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Garantziotis S, 2007, J IMMUNOL, V179, P4187, DOI 10.4049/jimmunol.179.6.4187; Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Gryparis A, 2004, AM J RESP CRIT CARE, V170, P1080, DOI 10.1164/rccm.200403-333OC; Hubbell BJ, 2005, ENVIRON HEALTH PERSP, V113, P73, DOI 10.1289/ehp.7186; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jourdain M, 1997, AM J RESP CRIT CARE, V156, P1825, DOI 10.1164/ajrccm.156.6.9611100; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; KATSOUYANNI K, 1995, EUR RESPIR J, V8, P1030; Lauer Mark E, 2015, Int J Cell Biol, V2015, P712507, DOI 10.1155/2015/712507; Lauer ME, 2015, J BIOL CHEM, V290, P23124, DOI 10.1074/jbc.M115.663823; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Lazrak A, 2015, AM J PHYSIOL-LUNG C, V308, pL891, DOI 10.1152/ajplung.00377.2014; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Li ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027137; Liang JR, 2011, J ALLERGY CLIN IMMUN, V128, P403, DOI 10.1016/j.jaci.2011.04.006; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; OBYRNE PM, 1984, AM REV RESPIR DIS, V130, P214; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Rahman MS, 2006, J IMMUNOL, V177, P4064, DOI 10.4049/jimmunol.177.6.4064; Sakai H, 2010, PFLUG ARCH EUR J PHY, V460, P645, DOI 10.1007/s00424-010-0844-y; Song WF, 2015, AM J PHYSIOL-LUNG C, V309, pL205, DOI 10.1152/ajplung.00159.2015; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Xie J, 2015, STEM CELLS, V33, P468, DOI 10.1002/stem.1851; Zhao M, 2006, MOL PHARMACOL, V69, P66, DOI 10.1124/mol.105.016923; Zhu S, 2008, ONCOGENE, V27, P1580, DOI 10.1038/sj.onc.1210790; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	49	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20845	20858		10.1074/jbc.M116.756627	http://dx.doi.org/10.1074/jbc.M116.756627			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29122888	Green Published, hybrid			2022-12-26	WOS:000418453400004
J	Garbuz, T; Arrizabalaga, G				Garbuz, Tamila; Arrizabalaga, Gustavo			Lack of mitochondrial MutS homolog 1 in Toxoplasma gondii disrupts maintenance and fidelity of mitochondrial DNA and reveals metabolic plasticity	PLOS ONE			English	Article							MISMATCH-REPAIR ACTIVITY; PLASMODIUM-FALCIPARUM; CYTOCHROME-B; ATOVAQUONE-RESISTANCE; MALARIAL PARASITE; SACCHAROMYCES-CEREVISIAE; DIHYDROFOLATE-REDUCTASE; EXTRACHROMOSOMAL DNAS; ELECTRON-TRANSPORT; RIBOSOMAL-RNA	The importance of maintaining the fidelity of the mitochondrial genome is underscored by the presence of various repair pathways within this organelle. Presumably, the repair of mitochondrial DNA would be of particular importance in organisms that possess only a single mitochondrion, like the human pathogens Plasmodium falciparum and Toxoplasma gondii. Understanding the machinery that maintains mitochondrial DNA in these parasites is of particular relevance, as mitochondrial function is a validated and effective target for anti-parasitic drugs. We previously determined that the Toxoplasma MutS homolog TgMSH1 localizes to the mitochondrion. MutS homologs are key components of the nuclear mismatch repair system in mammalian cells, and both yeast and plants possess MutS homologs that localize to the mitochondria where they regulate DNA stability. Here we show that the lack of TgMSH1 results in accumulation of single nucleotide variations in mitochondrial DNA and a reduction in mitochondrial DNA content. Additionally, parasites lacking TgMSH1 function can survive treatment with the cytochrome b inhibitor atovaquone. While the Tgmsh1 knockout strain has several missense mutations in cytochrome b, none affect amino acids known to be determinants of atovaquone sensitivity and atovaquone is still able to inhibit electron transport in the Tgmsh1 mutants. Furthermore, culture of Tgmsh1 mutant in the presence atovaquone leads to parasites with enhanced atovaquone resistance and complete shutdown of respiration. Thus, parasites lacking TgMSH1 overcome the disruption of mitochondrial DNA by adapting their physiology allowing them to forgo the need for oxidative phosphorylation. Consistent with this idea, the Tgmsh1 mutant is resistant to mitochondrial inhibitors with diverse targets and exhibits reduced ability to grow in the absence of glucose. This work shows TgMSH1 as critical for the maintenance and fidelity of the mitochondrial DNA in Toxoplasma, reveals a novel mechanism for atovaquone resistance, and exposes the physiological plasticity of this important human pathogen.	[Garbuz, Tamila; Arrizabalaga, Gustavo] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Arrizabalaga, Gustavo] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Arrizabalaga, G (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.; Arrizabalaga, G (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	garrizab@iu.edu			National Institutes of Health [RO1AI89808, R01AI123457]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123457, R01AI089808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants RO1AI89808 and R01AI123457 to G.A. from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Dr. John Boothroyd for providing the atovaquone resistant parasite strain as well as its parental strain. We also extend special gratitude to Dr. Jessie Kissinger for sharing her unpublished data on the sequencing of Toxoplasma's mitochondrial genome and providing the sequence of primers validated for specific amplification of mitochondrial DNA fragments. We also thank the Sullivan lab and members of the IUSM Biology of Intracellular Pathogens (BIP) group for their helpful discussions and suggestions. This research was supported by grants RO1AI89808 and R01AI123457 to G.A. from the National Institutes of Health.	Abdelnoor RV, 2006, J MOL EVOL, V63, P165, DOI 10.1007/s00239-005-0226-9; Abdelnoor RV, 2003, P NATL ACAD SCI USA, V100, P5968, DOI 10.1073/pnas.1037651100; [Anonymous], 1998, MICROSATELLITE INSTA, P17, DOI 10.1038sjonc1202112; Birth D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5029; Camps M, 2002, MOL MICROBIOL, V43, P1309, DOI 10.1046/j.1365-2958.2002.02825.x; CHI NW, 1994, J BIOL CHEM, V269, P29984; CHOI I, 1990, EXP PARASITOL, V71, P452, DOI 10.1016/0014-4894(90)90071-J; de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021; DIRAGO JP, 1988, J BIOL CHEM, V263, P12564; DONALD RGK, 1994, MOL BIOCHEM PARASIT, V63, P243, DOI 10.1016/0166-6851(94)90060-4; Esser L, 2014, CURR PHARM DESIGN, V20, P704, DOI 10.2174/138161282005140214163327; FEAGIN JE, 1992, NUCLEIC ACIDS RES, V20, P879, DOI 10.1093/nar/20.4.879; FEAGIN JE, 1991, J PROTOZOOL, V38, P243, DOI 10.1111/j.1550-7408.1991.tb04436.x; FEAGIN JE, 1994, ANNU REV MICROBIOL, V48, P81, DOI 10.1146/annurev.mi.48.100194.000501; FRENKEL J. K., 1957, ANTIBIOT AND CHE MOTHER, V7, P630; Fruth IA, 2007, INT J PARASITOL, V37, P1559, DOI 10.1016/j.ijpara.2007.05.010; FRY M, 1984, BIOCHEM PHARMACOL, V33, P2115, DOI 10.1016/0006-2952(84)90581-1; GARDNER MJ, 1988, MOL BIOCHEM PARASIT, V31, P11, DOI 10.1016/0166-6851(88)90140-5; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Garrison EM, 2009, MOL MICROBIOL, V72, P425, DOI 10.1111/j.1365-2958.2009.06655.x; Goodman CD, 2017, TRENDS PARASITOL, V33, P185, DOI 10.1016/j.pt.2016.10.002; Jones JL, 2014, AM J TROP MED HYG, V90, P794, DOI 10.4269/ajtmh.13-0722; JOSEPH JT, 1989, MOL CELL BIOL, V9, P3621, DOI 10.1128/MCB.9.9.3621; Kaniak A, 2009, DNA REPAIR, V8, P318, DOI 10.1016/j.dnarep.2008.11.004; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lavine MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042107; Lavine MD, 2011, ANTIMICROB AGENTS CH, V55, P745, DOI 10.1128/AAC.01092-10; Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167; Mather MW, 2008, J BIOENERG BIOMEMBR, V40, P425, DOI 10.1007/s10863-008-9176-4; McFadden DC, 1999, J EUKARYOT MICROBIOL, V46, p81S; McFadden DC, 1997, ANTIMICROB AGENTS CH, V41, P1849, DOI 10.1128/AAC.41.9.1849; McFadden DC, 2000, MOL BIOCHEM PARASIT, V108, P1, DOI 10.1016/S0166-6851(00)00184-5; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mookerjee SA, 2005, CURR GENET, V47, P84, DOI 10.1007/s00294-004-0537-1; Nixon GL, 2013, J ANTIMICROB CHEMOTH, V68, P977, DOI 10.1093/jac/dks504; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; OSSORIO PN, 1991, J MOL BIOL, V222, P525, DOI 10.1016/0022-2836(91)90494-Q; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; PFEFFERKORN ER, 1993, J PARASITOL, V79, P559, DOI 10.2307/3283383; Plucinski MM, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu059; Pogorzala L, 2009, GENETICS, V182, P699, DOI 10.1534/genetics.109.103796; REENAN RAG, 1992, GENETICS, V132, P975; Sakamoto W, 1996, PLANT CELL, V8, P1377, DOI 10.1105/tpc.8.8.1377; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; SMALL ID, 1987, EMBO J, V6, P865, DOI 10.1002/j.1460-2075.1987.tb04832.x; Smilkstein MJ, 2009, DRUG SELECTED PLASMO, V159, P64; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Srivastava IK, 1997, J BIOL CHEM, V272, P3961, DOI 10.1074/jbc.272.7.3961; SUPLICK K, 1988, MOL BIOCHEM PARASIT, V30, P289, DOI 10.1016/0166-6851(88)90098-9; Suswam E, 2001, EXP PARASITOL, V98, P180, DOI 10.1006/expr.2001.4639; Syafruddin D, 1999, MOL BIOCHEM PARASIT, V104, P185, DOI 10.1016/S0166-6851(99)00148-6; VAIDYA AB, 1987, MOL BIOCHEM PARASIT, V22, P249, DOI 10.1016/0166-6851(87)90056-9; VAIDYA AB, 1989, MOL BIOCHEM PARASIT, V35, P97, DOI 10.1016/0166-6851(89)90112-6; Vaidya AB, 2000, DRUG RESIST UPDATE, V3, P283, DOI 10.1054/drup.2000.0157; Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690; Vercesi AE, 1998, J BIOL CHEM, V273, P31040, DOI 10.1074/jbc.273.47.31040; WALTER RD, 1986, MOL BIOCHEM PARASIT, V19, P61, DOI 10.1016/0166-6851(86)90066-6; Winter RW, 2006, EXP PARASITOL, V114, P47, DOI 10.1016/j.exppara.2006.03.014	61	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188040	10.1371/journal.pone.0188040	http://dx.doi.org/10.1371/journal.pone.0188040			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141004	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400046
J	Brateanu, A; Barwacz, T; Kou, L; Wang, SH; Misra-Hebert, AD; Hu, B; Deshpande, A; Kobaivanova, N; Rothberg, MB				Brateanu, Andrei; Barwacz, Thomas; Kou, Lei; Wang, Sihe; Misra-Hebert, Anita D.; Hu, Bo; Deshpande, Abhishek; Kobaivanova, Nana; Rothberg, Michael B.			Determining the optimal screening interval for type 2 diabetes mellitus using a risk prediction model	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; TOLERANCE; SCORE; SMOKING; ADULTS; A1C	Background Progression to diabetes mellitus (DM) is variable and the screening time interval not well defined. The American Diabetes Association and US Preventive Services Task Force suggest screening every 3 years, but evidence is limited. The objective of the study was to develop a model to predict the probability of developing DM and suggest a risk-based screening interval. Methods We included non-diabetic adult patients screened for DM in the Cleveland Clinic Health System if they had at least two measurements of glycated hemoglobin (HbA1c), an initial one less than 6.5% (48 mmol/mol) in 2008, and another between January, 2009 and December, 2013. Cox proportional hazards models were created. The primary outcome was DM defined as HbA1C greater than 6.4% (46 mmol/mol). The optimal rescreening interval was chosen based on the predicted probability of developing DM. Results Of 5084 participants, 100 (4.4%) of the 2281 patients with normal HbA1c and 772 (27.5%) of the 2803 patients with prediabetes developed DM within 5 years. Factors associated with developing DM included HbA1c (HR per 0.1 units increase 1.20; 95% CI, 1.13-1.27), family history (HR 1.31; 95% CI, 1.13-1.51), smoking (HR 1.18; 95% CI, 1.03-1.35), triglycerides (HR 1.01; 95% CI, 1.00-1.03), alanine aminotransferase (HR 1.07; 95% CI, 1.03-1.11), body mass index (HR 1.06; 95% CI, 1.01-1.11), age (HR 0.95; 95% CI, 0.91-0.99) and high-density lipoproteins (HR 0.93; 95% CI, 0.90-0.95). Five percent of patients in the highest risk tertile developed DM within 8 months, while it took 35 months for 5% of the middle tertile to develop DM. Only 2.4% percent of the patients in the lowest tertile developed DM within 5 years. Conclusion A risk prediction model employing commonly available data can be used to guide screening intervals. Based on equal intervals for equal risk, patients in the highest risk category could be rescreened after 8 months, while those in the intermediate and lowest risk categories could be rescreened after 3 and 5 years respectively.	[Brateanu, Andrei; Misra-Hebert, Anita D.; Deshpande, Abhishek; Kobaivanova, Nana; Rothberg, Michael B.] Cleveland Clin, Med Inst, Cleveland, OH 44106 USA; [Barwacz, Thomas] Univ Hosp, Dept Med, Cleveland, OH USA; [Kou, Lei; Misra-Hebert, Anita D.; Hu, Bo] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Wang, Sihe] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; University Hospitals of Cleveland; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Brateanu, A (corresponding author), Cleveland Clin, Med Inst, Cleveland, OH 44106 USA.	abratean@ccf.org	Deshpande, Abhishek/A-7695-2012	Deshpande, Abhishek/0000-0001-5522-2995; Misra-Hebert, Anita/0000-0003-3079-7025				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; American Diabetes Association, 2016, Clin Diabetes, V34, P3, DOI 10.2337/diaclin.34.1.3; Brantsma AH, 2005, DIABETES CARE, V28, P2525, DOI 10.2337/diacare.28.10.2525; Gray LJ, 2010, DIABETIC MED, V27, P887, DOI 10.1111/j.1464-5491.2010.03037.x; Herman WH, 2015, DIABETES CARE, V38, P1449, DOI 10.2337/dc14-2459; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, pb880, DOI DOI 10.1136/bmj.b880; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; Kao WHL, 2001, AM J EPIDEMIOL, V154, P748, DOI 10.1093/aje/154.8.748; Khavandi K, 2013, THER ADV CHRONIC DIS, V4, P242, DOI 10.1177/2040622313494986; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Link CL, 2009, ETHNIC DIS, V19, P288; Luo JH, 2013, AM J EPIDEMIOL, V178, P937, DOI 10.1093/aje/kwt071; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Mortaz S, 2012, CLINICOECONOMIC OUTC, V4, P91, DOI 10.2147/CEOR.S30547; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Rahman M, 2008, FAM PRACT, V25, P191, DOI 10.1093/fampra/cmn024; Rasmussen SS, 2008, DIABETOLOGIA, V51, P249, DOI 10.1007/s00125-007-0893-8; Ruchat SM, 2010, ANN MED, V42, P196, DOI 10.3109/07853890903559716; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Siu AL, 2015, ANN INTERN MED, V163, P861, DOI 10.7326/M15-2345; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Takahashi O, 2010, DIABETES CARE, V33, P2016, DOI 10.2337/dc10-0588; Tuso Phillip, 2014, Perm J, V18, P88, DOI 10.7812/TPP/14-002; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187695	10.1371/journal.pone.0187695	http://dx.doi.org/10.1371/journal.pone.0187695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135987	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200027
J	Guo, J; Martin, PR; Zhang, CX; Zhang, JE				Guo, Jing; Martin, Pablo R.; Zhang, Chunxia; Zhang, Jia-en			Predation risk affects growth and reproduction of an invasive snail and its lethal effect depends on prey size	PLOS ONE			English	Article							FRESH-WATER SNAIL; POMACEA-CANALICULATA GASTROPODA; GOLDEN APPLE SNAIL; BIOLOGICAL-CONTROL; CAENOGASTROPODA AMPULLARIIDAE; ALARM RESPONSE; TRADE-OFF; MARINE SNAIL; LIFE-HISTORY; COMMON CARP	The behavior of invasive species under predation risk has been studied extensively, but their growth and reproductive responses have rarely been investigated. We conducted experiments with juveniles and adults of the invasive freshwater snail Pomacea canaliculata, and we observed changes in growth and reproduction in response to predation risk from a caged predator (Trachemys scripta elegans). P. canaliculata produced eggs earlier in the presence of predators and injured conspecifics compared with the control group (no risk), although the total number of egg masses laid by per female was exceeded by that of the controls after 15 days. Egg hatching success noticeably decreased under predation risk, and the incubation period was significantly prolonged; however, the oviposition height of the snails was not affected. A lethal effect of predation risk was detected in juvenile snails but not in adults. The growth of juvenile P. canaliculata was inhibited under predation risk, probably due to a reduction in food intake. Adult females exhibited a greater reduction in growth under predation risk than males, which likely resulted in part from the high reproductive investment of females in egg laying. These results indicate that P. canaliculata snails under predation risk face a trade-off between predator avoidance and growth and reproduction, where the lethal effect of predation risk is linked to the size of the prey.	[Guo, Jing; Zhang, Chunxia; Zhang, Jia-en] South China Agr Univ, Coll Nat Resources & Environm, Dept Ecol, Guangzhou, Guangdong, Peoples R China; [Martin, Pablo R.] Univ Nacl Sur, CONICET, Dept Biol Bioquim & Farm, Lab Ecol,INBIOSUR,UNS, Bahia Blanca, Buenos Aires, Argentina; [Zhang, Jia-en] Minist Agr, Key Lab Agroenvironm Trop, Guangzhou, Guangdong, Peoples R China; [Zhang, Jia-en] Guangdong Engn Res Ctr Modern Ecoagr & Circular A, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; Ministry of Agriculture & Rural Affairs	Zhang, JE (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Dept Ecol, Guangzhou, Guangdong, Peoples R China.; Zhang, JE (corresponding author), Minist Agr, Key Lab Agroenvironm Trop, Guangzhou, Guangdong, Peoples R China.; Zhang, JE (corresponding author), Guangdong Engn Res Ctr Modern Ecoagr & Circular A, Guangzhou, Guangdong, Peoples R China.	jeanzh@scau.edu.cn	Martín, Pablo/P-4916-2019	Martin, Pablo/0000-0002-2987-7901	National Natural Science Foundation of China [U1131006, 30770403]; National Natural Science Foundation of China; Science and Technology Planning Project of Guangdong Province [20156090903077]; Guangdong Provincial Department of Science and Technology; South China Agricultural University [2017LHPY017]; South China Agricultural University; People's Government of Guangdong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Guangdong Provincial Department of Science and Technology; South China Agricultural University; South China Agricultural University; People's Government of Guangdong Province	This work was supported by the National Natural Science Foundation of China (grant number U1131006). URL: ittp.//www.nsfc.gov.cn/; National Natural Science Foundation of China and People's Government of Guangdong Province to JZ; National Natural Science Foundation of China (grant number 30770403). URL: http://www.nsfc. gov.cn/; National Natural Science Foundation of China to JZ; Science and Technology Planning Project of Guangdong Province (grant number 20156090903077) URL: http://www.gdstc.gov.cn/; Guangdong Provincial Department of Science and Technology to JZ; Overseas Joint Doctoral Training Program of South China Agricultural University (grant number 2017LHPY017). URL: http://www.scau.edu.cn/ and South China Agricultural University to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki K, 2010, MALACOLOGIA, V52, P21, DOI 10.4002/040.052.0102; Aizaki K, 2009, J ETHOL, V27, P175, DOI 10.1007/s10164-008-0103-2; Albrecht EA, 1996, VELIGER, V39, P142; Auld JR, 2015, EVOLUTION, V69, P2793, DOI 10.1111/evo.12769; Auld JR, 2010, EVOLUTION, V64, P3476, DOI 10.1111/j.1558-5646.2010.01079.x; Brookes JI, 2007, J EVOLUTION BIOL, V20, P1015, DOI 10.1111/j.1420-9101.2007.01299.x; Burela S, 2011, J MOLLUS STUD, V77, P54, DOI 10.1093/mollus/eyq035; Carlsson N, 2004, FRESHWATER BIOL, V49, P1269, DOI 10.1111/j.1365-2427.2004.01269.x; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; COWIE RH, 2002, MOLLUSCS CROP PESTS; Creel S, 2014, BEHAV ECOL, V25, P773, DOI 10.1093/beheco/aru050; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; De Roeck ERM, 2005, HYDROBIOLOGIA, V542, P103, DOI 10.1007/s10750-004-2411-z; Dong SZ, 2012, SCI AGR, V69, P142, DOI 10.1590/S0103-90162012000200009; Estebenet AL, 2003, J MOLLUS STUD, V69, P301, DOI 10.1093/mollus/69.4.301; Estebenet AL, 2002, BIOCELL, V26, P83; Estebenet AL, 2006, BIOCELL, V30, P329; FRASER DF, 1992, ECOLOGY, V73, P959, DOI 10.2307/1940172; Ghalambor CK, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0154; Gilal Arfan Ahmed, 2015, Journal of Entomology and Zoology Studies, V3, P254; Guo J, 2016, BIOCONTROL SCI TECHN, V26, P1100, DOI 10.1080/09583157.2016.1185511; Guo Jing, 2015, Shengtaixue Zazhi, V34, P2943; HALWART M, 1994, INT J PEST MANAGE, V40, P199, DOI 10.1080/09670879409371882; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hayes KA, 2015, MALACOLOGIA, V58, P245, DOI 10.4002/040.058.0209; Hoverman JT, 2007, ECOLOGY, V88, P693, DOI 10.1890/05-1697; Ichinose K, 2003, BEHAVIOUR, V140, P935, DOI 10.1163/156853903770238391; Ichinose K, 2003, ECOL RES, V18, P213, DOI 10.1046/j.1440-1703.2003.00548.x; Ichinose K, 2002, J CHEM ECOL, V28, P2017, DOI 10.1023/A:1020749911877; Ichinose K, 2002, INT J PEST MANAGE, V48, P133, DOI 10.1080/09670870110100703; Ip KKL, 2014, BIOL CONTROL, V71, P16, DOI 10.1016/j.biocontrol.2013.12.009; Ireland DH, 2007, OECOLOGIA, V152, P162, DOI 10.1007/s00442-006-0637-3; Ito K, 2002, APPL ENTOMOL ZOOL, V37, P655, DOI 10.1303/aez.2002.655; Koch N, 2007, INVERTEBR BIOL, V126, P257, DOI 10.1111/j.1744-7410.2007.00095.x; Liang KM, 2013, BIOCONTROL SCI TECHN, V23, P674, DOI 10.1080/09583157.2013.790933; Lindsay MK, 2013, AMPHIBIA-REPTILIA, V34, P75, DOI 10.1163/15685381-00002871; Liu D., 2011, B BIOL FR BELG, V46, P18, DOI DOI 10.3969/J.ISSN.0006-3193.2011.3906.3006; Manriquez PH, 2013, MAR ECOL PROG SER, V472, P169, DOI 10.3354/meps10055; Matsukura K, 2013, BIOL INVASIONS, V15, P2039, DOI 10.1007/s10530-013-0431-1; McCauley SJ, 2011, ECOLOGY, V92, P2043, DOI 10.1890/11-0455.1; McPeek MA, 2001, ECOLOGY, V82, P1535, DOI 10.1890/0012-9658(2001)082[1535:PABRTP]2.0.CO;2; MINCHELLA DJ, 1981, AM NAT, V118, P876, DOI 10.1086/283879; Miner BG, 2010, OECOLOGIA, V163, P69, DOI 10.1007/s00442-010-1570-z; MOCHIDA O, 1991, MICRONESICA-SERIES, P51; Nystrom P, 2005, FRESHWATER BIOL, V50, P1938, DOI 10.1111/j.1365-2427.2005.01438.x; Orrock JL, 2013, ECOLOGY, V94, P573, DOI 10.1890/12-0502.1; Pavlova V, 2010, J THEOR BIOL, V264, P787, DOI 10.1016/j.jtbi.2010.03.009; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preston DL, 2014, FUNCT ECOL, V28, P1472, DOI 10.1111/1365-2435.12293; RAWLINGS TA, 1994, J EXP MAR BIOL ECOL, V181, P67, DOI 10.1016/0022-0981(94)90104-X; Rigby MC, 2000, P ROY SOC B-BIOL SCI, V267, P171, DOI 10.1098/rspb.2000.0983; Sandland GJ, 2006, ENVIRON TOXICOL CHEM, V25, P2216, DOI 10.1897/05-596R.1; Dreon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063782; Seuffert ME, 2010, BIOL INVASIONS, V12, P1695, DOI 10.1007/s10530-009-9582-5; Song HM, 2014, CELL STRESS CHAPERON, V19, P579, DOI 10.1007/s12192-013-0485-0; Steiner UK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006160; Stone AI, 2007, AM J PRIMATOL, V69, P127, DOI 10.1002/ajp.20334; Tamburi NE, 2016, CURR ZOOL, V62, P369, DOI 10.1093/cz/zow023; Tamburi NE, 2011, BIOL INVASIONS, V13, P2351, DOI 10.1007/s10530-011-0047-2; Ueshima E, 2015, J MOLLUS STUD, V81, P51, DOI 10.1093/mollus/eyu057; Urban MC, 2007, ECOLOGY, V88, P2587, DOI 10.1890/06-1946.1; Xu WB, 2014, J MOLLUS STUD, V80, P117, DOI 10.1093/mollus/eyt054; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713; Yoshie H, 2008, APPL ENTOMOL ZOOL, V43, P475, DOI 10.1303/aez.2008.475; Yusa Y, 2006, BIOL INVASIONS, V8, P137, DOI 10.1007/s10530-004-1790-4; Yusa Y, 2007, GENETICS, V175, P179, DOI 10.1534/genetics.106.060400; ZHOU W. C., 2003, FUJIAN J AGR SCI, V18, P25	67	11	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187747	10.1371/journal.pone.0187747	http://dx.doi.org/10.1371/journal.pone.0187747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136660	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200030
J	Kangwankai, K; Sani, S; Panpisut, P; Xia, W; Ashley, P; Petridis, H; Young, AM				Kangwankai, Kanokrat; Sani, Sarah; Panpisut, Piyaphong; Xia, Wendy; Ashley, Paul; Petridis, Haralampos; Young, Anne Margaret			Monomer conversion, dimensional stability, strength, modulus, surface apatite precipitation and wear of novel, reactive calcium phosphate and polylysine-containing dental composites	PLOS ONE			English	Article							RESIN-COMPOSITES; HYGROSCOPIC EXPANSION; MECHANICAL-PROPERTIES; TOOTHBRUSHING ALTERS; SECONDARY CARIES; COLOR-CHANGE; IN-VITRO; POLYMERIZATION; ROUGHNESS; SHRINKAGE	Purpose The aim was to assess monomer conversion, dimensional stability, flexural strength/modulus, surface apatite precipitation and wear of mono/tri calcium phosphate (CaP) and polylysine (PLS)-containing dental composites. These were formulated using a new, high molecular weight, fluid monomer phase that requires no polymerisation activator. Materials and methods Urethane and Polypropylene Glycol Dimethacrylates were combined with low levels of an adhesion promoting monomer and a light activated initiator. This liquid was mixed with a hybrid glass containing either 10 wt% CaP and 1 wt% PLS (F1) or 20 wt% CaP and 2 wt% PLS (F2). Powder to liquid mass ratio was 5: 1. Commercial controls included Gradia Direct Posterior (GD) and Filtek Z250 (FZ). Monomer conversion and polymerisation shrinkage were calculated using Fourier Transform Infrared (FTIR). Subsequent volume increases in water over 7 weeks were determined using gravimetric studies. Biaxial flexural strength (BFS)/modulus (BFM) reduction and surface apatite precipitation upon 1 and 4 weeks immersion in water versus simulated body fluid (SBF) were assessed using a mechanical testing frame and scanning electron microscope (SEM). Mass/volume loss and surface roughness (R-a) following 7 weeks water immersion and subsequent accelerated toothbrush abrasion were examined using gravimetric studies and profilometer. Results F1 and F2 exhibited much higher monomer conversion (72%) than FZ (54%) and low calculated polymerization shrinkage (2.2 vol%). Final hygroscopic expansions decreased in the order; F2 (3.5 vol%) > F1 (1.8 vol%) similar to Z250 (1.6 vol%) > Gradia (1.0 vol%). BFS and BFM were unaffected by storage medium type. Average BFS/BFM upon 4 weeks immersion reduced from 144 MPa/8 GPa to 107 MPa/5 GPa for F1 and 105 MPa/6 GPa to 82 MPa/4 GPa for F2. Much of this change was observed in the first week of immersion when water sorption rate was high. Surface apatite layers were incomplete at 1 week, but around 2 and 15 micron thick for F1 and F2 respectively following 4 weeks in SBF. Mass and volume loss following wear were equal. Average results for F1 (0.5%), F2 (0.7%), and FZ (0.5%) were comparable but lower than that of GD (1%). R-a, however, decreased in the order; F1 (15 mu m) > F2 (11 mu m) > GD (9 mu m) > FZ (5 mu m). Conclusions High monomer conversion in combination with large monomer size and lack of amine activator should improve cytocompatibility of the new composites. High monomer molecular weight and powder content enables low polymerisation shrinkage despite high conversion. Increasing active filler provides enhanced swelling to balance shrinkage, which, in combination with greater surface apatite precipitation, may help seal gaps and reduce bacterial microleakage. High monomer conversion also ensures competitive mechanical/wear characteristics despite enhanced water sorption. Furthermore, increased active filler could help reduce surface roughness upon wear.	[Kangwankai, Kanokrat; Sani, Sarah; Petridis, Haralampos] UCL Eastman Dent Inst, Unit Prosthodont, Dept Restorat Dent, London, England; [Kangwankai, Kanokrat] UCL Eastman Dent Inst, Unit Orthodont, London, England; [Panpisut, Piyaphong; Xia, Wendy; Young, Anne Margaret] UCL Eastman Dent Inst, Dept Biomat & Tissue Engn, London, England; [Panpisut, Piyaphong] Thammasat Univ, Fac Dent, Pathum Thani, Thailand; [Ashley, Paul] UCL Eastman Dent Inst, Unit Paediat Dent, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Thammasat University; University of London; University College London	Young, AM (corresponding author), UCL Eastman Dent Inst, Dept Biomat & Tissue Engn, London, England.	Anne.Young@ucl.ac.uk	panpisut, piyaphong/L-7363-2019; Panpisut, Piyaphong/AAW-1712-2020; Panpisut, Piyaphong/AAJ-5419-2021	Panpisut, Piyaphong/0000-0002-8649-857X; Ashley, Paul/0000-0003-0312-5311; Young, Anne/0000-0001-8485-2056	Royal Thai Government (Ministry of Sciences and Technology); National Institute for Health Research (Invention for Innovation i4i); UK EPSRC (Engineering and Physical Sciences Research Council) [EP/I022341/1]; Wellcome Trust (Institutional Strategic Support Fund (Issf) Third Tranche) [ISSF/FHCE/0079]; Optimisation and commercial manufacture of tooth-coloured composite dental-fillings with added polyantimicrobial (PAM) and remineralising calcium phosphate (CaP) [II-LB-0214-20002]; Engineering and Physical Sciences Research Council [EP/I022341/1] Funding Source: researchfish; National Institute for Health Research [II-LB-0214-20002] Funding Source: researchfish; EPSRC [EP/I022341/1] Funding Source: UKRI	Royal Thai Government (Ministry of Sciences and Technology); National Institute for Health Research (Invention for Innovation i4i); UK EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust (Institutional Strategic Support Fund (Issf) Third Tranche); Optimisation and commercial manufacture of tooth-coloured composite dental-fillings with added polyantimicrobial (PAM) and remineralising calcium phosphate (CaP); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by The Royal Thai Government (Ministry of Sciences and Technology) (PP); National Institute for Health Research (Invention for Innovation i4i, https://nihr.ac.uk/research-and-impact/research/nihr-studies/invention-for-innovation.htm);Optimisation and commercial manufacture of tooth-coloured composite dental-fillings with added polyantimicrobial (PAM) and remineralising calcium phosphate (CaP)), grant number II-LB-0214-20002 (WX); UK EPSRC (Engineering and Physical Sciences Research Council, https./www.epsrc.ac.uk), grant number EP/I022341/1 (WX); and Wellcome Trust (Institutional Strategic Support Fund (Issf) Third Tranche, www.wellcome.ac.uk/Funding/WTP057769.htm), grant number ISSF/FHCE/0079 (WX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Neel EA, 2016, INT J NANOMED, V11, P4743, DOI 10.2147/IJN.S107624; Aljabo A, 2015, DENT MATER, V31, P1279, DOI 10.1016/j.dental.2015.08.149; Aljabo A, 2016, MAT SCI ENG C-MATER, V60, P285, DOI 10.1016/j.msec.2015.11.047; Alrahlah A, 2014, DENT MATER, V30, P143, DOI 10.1016/j.dental.2013.10.010; Aoba T, 2004, ORAL DIS, V10, P249, DOI 10.1111/j.1601-0825.2004.01030.x; Asmussen E, 1998, DENT MATER, V14, P51, DOI 10.1016/S0109-5641(98)00009-8; Atai M, 2005, BIOMATERIALS, V26, P5015, DOI 10.1016/j.biomaterials.2005.01.022; Bakhurji E, 2017, J PUBLIC HEALTH DENT, V77, P207, DOI 10.1111/jphd.12198; Benetti AR, 2015, OPER DENT, V40, P190, DOI 10.2341/13-324-L; Bicalho A, 2014, OPER DENT, V39, P83, DOI DOI 10.2341/12-442-L; Bicalho A A, 2014, Oper Dent, V39, pE83, DOI 10.2341/12-442-L; Blackham JT, 2009, OPER DENT, V34, P697, DOI 10.2341/08-118-L; British Standard, 2012, 23317 BS ISO; British Standard, 2009, 40492009 BS EN; British Standards, 2007, 1456912007 PD ISOTR; Chen Q, 2009, WEAR, V267, P1153, DOI 10.1016/j.wear.2008.12.058; Chen RS, 2003, J DENT, V31, P223, DOI 10.1016/S0300-5712(02)00088-X; Cheng L, 2016, INT J ORAL SCI, V8, P172, DOI 10.1038/ijos.2016.13; Curtis AR, 2008, J DENT, V36, P186, DOI 10.1016/j.jdent.2007.11.015; Derchi G, 2016, J PROSTHET DENT; Dorozhkin SV, 2009, MATERIALS, V2, P221, DOI 10.3390/ma2010221; Farrugia C, 2015, DENT MATER, V31, pE89, DOI 10.1016/j.dental.2014.12.005; Ferracane JL, 2006, DENT MATER, V22, P211, DOI 10.1016/j.dental.2005.05.005; Finan L, 2013, DENT MATER, V29, P906, DOI 10.1016/j.dental.2013.05.008; Gandolfi MG, 2011, DENT MATER, V27, P1055, DOI 10.1016/j.dental.2011.07.007; Hatamleh MM, 2010, DENT MATER, V26, P185, DOI 10.1016/j.dental.2009.10.001; Herrera D, 2003, J CLIN PERIODONTOL, V30, P307, DOI 10.1034/j.1600-051X.2003.00341.x; Hubbezoglu I, 2008, DENT MATER J, V27, P105, DOI 10.4012/dmj.27.105; Ilie N, 2017, DENT MATER, V33, P880, DOI 10.1016/j.dental.2017.04.013; Jokstad A, 2016, DENT MATER, V32, P11, DOI 10.1016/j.dental.2015.09.006; Kamonkhantikul K, 2016, DENT MATER J, V35, P225, DOI 10.4012/dmj.2015-228; Kamonkhantikul K, 2014, DENT MATER J, V33, P599, DOI 10.4012/dmj.2014-111; Kopperud SE, 2012, EUR J ORAL SCI, V120, P539, DOI 10.1111/eos.12004; Lepri CP, 2012, DENT MATER J, V31, P689, DOI 10.4012/dmj.2012-063; Marovic D, 2014, DENT MATER, V30, P1052, DOI 10.1016/j.dental.2014.06.001; Mehdawi I, 2009, ACTA BIOMATER, V5, P2525, DOI 10.1016/j.actbio.2009.03.030; Mehdawi IM, 2013, DENT MATER, V29, P473, DOI 10.1016/j.dental.2013.01.010; Nedeljkovic I, 2015, DENT MATER, V31, pE247, DOI 10.1016/j.dental.2015.09.001; Nomura Y, 2006, J MATER SCI-MATER M, V17, P29, DOI 10.1007/s10856-006-6326-2; Panpisut P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164653; Park JW, 2014, J DENT RES, V93, P195, DOI 10.1177/0022034513513905; Pemberton Michael N, 2016, Dent Update, V43, P272; Pick B, 2010, DENT MATER, V26, P83, DOI 10.1016/j.dental.2009.09.002; Regnault WF, 2008, J MATER SCI-MATER M, V19, P507, DOI 10.1007/s10856-007-3178-3; Roselino Lourenço de Moraes Rego, 2015, Braz. Dent. J., V26, P507, DOI 10.1590/0103-6440201300399; Lessa FCR, 2010, J APPL ORAL SCI, V18, P50, DOI 10.1590/S1678-77572010000100010; Santos M, 2013, J DENT, V41, P802, DOI 10.1016/j.jdent.2013.06.011; Shih IL, 2006, BIORESOURCE TECHNOL, V97, P1148, DOI 10.1016/j.biortech.2004.08.012; Shin DH, 2009, DENT MATER, V25, P1030, DOI 10.1016/j.dental.2009.03.004; Skrtic D, 2007, J BIOMATER APPL, V21, P375, DOI 10.1177/0885328206064823; Suiter EA, 2016, J DENT RES, V95, P543, DOI 10.1177/0022034516633450; Sumino N, 2013, ACTA ODONTOL SCAND, V71, P820, DOI 10.3109/00016357.2012.734405; Versluis A, 2011, DENT MATER, V27, P126, DOI 10.1016/j.dental.2010.09.007; Walters NJ, 2016, DENT MATER, V32, P264, DOI 10.1016/j.dental.2015.11.017; Wei YJ, 2013, DENT MATER, V29, pE218, DOI 10.1016/j.dental.2013.05.010; Young AM, 2004, BIOMATERIALS, V25, P823, DOI 10.1016/S0142-9612(03)00599-4; Zhang L, 2016, DENT MATER, V32, P285, DOI 10.1016/j.dental.2015.11.015	57	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187757	10.1371/journal.pone.0187757	http://dx.doi.org/10.1371/journal.pone.0187757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136013	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200031
J	Arns, A; Blessing, M; Fleckenstein, J; Stsepankou, D; Boda-Heggemann, J; Hesser, J; Lohr, F; Wenz, F; Wertz, H				Arns, Anna; Blessing, Manuel; Fleckenstein, Jens; Stsepankou, Dzmitry; Boda-Heggemann, Judit; Hesser, Juergen; Lohr, Frank; Wenz, Frederik; Wertz, Hansjoerg			Phantom-based evaluation of dose exposure of ultrafast combined kV-MV-CBCT towards clinical implementation for IGRT of lung cancer	PLOS ONE			English	Article							CONE-BEAM CT; IMAGE-GUIDED RADIOTHERAPY; RADIATION-THERAPY; COMPUTED-TOMOGRAPHY; BIOLOGICAL EFFECTIVENESS; GAMMA-RAYS; X-RAYS; KILOVOLTAGE; QUALITY; ENERGY	Purpose Combined ultrafast 90 degrees + 90 degrees kV-MV-CBCT within single breath-hold of 15s has high clinical potential for accelerating imaging for lung cancer patients treated with deep inspiration breath-hold (DIBH). For clinical feasibility of kV-MV-CBCT, dose exposure has to be small compared to prescribed dose. In this study, kV-MV dose output is evaluated and compared to clinically-established kV-CBCT. Methods Accurate dose calibration was performed for kV and MV energy; beam quality was determined. For direct comparison of MV and kV dose output, relative biological effectiveness (RBE) was considered. CT dose index (CTDI) was determined and measurements in various representative locations of an inhomogeneous thorax phantom were performed to simulate the patient situation. Results A measured dose of 20.5mGE (Gray-equivalent) in the target region was comparable to kV-CBCT (31.2mGy for widely-used, and 9.1mGy for latest available preset), whereas kV-MV spared healthy tissue and reduced dose to 6.6mGE (30%) due to asymmetric dose distribution. The measured weighted CTDI of 12mGE for kV-MV lay in between both clinical presets. Conclusions Dosimetric properties were in agreement with established imaging techniques, whereas exposure to healthy tissue was reduced. By reducing the imaging time to a single breath-hold of 15s, ultrafast combined kV-MV CBCT shortens patient time at the treatment couch and thus improves patient comfort. It is therefore usable for imaging of hypofractionated lung DIBH patients.	[Arns, Anna; Blessing, Manuel; Fleckenstein, Jens; Stsepankou, Dzmitry; Boda-Heggemann, Judit; Hesser, Juergen; Wenz, Frederik; Wertz, Hansjoerg] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Dept Radiat Oncol, Mannheim, Germany; [Lohr, Frank] Az Osped Univ Modena, Struttura Complessa Radioterapia, Dipartimento Oncol, Modena, Italy	Ruprecht Karls University Heidelberg	Arns, A (corresponding author), Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Dept Radiat Oncol, Mannheim, Germany.	anna.arns@medma.uni-heidelberg.de	Lohr, Frank/AAC-2528-2022	Lohr, Frank/0000-0003-1014-5556	Elekta AB, Stockholm, Sweden; German Research Council (DFG) [B03192/1-1, WE5294/1-1, L0713/3-1]	Elekta AB, Stockholm, Sweden; German Research Council (DFG)(German Research Foundation (DFG))	The department received funding by a research grant from Elekta AB, Stockholm, Sweden, as well as by grant numbers B03192/1-1, WE5294/1-1, and L0713/3-1 of the German Research Council (DFG). The funders, however, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaei P, 2015, PHYS MEDICA, V31, P647, DOI 10.1016/j.ejmp.2015.06.003; Almond PR, 1999, MED PHYS, V26, P1847, DOI 10.1118/1.598691; Amer A, 2007, BRIT J RADIOL, V80, P476, DOI 10.1259/bjr/80446730; Arns A, 2016, STRAHLENTHER ONKOL, V192, P312, DOI 10.1007/s00066-016-0947-2; Bissonnette JP, 2012, MED PHYS, V39, P1946, DOI 10.1118/1.3690466; BJARNGARD BE, 1994, MED PHYS, V21, P1069, DOI 10.1118/1.597349; Blessing M, 2014, INT J RADIAT ONCOL, V90, pS828, DOI 10.1016/j.ijrobp.2014.05.2385; Blessing M, 2010, INT J RADIAT ONCOL, V78, P1219, DOI 10.1016/j.ijrobp.2010.01.030; Boda-Heggemann J, 2014, INT J RADIAT ONCOL, V90, pS826, DOI 10.1016/j.ijrobp.2014.05.2378; Boda-Heggemann J, 2016, INT J RADIAT ONCOL, V94, P478, DOI 10.1016/j.ijrobp.2015.11.049; Boda-Heggemann J, 2013, RADIOTHER ONCOL, V109, P505, DOI 10.1016/j.radonc.2013.09.014; Boda-Heggemann J, 2011, STRAHLENTHER ONKOL, V187, P284, DOI 10.1007/s00066-011-2236-4; BOREK C, 1983, NATURE, V301, P156, DOI 10.1038/301156a0; Chen J, 2006, BRIT J RADIOL, V79, pS87, DOI 10.1259/bjr/60612178; Cheng HCY, 2011, INT J RADIAT ONCOL, V80, P291, DOI 10.1016/j.ijrobp.2010.06.014; Ding GX, 2008, MED PHYS, V35, P1135, DOI 10.1118/1.2839096; Ding GX, 2010, MED PHYS, V37, P4880, DOI 10.1118/1.3483099; Dixon RL, 2003, MED PHYS, V30, P1272, DOI 10.1118/1.1576952; Doerr WG, 2008, STRAHLENTHER ONKOL, V184, P67, DOI 10.1007/s00066-008-1807-5; Goldsmith C, 2012, CANCER IMAGING, V12, P351, DOI 10.1102/1470-7330.2012.9015; Green S, 2005, BRIT J RADIOL, V78, P469, DOI 10.1259/bjr/89346355; Guckenberger M, 2009, RADIOTHER ONCOL, V91, P288, DOI 10.1016/j.radonc.2008.08.010; Hill MA, 2004, RADIAT PROT DOSIM, V112, P471, DOI 10.1093/rpd/nch091; Hunter N, 2009, J RADIOL PROT, V29, P5, DOI 10.1088/0952-4746/29/1/R01; Hyer DE, 2010, MED PHYS, V37, P4620, DOI 10.1118/1.3476459; Hyer DE, 2010, J APPL CLIN MED PHYS, V11, P181, DOI 10.1120/jacmp.v11i2.3183; ICRP, 1990, ICRP PUBL, V21, P1; ICRP (International Commission on Radiological Protection), 2007, ANN ICRP, V37; International Atomic Energy Agency, 2000, INT AR EN AG TECHN R, V398; Islam MK, 2006, MED PHYS, V33, P1573, DOI 10.1118/1.2198169; Jaffray DA, 2002, INT J RADIAT ONCOL, V53, P1337, DOI 10.1016/S0360-3016(02)02884-5; Kamath S, 2011, J APPL CLIN MED PHYS, V12, P376, DOI 10.1120/jacmp.v12i2.3435; Kim S, 2010, MED PHYS, V37, P3648, DOI 10.1118/1.3438478; Kirkby C, 2013, PHYS MED BIOL, V58, P5693, DOI 10.1088/0031-9155/58/16/5693; Liu LGC, 2015, MED PHYS, V42, P2072, DOI 10.1118/1.4915120; Liu M, 2015, RADIAT PROT DOSIM, P1; Ma CM, 2001, MED PHYS, V28, P868, DOI 10.1118/1.1374247; Mail N, 2009, MED PHYS, V36, P22, DOI 10.1118/1.3017470; Murphy MJ, 2007, MED PHYS, V34, P4041, DOI 10.1118/1.2775667; Navarria P, 2013, RADIOTHER ONCOL, V107, P414, DOI 10.1016/j.radonc.2013.04.016; Nikjoo H, 2010, PHYS MED BIOL, V55, pR65, DOI 10.1088/0031-9155/55/10/R01; Pouliot J, 2005, INT J RADIAT ONCOL, V61, P552, DOI 10.1016/j.ijrobp.2004.10.011; Simeonova AO, 2014, INT J RADIAT ONCOL, V90, pS891, DOI 10.1016/j.ijrobp.2014.05.2537; Song WY, 2008, MED PHYS, V35, P480, DOI 10.1118/1.2825619; Spezi E, 2012, INT J RADIAT ONCOL, V83, P419, DOI 10.1016/j.ijrobp.2011.06.1972; Sykes JR, 2013, J PHYS CONF SER, V444, DOI 10.1088/1742-6596/444/1/012017; Timmerman RD, 2007, J CLIN ONCOL, V25, P947, DOI 10.1200/JCO.2006.09.7469; TROUT ED, 1971, AMER J ROENTGENOL RA, V112, P622, DOI 10.2214/ajr.112.3.622; Wertz H, 2010, PHYS MED BIOL, V55, P4203, DOI 10.1088/0031-9155/55/15/001; Yin FF, 2005, MED PHYS, V32, P2819, DOI 10.1118/1.1997307	50	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187710	10.1371/journal.pone.0187710	http://dx.doi.org/10.1371/journal.pone.0187710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125857	Green Published, gold, Green Submitted			2022-12-26	WOS:000414866000020
J	Franse, CB; van Grieken, A; Qin, L; Melis, RJF; Rietjens, JAC; Raat, H				Franse, Carmen B.; van Grieken, Amy; Qin, Li; Melis, Rene J. F.; Rietjens, Judith A. C.; Raat, Hein			Socioeconomic inequalities in frailty and frailty components among community-dwelling older citizens	PLOS ONE			English	Article							LONG-TERM MORTALITY; EUROPEANS ASSOCIATION; CLINICAL FRAILTY; ELDERLY SUBJECTS; HEALTH; INDEX; ADULTS; SELECTION; DETERMINANTS; OUTCOMES	Background So far, it has not yet been studied whether socioeconomic status is associated with distinct frailty components and for which frailty component this association is the strongest. We aimed to examine the association between socioeconomic status and frailty and frailty components. In addition we assessed the mediating effect of the number of morbidities on the association between socioeconomic status and other frailty components. Methods This is a cross-sectional study of pooled data of The Older Persons and Informal Caregivers Survey Minimum DataSet in the Netherlands among community-dwelling persons aged 55 years and older (n = 26,014). Frailty was measured with a validated Frailty Index that consisted of 45 items. The Frailty Index contained six components: morbidities, limitations in activities of daily living (ADL), limitations in instrumental ADL (IADL), health-related quality of life, psychosocial health and self-rated health. Socioeconomic indicators used were education level and neighbourhood socioeconomic status. Results Persons with primary or secondary education had higher overall frailty and frailty component scores compared to persons with tertiary education (P < .001). Lower education levels were most consistently associated with higher overall frailty, more morbidities and worse selfrated health (P < .05 in all age groups). The strongest association was found between primary education and low psychosocial health for persons aged 55-69 years and more IADL limitations for persons aged 80+ years. Associations between neighborhood socioeconomic status and frailty (components) also showed inequalities, although less strong. The number of morbidities moderately to strongly mediated the association between socioeconomic indicators and other frailty components. Conclusion There are socioeconomic inequalities in frailty and frailty components. Inequalities in frailty, number of morbidities and self-rated health are most consistent across age groups. The number of morbidities a person has play an important role in explaining socioeconomic inequalities in frailty and should be taken into account in the management of frailty.	[Franse, Carmen B.; van Grieken, Amy; Rietjens, Judith A. C.; Raat, Hein] Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands; [Qin, Li; Melis, Rene J. F.] Radboud Univ Nijmegen, Dept Geriatr Med, Med Ctr, Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	Franse, CB (corresponding author), Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands.	c.franse@erasmusmc.nl	Qin, Li/A-3244-2016; Melis, René/J-5943-2012; van Grieken, Amy/N-1583-2014	Qin, Li/0000-0001-5002-3372; Melis, René/0000-0002-7863-4738; van Grieken, Amy/0000-0001-6767-9159	National Care for older citizens Programme on behalf of the Organisation of Health Research and Development (ZonMw-The Netherlands) [310300002]; Organisation of Health Research and Development (ZonMw-The Netherlands) [633400009]	National Care for older citizens Programme on behalf of the Organisation of Health Research and Development (ZonMw-The Netherlands); Organisation of Health Research and Development (ZonMw-The Netherlands)	Funding for the TOPICS-MDS project was provided by the National Care for older citizens Programme on behalf of the Organisation of Health Research and Development (ZonMw-The Netherlands, Grant reference 310300002). Funding was provided to the first author (Carmen B. Franse) by the Organisation of Health Research and Development (ZonMw-The Netherlands, Grant No. 633400009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bell CL, 2014, J AM GERIATR SOC, V62, P880, DOI 10.1111/jgs.12796; Benzeval M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-947; Cacciatore F, 2013, ACTA DIABETOL, V50, P251, DOI 10.1007/s00592-012-0413-2; Chamberlain AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011410; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Edjolo A, 2016, AM J EPIDEMIOL, V183, P277, DOI 10.1093/aje/kwv223; Enroth L, 2015, AGE AGEING, V44, P123, DOI 10.1093/ageing/afu092; Etman A, 2014, EUR J PUBLIC HLTH; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Galizia G, 2011, AGING CLIN EXP RES, V23, P118, DOI 10.1007/BF03351076; Gobbens RJJ, 2014, ARCH GERONTOL GERIAT, V59, P280, DOI 10.1016/j.archger.2014.06.008; Gobbens RJJ, 2010, J AM MED DIR ASSOC, V11, P356, DOI 10.1016/j.jamda.2009.11.008; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Hajizadeh M, 2016, HEALTH POLICY, V120, P1040, DOI 10.1016/j.healthpol.2016.07.019; Harttgen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075847; Hoogendijk EO, 2014, ANN EPIDEMIOL, V24, P538, DOI 10.1016/j.annepidem.2014.05.002; Huisman M, 2003, SOC SCI MED, V57, P861, DOI 10.1016/S0277-9536(02)00454-9; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Knol F.A, 1998, HOOG NAAR LAAG LAAG; Krabbe PFM, 1999, J CLIN EPIDEMIOL, V52, P293, DOI 10.1016/S0895-4356(98)00163-2; Kroger H, 2015, EUR J PUBLIC HEALTH, V25, P951, DOI 10.1093/eurpub/ckv111; Laan W, 2014, J NUTR HEALTH AGING, V18, P848, DOI [10.1007/s12603-014-0558-5, 10.1007/s12603-014-0479-3]; Lang IA, 2009, J AM GERIATR SOC, V57, P1776, DOI 10.1111/j.1532-5415.2009.02480.x; Leopold L, 2013, INT J PUBLIC HEALTH, V58, P23, DOI 10.1007/s00038-012-0399-0; Lutomski JE, 2016, J CLIN EPIDEMIOL, V74, P207, DOI 10.1016/j.jclinepi.2015.11.006; Lutomski JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081673; Lutomski JE, 2013, J AM GERIATR SOC, V61, P1625, DOI 10.1111/jgs.12430; McDonald J.H., 2009, HDB BIOL STAT; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Mitnitski A, 2005, J AM GERIATR SOC, V53, P2184, DOI 10.1111/j.1532-5415.2005.00506.x; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Organisation for Economic C-o Development, 1999, CLASS ED PROGR MAN I; Palacios-Cena D, 2012, J AM MED DIR ASSOC, V13, P136, DOI 10.1016/j.jamda.2010.05.007; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Romero-Ortuno R, 2014, GERIATR GERONTOL INT, V14, P420, DOI 10.1111/ggi.12122; Romero-Ortuno R, 2012, AGE AGEING, V41, P684, DOI 10.1093/ageing/afs051; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Soler-Vila H, 2016, J EPIDEMIOL COMMUN H, V70, P354, DOI 10.1136/jech-2015-206406; Statistics Netherlands (CBS), 1999, STAND OND; Statistics Netherlands (CBS), 2012, KERNC POST 2008 2010; Stolz E, 2016, J EPIDEMIOL COMMUNIT; Theou O, 2013, J AM GERIATR SOC, V61, P1537, DOI 10.1111/jgs.12420; Tsai Y, 2016, J PUBLIC HLTH OXF; Vaughan L, 2016, J GERONTOL A-BIOL, V71, pS79, DOI 10.1093/gerona/glv061; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, 2001, WHO INT CLASS FUNCT; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Yang F, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0317-z	51	43	43	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187946	10.1371/journal.pone.0187946	http://dx.doi.org/10.1371/journal.pone.0187946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121677	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900100
J	Mistry, D; Wise, RP; Dickerson, JA				Mistry, Divya; Wise, Roger P.; Dickerson, Julie A.			DiffSLC: A graph centrality method to detect essential proteins of a protein-protein interaction network	PLOS ONE			English	Article							RNA-SEQ; DATABASE; DEG	Identification of central genes and proteins in biomolecular networks provides credible candidates for pathway analysis, functional analysis, and essentiality prediction. The DiffSLC centrality measure predicts central and essential genes and proteins using a protein-protein interaction network. Network centrality measures prioritize nodes and edges based on their importance to the network topology. These measures helped identify critical genes and proteins in biomolecular networks. The proposed centrality measure, DiffSLC, combines the number of interactions of a protein and the gene coexpression values of genes from which those proteins were translated, as a weighting factor to bias the identification of essential proteins in a protein interaction network. Potentially essential proteins with low node degree are promoted through eigenvector centrality. Thus, the gene coexpression values are used in conjunction with the eigenvector of the network's adjacency matrix and edge clustering coefficient to improve essentiality prediction. The outcome of this prediction is shown using three variations: (1) inclusion or exclusion of gene co-expression data, (2) impact of different coexpression measures, and (3) impact of different gene expression data sets. For a total of seven networks, DiffSLC is compared to other centrality measures using Saccharomyces cerevisiae protein interaction networks and gene expression data. Comparisons are also performed for the top ranked proteins against the known essential genes from the Saccharomyces Gene Deletion Project, which show that DiffSLC detects more essential proteins and has a higher area under the ROC curve than other compared methods. This makes DiffSLC a stronger alternative to other centrality methods for detecting essential genes using a protein-protein interaction network that obeys centrality-lethality principle. DiffSLC is implemented using the igraph package in R, and networkx package in Python. The python package can be obtained from git.io/diffslcpy. The R implementation and code to reproduce the analysis is available via git.io/diffslc.	[Mistry, Divya; Wise, Roger P.; Dickerson, Julie A.] Iowa State Univ, Bioinformat & Computat Biol, Ames, IA 50011 USA; [Mistry, Divya; Dickerson, Julie A.] Iowa State Univ, Dept Elect & Comp Engn, Ames, IA 50011 USA; [Wise, Roger P.] USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Wise, Roger P.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA	Iowa State University; Iowa State University; United States Department of Agriculture (USDA); Iowa State University	Dickerson, JA (corresponding author), Iowa State Univ, Bioinformat & Computat Biol, Ames, IA 50011 USA.; Dickerson, JA (corresponding author), Iowa State Univ, Dept Elect & Comp Engn, Ames, IA 50011 USA.	julied@iastate.edu		Wise, Roger/0000-0001-7786-1528; Dickerson, Julie A/0000-0003-4973-5641	National Science Foundation from National Science Foundation [IOS-1062546, IOS-0922746]; National Science Foundation [IOS-1062546, IOS-0922746]	National Science Foundation from National Science Foundation; National Science Foundation(National Science Foundation (NSF))	This research was supported by National Science Foundation (http://www.nsf.gov/) grants IOS-1062546 (JAD) and IOS-0922746 (JAD, RW) from National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This material is based upon work supported by the National Science Foundation under Grant No. IOS-1062546 and IOS-0922746.	Baker KE, 2004, NONSENSE MEDIATED MR; Ballouz S, 2015, BIOINFORMATICS, V31, P2123, DOI 10.1093/bioinformatics/btv118; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Estrada E, 2006, PROTEOMICS, V6, P35, DOI 10.1002/pmic.200500209; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fayruzov T, 2009, IEEE INT C BIOINFORM, P99, DOI 10.1109/BIBM.2009.9; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giorgi FM, 2013, BIOINFORMATICS, V29, P717, DOI 10.1093/bioinformatics/btt053; Gould PR, 1967, GEOGRAPHICAL INTERPR; Guan QN, 2006, PLOS GENET, V2, P1924, DOI 10.1371/journal.pgen.0020203; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Han YX, 2015, BIOINFORM BIOL INSIG, V9, P29, DOI 10.4137/BBI.S28991; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Iancu OD, 2012, BIOINFORMATICS, V28, P1592, DOI 10.1093/bioinformatics/bts245; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kerrien S, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-44; Kim J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00900; Li M, 2014, METHODS, V67, P325, DOI 10.1016/j.ymeth.2014.02.016; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Newman M.E.J., 2008, NEW PALGRAVE ENCY EC, P312, DOI [DOI 10.1057/978-1-349-95121-5_2565-1, 10.1057/978-1-349-95121-5_2565-1]; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Peng W, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-87; Petschnigg J, 2011, CURR OPIN BIOTECH, V22, P50, DOI 10.1016/j.copbio.2010.09.001; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Plaimas K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-56; Qin C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161042; R Core Team, 2021, R LANGUAGE ENV STAT; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ram R, 2008, LECT N BIOINFORMAT, V5265, P201, DOI 10.1007/978-3-540-88436-1_18; Raman Karthik, 2014, Syst Synth Biol, V8, P73, DOI 10.1007/s11693-013-9123-5; Rizzo ML, 2014, ENERGY E STAT ENERGY; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sprinzak E, 2003, J MOL BIOL, V327, P919, DOI 10.1016/S0022-2836(03)00239-0; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Tang XW, 2014, IEEE ACM T COMPUT BI, V11, P407, DOI 10.1109/TCBB.2013.2295318; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Uhlen M, 2008, BIOTECHNIQUES, V44, P649, DOI 10.2144/000112803; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xiao QH, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S3-S1; Young KH, 1998, BIOL REPROD, V58, P302, DOI 10.1095/biolreprod58.2.302; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024; Zhang XY, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00151; Zhang X, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1166-7; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	58	26	27	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187091	10.1371/journal.pone.0187091	http://dx.doi.org/10.1371/journal.pone.0187091			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121073	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900019
J	Baty, F; Ritz, C; Jensen, SM; Kern, L; Tamm, M; Brutsche, MH				Baty, Florent; Ritz, Christian; Jensen, Signe Marie; Kern, Lukas; Tamm, Michael; Brutsche, Martin Hugo			Multimodel inference applied to oxygen recovery kinetics after 6-min walk tests in patients with chronic obstructive pulmonary disease	PLOS ONE			English	Article							SKELETAL-MUSCLE; EXERCISE; METABOLISM; CARDIOPULMONARY; CONSUMPTION; FAILURE	6-min walk tests (6MWT) are routinely performed in patients with chronic obstructive pulmonary disease (COPD). Oxygen uptake (VO2) kinetics during 6MWT can be modeled and derived parameters provide indicators of patients' exercise capacity. Post-exercise VO2 recovery also provides important parameters of patients' fitness which has not been extensively investigated in COPD. Several nonlinear regression models with different underlying biological assumptions may be suitable for describing recovery kinetics. Multimodel inference (model averaging) can then be used to capture the uncertainty in considering several models. Our aim was to apply multimodel inference in order to better understand the physiological underpinnings of VO2 recovery after 6MWT in patients with COPD. 61 patients with COPD (stages 2 to 4) were included in this study. Oxygen kinetics during 6MWT were modeled using nonlinear regression. Three statistical approaches (mixed-effects, meta -analysis and weighted regression) were compared in order to summarize estimates obtained from multiple kinetics. The recovery phase was modeled using 3 distinct equations (log-logistic, Weibull 1 and Weibull 2). Three models were fitted to the set of 61 kinetics. A significant model-averaged difference of 40.39 sec (SE = 17.1) in the time to half decrease of VO2 level (T-1/2 VO2) was found between stage 2 and 4 (p = 0.0178). In addition, the Weibull 1 model characterized by a steeper decrease at the beginning of the recovery phase showed some improvement of goodness of fit when fitted to the kinetics of patients with stage 2 COPD in comparison with the 2 other models. Multimodel inference was successfully used to model VO2 recovery after 6MWT in patients with COPD. Significant model-averaged differences in T-1/2 VO2 were found between moderate and very severe COPD patients. Furthermore, specific patterns of VO2 recovery could be identified across COPD stages.	[Baty, Florent; Kern, Lukas; Brutsche, Martin Hugo] Cantonal Hosp St Gallen, Dept Pulm Med, St Gallen, Switzerland; [Ritz, Christian] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Jensen, Signe Marie] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark; [Tamm, Michael] Univ Hosp Basel, Dept Pulm Med, Basel, Switzerland	Kantonsspital St. Gallen; University of Copenhagen; University of Copenhagen; University of Basel	Baty, F (corresponding author), Cantonal Hosp St Gallen, Dept Pulm Med, St Gallen, Switzerland.	florentbaty@kssg.ch	; Jensen, Signe Marie/G-1026-2016; Ritz, Christian/P-6159-2014	Brutsche, Martin/0000-0002-1612-3609; Jensen, Signe Marie/0000-0002-7738-5231; Ritz, Christian/0000-0002-5095-0624; Baty, Florent/0000-0002-1425-0428	Lungenliga St. Gallen; Cantonal Hospital St. Gallen	Lungenliga St. Gallen; Cantonal Hospital St. Gallen	The study was supported by an unconditional research grant by the Lungenliga St. Gallen and an institutional grant by the Cantonal Hospital St. Gallen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baty F, 2016, RESPIRATION, V92, P371, DOI 10.1159/000452307; Baty F, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0173-8; Bellefleur M, 2016, PULM MED, V2016, DOI 10.1155/2016/9160781; Bringard A, 2014, EUR J APPL PHYSIOL, V114, P1983, DOI 10.1007/s00421-014-2920-z; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnham K P, 2003, MODEL SELECT MULTIMO; CHICK TW, 1990, CHEST, V97, P276, DOI 10.1378/chest.97.2.276; COHENSOLAL A, 1995, CIRCULATION, V91, P2924, DOI 10.1161/01.CIR.91.12.2924; Davidian M., 1995, NONLINEAR MODELS REP; GAESSER GA, 1984, MED SCI SPORT EXER, V16, P29; Gerhard D, 2015, MEDRC MIXED EFFECT D; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jensen SM, 2015, RISK ANAL, V35, P68, DOI 10.1111/risa.12242; Jensen SM, 2017, SEED SCI RES, P1; Jiang XQ, 2014, BIOMETRICAL J, V56, P493, DOI 10.1002/bimj.201300123; Keir DA, 2014, EXP PHYSIOL, V99, P1511, DOI 10.1113/expphysiol.2014.080812; Kemps HMC, 2007, EUR J APPL PHYSIOL, V100, P45, DOI 10.1007/s00421-007-0398-7; Kern L, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-167; KUTSUZAWA T, 1995, AM J RESP CRIT CARE, V152, P647, DOI 10.1164/ajrccm.152.2.7633721; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Stanley TD, 2015, STAT MED, V34, P2116, DOI 10.1002/sim.6481; THOMPSON CH, 1993, THORAX, V48, P486, DOI 10.1136/thx.48.5.486; Tueller C, 2010, RESPIRATION, V80, P410, DOI 10.1159/000319834; van Gestel AJR, 2014, RESPIRATION, V88, P307, DOI 10.1159/000365997; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; WUYAM B, 1992, EUR RESPIR J, V5, P157	29	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187548	10.1371/journal.pone.0187548	http://dx.doi.org/10.1371/journal.pone.0187548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117249	gold, Green Published, Green Submitted			2022-12-26	WOS:000414659600044
J	Meireles, S; Wesseling, M; Smith, CR; Thelen, DG; Verschueren, S; Jonkers, I				Meireles, Susana; Wesseling, Mariska; Smith, Colin R.; Thelen, Darryl G.; Verschueren, Sabine; Jonkers, Ilse			Medial knee loading is altered in subjects with early osteoarthritis during gait but not during step-up-and-over task	PLOS ONE			English	Article							MEASURED IN-VIVO; ADDUCTION MOMENT; MUSCLE STRENGTH; QUADRICEPS WEAKNESS; DISEASE PROGRESSION; JOINT MECHANICS; CONTACT FORCES; LOWER-LIMB; BASE-LINE; WALKING	This study evaluates knee joint loading during gait and step-up-and-over tasks in control subjects, subjects with early knee OA and those with established knee OA. Thirty-seven subjects with varying degrees of medial compartment knee OA severity (eighteen with early OA and sixteen with established OA), and nineteen healthy controls performed gait and step-up-and-over tasks. Knee joint moments, contact forces (KCF), the magnitude of contact pressures and center of pressure (CoP) location were analyzed for the three groups for both activities using a multi-body knee model with articular cartilage contact, 14 ligaments, and six degrees of freedom tibiofemoral and patellofemoral joints. During gait, the first peak of the medial KCF was significantly higher for patients with early knee OA (p = 0.048) and established knee OA (p = 0.001) compared to control subjects. Furthermore, the medial contact pressure magnitudes and CoP location were significantly different in both groups of patients compared to controls. Knee rotation moments (KRMs) and external rotation angles were significantly higher during early stance in both patient groups (p < 0.0001) compared to controls. During step-up-and-over, there was a high variability between the participants and no significant differences in KCF were observed between the groups. Knee joint loading and kinematics were found to be altered in patients with early knee OA only during gait. This is an indication that an excessive medial KCF and altered loading location, observed in these patients, is a contributor to early progression of knee OA.	[Meireles, Susana; Wesseling, Mariska; Jonkers, Ilse] Katholieke Univ Leuven, Dept Kinesiol, Leuven, Belgium; [Smith, Colin R.; Thelen, Darryl G.] Univ Wisconsin Madison, Dept Mech Engn, Madison, WI USA; [Verschueren, Sabine] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium	KU Leuven; University of Wisconsin System; University of Wisconsin Madison; KU Leuven	Meireles, S (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Leuven, Belgium.	susana.meireles@kuleuven.be	; Meireles, Susana/O-8107-2018; Verschueren, Sabine/K-4213-2015	Thelen, Darryl/0000-0002-7873-2477; Meireles, Susana/0000-0001-8047-7172; Wesseling, Mariska/0000-0002-3347-2130; Verschueren, Sabine/0000-0003-2592-494X; Smith, Colin/0000-0003-0884-5588	European Commission as part of the Erasmus Mundus program; KU Leuven research council [0T/13/083]	European Commission as part of the Erasmus Mundus program; KU Leuven research council(KU Leuven)	Integrated in Move-Age program funded by the European Commission as part of the Erasmus Mundus program. Research was supported by funding of the KU Leuven research council (0T/13/083).	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Andriacchi TP, 2006, CLIN ORTHOP RELAT R, P39, DOI 10.1097/01.blo.0000197079.26600.09; Andriacchi TP, 2009, J BONE JOINT SURG AM, V91A, P95, DOI 10.2106/JBJS.H.01408; ANDRIACCHI TP, 1994, ORTHOP CLIN N AM, V25, P395; Andriacchi TP, 1997, BASIC ORTHOPAEDIC BI, p37 ; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Asay JL, 2009, J ORTHOP RES, V27, P325, DOI 10.1002/jor.20751; Astephen JL, 2008, J ORTHOP RES, V26, P332, DOI 10.1002/jor.20496; Baert IAC, 2014, KNEE SURG SPORT TR A, V22, P2013, DOI 10.1007/s00167-013-2434-y; Baert IAC, 2013, CLIN RHEUMATOL, V32, P1365, DOI 10.1007/s10067-013-2285-4; Baert IAC, 2013, CLIN BIOMECH, V28, P40, DOI 10.1016/j.clinbiomech.2012.10.007; Baliunas AJ, 2002, OSTEOARTHR CARTILAGE, V10, P573, DOI 10.1053/joca.2002.0797; Baudet A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102098; Bei YH, 2004, MED ENG PHYS, V26, P777, DOI 10.1016/j.medengphy.2004.07.004; Benedetti MG, 2003, CLIN BIOMECH, V18, P871, DOI 10.1016/S0268-0033(03)00146-3; Buckwalter JA, 2006, ADV DRUG DELIVER REV, V58, P150, DOI 10.1016/j.addr.2006.01.006; Butler RJ, 2011, PHYS THER, V91, P1235, DOI 10.2522/ptj.20100324; Cohen J.E., 1988, STAT POWER ANAL BEHA; D'Lima DD, 2006, J ARTHROPLASTY, V21, P255, DOI 10.1016/j.arth.2005.07.011; D'Lima DD, 2005, CLIN ORTHOP RELAT R, P45, DOI 10.1097/01.blo.0000186559.62942.8c; de Groot IB, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-16; Duffell LD, 2014, GAIT POSTURE, V39, P1057, DOI 10.1016/j.gaitpost.2014.01.005; Dyrby CO, 2004, J ORTHOP RES, V22, P794, DOI 10.1016/j.orthres.2003.11.003; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fregly BJ, 2007, IEEE T BIO-MED ENG, V54, P1687, DOI 10.1109/TBME.2007.891934; Gok H, 2002, ACTA ORTHOP SCAND, V73, P647, DOI 10.1080/000164702321039606; Guo M, 2007, GAIT POSTURE, V26, P436, DOI 10.1016/j.gaitpost.2006.10.008; Harding GT, 2012, OSTEOARTHR CARTILAGE, V20, P1234, DOI 10.1016/j.joca.2012.08.004; Heinlein B, 2009, CLIN BIOMECH, V24, P315, DOI 10.1016/j.clinbiomech.2009.01.011; Hensor EMA, 2015, ARTHRIT CARE RES, V67, P40, DOI 10.1002/acr.22418; Hubley-Kozey C, 2008, CLIN BIOMECH, V23, P71, DOI 10.1016/j.clinbiomech.2007.08.019; Hurley Michael V., 1998, Current Opinion in Rheumatology, V10, P246, DOI 10.1097/00002281-199805000-00015; Hurwitz DE, 2002, J ORTHOPAED RES, V20, P101, DOI 10.1016/S0736-0266(01)00081-X; Hurwitz DE, 2000, J ORTHOPAED RES, V18, P572, DOI 10.1002/jor.1100180409; Igawa T, 2014, J PHYS THER SCI, V26, P629, DOI 10.1589/jpts.26.629; Kang SH, 2014, J NEUROSCI METH, V231, P9, DOI 10.1016/j.jneumeth.2013.12.001; Kaufman KR, 2001, J BIOMECH, V34, P907, DOI 10.1016/S0021-9290(01)00036-7; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kito N, 2010, CLIN BIOMECH, V25, P914, DOI 10.1016/j.clinbiomech.2010.06.008; Knoop J, 2012, ARTHRIT CARE RES, V64, P38, DOI 10.1002/acr.20597; Koo S, 2003, P 2003 ASME SUMM C M; Kumar D, 2013, OSTEOARTHR CARTILAGE, V21, P298, DOI 10.1016/j.joca.2012.11.008; Kutzner I, 2010, J BIOMECH, V43, P2164, DOI 10.1016/j.jbiomech.2010.03.046; Kutzner I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081036; Landry SC, 2007, J BIOMECH, V40, P1754, DOI 10.1016/j.jbiomech.2006.08.010; Lenhart RL, 2015, ANN BIOMED ENG, V43, P2675, DOI 10.1007/s10439-015-1326-3; Lewek MD, 2004, OSTEOARTHR CARTILAGE, V12, P745, DOI 10.1016/j.joca.2004.05.005; Li G, 1999, J BIOMECH, V32, P395, DOI 10.1016/S0021-9290(98)00181-X; Liikavaino T., 2010, THESIS, V13, P98; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; Mahmoudian A, 2017, GAIT POSTURE, V57, P46, DOI 10.1016/j.gaitpost.2017.05.024; Mahmoudian A, 2016, CLIN BIOMECH, V39, P109, DOI 10.1016/j.clinbiomech.2016.10.006; Mahmoudian A, 2016, GAIT POSTURE, V44, P184, DOI 10.1016/j.gaitpost.2015.12.010; Marin F, 2003, HUM MOVEMENT SCI, V22, P285, DOI 10.1016/S0167-9457(03)00036-8; Marouane H, 2015, J BIOMECH, V48, P1899, DOI 10.1016/j.jbiomech.2015.04.017; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Meireles S, 2017, GAIT POSTURE, V53, P104, DOI 10.1016/j.gaitpost.2017.01.013; Meireles S, 2016, GAIT POSTURE, V45, P115, DOI 10.1016/j.gaitpost.2016.01.016; Meyer AJ, 2013, J ORTHOP RES, V31, P921, DOI 10.1002/jor.22304; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Mundermann A, 2008, J ORTHOP RES, V26, P1167, DOI 10.1002/jor.20655; Mundermann A, 2008, J BIOMECH, V41, P165, DOI 10.1016/j.jbiomech.2007.07.001; Nuki G, 2007, OSTEOARTHRITIS COMPA, P33; O'Reilly SC, 1998, ANN RHEUM DIS, V57, P588, DOI 10.1136/ard.57.10.588; RADIN EL, 1986, CLIN ORTHOP RELAT R, P34; Reid S, 2010, THESIS, P2685; Richards C, 2010, J BIOMECH, V43, P2595, DOI 10.1016/j.jbiomech.2010.05.006; Robinson MA, 2012, J BIOMECH, V45, P1941, DOI 10.1016/j.jbiomech.2012.05.017; Roos EM, 2011, NAT REV RHEUMATOL, V7, P57, DOI 10.1038/nrrheum.2010.195; Schmitt LC, 2008, J ORTHOP RES, V26, P1180, DOI 10.1002/jor.20619; Shakoor N, 2006, ARTHRITIS RHEUM, V54, P2923, DOI 10.1002/art.22123; Sharma L, 1998, ARTHRITIS RHEUM, V41, P1233, DOI 10.1002/1529-0131(199807)41:7<1233::AID-ART14>3.0.CO;2-L; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Slemenda C, 1997, ANN INTERN MED, V127, P97, DOI 10.7326/0003-4819-127-2-199707150-00001; Smith CR, 2015 ANN M ORTH RES; Smith CR, 2016, COMPUT METHODS BIOME; Van Campen A, 2011, J BIOMECH, V44, P2595, DOI 10.1016/j.jbiomech.2011.08.022; Walter JP, 2010, J ORTHOP RES, V28, P1348, DOI 10.1002/jor.21142; Westphal CJ, 2013, J BIOMECH, V46, P2045, DOI 10.1016/j.jbiomech.2013.05.027; Wilson JLA, 2013, OSTEOARTHR CARTILAGE, V21, pS49; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; Yoshida Y, 2008, CLIN BIOMECH, V23, P320, DOI 10.1016/j.clinbiomech.2007.10.008; Zhao D, 2007, J ORTHOP RES, V25, P593, DOI 10.1002/jor.20362	84	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187583	10.1371/journal.pone.0187583	http://dx.doi.org/10.1371/journal.pone.0187583			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117248	Green Submitted, Green Published, gold			2022-12-26	WOS:000414659600049
J	Mele, F; Fornara, C; Jarrossay, D; Furione, M; Arossa, A; Spinillo, A; Lanzavecchia, A; Gerna, G; Sallusto, F; Lilleri, D				Mele, Federico; Fornara, Chiara; Jarrossay, David; Furione, Milena; Arossa, Alessia; Spinillo, Arsenio; Lanzavecchia, Antonio; Gerna, Giuseppe; Sallusto, Federica; Lilleri, Daniele			Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7R(pos) long-term memory phenotype is associated with protection from vertical transmission	PLOS ONE			English	Article							CONGENITAL CYTOMEGALOVIRUS; SELECTIVE EXPRESSION; TRANSMITTER MOTHERS; IL-7 RECEPTOR; CD8(+); CD4(+); FETUS; WOMEN; ANTIBODIES; DIAGNOSIS	Congenital human cytomegalovirus (HCMV) infection is the major cause of birth defects and a precise definition of the HCMV-specific T-cell response in primary infection may help define reliable correlates of immune protection during pregnancy. In this study, a high throughput method was used to define the frequency of CD4(+) and CD8(+) T cells specific for four HCMV proteins in the naive compartment of seronegative subjects and the effector/memory compartments of subjects with primary/remote HCMV infection. The naive repertoire displayed comparable frequencies of T cells that were reactive with HCMV structural (pp65, gB and the pentamer gHgLpUL128L) and non-structural (IE-1) proteins. Whereas, following natural infection, the majority of effector/memory CD4(+) and CD8(+) T cells recognized either gB or IE-1, respectively, and pp65. The pattern of T cell reactivity was comparable at early and late stages of infection and in pregnant women with primary HCMV infection transmitting or not transmitting the virus to the fetus. At an early stage of primary infection, about 50% of HCMV-reactive CD4(+) T cells were long-term IL-7R pos memory cells, while 6-12 months later, the frequency of these cells increased to 70%, approaching 100% in remote infections. In contrast, only 10-20% of HCMV-specific CD8(+) T cells were long-term memory cells up to 12 months after infection onset, thereafter increasing to 70% in remote infections. Interestingly, a significantly higher frequency of HCMV-specific CD4(+) T cells with a long-term IL-7R pos memory phenotype was observed in non-transmitting compared to transmitting women. These findings indicate that immunodominance in HCMV infection is not predetermined in the naive compartment, but is the result of virus-host interactions and suggest that prompt control of HCMV infection in pregnancy is associated with the rapid development of long-term IL-7R pos memory HCMV-specific CD4(+) T cells and a low risk of virus transmission to the fetus.	[Mele, Federico; Sallusto, Federica] Univ Svizzera Italiana, Inst Res Biomed, Ctr Med Immunol, Bellinzona, Switzerland; [Fornara, Chiara; Gerna, Giuseppe; Lilleri, Daniele] Fdn IRCCS Policlin San Matteo, Lab Sperimentali Ric Area Trapiantol & Area Biote, Pavia, Italy; [Jarrossay, David; Lanzavecchia, Antonio] Univ Svizzera Italiana, Immune Regulat Lab, Inst Res Biomed, Bellinzona, Switzerland; [Furione, Milena] Fdn IRCCS Policlin San Matteo, Struttura Complessa Microbiol & Virol, Struttura Semplice Virol Mol, Pavia, Italy; [Arossa, Alessia; Spinillo, Arsenio] Univ Pavia, Fdn IRCCS Policlin San Matteo, Clin Ostetr & Ginecol, Pavia, Italy; [Sallusto, Federica] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland	Universita della Svizzera Italiana; IRCCS Fondazione San Matteo; Universita della Svizzera Italiana; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sallusto, F (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Ctr Med Immunol, Bellinzona, Switzerland.; Lilleri, D (corresponding author), Fdn IRCCS Policlin San Matteo, Lab Sperimentali Ric Area Trapiantol & Area Biote, Pavia, Italy.; Sallusto, F (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland.	federica.sallusto@irb.usi.ch; d.lilleri@smatteo.pv.it	Fornara, Chiara/Z-3464-2019; Spinillo, Arsenio/AAB-9315-2022; Furione, Milena/AAC-1945-2022	Fornara, Chiara/0000-0002-8589-2647; Spinillo, Arsenio/0000-0002-7755-1084; Gerna, Giuseppe/0000-0001-5956-2786; Lilleri, Daniele/0000-0001-7747-7622	Ministero della Salute [GR-2010-2311329, 8053615]; Fondazione Cariplo [2012-0626]; European Research Council [323183 PREDICT]; Helmut Horten Foundation	Ministero della Salute(Ministry of Health, Italy); Fondazione Cariplo(Fondazione Cariplo); European Research Council(European Research Council (ERC)European Commission); Helmut Horten Foundation	This work was supported by the Ministero della Salute, Ricerca Finalizzata (Grant GR-2010-2311329) to DL, and Ricerca Corrente (Grant 8053615) to AS, Fondazione Cariplo (Grant 2012-0626) to DL, and the European Research Council (Grant 323183 PREDICT) to FS. The Institute for Research in Biomedicine and the Center of Medical Immunology are supported by the Helmut Horten Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves NL, 2008, J IMMUNOL, V180, P5201, DOI 10.4049/jimmunol.180.8.5201; Bialas KM, 2015, P NATL ACAD SCI USA, V112, P13645, DOI 10.1073/pnas.1511526112; Buentke E, 2006, BLOOD, V108, P1949, DOI 10.1182/blood-2006-04-016857; Buscher N, 2015, MED MICROBIOL IMMUN, V204, P285, DOI 10.1007/s00430-015-0397-y; Cannon MJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-70; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Fornara C, 2016, J MED VIROL, V88, P1238, DOI 10.1002/jmv.24449; Fornara C, 2011, J CLIN IMMUNOL, V31, P1054, DOI 10.1007/s10875-011-9577-8; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Gerna G, 2005, J GEN VIROL, V86, P275, DOI 10.1099/vir.0.80474-0; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kabanova A, 2014, P NATL ACAD SCI USA, V111, P17965, DOI 10.1073/pnas.1415310111; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Lilleri D, 2016, J CLIN VIROL, V81, P16, DOI 10.1016/j.jcv.2016.05.007; Lilleri D, 2008, J INFECT DIS, V198, P536, DOI 10.1086/590118; Lilleri D, 2007, J INFECT DIS, V195, P1062, DOI 10.1086/512245; Lilleri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059863; Lozza L, 2008, EUR J IMMUNOL, V38, P30, DOI 10.1002/eji.200737852; Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09; Revello MG, 2014, J CLIN VIROL, V61, P590, DOI 10.1016/j.jcv.2014.10.002; Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214; Revello MG, 1998, J INFECT DIS, V177, P1170, DOI 10.1086/515277; Revello MG, 2006, J INFECT DIS, V193, P269, DOI 10.1086/498872; Revello MG, 2004, J CLIN VIROL, V29, P71, DOI 10.1016/j.jcv.2003.09.012; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; van Leeuwen EMM, 2005, BLOOD, V106, P2091, DOI 10.1182/blood-2005-02-0449; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wussow F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004524; Zavattoni M, 2016, J CLIN VIROL, V82, P89, DOI 10.1016/j.jcv.2016.07.005	34	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187731	10.1371/journal.pone.0187731	http://dx.doi.org/10.1371/journal.pone.0187731			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112951	Green Submitted, Green Published, gold			2022-12-26	WOS:000414572100035
J	Stevens, RRF; Grytsan, A; Biasetti, J; Roy, J; Liljeqvist, ML; Gasser, TC				Stevens, Raoul R. F.; Grytsan, Andrii; Biasetti, Jacopo; Roy, Joy; Liljeqvist, Moritz Lindquist; Gasser, T. Christian			Biomechanical changes during abdominal aortic aneurysm growth	PLOS ONE			English	Article							RUPTURE POTENTIAL INDEX; MECHANICAL WALL STRESS; INTRALUMINAL THROMBUS; RISK-ASSESSMENT; DIAMETER; FLOW; ASSOCIATION; IMPACT	The biomechanics-based Abdominal Aortic Aneurysm (AAA) rupture risk assessment has gained considerable scientific and clinical momentum. However, such studies have mainly focused on information at a single time point, and little is known about how AAA properties change over time. Consequently, the present study explored how geometry, wall stress-related and blood flow-related biomechanical properties change during AAA expansion. Four patients with a total of 23 Computed Tomography-Angiography (CT-A) scans at different time points were analyzed. At each time point, patient-specific properties were extracted from (i) the reconstructed geometry, (ii) the computed wall stress at Mean Arterial Pressure (MAP), and (iii) the computed blood flow velocity at standardized inflow and outflow conditions. Testing correlations between these parameters identified several nonintuitive dependencies. Most interestingly, the Peak Wall Rupture Index (PWRI) and the maximum Wall Shear Stress (WSS) independently predicted AAA volume growth. Similarly, Intra-luminal Thrombus (ILT) volume growth depended on both the maximum WSS and the ILT volume itself. In addition, ILT volume, ILT volume growth, and maximum ILT layer thickness correlated with PWRI as well as AAA volume growth. Consequently, a large ILT volume as well as fast increase of ILT volume over time may be a risk factor for AAA rupture. However, tailored clinical studies would be required to test this hypothesis and to clarify whether monitoring ILT development has any clinical benefit.	[Stevens, Raoul R. F.] Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands; [Stevens, Raoul R. F.] Maastricht Univ, Dept Biomed Engn, Maastricht, Netherlands; [Stevens, Raoul R. F.; Grytsan, Andrii; Gasser, T. Christian] KTH Royal Inst Technol, Sch Engn Sci, KTH Solid Mech, Stockholm, Sweden; [Biasetti, Jacopo] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Roy, Joy; Liljeqvist, Moritz Lindquist] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Eindhoven University of Technology; Maastricht University; Royal Institute of Technology; Johns Hopkins University; Karolinska Institutet	Gasser, TC (corresponding author), KTH Royal Inst Technol, Sch Engn Sci, KTH Solid Mech, Stockholm, Sweden.	gasser@kth.se		Stevens, Raoul/0000-0003-1860-2846				Adolph R, 1997, J VASC SURG, V25, P916, DOI 10.1016/S0741-5214(97)70223-4; Auer M, 2010, IEEE T MED IMAGING, V29, P1022, DOI 10.1109/TMI.2009.2039579; Back M, 2013, CARDIOVASC RES, V99, P232, DOI 10.1093/cvr/cvt040; Biasetti J, 2011, J R SOC INTERFACE, V8, P1449, DOI 10.1098/rsif.2011.0041; Biasetti J, 2010, ANN BIOMED ENG, V38, P380, DOI 10.1007/s10439-009-9843-6; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Choke E, 2005, EUR J VASC ENDOVASC, V30, P227, DOI 10.1016/j.ejvs.2005.03.009; Choksy SA, 1999, ANN ROY COLL SURG, V81, P27; DARLING RC, 1977, CIRCULATION, V56, P161; Dua MM, 2010, VASC PHARMACOL, V53, P11, DOI 10.1016/j.vph.2010.03.004; Fillinger MF, 2003, J VASC SURG, V37, P724, DOI 10.1067/mva.2003.213; Fillinger MF, 2002, J VASC SURG, V36, P589, DOI 10.1067/mva.2002.125478; Gasser TC, 2014, EUR J VASC ENDOVASC, V47, P288, DOI 10.1016/j.ejvs.2013.12.018; Gasser TC, 2010, EUR J VASC ENDOVASC, V40, P176, DOI 10.1016/j.ejvs.2010.04.003; Gasser TC, 2008, J VASC SURG, V48, P179, DOI 10.1016/j.jvs.2008.01.036; Gasser T Christian, 2016, Aorta (Stamford), V4, P42; Geest JPV, 2008, ANN BIOMED ENG, V36, P921, DOI 10.1007/s10439-008-9490-3; Geest JPV, 2006, ANN NY ACAD SCI, V1085, P11, DOI 10.1196/annals.1383.046; Hyhlik-Durr A, 2011, J ENDOVASC THER, V18, P289, DOI 10.1583/10-3384MR.1; Kazi M, 2003, J VASC SURG, V38, P1283, DOI 10.1016/S0741-5214(03)00791-2; Kibaek Leea, 2012, ANN BIOMED ENG, V100, P130; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Leuprecht A, 2001, Comput Methods Biomech Biomed Engin, V4, P149; Li ZY, 2008, J VASC SURG, V47, P928, DOI 10.1016/j.jvs.2008.01.006; Maier A, 2010, ANN BIOMED ENG, V38, P3124, DOI 10.1007/s10439-010-0067-6; Martufi G, 2014, EUR J VASC ENDOVASC, V48, P349; McGloughlin TM, 2010, ARTERIOSCL THROM VAS, V30, P1687, DOI 10.1161/ATVBAHA.110.204529; MILLS CJ, 1970, CARDIOVASC RES, V4, P405, DOI 10.1093/cvr/4.4.405; Mower WR, 1997, P 1 JT BMES EMBS C, V27, P244; Nicholls SC, 1998, J VASC SURG, V28, P884, DOI 10.1016/S0741-5214(98)70065-5; Odero A, 2010, NEW ENGL J MED, V363, P1480, DOI 10.1056/NEJMc1007807; Powell JT, 1998, LANCET, V352, P1649; Prakash S, 2001, J BIOMECH ENG-T ASME, V123, P134, DOI 10.1115/1.1351807; Raghavan ML, 2000, J BIOMECH, V33, P475, DOI 10.1016/S0021-9290(99)00201-8; Riveros F, 2015, ANN BIOMED ENG, V43, P2253, DOI 10.1007/s10439-015-1267-x; Satriano A, 2015, J BIOMECH, V48, P354, DOI 10.1016/j.jbiomech.2014.11.016; SIMO JC, 1991, COMPUT METHOD APPL M, V85, P273, DOI 10.1016/0045-7825(91)90100-K; Stenbaek J, 2000, EUR J VASC ENDOVASC, V20, P466, DOI 10.1053/ejvs.2000.1217; Swedenborg J, 2006, ANN NY ACAD SCI, V1085, P133, DOI 10.1196/annals.1383.044; Teutelink A, 2012, J VASC SURG, V55, P326, DOI 10.1016/j.jvs.2011.08.012; Thubrikar MJ, 2003, J CARDIOVASC SURG, V44, P67; Truijers M, 2007, EUR J VASC ENDOVASC, V33, P401, DOI 10.1016/j.ejvs.2006.10.009; Venkatasubramaniam AK, 2004, EUR J VASC ENDOVASC, V28, P168, DOI 10.1016/j.ejvs.2004.03.029; Vorp DA, 1998, J VASC SURG, V27, P632, DOI 10.1016/S0741-5214(98)70227-7; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Wanhainen A, 2016, ARTERIOSCL THROM VAS, V36, P236, DOI 10.1161/ATVBAHA.115.306538; Zambrano BA, 2016, ANN BIOMED ENG, V44, P1502, DOI 10.1007/s10439-015-1461-x	47	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187421	10.1371/journal.pone.0187421	http://dx.doi.org/10.1371/journal.pone.0187421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112945	Green Submitted, Green Published, gold			2022-12-26	WOS:000414572100017
J	Kingsley, CN; Antanasijevic, A; Palka-Hamblin, H; Durst, M; Ramirez, B; Lavie, A; Caffrey, M				Kingsley, Carolyn N.; Antanasijevic, Aleksandar; Palka-Hamblin, Helena; Durst, Matthew; Ramirez, Benjamin; Lavie, Arnon; Caffrey, Michael			Probing the metastable state of influenza hemagglutinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein structure; influenza virus; nuclear magnetic resonance (NMR); peptide conformation; virus; hemagglutinin	MEMBRANE-FUSION; ENTRY; PEPTIDES; TRIFLUOROETHANOL; MECHANISMS; INFECTION; SYSTEM	Viral entry into host cells is mediated by membrane proteins in a metastable state that transition to a more stable state upon a stimulus. For example, in the influenza envelope protein hemagglutinin (HA), the low pH in the endosome triggers a transition from the metastable prefusion conformation to the stable fusion conformation. To identify probes that interfere with HA function, here we screened a library of H7 HA peptides for inhibition of H7 HA-mediated entry. We discovered a peptide, PEP87 (WSYNAELLVAMENQHTI), that inhibited H7 and H5 HA-mediated entry. PEP87 corresponds to a highly conserved helical region of the HA2 subunit of HA that self-interacts in the neutral pH conformation. Mutagenesis experiments indicated that PEP87 binds to its native region in the HA trimer. We also found that PEP87 is unstructured in isolation but tends to form a helix as evidenced by CD and NMR studies. Fluorescence, chemical cross-linking, and saturation transfer difference NMR data suggested that PEP87 binds to the neutral pH conformation of HA and disrupts the HA structure without affecting its oligomerization state. Together, this work provides support for a model in which PEP87 disrupts HA function by displacing native interactions of the neutral pH conformation. Moreover, our observations indicate that the HA prefusion structure (and perhaps the metastable states of other viral entry proteins) is more dynamic with transient motions being larger than generally appreciated. These findings also suggest that the ensemble of prefusion structures presents many potential sites for targeting in therapeutic interventions.	[Kingsley, Carolyn N.; Antanasijevic, Aleksandar; Palka-Hamblin, Helena; Durst, Matthew; Ramirez, Benjamin; Lavie, Arnon; Caffrey, Michael] Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Caffrey, M (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.	caffrey@uic.edu		Lavie, Arnon/0000-0001-5591-8722; Durst, Matthew/0000-0001-9513-2361; Kingsley, Carolyn/0000-0001-8564-7345	Chicago Biomedical Consortium; Chicago Community Trust	Chicago Biomedical Consortium; Chicago Community Trust	This work was supported by the Chicago Biomedical Consortium with support from Searle Funds at the Chicago Community Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Antanasijevic A, 2016, J BIOMOL NMR, V64, P255, DOI 10.1007/s10858-016-0025-1; Antanasijevic A, 2014, J BIOMOL NMR, V60, P37, DOI 10.1007/s10858-014-9848-9; Antanasijevic A, 2014, J BIOL CHEM, V289, P22237, DOI 10.1074/jbc.M114.572974; Antanasijevic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076363; Basu A, 2014, J VIROL, V88, P1447, DOI 10.1128/JVI.01225-13; Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bosch BJ, 2004, P NATL ACAD SCI USA, V101, P8455, DOI 10.1073/pnas.0400576101; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Celigoy J, 2011, J BIOL CHEM, V286, P23975, DOI 10.1074/jbc.M111.251025; Chen Q, 2016, ACS INFECT DIS, V2, P187, DOI 10.1021/acsinfecdis.5b00139; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guilhaudis L, 2002, EUR J BIOCHEM, V269, P4860, DOI 10.1046/j.1432-1033.2002.03187.x; Guo Y, 2009, J MOL BIOL, V394, P600, DOI 10.1016/j.jmb.2009.10.032; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Jiang SB, 2002, CURR PHARM DESIGN, V8, P563; Klein M, 2017, EXPERT OPIN DRUG DIS, V12, P1117, DOI 10.1080/17460441.2017.1372745; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; McCullough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033958; McReynolds S, 2008, BIOCHEMISTRY-US, V47, P6802, DOI 10.1021/bi800622t; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Warschawski DE, 2011, BBA-BIOMEMBRANES, V1808, P1957, DOI 10.1016/j.bbamem.2011.03.016; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q	33	3	3	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21590	21597		10.1074/jbc.M117.815043	http://dx.doi.org/10.1074/jbc.M117.815043			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29127198	Green Published, hybrid			2022-12-26	WOS:000419013000033
J	Vidal, T; Lusley, P; Leconte, M; de Vallavieille-Pope, C; Huber, L; Saint-Jean, S				Vidal, Tiphaine; Lusley, Pauline; Leconte, Marc; de Vallavieille-Pope, Claude; Huber, Laurent; Saint-Jean, Sebastien			Cultivar architecture modulates spore dispersal by rain splash: A new perspective to reduce disease progression in cultivar mixtures	PLOS ONE			English	Article							SEPTORIA-TRITICI BLOTCH; MYCOSPHAERELLA-GRAMINICOLA; CANOPY ARCHITECTURE; ZYMOSEPTORIA-TRITICI; FOOD SECURITY; PLANT-DISEASE; WINTER-WHEAT; RESISTANCE; PATHOGENS; SPREAD	Cultivar mixtures can be used to improve the sustainability of disease management within farming systems by growing cultivars that differ in their disease resistance level in the same field. The impact of canopy aerial architecture on rain-splash dispersal could amplify disease reduction within mixtures. We designed a controlled conditions experiment to study single splash-dispersal events and their consequences for disease. We quantified this impact through the spore interception capacities of the component cultivars of a mixture. Two wheat cultivars, differing in their aerial architecture ( mainly leaf area density) and resistance to Septoria tritici blotch, were used to constitute pure stands and mixtures with 75% of resistant plants that accounted for 80% of the canopy leaf area. Canopies composed of 3 rows of plants were exposed to standardized spore fluxes produced by splashing calibrated rain drops on a linear source of inoculum. Disease propagation was measured through spore fluxes and several disease indicators. Leaf susceptibility was higher for upper than for lower leaves. Dense canopies intercepted more spores and mainly limited horizontal spore transfer to the first two rows. The presence of the resistant and dense cultivar made the mixed canopy denser than the susceptible pure stand. No disease symptoms were observed on susceptible plants of the second and third rows in the cultivar mixture, suggesting that the number of spores intercepted by these plants was too low to cause disease symptoms. Both lesion area and disease conditional severity were significantly reduced on susceptible plants within mixtures on the first row beside the inoculum source. Those reductions on one single-splash dispersal event, should be amplified after several cycle over the full epidemic season. Control of splash-dispersed diseases within mixtures could therefore be improved by a careful choice of cultivars taking into consideration both resistance and architecture.	[Vidal, Tiphaine; Lusley, Pauline; Huber, Laurent; Saint-Jean, Sebastien] Univ Paris Saclay, UMR ECOSYS INRA, AgroParisTech, F-78850 Thiverval Grignon, France; [Vidal, Tiphaine; Leconte, Marc; de Vallavieille-Pope, Claude] Univ Paris Saclay, UMR BIOGER INRA, AgroParisTech, F-78850 Thiverval Grignon, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Saint-Jean, S (corresponding author), Univ Paris Saclay, UMR ECOSYS INRA, AgroParisTech, F-78850 Thiverval Grignon, France.	Sebastien.Saint-Jean@AgroParisTech.fr	Saint-Jean, Sébastien/D-9069-2012	Saint-Jean, Sébastien/0000-0002-0401-0711	ABIES doctoral school for Tiphaine Vidal; National Agency of Research [ANR-13-AGRO-0008]	ABIES doctoral school for Tiphaine Vidal; National Agency of Research(French National Research Agency (ANR))	We thank the ABIES doctoral school for Tiphaine Vidal's PhD grant and the Wheatamix project financed by the National Agency of Research (ANR-13-AGRO-0008, www6.inra.fr/wheatamix/) for financial support.; We thank the ABIES doctoral school for Tiphaine Vidal's PhD grant and the Wheatamix project financed by the National Agency of Research (ANR-13-AGRO-0008, www6.inra.fr/wheatamix/) for financial support. We are grateful to Michel Burban, Pascal Duprix, Alain Fortineau, Laurent Gerard, Samuel Joseph and Francois Lecourt for technical assistance, to Frederic Suffert and Thierry Marcel for helpful discussions and advice, and to Bruno Andrieu, Christophe Gigot, Corinne Robert and the anonymous reviewers for their comments on the manuscript. We have special thoughts for Witho Anatinae. We also thank Jane Curtis for English corrections.	Brown JKM, 2015, FUNGAL GENET BIOL, V79, P33, DOI 10.1016/j.fgb.2015.04.017; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; Calonnec A, 2013, EUR J PLANT PATHOL, V135, P479, DOI 10.1007/s10658-012-0111-5; Cevallos-Cevallos JM, 2012, J FOOD PROTECT, V75, P472, DOI 10.4315/0362-028X.JFP-11-399; Cowger C, 2002, PHYTOPATHOLOGY, V92, P617, DOI 10.1094/PHYTO.2002.92.6.617; de Vallavieille-Pope C, 2004, CR BIOL, V327, P611, DOI 10.1016/j.crvi.2003.11.014; de Vallavieille-Pope C, 2012, PLANT DIS, V96, P131, DOI 10.1094/PDIS-02-11-0078; Develey-Riviere MP, 2007, NEW PHYTOL, V175, P405, DOI 10.1111/j.1469-8137.2007.02130.x; Essah SYC, 2002, CAN J PLANT SCI, V82, P1; Fang Y, 2014, FIELD CROP RES, V156, P12, DOI 10.1016/j.fcr.2013.10.013; Finckh Maria R., 2006, P269, DOI 10.1007/1-4020-4581-6_10; Fones H, 2015, FUNGAL GENET BIOL, V79, P3, DOI 10.1016/j.fgb.2015.04.004; Fortineau A, 2012, DISPOSITIF COUPLE BA; Fournier C, 2003, ADEL WHEAT 3D ARCHIT, P54; Garin G, 2014, ANN BOT; Garrett KA, 1999, PHYTOPATHOLOGY, V89, P984, DOI 10.1094/PHYTO.1999.89.11.984; Geagea L, 2000, AGR FOREST METEOROL, V101, P53, DOI 10.1016/S0168-1923(99)00155-0; Gigot C, 2013, PLANT PATHOL, V62, P1011, DOI 10.1111/ppa.12012; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Godin C, 2000, ANN FOREST SCI, V57, P413; Hiddink GA, 2010, SUSTAIN AGR REV, V4, P119, DOI 10.1007/978-90-481-8741-6_5; Jackson LF, 1997, FIELD CROP RES, V52, P261, DOI 10.1016/S0378-4290(97)00007-5; Leroux P, 2011, PEST MANAG SCI, V67, P44, DOI 10.1002/ps.2028; Lovell DJ, 1997, PLANT PATHOL, V46, P126, DOI 10.1046/j.1365-3059.1997.d01-206.x; Madden LV, 1997, CAN J PLANT PATHOL, V19, P225, DOI 10.1080/07060669709500557; Madden LV, 1997, PHYTOPATHOLOGY, V87, P828, DOI 10.1094/PHYTO.1997.87.8.828; McCartney H. A., 2006, P159; Newton AC, 2011, FIELD CROP RES, V123, P74, DOI 10.1016/j.fcr.2011.05.002; Orton ES, 2011, MOL PLANT PATHOL, V12, P413, DOI 10.1111/j.1364-3703.2010.00688.x; Pielaat A, 2002, ECOL MODEL, V151, P195, DOI 10.1016/S0304-3800(01)00484-7; Pradal C, 2008, FUNCT PLANT BIOL, V35, P751, DOI 10.1071/FP08084; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; Saint-Jean S, 2006, AGR FOREST METEOROL, V141, P257, DOI 10.1016/j.agrformet.2006.10.009; Saint-Jean S, 2004, AGR FOREST METEOROL, V121, P183, DOI 10.1016/j.agrformet.2003.08.034; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoeny A, 2008, PLANT PATHOL, V57, P1073, DOI 10.1111/j.1365-3059.2008.01888.x; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Suffert F, 2013, PLANT PATHOL, V62, P1330, DOI 10.1111/ppa.12050; Team RDC, 2010, R LANG ENV STAT COMP; Tivoli B, 2013, EUR J PLANT PATHOL, V135, P471, DOI 10.1007/s10658-012-0066-6; Torriani SFF, 2015, FUNGAL GENET BIOL, V79, P8, DOI 10.1016/j.fgb.2015.04.010; ULBRICH CW, 1983, J CLIM APPL METEOROL, V22, P1764, DOI 10.1175/1520-0450(1983)022<1764:NVITAF>2.0.CO;2; Vidal T, 2017, AGR FOREST METEOROL, V246, P154, DOI 10.1016/j.agrformet.2017.06.014; WALKLATE PJ, 1989, PLANT PATHOL, V38, P56, DOI 10.1111/j.1365-3059.1989.tb01427.x; YANG XS, 1993, AGR FOREST METEOROL, V65, P1, DOI 10.1016/0168-1923(93)90035-G; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhu YY, 2005, PHYTOPATHOLOGY, V95, P433, DOI 10.1094/PHYTO-95-0433	47	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187788	10.1371/journal.pone.0187788	http://dx.doi.org/10.1371/journal.pone.0187788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140990	gold, Green Published, Green Submitted			2022-12-26	WOS:000415260400030
J	Zhang, X; Xu, GH; Xie, J; Zhang, X				Zhang, Xin; Xu, Guanghua; Xie, Jun; Zhang, Xun			Brain response to luminance-based and motion-based stimulation using inter-modulation frequencies	PLOS ONE			English	Article							SSVEP-BCI; CORTEX	Steady state visual evoked potential (SSVEP)-based brain computer interface (BCI) has advantages of high information transfer rate (ITR), less electrodes and little training. So it has been widely investigated. However, the available stimulus frequencies are limited by brain responses. Simultaneous modulation of stimulus luminance is a novel method to resolve this problem. In this study, three experiments were devised to gain a deeper understanding of the brain response to the stimulation using inter-modulation frequencies. First, luminance-based stimulation using one to five inter-modulation frequencies was analyzed for the first time. The characteristics of the brain responses to the proposed stimulation were reported. Second, the motion-based stimulation with equal luminance using inter-modulation frequencies was also proposed for the first time. The response of the brain under these conditions were similar to that of luminance-based stimulation which can induce combination frequencies. And an elementary analysis was conducted to explain the reason of the occurrence of combination frequencies. Finally, the online test demonstrated the efficacy of our proposed two stimulation methods for BCI. The average ITRs reached 34.7836 bits/min and 39.2856 bits/min for luminance-based and motion-based stimulation respectively. This study demonstrated that the simultaneous modulation of stimulus luminance could extend to at least five frequencies to induce SSVEP and the brain response to the stimulus still maintained a certain positive correlation with luminance. And not only luminance-based stimulation, but also motion-based stimulation with equal luminance can elicit inter-modulation frequencies to effectively increase the number of targets for multi-class SSVEP.	[Zhang, Xin; Xu, Guanghua; Xie, Jun; Zhang, Xun] Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Shaanxi, Peoples R China; [Xu, Guanghua] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Xu, GH (corresponding author), Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Shaanxi, Peoples R China.; Xu, GH (corresponding author), Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China.	ghxu@mail.xjtu.edu.cn		Zhang, Xin/0000-0002-0827-6605	Integration Project of Major Research plan of the Natural Science Foundation of China [91420301]; science and technology plan project of Guangdong province [2015B020214001]; National Natural Science Foundation of China [51475360]	Integration Project of Major Research plan of the Natural Science Foundation of China; science and technology plan project of Guangdong province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Integration Project of Major Research plan of the Natural Science Foundation of China (91420301), the National Natural Science Foundation of China (no. 51475360) and the science and technology plan project of Guangdong province under grant no. 2015B020214001. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ales JM, 2009, J VISION, V9, DOI 10.1167/9.7.8; Belmonte M, 1998, COGNITIVE BRAIN RES, V6, P295, DOI 10.1016/S0926-6410(98)00007-X; Bromm B., 1989, PAIN, V39, P371; Chang MH, 2016, J NEUROSCI METH, V258, P104, DOI 10.1016/j.jneumeth.2015.11.001; Chang MH, 2014, CLIN NEUROPHYSIOL, V125, P1380, DOI 10.1016/j.clinph.2013.11.016; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE6058, DOI 10.1073/pnas.1508080112; Chen XG, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066009; Chien YY, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa550d; Delon-Martin C, 2006, NEUROIMAGE, V31, P1567, DOI 10.1016/j.neuroimage.2006.02.013; Giani AS, 2012, NEUROIMAGE, V60, P1478, DOI 10.1016/j.neuroimage.2012.01.114; Hakvoort G, 2011, COMP PSDA CCA DETECT; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Lee PL, 2010, ANN BIOMED ENG, V38, P2383, DOI 10.1007/s10439-010-9964-y; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; Mukesh TMS, 2006, PHYSIOL MEAS, V27, P61, DOI 10.1088/0967-3334/27/1/006; Muller SM, 2011, INT C IEEE ENG MED B; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; Ortner R, 2011, IEEE T NEUR SYS REH, V19, P1, DOI 10.1109/TNSRE.2010.2076364; Shyu KK, 2010, NEUROSCI LETT, V483, P28, DOI 10.1016/j.neulet.2010.07.043; Teng F, 2010, SE REG C 2010 OXF MS; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Volosyak I, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036020; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576; Wang YT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025018; Wu ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22801; Xiaogang C, 2017, J NEURAL ENG, V14; Xie J, 2011, PLOS ONE, V7; Yan Z, 2009, C INT C IEEE ENG MED; ZEMON V, 1984, BIOL CYBERN, V50, P401, DOI 10.1007/BF00335197; Zhang F, 2015, SHOCK VIB, V2015, P1, DOI DOI 10.2118/174384-MS	31	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188073	10.1371/journal.pone.0188073	http://dx.doi.org/10.1371/journal.pone.0188073			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141030	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400054
J	Filippopulos, FM; Albers, L; Straube, A; Gerstl, L; Blum, B; Langhagen, T; Jahn, K; Heinen, F; von Kries, R; Landgraf, MN				Filippopulos, Filipp M.; Albers, Lucia; Straube, Andreas; Gerstl, Lucia; Blum, Bernhard; Langhagen, Thyra; Jahn, Klaus; Heinen, Florian; von Kries, Rudiger; Landgraf, Mirjam N.			Vertigo and dizziness in adolescents: Risk factors and their population attributable risk	PLOS ONE			English	Article							TENSION-TYPE HEADACHE; GENDER-DIFFERENCES; ORTHOSTATIC HYPOTENSION; SUBJECTIVE HEALTH; PHYSICAL-ACTIVITY; GRAMMAR SCHOOLS; WHIPLASH INJURY; MENSTRUAL-CYCLE; UNITED-STATES; MIGRAINE	Objectives To assess potential risk factors for vertigo and dizziness in adolescents and to evaluate their variability by different vertigo types. The role of possible risk factors for vertigo and dizziness in adolescents and their population relevance needs to be addressed in order to design preventive strategies. Study design The study population consisted of 1482 school-children between the age of 12 and 19 years, who were instructed to fill out a questionnaire on different vertigo types and related potential risk factors. The questionnaire specifically asked for any vertigo, spinning vertigo, swaying vertigo, orthostatic dizziness, and unspecified dizziness. Further a wide range of potential risk factors were addressed including gender, stress, muscular pain in the neck and shoulder region, sleep duration, migraine, coffee and alcohol consumption, physical activity and smoking. Results Gender, stress, muscular pain in the neck and shoulder region, sleep duration and migraine were identified as independent risk factors following mutual adjustment: The relative risk was 1.17 [1.10 - 1.25] for female sex, 1.07 [1.02 - 1.13] for stress, 1.24 [1.17 - 1.32] for muscular pain, and 1.09 [1.03 - 1.14] for migraine. The population attributable risk explained by these risk factors was 26%, with muscular pain, stress, and migraine accounting for 11%, 4%, and 3% respectively. Conclusion Several established risk factors in adults were also identified in adolescents. Risk factors amenable to prevention accounted for 17% of the total population risk. Therefore, interventions targeting these risk factors may be warranted.	[Filippopulos, Filipp M.; Straube, Andreas; Blum, Bernhard] LMU, Univ Hosp, Dept Neurol, Munich, Germany; [Filippopulos, Filipp M.; Straube, Andreas; Langhagen, Thyra; Jahn, Klaus] LMU, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Albers, Lucia; von Kries, Rudiger] LMU, Div Epidemiol, Inst Social Paediat & Adolescents Med, Munich, Germany; [Gerstl, Lucia; Langhagen, Thyra; Heinen, Florian; Landgraf, Mirjam N.] LMU, Hauner Childrens Hosp, Dept Paediat Neurol & Dev Med, Munich, Germany; [Jahn, Klaus] Schon Klin Bad Aibling, Dept Neurol, Bad Aibling, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Filippopulos, FM (corresponding author), LMU, Univ Hosp, Dept Neurol, Munich, Germany.; Filippopulos, FM (corresponding author), LMU, German Ctr Vertigo & Balance Disorders, Munich, Germany.	filipp.filippopulos@med.uni-muenchen.de	Jahn, Klaus/F-9902-2010; Jahn, Klaus/AAC-4969-2021; Heinen, Florian/B-6594-2015	Jahn, Klaus/0000-0002-1669-3652; Heinen, Florian/0000-0002-3872-6136; Filippopulos, Filipp/0000-0002-2649-653X	DMKG (German Headache Society)	DMKG (German Headache Society)	The study was supported by an unrestricted fund of the DMKG (German Headache Society). The authors have no financial relationships relevant to this article to disclose.	Aggarwal NT, 2000, J GERONTOL A-BIOL, V55, pM288, DOI 10.1093/gerona/55.5.M288; Albers L, 2015, EUR J NEUROL, V22, P270, DOI 10.1111/ene.12558; Andersson G, 2000, SCAND J PSYCHOL, V41, P49, DOI 10.1111/1467-9450.00170; Anttila P, 2001, J PEDIATR-US, V138, P176, DOI 10.1067/mpd.2001.112159; Attry S, 2016, IOSR J DENT MED SCI, V15, P98, DOI [10.9790/0853-1507698107, DOI 10.9790/0853-1507698107]; Balatsouras DG, 2007, INT J PEDIATR OTORHI, V71, P487, DOI 10.1016/j.ijporl.2006.11.024; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Blaschek A, 2012, CEPHALALGIA, V32, P241, DOI 10.1177/0333102411434808; Boyd-Clark LC, 2002, SPINE, V27, P694, DOI 10.1097/00007632-200204010-00005; Brandt T, 1996, Audiol Neurootol, V1, P187; Brandt T, 2001, J NEUROL NEUROSUR PS, V71, P8, DOI 10.1136/jnnp.71.1.8; Choung YH, 2003, INT J PEDIATR OTORHI, V67, P889, DOI 10.1016/S0165-5876(03)00136-8; Chung KF, 2008, SLEEP, V31, P185, DOI 10.1093/sleep/31.2.185; Cullen KE, 2004, J NEUROPHYSIOL, V91, P1919, DOI 10.1152/jn.00988.2003; De Jong J, 1986, CERVICAL DIZZINESS A, P185; Diepenmaat ACM, 2006, PEDIATRICS, V117, P412, DOI 10.1542/peds.2004-2766; Dieterich M, 1999, J NEUROL, V246, P883, DOI 10.1007/s004150050478; EIDE GE, 1995, J CLIN EPIDEMIOL, V48, P645, DOI 10.1016/0895-4356(94)00161-I; Erginoz E, 2004, EUR J PEDIATR, V163, P485, DOI 10.1007/s00431-004-1446-5; Fendrich K, 2007, CEPHALALGIA, V27, P347, DOI 10.1111/j.1468-2982.2007.01289.x; Fritsche G, 2007, HEADACHE, V47, P546, DOI 10.1111/j.1526-4610.2007.00758.x; Fu Q, 2005, AM J PHYSIOL-REG I, V289, pR109, DOI 10.1152/ajpregu.00013.2005; Furman JM, 2013, LANCET NEUROL, V12, P706, DOI 10.1016/S1474-4422(13)70107-8; Garber J., 1991, PSYCHOL ASSESSMENT, V3, P588, DOI DOI 10.1037/1040-3590.3.4.588; Garralda ME, 1996, J CHILD PSYCHOL PSYC, V37, P13, DOI 10.1111/j.1469-7610.1996.tb01378.x; Hain TC, 2015, CURR OPIN NEUROL, V28, P69, DOI 10.1097/WCO.0000000000000161; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Humphriss RL, 2011, INT J PEDIATR OTORHI, V75, P395, DOI 10.1016/j.ijporl.2010.12.015; Jacob RG, 2001, CURR OPIN NEUROL, V14, P41, DOI 10.1097/00019052-200102000-00007; Jahn K, 2011, NEUROPEDIATRICS, V42, P129, DOI 10.1055/s-0031-1283158; Jarjour IT, 2013, SEMIN PEDIAT NEUROL; JOHANNES CB, 1995, NEUROLOGY, V45, P1076, DOI 10.1212/WNL.45.6.1076; Jonsson R, 2004, J VESTIBUL RES-EQUIL, V14, P47; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Kujala UM, 1999, BRIT J SPORT MED, V33, P325, DOI 10.1136/bjsm.33.5.325; Langhagen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136512; Langhagen T, 2013, NEUROPEDIATRICS, V44, P55, DOI 10.1055/s-0032-1333433; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Lempert T, 2009, J NEUROL, V256, P333, DOI 10.1007/s00415-009-0149-2; Lewis Donald W, 2007, Curr Probl Pediatr Adolesc Health Care, V37, P207, DOI 10.1016/j.cppeds.2007.03.003; Lieb R, 2000, ACTA PSYCHIAT SCAND, V101, P194, DOI 10.1034/j.1600-0447.2000.101003194.x; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Maarsingh OR, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-2; MacGregor EA, 2006, NEUROLOGY, V67, P2154, DOI 10.1212/01.wnl.0000233888.18228.19; Milde-Busch A, 2011, CEPHALALGIA, V31, P774, DOI 10.1177/0333102410390397; Milde-Busch A, 2010, HEADACHE, V50, P1104, DOI 10.1111/j.1526-4610.2010.01706.x; Monzani D, 2001, J PSYCHOSOM RES, V50, P319, DOI 10.1016/S0022-3999(01)00208-2; Mullick M S I, 2002, Bangladesh Med Res Counc Bull, V28, P112; Murdin L, 2015, OTOL NEUROTOL, V36, P387, DOI 10.1097/MAO.0000000000000691; Murphy S, 2007, APPL ERGON, V38, P797, DOI 10.1016/j.apergo.2006.09.003; Neuhauser HK, 2007, CURR OPIN NEUROL, V20, P40, DOI 10.1097/WCO.0b013e328013f432; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; O'Reilly RC, 2010, OTOL NEUROTOL, V31, P1441, DOI 10.1097/MAO.0b013e3181f20673; Paiva T, 2015, SLEEP MED, V16, P521, DOI 10.1016/j.sleep.2014.10.010; Partheni M, 2000, CLIN EXP RHEUMATOL, V18, P67; Paruthi S, 2016, J CLIN SLEEP MED, V12, P785, DOI 10.5664/jcsm.5866; Peroutka SJ, 1997, NEUROLOGY, V49, P650, DOI 10.1212/WNL.49.3.650; Pollak L, 2003, ISR MED ASSOC J, V5, P720; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; Radtke A, 2011, CLIN AUTON RES, V21, P161, DOI 10.1007/s10286-010-0114-2; Raj Satish R, 2006, Indian Pacing Electrophysiol J, V6, P84; Reid SA, 2014, MAN THER, V10, P4; Riina N, 2005, ARCH OTOLARYNGOL, V131, P996, DOI 10.1001/archotol.131.11.996; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Schraml K, 2011, J ADOLESCENCE, V34, P987, DOI 10.1016/j.adolescence.2010.11.010; Schulz P, 2004, TRIER INVENTORY ASSE; Silberstein SD, 2000, CEPHALALGIA, V20, P148, DOI 10.1046/j.1468-2982.2000.00034.x; SLOANE PD, 1989, J FAM PRACTICE, V29, P33; Smitherman TA, 2013, HEADACHE, V53, P427, DOI 10.1111/head.12074; Somefun OA, 2010, EUR ARCH OTO-RHINO-L, V267, P1515, DOI 10.1007/s00405-010-1272-5; Stewart JM, 2002, J PEDIATR-US, V140, P404, DOI 10.1067/mpd.2002.122727; Stewart JM, 2002, J PEDIATR-US, V140, P418, DOI 10.1067/mpd.2002.122643; Stewart JM, 2011, J PEDIATR-US, V158, P499, DOI 10.1016/j.jpeds.2010.09.004; STEWART WF, 1995, J CLIN EPIDEMIOL, V48, P269, DOI 10.1016/0895-4356(94)00128-D; Strupp M, 2008, DTSCH ARZTEBL INT, V105, P173, DOI 10.3238/arztebl.2008.0173; Thieben MJ, 2007, MAYO CLIN P; Thijs RD, 2006, NEUROLOGY, V66, P1034, DOI 10.1212/01.wnl.0000204186.43597.66; Torsheim T, 2006, SOC SCI MED, V62, P815, DOI 10.1016/j.socscimed.2005.06.047; Torsheim T, 2001, J ADOLESCENT RES, V16, P293, DOI 10.1177/0743558401163003; Ursin H, 1997, INT J BEHAV MED, V4, P105, DOI 10.1207/s15327558ijbm0402_1; Weisleder P, 2001, J CHILD NEUROL, V16, P727, DOI 10.1177/088307380101601004; Wieling W, 2007, CLIN SCI, V112, P157, DOI 10.1042/CS20060091; Wiltink J, 2009, J PSYCHOSOM RES, V66, P417, DOI 10.1016/j.jpsychores.2008.09.012; Wittchen HU, 1998, PSYCHOL MED, V28, P109, DOI 10.1017/S0033291797005928; WOOL CA, 1994, PSYCHOSOMATICS, V35, P445, DOI 10.1016/S0033-3182(94)71738-2; Wrisley DM, 2000, J ORTHOP SPORT PHYS, V30, P755, DOI 10.2519/jospt.2000.30.12.755; Yacovino DA, 2013, SEMIN NEUROL; Yin M, 2009, AURIS NASUS LARYNX, V36, P30, DOI 10.1016/j.anl.2008.03.006	90	12	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187819	10.1371/journal.pone.0187819	http://dx.doi.org/10.1371/journal.pone.0187819			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM4OL	29131843	gold, Green Published, Green Submitted			2022-12-26	WOS:000414997800025
J	He, CY; Ma, JJ; Jiang, YL; Su, X; Zhang, X; Chen, WC; Ye, ZL; Deng, TC; Deng, WZ; Yang, AK				He, Caiyun; Ma, Jiangjun; Jiang, Yongle; Su, Xuan; Zhang, Xiao; Chen, Weichao; Ye, Zulu; Deng, Tiancheng; Deng, Wenze; Yang, Ankui			Associations between RET tagSNPs and their haplotypes and susceptibility, clinical severity, and thyroid function in patients with differentiated thyroid cancer	PLOS ONE			English	Article							TYROSINE KINASE; POLYMORPHISMS; RISK; CHINESE; GENES	Background It is unclear whether common genetic variants of the RET proto-oncogene contribute to disease susceptibility, clinical severity, and thyroid function in differentiated thyroid cancer (DTC). Methods A total of 300 DTC patients and 252 healthy controls were enrolled in this study. Seven RET tagging single nucleotide polymorphisms were genotyped using the KASPar platform. Results Subgroup analysis showed that concomitant thyroid benign diseases were less likely to occur in DTC subjects with the rs1799939 AG or AG plus AA genotypes (odds ratio (OR) = 1.93 and 1.88, P = 0.009 and 0.011, respectively). A rare haplotype, CGGATAA, was associated statistically with a reduced risk of DTC (OR = 0.18, P = 0.001). Concerning the aggressive features of DTC, higher level of N stage was more likely to occur in subjects carrying the wild-type genotypes at rs1800860 site (for dominant model: OR = 0.48, P = 0.008). Another rare haplotype, CAAGCGT, conferred increased risk for the occurrence of distant metastasis (OR = 7.57, P = 0.009). Notably, higher thyroid stimulating hormone levels and lower parathyroid hormone levels were found in patients with rs2075912, rs2565200, and rs2742240 heterozygotes and rare homozygotes; similar results were observed between PTH levels and rs1800858. Conclusion This study provided useful information on RET variants that should be subjected to further study.	[He, Caiyun; Ma, Jiangjun; Zhang, Xiao; Ye, Zulu] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Mol Diagnost,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Jiang, Yongle] Sun Yat Sen Univ, Guangzhou, Guangdong, Peoples R China; [Su, Xuan; Chen, Weichao; Yang, Ankui] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Head & Neck,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Deng, Tiancheng; Deng, Wenze] Guangzhou Univ Chinese Med, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou University of Chinese Medicine	Yang, AK (corresponding author), Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Head & Neck,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	yangak@sysucc.org.cn		yang, ankui/0000-0002-8534-3883	National Natural Science Foundation of China [81602426]; Science and Technology Projects of Guangdong Province, China [2014A020212100, 2016A020215082]; Medical Science and Technology Research Fund Project of Guangdong Province, China [A2015003]; Natural Science Foundation of Guangdong Province, China [2016A030310198]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Projects of Guangdong Province, China; Medical Science and Technology Research Fund Project of Guangdong Province, China; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China [grant number 81602426]; Science and Technology Projects of Guangdong Province, China [grant number 2014A020212100 and 2016A020215082]; the Medical Science and Technology Research Fund Project of Guangdong Province, China [grant number A2015003]; and the Natural Science Foundation of Guangdong Province, China [grant number 2016A030310198]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; He CY, 2013, CARCINOGENESIS, V34, P1450, DOI 10.1093/carcin/bgt079; He CF, 2014, SHOCK VIB, V2014, DOI 10.1155/2014/727404; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Ho T, 2005, LARYNGOSCOPE, V115, P1035, DOI 10.1097/01.MLG.0000162653.22384.10; Huang RX, 2015, INT J CLIN EXP PATHO, V8, P5793; Khan MS, 2015, J CELL BIOCHEM, V116, P1712, DOI 10.1002/jcb.25130; LABOVITZ S, 1968, AM SOCIOL, V3, P220; Nikiforov YE, 2002, ENDOCR PATHOL, V13, P3, DOI 10.1385/EP:13:1:03; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; Pan ZW, 2012, J PEDIATR SURG, V47, P1699, DOI 10.1016/j.jpedsurg.2012.03.057; Santos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109822; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Su X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165596; Su X, 2016, ONCOTARGET, V7, P16716, DOI 10.18632/oncotarget.7574; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Vigneri R, 2015, CURR OPIN ONCOL, V27, P1, DOI 10.1097/CCO.0000000000000148; Wang BG, 2016, ONCOTARGET, V7, P20357, DOI 10.18632/oncotarget.7952; Zhang Z, 2008, J AM SOC NEPHROL, V19, P2027, DOI 10.1681/ASN.2007101098	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187968	10.1371/journal.pone.0187968	http://dx.doi.org/10.1371/journal.pone.0187968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131865	gold, Green Published, Green Submitted			2022-12-26	WOS:000414997800032
J	Wu, CC; Chen, CH; Shete, S				Wu, Chih-Chieh; Chen, Chien-Hsiun; Shete, Sanjay			Assessing current temporal and space-time anomalies of disease incidence	PLOS ONE			English	Article							SURVEILLANCE DATA; PUBLIC-HEALTH; CLUSTERS; DENGUE; INFERENCE; ALGORITHM; OUTBREAKS; VALUES	Approaches used to early and accurately characterize epidemiologic patterns of disease incidence in a temporal and spatial series are becoming increasingly important. Cluster tests are generally designed for retrospective detection of epidemiologic anomalies in a temporal or space-time series. Timely identification of anomalies of disease or poisoning incidence during ongoing surveillance or an outbreak requires the use of sensitive statistical methods that recognize an incidence pattern at the time of occurrence. This report describes 2 novel analytical methods that focus on detecting anomalies of incidence at the time of occurrence in a temporal and space-time series. The first method describes the paucity of incidence at the time of occurrence in an ongoing surveillance and is designed to evaluate whether a decline in incidence occurs on the single current day or during the most recent few days. The second method provides an overall assessment of current clustering or paucity of incidence in a space-time series, allowing for several space regions. We illustrate the application of these methods using a subsample of a temporal series of data on the largest dengue outbreak in Taiwan in 2015 since World War II and demonstrate that they are useful to efficiently monitor incoming data for current clustering and paucity of incidence in a temporal and space-time series. In light of the recent global emergence and resurgence of Zika, dengue, and chikungunya infection, these approaching for detecting current anomalies of incidence in the ongoing surveillance of disease are particularly desired and needed.	[Wu, Chih-Chieh] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan, Taiwan; [Chen, Chien-Hsiun] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chien-Hsiun] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	National Cheng Kung University; Academia Sinica - Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center	Wu, CC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan, Taiwan.	cc_wu@mail.ncku.edu.tw	Chen, Chien Hsiun/Q-3826-2018	Wu, Chih-Chieh/0000-0002-9846-4086	Taiwan Ministry of Science and Technology [MOST104-2118-M-0 06-006, 105-2118-M-006-008]; Academia Sinica Genomic Medicine Multicenter Study, Taiwan; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Taiwan Ministry of Science and Technology; Academia Sinica Genomic Medicine Multicenter Study, Taiwan(Academia Sinica - Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research presented in this manuscript was partially supported by the Taiwan Ministry of Science and Technology (https://www. most.gov.tw/en/public) grants MOST104-2118-M-0 06-006 and 105-2118-M-006-008 to C.C.W. The grant of the Academia Sinica Genomic Medicine Multicenter Study, Taiwan, to C.H.C. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, LANCET INFECT DIS; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; EDERER F, 1964, BIOMETRICS, V20, P626, DOI 10.2307/2528500; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Grimson RC, 2000, J TOXICOL-CLIN TOXIC, V38, P761, DOI 10.1081/CLT-100102389; GRIMSON RC, 1993, STAT MED, V12, P1773, DOI 10.1002/sim.4780121906; Grimson RC, 1996, STAT MED, V15, P851, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<851::AID-SIM255>3.0.CO;2-4; GRIMSON RC, 1992, STAT MED, V11, P761, DOI 10.1002/sim.4780110607; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HRYHORCZUK DO, 1992, J TOXICOL-CLIN TOXIC, V30, P459, DOI 10.3109/15563659209021560; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; JONES DR, 1982, INT J EPIDEMIOL, V11, P276, DOI 10.1093/ije/11.3.276; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; MANTEL N, 1976, AM J EPIDEMIOL, V104, P576, DOI 10.1093/oxfordjournals.aje.a112333; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; NOBRE FF, 1994, INT J EPIDEMIOL, V23, P408, DOI 10.1093/ije/23.2.408; Reis Ben Y, 2003, BMC Med Inform Decis Mak, V3, P2, DOI 10.1186/1472-6947-3-2; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Sonesson C, 2003, J R STAT SOC A STAT, V166, P5, DOI 10.1111/1467-985X.00256; THOMAS DC, 1985, AM J EPIDEMIOL, V122, P1080, DOI 10.1093/oxfordjournals.aje.a114189; WALLENSTEIN S, 1989, AM J EPIDEMIOL, V130, P1057, DOI 10.1093/oxfordjournals.aje.a115406; WALLENSTEIN S, 1987, STAT MED, V6, P197, DOI 10.1002/sim.4780060212; Wilder-Smith A, 2015, SCIENCE, V350, P626, DOI 10.1126/science.aab4047; Wu CC, 2008, BIOMETRICAL J, V50, P86, DOI 10.1002/bimj.200610374; Wu CC, 2010, COMMUN STAT-SIMUL C, V39, P612, DOI 10.1080/03610910903528335	27	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0188065	10.1371/journal.pone.0188065	http://dx.doi.org/10.1371/journal.pone.0188065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131869	Green Published, gold, Green Submitted			2022-12-26	WOS:000414997800044
J	El-Serafi, I; Terelius, Y; Abedi-Valugerdi, M; Naughton, S; Saghafian, M; Moshfegh, A; Mattsson, J; Potacova, Z; Hassan, M				El-Serafi, Ibrahim; Terelius, Ylva; Abedi-Valugerdi, Manuchehr; Naughton, Sean; Saghafian, Maryam; Moshfegh, Ali; Mattsson, Jonas; Potacova, Zuzana; Hassan, Moustapha			Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway	PLOS ONE			English	Article							HEMATOPOIETIC-CELL TRANSPLANTATION; HIGH-DOSE BUSULFAN; GENETIC POLYMORPHISMS; LIVER TOXICITY; IN-VITRO; PHARMACOKINETICS; PLASMA; MOUSE; CYCLOPHOSPHAMIDE; THERAPY	Busulphan (Bu) is an alkylating agent used in the conditioning regimen prior to hematopoietic stem cell transplantation (HSCT). Bu is extensively metabolized in the liver via conjugations with glutathione to form the intermediate metabolite (sulfonium ion) which subsequently is degraded to tetrahydrothiophene (THT). THT was reported to be oxidized forming THT-1-oxide that is further oxidized to sulfolane and finally 3-hydroxysulfolane. However, the underlying mechanisms for the formation of these metabolites remain poorly understood. In the present study, we performed in vitro and in vivo investigations to elucidate the involvement of flavin-containing monooxygenase-3 (FMO3) and cytochrome P450 enzymes (CYPs) in Bu metabolic pathway. Rapid clearance of THT was observed when incubated with human liver microsomes. Furthermore, among different recombinant microsomal enzymes, the highest intrinsic clearance for THT was obtained via FMO3 followed by several CYPs including 2B6, 2C8, 2C9, 2C19, 2E1 and 3A4. In Buor THT-treated mice, inhibition of FMO3 by phenylthiourea significantly suppressed the clearance of both Bu and THT. Moreover, the simultaneous administration of a high dose of THT (200 mu mol/kg) to Bu-treated mice reduced the clearance of Bu. Consistently, in patients undergoing HSCT, repeated administration of Bu resulted in a significant up-regulation of FMO3 and glutathione-S-transfrase - 1 (GSTA1) genes. Finally, in a Bu-treated patient, additional treatment with voriconazole (an antimycotic drug known as an FMO3-substrate) significantly altered the Bu clearance. In conclusion, we demonstrate for the first time that FMO3 along with CYPs contribute a major part in busulphan metabolic pathway and certainly can affect its kinetics. The present results have high clinical impact. Furthermore, these findings might be important for reducing the treatment-related toxicity of Bu, through avoiding interaction with other concomitant used drugs during conditioning and hence improving the clinical outcomes of HSCT.	[El-Serafi, Ibrahim; Terelius, Ylva; Abedi-Valugerdi, Manuchehr; Naughton, Sean; Saghafian, Maryam; Potacova, Zuzana; Hassan, Moustapha] Karolinska Inst, Dept Lab Med, Clin Res Ctr KFC, ECM, Stockholm, Sweden; [Moshfegh, Ali] Karolinska Inst, Dept Oncol Pathol, CCK, Stockholm, Sweden; [Mattsson, Jonas] Karolinska Univ Hosp Huddinge, Ctr Allogene Stem Cell Transplantat, Stockholm, Sweden; [Mattsson, Jonas] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; [Potacova, Zuzana; Hassan, Moustapha] Karolinska Univ Hosp, Clin Res Ctr KFC, ECM, Novum, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Hassan, M (corresponding author), Karolinska Inst, Dept Lab Med, Clin Res Ctr KFC, ECM, Stockholm, Sweden.; Hassan, M (corresponding author), Karolinska Univ Hosp, Clin Res Ctr KFC, ECM, Novum, Huddinge, Sweden.		Hassan, Moustapha/H-9260-2015	Hassan, Moustapha/0000-0003-1927-5859; Abedi-Valugerdi, Manuchehr/0000-0002-4122-2879; El-Serafi, Ibrahim/0000-0002-0463-1518	Swedish Cancer Society [CAN2011/595, CAN2014/759]; Swedish Childhood Cancer Foundation [PROJ11/112]	Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission)	This work was supported by the Swedish Cancer Society (CAN2011/595, CAN2014/759) and the Swedish Childhood Cancer Foundation (PROJ11/112).	Ansari M, 2013, BONE MARROW TRANSPL, V48, P939, DOI 10.1038/bmt.2012.265; Beumer JH, 2014, CANCER CHEMOTH PHARM, V74, P927, DOI 10.1007/s00280-014-2571-0; Bloom AJ, 2013, PHARMACOGENET GENOM, V23, P706, DOI [10.1097/FPC.0b013e32835c3b48, 10.1097/FPC.0000000000000011]; Buggia I, 1996, ANTICANCER RES, V16, P2083; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Cantoni N, 2011, BONE MARROW TRANSPL, V46, P344, DOI 10.1038/bmt.2010.137; Capolongo F, 2010, J VET PHARMACOL THER, V33, P341, DOI 10.1111/j.1365-2885.2009.01145.x; CASHMAN JR, 1995, CHEM RES TOXICOL, V8, P165, DOI 10.1021/tx00044a001; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032890; Cho JY, 2004, DRUG METAB DISPOS, V32, P1341, DOI 10.1124/dmd.104.001107; EHRSSON H, 1983, J PHARM SCI, V72, P1203, DOI 10.1002/jps.2600721024; El-Serafi I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141979; El-Serafi I, 2013, J CHROMATOGR B, V913, P98, DOI 10.1016/j.jchromb.2012.12.001; Falls JG, 1997, ARCH BIOCHEM BIOPHYS, V347, P9, DOI 10.1006/abbi.1997.0322; Gibbs JP, 1996, CANCER RES, V56, P3678; Gulbis Alison M, 2011, Ann Pharmacother, V45, pe39, DOI 10.1345/aph.1Q087; Hart SN, 2008, EXPERT OPIN DRUG MET, V4, P439, DOI [10.1517/17425255.4.4.439, 10.1517/17425255.4.4.439 ]; Hart SN, 2008, PHARMACOGENET GENOM, V18, P11, DOI 10.1097/FPC.0b013e3282f2f121; HASSAN M, 1991, CANCER CHEMOTH PHARM, V28, P130, DOI 10.1007/BF00689702; Hassan M, 2000, THER DRUG MONIT, V22, P383, DOI 10.1097/00007691-200008000-00003; HASSAN M, 1988, EUR J DRUG METAB PH, V13, P301, DOI 10.1007/BF03190094; Hassan M, 2000, BONE MARROW TRANSPL, V25, P915, DOI 10.1038/sj.bmt.1702377; HASSAN M, 1983, J CHROMATOGR, V277, P374, DOI 10.1016/S0378-4347(00)84861-6; HASSAN M, 1987, DRUG METAB DISPOS, V15, P399; HASSAN M, 1987, EUR J DRUG METAB PH, V12, P71, DOI 10.1007/BF03189864; HASSAN M, 1993, CANCER CHEMOTH PHARM, V33, P181, DOI 10.1007/BF00686213; Hassan M, 2013, PHARMACOGENOMICS, V14, P75, DOI [10.2217/PGS.12.185, 10.2217/pgs.12.185]; Hernandez D, 2003, HUM MUTAT, V22, P209, DOI 10.1002/humu.10252; Hernandez D, 2004, PHARMACOGENETICS, V14, P117, DOI 10.1097/00008571-200402000-00006; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Johnson-Davis KL, 2010, CLIN CHEM, V56, P1061, DOI 10.1373/clinchem.2009.134940; Koukouritaki SB, 2002, PEDIATR RES, V51, P236, DOI 10.1203/00006450-200202000-00018; Koukouritaki SB, 2005, PHARMACOGENOMICS, V6, P807, DOI 10.2217/14622416.6.8.807; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; LAWTON MP, 1994, ARCH BIOCHEM BIOPHYS, V308, P254, DOI 10.1006/abbi.1994.1035; McCune JS, 2007, BIOL BLOOD MARROW TR, V13, P853, DOI 10.1016/j.bbmt.2007.03.012; McCune JS, 2014, CLIN CANCER RES, V20, P754, DOI 10.1158/1078-0432.CCR-13-1960; Nilsson C, 2003, BONE MARROW TRANSPL, V31, P429, DOI 10.1038/sj.bmt.1703896; Prigol M, 2012, CHEM-BIOL INTERACT, V200, P65, DOI 10.1016/j.cbi.2012.09.007; Raccor BS, 2012, DRUG METAB DISPOS, V40, P54, DOI 10.1124/dmd.111.039347; Rezvani AR, 2013, BIOL BLOOD MARROW TR, V19, P1033, DOI 10.1016/j.bbmt.2013.04.005; Sadeghi B, 2008, BONE MARROW TRANSPL, V41, P895, DOI 10.1038/sj.bmt.1705996; Sadeghi B, 2008, BONE MARROW TRANSPL, V42, P807, DOI 10.1038/bmt.2008.261; Shah V P, 2000, Pharm Res, V17, P1551, DOI 10.1023/A:1007669411738; SHAH VP, 1991, EUR J DRUG METAB PH, V16, P249; SLADEK NE, 1988, PHARMACOL THERAPEUT, V37, P301, DOI 10.1016/0163-7258(88)90004-6; Smith PB, 2002, BIOCHEM PHARMACOL, V63, P1941, DOI 10.1016/S0006-2952(02)00978-4; Subramanian M, 2012, PHARMACOGENET GENOM, V22, P590, DOI 10.1097/FPC.0b013e3283544062; Uppugunduri CR, 2013, PHARMACOGENOMICS J; VASSAL G, 1993, BLOOD, V82, P1030; Yamazaki H, 2013, BIOCHEM PHARMACOL, V85, P1588, DOI 10.1016/j.bcp.2013.03.020; Yanni SB, 2008, DRUG METAB DISPOS, V36, P1119, DOI 10.1124/dmd.107.019646; Younis IR, 2008, IN VITRO ELUCIDATION	53	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187294	10.1371/journal.pone.0187294	http://dx.doi.org/10.1371/journal.pone.0187294			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121650	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900027
J	Mendes-Oliveira, AC; Peres, CA; Maues, PCRD; Oliveira, GL; Mineiro, IGB; de Maria, SLS; Lima, RCS				Mendes-Oliveira, Ana Cristina; Peres, Carlos A.; Maues, Paula Cristina R. de A.; Oliveira, Geovana Linhares; Mineiro, Ivo G. B.; Silva de Maria, Susanne L.; Lima, Renata C. S.			Oil palm monoculture induces drastic erosion of an Amazonian forest mammal fauna	PLOS ONE			English	Article							BIODIVERSITY; AGRICULTURE; PLANTATIONS; IMPACT; SABAH; CONSERVATION; COMMUNITIES; CONVERSION; DIVERSITY; EXPANSION	Oil palm monoculture comprises one of the most financially attractive land-use options in tropical forests, but cropland suitability overlaps the distribution of many highly threatened vertebrate species. We investigated how forest mammals respond to a landscape mosaic, including mature oil palm plantations and primary forest patches in Eastern Amazonia. Using both line-transect censuses (LTC) and camera-trapping (CT), we quantified the general patterns of mammal community structure and attempted to identify both species life-history traits and the environmental and spatial covariates that govern species intolerance to oil palm monoculture. Considering mammal species richness, abundance, and species composition, oil palm plantations were consistently depauperate compared to the adjacent primary forest, but responses differed between functional groups. The degree of forest habitat dependency was a leading trait, determining compositional dissimilarities across habitats. Considering both the LTC and CT data, distance from the forest-plantation interface had a significant effect on mammal assemblages within each habitat type. Approximately 87% of all species detected within oil palm were never farther than 1300 m from the forest edge. Our study clearly reinforces the notion that conventional oil palm plantations are extremely hostile to native tropical forest biodiversity, which does not bode well given prospects for oil palm expansion in both aging and new Amazonian deforestation frontiers.	[Mendes-Oliveira, Ana Cristina; Maues, Paula Cristina R. de A.; Oliveira, Geovana Linhares; Mineiro, Ivo G. B.; Silva de Maria, Susanne L.; Lima, Renata C. S.] Fed Univ Para, Lab Ecol & Zool Vertebrate, Inst Biol Sci, Belem, Para, Brazil; [Mendes-Oliveira, Ana Cristina; Peres, Carlos A.] Univ East Anglia, Ctr Ecol Evolut & Conservat, Sch Environm Sci, Norwich, Norfolk, England	Universidade Federal do Para; University of East Anglia	Mendes-Oliveira, AC (corresponding author), Fed Univ Para, Lab Ecol & Zool Vertebrate, Inst Biol Sci, Belem, Para, Brazil.; Mendes-Oliveira, AC (corresponding author), Univ East Anglia, Ctr Ecol Evolut & Conservat, Sch Environm Sci, Norwich, Norfolk, England.	cris.mastozoologia@gmail.com	Peres, Carlos A./B-1276-2013; de Oliveira, Ana Cristina Mendes/I-2680-2012; Peres, Carlos Augusto/N-8275-2019; Lima, Renata/AAC-6777-2020; Peres, Carlos A./ABE-8361-2020	Peres, Carlos A./0000-0002-1588-8765; Lima, Renata/0000-0001-8712-1144; Peres, Carlos A./0000-0002-1588-8765; Mendes Oliveira, Ana Cristina/0000-0002-7863-9678	Conservation International - Brazil; CNPq Post-Doctoral grant	Conservation International - Brazil; CNPq Post-Doctoral grant	Conservation International - Brazil provided financial support during the first stage of the project. A.C.M.O. was supported by a CNPq Post-Doctoral grant during a study leave at University of East Anglia.	Aratrakorn S, 2006, BIRD CONSERV INT, V16, P71, DOI 10.1017/S0959270906000062; ARITA HT, 1990, CONSERV BIOL, V4, P181, DOI 10.1111/j.1523-1739.1990.tb00107.x; Azhar B, 2014, BIODIVERS CONSERV, V23, P1175, DOI 10.1007/s10531-014-0656-z; Beca G, 2017, BIOL CONSERV, V210, P352, DOI 10.1016/j.biocon.2017.02.033; Bencsik M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141926; Bernard H, 2009, MAMM STUDY, V34, P85, DOI 10.3106/041.034.0204; Biz M, 2017, PERSPECT ECOL CONSER, V15, P10, DOI 10.1016/j.pecon.2017.03.001; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; BRITO TD, 2006, COMPETITIVIDADE SUST; Bruhl CA, 2010, BIODIVERS CONSERV, V19, P519, DOI 10.1007/s10531-009-9596-4; Busch J, 2015, P NATL ACAD SCI USA, V112, P1328, DOI 10.1073/pnas.1412514112; Butler RA, 2009, TROP CONSERV SCI, V2, P1, DOI 10.1177/194008290900200102; Chiarello AG, 2001, INT J PRIMATOL, V22, P379, DOI 10.1023/A:1010751527749; Chung AYC, 2000, B ENTOMOL RES, V90, P475, DOI 10.1017/S0007485300000602; Coelho M, 2014, BIODIVERS CONSERV, V23, P3171, DOI 10.1007/s10531-014-0772-9; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Cunha A., 2012, LINE TRANSECT CENSUS; Cunha EJ, 2017, J INSECT CONSERV; Cunha EJ, 2015, ECOL INDIC, V52, P422, DOI 10.1016/j.ecolind.2014.12.024; Danielsen F., 1995, MANAGEMENT TROPICAL, P73; Edwards DP, 2010, CONSERV LETT, V3, P236, DOI 10.1111/j.1755-263X.2010.00107.x; Estrada-Pena A., 2017, TICKS EUROPE N AFRIC, P1; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Fleagle JG, 1967, GREAT TRANSFORMATION, P257; Gehring TM, 2003, BIOL CONSERV, V109, P283, DOI 10.1016/S0006-3207(02)00156-8; Gibbs HK, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034001; Gilroy JJ, 2015, GLOBAL CHANGE BIOL, V21, P1531, DOI 10.1111/gcb.12696; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; Hurtiene T. P., 1999, NOVOS CAD NAEA, P75, DOI [10.5801/ncn.v2i1.206, DOI 10.5801/NCN.V2I1.206]; IPEA, 2015, REL PROD INT BRUT BR; Jennings AP, 2015, MAMMAL RES, V60, P181, DOI 10.1007/s13364-015-0217-1; Keinath DA, 2017, GLOBAL ECOL BIOGEOGR, V26, P115, DOI 10.1111/geb.12509; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Koh LP, 2008, CAN OIL PALM PLANTAT, P1002; Lapola DM, 2014, NAT CLIM CHANGE, V4, P27, DOI 10.1038/NCLIMATE2056; Lees AC, 2008, CONSERV BIOL, V22, P439, DOI 10.1111/j.1523-1739.2007.00870.x; Lees AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122432; Lopez-Ricaurte L, 2017, BIOL CONSERV, V213, P225, DOI 10.1016/j.biocon.2017.07.009; Martins CA, 2016, ENERG SOURCE PART A, V38, P277, DOI 10.1080/15567036.2012.716139; Mazel F, 2017, REPORT GEOGRAPHY ECO, P1369; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; NELSON B. P. N., 2002, SOIL ACIDIFICATION O, P22; Nepstad D, 2007, TROPICAL FORESTED LA, P6; Niebuhr BBS, 2015, SURVIVAL PATCHY LAND, P1; O'Brien TG, 2010, ANIM CONSERV, V13, P335, DOI 10.1111/j.1469-1795.2010.00357.x; Paglia A.P., 2012, OCCASIONAL PAPERS CO, V6, P1, DOI DOI 10.1646/0006-3606(2000)032[; Peres C.A., 1999, MAMMALS NEOTROPICS, V3, P564; Peres CA, 2005, MEGADIVERSIDADE, V1, P174; PRODES/INPE, 2015, REL AN TAX DESM CONS; Rodrigues ASL, 2001, ECOL LETT, V4, P602, DOI 10.1046/j.1461-0248.2001.00275.x; Siregar K, 2015, ENRGY PROCED, V65, P170, DOI 10.1016/j.egypro.2015.01.054; Sodhi NS, 2010, BIOL CONSERV; Tao HH, 2016, AGR ECOSYST ENVIRON, V218, P133, DOI 10.1016/j.agee.2015.11.012; Tripathi BM, 2016, MOL ECOL, V25, P2244, DOI 10.1111/mec.13620; Turner EC, 2009, J TROP ECOL, V25, P23, DOI 10.1017/S0266467408005658; United States Department of Agriculture (USDA), 2014, ANN REP USDA OILS WO; Vieira EM, 2007, J ZOOL, V272, P57, DOI 10.1111/j.1469-7998.2006.00237.x; Vijayakumar V, 2018, IMA J MATH CONTROL I, V35, P297, DOI 10.1093/imamci/dnw049; Villela AA, 2014, BIOMASS BIOENERGY; Yeboua Kabrah, 2000, Cahiers Agricultures, V9, P73	61	32	33	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187650	10.1371/journal.pone.0187650	http://dx.doi.org/10.1371/journal.pone.0187650			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117202	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000414659600054
J	Zhu, ZG; Noel, SJ; Difford, GF; Abu Al-Soud, W; Brejnrod, A; Sorensen, SJ; Lassen, J; Lovendahl, P; Hojberg, O				Zhu, Zhigang; Noel, Samantha Joan; Difford, Gareth Frank; Abu Al-Soud, Waleed; Brejnrod, Asker; Sorensen, Soren Johannes; Lassen, Jan; Lovendahl, Peter; Hojberg, Ole			Community structure of the metabolically active rumen bacterial and archaeal communities of dairy cows over the transition period	PLOS ONE			English	Article							METHANOGENIC COMMUNITIES; RUMINAL BACTERIA; RNA; SHEEP; DIVERSITY; DNA; IDENTIFICATION; HYBRIDIZATION; SEQUENCES; ABUNDANCE	Dairy cows experience dramatic changes in host physiology from gestation to lactation period and dietary switch from high-forage prepartum diet to high-concentrate postpartum diet over the transition period (parturition +/- three weeks). Understanding the community structure and activity of the rumen microbiota and its associative patterns over the transition period may provide insight for e.g. improving animal health and production. In the present study, rumen samples from ten primiparous Holstein dairy cows were collected over seven weeks spanning the transition period. Total RNA was extracted from the rumen samples and cDNA thereof was subsequently used for characterizing the metabolically active bacterial (16S rRNA transcript amplicon sequencing) and archaeal (qPCR, T-RFLP and mcrA and 16S rRNA transcript amplicon sequencing) communities. The metabolically active bacterial community was dominated by three phyla, showing significant changes in relative abundance range over the transition period: Firmicutes (from prepartum 57% to postpartum 35%), Bacteroidetes (from prepartum 22% to postpartum 18%) and Proteobacteria (from prepartum 7% to postpartum 32%). For the archaea, qPCR analysis of 16S rRNA transcript number, revealed a significant prepartum to postpartum increase in Methanobacteriales, in accordance with an observed increase (from prepartum 80% to postpartum 89%) in relative abundance of 16S rRNA transcript amplicons allocated to this order. On the other hand, a significant prepartum to postpartum decrease ( from 15% to 2%) was observed in relative abundance of Methanomassiliicoccales 16S rRNA transcripts. In contrast to qPCR analysis of the 16S rRNA transcripts, quantification of mcrA transcripts revealed no change in total abundance of metabolically active methanogens over the transition period. According to TRFLP analysis of the mcrA transcripts, two Methanobacteriales genera, Methanobrevibacter and Methanosphaera (represented by the T-RFs 39 and 267 bp), represented more than 70% of the metabolically active methanogens, showing no significant changes over the transition period; minor T-RFs, likely to represent members of the order Methanomassiliicoccales and with a relative abundance below 5% in total, decreased significantly over the transition period. In accordance with the T-RFLP analysis, the mcrA transcript amplicon sequencing revealed Methanobacteriales to cover 99% of the total reads, dominated by the genera Methanobrevibacter (75%) and Methanosphaera (24%), whereas the Methanomas-siliicoccales order covered only 0.2% of the total reads. In conclusion, the present study showed that the structure of the metabolically active bacterial and archaeal rumen communities changed over the transition period, likely in response to the dramatic changes in physiology and nutritional factors like dry matter intake and feed composition. It should be noted however that for the methanogens, the observed community changes were influenced by the analyzed gene (mcrA or 16S rRNA).	[Zhu, Zhigang; Noel, Samantha Joan; Hojberg, Ole] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Difford, Gareth Frank; Lassen, Jan; Lovendahl, Peter] Aarhus Univ, Ctr Quantitat Genet & Genom, Dept Mol Biol & Genet, Tjele, Denmark; [Abu Al-Soud, Waleed; Brejnrod, Asker; Sorensen, Soren Johannes] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen	Zhu, ZG; Hojberg, O (corresponding author), Aarhus Univ, Dept Anim Sci, Tjele, Denmark.	zhigang.zhu8800@gmail.com; ole.hojberg@anis.au.dk	Sørensen, Søren J/J-5015-2014; Abu Al-Soud, Waleed/AAH-3477-2021; Lovendahl, Peter/AAC-8688-2020; Difford, Gareth/AAJ-7221-2021; Noel, Samantha/AAM-4090-2021; Abu Al-Soud, Waleed/K-4408-2014; Sørensen, Søren Johannes/N-2120-2019	Sørensen, Søren J/0000-0001-6227-9906; Abu Al-Soud, Waleed/0000-0002-1143-9233; Lovendahl, Peter/0000-0002-9852-2944; Difford, Gareth/0000-0002-6792-8722; Abu Al-Soud, Waleed/0000-0002-1143-9233; Sørensen, Søren Johannes/0000-0001-6227-9906; Brejnrod, Asker/0000-0002-1327-2051; Noel, Samantha Joan/0000-0003-4529-9598	Innovation Fund Denmarkor [12-132447]	Innovation Fund Denmarkor	This work is financially supported by Innovation Fund Denmarkor (grant number 12-132447). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanche A, 2012, J NUTR, V142, P1684, DOI 10.3945/jn.112.159574; BELL AW, 1995, J ANIM SCI, V73, P2804, DOI 10.2527/1995.7392804x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carberry CA, 2014, APPL ENVIRON MICROB, V80, P586, DOI 10.1128/AEM.03131-13; Chaudhary PP, 2012, GENE, V493, P13, DOI 10.1016/j.gene.2011.11.041; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fish JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00291; Geishauser T, 2012, J DAIRY SCI, V95, P4556, DOI 10.3168/jds.2012-5380; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hildebrand F, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-30; Huws SA, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv137; Jami E, 2012, ANAEROBE, V18, P338, DOI 10.1016/j.anaerobe.2012.04.003; Jeyanathan J, 2011, FEMS MICROBIOL ECOL, V76, P311, DOI 10.1111/j.1574-6941.2011.01056.x; Kang SH, 2013, J APPL MICROBIOL, V115, P644, DOI 10.1111/jam.12270; KERKHOF L, 1993, APPL ENVIRON MICROB, V59, P1303, DOI 10.1128/AEM.59.5.1303-1309.1993; Kumar S., 2015, FRONT MICROBIOL, V6; LEE SH, 1994, LIMNOL OCEANOGR, V39, P869, DOI 10.4319/lo.1994.39.4.0869; Lettat A, 2013, J DAIRY SCI, V96, P5237, DOI 10.3168/jds.2012-6481; Lettat A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060978; Li FY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00987; Lima FS, 2015, APPL ENVIRON MICROB, V81, P1327, DOI 10.1128/AEM.03138-14; Mao SY, 2016, ENVIRON MICROBIOL, V18, P525, DOI 10.1111/1462-2920.12724; Martinez ME, 2010, J DAIRY SCI, V93, P3699, DOI 10.3168/jds.2009-2934; McSweeney CS, 2007, ASIAN AUSTRAL J ANIM, V20, P283; Minuti A, 2015, J DAIRY SCI, V98, P8940, DOI 10.3168/jds.2015-9722; Moeseneder MM, 2005, FEMS MICROBIOL ECOL, V51, P341, DOI 10.1016/j.femsec.2004.09.012; Morgavi DP, 2010, ANIMAL, V4, P1024, DOI 10.1017/S1751731110000546; Park AF, 2011, J ANIM PHYSIOL AN N, V95, P571, DOI 10.1111/j.1439-0396.2010.01085.x; Paul K, 2012, APPL ENVIRON MICROB, V78, P8245, DOI 10.1128/AEM.02193-12; Paulin MM, 2013, SOIL BIOL BIOCHEM, V63, P37, DOI 10.1016/j.soilbio.2013.02.007; Penner GB, 2007, J DAIRY SCI, V90, P365, DOI 10.3168/jds.S0022-0302(07)72638-3; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Pitta DW, 2014, J ANIM SCI, V92, P4014, DOI 10.2527/jas.2014-7621; Popova M, 2013, APPL ENVIRON MICROB, V79, P1777, DOI 10.1128/AEM.03115-12; Poulsen M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2432; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Seedorf H, 2015, APPL ENVIRON MICROB, V81, P986, DOI 10.1128/AEM.03018-14; Shi WB, 2014, GENOME RES, V24, P1517, DOI 10.1101/gr.168245.113; Sirohi SK, 2013, GENE, V523, P161, DOI 10.1016/j.gene.2013.04.002; Snelling TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106491; Sollinger A, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv149; Steinberg LM, 2008, APPL ENVIRON MICROB, V74, P6663, DOI 10.1128/AEM.00553-08; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang XX, 2012, APPL ENVIRON MICROB, V78, P2386, DOI 10.1128/AEM.07545-11; Wilkins D, 2015, APPL ENVIRON MICROB, V81, P604, DOI 10.1128/AEM.02566-14; Wright ADG, 2004, APPL ENVIRON MICROB, V70, P1263, DOI 10.1128/AEM.70.3.1263-1270.2004; Yang SZ, 2014, J MICROBIOL METH, V103, P3, DOI 10.1016/j.mimet.2014.05.006; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	54	22	23	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187858	10.1371/journal.pone.0187858	http://dx.doi.org/10.1371/journal.pone.0187858			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117259	Green Published, gold			2022-12-26	WOS:000414659600083
J	Blanquez, A; Ball, AS; Gonzalez-Perez, JA; Jimenez-Morillo, NT; Gonzalez-Vila, F; Arias, ME; Hernandez, M				Blanquez, Alba; Ball, Andrew S.; Antonio Gonzalez-Perez, Jose; Jimenez-Morillo, Nicasio T.; Gonzalez-Vila, Francisco; Enriqueta Arias, M.; Hernandez, Manuel			Laccase SilA from Streptomyces ipomoeae CECT 3341, a key enzyme for the degradation of lignin from agricultural residues?	PLOS ONE			English	Article							BACTERIAL LACCASE; SOLID-STATE; AZO DYES; EXPRESSION; OXIDASE; DETOXIFICATION; PURIFICATION; COELICOLOR; STRAINS; CLONING	The role of laccase SilA produced by Streptomyces ipomoeae CECT 3341 in lignocellulose degradation was investigated. A comparison of the properties and activities of a laccase-negative mutant strain (SilA(-)) with that of the wild-type was studied in terms of their ability to degrade lignin from grass lignocellulose. The yields of solubilized lignin (acid precipitable polymeric lignin, APPL) obtained from wheat straw by both strains in Solid State Fermentation (SSF) conditions demonstrated the importance of SilA laccase in lignin degradation with the wild-type showing 5-fold more APPL produced compared with the mutant strain (SilA-). Analytical pyrolysis and FT-IR (Fourier Transform Infrared Spectroscopy) confirmed that the APPL obtained from the substrate fermented by wild-type strain was dominated by lignin derived methoxyphenols whereas those from SilA(-) and control APPLs were composed mainly of polysaccharides. This is the first report highlighting the role of this laccase in lignin degradation.	[Blanquez, Alba; Enriqueta Arias, M.; Hernandez, Manuel] Univ Alcala, Dept Biomed & Biotecnol, Madrid, Spain; [Ball, Andrew S.] RMIT Univ, Sch Sci, Ctr Environm Sustainabil & Remediat, Bundoora, Vic, Australia; [Antonio Gonzalez-Perez, Jose; Jimenez-Morillo, Nicasio T.; Gonzalez-Vila, Francisco] Inst Recursos Nat & Agrobiol IRNAS CSIC, Dept Biogeoquim Ecol Vegetal & Microbiana, Seville, Spain	Universidad de Alcala; Royal Melbourne Institute of Technology (RMIT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS)	Hernandez, M (corresponding author), Univ Alcala, Dept Biomed & Biotecnol, Madrid, Spain.	manuel.hernandez@uah.es	González-Pérez, José A./E-5666-2010; Hernández, Manuel/R-7013-2018; González-Vila, Francisco J./P-5587-2014; Blanquez Moya, Alba/U-1621-2017; Ball, Andrew S/I-3389-2013; Morillo, Nicasio Jiménez/AGK-1793-2022	González-Pérez, José A./0000-0001-7607-1444; González-Vila, Francisco J./0000-0002-6320-5391; Blanquez Moya, Alba/0000-0001-9513-6098; Morillo, Nicasio Jiménez/0000-0001-5746-1922; Hernandez Cutuli, Manuel/0000-0002-1430-9952; Ball, Andrew/0000-0003-2387-968X	Spanish Ministry for Economy and Competitiveness [CTQ2014-56038-C3-2-R, CGL2016-78937-R]; FPI research grant [BES-2013-062573]	Spanish Ministry for Economy and Competitiveness(Spanish Government); FPI research grant	This study was funded in part by projects CTQ2014-56038-C3-2-R and CGL2016-78937-R (INTERCARBON) from the Spanish Ministry for Economy and Competitiveness. N.T Jimenez-Morillo acknowledges a FPI research grant (BES-2013-062573) and A.Blanquez is awarded with a grant from the project CTQ2014-56038-C3-2-R.	ALMENDROS G, 1992, SCI TOTAL ENVIRON, V118, P63, DOI 10.1016/0048-9697(92)90073-2; Anusha NC, 2017, MINERVA BIOTECNOL, V29, P53, DOI 10.23736/S1120-4826.16.01793-6; Arias ME, 2005, J ANAL APPL PYROL, V74, P138, DOI 10.1016/j.jaap.2004.11.028; Arias ME, 2003, APPL ENVIRON MICROB, V69, P1953, DOI 10.1128/AEM.69.4.1953-1958.2003; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; CRAWFORD DL, 1978, APPL ENVIRON MICROB, V35, P1041, DOI 10.1128/AEM.35.6.1041-1045.1978; Diamantidis G, 2000, SOIL BIOL BIOCHEM, V32, P919, DOI 10.1016/S0038-0717(99)00221-7; Dorado J, 2001, ENZYME MICROB TECH, V28, P550, DOI 10.1016/S0141-0229(00)00363-X; Dube E, 2008, APPL MICROBIOL BIOT, V79, P597, DOI 10.1007/s00253-008-1475-5; Endo K, 2003, J BIOCHEM, V133, P671, DOI 10.1093/jb/mvg086; Eugenio ME, 2011, BIORESOURCES, V6, P3231; Fengel D., 1984, Wood: chemistry, ultrastructure, reactions.; Fernandes AT, 2007, FEBS J, V274, P2683, DOI 10.1111/j.1742-4658.2007.05803.x; Gonzalez-Vila FJ, 2009, BIORESOURCE TECHNOL, V100, P1304, DOI 10.1016/j.biortech.2008.06.067; Gutierrez A, 1996, APPL ENVIRON MICROB, V62, P1928, DOI 10.1128/AEM.62.6.1928-1934.1996; Hattori M, 2010, INSECT BIOCHEM MOLEC, V40, P331, DOI 10.1016/j.ibmb.2010.02.009; Hernandez M, 2001, J ANAL APPL PYROL, V58, P539, DOI 10.1016/S0165-2370(00)00194-7; HernandezCoronado MJ, 1997, MICROBIOL-SGM, V143, P1359, DOI 10.1099/00221287-143-4-1359; LIN SS, 1992, STOCHASTIC HYDRAULICS '92, P83; Ludwig CH, 1971, LIGNINS OCCURRENCE F; Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104; Majumdar S, 2014, BIOCHEMISTRY-US, V53, P4047, DOI 10.1021/bi500285t; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Molina-Guijarro JM, 2009, INT MICROBIOL, V12, P13, DOI 10.2436/20.1501.01.77; Moya R, 2010, BIORESOURCE TECHNOL, V101, P2224, DOI 10.1016/j.biortech.2009.11.061; Mussatto S. I., 2010, TOP APPL MICROBIOL M, V2, P897, DOI DOI 10.1016/J.JRRAS.2014.02.003; Niladevi KN, 2008, PROCESS BIOCHEM, V43, P654, DOI 10.1016/j.procbio.2008.02.002; Pandey KK, 2003, INT BIODETER BIODEGR, V52, P151, DOI 10.1016/S0964-8305(03)00052-0; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Santhanam N, 2011, TRENDS BIOTECHNOL, V29, P480, DOI 10.1016/j.tibtech.2011.04.005; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Skalova T, 2007, ACTA CRYSTALLOGR F, V63, P1077, DOI 10.1107/S1744309107060721; Steudler S, 2015, ADV BIOCHEM ENG BIOT, V149, P223, DOI 10.1007/10_2014_300; Tandy S, 2010, BIORESOURCE TECHNOL, V101, P5431, DOI 10.1016/j.biortech.2010.02.033; Trubitsina LI, 2015, BIOCHIMIE, V112, P151, DOI 10.1016/j.biochi.2015.03.005; Widsten P, 2008, ENZYME MICROB TECH, V42, P293, DOI 10.1016/j.enzmictec.2007.12.003	36	12	12	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187649	10.1371/journal.pone.0187649	http://dx.doi.org/10.1371/journal.pone.0187649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112957	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100029
J	Schnitzler, A; Genet, F; Diebold, A; Mailhan, L; Jourdan, C; Denormandie, P				Schnitzler, Alexis; Genet, Francois; Diebold, Aurelie; Mailhan, Laurence; Jourdan, Claire; Denormandie, Philippe			Lengthening of knee flexor muscles by percutaneous needle tenotomy: Description of the technique and preliminary results	PLOS ONE			English	Article							DUPUYTRENS DISEASE; CEREBRAL-PALSY; CONTRACTURES; TENDINOSIS; DEFINITION; PREVALENCE; FLEXION	Background Knee flexion contractures occur frequently in non-ambulatory, aged persons and persons with central nervous system lesions, rendering positioning and nursing care difficult. There are often risks associated with surgical interventions. Objective To evaluate the effectiveness of percutaneous needle tenotomy to lengthen the knee flexor muscles and improve passive function. Methods This was a retrospective study of all patients who underwent percutaneous needle tenotomy between 2012 and 2014. Tenotomy was carried out in the semi-tendinosus, biceps femoris and gracillis muscles under local anesthesia. The procedure took no more than 40 minutes. Range of motion (ROM) was evaluated immediately post-operatively and 3 months later. Results Thirty-four needle tenotomies were carried out. Mean lack of knee extension was 94.2 degrees (range 35-120 degrees) pre-op, (range 15-90 degrees; p<0.05) immediately post-op and 50.1 degrees (range 10-90 degrees; p<0.05) three months later, thus a mean increase of 44.1 degrees knee extension (range 0-90 degrees). All care and positioning objectives were achieved. There were no complications and procedure-related pain was rated as 3-4/10. Conclusions Needle tenotomy was well tolerated and yielded a significant increase in ROM with no unwanted effects. All objectives were achieved. This technique could be used in an ambulatory care setting or within institutions for severely disabled individuals.	[Schnitzler, Alexis; Genet, Francois; Diebold, Aurelie; Jourdan, Claire] CHU R Poincare, Dept Phys Med & Rehabil, Garches, France; [Mailhan, Laurence; Denormandie, Philippe] CHU R Poincare, Dept Orthopaed Surg, Garches, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Schnitzler, A (corresponding author), CHU R Poincare, Dept Phys Med & Rehabil, Garches, France.	alexis.schnitzler@aphp.fr			IPSEN	IPSEN(Ipsen)	IPSEN provided financial support for the data analysis and ALLERGAN for translation and editing of the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Authors thank IPSEN for financial support with the data analysis and ALLERGAN for support with translation and editing of the article.	BADOIS FJ, 1993, REV RHUM, V60, P808; Beaudreuil J, 2012, JOINT BONE SPINE, V79, P13, DOI 10.1016/j.jbspin.2011.03.003; Chang WN, 2004, GAIT POSTURE, V19, P298, DOI 10.1016/S0966-6362(03)00070-5; Chesnel C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143495; DAMRON TA, 1993, J PEDIATR ORTHOPED, V13, P188; Dehail P., 2014, Annals of Physical and Rehabilitation Medicine, V57, P11, DOI 10.1016/j.rehab.2013.11.001; El Hage S, 2010, J PEDIATR ORTHOPED, V30, P485, DOI 10.1097/BPO.0b013e3181df619d; Esterline ML, 2005, VET COMP ORTHOPAED, V18, P135, DOI 10.1055/s-0038-1632952; Fergusson D, 2007, CLIN ORTHOP RELAT R, P22, DOI 10.1097/01.BLO.0b013e3180308456; Finnoff JT, 2011, PM&R, V3, P900, DOI 10.1016/j.pmrj.2011.05.015; Housner JA, 2009, J ULTRAS MED, V28, P1187, DOI 10.7863/jum.2009.28.9.1187; Lakhey S, 2007, Kathmandu Univ Med J (KUMJ), V5, P446; Martin JN, 2006, J BONE JOINT SURG AM, V88A, P840, DOI 10.2106/JBJS.E.00717; McShane JM, 2006, J ULTRAS MED, V25, P1281, DOI 10.7863/jum.2006.25.10.1281; Minkowitz Barbara, 2004, J Foot Ankle Surg, V43, P263, DOI 10.1053/j.jfas.2004.05.012; MOLLINGER LA, 1993, PHYS THER, V73, P437, DOI 10.1093/ptj/73.7.437; Offenbacher M, 2014, DISABIL REHABIL, V36, P529, DOI 10.3109/09638288.2013.800596; Parada CPTSA, 2009, J PEDIATR ORTHOPED, V29, P916, DOI 10.1097/BPO.0b013e3181c18ab5; Schnitzler A, 2016, ANN PHYS REHABIL MED, V59, P83, DOI 10.1016/j.rehab.2015.11.005; Wagner LM, 2010, J AM MED DIR ASSOC, V11, P94, DOI 10.1016/j.jamda.2009.04.010	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0182062	10.1371/journal.pone.0182062	http://dx.doi.org/10.1371/journal.pone.0182062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112966	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100002
J	Paula, FMM; Leite, NC; Borck, PC; Freitas-Dias, R; Cnop, M; Chacon-Mikahil, MPT; Cavaglieri, CR; Marchetti, P; Boschero, AC; Zoppi, CC; Eizirik, DL				Paula, Flavia M. M.; Leite, Nayara C.; Borck, Patricia C.; Freitas-Dias, Ricardo; Cnop, Miriam; Chacon-Mikahil, Mara P. T.; Cavaglieri, Claudia R.; Marchetti, Piero; Boschero, Antonio C.; Zoppi, Claudio C.; Eizirik, Decio L.			Exercise training protects human and rodent beta cells against endoplasmic reticulum stress and apoptosis	FASEB JOURNAL			English	Article						T1D; STAT3; pancreatic islets; myokine; IL6	SKELETAL-MUSCLE; INSULIN-SECRETION; CANDIDATE GENE; GLUCOSE-UPTAKE; TYPE-1; MECHANISMS; ACTIVATION; RAT; IDENTIFICATION; INTERLEUKIN-6	Prolonged exercise has positive metabolic effects in obese or diabetic individuals. These effects are usually ascribed to improvements in insulin sensitivity. We evaluated whether exercise also generates circulating signals that protect human and rodent beta cells against endoplasmic reticulum (ER) stress and apoptosis. For this purpose, we obtained serum from humans or mice before and after an 8 wk training period. Exposure of human islets or mouse or rat b cells to human or rodent sera, respectively, obtained from trained individuals reduced cytokine (IL-1 beta+IFN-gamma)- or chemical ER stressor-induced beta-cell ER stress and apoptosis, at least in part via activation of the transcription factor STAT3. These findings indicate that exercise training improves human and rodent beta-cell survival under diabetogenic conditions and support lifestyle interventions as a protective approach for both type 1 and 2 diabetes.	[Paula, Flavia M. M.; Cnop, Miriam; Eizirik, Decio L.] ULB, Erasmus Hosp, Ctr Diabet Res, Brussels, Belgium; [Cnop, Miriam] ULB, Erasmus Hosp, Div Endocrinol, Brussels, Belgium; [Leite, Nayara C.; Borck, Patricia C.; Freitas-Dias, Ricardo; Boschero, Antonio C.; Zoppi, Claudio C.] Univ Campinas UNICAMP, Obes & Comorbid Res Ctr, Inst Biol, Dept Struct & Funct Biol, Campinas, Brazil; [Chacon-Mikahil, Mara P. T.; Cavaglieri, Claudia R.] Univ Campinas UNICAMP, Fac Phys Educ, Exercise Physiol Lab FISEX, Campinas, Brazil; [Freitas-Dias, Ricardo] Univ Pernambuco, Dept Phys Therapy, Petrolina, Brazil; [Marchetti, Piero] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Pernambuco (UPE); University of Pisa	Paula, FMM (corresponding author), ULB, Erasmus Hosp, Ctr Diabet Res, Brussels, Belgium.; Paula, FMM (corresponding author), ULB, Ctr Diabet Res, Med Fac, Route Lennik 808, B-1070 Brussels, Belgium.	flaviammdepaula@gmail.com	Cavaglieri, Cláudia Regina/C-4291-2012; Dias, Ricardo Freitas/E-1657-2013	Cavaglieri, Cláudia Regina/0000-0002-7795-6575; Cnop, Miriam/0000-0002-5112-1692; Leite, Nayara/0000-0003-4436-6947; Chacon-Mikahil, Mara Patricia Traina/0000-0002-6109-5141	Sao Paulo Research Foundation (FAPESP) [2015/12611-0]; CNPq [310398/2015]; Faepex [850/2015]; European Union's Horizon 2020 Research and Innovation Programme; project T2DSystems [667191]; Innovative Medicines Initiative 2 [115797]; Union's Horizon 2020 research and innovation program; European Federation of Pharmaceutical Industries and Associations (EFPIA); Juvenile Diabetes Reach Foundation; Leona M. and Harry B. Helmsley Charitable Trust	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faepex; European Union's Horizon 2020 Research and Innovation Programme; project T2DSystems; Innovative Medicines Initiative 2; Union's Horizon 2020 research and innovation program; European Federation of Pharmaceutical Industries and Associations (EFPIA); Juvenile Diabetes Reach Foundation; Leona M. and Harry B. Helmsley Charitable Trust	The authors thank A. Musuaya, M. Pangerl, and I. Millard for excellent technical support. The work was supported by Sao Paulo Research Foundation (FAPESP) Grant 2015/12611-0 (to A.C.B. and C.C.Z.), CNPq Grant 310398/2015, and Faepex Grant 850/2015 (to M.P.T.C.-M. and C.R.C.). D.L.E., M.C., and P.M. received funding from the European Union's Horizon 2020 Research and Innovation Programme, project T2DSystems, under Grant Agreement 667191, and the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement 115797 (INNODIA). This joint undertaking received support from the Union's Horizon 2020 research and innovation program and the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Reach Foundation and The Leona M. and Harry B. Helmsley Charitable Trust. C.C.Z. and D.L.E. are co-senior authors. The authors declare no conflicts of interest.	BORDIN S, 1995, J MEMBRANE BIOL, V148, P177; Brozzi F, 2015, DIABETOLOGIA, V58, P2307, DOI 10.1007/s00125-015-3669-6; Calegari VC, 2012, J APPL PHYSIOL, V112, P711, DOI 10.1152/japplphysiol.00318.2011; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Catoire M, 2014, PHYSIOL GENOMICS, V46, P256, DOI 10.1152/physiolgenomics.00174.2013; Christensen CS, 2015, J CLIN ENDOCR METAB, V100, pE1289, DOI 10.1210/jc.2014-4506; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; Conceicao MS, 2016, MED SCI SPORT EXER, V48, P1699, DOI 10.1249/MSS.0000000000000970; Coskun O, 2004, TOHOKU J EXP MED, V203, P145, DOI 10.1620/tjem.203.145; Czepluch FS, 2011, THROMB HAEMOSTASIS, V105, P122, DOI 10.1160/TH10-06-0363; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Darling NJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184907; De Groef S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.171; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; HAMMACHER A, 1994, PROTEIN SCI, V3, P2280, DOI 10.1002/pro.5560031213; Huang HW, 2011, EXP DIABETES RES, DOI 10.1155/2011/465910; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Igoillo-Esteve M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003888; International Diabetes Federation (IDF), 2015, IDF DIAB ATL; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karstoft K, 2016, IMMUNOL CELL BIOL, V94, P146, DOI 10.1038/icb.2015.101; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kolb H, 2012, NAT REV ENDOCRINOL, V8, P183, DOI 10.1038/nrendo.2011.158; Krolopp JE, 2016, FRONT PHYSIOL, V7, DOI [10.3339/fphys.2016.00626, 10.3389/fphys.2016.00626]; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729; Lindholm ME, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006294; Liu DB, 2001, ENDOCRINOLOGY, V142, P2593, DOI 10.1210/en.142.6.2593; Liu SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175498; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marroqui L, 2015, EBIOMEDICINE, V2, P378, DOI 10.1016/j.ebiom.2015.03.012; Marroqui L, 2014, DIABETES, V63, P2516, DOI 10.2337/db13-1443; Miani M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.236; Mitsuyama K, 2006, CYTOKINE GROWTH F R, V17, P451, DOI 10.1016/j.cytogfr.2006.09.003; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Narendran P, 2015, DIABETOLOGIA, V58, P10, DOI 10.1007/s00125-014-3412-8; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Paula FMM, 2015, FASEB J, V29, P1805, DOI 10.1096/fj.14-264820; Peake JM, 2015, J APPL PHYSIOL, V119, P172, DOI 10.1152/japplphysiol.01055.2014; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rezende EL, 2006, J EXP BIOL, V209, P115, DOI 10.1242/jeb.01883; Stanford KI, 2014, ADV PHYSIOL EDUC, V38, P308, DOI 10.1152/advan.00080.2014; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Wang SW, 2014, INT J ONCOL, V44, P1032, DOI 10.3892/ijo.2014.2259; Weigert C, 2014, PROTEOM CLIN APPL, V8, P5, DOI 10.1002/prca.201300094	53	18	20	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1524	1536		10.1096/fj.201700710R	http://dx.doi.org/10.1096/fj.201700710R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29133342				2022-12-26	WOS:000427246000032
J	Kajimoto, T; Mohamed, NNI; Badawy, SMM; Matovelo, SA; Hirase, M; Nakamura, S; Yoshida, D; Okada, T; Ijuin, T; Nakamura, S				Kajimoto, Taketoshi; Mohamed, Nesma Nabil Ibrahim; Badawy, Shaymaa Mohamed Mohamed; Matovelo, Shubi Ambwene; Hirase, Mitsuhiro; Nakamura, Shunsuke; Yoshida, Daisuke; Okada, Taro; Ijuin, Takeshi; Nakamura, Shun-ichi			Involvement of G beta gamma subunits of G(i) protein coupled with S1P receptor on multivesicular endosomes in F-actin formation and cargo sorting into exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SPHINGOSINE 1-PHOSPHATE; BIOGENESIS; ACTIVATION; MEMBRANE; RAC; SPHINGOSINE-1-PHOSPHATE; CYTOSKELETON; MECHANISM; CERAMIDE	Exosomes play a critical role in cell-to-cell communication by delivering cargo molecules to recipient cells. However, the mechanism underlying the generation of the exosomal multivesicular endosome (MVE) is one of the mysteries in the field of endosome research. Although sphingolipid metabolites such as ceramide and sphingosine 1-phosphate (S1P) are known to play important roles in MVE formation and maturation, the detailed molecular mechanisms are still unclear. Here, we show that Rho family GTPases, including Cdc42 and Rac1, are constitutively activated on exosomal MVEs and are regulated by S1P signaling as measured by fluorescence resonance energy transfer (FRET)based conformational changes. Moreover, we detected S1P signaling- induced filamentous actin (F-actin) formation. A selective inhibitor of G beta gamma subunits, M119, strongly inhibited both F-actin formation on MVEs and cargo sorting into exosomal intralumenal vesicles of MVEs, both of which were fully rescued by the simultaneous expression of constitutively active Cdc42 and Rac1. Our results shed light on the mechanism underlying exosomal MVE maturation and inform the understanding of the physiological relevance of continuous activation of the S1P receptor and subsequent downstream G protein signaling to G beta gamma subunits/Rho family GTPases-regulated F-actin formation on MVEs for cargo sorting into exosomal intralumenal vesicles.	[Kajimoto, Taketoshi; Mohamed, Nesma Nabil Ibrahim; Badawy, Shaymaa Mohamed Mohamed; Matovelo, Shubi Ambwene; Hirase, Mitsuhiro; Nakamura, Shunsuke; Yoshida, Daisuke; Okada, Taro; Ijuin, Takeshi; Nakamura, Shun-ichi] Kobe Univ, Div Biochem, Dept Biochem & Mol Biol, Grad Sch Med, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan	Kobe University	Nakamura, S (corresponding author), Kobe Univ, Div Biochem, Dept Biochem & Mol Biol, Grad Sch Med, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan.	snakamur@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Technology Development Research Grant from the Nakatani Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Technology Development Research Grant from the Nakatani Foundation	This work was supported in part by a Grant-in-Aid for challenging Exploratory Research (to S.-i. N.), a Grant-in-Aid for Scientific Research (C) (to T. O.), a Grant-in-Aid for Scientific Research (C) (to T. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Technology Development Research Grant from the Nakatani Foundation (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ledezma-Sanchez BA, 2010, BIOCHEM BIOPH RES CO, V391, P1647, DOI 10.1016/j.bbrc.2009.12.108; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Kajimoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3712; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Naito Yuki, 2013, Methods Mol Biol, V942, P57, DOI 10.1007/978-1-62703-119-6_3; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Perry DK, 1998, BBA-MOL CELL BIOL L, V1436, P233, DOI 10.1016/S0005-2760(98)00145-3; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	31	36	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					245	253		10.1074/jbc.M117.808733	http://dx.doi.org/10.1074/jbc.M117.808733			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29133526	hybrid, Green Published			2022-12-26	WOS:000419453200021
J	Woodcock, JM; Goodwin, KL; Sandow, JJ; Coolen, C; Perugini, MA; Webb, AI; Pitson, SM; Lopez, AF; Carver, JA				Woodcock, Joanna M.; Goodwin, Katy L.; Sandow, Jarrod J.; Coolen, Carl; Perugini, Matthew A.; Webb, Andrew I.; Pitson, Stuart M.; Lopez, Angel F.; Carver, John A.			Role of salt bridges in the dimer interface of 14-3-3 zeta in dimer dynamics, N-terminal alpha-helical order, and molecular chaperone activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; PHOSPHORYLATION; BINDING; DIMERIZATION; EXCHANGE	The 14-3-3 family of intracellular proteins are dimeric, multifunctional adaptor proteins that bind to and regulate the activities of many important signaling proteins. The subunits within 14-3-3 dimers are predicted to be stabilized by salt bridges that are largely conserved across the 14-3-3 protein family and allow the different isoforms to form heterodimers. Here, we have examined the contributions of conserved salt-bridging residues in stabilizing the dimeric state of 14-3-3 zeta. Using analytical ultracentrifugation, our results revealed that Asp21 and Glu89 both play key roles in dimer dynamics and contribute to dimer stability. Furthermore, hydrogen-deuterium exchange coupled with mass spectrometry showed that mutation of Asp21 promoted disorder in the N-terminal helices of 14-3-3 zeta, suggesting that this residue plays an important role in maintaining structure across the dimer interface. Intriguingly, a D21N 14-3-3 zeta mutant exhibited enhanced molecular chaperone ability that prevented amorphous protein aggregation, suggesting a potential role for N-terminal disorder in 14-3-3 zeta's poorly understood chaperone action. Taken together, these results imply that disorder in the N-terminal helices of 14-3-3 zeta is a consequence of the dimermonomer dynamics and may play a role in conferring chaperone function to 14-3-3 zeta protein.	[Woodcock, Joanna M.; Coolen, Carl; Pitson, Stuart M.; Lopez, Angel F.] Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Woodcock, Joanna M.; Coolen, Carl; Pitson, Stuart M.; Lopez, Angel F.] SA Pathol, Adelaide, SA 5000, Australia; [Goodwin, Katy L.] Univ Adelaide, Sch Phys Sci, Adelaide, SA 5005, Australia; [Sandow, Jarrod J.; Webb, Andrew I.] Walter & Eliza Hall Inst Med Res, Div Syst Biol & Personalised Med, Parkville, Vic 3052, Australia; [Sandow, Jarrod J.; Webb, Andrew I.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Perugini, Matthew A.] La Trobe Univ, LA Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Carver, John A.] Australian Natl Univ, Res Sch Chem, Acton, ACT 2601, Australia	Centre for Cancer Biology; University of South Australia; SA Pathology; University of Adelaide; Walter & Eliza Hall Institute; University of Melbourne; La Trobe University; Australian National University	Woodcock, JM (corresponding author), Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia.; Woodcock, JM (corresponding author), SA Pathol, Adelaide, SA 5000, Australia.	Joanna.Woodcock@health.sa.gov.au	Pitson, Stuart/B-9342-2009; Carver, John Adrian/J-3825-2014	Pitson, Stuart/0000-0002-9527-2740; Carver, John Adrian/0000-0002-2441-8108; Perugini, Matthew/0000-0001-8052-5584; Woodcock, Joanna/0000-0001-5127-9687	Australian National Health and Medical Research Council [1068087]; National Health and Medical Research Council [1071897]; Fay Fuller Foundation; National Health and Medical Research Council Senior Research Fellowship [1042589]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Fay Fuller Foundation; National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian National Health and Medical Research Council Project Grant 1068087 (to J. A. C.), National Health and Medical Research Council Program Grant 1071897 (to A. F. L.), and the Fay Fuller Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Health and Medical Research Council Senior Research Fellowship 1042589.	Cox D, 2014, BBA-MOL BASIS DIS, V1842, P1830, DOI 10.1016/j.bbadis.2014.06.024; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Goodwin K. L., 2015, THESIS; Haladova K, 2012, J STRUCT BIOL, V179, P10, DOI 10.1016/j.jsb.2012.04.016; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Kaneko K, 2006, MED HYPOTHESES, V67, P169, DOI 10.1016/j.mehy.2006.01.019; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Obsilova V, 2004, J BIOL CHEM, V279, P4531, DOI 10.1074/jbc.M306939200; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Peverelli MG, 2016, J BIOL CHEM, V291, P9785, DOI 10.1074/jbc.M115.696591; Powell DW, 2003, MOL CELL BIOL, V23, P5376, DOI 10.1128/MCB.23.15.5376-5387.2003; Sheluho D, 2001, J BIOL CHEM, V276, P39945, DOI 10.1074/jbc.M107252200; Sluchanko NN, 2008, ARCH BIOCHEM BIOPHYS, V477, P305, DOI 10.1016/j.abb.2008.05.020; Sluchanko NN, 2017, FEBS J, V284, P1279, DOI 10.1111/febs.13986; Sluchanko NN, 2015, BBA-PROTEINS PROTEOM, V1854, P492, DOI 10.1016/j.bbapap.2015.02.017; Sluchanko NN, 2014, ARCH BIOCHEM BIOPHYS, V549, P32, DOI 10.1016/j.abb.2014.03.008; Sluchanko NN, 2012, FEBS LETT, V586, P4249, DOI 10.1016/j.febslet.2012.10.048; Sluchanko NN, 2012, BIOCHEMISTRY-US, V51, P6127, DOI 10.1021/bi300674e; Sluchanko NN, 2011, BIOCHEMISTRY-US, V50, P9797, DOI 10.1021/bi201374s; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Williams DM, 2011, BIOCHEM J, V437, P493, DOI 10.1042/BJ20102178; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Woodcock JM, 2015, ONCOTARGET, V6, P14522, DOI 10.18632/oncotarget.3995; Woodcock JM, 2010, CELL SIGNAL, V22, P1291, DOI 10.1016/j.cellsig.2010.04.004; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yano M, 2006, MOL BIOL CELL, V17, P4769, DOI 10.1091/mbc.E06-03-0229	32	15	15	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					89	99		10.1074/jbc.M117.801019	http://dx.doi.org/10.1074/jbc.M117.801019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29109150	Green Published, hybrid			2022-12-26	WOS:000419453200006
J	Wu, C; Woo, JG; Zhang, NH				Wu, Cynthia; Woo, Jessica G.; Zhang, Nanhua			Association between urinary manganese and blood pressure: Results from National Health and Nutrition Examination Survey (NHANES), 2011-2014	PLOS ONE			English	Article							OXIDATIVE STRESS; BIOMARKERS; EXPOSURE; TOENAIL	Manganese is a trace mineral required for metabolism, growth and tissue formation, and reproduction. It is mainly obtained through food and water, as well as through occupational exposure. This study used data from National Health and Nutrition Examination Survey, combining the 2011-12 and 2013-14 cycles. We conducted linear regression analyses on urinary manganese and blood pressure. Significant negative associations (p<0.01) between urinary manganese and both systolic and diastolic blood pressure existed after adjusting for age, sex, body mass index, race/ethnicity, and status of taking antihypertensive medication. These results indicate that urinary manganese may play some role in blood pressure and protecting against hypertension, a major risk factor for cardiovascular disease.	[Wu, Cynthia; Woo, Jessica G.; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Wu, Cynthia] Johns Hopkins Univ, Krieger Sch Arts & Sci, Baltimore, MD USA	Cincinnati Children's Hospital Medical Center; Johns Hopkins University	Zhang, NH (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA.	nanhua.zhang@cchmc.org	Woo, Jessica/M-4984-2015	Woo, Jessica/0000-0003-3644-8432; Zhang, Nanhua/0000-0001-5796-3404				Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; *ATSDR, 2012, TOX PROF MAN; Baradaran A, 2014, J RES MED SCI, V19, P358; Benjamin EJ, 2017, CIRCULATION, V135, P146; Cameron AC, 1997, J ECONOMETRICS, V77, P329; ELYAZIGI A, 1991, DIABETES RES CLIN EX, V18, P129; Hassani H, 2016, IND HEALTH, V54, P79, DOI 10.2486/indhealth.2014-0250; Jiang YM, 2005, CARDIOVASC TOXICOL, V5, P345, DOI 10.1385/CT:5:4:345; Laohaudomchok W, 2011, J OCCUP ENVIRON MED, V53, P506, DOI 10.1097/JOM.0b013e31821854da; Lee Yeon-Kyung, 2015, Clin Nutr Res, V4, P259, DOI 10.7762/cnr.2015.4.4.259; LUCCHINI R, 1995, SCAND J WORK ENV HEA, V21, P143, DOI 10.5271/sjweh.1369; Mordukhovich I, 2012, ENVIRON HEALTH PERSP, V120, P98, DOI 10.1289/ehp.1002805; O'Neal Stefanie L, 2015, Curr Environ Health Rep, V2, P315, DOI 10.1007/s40572-015-0056-x; SARIC M, 1975, ENVIRON RES, V10, P314, DOI 10.1016/0013-9351(75)90092-4	15	22	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188145	10.1371/journal.pone.0188145	http://dx.doi.org/10.1371/journal.pone.0188145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141052	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400065
J	Bao, XA; Xiong, ZJ; Zhang, N; Qian, JY; Wu, B; Zhang, W				Bao, Xiaoan; Xiong, Zijian; Zhang, Na; Qian, Junyan; Wu, Biao; Zhang, Wei			Path-oriented test cases generation based adaptive genetic algorithm	PLOS ONE			English	Article							EVOLUTIONARY ALGORITHMS	The automatic generation of test cases oriented paths in an effective manner is a challenging problem for structural testing of software. The use of search-based optimization methods, such as genetic algorithms (GAs), has been proposed to handle this problem. This paper proposes an improved adaptive genetic algorithm (IAGA) for test cases generation by maintaining population diversity. It uses adaptive crossover rate and mutation rate in dynamic adjustment according to the differences between individual similarity and fitness values, which enhances the exploitation of searching global optimum. This novel approach is experimented and tested on a benchmark and six industrial programs. The experimental results confirm that the proposed method is efficient in generating test cases for path coverage.	[Bao, Xiaoan; Xiong, Zijian; Zhang, Na; Wu, Biao; Zhang, Wei] Zhejiang Sci Tech Univ, Dept Informat Technol, Hangzhou, Zhejiang, Peoples R China; [Qian, Junyan] Guilin Univ Elect Technol, Guangxi Key Lab Trusted Software, Guilin, Peoples R China	Zhejiang Sci-Tech University; Guilin University of Electronic Technology	Zhang, N (corresponding author), Zhejiang Sci Tech Univ, Dept Informat Technol, Hangzhou, Zhejiang, Peoples R China.	zhangna@zstu.edu.cn			National Natural Science Foundation of China [61379036, 61502430, 61562015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported in part by the National Natural Science Foundation of China (grant Nos. 61379036, 61502430, and 61562015). The funder information can be found at http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action. There was no additional external funding received for this study.	Abdul-Rahman OA, 2013, INFORM SCIENCES, V233, P54, DOI 10.1016/j.ins.2013.01.005; Alba E, 2008, COMPUT OPER RES, V35, P3161, DOI 10.1016/j.cor.2007.01.016; Aleti A, 2015, J SYST SOFTWARE, V103, P343, DOI 10.1016/j.jss.2014.11.035; Aleti A, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1501; Arcuri A, 2013, SOFTW TEST VERIF REL, V23, P119, DOI 10.1002/stvr.457; Awedikian Z., 2009, P 11 ANN C GENETIC E, P1657; Ribeiro JCB, 2010, STUD COMPUT INTELL, V284, P185; Do HS, 2005, EMPIR SOFTW ENG, V10, P405, DOI 10.1007/s10664-005-3861-2; Eiben AE, 2011, SWARM EVOL COMPUT, V1, P19, DOI 10.1016/j.swevo.2011.02.001; Ferrer J, 2012, SOFTWARE PRACT EXPER, V42, P1331, DOI 10.1002/spe.1135; [傅博 Fu Bo], 2005, [计算机工程与应用, Computer Engineering and Application], V41, P82; Girgis M. R., 2014, INT, V89, P29; Harman M, 2010, IEEE T SOFTWARE ENG, V36, P226, DOI 10.1109/TSE.2009.71; Korel B., 1992, Software Testing, Verification and Reliability, V2, P203, DOI 10.1002/stvr.4370020405; Maragathavalli P., 2012, 2012 International Conference on Advances in Engineering, Science and Management (ICAESM), P349; Mc Ginley B, 2011, IEEE T EVOLUT COMPUT, V15, P692, DOI 10.1109/TEVC.2010.2046173; McMinn P, 2004, SOFTW TEST VERIF REL, V14, P105, DOI 10.1002/stvr.294; Mei J, 2014, CHINESE J ELECTRON, V23, P494; Miller W., 1976, IEEE Transactions on Software Engineering, VSE-2, P223, DOI 10.1109/TSE.1976.233818; Nirpal Premal B., 2011, International Journal of Advanced Networking and Applications, V2, P911; Pachauri A, 2013, J SYST SOFTWARE, V86, P1191, DOI 10.1016/j.jss.2012.11.045; Park T, 2010, IEEE T EVOLUT COMPUT, V14, P865, DOI 10.1109/TEVC.2010.2043362; Srivastava P R, 2009, SCI REPORTS, V3, P134; Tracey N, 1998, 13TH IEEE INTERNATIONAL CONFERENCE ON AUTOMATED SOFTWARE ENGINEERING, PROCEEDINGS, P285, DOI 10.1109/ASE.1998.732680; Varshney Sapna, 2013, Software Engineering Notes, V38, P146, DOI 10.1145/2492248.2492277; Wegener J, 2001, INFORM SOFTWARE TECH, V43, P841, DOI 10.1016/S0950-5849(01)00190-2; Windisch A, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1121; Xanthakis S, 1992, P 5 INT C SOFTW ENG; Zhang JQ, 2009, IEEE T EVOLUT COMPUT, V13, P945, DOI 10.1109/TEVC.2009.2014613	29	11	12	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187471	10.1371/journal.pone.0187471	http://dx.doi.org/10.1371/journal.pone.0187471			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136028	Green Submitted, Green Published, gold			2022-12-26	WOS:000415121200020
J	Kowalska, JD; Wojcik, G; Rutkowski, J; Ankiersztejn-Bartczak, M; Siewaszewicz, E				Kowalska, Justyna D.; Wojcik, Grzegorz; Rutkowski, Jakub; Ankiersztejn-Bartczak, Magdalena; Siewaszewicz, Ewa			Modelling the cost-effectiveness of HIV care shows a clear benefit when transmission risk is considered in the calculations - A message for Central and Eastern Europe	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; INFECTION; COHORT; PREVENTION; NAIVE; MEN; INDIVIDUALS; MORTALITY; DIAGNOSIS; DISEASE	Background HIV epidemic remains a major global health issue. Data from cost-effectiveness analyses base on CD4+ count and morbidity in patients with symptomatic and asymptomatic HIV infection. The approach adopted in these analyses includes many other factors, previously not investigated. Additionally, we evaluate the impact of sexual HIV transmission due to delayed cART on the cost-effectiveness of care. Methods A lifetime Markov model (1-month cycle) was developed to estimate the cost per quality adjusted life years (QALY) for a 1- and 3-year delay in starting cART (as compared to starting immediately at linkage to care) lifetime costs, clinical outcomes and cost-effectiveness. Patients were categorized into having asymptomatic HIV, AIDS, Hodgkin's Lymphoma, and non-AIDS defining condition. Mortality rates and utility values were obtained from published literature. The number of new infected persons was estimated on the basis of sexual orientation, the number of sexual partners per year, the number of sex acts per month, frequency of condom use and use of cART. For the input Test and Keep in Care (TAK) project cohort data were used. Costs of care, cART and potential life-years lost were based on estimated total costs and the difference in expected QALY gained between an HIV-positive and an average person in Polish population. Costs were based on real expenditures of the Ministry of Health, National Health Fund, available studies and experts' opinion. Costs and effects were discounted at rates of 5% and 3.5%, respectively. Results Input data were available for 141 patients form TAK cohort. The estimated number of new HIV infections in low, medium and high risk transmission groups were 0.28, 0.61, 2.07 with 1 and 0.82, 1.80, 6.11 with a 3-year delay, respectively. This reflected QALY loss due to cART delay of 0.52, 1.13, 3.84 and 2.02, 4.43, 15.03 for a 1- and 3-year delay, respectively. If additional costs of treatment and potential life-years lost due to new HIV infections were not taken into account, initiating cART immediately at linkage to care was not cost-saving irrespective of cART delay. Otherwise, when additional costs and QALY lost due to new HIV infections were included, immediate cART initiation was cost-saving regardless of the chosen scenarios. Conclusions If new HIV infections are not taken into account, then starting cART immediately does not dominate comparing to delaying cART. When taking into account HIV transmission in cost-effectiveness analysis, immediate initiation of HIV treatment is a profitable decision from the public payer's perspective.	[Kowalska, Justyna D.] Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland; [Kowalska, Justyna D.] Hosp Infect Dis Warsaw, HIV Out Patients Clin, Warsaw, Poland; [Wojcik, Grzegorz; Rutkowski, Jakub] HTA Consulting, Krakow, Poland; [Ankiersztejn-Bartczak, Magdalena] Fdn Social Educ FES, Warsaw, Poland; [Siewaszewicz, Ewa] Gilead Sci Inc, Warsaw, Poland	Medical University of Warsaw	Kowalska, JD (corresponding author), Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland.; Kowalska, JD (corresponding author), Hosp Infect Dis Warsaw, HIV Out Patients Clin, Warsaw, Poland.	jdkowalska@gmail.com			Gilead Sciences Poland	Gilead Sciences Poland	The study has been supported by Gilead Sciences Poland by covering the cost of work performed by HTA Consulting, a commercial company. However the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the "author contributions" section. JR and GW are hired by HTA Consulting. ES is hired by the Gilead Sciences Poland company. JDK is not hired by either of these commercial institutions and did not receive financial support or author's salary in relation to this work.	Amarowicz J, 2015, ORTOPEDIA TRAUMATOLO, V1, P59; Ankiersztejn-Bartczak M, 2015, HIV MED, V16, P88, DOI 10.1111/hiv.12175; [Anonymous], 2016, EUROPEAN AIDS CLIN S; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Friis-Moller N, 2016, EUR J PREV CARDIOL, V23, P214, DOI 10.1177/2047487315579291; Golicki D, 2015, POL ARCH MED WEWN, V125, P18, DOI 10.20452/pamw.2638; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Hleyhel M, 2015, INT J CANCER, V137, P2443, DOI 10.1002/ijc.29603; Kaczor MP, 2012, VALUE HEALTH, V15, pA331, DOI 10.1016/j.jval.2012.08.778; Kahn JG, 2011, CURR HIV RES, V9, P405, DOI 10.2174/157016211798038542; Kerr CC, 2015, JAIDS-J ACQ IMM DEF, V69, P365, DOI 10.1097/QAI.0000000000000605; Kinalska I., 2004, DIABETOLOGIA PRAKTYC, V5, P1; Kolaric B, 2011, COLLEGIUM ANTROPOL, V35, P855; Kovari H, 2015, J HEPATOL, V63, P573, DOI 10.1016/j.jhep.2015.04.019; Kowalska JD, 2016, HIV MED; Kowalska JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162739; Kowalska JD, 2012, AIDS, V26, P315, DOI 10.1097/QAD.0b013e32834e8805; Lasry A, 2014, AIDS, V28, P1521, DOI 10.1097/QAD.0000000000000307; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 2009, CLIN INFECT DIS, V48, P1138, DOI 10.1086/597468; Moeremans K, 2010, PHARMACOECONOMICS, V28, P147, DOI 10.2165/11587500-000000000-00000; Nakagawa F, 2014, AIDS, V28, P1351, DOI 10.1097/QAD.0000000000000224; National Center for Epidemiology, 2015, HUNGARIAN EPINFO, V47, P574; Petoumenos K, 2014, HIV MED, V15, P595, DOI 10.1111/hiv.12162; Petoumenos K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17426; Prabhu VS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019936; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Rosinska M, 2013, EUROSURVEILLANCE, V18, P20642; Ryom L, 2014, AIDS, V28, P187, DOI 10.1097/QAD.0000000000000042; Schmidt AJ, 2016, INT J DRUG POLICY, V38, P4, DOI 10.1016/j.drugpo.2016.09.007; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Tan-Torres Edejer T, 2003, WHO GUIDE COST EFFEC, P245; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; UNAIDS, GLOB AIDS UPD 2016; Wilkins E, 2016, HIV MED, V17, P505, DOI 10.1111/hiv.12349; Worm SW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-471	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0186131	10.1371/journal.pone.0186131	http://dx.doi.org/10.1371/journal.pone.0186131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131849	Green Published, Green Submitted, gold			2022-12-26	WOS:000414997800003
J	Zaveska Drabkova, L; Honys, D				Zaveska Drabkova, Lenka; Honys, David			Evolutionary history of callose synthases in terrestrial plants with emphasis on proteins involved in male gametophyte development	PLOS ONE			English	Article							EXINE PATTERN-FORMATION; POLLEN WALL PATTERN; GENE-EXPRESSION; TRANSCRIPTOME ANALYSIS; MALE-FERTILITY; UDP-GLUCOSE; ARABIDOPSIS; DIVERSIFICATION; BIOSYNTHESIS; ACCUMULATION	Callose is a plant-specific polysaccharide (beta-1,3-glucan) playing an important role in angio-sperms in many developmental processes and responses to biotic and abiotic stresses. Callose is synthesised at the plasma membrane of plant cells by callose synthase (CalS) and, among others, represents the main polysaccharide in the callose wall surrounding the tetrads of developing microspores and in the growing pollen tube wall. CalS proteins involvement in spore development is a plesiomorphic feature of terrestrial plants, but very little is known about their evolutionary origin and relationships amongst the members of this protein family. We performed thorough comparative analyses of callose synthase family proteins from major plant lineages to determine their evolutionary history across the plant kingdom. A total of 1211 candidate CalS sequences were identified and compared amongst diverse taxonomic groups of plants, from bryophytes to angiosperms. Phylogenetic analyses identified six main clades of CalS proteins and suggested duplications during the evolution of specialised functions. Twelve family members had previously been identified in Arabidopsis thaliana. We focused on five CalS subfamilies directly linked to pollen function and found that proteins expressed in pollen evolved twice. CalS9/10 and CalS11/12 formed well-defined clades, whereas pollen-specific CalS5 was found within subfamilies that mostly did not express in mature pollen vegetative cell, although were found in sperm cells. Expression of five out of seven mature pollen-expressed CalS genes was affected by mutations in bzip transcription factors. Only three subfamilies, CalS5, CalS10, and CalS11, however, formed monophyletic, mostly conserved clades. The pairs CalS9/CalS10, CalS11/CalS12 and CalS3 may have diverged after angiosperms diversified from lycophytes and bryophytes. Our analysis of fully sequenced plant proteins identified new evolutionary lineages of callose synthase subfamilies and has established a basis for understanding their functional evolution in terrestrial plants.	[Zaveska Drabkova, Lenka; Honys, David] Acad Sci Czech Republ, Lab Pollen Biol, Inst Expt Bot, Rozvojova 263, Prague 6, Czech Republic	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Zaveska Drabkova, L; Honys, D (corresponding author), Acad Sci Czech Republ, Lab Pollen Biol, Inst Expt Bot, Rozvojova 263, Prague 6, Czech Republic.	l.zaveska.drabkova@ueb.cas.cz; david@ueb.cas.cz	Drabkova, Lenka Zaveska/F-6999-2012; Honys, David/I-6707-2013	Drabkova, Lenka Zaveska/0000-0003-1140-6607; Honys, David/0000-0002-6848-4887	Czech Science Foundation [15-16050S, 17-23183S]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by the Czech Science Foundation (https://gacr.cz/en/), grants no. 15-16050S and 17-23183S, to DH.r The authors gratefully acknowledge the financial support from the Czech Science Foundation (grants no. 15-16050S and 17-23183S). The access to the computing and storage facilities owned by parties and projects contributing to the National Grid Infrastructure MetaCentrum provided under the programme "Projects of Large Infrastructure for Research, Development, and Innovations" (LM2010005) was highly appreciated, as was the access to the CERIT-SC computing and storage facilities provided under the programme "Center CERIT Scientific Cloud", part of the Operational Program Research and Development for Innovations, reg. no. CZ.1.05/3.2.00/08.0144.	Abercrombie JM, 2011, EVOL DEV, V2, P13; Ariizumi T, 2004, PLANT J, V39, P170, DOI 10.1111/j.1365-313X.2004.02118.x; Backues SK, 2010, PLANT CELL, V22, P3218, DOI 10.1105/tpc.110.077727; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bokvaj P, 2015, GENOM DATA, V3, P106, DOI 10.1016/j.gdata.2014.12.002; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Chen XY, 2009, PLANT SIGNAL BEHAV, V4, P489, DOI 10.4161/psb.4.6.8359; Chen YH, 2014, J PLANT BIOL, V57, P93, DOI 10.1007/s12374-013-0272-6; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Cui W, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.34, 10.1038/nplants.2016.34]; Dobritsa AA, 2010, PLANT PHYSIOL, V153, P937, DOI 10.1104/pp.110.157446; Dong XY, 2005, PLANT J, V42, P315, DOI 10.1111/j.1365-313X.2005.02379.x; Edwards KD, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3791-6; Ellinger D, 2014, ANN BOT-LONDON, V114, P1349, DOI 10.1093/aob/mcu120; Enns LC, 2005, PLANT MOL BIOL, V58, P333, DOI 10.1007/s11103-005-4526-7; Falter C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13722; Fila J., 2017, POLLEN TIP GROWTH, P247, DOI [10.1007/978-3-319-56645-0_10, DOI 10.1007/978-3-319-56645-0_10]; Firon N, 2012, ANN BOT-LONDON, V109, P1201, DOI 10.1093/aob/mcs070; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gibalova A, 2017, PLANT REPROD, V30, P1, DOI 10.1007/s00497-016-0295-5; Gibalova A, 2009, PLANT MOL BIOL, V70, P581, DOI 10.1007/s11103-009-9493-y; Guan YF, 2008, PLANT PHYSIOL, V147, P852, DOI 10.1104/pp.108.118026; Guseman JM, 2010, DEVELOPMENT, V137, P1731, DOI 10.1242/dev.049197; Hafidh S, 2012, PLANT SIGNAL BEHAV, V7, P918, DOI 10.4161/psb.20745; Hafidh S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-24; Hemsley AR, 2004, EVOLUTION PLANT PHYS, V21, P43; Hong ZL, 2001, PLANT CELL, V13, P755, DOI 10.1105/tpc.13.4.755; Honys D, 2000, SEX PLANT REPROD, V13, P135, DOI 10.1007/s004970000047; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Honys D, 2009, J PROTEOME RES, V8, P2015, DOI 10.1021/pr8009897; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huang LJ, 2009, J PLANT PHYSIOL, V166, P344, DOI 10.1016/j.jplph.2008.06.010; Jureckova JF, 2017, PLANTA, V245, P549, DOI 10.1007/s00425-016-2624-1; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Lu PL, 2014, PLANT PHYSIOL, V164, P1893, DOI 10.1104/pp.113.233387; Maeda H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00046; Majerska J, 2016, PROTOPLASMA; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Nishikawa SI, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-22; Pacini E, 2016, ABIOTIC AND BIOTIC STRESS IN PLANTS - RECENT ADVANCES AND FUTURE PERSPECTIVES, P703, DOI 10.5772/61671; Park JI, 2010, PLANT CELL PHYSIOL, V51, P981, DOI 10.1093/pcp/pcq057; Paxson-Sowders DM, 2001, PLANT PHYSIOL, V127, P1739, DOI 10.1104/pp.010517; Pirselova B, 2013, ACTA PHYSIOL PLANT, V35, P635, DOI 10.1007/s11738-012-1103-y; Quilichini TD, 2015, THESIS, V113, P170, DOI DOI 10.1016/J.PHYTOCHEM.2014.05.002; Quilichini TD, 2010, PLANT PHYSIOL, V154, P678, DOI 10.1104/pp.110.161968; Reyes F, 2010, PLANT J, V61, P423, DOI 10.1111/j.1365-313X.2009.04066.x; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schuette S, 2009, ANN BOT-LONDON, V103, P749, DOI 10.1093/aob/mcn268; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stone B. A., 1992, CHEM BIOL 1 3 BETA G, P365; Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109; Thiele K, 2009, PLANT J, V58, P13, DOI 10.1111/j.1365-313X.2008.03760.x; Toller A, 2008, PLANT J, V54, P911, DOI 10.1111/j.1365-313X.2008.03462.x; Vaten A, 2011, DEV CELL, V21, P1144, DOI 10.1016/j.devcel.2011.10.006; Verma DPS, 2001, PLANT MOL BIOL, V47, P693, DOI 10.1023/A:1013679111111; Voigt CA, 2006, PLANT PHYSIOL BIOCH, V44, P242, DOI 10.1016/j.plaphy.2006.05.001; Wallace S, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr027; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; WATERKEYN L, 1970, Grana, V10, P13; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Williams JH, 2008, P NATL ACAD SCI USA, V105, P11259, DOI 10.1073/pnas.0800036105; Williams JH, 2014, AM J BOT, V101, P559, DOI 10.3732/ajb.1300423; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xie B, 2012, PLANT SCI, V183, P1, DOI 10.1016/j.plantsci.2011.10.015; Xu T, 2016, SCI BULL, V61, P832, DOI 10.1007/s11434-016-1062-6; Yang J, 2013, PLANT PHYSIOL, V162, P720, DOI 10.1104/pp.113.214940; Zhang CH, 2002, PROTOPLASMA, V219, P59, DOI 10.1007/s007090200006	77	22	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187331	10.1371/journal.pone.0187331	http://dx.doi.org/10.1371/journal.pone.0187331			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131847	Green Published, gold, Green Submitted			2022-12-26	WOS:000414997800010
J	Kong, LH; Wang, Q; Jin, JW; Xiang, Z; Chen, TY; Shen, SM; Wang, HW; Gao, Q; Wang, Y				Kong, Linghui; Wang, Qien; Jin, Jiewen; Xiang, Zou; Chen, Taoyu; Shen, Shanmei; Wang, Hongwei; Gao, Qian; Wang, Yong			Insulin resistance enhances the mitogen-activated protein kinase signaling pathway in ovarian granulosa cells	PLOS ONE			English	Article							PROGESTERONE PRODUCTION; CUSHINGS-SYNDROME; WOMEN; HORMONE; INHIBITION; METABOLISM; MECHANISMS; PROMOTES; MODELS; MAPK	The ovary is the main regulator of female fertility. Granulosa cell dysfunction may be involved in various reproductive endocrine disorders. Here we investigated the effect of insulin resistance on the metabolism and function of ovarian granulosa cells, and dissected the functional status of the mitogen-activated protein kinase signaling pathway in these cells. Our data showed that dexamethasone-induced insulin resistance in mouse granulosa cells reduced insulin sensitivity, accompanied with an increase in phosphorylation of p44/42 mitogen-activated protein kinase. Furthermore, up-regulation of cytochrome P450 subfamily 17 and testosterone and down-regulation of progesterone were observed in insulin-resistant mouse granulosa cells. Inhibition of p44/42 mitogen-activated protein kinase after induction of insulin resistance in mouse granulosa cells decreased phosphorylation of p44/42 mitogen- activated protein kinase, downregulated cytochrome P450 subfamily 17 and lowered progesterone production. This insulin resistance cell model can successfully demonstrate certain mechanisms such as hyperandrogenism, which may inspire a new strategy for treating reproductive endocrine disorders by regulating cell signaling pathways.	[Kong, Linghui; Wang, Qien; Jin, Jiewen; Chen, Taoyu; Wang, Hongwei; Gao, Qian; Wang, Yong] Nanjing Univ, Sch Med, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China; [Kong, Linghui; Wang, Qien; Jin, Jiewen; Chen, Taoyu; Wang, Hongwei; Gao, Qian; Wang, Yong] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China; [Xiang, Zou] Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Shen, Shanmei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Div Endocrinol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Hong Kong Polytechnic University; Nanjing University	Gao, Q; Wang, Y (corresponding author), Nanjing Univ, Sch Med, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China.; Gao, Q; Wang, Y (corresponding author), Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China.	qian_gao@nju.edu.cn; yongwang@nju.edu.cn		Chen, Taoyu/0000-0002-8966-1264	National Natural Science Foundation of China [81471422, 81170541]; Foundation of State Key Laboratory of Analytical Chemistry for Life Science [5431ZZXM1603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of State Key Laboratory of Analytical Chemistry for Life Science	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (81471422 and 81170541) (Y.W.) and the Foundation of State Key Laboratory of Analytical Chemistry for Life Science (http://sklac.nju.edu.cn/) (5431ZZXM1603) (Y.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimani T, 2016, J ASSIST REPROD GEN, V33, P101, DOI 10.1007/s10815-015-0620-1; Bazuine M, 2004, MOL ENDOCRINOL, V18, P1697, DOI 10.1210/me.2003-0213; BenChetrit A, 1996, FERTIL STERIL, V65, P711, DOI 10.1016/S0015-0282(16)58201-6; Brower M, 2013, J CLIN ENDOCR METAB, V98, pE1967, DOI 10.1210/jc.2013-2815; Brzana J, 2014, EUR J OBSTET GYN R B, V175, P145, DOI 10.1016/j.ejogrb.2013.12.038; Caglar GS, 2013, ARCH GYNECOL OBSTET, V288, P905, DOI 10.1007/s00404-013-2833-9; Cao BY, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7914387; Chaturvedi G, 2008, MOL CELL BIOCHEM, V318, P191, DOI 10.1007/s11010-008-9871-9; Covington JD, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0492; Dai CW, 2016, AM J TRANSL RES, V8, P3329; Dale Stovall, 2011, J WOMENS HLTH; Dionisio TJ, 2014, HORM METAB RES, V46, P484, DOI 10.1055/s-0034-1370990; Dou YD, 2016, SCI REP-UK, V6, DOI 10.1038/srep26691; Du YP, 2014, PROTEIN CELL, V5, P203, DOI 10.1007/s13238-014-0030-7; Fadhillah, 2014, J REPROD DEVELOP, V60, P194, DOI 10.1262/jrd.2014-014; Fegan PG, 2007, NAT CLIN PRACT ENDOC, V3, P778, DOI 10.1038/ncpendmet0665; Galic S, 2014, BIOCHEM J, V461, P177, DOI 10.1042/BJ20140143; Geer EB, 2014, ENDOCRIN METAB CLIN, V43, P75, DOI 10.1016/j.ecl.2013.10.005; Gong H, 2016, ARCH BIOCHEM BIOPHYS, V603, P102, DOI 10.1016/j.abb.2016.05.020; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Huang XL, 2016, IEEE ANN INT CONF CY, P19, DOI 10.1109/CYBER.2016.7574788; Huang YG, 2014, FERTIL STERIL, V102, P589, DOI 10.1016/j.fertnstert.2014.05.012; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; KOTSUJI F, 1994, MICROSC RES TECHNIQ, V27, P97, DOI 10.1002/jemt.1070270204; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Maruthini D, 2014, HUM REPROD, V29, P2302, DOI 10.1093/humrep/deu187; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Metallinou C, 2012, IN VIVO, V26, P835; Pasieka AM, 2016, METABOLITES, V6, DOI 10.3390/metabo6030024; Penezic Z, 2005, GYNECOL ENDOCRINOL, V20, P150, DOI 10.1080/09513590400027190; Protzek AOP, 2016, J STEROID BIOCHEM, V155, P1, DOI 10.1016/j.jsbmb.2015.09.020; Rachon D, 2012, EXP CLIN ENDOCR DIAB, V120, P205, DOI 10.1055/s-0031-1299765; Rice S, 2009, ENDOCRINOLOGY, V150, P4794, DOI 10.1210/en.2009-0540; Sah SP, 2016, PHARMACOL REP, V68, P1165, DOI 10.1016/j.pharep.2016.07.010; Shah KN, 2016, PHARM BIOL, V54, P975, DOI 10.3109/13880209.2015.1091482; Shahrami Seyedeh Hajar, 2016, Acta Med Iran, V54, P134; Sharma S, 2011, BIOL REPROD, V84, P466, DOI 10.1095/biolreprod.110.088005; Shimizu T, 2016, J BIOCHEM MOL TOXIC, V30, P206, DOI 10.1002/jbt.21783; Shoko H, 2016, BIOMED RES INT, V2016, P1; Tatone C, 2013, FERTIL STERIL, V99, P12, DOI 10.1016/j.fertnstert.2012.11.029; Tsai YH, 2013, BRIT J NUTR, V109, P2190, DOI 10.1017/S0007114512004369; Wellbrock C, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00033; Wunderlich Claudia M, 2013, JAKSTAT, V2, pe23878, DOI 10.4161/jkst.23878; Xiong Y, 2017, GENE, V596, P1, DOI 10.1016/j.gene.2016.10.011; Yogo K, 2006, J REPROD DEVELOP, V52, P321, DOI 10.1262/jrd.17107; Zhang RN, 2014, PHARMACOLOGY, V94, P259, DOI 10.1159/000369171; Zhang XL, 2013, HUM REPROD, V28, P3074, DOI 10.1093/humrep/det341; Zhao Y, 2015, GEN COMP ENDOCR, V224, P228, DOI 10.1016/j.ygcen.2015.08.019; Zhu QL, 2016, J CLIN ENDOCR METAB, V101, P2168, DOI 10.1210/jc.2015-3899	49	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0188029	10.1371/journal.pone.0188029	http://dx.doi.org/10.1371/journal.pone.0188029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125859	Green Published, Green Submitted, gold			2022-12-26	WOS:000414866000036
J	Frye, SA; Beyene, GT; Namouchi, A; Gomez-Munoz, M; Homberset, H; Kalayou, S; Riaz, T; Tonjum, T; Balasingham, SV				Frye, Stephan A.; Beyene, Getachew Tesfaye; Namouchi, Amine; Gomez-Munoz, Marta; Homberset, Havard; Kalayou, Shewit; Riaz, Tahira; Tonjum, Tone; Balasingham, Seetha V.			The helicase DinG responds to stress due to DNA double strand breaks	PLOS ONE			English	Article							IRON-SULFUR CLUSTER; PILIN ANTIGENIC VARIATION; BINDING-PROTEIN SSB; NEISSERIA-GONORRHOEAE; ESCHERICHIA-COLI; MITOMYCIN-C; PATHOGENIC NEISSERIA; TOPOISOMERASE-I; MENINGITIDIS; TRANSFORMATION	Neisseria meningitidis (Nm) is a Gram-negative nasopharyngeal commensal that can cause septicaemia and meningitis. The neisserial DNA damage-inducible protein DinG is a helicase related to the mammalian helicases XPD and FANCJ. These helicases belong to superfamily 2, are ATP dependent and exert 5' -> 3' directionality. To better understand the role of DinG in neisserial genome maintenance, the Nm DinG (DinG(Nm)) enzymatic activities were assessed in vitro and phenotypical characterization of a dinG null mutant (Nm Delta dinG) was performed. Like its homologues, DinGNm possesses 5' -> 3' directionality and prefers DNA substrates containing a 5'-overhang. ATPase activity of DinGNm is strictly DNA-dependent and DNA unwinding activity requires nucleoside triphosphate and divalent metal cations. DinGNm directly binds SSBNm with a K-d of 313 nM. Genotoxic stress analysis demonstrated that Nm Delta dinG was more sensitive to double-strand DNA breaks (DSB) induced by mitomycin C (MMC) than the Nm wildtype, defining the role of neisserial DinG in DSB repair. Notably, when Nm Delta dinG cells grown under MMC stress assessed by quantitative mass spectrometry, 134 proteins were shown to be differentially abundant (DA) compared to unstressed Nm Delta dinG cells. Among the DNA replication, repair and recombination proteins affected, polymerase III subunits and recombinational repair proteins RuvA, RuvB, RecB and RecD were significantly down regulated while TopA and SSB were upregulated under stress condition. Most of the other DA proteins detected are involved in metabolic functions. The present study shows that the helicase DinG is probably involved in regulating metabolic pathways as well as in genome maintenance.	[Frye, Stephan A.; Namouchi, Amine; Kalayou, Shewit; Riaz, Tahira; Tonjum, Tone; Balasingham, Seetha V.] Oslo Univ Hosp, Dept Microbiol, Oslo, Norway; [Beyene, Getachew Tesfaye; Gomez-Munoz, Marta; Homberset, Havard; Tonjum, Tone] Univ Oslo, Dept Microbiol, Oslo, Norway; [Namouchi, Amine] Univ Oslo, Ctr Ecol & Evolutionary Synth, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Frye, SA; Balasingham, SV (corresponding author), Oslo Univ Hosp, Dept Microbiol, Oslo, Norway.	sfrye@rr-research.no; sbala@rr-research.no	Tønjum, Tone/J-4581-2014	Kalayou, Shewit/0000-0001-5498-9836; Tonjum, Tone/0000-0002-1709-6921; Riaz, Tahira/0000-0002-9759-5316	Research Council of Norway (RCN) (GLOBVAC) [220901]; UNIFOR; University of Oslo; Norwegian Agency for Development Cooperation (NORAD); University of Oslo Quota program / Norwegian State Educational Loan Fund	Research Council of Norway (RCN) (GLOBVAC); UNIFOR; University of Oslo; Norwegian Agency for Development Cooperation (NORAD); University of Oslo Quota program / Norwegian State Educational Loan Fund	This work was supported by the Research Council of Norway (RCN) (GLOBVAC #220901), UNIFOR, University of Oslo, the Norwegian Agency for Development Cooperation (NORAD) research funding, and the University of Oslo Quota program / Norwegian State Educational Loan Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Research Council of Norway (RCN) (GLOBVAC #220901), the Norwegian Agency for Development Cooperation (NORAD) research funding, UNIFOR, University of Oslo and the University of Oslo Quota program / Norwegian State Educational Loan Fund.	Ambur OH, 2007, J BACTERIOL, V189, P2077, DOI 10.1128/JB.01408-06; Ambur OH, 2014, PLOS ONE, V9; Anjum MF, 2002, J BACTERIOL, V184, P2987, DOI 10.1128/JB.184.11.2987-2993.2002; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Balasingham SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036960; Banda S, 2016, GENE, V585, P65, DOI 10.1016/j.gene.2016.03.013; Baumann RP, 2001, CANCER RES, V61, P7770; Benam AV, 2011, MICROBIOL-SGM, V157, P1329, DOI 10.1099/mic.0.046896-0; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; Black CG, 1998, GENE, V208, P61, DOI 10.1016/S0378-1119(97)00653-7; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cheng ZS, 2012, FEBS LETT, V586, P3825, DOI 10.1016/j.febslet.2012.09.032; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; Courcelle J, 2001, GENETICS, V158, P41; Davidsen T, 2006, NAT REV MICROBIOL, V4, P11, DOI 10.1038/nrmicro1324; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; De Nicolo A, 2008, CLIN CANCER RES, V14, P4672, DOI 10.1158/1078-0432.CCR-08-0087; Downey CD, 2010, MOL CELL, V37, P481, DOI 10.1016/j.molcel.2010.01.013; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; FRASCH CE, 1972, INFECT IMMUN, V5, P98, DOI 10.1128/IAI.5.1.98-102.1972; Frye SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003458; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; Greco-Stewart V, 2007, ARCH MICROBIOL, V187, P451, DOI 10.1007/s00203-007-0210-4; Gustafson D L, 1992, Proc West Pharmacol Soc, V35, P147; Hedman AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039718; Ieva R, 2008, MOL MICROBIOL, V70, P1152, DOI 10.1111/j.1365-2958.2008.06468.x; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kanehisa M, 2015, J MOL BIOL, V14; KINGSBURY DT, 1966, J BACTERIOL, V91, P1696, DOI 10.1128/JB.91.5.1696-1699.1966; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; LEWIS LK, 1992, J BACTERIOL, V174, P3377, DOI 10.1128/jb.174.10.3377-3385.1992; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; Liu IF, 2011, J ANTIMICROB CHEMOTH, V66, P1518, DOI 10.1093/jac/dkr150; Liu Z, 2016, BBA-PROTEINS PROTEOM, V1864, P115, DOI 10.1016/j.bbapap.2015.04.009; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; Nassif X, 2000, SCIENCE, V287, P1767, DOI 10.1126/science.287.5459.1767; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Pagano G, 2001, HUM EXP TOXICOL, V20, P651, DOI 10.1191/096032701718890577; Parti RR, 2013, RES MICROBIOL, V164, P406, DOI 10.1016/j.resmic.2013.02.002; Ramirez-Arcos S, 2001, MICROBIOL-SGM, V147, P225, DOI 10.1099/00221287-147-1-225; Remmele CW, 2014, NUCLEIC ACIDS RES, V42, P10579, DOI 10.1093/nar/gku762; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Sa E, 2009, CELL MICROBIOL, V11, P389, DOI DOI 10.1111/J.1462-5822.2008.01262.X; Sadarangani M, 2016, J BIOSCIENCES, V41, P13, DOI 10.1007/s12038-016-9588-y; Schook POP, 2011, MOL MICROBIOL, V79, P846, DOI 10.1111/j.1365-2958.2010.07491.x; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Seib KL, 2006, MICROBIOL MOL BIOL R, V70, P344, DOI 10.1128/MMBR.00044-05; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SHIBA T, 1991, P NATL ACAD SCI USA, V88, P8445, DOI 10.1073/pnas.88.19.8445; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Spies M, 2013, ADV EXP MED BIOL, V973, P1, DOI [10.1007/978-1-4614-5037-5_14, 10.1007/978-1-4614-5037-5]; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thakur RS, 2014, J BIOL CHEM, V289, P25112, DOI 10.1074/jbc.M114.563569; TOMASZ M, 1976, CHEM-BIOL INTERACT, V13, P89, DOI 10.1016/0009-2797(76)90016-8; Tonjum T, 1998, MOL MICROBIOL, V29, P111, DOI 10.1046/j.1365-2958.1998.00910.x; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; Turner SM, 2005, BIOCHEM J, V388, P545, DOI 10.1042/BJ20041766; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; White MF, 2009, BIOCHEM SOC T, V37, P547, DOI 10.1042/BST0370547; Wolfgang M, 1999, MOL MICROBIOL, V31, P1345, DOI 10.1046/j.1365-2958.1999.01269.x; WU CA, 1992, J BIOL CHEM, V267, P4074; Wu YL, 2012, NUCLEIC ACIDS RES, V40, P4247, DOI 10.1093/nar/gks039; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200; Yu CX, 2012, J BACTERIOL, V194, P6372, DOI 10.1128/JB.00262-12; Zegeye ED, 2012, MICROBIOL-SGM, V158, P1982, DOI 10.1099/mic.0.058693-0	77	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187900	10.1371/journal.pone.0187900	http://dx.doi.org/10.1371/journal.pone.0187900			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121674	gold, Green Submitted, Green Published			2022-12-26	WOS:000414769900091
J	Ladfors, L; Shaat, N; Wiberg, N; Katasarou, A; Berntorp, K; Kristensen, K				Ladfors, Linnea; Shaat, Nael; Wiberg, Nana; Katasarou, Anastasia; Berntorp, Kerstin; Kristensen, Karl			Fetal overgrowth in women with type 1 and type 2 diabetes mellitus	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; BIRTH-WEIGHT; GLYCEMIC CONTROL; RISK-FACTORS; 3RD TRIMESTER; PREGNANCY; GROWTH; IMPACT; MACROSOMIA; HBA(1C)	Objectives Despite improved glycemic control, the rate of large-for-gestational-age (LGA) infants remains high in pregnancies complicated by diabetes mellitus type 1 (T1DM) and type 2 (T2DM). Poor glycemic control, obesity, and excessive gestational weight gain are the main risk factors. The aim of this study was to determine the relative contribution of these risk factors for LGA in women with T1DM and T2DM, after controlling for important confounders such as age, smoking, and parity. Methods In this retrospective chart review study, we analyzed the medical files of pregnant women with T1DM and T2DM who attended the antenatal care program at Skane University Hospital during the years 2006 to 2016. HbA1c was used as a measure of glycemic control. Maternal weight in early pregnancy and at term was registered. LGA was defined as birth weight > 2 standard deviations of the mean. Univariable and multivariable logistic regression analysis was used to calculate odds ratios (OR's) and 95% confidence intervals (CIs) for LGA. Results Over the 11-year period, we identified 308 singleton pregnancies in 221 women with T1DM and in 87 women with T2DM. The rate of LGA was 50% in women with T1DM and 23% in women with T2DM. The multivariable regression model identified gestational weight gain and second-trimester HbA1c as risk factors for LGA in T1DM pregnancies (OR = 1.107, 95% CI: 1.044-1.17, and OR = 1.047, 95% CI: 1.015-1.080, respectively) and gestational weight gain as a risk factor in T2DM pregnancies (OR = 1.175, 95% CI: 1.048-1.318), independent of body mass index. Conclusions Gestational weight gain was associated with LGA in women with T1DM and T2DM, independent of maternal body mass index. The findings suggest that monitoring and regulation of gestational weight gain is important in the clinical care of these women, to minimize the risk of fetal overgrowth.	[Ladfors, Linnea; Wiberg, Nana; Kristensen, Karl] Skane Univ Hosp, Dept Obstet & Gynecol, Malmo, Sweden; [Shaat, Nael; Katasarou, Anastasia; Berntorp, Kerstin] Skane Univ Hosp, Dept Endocrinol, Malmo, Sweden; [Shaat, Nael; Katasarou, Anastasia; Berntorp, Kerstin] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Wiberg, Nana; Kristensen, Karl] Lund Univ, Dept Clin Sci, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Lund University	Kristensen, K (corresponding author), Skane Univ Hosp, Dept Obstet & Gynecol, Malmo, Sweden.; Kristensen, K (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	karl.kristensen@med.lu.se		Kristensen, Karl/0000-0003-3209-2459	Skane University Hospital; Skane County Council and Development Foundation	Skane University Hospital; Skane County Council and Development Foundation	This study was supported by grants from the research funds of Skane University Hospital and from the Skane County Council and Development Foundation.; This study was supported by grants from the research funds of Skane University Hospital and from the Skane County Council and Development Foundation. We are indebted to Per-Erik Isberg for statistical support.	Allen K, 2013, OBSTET GYNECOL REPRO, V6, P185; American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P210, DOI http://10.1097/01.AOG.0000425668.87506.4c; [Anonymous], 2015, SWED MED BIRTH REG 1; Asbjornsdottir B, 2013, DIABETES CARE, V36, P1102, DOI 10.2337/dc12-1232; Balsells M, 2009, J CLIN ENDOCR METAB, V94, P4284, DOI 10.1210/jc.2009-1231; Clausen TD, 2005, DIABETES CARE, V28, P323, DOI 10.2337/diacare.28.2.323; Colstrup M, 2013, J MATERN-FETAL NEO M, V26, P1682, DOI 10.3109/14767058.2013.794214; Dabelea D, 2011, DIABETES, V60, P1849, DOI 10.2337/db11-0400; Damm P, 2014, J MATERN-FETAL NEO M, V27, P149, DOI 10.3109/14767058.2013.806896; Desoye G, 2016, DIABETOLOGIA, V59, P1089, DOI 10.1007/s00125-016-3931-6; Ehrenberg HM, 2003, AM J OBSTET GYNECOL, V189, P944, DOI 10.1067/S0002-9378(03)00761-0; Gaudet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/640291; Glinianaia SV, 2012, DIABETOLOGIA, V55, P3193, DOI 10.1007/s00125-012-2721-z; Gold AE, 1998, DIABETES CARE, V21, P535, DOI 10.2337/diacare.21.4.535; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Hopkins SA, 2010, J CLIN ENDOCR METAB, V95, P2080, DOI 10.1210/jc.2009-2255; Inkster Melanie E, 2006, BMC Pregnancy Childbirth, V6, P30, DOI 10.1186/1471-2393-6-30; Jolly MC, 2003, EUR J OBSTET GYN R B, V111, P9, DOI 10.1016/S0301-2115(03)00154-4; JOVANOVICPETERSON L, 1991, AM J OBSTET GYNECOL, V164, P103, DOI 10.1016/0002-9378(91)90637-7; Lindell G, 2012, ULTRASOUND OBST GYN, V40, P680, DOI 10.1002/uog.11125; Maresh MJA, 2015, DIABETES CARE, V38, P34, DOI 10.2337/dc14-1755; Lloreda-Garcia JM, 2016, ENDOCRINOL NUTR, V63, P409, DOI 10.1016/j.endonu.2016.04.010; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McGowan CA, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-140; Mollberg M, 2005, ACTA OBSTET GYN SCAN, V84, P654, DOI 10.1111/j.0001-6349.2005.00632.x; Moore TR, 2010, AM J OBSTET GYNECOL, V202, P643, DOI 10.1016/j.ajog.2010.02.059; Morrens A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0958-0; Mudd LM, 2012, J PHYS ACT HEALTH, V9, P1168, DOI 10.1123/jpah.9.8.1168; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; Olmos PR, 2009, DIABETES RES CLIN PR, V85, P53, DOI 10.1016/j.diabres.2009.04.015; Parellada CB, 2014, DIABETIC MED, V31, P1681, DOI 10.1111/dme.12558; PEDERSEN J, 1954, ACTA ENDOCRINOL-COP, V16, P330, DOI 10.1530/acta.0.0160330; Persson M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000601; Persson M, 2009, DIABETES CARE, V32, P2005, DOI 10.2337/dc09-0656; Raychaudhuri K, 2000, OBSTET GYNECOL, V95, P190, DOI 10.1016/S0029-7844(99)00485-8; Rey E, 1999, AM J OBSTET GYNECOL, V181, P202, DOI 10.1016/S0002-9378(99)70460-6; Rowan JA, 2010, DIABETES CARE, V33, P9, DOI 10.2337/dc09-1407; Secher AL, 2014, DIABETES CARE, V37, P2677, DOI 10.2337/dc14-0896; SULTAN AH, 1994, BRIT MED J, V308, P887, DOI 10.1136/bmj.308.6933.887; Wang Q, 2015, PRIM CARE DIABETES, V9, P362, DOI 10.1016/j.pcd.2014.10.008; Zawiejska A, 2008, J PHYSIOL PHARMACOL, V59, P5	41	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187917	10.1371/journal.pone.0187917	http://dx.doi.org/10.1371/journal.pone.0187917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121112	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900094
J	Bravo-Tello, K; Ehrenfeld, N; Solis, CJ; Ulloa, PE; Hedrera, M; Pizarro-Guajardo, M; Paredes-Sabja, D; Feijoo, CG				Bravo-Tello, Karina; Ehrenfeld, Nicole; Solis, Camila J.; Ulloa, Pilar E.; Hedrera, Manuel; Pizarro-Guajardo, Marjorie; Paredes-Sabja, Daniel; Feijoo, Carmen G.			Effect of microalgae on intestinal inflammation triggered by soybean meal and bacterial infection in zebrafish	PLOS ONE			English	Article							HOT-WATER EXTRACT; CHLORELLA-VULGARIS; BACILLUS-SUBTILIS; GENE-EXPRESSION; IMMUNE-RESPONSE; RESISTANCE; AUGMENTATION; PROBIOTICS; MORPHOLOGY; ENTERITIS	Soybean meal has been used in many commercial diets for farm fish; despite this component inducing intestinal inflammation. On the other hand, microalgae have increasingly been used as dietary supplements in fish feed. Nevertheless, the vast quantity of microalgae species means that many remain under- or unstudied, thus limiting wide scale commercial application. In this work, we evaluated the effects to zebrafish (Danio rerio) of including Tetraselmis sp (Ts); Phaeodactylum tricornutum (Pt); Chlorella sp (Ch); Nannochloropsis oculata (No); or Nannochloropsis gaditana (Ng) as additives in a soybean meal-based diet on intestinal inflammation and survival after Edwardsiella tarda infection. In larvae fed a soybean meal diet supplemented with Ts, Pt, Ch, or Ng, the quantity of neutrophils present in the intestine drastically decreased as compared to larvae fed only the soybean meal diet. Likewise, Ts or Ch supplements in soybean meal or fishmeal increased zebrafish survival by more than 20% after being challenged. In the case of Ts, the observed effect correlated with an increased number of neutrophils present at the infection site. These results suggest that the inclusion of Ts or Ch in fish diets could allow the use of SBM and at the same time improve performance against pathogen.	[Bravo-Tello, Karina; Solis, Camila J.; Ulloa, Pilar E.; Hedrera, Manuel; Feijoo, Carmen G.] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile; [Bravo-Tello, Karina; Solis, Camila J.; Feijoo, Carmen G.] Interdisciplinary Ctr Aquaculture Res, Concepcion, Chile; [Ehrenfeld, Nicole] Univ Santo Tomas, Ctr Invest Austral Biotech, Escuela Biotecnol, Santiago, Chile; [Ulloa, Pilar E.] Univ Las Amer, Escuela Agron, Fac Med Vet & Agron, Santiago, Chile; [Pizarro-Guajardo, Marjorie; Paredes-Sabja, Daniel] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Microbiota Host Interact & Clostridia Res Grp, Santiago, Chile	Universidad Andres Bello; Universidad Santo Tomas; Universidad de Las Americas - Chile; Universidad Andres Bello	Feijoo, CG (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile.; Feijoo, CG (corresponding author), Interdisciplinary Ctr Aquaculture Res, Concepcion, Chile.	cfeijoo@unab.cl	Feijoo, Carmen G/AAF-9003-2019; Pizarro-Guajardo, Marjorie/ABG-8107-2020; Paredes-Sabja, Daniel/ABI-4293-2020	Pizarro-Guajardo, Marjorie/0000-0002-8089-5398; Feijoo, Carmen G/0000-0003-1128-403X	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1171199]; Direccion de Investigacion UNAB [DI-1229-16/R]; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias [15110027]; Fundacion para la Innovacion Agraria [PYT 2016-0339]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion UNAB; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias; Fundacion para la Innovacion Agraria	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico [grant number 1171199] to CGF, http://www.conicyt.cl/fondecyt/sobretfondecytique-es-fondecy; Direccion de Investigacion UNAB [grant number DI-1229-16/R] to CGF, http://investigacior.unah.clanvestigaciar/oportunidades-de-financiamiento/; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias [grant number 15110027] to CGF, http//www.incar.cl/; Fundacion para la Innovacion Agraria [grant number PYT 2016-0339] to NE, http://www.fia.cl/.	AUSTIN B, 1990, AQUACULTURE, V90, P389, DOI 10.1016/0044-8486(90)90261-K; Brown M.R., 2002, ADV NUTR ACULCOLA, P281, DOI DOI 10.5772/1516; Brown MR, 1997, AQUACULTURE, V151, P315, DOI 10.1016/S0044-8486(96)01501-3; Cerezuela R, 2013, FISH SHELLFISH IMMUN, V34, P843, DOI 10.1016/j.fsi.2012.12.026; Cerezuela R, 2012, CELL TISSUE RES, V350, P477, DOI 10.1007/s00441-012-1495-4; Cerezuela R, 2012, FISH SHELLFISH IMMUN, V33, P342, DOI 10.1016/j.fsi.2012.05.004; Dahoumane SA, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2607-8; FABREGAS J, 1986, AQUACULTURE, V51, P237, DOI 10.1016/0044-8486(86)90315-7; FAO, 2014, EST MUND PESC AC; Feijoo CG, 2009, DEV DYNAM, V238, P2034, DOI 10.1002/dvdy.22006; Grammes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083213; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Haffter P, 1996, DEVELOPMENT, V123, P1; Hai NV, 2015, J APPL MICROBIOL, V119, P917, DOI 10.1111/jam.12886; Hardy RW, 2010, AQUAC RES, V41, P770, DOI 10.1111/j.1365-2109.2009.02349.x; HASEGAWA T, 1994, IMMUNOPHARM IMMUNOT, V16, P191, DOI 10.3109/08923979409007090; Hasegawa T, 1997, IMMUNOPHARMACOLOGY, V35, P273, DOI 10.1016/S0162-3109(96)00150-6; Hedrera MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069983; Jiang WD, 2015, BRIT J NUTR, V114, P1569, DOI 10.1017/S0007114515003219; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knudsen D, 2008, BRIT J NUTR, V100, P120, DOI 10.1017/S0007114507886338; Knudsen D, 2007, J AGR FOOD CHEM, V55, P2261, DOI 10.1021/jf0626967; KONISHI F, 1990, CANCER IMMUNOL IMMUN, V32, P1, DOI 10.1007/BF01741717; Kousoulaki K, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2015.14; Merrifield DL, 2009, J FISH DIS, V32, P755, DOI 10.1111/j.1365-2761.2009.01052.x; Montero D, 2010, FISH SHELLFISH IMMUN, V29, P1073, DOI 10.1016/j.fsi.2010.08.024; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P18040, DOI 10.1073/pnas.0910577106; Pressley ME, 2005, DEV COMP IMMUNOL, V29, P501, DOI 10.1016/j.dci.2004.10.007; Priyadarshani I., 2012, J ALGAL BIOMASS UTIL, V3, P89; Refstie S, 2010, AQUACULTURE, V305, P109, DOI 10.1016/j.aquaculture.2010.04.005; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Reyes-Becerril M, 2014, FISH SHELLFISH IMMUN, V40, P208, DOI 10.1016/j.fsi.2014.06.032; Reyes-Becerril M, 2013, FISH SHELLFISH IMMUN, V35, P883, DOI 10.1016/j.fsi.2013.06.026; Sarker PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156684; TANAKA K, 1986, INFECT IMMUN, V53, P267, DOI 10.1128/IAI.53.2.267-271.1986; Ulloa PE, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1639720; Ulloa PE, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00313; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; van Soest JJ, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-58; Wassef E.A., 2005, EGYPT J AQUAT RES, V31, P321; Westerfield M., 1995, GUIDE LAB USE ZEBRAF; Zhang QH, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.3168	42	27	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187696	10.1371/journal.pone.0187696	http://dx.doi.org/10.1371/journal.pone.0187696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117213	Green Submitted, Green Published, gold			2022-12-26	WOS:000414659600067
J	Chitchumroonchokchai, C; Diretto, G; Parisi, B; Giuliano, G; Failla, ML				Chitchumroonchokchai, Chureeporn; Diretto, Gianfranco; Parisi, Bruno; Giuliano, Giovanni; Failla, Mark L.			Potential of golden potatoes to improve vitamin A and vitamin E status in developing countries	PLOS ONE			English	Article							IN-VITRO BIOACCESSIBILITY; BETA-CAROTENE CONTENT; SOLANUM-TUBEROSUM; INTESTINAL-ABSORPTION; SWEET-POTATO; PROVITAMIN; BIOAVAILABILITY; CASSAVA; BIOFORTIFICATION; ACCUMULATION	Potato (Solanum tuberosum L.) is the third most widely consumed plant food by humans. Its tubers are rich in starch and vitamin C, but have low or null levels of essential nutrients such as provitamin A and vitamin E. Transformation of potato with a bacterial mini-pathway for beta-carotene in a tuber-specific manner results in a "golden" potato (GP) tuber phenotype resulting from accumulation of provitamin A carotenoids (alpha- and beta-carotene) and xanthophylls. Here, we investigated the bioaccessibility of carotenoids and vitamin E as alpha-tocopherol (aTC) in boiled wild type and golden tubers using in vitro digestion. Golden tubers contained up to 91 mu g provitamin A carotenes (PAC)/g D, increased levels of xanthophylls, phytoene and phytofluene, as well as up to 78 pg vitamin E/g DW. Cubes from wild type and GP tubers were boiled and subjected to simulated digestion to estimate bioaccessibility of carotenoids and alpha TC. Retention in boiled GPs exceeded 80% for beta-carotene (beta C), alpha-carotene (alpha C), lutein, phytoene and alpha TC, but less than 50% for phytofluene. The efficiency of partitioning of total beta C, alpha C, E-lutein, phytoene, phytofluene and alpha TC in the mixed micelle fraction during small intestinal digestion was influenced by genotype, tuber content and hydrophobicity. Apical uptake of the compounds that partitioned in mixed micelles by monolayers of human intestinal Caco-2 cells during incubation for 4h was 14-20% for provitamin A and xanthophylls, 43-45% for phytoene, 23-27% for phytofluene, and 53% for alpha TC. These results suggest that a 150 g serving of boiled golden potatoes has the potential to contribute 42% and 23% of the daily requirement of retinol activity equivalents (RAE), as well as 34 and 17% of the daily vitamin E requirement for children and women of reproductive age, respectively.	[Chitchumroonchokchai, Chureeporn; Failla, Mark L.] Ohio State Univ, Human Nutr Program, Columbus, OH 43210 USA; [Diretto, Gianfranco; Giuliano, Giovanni] Italian Natl Agcy New Technol Energy & Sustainabl, Casaccia Res Ctr, Rome, Italy; [Parisi, Bruno] Council Agr Res & Econ CREA, Res Ctr Cereal & Ind Crops, Bologna, Italy	University System of Ohio; Ohio State University; Italian National Agency New Technical Energy & Sustainable Economics Development; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Failla, ML (corresponding author), Ohio State Univ, Human Nutr Program, Columbus, OH 43210 USA.; Giuliano, G (corresponding author), Italian Natl Agcy New Technol Energy & Sustainabl, Casaccia Res Ctr, Rome, Italy.	govanni.giuliano@enea.it; failla.3@osu.edu	Diretto, Gianfranco/L-9279-2017; Giuliano, Giovanni/A-2701-2012	Diretto, Gianfranco/0000-0002-1441-0233; Failla, Mark/0000-0002-7666-8037; Giuliano, Giovanni/0000-0002-2486-0510	European Community [613513, 677379]; Ohio Agricultural Research and Development Center	European Community(European Commission); Ohio Agricultural Research and Development Center	The authors thank the Italian Ministry of Agriculture (projects ALISAL and NUTRISOL), the European Community (projects DISCO, contract n. 613513 and G2P-SOL, contract n. 677379) to GG, and benefited from the networking activities within the European Cooperation in Science and Technology Action FM106 (Qualilyfruit) and CM 5136 (EUROCAROTEN) and partial support from the Ohio Agricultural Research and Development Center to MF. The funders had no role in study design, data collection and analysis, decision to prepare and publish the manuscript.	Andre CM, 2007, J AGR FOOD CHEM, V55, P10839, DOI 10.1021/jf0726583; [Anonymous], 2009, WHO GLOBAL DATABASE; Barua AB, 2001, J NUTR, V131, P3212, DOI 10.1093/jn/131.12.3212; Berni P, 2015, PLANT FOOD HUM NUTR, V70, P1, DOI 10.1007/s11130-014-0458-1; Burgos G, 2013, PLANT FOOD HUM NUTR, V68, P385, DOI 10.1007/s11130-013-0381-x; Burmeister A, 2011, J FOOD COMPOS ANAL, V24, P865, DOI 10.1016/j.jfca.2011.03.006; Castenmiller JJM, 1998, ANNU REV NUTR, V18, P19, DOI 10.1146/annurev.nutr.18.1.19; Che P, 2016, P NATL ACAD SCI USA, V113, P11040, DOI 10.1073/pnas.1605689113; Chitchumroonchokchai C, 2004, J NUTR, V134, P2280, DOI 10.1093/jn/134.9.2280; Crowell EF, 2008, TRANSGENIC RES, V17, P205, DOI 10.1007/s11248-007-9091-1; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Diretto G, 2010, PLANT PHYSIOL, V154, P899, DOI 10.1104/pp.110.159368; Dror DK, 2011, FOOD NUTR BULL, V32, P124, DOI 10.1177/156482651103200206; Ducreux LJM, 2005, J EXP BOT, V56, P81, DOI 10.1093/jxb/eri016; Engelmann NJ, 2011, ADV NUTR, V2, P51, DOI 10.3945/an.110.000075; Ezekiel R, 2013, FOOD RES INT, V50, P487, DOI 10.1016/j.foodres.2011.04.025; Failla ML, 2012, J AGR FOOD CHEM, V60, P3861, DOI 10.1021/jf204958w; Failla ML, 2009, J AGR FOOD CHEM, V57, P10922, DOI 10.1021/jf900415g; Fernandez-Garcia E, 2009, NUTR RES, V29, P751, DOI 10.1016/j.nutres.2009.09.016; Garrett DA, 1999, J AGR FOOD CHEM, V47, P4301, DOI 10.1021/jf9903298; Giuliano G, 2008, TRENDS BIOTECHNOL, V26, P139, DOI 10.1016/j.tibtech.2007.12.003; Giuliano G, 2017, CURR OPIN BIOTECH, V44, P169, DOI 10.1016/j.copbio.2017.02.001; Giuliano G, 2014, CURR OPIN PLANT BIOL, V19, P111, DOI 10.1016/j.pbi.2014.05.006; Goncalves A, 2015, FOOD CHEM, V172, P155, DOI 10.1016/j.foodchem.2014.09.021; Harrison EH, 2012, BBA-MOL CELL BIOL L, V1821, P70, DOI 10.1016/j.bbalip.2011.06.002; Jiang Q, 2014, FREE RADICAL BIO MED, V72, P76, DOI 10.1016/j.freeradbiomed.2014.03.035; Kimura M, 2007, FOOD CHEM, V100, P1734, DOI 10.1016/j.foodchem.2005.10.020; Lachman J, 2016, PLANT SOIL ENVIRON, V62, P474, DOI 10.17221/459/2016-PSE; Lemmens L, 2014, TRENDS FOOD SCI TECH, V38, P125, DOI 10.1016/j.tifs.2014.05.005; Lipkie TE, 2013, J AGR FOOD CHEM, V61, P5764, DOI 10.1021/jf305361s; Lu S, 2006, PLANT CELL, V18, P3594, DOI 10.1105/tpc.106.046417; Melendez-Martinez AJ, 2015, ARCH BIOCHEM BIOPHYS, V572, P188, DOI 10.1016/j.abb.2015.01.003; Moran NE, 2013, J NUTR, V143, P1920, DOI 10.3945/jn.113.181461; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; National Research Council, 2010, DIETARY REFERENCE IN; Otten JJ, 2006, DIETARY REFERENCE IN, P170; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Palermo M, 2014, J SCI FOOD AGR, V94, P1057, DOI 10.1002/jsfa.6478; Reboul E, 2013, NUTRIENTS, V5, P3563, DOI 10.3390/nu5093563; Rodrigo MJ, 2015, FOOD FUNCT, V6, P1950, DOI [10.1039/c5fo00258c, 10.1039/C5FO00258C]; Rumold CU, 2016, P NATL ACAD SCI USA, V113, P13672, DOI 10.1073/pnas.1604265113; Sayre R, 2011, ANNU REV PLANT BIOL, V62, P251, DOI 10.1146/annurev-arplant-042110-103751; Sestak Z., 2004, CAROTENOIDS, V42, DOI 10.1023/b:phot.0000040641.40049.19,2; Thakkar SK, 2007, J NUTR, V137, P2229, DOI 10.1093/jn/137.10.2229; Thakkar SK, 2009, J AGR FOOD CHEM, V57, P1344, DOI 10.1021/jf803053d; Tierno R, 2015, J FOOD COMPOS ANAL, V41, P58, DOI 10.1016/j.jfca.2015.01.013; Traber MG, 2014, ADV NUTR, V5, P503, DOI 10.3945/an.114.006254; UGENT D, 1987, ECON BOT, V41, P17, DOI 10.1007/BF02859340; Van Eck J, 2007, AM J POTATO RES, V84, P331, DOI 10.1007/BF02986245; Weller P, 2003, J AGR FOOD CHEM, V51, P7044, DOI 10.1021/jf034803s; World Health Organization (WHO), FACT SHEET WORLD HIV	51	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187102	10.1371/journal.pone.0187102	http://dx.doi.org/10.1371/journal.pone.0187102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117188	Green Submitted, gold, Green Published			2022-12-26	WOS:000414659600023
J	Hayward, N; McGovern, A; de Lusignan, S; Cole, N; Hinton, W; Jones, S				Hayward, Nicholas; McGovern, Andrew; de Lusignan, Simon; Cole, Nicholas; Hinton, William; Jones, Simon			U-shaped relationship between serum phosphate and cardiovascular risk: A retrospective cohort study	PLOS ONE			English	Article							DISEASE; CALCIUM; VALIDATION; PHOSPHORUS	Background High serum phosphate is associated with coronary artery disease in patients with normal and impaired renal function. We asked: Does the serum phosphate range provide prediction of primary cardiac events? We extracted coded primary care data for over 100,000 patients from a database of 135 primary medical practices. Patients aged between 18 and 90 years without pre-existing cardiovascular diagnoses were included from a potential sample of over 1.2 million individuals. Methods and findings Binary logistic regression models were used to evaluate the contribution of QRISK factors and electrolytes, including serum phosphate, to cardiac outcomes at five and nine years following an initial phosphate measurement. At five-year review (n = 113,993), low serum phosphate (OR 1.75, 95%Cl 1.36-2-23, p<0.001), high -normal (OR 1.50, 95%Cl 1.29-1-74, p<0.001), and high serum phosphate (OR 1.74, 95%Cl 1.06-2-70, p = 0.02) were long-term risk factors for primary cardiac disease events after adjusting for confounding variables. A similar pattern was seen at our nine-year review. Conclusions The extremes of serum phosphate may confer cardiac event risk with a U-shaped trend. In particular, we raise new cardiac concerns for low serum phosphate in the general population. Also, the normal range for phosphate may require redefinition among healthy adults.	[Hayward, Nicholas; McGovern, Andrew; de Lusignan, Simon; Cole, Nicholas; Hinton, William; Jones, Simon] Univ Surrey, Dept Healthcare Management & Policy, Guildford, Surrey, England; [Jones, Simon] NYU, Sch Med, Ctr Healthcare Innovat & Delivery Sci, Dept Populat Hlth, New York, NY USA	University of Surrey; New York University	Hayward, N (corresponding author), Univ Surrey, Dept Healthcare Management & Policy, Guildford, Surrey, England.	nickhayward@doctors.org.uk	McGovern, Andrew/N-4179-2015	McGovern, Andrew/0000-0002-6833-9399; Jones, Simon/0000-0002-8267-5647; Cole, Nicholas/0000-0002-5379-580X; Hayward, Nick/0000-0001-9496-7332; Hinton, William/0000-0003-4927-0901	South Thames Foundation School	South Thames Foundation School	NH's time was funded as a research placement by the South Thames Foundation School; his research post was part of his NHS Foundation medical training programme and SdeL is his academic supervisor. There was no specific funding for any of the academics who provided time. The Royal College of General Practitioners' Research and Surveillance Centre dataset was approved for use for this project without charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed J, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-90; Brunelli SM, 2007, J AM SOC NEPHROL, V18, P1999, DOI 10.1681/ASN.2007020143; Correa A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011092; de Lusignan S, 2010, DIABETIC MED, V27, P203, DOI 10.1111/j.1464-5491.2009.02917.x; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; di Masi A, 2016, J CONTROL RELEASE, V228, P191, DOI 10.1016/j.jconrel.2016.02.049; Fujino M, 2016, J CARDIOL, V68, P392, DOI 10.1016/j.jjcc.2016.05.004; Gonzalez-Parra E, 2012, CARDIOVASC PATHOL, V21, P372, DOI 10.1016/j.carpath.2012.02.008; Gronhoj MH, 2016, ATHEROSCLEROSIS, V251, P101, DOI 10.1016/j.atherosclerosis.2016.06.001; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; Maindonald J., 2006, DATA ANAL GRAPHICS U; McGovern AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074996; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Park KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151007; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; R Core Team, 2016, R LANG ENV STAT COMP; Takeda E, 2004, BIOFACTORS, V21, P345, DOI 10.1002/biof.552210167; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Vemula P, 2015, AM J CARDIOL, V115, P147, DOI 10.1016/j.amjcard.2014.09.038	20	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0184774	10.1371/journal.pone.0184774	http://dx.doi.org/10.1371/journal.pone.0184774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117214	Green Submitted, gold, Green Published			2022-12-26	WOS:000414659600001
J	Tranquet, O; Gaudin, JC; Patil, S; Steinbrecher, J; Matsunaga, K; Teshima, R; Sakai, S; Larre, C; Denery-Papini, S				Tranquet, Olivier; Gaudin, Jean-Charles; Patil, Sarita; Steinbrecher, Johanna; Matsunaga, Kayoko; Teshima, Reiko; Sakai, Shinobu; Larre, Colette; Denery-Papini, Sandra			A chimeric IgE that mimics IgE from patients allergic to acid-hydrolyzed wheat proteins is a novel tool for in vitro allergenicity assessment of functionalized glutens	PLOS ONE			English	Article							FOOD ALLERGY; CELL DEGRANULATION; DEAMIDATED GLUTEN; BINDING EPITOPES; COSMETIC CREAM; FACIAL SOAP; BALB/C MICE; GLIADINS; ANAPHYLAXIS; IDENTIFICATION	Background Acid-hydrolyzed wheat proteins (acid-HWPs) have been shown to provoke severe allergic reactions in Europe and Japan that are distinct from classical wheat allergies. Acid-HWPs were shown to contain neo-epitopes induced by the deamidation of gluten proteins. However, products with variable rates of deamidation can be found. Objectives In this work, we studied the effect of the extent of wheat proteins deamidation on its allergenicity. A recombinant chimeric IgE was produced and compared to patients' IgE for its capacity to assess the IgE-mediated triggering potential of acid-HWPs. Methods Sera from acid-HWP allergic patients were analyzed via ELISA and a functional basophil assay for their IgE reactivity to wheat proteins with different deamidation levels. A chimeric mouse/human IgE (chlgE-DG1) specific for the main neo-epitope, QPEEPFPE, involved in allergy to acid-HWPs was characterized with respect to its functionality and its reactivity compared to that of patients' IgE. Results Acid-HWPs with medium (30%) and high (50-60%) deamidation levels displayed a markedly stronger IgE binding and capacity to activate basophils than those of samples with weak (15%) deamidation levels. The monoclonal chlgE-DG1 allowed basophil degranulation in the presence of deamidated wheat proteins. ChlgE-DG1 was found to mimic patients' IgE reactivity and displayed the same ability to rank acid-HWP products in a degranulation assay. Conclusion Increasing the deamidation level of products from 15% to 60% resulted in an approximately 2-fold increase in their antigenicity and a 100-fold increase in their eliciting potential. The chimeric ChlgE-DG1 may be a useful tool to evaluate functionalized glutens for their allergenic potential. By mimicking patient sera reactivity, chlgE-DG1 also provided data on the patients' IgE repertoire and on the functionality of certain repeated epitopes in gluten proteins.	[Tranquet, Olivier; Gaudin, Jean-Charles; Larre, Colette; Denery-Papini, Sandra] INRA, UR Biopolymers Interact Assemblies 1268, Nantes, France; [Patil, Sarita; Steinbrecher, Johanna] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Patil, Sarita; Steinbrecher, Johanna] Harvard Med Sch, Boston, MA USA; [Matsunaga, Kayoko] Fujita Hlth Univ, Sch Med, Dept Integrat Med Sci Allerg Dis, Toyoake, Aichi, Japan; [Teshima, Reiko; Sakai, Shinobu] Natl Inst Hlth Sci, Tokyo, Japan; [Gaudin, Jean-Charles] AGPF Unite Rech Ameliorat Genet & Physiol Foresti, Orleans, France	INRAE; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Fujita Health University; National Institute of Health Sciences - Japan	Tranquet, O (corresponding author), INRA, UR Biopolymers Interact Assemblies 1268, Nantes, France.	olivier.tranquet@nantes.inra.fr		Tranquet, Olivier/0000-0002-3359-3194; Gaudin, Jean-Charles/0000-0003-1933-5647				Adachi R, 2012, ALLERGY, V67, P1392, DOI 10.1111/all.12018; Baar A, 2014, ALLERGY, V69, P1316, DOI 10.1111/all.12464; Battais F, 2005, ALLERGY, V60, P815, DOI 10.1111/j.1398-9995.2005.00795.x; Battais F, 2003, CLIN EXP ALLERGY, V33, P962, DOI 10.1046/j.1365-2222.2003.01592.x; Battais F, 2006, Eur Ann Allergy Clin Immunol, V38, P59; BINAGHI RA, 1983, J IMMUNOL METHODS, V65, P225, DOI 10.1016/0022-1759(83)90319-8; Bodinier M, 2008, INT ARCH ALLERGY IMM, V146, P307, DOI 10.1159/000121465; Budde IK, 2001, INT ARCH ALLERGY IMM, V126, P277, DOI 10.1159/000049524; Chinuki Y, 2012, ALLERGOL INT, V61, P529, DOI 10.2332/allergolint.12-RAI-0494; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Cui C, 2013, J AGR FOOD CHEM, V61, P5706, DOI 10.1021/jf400281v; Day L, 2006, TRENDS FOOD SCI TECH, V17, P82, DOI 10.1016/j.tifs.2005.10.003; Denery-Papini S, 2012, ALLERGY, V67, P1023, DOI 10.1111/j.1398-9995.2012.02860.x; Denery-Papini S, 2011, CLIN EXP ALLERGY, V41, P1478, DOI 10.1111/j.1365-2222.2011.03808.x; Flicker S, 2000, J IMMUNOL, V165, P3849, DOI 10.4049/jimmunol.165.7.3849; Gieras A, 2015, J ALLERGY CLIN IMMUN, p1 ; Gourbeyre P, 2013, J AGR FOOD CHEM, V61, P6311, DOI 10.1021/jf305315g; Gourbeyre P, 2012, MOL NUTR FOOD RES, V56, P336, DOI 10.1002/mnfr.201100353; Hann S, 2007, CONTACT DERMATITIS, V56, P119, DOI 10.1111/j.1600-0536.2007.00977.x; Knipping K, 2016, TOXICOL IN VITRO, V33, P29, DOI 10.1016/j.tiv.2016.02.018; Knipping K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106025; Kroghsbo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107137; Leduc V, 2003, J ALLERGY CLIN IMMUN, V111, P897, DOI 10.1067/mai.2003.1345; Liao L, 2009, J SCI FOOD AGR, P90; Lupi R, 2014, J CEREAL SCI, V60, P179, DOI 10.1016/j.jcs.2014.02.009; Madritsch C, 2011, CLIN EXP ALLERGY, V41, P270, DOI 10.1111/j.1365-2222.2010.03666.x; Mameri H, 2015, J AGR FOOD CHEM, V63, P6546, DOI 10.1021/acs.jafc.5b01922; Masiri J, 2016, J AGR FOOD CHEM, V64, P3678, DOI 10.1021/acs.jafc.5b06085; Nakamura M, 2016, CONTACT DERMATITIS, V74, P346, DOI 10.1111/cod.12551; Nakamura R, 2013, INT ARCH ALLERGY IMM, V160, P259, DOI 10.1159/000341671; Osman AA, 2001, EUR J GASTROEN HEPAT, V13, P1189, DOI 10.1097/00042737-200110000-00011; Santos AF, 2015, J ALLERGY CLIN IMMUN, V135, P1249, DOI 10.1016/j.jaci.2015.01.012; Shewry PR, 1999, SEED PROTEINS, P11; Tatham AS, 2008, CLIN EXP ALLERGY, V38, P1712, DOI 10.1111/j.1365-2222.2008.03101.x; Tranquet O, 2015, P 28 M WORK GROUP PR, p21 ; Tranquet O, 2015, J AGR FOOD CHEM, V63, P5403, DOI 10.1021/acs.jafc.5b00923; Varjonen E, 2000, ALLERGY, V55, P294, DOI 10.1034/j.1398-9995.2000.00516.x; Wiegand TW, 1996, J IMMUNOL, V157, P221; Yagami A, 2017, J ALLERGY CLIN IMMUN, V140, P879, DOI 10.1016/j.jaci.2017.03.019; Yokooji T, 2013, ALLERGOL INT, V62, P435, DOI 10.2332/allergolint.13-OA-0561	40	6	6	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187415	10.1371/journal.pone.0187415	http://dx.doi.org/10.1371/journal.pone.0187415			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117222	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600038
J	Tran, HB; Jersmann, H; Truong, TT; Hamon, R; Roscioli, E; Ween, M; Pitman, MR; Pitson, SM; Hodge, G; Reynolds, PN; Hodge, S				Tran, Hai B.; Jersmann, Hubertus; Tung Thanh Truong; Hamon, Rhys; Roscioli, Eugene; Ween, Miranda; Pitman, Melissa R.; Pitson, Stuart M.; Hodge, Greg; Reynolds, Paul N.; Hodge, Sandra			Disrupted epithelial/macrophage crosstalk via Spinster homologue 2-mediated S1P signaling may drive defective macrophage phagocytic function in COPD	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; TRANSPORTER SPNS2; CIGARETTE-SMOKE; SPHINGOSINE-1-PHOSPHATE TRANSPORTER; SPHINGOSINE 1-PHOSPHATE; RECEPTOR 2; AIRWAY; LUNG; EFFEROCYTOSIS; EXPRESSION	Introduction We have previously established a link between impaired phagocytic capacity and deregulated S1P signaling in alveolar macrophages from COPD subjects. We hypothesize that this defect may include a disruption of epithelial-macrophage crosstalk via Spns2-mediated intercellular S1P signaling. Methods Primary alveolar macrophages and bronchial epithelial cells from COPD subjects and controls, cell lines, and a mouse model of chronic cigarette smoke exposure were studied. Cells were exposed to 10% cigarette smoke extract, or vehicle control. Spns2 expression and subcellular localization was studied by immunofluorescence, confocal microscopy and RT-PCR. Phagocytosis was assessed by flow-cytometry. Levels of intra-and extracellular S1P were measured by S1P [3H]-labeling. Results Spns2 expression was significantly increased (p<0.05) in alveolar macrophages from current-smokers/COPD patients (n = 5) compared to healthy nonsmokers (n = 8) and nonsmoker lung transplant patients (n = 4). Consistent with this finding, cigarette smoke induced a significant increase in Spns2 expression in both human alveolar and THP-1 macrophages. In contrast, a remarkable Spns2 down-regulation was noted in response to cigarette smoke in 16HBE14o- cell line (p<0.001 in 3 experiments), primary nasal epithelial cells (p<0.01 in 2 experiments), and in smoke-exposed mice (p<0.001, n = 6 animals per group). Spns2 was localized to cilia in primary bronchial epithelial cells. In both macrophage and epithelial cell types, Spns2 was also found localized to cytoplasm and the nucleus, in line with a predicted bipartile Nuclear Localization Signal at the position aa282 of the human Spns2 sequence. In smoke-exposed mice, alveolar macrophage phagocytic function positively correlated with Spns2 protein expression in bronchial epithelial cells. Conclusion Our data suggest that the epithelium may be the major source for extracellular S1P in the airway and that there is a possible disruption of epithelial/macrophage cross talk via Spns2-mediated S1P signaling in COPD and in response to cigarette smoke exposure.	[Tran, Hai B.; Jersmann, Hubertus; Tung Thanh Truong; Hamon, Rhys; Roscioli, Eugene; Ween, Miranda; Hodge, Greg; Reynolds, Paul N.; Hodge, Sandra] Univ Adelaide, Hanson Inst, Lung Res Unit, Adelaide, SA, Australia; [Tran, Hai B.; Jersmann, Hubertus; Tung Thanh Truong; Hamon, Rhys; Roscioli, Eugene; Ween, Miranda; Hodge, Greg; Reynolds, Paul N.; Hodge, Sandra] Univ Adelaide, Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA, Australia; [Tran, Hai B.; Jersmann, Hubertus; Tung Thanh Truong; Hamon, Rhys; Roscioli, Eugene; Ween, Miranda; Hodge, Greg; Reynolds, Paul N.; Hodge, Sandra] Univ Adelaide, Dept Med, Adelaide, SA, Australia; [Tung Thanh Truong] Hosp 175, Dept TB & Lung Dis, Hochiminh City, Vietnam; [Pitman, Melissa R.; Pitson, Stuart M.] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia; [Pitman, Melissa R.; Pitson, Stuart M.] SA Pathol, Adelaide, SA, Australia	Hanson Institute; University of Adelaide; Royal Adelaide Hospital; University of Adelaide; University of Adelaide; Centre for Cancer Biology; University of South Australia; SA Pathology	Tran, HB (corresponding author), Univ Adelaide, Hanson Inst, Lung Res Unit, Adelaide, SA, Australia.; Tran, HB (corresponding author), Univ Adelaide, Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA, Australia.; Tran, HB (corresponding author), Univ Adelaide, Dept Med, Adelaide, SA, Australia.	Hai.Tran@sa.gov.au	Jersmann, Hubertus/ABC-5287-2020; Pitson, Stuart/B-9342-2009	Jersmann, Hubertus/0000-0003-1763-2736; Pitson, Stuart/0000-0002-9527-2740; Tran, Hai Bac/0000-0002-9463-4033; Hamon, Rhys/0000-0002-5474-8490; Roscioli, Eugene/0000-0002-3201-3899; Pitman, Melissa/0000-0002-9587-3837	National Health and Medical Research Council (NHMRC) Project [App1044414]; NHMRC Senior Research Fellowship; Royal Adelaide Hospital Research Fund Early Career Fellowship; Asian Pacific Society of Respirology Scholarship	National Health and Medical Research Council (NHMRC) Project(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Royal Adelaide Hospital Research Fund Early Career Fellowship; Asian Pacific Society of Respirology Scholarship	This work was supported by National Health and Medical Research Council (NHMRC) Project Grant App1044414 (Chief Investigator A: SH, other chief investigators: SMP, R Haberberger, and PNR); NHMRC Senior Research Fellowship (SMP); Royal Adelaide Hospital Research Fund Early Career Fellowship (MRP); and Asian Pacific Society of Respirology Scholarship (TTT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Gary P, 2016, F1000Res, V5; Barnawi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122771; Bradley E, 2014, PLOS ONE, V9; Cordts F, 2011, LIFE SCI, V89, P806, DOI 10.1016/j.lfs.2011.08.018; Donoviel MS, 2015, FASEB J, V29, P5018, DOI 10.1096/fj.15-274936; Ebenezer DL, 2016, PHARMACOL THERAPEUT, V168, P143, DOI 10.1016/j.pharmthera.2016.09.008; Fuerst E, 2014, ALLERGY, V69, P1531, DOI 10.1111/all.12489; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Gu YP, 2011, J CELL BIOL, V193, P667, DOI 10.1083/jcb.201010075; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Harijith A, 2016, AM J PHYSIOL-LUNG C, V311, pL337, DOI 10.1152/ajplung.00447.2015; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Hodge S, 2006, EUR RESPIR J, V28, P486, DOI 10.1183/09031936.06.00001506; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Hodge S, 2016, AM J RESP CRIT CARE, V194, P912, DOI 10.1164/rccm.201601-0019LE; Hodge S, 2016, CHEST, V149, P508, DOI 10.1016/j.chest.2015.10.066; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hodge S, 2011, J HEART LUNG TRANSPL, V30, P589, DOI 10.1016/j.healun.2011.01.710; Hodge S, 2010, AM J RESP CELL MOL, V42, P235, DOI 10.1165/rcmb.2008-0486OC; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Malik Z, 2015, INT FORUM ALLERGY RH, V5, P551, DOI 10.1002/alr.21517; Moon MH, 2012, INT J MOL MED, V30, P1451, DOI 10.3892/ijmm.2012.1135; Nagahashi M, 2013, FASEB J, V27, P1001, DOI 10.1096/fj.12-219618; Simpson J, 2013, CLIN EXP ALLERGY, V43, P145; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Tran HB, 2016, J LEUKOCYTE BIOL, V100, P195, DOI 10.1189/jlb.3A1015-471R; Tran Hai B, 2012, J Allergy (Cairo), V2012, P819176, DOI 10.1155/2012/819176; Volzke A, 2014, BBA-MOL CELL BIOL L, V1841, P11, DOI 10.1016/j.bbalip.2013.09.009; Ween M, 2016, J IMMUNOL METHODS, V429, P7, DOI 10.1016/j.jim.2015.12.004; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Zhu W, 2016, ONCOGENE	35	18	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0179577	10.1371/journal.pone.0179577	http://dx.doi.org/10.1371/journal.pone.0179577			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112690	Green Published, Green Submitted, gold			2022-12-26	WOS:000414572100001
J	Zhang, SW; Zhang, R; Liu, TX; Song, X; Adams, MA				Zhang, Shengwei; Zhang, Rui; Liu, Tingxi; Song, Xin; Adams, Mark A.			Empirical and model-based estimates of spatial and temporal variations in net primary productivity in semi-arid grasslands of Northern China	PLOS ONE			English	Article							LIGHT USE EFFICIENCY; REMOTE-SENSING DATA; INNER-MONGOLIA; CLIMATE-CHANGE; SANDY LAND; ECOSYSTEM; PRECIPITATION; VEGETATION; SATELLITE; CARBON	Spatiotemporal variations in net primary productivity (NPP) reflect the dynamics of water and carbon in the biosphere, and are often closely related to temperature and precipitation. We used the ecosystem model known as the Carnegie-Ames-Stanford Approach (CASA) to estimate NPP of semiarid grassland in northern China counties between 2001 and 2013. Model estimates were strongly linearly correlated with observed values from different counties (slope = 0.76 (p < 0.001), intercept = 34.7 (p < 0.01), R-2 = 0.67, RMSE = 35 g C.m(-2).year(-1), bias = -0.11 g C.m(-2).year(-1)). We also quantified inter-annual changes in NPP over the 13-year study period. NPP varied between 141 and 313 g C.m(-2).year(-1), with a mean of 240 g C.m(-2).year(-1). NPP increased from west to east each year, and mean precipitation in each county was significantly positively correlated with NPP D annually, and in summer and autumn. Mean precipitation was positively related to NPP in spring, but not significantly so. Annual and summer temperatures were mostly negatively correlated with NPP, but temperature was positively correlated with spring and autumn NPP. Spatial correlation and partial correlation analyses at the pixel scale confirmed precipitation is a major driver of NPP. Temperature was negatively correlated with NPP in 99% of the regions at the annual scale, but after removing the effect of precipitation, temperature was positively correlated with the NPP in 77% of the regions. Our data show that temperature effects on production depend heavily on recent precipitation. Results reported here have significant and far-reaching implications for natural resource management, given the enormous size of these grasslands and the numbers of people dependent on them.	[Zhang, Shengwei; Zhang, Rui; Liu, Tingxi] Inner Mongolia Agr Univ, Coll Water Conservancy & Civil Engn, Hohhot, Peoples R China; [Zhang, Shengwei] Univ Sydney, Ctr Carbon Water & Food, Sydney, NSW, Australia; [Song, Xin] Shenzhen Univ, Coll Life Sci & Oceanog, Shenzhen, Peoples R China; [Adams, Mark A.] Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic, Australia	Inner Mongolia Agricultural University; University of Sydney; Shenzhen University; Swinburne University of Technology	Liu, TX (corresponding author), Inner Mongolia Agr Univ, Coll Water Conservancy & Civil Engn, Hohhot, Peoples R China.	txliu1966@163.com	adams, mark a/H-1303-2012	adams, mark a/0000-0002-8154-0097; Zhang, Shengwei/0000-0001-9153-4398	National Natural Science Foundation of China [51569017, 51269014]; Program for Changjiang Scholars and Innovative Research Team of Chinese Ministry of Education [IRT13069]; Natural Science Foundation of Inner Mongolia [2015MS0514]; Western Region China Postdoctoral Science Foundation [2015M572630XB]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team of Chinese Ministry of Education(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of Inner Mongolia; Western Region China Postdoctoral Science Foundation	This research was supported by the National Natural Science Foundation of China (No. 51569017, 51269014), the Program for Changjiang Scholars and Innovative Research Team of Chinese Ministry of Education (IRT13069), the Natural Science Foundation of Inner Mongolia (2015MS0514) and the Western Region China Postdoctoral Science Foundation (2015M572630XB).	Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; An N, 2013, INT J REMOTE SENS, V34, P3717, DOI 10.1080/01431161.2012.757376; Chirici G, 2015, EUR J FOREST RES, V134, P453, DOI 10.1007/s10342-015-0864-4; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Dou Jing-xin, 2009, Yingyong Shengtai Xuebao, V20, P1845; FIELD CB, 1995, REMOTE SENS ENVIRON, V51, P74, DOI 10.1016/0034-4257(94)00066-V; Gang CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080394; Gao YZ, 2011, OECOLOGIA, V165, P855, DOI 10.1007/s00442-010-1890-z; Han Bin, 2006, Zhiwu Shengtai Xuebao, V30, P553; Hashimoto H, 2010, GLOBAL CHANGE BIOL, V16, P255, DOI 10.1111/j.1365-2486.2009.01921.x; Hornik K., 2017, TSERIES TIME SERIES; [黄文华 Huang Wenhua], 2014, [草业科学, Pratacultural Science], V31, P2069; Jiang GM, 2006, AMBIO, V35, P269, DOI 10.1579/06-S-158.1; Jobbagy EG, 2000, ECOL APPL, V10, P541, DOI 10.1890/1051-0761(2000)010[0541:COGASA]2.0.CO;2; Li AN, 2012, REMOTE SENS-BASEL, V4, P3857, DOI 10.3390/rs4123857; Li A, 2012, LANDSCAPE ECOL, V27, P969, DOI 10.1007/s10980-012-9751-2; Li F, 2016, ECOL INDIC, V62, P279, DOI 10.1016/j.ecolind.2015.11.005; Li J, 2013, ECOL MODEL, V252, P3, DOI 10.1016/j.ecolmodel.2012.11.026; Li WJ, 2007, J ENVIRON MANAGE, V85, P461, DOI 10.1016/j.jenvman.2006.10.010; Li XB, 2015, GEOSCI J, V19, P561, DOI 10.1007/s12303-014-0057-z; Li Y, 2003, J NATURAL RESOURCES, V19, P610; Liu H, 2013, HYDROL EARTH SYST SC, V17, P805, DOI 10.5194/hess-17-805-2013; Lkhagva A, 2013, GRASSL SCI, V59, P135, DOI 10.1111/grs.12022; Lu X, 2014, SCI REPORTS, V4, P2341; Luo YQ, 2008, GLOBAL CHANGE BIOL, V14, P1986, DOI 10.1111/j.1365-2486.2008.01629.x; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Michaletz ST, 2014, NATURE, V512, P39, DOI 10.1038/nature13470; Mowll W, 2015, OECOLOGIA, V177, P959, DOI 10.1007/s00442-015-3232-7; [穆少杰 Mu Shaojie], 2013, [生态学报, Acta Ecologica Sinica], V33, P3752; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Neumann M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8070554; Parton W, 2012, GLOBAL CHANGE BIOL, V18, P915, DOI 10.1111/j.1365-2486.2011.02611.x; Potter C, 2012, CLIMATIC CHANGE, V115, P365, DOI 10.1007/s10584-012-0460-2; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Rafique R, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030177; RAICH JW, 1991, ECOL APPL, V1, P399, DOI 10.2307/1941899; RCore Team, 2020, R LANG ENV STAT COMP; Reeves MC, 2014, CLIMATIC CHANGE, V126, P429, DOI 10.1007/s10584-014-1235-8; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Robertson TR, 2009, NEW PHYTOL, V181, P230, DOI 10.1111/j.1469-8137.2008.02643.x; RStudio Team, 2017, RSTUDIO INT DEV ENV; Shen W, 2012, GLOBAL PLANET CHANGE, V86-87, P37, DOI 10.1016/j.gloplacha.2012.01.012; Sjostrom M, 2013, REMOTE SENS ENVIRON, V131, P275, DOI 10.1016/j.rse.2012.12.023; Soylu ME, 2011, HYDROL EARTH SYST SC, V15, P787, DOI 10.5194/hess-15-787-2011; Su HX, 2015, SCI REP-UK, V5, DOI 10.1038/srep09115; Tan K, 2007, FOREST ECOL MANAG, V240, P114, DOI 10.1016/j.foreco.2006.12.018; Tang GP, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00087.1; Wang C, 2014, SCI REPORTS, V4, P157; Wang Y, 2016, BIODIVERS CONSERV, V25, P2401, DOI 10.1007/s10531-015-1034-1; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Yan HM, 2009, GLOBAL PLANET CHANGE, V67, P13, DOI 10.1016/j.gloplacha.2008.12.012; Yang K, 2008, SCI CHINA SER D, V51, P721, DOI 10.1007/s11430-008-0036-1; Yang Z, 2015, INNER MONGOLIA STAT, DOI [10.1007/s11434-006-0457-1, DOI 10.1007/S11434-006-0457-1]; Youhua R., 2010, LAND COVER PRODUCTS, DOI [10.3972/westdc.007.2013.db., DOI 10.3972/WESTDC.007.2013.DB]; Yu DY, 2011, ECOL ENG, V37, P1387, DOI 10.1016/j.ecoleng.2011.03.011; Zhang Cun-hou, 2012, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V32, P1229; Zhang ML, 2016, SCI TOTAL ENVIRON, V553, P184, DOI 10.1016/j.scitotenv.2016.02.106; Zhang S, 2015, CHINESE JOURNAL OF G, P66; Zhang S, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/819296; Zhang T, 2016, AGR FOREST METEOROL, V225, P48, DOI 10.1016/j.agrformet.2016.05.004; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590; Zhao WZ, 2005, CATENA, V59, P173, DOI 10.1016/j.catena.2004.06.004; Zheng YR, 2006, J ARID ENVIRON, V64, P523, DOI 10.1016/j.jaridenv.2005.06.007; Zhu LK, 2013, REMOTE SENS-BASEL, V5, P3803, DOI 10.3390/rs5083803; Zhu Wen-Quan, 2007, Zhiwu Shengtai Xuebao, V31, P413; Zhu WQ, 2006, CHINESE SCI BULL, V51, P457, DOI [10.1007/s11434-006-0457-1, 10.1007/S11434-006-0457-1]	67	8	9	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187678	10.1371/journal.pone.0187678	http://dx.doi.org/10.1371/journal.pone.0187678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112982	Green Submitted, Green Published, gold			2022-12-26	WOS:000414572100033
J	Garcia-Marchena, N; Silva-Pena, D; Martin-Velasco, AI; Villanua, MA; Araos, P; Pedraz, M; Maza-Ouiroga, R; Romero-Sanchiz, P; Rubio, G; Castilla-Ortega, E; Suarez, J; de Fonseca, FR; Serrano, A; Pavon, FJ				Garcia-Marchena, Nuria; Silva-Pena, Daniel; Isabel Martin-Velasco, Ana; Angeles Villanua, Maria; Araos, Pedro; Pedraz, Maria; Maza-Ouiroga, Rosa; Romero-Sanchiz, Pablo; Rubio, Gabriel; Castilla-Ortega, Estela; Suarez, Juan; Rodriguez de Fonseca, Fernando; Serrano, Antonia; Javier Pavon, Francisco			Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders	PLOS ONE			English	Article							GROWTH-FACTOR-I; COMORBID PSYCHIATRIC-DISORDERS; NEUROTROPHIC FACTOR LEVELS; RESEARCH INTERVIEW; MENTAL-DISORDERS; SERUM-LEVELS; BRAIN; INSULIN; DEPRESSION; ASSOCIATIONS	The identification of growth factors as potential biomarkers in alcohol addiction may help to understand underlying mechanisms associated with the pathogenesis of alcohol use disorders (AUDs). Previous studies have linked growth factors to neural plasticity in neurocognitive impairment and mental disorders. In order to further clarify the impact of chronic alcohol consumption on circulating growth factors, a cross-sectional study was performed in abstinent AUD patients (alcohol group, N = 91) and healthy control subjects (control group, N = 55) to examine plasma concentrations of brain-derived neurotrophic factor (BDNF), insulin-like growth factor-1 (IGF-1) and IGF-1 binding protein-3 (IGFBP-3). The association of these plasma peptides with relevant AUD-related variables and psychiatric comorbidity was explored. The alcohol group was diagnosed with severe AUD and showed an average of 13 years of problematic use and 10 months of abstinence at the moment of participating in the study. Regarding common medical conditions associated with AUD, we observed an elevated incidence of alcohol-induced liver and pancreas diseases (18.7%) and psychiatric comorbidity (76.9%). Thus, AUD patients displayed a high prevalence of dual diagnosis (39.3%) [mainly depression (19.9%)] and comorbid substance use disorders (40.7%). Plasma BDNF and IGF-1 concentrations were significantly lower in the alcohol group than in the control group (p<0.001). Remarkably, there was a negative association between IGF-1 concentrations and age in the control group (r = -0.52, p<0.001) that was not found in the alcohol group. Concerning AUD-related variables, AUD patients with liver and pancreas diseases showed even lower concentrations of BDNF (p<0.05). In contrast, the changes in plasma concentrations of these peptides were not associated with abstinence, problematic use, AUD severity or lifetime psychiatric comorbidity. These results suggest that further research is necessary to elucidate the role of BDNF in alcohol-induced toxicity and the biological significance of the lack of correlation between age and plasma IGF-1 levels in abstinent AUD patients.	[Garcia-Marchena, Nuria; Silva-Pena, Daniel; Araos, Pedro; Pedraz, Maria; Maza-Ouiroga, Rosa; Romero-Sanchiz, Pablo; Castilla-Ortega, Estela; Suarez, Juan; Rodriguez de Fonseca, Fernando; Serrano, Antonia; Javier Pavon, Francisco] Univ Malaga, Hosp Reg Univ Malaga, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Salud Mental, Malaga, Spain; [Isabel Martin-Velasco, Ana; Angeles Villanua, Maria] Univ Complutense Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Rubio, Gabriel] Hosp Univ 12 Octubre, Inst i 12, Madrid, Spain	Universidad de Malaga; Complutense University of Madrid; Hospital Universitario 12 de Octubre	de Fonseca, FR; Serrano, A; Pavon, FJ (corresponding author), Univ Malaga, Hosp Reg Univ Malaga, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Salud Mental, Malaga, Spain.	fernando.rodriguez@ibima.eu; antonia.serrano@ibima.edu; javier.pavon@ibima.eu	VALLADOLID, GABRIEL RUBIO/O-1752-2018; GÓMEZ, PEDRO FERNANDO ARAOS/AAX-1715-2021; Romero-Sanchiz, Pablo/B-8454-2011; Suarez, Juan/I-5188-2015; Castilla-Ortega, Estela/K-2811-2015; Martín, Ana Isabel/K-5301-2014; Pavón Morón, Francisco Javier/AAG-9721-2020	VALLADOLID, GABRIEL RUBIO/0000-0002-1171-1508; GÓMEZ, PEDRO FERNANDO ARAOS/0000-0001-5172-8796; Romero-Sanchiz, Pablo/0000-0002-3683-3835; Suarez, Juan/0000-0001-5254-9802; Castilla-Ortega, Estela/0000-0002-4496-1167; Martín, Ana Isabel/0000-0002-4445-590X; Pavón Morón, Francisco Javier/0000-0002-5256-8904; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795; Serrano, Antonia/0000-0002-8017-9754	RETICS Red de Trastornos Adictivos - Instituto de Salud Carlos III (ISC-III) [RD16/0017/0001]; European Regional Development Funds-European Union (ERDF-EU); ISC-III [PI13/02261, PI16/01698, PI16/01953]; Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas [PNSD 049/2013]; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia; ERDF-EU [CTS-433, CP12/03109, CP14/00173, CP14/00212, CD12/00455]; Consejeria de Salud y Bienestar Social, Junta Andalucia [PI0228-2013]; ISC-III; Ministerio de Economia y Competitividad	RETICS Red de Trastornos Adictivos - Instituto de Salud Carlos III (ISC-III); European Regional Development Funds-European Union (ERDF-EU); ISC-III(Instituto de Salud Carlos III); Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia(Junta de Andalucia); ERDF-EU(European Commission); Consejeria de Salud y Bienestar Social, Junta Andalucia; ISC-III(Instituto de Salud Carlos III); Ministerio de Economia y Competitividad(Spanish Government)	The present study has been supported by RETICS Red de Trastornos Adictivos (RD16/0017/0001) funded by Instituto de Salud Carlos III (ISC-III) and European Regional Development Funds-European Union (ERDF-EU); Research project funded by Ministerio de Economia y Competitividad and ISC-III (PI13/02261, PI16/01698 and PI16/01953); Research project funded by Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas (PNSD 049/2013); Research project funded by Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia and ERDF-EU (CTS-433); Research projects funded by Consejeria de Salud y Bienestar Social, Junta Andalucia (PI0228-2013). JS, AS and FJP hold Miguel Servet research contracts funded by ISC-III and ERDF-EU (CP12/03109, CP14/00173 and CP14/00212, respectively). EC-O holds a "Sara Borrell" research contract funded by ISC-III and ERDF-EU (CD12/00455).	Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Araos P, 2015, ADDICT BIOL, V20, P756, DOI 10.1111/adb.12156; Bartoli F, 2015, ADDICT BEHAV, V41, P46, DOI 10.1016/j.addbeh.2014.09.029; Bernardin F, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00078; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Boschen KE, 2017, VITAM HORM, V104, P197, DOI 10.1016/bs.vh.2016.10.008; Bus BAA, 2011, PSYCHONEUROENDOCRINO, V36, P228, DOI 10.1016/j.psyneuen.2010.07.013; Castren E, 2004, MOL NEUROBIOL, V29, P289, DOI 10.1385/MN:29:3:289; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chul BL, 2009, ALCOHOL, V43, P265, DOI 10.1016/j.alcohol.2009.04.003; Colao A, 2005, J ENDOCRINOL INVEST, V28, P440, DOI 10.1007/BF03347225; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Garcia Marchena Nuria, 2016, Adicciones, V29, P83, DOI 10.20882/adicciones.728; Garcia-Marchena N, 2017, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00214; Garcia-Valdecasas-Campelo E, 2007, ALCOHOL ALCOHOLISM, V42, P533, DOI 10.1093/alcalc/agm065; Gitto S, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010011; Guerri C, 2009, ALCOHOL ALCOHOLISM, V44, P108, DOI 10.1093/alcalc/agn105; Hasin D, 2006, AM J PSYCHIAT, V163, P689, DOI 10.1176/appi.ajp.163.4.689; Heberlein A, 2010, PROG NEURO-PSYCHOPH, V34, P1060, DOI 10.1016/j.pnpbp.2010.05.025; Huang MC, 2008, ALCOHOL ALCOHOLISM, V43, P241, DOI 10.1093/alcalc/agm172; Hughes MS, 2011, PANCREAS, V40, P551, DOI 10.1097/MPA.0b013e318214fb77; Ilias I, 2011, MED SCI MONITOR, V17, pCR547, DOI 10.12659/MSM.881979; Janak PH, 2006, ALCOHOL CLIN EXP RES, V30, P214, DOI 10.1111/j.1530-0277.2006.00026.x; Jockers-Scherubl MC, 2007, NEUROSCI LETT, V419, P78, DOI 10.1016/j.neulet.2007.03.051; Joe KH, 2007, ALCOHOL CLIN EXP RES, V31, P1833, DOI 10.1111/j.1530-0277.2007.00507.x; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Klintsova AY, 2013, BRAIN SCI, V3, P1, DOI 10.3390/brainsci3010001; Lanni C, 2010, CURR PHARM DESIGN, V16, P698, DOI 10.2174/138161210790883741; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Leggio L, 2008, ALCOHOL CLIN EXP RES, V32, P450, DOI 10.1111/j.1530-0277.2007.00589.x; Lin F, 2014, PSYCHONEUROENDOCRINO, V42, P118, DOI 10.1016/j.psyneuen.2014.01.006; Liu XH, 2014, PSYCHIAT RES, V218, P54, DOI 10.1016/j.psychres.2014.03.042; Luo J, 1998, BRAIN RES REV, V27, P157, DOI 10.1016/S0165-0173(98)00009-5; Malberg JE, 2007, NEUROPSYCHOPHARMACOL, V32, P2360, DOI 10.1038/sj.npp.1301358; Martin RM, 2008, J CLIN ENDOCR METAB, V93, P1331, DOI 10.1210/jc.2007-2295; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; Miller MW, 2004, J NEUROBIOL, V60, P490, DOI 10.1002/neu.20059; Modabbernia A, 2011, BIOL PSYCHIAT, V70, pE31, DOI 10.1016/j.biopsych.2011.01.028; Moreau R, 2015, J CLIN EXP HEPATOL, V5, P81, DOI 10.1016/j.jceh.2014.09.003; Muller AP, 2012, MOL CELL NEUROSCI, V49, P9, DOI 10.1016/j.mcn.2011.07.008; O'Kusky J, 2012, FRONT NEUROENDOCRIN, V33, P230, DOI 10.1016/j.yfrne.2012.06.002; Organization WH, 2015, GLOB STAT REP ALCH H; Pardridge William M, 2002, Curr Opin Investig Drugs, V3, P1753; Pedraz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118610; Reece AS, 2013, NEUROENDOCRINOL LETT, V34, P18; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rojdmark S, 2001, J ENDOCRINOL INVEST, V24, P476; Stouthart PJHM, 2003, PSYCHONEUROENDOCRINO, V28, P612, DOI 10.1016/S0306-4530(02)00045-8; Suliman S, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00055; Torrens M, 2004, AM J PSYCHIAT, V161, P1231, DOI 10.1176/appi.ajp.161.7.1231; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; Toth C, 2006, NEUROBIOL DIS, V23, P445, DOI 10.1016/j.nbd.2006.03.015; Valsecchi AE, 2011, EUR J PHARMACOL, V650, P694, DOI 10.1016/j.ejphar.2010.10.060; Villanueva R, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/873278; Wang YF, 2014, NORD J BOT, V32, P185, DOI 10.1111/j.1756-1051.2013.00200.x; Yoon SJ, 2006, ALCOHOL CLIN EXP RES, V30, P1060, DOI 10.1111/j.1530-0277.2006.00120.x; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Ziegenhorn AA, 2007, NEUROBIOL AGING, V28, P1436, DOI 10.1016/j.neurobiolaging.2006.06.011	62	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187634	10.1371/journal.pone.0187634	http://dx.doi.org/10.1371/journal.pone.0187634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108028	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600050
J	Dou, XW; Menkari, C; Mitsuyama, R; Foroud, T; Wetherill, L; Hammond, P; Suttie, M; Chen, XP; Chen, SY; Charness, ME				Dou, Xiaowei; Menkari, Carrie; Mitsuyama, Rei; Foroud, Tatiana; Wetherill, Leah; Hammond, Peter; Suttie, Michael; Chen, Xiaopan; Chen, Shao-Yu; Charness, Michael E.		Collaborative Initiative Fetal Alc	L1 coupling to ankyrin and the spectrin-actin cytoskeleton modulates ethanol inhibition of L1 adhesion and ethanol teratogenesis	FASEB JOURNAL			English	Article						FASD; alcohol; phosphorylation; susceptibility	FETAL ALCOHOL SPECTRUM; CELL-ADHESION; MOLECULE L1; NEURITE OUTGROWTH; STRUCTURAL REQUIREMENTS; BINDING-ACTIVITY; BRAIN STRUCTURES; CRASH SYNDROME; OUTSIDE-IN; MUTATIONS	Ethanol causes fetal alcohol spectrum disorders (FASDs) partly by inhibiting cell adhesion mediated by the L1 neural cell adhesion molecule. Ethanol interacts with an alcohol binding pocket in the L1 extracellular domain (ECD), and dephosphorylation of S1248 in the L1 cytoplasmic domain (CD) renders L1 adhesion insensitive to inhibition by ethanol (L1 insensitive). The mechanism underlying this inside-out signaling is unknown. Here we show that phosphorylation of the human L1-CD at S1152, Y1176, S1181, and S1248 renders L1 sensitive to ethanol by promoting L1 coupling with ankyrin-G and the spectrin-actin cytoskeleton. Knockdown of ankyrin-G or L1 mutations that uncouple L1 from ankyrin reduce L1 sensitivity to ethanol, but not methanol, consistent with a small conformational change in the extracellular alcohol binding pocket. Phosphorylation of Y1176 and ankyrin-G coupling with L1 are higher in NIH/3T3 clonal cell lines in which ethanol inhibits L1 adhesion than in ethanol-resistant NIH/3T3 clonal cell lines. Similarly, phosphorylation of Y1176 is higher in C57BL/6J mice that are sensitive to ethanol teratogenesis than in ethanol resistant C57BL/6N mice. Finally, poly-morphisms in genes that encode ankyrin-G and p90rsk, a kinase that phosphorylates S1152, are linked to facial dysmorphology in children with heavy prenatal ethanol exposure. These findings indicate that genes that regulate L1 coupling to ankyrin may influence susceptibility to FASD.-Dou, X., Menkari, C., Mitsuyama, R., Foroud, T., Wetherill, L., Hammond, P., Suttie, M., Chen, X., Chen, S.-Y., Charness, M. E., Collaborative Initiative on Fetal Alcohol Spectrum Disorders. L1 coupling to ankyrin and the spectrin-actin cytoskeleton modulates ethanol inhibition of L1 adhesion and ethanol teratogenesis.	[Dou, Xiaowei; Menkari, Carrie; Mitsuyama, Rei; Charness, Michael E.] Harvard Med Sch, Vet Affairs Boston Healthcare Syst, Dept Neurol, West Roxbury, MA 02132 USA; [Foroud, Tatiana; Wetherill, Leah] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Hammond, Peter; Suttie, Michael] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Chen, Xiaopan] Zhejiang Prov Peoples Hosp, Dept Reprod Endocrinol, Hangzhou, Zhejiang, Peoples R China; [Chen, Shao-Yu] Univ Louisville, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Charness, Michael E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Indiana University System; Indiana University Bloomington; University of Oxford; Zhejiang Provincial People's Hospital; University of Louisville; Boston University	Charness, ME (corresponding author), Harvard Med Sch, VA Boston Healthcare Syst, 1400 VFW Pkwy, West Roxbury, MA 02132 USA.	mcharness@hms.harvard.edu	Dou, Xiaowei/ABC-8814-2021; Wetherill, Leah/AAJ-2791-2020	Wetherill, Leah/0000-0003-2888-9051; Chen, Xiaopan/0000-0003-4289-7541; Suttie, Michael/0000-0002-5538-8431; Charness, Michael/0000-0002-3301-8966	U.S. National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIAAA [R01AA012974, U24AA014811, U01AA014809, R01AA020265, R01AA021434, P50AA024337]; Medical Research Service and Veterans Affairs Merit Review [5I01BX002374]; Department of Defense [W81XWH-12- 2-0048, 8742sc]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012974, P50AA024337, R01AA020265, U24AA014811, R01AA021434, U01AA014809, U01AA026103] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002374] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Service and Veterans Affairs Merit Review; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Valerie Novakovic and Jerry Lee (Veterans Affairs Boston Healthcare System; Harvard Medical School) for assistance with FACS measurements and critical review of the manuscript. Part of this work was done in conjunction with the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), which is funded by grants from the U.S. National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA). Additional information about CIFASD can be found at www.cifasd.org. This work was supported by NIAAA Grant R01AA012974 (to M.E.C.), NIAAA U24AA014811 as a component of CIFASD (to M.E.C.); The Medical Research Service and Veterans Affairs Merit Review 5I01BX002374 (to M.E.C.); Department of Defense Grant W81XWH-12- 2-0048 Subaward 8742sc (to M.E.C.); NIAAA U01AA014809 (to T.F. and P.H.); NIAAA R01AA020265 (to S.-Y.C), NIAAA R01AA021434 ( to S.-Y.C) and NIAAA P50AA024337 (to S.-Y.C). The authors declare no conflicts of interest.	Arevalo E, 2008, P NATL ACAD SCI USA, V105, P371, DOI 10.1073/pnas.0707815105; Bearer CF, 1999, J BIOL CHEM, V274, P13264, DOI 10.1074/jbc.274.19.13264; Bennett V, 1999, J NEUROCYTOL, V28, P303, DOI 10.1023/A:1007005528505; Bi C, 2012, HUM MUTAT, V33, P1635, DOI 10.1002/humu.22174; Blankenship J, 2016, PEDIATRICS, V138; BONTHIUS DJ, 1988, ALCOHOL, V5, P209, DOI 10.1016/0741-8329(88)90054-7; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Chen MM, 2010, MOL BIOL CELL, V21, P1671, DOI 10.1091/mbc.E09-10-0900; Chen SZ, 2008, P NATL ACAD SCI USA, V105, P19962, DOI 10.1073/pnas.0807758105; Chen SY, 2005, DEV NEUROSCI-BASEL, V27, P13, DOI 10.1159/000084528; Chen SY, 2001, FASEB J, V15, P1649, DOI 10.1096/fj.00-0862fje; Dai JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073000; Dai JX, 2012, MOL CELL NEUROSCI, V50, P201, DOI 10.1016/j.mcn.2012.05.001; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; Dou XW, 2014, ALCOHOL CLIN EXP RES, V38, P2707, DOI 10.1111/acer.12556; Dou XW, 2013, P NATL ACAD SCI USA, V110, P5683, DOI 10.1073/pnas.1221386110; Dou XW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209254; Eberhart JK, 2016, ALCOHOL CLIN EXP RES, V40, P1154, DOI 10.1111/acer.13066; Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1998, J MED GENET, V35, P399, DOI 10.1136/jmg.35.5.399; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Haspel J, 2003, FRONT BIOSCI-LANDMRK, V8, pS1210, DOI 10.2741/1108; Hoffman EJ, 2008, NEUROSCIENCE, V157, P556, DOI 10.1016/j.neuroscience.2008.08.071; Hortsch M, 1998, J CELL BIOL, V142, P251, DOI 10.1083/jcb.142.1.251; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; Iqbal Z, 2013, HUM MOL GENET, V22, P1960, DOI 10.1093/hmg/ddt043; Jenkins PM, 2015, P NATL ACAD SCI USA, V112, P957, DOI 10.1073/pnas.1416544112; Kietzman HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089448; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Lipinski RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043067; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; McCarthy N, 2013, DEVELOPMENT, V140, P3254, DOI 10.1242/dev.094938; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; Ota M, 2016, PSYCHIAT CLIN NEUROS, V70, P498, DOI 10.1111/pcn.12431; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; STREISSGUTH AP, 1993, AM J MED GENET, V47, P857, DOI 10.1002/ajmg.1320470612; Suttie M, 2013, PEDIATRICS, V131, pE779, DOI 10.1542/peds.2012-1371; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; Vallejo Y, 1997, J BIOL CHEM, V272, P12244, DOI 10.1074/jbc.272.18.12244; Wilkemeyer MF, 1999, ALCOHOL CLIN EXP RES, V23, P1711, DOI 10.1097/00000374-199911000-00002; Wilkemeyer MF, 2003, P NATL ACAD SCI USA, V100, P8543, DOI 10.1073/pnas.1331636100; Wilkemeyer MF, 1998, J NEUROCHEM, V71, P2382; Wong EV, 1996, J NEUROCHEM, V66, P779; Wong EV, 1996, J BIOL CHEM, V271, P18217, DOI 10.1074/jbc.271.30.18217; Yamasaki M, 1997, NEUROPEDIATRICS, V28, P175, DOI 10.1055/s-2007-973696; Zeniou M, 2002, HUM MOL GENET, V11, P2929, DOI 10.1093/hmg/11.23.2929; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785; Zhao X, 1996, J BIOL CHEM, V271, P6563, DOI 10.1074/jbc.271.12.6563	52	9	9	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1364	1374		10.1096/fj.201700970	http://dx.doi.org/10.1096/fj.201700970			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29109170	Green Published			2022-12-26	WOS:000427246000020
J	Liang, PD; Rosas-Lemus, M; Patel, D; Fang, X; Tuz, K; Juarez, O				Liang, Pingdong; Rosas-Lemus, Monica; Patel, Dhwani; Fang, Xuan; Tuz, Karina; Juarez, Oscar			Dynamic energy dependency of Chlamydia trachomatis on host cell metabolism during intracellular growth: Role of sodium-based energetics in chlamydial ATP generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; Chlamydia trachomatis; energy metabolism; host-pathogen interaction; mitochondrial metabolism; respiratory chain	NADH-QUINONE OXIDOREDUCTASE; PUMPING NADHQUINONE OXIDOREDUCTASE; UBIQUINONE-BINDING-SITE; VIBRIO-CHOLERAE; RESPIRATORY-CHAIN; ESCHERICHIA-COLI; AZITHROMYCIN RESISTANCE; DEVELOPMENTAL CYCLE; NA+-NQR; MEMBRANE	Chlamydia trachomatis is an obligate intracellular human pathogen responsible for the most prevalent sexually-transmitted infection in the world. For decades C. trachomatis has been considered an energy parasite that relies entirely on the uptake of ATP from the host cell. The genomic data suggest that C. trachomatis respiratory chain could produce a sodium gradient that may sustain the energetic demands required for its rapid multiplication. However, this mechanism awaits experimental confirmation. Moreover, the relationship of chlamydiae with the host cell, in particular its energy dependence, is not well understood. In this work, we are showing that C. trachomatis has an active respiratory metabolism that seems to be coupled to the sodium-dependent synthesis of ATP. Moreover, our results show that the inhibition of mitochondrial ATP synthesis at an early stage decreases the rate of infection and the chlamydial inclusion size. In contrast, the inhibition of the chlamydial respiratory chain at mid-stage of the infection cycle decreases the inclusion size but has no effect on infection rate. Remarkably, the addition of monensin, a Na+/H+ exchanger, completely halts the infection. Altogether, our data indicate that chlamydial development has a dynamic relationship with the mitochondrial metabolism of the host, in which the bacterium mostly depends on host ATP synthesis at an early stage, and at later stages it can sustain its own energy needs through the formation of a sodium gradient.	[Liang, Pingdong; Rosas-Lemus, Monica; Patel, Dhwani; Fang, Xuan; Tuz, Karina; Juarez, Oscar] IIT, Dept Biol Sci, Chicago, IL 60616 USA	Illinois Institute of Technology	Tuz, K; Juarez, O (corresponding author), IIT, Life Sci Bldg,3101 S Dearborn St, Chicago, IL 60616 USA.	ktuz@iit.edu; ojuarez@iit.edu	Rosas-Lemus, Monica/U-4691-2019; Fang, Xuan/CAG-5381-2022	Fang, Xuan/0000-0001-6394-4015; Tuz, Karina/0000-0002-1669-4612; Juarez, Oscar/0000-0002-2915-8413; Liang, Pingdong/0000-0002-8950-5755	IIT startup funds; "Programa de estancias posdoctorales al extranjero" from the National Council for Science and Technology (CONACyT), Mexico	IIT startup funds; "Programa de estancias posdoctorales al extranjero" from the National Council for Science and Technology (CONACyT), Mexico	This work was supported in part by IIT startup funds (to O. J.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by "Programa de estancias posdoctorales al extranjero" from the National Council for Science and Technology (CONACyT), Mexico.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALLEN EG, 1957, J EXP MED, V105, P539, DOI 10.1084/jem.105.6.539; ALLEN EG, 1962, ANN NY ACAD SCI, V98, P229, DOI 10.1111/j.1749-6632.1962.tb30547.x; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barta ML, 2014, J BIOL CHEM, V289, P32214, DOI 10.1074/jbc.M114.594325; Bas S, 1998, BRIT J RHEUMATOL, V37, P1054; BAVOIL P, 1984, INFECT IMMUN, V44, P479, DOI 10.1128/IAI.44.2.479-485.1984; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Bertsova YV, 2004, FEBS LETT, V563, P207, DOI 10.1016/S0014-5793(04)00312-6; Binet R, 2007, ANTIMICROB AGENTS CH, V51, P4267, DOI 10.1128/AAC.00962-07; Binet R, 2010, ANTIMICROB AGENTS CH, V54, P1094, DOI 10.1128/AAC.01321-09; BOGACHEV AV, 1993, BIOCHIM BIOPHYS ACTA, V1142, P321, DOI 10.1016/0005-2728(93)90160-H; Byrne GI, 2010, J INFECT DIS, V201, pS126, DOI 10.1086/652398; Chowdhary Anuradha, 1998, Journal of Communicable Diseases, V30, P163; CLARK LC, 1968, ANN NY ACAD SCI, V148, P133, DOI 10.1111/j.1749-6632.1968.tb20346.x; Craigen WJ, 2008, J BIOENERG BIOMEMBR, V40, P207, DOI 10.1007/s10863-008-9146-x; de Gannes FMP, 1998, CYTOMETRY, V33, P333; Dean D, 2009, DRUG TODAY, V45, P25; Dessus-Babus S, 1998, ANTIMICROB AGENTS CH, V42, P2474, DOI 10.1128/AAC.42.10.2474; Dibrov P, 2005, BIOCHEMISTRY-MOSCOW+, V70, P150, DOI 10.1007/s10541-005-0094-3; Dibrov P, 2004, J MOL MICROB BIOTECH, V8, P1, DOI 10.1159/000082075; Dibrov P, 2017, CAN J PHYSIOL PHARM, V95, P595, DOI 10.1139/cjpp-2016-0505; Divakaruni AS, 2014, CURR PROTOC TOXICOL, V60, P1, DOI [10.1002/0471140856.tx2502s60, DOI 10.1002/0471140856.TX2502S60]; Dzioba J, 2003, J BACTERIOL, V185, P674, DOI 10.1128/JB.185.2.674-678.2003; Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30; Engstrom P, 2015, INT J MED MICROBIOL, V305, P378, DOI 10.1016/j.ijmm.2015.02.007; ERNSTER L, 1963, J BIOL CHEM, V238, P1124; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; GHOUL M, 1989, APPL ENVIRON MICROB, V55, P1040, DOI 10.1128/AEM.55.4.1040-1043.1989; Grieshaber S, 2002, CELL MICROBIOL, V4, P273, DOI 10.1046/j.1462-5822.2002.00191.x; HACKER B, 1993, BIOCHEMISTRY-US, V32, P4403, DOI 10.1021/bi00067a033; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hammerschlag Margaret R, 2002, Semin Pediatr Infect Dis, V13, P239, DOI 10.1053/spid.2002.127201; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; HATCH TP, 1982, J BACTERIOL, V150, P662, DOI 10.1128/JB.150.2.662-670.1982; HATCH TP, 1985, J BACTERIOL, V162, P938, DOI 10.1128/JB.162.3.938-942.1985; Hayashi M, 1996, FEBS LETT, V381, P174, DOI 10.1016/0014-5793(96)00114-7; Herz K, 2003, J BACTERIOL, V185, P1236, DOI 10.1128/JB.185.4.1236-1244.2003; HEYTLER PG, 1963, BIOCHEMISTRY-US, V2, P357, DOI 10.1021/bi00902a031; Iliffe-Lee ER, 1999, MOL MICROBIOL, V33, P177, DOI 10.1046/j.1365-2958.1999.01464.x; Iliffe-Lee ER, 2002, MOL MICROBIOL, V44, P819, DOI 10.1046/j.1365-2958.2002.02924.x; INABAYASHI M, 1995, BIOCHEMISTRY-US, V34, P3455, DOI 10.1021/bi00010a038; Juarez O, 2004, BBA-BIOENERGETICS, V1658, P244, DOI 10.1016/j.bbabio.2004.06.005; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kalbacova M, 2003, CYTOM PART A, V52A, P110, DOI 10.1002/cyto.a.10031; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Malhotra M, 2013, INDIAN J MED RES, V138, P303; McClarty G, 1999, CHLAMYDIA, P69; McMillan DGG, 2011, J BIOL CHEM, V286, P39882, DOI 10.1074/jbc.M111.281675; Mehlitz A, 2017, MOL MICROBIOL, V103, P1004, DOI 10.1111/mmi.13603; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; MIYOSHI H, 1991, FEBS LETT, V292, P61, DOI 10.1016/0014-5793(91)80834-P; Morrissey I, 2002, J ANTIMICROB CHEMOTH, V49, P757, DOI 10.1093/jac/dkf031; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; MOURAD A, 1980, ANTIMICROB AGENTS CH, V18, P696, DOI 10.1128/AAC.18.5.696; Muller V, 2005, J MOL MICROB BIOTECH, V10, P167, DOI 10.1159/000091563; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; NEVEL CJV, 1977, APPL ENVIRON MICROB, V34, P251, DOI 10.1128/AEM.34.3.251-257.1977; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Omsland A, 2012, P NATL ACAD SCI USA, V109, P19781, DOI 10.1073/pnas.1212831109; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; PENEFSKY HS, 1985, P NATL ACAD SCI USA, V82, P1589, DOI 10.1073/pnas.82.6.1589; PETERSEN LC, 1977, BIOCHIM BIOPHYS ACTA, V460, P299, DOI 10.1016/0005-2728(77)90216-X; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; Ruppert C, 1998, J BACTERIOL, V180, P3448, DOI 10.1128/JB.180.13.3448-3452.1998; Schramm N, 1996, INFECT IMMUN, V64, P1208, DOI 10.1128/IAI.64.4.1208-1214.1996; Schwoppe C, 2002, J BACTERIOL, V184, P2108, DOI 10.1128/JB.184.8.2108-2115.2002; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Skipp PJS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149011; Somani Jyoti, 2000, Journal of Infectious Diseases, V181, P1421, DOI 10.1086/315372; SOPER JW, 1979, J BIOL CHEM, V254, P1170; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Steuber J, 2014, BIOL CHEM, V395, P1389, DOI 10.1515/hsz-2014-0204; Strickland M, 2014, J BIOL CHEM, V289, P23723, DOI 10.1074/jbc.M114.574640; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Szaszak M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002108; Takehara K, 2009, ANAL SCI, V25, P115, DOI 10.2116/analsci.25.115; Taylor HR, 2014, LANCET, V384, P2142, DOI 10.1016/S0140-6736(13)62182-0; Tjaden J, 1999, J BACTERIOL, V181, P1196, DOI 10.1128/JB.181.4.1196-1202.1999; TOKUDA H, 1984, J BIOL CHEM, V259, P7785; Tuz K, 2017, J BIOL CHEM, V292, P3039, DOI [10.1074/jbc.M116.770982, 10.1074/jbc.m116.770982]; Tuz K, 2015, J BIOL CHEM, V290, P20009, DOI 10.1074/jbc.M115.658773; Tuz K, 2013, J BIOL CHEM, V288, P13676, DOI 10.1074/jbc.M112.420786; Uriarte SM, 2002, J INFECT DIS, V185, P1631, DOI 10.1086/340575; Vandahl BBS, 2004, PROTEOMICS, V4, P2831, DOI 10.1002/pmic.200400940; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; Vonck RA, 2011, INFECT IMMUN, V79, P1566, DOI 10.1128/IAI.01155-10; WANG JH, 1974, ARCH BIOCHEM BIOPHYS, V162, P64, DOI 10.1016/0003-9861(74)90105-2; WHO, 2012, GLOB INC PREV SEL CU	105	21	21	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					510	522		10.1074/jbc.M117.797209	http://dx.doi.org/10.1074/jbc.M117.797209			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29123027	Green Published, hybrid			2022-12-26	WOS:000419915400008
J	Patel, AA; Durer, ZAO; van Loon, AP; Bremer, KV; Quinlan, ME				Patel, Aanand A.; Durer, Zeynep A. Oztug; van Loon, Aaron P.; Bremer, Kathryn V.; Quinlan, Margot E.			Drosophila and human FHOD family formin proteins nucleate actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cytoskeleton; Drosophila; formin; processivity; Fhod; Fhos; TIRF	STRESS FIBER FORMATION; HOMOLOGY 2 DOMAIN; CAPPING PROTEIN; FISSION YEAST; BARBED END; ADP-ACTIN; MOUSE FORMIN; FH1 DOMAIN; ATP-ACTIN; MIGRATION	Formins are a conserved group of proteins that nucleate and processively elongate actin filaments. Among them, the formin homology domain-containing protein (FHOD) family of formins contributes to contractility of striated muscle and cell motility in several contexts. However, the mechanisms by which they carry out these functions remain poorly understood. Mammalian FHOD proteins were reported not to accelerate actin assembly in vitro; instead, they were proposed to act as barbed end cappers or filament bundlers. Here, we show that purified Drosophila Fhod and human FHOD1 both accelerate actin assembly by nucleation. The nucleation activity of FHOD1 is restricted to cytoplasmic actin, whereas Drosophila Fhod potently nucleates both cytoplasmic and sarcomeric actin isoforms. Drosophila Fhod binds tightly to barbed ends, where it slows elongation in the absence of profilin and allows, but does not accelerate, elongation in the presence of profilin. Fhod antagonizes capping protein but dissociates from barbed ends relatively quickly. Finally, we determined that Fhod binds the sides of and bundles actin filaments. This work establishes that Fhod shares the capacity of other formins to nucleate and bundle actin filaments but is notably less effective at processively elongating barbed ends than most well studied formins.	[Patel, Aanand A.; van Loon, Aaron P.] Univ Calif Los Angeles, Mol Biol Interdept Doctoral Program, Los Angeles, CA 90095 USA; [Durer, Zeynep A. Oztug; Bremer, Kathryn V.; Quinlan, Margot E.] Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr E, Los Angeles, CA 90095 USA; [Quinlan, Margot E.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Durer, Zeynep A. Oztug] Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Biophys, TR-34752 Istanbul, Turkey	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Acibadem University	Quinlan, ME (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr E, Los Angeles, CA 90095 USA.	Margot@chem.ucla.edu	durer, zeynep/G-5626-2019	Patel, Aanand/0000-0002-1509-9950; Durer, Zeynep/0000-0001-9912-510X; van Loon, Aaron/0000-0002-8597-1572	National Institutes of Health [NRSA F30 HL137263]; UCLA Medical Scientist Training Program [T32 GM008042, R01 GM096133]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL137263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096133, T32GM008042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Medical Scientist Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant NRSA F30 HL137263 (to A. A. P.), UCLA Medical Scientist Training Program T32 GM008042 (to A. A. P.), and R01 GM096133 (to M. E. Q.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Haj A, 2015, EUR J CELL BIOL, V94, P101, DOI 10.1016/j.ejcb.2014.11.003; Arimura T, 2013, CIRC J, V77, P2990, DOI 10.1253/circj.CJ-13-0255; Barko S, 2010, J BIOL CHEM, V285, P13154, DOI 10.1074/jbc.M109.093914; Bombardier JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9707; Bor B, 2012, MOL BIOL CELL, V23, P3801, DOI 10.1091/mbc.E12-04-0288; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; Dwyer J, 2014, ANAT REC, V297, P1560, DOI 10.1002/ar.22984; Esslinger U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172995; Fujimoto N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148472; Gardberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074923; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Grintsevich EE, 2016, NAT CELL BIOL, V18, P876, DOI 10.1038/ncb3390; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Henty-Ridilla JL, 2016, SCIENCE, V352, P1004, DOI 10.1126/science.aaf1709; Iskratsch T, 2013, DEV CELL, V27, P545, DOI 10.1016/j.devcel.2013.11.003; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kan-o M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034765; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Krainer EC, 2013, CYTOSKELETON, V70, P424, DOI 10.1002/cm.21113; Kucherenko MM, 2011, DEV BIOL, V352, P228, DOI 10.1016/j.ydbio.2011.01.013; Lammel U, 2014, DEVELOPMENT, V141, P1366, DOI 10.1242/dev.101352; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Monzo P, 2016, MOL BIOL CELL, V27, P1246, DOI 10.1091/mbc.E15-08-0565; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Paul NR, 2015, J CELL BIOL, V210, P1013, DOI 10.1083/jcb.201502040; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Roth-Johnson EA, 2014, J BIOL CHEM, V289, P4395, DOI 10.1074/jbc.M113.499921; Schonichen A, 2013, J CELL SCI, V126, P1891, DOI 10.1242/jcs.126706; Schulze N, 2014, J CELL SCI, V127, P1379, DOI 10.1242/jcs.134627; Scott BJ, 2011, MOL BIOL CELL, V22, P3826, DOI 10.1091/mbc.E11-06-0492; Shekhar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9730; Shwartz A, 2016, ELIFE, V5, DOI 10.7554/eLife.16540; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Taniguchi K, 2009, J BIOL CHEM, V284, P29873, DOI 10.1074/jbc.M109.059303; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Vizcarra CL, 2014, J BIOL CHEM, V289, P30602, DOI 10.1074/jbc.M114.588368; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Wooten EC, 2013, CIRC-CARDIOVASC GENE, V6, P10, DOI 10.1161/CIRCGENETICS.112.965277; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zuchero J Bradley, 2007, Methods Mol Biol, V370, P213	51	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					532	540		10.1074/jbc.M117.800888	http://dx.doi.org/10.1074/jbc.M117.800888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29127202	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000419915400010
J	Cui, ZH; Ai, C; Lv, L; Yin, FX				Cui, Zhihua; Ai, Chi; Lv, Lei; Yin, Fangxian			Effect of pulse pressure on borehole stability during shear swirling flow vibration cementing	PLOS ONE			English	Article							VISCOPLASTIC FLUIDS; ECCENTRIC ANNULI; MUD REMOVAL; OIL-WELL; PART 2; DISPLACEMENTS; PLACEMENT; LAYER	The shear swirling flow vibration cementing (SSFVC) technique rotates the downhole eccentric cascade by circulating cementing fluid. It makes the casing eccentrically revolve at high speed around the borehole axis. It produces strong agitation action to the annulus fluid, makes it in the state of shear turbulent flow, and results in the formation of pulse pressure which affects the surrounding rock stress. This study was focused on 1) the calculation of the pulse pressure in an annular turbulent flow field based on the finite volume method, and 2) the analysis of the effect of pulse pressure on borehole stability. On the upside, the pulse pressure is conducive to enhancing the liquidity of the annulus fluid, reducing the fluid gel strength, and preventing the formation of fluid from channeling. But greater pulse pressure may cause lost circulation and even formation fracturing. Therefore, in order to ensure smooth cementing during SSFVC, the effect of pulse pressure should be considered when cementing design.	[Cui, Zhihua; Lv, Lei] Yanan Univ, Sch Petr & Environm Engn, Yanan, Shaanxi, Peoples R China; [Cui, Zhihua; Ai, Chi] Northeast Petr Univ, Key Lab, Educ Minist Enhanced Oil Recovery, Daqing, Heilongjiang, Peoples R China; [Yin, Fangxian] North China Univ Technol, Sch Mech & Mat Engn, Beijing, Peoples R China	Yanan University; Northeast Petroleum University; North China University of Technology	Cui, ZH (corresponding author), Yanan Univ, Sch Petr & Environm Engn, Yanan, Shaanxi, Peoples R China.; Cui, ZH (corresponding author), Northeast Petr Univ, Key Lab, Educ Minist Enhanced Oil Recovery, Daqing, Heilongjiang, Peoples R China.	hi891012hi@163.com			Doctoral Scientific Research Start-up Foundation of Yan'an University [YDBK2017-27]	Doctoral Scientific Research Start-up Foundation of Yan'an University	This work was supported by the Doctoral Scientific Research Start-up Foundation of Yan'an University (Project No. YDBK2017-27).	Allouche M, 2000, J FLUID MECH, V424, P243, DOI 10.1017/S0022112000001956; Bin Z., 2011, THESIS; Bin Zhou, 2013, RES CEMENTING TECHNO; Bird R. B., 1987, FLUID MECH, V1, P12; Bittleston SH, 2002, J ENG MATH, V43, P229, DOI 10.1023/A:1020370417367; Carrasco-Teja M, 2008, J FLUID MECH, V605, P293, DOI 10.1017/S0022112008001535; Duvaut G, 1976, INEQUALITIES MECH PH, DOI DOI 10.1007/978-3-642-66165-5; Fitt AD, 2001, J ENG MATH, V39, P345, DOI 10.1023/A:1004834004732; Glowinski R., 1984, NUMERICAL METHODS NO; Haige Wang, 1993, J U PETROLEUM CHINA, V17, P26; Hussain QE, 2000, AICHE J, V46, P1937, DOI 10.1002/aic.690461006; Lavrov A, 2013, CHEM ENG SCI, V99, P81, DOI 10.1016/j.ces.2013.05.045; Li J, 2000, SIAM REV, V42, P417, DOI 10.1137/S0036144599354604; Li M., 2012, PET DRILL TECH, V40, P40; LIU KF, 1994, PHYS FLUIDS, V6, P2577, DOI 10.1063/1.868148; Mao ZS, 2012, CHINESE J CHEM ENG, V20, P191, DOI 10.1016/S1004-9541(12)60379-6; Meng C., 2009, THESIS; Meuric OFJ, 1998, CAN J CHEM ENG, V76, P27, DOI 10.1002/cjce.5450760105; Mitsoulis E, 2004, J NON-NEWTON FLUID, V122, P45, DOI 10.1016/j.jnnfm.2003.10.007; Moyers-Gonzalez MA, 2009, J ENG MATH, V65, P25, DOI 10.1007/s10665-008-9260-0; NOURI JM, 1994, J FLUID ENG-T ASME, V116, P821, DOI 10.1115/1.2911856; Pelipenko S, 2004, J ENG MATH, V48, P1, DOI 10.1023/B:ENGI.0000009499.63859.f0; Reddy MG, 2014, INT J HEAT TECHNOL, V32, P1; Ruihe Wang, 2013, NATURAL GAS IND, V33, P69; SABINS FL, 1990, J PETROL TECHNOL, V42, P398, DOI 10.2118/20005-PA; Shu Q.G., 2012, DRILLING TECHNOLOGY, V35, P29; Shuyun Zh, 2011, THESIS; SZABO P, 1992, J NON-NEWTON FLUID, V45, P149, DOI 10.1016/0377-0257(92)85001-D; Uner D, 1989, FLOW POWER LAW FLUID, V2, P269; Zhang S. J., 2012, DRILL PRODUCT TECHNO, V35, P15; Zhihua C, 2016, AIP C P, V1794	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187279	10.1371/journal.pone.0187279	http://dx.doi.org/10.1371/journal.pone.0187279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145408	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800014
J	Hironaka-Mitsuhashi, A; Matsuzaki, J; Takahashi, RU; Yoshida, M; Nezu, Y; Yamamoto, Y; Shiino, S; Kinoshita, T; Ushijima, T; Hiraoka, N; Shimizu, C; Tamura, K; Ochiya, T				Hironaka-Mitsuhashi, Ai; Matsuzaki, Juntaro; Takahashi, Ryou-u; Yoshida, Masayuki; Nezu, Yutaka; Yamamoto, Yusuke; Shiino, Sho; Kinoshita, Takayuki; Ushijima, Toshikazu; Hiraoka, Nobuyoshi; Shimizu, Chikako; Tamura, Kenji; Ochiya, Takahiro			A tissue microRNA signature that predicts the prognosis of breast cancer in young women	PLOS ONE			English	Article							CLINICAL ONCOLOGY/COLLEGE; LESS-THAN-35 YEARS; AMERICAN SOCIETY; EXPRESSION; ESTROGEN; RECOMMENDATIONS; AGE; IMMUNOHISTOCHEMISTRY; PROLIFERATION; RELAPSE	Since breast cancers in young women are generally aggressive, young patients tend to be intensively treated with anti-cancer drugs. To optimize the strategy for treatment, particularly in young women, prognostic biomarkers are urgently required. The objective of this study was to identify a tissue microRNA (miRNA) signature that predicts prognosis in young breast cancer patients. Total RNA from 45 breast cancer patients aged <35 years was extracted from formalin-fixed paraffin-embedded (FFPE) tissues and analyzed using miRNA microarrays. Patients were categorized into two groups according to recurrence status within the 5 year period after surgery: recurrence (n = 11) and non-recurrent (n = 34). Histological parameters of hormone receptors and Ki-67 were statistically compared between the two groups. Differentially expressed miRNAs were identified, and their associations with overall survival (OS) were evaluated by log-rank test. The median observation period was 5.8 years for the recurrent group, and 9.1 years for the non-recurrent group. Nine miRNAs were significantly differentially expressed between the recurrent and non-recurrent groups. Receiver Operating Characteristic curve analysis was performed to evaluate the prediction accuracy of the identified miRNAs, and the resultant area under the curve was >0.7. Five of the miRNAs were validated by qRT-PCR, and the expression levels of three of those five (miR-183-5p, miR-194-5p, and miR-1285-5p), both alone and in combination, were associated with OS. In conclusion, we identified three candidate miRNAs that could be used separately or in combination as prognostic biomarkers in young breast cancer patients. This miRNA signature may enable selection of better treatment choices for young women with this disease.	[Hironaka-Mitsuhashi, Ai; Matsuzaki, Juntaro; Takahashi, Ryou-u; Nezu, Yutaka; Yamamoto, Yusuke; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo, Japan; [Hironaka-Mitsuhashi, Ai; Kinoshita, Takayuki] Juntendo Univ, Grad Sch Med, Courses Adv Clin Res Canc, Tokyo, Japan; [Yoshida, Masayuki; Hiraoka, Nobuyoshi] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo, Japan; [Shiino, Sho; Kinoshita, Takayuki] Natl Canc Ctr, Dept Breast Surg, Tokyo, Japan; [Ushijima, Toshikazu] Natl Canc Ctr, Res Inst, Div Epigen, Tokyo, Japan; [Shimizu, Chikako; Tamura, Kenji] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan	National Cancer Center - Japan; Juntendo University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Ochiya, T (corresponding author), Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo, Japan.	tochiya@ncc.go.jp	Kinoshita, Takayuki/AAA-5722-2020; Ochiya, Takahiro/AAH-7585-2019; Matsuzaki, Juntaro/S-4107-2019; Ushijima, Toshikazu/AAP-5742-2021	Matsuzaki, Juntaro/0000-0002-3204-5049; Ushijima, Toshikazu/0000-0003-3405-7817	Japan Science and Technology Agency (JST) [16K08261]; Japan Agency for Medical Research and Development (AMED)	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	The present work was supported in part by a Grant-in-Aid from the Japan Science and Technology Agency (JST) grant 16K08261 to RT and the "Development of Diagnostic Technology for Detection of miRNA in Body Fluids" grant from the Japan Agency for Medical Research and Development (AMED) to TO.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Allred DC, 1998, MODERN PATHOL, V11, P155; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Azim Hatem A Jr, 2016, Am Soc Clin Oncol Educ Book, V35, P23, DOI 10.14694/EDBK_159069; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cancello G, 2010, ANN ONCOL, V21, P1974, DOI 10.1093/annonc/mdq072; Cheng Y, 2016, REPROD BIOL, V16, P225, DOI 10.1016/j.repbio.2016.07.002; Chollet-Hinton L, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0736-y; Das R, 2016, CANC RES; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Han W, 2010, BREAST CANCER RES TR, V119, P193, DOI 10.1007/s10549-009-0388-z; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hoppe R, 2013, EUR J CANCER, V49, P3598, DOI 10.1016/j.ejca.2013.07.145; Huiart L, 2012, EUR J CANCER, V48, P1939, DOI 10.1016/j.ejca.2012.03.004; Huo DZ, 2016, ONCOTARGET, V7, P55231, DOI 10.18632/oncotarget.10485; Johnson RH, 2015, ONCOTARGET, V6, P13688, DOI 10.18632/oncotarget.4051; Kataoka A, 2016, BREAST CANCER RES TR, V160, P163, DOI 10.1007/s10549-016-3984-8; Kataoka A, 2014, BREAST CANCER-TOKYO, V21, P643, DOI 10.1007/s12282-013-0466-2; Kim EK, 2011, WORLD J SURG, V35, P1244, DOI 10.1007/s00268-011-1071-1; Le Quesne J, 2012, J PATHOL, V227, P306, DOI 10.1002/path.3983; Le XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041170; Li P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0473-z; Liu JJ, 2013, CHINESE J CANCER RES, V25, P46, DOI 10.3978/j.issn.1000-9604.2012.11.04; Lowery AJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-502; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Markou A, 2014, CLIN CHEM, V60, P197, DOI 10.1373/clinchem.2013.210542; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Nofech-Mozes R, 2016, CANCER MED-US, V5, P656, DOI 10.1002/cam4.631; Qiao ZW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114536; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Regan MM, 2016, J CLIN ONCOL, V34, P2221, DOI 10.1200/JCO.2015.64.3171; Ruddy KJ, 2014, J CLIN ONCOL, V32, P1151, DOI 10.1200/JCO.2013.52.8877; Sahlberg KK, 2015, CLIN CANCER RES, V21, P1207, DOI 10.1158/1078-0432.CCR-14-2011; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Song CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24502; Tjokrowidjaja A, 2014, INTERN MED J, V44, P764, DOI 10.1111/imj.12481; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; YE XM, 2014, BMC CANCER, V14, DOI DOI 10.1038/ONC.2012.128; Zehentmayr F, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0198-1; Zhang PJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6671; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077; Zhao YL, 2015, INT J CLIN EXP PATHO, V8, P12446	48	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187638	10.1371/journal.pone.0187638	http://dx.doi.org/10.1371/journal.pone.0187638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141042	Green Submitted, Green Published, gold			2022-12-26	WOS:000415260400026
J	Matsuda, K; Miyoshi, H; Hiraoka, K; Yokoyama, S; Haraguchi, T; Hashiguchi, T; Hamada, T; Shiba, N; Ohshima, K				Matsuda, Kotaro; Miyoshi, Hiroaki; Hiraoka, Koji; Yokoyama, Shintaro; Haraguchi, Toshiaki; Hashiguchi, Toshihiro; Hamada, Tetsuya; Shiba, Naoto; Ohshima, Koichi			Clinicopathological and prognostic value of transforming acidic coiled-coil-containing protein 3 (TACC3) expression in soft tissue sarcomas	PLOS ONE			English	Article							POOR-PROGNOSIS; CANCER; P53; CARCINOMA; STEMNESS; MARKER	Transforming acidic coiled-coil-containing protein 3 (TACC3), a microtubule regulator, is associated with various cancers. However, the relationship between TACC3 and soft tissue sarcomas (STS) remains unclear. We investigated the expression of TACC3 in 136 STS patient samples using immunohistochemical (IHC) staining, and the statistical associations between TACC3 expression and clinicopathological characteristics were evaluated. Additionally, the expression levels of the tumor suppressor p53 and of the cell proliferation marker Ki-67 were also assessed by IHC. High TACC3 expression was detected in 94/136 of STS cases (69.1%), and significantly correlated with higher grade according to the French Fe A de A ration Nationale des Centres de Lutte Contre le Cancer system (P < 0.0001), poorer tumor differentiation (P < 0.0001), increased mitotic counts (P < 0.0001), advanced stage per American Joint Committee on Cancer guidelines (P < 0.0001), higher p53 expression (P = 0.0487), higher Ki-67 expression (P < 0.0001), and undergoing postoperative therapy (P = 0.0001). Disease-free survival (DFS) and overall survival (OS) of patients with high TACC3 expression were significantly shorter (P < 0.0001 and P< 0.0001, respectively). On multivariate analyses, high TACC3 expression was an independent negative prognostic factor for both DFS and OS (hazard ratio [HR]: 3.074; P = 0.0235 and HR: 8.521; P = 0.0415, respectively). Our results suggest that TACC3 is an independent prognostic factor and may be a novel therapeutic target for the treatment of STS.	[Matsuda, Kotaro; Miyoshi, Hiroaki; Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka, Japan; [Matsuda, Kotaro; Hiraoka, Koji; Haraguchi, Toshiaki; Hamada, Tetsuya; Shiba, Naoto] Kurume Univ, Dept Orthoped Surg, Sch Med, Kurume, Fukuoka, Japan; [Yokoyama, Shintaro; Hashiguchi, Toshihiro] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka, Japan	Kurume University; Kurume University; Kurume University	Miyoshi, H (corresponding author), Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka, Japan.	miyoshi_hiroaki@med.kurume-u.ac.jp	Yokoyama, Shintaro/HHC-8479-2022					Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Coindre JM, 1996, J CLIN ONCOL, V14, P869, DOI 10.1200/JCO.1996.14.3.869; Constantinidou A, 2013, EXPERT REV ANTICANC, V13, P211, DOI [10.1586/ERA.12.161, 10.1586/era.12.161]; Du Y, 2016, ONCOTARGET, V7, P41885, DOI 10.18632/oncotarget.9628; GERDES J, 1984, J IMMUNOL, V133, P1710; Gergely F, 2002, BIOESSAYS, V24, P915, DOI 10.1002/bies.10162; Ha GH, 2015, ONCOGENE, V34, P1667, DOI 10.1038/onc.2014.105; Ha GH, 2013, CANCER LETT, V336, P24, DOI 10.1016/j.canlet.2013.04.022; Ha GH, 2013, CANCER LETT, V332, P63, DOI 10.1016/j.canlet.2013.01.013; Haraguchi T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156524; Harris CC, 1996, JNCI-J NATL CANCER I, V88, P1442, DOI 10.1093/jnci/88.20.1442; Harrison Michael R, 2009, Clin Adv Hematol Oncol, V7, P54; He JC, 2016, ONCOTARGET, V7, P75441, DOI 10.18632/oncotarget.12254; Huang ZL, 2015, ONCOTARGET, V6, P6850, DOI 10.18632/oncotarget.3190; Jiang F, 2016, ONCOL REP, V35, P436, DOI 10.3892/or.2015.4373; Judson I, 2014, LANCET ONCOL, V15, P415, DOI 10.1016/S1470-2045(14)70063-4; Jung CK, 2006, PATHOL INT, V56, P503, DOI 10.1111/j.1440-1827.2006.01998.x; KAWAI A, 1994, CANCER, V73, P2499, DOI 10.1002/1097-0142(19940515)73:10<2499::AID-CNCR2820731008>3.0.CO;2-G; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Liu CY, 2010, ANN SURG ONCOL, V17, P2102, DOI 10.1245/s10434-010-0997-0; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Nahm JH, 2016, TUMOR BIOL, V37, P393, DOI 10.1007/s13277-015-3810-7; Ohoka N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.471; Piekorz RP, 2002, EMBO J, V21, P653, DOI 10.1093/emboj/21.4.653; Sadek CM, 2003, GENE EXPR PATTERNS, V3, P203, DOI 10.1016/S1567-133X(02)00066-2; Schmidt S, 2010, ONCOGENE, V29, P6184, DOI 10.1038/onc.2010.354; Schneider L, 2008, ONCOGENE, V27, P116, DOI 10.1038/sj.onc.1210628; Song H, 2016, APPL IMMUNOHISTOCHEM; Takahiro T, 2003, CLIN CANCER RES, V9, P2204; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wurl P, 1997, J CANCER RES CLIN, V123, P502, DOI 10.1007/s004320050095; Yao R, 2014, ONCOGENE, V33, P4242, DOI 10.1038/onc.2013.382; Yao R, 2012, ONCOGENE, V31, P135, DOI 10.1038/onc.2011.235; Yun M, 2015, ONCOL REP, V34, P1397, DOI 10.3892/or.2015.4093; Zhou DS, 2015, ONCOTARGET, V6, P24163, DOI 10.18632/oncotarget.4643	36	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188096	10.1371/journal.pone.0188096	http://dx.doi.org/10.1371/journal.pone.0188096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135996	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200064
J	Zhou, S; Sternglanz, R; Neiman, AM				Zhou, Sai; Sternglanz, Rolf; Neiman, Aaron M.			Developmentally regulated internal transcription initiation during meiosis in budding yeast	PLOS ONE			English	Article							SYNTHASE KINASE 3; NONCODING RNA EXPRESSION; PROTEIN-KINASE; MESSENGER-RNAS; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL CONTROL; GENOMIC ANALYSIS; SPORULATION; HOMOLOG; GENES	Sporulation of budding yeast is a developmental process in which cells undergo meiosis to generate stress-resistant progeny. The dynamic nature of the budding yeast meiotic transcriptome has been well established by a number of genome-wide studies. Here we develop an analysis pipeline to systematically identify novel transcription start sites that reside internal to a gene. Application of this pipeline to data from a synchronized meiotic time course reveals over 40 genes that display specific internal initiations in mid-sporulation. Consistent with the time of induction, motif analysis on upstream sequences of these internal transcription start sites reveals a significant enrichment for the binding site of Ndt80, the transcriptional activator of middle sporulation genes. Further examination of one gene, MRK1, demonstrates the Ndt80 binding site is necessary for internal initiation and results in the expression of an N-terminally truncated protein isoform. When the MRK1 paralog RIM11 is downregulated, the MRK1 internal transcript promotes efficient sporulation, indicating functional significance of the internal initiation. Our findings suggest internal transcriptional initiation to be a dynamic, regulated process with potential functional impacts on development.	[Zhou, Sai; Sternglanz, Rolf; Neiman, Aaron M.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Zhou, Sai] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Neiman, AM (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	aaron.neiman@stonybrook.edu		Neiman, Aaron/0000-0002-6600-6996	National Institutes of Health [R01 GM072540, P01 GM088297]; NIH [R01 GM072540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM088297, R01GM072540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 GM072540 to A.M.N. and P01 GM088297 to R.S. and A.M.N. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Bruce Futcher, Yuping Chen and Justin Gardin for extensive suggestions on the development of the algorithm, and Alisa Yurovski for general guidance on RNA-Seq data processing. We thank Nancy Hollingsworth for the 12CA5 anti-HA antibody, and Bruce Futcher and Gang Zhao for the CRISPR/Cas9 plasmid. We are greatly indebted to Bruce Futcher, Yifeng Xu and Folkert van Werven for the RNA-Seq data of the P<INF>CUP1</INF>-IME1 P<INF>CUP1</INF>-IME4 meiotic time-course. We also thank Janet Leatherwood, members of the Neiman and the Futcher labs for helpful discussions. This work was supported by NIH grant R01 GM072540 to A.M.N.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Andoh T, 2000, MOL CELL BIOL, V20, P6712, DOI 10.1128/MCB.20.18.6712-6720.2000; Arguello-Miranda O, 2017, DEV CELL, V40, P37, DOI 10.1016/j.devcel.2016.11.021; Bajgier BK, 2001, MOL BIOL CELL, V12, P1611, DOI 10.1091/mbc.12.6.1611; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Berchowitz LE, 2013, GENE DEV, V27, P2147, DOI 10.1101/gad.224253.113; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BOWDISH KS, 1994, MOL CELL BIOL, V14, P7909, DOI 10.1128/MCB.14.12.7909; BOWDISH KS, 1995, MOL CELL BIOL, V15, P2955; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041374; Chia MH, 2016, G3-GENES GENOM GENET, V6, P3553, DOI 10.1534/g3.116.034983; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Connolly JE, 2006, EUKARYOT CELL, V5, P112, DOI 10.1128/EC.5.1.112-124.2006; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; DAWES IW, 1974, MOL GEN GENET, V131, P281, DOI 10.1007/BF00264859; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; Enyenihi AH, 2003, GENETICS, V163, P47; Erb I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024279; Floor SN, 2016, ELIFE, V5, DOI 10.7554/eLife.10921; Griffioen G, 2003, J BIOL CHEM, V278, P23460, DOI 10.1074/jbc.M210691200; Guisbert KSK, 2012, RNA, V18, P1142, DOI 10.1261/rna.030510.111; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hirata Y, 2003, MOL BIOL CELL, V14, P302, DOI 10.1091/mbc.E02-05-0247; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Hurtado S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105058; Ikui AE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003099; Jin L, 2015, MOL CELL BIOL, V35, P3448, DOI 10.1128/MCB.00189-15; Jolly ER, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-275; KABACK DB, 1985, MOL CELL BIOL, V5, P751, DOI 10.1128/MCB.5.4.751; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Lin CPC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003700; Lo HC, 2008, MOL BIOL CELL, V19, P4956, DOI 10.1091/mbc.E08-07-0755; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malathi K, 1999, GENETICS, V153, P1145; Malathi K, 1997, MOL CELL BIOL, V17, P7230, DOI 10.1128/MCB.17.12.7230; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; NEIGEBORN L, 1991, GENE DEV, V5, P533, DOI 10.1101/gad.5.4.533; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Pak J, 2002, MOL CELL BIOL, V22, P6430, DOI 10.1128/MCB.22.18.6430-6440.2002; PAMMER M, 1992, YEAST, V8, P1089, DOI 10.1002/yea.320081211; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; PUZISS JW, 1994, MOL CELL BIOL, V14, P831, DOI 10.1128/MCB.14.1.831; Quan ZZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005282; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112; Rose MD., 1990, METHODS YEAST GENETI; Rubin-Bejerano I, 2004, MOL CELL BIOL, V24, P6967, DOI 10.1128/MCB.24.16.6967-6979.2004; Sasanuma H, 2013, GENETICS, V194, P859, DOI 10.1534/genetics.113.150615; SHERO JH, 1991, GENE DEV, V5, P549, DOI 10.1101/gad.5.4.549; Spivak AT, 2012, NUCLEIC ACIDS RES, V40, pD162, DOI 10.1093/nar/gkr1180; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Werven FJ, 2011, PHILOS T R SOC B, V366, P3521, DOI 10.1098/rstb.2011.0081; Waern K, 2013, G3-GENES GENOM GENET, V3, P343, DOI 10.1534/g3.112.003640; Wan LH, 2006, GENETICS, V174, P1767, DOI 10.1534/genetics.106.064303; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wiesner T, 2015, NATURE, V526, P453, DOI 10.1038/nature15258; Xiao Y, 2000, MOL CELL BIOL, V20, P5447, DOI 10.1128/MCB.20.15.5447-5453.2000; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	74	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188001	10.1371/journal.pone.0188001	http://dx.doi.org/10.1371/journal.pone.0188001			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136644	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200055
J	Dai, XF; He, Y; Zhang, H; Zhang, YY; Liu, Y; Wang, MR; Chen, H; Pang, JJ				Dai, Xufeng; He, Ying; Zhang, Hua; Zhang, Yangyang; Liu, Yan; Wang, Muran; Chen, Hao; Pang, Ji-Jing			Long-term retinal cone rescue using a capsid mutant AAV8 vector in a mouse model of CNGA3-achromatopsia	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; AUTOSOMAL RECESSIVE ACHROMATOPSIA; HIGH-EFFICIENCY TRANSDUCTION; GENE AUGMENTATION THERAPY; ALPHA-SUBUNIT; RESTORES VISION; GATED CHANNEL; IN-VITRO; MUTATIONS; CNGA3	Adeno-associated virus (AAV) vectors are important gene delivery tools for the treatment of many recessively inherited retinal diseases. For example, a wild-type (WT) AAV5 vector can deliver a full-length Cnga3 (cyclic nucleotide-gated channel alpha-3) cDNA to target cells of the cone photoreceptor function loss 5 (cpfl5) mouse, a spontaneous animal model of achromatopsia with a Cnga3 mutation. Gene therapy restores cone-mediated function and blocks cone degeneration in the mice. However, since transgene expression delivered by an AAV vector shows relatively short-term effectiveness, this cannot be regarded as a very successful therapy. AAV2 and AAV8 vectors with capsid mutations have significantly enhanced transduction efficiency in retinas compared to WT AAV controls. In this study, AAV8 (Y447, 733F+T494V)-treated cpfl5 retinas showed greater preservation of short-term cone electroretinogram (ERG) responses than AAV8 (Y447, 733F)-or AAV2 (Y272, 444, 500, 730F+T491V)-mediated treatments. To explore the long-term rescue effect, AAV8 (Y447, 733F+T494V)-treated cpfl5 retinas were evaluated at 9 months following postnatal day 14 (P14) treatment. Rescued ERG responses in the cones of treated cpfl5 eyes decreased with increasing age, but still maintained more than 60% of the WT mouse responses at the oldest time point examined. Expression of CNGA3 and M/S-opsins was maintained in cone outer segments of the treated cpfl5 eyes and was equal to expression in age-matched WT retinas. Near-normal cone-mediated water maze behavior was observed in the treated cpfl5 mice. As these are the longest follow-up data reported thus far, AAV8 with capsid Y-F and T-V mutations may be one of the most effective AAV vectors for long-term treatment in a naturally occurring mouse model of CNGA3 achromatopsia.	[Dai, Xufeng; He, Ying; Zhang, Hua; Zhang, Yangyang; Liu, Yan; Wang, Muran; Chen, Hao; Pang, Ji-Jing] Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [He, Ying] Yucheng Peoples Hosp, Yucheng, Shandong, Peoples R China	Wenzhou Medical University	Chen, H; Pang, JJ (corresponding author), Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	chenhao823@mail.eye.ac.cn; jpangoph@hotmail.com	zhang, yangyang/GZG-7467-2022	Dai, Xufeng/0000-0003-4205-5774	Natural Science Foundation of Zhejiang Province [LY15H120002]; National Natural Science Foundation of China [81371060, 81600771]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by Natural Science Foundation of Zhejiang Province (CN) (LY15H120002, http://www.zjnsf.gov.cn/b/02/fundapply/fundapply_edit.aspx?appid=GUDA9222519E7379B345F01F2BE3C7B95B5, XD), National Natural Science Foundation of China (81371060, https://isisn.nsfc.gov.cn/egrantweb/contract/index, JP and 81600771, https://isisn.nsfc.gov.cn/egrantweb/contract/index, HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansar M, 2015, HUM GENET, V134, P941, DOI 10.1007/s00439-015-1571-4; Aslanidi GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059142; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Banin E, 2015, MOL THER, V23, P1423, DOI 10.1038/mt.2015.114; Black A, 2014, J GENE MED, V16, P122, DOI 10.1002/jgm.2768; Boye SL, 2016, J VIROL, V90, P4215, DOI 10.1128/JVI.00200-16; Brennenstuhl C, 2015, J BIOL CHEM, V290, P10242, DOI 10.1074/jbc.M114.611921; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dai X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126653; Dai XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156542; Dai XF, 2014, INVEST OPHTH VIS SCI, V55, P1724, DOI 10.1167/iovs.13-13654; Deng WT, 2012, INVEST OPHTH VIS SCI, V53, P1895, DOI 10.1167/iovs.11-8831; Du W, 2015, HUM MOL GENET, V24, P3699, DOI 10.1093/hmg/ddv114; Gootwine E, 2017, HUM GENE THER CL DEV, V28, P96, DOI 10.1089/humc.2017.028; Gootwine E, 2017, INVEST OPHTH VIS SCI, V58, P1577, DOI 10.1167/iovs.16-20986; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Katagiri S, 2015, OPHTHALMIC GENET, V36, P137, DOI 10.3109/13816810.2014.991932; Kay CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062097; Kohl S, 2005, EUR J HUM GENET, V13, P302, DOI 10.1038/sj.ejhg.5201269; Kohl S, 2002, AM J HUM GENET, V71, P422, DOI 10.1086/341835; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Kohl S, 2015, NAT GENET, V47, P757, DOI 10.1038/ng.3319; Kohl S, 2012, AM J HUM GENET, V91, P527, DOI 10.1016/j.ajhg.2012.07.006; Kuniyoshi K, 2016, JPN J OPHTHALMOL, V60, P187, DOI 10.1007/s10384-016-0424-6; Li X, 2011, INVEST OPHTH VIS SCI, V52, P7, DOI 10.1167/iovs.10-6138; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Michalakis S, 2017, J GENE MED, V19, DOI 10.1002/jgm.2944; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Ouechtati F, 2011, J HUM GENET, V56, P22, DOI 10.1038/jhg.2010.128; Pang JJ, 2012, CURR MOL MED, V12, P316, DOI 10.2174/156652412799218877; Pang JJ, 2008, VISION RES, V48, P377, DOI 10.1016/j.visres.2007.08.009; Pang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035250; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Pang JJ, 2010, ADV EXP MED BIOL, V664, P639, DOI 10.1007/978-1-4419-1399-9_73; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Petrs-Silva H, 2011, MOL THER, V19, P293, DOI 10.1038/mt.2010.234; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Qi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136523; Remmer MH, 2015, CURR OPIN OPHTHALMOL, V26, P333, DOI 10.1097/ICU.0000000000000189; Schimmer J, 2015, HUM GENE THER CL DEV, V26, P208, DOI 10.1089/humc.2015.29004.sch; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Vandenberghe LH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002103; Wawrocka A, 2014, MOL VIS, V20, P1732; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zhong L, 2007, MOL THER, V15, P1323, DOI 10.1038/sj.mt.6300170	52	11	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0188032	10.1371/journal.pone.0188032	http://dx.doi.org/10.1371/journal.pone.0188032			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131863	Green Published, gold, Green Submitted			2022-12-26	WOS:000414997800039
J	Hahn, C; Oh, JH; Joo, SH; Jeong, JE; Chae, JH; Lee, CU; Kim, TS				Hahn, Changtae; Oh, Ji Hoon; Joo, Soo-Hyun; Jeong, Jo-Eun; Chae, Jeong-Ho; Lee, Chang-Uk; Kim, Tae-Suk			Association between mental health status and bone mineral density: Analysis of the 2008-2010 Korea national health and nutrition examination survey	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; RISK-FACTOR; OSTEOPOROSIS; ADOLESCENTS; ADULTS; WOMEN; IDEATION; COHORT; IMPACT; MASS	The current study aimed to investigate the association between mental health status and bone mineral density (BMD) using data from the Korean National Health and Nutrition Examination Survey (KNHANES) 2008-2010. We enrolled 15,876 South Korean participants (4,010 postmenopausal females, 4,836 premenopausal females, and 7,016 males, all aged 20 years or older). BMD was measured using dual-energy radiography absorptiometry at the femoral neck (NK), lumbar spine (LSP), and total femur (TFM). Mental health status data were obtained from a self-report questionnaire that assessed psychological stress, depressed mood, and suicidal ideation. Psychological stress was negatively correlated with BMD in the LSP, NK, and TFM for the male group. Depressed mood was associated with lower BMD in the LSP, NK and TFM for the premenopausal female group, and in the LSP for the male group. Suicidal ideation was associated with lower BMD in the NK and TFM for the male group. Mental health problems were associated with lower BMD, especially in premenopausal females and males. Future investigations should focus on the shared pathophysiology between mental health problems and BMD, and the interrelationship between increased BMD and recovery from mental health problems.	[Hahn, Changtae] Catholic Univ Korea, Coll Med, Dept Psychiat, Daejeon St Marys Hosp, Daejeon, South Korea; [Oh, Ji Hoon; Joo, Soo-Hyun; Jeong, Jo-Eun; Chae, Jeong-Ho; Lee, Chang-Uk; Kim, Tae-Suk] Catholic Univ Korea, Dept Psychiat, Coll Med, Seoul St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Kim, TS (corresponding author), Catholic Univ Korea, Dept Psychiat, Coll Med, Seoul St Marys Hosp, Seoul, South Korea.	bluenote@catholic.ac.kr		Jeong, Jo-Eun/0000-0002-4200-278X	Catholic Medical Center Research Foundation	Catholic Medical Center Research Foundation	The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2014 and 2016. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2014, 2016 and thank the Korean Center for Disease Control and Prevention, which conducted the KNHANES studies, and the subjects who participated in the KNHANES. We also thank Kyungdo Han for statistical analyses.	Abma FI, 2012, SCAND J WORK ENV HEA, V38, P5, DOI 10.5271/sjweh.3190; Aloumanis K, 2013, HORM-INT J ENDOCRINO, V12, P350, DOI 10.1007/BF03401301; Bab Itai, 2010, Curr Osteoporos Rep, V8, P185, DOI 10.1007/s11914-010-0026-z; Bab IA, 2010, ANN NY ACAD SCI, V1192, P170, DOI 10.1111/j.1749-6632.2009.05218.x; Calarge CA, 2014, J BONE MINER RES, V29, P2230, DOI 10.1002/jbmr.2249; Cameron JL, 1997, SEMIN REPROD ENDOCR, V15, P37, DOI 10.1055/s-2008-1067966; Charlson FJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-250; Choi HS, 2017, OSTEOPOROSIS INT, V28, P955, DOI 10.1007/s00198-016-3806-1; Cizza G, 2010, HORM METAB RES, V42, P467, DOI 10.1055/s-0030-1252020; Cizza G, 2001, TRENDS ENDOCRIN MET, V12, P198, DOI 10.1016/S1043-2760(01)00407-6; Cizza Giovanni, 2011, Dialogues Clin Neurosci, V13, P73; Cizza G, 2010, J CLIN PSYCHIAT, V71, P1079, DOI 10.4088/JCP.09m05314blu; Cizza G, 2009, TRENDS ENDOCRIN MET, V20, P367, DOI 10.1016/j.tem.2009.05.003; Connell J, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-138; Doherty AM, 2014, SOC PSYCH PSYCH EPID, V49, P673, DOI 10.1007/s00127-014-0847-7; Evans VC, 2014, J CLIN PSYCHIAT, V75, P1359, DOI 10.4088/JCP.13r08939; Gaynes BN, 2004, ANN INTERN MED, V140, P822, DOI 10.7326/0003-4819-140-10-200405180-00015; Guo Ping, 2012, Shanghai Arch Psychiatry, V24, P262, DOI 10.3969/j.issn.1002-0829.2012.05.003; Hasan SS, 2013, ASIAN J PSYCHIATR, V6, P460, DOI 10.1016/j.ajp.2013.09.008; Iosifescu DV, 2012, EUR NEUROPSYCHOPHARM, V22, pS499, DOI 10.1016/j.euroneuro.2012.08.002; Jang KM, 2015, MATURITAS, V82, P360, DOI 10.1016/j.maturitas.2015.07.016; Kim SM, 2014, ANXIETY STRESS COPIN, V27, P439, DOI 10.1080/10615806.2013.876010; Lee CWS, 2015, MAYO CLIN PROC, V90, P63, DOI 10.1016/j.mayocp.2014.11.009; Lim Y, 2016, OSTEOPOROSIS INT, V27, P2249, DOI 10.1007/s00198-016-3527-5; Mezuk B, 2008, OSTEOPOROSIS INT, V19, P1, DOI 10.1007/s00198-007-0449-2; Nargund VH, 2015, NAT REV UROL, V12, P372, DOI 10.1038/nrurol.2015.112; Panagioti M, 2014, INT J CHRONIC OBSTR, V9, P1289, DOI 10.2147/COPD.S72073; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Park S, 2013, ARCH PSYCHIAT NURS, V27, P253, DOI 10.1016/j.apnu.2013.06.001; Ranabir Salam, 2011, Indian J Endocrinol Metab, V15 Suppl 3, pS188, DOI [10.4103/2230-8210.77573, 10.4103/2230-8210.84862]; Reginster JY, 1999, MATURITAS, V33, P133, DOI 10.1016/S0378-5122(99)00057-2; Tsujimura A, 2013, WORLD J MENS HEALTH, V31, P126, DOI 10.5534/wjmh.2013.31.2.126; Vrkljan M, 2001, COLLEGIUM ANTROPOL, V25, P485; Watkins C, 2001, BRIT MED J, V323, P1159, DOI 10.1136/bmj.323.7322.1159; Xu HW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2257-5	35	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187425	10.1371/journal.pone.0187425	http://dx.doi.org/10.1371/journal.pone.0187425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM4OL	29131866	Green Published, gold			2022-12-26	WOS:000414997800012
J	Sims, MT; Detweiler, BN; Scott, JT; Howard, BM; Detten, GR; Vassar, M				Sims, Matthew Thomas; Detweiler, Byron Nice; Scott, Jared Thomas; Howard, Benjamin McKinnley; Detten, Grant Richard; Vassar, Matt			Inconsistent selection of outcomes and measurement devices found in shoulder arthroplasty research: An analysis of studies on ClinicalTrials.gov	PLOS ONE			English	Article							PATIENT-CENTERED OUTCOMES; SURGERY; TRIALS; SET; OPPORTUNITIES; QUALITY; INFORM; PAIN	Introduction Recent evidence suggests a lack of standardization of shoulder arthroplasty outcomes. This issue is a limiting factor in systematic reviews. Core outcome set (COS) methodology could address this problem by delineating a minimum set of outcomes for measurement in all shoulder arthroplasty trials. Methods A ClinicalTrials.gov search yielded 114 results. Eligible trials were coded on the following characteristics: study status, study type, arthroplasty type, sample size, measured outcomes, outcome measurement device, specific metric of measurement, method of aggregation, outcome classification, and adverse events. Results Sixty-six trials underwent data abstraction and data synthesis. Following abstraction, 383 shoulder arthroplasty outcomes were organized into 11 outcome domains. The most commonly reported outcomes were shoulder outcome score (n = 58), pain (n = 33), and quality of life (n = 15). The most common measurement devices were the Constant-Murley Shoulder Outcome Score (n = 38) and American Shoulder and Elbow Surgeons Shoulder Score (n = 33). Temporal patterns of outcome use was also found. Conclusion Our study suggests the need for greater standardization of outcomes and instruments. The lack of consistency across trials indicates that developing a core outcome set for shoulder arthroplasty trials would be worthwhile. Such standardization would allow for more effective comparison across studies in systematic reviews, while at the same time consider important outcomes that may be underrepresented otherwise. This review of outcomes provides an evidence-based foundation for the development of a COS for shoulder arthroplasty.	[Sims, Matthew Thomas; Detweiler, Byron Nice; Scott, Jared Thomas; Howard, Benjamin McKinnley; Detten, Grant Richard; Vassar, Matt] Oklahoma State Univ, Ctr Hlth Sci, Tulsa, OK 74106 USA	Oklahoma State University System; Oklahoma State University Center for Health Sciences	Sims, MT (corresponding author), Oklahoma State Univ, Ctr Hlth Sci, Tulsa, OK 74106 USA.	matt.sims@okstate.edu	Vassar, Matt/AAD-5385-2020	Sims, Matthew/0000-0001-8430-1983; Vassar, Ben Matthew/0000-0003-2859-6152				Angst F, 2011, ARTHRIT CARE RES, V63, pS174, DOI 10.1002/acr.20630; Beaton DE, 2001, J RHEUMATOL, V28, P400; Benstoem C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122204; Boers M., 2014, THE OMERACT HDB; Bohsali KI, 2006, J BONE JOINT SURG AM, V88A, P2279, DOI 10.2106/JBJS.F.00125; Buchbinder R, 2017, J RHEUMATOL; Chau DB, 2016, J PEDIATR SURG, V51, P117, DOI 10.1016/j.jpedsurg.2015.10.029; Cheung EV, 2015, INSTR COURSE LECT, V65, P109; Clarke M, 2016, SYST REV, V5; Clarke M, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0738-6; ClinicalTrials.gov, TRENDS CHARTS MAPS; Cvetanovich GL, 2016, ORTHOPEDICS, V39, pE465, DOI 10.3928/01477447-20160324-02; Day JS, 2010, J SHOULDER ELB SURG, V19, P1115, DOI 10.1016/j.jse.2010.02.009; Fleming PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127495; Harman NL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129514; Head ML, 2010, PLOS BIOL, V13; Hopkins JC, 2015, OBES REV, V16, P88, DOI 10.1111/obr.12240; Horner NS, 2016, J SHOULDER ELB SURG, V25, P510, DOI 10.1016/j.jse.2015.09.013; Howard B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180986; Izquierdo R, 2010, J AM ACAD ORTHOP SUR, V18, P375, DOI 10.5435/00124635-201006000-00010; Killian ML, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3846; Lang, 2013, BASIC STAT REPORTING; Li T, ANN INTERN MED, V162, P287; Mancuso CA, 2016, SPINE, V41, P963, DOI 10.1097/BRS.0000000000001378; McNair AGK, 2015, COLORECTAL DIS, V17, pO217, DOI 10.1111/codi.13021; Moja Lorenzo P, 2009, Trials, V10, P56, DOI 10.1186/1745-6215-10-56; Mollon B, 2016, BONE JOINT J, V98B, P818, DOI 10.1302/0301-620X.98B6.37208; Nissen T, 2017, CLIN OBES, V7, P34, DOI 10.1111/cob.12174; Page MJ, 2015, J CLIN EPIDEMIOL, V68, P1270, DOI 10.1016/j.jclinepi.2015.06.006; Page MJ, 2017, ARTHRITIS CARE RES; Rising KL, 2016, ACAD EMERG MED, V23, P497, DOI 10.1111/acem.12944; Roe Y, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-73; Rongen JJ, 2016, J BONE JOINT SURG AM, V98, P403, DOI 10.2106/JBJS.15.00400; Roy JS, 2010, J SHOULDER ELB SURG, V19, P157, DOI 10.1016/j.jse.2009.04.008; Roy JS, 2009, ARTHRIT RHEUM-ARTHR, V61, P623, DOI 10.1002/art.24396; Saldanha IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109400; Singh JA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008089.pub2; Tunis SR, 2016, J COMP EFFECT RES, V5, P193, DOI 10.2217/cer-2015-0007; Wayant C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178379; Whitehead L, 2015, RESUSCITATION, V88, P150, DOI 10.1016/j.resuscitation.2014.11.013; Wiater JM, 2009, J AM ACAD ORTHOP SUR, V17, P415; Williams RJ, 2010, CAN MED ASSOC J, V182, P1638, DOI 10.1503/cmaj.092252; Wright RW, 2010, J AM ACAD ORTHOP SUR, V18, P436, DOI 10.5435/00124635-201007000-00006; Xu M, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-48; Zygmont ME, 2016, ACAD RADIOL, V23, P8, DOI 10.1016/j.acra.2015.08.027	45	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187865	10.1371/journal.pone.0187865	http://dx.doi.org/10.1371/journal.pone.0187865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125866	Green Submitted, Green Published, gold			2022-12-26	WOS:000414866000028
J	Been, SK; Yildiz, E; Nieuwkerk, PT; Pogany, K; van de Vijver, DAMC; Verbon, A				Been, Sabrina K.; Yildiz, Elif; Nieuwkerk, Pythia T.; Pogany, Katalin; van de Vijver, David A. M. C.; Verbon, Annelies			Self-reported adherence and pharmacy refill adherence are both predictive for an undetectable viral load among HIV-infected migrants receiving cART	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; HIV-1-INFECTED PATIENTS; CLINICAL-TRIALS; NONADHERENCE; IMMIGRANT; ART	HIV-infected migrants were shown to have poorer treatment outcomes than Dutch HIV-infected patients, often due to worse treatment adherence. Self-reported adherence would be an easy way to monitor adherence, but its validity relative to pharmacy refill adherence has not been extensively evaluated in migrants. All HIV-infected migrants older than 18 years and in care at the two Rotterdam HIV-treatment centers were eligible. Refill data with leftover medication (PRL) (residual pill count) were obtained from their pharmacies up to 15 months prior to inclusion. Self-reported adherence to combination Antiretroviral Therapy was assessed by four questions about adherence at inclusion. Additionally, risk factors for pharmacy refill non-adherence were examined. In total, 299 HIV-infected migrants were included. Viral load (VL) was detectable in 11% of the patients. Specificity of PRL was 53% for patients with an adherence of 100% and decreased with lower cut-off values. Sensitivity and negative predictive value (NPV) were 68% and 15% and increased with lower cut-off values. Positive predictive value (PPV) was around 93% for all cut-off values. Using the self-reported questions, 139 patients (47%) reported to be adherent. Sensitivity was 49% and specificity was 72%. PPV and NPV were 95% and 13%. No risk factors for pharmacy refill non-adherence were found in multivariable analyses. Both PRL and self-reported adherence, can predict undetectable VL in HIV-infected migrants. PPV and NPV are similar for both methods. This study shows that using four self-reported items is sufficient to predict adherence which is crucial for optimal clinical outcome in HIV-infected migrants.	[Been, Sabrina K.; Yildiz, Elif; Verbon, Annelies] Erasmus Univ, Med Ctr, Div Infect Dis, Dept Internal Med, Rotterdam, Netherlands; [Yildiz, Elif; Verbon, Annelies] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Nieuwkerk, Pythia T.] Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Pogany, Katalin] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands; [van de Vijver, David A. M. C.] Erasmus Univ, Med Ctr, Virosci Dept, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Maasstad Hospital; Erasmus University Rotterdam; Erasmus MC	Been, SK; Verbon, A (corresponding author), Erasmus Univ, Med Ctr, Div Infect Dis, Dept Internal Med, Rotterdam, Netherlands.; Verbon, A (corresponding author), Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	been@erasmusmc.nl; a.verbon@erasmusmc.nl	; Nieuwkerk, Pythia/S-4084-2017	Been, Sabrina/0000-0002-5755-3306; van de Vijver, David/0000-0001-5877-8526; Nieuwkerk, Pythia/0000-0002-2616-1414	Dutch Aids Fonds [2011107]	Dutch Aids Fonds	This study was supported by a grant from the Dutch Aids Fonds, Grant number: 2011107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Been SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162800; Beer L, 2014, AIDS EDUC PREV, V26, P521, DOI 10.1521/aeap.2014.26.6.521; Berg KM, 2012, AIDS BEHAV, V16, P461, DOI 10.1007/s10461-010-9864-z; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; de Boer IM, 2010, JAIDS-J ACQ IMM DEF, V55, P635, DOI 10.1097/QAI.0b013e3181fba6ab; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Glass TR, 2006, JAIDS-J ACQ IMM DEF, V41, P385, DOI 10.1097/01.qai.0000186371.95301.52; Gordon LL, 2015, AIDS PATIENT CARE ST, V29, P384, DOI 10.1089/apc.2014.0165; Kabore Lassane, 2015, J Int Assoc Provid AIDS Care, V14, P156, DOI 10.1177/2325957414557263; Leierer G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142923; Li JZ, 2014, AIDS, V28, P181, DOI 10.1097/QAD.0000000000000123; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Mekuria LA, 2016, TROP MED INT HEALTH, V21, P856, DOI 10.1111/tmi.12709; Monge S, 2013, HIV MED, V14, P273, DOI 10.1111/hiv.12001; Nellen JFJB, 2009, AIDS CARE, V21, P842, DOI 10.1080/09540120802612816; Nellen JF, 2004, JAIDS-J ACQ IMM DEF, V36, P943, DOI 10.1097/00126334-200408010-00008; Nieuwkerk P, 2001, ANTIVIR THER, V6, P97; Nieuwkerk PT, 2001, ARCH INTERN MED, V161, P1962, DOI 10.1001/archinte.161.16.1962; Nieuwkerk PT, 2010, ANTIVIR THER, V15, P913, DOI 10.3851/IMP1644; Ochieng W, 2015, JAIDS-J ACQ IMM DEF, V69, pE49, DOI 10.1097/QAI.0000000000000580; Pasternak AO, 2012, J INFECT DIS, V206, P1443, DOI 10.1093/infdis/jis502; Saberi P, 2015, AIDS PATIENT CARE ST, V29, P111, DOI 10.1089/apc.2014.0255; Safren SA, 2015, JAIDS-J ACQ IMM DEF, V69, P234, DOI 10.1097/QAI.0000000000000593; Sangeda RZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1035; Saracino A, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.026; Sumari-de Boer IM, 2012, AIDS BEHAV, V16, P1681, DOI 10.1007/s10461-011-0112-y; van den Berg JB, 2005, HIV MED, V6, P299, DOI 10.1111/j.1468-1293.2005.00304.x	27	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0186912	10.1371/journal.pone.0186912	http://dx.doi.org/10.1371/journal.pone.0186912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121665	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900015
J	Du, ZQ; Wang, K; Shen, XL; Jin, YH; Jin, HX; Li, XC				Du, Zhi-qiang; Wang, Kai; Shen, Xiu-li; Jin, Yan-hui; Jin, Hai-xia; Li, Xin-cang			Identification and characterization of intestine microRNAs and targets in red swamp crayfish, Procambarus clarkii infected with white spot syndrome virus	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; LITOPENAEUS-VANNAMEI; IMMUNE-RESPONSE; SHRIMP; ANNOTATION; PROTEIN	MicroRNAs (miRNAs) are small non-coding endogenous RNA molecules that play important roles in the innate immunity system of invertebrates, especially in the aspect of antivirus. In the present study, high-throughput small RNA Illumina sequencing systems were used to identify differentially expressed miRNAs (DEMs) from the intestines of Procambarus clarkii that were infected with white spot syndrome virus (WSSV). As a result, 39 known and 12 novel miRNAs were identified in both NG and WG small RNA libraries. Seven DEMs were determined to be involved in the antiviral innate immunity in the intestines of P. clarkii. The results of the target gene predictions of the DEMs showed that the putative target genes of these 7 DEMs are related to tight junctions, vascular smooth muscle contraction regulation of the actin cytoskeleton, focal adhesion, RNA transport, mRNA surveillance, viral carcinogenesis, and Salmonella infection. These results provide theoretical insights for future studies on the antiviral immunity of crustaceans.	[Du, Zhi-qiang; Wang, Kai; Jin, Yan-hui; Jin, Hai-xia] Inner Mongolia Univ Sci & Technol, Sch Life Sci & Technol, Baotou, Inner Mongolia, Peoples R China; [Shen, Xiu-li] Inner Mongolia Univ Sci & Technol, Baotou, Inner Mongolia, Peoples R China; [Li, Xin-cang] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China	Inner Mongolia University of Science & Technology; Inner Mongolia University of Science & Technology; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Li, XC (corresponding author), Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China.	lixin8687@163.com	jin, haixia/HGA-9179-2022		National Natural Science Foundation of China [31460698, 31660260]; Central Public interest Scientific Institution Basal Research Foundation, CAFS [2016RC-LX04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public interest Scientific Institution Basal Research Foundation, CAFS	This work was supported by the National Natural Science Foundation of China (Grant No. 31460698, 31660260), and the Central Public interest Scientific Institution Basal Research Foundation, CAFS (No. 2016RC-LX04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (Grant No. 31460698, 31660260), and the Central Public-interest Scientific Institution Basal Research Foundation, CAFS (No. 2016RC-LX04).	Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Du ZQ, 2016, FISH SHELLFISH IMMUN, V55, P384, DOI 10.1016/j.fsi.2016.06.015; Du ZQ, 2009, COMP BIOCHEM PHYS B, V154, P203, DOI 10.1016/j.cbpb.2009.06.004; Du ZQ, 2010, FISH SHELLFISH IMMUN, V28, P134, DOI 10.1016/j.fsi.2009.10.009; Du ZQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26780; Ge X, 2013, INT J BIOL SCI, V9, P1, DOI 10.7150/ijbs.5249; Huang TZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-159; Kaewkascholkul N, 2016, DEV COMP IMMUNOL, V60, P191, DOI 10.1016/j.dci.2016.03.002; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lindow M, 2011, METHODS MOL BIOL, V703, P311, DOI 10.1007/978-1-59745-248-9_21; Liu CZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28678; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Ou JT, 2013, FISH SHELLFISH IMMUN, V35, P607, DOI 10.1016/j.fsi.2013.05.013; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Ruan LW, 2011, FISH SHELLFISH IMMUN, V31, P334, DOI 10.1016/j.fsi.2011.05.023; Shen HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110548; Sun XY, 2016, FISH SHELLFISH IMMUN, V58, P18, DOI 10.1016/j.fsi.2016.08.062; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171120; Xu WN, 2014, FISH SHELLFISH IMMUN, V39, P1, DOI 10.1016/j.fsi.2014.04.005; Zeng DG, 2015, GENET MOL RES, V14, P4818, DOI 10.4238/2015.May.11.14; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhao MR, 2016, FISH SHELLFISH IMMUN, V59, P469, DOI 10.1016/j.fsi.2016.11.012; Zhong L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17763; Zhu F, 2016, DEV COMP IMMUNOL, V55, P76, DOI 10.1016/j.dci.2015.10.012	26	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187760	10.1371/journal.pone.0187760	http://dx.doi.org/10.1371/journal.pone.0187760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121070	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900073
J	Ventetuolo, CE; Hess, E; Austin, ED; Baron, AE; Klinger, JR; Lahm, T; Maddox, TM; Plomondon, ME; Thompson, L; Zamanian, RT; Choudhary, G; Maron, BA				Ventetuolo, Corey E.; Hess, Edward; Austin, Eric D.; Baron, Anna E.; Klinger, James R.; Lahm, Tim; Maddox, Thomas M.; Plomondon, Mary E.; Thompson, Lauren; Zamanian, Roham T.; Choudhary, Gaurav; Maron, Bradley A.			Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; RIGHT-VENTRICULAR FUNCTION; CARE-SYSTEM INSIGHTS; ARTERIAL-HYPERTENSION; HEART-FAILURE; CARDIAC-CATHETERIZATION; DISEASE MANAGEMENT; MEDIATION ANALYSIS; AFRICAN-AMERICANS; PULSE PRESSURE	Women have an increased risk of pulmonary hypertension (PH) but better survival compared to men. Few studies have explored sex-based differences in population-based cohorts with PH. We sought to determine whether sex was associated with hemodynamics and survival in US veterans with PH (mean pulmonary artery pressure [mPAP] >= 25 mm Hg) from the Veterans Affairs Clinical Assessment, Reporting, and Tracking database. The relationship between sex and hemodynamics was assessed with multivariable linear mixed modeling. Cox proportional hazards models were used to compare survival by sex for those with PH and precapillary PH (mPAP >= 25 mm Hg, pulmonary artery wedge pressure [PAWP] <= 15 mm Hg and pulmonary vascular resistance [PVR] > 3 Wood units) respectively. The study population included 15,464 veterans with PH, 516 (3%) of whom were women; 1,942 patients (13%) had precapillary PH, of whom 120 (6%) were women. Among those with PH, women had higher PVR and pulmonary artery pulse pressure, and lower right atrial pressure and PAWP (all p < 0.001) compared with men. There were no significant differences in hemodynamics according to sex in veterans with precapillary PH. Women with PH had 18% greater survival compared to men with PH (adjusted HR 0.82, 95% CI 0.69-0.97, p = 0.020). Similarly, women with precapillary PH were 29% more likely to survive as compared to men with PH (adjusted HR 0.71, 95% CI 0.52-0.98, p = 0.040). In conclusion, female veterans with PH have better survival than males despite higher pulmonary afterload.	[Ventetuolo, Corey E.; Klinger, James R.; Choudhary, Gaurav] Brown Univ, Alpert Med Sch, Dept Med, Providence, RI 02912 USA; [Ventetuolo, Corey E.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Hess, Edward; Baron, Anna E.; Maddox, Thomas M.; Plomondon, Mary E.] Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO USA; [Austin, Eric D.] Vanderbilt Univ, Div Pediat Pulm Allergy & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Lahm, Tim] Indiana Univ Sch Med, Div Pulm Crit Care Occupat & Sleep Med, Indianapolis, IN 46202 USA; [Lahm, Tim] Richard L Roudebush Vet Affairs Med Ctr, 1481 W 10th St, Indianapolis, IN 46202 USA; [Thompson, Lauren] Univ Colorado, Sch Med, Aurora, CO USA; [Zamanian, Roham T.] Stanford Univ, Sch Med, Vera Moulton Wall Ctr Pulm Vasc Dis, Stanford, CA 94305 USA; [Choudhary, Gaurav] Providence Vet Affairs Med Ctr, Providence, RI USA; [Maron, Bradley A.] Boston Vet Affairs Healthcare Syst, Boston, MA USA; [Maron, Bradley A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Maron, Bradley A.] Harvard Med Sch, Boston, MA USA	Brown University; Brown University; Vanderbilt University; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ventetuolo, CE (corresponding author), Brown Univ, Alpert Med Sch, Dept Med, Providence, RI 02912 USA.; Ventetuolo, CE (corresponding author), Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA.	corey_ventetuolo@brown.edu	Ventetuolo, Corey/W-4871-2017; Choudhary, Gaurav/M-1643-2019; Lahm, Tim/AAF-7162-2020	Ventetuolo, Corey/0000-0002-4223-4775; Choudhary, Gaurav/0000-0001-9343-5481; 	(NIH) Institutional Development Award (IDeA) from National Institute of General Medical Sciences [P20GM103652]; American Heart Association [11FTF7400032]; Department of Veterans Affairs [1101BX002042-01A2]; Catherine and Lowe Berger and Pauline L. Ford Chair at Indiana University; National Institutes of Health [1R01HL128661, 1K08HL11207-01A1]; American Heart Association (AHA) [15GRNT25080016]; Pulmonary Hypertension Association; Cardiovascular Medical Research and Education Fund (CMREF); Klarman Foundation at Brigham; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139613, K08HL111207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103652] Funding Source: NIH RePORTER	(NIH) Institutional Development Award (IDeA) from National Institute of General Medical Sciences; American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); Catherine and Lowe Berger and Pauline L. Ford Chair at Indiana University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); Pulmonary Hypertension Association; Cardiovascular Medical Research and Education Fund (CMREF); Klarman Foundation at Brigham; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: CEV: (NIH) Institutional Development Award (IDeA) from the National Institute of General Medical Sciences P20GM103652, American Heart Association (11FTF7400032); TL: Department of Veterans Affairs (VA Merit 1101BX002042-01A2), Catherine and Lowe Berger and Pauline L. Ford Chair at Indiana University; GC: National Institutes of Health, 1R01HL128661; B.A.M.: National Institutes of Health 1K08HL11207-01A1, American Heart Association (AHA 15GRNT25080016), Pulmonary Hypertension Association, Cardiovascular Medical Research and Education Fund (CMREF), and Klarman Foundation at Brigham and Women's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assad TR, 2016, J AM COLL CARDIOL, V68, P2525, DOI 10.1016/j.jacc.2016.09.942; Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Blyth KG, 2007, RESP MED, V101, P2495, DOI 10.1016/j.rmed.2007.07.004; Bradley SM, 2014, AM HEART J, V168, P381, DOI 10.1016/j.ahj.2014.05.015; Bradley SM, 2014, J AM COLL CARDIOL, V63, P417, DOI 10.1016/j.jacc.2013.09.055; Byrd JB, 2013, AM HEART J, V165, P434, DOI 10.1016/j.ahj.2012.12.009; Castelain V, 2001, J AM COLL CARDIOL, V37, P1085, DOI 10.1016/S0735-1097(00)01212-2; Choudhary G, 2014, CIRC-HEART FAIL, V7, P558, DOI 10.1161/CIRCHEARTFAILURE.114.001366; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Davis KK, 2008, J NATL MED ASSOC, V100, P69, DOI 10.1016/S0027-9684(15)31177-9; Davis MB, 2015, CIRC-CARDIOVASC QUAL, V8, pS39, DOI 10.1161/CIRCOUTCOMES.114.001613; Dries DL, 2002, J AM COLL CARDIOL, V40, P311, DOI 10.1016/S0735-1097(02)01943-5; Frazier CG, 2007, J AM COLL CARDIOL, V49, P1450, DOI 10.1016/j.jacc.2006.11.041; Frump AL, 2015, AM J PHYSIOL-LUNG C, V308, pL873, DOI 10.1152/ajplung.00006.2015; Gabler NB, 2012, CHEST, V141, P20, DOI 10.1378/chest.11-0404; Galie N, 2015, EUR RESPIR J, V46, P903, DOI 10.1183/13993003.01032-2015; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Hyduk Alexandra, 2005, Morbidity and Mortality Weekly Report, V54, P1; Iacobucci D, 2012, J CONSUM PSYCHOL, V22, P582, DOI 10.1016/j.jcps.2012.03.006; Jacobs W, 2014, CHEST, V145, P1230, DOI 10.1378/chest.13-1291; Kawut SA, 2009, CHEST, V135, P752, DOI 10.1378/chest.08-1758; Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515; Lahm T, 2016, AM J PHYSIOL-LUNG C, V311, pL375, DOI 10.1152/ajplung.00132.2016; Lane AD, 2014, EUR J APPL PHYSIOL, V114, P2597, DOI 10.1007/s00421-014-2981-z; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC; Liu AP, 2015, HYPERTENSION, V66, P1082, DOI 10.1161/HYPERTENSIONAHA.115.05843; Maddox TM, 2014, AM J CARDIOL, V114, P1750, DOI 10.1016/j.amjcard.2014.08.045; Maron BA, 2016, CIRCULATION, V133, P1240, DOI 10.1161/CIRCULATIONAHA.115.020207; Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7; Mathai SC, 2015, CHEST, V147, P188, DOI 10.1378/chest.14-0263; McLaughlin VV, 2009, CIRCULATION, V119, P2250, DOI 10.1161/CIRCULATIONAHA.109.192230; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Melenovsky V, 2014, EUR HEART J, V35, P3452, DOI 10.1093/eurheartj/ehu193; Meyer P, 2010, CIRCULATION, V121, P252, DOI 10.1161/CIRCULATIONAHA.109.887570; Mohammed SF, 2014, CIRCULATION, V130, P2310, DOI 10.1161/CIRCULATIONAHA.113.008461; MORRISON DA, 1987, J AM COLL CARDIOL, V9, P1219, DOI 10.1016/S0735-1097(87)80459-X; Najjar SS, 2004, J AM COLL CARDIOL, V44, P611, DOI 10.1016/j.jacc.2004.04.041; O'Meara E, 2007, CIRCULATION, V115, P3111, DOI 10.1161/CIRCULATIONAHA.106.673442; Opitz CF, 2016, J AM COLL CARDIOL, V68, P368, DOI 10.1016/j.jacc.2016.05.047; Scantlebury DC, 2011, CURR OPIN CARDIOL, V26, P562, DOI 10.1097/HCO.0b013e32834b7faf; Shapiro S, 2012, CHEST, V141, P363, DOI 10.1378/chest.10-3114; Simonneau G, 2013, J AM COLL CARDIOL, V62; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P582, DOI 10.1097/EDE.0b013e31821db37e; Ventetuolo CE, 2014, EUR RESPIR J, V43, P523, DOI 10.1183/09031936.00027613; Zhang R, 2011, CHEST, V140, P301, DOI 10.1378/chest.10-2327	50	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187734	10.1371/journal.pone.0187734	http://dx.doi.org/10.1371/journal.pone.0187734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121097	gold, Green Submitted, Green Published			2022-12-26	WOS:000414769900068
J	Wen, J; Yablonskiy, DA; Salter, A; Cross, AH				Wen, Jie; Yablonskiy, Dmitriy A.; Salter, Amber; Cross, Anne H.			Limbic system damage in MS: MRI assessment and correlations with clinical testing	PLOS ONE			English	Article							GRADIENT-ECHO MRI; ADULT HUMAN BRAIN; DEEP GREY-MATTER; MULTIPLE-SCLEROSIS; COGNITIVE DYSFUNCTION; WHITE-MATTER; ATROPHY; IMPAIRMENT; MEMORY; T2-ASTERISK	Volume loss in some limbic region structures has been observed in multiple sclerosis (MS) patients. However, in vivo evaluation of existing tissue cellular microstructure integrity has received less attention. The goal of studies reported here was to quantitatively assess loss of limbic system volumes and tissue integrity, and to evaluate associations of these measures with cognitive and physical dysfunction in MS patients. Thirty-one healthy controls (HC) and 80 MS patients, including 32 relapsing remitting (RRMS), 32 secondary progressive (SPMS) and 16 primary progressive (PPMS), participated in this study. Tissue cellular integrity was evaluated by means of recently introduced tissue-specific parameter R2t* that was calculated from multi-gradient-echo MRI signals using a recently developed method that separates R2t* from BOLD (blood oxygen level dependent) contributions to GRE signal decay rate constant (R2*), and accounting for physiological fluctuations and artifacts from background gradients. Volumes in limbic system regions, normalized to skull size (NV), were measured from standard MPRAGE images. MS patients had lower R2t* and smaller normalized volumes in the hippocampus, amygdala, and several other limbic system regions, compared to HC. Alterations in R2t* of several limbic system regions correlated with clinical and neurocognitive test scores in MS patients. In contrast, smaller normalized volumes in MS were only correlated with neurocognitive test scores in the hippocampus and amygdala. This study reports the novel finding that R2t*, a measure that estimates tissue integrity, is more sensitive to tissue damage in limbic system structures than is atrophy. R2t* measurements can serve as a biomarker that is distinct from and complementary to volume measurements.	[Wen, Jie; Yablonskiy, Dmitriy A.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Salter, Amber] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Cross, Anne H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Cross, AH (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	crossa@wustl.edu	Wen, Jie/O-9991-2019; Yablonskiy, Dmitriy/N-7252-2017	Wen, Jie/0000-0002-8957-8444; Cross, Anne/0000-0003-0829-7569; Yablonskiy, Dmitriy/0000-0003-2898-8797	National Multiple Sclerosis Society [RG4463, G-1508-08577]; Conrad N Hilton Foundation; Manny & Rosalyn Rosenthal - Dr. John L. Trotter MS Center Chair in Neuroimmunology of the Foundation for Barnes-Jewish Hospital	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Conrad N Hilton Foundation; Manny & Rosalyn Rosenthal - Dr. John L. Trotter MS Center Chair in Neuroimmunology of the Foundation for Barnes-Jewish Hospital	This work was supported by the National Multiple Sclerosis Society (http://www.nationalmssociety.org/) (RG4463 to AHC, G-1508-08577 to JW); by the Conrad N Hilton Foundation (https://www.hiltonfoundation.org/) (Marilyn Hilton Award for Innovation in MS Research to AHC); the Manny & Rosalyn Rosenthal - Dr. John L. Trotter MS Center Chair in Neuroimmunology of the Foundation for Barnes-Jewish Hospital (https://www.barnesjewish.org/Giving/About-The-Foundation) (AHC).	Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Audoin B, 2010, J NEUROL NEUROSUR PS, V81, P690, DOI 10.1136/jnnp.2009.188748; Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chiaravalloti ND, 2013, J CLIN EXP NEUROPSYC, V35, P180, DOI 10.1080/13803395.2012.760537; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Keser Z, 2017, J NEUROIMAGING, V27, P37, DOI 10.1111/jon.12381; Koenig KA, 2015, MULT SCLER J, V21, P1794, DOI 10.1177/1352458515576983; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Luo J, 2012, NEUROIMAGE, V60, P1073, DOI 10.1016/j.neuroimage.2012.01.108; McAuliffe MJ, 2001, COMP MED SY, P381; Meijer KA, 2016, MULT SCLER J, V22, P1429, DOI 10.1177/1352458515622694; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Patel K, 2015, MULT SCLER IN PRESS; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Sati P, 2010, NEUROIMAGE, V51, P1089, DOI 10.1016/j.neuroimage.2010.03.045; Schmalbrock P, 2016, AM J NEURORADIOL, V37, P439, DOI 10.3174/ajnr.A4599; Schoonheim MM, 2012, NEUROLOGY, V79, P1754, DOI 10.1212/WNL.0b013e3182703f46; Seewann A, 2009, ARCH NEUROL-CHICAGO, V66, P601, DOI 10.1001/archneurol.2009.57; Shiee N, 2010, NEUROIMAGE, V49, P1524, DOI 10.1016/j.neuroimage.2009.09.005; Sicotte NL, 2008, BRAIN, V131, P1134, DOI 10.1093/brain/awn030; Szabo CA, 2003, AM J NEURORADIOL, V24, P644; Ulrich X, 2016, MAGN RESON MED, V75, P606, DOI 10.1002/mrm.25610; Wen J, 2015, NEUROIMAGE-CLIN, V9, P164, DOI 10.1016/j.nicl.2015.08.003; Wen J, 2015, MAGN RESON MED, V73, P195, DOI 10.1002/mrm.25114; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Yablonskiy DA, 2000, RADIOLOGY, V217, P204; Yablonskiy DA, 2013, MAGN RESON MED, V70, P1283, DOI 10.1002/mrm.24585; Zhao Y, 2017, NEUROIMAGE, V148, P296, DOI 10.1016/j.neuroimage.2016.12.026; Zhao Y, 2016, NEUROIMAGE, V133, P417, DOI 10.1016/j.neuroimage.2016.03.022	34	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187915	10.1371/journal.pone.0187915	http://dx.doi.org/10.1371/journal.pone.0187915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121642	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900093
J	Castro-Sanguino, C; Bozec, YM; Dempsey, A; Samaniego, BR; Lubarsky, K; Andrews, S; Komyakova, V; Ortiz, JC; Robbins, WD; Renaud, PG; Mumby, PJ				Castro-Sanguino, Carolina; Bozec, Yves-Marie; Dempsey, Alexandra; Samaniego, Badi R.; Lubarsky, Katie; Andrews, Stefan; Komyakova, Valeriya; Ortiz, Juan Carlos; Robbins, William D.; Renaud, Philip G.; Mumby, Peter J.			Detecting conservation benefits of marine reserves on remote reefs of the northern GBR	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PROTECTED AREAS; HABITAT COMPLEXITY; CORAL COVER; FISH; BIOMASS; FISHERIES; ABUNDANCE; RECOVERY; ISLANDS	The Great Barrier Reef Marine Park (GBRMP) is the largest network of marine reserves in the world, yet little is known of the efficacy of no -fishing zones in the relatively lightly exploited remote parts of the system (i.e., northern regions). Here, we find that the detection of reserve effects is challenging and that heterogeneity in benthic habitat composition, specifically branching coral cover, is one of the strongest driving forces of fish assemblages. As expected, the biomass of targeted fish species was generally greater (up to 5 -fold) in no take zones than in fished zones, but we found no differences between the two forms of no take zone: `no-take' versus 'no-entry'. Strong effects of zoning were detected in the remote Far -North inshore reefs and more central outer reefs, but surprisingly fishing effects were absent in the less remote southern locations. Moreover, the biomass of highly targeted species was nearly 2 -fold greater in fished areas of the Far -North than in any reserve (no -take or no -entry) further south. Despite high spatial variability in fish biomass, our results suggest that fishing pressure is greater in southern areas and that poaching within reserves may be common. Our results also suggest that fishers 'fish the line' as stock sizes in exploited areas decreased near larger no -take zones. Interestingly, an analysis of zoning effects on small, non -targeted fishes appeared to suggest a top-down effect from mesopredators, but was instead explained by variability in benthic composition. Thus, we demonstrate the importance of including appropriate covariates when testing for evidence of trophic cascades and reserve successes or failures.	[Castro-Sanguino, Carolina; Bozec, Yves-Marie; Ortiz, Juan Carlos; Mumby, Peter J.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, Brisbane, Qld, Australia; [Bozec, Yves-Marie; Mumby, Peter J.] ARC Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia; [Dempsey, Alexandra; Renaud, Philip G.] Khaled Bin Sultan Living Oceans Fdn, Annapolis, MD USA; [Samaniego, Badi R.] Univ Philippines, Sch Environm Sci & Management, Los Banos, Philippines; [Lubarsky, Katie] State Hawaii Div Aquat Resources, Honolulu, HI USA; [Andrews, Stefan] Univ Western Australia, Sch Biol Sci, Perth, WA, Australia; [Komyakova, Valeriya] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia; [Robbins, William D.] Wildlife Marine, Perth, WA, Australia; [Robbins, William D.] Curtin Univ, Dept Environm & Agr, Perth, WA, Australia; [Robbins, William D.] Univ Technol Sydney, Sch Life Sci, Sydney, NSW, Australia	University of Queensland; University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University; University of Western Australia; University of Melbourne; Curtin University; University of Technology Sydney	Castro-Sanguino, C (corresponding author), Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, Brisbane, Qld, Australia.	cc.sanguino@uq.net.au	Bozec, Yves-Marie/J-7168-2013; Mumby, Peter/F-9914-2010; Andrews, Stefan/GRO-1527-2022; Komyakova, Valeriya/H-4632-2013; Ortiz Cuellar, Juan carlos/GQZ-3899-2022	Bozec, Yves-Marie/0000-0002-7190-5187; Mumby, Peter/0000-0002-6297-9053; Komyakova, Valeriya/0000-0003-3755-1546; Castro Sanguino, Carolina/0000-0002-2515-5186	CCS	CCS	The Khaled bin Sultan Living Oceans Foundation URL:www.livingoeceansfoundation.org designed the study in consultation with PJM and implemented the collection of the data, curation and quality control of data in collaboration with the co-authors. They also funded CCS to undertake the analysis and collaborated on the preparation of the manuscript. This study was a component of the Khaled bin Sultan Living Oceans Foundation Global Reef Expedition (2011-2015).	Abesamis RA, 2006, FISH B-NOAA, V104, P360; Abesamis RA, 2014, REV FISH BIOL FISHER, V24, P1033, DOI 10.1007/s11160-014-9362-x; Alcala AC, 2006, AMBIO, V35, P245, DOI 10.1579/05-A-054R1.1; Allison GW, 1998, ECOLOGICAL APPL S1, V8; Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], OECOLOGIA; [Anonymous], PMID; Ayling A.M., 2008, ABUNDANCE PATTERNS R; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bergseth BJ, 2017, FRONT ECOL ENVIRON, V15, P67, DOI 10.1002/fee.1457; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; Boaden AE, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00292.1; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Costello MJ, 2014, BIOL CONSERV, V176, P289, DOI 10.1016/j.biocon.2014.04.023; Crainiceanu CM, 2004, J ROY STAT SOC B, V66, P165, DOI 10.1111/j.1467-9868.2004.00438.x; Davis KLF, 2004, COAST MANAGE, V32, P373, DOI 10.1080/08920750490487223; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Denny CM, 2004, BIOL CONSERV, V116, P119, DOI 10.1016/S0006-3207(03)00183-6; Department of Empoyment Economic Development and Innovation (DEEDI), 2011, ANN STAT REP 2010 CO; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Emslie MJ, 2015, CURR BIOL, V25, P983, DOI 10.1016/j.cub.2015.01.073; Emslie MJ, 2017, CORAL REEFS, P1; Evans RD, 2004, AQUAT CONSERV, V14, P505, DOI 10.1002/aqc.631; Fletcher WJ, 2015, ECOL APPL, V25, P1187, DOI 10.1890/14-1427.1; Floeter SR, 2007, ENVIRON BIOL FISH, V78, P147, DOI 10.1007/s10641-006-9084-6; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; GBRMPA GBRMPA, 2002, FAR NO SECTION ZONIN; GBRMPA (Great Barrier Reef Marine Park Authority), 2005, REP GREAT BARR REEF; GBRMPA (Great Barrier Reef Marine Park Authority), 2014, GREAT BARR REEF OUTL; Gill DA, 2017, NATURE, V543, P665, DOI 10.1038/nature21708; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Grech A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021094; Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Halpern BS, 2003, ECOL APPL, V13, pS117; Harborne AR, 2008, J APPL ECOL, V45, P1010, DOI 10.1111/j.1365-2664.2008.01490.x; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hock K, 2014, J APPL ECOL, V51, P1188, DOI 10.1111/1365-2664.12320; Hughes TP, 2016, ECOL APPL, V26, P637, DOI 10.1890/15-0457; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 1997, CORAL REEFS, V16, P71, DOI 10.1007/s003380050061; Kaiser MJ, 2005, CAN J FISH AQUAT SCI, V62, P1194, DOI 10.1139/F05-056; Kellner JB, 2007, ECOL APPL, V17, P1039, DOI 10.1890/05-1845; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Komyakova V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083178; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McB. Williams D., 1991, P437; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2009, MAR ECOL PROG SER, V396, P99, DOI 10.3354/meps08279; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McDonald A.D., 2004, EFFECTS LINE FISHING; Miller KI, 2014, OCEAN COAST MANAGE, V96, P51, DOI 10.1016/j.ocecoaman.2014.05.003; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Nardi K, 2004, ENVIRON CONSERV, V31, P160, DOI 10.1017/S0376892904001274; Nash KL, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1362; Newman SJ, 1996, ENVIRON BIOL FISH, V46, P123, DOI 10.1007/BF00005214; O'Farrell S, 2015, MAR ECOL PROG SER, V522, P245, DOI 10.3354/meps11134; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Rizzari JR, 2015, CONSERV BIOL, V29, P418, DOI 10.1111/cobi.12385; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Rogers A, 2014, CURR BIOL, V24, P1000, DOI 10.1016/j.cub.2014.03.026; Russ G.R., 1991, P601; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; Samoilys MA, 1997, CORAL REEFS, V16, P151, DOI 10.1007/s003380050069; Simpson SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10544; Taylor S., 2012, STATEWIDE RECREATION; Williams ID, 2006, MAR ECOL PROG SER, V310, P185, DOI 10.3354/meps310185; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wolff NH, 2016, CORAL REEFS, V35, P613, DOI 10.1007/s00338-016-1400-9	90	12	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0186146	10.1371/journal.pone.0186146	http://dx.doi.org/10.1371/journal.pone.0186146			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117191	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000414659600003
J	Molina-Romero, D; Baez, A; Quintero-Hernandez, V; Castaneda-Lucio, M; Fuentes-Ramirez, LE; Bustillos-Cristales, MD; Rodriguez-Andrade, O; Morales-Garcia, YE; Munive, A; Munoz-Rojas, J				Molina-Romero, Dalia; Baez, Antonino; Quintero-Hernandez, Veronica; Castaneda-Lucio, Miguel; Ernesto Fuentes-Ramirez, Luis; del Rocio Bustillos-Cristales, Maria; Rodriguez-Andrade, Osvaldo; Elizabeth Morales-Garcia, Yolanda; Munive, Antonio; Munoz-Rojas, Jesus			Compatible bacterial mixture, tolerant to desiccation, improves maize plant growth	PLOS ONE			English	Article							PROMOTING RHIZOBACTERIA PGPR; PSEUDOMONAS-PUTIDA KT2440; GLUCONACETOBACTER-DIAZOTROPHICUS; BRADYRHIZOBIUM-JAPONICUM; NITROGEN-FERTILIZATION; STRAINS; RHIZOBIUM; SUGARCANE; RHIZOSPHERE; BURKHOLDERIA	Plant growth-promoting rhizobacteria (PGPR) increase plant growth and crop productivity. The inoculation of plants with a bacterial mixture (consortium) apparently provides greater benefits to plant growth than inoculation with a single bacterial strain. In the present work, a bacterial consortium was formulated containing four compatible and desiccation-tolerant strains with potential as PGPR. The formulation had one moderately (Pseudomonas putida KT2440) and three highly desiccation-tolerant (Sphingomonas sp. OF178, Azospirillum brasilense Sp7 and Acinetobacter sp. EMM02) strains. The four bacterial strains were able to adhere to seeds and colonize the rhizosphere of plants when applied in both mono-inoculation and multi-inoculation treatments, showing that they can also coexist without antagonistic effects in association with plants. The effects of the bacterial consortium on the growth of blue maize were evaluated. Seeds inoculated with either individual bacterial strains or the bacterial consortium were subjected to two experimental conditions before sowing: normal hydration or desiccation. In general, inoculation with the bacterial consortium increased the shoot and root dry weight, plant height and plant diameter compared to the non-inoculated control or mono-inoculation treatments. The bacterial consortium formulated in this work had greater benefits for blue maize plants even when the inoculated seeds underwent desiccation stress before germination, making this formulation attractive for future field applications.	[Molina-Romero, Dalia; Baez, Antonino; Ernesto Fuentes-Ramirez, Luis; del Rocio Bustillos-Cristales, Maria; Rodriguez-Andrade, Osvaldo; Elizabeth Morales-Garcia, Yolanda; Munive, Antonio; Munoz-Rojas, Jesus] BUAP, LEMM, CICM, IC, Edificio IC11,Ciudad Univ, Puebla, Mexico; [Molina-Romero, Dalia; Elizabeth Morales-Garcia, Yolanda] BUAP, Lab Biol Mol & Microbiol, Fac Ciencias Biol, Edificio 112-A,Ciudad Univ, Puebla, Mexico; [Quintero-Hernandez, Veronica] IC BUAP, CONACYT, LEMM, CICM, Edificio IC11,Ciudad Univ, Puebla, Mexico; [Castaneda-Lucio, Miguel] IC BUAP, CICM, Genet Mol Microbiana, Edificio IC11,Ciudad Univ, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla	Munoz-Rojas, J (corresponding author), BUAP, LEMM, CICM, IC, Edificio IC11,Ciudad Univ, Puebla, Mexico.	joymerre@yahoo.com.mx	Fuentes, Luis E/Q-9675-2018; BC, Rocio/AAE-1090-2019; Morales-García, Yolanda Elizabeth/AAU-5882-2020; Baez, Antonino/T-6638-2017; Muñoz-Rojas, Jesús/B-9786-2019; Bustillos, Rocio/Y-5975-2019; Rodríguez-Andrade, Osvaldo/AAD-8587-2021; Munive, José-Antonio/P-4379-2018; Molina-Romero, Dalia/ABB-4987-2020	Fuentes, Luis E/0000-0002-8053-7742; BC, Rocio/0000-0002-6325-3764; Morales-García, Yolanda Elizabeth/0000-0003-0376-034X; Baez, Antonino/0000-0001-8453-3178; Muñoz-Rojas, Jesús/0000-0002-1151-9778; Munive, José-Antonio/0000-0003-4509-6563; Molina-Romero, Dalia/0000-0003-2548-8332; Rodriguez-Andrade, Osvaldo/0000-0001-8830-3222; Quintero-Hernandez, Veronica/0000-0002-1856-8134	Apoyo Redes PRODEP [CA-262, CA-244]; Ciencia Basica CONACYT [CB2010-156576-Z, DITCo2016-3, DITCo2016-4]; VIEP-BUAP [00450, 00513, 00476, 00510]	Apoyo Redes PRODEP; Ciencia Basica CONACYT; VIEP-BUAP	The work was supported by the following: Apoyo Redes PRODEP 2015-2016 (CA-262 and CA-244); Ciencia Basica CONACYT CB2010-156576-Z; DITCo2016-3, DITCo2016-4; and VIEP-BUAP-2016 (00450, 00513, 00476, 00510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen IM, 2000, APPL MICROBIOL BIOT, V53, P159, DOI 10.1007/s002530050003; Ahmad M, 2013, PLANT PHYSIOL BIOCH, V63, P170, DOI 10.1016/j.plaphy.2012.11.024; Albareda M, 2008, SOIL BIOL BIOCHEM, V40, P2771, DOI 10.1016/j.soilbio.2008.07.021; Anacarso I, 2014, PLANT PATHOL MICROB, P5; [Anonymous], 2017, MICROB BIOTECHNOL, DOI DOI 10.1111/1751-7915.12448; BACHHAWAT AK, 1989, J BACTERIOL, V171, P4092, DOI 10.1128/jb.171.7.4092-4094.1989; Baez-Rogelio A, 2017, MICROB BIOTECHNOL, V10, P19, DOI 10.1111/1751-7915.12448; Barea JM, 2002, NUTR CYCL AGROECOSYS, V63, P35, DOI 10.1023/A:1020589732436; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; Bogino P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079614; Bonito G, 2014, MOL ECOL, V23, P3356, DOI 10.1111/mec.12821; Caceres E A, 1982, Appl Environ Microbiol, V44, P990; Camelo-Mendez GA, 2016, FOOD CHEM, V211, P281, DOI 10.1016/j.foodchem.2016.05.024; Carreno-Lopez R, 2000, MOL GEN GENET, V264, P521, DOI 10.1007/s004380000340; Casteriano A, 2013, APPL ENVIRON MICROB, V79, P3998, DOI 10.1128/AEM.00082-13; Chauhan H, 2015, SCI HORTIC-AMSTERDAM, V197, P441, DOI 10.1016/j.scienta.2015.10.001; Corral-Lugo A, 2012, COLOMB BIOTECNOLOGIC, V14, p147 ; Cytryn EJ, 2007, J BACTERIOL, V189, P6751, DOI 10.1128/JB.00533-07; Donati AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076559; Estrada-De los Santos P, 2001, APPL ENVIRON MICROB, V67, P2790, DOI 10.1128/AEM.67.6.2790-2798.2001; Suarez RF, 2013, REV FITOTEC MEX, V36, P275; Rojas-Tapias DF, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2232-2; Gulati A, 2009, CURR MICROBIOL, V58, P371, DOI 10.1007/s00284-008-9339-x; Gunasekera TS, 2002, APPL ENVIRON MICROB, V68, P1988, DOI 10.1128/AEM.68.4.1988-1993.2002; Imran A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00859; Lopez-Martinez LX, 2009, LWT-FOOD SCI TECHNOL, V42, P1187, DOI 10.1016/j.lwt.2008.10.010; Velazquez-Hernandez ML, 2011, ARCH MICROBIOL, V193, P137, DOI 10.1007/s00203-010-0651-z; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Marin-Cevada V, 2012, APPL SOIL ECOL, V61, P230, DOI 10.1016/j.apsoil.2011.11.014; Marks BB, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-21; de Oliveira ALM, 2006, PLANT SOIL, V284, P23, DOI 10.1007/s11104-006-0025-0; Masciarelli O, 2014, MICROBIOL RES, V169, P609, DOI 10.1016/j.micres.2013.10.001; Matilla MA, 2010, ENV MICROBIOL REP, V2, P381, DOI 10.1111/j.1758-2229.2009.00091.x; Molina-Romero D, 2017, REV IBEROAM CIENCIAS, p1 ; Munoz-Rojas J, 2006, APPL ENVIRON MICROB, V72, P472, DOI 10.1128/AEM.72.1.472-477.2006; Munoz-Rojas J, 2005, FEMS MICROBIOL ECOL, V54, P57, DOI 10.1016/j.femsec.2005.02.011; Munoz-Rojas J, 2003, MICROB ECOL, V46, P454, DOI 10.1007/s00248-003-0110-3; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Myresiotis CK, 2015, PEST MANAG SCI, V71, P1258, DOI 10.1002/ps.3919; NOEL KD, 1984, J BACTERIOL, V158, P148, DOI 10.1128/JB.158.1.148-155.1984; Oliveira ALM, 2009, EUR J SOIL BIOL, V45, P106, DOI 10.1016/j.ejsobi.2008.09.004; Panikov NS, 2015, ENVIRON MICROBIOL, V17, P215, DOI 10.1111/1462-2920.12584; Perez-Miranda S, 2007, J MICROBIOL METH, V70, P127, DOI 10.1016/j.mimet.2007.03.023; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; Planchamp C, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00719; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Reina-Bueno M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-207; dos Santos CLR, 2017, APPL SOIL ECOL, V113, P96, DOI 10.1016/j.apsoil.2017.02.008; Rodriguez H, 2004, NATURWISSENSCHAFTEN, V91, P552, DOI 10.1007/s00114-004-0566-0; Rodriguez-Andrade O, 2015, REV ARGENT MICROBIOL, V47, P335, DOI 10.1016/j.ram.2015.09.004; Saia S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00815; Schreiter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103726; SEGOVIA L, 1993, INT J SYST BACTERIOL, V43, P374, DOI 10.1099/00207713-43-2-374; Shahzad SM, 2014, BIOL FERT SOILS, V50, P1, DOI 10.1007/s00374-013-0826-2; Singh A, 2014, MICROBIOL RES, V169, P353, DOI 10.1016/j.micres.2013.09.014; Somers E, 2005, APPL ENVIRON MICROB, V71, P1803, DOI 10.1128/AEM.71.4.1803-1810.2005; Streeter JG, 2003, J APPL MICROBIOL, V95, P484, DOI 10.1046/j.1365-2672.2003.02017.x; Summers MAM, 2012, BENJAMIN MAJ, DOI [10.7287/peerj.preprints.35v1, DOI 10.7287/PEERJ.PREPRINTS.35V1]; Sundaramoorthy S, 2012, BIOL CONTROL, V60, P59, DOI 10.1016/j.biocontrol.2011.10.002; TAPIAHERNANDEZ A, 1990, MICROBIOS, V64, P73; Thakur R, 2017, INDIAN J MICROBIOL, V57, P195, DOI 10.1007/s12088-017-0642-8; Vilchez JI, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01577; Vilchez S, 2011, APPL MICROBIOL BIOT, V91, P1297, DOI 10.1007/s00253-011-3461-6; Von Felten A, 2010, J MICROBIOL METH, V81, P108, DOI 10.1016/j.mimet.2010.02.003; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zoppellari F, 2014, ITAL J AGROMETEOROL, V19, P5	66	62	68	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187913	10.1371/journal.pone.0187913	http://dx.doi.org/10.1371/journal.pone.0187913			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117218	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600086
J	Matho, MH; Schlossman, A; Gilchuk, IM; Miller, G; Mikulski, Z; Hupfer, M; Wang, J; Bitra, A; Meng, XZ; Xiang, Y; Kaever, T; Doukov, T; Ley, K; Crotty, S; Peters, B; Hsieh-Wilson, LC; Crowe, JE; Zajonc, DM				Matho, Michael H.; Schlossman, Andrew; Gilchuk, Iuliia M.; Miller, Greg; Mikulski, Zbigniew; Hupfer, Matthias; Wang, Jing; Bitra, Aruna; Meng, Xiangzhi; Xiang, Yan; Kaever, Tom; Doukov, Tzanko; Ley, Klaus; Crotty, Shane; Peters, Bjoern; Hsieh-Wilson, Linda C.; Crowe, James E., Jr.; Zajonc, Dirk M.			Structure-function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; glycosaminoglycan; protein crystallization; protein structure; vaccine; viral protein; X-ray crystallography	SURFACE HEPARAN-SULFATE; CHONDROITIN SULFATE; NEUTRALIZING ANTIBODY; MONOCLONAL-ANTIBODIES; SMALLPOX VACCINE; OVARIAN-CANCER; PROTEIN BINDS; A27L PROTEIN; L1 PROTEIN; EPITOPES	Vaccinia virus (VACV) envelope protein D8 is one of three glycosaminoglycan adhesion molecules and binds to the linear polysaccharide chondroitin sulfate (CS). D8 is also a target for neutralizing antibody responses that are elicited by the smallpox vaccine, which has enabled the first eradication of a human viral pathogen and is a useful model for studying antibody responses. However, to date, VACV epitopes targeted by human antibodies have not been characterized at atomic resolution. Here, we characterized the binding properties of several human anti-D8 antibodies and determined the crystal structures of three VACV-mAb variants, VACV-66, VACV-138, and VACV-304, separately bound to D8. Although all these antibodies bound D8 with high affinity and were moderately neutralizing in the presence of complement, VACV-138 and VACV-304 also fully blocked D8 binding to CS-A, the low affinity ligand for D8. VACV-138 also abrogated D8 binding to the high-affinity ligand CS-E, but we observed residual CS-E binding was observed in the presence of VACV-304. Analysis of the VACV-138- and VACV-304-binding sites along the CS-binding crevice of D8, combined with different efficiencies of blocking D8 adhesion to CS-A and CS-E allowed us to propose that D8 has a high- and low-affinity CS-binding region within its central crevice. The crevice is amenable to protein engineering to further enhance both specificity and affinity of binding to CS-E. Finally, a wild-type D8 tetramer specifically bound to structures within the developing glomeruli of the kidney, which express CS-E. We propose that through structure-based protein engineering, an improved D8 tetramer could be used as a potential diagnostic tool to detect expression of CS-E, which is a possible biomarker for ovarian cancer.	[Matho, Michael H.; Schlossman, Andrew; Hupfer, Matthias; Wang, Jing; Bitra, Aruna; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Cir, La Jolla, CA 92037 USA; [Mikulski, Zbigniew; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA; [Kaever, Tom; Crotty, Shane; Peters, Bjoern] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Gilchuk, Iuliia M.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Gilchuk, Iuliia M.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Gilchuk, Iuliia M.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Miller, Greg; Hsieh-Wilson, Linda C.] CALTECH, Howard Hughes Med Inst, Div Chem & Chem Engn, Pasadena, CA 91126 USA; [Meng, Xiangzhi; Xiang, Yan] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX 78229 USA; [Doukov, Tzanko] SLAC, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Crotty, Shane] Univ Calif San Diego, La Jolla, CA 92037 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; La Jolla Institute for Immunology; La Jolla Institute for Immunology; Vanderbilt University; Vanderbilt University; Vanderbilt University; California Institute of Technology; Howard Hughes Medical Institute; University of Texas System; University of Texas Health San Antonio; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California San Diego; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Cir, La Jolla, CA 92037 USA.	dzajonc@lji.org	Mikulski, Zbigniew/AAB-4447-2020; Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019; Crowe, James/B-5549-2009	Mikulski, Zbigniew/0000-0002-1918-9216; Crotty, Shane/0000-0002-6484-6262; Crowe, James/0000-0002-0049-1079; Doukov, Tzanko/0000-0001-8625-2572; Xiang, Yan/0000-0002-7633-1629; Zajonc, Dirk/0000-0001-7215-1981	United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093627, P41GM103393] Funding Source: NIH RePORTER	United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Angela Lamberth for technical assistance in preparing and staining the tissue sections for immunofluorescence microscopy. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences Grant P41GM103393.	Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Bartlett AH, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001367; Benhnia MREI, 2008, J VIROL, V82, P3751, DOI 10.1128/JVI.02244-07; Benhnia MREI, 2009, J VIROL, V83, P12355, DOI 10.1128/JVI.01593-09; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Deepa SS, 2007, GLYCOBIOLOGY, V17, P631, DOI 10.1093/glycob/cwm021; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gilchuk I, 2016, CELL, V167, P684, DOI 10.1016/j.cell.2016.09.049; Henderson DA, 2011, VACCINE, V29, pD7, DOI 10.1016/j.vaccine.2011.06.080; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Hsiao JC, 1998, J VIROL, V72, P8374, DOI 10.1128/JVI.72.10.8374-8379.1998; Joo EJ, 2014, OMICS, V18, P231, DOI 10.1089/omi.2013.0128; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaever T, 2016, J VIROL, V90, P4334, DOI 10.1128/JVI.02878-15; Kaever T, 2014, J VIROL, V88, P11339, DOI 10.1128/JVI.01491-14; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matho MH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005148; Matho MH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004495; Matho MH, 2012, J VIROL, V86, P8050, DOI 10.1128/JVI.00836-12; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meng XZ, 2011, VIROLOGY, V409, P271, DOI 10.1016/j.virol.2010.10.019; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Moss B, 2011, IMMUNOL REV, V239, P8, DOI 10.1111/j.1600-065X.2010.00975.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Rogers CJ, 2011, P NATL ACAD SCI USA, V108, P9747, DOI 10.1073/pnas.1102962108; Roper RL, 1998, J VIROL, V72, P4192, DOI 10.1128/JVI.72.5.4192-4204.1998; Salanti A, 2015, CANCER CELL, V28, P500, DOI 10.1016/j.ccell.2015.09.003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sela-Culang I, 2014, STRUCTURE, V22, P646, DOI 10.1016/j.str.2014.02.003; Shipp EL, 2007, CHEM BIOL, V14, P195, DOI 10.1016/j.chembiol.2006.12.009; Su HP, 2007, VIROLOGY, V368, P331, DOI 10.1016/j.virol.2007.06.042; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Tully SE, 2006, J AM CHEM SOC, V128, P7740, DOI 10.1021/ja061906t; Uyama T., 2007, COMPR GLYCOSCI, V3, P79; Vallen MJE, 2014, BIOMARK MED, V8, P699, DOI [10.2217/BMM.14.6, 10.2217/bmm.14.6]; Wadstrom T, 1999, J MED MICROBIOL, V48, P223, DOI 10.1099/00222615-48-3-223; Watanabe I, 2015, GLYCOBIOLOGY, V25, P953, DOI 10.1093/glycob/cwv039; Weitkamp JH, 2003, J IMMUNOL METHODS, V275, P223, DOI 10.1016/S0022-1759(03)00013-9; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	49	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					390	401		10.1074/jbc.M117.814541	http://dx.doi.org/10.1074/jbc.M117.814541			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29123031	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-26	WOS:000419453200033
J	Pelz, L; Purfurst, B; Rathjen, FG				Pelz, Laura; Purfuerst, Bettina; Rathjen, Fritz G.			The cell adhesion molecule BT-IgSF is essential for a functional blood-testis barrier and male fertility in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						blood-testis barrier; BT-IgSF (IgSF11); connexin43; IgCAM; male fertility; cell adhesion; testis; spermatogenesis; IgCAM BT-IgSF (IgSF11)	ADENOVIRUS RECEPTOR; SERTOLI-CELLS; JUNCTION PROTEIN; COMPONENT; GENE; EXPRESSION; CONNEXIN43; RAT; SPERMATOGENESIS; COXSACKIEVIRUS	The Ig-like cell adhesion molecule (IgCAM) BT-IgSF (brain- and testis-specific Ig superfamily protein) plays a major role in male fertility in mice. However, the molecular mechanism by which BT-IgSF supports fertility is unclear. Here, we found that it is localized in Sertoli cells at the blood-testis barrier (BTB) and at the apical ectoplasmic specialization. The absence of BT-IgSF in Sertoli cells in both global and conditional mouse mutants (i.e. AMHCre and Rosa26CreERT2 lines) resulted in male infertility, atrophic testes with vacuolation, azoospermia, and spermatogenesis arrest. Although transcripts of junctional proteins such as connexin43, ZO-1, occludin, and claudin11 were up-regulated in the absence of BT-IgSF, the functional integrity of the BTB was impaired, as revealed by injection of a BTB-impermeable component into the testes under in vivo conditions. Disruption of the BTB coincided with mislocalization of connexin43, which was present throughout the seminiferous epithelium and not restricted to the BTB as in wild-type tissues, suggesting impaired cell-cell communication in the BT-IgSF-KO mice. Because EM images revealed a normal BTB structure between Sertoli cells in the BT-IgSF-KO mice, we conclude that infertility in these mice is most likely caused by a functionally impaired BTB. In summary, our results indicate that BT-IgSF is expressed at the BTB and is required for male fertility by supporting the functional integrity of the BTB.	[Pelz, Laura; Rathjen, Fritz G.] Helmholtz Assoc, Dept Neurobiol, Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Purfuerst, Bettina] Helmholtz Assoc, Core Facil Electron Microscopy, Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rathjen, FG (corresponding author), Helmholtz Assoc, Dept Neurobiol, Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.	rathjen@mdc-berlin.de			Velocigene at Regeneron Inc.; National Institutes of Health [U01HG004085, U01HG004080, U42RR024244]; CSD Consortium; KOMP Program [8500]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR024244] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004080, U01HG004085] Funding Source: NIH RePORTER	Velocigene at Regeneron Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSD Consortium; KOMP Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Anne Banerjee, Maria Steinecker, and Christina Schiel for technical assistance and Karola Bach for mouse breeding. We also acknowledge Dr. Karin Muller (Leibniz Institute for Zoo and Wildlife Research, Berlin, Germany) and Andreas Pelz (Charite, Berlin, Germany) for flow cytometry experiments and critical reading of the manuscript. We thank the transgenic core facility of the Max Delbruck Center for blastocyst injections and sperm rederivation. The ES cells and sperm used for this research project were generated by the trans-NIH KOMP and obtained from the KOMP Repository (www.komp.org).<SUP>3</SUP> We thank Dr. Thomas Jentsch (Max Delbruck Center and FMP, Berlin) and Dr. Florian Guillou (INRA, Paris) for providing AMHCre mice and Karina Oberheide and Corinna Goppner (both from the Max Delbruck Center) for discussion. We thank Dr. Spagnoli (Max Delbruck Center) for providing Rosa26CreERT2 mice. We acknowledge support from Velocigene at Regeneron Inc. (supported by National Institutes of Health Grant U01HG004085) and the CSD Consortium (supported by National Institutes of Health Grant U01HG004080), which funded the generation of gene-targeted ES cells for 8500 genes in the KOMP Program. Also, the archiving and distribution by the KOMP Repository at UC Davis and CHORI were supported by National Institutes of Health Grant U42RR024244.	Ahi EP, 2017, PEERJ, V5, DOI 10.7717/peerj.2843; Brehm R, 2007, AM J PATHOL, V171, P19, DOI 10.2353/ajpath.2007.061171; Carette D, 2010, DEV BIOL, V346, P54, DOI 10.1016/j.ydbio.2010.07.014; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; COQUELIN A, 1982, AM J PHYSIOL, V243, pE257, DOI 10.1152/ajpendo.1982.243.3.E257; Defamie N, 2003, LAB INVEST, V83, P449, DOI 10.1097/01.LAB.0000059928.82702.6D; deFeijter AW, 1996, MOL CARCINOGEN, V16, P203, DOI 10.1002/(SICI)1098-2744(199608)16:4<203::AID-MC4>3.3.CO;2-F; Duffy HS, 2002, J PHYSIOL-PARIS, V96, P243, DOI 10.1016/S0928-4257(02)00012-8; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Eom DS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002899; Franca LR, 2016, ANDROLOGY-US, V4, P189, DOI 10.1111/andr.12165; Gerber J, 2014, HISTOL HISTOPATHOL, V29, P935, DOI 10.14670/HH-29.935; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Harada H, 2005, J CELL PHYSIOL, V204, P919, DOI 10.1002/jcp.20361; Holembowski L, 2014, J CELL BIOL, V204, P1173, DOI 10.1083/jcb.201306066; Jang S, 2016, NAT NEUROSCI, V19, P84, DOI 10.1038/nn.4176; Jiang XH, 2014, ASIAN J ANDROL, V16, P572, DOI 10.4103/1008-682X.125401; Juneja SC, 1999, BIOL REPROD, V60, P1263, DOI 10.1095/biolreprod60.5.1263; Katoh M, 2003, INT J ONCOL, V23, P525; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Lee JH, 2006, MOL REPROD DEV, V73, P173, DOI 10.1002/mrd.20391; Luangpraseuth-Prosper A, 2015, DEV BIOL, V406, P158, DOI 10.1016/j.ydbio.2015.09.002; Matthaus C, 2017, MOL CELL NEUROSCI, V81, P32, DOI 10.1016/j.mcn.2016.11.009; Mazaud-Guittot S, 2010, BIOL REPROD, V82, P202, DOI 10.1095/biolreprod.109.078907; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Mruk DD, 2015, ENDOCR REV, V36, P681, DOI [10.1210/er.2015-1127, 10.1210/er.2014-1101]; Mruk Dolores D, 2012, Spermatogenesis, V2, P6; Raschperger E, 2004, J BIOL CHEM, V279, P796, DOI 10.1074/jbc.M308249200; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Silva C, 2009, MOL REPROD DEV, V76, P11, DOI 10.1002/mrd.20925; Sridharan S, 2007, BIOL REPROD, V76, P804, DOI 10.1095/biolreprod.106.059212; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Sultana T, 2014, REPRODUCTION, V147, P875, DOI 10.1530/REP-13-0653; Suzu S, 2002, BIOCHEM BIOPH RES CO, V296, P1215, DOI 10.1016/S0006-291X(02)02025-9; Sze KL, 2008, J CELL PHYSIOL, V214, P334, DOI 10.1002/jcp.21201; Wang CQF, 2007, EXP CELL RES, V313, P1373, DOI 10.1016/j.yexcr.2007.01.017; Xiao X, 2014, PHYSIOLOGY, V29, P286, DOI 10.1152/physiol.00001.2014; Xu JL, 2009, MOL BIOL CELL, V20, P4268, DOI 10.1091/mbc.E08-12-1236; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513	45	14	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21490	21503		10.1074/jbc.RA117.000113	http://dx.doi.org/10.1074/jbc.RA117.000113			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29123028	Green Accepted, hybrid, Green Submitted, Green Published			2022-12-26	WOS:000419013000024
J	Coroller, TP; Bi, WL; Huynh, E; Abedalthagafi, M; Aizer, AA; Greenwald, NF; Parmar, C; Narayan, V; Wu, WW; de Moura, SM; Gupta, S; Beroukhim, R; Wen, PY; Al-Mefty, O; Dunn, IF; Santagata, S; Alexander, BM; Huang, RY; Aerts, HJWL				Coroller, Thibaud P.; Bi, Wenya Linda; Huynh, Elizabeth; Abedalthagafi, Malak; Aizer, Ayal A.; Greenwald, Noah F.; Parmar, Chintan; Narayan, Vivek; Wu, Winona W.; de Moura, Samuel Miranda; Gupta, Saksham; Beroukhim, Rameen; Wen, Patrick Y.; Al-Mefty, Ossama; Dunn, Ian F.; Santagata, Sandro; Alexander, Brian M.; Huang, Raymond Y.; Aerts, Hugo J. W. L.			Radiographic prediction of meningioma grade by semantic and radiomic features	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; DIFFUSION; REPRODUCIBILITY; HETEROGENEITY; ASSOCIATION; TUMORS	Objectives The clinical management of meningioma is guided by tumor grade and biological behavior. Currently, the assessment of tumor grade follows surgical resection and histopathologic review. Reliable techniques for pre-operative determination of tumor grade may enhance clinical decision-making. Methods A total of 175 meningioma patients (103 low-grade and 72 high-grade) with pre-operative contrast-enhanced T1-MRI were included. Fifteen radiomic (quantitative) and 10 semantic (qualitative) features were applied to quantify the imaging phenotype. Area under the curve (AUC) and odd ratios (OR) were computed with multiple-hypothesis correction. Random-forest classifiers were developed and validated on an independent dataset (n = 44). Results Twelve radiographic features (eight radiomic and four semantic) were significantly associated with meningioma grade. High-grade tumors exhibited necrosis/hemorrhage (ORsem = 6.6, AUC(rad) = 0.62 +/- 0.68), intratumoral heterogeneity (ORsem = 7.9, AUC(rad) = 0.65), non-spherical shape (AUC(rad) = 0.61), and larger volumes (AUC(rad) = 0.69) compared to lowgrade tumors. Radiomic and sematic classifiers could significantly predict meningioma grade (AUC(sem) = 0.76 and AUC(rad) = 0.78). Furthermore, combining them increased the classification power (AUC(radio) = 0.86). Clinical variables alone did not effectively predict tumor grade (AUC(clin) = 0.65) or show complementary value with imaging data (AUC(comb) = 0.84). Conclusions We found a strong association between imaging features of meningioma and histopathologic grade, with ready application to clinical management. Combining qualitative and quantitative radiographic features significantly improved classification	[Coroller, Thibaud P.; Huynh, Elizabeth; Aizer, Ayal A.; Parmar, Chintan; Narayan, Vivek; Alexander, Brian M.; Aerts, Hugo J. W. L.] Harvard Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA; [Bi, Wenya Linda; Greenwald, Noah F.; Wu, Winona W.; de Moura, Samuel Miranda; Gupta, Saksham; Al-Mefty, Ossama; Dunn, Ian F.] Harvard Med Sch, Dept Neurosurg, Brigham & Womens Hosp, Boston, MA USA; [Bi, Wenya Linda; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Abedalthagafi, Malak; Santagata, Sandro] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA; [Abedalthagafi, Malak] King Fahad Med City, King Abdulaziz City Sci & Technol & Res Ctr, Saudi Human Genome Project, Riyadh, Saudi Arabia; [Beroukhim, Rameen; Wen, Patrick Y.] Dana Farber Canc Inst, Dept Neurooncol, Boston, MA 02115 USA; [Huang, Raymond Y.; Aerts, Hugo J. W. L.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; King Fahad Medical City; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Huang, RY (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA.	tcoroller@lroc.harvard.edu; ryhuang@bwh.harvard.edu	Greenwald, Noah/GNH-3982-2022; parmar, chintan/J-2977-2019; Wen, Patrick/AAE-3776-2022; Abedalthagafi, Malak/Q-7434-2019; Aerts, Hugo/ABF-2821-2020	Greenwald, Noah/0000-0002-7836-4379; parmar, chintan/0000-0002-2140-814X; Aerts, Hugo/0000-0002-2122-2003; Santagata, Sandro/0000-0002-7528-9668; Abedalthagafi, Malak/0000-0003-1786-3366; Coroller, Thibaud/0000-0001-7662-8724; Huang, Raymond/0000-0001-7661-797X	National Institute of Health [NIH-USA U24CA194354, NIH-USA U01CA190234]; Kaye Scholar Award; Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant; King Abdulaziz City for Science and Technology grant	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kaye Scholar Award; Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant; King Abdulaziz City for Science and Technology grant	Authors acknowledge financial support from the National Institute of Health (NIH-USA U24CA194354, and NIH-USA U01CA190234). This project was partially funded by the Kaye Scholar Award, the Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant, and King Abdulaziz City for Science and Technology grant (MA).	Abedalthagafi MS, 2014, LAB INVEST, p433A; Aerts HJWL, 2016, JAMA ONCOL; Aerts M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4789; Antunes J, 2016, TRANSL ONCOL, V9, P155, DOI 10.1016/j.tranon.2016.01.008; Backer-Grondahl T, 2012, INT J CLIN EXP PATHO, V5, P231; Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bi WL, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00040; Bi WL, 2016, J NEUROSURG, V125, P525, DOI 10.3171/2015.6.JNS15591; Bi WL, 2016, IMMUNOTHERAPY-UK, V8, P721, DOI 10.2217/imt-2016-0017; Bondy M, 1996, J NEURO-ONCOL, V29, P197, DOI 10.1007/BF00165649; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BUETOW MP, 1991, RADIOGRAPHICS, V11, P1087, DOI 10.1148/radiographics.11.6.1749851; Chernov MF, 2011, CLIN NEUROL NEUROSUR, V113, P202, DOI 10.1016/j.clineuro.2010.11.008; Coroller TP, 2017, J THORAC ONCOL, V12, P467, DOI 10.1016/j.jtho.2016.11.2226; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; Coroller TP, 2016, RADIOTHER ONCOL; Desseroit M-C, 2016, J NUCL MED OFF PUBL; Desseroit MC, 2016, EUR J NUCL MED MOL I, V43, P1477, DOI 10.1007/s00259-016-3325-5; Dolnicar S, 2007, J RETAIL CONSUM SERV, V14, P108, DOI 10.1016/j.jretconser.2006.09.006; Fried DV, 2014, INT J RAD ONCOL; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gillies RJ, 2015, RADIOLOGY, DOI DOI 10.1148/RADIOL.2015151169; Gimenez Francisco, 2012, AMIA Annu Symp Proc, V2012, P257; Hakyemez B, 2006, NEURORADIOLOGY, V48, P513, DOI 10.1007/s00234-006-0094-z; Hassan I, 2016, SCI REP-UK, V6, DOI 10.1038/srep25295; Hatt M, 2016, J NUCL MED; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Huynh E, 2016, RADIOTHER ONCOL; Huynh E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169172; Ingrisch M, 2017, INVEST RADIOL; Kickingereder P, 2016, CLIN CANCER RES, V22, P5765, DOI 10.1158/1078-0432.CCR-16-0702; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Larue RTHM, 2016, BRIT J RADIOL; Lee HJ, 2013, RADIOLOGY, V268, P254, DOI 10.1148/radiol.13112553; Leijenaar RTH, 2015, ACTA ONCOL, V54, P1423, DOI 10.3109/0284186X.2015.1061214; Liu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118908; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Nakasu S, 1999, J NEUROSURG, V90, P455, DOI 10.3171/jns.1999.90.3.0455; PARMAR C, 2015, SCI REP UK, V5; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Pavlisa G, 2008, CLIN IMAG, V32, P22, DOI 10.1016/j.clinimag.2007.07.007; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; Piper RJ, 2016, MAGN RESON IMAGING, V34, P596, DOI 10.1016/j.mri.2015.12.006; R Core Team, 2021, R LANGUAGE ENV STAT; ROHRINGER M, 1989, J NEUROSURG, V71, P665, DOI 10.3171/jns.1989.71.5.0665; Sachdeva J, 2012, INT J NUMER METH BIO, V28, P1107, DOI 10.1002/cnm.2481; Santelli L, 2010, ACTA NEUROCHIR, V152, P1315, DOI 10.1007/s00701-010-0657-y; Sanverdi SE, 2012, EUR J RADIOL, V81, P2389, DOI 10.1016/j.ejrad.2011.06.031; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; SERVO A, 1990, NEURORADIOLOGY, V32, P94, DOI 10.1007/BF00588556; Surov A, 2016, WORLD NEUROSURG, V88, P598, DOI 10.1016/j.wneu.2015.10.049; Surov A, 2015, TRANSL ONCOL, V8, P517, DOI 10.1016/j.tranon.2015.11.012; Tang Y, 2014, AM J ROENTGENOL, V202, P1303, DOI 10.2214/AJR.13.11637; van den Burg EL, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00190; Wang H, 2015, CLIN LUNG CANCER, V16, pE141, DOI 10.1016/j.cllc.2015.05.007; Yanagawa M, 2010, LUNG CANCER, V70, P286, DOI 10.1016/j.lungcan.2010.03.009; Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150; Zhao BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23428	61	67	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187908	10.1371/journal.pone.0187908	http://dx.doi.org/10.1371/journal.pone.0187908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145421	gold, Green Submitted, Green Published			2022-12-26	WOS:000415378800037
J	Agren, J; Schafer, MO; Forsgren, E				Agren, Joakim; Schaefer, Marc Oliver; Forsgren, Eva			Using whole genome sequencing to study American foulbrood epidemiology in honeybees	PLOS ONE			English	Article							PAENIBACILLUS-LARVAE; TYPING SCHEME; BACTERIA; OUTBREAK; MLST	American foulbrood (AFB), caused by Paenibacillus larvae, is a devastating disease in honeybees. In most countries, the disease is controlled through compulsory burning of symptomatic colonies causing major economic losses in apiculture. The pathogen is endemic to honeybees world-wide and is readily transmitted via the movement of hive equipment or bees. Molecular epidemiology of AFB currently largely relies on placing isolates in one of four ERIC-genotypes. However, a more powerful alternative is multi-locus sequence typing (MLST) using whole-genome sequencing (WGS), which allows for high-resolution studies of disease outbreaks. To evaluate WGS as a tool for AFB-epidemiology, we applied core genome MLST (cgMLST) on isolates from a recent outbreak of AFB in Sweden. The high resolution of the cgMLST allowed different bacterial clones involved in the disease outbreak to be identified and to trace the source of infection. The source was found to be a beekeeper who had sold bees to two other beekeepers, proving the epidemiological link between them. No such conclusion could have been made using conventional MLST or ERIC-typing. This is the first time that WGS has been used to study the epidemiology of AFB. The results show that the technique is very powerful for high-resolution tracing of AFB-outbreaks.	[Agren, Joakim] Natl Vet Inst, Dept Microbiol, Uppsala, Sweden; [Schaefer, Marc Oliver] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Insel Riems, Germany; [Forsgren, Eva] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	National Veterinary Institute SVA; Friedrich Loeffler Institute; Swedish University of Agricultural Sciences	Forsgren, E (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	eva.forsgren@slu.se		Forsgren, Eva/0000-0002-8244-7265				Antwerpen MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123298; Aring;ogren J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089112; Azarian T, 2015, INFECT CONT HOSP EP, V36, P777, DOI 10.1017/ice.2015.73; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Djukic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090914; ECDC, 2015, EXP OP INTR NEXT GEN; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Forsgren E, 2014, APIDOLOGIE, V45, P10, DOI 10.1007/s13592-013-0225-6; Genersch E, 2008, J VERBRAUCH LEBENSM, V3, P429, DOI 10.1007/s00003-008-0379-8; Genersch E, 2006, INT J SYST EVOL MICR, V56, P501, DOI 10.1099/ijs.0.63928-0; Genersch E, 2003, APIDOLOGIE, V34, P195, DOI 10.1051/apido:2003025; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jordbruksverket, 2001, 48 JORDBR; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Morrissey BJ, 2015, ENVIRON MICROBIOL, V17, P1414, DOI 10.1111/1462-2920.12625; Nordstrom S, 1995, J APICULT RES, V34, P97, DOI 10.1080/00218839.1995.11100894; Nordstrom S, 2002, J APIC SCI, V46, P1643; Pentikainen J, 2009, APIDOLOGIE, V40, P73, DOI 10.1051/apido:2008061; Pinholt M, 2015, J ANTIMICROB CHEMOTH, V70, P2474, DOI 10.1093/jac/dkv142; Ruppitsch W, 2015, J CLIN MICROBIOL, V53, P2869, DOI 10.1128/JCM.01193-15; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Weterings V, 2015, EUR J CLIN MICROBIOL, V34, P1647, DOI 10.1007/s10096-015-2401-2	29	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187924	10.1371/journal.pone.0187924	http://dx.doi.org/10.1371/journal.pone.0187924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140998	Green Submitted, Green Published, gold			2022-12-26	WOS:000415260400037
J	Farias, ME; Rasuk, MC; Gallagher, KL; Contreras, M; Kurth, D; Fernandez, AB; Poire, D; Novoa, F; Visscher, PT				Eugenia Farias, Maria; Cecilia Rasuk, Maria; Gallagher, Kimberley L.; Contreras, Manuel; Kurth, Daniel; Beatriz Fernandez, Ana; Poire, Daniel; Novoa, Fernando; Visscher, Pieter T.			Prokaryotic diversity and biogeochemical characteristics of benthic microbial ecosystems at La Brava, a hypersaline lake at Salar de Atacama, Chile	PLOS ONE			English	Article							MODERN MARINE STROMATOLITES; CARBONATE PRECIPITATION; CYANOBACTERIAL MATS; BACTERIAL DIVERSITY; SULFATE REDUCTION; HIGHBORNE CAY; ARCHAEA; GYPSUM; GEOCHEMISTRY; SEDIMENTS	Benthic microbial ecosystems of Laguna La Brava, Salar de Atacama, a high altitude hypersaline lake, were characterized in terms of bacterial and archaeal diversity, biogeochemistry, (including O-2 and sulfide depth profiles and mineralogy), and physicochemical characteristics. La Brava is one of several lakes in the Salar de Atacama where microbial communities are growing in extreme conditions, including high salinity, high solar insolation, and high levels of metals such as lithium, arsenic, magnesium, and calcium. Evaporation creates hypersaline conditions in these lakes and mineral precipitation is a characteristic geomicrobiological feature of these benthic ecosystems. In this study, the La Brava non-lithifying microbial mats, microbialites, and rhizome-associated concretions were compared to each other and their diversity was related to their environmental conditions. All the ecosystems revealed an unusual community where Euryarchaeota, Crenarchaeota, Acetothermia, Firmicutes and Planctomycetes were the most abundant groups, and cyanobacteria, typically an important primary producer in microbial mats, were relatively insignificant or absent. This suggests that other microorganisms, and possibly novel pathways unique to this system, are responsible for carbon fixation. Depth profiles of O-2 and sulfide showed active production and respiration. The mineralogy composition was calcium carbonate (as aragonite) and increased from mats to microbialites and rhizome-associated concretions. Halite was also present. Further analyses were performed on representative microbial mats and microbialites by layer. Different taxonomic compositions were observed in the upper layers, with Archaea dominating the non-lithifying mat, and Planctomycetes the microbialite. The bottom layers were similar, with Euryarchaeota, Crenarchaeota and Planctomycetes as dominant phyla. Sequences related to Cyanobacteria were very scarce. These systems may contain previously uncharacterized community metabolisms, some of which may be contributing to net mineral precipitation. Further work on these sites might reveal novel organisms and metabolisms of biotechnological interest.	[Eugenia Farias, Maria; Cecilia Rasuk, Maria; Kurth, Daniel; Beatriz Fernandez, Ana] Consejo Nacl Invest Cient & Tecn, CCT Tucuman, Planta Piloto Proc Ind Microbiol PROIMI, LIMLA, San Miguel De Tucuman, Argentina; [Contreras, Manuel; Novoa, Fernando] CEA, Santiago, Chile; [Poire, Daniel] Univ Nacl La Plata, Conicet, Ctr Invest Geol, La Plata, Buenos Aires, Argentina; [Gallagher, Kimberley L.; Visscher, Pieter T.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Visscher, Pieter T.] Univ New South Wales, Australian Ctr Astrobiol, Sydney, NSW, Australia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of Connecticut; University of New South Wales Sydney	Farias, ME (corresponding author), Consejo Nacl Invest Cient & Tecn, CCT Tucuman, Planta Piloto Proc Ind Microbiol PROIMI, LIMLA, San Miguel De Tucuman, Argentina.	mefarias2009@gmail.com	Rasuk, Maria/AAN-5887-2021; Kurth, Daniel/AAG-4696-2019; Visscher, Pieter/T-7464-2017	Rasuk, Maria/0000-0002-4852-0924; Kurth, Daniel/0000-0001-8481-4359; Visscher, Pieter/0000-0001-6911-1532; Gallagher, Kimberley/0000-0001-5835-3608; Farias, Maria Eugenia/0000-0002-2771-8915; FERNANDEZ, ANA BEATRIZ/0000-0003-3301-6503; Poire, Daniel G./0000-0003-0966-122X	Centro de Ecologia Aplicada Chile; MinCyT Argentina [PICT 1788, PICT 3825]; NASA Exobiology CAN [NNX12AD64G]	Centro de Ecologia Aplicada Chile; MinCyT Argentina; NASA Exobiology CAN	This work was supported by Centro de Ecologia Aplicada Chile and the projects PICT 1788 and PICT 3825 from MinCyT Argentina to MEF. PTV acknowledges support from NASA Exobiology CAN NNX12AD64G.	Ali-Bik MW, 2011, ENVIRON EARTH SCI, V62, P151, DOI 10.1007/s12665-010-0510-x; Alonso H, 1996, REV GEOL CHILE, V23, P113; Arp G, 2012, GEOMICROBIOL J, V29, P29, DOI 10.1080/01490451.2010.521436; BARDOU P, 2014, BMC BIOINFORMATICS, V15, P17060, DOI DOI 10.1128/AEM.00062-07; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Baumgartner LK, 2009, ASTROBIOLOGY, V9, P861, DOI 10.1089/ast.2008.0329; Baumgartner LK, 2009, ENVIRON MICROBIOL, V11, P2710, DOI 10.1111/j.1462-2920.2009.01998.x; BEVACQUA P, 1992, GEOMORFOLOGIA SALAR, P17060, DOI DOI 10.3389/FMICB.2017.00646; Beveridge T J, 1981, Int Rev Cytol, V72, P229, DOI 10.1016/S0074-7696(08)61198-5; Bolhuis H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063166; Braissant O, 2009, FEMS MICROBIOL ECOL, V67, P293, DOI 10.1111/j.1574-6941.2008.00614.x; CABRERA D, 1992, ARCH HYDROBIOL, V43, P123, DOI DOI 10.1016/S0012-8252(03)00037-0; Caceres L, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000344; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Rasuk MC, 2014, MICROB ECOL, V68, P483, DOI 10.1007/s00248-014-0431-4; Cockbain A. E., 1976, STROMATOLITES, P389, DOI 10.1016/S0070-4571(08)71147-6; CODY AM, 1989, J CRYST GROWTH, V98, P721, DOI 10.1016/0022-0248(89)90310-2; Costa KC, 2009, EXTREMOPHILES, V13, P447, DOI 10.1007/s00792-009-0230-x; Decho AW, 2000, MICROBIAL SEDIMENTS, P9; DESMARAIS DJ, 1995, BIOGEOCHEMISTRY HYPE, P251, DOI DOI 10.1007/978-1-4684-7724-5_6; Douglas S, 2005, AM J SCI, V305, P503, DOI 10.2475/ajs.305.6-8.503; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Dupraz C, 2004, SEDIMENTOLOGY, V51, P745, DOI 10.1111/j.1365-3091.2004.00649.x; Dupraz C., 2011, ENCY GEOBIOLOGY, P617, DOI [DOI 10.1007/978-1-4020-9212-1, DOI 10.1007/978-1-4020-9212-1_195]; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Eaton A. D., 2005, STANDARD METHODS EXA; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farias ME, 2014, EXTREMOPHILES, V18, P311, DOI 10.1007/s00792-013-0617-6; Farias ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053497; Fenchel T, 1998, AQUAT MICROB ECOL, V14, P253, DOI 10.3354/ame014253; Fernandez AB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01284; Gallagher KL, 2012, GEOBIOLOGY, V10, P518, DOI 10.1111/j.1472-4669.2012.00342.x; GOLDIN A, 1987, COMMUN SOIL SCI PLAN, V18, P1111, DOI 10.1080/00103628709367886; Gomez FJ, 2014, PALAIOS, V29, P233, DOI 10.2110/palo.2013.049; Harrison BK, 2009, APPL ENVIRON MICROB, V75, P1487, DOI 10.1128/AEM.01812-08; Hoffman P, 1976, STROMATOLITES, V20, P261, DOI DOI 10.1016/S0070-4571(08)71139-7; Houghton J, 2014, GEOBIOLOGY, V12, P557, DOI 10.1111/gbi.12113; Hu P, 2016, MBIO, V7, DOI 10.1128/mBio.01669-15; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Hugler M, 2003, ARCH MICROBIOL, V179, P160, DOI 10.1007/s00203-002-0512-5; Ionescu D, 2015, GEOBIOLOGY, V13, P170, DOI 10.1111/gbi.12120; Jahnke LL, 2014, GEOBIOLOGY, V12, P62, DOI 10.1111/gbi.12068; Kazmierczak Jozef, 2015, Life-Basel, V5, P744, DOI 10.3390/life5010744; KELLY DP, 1969, ANAL CHEM, V41, P898, DOI 10.1021/ac60276a029; Kim J.J., 2014, COMPENDIUM METHODS M; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Kurth D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00896-0; Lara J, 2012, EXTREMOPHILES, V16, P523, DOI 10.1007/s00792-012-0452-1; LEE JZ, 2014, FRONT MICROBIOL, V5, P17060, DOI DOI 10.1089/AST.2008.0329; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Leyval C, 1997, MYCORRHIZA, V7, P139, DOI 10.1007/s005720050174; Louyakis A, 2017, ASTROBIOLOG IN PRESS; Marvasi M, 2012, GEOMICROBIOL J, V29, P916, DOI 10.1080/01490451.2011.636145; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Myshrall KL, 2010, GEOBIOLOGY, V8, P337, DOI 10.1111/j.1472-4669.2010.00245.x; Nielsen M, 2015, SENSOR ACTUAT B-CHEM, V215, P1, DOI 10.1016/j.snb.2015.03.035; Nubel U, 2002, APPL ENVIRON MICROB, V68, P4593, DOI 10.1128/AEM.68.9.4593-4603.2002; Orell A, 2012, EXTREMOPHILES, V16, P573, DOI 10.1007/s00792-012-0457-9; Pace A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31495; Pages A, 2014, MAR CHEM, V167, P102, DOI 10.1016/j.marchem.2014.05.003; Pedley M, 2000, MICROBIAL SEDIMENTS, P179; Rascovan N, 2016, ISME J, V10, P299, DOI 10.1038/ismej.2015.109; REID RP, 1995, FACIES, V33, P1, DOI 10.1007/BF02537442; Remonsellez F, 2006, MICROBIOL-SGM, V152, P59, DOI 10.1099/mic.0.28241-0; Risacher F, 2003, EARTH-SCI REV, V63, P249, DOI 10.1016/S0012-8252(03)00037-0; Robertson CE, 2009, APPL ENVIRON MICROB, V75, P1801, DOI 10.1128/AEM.01811-08; Roos JC, 1998, J PHYCOL, V34, P118, DOI 10.1046/j.1529-8817.1998.340118.x; Russell JA, 2014, GEOBIOLOGY, V12, P250, DOI 10.1111/gbi.12082; Ruvindy R, 2016, ISME J, V10, P183, DOI 10.1038/ismej.2015.87; Schneider DI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082402; Schouten S, 2002, EARTH PLANET SC LETT, V204, P265, DOI 10.1016/S0012-821X(02)00979-2; Seufferheld MJ, 2008, APPL ENVIRON MICROB, V74, P5867, DOI 10.1128/AEM.00501-08; SHERWOOD JE, 1991, LIMNOL OCEANOGR, V36, P235, DOI 10.4319/lo.1991.36.2.0235; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Sorensen KB, 2005, APPL ENVIRON MICROB, V71, P7352, DOI 10.1128/AEM.71.11.7352-7365.2005; Souza V, 2006, P NATL ACAD SCI USA, V103, P6565, DOI 10.1073/pnas.0601434103; Souza V, 2012, ASTROBIOLOGY, V12, P641, DOI 10.1089/ast.2011.0675; Spring S, 2016, ISME J, V10, P2801, DOI 10.1038/ismej.2016.84; Stivaletta N, 2011, GEOMICROBIOL J, V28, P83, DOI 10.1080/01490451003653102; Takai K, 1999, GENETICS, V152, P1285; TAKAMI H, 2012, PLOONE PUBLIC LIB, V7, DOI DOI 10.1371/JOURNAL.PONE.0062901; Takashima C., 2005, J GEOL SOC JAPAN, V111, P751, DOI DOI 10.1128/AEM.01811-08; Takashima C, 2008, SEDIMENT GEOL, V208, P114, DOI 10.1016/j.sedgeo.2008.06.001; Ter Braak CJF, 2002, ENV MICROBIOL; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Teske A, 1998, APPL ENVIRON MICROB, V64, P2943; TONEATTI DM, 2017, FRONT MICROBIOL, V8, P17060, DOI DOI 10.3389/FMICB.2017.00646; VANGEMERDEN H, 1993, MAR GEOL, V113, P3, DOI 10.1016/0025-3227(93)90146-M; Vasconcelos C, 2006, SEDIMENT GEOL, V185, P175, DOI 10.1016/j.sedgeo.2005.12.022; Vick TJ, 2010, GEOBIOLOGY, V8, P140, DOI 10.1111/j.1472-4669.2009.00228.x; Visscher PT, 1998, AM MINERAL, V83, P1482, DOI 10.2138/am-1998-11-1236; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016; VISSCHER PT, 1992, FEMS MICROBIOL ECOL, V86, P283, DOI 10.1016/0378-1097(92)90792-M; VISSCHER PT, 1991, LIMNOL OCEANOGR, V36, P1476, DOI 10.4319/lo.1991.36.7.1476; VISSCHER PT, 2010, CELLULAR ORIGIN LIFE, V14, P443, DOI DOI 10.1128/AEM.01812-08; WALTER MR, 1972, SCIENCE, V178, P402, DOI 10.1126/science.178.4059.402; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WANG S, 2013, PLOS ONE, V8, P17060, DOI DOI 10.1128/AEM.72.5.3685-3695.2006; WHITMAN WB, 2015, BERGEYS MANUAL SYSTE, P17060, DOI DOI 10.1093/BIOINFORMATICS/BTQ461; Wong H, 2017, NAT SCI REPORTS	103	30	31	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186867	10.1371/journal.pone.0186867	http://dx.doi.org/10.1371/journal.pone.0186867			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140980	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400012
J	Yamako, G; Chosa, E; Totoribe, K; Fukao, Y; Deng, G				Yamako, Go; Chosa, Etsuo; Totoribe, Koji; Fukao, Yuu; Deng, Gang			Quantification of the sit-to-stand movement for monitoring age-related motor deterioration using the Nintendo Wii Balance Board	PLOS ONE			English	Article							PRESSURE MEASURES; MUSCLE STRENGTH; ELDERLY PERSONS; FORCE PLATFORM; RISK-FACTORS; CHAIR-RISE; BIOMECHANICS; STRATEGIES; MOBILITY; WOMEN	Simple methods for quantitative evaluations of individual motor performance are crucial for the early detection of motor deterioration. Sit-to-stand movement from a chair is a mechanically demanding component of activities of daily living. Here, we developed a novel method using the ground reaction force and center of pressure measured from the Nintendo Wii Balance Board to quantify sit-to-stand movement (sit-to-stand score) and investigated the agerelated change in the sit-to-stand score as a method to evaluate reduction in motor performance. The study enrolled 503 participants (mean age +/- standard deviation, 51.0 +/- 19.7 years; range, 20 +/- 88 years; male/female ratio, 226/277) without any known musculoskeletal conditions that limit sit-to-stand movement, which were divided into seven 10-year age groups. The participants were instructed to stand up as quickly as possible, and the sit-tostand score was calculated as the combination of the speed and balance indices, which have a tradeoff relationship. We also performed the timed up and go test, a well-known clinical test used to evaluate an individual's mobility. There were significant differences in the sit-to-stand score and timed up and go time among age groups. The mean sit-to-stand score for 60s, 70s, and 80s were 77%, 68%, and 53% of that for the 20s, respectively. The timed up and go test confirmed the age-related decrease in mobility of the participants. In addition, the sit-to-stand score measured using the Wii Balance Board was compared with that from a laboratory-graded force plate using the Bland-Altman plot (bias = -3.1 [ms](-1), 95% limit of agreement: -11.0 to 3.9 [ms](-1)). The sit-to-stand score has good inter-device reliability (intraclass correlation coefficient = 0.87). Furthermore, the test-retest reliability is substantial (intraclass correlation coefficient = 0.64). Thus, the proposed STS score will be useful to detect the early deterioration of motor performance.	[Yamako, Go] Univ Miyazaki, Org Promot Tenure Track, Miyazaki, Japan; [Chosa, Etsuo; Totoribe, Koji; Fukao, Yuu] Univ Miyazaki, Div Orthoped Surg, Dept Med Sensory & Motor Organs, Fac Med, Miyazaki, Japan; [Deng, Gang] Univ Miyazaki, Dept Mech Design Syst, Fac Engn, Miyazaki, Japan	University of Miyazaki; University of Miyazaki; University of Miyazaki	Yamako, G (corresponding author), Univ Miyazaki, Org Promot Tenure Track, Miyazaki, Japan.	g.yamako@cc.miyazaki-u.ac.jp		Yamako, Go/0000-0001-9270-0212	Japan Science and Technology Agency [MP27115658746]; LEXI Co., Ltd.; Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [17K01362] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); LEXI Co., Ltd.; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Science and Technology Agency (MP27115658746, URL: http://www.jst.go.jp/EN/index.html), by LEXI Co., Ltd., URL: https://www.lexi.co.jp/en/), and by the Program to Disseminate Tenure Tracking from the Ministry of Education, Culture, Sports, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujaber S, 2015, GAIT POSTURE, V41, P676, DOI 10.1016/j.gaitpost.2015.01.023; Abujaber SB, 2015, J ARTHROPLASTY, V30, P2027, DOI 10.1016/j.arth.2015.05.024; Bartlett HL, 2014, GAIT POSTURE, V39, P224, DOI 10.1016/j.gaitpost.2013.07.010; Bishop M, 2005, CLIN BIOMECH, V20, P112, DOI 10.1016/j.clinbiomech.2004.08.002; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen HB, 2010, GAIT POSTURE, V32, P576, DOI 10.1016/j.gaitpost.2010.08.005; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; CLEMENT FJ, 1974, J GERONTOL, V29, P423, DOI 10.1093/geronj/29.4.423; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; DOHERTY TJ, 1993, CAN J APPL PHYSIOL, V18, P331, DOI 10.1139/h93-029; Frontera WR, 1985, J APPL PHYSIOL, V1991, P644; Goble DJ, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-12; Granacher U, 2011, GERONTOLOGY, V57, P304, DOI 10.1159/000320250; Gross MM, 1998, GAIT POSTURE, V8, P175, DOI 10.1016/S0966-6362(98)00033-2; Hsu WL, 2013, AGE, V35, P1299, DOI 10.1007/s11357-012-9422-x; HUGHES MA, 1994, CLIN BIOMECH, V9, P187, DOI 10.1016/0268-0033(94)90020-5; Huurnink A, 2013, J BIOMECH, V46, P1392, DOI 10.1016/j.jbiomech.2013.02.018; Janssen WGM, 2002, PHYS THER, V82, P866, DOI 10.1093/ptj/82.9.866; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Leach JM, 2014, SENSORS-BASEL, V14, P18244, DOI 10.3390/s141018244; Lindemann U, 2003, EUR J APPL PHYSIOL, V89, P466, DOI 10.1007/s00421-003-0837-z; Mazza C, 2005, GAIT POSTURE, V21, P425, DOI 10.1016/j.gaitpost.2004.05.006; Narumi K, 2017, J ORTHOP SCI, V22, P765, DOI 10.1016/j.jos.2017.03.012; Papa E, 2000, J BIOMECH, V33, P1113, DOI 10.1016/S0021-9290(00)00046-4; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; RILEY PO, 1991, J BIOMECH, V24, P77, DOI 10.1016/0021-9290(91)90328-K; RODOSKY MW, 1989, J ORTHOPAED RES, V7, P266, DOI 10.1002/jor.1100070215; Roy G, 2007, CLIN BIOMECH, V22, P795, DOI 10.1016/j.clinbiomech.2007.03.007; Sibella F, 2003, CLIN BIOMECH, V18, P745, DOI 10.1016/S0268-0033(03)00144-X; Spyropoulos G, 2013, GAIT POSTURE, V38, P62, DOI 10.1016/j.gaitpost.2012.10.013; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Taylor ME, 2013, INT PSYCHOGERIATR, V25, P148, DOI 10.1017/S1041610212001184; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tsai YC, 2014, J BIOMECH, V47, P482, DOI 10.1016/j.jbiomech.2013.10.047; van Lummel RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157968; Yamako G, 2016, J ORTHOP SCI, V21, P517, DOI 10.1016/j.jos.2016.04.006; Young W, 2011, GAIT POSTURE, V33, P303, DOI 10.1016/j.gaitpost.2010.10.089	37	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188165	10.1371/journal.pone.0188165	http://dx.doi.org/10.1371/journal.pone.0188165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136031	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200074
J	Devetter, M; Hanel, L; Rehakova, K; Dolezal, J				Devetter, Miloslav; Hanel, Ladislav; Rehakova, Klara; Dolezal, Jiri			Diversity and feeding strategies of soil microfauna along elevation gradients in Himalayan cold deserts	PLOS ONE			English	Article							DRONNING-MAUD-LAND; COMMUNITY STRUCTURE; NITROGEN MINERALIZATION; VERTICAL-DISTRIBUTION; NEMATODE POPULATIONS; ANIMAL DIVERSITY; CLIMATE-CHANGE; BIODIVERSITY; SUCCESSION; ROTIFERS	High-elevation cold deserts in Tibet and Himalaya are one of the most extreme environments. One consequence is that the diversity of macrofauna in this environment is often limited, and soil microorganisms have a more influential role in governing key surface and subsurface bioprocesses. High-elevation soil microfauna represent important components of cold ecosystems and dominant consumers of microbial communities. Still little is known about their diversity and distribution on the edge of their reproductive and metabolic abilities. In this study, we disentangle the impact of elevation and soil chemistry on diversity and distribution of rotifers, nematodes and tardigrades and their most frequent feeding strategies (microbial filter-feeders, bacterivores, fungivores, root-fungal feeders, omnivores) along two contrasting altitudinal gradients in Indian NW Himalaya (Zanskar transect from 3805 to 4714 m a.s.l.) and southwestern Tibet (Tso Moriri transect from 4477 to 6176 m a. s. l.), using a combination of multivariate analysis, variation partitioning and generalized additive models. Zanskar transect had higher precipitation, soil moisture, organic matter and available nutrients than dry Tso Moriri transect. In total, 40 species of nematodes, 19 rotifers and 1 tardigrade were discovered. Species richness and total abundance of rotifers and nematodes showed mid-elevation peaks in both investigated transects. The optimum for rotifers was found at higher elevation than for nematodes. Diversity and distribution of soil microfauna was best explained by soil nitrogen, phosphorus and organic matter. More fertile soils hosted more diverse and abundant faunal communities. In Tso Moriri, bacterivores represented 60% of all nematodes, fungivores 35%, root-fungal feeders 1% and omnivores 3%. For Zanskar the respective proportions were 21%, 13%, 56% and 9%. Elevational optima of different feeding strategies occurred in Zanskar in one elevation zone (4400-4500 m), while in Tso Moriri each feeding strategy had their unique optima with fungivores at 5300 m (steppes), bacterivores at 5500 m (alpine grassland), filter-feeders at 5600 m and predators and omnivores above 5700 m (subnival zone). Our results shed light on the diversity of microfauna in the high-elevation cold deserts and disentangle the role of different ecological filters in structuring microfaunal communities in the rapidly-warming Himalayas.	[Devetter, Miloslav; Hanel, Ladislav] Czech Acad Sci, Biol Ctr, Inst Soil Biol, Ceske Budejovice, Czech Republic; [Devetter, Miloslav] Univ South Bohemia, Ctr Polar Ecol, Fac Sci, Ceske Budejovice, Czech Republic; [Rehakova, Klara; Dolezal, Jiri] Czech Acad Sci, Inst Bot, Sect Plant Ecol, Trebon, Czech Republic; [Rehakova, Klara] Czech Acad Sci, Biol Ctr, Inst Hydrobiol, Ceske Budejovice, Czech Republic; [Dolezal, Jiri] Univ South Bohemia, Dept Bot, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Devetter, M (corresponding author), Czech Acad Sci, Biol Ctr, Inst Soil Biol, Ceske Budejovice, Czech Republic.; Devetter, M (corresponding author), Univ South Bohemia, Ctr Polar Ecol, Fac Sci, Ceske Budejovice, Czech Republic.	devetter@upb.cas.cz	Rehakova, Klara/B-2143-2012; Háněl, Ladislav/G-2732-2014; Devetter, Miloslav/AAE-1676-2021	Devetter, Miloslav/0000-0003-1767-4266; Rehakova, Klara/0000-0002-8871-9989; Dolezal, Jiri/0000-0002-5829-4051	Czech Science Foundation: Grant Agency of The Czech Republic [13-13368S]; Grant Agency of The Czech Republic [17-19376S]; Ministry of Education Youth and Sports [LTC17019]; Czech Science Foundation [17-19376S, GACR 13-13368S]	Czech Science Foundation: Grant Agency of The Czech Republic(Grant Agency of the Czech Republic); Grant Agency of The Czech Republic(Grant Agency of the Czech Republic); Ministry of Education Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This project was supported by Czech Science Foundation: Grant Agency of The Czech Republic, https://gacr.cz/, 13-13368S, data collection, Grant Agency of The Czech Republic, https://gacr.cz/, 17-19376S, data analysis, and Ministry of Education Youth and Sports, http://www.msmt.cz/, LTC17019, preparation of the manuscript, data analysis.	Andrassy I., 2005, FREE LIVING NEMATODE, VI; Andrassy I, 2007, FREE LIVING NEMATODE, VII; Andrassy I., 2009, FREE LIVING NEMATODE; Ayres E, 2010, POLAR BIOL, V33, P897, DOI 10.1007/s00300-010-0766-3; Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Bhutiyani MR, 2007, CLIMATIC CHANGE, V85, P159, DOI 10.1007/S10584-006-9196-1; Boag B, 1998, BIODIVERS CONSERV, V7, P617, DOI 10.1023/A:1008852301349; Bongers T, 1999, PLANT SOIL, V212, P13, DOI 10.1023/A:1004571900425; Cole L, 2008, SOIL BIOL BIOCHEM, V40, P505, DOI 10.1016/j.soilbio.2007.09.018; Coulson SJ, 2003, POLAR BIOL, V26, P530, DOI 10.1007/s00300-003-0516-x; Crawford C.S., 1981, BIOL DESERT INVERTEB; Darby BJ, 2011, SOIL BIOL BIOCHEM, V43, P1474, DOI 10.1016/j.soilbio.2011.03.020; Degens BP, 2001, SOIL BIOL BIOCHEM, V33, P1143, DOI 10.1016/S0038-0717(01)00018-9; Devetter M, 2014, SOIL BIOL BIOCHEM, V69, P393, DOI 10.1016/j.soilbio.2013.11.005; Devetter M, 2011, INT REV HYDROBIOL, V96, P164, DOI 10.1002/iroh.201011251; Devetter M, 2010, PEDOBIOLOGIA, V53, P115, DOI 10.1016/j.pedobi.2009.07.001; DONNER J, 1965, ORDNUNG BDELLOIDEA; Dvorsky M, 2011, APPL VEG SCI, V14, P132, DOI 10.1111/j.1654-109X.2010.01103.x; Dvorsky M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053514; Ettema CH, 1999, SOIL BIOL BIOCHEM, V31, P1625, DOI 10.1016/S0038-0717(99)00072-3; Ferris H, 2004, APPL SOIL ECOL, V25, P19, DOI 10.1016/j.apsoil.2003.07.001; Geraert E., 2008, TYLENCHIDAE WORLD ID; Hanel L, 2003, APPL SOIL ECOL, V22, P255, DOI 10.1016/S0929-1393(02)00152-X; Hanel L, 2003, BIOLOGIA, V58, P205; Hanel L, 2001, APPL SOIL ECOL, V16, P23, DOI 10.1016/S0929-1393(00)00101-3; Hanel L, 2014, SOIL BIOTA ECOSYSTEM; Hanel L, 2010, APPL SOIL ECOL, V46, P355, DOI 10.1016/j.apsoil.2010.10.005; Harris N, 2006, PALAEOGEOGR PALAEOCL, V241, P4, DOI 10.1016/j.palaeo.2006.07.009; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hooper DU, 2000, BIOSCIENCE, V50, P1049, DOI 10.1641/0006-3568(2000)050[1049:IBAABB]2.0.CO;2; Hoschitz M, 2004, NEMATOLOGY, V6, P737, DOI 10.1163/1568541042843531; Hoschitz M, 2004, PEDOBIOLOGIA, V48, P313, DOI 10.1016/j.pedobi.2004.03.004; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Housman DC, 2007, SOIL BIOL BIOCHEM, V39, P2138, DOI 10.1016/j.soilbio.2007.03.015; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; INGHAM RE, 1985, ECOL MONOGR, V55, P119, DOI 10.2307/1942528; Janatkova K, 2013, ENVIRON MICROBIOL, V15, P2505, DOI 10.1111/1462-2920.12132; Killham K., 1994, SOIL ECOLOGY, V4th ed.; Klimes L, 2010, ECOGRAPHY, V33, P590, DOI 10.1111/j.1600-0587.2009.05967.x; Lavelle P., 2001, SOIL ECOLOGY; LOOF P A A, 1971, Mededelingen Landbouwhogeschool Wageningen, V71, P1; Maraun M, 2003, EUR J SOIL BIOL, V39, P85, DOI 10.1016/S1164-5563(03)00006-2; McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, P1, DOI DOI 10.1007/978-1-4899-3242-6; Miehe G, 2011, QUATERNARY RES, V76, P243, DOI 10.1016/j.yqres.2011.06.002; Neher DA, 2012, APPL SOIL ECOL, V54, P14, DOI 10.1016/j.apsoil.2011.12.001; Nielsen UN, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00325.1; Nielsen UN, 2011, POLAR BIOL, V34, P1701, DOI 10.1007/s00300-011-1021-2; Nkem JN, 2006, POLAR BIOL, V29, P346, DOI 10.1007/s00300-005-0061-x; Ou W, 2005, PEDOBIOLOGIA, V49, P139, DOI 10.1016/j.pedobi.2004.10.001; Pen-Mouratov S, 2010, PEDOSPHERE, V20, P273, DOI 10.1016/S1002-0160(10)60015-X; Petz W, 1997, POLAR BIOL, V18, P33, DOI 10.1007/s003000050156; Powers Laura E., 1994, Antarctic Journal of the United States, V29, P228; Rehakova K, 2011, MICROB ECOL, V62, P337, DOI 10.1007/s00248-011-9878-8; RICCI CN, 1987, HYDROBIOLOGIA, V147, P117, DOI 10.1007/BF00025734; Ruess L, 1999, NEMATOLOGY, V1, P513, DOI 10.1163/156854199508513; Sadaka N, 2003, EUR J SOIL BIOL, V39, P197, DOI 10.1016/j.ejsobi.2003.06.001; Sanchez-Moreno S, 2007, AGR ECOSYST ENVIRON, V119, P75, DOI 10.1016/j.agee.2006.06.012; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Schlaghamersky J, 2014, APPL SOIL ECOL, V83, P30, DOI 10.1016/j.apsoil.2013.11.014; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Simmons BL, 2009, SOIL BIOL BIOCHEM, V41, P2052, DOI 10.1016/j.soilbio.2009.07.009; Sohlenius B, 2008, POLAR BIOL, V31, P817, DOI 10.1007/s00300-008-0420-5; SOHLENIUS B, 1979, Holarctic Ecology, V2, P30; Sohlenius B, 1996, POLAR BIOL, V16, P191, DOI 10.1007/BF02329207; SOHLENIUS B, 1995, POLAR BIOL, V15, P51, DOI 10.1007/BF00236124; Sohlenius B, 1999, APPL SOIL ECOL, V12, P113, DOI 10.1016/S0929-1393(98)00168-1; Stanton N. L., 1982, Reclamation and Revegetation Research, V1, P233; Sylvain ZA, 2011, AM J BOT, V98, P517, DOI 10.3732/ajb.1000305; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Tong Fu-chun, 2010, Journal of Forestry Research (Harbin), V21, P93, DOI 10.1007/s11676-010-0016-0; Treonis AM, 1999, ECOSYSTEMS, V2, P482, DOI 10.1007/s100219900096; VDLUFA (Association of German Agricultural Analytic and Research Institutes), 1991, METH BOOK I SOIL AN; Velasco-Castrillon A, 2014, POLAR BIOL, V37, P1517, DOI 10.1007/s00300-014-1544-4; Velasco-Castrillon A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087529; Verschoor BC, 2001, PEDOBIOLOGIA, V45, P213, DOI 10.1078/0031-4056-00081; Walker MD, 1999, HYDROL PROCESS, V13, P2315, DOI 10.1002/(SICI)1099-1085(199910)13:14/15&lt;2315::AID-HYP888&gt;3.0.CO;2-A; Wall DH, 2007, PHILOS T R SOC B, V362, P2291, DOI 10.1098/rstb.2006.1950; Wardle DA, 2004, FRONT ECOL ENVIRON, V2, P145, DOI 10.1890/1540-9295(2004)002[0145:HCILHM]2.0.CO;2; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wharton DA, 2002, ORGANISMS EXTREME EN; Wolters V, 2001, EUR J SOIL BIOL, V37, P221, DOI 10.1016/S1164-5563(01)01088-3; YEATES GW, 1993, J NEMATOL, V25, P315; Yeates GW, 1997, PEDOBIOLOGIA, V41, P549; Zhang XK, 2015, SOIL BIOL BIOCHEM, V80, P118, DOI 10.1016/j.soilbio.2014.10.003	85	15	16	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187646	10.1371/journal.pone.0187646	http://dx.doi.org/10.1371/journal.pone.0187646			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131839	gold, Green Submitted, Green Published			2022-12-26	WOS:000414997800019
J	Lin, YL; Zou, WK; Lin, SQ; Onofua, DN; Yang, ZJ; Chen, HZ; Wang, SL; Chen, XY				Lin, Yuli; Zou, Weikun; Lin, Shiqiang; Onofua, Dennis; Yang, Zhijian; Chen, Haizhou; Wang, Songliang; Chen, Xuanyang			Transcriptome profiling and digital gene expression analysis of sweet potato for the identification of putative genes involved in the defense response against Fusarium oxysporum f. sp batatas	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEIN; ANTHOCYANIN ACCUMULATION; HETEROLOGOUS EXPRESSION; SALICYLIC-ACID; RESISTANCE; GENERATION; JASMONATE; PATHWAYS; DISEASE; IBMYB1A	Sweet potato production is constrained by Fusarium wilt, which is caused by Fusarium oxysporum f. sp. batatas (Fob). The identification of genes related to disease resistance and the underlying mechanisms will contribute to improving disease resistance via sweet potato breeding programs. In the present study, we performed de novo transcriptome assembly and digital gene expression (DGE) profiling of sweet potato challenged with Fob using Illumina HiSeq technology. In total, 89,944,188 clean reads were generated from 12 samples and assembled into 101,988 unigenes with an average length of 666 bp; of these unigenes, 62,605 (61.38%) were functionally annotated in the NCBI non-redundant protein database by BLASTX with a cutoff E-value of 10(-5). Clusters of Orthologous Groups (COG), Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations were examined to explore the unigenes' functions. We constructed four DGE libraries for the sweet potato cultivars JinShan57 (JS57, highly resistant) and XinZhongHua (XZH, highly susceptible), which were challenged with pathogenic Fob. Genes that were differentially expressed in the four libraries were identified by comparing the transcriptomes. Various genes that were differentially expressed during defense, including chitin elicitor receptor kinase 1 (CERK), mitogen-activated protein kinase (MAPK), WRKY, NAC, MYB, and ethylene-responsive transcription factor (ERF), as well as resistance genes, pathogenesisrelated genes, and genes involved in salicylic acid (SA) and jasmonic acid (JA) signaling pathways, were identified. These data represent a sequence resource for genetic and genomic studies of sweet potato that will enhance the understanding of the mechanism of disease resistance.	[Lin, Yuli; Lin, Shiqiang; Yang, Zhijian; Chen, Xuanyang] Fujian Prov Univ, Fujian Agr & Forestry Univ, Key Lab Crop Biotechnol, Fuzhou, Fujian, Peoples R China; [Lin, Yuli; Chen, Xuanyang] Minist Educ, Key Lab Genet Breeding & Multiple Applicat Crops, Fuzhou, Fujian, Peoples R China; [Lin, Yuli; Zou, Weikun; Onofua, Dennis; Yang, Zhijian; Chen, Haizhou; Wang, Songliang; Chen, Xuanyang] Fujian Agr & Forestry Univ, Dept Agron, Coll Crop Sci, Fuzhou, Fujian, Peoples R China; [Lin, Shiqiang] Fujian Agr & Forestry Univ, Coll Life Sci, Dept Bioinformat, Fuzhou, Fujian, Peoples R China; [Chen, Xuanyang] Fujian Prov Key Lab Crop Breeding Design, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fuzhou University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Chen, XY (corresponding author), Fujian Prov Univ, Fujian Agr & Forestry Univ, Key Lab Crop Biotechnol, Fuzhou, Fujian, Peoples R China.; Chen, XY (corresponding author), Minist Educ, Key Lab Genet Breeding & Multiple Applicat Crops, Fuzhou, Fujian, Peoples R China.; Chen, XY (corresponding author), Fujian Agr & Forestry Univ, Dept Agron, Coll Crop Sci, Fuzhou, Fujian, Peoples R China.; Chen, XY (corresponding author), Fujian Prov Key Lab Crop Breeding Design, Fuzhou, Fujian, Peoples R China.	cxy@fafu.edu.cn		Lin, Shiqiang/0000-0001-7181-4261	Education Department of Fujian Province (CN) [JA14101]; Fujian Provincial Department of Science & Technology (CN) [2017NZ0002-2]	Education Department of Fujian Province (CN); Fujian Provincial Department of Science & Technology (CN)	This work was financially sponsored by grants from The Education Department of Fujian Province (CN) (JA14101) and the Fujian Provincial Department of Science & Technology (CN) (2017NZ0002-2).	Abbruscato P, 2012, MOL PLANT PATHOL, V13, P828, DOI 10.1111/j.1364-3703.2012.00795.x; Afuape S. O., 2014, American Journal of Experimental Agriculture, V4, P114; An CH, 2015, PLANT PHYSIOL BIOCH, V89, P1, DOI 10.1016/j.plaphy.2015.02.002; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Guevara-Morato M, 2010, J EXP BOT, V61, P3259, DOI 10.1093/jxb/erq148; Bakshi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27700; Boachon B, 2014, EUR J PLANT PATHOL, V139, P707, DOI 10.1007/s10658-014-0424-7; Brunner F, 1998, PLANT J, V14, P225, DOI 10.1046/j.1365-313X.1998.00116.x; Cheng YJ, 2013, J MICROBIOL BIOTECHN, V23, P1737, DOI 10.4014/jmb.1307.07024; Choi C, 2016, PLANT BIOTECHNOL REP, V10, P301, DOI 10.1007/s11816-016-0406-7; Choi C, 2015, NEW PHYTOL, V208, P846, DOI 10.1111/nph.13516; Chu H, 2013, PHYSIOL PLANTARUM, V148, P189, DOI 10.1111/j.1399-3054.2012.01706.x; Clark CA, 1998, PLANT DIS, V82, P530, DOI 10.1094/PDIS.1998.82.5.530; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Fang S, 2001, J PLANT GENETIC RESO, V2, P37; Fang ShuMin, 1997, Journal of Fujian Agricultural University, V26, P446; FAOSTAT, 2014, FOOD AGR ORG UN CROP; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; Foroud NA, 2012, PLANT PATHOL, V61, P296, DOI 10.1111/j.1365-3059.2011.02512.x; Fravel D, 2003, NEW PHYTOL, V157, P10; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Gallou A, 2012, FUNCT INTEGR GENOMIC, V12, P183, DOI 10.1007/s10142-011-0241-4; Gao R, 2016, SCI REPORTS, P6; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Huang Q, 2015, BMC PLANT BIOL, V15, P1, DOI DOI 10.1145/2835185.2835189; Imam J, 2014, EUPHYTICA, V196, P199, DOI 10.1007/s10681-013-1024-x; Jimmy JL, 2015, TROP PLANT PATHOL, V40, P355, DOI 10.1007/s40858-015-0058-0; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lei J, 2011, HUBEI AGR SCI, V50, P4775; Lemarie A S, 2015, PLANT CELL PHYSL, V56; Li CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-245; LI R, 2015, INT J DISTRIB SENS N, V2015, P1, DOI DOI 10.1155/2015/843802; Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006; Lu SW, 2014, MOL PLANT PATHOL, V15, P650, DOI 10.1111/mpp.12122; Muencha S, 2008, J PLANT PHYSIOL, V165, P41, DOI 10.1016/j.jplph.2007.06.008; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Pandey D, 2016, J PLANT GROWTH REGUL, V35, P1159, DOI 10.1007/s00344-016-9600-7; Park SU, 2012, J HYDROL ENG, V17, P10, DOI 10.1061/(ASCE)HE.1943-5584.0000412; Park SH, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1111/PPL.12281; Pei Y, 2014, J TROPICAL BIOL, V5, P92; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pritesh Parmar, 2013, African Journal of Biotechnology, V12, P6076; Saucet SB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7338; Schafleitner R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-604; Singh R., 2014, INT J ADV RES, V2, P210; Son GH, 2012, MOL PLANT MICROBE IN, V25, P48, DOI 10.1094/MPMI-06-11-0165; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Stahl EA, 2000, CURR OPIN PLANT BIOL, V3, P299, DOI 10.1016/S1369-5266(00)00083-2; Takken F, 2010, MOL PLANT PATHOL, V11, P309, DOI 10.1111/j.1364-3703.2009.00605.x; Tamaoki D, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24260; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Thatcher LF, 2012, MOL PLANT MICROBE IN, V25, P180, DOI 10.1094/MPMI-08-11-0212; Thirugnanasambantham K., 2015, PLANT MOL BIOL REP, V33, P1, DOI [10.1007/s11105-014-0799-9, DOI 10.1007/S11105-014-0799-9]; Tong CF, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-148; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang Z, 2015, IEEE ST CONF RES DEV, P1, DOI 10.1109/SCORED.2015.7449302; Wang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-650; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Xing DH, 2008, MOL PLANT, V1, P459, DOI 10.1093/mp/ssn020; Xu RR, 2006, MOL BIOL REP, V33, P223, DOI 10.1007/s11033-005-4823-x; Yang YX, 2015, CURR PROTEIN PEPT SC, V16, P450, DOI 10.2174/1389203716666150330141638; [殷晓敏 Yin Xiaomin], 2011, [植物病理学报, Acta Phytopathologica Sinica], V41, P570	69	12	19	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187838	10.1371/journal.pone.0187838	http://dx.doi.org/10.1371/journal.pone.0187838			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131830	Green Published, Green Submitted, gold			2022-12-26	WOS:000414997800026
J	Rozek, JC; Camp, RJ; Reed, JM				Rozek, Jessica C.; Camp, Richard J.; Reed, J. Michael			No evidence of critical slowing down in two endangered Hawaiian honeycreepers	PLOS ONE			English	Article							EARLY WARNING SIGNALS; MISLEADING TREND ANALYSIS; NATIONAL WILDLIFE REFUGE; FOREST BIRDS; POPULATION COLLAPSE; GENERIC INDICATORS; ECOLOGICAL-SYSTEMS; TIPPING POINT; REGIME SHIFT; L-MOMENT	There is debate about the current population trends and predicted short-term fates of the endangered forest birds, Hawai'i Creeper (Loxops mana) and Hawai'i 'Akepa (L. coccineus). Using long-term population size estimates, some studies report forest bird populations as stable or increasing, while other studies report signs of population decline or impending extinction associated with introduced Japanese White-eye (Zosterops japonicus) increase. Reliable predictors of impending population collapse, well before the collapse begins, have been reported in simulations and microcosm experiments. In these studies, statistical indicators of critical slowing down, a phenomenon characterized by longer recovery rates after population size perturbation, are reported to be early warning signals of an impending regime shift observable prior to the tipping point. While the conservation applications of these metrics are commonly discussed, early warning signal detection methods are rarely applied to population size data from natural populations, so their efficacy and utility in species management remain unclear. We evaluated two time series of state-space abundance estimates (1987-2012) from Hakalau Forest National Wildlife Refuge, Hawai'i to test for evidence of early warning signals of impending population collapse for the Hawai'i Creeper and Hawai'i 'Akepa. We looked for signals throughout the time series, and prior to 2000, when white-eye abundance began increasing. We found no evidence for either species of increasing variance, autocorrelation, or skewness, which are commonly reported early warning signals. We calculated linear rather than ordinary skewness because the latter is biased, particularly for small sample sizes. Furthermore, we identified break-points in trends over time for both endangered species, indicating shifts in slopes away from strongly increasing trends, but they were only weakly supported by Bayesian change-point analyses (i.e., no step-wise changes in abundance). The break-point and change-point test results, in addition to the early warning signal analyses, support that the two populations do not appear to show signs of critical slowing down or decline.	[Rozek, Jessica C.; Reed, J. Michael] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Camp, Richard J.] Univ Hawaii, Hawaii Cooperat Studies Unit, Hawaii Natl Pk, Hilo, HI 96720 USA; [Camp, Richard J.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Hawaii Natl Pk, Volcano, HI USA	Tufts University; University of Hawaii System; United States Department of the Interior; United States Geological Survey	Rozek, JC (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	jessica.rozek@tufts.edu		Canizares, Jessica R./0000-0002-8099-8557	Tufts University Water Diplomacy IGERT (National Science Foundation) [0966093]; USGS - Pacific Island Ecosystems Research Center; Hawai'i Cooperative Studies Unit, University of Hawai'i at Hilo; Tufts University Water Diplomacy IGERT [NSF 0966093]; USGS-Pacific Island Ecosystems Research Center	Tufts University Water Diplomacy IGERT (National Science Foundation); USGS - Pacific Island Ecosystems Research Center; Hawai'i Cooperative Studies Unit, University of Hawai'i at Hilo; Tufts University Water Diplomacy IGERT; USGS-Pacific Island Ecosystems Research Center	This research was supported by the Tufts University Water Diplomacy IGERT (National Science Foundation 0966093), USGS - Pacific Island Ecosystems Research Center, and Hawai'i Cooperative Studies Unit, University of Hawai'i at Hilo.	Aagaard K, 2016, ECOL MODEL, V328, P78, DOI 10.1016/j.ecolmodel.2016.02.014; [Anonymous], 2021, LANG ENV STAT COMP; Atkinson CT, 2014, GLOBAL CHANGE BIOL, V20, P2426, DOI 10.1111/gcb.12535; Atkinson Carter T., 2009, P234; Atkinson CT, 2009, J AVIAN MED SURG, V23, P53, DOI 10.1647/2008-059.1; Banko Winston E., 2009, P25; Bertrand JAM, 2014, HEREDITY, V112, P190, DOI 10.1038/hdy.2013.91; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Boerlijst MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062033; Boettiger C, 2013, THEOR ECOL-NETH, V6, P255, DOI 10.1007/s12080-013-0192-6; Boettiger C, 2012, J R SOC INTERFACE, V9, P2527, DOI 10.1098/rsif.2012.0125; Borchers HW, 2016, PRACMA PRACTICAL NUM; Camp RJ, 2016, BIRD CONSERV INT, V26, P225, DOI 10.1017/S0959270915000088; Camp RJ, 2014, CONDOR, V116, P97, DOI 10.1650/CONDOR-13-089.1; Camp RJ, 2010, CONDOR, V112, P196, DOI 10.1525/cond.2010.080113; Clements CF, 2015, AM NAT, V186, P50, DOI 10.1086/681573; Courchamp F., 2008, ALLEE EFFECTS ECOLOG, DOI DOI 10.1017/S0376892909005384; Dai L, 2015, P NATL ACAD SCI USA, V112, P10056, DOI 10.1073/pnas.1418415112; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Dakos V, 2012, ECOLOGY, V93, P264, DOI 10.1890/11-0889.1; Ditlevsen PD, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044486; Douglas Pratt H., 2005, HAWAIIAN HONEYCREEPE; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Elphick CS, 2010, BIOL CONSERV, V143, P617, DOI 10.1016/j.biocon.2009.11.026; Fleischer RC, 2001, STUD AVIAN BIOL-SER, P51; Foley MM, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00095; Fortini LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140389; Foster Jeffrey T., 2009, P312; Freed LA, 2008, J PARASITOL, V94, P1009, DOI 10.1645/GE-1378.1; Freed LA, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00289.1; Freed LA, 2013, CONDOR, V115, P442, DOI 10.1525/cond.2013.110165; Freed LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029834; Freed LA, 2010, CONDOR, V112, P213, DOI 10.1525/cond.2010.090092; Freed LA, 2008, EVOL ECOL RES, V10, P931; Gandhi A, 1998, J THEOR BIOL, V192, P363, DOI 10.1006/jtbi.1998.0660; Gorresen P. Marcos, 2009, P108; Guillaumet A, 2016, J AVIAN BIOL, V47, P185, DOI 10.1111/jav.00756; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Hefley TJ, 2013, THEOR ECOL-NETH, V6, P319, DOI 10.1007/s12080-013-0195-3; Hess Steven C., 2010, Pacific Conservation Biology, V16, P144; Hosking J.R.M., 1997, REGIONAL FREQUENCY A, DOI DOI 10.1017/CBO9780511529443; HOSKING JRM, 1992, AM STAT, V46, P186, DOI 10.2307/2685210; HOSKING JRM, 1990, J ROY STAT SOC B MET, V52, P105; Kingsford RT, 2010, CONDOR, V112, P193, DOI 10.1525/cond.2010.100080; Krkosek M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3221; Leopold CR, 2016, HCSU075; Lepson JK, 2002, BIRDS N AM; Lindegren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038410; Lindsey Gerald D., 2009, P274; Litzow MA, 2013, ECOL APPL, V23, P1475, DOI 10.1890/12-0670.1; Mila A B, 2010, BMC EVOL BIOL, V10, P1; Otero LM, 2015, AM NAT, V186, pE72, DOI 10.1086/682359; Perretti CT, 2012, ECOL APPL, V22, P1772, DOI 10.1890/11-0161.1; Petraitis PS, 2016, MAR FRESHWATER RES, V67, P37, DOI 10.1071/MF14229; Pinheiro J, R PACKAGE VERSION; Pratt T.K., 2009, CONSERVATION BIOL HA; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reed JM, 2012, BIOSCIENCE, V62, P881, DOI 10.1525/bio.2012.62.10.8; Regnier C, 2015, CONSERV BIOL, V29, P1715, DOI 10.1111/cobi.12565; Roderick GK, 1998, MOL ECOL, V7, P519, DOI 10.1046/j.1365-294x.1998.00309.x; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2015, ANNU REV ECOL EVOL S, V46, P145, DOI 10.1146/annurev-ecolsys-112414-054242; Scott JM, 1986, STUDIES AVIAN BIOL, P9; SCOTT JM, 2001, STUDIES AVIAN BIOL, V22; Seavy NE, 2009, J WILDLIFE MANAGE, V73, P414, DOI 10.2193/2007-420; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; U. S. Fish and Wildlife Service, 2003, HAW FOR BIRD REC PLA; US Fish and Wildlife Service, 2016, ENV CONS ONL SYST; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; VOGEL RM, 1993, WATER RESOUR RES, V29, P1745, DOI 10.1029/93WR00341; Vorsino AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095427; Wilmshurst JM, 2011, P NATL ACAD SCI USA, V108, P1815, DOI 10.1073/pnas.1015876108; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470; Yelenik SG., 2016, RESTORATION ECOL	76	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187518	10.1371/journal.pone.0187518	http://dx.doi.org/10.1371/journal.pone.0187518			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131835	gold, Green Published, Green Submitted			2022-12-26	WOS:000414997800016
J	Iaea, DB; Maxfield, FR				Iaea, David B.; Maxfield, Frederick R.			Membrane order in the plasma membrane and endocytic recycling compartment	PLOS ONE			English	Article							ANCHORED PROTEINS; CHOLESTEROL; UNSATURATION; TRAFFICKING; DOMAINS	The cholesterol content of membranes plays an important role in organizing membranes for signal transduction and protein trafficking as well as in modulating the biophysical properties of membranes. While the properties of model or isolated membranes have been extensively studied, there has been little evaluation of internal membranes in living cells. Here, we use a Nile Red based probe, NR12S, and ratiometric live cell imaging, to analyze the membrane order of the plasma membrane and endocytic recycling compartment. We find that after a brief incubation to allow endocytosis, NR12S is distributed between the plasma membrane and the endocytic recycling compartment. The NR12S reports that the endocytic recycling compartment is more highly ordered than the plasma membrane. We also find that the plasma membrane and the endocytic recycling compartment are differentially affected by altering cellular cholesterol levels. The membrane order of the plasma membrane, but not the endocytic recycling compartment, is altered significantly when cellular cholesterol content is increased or decreased by 20%. These results demonstrate that changes in cellular cholesterol differentially alter membrane order within different organelles.	[Iaea, David B.; Maxfield, Frederick R.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Iaea, David B.; Maxfield, Frederick R.] Rockefeller Univ, Weill Cornell Med Coll, 1230 York Ave, New York, NY 10021 USA; [Iaea, David B.; Maxfield, Frederick R.] Mem Sloan Kettering Canc Ctr, Tri Inst Chem Biol Program, 1275 York Ave, New York, NY 10021 USA; [Iaea, David B.] Genentech Inc, San Francisco, CA USA	Cornell University; Cornell University; Rockefeller University; Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech	Maxfield, FR (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA.; Maxfield, FR (corresponding author), Rockefeller Univ, Weill Cornell Med Coll, 1230 York Ave, New York, NY 10021 USA.; Maxfield, FR (corresponding author), Mem Sloan Kettering Canc Ctr, Tri Inst Chem Biol Program, 1275 York Ave, New York, NY 10021 USA.	frmaxfie@med.cornell.edu			National Institutes of Health grants [F31-DK104631, R37-DK27083]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027083, F31DK104631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123462] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants F31-DK104631 (DBI) and R37-DK27083 (FRM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health grants F31-DK104631 (DBI) and R37-DK27083 (FRM). We thank Andrey S. Klymenchko (CNRS, Strasbourg) for providing the NR12S probe and technical guidance. We would also like to thank Natalya Gertsik and Frederik Wendelboe Lund for critical reading of this manuscript.	Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Engberg O, 2016, BIOPHYS J, V111, P546, DOI 10.1016/j.bpj.2016.06.036; Hao MM, 2004, J BIOL CHEM, V279, P14171, DOI 10.1074/jbc.M309793200; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Iaea DB, 2015, ESSAYS BIOCHEM, V57, P43, DOI [10.1042/BSE0570043, 10.1042/bse0570043]; Jin L, 2005, BIOPHYS J, V89, pL4, DOI 10.1529/biophysj.105.064816; Klymchenko AS, 2014, CHEM BIOL, V21, P97, DOI 10.1016/j.chembiol.2013.11.009; Kucherak OA, 2010, J AM CHEM SOC, V132, P4907, DOI 10.1021/ja100351w; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; London E, 2016, BIOPHYS J, V111, P465, DOI 10.1016/j.bpj.2016.06.037; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; Mondal M, 2009, MOL BIOL CELL, V20, P581, DOI 10.1091/mbc.E08-07-0785; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Pipalia NH, 2017, J LIPID RES, V58, P695, DOI 10.1194/jlr.M072140; Refaei M, 2011, TRAFFIC, V12, P1012, DOI 10.1111/j.1600-0854.2011.01206.x; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5	17	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0188041	10.1371/journal.pone.0188041	http://dx.doi.org/10.1371/journal.pone.0188041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125865	Green Submitted, gold, Green Published			2022-12-26	WOS:000414866000039
J	Liu, KT; Zheng, DW; Xu, GD; Du, ZN; Wu, SB				Liu, Kaitai; Zheng, Dawei; Xu, GuoDong; Du, Zhennan; Wu, Shibo			Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis	PLOS ONE			English	Article							1ST-LINE SYSTEMIC THERAPY; SURGICAL-TREATMENT; RADIATION-THERAPY; RADIOTHERAPY; MULTICENTER; PHASE-2; TRIAL; RTOG; RET	Patients with stage IV non-small cell lung cancer (NSCLC) comprise a heterogeneous group, and the optimal treatment for this group of patients is complex and debatable. We aimed to assess the effect of local thoracic therapy combined with chemotherapy on cancer specific survival (CSS). To evaluate the CSS of four subgroups of patients with stage IV NSCLC according to four different treatment modalities: combined modality of Chemotherapy, Surgery, and Radiation (Chem+Sur+RT), Chemotherapy and Radiation (Chem+RT), Chemotherapy and Surgery (Chem+Sur), and Chemotherapy only (Chem Only) by analyzing the Surveillance, Epidemiology, and End Results (SEER)-registered database. Kaplan-Meier methods were adopted and multivariable Cox regression models were built for the analysis of survival outcomes and risk factors. The 3-year CSS was 33.5% in "Chem+Sur +RT" group, 9.3% in "Chem+RT" group, 42.7% in "Chem+Sur" group and 11.8% in Chem Only" group, which had significant difference in univariate log-rank test (P<0.001) and multivariate Cox regression (P<0.001). Moreover, we observed significant survival benefits in "Chem+Sur" group in all stage of T/N categories, including stage I, stage II, stage IIIa and stage IIIb (all P<0.001). Multimodality therapy, especially combined thoracic surgery and chemotherapy is associated with dramatically improved prognosis for patients with stage IV NSCLC.	[Liu, Kaitai] Ningbo Med Ctr, Lihuili Hosp, Dept Radiat Oncol, Ningbo, Zhejiang, Peoples R China; [Zheng, Dawei; Xu, GuoDong] Ningbo Med Ctr, Lihuili Hosp, Dept Thorac Surg, Ningbo, Zhejiang, Peoples R China; [Du, Zhennan] Ningbo Med Ctr, Lihuili Hosp, Dept Resp Med, Ningbo, Zhejiang, Peoples R China; [Wu, Shibo] Second Hosp Yinzhou, Dept Resp Med, Ningbo, Peoples R China		Wu, SB (corresponding author), Second Hosp Yinzhou, Dept Resp Med, Ningbo, Peoples R China.	woshibo2015@yeah.net	liu, kt/AFU-9413-2022					Albain KS, 2009, LANCET, V374, P379, DOI 10.1016/S0140-6736(09)60737-6; Ashworth AB, 2014, CLIN LUNG CANCER, V15, P346, DOI 10.1016/j.cllc.2014.04.003; Ben Abdallah FC, 2014, REV MAL RESPIR, V31, P214, DOI 10.1016/j.rmr.2013.09.002; Ben Amar Jihen, 2016, Tunis Med, V94, P360; Billing PS, 2001, J THORAC CARDIOV SUR, V122, P548, DOI 10.1067/mtc.2001.116201; Cheruvu P, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-80; Curran WJ, 2011, J NATL CANCER I, V103, P1452, DOI 10.1093/jnci/djr325; Delaney G, 2003, LANCET ONCOL, V4, P120, DOI 10.1016/S1470-2045(03)00984-7; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; Fairchild A, 2008, J CLIN ONCOL, V26, P4001, DOI 10.1200/JCO.2007.15.3312; Ferlay J, GLOBOCAN 2012 1 0 CA; Gill R D, 1992, Math Popul Stud, V3, P259; Gomez DR, 2016, LANCET ONCOL, V17, P1672, DOI 10.1016/S1470-2045(16)30532-0; Grossi F, 2010, ONCOLOGIST, V15, P1102, DOI 10.1634/theoncologist.2010-0322; He JY, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-017-1105-8; Howlader N, 2011, SEER CANC STAT REV 1; Langendijk JA, 2000, INT J RADIAT ONCOL, V47, P149, DOI 10.1016/S0360-3016(99)00540-4; Mantel N, 1996, CANC CHEMOTHER REP, V50, P163; Mazieres J, 2015, J CLIN ONCOL, V33, P992, DOI 10.1200/JCO.2014.58.3302; National Comprehensive Cancer Network (NCCN), 2017, NCCN NON SMALL CELL; Novoa NM, 2016, J THORAC DIS, V8, pS895, DOI 10.21037/jtd.2016.08.13; Ou SHI, 2016, J CLIN ONCOL, V34, P661, DOI 10.1200/JCO.2015.63.9443; Rusthoven KE, 2009, ACTA ONCOL, V48, P578, DOI 10.1080/02841860802662722; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Sheu T, 2014, INT J RADIAT ONCOL, V90, P850, DOI 10.1016/j.ijrobp.2014.07.012; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Su SF, 2015, INT J RADIAT ONCOL, V93, P769, DOI 10.1016/j.ijrobp.2015.08.012; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Torre LA, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1_1; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Tyldesley S, 2001, INT J RADIAT ONCOL, V49, P973, DOI 10.1016/S0360-3016(00)01401-2; Yoshinaga Y, 2006, Kyobu Geka, V59, P41	32	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187350	10.1371/journal.pone.0187350	http://dx.doi.org/10.1371/journal.pone.0187350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125868	Green Submitted, gold, Green Published			2022-12-26	WOS:000414866000012
J	Pettis, JS; Rose, R; Chaimanee, V				Pettis, Jeffery S.; Rose, Robyn; Chaimanee, Veeranan			Chemical and cultural control of Tropilaelaps mercedesae mites in honeybee (Apis mellifera) colonies in Northern Thailand	PLOS ONE			English	Article							BEE; CLAREAE; CELLS	At least two parasitic mites have moved from Asian species of honeybees to infest Apis mellifera. Of these two, Varroa destructor is more widespread globally while Tropilaelaps mercedesae has remained largely in Asia. Tropilaelaps mites are most problematic when A. mellifera is managed outside its native range in contact with Asian species of Apis. In areas where this occurs, beekeepers of A. mellifera treat aggressively for Tropilaelaps and Varroa is either outcompeted or is controlled as a result of the aggressive treatment regime used against Tropilaelaps. Many mite control products used worldwide may in fact control both mites but environmental conditions differ globally and thus a control product that works well in one area may be less or ineffective in other areas. This is especially true of volatile compounds. In the current research we tested several commercial products known to control Varroa and powdered sulfur for efficacy against Tropilaelaps. Additionally, we tested the cultural control method of making a hive division to reduce Tropilaelaps growth in both the parent and offspring colony. Making a split or nucleus colony significantly reduced mite population in both the parent and nucleus colony when compared to un-manipulated control colonies. The formic acid product, Mite-Away Quick Strips (R), was the only commercial product that significantly reduced mite population 8 weeks after initiation of treatment without side effects. Sulfur also reduced mite populations but both sulfur and Hopguard (R) significantly impacted colony growth by reducing adult bee populations. Apivar (R) (amitraz) strips had no effect on mite or adult bee populations under the conditions tested.	[Pettis, Jeffery S.] ARS, Bee Res Lab, USDA, Beltsville, MD USA; [Rose, Robyn] USDA, Plant Protect & Quarantine, APHIS, Riverdale, MD USA; [Chaimanee, Veeranan] Maejo Univ, Dept Biotechnol, Phrae Campus, Rong Kwang, Phrae, Thailand; [Pettis, Jeffery S.] Univ Bern, Inst Bee Hlth, Bern, Switzerland	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Maejo University; University of Bern	Chaimanee, V (corresponding author), Maejo Univ, Dept Biotechnol, Phrae Campus, Rong Kwang, Phrae, Thailand.	chveeranan@gmail.com			USDA-APHIS; Maejo University [58-8042-5-089F]; USDA-ARS Bee Research Laboratory, Beltsville, MD, USA; Maejo University Phrae Campus, Phrae, Thailand	USDA-APHIS(United States Department of Agriculture (USDA)); Maejo University; USDA-ARS Bee Research Laboratory, Beltsville, MD, USA; Maejo University Phrae Campus, Phrae, Thailand	Primary funding was from USDA-APHIS, RR, to USDA-ARS and Maejo University under agreement number 58-8042-5-089F to JSP and VC. Additional support was provided from base funding by USDA-ARS Bee Research Laboratory, Beltsville, MD, USA, to JSP and Maejo University Phrae Campus, Phrae, Thailand, to VC. Lastly, commercial products were supplied by NOD Apiary Products and J.I. Hass Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DL, 2007, EXP APPL ACAROL, V43, P1, DOI 10.1007/s10493-007-9103-0; BURGETT M, 1983, BEE WORLD, V64, P25, DOI 10.1080/0005772X.1983.11097904; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; DELFINADO MERCEDES D., 1961, FIELDIANA ZOOL, V44, P53; Garrido C, 2003, EXP APPL ACAROL, V31, P269, DOI 10.1023/B:APPA.0000010386.10686.9f; HOPPE H, 1989, AM BEE J, V129, P739; Koeniger G, 2002, APIDOLOGIE, V33, P15, DOI 10.1051/apido:2001005; KUMAR NR, 1993, BEE WORLD, V74, P101, DOI 10.1080/0005772X.1993.11099168; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; OIE, 2004, MAN DIAGN TESTS VACC; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Pettis JS, 2004, J ECON ENTOMOL, V97, P171, DOI 10.1603/0022-0493-97.2.171; Ritter W., 2008, MANUAL DIAGNOSTIC TE, P419; Ritter W, 1988, AFR HON BEE MIT P; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Straub L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0506; Wu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024948	19	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0188063	10.1371/journal.pone.0188063	http://dx.doi.org/10.1371/journal.pone.0188063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125881	Green Submitted, Green Published, gold			2022-12-26	WOS:000414866000040
J	Kendrick, SK; Zheng, Q; Garbett, NC; Brock, GN				Kendrick, Sarah K.; Zheng, Qi; Garbett, Nichola C.; Brock, Guy N.			Application and interpretation of functional data analysis techniques to differential scanning calorimetry data from lupus patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BLOOD-PLASMA; DSC ANALYSIS; CANCER PATIENTS; SERUM; PROTEOME	Background DSC is used to determine thermally-induced conformational changes of biomolecules within a blood plasma sample. Recent research has indicated that DSC curves (or thermograms) may have different characteristics based on disease status and, thus, may be useful as a monitoring and diagnostic tool for some diseases. Since thermograms are curves measured over a range of temperature values, they are considered functional data. In this paper we apply functional data analysis techniques to analyze differential scanning calorimetry (DSC) data from individuals from the Lupus Family Registry and Repository (LFRR). The aim was to assess the effect of lupus disease status as well as additional covariates on the thermogram profiles, and use FD analysis methods to create models for classifying lupus vs. control patients on the basis of the thermogram curves. Methods Thermograms were collected for 300 lupus patients and 300 controls without lupus who were matched with diseased individuals based on sex, race, and age. First, functional regression with a functional response (DSC) and categorical predictor (disease status) was used to determine how thermogram curve structure varied according to disease status and other covariates including sex, race, and year of birth. Next, functional logistic regression with disease status as the response and functional principal component analysis (FPCA) scores as the predictors was used to model the effect of thermogram structure on disease status prediction. The prediction accuracy for patients with Osteoarthritis and Rheumatoid Arthritis but without Lupus was also calculated to determine the ability of the classifier to differentiate between Lupus and other diseases. Data were divided 1000 times into separate 2/3 training and 1/3 test data for evaluation of predictions. Finally, derivatives of thermogram curves were included in the models to determine whether they aided in prediction of disease status. Results Functional regression with thermogram as a functional response and disease status as predictor showed a clear separation in thermogram curve structure between cases and controls. The logistic regression model with FPCA scores as the predictors gave the most accurate results with a mean 79.22% correct classification rate with a mean sensitivity = 79.70%, and specificity = 81.48%. The model correctly classified OA and RA patients without Lupus as controls at a rate of 75.92% on average with a mean sensitivity = 79.70% and specificity = 77.6%. Regression models including FPCA scores for derivative curves did not perform as well, nor did regression models including covariates. Conclusion Changes in thermograms observed in the disease state likely reflect covalent modifications of plasma proteins or changes in large protein-protein interacting networks resulting in the stabilization of plasma proteins towards thermal denaturation. By relating functional principal components from thermograms to disease status, our Functional Principal Component Analysis model provides results that are more easily interpretable compared to prior studies. Further, the model could also potentially be coupled with other biomarkers to improve diagnostic classification for lupus.	[Kendrick, Sarah K.; Zheng, Qi; Brock, Guy N.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Garbett, Nichola C.] Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Brock, Guy N.] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA	University of Louisville; University of Louisville; University System of Ohio; Ohio State University	Kendrick, SK (corresponding author), Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Bioinformat & Biostat, Louisville, KY 40292 USA.; Garbett, NC (corresponding author), Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	Sarah.Kendrick@Louisville.Edu; Nichola.Garbett@Louisville.Edu		brock, guy/0000-0001-5317-079X	Biophysical Core Facility at the James Graham Brown Cancer Center; National Institutes of Health [P20 RR018733, P20 GM103482, UL1TR001070]; National Cancer Institute of the National Institutes of Health [R21CA187345]; Department of Defense Lung Cancer Research Program [W81XWH-15-1-0178]; Kentucky Science and Technology Corporation [COMMFUND-1517-RFP-017]; NATIONAL CANCER INSTITUTE [R21CA187345] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103482] Funding Source: NIH RePORTER	Biophysical Core Facility at the James Graham Brown Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Lung Cancer Research Program; Kentucky Science and Technology Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the immensely valuable resource of the Lupus Family Registry and Repository for generously providing access to patient samples and data for this study. Collection of plasma thermogram data was supported by use of the Biophysical Core Facility at the James Graham Brown Cancer Center and by grants P20 RR018733 and P20 GM103482 from the National Institutes of Health (www.nih.gov). NCG was supported by the National Cancer Institute of the National Institutes of Health (www.cancer.gov) under Award Number R21CA187345, by the Department of Defense Lung Cancer Research Program (http://cdmrp.army.mil/Icrp/defauIt) under Award Number W81XWH-15-1-0178 and by the Kentucky Science and Technology Corporation (www.kst.com) under Award Number COMMFUND-1517-RFP-017. GNB was supported in part by the National Institutes of Health grant UL1TR001070. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120316; Centers for Disease Control and Prevention, 2015, SYST LUP ER SLE; Febrero-Bande M, 2012, STAT COMPUTING FUNCT, V51, P28; Fekecs T, 2012, J THERM ANAL CALORIM, V108, P149, DOI 10.1007/s10973-011-1800-6; Fish DJ, 2010, BIOPHYS CHEM, V152, P184, DOI 10.1016/j.bpc.2010.09.007; Garbett N. C., 2006, Journal of Clinical Ligand Assay, V29, P194; Garbett NC, 2015, DIFFERENTIAL SCANNIN; Garbett NC, 2007, SEMIN NEPHROL, V27, P621, DOI 10.1016/j.semnephrol.2007.09.004; Garbett NC, 2007, CLIN CHEM, V53, P2012, DOI 10.1373/clinchem.2007.091165; Garbett NC, 2015, METHODS, V76, P41, DOI 10.1016/j.ymeth.2014.10.030; Garbett NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084710; Garbett NC, 2009, EXP MOL PATHOL, V86, P186, DOI 10.1016/j.yexmp.2008.12.001; Ginzler E, 2015, AM COLL RHEUM; James GM, 2002, J ROY STAT SOC B, V64, P411, DOI 10.1111/1467-9868.00342; James GM, 2001, J ROY STAT SOC B, V63, P533, DOI 10.1111/1467-9868.00297; Kikalishvili L, 2015, J THERM ANAL CALORIM, V120, P501, DOI 10.1007/s10973-015-4426-2; Krumova S, 2013, THERMOCHIM ACTA, V572, P59, DOI 10.1016/j.tca.2013.09.015; Mayo Clinic, 2014, DIS COND; Mehdi M, 2013, J THERM ANAL CALORIM, V111, P1801, DOI 10.1007/s10973-012-2468-2; Michnik A, 2010, J THERM ANAL CALORIM, V102, P57, DOI 10.1007/s10973-009-0602-6; Michnik A, 2013, J THERM ANAL CALORIM, V113, P365, DOI 10.1007/s10973-013-3130-3; Moezzi M, 2014, J THERM ANAL CALORIM, V116, P557, DOI 10.1007/s10973-013-3585-2; Park C, 2008, COMPUT STAT DATA AN, V52, P2578, DOI 10.1016/j.csda.2007.09.002; Ramsay JO, 2009, USE R, P1, DOI 10.1007/978-0-387-98185-7_1; Rasmussen A, 2011, RHEUMATOLOGY, V50, P47, DOI 10.1093/rheumatology/keq302; Silverman B, 2005, FUNCT DAT AN; Szalai Z, 2013, J THERM ANAL CALORIM, V113, P259, DOI 10.1007/s10973-013-2999-1; Todinova S, 2012, BBA-GEN SUBJECTS, V1820, P1879, DOI 10.1016/j.bbagen.2012.08.001; Todinova S, 2011, ANAL CHEM, V83, P7992, DOI 10.1021/ac202055m; Vega S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07988; Zapf I, 2011, THERMOCHIM ACTA, V524, P88, DOI 10.1016/j.tca.2011.06.019	31	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0186232	10.1371/journal.pone.0186232	http://dx.doi.org/10.1371/journal.pone.0186232			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121669	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900010
J	Kumssa, DB; Joy, EJM; Young, SD; Odee, DW; Ander, EL; Magare, C; Gitu, J; Broadley, MR				Kumssa, Diriba B.; Joy, Edward J. M.; Young, Scott D.; Odee, David W.; Ander, E. Louise; Magare, Charles; Gitu, James; Broadley, Martin R.			Challenges and opportunities for Moringa growers in southern Ethiopia and Kenya	PLOS ONE			English	Article							AQUEOUS LEAF EXTRACT; MEDICINAL-PLANTS; OLEIFERA LAM.; DIABETES-MELLITUS; LOCAL KNOWLEDGE; PROTEIN-SOURCE; FEED-INTAKE; FOOD PLANT; SEED OIL; QUALITY	Moringa oleifera (MO) and M. stenopetala (MS) are two commonly cultivated species of the Moringaceae family. Some households in southern Ethiopia (S. ETH) and Kenya (KEN) plant MS and MO, respectively. The edible parts of these species are rich in amino acids, vitamins and minerals, especially selenium. Despite their nutritional value, Moringa is sometimes considered as a "famine food". The aim of this study was to determine the extent of dietary utilization of these plants by Moringa Growing Households (MGHs). Moringa growing households were surveyed in 2015. Twenty-four and 56 heads of MGHs from S. ETH and KEN, respectively, were interviewed using semi-structured questionnaires. Subsistence agriculture was the main source of livelihood for all MGHs in S. ETH and 71% of those in KEN. All MGHs in S. ETH cultivated MS while those in KEN cultivated MO. Of the MGH heads in S. ETH, 71% had grown MS as long as they remember; the median cultivation period of MO in KEN was 15 years. All MGHs in S. ETH and 79% in KEN used Moringa leaves as a source of food. Forms of consumption of leaves were boiled fresh leaves, and leaf powder used in tea or mixed with other dishes. Other uses of Moringa include as medicine, fodder, shade, agroforestry, and as a source of income. Although MO and MS have multiple uses, MGHs face several challenges, including a lack of reliable information on nutritional and medicinal values, inadequate access to markets for their products, and pest and disease stresses to their plants. Research and development to address these challenges and to promote the use of these species in the fight against hidden hunger are necessary.	[Kumssa, Diriba B.; Young, Scott D.; Broadley, Martin R.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Kumssa, Diriba B.; Ander, E. Louise] British Geol Survey, Ctr Environm Geochem, Keyworth, Notts, England; [Kumssa, Diriba B.] Univ Nottingham, Crops Future, Malaysia Campus,Jalan Broga, Semenyih, Selangor Darul, Malaysia; [Joy, Edward J. M.] London Sch Hyg Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Odee, David W.; Magare, Charles; Gitu, James] Kenya Forestry Res Inst, Nairobi, Kenya; [Odee, David W.] Ctr Ecol & Hydrol, Bush Estate, Penicuik, Midlothian, Scotland	University of Nottingham; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Nottingham Malaysia; University of London; London School of Hygiene & Tropical Medicine; UK Centre for Ecology & Hydrology (UKCEH)	Broadley, MR (corresponding author), Univ Nottingham, Sch Biosci, Loughborough, Leics, England.	Martin.Broadley@nottingham.ac.uk	Kumssa, Diriba/AAR-7547-2020; Ander, E.L./D-2009-2013; broadley, martin r/E-9081-2011; BGS, CEG/K-2113-2014; Kumssa, Diriba B/C-3774-2017; Broadley, Martin/AAW-4638-2021	Kumssa, Diriba/0000-0002-5869-4864; Ander, E.L./0000-0003-3901-1949; broadley, martin r/0000-0003-3964-7226; Kumssa, Diriba B/0000-0002-5869-4864; Broadley, Martin/0000-0003-3964-7226	Crops for the Future; Natural Environment Research Council [nigl010001] Funding Source: researchfish; NERC [nigl010001] Funding Source: UKRI	Crops for the Future; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DBK's PhD studentship was funded by the Crops for the Future. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2010, P I CIVIL ENG-WAT M, V163, P381, DOI 10.1680/wama.900080; Alsharaa A, 2016, INT J ENVIRON SCI TE, V13, P2609, DOI 10.1007/s13762-016-1079-z; Amagloh F, 2016, AM J HEMATOL, V91, pE26; [Anonymous], [No title captured]; Anwar F, 2005, J AM OIL CHEM SOC, V82, P45, DOI 10.1007/s11746-005-1041-1; Anwar F, 2007, PHYTOTHER RES, V21, P17, DOI 10.1002/ptr.2023; Arancibia RA, 2007, HORTSCIENCE, V42, P444; Ayerza R, 2011, IND CROP PROD, V33, P389, DOI 10.1016/j.indcrop.2010.11.003; Balemie K, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-53; Bibi A, 2016, ACTA AGR SCAND B-S P, V66, P469, DOI 10.1080/09064710.2016.1173225; Cernansky R, 2015, NATURE, V522, P146, DOI 10.1038/522146a; Chilimba A. D. C., 2015, BMC NUTR, V1, P42, DOI DOI 10.1186/S40795-015-0036-4; Dalvand A, 2016, ENVIRON SCI POLLUT R, V23, P16396, DOI 10.1007/s11356-016-6708-z; Degefu DM, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1719-6; del Real-Olvera J, 2016, DESALIN WATER TREAT, V57, P9971, DOI 10.1080/19443994.2015.1033479; Diouf M, 2007, WATER SA, V33, P343; Ebert AW, 2014, SUSTAINABILITY-BASEL, V6, P319, DOI 10.3390/su6010319; EILERT U, 1981, PLANTA MED, V42, P55, DOI 10.1055/s-2007-971546; Ejigu A, 2010, GREEN CHEM, V12, P316, DOI 10.1039/b916500b; Eloka-Eboka AC, 2016, ENERG SOURCE PART A, V38, P1495, DOI 10.1080/15567036.2014.934413; Foidl N., 2001, WHAT DEV POTENTIAL M, V20, P1; Fotouo-M H, 2016, IND CROP PROD, V84, P80, DOI 10.1016/j.indcrop.2016.01.032; Frison EA, 2011, SUSTAINABILITY-BASEL, V3, P238, DOI 10.3390/su3010238; Geleta B, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00097; Gopalakrishnan L., 2016, FOOD SCI HUM WELL, V5, P49, DOI DOI 10.1016/J.FSHW.2016.04.001; Hamid SHA, 2016, INT BIODETER BIODEGR, V113, P310, DOI 10.1016/j.ibiod.2016.03.027; JAHN SA, 1991, AMBIO, V20, P244; Jiru D., 2006, P MOR OTH HIGHL NUTR, P16; Kamau LN, 2016, J ETHNOPHARMACOL, V189, P218, DOI 10.1016/j.jep.2016.05.021; Kholif AE, 2015, SMALL RUMINANT RES, V129, P129, DOI 10.1016/j.smallrumres.2015.05.007; Kotikal Y, 2016, ENTOMOL ORNITHOL HER, V5; Kubitzki K, 2003, FA GE VAS P, V5, P312; Kumar PS, 2016, DESALIN WATER TREAT, V57, P5488, DOI 10.1080/19443994.2014.1003977; Kumssa DB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175503; Lim T. K, 2012, FRUITS, V3, P453; Lockett CT, 2000, INT J FOOD SCI NUTR, V51, P195, DOI [10.1080/09637480050029700, 10.1080/096374899101238]; Lunyera J, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1262-2; Madi N, 2016, J AM COLL NUTR, V35, P604, DOI 10.1080/07315724.2015.1080128; Mageshkumar M, 2016, DESALIN WATER TREAT, V57, P14954, DOI 10.1080/19443994.2015.1070294; Mekonnen Y, 2004, SINET ETHIOP J SCI, V21, P287; Melesse A, 2015, AGRICULTURE-BASEL, V5, P1183, DOI 10.3390/agriculture5041183; Melesse A, 2013, LIVEST SCI, V157, P498, DOI 10.1016/j.livsci.2013.08.012; Melesse A, 2012, AGROFOREST SYST, V86, P505, DOI 10.1007/s10457-012-9514-8; Mengistu M, 2012, AFR HEALTH SCI, V12, P545, DOI 10.4314/ahs.v12i4.23; Michl C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157430; Miller DD, 2013, FOOD POLICY, V42, P115, DOI 10.1016/j.foodpol.2013.06.008; Monera TG, 2010, JIAS S4, V13, P1; MORTON JF, 1991, ECON BOT, V45, P318, DOI 10.1007/BF02887070; Moyo B, 2011, AFR J BIOTECHNOL, V10, P12925; Mutheeswaran S, 2011, J ETHNOPHARMACOL, V137, P523, DOI 10.1016/j.jep.2011.06.003; Nambiar VS, 2001, PLANT FOOD HUM NUTR, V56, P83, DOI 10.1023/A:1008132503972; Nasir M, 2016, SCI HORTIC-AMSTERDAM, V210, P227, DOI 10.1016/j.scienta.2016.07.032; Nawaz H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00597; Ndabigengesere A, 1998, WATER RES, V32, P781, DOI 10.1016/S0043-1354(97)00295-9; Nouman W, 2013, TURK J AGRIC FOR, V37, P410, DOI 10.3906/tar-1206-29; Ocho DL, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-30; Olson ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159782; Padayachee B., 2012, Journal of Medicinal Plants Research, V6, P5831; Palada M C, 2008, INTEGRATING HIGH VAL, P93; Petit-Aldana J, 2012, REV CHAPINGO SER CIE, V18, P5, DOI 10.5154/r.rchscfa.2011.03.025; Ferreira PMP, 2008, REV NUTR, V21, P431, DOI 10.1590/S1415-52732008000400007; Popoola JO, 2013, J ETHNOPHARMACOL, V150, P682, DOI 10.1016/j.jep.2013.09.043; Rakotosamimanana VR, 2015, APPETITE, V95, P533, DOI 10.1016/j.appet.2015.08.011; Randriamboavonjy JI, 2016, AM J HYPERTENS, V29, P873, DOI 10.1093/ajh/hpw001; Richter N, 2003, AQUACULTURE, V217, P599, DOI 10.1016/S0044-8486(02)00497-0; Saini RK, 2016, J FOOD SCI TECH MYS, V53, P511, DOI 10.1007/s13197-015-1828-x; Saini RK, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0526-3; Sanchez NR, 2006, LIVEST SCI, V101, P24, DOI 10.1016/j.livprodsci.2005.09.010; Semenya S, 2012, J ETHNOPHARMACOL, V141, P440, DOI 10.1016/j.jep.2012.03.008; Sena LP, 1998, PLANT FOOD HUM NUTR, V52, P17, DOI 10.1023/A:1008010009170; Sharma P, 2017, FOOD REV INT, V33, P359, DOI 10.1080/87559129.2016.1175009; Silambarasan R, 2015, J ETHNOPHARMACOL, V172, P162, DOI 10.1016/j.jep.2015.05.046; Sivasankari B, 2014, J ETHNOPHARMACOL, V153, P408, DOI 10.1016/j.jep.2014.02.040; Stevens CO, 2015, INT LETT NAT SCI, V40, P30, DOI 10.18052/www.scipress.com/ILNS.40.30; Tejas G.H., 2012, INT RES J PHARM, V3, P1; Teklehaymanot T, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-23; Tenaye A, INT S UND PLANTS FOO, P115; TFLI, MOR BOOK 2014; Tiloke C, 2016, J CELL BIOCHEM, V117, P2302, DOI 10.1002/jcb.25528; Tiloke C, 2016, J MED FOOD, V19, P398, DOI 10.1089/jmf.2015.0113; Toma A, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-180; Tsaknis J, 1999, J AGR FOOD CHEM, V47, P4495, DOI 10.1021/jf9904214; Undie U. L., 2013, EUR J AGR FOR RES, V1, P17; Virchow D., 2008, INDIGENOUS VEGETABLE, P79; Welch RM, 1999, FIELD CROP RES, V60, P1, DOI 10.1016/S0378-4290(98)00129-4; Yang RY, ACS S SERIES, P224; Yassa HD, 2014, ACTA HISTOCHEM, V116, P844, DOI 10.1016/j.acthis.2014.02.002; Yusuf S. R., 2014, Bayero Journal of Pure and Applied Sciences, V7, P127, DOI 10.4314/bajopas.v7i1.23; Zeeshan M, 2016, SPRING PR ENERG, P149, DOI 10.1007/978-81-322-2773-1_11; Zheng YX, 2016, IND CROP PROD, V91, P88, DOI 10.1016/j.indcrop.2016.06.032	90	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187651	10.1371/journal.pone.0187651	http://dx.doi.org/10.1371/journal.pone.0187651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121079	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000414769900060
J	Samiak, L; Emeto, TI				Samiak, Louis; Emeto, Theophilus I.			Vaccination and nutritional status of children in Karawari, East Sepik Province, Papua New Guinea	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; MALNUTRITION; HEALTH; PREVALENCE; MORTALITY	Delivery of health care services to rural and remote populations in Papua New Guinea (PNG) is problematic. This is mainly due to difficulties with transportation and communication. Hence, the children in this region of PNG are likely to be at risk of malnutrition compounded by inadequate vaccination that may predispose them to preventable diseases. This study was conducted to determine the vaccination and nutritional status of children less than 5 years old in the remote and rural Karawari area of PNG. 105 children were included in the study, of whom 55% were male and 45% female. The mean age of children included in the study was 32.6 months. Their age, height, and weight by gender was not significantly different. Overall, 85% of children had incomplete vaccination. However, children above the median age of 32 months (34%) were more likely to be fully vaccinated for their age,chi 2 (1) = 23.294, p < 0.005. In addition, 25% of children were below the -1 SD (Z-scores) for weight-for D-height, 33% below the -1 SD for weight-for-age, and 25.5% below the -1 SD for height-for-age compared to WHO standards. A large proportion of children had poor nutrition status and lack protection from vaccine preventable diseases. This study recommends that the government should introduce a surveillance system for detecting issues of importance to the rural majority. We also recommend that the PNG government reopen the nearby health centre, and/or establish new facilities within the region, with adequately trained and compensated staff.	[Samiak, Louis] Univ Papua New Guinea, Sch Med & Hlth Sci, Dept Publ Hlth, Port Moresby, Papua N Guinea; [Emeto, Theophilus I.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Publ Hlth & Trop Med, Townsville, Qld, Australia	University of Papua New Guinea; James Cook University	Emeto, TI (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Publ Hlth & Trop Med, Townsville, Qld, Australia.	theophilus.emeto@jcu.edu.au	Emeto, Theophilus I/M-2912-2015	Emeto, Theophilus I/0000-0002-3282-1861	University of Papua New Guinea/James Cook University	University of Papua New Guinea/James Cook University	The authors would like to thank the University of Papua New Guinea/James Cook University twinning project (https://www.icu.edu.au/learning-and-teaching/directorate-of-learning-teaching-and-student-engagement/twinning-project) for provision of funds and support for this study.; The authors will like to thank the University of Papua New Guinea/James Cook University twinning project for provision of funds and support for this study. DR Alex Roberts for proof reading the draft.	Abubakar A, 2011, RURAL REMOTE HEALTH, V11; Aguayo VM, 2016, MATERN CHILD NUTR, V12, P121, DOI 10.1111/mcn.12259; Akombi BJ, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0770-z; Allen B., 2005, Asia Pacific Viewpoint, V46, P201, DOI 10.1111/j.1467-8373.2005.00274.x; [Anonymous], 1976, World Health Organ Tech Rep Ser, P1; [Anonymous], 2010, NAT HLTH PLAN 2011 2; [Anonymous], 2015, INT J INFECT, DOI DOI 10.17795/IJI28109; [Anonymous], 2011, PNG NAT CENS DAT 201; Ategbo S, 2010, SANTE MONTROUGE FRAN, V20; Bechir M, 2010, Med Trop (Mars), V70, P353; Bhanderi D, 2006, Indian J Public Health, V50, P213; Bloss E, 2004, J TROP PEDIATRICS, V50, P260, DOI 10.1093/tropej/50.5.260; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Chagomoka T, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.29425; Chataut J, 2016, Kathmandu Univ Med J (KUMJ), V14, P73; Commons W, 2016, FIL NOR POND LANG PN; De Onis M, 2006, WHO CHILD GROWTH STA, P312; Fernandez RC, 2011, RURAL REMOTE HEALTH, V11; Ghosh A, 2009, ANN HUM BIOL, V36, P38, DOI 10.1080/03014460802555650; GRAITCER PL, 1981, LANCET, V2, P297; Health PNGNDo, 2015, SECT PERF ANN REV 20; Inamara A, 2017, PACIFIC CLIMATE CHAN; Jayawardena N, 2012, J PAEDIATR CHILD H, V48, P210, DOI 10.1111/j.1440-1754.2010.01926.x; Juma OA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3751-0; Khan MMH, 2011, B WORLD HEALTH ORGAN, V89, P583, DOI 10.2471/BLT.11.087429; Lagani W, 2010, INT HEALTH, V2, P186, DOI 10.1016/j.inhe.2010.05.001; Lanaspa M, 2015, ACTA TROP, V149, P262, DOI 10.1016/j.actatropica.2015.06.007; Landoh DE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3625-5; LAPHAM RJ, 1986, POPUL INDEX, V52, P28, DOI 10.2307/3644791; Manary MJ, 2008, BMJ, V337; Mei ZG, 2007, B WORLD HEALTH ORGAN, V85, P441, DOI 10.2471/BLT.06.034421; Miller MA, 2006, VACCINE PREVENTABLE; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; PNG NDoH, PAP NEW GUIN CHILD H; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Rigby RA, 2004, STAT MED, V23, P3053, DOI 10.1002/sim.1861; Strasser R, 2003, FAM PRACT, V20, P457, DOI 10.1093/fampra/cmg422; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Zhou H, 2012, ASIA PAC J CLIN NUTR, V21, P234	40	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187796	10.1371/journal.pone.0187796	http://dx.doi.org/10.1371/journal.pone.0187796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121088	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000414769900075
J	Figueredo-Urbina, CJ; Casas, A; Torres-Garcia, I				Figueredo-Urbina, Carmen J.; Casas, Alejandro; Torres-Garcia, Ignacio			Morphological and genetic divergence between Agave inaequidens, A. cupreata and the domesticated A. hookeri. Analysis of their evolutionary relationships	PLOS ONE			English	Article							STENOCEREUS-STELLATUS CACTACEAE; MAXIMUM-LIKELIHOOD-ESTIMATION; NULL ALLELES; DIVERSITY; MANAGEMENT; POPULATIONS; CONSERVATION; SOFTWARE; WILD; CULTIVATION	Agave inaequidens and A. cupreata are wild species with some populations under incipient management, while A. hookeri is exclusively cultivated, used for producing the fermented beverage pulque. These species are closely related and sympatric members of the Crenatae group, but taxonomists have previously hypothesized that A. inaequidens is the most probable ancestor of A. hookeri. Our study aims at evaluating patterns of morphological and genetic divergence among populations of the three species, in order to analyze their ecological and possible evolutionary relationships. We studied 24 agave populations, 16 of them of Agave inaequidens, four of A. cupreata and four of A. hookeri. Population morphometric and genetics studies were performed using 39 morphological characters and 10 nuclear micro satellites, respectively. We estimated levels of morphological and genetic diversity and dissimilarity, as well as genetic structure and gene flow among populations and species. The three species were clearly differentiated by general plant size, lateral teeth, terminal spines, flowers and fruit size. The largest plants were those of A. hookeri followed by A. inaequidens and the smallest were A. cupreata. Multivariate analyses indicated greater morphological similarity between A. hookeri and cultivated A. inaequidens, while A. cupreata consistently appeared as a separate group. We identified similar levels of morphological diversity index (MDI) in the three species, but higher genetic diversity in A. inaequidens (MDI = 0.401-0.435; H-E = 0.704-0.733), than in A. cupreata (MDI = 0.455-0.523; H-E = 0.480-0.510) and the predominantly vegetative propagated crop A. hookeri (MDI = 0.335-0.688; H-E = 0.4500.567), a pattern consistent with our expectations. The morphological and genetic similarities between cultivated A. inaequidens and A. hookerisupport the hypothetical evolutionary relationships among these species, but studies with cpDNA and SNPs, and including other member of the Crenatae group are necessary to further resolve these relationships.	[Figueredo-Urbina, Carmen J.; Casas, Alejandro; Torres-Garcia, Ignacio] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Campus Morelia, Morelia, Michoacan, Mexico	Universidad Nacional Autonoma de Mexico	Casas, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Campus Morelia, Morelia, Michoacan, Mexico.	acasas@cieco.unam.mx	Figueredo Urbina, Carmen Julia/L-2014-2016	Figueredo Urbina, Carmen Julia/0000-0003-0906-8821; Casas, Alejandro/0000-0002-8181-5118	Domesticacion y manejo in situ de recursos geneticos forestales en Mesoamerica; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT); Direccion General de Asuntos del Personal Academic (DGAPA); Universidad Nacional Autonoma de Mexico (UNAM), Mexico [IN209214, IN206217]; Domesticacion y manejo in situ de recursos geneticos en el Nuevo Mundo: Mesoamerica, Los Andes y Amazonia, Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT), Mexico [CB-2013-01221800]; Domesticacion y manejo in situ de recursos geneticos en el Nuevo Mundo: Mesoamerica, la region andina, amazOnica y del nordeste de Brasil Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT); Direccion General de Asuntos del Personal Aacademico (DGAPA); Universidad Nacional Autonoma de Mexico (UNAM), Mexico	Domesticacion y manejo in situ de recursos geneticos forestales en Mesoamerica; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Direccion General de Asuntos del Personal Academic (DGAPA); Universidad Nacional Autonoma de Mexico (UNAM), Mexico(Universidad Nacional Autonoma de Mexico); Domesticacion y manejo in situ de recursos geneticos en el Nuevo Mundo: Mesoamerica, Los Andes y Amazonia, Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT), Mexico; Domesticacion y manejo in situ de recursos geneticos en el Nuevo Mundo: Mesoamerica, la region andina, amazOnica y del nordeste de Brasil Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Direccion General de Asuntos del Personal Aacademico (DGAPA); Universidad Nacional Autonoma de Mexico (UNAM), Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by (1) Grant name: Domesticacion y manejo in situ de recursos geneticos forestales en Mesoamerica, Funding Institution: Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academic (DGAPA), Universidad Nacional Autonoma de Mexico (UNAM), Mexico, Project number IN209214, Funded field and laboratory work, AC; (2) Project name: Domesticacion y manejo in situ de recursos geneticos en el Nuevo Mundo: Mesoamerica, Los Andes y Amazonia, Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT), Mexico, Project number CB-2013-01221800, Funded field and laboratory work, AC; (3) Project name: Domesticacion y manejo in situ de recursos geneticos en el Nuevo Mundo: Mesoamerica, la region andina, amazOnica y del nordeste de Brasil Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Aacademico (DGAPA), Universidad Nacional Autonoma de Mexico (UNAM), Mexico, Project number IN206217, Funded field and laboratory work, AC.	Aguirre-Dugua X, 2013, J ARID ENVIRON, V90, P36, DOI 10.1016/j.jaridenv.2012.10.018; Alfaro-Rojas G, 2007, REV FITOTEC MEX, V30, P1; [Anonymous], 1982, AGAVES CONTINENTAL N; [Anonymous], 1989, JMP VERS 8; Aureoles-Rodríguez F., 2008, Rev. Chapingo Ser.Hortic, V14, P263; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Blancas J., 2006, ZONAS ARIDAS, V10, P20; Blancas J, 2010, ECON BOT, V64, P287, DOI 10.1007/s12231-010-9133-0; Blancas J, 2009, ECON BOT, V63, P375, DOI 10.1007/s12231-009-9095-2; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; CALLEN E. O., 1965, ECON BOT, V19, P335, DOI 10.1007/BF02904803; Casas A, 1999, AM J BOT, V86, P522, DOI 10.2307/2656813; Casas A, 2006, BIODIVERS CONSERV, V15, P879, DOI 10.1007/s10531-004-2934-7; Casas A, 2007, ANN BOT-LONDON, V100, P1101, DOI 10.1093/aob/mcm126; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Colunga-GarciaMarin P, 1999, AM J BOT, V86, P115, DOI 10.2307/2656960; Colunga-GarciaMarin P, 1996, AM J BOT, V83, P1449; Colunga-GarciaMarin P, 2007, ANCESTRAL HAY FUTURO, P229; Colunga-GarciaMarin P, 2007, BIODIVERS CONSERV, V16, P1653, DOI 10.1007/s10531-006-9031-z; ColungaGarciaMarin P, 1997, AM J BOT, V84, P1449, DOI 10.2307/2446608; Corp I, 2013, REL 2013 IBM SPSS ST; Daniel W., 2006, BIOESTADISTICA; Darwin C., 1859, ORIGINS SPECIES MEAN; DOEBLEY J, 1992, MOL SYSTEMATICS PLAN, P202, DOI DOI 10.1007/978-1-4615-3276-7_9; Earl D.A., 2011, STRUCTURE HARVESTER; Eguiarte LE, 2000, B SOC BOT MEX, V66, P131, DOI [10.17129/botsci.1618, DOI 10.17129/B0TSCI.1618]; Estrella P., 2008, THESIS UNAM; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Figueredo Carmen Julia, 2014, J Ethnobiol Ethnomed, V10, P66, DOI 10.1186/1746-4269-10-66; Fish S. K., 1985, Desert Plants, V7, P107; Fish SK, 2000, IMPERFECT BALANCE LA, P251; Garcia-Mendoza A., 2002, Cactus and Succulent Journal, V74, P177; Garcia-Meneses PM, 2004, REPROD GERMINACION A; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hamrick JL, 1997, CROP SCI, V37, P26, DOI 10.2135/cropsci1997.0011183X003700010004x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Lefort F., 1999, Strategies for improvement of forest tree species: Proceedings of the symposium on forest genetics, Swift Theatre, Arts Building, Trinity College, Dublin, Ireland, 9th March, 1998, P19; Leon-Jacinto A., 2013, ASPECTOS FENOLOGIA V; Lindsay DL, 2012, AM J BOT, V99, pE295, DOI 10.3732/ajb.1200033; MacNeish R. S., 1967, PREHISTORY TEHUACAN, P290; Martinez-Palacios A, 2011, REV FITOTEC MEX, V34, P159; Miksicek C. H., 1984, ARIZONA STATE MUSEUM, V150, P53; Miller A, 2005, P NATL ACAD SCI USA, V102, P12801, DOI 10.1073/pnas.0505447102; Montemayor C, DICCIONARIO NAHUATL; Mora-Lopez JL, 2011, AGROCIENCIA-MEXICO, V45, P465; NABHAN GP, 1985, ECON BOT, V39, P387, DOI 10.1007/BF02858746; NEI M, 1974, GENETICS, V76, P379; Parker KC, 2007, AM J BOT, V94, P1479, DOI 10.3732/ajb.94.9.1479; Parker KC, 2014, ANN BOT-LONDON, V113, P939, DOI 10.1093/aob/mcu016; Parker KC, 2010, MOL ECOL, V19, P1622, DOI 10.1111/j.1365-294X.2010.04593.x; Parra F, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-32; Parsons M.H., 1990, MAGUEY UTILIZATION H; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez JM, EVOLUTION DOMESTICAT; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reveal JL, 2002, FLORA N AM N MEXICO, V26, P442; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sierra P., 2005, THESIS; Smith CE, 1986, GUILA NAQUITZ ARCHAI, P265; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Szarek SR, 1996, SOUTHWEST NAT, V41, P465; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torres I, 2013, ZONAS ARIDAS, V15, P1, DOI DOI 10.21704/za.v15i1.110; Torres I, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0043-1; Torres I, 2015, ECON BOT, V69, P26, DOI 10.1007/s12231-014-9295-2; Valenzuela-Zapata AG, 2011, ETHNOBIOL LETT, V2, P72; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vargas-Ponce O, 2007, ECON BOT, V61, P362, DOI 10.1663/0013-0001(2007)61[362:ISDAMO]2.0.CO;2; Vargas-Ponce O, 2009, AM J BOT, V96, P448, DOI 10.3732/ajb.0800176; Weir BS., 1996, GENETIC DATA ANAL; Zizumbo-Villarreal D, 2013, GENET RESOUR CROP EV, V60, P33, DOI 10.1007/s10722-012-9812-z	80	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187260	10.1371/journal.pone.0187260	http://dx.doi.org/10.1371/journal.pone.0187260			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117217	gold, Green Published, Green Submitted			2022-12-26	WOS:000414659600030
J	Spinosa, PC; Luker, KE; Luker, GD; Linderman, JJ				Spinosa, Phillip C.; Luker, Kathryn E.; Luker, Gary D.; Linderman, Jennifer J.			The CXCL12/CXCR7 signaling axis, isoforms, circadian rhythms, and tumor cellular composition dictate gradients in tissue	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; CXCR7; EXPRESSION; PROMOTES; SURVIVAL; CELLS; METASTASIS; INVASION; THERAPY	Chemokine CXCL12 gradients drive chemotaxis in a CXCR4-dependent mechanism and have been implicated in cancer metastasis. While CXCL12 gradients are typically studied in organized, defined environments, the tumor microenvironment is disorganized. In vivo, CXCL12 gradients depend on many factors: the number and arrangement of cells secreting and degrading CXCL12, isoform-dependent binding to the extracellular matrix, diffusion, and circadian fluctuations. We developed a computational model of the tumor microenvironment to simulate CXCL12 gradient dynamics in disorganized tissue. There are four major findings from the model. First, CXCL12-beta and -gamma form higher magnitude (steeper) gradients compared to CXCL12-alpha. Second, endothelial CXCR7+ cells regulate CXCL12 gradient direction by controlling concentrations near but not far from the vasculature. Third, the magnitude and direction of CXCL12 gradients are dependent on the local composition of secreting and scavenging cells within the tumor. We theorize that "micro-regions" of cellular heterogeneity within the tumor are responsible for forming strong gradients directed into the blood. Fourth, CXCL12 circadian fluctuations influence gradient magnitude but not direction. Our simulations provide predictions for future experiments in animal models. Understanding the generation of CXCL12 gradients is crucial to inhibiting cancer metastasis.	[Spinosa, Phillip C.; Linderman, Jennifer J.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Luker, Kathryn E.; Luker, Gary D.] Univ Michigan, Dept Radiol, Sch Med, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Luker, Gary D.; Linderman, Jennifer J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Linderman, JJ (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.; Linderman, JJ (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	linderma@umich.edu		luker, gary/0000-0001-6832-2581; Linderman, Jennifer/0000-0002-1519-5088	National Institute of Health [R01 CA196018]; National Institute of Health's Microfluidics in Biomedical Sciences Training Program National Institute of Biomedical Imaging and Bioengineering [T32 EB005582]; NATIONAL CANCER INSTITUTE [R01CA196018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005582] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health's Microfluidics in Biomedical Sciences Training Program National Institute of Biomedical Imaging and Bioengineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by the National Institute of Health grant R01 CA196018, awarded to GDL and JJL, and the National Institute of Health's Microfluidics in Biomedical Sciences Training Program National Institute of Biomedical Imaging and Bioengineering T32 EB005582 grant, awarded to PCS.	BARAKAT HZ, 1966, J HEAT TRANSF, V88, P421, DOI 10.1115/1.3691590; Berahovich RD, 2014, IMMUNOLOGY, V141, P111, DOI 10.1111/imm.12176; Bielekova B, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00102; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Campbell JJ, 2017, BIOMATERIALS, V114, P34, DOI 10.1016/j.biomaterials.2016.10.048; Cavnar SP, 2014, INTEGR BIOL-UK, V6, P564, DOI 10.1039/c4ib00015c; Chang SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123450; Choi YH, 2014, MOL CANCER RES, V12, P38, DOI 10.1158/1541-7786.MCR-12-0334; Cilfone NA, 2015, CELL MOL BIOENG, V8, P119, DOI 10.1007/s12195-014-0363-6; Clark AG, 2015, CURR OPIN CELL BIOL, V36, P13, DOI 10.1016/j.ceb.2015.06.004; Coggins NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098328; Connell BJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1839; Costantini S, 2013, CYTOKINE, V64, P316, DOI 10.1016/j.cyto.2013.05.024; Costello CM, 2012, EUR RESPIR J, V39, P1415, DOI 10.1183/09031936.00044911; Ella K, 2016, BRAIN BEHAV IMMUN, V57, P209, DOI 10.1016/j.bbi.2016.04.016; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Levi F, 2007, ADV DRUG DELIVER REV, V59, P1015, DOI 10.1016/j.addr.2006.11.001; Liao YX, 2015, ONCOL REP, V34, P33, DOI 10.3892/or.2015.3992; Lukaszewicz-Zajac M, 2016, DIS MARKERS, V2016; Luker KE, 2012, ONCOGENE, V31, P4750, DOI 10.1038/onc.2011.633; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Maishi N, 2012, PATHOL INT, V62, P309, DOI 10.1111/j.1440-1827.2012.02792.x; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Munson JM, 2013, CANCER RES, V73, P1536, DOI 10.1158/0008-5472.CAN-12-2838; Savvidis C, 2012, MOL MED, V18, P1249, DOI 10.2119/molmed.2012.00077; Stacer AC, 2016, ONCOGENE, V35, P1716, DOI 10.1038/onc.2015.236; Sun XJ, 2013, MOL CANCER THER, V12, P1163, DOI 10.1158/1535-7163.MCT-12-1092; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Sun YN, 2014, TUMOR BIOL, V35, P7765, DOI 10.1007/s13277-014-1816-1; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Taromi S, 2016, ONCOTARGET, V7, P85185, DOI 10.18632/oncotarget.13238; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Weitzenfeld P, 2014, CANCER LETT, V352, P36, DOI 10.1016/j.canlet.2013.10.006; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Yu PF, 2017, ONCOGENE, V36, P840, DOI 10.1038/onc.2016.252; Zhao S, 2014, TRANSL ONCOL, V7, P429, DOI 10.1016/j.tranon.2014.04.001; Zhu B, 2012, STEM CELLS, V30, P2571, DOI 10.1002/stem.1239	45	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187357	10.1371/journal.pone.0187357	http://dx.doi.org/10.1371/journal.pone.0187357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117251	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600034
J	Zoccola, D; Morain, J; Pages, G; Caminiti-Segonds, N; Giuliano, S; Tambutte, S; Allemand, D				Zoccola, Didier; Morain, Jonas; Pages, Gilles; Caminiti-Segonds, Natacha; Giuliano, Sandy; Tambutte, Sylvie; Allemand, Denis			Structural and functional analysis of coral Hypoxia Inducible Factor	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVITY; DEAD ZONES; FACTOR-I; OXYGEN; HIF; FACTOR-1-ALPHA; TRANSACTIVATION; CALCIFICATION; HYDROXYLATION; HIF-1-ALPHA	Tissues of symbiotic Cnidarians are exposed to wide, rapid and daily variations of oxygen concentration. Indeed, during daytime, intracellular 02 concentration increases due to symbiont photosynthesis, while during night, respiration of both host cells and symbionts leads to intra-tissue hypoxia. The Hypoxia Inducible Factor 1 (HI F-1) is a heterodimeric transcription factor used for maintenance of oxygen homeostasis and adaptation to hypoxia. Here, we carried out a mechanistic study of the response to variations of 02 concentrations of the coral model Stylophora pistillata. In silico analysis showed that homologs of HIF-1 alpha (SpiHI F-1 alpha) and HIF-1 beta (SpiHI F-1 beta) exist in coral. A specific SpiHI F-1 DNA binding on mammalian Hypoxia Response Element (HRE) sequences was shown in extracts from coral exposed to dark conditions. Then, we cloned the coral HIF-1 alpha and 13 genes and determined their expression and transcriptional activity. Although HIF-1 alpha has an incomplete Oxygen dependent Degradation Domain (ODD) relative to its human homolog, its protein level is increased under hypoxia when tested in mammalian cells. Moreover, co-transfection of SpiH1F-1 a and p in mammalian cells stimulated an artificial promoter containing HRE only in hypoxic conditions. This study shows the strong conservation of molecular mechanisms involved in adaptation to 02 concentration between Cnidarians and Mammals whose ancestors diverged about 1,200-1,500 million years ago.	[Zoccola, Didier; Morain, Jonas; Caminiti-Segonds, Natacha; Tambutte, Sylvie] Ctr Sci Monaco, Dept Marine Biol, 8 Quai Antoine Ler, Monaco, Monaco; [Pages, Gilles; Giuliano, Sandy] Ctr Sci Monaco, Dept Med Biol, 8 Quai Antoine Ler, Monaco, Monaco; [Pages, Gilles] Univ Cote Azur, IRCAN, INSERM, CNRS,UMR 7284,U1081, Nice, France; [Allemand, Denis] Ctr Sci Monaco, 8 Quai Antoine Ler, Monaco, Monaco	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Zoccola, D (corresponding author), Ctr Sci Monaco, Dept Marine Biol, 8 Quai Antoine Ler, Monaco, Monaco.	zoccola@centrescientifique.mc	Giuliano, Sandy/U-2498-2019; Zoccola, Didier/A-5997-2009	Zoccola, Didier/0000-0002-1524-8098	Centre Scientifique de Monaco Research Program - Government of the Principality of Monaco; "Cordon de Vie" foundation Monaco	Centre Scientifique de Monaco Research Program - Government of the Principality of Monaco; "Cordon de Vie" foundation Monaco	This work was supported by Centre Scientifique de Monaco Research Program, supported by the Government of the Principality of Monaco. This work was also partially funded by "Cordon de Vie" foundation Monaco.	Altieri AH, 2017, P NATL ACAD SCI USA, V114, P3660, DOI 10.1073/pnas.1621517114; Andre H, 2008, J BIOL CHEM, V283, P29375, DOI 10.1074/jbc.M805919200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bertucci A, 2015, MOL ECOL, V24, P4489, DOI 10.1111/mec.13328; Bhattacharya D, 2016, ELIFE, V5, DOI 10.7554/eLife.13288; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Foret S, 2010, TRENDS GENET; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hemond EM, 2015, MOL ECOL, V24, P4460, DOI 10.1111/mec.13320; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karako-Lampert S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088615; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Liew YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091101; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Michel G, 2002, BBA-GENE STRUCT EXPR, V1578, P73, DOI 10.1016/S0167-4781(02)00484-0; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Muscatine L., 1990, P75; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Richier S, 2005, J EXP BIOL, V208, P277, DOI 10.1242/jeb.01368; Richier S, 2003, BBA-GEN SUBJECTS, V1621, P84, DOI 10.1016/S0304-4165(03)00049-7; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Sokkar P, 2012, J MOL MODEL, V18, P1691, DOI 10.1007/s00894-011-1150-0; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Tambutte E, 1996, J EXP BIOL, V199, P1029; Voolstra CR, COMP ANAL GENOMES ST; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wijgerde T, 2014, BIOL OPEN, V3, P489, DOI 10.1242/bio.20147922	45	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0186262	10.1371/journal.pone.0186262	http://dx.doi.org/10.1371/journal.pone.0186262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117182	Green Submitted, Green Published, gold			2022-12-26	WOS:000414659600004
J	Yang, HQ; Jana, K; Rindler, MJ; Coetzee, WA				Yang, Hua Qian; Jana, Kundan; Rindler, Michael J.; Coetzee, William A.			The trafficking protein, EHD2, positively regulates cardiac sarcolemmal K-ATP channel surface expression: role in cardioprotection	FASEB JOURNAL			English	Article						caveolae; endocytosis; ischemic preconditioning; endocytic recycling	SENSITIVE POTASSIUM CHANNELS; PLASMA-MEMBRANE; KINASE-C; ENDOCYTIC TRAFFICKING; PROTEOMIC ANALYSIS; CAVEOLAE; ADENOSINE; MICRODOMAINS; ASSOCIATION; ADIPOCYTES	ATP-sensitive K+ (K-ATP) channels uniquely link cellular energy metabolism to membrane excitability and are expressed in diverse cell types that range from the endocrine pancreas to neurons and smooth, skeletal, and cardiac muscle. A decrease in the surface expression of K-ATP channels has been linked to various disorders, including dysregulated insulin secretion, abnormal blood pressure, and impaired resistance to cardiac injury. In contrast, up-regulation of K-ATP channel surface expression may be protective, for example, by mediating the beneficial effect of ischemic preconditioning. Molecular mechanisms that regulate K-ATP channel trafficking are poorly understood. Here, we used cellular assays with immunofluorescence, surface biotinylation, and patch clamping to demonstrate that Eps15 homology domain-containing protein 2 (EHD2) is a novel positive regulator of K-ATP channel trafficking to increase surface K-ATP channel density. EHD2 had no effect on cardiac Na+ channels (Nav1.5). The effect is specific to EHD2 as other members of the EHD family-EHD1, EHD3, and EHD4-had no effect on K-ATP channel surface expression. EHD2 did not directly affect K-ATP channel properties as unitary conductance and ATP sensitivity were unchanged. Instead, we observed that the mechanism by which EHD2 increases surface expression is by stabilizing K-ATP channel-containing caveolar structures, which results in a reduced rate of endocytosis. EHD2 also regulated K-ATP channel trafficking in isolated cardiomyocytes, which validated the physiologic relevance of these observations. Pathophysiologically, EHD2 may be cardioprotective as a dominant-negative EHD2 mutant sensitized cardiomyocytes to ischemic damage. Our findings highlight EHD2 as a potential pharmacologic target in the treatment of diseases with K-ATP channel trafficking defects.	[Yang, Hua Qian; Jana, Kundan; Coetzee, William A.] NYU, Sch Med, Dept Pediat, New York, NY USA; [Rindler, Michael J.] NYU, Sch Med, Dept Cell Biol, New York, NY USA; [Coetzee, William A.] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY USA; [Coetzee, William A.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA	New York University; New York University; New York University; New York University	Coetzee, WA (corresponding author), NYU, Sch Med, 450 E 29th St,ACLS 824, New York, NY 10016 USA.	william.coetzee@med.nyu.edu	Yang, Hua-Qian/ABE-8167-2021	Yang, Hua-Qian/0000-0002-9402-6222; Jana, Kundan/0000-0002-7804-9344; Coetzee, William/0000-0003-1522-8326	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL126905]; American Heart Association Postdoctoral Fellowship Award [17POST33370050]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126905] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Postdoctoral Fellowship Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grant HL126905; to W.A.C.) and an American Heart Association Postdoctoral Fellowship Award (17POST33370050; to H.Q.Y.).	Bao L, 2011, AM J PHYSIOL-HEART C, V300, pH262, DOI 10.1152/ajpheart.00857.2010; Benjamin S, 2011, BIOCHEM J, V439, P433, DOI 10.1042/BJ20111010; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Bruederle CE, 2011, TRAFFIC, V12, P1242, DOI 10.1111/j.1600-0854.2011.01227.x; Curran J, 2015, J BIOL CHEM, V290, P12210, DOI 10.1074/jbc.M115.646893; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Foster MN, 2016, PHYSIOL REV, V96, P177, DOI 10.1152/physrev.00003.2015; Garg V, 2009, CARDIOVASC RES, V82, P51, DOI 10.1093/cvr/cvp039; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Hong MY, 2011, FASEB J, V25, P2456, DOI 10.1096/fj.10-176669; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; Jakobsson J, 2011, J NEUROSCI, V31, P13972, DOI 10.1523/JNEUROSCI.1289-11.2011; Jiao JD, 2008, HYPERTENSION, V52, P499, DOI 10.1161/HYPERTENSIONAHA.108.110817; Kefaloyianni E, 2013, PROTEOMICS, V13, P368, DOI 10.1002/pmic.201200324; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; Mankouri J, 2006, EMBO J, V25, P4142, DOI 10.1038/sj.emboj.7601275; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miller SL, 2005, MOL ENDOCRINOL, V19, P939, DOI 10.1210/me.2004-0443; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Park SY, 2004, BIOCHEMISTRY-US, V43, P7552, DOI 10.1021/bi049970f; Sampson LJ, 2004, CIRC RES, V95, P1012, DOI 10.1161/01.RES.0000148634.47095.ab; Sierra A, 2013, J BIOL CHEM, V288, P1568, DOI 10.1074/jbc.M112.429548; Sorvina A, 2016, BIOL OPEN, V5, P678, DOI 10.1242/bio.016642; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; TSUCHIDA A, 1994, CIRC RES, V75, P576, DOI 10.1161/01.RES.75.3.576; Turrell HE, 2011, J MOL CELL CARDIOL, V51, P370, DOI 10.1016/j.yjmcc.2011.06.015; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Yang HQ, 2016, AM J PHYSIOL-HEART C, V310, pH1558, DOI 10.1152/ajpheart.00158.2016; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	41	11	12	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1613	1625		10.1096/fj.201700027R	http://dx.doi.org/10.1096/fj.201700027R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29133341	Green Published			2022-12-26	WOS:000427246000039
J	Lee, JY; Park, JE; Shim, WH; Jung, SC; Choi, CG; Kim, SJ; Kim, JH; Kim, HS				Lee, Ji Ye; Park, Ji Eun; Shim, Woo Hyun; Jung, Seung Chai; Choi, Choong Gon; Kim, Sang Joon; Kim, Jeong Hoon; Kim, Ho Sung			Joint approach based on clinical and imaging features to distinguish non-neoplastic from neoplastic pituitary stalk lesions	PLOS ONE			English	Article							LYMPHOCYTIC HYPOPHYSITIS; EXPERIENCE; GLAND; SARCOIDOSIS; CARCINOMA; DIAGNOSIS; TUMORS; MRI	Purpose Distinguishing non-neoplastic pituitary stalk lesions (non-NPSLs) from neoplastic pituitary stalk lesions (NPSLs) is a major concern in guiding treatment for a thickened pituitary stalk. Our study aimed to aid provide preoperative diagnostic assistance by combining clinical and magnetic resonance imaging (MRI) findings to distinguish non-NPSLs from NPSLs. Materials and methods We recruited 158 patients with thickened pituitary stalk lesions visible on MRI. Laboratory findings included hypopituitarism, diabetes insipidus (DI), and hyperprolactinemia. MR images were assessed for anterior-posterior thickness (mm), diffuse pituitary stalk thickening, cystic changes, a high T1 signal, and glandular or extrasellar involvement. A diagnostic model was developed using a recursive partitioning logistic regression analysis. The model was validated in an independent dataset comprising 63 patients, and its diagnostic performance was compared with that of the original radiological reports. Results A univariate analysis found significant associations of DI (P = 0.006), absence of extrasellar involvement (P = 0.002), and lower stalk thickness (P = 0.031) with non-NPSLs. A diagnostic model was created using the following parameters (in order of priority): 1) lack of extrasellar involvement, 2) stalk thickness < 5.3 mm, and 3) presence of DI. The diagnostic performance (area under the curve; AUC) of this model in the independent set was 0.813, representing a significant improvement over the original radiological reports (AUC: 0.713, P = 0.029). Conclusion The joint diagnostic approach based on clinical and imaging-based factors robustly distinguished non-NPSLs from NPSLs. This approach could guide treatment strategies and prevent unnecessary surgery in patients with non-NPSL.	[Lee, Ji Ye] Soonchunhyang Univ, Dept Radiol, Bucheon Hosp, 170 Jomaru Ro, Bucheon, South Korea; [Park, Ji Eun; Shim, Woo Hyun; Jung, Seung Chai; Choi, Choong Gon; Kim, Sang Joon; Kim, Ho Sung] Univ Ulsan, Dept Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Park, Ji Eun; Shim, Woo Hyun; Jung, Seung Chai; Choi, Choong Gon; Kim, Sang Joon; Kim, Ho Sung] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Kim, Jeong Hoon] Univ Ulsan, Dept Neurosurg, Asan Med Ctr, Coll Med, Seoul, South Korea	Soonchunhyang University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Park, JE (corresponding author), Univ Ulsan, Dept Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea.; Park, JE (corresponding author), Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea.	jieunp@gmail.com	Lee, Ji Ye/ABA-7830-2021	Park, Ji Eun/0000-0002-4419-4682	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2017R1C1B2007258]; Ministry of Health and Welfare, Republic of Korea [1720030]	National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (grant number: NRF-2017R1C1B2007258) and by the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1720030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Institutional Review Board of Asan Medical Center approved this study ([http://eirb.amc.seoul.kr]:S2016-0555) and waived the requirement for written informed consent. This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (grant number: NRF-2017R1C1B2007258), by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1720030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker FG, 2003, J CLIN ENDOCR METAB, V88, P4709, DOI 10.1210/jc.2003-030461; Buchfelder M, 2009, BEST PRACT RES CL EN, V23, P677, DOI 10.1016/j.beem.2009.05.002; Drange MR, 2000, J CLIN ENDOCR METAB, V85, P168, DOI 10.1210/jc.85.1.168; DUCHEN LW, 1966, J PATHOL BACTERIOL, V91, P347, DOI 10.1002/path.1700910208; Gutenberg A, 2005, AM J SURG PATHOL, V29, P329, DOI 10.1097/01.pas.0000149707.12335.8e; Gutenberg A, 2009, AM J NEURORADIOL, V30, P1766, DOI 10.3174/ajnr.A1714; Hamilton BE, 2007, AM J ROENTGENOL, V188, pW223, DOI 10.2214/AJR.05.2027; Honegger J, 1997, NEUROSURGERY, V40, P713, DOI 10.1097/00006123-199704000-00010; Hou N WC, 2014, AUSTIN J ENDOCRINOL, V1, P1025; Johnston PC, 2015, ENDOCRINE, V50, P531, DOI 10.1007/s12020-015-0707-6; Kinoshita M, 2015, AM J NEURORADIOL, V36, P904, DOI 10.3174/ajnr.A4220; KIOUMEHR F, 1994, NEURORADIOLOGY, V36, P93, DOI 10.1007/BF00588067; Kristof RA, 1999, J NEUROL NEUROSUR PS, V67, P398, DOI 10.1136/jnnp.67.3.398; Langrand C, 2012, QJM-INT J MED, V105, P981, DOI 10.1093/qjmed/hcs121; Lau GKK, 1998, J CLIN PATHOL, V51, P931, DOI 10.1136/jcp.51.12.931; Lee MH, 2001, ACTA RADIOL, V42, P129, DOI 10.1034/j.1600-0455.2001.042002129.x; Leung GKK, 2004, J NEUROSURG, V101, P262, DOI 10.3171/jns.2004.101.2.0262; Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692; Nishioka H, 1997, NEUROSURGERY, V41, P684, DOI 10.1097/00006123-199709000-00037; Park M, 2015, AM J NEURORADIOL, V36, P1866, DOI 10.3174/ajnr.A4387; ROBERTSON GL, 1995, ENDOCRIN METAB CLIN, V24, P549, DOI 10.1016/S0889-8529(18)30031-8; Rupp D, 2008, CURR OPIN ENDOCRINOL, V15, P339, DOI 10.1097/MED.0b013e3283050844; Satogami N, 2010, AM J NEURORADIOL, V31, P355, DOI 10.3174/ajnr.A1836; Seidenwurm DJ, 2008, AM J NEURORADIOL, V29, P613; SELTZER S, 1991, AM J NEURORADIOL, V12, P1227; Toni R, 2000, ENDOTEXT; Turcu AF, 2013, J CLIN ENDOCR METAB, V98, P1812, DOI 10.1210/jc.2012-4171; Yoon Sung Chul, 2014, Ann Pediatr Endocrinol Metab, V19, P202, DOI 10.6065/apem.2014.19.4.202	28	10	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187989	10.1371/journal.pone.0187989	http://dx.doi.org/10.1371/journal.pone.0187989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140989	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400042
J	Ojha, S; Dimov, L				Ojha, Santosh; Dimov, Luben			Variation in the diversity-productivity relationship in young forests of the eastern United States	PLOS ONE			English	Article							MIXED-SPECIES STANDS; FUNCTIONAL DIVERSITY; PLANT DIVERSITY; WOOD PRODUCTION; DENSITY INDEX; BIODIVERSITY; RICHNESS; SCALE; BIOMASS; TEMPERATE	The diversity-productivity relationship has not been studied as extensively in forests as in other ecosystems. We address this gap in our knowledge by examining the relationship of productivity (primarily the periodic annual increment in aboveground biomass, but also the mean annual increment) with five species diversity indices, stand, and environmental factors. We used 967 naturally regenerated Forest Inventory and Analysis plots with stand age <= 30 years, located in the conterminous thirty-one eastern states, and satisfying strict selection requirements. Generally, mixed-species (heterospecific) stands were as productive as or even somewhat more productive than pure (monospecific) stands. The periodic and mean annual increments were both positively correlated with species richness (R-2 = 0.04 and 0.20, p<0.001). Similarly, the zero-order and partial correlations with productivity were positive for four of the diversity indices (species richness, functional diversity, phylogenetic diversity, and phylogenetic species richness) and not significant for the fifth (functional dispersion). Greater diversity was more important on low-productivity sites and in stands with low stocking. As forests generally get more diverse and productive away from the poles, we tested if the nature of the productivity-diversity relationship changed latitudinally. Productivity was weakly positively correlated with four of the diversity indices north of 40 degrees latitude, but weakly negatively with three of the indices to the south. Our examination of the productivity-diversity relationship in stands containing either of the two most dominant species, quaking aspen or loblolly pine, revealed that pure loblolly pine stands were somewhat more productive than only three of the eight mixtures with loblolly in the composition, while pure aspen stands were no more productive than any of the aspen mixtures. Overall, monospecific stands did not seem to have a clear productivity advantage over mixtures. The findings of this study have implications for woody biomass production, carbon sequestration by forests, and biodiversity conservation.	[Ojha, Santosh; Dimov, Luben] Alabama A&M Univ, Dept Biol & Environm Sci, Normal, AL 35762 USA	Alabama A&M University	Dimov, L (corresponding author), Alabama A&M Univ, Dept Biol & Environm Sci, Normal, AL 35762 USA.	Luben.Dimov@gmail.com	Dimov, Luben/M-1814-2019; Dimov, Luben/M-8062-2019	Dimov, Luben/0000-0003-3148-6050; Ojha, Santosh/0000-0001-5697-9711	National Science Foundation's Alabama Experimental Program; National Science Foundation; Center of Research Excellence in Science and Technology (CREST); Center for Forest Ecosystem Assessment; CRESTCFEA [HRD 0420541]; United States Department of Agriculture, Forest Service Cooperative [06CA11330134074]; USDA National Institute of Food and Agriculture, McIntire-Stennis [1008953, 0218126]; CREST-CFEA [HRD 0420541]	National Science Foundation's Alabama Experimental Program; National Science Foundation(National Science Foundation (NSF)); Center of Research Excellence in Science and Technology (CREST); Center for Forest Ecosystem Assessment; CRESTCFEA; United States Department of Agriculture, Forest Service Cooperative; USDA National Institute of Food and Agriculture, McIntire-Stennis; CREST-CFEA	This work was supported by National Science Foundation's Alabama Experimental Program to Stimulate Competitive Research (Alabama EPSCoR) Graduate Research Scholars Program (GRSP) grant round 7, 8, and 9 (SO); the National Science Foundation, Center of Research Excellence in Science and Technology (CREST), Center for Forest Ecosystem Assessment, CRESTCFEA HRD 0420541 (LD); United States Department of Agriculture, Forest Service Cooperative Agreement number 06CA11330134074 (LD); and USDA National Institute of Food and Agriculture, McIntire-Stennis projects 1008953 and 0218126 (LD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This material is based upon work supported by the National Science Foundation's Alabama Experimental Program to Stimulate Competitive Research (Alabama EPSCoR) Graduate Research Scholars Program (GRSP) grant round 7, 8, and 9; the National Science Foundation, Center of Research Excellence in Science and Technology (CREST), Center for Forest Ecosystem Assessment, CREST-CFEA HRD 0420541; and by a United States Department of Agriculture, Forest Service Cooperative Agreement number 06CA11330134074. This work was also supported by the USDA National Institute of Food and Agriculture, McIntire-Stennis projects 1008953 and 0218126. We are thankful to the national forest inventory crews who collected the data and to Bill Burkman and Jeff Turner from the USDA Forest Service, Forest Inventory and Analysis (FIA) for their support in obtaining the data. We are grateful to Dr. Christopher W. Woodall for helpful suggestions concerning relative stand density and to Dr. Fernando Casanoves for guidance on using the Fdiversity software. We are also thankful to Dr. Andy Scott, Dr. Callie Schweitzer, Dr. Kozma Naka, Dr. Yong Wang, three anonymous reviewers and the Academic Editor of PLOS One for their reviews and valuable suggestions.	[Anonymous], 2009, FEDERAL FOREST HLTH; [Anonymous], 2010, MINNESOTA FOREST HLT; BEERS TW, 1966, J FOREST, V64, P691; Bell BA, 2013, INTERMEDIATE PRIMER; Belote RT, 2011, FOREST ECOL MANAG, V261, P1315, DOI 10.1016/j.foreco.2011.01.010; Black J.T, 1992, MULTIVARIATE DATA AN; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Casanoves F., 2008, USER MANUAL FDIVERSI, V2; Casanoves F, FDIVERSITY VERSION 2; Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x; Caspersen JP, 2001, ECOL RES, V16, P895, DOI 10.1046/j.1440-1703.2001.00455.x; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chhin S, 2016, FORESTS, V7, DOI 10.3390/f7100235; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Forrester DI, 2016, CURR FOR REP, V2, P45, DOI 10.1007/s40725-016-0031-2; Forrester DI, 2013, FOREST ECOL MANAG, V304, P233, DOI 10.1016/j.foreco.2013.04.038; Frayer WE, 1999, J FOREST, V97, P4; He JS, 2005, BASIC APPL ECOL, V6, P505, DOI 10.1016/j.baae.2005.04.002; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Hu LJ, 2013, NOT BOT HORTI AGROBO, V41, P36; Hulvey KB, 2013, NAT CLIM CHANGE, V3, P869, DOI [10.1038/nclimate1862, 10.1038/NCLIMATE1862]; Huston M A, 2000, Science, V289, P1255; Jenkins JC, 2003, FOREST SCI, V49, P12; John J. A., 1980, Applied Statistics, V29, P190, DOI 10.2307/2986305; Jucker T, 2014, J ECOL, V102, P1202, DOI 10.1111/1365-2745.12276; Kelty MJ, 2006, FOREST ECOL MANAG, V233, P195, DOI 10.1016/j.foreco.2006.05.011; KELTY MJ, 1992, FOR SCI, V40, P125; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Legendre P., 2012, NUMERICAL ECOLOGY, V24; Lohbeck M, 2012, PERSPECT PLANT ECOL, V14, P89, DOI 10.1016/j.ppees.2011.10.002; Long J. N., 1990, Western Journal of Applied Forestry, V5, P93; LONG JN, 1985, FOREST CHRON, V61, P23, DOI 10.5558/tfc61023-1; Ma WH, 2010, GLOBAL ECOL BIOGEOGR, V19, P233, DOI 10.1111/j.1466-8238.2009.00508.x; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Miles PD, 2009, NRS38 US DEP AGR FOR, P39; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Moore JC., 2001, ENCY BIODIVERSITY; Moser WK, 2009, P 8 ANN FOR INV AN S, P414; Moser WK, 2006, OAK COMPOSITION STRU; Neter J., 1996, APPL LINEAR STAT MOD; Ojha SK, 2015, TREE DIVERSITY PRODU; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Partel M, 2007, ECOLOGY, V88, P1091, DOI 10.1890/06-0997; Partel M, 2007, J ECOL, V95, P90, DOI 10.1111/j.1365-2745.2006.01185.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Pillon Y, 2006, BIOL CONSERV, V129, P4, DOI 10.1016/j.biocon.2005.06.036; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; Potter KM, 2014, FOREST ECOL MANAG, V321, P117, DOI 10.1016/j.foreco.2013.06.026; Reineke LH, 1933, J AGRIC RES, V46, P0627; Rodriguez-Loinaz G, 2008, SOIL BIOL BIOCHEM, V40, P49, DOI 10.1016/j.soilbio.2007.04.015; Scheiner SM, 2002, EVOL ECOL RES, V4, P1097; STOLINE MR, 1981, AM STAT, V35, P134, DOI 10.2307/2683979; Thoms C, 2010, SOIL BIOL BIOCHEM, V42, P1558, DOI 10.1016/j.soilbio.2010.05.030; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; USDA Forest Service, 2001, US FOR FACTS HIST TR; Vila M, 2005, ECOL STU AN, V176, P65; Vila M, 2003, OECOLOGIA, V135, P299, DOI 10.1007/s00442-003-1182-y; Vila M, 2007, ECOL LETT, V10, P241, DOI 10.1111/j.1461-0248.2007.01016.x; Vila M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053530; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Woodall CW, 2005, FOREST ECOL MANAG, V216, P367, DOI 10.1016/j.foreco.2005.05.050; Worrall JJ, 2013, FOREST ECOL MANAG, V299, P35, DOI 10.1016/j.foreco.2012.12.033; Woudenberg, 2010, FOREST INVENTORY ANA, DOI 10.2737/RMRS-GTR-245; Zifan A, 2016, US MAP KOPPEN CLIMAT; Zobel M, 2008, GLOBAL ECOL BIOGEOGR, V17, P679, DOI 10.1111/j.1466-8238.2008.00400.x	71	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187106	10.1371/journal.pone.0187106	http://dx.doi.org/10.1371/journal.pone.0187106			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140999	gold, Green Submitted, Green Published			2022-12-26	WOS:000415260400016
J	Triska, M; Solovyev, V; Baranova, A; Kel, A; Tatarinova, TV				Triska, Martin; Solovyev, Victor; Baranova, Ancha; Kel, Alexander; Tatarinova, Tatiana V.			Nucleotide patterns aiding in prediction of eukaryotic promoters	PLOS ONE			English	Article							ARABIDOPSIS INFORMATION RESOURCE; TRANSCRIPTION START SITES; FACTOR-BINDING SITES; R-LOOP FORMATION; GENE; DATABASE; IDENTIFICATION; EXPRESSION; SEQUENCE; ELEMENTS	Computational analysis of promoters is hindered by the complexity of their architecture. In less studied genomes with complex organization, false positive promoter predictions are common. Accurate identification of transcription start sites and core promoter regions remains an unsolved problem. In this paper, we present a comprehensive analysis of genomic features associated with promoters and show that probabilistic integrative algorithms-driven models allow accurate classification of DNA sequence into "promoters" and "non-promoters" even in absence of the full-length cDNA sequences. These models may be built upon the maps of the distributions of sequence polymorphisms, RNA sequencing reads on genomic DNA, methylated nucleotides, transcription factor binding sites, as well as relative frequencies of nucleotides and their combinations. Positional clustering of binding sites shows that the cells of Oryza sativa utilize three distinct classes of transcription factors: those that bind preferentially to the [-500,0] region (188 "promoter-specific" transcription factors), those that bind preferentially to the [0,500] region (282 "5' UTR-specific" TFs), and 207 of the "promiscuous" transcription factors with little or no location preference with respect to TSS. For the most informative motifs, their positional preferences are conserved between dicots and monocots.	[Triska, Martin] Univ Southern Calif, Childrens Hosp Los Angeles, Los Angeles, CA USA; [Triska, Martin] Univ South Wales, Fac Adv Technol, Pontypridd, M Glam, Wales; [Solovyev, Victor] Softberry Inc, Mt Kisco, NY USA; [Baranova, Ancha; Tatarinova, Tatiana V.] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Baranova, Ancha] Res Ctr Med Genet, Moscow, Russia; [Kel, Alexander] geneXplain GmbH, Wolfenbuettel, Germany; [Kel, Alexander] Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Tatarinova, Tatiana V.] Univ La Verne, Div Nat Sci, Dept Biol, La Verne, CA 91750 USA; [Tatarinova, Tatiana V.] RAS, Bioinformat Ctr, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Tatarinova, Tatiana V.] Vavilovs Inst Gen Genet, Moscow, Russia	Children's Hospital Los Angeles; University of Southern California; University of South Wales; George Mason University; Research Centre for Medical Genetics; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; University of La Verne; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Russian Academy of Sciences; Vavilov Institute for the History of Science & Technology of the Russian Academy of Sciences; Vavilov Institute of General Genetics	Tatarinova, TV (corresponding author), George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA.; Tatarinova, TV (corresponding author), Univ La Verne, Div Nat Sci, Dept Biol, La Verne, CA 91750 USA.; Tatarinova, TV (corresponding author), RAS, Bioinformat Ctr, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia.; Tatarinova, TV (corresponding author), Vavilovs Inst Gen Genet, Moscow, Russia.	ttatarinova@laverne.edu	Kel, Alexander E/I-7284-2013; Tatarinova, Tatiana Valerievna/AAU-4719-2021; Tatarinova, Tatiana/AAH-1915-2020; , Ancha/B-4608-2012; Baranova, Anna/HGB-3721-2022; Solovyev, Victor/C-4614-2013	Tatarinova, Tatiana/0000-0003-1787-1112; , Ancha/0000-0001-6810-5982; Solovyev, Victor/0000-0001-8885-493X	Federal Targeted Program "Research and development on priority directions of science and technology in Russia" [14.604.21.0101, RFMEFI60414X0101]; EU; NSF Division of Environmental Biology [1456634]; NSF STTR [1622840]; GeneXplain GmbH; Direct For Biological Sciences [1456634] Funding Source: National Science Foundation	Federal Targeted Program "Research and development on priority directions of science and technology in Russia"; EU(European Commission); NSF Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF STTR(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); GeneXplain GmbH; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AK was supported by a grant of the Federal Targeted Program "Research and development on priority directions of science and technology in Russia, 2014-2010", Contract No 14.604.21.0101, unique identifier of the applied scientific project: RFMEFI60414X0101. AK's work was also supported by the following grants of the EU FP7 program: "SYSCOL", "SysMedl BD", "RESOLVE" and "MIMOMICS". TT and MT were supported by the NSF Division of Environmental Biology (1456634). TT, MT and AB were supported by NSF STTR award 1622840. Additional funding was provided by GeneXplain GmbH in the form of salaries for AK, and by Softberry, Inc in the form of salary for VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; "AK was supported by a grant of the Federal Targeted Program "Research and development on priority directions of science and technology in Russia, 2014-2010", Contract No 14.604.21.0101, unique identifier of the applied scientific project: RFMEFI60414X0101. AK's work was also supported by the following grants of the EU FP7 program: "SYSCOL", "SysMedIBD", "RESOLVE" and "MIMOMICS". TT and MT were supported by the NSF Division of Environmental Biology (1456634). TT, MT and AB were supported by NSF STTR award 1622840. Additional funding was provided by GeneXplain GmbH in the form of salaries for AK, and by Softberry, Inc in the form salaries for VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Alexandrov NN, 2006, PLANT MOL BIOL, V60, P69, DOI 10.1007/s11103-005-2564-9; Ali MA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-47; Anwar F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-414; Azad AKM, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-19; Bajic VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s3; Batut P, 2013, CURR PROTOC MOL BIOL, V104, P11; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Dieterich C, 2003, NUCLEIC ACIDS RES, V31, P55, DOI 10.1093/nar/gkg007; Elhaik E, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-23; Fickett JW, 1997, GENOME RES, V7, P861, DOI 10.1101/gr.7.9.861; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Hieno A, 2014, NUCLEIC ACIDS RES, V42, pD1188, DOI 10.1093/nar/gkt1027; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Jenjaroenpun P, 2015, NUCLEIC ACIDS RES, V43, P10081, DOI 10.1093/nar/gkv974; Jenjaroenpun P, 2015, NUCLEIC ACIDS RES, V43, pD110, DOI 10.1093/nar/gku970; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034; Kawaji H, 2014, GENOME RES, V24, P708, DOI 10.1101/gr.156232.113; Kel A, 2006, BIOINFORMATICS, V22, P1190, DOI 10.1093/bioinformatics/btl041; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kiran K, 2006, PLANT PHYSIOL, V142, P364, DOI 10.1104/pp.106.084319; Kondrakhin Yu, 2016, EuPA Open Proteom, V13, P14, DOI 10.1016/j.euprot.2016.09.001; KONDRAKHIN YV, 1995, COMPUT APPL BIOSCI, V11, P477; Koschmann Jeannette, 2015, Microarrays (Basel), V4, P270, DOI 10.3390/microarrays4020270; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Law MY, 2015, PLANT PHYSIOL, V167, P25, DOI 10.1104/pp.114.245027; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Morton T, 2014, PLANT CELL, V26, P2746, DOI 10.1105/tpc.114.125617; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; PULLEN SS, 1995, J VIROL, V69, P3575, DOI 10.1128/JVI.69.6.3575-3583.1995; Rye M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-120; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sanz LA, 2016, MOL CELL, V63, P167, DOI 10.1016/j.molcel.2016.05.032; Shahmuradov IA, 2005, NUCLEIC ACIDS RES, V33, P1069, DOI 10.1093/nar/gki247; Shahmuradov IA, 2012, 2012 INT C BIOM ENG; Shahmuradov IA, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1353; SHINYA E, 1994, NUCLEIC ACIDS RES, V22, P2143, DOI 10.1093/nar/22.11.2143; Solovyev V, 2003, NUCL ACIDS RES, V31; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5; Stepanova M, 2005, BIOINFORMATICS, V21, P1789, DOI 10.1093/bioinformatics/bti307; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Stracke R, 2010, NEW PHYTOL, V188, P985, DOI 10.1111/j.1469-8137.2010.03421.x; Stracke R, 2010, PLANT CELL ENVIRON, V33, P88, DOI 10.1111/j.1365-3040.2009.02061.x; Tatarinova T, 2014, QUANT BIOL, V1, P261, DOI DOI 10.1007/S40484-013-0022-2; Tatarinova T, 2003, BIOINFORMATICS, V19, pi313, DOI 10.1093/bioinformatics/btg1043; Tatarinova T, 2013, GENOME BIOL EVOL, V5, P1443, DOI 10.1093/gbe/evt103; Tatarinova TV, 2016, SCI REP-UK, V6, DOI 10.1038/srep35730; Tatarinova TV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-308; Triska M, 2013, BIOINFORMATICS, V29, P2203, DOI 10.1093/bioinformatics/btt366; Troukhan M, 2009, OMICS, V13, P139, DOI 10.1089/omi.2008.0034; Umarov RK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171410; van Heeringen SJ, 2011, GENOME RES, V21, P410, DOI 10.1101/gr.111724.110; Viola IL, 2011, BIOCHEM J, V435, P143, DOI 10.1042/BJ20101019; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wongsurawat T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1075; Yao H, 2005, PLANT MOL BIOL, V57, P445, DOI 10.1007/s11103-005-0271-1	66	17	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187243	10.1371/journal.pone.0187243	http://dx.doi.org/10.1371/journal.pone.0187243			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141011	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400020
J	De Silva, G; Somaratne, V; Senaratne, S; Vipuladasa, M; Wickremasinghe, R; Wickremasinghe, R; Ranasinghe, S				De Silva, Gayani; Somaratne, Vijani; Senaratne, Sujai; Vipuladasa, Manuja; Wickremasinghe, Rajitha; Wickremasinghe, Renu; Ranasinghe, Shalindra			Efficacy of a new rapid diagnostic test kit to diagnose Sri Lankan cutaneous leishmaniasis caused by Leishmania donovani	PLOS ONE			English	Article							DNA; POLYMORPHISMS; SURVEILLANCE; DISTRICT; SAMPLES	Background Cutaneous leishmaniasis (CL) in Sri Lanka is caused by Leishmania donovani. This study assessed the diagnostic value of a new rapid diagnostic immunochromatographic strip (CL-Detect T IC-RDT), that captures the peroxidoxin antigen of Leishmania amastigotes. Methodology/Principal findings We sampled 74 clinically suspected CL lesions, of which 59 (79.7%) were positive by PCR, 43 (58.1%) by Giemsa stained slit skin smear (SSS) and 21 (28.4%) by the new IC-RDT. All samples which were positive either by SSS or IC-RDT or both were positive by PCR. The sensitivities of the IC-RDT and SSS compared to PCR were 36% and 73%, respectively. Fifteen patients from this endemic region were negative by all three tests. Twenty two clinically non-CL skin lesions from a CL non-endemic region were also negative by all three methods. Specificity and PPV of both IC-RDT and SSS compared to PCR were 100%; the NPVs of IC-RDT and SSS were 37% and 58%, respectively. The median parasite grading of the 59 PCR positive samples was 2+ (1-10 parasites/100 HPFs) and IC-RDT positive lesions was 3+ (1-10 parasites /10HPFs). The duration of the lesion was not associated with IC-RDT positivity. Conclusions/Significance The median parasite grade of Sri Lankan CL lesions is low. The low sensitivities of SSS and CL Detect T IC-RDT may be due to low parasite counts or low expression of peroxidoxin antigen in amastigotes of the Sri Lankan L. donovani strain. Our results indicate that negative SSS has to be combined with PCR for confirmation of CL in Sri Lanka. The current commercially available IC-RDT is not suitable to diagnose CL in Sri Lanka; an IC-RDT with improved sensitivity to detect L. donovani would be a valuable addition in the diagnostic tool kit for Sri Lanka.	[De Silva, Gayani; Senaratne, Sujai; Wickremasinghe, Renu; Ranasinghe, Shalindra] Univ Sri Jayewardenepura, Dept Parasitol, Nugegoda, Sri Lanka; [Somaratne, Vijani; Vipuladasa, Manuja] Dist Gen Hosp Hambantota, Hambantota, Sri Lanka; [Wickremasinghe, Rajitha] Univ Kelaniya, Dept Publ Hlth, Colombo, Sri Lanka	University Sri Jayewardenepura; University Kelaniya	Ranasinghe, S (corresponding author), Univ Sri Jayewardenepura, Dept Parasitol, Nugegoda, Sri Lanka.	ishalindra@sjp.ac.lk			University of Sri Jayewardenepura Sri Lanka [ASP/06/RE/MED/2012/30, ASP/06/RE/MED/2013/37]	University of Sri Jayewardenepura Sri Lanka	SR was funded by University of Sri Jayewardenepura Sri Lanka Grant number ASP/06/RE/MED/2012/30 and RW was funded by University of Sri Jayewardenepura Sri Lanka Grant number ASP/06/RE/MED/2013/37, http://research. sip.ac.ik/rersearch-grant/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; ATHUKORALE DN, 1992, J TROP MED HYG, V95, P432; Barr SD, 2001, J BIOL CHEM, V276, P34279, DOI 10.1074/jbc.M104406200; Bayih AG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003391; Ben Salah A, 2014, CLIN EVALUATION CL D; Ben Salah ANB., 2012, CL DETECT SELECTION; Campbell MJ, 2009, STAT SQUARE ONE; Castro H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002325; El Tai NO, 2000, T ROY SOC TROP MED H, V94, P575, DOI 10.1016/S0035-9203(00)90093-2; El Tai NO, 2001, EXP PARASITOL, V97, P35, DOI 10.1006/expr.2001.4592; Epidemiology Unit, 2009, WEEKL EP REP; Gajapathy K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-302; Harder S, 2006, EUKARYOT CELL, V5, P861, DOI 10.1128/EC.5.5.861-870.2006; Jing Bao-qian, 2009, Chinese Journal of Parasitology and Parasitic Diseases, V27, P102; Kariyawasam KKGDUL, 2015, PATHOG GLOB HEALTH, V109, P336, DOI 10.1179/2047773215Y.0000000032; Karunaweera ND, 2003, T ROY SOC TROP MED H, V97, P380, DOI 10.1016/S0035-9203(03)90061-7; Kassi M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000259; Kolivand M, 2015, J RES HEALTH SCI, V15, P104; McCall LI, 2015, J PROTEOME RES, V14, P1033, DOI 10.1021/pr5010604; McCall LI, 2013, VACCINE, V31, P1420, DOI 10.1016/j.vaccine.2012.11.065; Medley GF, 2015, NATURE, V528, pS102, DOI 10.1038/nature16042; Nawaratna SSK, 2007, EMERG INFECT DIS, V13, P1068, DOI 10.3201/eid1307.070227; Nawaratna SSK, 2009, INT J INFECT DIS, V13, P513, DOI 10.1016/j.ijid.2008.08.023; Ranasinghe S, 2015, MEM I OSWALDO CRUZ, V110, P1017, DOI 10.1590/0074-02760150286; Ranasinghe S, 2013, AM J TROP MED HYG, V89, P742, DOI 10.4269/ajtmh.12-0640; Ranawaka RR, 2012, CEYLON MED J, V57, P149, DOI 10.4038/cmj.v57i4.5082; RODGERS MR, 1990, EXP PARASITOL, V71, P267, DOI 10.1016/0014-4894(90)90031-7; Ronet C, 2011, VIRULENCE, V2, P547, DOI 10.4161/viru.2.6.17839; Rosypal AC, 2010, J PARASITOL, V96, P230, DOI 10.1645/GE-2288; Rycroft RJG, 2002, COLOUR HDB DERMATOLO; Semage SN, 2014, INT J INFECT DIS, V25, P53, DOI 10.1016/j.ijid.2014.03.1382; Sirimanna G, 2013, GUIDELINES MANAGEMEN, P7; Siriwardana HVYD, 2010, ANN TROP MED PARASIT, V104, P213, DOI 10.1179/136485910X12647085215615; Spotin A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/913510; Teixeira F, 2015, P NATL ACAD SCI USA, V112, pE616, DOI 10.1073/pnas.1419682112; Webb JR, 1998, INFECT IMMUN, V66, P3279, DOI 10.1128/IAI.66.7.3279-3289.1998; World Health Organization, 2010, CONTR LEISHM TECHN R; Zhang WW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004244	38	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187024	10.1371/journal.pone.0187024	http://dx.doi.org/10.1371/journal.pone.0187024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135995	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200012
J	Tang, L; Liu, ZC; Zhang, RP; Su, CM; Yang, WJ; Yao, YL; Zhao, SH				Tang, Li; Liu, Zichao; Zhang, Ruopeng; Su, Cunmei; Yang, Wenjuan; Yao, Youlin; Zhao, Shuhua			Imprinting alterations in sperm may not significantly influence ART outcomes and imprinting patterns in the cord blood of offspring	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; ABERRANT DNA METHYLATION; LOW-BIRTH-WEIGHT; FETAL-GROWTH; MALE-INFERTILITY; DISORDERS; GENES; LOCI; CONCEPTION	An increase in imprinting disorders in children conceived though assisted reproductive technologies (ARTs) has been the subject of several reports. The transmission of imprinting errors from the sperm of infertile fathers is believed to be a possible reason for the increased occurrence of these disorders. However, whether the imprinting alterations in sperm affect ART outcomes and the imprinting of offspring is unclear. In the current study, we analyzed the methylation of H19, SNRPN and KCNQ1OT1 by pyrosequencing sperm samples from 97 infertile patients and 31 proven fertile males as well as cord blood samples from 13 infantswho were conceived by infertile parents through intracytoplasmic sperm injection (ICSI) and 30 healthy newborns who were conceived naturally. After four cases were excluded owing to the lack of a sequencing signal, the infertile patients were subgrouped into normal (69 cases) and abnormal (24 cases) imprinting groups according to the reference range set by the control group. Between the groups, there were no significant differences in ART outcomes. Significantly different levels of methylation were detected in H19, but none of the imprinted genes were determined to be outside of the methylation reference range set by the values derived from the naturally conceived controls. Three CpG loci were found to be significantly hypomethylated in the maternally imprinted gene KCNQ1OT1 in two patients from the abnormal imprinting group, none of which were caused by sperm imprinting errors. In addition, the paternal H19 gene exhibited discrepant methylation patterns between the sperm controls and the cord blood controls. Our data suggest that increased imprinting errors in the sperm of infertile patients do not have an obvious influence on ART outcomes or the imprinting of offspring.	[Tang, Li; Su, Cunmei; Yang, Wenjuan; Yao, Youlin; Zhao, Shuhua] Kunming Med Univ, Affiliated Hosp 1, Dept Reprod & Genet, Kunming, Yunnan, Peoples R China; [Liu, Zichao] Kunming Univ, Dept Life Sci & Technol, Key Lab Special Biol Resource Dev & Utilizat Univ, Kunming, Yunnan, Peoples R China; [Zhang, Ruopeng] Dali Univ, Affiliated Hosp 1, Dept Reprod Med, Dali, Yunnan, Peoples R China; [Zhao, Shuhua] Yunnan Populat & Family Planning Res Inst, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming University; Dali University	Zhao, SH (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Reprod & Genet, Kunming, Yunnan, Peoples R China.; Zhao, SH (corresponding author), Yunnan Populat & Family Planning Res Inst, Kunming, Yunnan, Peoples R China.	kmshh1982@126.com			National Natural Science Foundation of China [81300542, 81260510]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under grants 81300542 and 81260510 (www.nsfc.gov.cn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero S, 2006, CYTOGENET GENOME RES, V113, P262, DOI 10.1159/000090841; Boissonnas CC, 2010, EUR J HUM GENET, V18, P73, DOI 10.1038/ejhg.2009.117; Camprubi C, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108456; Camprubi C, 2012, EPIGENETICS-US, V7, P1115, DOI 10.4161/epi.21743; Chiba H, 2013, PEDIATR INT, V55, P542, DOI 10.1111/ped.12185; Denomme MM, 2012, REPRODUCTION, V144, P393, DOI 10.1530/REP-12-0237; Eroglu A, 2012, SEMIN REPROD MED, V30, P92, DOI 10.1055/s-0032-1307417; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Ibala-Romdhane S, 2011, EUR J HUM GENET, V19, P1138, DOI 10.1038/ejhg.2011.99; Kagami M, 2007, J ASSIST REPROD GEN, V24, P131, DOI 10.1007/s10815-006-9096-3; Kanber D, 2009, EUR J HUM GENET, V17, P22, DOI 10.1038/ejhg.2008.177; Kitamura A, 2015, CONGENIT ANOM, V55, P133, DOI 10.1111/cga.12113; Klaver R, 2014, ASIAN J ANDROL, V16, P669, DOI 10.4103/1008-682X.125412; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kobayashi H, 2009, EUR J HUM GENET, V17, P1582, DOI 10.1038/ejhg.2009.68; Kuhtz J, 2014, HUM REPROD, V29, P1995, DOI 10.1093/humrep/deu155; Kuhtz J, 2014, EPIGENETICS-US, V9, P1648, DOI 10.4161/15592294.2014.988063; Laurentino S, 2015, HUM MOL GENET, V24, P1295, DOI 10.1093/hmg/ddu540; Lazaraviciute G, 2014, HUM REPROD UPDATE, V20, P840, DOI 10.1093/humupd/dmu033; Manipalviratn S, 2009, FERTIL STERIL, V91, P305, DOI 10.1016/j.fertnstert.2009.01.002; Market-Velker BA, 2010, HUM MOL GENET, V19, P36, DOI 10.1093/hmg/ddp465; McGovern PG, 2004, FERTIL STERIL, V82, P1514, DOI 10.1016/j.fertnstert.2004.06.038; Miozzo M, 2002, BIOL NEONATE, V81, P217, DOI 10.1159/000056752; Montjean D, 2013, FERTIL STERIL, V100, P1241, DOI 10.1016/j.fertnstert.2013.06.047; Moore GE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0074; Murphy SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040924; Oliver VF, 2012, FERTIL STERIL, V97, P147, DOI 10.1016/j.fertnstert.2011.10.027; Owen CM, 2009, SEMIN REPROD MED, V27, P417, DOI 10.1055/s-0029-1237430; Piedrahita JA, 2011, BIRTH DEFECTS RES A, V91, P682, DOI 10.1002/bdra.20795; Poplinski A, 2010, INT J ANDROL, V33, P642, DOI 10.1111/j.1365-2605.2009.01000.x; Sakian S, 2015, PLACENTA, V36, P1100, DOI 10.1016/j.placenta.2015.08.008; Sanchez-Delgado M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006427; Savage T, 2011, HUM REPROD, V26, P2392, DOI 10.1093/humrep/der212; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tabano S, 2010, EPIGENETICS-US, V5, P313, DOI 10.4161/epi.5.4.11637; Tierling S, 2010, J MED GENET, V47, P371, DOI 10.1136/jmg.2009.073189; Tomizawa S, 2012, J HUM GENET, V57, P84, DOI 10.1038/jhg.2011.151; Uyar A, 2014, CURR OPIN OBSTET GYN, V26, P210, DOI 10.1097/GCO.0000000000000071; Whitelaw N, 2014, HUM REPROD, V29, P1452, DOI 10.1093/humrep/deu094; Wisborg K, 2010, FERTIL STERIL, V94, P2102, DOI 10.1016/j.fertnstert.2010.01.014; Zheng HY, 2013, HUM REPROD, V28, P265, DOI 10.1093/humrep/des358	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187869	10.1371/journal.pone.0187869	http://dx.doi.org/10.1371/journal.pone.0187869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136648	gold, Green Submitted, Green Published			2022-12-26	WOS:000415121200039
J	Zhang, YF; Alekseyenko, AV				Zhang, Yifei; Alekseyenko, Alexander V.			Phylogenic inference using alignment-free methods for applications in microbial community surveys using 16s rRNA gene	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INTESTINAL MICROBIOTA; ANTIBIOTICS; DISTANCES; DATABASE; TOOL	The diversity of microbiota is best explored by understanding the phylogenetic structure of the microbial communities. Traditionally, sequence alignment has been used for phylogenetic inference. However, alignment-based approaches come with significant challenges and limitations when massive amounts of data are analyzed. In the recent decade, alignment-free approaches have enabled genome-scale phylogenetic inference. Here we evaluate three alignment-free methods: ACS, CVTree, and Kr for phylogenetic inference with 16s rRNA gene data. We use a taxonomic gold standard to compare the accuracy of alignment-free phylogenetic inference with that of common microbiome-wide phylogenetic inference pipelines based on PyNAST and MUSCLE alignments with FastTree and RAxML. We resimulate fecal communities from Human Microbiome Project data to evaluate the performance of the methods on datasets with properties of real data. Our comparisons show that alignment-free methods are not inferior to alignment-based methods in giving accurate and robust phylogenic trees. Moreover, consensus ensembles of alignment-free phylogenies are superior to those built from alignment-based methods in their ability to highlight community differences in low power settings. In addition, the overall running times of alignment-based and alignment-free phylogenetic inference are comparable. Taken together our empirical results suggest that alignment-free methods provide a viable approach for microbiome-wide phylogenetic inference.	[Zhang, Yifei; Alekseyenko, Alexander V.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Alekseyenko, Alexander V.] Med Univ S Carolina, Biomed Informat Ctr, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Alekseyenko, Alexander V.] Med Univ S Carolina, Dept Oral Hlth Sci, Program Human Microbiome Res, Charleston, SC 29425 USA	New York University; Medical University of South Carolina; Medical University of South Carolina	Alekseyenko, AV (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.; Alekseyenko, AV (corresponding author), Med Univ S Carolina, Biomed Informat Ctr, Dept Publ Hlth Sci, Charleston, SC 29425 USA.; Alekseyenko, AV (corresponding author), Med Univ S Carolina, Dept Oral Hlth Sci, Program Human Microbiome Res, Charleston, SC 29425 USA.	alekseye@musc.edu		zhang, yifei/0000-0003-4981-5844; Alekseyenko, Alexander/0000-0002-5748-2085	NYU internal medicine fellowship; National Cancer Institute [5R01CA164964]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [5R21AR067459]	NYU internal medicine fellowship; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NYU internal medicine fellowship, National Cancer Institute, 5R01CA164964, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 5R21AR067459.	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI [10.1093/nar/gkv1290, 10.1093/nar/gku1130]; Allen EK, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-22; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BLAISDELL BE, 1986, P NATL ACAD SCI USA, V83, P5155, DOI 10.1073/pnas.83.14.5155; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Haubold B, 2009, J COMPUT BIOL, V16, P1487, DOI 10.1089/cmb.2009.0106; Ianiro G, 2015, HELICOBACTER, V20, P68, DOI 10.1111/hel.12260; Kelly BJ, 2015, BIOINFORMATICS, V31, P2461, DOI 10.1093/bioinformatics/btv183; Kleiman SC, 2015, PSYCHOSOM MED, V77, P969, DOI 10.1097/PSY.0000000000000247; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Obata J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103712; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Ragan MA, 2014, RNA BIOL, V11, P176, DOI 10.4161/rna.27505; Redel H, 2013, J INFECT DIS, V207, P1105, DOI 10.1093/infdis/jit005; Rup L, 2012, INDIAN J MICROBIOL, V52, P315, DOI 10.1007/s12088-012-0304-9; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Song K, 2014, BRIEF BIOINFORM, V15, P343, DOI 10.1093/bib/bbt067; Song Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081330, 10.1371/journal.pone.0075729]; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Ulitsky I, 2006, J COMPUT BIOL, V13, P336, DOI 10.1089/cmb.2006.13.336; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Xu Z, 2009, NUCLEIC ACIDS RES, V37, pW174, DOI 10.1093/nar/gkp278; Zanvit P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9424	30	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e187940	10.1371/journal.pone.0187940	http://dx.doi.org/10.1371/journal.pone.0187940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136663	gold, Green Published, Green Submitted			2022-12-26	WOS:000415121200049
J	Krauss, S; Michaelis, L; Vetter, W				Krauss, Stephanie; Michaelis, Lea; Vetter, Walter			Phytyl fatty acid esters in vegetables pose a risk for patients suffering from Refsum's disease	PLOS ONE			English	Article							HEREDOPATHIA-ATACTICA POLYNEURITIFORMIS; VITRO DIGESTION MODEL; PHYTANIC ACID; BREAKDOWN; OILS; IDENTIFICATION; CHROMATOGRAPHY; MANAGEMENT; OXIDATION; FRACTION	Patients suffering from Refsum's disease show mutations in the enzyme necessary for the degradation of phytanic acid. Accumulation of this tetramethyl-branched fatty acid in inner organs leads to severe neurological and cardiac dysfunctions which can even result in death. Thus, patients with Refsum's disease have to follow a specific diet resigning foods with high levels of phytanic acid and trans-phytol like products from ruminant animals with a tolerable daily intake (TDI) of <= 10 mg/d. We recently reported the occurrence of phytyl fatty acid esters (PFAE, trans-phytol esterified with a fatty acid) in bell pepper with trans-phytol amounts of up to 5.4 mg/100 g fresh weight (FW). In this study we carried out in vitro-digestion experiments of PFAE with artificial digestion fluids. Our results demonstrate that PFAE actually are a source for bioavailable trans-phytol and thus add to the TDI. Eating only one portion of bell pepper (similar to 150 g) could therefore lead to exploitation of the TDI of up to 81%. Analysis of additional vegetable matrices showed that also rocket salad with up to 4.2 mg/100 g FW trans-phytol bound in PFAE represents a risk-relevant food for patients with Refsum's disease and should therefore be taken into account.	[Krauss, Stephanie; Michaelis, Lea; Vetter, Walter] Univ Hohenheim, Inst Food Chem, Stuttgart, Germany	University Hohenheim	Vetter, W (corresponding author), Univ Hohenheim, Inst Food Chem, Stuttgart, Germany.	walter.vetter@uni-hohenheim.de						Baldwin EJ, 2016, INT J CLIN PRACT, V70, P229, DOI 10.1111/ijcp.12770; BAXTER JH, 1968, J LIPID RES, V9, P636; Biedermann M, 2008, EUR J LIPID SCI TECH, V110, P1084, DOI 10.1002/ejlt.200800090; BROWN PJ, 1993, J HUM NUTR DIET, V6, P295, DOI 10.1111/j.1365-277X.1993.tb00375.x; Hammann S, 2015, ANAL BIOANAL CHEM, V407, P9019, DOI 10.1007/s00216-015-9068-5; Heinlein A, 2012, FOOD FUNCT, V3, P1059, DOI 10.1039/c2fo30061c; Ma LF, 1999, PHYTOCHEMISTRY, V50, P195, DOI 10.1016/S0031-9422(98)00584-6; MASTERSTHOMAS A, 1980, J HUM NUTR, V34, P245; Oomen AG, 2003, ARCH ENVIRON CON TOX, V44, P281, DOI 10.1007/s00244-002-1278-0; PATTON S, 1966, BIOCHIM BIOPHYS ACTA, V125, P22, DOI 10.1016/0005-2760(66)90140-8; Pereira AS, 2002, PHYTOCHEMISTRY, V61, P711, DOI 10.1016/S0031-9422(02)00348-5; Reiter B, 2001, J AM OIL CHEM SOC, V78, P881, DOI 10.1007/s11746-001-0359-z; Roca-Saavedra P, 2017, FOOD CHEM, V221, P237, DOI 10.1016/j.foodchem.2016.10.074; Scheer H, 2012, P NATL ACAD SCI USA, V109, P17311, DOI 10.1073/pnas.1214999109; Schroder M, 2014, EUR J LIPID SCI TECH, V116, P1372, DOI 10.1002/ejlt.201400095; Schroder M, 2014, CHROMATOGRAPHIA, V77, P379, DOI 10.1007/s10337-013-2588-2; STEINBER.D, 1965, BIOCHEM BIOPH RES CO, V19, P783, DOI 10.1016/0006-291X(65)90328-1; STEINBERG D, 1967, SCIENCE, V156, P1740, DOI 10.1126/science.156.3783.1740; STEINBERG D, 1967, J CLIN INVEST, V46, P313, DOI 10.1172/JCI105533; STOFFEL W, 1965, BIOCHEM BIOPH RES CO, V19, P33, DOI 10.1016/0006-291X(65)90114-2; SUGA T, 1974, PHYTOCHEMISTRY, V13, P1623, DOI 10.1016/0031-9422(74)80345-6; van den Brink DM, 2006, CELL MOL LIFE SCI, V63, P1752, DOI 10.1007/s00018-005-5463-y; van den Brink DM, 2004, MOL GENET METAB, V82, P33, DOI 10.1016/j.ymgme.2004.01.019; van den Brink DM, 2003, AM J HUM GENET, V72, P471, DOI 10.1086/346093; Vetter W., 2011, Lipid Technology, V23, P175, DOI 10.1002/lite.201100127; Vetter W, 2010, FOOD CHEM, V119, P746, DOI 10.1016/j.foodchem.2009.07.027; Villeneuve P, 2005, ENZYME MICROB TECH, V37, P150, DOI 10.1016/j.enzmictec.2005.02.002; Weinstein R, 1999, J CLIN APHERESIS, V14, P181, DOI 10.1002/(SICI)1098-1101(1999)14:4<181::AID-JCA5>3.0.CO;2-Z; Wierzbicki AS, 2002, J NEUROCHEM, V80, P727, DOI 10.1046/j.0022-3042.2002.00766.x	29	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0188035	10.1371/journal.pone.0188035	http://dx.doi.org/10.1371/journal.pone.0188035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131855	Green Published, Green Submitted, gold			2022-12-26	WOS:000414997800040
J	Matsumoto, C; Yamada, C; Sadakane, C; Nahata, M; Hattori, T; Takeda, H				Matsumoto, Chinami; Yamada, Chihiro; Sadakane, Chiharu; Nahata, Miwa; Hattori, Tomohisa; Takeda, Hiroshi			Psychological stress in aged female mice causes acute hypophagia independent of central serotonin 2C receptor activation	PLOS ONE			English	Article							PITUITARY-ADRENAL-AXIS; NOVELTY-INDUCED HYPOPHAGIA; ELEVATED PLUS-MAZE; GENDER-DIFFERENCES; SEX-DIFFERENCES; FOOD-INTAKE; RAT-BRAIN; LATE-LIFE; DEPRESSION; BEHAVIOR	Sex differences exist in the activation of the hypothalamic-pituitary-adrenal axis following exposure to stress, and the stress response is further affected by aging. This study was conducted to elucidate the mechanism of hypophagia in aged female mice exposed to stress. Immediately after a stress load, aged female mice exhibited acute hypophagia and a rise in plasma corticosterone levels. The administration of a serotonin 2C receptor (5-T2CR) antagonist suppressed plasma corticosterone but did not affect the reduction in food intake. In contrast, an endogenous ghrelin enhancer, rikkunshito (RKT), significantly inhibited the reduction in food intake. An increase in peripheral acylated ghrelin levels during fasting, which occurs in young mice, was not observed in aged female mice. Moreover, in these mice, significantly increased levels of ghrelin and gastric preproghrelin mRNA expression were observed in the fed status. Moreover, plasma ghrelin levels were elevated by RKT and not by the 5-HT2CR antagonist. In female mice, the hypothalamic non-edited (INI) and partially edited mRNA 5-HT2CR isoforms (VNV, VNI, VSV or VSI) decreased with age, while in male mice, the editing isoform was unchanged by aging or stress. Estrogen receptor alpha (ER alpha)-positive cell counts in the arcuate nucleus of young male mice exposed to stress and control aged male mice were increased compared with those in young control mice. In aged male mice exposed to stress, the number of ER alpha-expressing cells in the paraventricular nucleus were significantly increased compared with those in aged control mice; in female mice, there was no increase in the number of ER alpha-positive cells. Hypophagia in aged female mice exposed to stress may be independent of 5-HT2CR activation. It seems likely that the mechanisms may be caused by sex dependent, differential regulation in 5-HT2CR mRNA expression, peripheral acylated ghrelin secretion and/or hypothalamic ER alpha expression.	[Matsumoto, Chinami; Yamada, Chihiro; Sadakane, Chiharu; Nahata, Miwa; Hattori, Tomohisa] Tsumura & Co, Tsumura Res Labs, Ibaraki, Japan; [Takeda, Hiroshi] Hokkaido Univ, Fac Pharmaceut Sci, Pathophysiol & Therapeut, Sapporo, Hokkaido, Japan; [Takeda, Hiroshi] Hokkaido Univ Hosp Gastroenterol Med, Sapporo, Hokkaido, Japan	Tsumura & Company; Hokkaido University; Hokkaido University	Hattori, T (corresponding author), Tsumura & Co, Tsumura Res Labs, Ibaraki, Japan.	hattori_tomohisa@mail.tsumura.co.jp		Nahata, Miwa/0000-0002-4462-6887; Yamada, Chihiro/0000-0002-3690-893X	Tsumura Co.	Tsumura Co.(Tsumura & Company)	HT received a research grant from Tsumura & Co. Tsumura & Co. provided support in the form of salaries for authors CM, CY, CS, MN and TH. The specific roles of these authors are articulated in the 'author contributions' section. This study was funded by Tsumura & Co. Tsumura & Co. was responsible for the study design, and the collection, analysis and interpretation of data.	Arndt SS, 2009, PHYSIOL BEHAV, V97, P385, DOI 10.1016/j.physbeh.2009.03.008; Asarian L, 2013, AM J PHYSIOL-REG I, V305, pR1215, DOI 10.1152/ajpregu.00446.2012; Avissar S, 2004, AM J PSYCHIAT, V161, P2066, DOI 10.1176/appi.ajp.161.11.2066; Cruz APM, 2005, PSYCHOPHARMACOLOGY, V182, P345, DOI 10.1007/s00213-005-0108-2; De la Fuente M, 2003, NEUROCHEM INT, V43, P165, DOI 10.1016/S0197-0186(02)00212-7; Diniz BS, 2014, DEPRESS ANXIETY, V31, P787, DOI 10.1002/da.22226; Dombrovski AY, 2008, AM J GERIAT PSYCHIAT, V16, P905, DOI 10.1097/JGP.0b013e3181860034; Dryden S, 1996, PEPTIDES, V17, P943, DOI 10.1016/0196-9781(96)00142-8; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Ehlert U, 2001, BIOL PSYCHOL, V57, P141, DOI 10.1016/S0301-0511(01)00092-8; Fujitsuka N, 2016, MOL PSYCHIATR, V21, P1613, DOI 10.1038/mp.2015.220; Fujitsuka N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.25; Gardiner Katheleen, 2006, Briefings in Functional Genomics & Proteomics, V5, P37, DOI 10.1093/bfgp/ell006; Gatch MB, 2003, LIFE SCI, V73, P1347, DOI 10.1016/S0024-3205(03)00422-3; Gorwood P, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00256; Hackler EA, 2006, NEUROSCI RES, V55, P96, DOI 10.1016/j.neures.2006.02.005; Handa RJ, 2014, FRONT NEUROENDOCRIN, V35, P197, DOI 10.1016/j.yfrne.2013.11.001; Handa RJ, 2012, NEUROENDOCRINOLOGY, V96, P111, DOI 10.1159/000338397; Hayashi A, 2005, PSYCHOPHARMACOLOGY, V178, P241, DOI 10.1007/s00213-004-2019-z; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Heisler LK, 2007, J NEUROSCI, V27, P6956, DOI 10.1523/JNEUROSCI.2584-06.2007; Hemrick-Luecke SK, 2002, NEUROPHARMACOLOGY, V42, P162, DOI 10.1016/S0028-3908(01)00166-6; Henderson JA, 2008, ENDOCRINE, V33, P285, DOI 10.1007/s12020-008-9087-5; Hotta M, 1999, BRAIN RES, V823, P221, DOI 10.1016/S0006-8993(99)01177-4; Iwasaki-Sekino A, 2009, PSYCHONEUROENDOCRINO, V34, P226, DOI 10.1016/j.psyneuen.2008.09.003; Kennett GA, 1997, NEUROPHARMACOLOGY, V36, P609, DOI 10.1016/S0028-3908(97)00038-5; Kornstein SG, 1997, J CLIN PSYCHIAT, V58, P12; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; Lanfranco MF, 2009, J NEUROSCI METH, V179, P247, DOI 10.1016/j.jneumeth.2009.01.027; Liu J, 2012, ENDOCRINOLOGY, V153, P3337, DOI 10.1210/en.2011-2176; Miura H, 2002, SYNAPSE, V46, P116, DOI 10.1002/syn.10133; MORLEY JE, 1993, J AM COLL NUTR, V12, P337, DOI 10.1080/07315724.1993.10718319; Morley JE, 2010, CLIN GERIATR MED, V26, P287, DOI 10.1016/j.cger.2010.02.008; Nahata M, 2013, PSYCHONEUROENDOCRINO, V38, P2051, DOI 10.1016/j.psyneuen.2013.03.014; Nahata M, 2012, AM J PHYSIOL-GASTR L, V303, pG42, DOI 10.1152/ajpgi.00462.2011; Navarro A, 2013, AGE, V35, P821, DOI 10.1007/s11357-012-9415-9; Nonogaki K, 2008, VITAM HORM, V77, P149, DOI 10.1016/S0083-6729(06)77007-8; PAYKEL ES, 1994, ACTA PSYCHIAT SCAND, V89, P50, DOI 10.1111/j.1600-0447.1994.tb05803.x; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Saegusa Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE685, DOI 10.1152/ajpendo.00121.2011; Santollo J, 2012, BEHAV BRAIN RES, V232, P159, DOI 10.1016/j.bbr.2012.04.010; Schellekens H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032266; SEEMAN TE, 1994, ENDOCR REV, V15, P233, DOI 10.1210/er.15.2.233; STEENBERGEN HL, 1990, PHYSIOL BEHAV, V48, P571, DOI 10.1016/0031-9384(90)90302-K; Takeda H, 2008, GASTROENTEROLOGY, V134, P2004, DOI 10.1053/j.gastro.2008.02.078; Tsubouchi H, 2014, AM J PHYSIOL-LUNG C, V306, pL233, DOI 10.1152/ajplung.00096.2013; Yamada C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140094; Yamada C, 2015, PSYCHONEUROENDOCRINO, V55, P81, DOI 10.1016/j.psyneuen.2015.02.006; Zorrilla EP, 2003, TRENDS PHARMACOL SCI, V24, P421, DOI 10.1016/S0165-6147(03)00177-9	50	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187937	10.1371/journal.pone.0187937	http://dx.doi.org/10.1371/journal.pone.0187937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125864	Green Published, gold, Green Submitted			2022-12-26	WOS:000414866000030
J	Albacker, LA; Wu, J; Smith, P; Warmuth, M; Stephens, PJ; Zhu, P; Yu, LH; Chmielecki, J				Albacker, Lee A.; Wu, Jeremy; Smith, Peter; Warmuth, Markus; Stephens, Philip J.; Zhu, Ping; Yu, Lihua; Chmielecki, Juliann			Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; REGULATORY T-CELLS; PD-1 BLOCKADE; EXPRESSION; SURVIVAL	Immune evasion is a well-recognized hallmark of cancer and recent studies with immunotherapy agents have suggested that tumors with increased numbers of neoantigens elicit greater immune responses. We hypothesized that the immune system presents a common selective pressure on high mutation burden tumors and therefore immune evasion mutations would be enriched in high mutation burden tumors. The JAK family of kinases is required for the signaling of a host of immune modulators in tumor, stromal, and immune cells. Therefore, we analyzed alterations in this family for the hypothesized signature of an immune evasion mutation. Here, we searched a database of 61,704 unique solid tumors for alterations in the JAK family kinases (JAK1/2/3, TYK2). We used The Cancer Genome Atlas and Cancer Cell Line Encyclopedia data to confirm and extend our findings by analyzing gene expression patterns. Recurrent frameshift mutations in JAK1 were associated with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including endometrial, colorectal, stomach, and prostate carcinomas. Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1 frameshift exhibited reduced expression of interferon response signatures and multiple anti-tumor immune signatures. Importantly, endometrial cancer cell lines exhibited similar gene expression changes that were expected to be tumor cell intrinsic (e.g. interferon response) but not those expected to be tumor cell extrinsic (e.g. NK cells). From these data, we derive two primary conclusions: 1) JAK1 frameshifts are loss of function alterations that represent a potential pan-cancer adaptation to immune responses against tumors with microsatellite instability; 2) The mechanism by which JAK1 loss of function contributes to tumor immune evasion is likely associated with loss of the JAK1-mediated interferon response.	[Albacker, Lee A.; Stephens, Philip J.; Chmielecki, Juliann] Fdn Med Inc, Cambridge, MA 02141 USA; [Wu, Jeremy; Smith, Peter; Warmuth, Markus; Zhu, Ping; Yu, Lihua] H3 Biomed, Cambridge, MA 02139 USA	Foundation Medicine	Albacker, LA (corresponding author), Fdn Med Inc, Cambridge, MA 02141 USA.; Yu, LH (corresponding author), H3 Biomed, Cambridge, MA 02139 USA.	lalbacker@foundationmedicine.com; lihua_yu@h3biomedicine.com			Foundation Medicine Inc.; H3 Biosciences	Foundation Medicine Inc.; H3 Biosciences	This work was funded by Foundation Medicine Inc. and H3 Biosciences. This work was conducted by employees of these companies. The funders provided support in the form of salaries for authors (FMI: LAA, PJS, JC; H3 Biomedicine: JW, PS, MW, PZ, LY), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2015, CONT AN; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Begitt A, 2014, NAT IMMUNOL, V15, P168, DOI 10.1038/ni.2794; Bristol Myers Squib Company, 2014, OPDIVO NIV INJ PACK; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eletto D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13992; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Howitt BE, 2015, JAMA ONCOL, V1, P1319, DOI 10.1001/jamaoncol.2015.2151; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; JASS JR, 1986, J CLIN PATHOL, V39, P585, DOI 10.1136/jcp.39.6.585; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Merck & Co, 2014, KEYTRUDA PEMBR PACK; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naito Y, 1998, CANCER RES, V58, P3491; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Pachter L., 2011, MODELS TRANSCRIPT QU, P11043889, DOI 10.48550/arXiv.1104.3889; R Computer Team, 2015, R LANG ENV STAT COMP; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Ren Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03042; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Rstudio Team, 2015, RSTUDIO INT DEV R; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Schumacher K, 2001, CANCER RES, V61, P3932; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Smyrk TC, 2001, CANCER, V91, P2417, DOI 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.3.CO;2-L; Stelloo E, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9414; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun G. M., AM ASS CANC RES ANN; Thomas SJ, 2015, BRIT J CANCER, V113, P365, DOI 10.1038/bjc.2015.233; Tikidzhieva A, 2012, BRIT J CANCER, V106, P1239, DOI 10.1038/bjc.2012.53; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Yang CH, 2005, J BIOL CHEM, V280, P25849, DOI 10.1074/jbc.M413721200; Yelensky A., AM ASS CANC RES ANN; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	50	57	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0176181	10.1371/journal.pone.0176181	http://dx.doi.org/10.1371/journal.pone.0176181			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121062	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900001
J	Baaklini, S; Afridi, S; Nguyen, TN; Koukouikila-Koussounda, F; Ndounga, M; Imbert, J; Torres, M; Pradel, L; Ntoumi, F; Rihet, P				Baaklini, Sabrina; Afridi, Sarwat; Thy Ngoc Nguyen; Koukouikila-Koussounda, Felix; Ndounga, Mathieu; Imbert, Jean; Torres, Magali; Pradel, Lydie; Ntoumi, Francine; Rihet, Pascal			Beyond genome-wide scan: Association of a cis-regulatory NCR3 variant with mild malaria in a population living in the Republic of Congo	PLOS ONE			English	Article							FAMILY-BASED ASSOCIATION; NATURAL-KILLER-CELLS; ACUTE MYELOID-LEUKEMIA; FACTOR-ALPHA PROMOTER; PLASMODIUM-FALCIPARUM; NK CELLS; SICKLE-CELL; CYTOTOXICITY; EXPRESSION; NKP30	Linkage studies have revealed a linkage of mild malaria to chromosome 6p21 that contains the NCR3 gene encoding a natural killer cell receptor, whereas NCR3-412G>C (rs2736191) located in its promoter region was found to be associated with malaria in Burkina Faso. Here we confirmed the association of rs2736191 with mild malaria in a Congolese cohort and investigated its potential cis-regulatory effect. Luciferase assay results indicated that rs2736191-G allele had a significantly increased promoter activity compared to rs2736191-C allele. Furthermore, EMSAs demonstrated an altered binding of two nuclear protein complexes to the rs2736191-C allele in comparison to rs2736191-G allele. Finally, after in silico identification of transcription factor candidates, pull-down western blot experiments confirmed that both STAT4 and RUNX3 bind the region encompassing rs2736191 with a higher affinity for the G allele. To our knowledge, this is the first report that explored the functional role of rs2736191. These results support the hypothesis that genetic variation within natural killer cell receptors alters malaria resistance in humans.	[Baaklini, Sabrina; Afridi, Sarwat; Thy Ngoc Nguyen; Imbert, Jean; Torres, Magali; Pradel, Lydie; Rihet, Pascal] INSERM, TAGC UMR1090, Marseille, France; [Baaklini, Sabrina; Afridi, Sarwat; Thy Ngoc Nguyen; Imbert, Jean; Torres, Magali; Pradel, Lydie; Rihet, Pascal] Aix Marseille Univ, Marseille, France; [Koukouikila-Koussounda, Felix; Ntoumi, Francine] FCRM, Villa D6,Cite OMS AFRO, Brazzaville, Rep Congo; [Koukouikila-Koussounda, Felix; Ntoumi, Francine] Univ Marien Ngouabi, Fac Sci & Tech, Brazzaville, Rep Congo; [Ndounga, Mathieu] Ctr Etud Ressources Vegetales CERVE, Unite Rech Paludisme, Brazzaville, Rep Congo; [Ntoumi, Francine] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Afridi, Sarwat] Balochistan Univ Informat Technol Engn & Manageme, Quetta, Pakistan; [Thy Ngoc Nguyen] USTH, VAST, Hanoi, Vietnam	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Eberhard Karls University of Tubingen; Balochistan University of Information Technology, Engineering & Management Sciences BUITEMS; Vietnam Academy of Science & Technology (VAST)	Rihet, P (corresponding author), INSERM, TAGC UMR1090, Marseille, France.; Rihet, P (corresponding author), Aix Marseille Univ, Marseille, France.	pascal.rihet@univ-amu.fr	Imbert, Jean/AAG-1165-2020; pradel, lydie lp/M-5269-2016; Rihet, Pascal/GQP-1381-2022; Imbert, Jean/G-3248-2013; Rihet, Pascal/AAD-2018-2022; Inserm U1090, TAGC/ABE-9980-2021; Rihet, Pascal/L-2173-2016	Imbert, Jean/0000-0002-0478-9593; pradel, lydie lp/0000-0001-6385-5127; Rihet, Pascal/0000-0002-9459-3905; Imbert, Jean/0000-0002-0478-9593; Rihet, Pascal/0000-0002-9459-3905; Rihet, Pascal/0000-0002-9459-3905; Nguyen, Thy Ngoc/0000-0002-3181-9209	Institut National de la Sante et de la Recherche Medicale; Aix-Marseille University; French ministry of research and technology; Higher Education Commission from Pakistan; Vietnamese government; EDCTP	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Aix-Marseille University; French ministry of research and technology; Higher Education Commission from Pakistan; Vietnamese government; EDCTP	This work was supported by Institut National de la Sante et de la Recherche Medicale (Inserm) and Aix-Marseille University. SB, SA and TNN were supported by a PhD fellowship from the French ministry of research and technology, the Higher Education Commission from Pakistan, and the Vietnamese government, respectively. FKK, MD and FN are members of the Central African Network on Tuberculosis, HIV/AIDS and Malaria, CANTAM, supported by EDCTP. The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Ackerman H, 2005, ANN HUM GENET, V69, P559, DOI 10.1111/j.1529-8817.2005.00180.x; Agudelo O, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-38; Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2016, WORLD MAL REP 2015; Artavanis-Tsakonas K, 2003, J IMMUNOL, V171, P5396, DOI 10.4049/jimmunol.171.10.5396; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Baratin M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000228; Barbier M, 2008, MICROBES INFECT, V10, P673, DOI 10.1016/j.micinf.2008.03.001; Bottger E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033774; Bouyou-Akotet MK, 2004, CLIN INFECT DIS, V38, P342, DOI 10.1086/380646; Brisebarre A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-198; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Chen QF, 2014, P NATL ACAD SCI USA, V111, P1479, DOI 10.1073/pnas.1323318111; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chung EY, 2007, GENES IMMUN, V8, P577, DOI 10.1038/sj.gene.6364420; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; D'Ombrain MC, 2007, CELL HOST MICROBE, V2, P130, DOI 10.1016/j.chom.2007.06.012; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; Delahaye NF, 2007, MICROBES INFECT, V9, P160, DOI 10.1016/j.micinf.2006.11.002; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Flori L, 2003, HUM MOL GENET, V12, P375, DOI 10.1093/hmg/ddg033; Flori L, 2005, GENES IMMUN, V6, P472, DOI 10.1038/sj.gene.6364231; Golden-Mason L, 2010, HEPATOLOGY, V52, P1581, DOI 10.1002/hep.23896; Griffon A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1280; Hermsen CC, 2003, CLIN EXP IMMUNOL, V132, P467, DOI 10.1046/j.1365-2249.2003.02160.x; Hill AVS, 1999, BRIT MED BULL, V55, P401, DOI 10.1258/0007142991902457; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Kaluza W, 2000, J INVEST DERMATOL, V114, P1180, DOI 10.1046/j.1523-1747.2000.00001.x; Karimi M, 2009, EUR J HUM GENET, V17, P1454, DOI 10.1038/ejhg.2009.80; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kiss-Toth E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076034; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Korbel DS, 2005, J IMMUNOL, V175, P7466, DOI 10.4049/jimmunol.175.11.7466; Koukouikila-Koussounda F, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1617-7; Koukouikila-Koussounda F, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-9; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lai CB, 2012, J BIOL CHEM, V287, P7324, DOI 10.1074/jbc.M111.306936; Levanon D, 2014, MOL CELL BIOL, V34, P1158, DOI 10.1128/MCB.01202-13; Li SS, 2013, CELL HOST MICROBE, V14, P387, DOI 10.1016/j.chom.2013.09.007; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; Mavoungou E, 2003, EUR CYTOKINE NETW, V14, P134; Mavoungou E, 2007, J INFECT DIS, V195, P1521, DOI 10.1086/515579; Ndounga M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0918-6; Ohno SI, 2008, INT IMMUNOL, V20, P71, DOI 10.1093/intimm/dxm120; ORAGO ASS, 1991, CLIN EXP IMMUNOL, V86, P22, DOI 10.1111/j.1365-2249.1991.tb05768.x; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Quadt KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045658; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Srivastava BIS, 2006, LEUKEMIA RES, V30, P37, DOI 10.1016/j.leukres.2005.06.020; Subramani R, 2015, MBIO, V6, DOI 10.1128/mBio.01456-15; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P10, DOI 10.1016/0035-9203(87)90472-X; Urlaub D, 2017, J IMMUNOL, V198, P1944, DOI 10.4049/jimmunol.1601004; Venton G, 2016, IMMUNOL RES, V64, P1225, DOI 10.1007/s12026-016-8848-0; Wang KS, 2000, BLOOD, V95, P3183, DOI 10.1182/blood.V95.10.3183.010k36_3183_3190; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Yamamoto K, 2002, BIOCHEM BIOPH RES CO, V297, P1245, DOI 10.1016/S0006-291X(02)02378-1	63	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187818	10.1371/journal.pone.0187818	http://dx.doi.org/10.1371/journal.pone.0187818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121672	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900082
J	Ku, B; Hong, W; Keum, CW; Kim, M; Ryu, H; Jeon, D; Shin, HC; Kim, JH; Kim, SJ; Ryu, SE				Ku, Bonsu; Hong, Won; Keum, Chae Won; Kim, Myeongbin; Ryu, Hyunyeol; Jeon, Donghwan; Shin, Ho-Chul; Kim, Jae Hoon; Kim, Seung Jun; Ryu, Seong Eon			Structural and biochemical analysis of atypically low dephosphorylating activity of human dual-specificity phosphatase 28	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; CATALYTIC ACTIVATION; KINASE PHOSPHATASE; CRYSTAL-STRUCTURE; MECHANISM; MIGRATION; JNK	Dual-specificity phosphatases (DUSPs) constitute a subfamily of protein tyrosine phosphatases, and are intimately involved in the regulation of diverse parameters of cellular signaling and essential biological processes. DUSP28 is one of the DUSP subfamily members that is known to be implicated in the progression of hepatocellular and pancreatic cancers, and its biological functions and enzymatic characteristics are mostly unknown. Herein, we present the crystal structure of human DUSP28 determined to 2.1 angstrom resolution. DUSP28 adopts a typical DUSP fold, which is composed of a central beta-sheet covered by alpha-helices on both sides and contains a well-ordered activation loop, as do other enzymatically active DUSP proteins. The catalytic pocket of DUSP28, however, appears hardly accessible to a substrate because of the presence of nonconserved bulky residues in the protein tyrosine phosphatase signature motif. Accordingly, DUSP28 showed an atypically low phosphatase activity in the biochemical assay, which was remarkably improved by mutations of two nonconserved residues in the activation loop. Overall, this work reports the structural and biochemical basis for understanding a putative oncological therapeutic target, DUSP28, and also provides a unique mechanism for the regulation of enzymatic activity in the DUSP subfamily proteins.	[Ku, Bonsu; Keum, Chae Won; Shin, Ho-Chul; Kim, Seung Jun] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea; [Ku, Bonsu; Keum, Chae Won; Kim, Seung Jun] Univ Sci & Technol, KRIBB Sch, Dept Biosci, Daejeon, South Korea; [Hong, Won; Kim, Myeongbin; Ryu, Hyunyeol; Jeon, Donghwan; Ryu, Seong Eon] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul, South Korea; [Kim, Jae Hoon] Jeju Natl Univ, Coll Appl Life Sci, Dept Biotechnol, Cheju, Jeju Do, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Hanyang University; Jeju National University	Kim, SJ; Ryu, SE (corresponding author), Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea.; Kim, SJ (corresponding author), Univ Sci & Technol, KRIBB Sch, Dept Biosci, Daejeon, South Korea.; Ryu, SE (corresponding author), Hanyang Univ, Coll Engn, Dept Bioengn, Seoul, South Korea.	ksj@kribb.re.kr; ryuse@hanyang.ac.kr	Jeon, Donghwan/AAO-7146-2020; Kim, Seung Jun/N-5248-2019	Kim, Seung Jun/0000-0002-6913-6358; Ku, Bonsu/0000-0003-1784-8975	National Research Foundation of Korea - Ministry of Science, ICT and Future Planning of Korea [2015M3A9B5030308, 2015M3A9B5030302]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	National Research Foundation of Korea - Ministry of Science, ICT and Future Planning of Korea; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This work was supported by the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning of Korea (Grant number 2015M3A9B5030308; to SJK and Grant number 2015M3A9B5030302; to SER) and by the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program (to SJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal R, 2008, J BIOL CHEM, V283, P8946, DOI 10.1074/jbc.M708945200; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2004, J BIOL CHEM, V279, P32586, DOI 10.1074/jbc.M403442200; Bonham CA, 2009, J BIOL CHEM, V284, P22853, DOI 10.1074/jbc.M109.038612; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Defelipe LA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004051; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hong SB, 2005, BIOORG CHEM, V33, P34, DOI 10.1016/j.bioorg.2004.08.001; Jeong DG, 2014, ACTA CRYSTALLOGR D, V70, P421, DOI 10.1107/S1399004713029866; Kidger AM, 2016, SEMIN CELL DEV BIOL, V50, P125, DOI 10.1016/j.semcdb.2016.01.009; Kim JH, 2001, J BIOL CHEM, V276, P27568, DOI 10.1074/jbc.M010526200; Kolmodin K, 2001, FEBS LETT, V498, P208, DOI 10.1016/S0014-5793(01)02479-6; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ku B, 2016, BIOCHEM BIOPH RES CO, V478, P1217, DOI 10.1016/j.bbrc.2016.08.097; Lee J, 2016, TUMOR BIOL, V37, P12193, DOI 10.1007/s13277-016-5079-x; Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12296; Lokareddy RK, 2013, BIOCHEMISTRY-US, V52, P938, DOI 10.1021/bi301476m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pulido R, 2008, FEBS J, V275, P848, DOI 10.1111/j.1742-4658.2008.06250.x; Rios P, 2014, ANTIOXID REDOX SIGN, V20, P2251, DOI 10.1089/ars.2013.5709; Schumacher MA, 2002, BIOCHEMISTRY-US, V41, P3009, DOI 10.1021/bi015799l; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Takagaki K, 2004, BIOCHEM J, V383, P447, DOI 10.1042/BJ20040498; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wang D, 2014, INT J ONCOL, V45, P2596, DOI 10.3892/ijo.2014.2653; Won EY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162115; Won EY, 2013, ACTA CRYSTALLOGR D, V69, P1160, DOI 10.1107/S0907444913004770; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526	38	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187701	10.1371/journal.pone.0187701	http://dx.doi.org/10.1371/journal.pone.0187701			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121083	gold, Green Submitted, Green Published			2022-12-26	WOS:000414769900066
J	Sharma, V; Chow, HY; Siegel, D; Wurmbach, E				Sharma, Vishakha; Chow, Hoi Yan; Siegel, Donald; Wurmbach, Elise			Qualitative and quantitative assessment of Illumina's forensic STR and SNP kits on MiSeq FGx (TM)	PLOS ONE			English	Article							AMPLISEQ(TM) IDENTITY PANEL; VALIDATION; SYSTEM; PERFORMANCE; MULTIPLEX; POPULATION; CHALLENGES; MUTATION; LOCI	Massively parallel sequencing (MPS) is a powerful tool transforming DNA analysis in multiple fields ranging from medicine, to environmental science, to evolutionary biology. In forensic applications, MPS offers the ability to significantly increase the discriminatory power of human identification as well as aid in mixture deconvolution. However, before the benefits of any new technology can be employed, a thorough evaluation of its quality, consistency, sensitivity, and specificity must be rigorously evaluated in order to gain a detailed understanding of the technique including sources of error, error rates, and other restrictions/limitations. This extensive study assessed the performance of Illumina's MiSeq FGx MPS system and ForenSeq (TM) kit in nine experimental runs including 314 reaction samples. In-depth data analysis evaluated the consequences of different assay conditions on test results. Variables included: sample numbers per run, targets per run, DNA input per sample, and replications. Results are presented as heat maps revealing patterns for each locus. Data analysis focused on read numbers (allele coverage), drop-outs, drop-ins, and sequence analysis. The study revealed that loci with high read numbers performed better and resulted in fewer drop-outs and well balanced heterozygous alleles. Several loci were prone to drop-outs which led to falsely typed homozygotes and therefore to genotype errors. Sequence analysis of allele drop-in typically revealed a single nucleotide change (deletion, insertion, or substitution). Analyses of sequences, no template controls, and spurious alleles suggest no contamination during library preparation, pooling, and sequencing, but indicate that sequencing or PCR errors may have occurred due to DNA polymerase infidelities. Finally, we found utilizing Illumina's FGx System at recommended conditions does not guarantee 100% outcomes for all samples tested, including the positive control, and required manual editing due to low read numbers and/or allele drop-in. These findings are important for progressing towards implementation of MPS in forensic DNA testing.	[Sharma, Vishakha; Chow, Hoi Yan; Siegel, Donald; Wurmbach, Elise] Off Chief Med Examiner, Dept Forens Biol, New York, NY 10016 USA; [Chow, Hoi Yan] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Wurmbach, E (corresponding author), Off Chief Med Examiner, Dept Forens Biol, New York, NY 10016 USA.	ewurmbach@ocme.nyc.gov		Khosla, Pavan/0000-0002-6966-6084	National Institute of Justice, Office of Justice Programs, U.S. Department of Justice [2015-DN-BX-K005]	National Institute of Justice, Office of Justice Programs, U.S. Department of Justice	Parts of this project were supported by award No. 2015-DN-BX-K005 funded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect those of the Department of Justice.	Alessandrini F, 2003, J FORENSIC SCI, V48, P586; Almalki N, 2017, ELECTROPHORESIS, V38, P846, DOI 10.1002/elps.201600511; [Anonymous], 2021, LANG ENV STAT COMP; Bregu J, 2013, J FORENSIC SCI, V58, P120, DOI 10.1111/1556-4029.12008; Buchan JC, 2005, MOL ECOL NOTES, V5, P680, DOI 10.1111/j.1471-8286.2005.01002.x; Butler JM, 2012, ADVANCED TOPICS IN FORENSIC DNA TYPING: METHODOLOGY, P1; Churchill JD, 2016, FORENSIC SCI INT-GEN, V20, P20, DOI 10.1016/j.fsigen.2015.09.009; Churchill JD, 2015, CROAT MED J, V56, P218, DOI 10.3325/cmj.2015.56.218; Cowen S, 2011, FORENSIC SCI INT-GEN, V5, P400, DOI 10.1016/j.fsigen.2010.08.010; Eduardoff M, 2015, FORENSIC SCI INT-GEN, V17, P110, DOI 10.1016/j.fsigen.2015.04.007; Elena S, 2016, FORENSIC SCI INT-GEN, V22, P25, DOI 10.1016/j.fsigen.2015.07.011; Endrullat C, 2016, APPL TRANSL GENOM, V10, P2, DOI 10.1016/j.atg.2016.06.001; Fan Hao, 2007, Genomics Proteomics & Bioinformatics, V5, P7, DOI 10.1016/S1672-0229(07)60009-6; Fox E.J., 2014, NEXT GENER SEQ APPL, V1; Gettings KB, 2016, FORENSIC SCI INT-GEN, V21, P15, DOI 10.1016/j.fsigen.2015.11.005; Guo F, 2016, FORENSIC SCI INT-GEN, V25, P73, DOI 10.1016/j.fsigen.2016.07.021; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Jager AC, 2017, FORENSIC SCI INT-GEN, V28, P52, DOI 10.1016/j.fsigen.2017.01.011; Just RS, 2017, FORENSIC SCI INT-GEN, V28, P1, DOI 10.1016/j.fsigen.2017.01.001; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Luthra R, 2014, HAEMATOLOGICA, V99, P465, DOI 10.3324/haematol.2013.093765; LYGO JE, 1994, INT J LEGAL MED, V107, P77, DOI 10.1007/BF01225493; Mannhalter C, 2017, HAMOSTASEOLOGIE, V37, P138, DOI 10.5482/HAMO-17-01-0001; Mardis ER, 2017, NAT PROTOC, V12, P213, DOI 10.1038/nprot.2016.182; Matthijs G, 2016, EUR J HUM GENET, V24, P1515, DOI 10.1038/ejhg.2016.63; Moretti TR, 2001, J FORENSIC SCI, V46, P647; Mulero JJ, 2008, J FORENSIC SCI, V53, P838, DOI 10.1111/j.1556-4029.2008.00760.x; Papasavva T, 2013, EUR J HUM GENET, V21, P1403, DOI 10.1038/ejhg.2013.47; Peters FT, 2007, FORENSIC SCI INT, V165, P216, DOI 10.1016/j.forsciint.2006.05.021; Silvia A.L., 2016, INT J LEGAL MED; Strom SP, 2016, CANCER BIOL MED, V13, P3, DOI 10.28092/j.issn.2095-3941.2016.0004; SWGDAM, 2012, VAL GUID DNA AN METH; van der Gaag KJ, 2016, FORENSIC SCI INT-GEN, V24, P86, DOI 10.1016/j.fsigen.2016.05.016; Walsh PS, 1996, NUCLEIC ACIDS RES, V24, P2807, DOI 10.1093/nar/24.14.2807; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Willems T, 2016, AM J HUM GENET, V98, P919, DOI 10.1016/j.ajhg.2016.04.001; Xavier C, 2017, FORENSIC SCI INT-GEN, V28, P188, DOI 10.1016/j.fsigen.2017.02.018; Yang Yaran, 2014, Genomics Proteomics & Bioinformatics, V12, P190, DOI 10.1016/j.gpb.2014.09.001; Young B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178005; Zeng XP, 2015, FORENSIC SCI INT-GEN, V19, P172, DOI 10.1016/j.fsigen.2015.07.015; Zhao XY, 2016, FORENSIC SCI INT-GEN, V25, P34, DOI 10.1016/j.fsigen.2016.07.014; Zhao Z, 2015, META GENE, V5, P150, DOI 10.1016/j.mgene.2015.07.006	42	24	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187932	10.1371/journal.pone.0187932	http://dx.doi.org/10.1371/journal.pone.0187932			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121662	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900097
J	Spence, ES; Beck, JL; Gregory, AJ				Spence, Emma Suzuki; Beck, Jeffrey L.; Gregory, Andrew J.			Probability of lek collapse is lower inside sage-grouse Core Areas: Effectiveness of conservation policy for a landscape species	PLOS ONE			English	Article							ENERGY DEVELOPMENT; HABITAT; THRESHOLDS; RESPONSES	Greater sage-grouse (Centrocercus urophasianus) occupy sagebrush (Artemisia spp.) habitats in 11 western states and 2 Canadian provinces. In September 2015, the U.S. Fish and Wildlife Service announced the listing status for sage-grouse had changed from warranted but precluded to not warranted. The primary reason cited for this change of status was that the enactment of new regulatory mechanisms was sufficient to protect sage-grouse populations. One such plan is the 2008, Wyoming Sage Grouse Executive Order (SGEO), enacted by Governor Freudenthal. The SGEO identifies "Core Areas" that are to be protected by keeping them relatively free from further energy development and limiting other forms of anthropogenic disturbances near active sage-grouse leks. Using the Wyoming Game and Fish Department's sage-grouse lek count database and the Wyoming Oil and Gas Conservation Commission database of oil and gas well locations, we investigated the effectiveness of Wyoming's Core Areas, specifically: 1) how well Core Areas encompass the distribution of sage-grouse in Wyoming, 2) whether Core Area leks have a reduced probability of lek collapse, and 3) what, if any, edge effects intensification of oil and gas development adjacent to Core Areas may be having on Core Area populations. Core Areas contained 77% of male sage-grouse attending leks and 64% of active leks. Using Bayesian binomial probability analysis, we found an average 10.9% probability of lek collapse in Core Areas and an average 20.4% probability of lek collapse outside Core Areas. Using linear regression, we found development density outside Core Areas was related to the probability of lek collapse inside Core Areas. Specifically, probability of collapse among leks >4.83 km from inside Core Area boundaries was significantly related to well density within 1.61 km (1-mi) and 4.83 km (3-mi) outside of Core Area boundaries. Collectively, these data suggest that the Wyoming Core Area Strategy has benefited sage-grouse and sage-grouse habitat conservation; however, additional guidelines limiting development densities adjacent to Core Areas may be necessary to effectively protect Core Area populations.	[Spence, Emma Suzuki; Gregory, Andrew J.] Bowling Green State Univ, Sch Earth Environm & Soc, Bowling Green, OH 43403 USA; [Beck, Jeffrey L.] Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA	University System of Ohio; Bowling Green State University; University of Wyoming	Gregory, AJ (corresponding author), Bowling Green State Univ, Sch Earth Environm & Soc, Bowling Green, OH 43403 USA.	agregor@bgsu.edu		Gregory, Andrew/0000-0003-1905-3236; Spence, Emma/0000-0003-1595-0167	State of Wyoming via the Wyoming Natural Resource Conservation Trust (WWNRCT) [1002524]; Wyoming Wildlife and Natural Resource Trust; Bowling Green State University; University of Wyoming	State of Wyoming via the Wyoming Natural Resource Conservation Trust (WWNRCT); Wyoming Wildlife and Natural Resource Trust; Bowling Green State University; University of Wyoming	Funding was provided by the State of Wyoming via the Wyoming Natural Resource Conservation Trust (WWNRCT) (http://wwnrt.wyo. gov/) Grant #1002524 made to Jeffrey Beck at the University of Wyoming and Andrew Gregory at Bowling Green State University. The grant was administered by Mary Flandarka. The WWNRCT had no input into research design, data collection or project management.; We thank the Wyoming Wildlife and Natural Resource Trust for funding support, and Wyoming Oil and Gas Conservation Commission and Wyoming Game and Fish Department for providing data; Bowling Green State University for supporting E.S.S. and A.J.G., and the University of Wyoming for supporting J.L.B. We also thank our colleagues and journal reviewers who commented on and assisted in revising earlier versions of this paper.	[Anonymous], 2014, R LANG ENV STAT COMP; Applegate DH, 2014, HUM-WILDL INTERACT, V8, P284; Baumgart J., 2011, THESIS; Blomberg EJ, 2014, ECOL EVOL, V4, P4488, DOI 10.1002/ece3.1139; Braun C. E., 1998, P W ASS STATE FISH W, V78, P139; Candolin U, 2009, J FISH BIOL, V75, P2108, DOI 10.1111/j.1095-8649.2009.02405.x; Clifford D, 2014, REGRESS PACKAGE R PA; Coates PS, 2016, J APPL ECOL, V53, P83, DOI 10.1111/1365-2664.12558; Connelly J. W., 2004, UNPUB; Department of the Interior, 2015, END THREAT WILDL PLA; Department of the Interior, 2010, END THREAT WILDL PLA; Dinkins JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150798; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Doherty KE, 2010, J WILDLIFE MANAGE, V74, P1544, DOI 10.2193/2009-043; Doherty KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010339; ESRI, 2011, ARCGIS DESKT REL 10; Fedy BC, 2012, J WILDLIFE MANAGE, V76, P1062, DOI 10.1002/jwmg.337; Fedy BC, 2011, J WILDLIFE MANAGE, V75, P1022, DOI 10.1002/jwmg.155; Fedy BC, 2011, OECOLOGIA, V165, P915, DOI 10.1007/s00442-010-1768-0; Flashpole DJ, 2001, SPECIES SPECIFIC EDG; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gamo RS, 2017, ENVIRON MANAGE, V59, P189, DOI 10.1007/s00267-016-0789-9; Gardner R. H., 2001, SCALING RELATIONS EX; Garton EO, 2011, STUD AVIAN BIOL, P293; Gregory AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097132; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Haven WR, 1978, SCI AM, V238, P260; Hess JE, 2012, J WILDLIFE MANAGE, V76, P1625, DOI 10.1002/jwmg.417; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Hornaday W.T., 1916, NEW YORK ZOOLOGICAL, V5, P179; Knight D.H., 2014, MOUNTAINS PLAINS ECO; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Nielson R.M., 2015, ANAL GREATER SAGE GR; PAW: Petroleum Association of Wyoming, 2015, OIL GAS FACTS FIG; Richards H, 2015, BUFFALO B; Schroeder MA, 2004, CONDOR, V106, P363, DOI 10.1650/7425; Smith KT, 2016, ENVIRON MANAGE, V58, P585, DOI 10.1007/s00267-016-0745-8; State of Wyoming, 2008, GREAT SAG GROUS AR P; Taylor RL, 2012, G09AC00013 BUR LAND; Taylor RL, 2015, PLOS ONE, V8; Thuermer AMJ, 2014, HIGH COUNTRY NEWS; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; U. S. Fish and Wildlife Service, 2015, GREAT SAG GROUS CONS; U.S. Fish and Wildlife Service, 2013, GREAT SAG GROUS CENT; Walsh DP, 2001, WILDLIFE SOC, V32, P56; Winder VL, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00536.1; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; WOGCC, 2012, SPUD REP; Wyoming Business Alliance, 2008, WYOM OIL GAS EC CONT; [No title captured]	51	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0185885	10.1371/journal.pone.0185885	http://dx.doi.org/10.1371/journal.pone.0185885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121066	gold, Green Submitted, Green Published			2022-12-26	WOS:000414769900009
J	Veite-Schmahl, MJ; Rivers, AC; Regan, DP; Kennedy, MA				Veite-Schmahl, Michelle J.; Rivers, Adam C.; Regan, Daniel P.; Kennedy, Michael A.			The Mouse Model of Pancreatic Cancer Atlas (MMPCA) for classification of pancreatic cancer lesions: A large histological investigation of the Ptf1a(Cre/+); LSL-Kras(G12D/+) transgenic mouse model of pancreatic cancer	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; STATISTICS; CONSENSUS; SYSTEM	Pancreatic ductal adenocarcinoma (PDAC) is one of the leading forms of cancer related deaths in the United States. With limited treatment options and unreliable diagnostic methods, long-term survival rates following a diagnosis of pancreatic cancer remain poor. Pancreatic intraepithelial neoplasia (PanIN) are precancerous lesions that precede progression towards PDAC. PanIN occur in increasing complexity as the disease progresses and the description of PanIN plays a critical role in describing, staging and diagnosing PDAC. Inconsistencies in PanIN classifications exist even amongst leading pathologists. This has led to debate and confusion among researchers and pathologists involved in pancreatic cancer research, diagnosis and treatment. We have sought to initiate a discussion with leading pathologists with a goal of increasing consensus in the interpretation of PanIN and associated structures within the precancerous pancreas. Toward achieving this goal, we are in the process of conducting an extensive study of over 1000 male and female pancreata in varying stages of PanIN progression isolated from the Ptf1a(Cre/+); LSL-Kras(G12D/+) transgenic mouse model of pancreatic cancer. Using this extensive database, we have established the Mouse Model of Pancreatic Cancer Atlas (MMPCA) to serve as a platform for meaningful and interactive discussion among researchers and pathologists who study pancreatic disease. We hope that the MMPCA will be an effective tool for promoting a more consistent and accurate consensus of PanIN classifications in the future.	[Veite-Schmahl, Michelle J.; Rivers, Adam C.; Regan, Daniel P.; Kennedy, Michael A.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA	Miami University	Kennedy, MA (corresponding author), Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA.	kennedm4@miamioh.edu	Kennedy, Michael/ABE-6002-2021; Kennedy, Michael/M-2578-2019	Regan, Daniel/0000-0002-6363-0144; Kennedy, Michael/0000-0001-6462-665X	National Cancer Institute of the National Institutes of Health [1R15CA152985]	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant to MAK from the National Cancer Institute of the National Institutes of Health through grant number 1R15CA152985.	Andea A, 2003, MODERN PATHOL, V16, P996, DOI 10.1097/01.MP.0000087422.24733.62; Basturk O, 2015, AM J SURG PATHOL, V39, P1730, DOI 10.1097/PAS.0000000000000533; Funahashi H, 2007, CANCER RES, V67, P7068, DOI 10.1158/0008-5472.CAN-07-0970; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Lopes RB, 2007, INT J CANCER, V120, P2344, DOI 10.1002/ijc.22554; Luttges J, 2001, AM J PATHOL, V158, P1677, DOI 10.1016/S0002-9440(10)64123-5; Ottenhof NA, 2009, ARCH PATHOL LAB MED, V133, P375, DOI 10.1043/1543-2165-133.3.375; Reichert M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9298535; Schmid RM, 2002, J CLIN INVEST, V109, P1403, DOI 10.1172/JCI200215889; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Storz P, 2017, NAT REV GASTRO HEPAT, V14, P296, DOI 10.1038/nrgastro.2017.12; Takaori Kyoichi, 2003, J Hepatobiliary Pancreat Surg, V10, P125, DOI 10.1007/s00534-003-0756-8; Veite-Schmahl MJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55647; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706	22	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187552	10.1371/journal.pone.0187552	http://dx.doi.org/10.1371/journal.pone.0187552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121082	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900047
J	Xiao, WJ; Zhu, Y; Dai, B; Ye, DW				Xiao, Wen-jun; Zhu, Yao; Dai, Bo; Ye, Ding-wei			Evaluation of the major changes in eighth edition of the American Joint Committee on Cancer pathological staging for prostate cancer treated with prostatectomy	PLOS ONE			English	Article								This study aimed to evaluate the major changes of the eighth edition of the American Joint Committee on Cancer (AJCC) pathologic staging for prostate cancer treated with radical prostatectomy. A total of 138,176 patients diagnosed with prostate adenocarcinoma undergoing radical prostatectomy were selected from the Surveillance, Epidemiology and End Results (SEER) database during 2004-2014 period. Excluded were cases with incomplete or unavailable staging, PSA and Gleason score information. Two subgroups were established: group a, T2 stage with PSA >= 20ng/ml; group b, T2 stage with Gleason score grade group 5 and PSA<20ng/ml. The median follow-up time was 58 months. The median age at diagnosis for the overall group was 61 years, and the median PSA was 5.7ng/ml. Cancer-specific survival (CSS) at tenth years was 99.3% for T2a/T2b, 99.2% for T2c, respectively. The survival differences between T2a/T2b and T2c did not have statistical significance (P = .323). It was necessary for the current eighth edition to define a single pathologic T2 category, eliminating the subcategories, for all organ-confined disease. CSS at the tenth years was 98.4% for group a, 92.6% for group b, respectively. The prognosis of group a was worse than AJCC II (P = .002). The prognosis of group b was not only worse than AJCC II (P < .001), but also worse than AJCC IIIB. There was necessity to separate the disease with PSA >= 20ng/ml or Gleason score grade group 5 from other organ-confined disease. The present study supported the scientificity of the eighth edition of AJCC pathologic staging for prostate cancer.	[Xiao, Wen-jun; Zhu, Yao; Dai, Bo; Ye, Ding-wei] Fudan Univ, Dept Urol, Shanghai Canc Ctr, Shanghai, Peoples R China; [Xiao, Wen-jun; Zhu, Yao; Dai, Bo; Ye, Ding-wei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China	Fudan University; Fudan University	Zhu, Y; Ye, DW (corresponding author), Fudan Univ, Dept Urol, Shanghai Canc Ctr, Shanghai, Peoples R China.; Zhu, Y; Ye, DW (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.	mailzhuyao@163.com; dwyeli@163.com			Shanghai Municipal Commission of Health and Family Planning [20164Y0256]	Shanghai Municipal Commission of Health and Family Planning	This work was supported by the Research Projects of Shanghai Municipal Commission of Health and Family Planning (grant no. 20164Y0256), http://www.wsjsw.gov.cn/wsj/.	Bostwick DG, 1997, EUR UROL, V32, P2; Buyyounouski MK, 2017, CA-CANCER J CLIN, V67, P246, DOI 10.3322/caac.21391; Buyyounouski MK, 2017, AJCC CANC STAGING MA, P715, DOI DOI 10.1007/978-3-319-40618-3; Chun FKH, 2006, EUR UROL, V49, P273, DOI 10.1016/j.eururo.2005.12.009; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Epstein JI, 2016, EUR UROL, V69, P428, DOI 10.1016/j.eururo.2015.06.046; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Shukla ME, 2015, CLIN GENITOURIN CANC, V13, P17, DOI 10.1016/j.clgc.2014.07.003; van der Kwast TH, 2011, MODERN PATHOL, V24, P16, DOI 10.1038/modpathol.2010.156; Zaorsky NG, 2012, CANCER-AM CANCER SOC, V118, P5535, DOI 10.1002/cncr.27597	10	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187887	10.1371/journal.pone.0187887	http://dx.doi.org/10.1371/journal.pone.0187887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121104	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900088
J	Garg, PK; Lokitz, SJ; Truong, L; Putegnat, B; Reynolds, C; Rodriguez, L; Nazih, R; Nedrelow, J; de la Guardia, M; Uffman, JK; Garg, S; Thornton, PS				Garg, Pradeep K.; Lokitz, Stephen J.; Truong, Lisa; Putegnat, Burton; Reynolds, Courtney; Rodriguez, Larry; Nazih, Rachid; Nedrelow, Jonathan; de la Guardia, Miguel; Uffman, John K.; Garg, Sudha; Thornton, Paul S.			Pancreatic uptake and radiation dosimetry of 6-[F-18]fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; COMPUTED TOMOGRAPHY; F-18-DOPA PET; BRAIN-TUMORS; INSULIN; DIAGNOSIS; RECONSTRUCTION; ACCURACY; HUMANS	The aim of this study is to assess the radiation absorbed dose of F-18-Fluoro-L-DOPA derived from the Positron Emission Tomography (PET) images of infants age ranging from 2 weeks 32 weeks and a median age of 4.84 weeks (Mean 10.0 +/- 10.3 weeks) with congenital hyperinsulinism. Methods After injecting 25.6 +/- 8.8 MBq (0.7 +/- 0.2 mCi) of F-18-Fluoro-L-DOPA intravenously, three static PET scans were acquired at 20, 30, and 40 min post injection in 3-D mode on 10 patients (6 male, 4 female) with congenital hyperinsulinism. Regions of interest (ROls) were drawn over several organs visible in the reconstructed PET/CT images and time activity curves (TACs) were generated. Residence times were calculated using the TAC data. The radiation absorbed dose for the whole body was calculated by entering the residence times in the OLINDA/EXM 1.0 software. Results The mean residence times for the 18F-Fluoro-L-DOPA in the liver, lungs, kidneys, muscles, and pancreas were 11.54 +/- 2.84, 1.25 +/- 0.38, 4.65 +/- 0.97, 17.13 +/- 2.62, and 0.89 +/- 0.34 min, respectively. The mean effective dose equivalent for 18F-Fluoro-L-DOPA was 0.40 +/- 0.04 mSv/MBq. The CT scan used for attenuation correction delivered an additional radiation dose of 5.7 mSv. The organs receiving the highest radiation absorbed dose from F-18-Fluoro-L-DOPA were the urinary bladder wall (2.76 +/- 0.95 mGy/MBq), pancreas (0.87 0.30 mGy/MBq), liver (0.34 +/- 0.07 mGy/MBq), and kidneys (0.61 +/- 0.11 mGy/MBq). The renal system was the primary route for the radioactivity clearance and excretion. Conclusions The estimated radiation dose burden from F-18-Fluoro-L-DOPA is relatively modest to newborns.	[Garg, Pradeep K.; Lokitz, Stephen J.; Nazih, Rachid; Garg, Sudha] Biomed Res Fdn, Ctr Mol Imaging & Therapy, Shreveport, LA 71103 USA; [Truong, Lisa; Putegnat, Burton; Reynolds, Courtney; Rodriguez, Larry; Nedrelow, Jonathan; de la Guardia, Miguel; Uffman, John K.; Thornton, Paul S.] Cook Childrens Med Ctr, Ft Worth, TX USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Cook Children's Medical Center	Garg, PK (corresponding author), Biomed Res Fdn, Ctr Mol Imaging & Therapy, Shreveport, LA 71103 USA.	pradeep.garg@cmitla.org		Garg, Pradeep/0000-0002-8874-7082	Center for Molecular Imaging and Therapy; JES Edwards Foundation; Fort Worth TX; Once Upon A Time Foundation; Cook Children's Health Care System, Fort Worth, TX Endowed Chair for Hyperinsulinism; Biomedical Research Foundation of Northwest Louisiana [CMIT-2016.1]	Center for Molecular Imaging and Therapy; JES Edwards Foundation; Fort Worth TX; Once Upon A Time Foundation; Cook Children's Health Care System, Fort Worth, TX Endowed Chair for Hyperinsulinism; Biomedical Research Foundation of Northwest Louisiana	The Center for Molecular Imaging and Therapy (PKG), JES Edwards Foundation, Fort Worth TX (PST), The Once Upon A Time Foundation, Fort Worth TX (PST), and the Cook Children's Health Care System, Fort Worth, TX Endowed Chair for Hyperinsulinism and the Biomedical Research Foundation of Northwest Louisiana (CMIT-2016.1) to PKG. The funders have no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adzick NS, 2004, J PEDIATR SURG, V39, P270, DOI 10.1016/j.jpedsurg.2003.11.019; [Anonymous], 1981, ANN ICRP, V6, P1; [Anonymous], 1991, ICRP60; Barthlen W, 2008, J CLIN ENDOCR METAB, V93, P869, DOI 10.1210/jc.2007-2036; Blomberg BA, 2013, MOL IMAGING BIOL, V15, P97, DOI 10.1007/s11307-012-0572-0; Brady C, 2015, INT J PEDIATR ENDOCR, DOI 10.1186/s13633-015-0012-4; Brown WD, 1998, J NUCL MED, V39, P1884; Chen W, 2006, J NUCL MED, V47, P904; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Dhawan V, 1996, J NUCL MED, V37, P1850; Gleich T, 2015, J NEUROSCI, V35, P9615, DOI 10.1523/JNEUROSCI.0329-15.2015; Hardy OT, 2007, J CLIN ENDOCR METAB, V92, P4706, DOI 10.1210/jc.2007-1637; Hardy OT, 2007, J PEDIATR-US, V150, P140, DOI 10.1016/j.jpeds.2006.08.028; HARVEY J, 1985, J NUCL MED, V26, P931; Hoegerle S, 2003, EUR J NUCL MED MOL I, V30, P689, DOI 10.1007/s00259-003-1115-3; Hussain K, 2006, J CLIN ENDOCR METAB, V91, P2839, DOI 10.1210/jc.2006-0455; Iatrou M, 2004, IEEE NUCL SCI CONF R, P2493; Imperiale A, 2015, EUR J NUCL MED MOL I, V42, P409, DOI 10.1007/s00259-014-2943-z; Ishiwata K, 1996, NUCL MED BIOL, V23, P295, DOI 10.1016/0969-8051(95)02083-7; Jakoby BW, 2011, PHYS MED BIOL, V56, P2375, DOI 10.1088/0031-9155/56/8/004; Kauhanen S, 2008, J CLIN ONCOL, V26, P5307, DOI 10.1200/JCO.2008.18.8581; Kaul Alexander, 2008, Annals of the ICRP, V38, P1; Laje P, 2013, J PEDIATR SURG, V48, P388, DOI 10.1016/j.jpedsurg.2012.11.025; LEENDERS KL, 1990, ARCH NEUROL-CHICAGO, V47, P1290, DOI 10.1001/archneur.1990.00530120034007; LINDSTROM P, 1986, BIOCHIM BIOPHYS ACTA, V884, P276, DOI 10.1016/0304-4165(86)90174-1; LOVENBERG W, 1962, J BIOL CHEM, V237, P89; LUXEN A, 1992, NUCL MED BIOL, V19, P149, DOI 10.1016/0883-2897(92)90002-G; Meintjes M, 2013, NUCL MED COMMUN, V34, P601, DOI 10.1097/MNM.0b013e32836069d0; MEJIA AA, 1991, J NUCL MED, V32, P699; Mohnike K, 2006, HORM RES, V66, P40, DOI 10.1159/000093471; Nioche C, 2013, CLIN NUCL MED, V38, P81, DOI 10.1097/RLU.0b013e318279fd5a; Nurmi E, 2001, MOVEMENT DISORD, V16, P608, DOI 10.1002/mds.1139; OIE HK, 1983, ENDOCRINOLOGY, V112, P1070, DOI 10.1210/endo-112-3-1070; Panin VY, 2006, IEEE T MED IMAGING, V25, P907, DOI 10.1109/TMI.2006.876171; Ribeiro MJ, 2007, EUR J NUCL MED MOL I, V34, P2120, DOI 10.1007/s00259-007-0498-y; Ribeiro MJ, 2005, J NUCL MED, V46, P560; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; Ruotsalainen U, 1996, J NUCL MED, V37, P387; Santhanam P, 2014, CLIN ENDOCRINOL, V81, P789, DOI 10.1111/cen.12566; Stabin MG, 2005, J NUCL MED, V46, P1023; Tessonnier L, 2010, J CLIN ENDOCR METAB, V95, P303, DOI 10.1210/jc.2009-1357; Wagner FM, 2009, J NUCL MED, V50, P1724, DOI 10.2967/jnumed.109.063297; Walter F, 2012, J NUCL MED, V53, P393, DOI 10.2967/jnumed.111.095711; Yakemchuk VN, 2012, NUCL MED COMMUN, V33, P322, DOI 10.1097/MNM.0b013e32834f2603; Zani A, 2011, J PEDIATR SURG, V46, P204, DOI 10.1016/j.jpedsurg.2010.09.093	45	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0186340	10.1371/journal.pone.0186340	http://dx.doi.org/10.1371/journal.pone.0186340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117181	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600005
J	Saeed-Zidane, M; Linden, L; Salilew-Wondim, D; Held, E; Neuhoff, C; Tholen, E; Hoelker, M; Schellander, K; Tesfaye, D				Saeed-Zidane, Mohammed; Linden, Lea; Salilew-Wondim, Dessie; Held, Eva; Neuhoff, Christiane; Tholen, Ernst; Hoelker, Michael; Schellander, Karl; Tesfaye, Dawit			Cellular and exosome mediated molecular defense mechanism in bovine granulosa cells exposed to oxidative stress	PLOS ONE			English	Article							INTERCELLULAR COMMUNICATION; FOLLICULAR-FLUID; DAIRY-COWS; EXTRACELLULAR VESICLES; MELATONIN PROTECTS; INDUCED APOPTOSIS; MOUSE OOCYTES; UP-REGULATION; PLASMA; MICRORNAS	Various environmental insults including diseases, heat and oxidative stress could lead to abnormal growth, functions and apoptosis in granulosa cells during ovarian follicle growth and oocyte maturation. Despite the fact that cells exposed to oxidative stress are responding transcriptionally, the potential release of transcripts associated with oxidative stress response into extracellular space through exosomes is not yet determined. Therefore, here we aimed to investigate the effect of oxidative stress in bovine granulosa cells in vitro on the cellular and exosome mediated defense mechanisms. Bovine granulosa cells were aspirated from ovarian follicles and cultured in DMEM/F-12 Ham culture medium supplemented with 10% exosome-depleted fetal bovine serum. In the first experiment sub-confluent cells were treated with 5 pM H2O2 for 40 min to induce oxidative stress. Thereafter, cells were subjected to ROS and mitochondrial staining, cell proliferation and cell cycle assays. Furthermore, gene and protein expression analysis were performed in H2O2-challenged versus control group 24 hr post-treatment using qRT-PCR and immune blotting or immunocytochemistry assay, respectively. Moreover, exosomes were isolated from spent media using ultracentrifugation procedure, and subsequently used for RNA isolation and qRT-PCR. In the second experiment, exosomes released by granulosa cells under oxidative stress (StressExo) or those released by granulosa cells without oxidative stress (NormalExo) were co-incubated with bovine granulosa cells in vitro to proof the potential horizontal transfer of defense molecules from exosomes to granulosa cells and investigate any phenotype changes. Exposure of bovine granulosa cells to H2O2 induced the accumulation of ROS, reduced mitochondrial activity, increased expression of Nrf2 and its downstream antioxidant genes (both mRNA and protein), altered the cell cycle transitions and induced cellular apoptosis. Granulosa cells exposed to oxidative stress released exosomes enriched with mRNA of Nrf2 and candidate antioxidants. Subsequent co-incubation of StressExo with cultured granulosa cells could alter the relative abundance of cellular oxidative stress response molecules including Nrf2 and antioxidants CAT, PRDX1 and TXN1. The present study provide evidences that granulosa cells exposed to oxidative stress conditions react to stress by	[Saeed-Zidane, Mohammed; Linden, Lea; Salilew-Wondim, Dessie; Held, Eva; Neuhoff, Christiane; Tholen, Ernst; Hoelker, Michael; Schellander, Karl; Tesfaye, Dawit] Univ Bonn, Dept Anim Breeding & Husb, Inst Anim Sci, Bonn, Germany; [Hoelker, Michael; Schellander, Karl; Tesfaye, Dawit] Univ Bonn, Teaching & Res Stn Frankenforst, Fac Agr, Konigswinter, Germany; [Hoelker, Michael] Univ Bonn, Ctr Integrated Dairy Res, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Tesfaye, D (corresponding author), Univ Bonn, Dept Anim Breeding & Husb, Inst Anim Sci, Bonn, Germany.; Tesfaye, D (corresponding author), Univ Bonn, Teaching & Res Stn Frankenforst, Fac Agr, Konigswinter, Germany.	tesfaye@itw.uni-bonn.de		Wondim, Dr. Dessie Salilew/0000-0002-8756-0865; Tesfaye, Dawit/0000-0001-8166-0606				Abuelo A, 2015, J ANIM PHYSIOL AN N, V99, P1003, DOI 10.1111/jpn.12273; Adeldust Hamideh, 2015, Journal of Animal Science and Technology, V57, P27, DOI 10.1186/s40781-015-0061-5; Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Ailawadi S, 2015, BBA-MOL BASIS DIS, V1852, P1, DOI 10.1016/j.bbadis.2014.10.008; Amin A, 2014, MOL REPROD DEV, V81, P497, DOI [10.1002/mrd.22316, 1]; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Aprioku Jonah Sydney, 2013, J Reprod Infertil, V14, P158; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Bernabucci U, 2005, J DAIRY SCI, V88, P2017, DOI 10.3168/jds.S0022-0302(05)72878-2; Bernabucci U, 2002, J DAIRY SCI, V85, P2173, DOI 10.3168/jds.S0022-0302(02)74296-3; Berridge Michael J., 2012, CELL SIGNALING BIOL, V16, P1150; Betteridge DJ, 2000, METABOLISM, V49, P3, DOI 10.1016/S0026-0495(00)80077-3; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Braccioli L, 2014, MOL NEUROBIOL, V49, P113, DOI 10.1007/s12035-013-8504-9; BRANNSTROM M, 1993, HUM REPROD, V8, P1762; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Burton GJ, 2011, CLIN OBSTET GYNAECOL, V25, P287, DOI [DOI 10.1016/J.BP0BGYN.2010.10.016, 10.1016/j.bpobgyn.2010.10.016]; Castillo C, 2006, RES VET SCI, V80, P133, DOI 10.1016/j.rvsc.2005.06.003; Chaube Shail K., 2016, CELL STRESS CHAPERON, V3, P467; Chernyak BV, 2006, BBA-BIOENERGETICS, V1757, P525, DOI 10.1016/j.bbabio.2006.02.019; Ciardiello C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020175; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; da Silveira Juliano C, 2012, Biol Reprod, V86, P71, DOI 10.1095/biolreprod.111.093252; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; De Rensis F, 2003, THERIOGENOLOGY, V60, P1139, DOI 10.1016/S0093-691X(03)00126-2; Devine PJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095224; Di Pietro C, 2016, J ASSIST REPROD GEN, V33, P303, DOI 10.1007/s10815-016-0657-9; EL Andaloussi S, 2013, ADV DRUG DELIVER REV, V65, P391, DOI 10.1016/j.addr.2012.08.008; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Frydrychowicz M, 2015, SCAND J IMMUNOL, V81, P2, DOI 10.1111/sji.12247; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Guo YQ, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-31; Haney MJ, 2015, J CONTROL RELEASE, V207, P18, DOI 10.1016/j.jconrel.2015.03.033; Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240; Harmati M, 2017, J ORAL PATHOL MED, V46, P259, DOI 10.1111/jop.12486; HICKEY GJ, 1988, ENDOCRINOLOGY, V122, P1426, DOI 10.1210/endo-122-4-1426; Hung WT, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132977; Jin XL, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2572175; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kidder GM, 2010, CAN J PHYSIOL PHARM, V88, P399, DOI [10.1139/Y10-009, 10.1139/y10-009]; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee L, 2013, ENDOCRINOLOGY, V154, P458, DOI 10.1210/en.2012-1610; Li L, 2016, CELL STRESS CHAPERON, V21, P467, DOI 10.1007/s12192-016-0673-9; Li M, 2009, ANAT REC, V292, P1107, DOI 10.1002/ar.20925; Li M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0502; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Navakanitworakul R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25486; Omata Y, 2008, FREE RADICAL BIO MED, V45, P1437, DOI 10.1016/j.freeradbiomed.2008.08.018; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Qu F, 2012, J MOL MED, V90, P911, DOI 10.1007/s00109-012-0881-4; Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200; Santonocito M, 2014, FERTIL STERIL, V102, P1751, DOI 10.1016/j.fertnstert.2014.08.005; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Sharma A, 2016, NANOMEDICINE-UK, V11, P421, DOI 10.2217/nnm.15.210; Shiota M, 2003, ZOOL SCI, V20, P193, DOI 10.2108/zsj.20.193; Silva M, 2015, CURR GENOMICS, V16, P295, DOI 10.2174/1389202916666150707154719; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Sluijter JPG, 2014, CARDIOVASC RES, V102, P302, DOI 10.1093/cvr/cvu022; Sohel MMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078505; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; Szypowska AA, 2011, ANTIOXID REDOX SIGN, V14, P563, DOI 10.1089/ars.2010.3243; Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X; Tanabe M, 2015, J REPROD DEVELOP, V61, P35, DOI 10.1262/jrd.2014-105; Thery C., 2002, EXOSOMES COMPOSITION; Tripathi Anima, 2013, Int J Appl Basic Med Res, V3, P27, DOI 10.4103/2229-516X.112238; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VANDERHYDEN BC, 1992, BIOL REPROD, V46, P1196, DOI 10.1095/biolreprod46.6.1196; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang YM, 2017, SAUDI J BIOL SCI, V24, P837, DOI 10.1016/j.sjbs.2016.12.004; Weiss WP, 2004, J DAIRY SCI, V87, P32, DOI 10.3168/jds.S0022-0302(04)73138-0; Yang HY, 2017, ONCOTARGET, V8, P25310, DOI 10.18632/oncotarget.15813; Yousefpour P, 2014, BIOTECHNOL BIOENG, V111, P1699, DOI 10.1002/bit.25307; Yuan MJ, 2016, INT J MED SCI, V13, P113, DOI 10.7150/ijms.14112; Zhang J, 2016, FRONT MED-PRC, V10, P1, DOI 10.1007/s11684-016-0439-x	81	85	86	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187569	10.1371/journal.pone.0187569	http://dx.doi.org/10.1371/journal.pone.0187569			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117219	Green Submitted, gold, Green Published			2022-12-26	WOS:000414659600046
J	Turnbull, LB; Siwo, GH; Button-Simons, KA; Tan, A; Checkley, LA; Painter, HJ; Llinas, M; Ferdig, MT				Turnbull, Lindsey B.; Siwo, Geoffrey H.; Button-Simons, Katrina A.; Tan, Asako; Checkley, Lisa A.; Painter, Heather J.; Llinas, Manuel; Ferdig, Michael T.			Simultaneous genome-wide gene expression and transcript isoform profiling in the human malaria parasite	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; RNA-SEQ; MICROARRAY; DISCOVERY; STRAINS; CYCLE	Gene expression DNA microarrays have been vital for characterizing whole-genome transcriptional profiles. Nevertheless, their effectiveness relies heavily on the accuracy of genome sequences, the annotation of gene structures, and the sequence-dependent performance of individual probes. Currently available gene expression arrays for the malaria parasite Plasmodium falciparum rely on an average of 2 probes per gene, usually positioned near the 30 end of genes; consequently, existing designs are prone to measurement bias and cannot capture complexities such as the occurrence of transcript isoforms arising from alternative splicing or alternative start/stop sites. Here, we describe two novel gene expression arrays with exon-focused probes designed with an average of 12 and 20 probes spanning each gene. This high probe density minimizes signal noise inherent in probe-to-probe sequence-dependent hybridization intensity. We demonstrate that these exon arrays accurately profile genome-wide expression, comparing favorably to currently available arrays and RNA-seq profiling, and can detect alternatively spliced transcript isoforms as well as non-coding RNAs (ncRNAs). Of the 964 candidate alternate splicing events from published RNA-seq studies, 162 are confirmed using the exon array. Furthermore, the exon array predicted 330 previously unidentified alternate splicing events. Gene expression microarrays continue to offer a cost-effective alternative to RNA-seq for the simultaneous monitoring of gene expression and alternative splicing events. Microarrays may even be preferred in some cases due to their affordability and the rapid turn-around of results when hundreds of samples are required for fine-scale systems biology investigations, including the monitoring of the networks of gene co-expression in the emergence of drug resistance.	[Turnbull, Lindsey B.; Siwo, Geoffrey H.; Button-Simons, Katrina A.; Tan, Asako; Checkley, Lisa A.; Ferdig, Michael T.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Turnbull, Lindsey B.] Indiana Univ, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46204 USA; [Siwo, Geoffrey H.] IBM Res Africa, Johannesburg, South Africa; [Tan, Asako] Illumina, Madison, WI USA; [Painter, Heather J.; Llinas, Manuel] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Painter, Heather J.; Llinas, Manuel] Penn State Univ, Ctr Malaria Res, University Pk, PA 16802 USA; [Llinas, Manuel] Penn State Univ, Dept Chem, University Pk, PA USA	University of Notre Dame; Indiana University System; Indiana University-Purdue University Indianapolis; Illumina; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ferdig, MT (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	ferdig.1@nd.edu		Button-Simons, Katrina/0000-0001-5248-7939	Eck Institute for Global Health Fellowships; Indiana Clinical and Translational Sciences Institute - National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR001108]; Center for Quantitative Biology [P50 GM071508]; Neither IBM Research Africa nor Illumina; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	Eck Institute for Global Health Fellowships; Indiana Clinical and Translational Sciences Institute - National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; Center for Quantitative Biology; Neither IBM Research Africa nor Illumina(International Business Machines (IBM)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LBT, GHS, and KAB were supported by Eck Institute for Global Health Fellowships. This project was supported by the Indiana Clinical and Translational Sciences Institute funded, in part by Award Number UL1TR001108 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award and with support from the Center for Quantitative Biology (P50 GM071508) (ML). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Neither IBM Research Africa nor Illumina provided financial or salary support for the associated authors GHS and AT. The specific roles of these authors are articulated in the author contributions section. Neither has commercial affiliation or any intellectual, commercial, or ownership rights over the products or ideas presented in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LBT, GHS, and KAB were supported by Eck Institute for Global Health Fellowships. This project was supported by the Indiana Clinical and Translational Sciences Institute funded, in part by Award Number UL1TR001108 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award and with support from the Center for Quantitative Biology (P50 GM071508) (ML). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Neither IBM Research Africa nor Illumina provided financial or salary support for the associated authors GHS and AT. The specific roles of these authors are articulated in the 'author contributions' section. Neither has commercial affiliation or any intellectual, commercial, or ownership rights over the products or ideas presented in this manuscript.	Agbavwe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022177; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Becker JVW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-235; Bemmo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-529; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Broadbent KM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r56; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chaal BK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000737; Chou CC, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh099; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gonzales JM, 2008, PLOS BIOL, V6, P2016, DOI 10.1371/journal.pbio.0060238; Ha KCH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-519; Hu G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-350; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Hull R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-53; Iriko H, 2009, PARASITOL INT, V58, P196, DOI 10.1016/j.parint.2009.02.002; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson N.L., 1992, BIOMETRICAL J, V36, P565, DOI [10.1002/bimj.4710360207, DOI 10.1002/BIMJ.4710360207]; Kafsack BFC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-187; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lei R, 2015, GENE, V557, P82, DOI 10.1016/j.gene.2014.12.013; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Llinas M, 2004, CURR OPIN MICROBIOL, V7, P382, DOI 10.1016/j.mib.2004.06.014; Lopez-Barragan MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-587; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mourier T, 2008, GENOME RES, V18, P281, DOI 10.1101/gr.6836108; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Painter Heather J, 2013, Methods Mol Biol, V923, P213; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Siwo GH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2165-1; Siwo GH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1261-6; Sorber K, 2011, NUCLEIC ACIDS RES, V39, P3820, DOI 10.1093/nar/gkq1223; Su Z, 2014, GENOME BIOL, V15, P3273; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subudhi AK, 2016, GENOM DATA, V9, P118, DOI 10.1016/j.gdata.2016.07.006; Tamez PA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000118; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Brummelen AC, 2009, J BIOL CHEM, V284, P4635, DOI 10.1074/jbc.M807085200; van Oort RJ, 2008, J MOL CELL CARDIOL, V45, P709, DOI 10.1016/j.yjmcc.2008.08.016; Wirth D, 2009, P NATL ACAD SCI USA, V106, pE70, DOI 10.1073/pnas.0904478106; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	53	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187595	10.1371/journal.pone.0187595	http://dx.doi.org/10.1371/journal.pone.0187595			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112986	Green Published, Green Submitted, gold			2022-12-26	WOS:000414572100024
J	Wang, PH; Wittmeyer, KT; Lee, TF; Meyers, BC; Chopra, S				Wang, Po-Hao; Wittmeyer, Kameron T.; Lee, Tzuu-fen; Meyers, Blake C.; Chopra, Surinder			Overlapping RdDM and non-RdDM mechanisms work together to maintain somatic repression of a paramutagenic epiallele of maize pericarp color1	PLOS ONE			English	Article							GENERATIONAL REGULATORY STATES; DNA METHYLATION; ZEA-MAYS; TRANSPOSABLE ELEMENTS; CHROMATIN-STRUCTURE; MUDR TRANSPOSON; RNA-POLYMERASE; MYB GENE; B1 LOCUS; P1 GENE	Allelic variation at the Zea mays (maize) pericarp color1 (p1) gene has been attributed to epigenetic gene regulation. A p1 distal enhancer, 5.2 kb upstream of the transcriptional start site, has demonstrated variation in DNA methylation in different p1 alleles/epialleles. In addition, DNA methylation of sequences within the 3' end of intron 2 also plays a role in tissue-specific expression of p1 alleles. We show here a direct evidence for small RNAs' involvement in regulating p1 that has not been demonstrated previously. The role of mediator of paramutation1 (mop1) was tested in the maintenance of somatic silencing at distinct p1 alleles: the non-paramutagenic P1-wr allele and paramutagenic P1-rr' epiallele. The mop1-1 mutation gradually relieves the silenced phenotype after multiple generations of exposure; P1-wr; mop1-1 plants display a loss of 24-nt small RNAs and DNA methylation in the 3' end of the intron 2, a region close to a Stowaway transposon. In addition, a MULE sequence within the proximal promoter of P1-wr shows depletion of 24nt siRNAs in mop1-1 plants. Release of silencing was not correlated with small RNAs at the distal enhancer region of the P1-wr allele. We found that the somatic silencing of the paramutagenic P1-rr' is correlated with significantly reduced H3K9me2 in the distal enhancer of P1-rr'; mop1-1 plants, while symmetric DNA methylation is not significantly different. This study highlights that the epigenetic regulation of p1 alleles is controlled both via RdDM as well as non-RdDM mechanisms.	[Wang, Po-Hao; Wittmeyer, Kameron T.; Chopra, Surinder] Penn State Univ, Dept Plant Sci, University Pk, PA 16802 USA; [Wittmeyer, Kameron T.; Chopra, Surinder] Penn State Univ, Plant Biol Program, University Pk, PA 16802 USA; [Lee, Tzuu-fen; Meyers, Blake C.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Lee, Tzuu-fen; Meyers, Blake C.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA; [Wang, Po-Hao] Dow Agrosci, Indianapolis, IN USA; [Lee, Tzuu-fen] Dupont Pioneer, Johnston, IA USA; [Meyers, Blake C.] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Meyers, Blake C.] Univ Missouri, Div Plant Sci, Columbia, MO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Delaware; University of Delaware; Dow Chemical Company; DuPont; Pioneer Hi-Bred International, Inc.; Donald Danforth Plant Science Center; University of Missouri System; University of Missouri Columbia	Chopra, S (corresponding author), Penn State Univ, Dept Plant Sci, University Pk, PA 16802 USA.; Chopra, S (corresponding author), Penn State Univ, Plant Biol Program, University Pk, PA 16802 USA.	sic3@psu.edu	Meyers, Blake/B-6535-2012	Meyers, Blake/0000-0003-3436-6097; Chopra, Surinder/0000-0002-2614-4964	National Science Foundation collaborative awards [0619330, 1051654, 1051576]; Hatch awards [PEN04452, PEN04613]	National Science Foundation collaborative awards; Hatch awards	This work was supported by National Science Foundation collaborative awards 0619330 and 1051654 to SC and 1051576 to BCM. Support from Hatch awards PEN04452 and PEN04613 to SC is acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P12986, DOI 10.1073/pnas.1007972107; Barbour JE, 2012, PLANT CELL, V24, P1761, DOI 10.1105/tpc.112.097618; Belele CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003773; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; BRINK RA, 1956, GENETICS, V41, P872; BRINK RA, 1966, MAIZE GENET COOP NEW, V40, P149; Chandler VL, 2010, SCIENCE, V330, P628, DOI 10.1126/science.1191044; Chopra S, 1998, MOL GEN GENET, V260, P372, DOI 10.1007/s004380050906; Chopra S, 2003, GENETICS, V163, P1135; COE EH, 1959, P NATL ACAD SCI USA, V45, P828, DOI 10.1073/pnas.45.6.828; DAS OP, 1994, GENETICS, V136, P1121; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Eichten SR, 2013, PLANT CELL, V25, P2783, DOI 10.1105/tpc.113.114793; Enke RA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002350; Erhard KF, 2011, CURR OPIN PLANT BIOL, V14, P210, DOI 10.1016/j.pbi.2011.02.005; Fujimoto R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000048; Fultz D, 2015, CURR OPIN PLANT BIOL, V27, P67, DOI 10.1016/j.pbi.2015.05.027; Gehring M, 2013, ANNU REV GENET, V47, P187, DOI 10.1146/annurev-genet-110711-155527; Gent JI, 2014, PLANT CELL, V26, P4903, DOI 10.1105/tpc.114.130427; Gent JI, 2013, GENOME RES, V23, P628, DOI 10.1101/gr.146985.112; Giacopelli BJ, 2015, PLANT PHYSIOL, V168, P1226, DOI 10.1104/pp.15.00591; Goettel W, 2013, GENE, V516, P8, DOI 10.1016/j.gene.2012.12.034; Goettel W, 2013, THEOR APPL GENET, V126, P159, DOI 10.1007/s00122-012-1970-z; GROTEWOLD E, 1991, P NATL ACAD SCI USA, V88, P4587, DOI 10.1073/pnas.88.11.4587; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; Hale CJ, 2007, PLOS BIOL, V5, P2156, DOI 10.1371/journal.pbio.0050275; Haring M, 2010, PLANT J, V63, P366, DOI 10.1111/j.1365-313X.2010.04245.x; Hoekenga OA, 2000, GENETICS, V155, P1889; Hollick JB, 2017, NAT REV GENET, V18, P5, DOI 10.1038/nrg.2016.115; Hollick JB, 2012, CURR OPIN PLANT BIOL, V15, P536, DOI 10.1016/j.pbi.2012.09.003; Hollick JB, 2005, GENETICS, V171, P725, DOI 10.1534/genetics.105.045260; HOLLICK JB, 1995, GENETICS, V141, P709; Huang J, 2016, INT REV CELL MOL BIO; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jia Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000737; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Li Q, 2015, P NATL ACAD SCI USA, V112, P14728, DOI 10.1073/pnas.1514680112; Lisch D, 2002, P NATL ACAD SCI USA, V99, P6130, DOI 10.1073/pnas.052152199; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; McGinnis KM, 2006, GENETICS, V173, P1637, DOI 10.1534/genetics.106.058669; Nobuta K, 2008, P NATL ACAD SCI USA, V105, P14958, DOI 10.1073/pnas.0808066105; Pilu R, 2009, HEREDITY, V102, P236, DOI 10.1038/hdy.2008.96; Quadrana L, 2016, ANNU REV GENET, V50, P467, DOI 10.1146/annurev-genet-120215-035254; Rhee Y, 2010, GENETICS, V186, P843, DOI 10.1534/genetics.110.117929; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sekhon RS, 2007, GENETICS, V175, P1059, DOI 10.1534/genetics.106.066134; Sekhon RS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002980; Sekhon RS, 2009, GENETICS, V181, P81, DOI 10.1534/genetics.108.097170; Sidorenko LV, 2000, PLANT J, V22, P471, DOI 10.1046/j.1365-313x.2000.00750.x; Sidorenko LV, 2001, PLANT CELL, V13, P319, DOI 10.1105/tpc.13.2.319; Sidorenko L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000725; Sidorenko L, 2008, GENETICS, V180, P1983, DOI 10.1534/genetics.108.095281; Sloan AE, 2014, GENETICS, V198, P1031, DOI 10.1534/genetics.114.168518; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Stonaker JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000706; Walker EL, 2001, GENETICS, V159, P1201; Wei LY, 2014, P NATL ACAD SCI USA, V111, P3877, DOI 10.1073/pnas.1318131111; Woodhouse MR, 2006, PLOS BIOL, V4, P1678, DOI 10.1371/journal.pbio.0040339; Woodhouse MR, 2006, GENETICS, V172, P579, DOI 10.1534/genetics.105.051383	59	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187157	10.1371/journal.pone.0187157	http://dx.doi.org/10.1371/journal.pone.0187157			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112965	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100009
J	Buckley, C; Nelson, RJ; Mullins, LJ; Sharp, MGF; Fleming, S; Kenyon, CJ; Semprini, S; Steppan, D; Peti-Peterdi, J; Kurtz, A; Christian, H; Mullins, JJ				Buckley, Charlotte; Nelson, Robert J.; Mullins, Linda J.; Sharp, Matthew G. F.; Fleming, Stewart; Kenyon, Christopher J.; Semprini, Sabrina; Steppan, Dominik; Peti-Peterdi, Janos; Kurtz, Armin; Christian, Helen; Mullins, John J.			Phenotypic dissection of the mouse Ren1d knockout by complementation with human renin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						granulation; human renin; juxtaglomerular; macula densa; renin; renin angiotensin system; electron microscopy (EM); confocal microscopy; immunochemistry; mouse; secretion; animal model; transgenic mice	MACULA DENSA; JUXTAGLOMERULAR CELLS; EXPRESSION; RELEASE; GENES; GRANULATION; INHIBITION; SECRETION; PRORENIN; DISTINCT	Normal renin synthesis and secretion is important for the maintenance of juxtaglomerular apparatus architecture. Mice lacking a functional Ren1d gene are devoid of renal juxtaglomerular cell granules and exhibit an altered macula densa morphology. Due to the species-specificity of renin activity, transgenic mice are ideal models for experimentally investigating and manipulating expression patterns of the human renin gene in a native cellular environment without confounding renin-angiotensin system interactions. A 55-kb transgene encompassing the human renin locus was crossed onto the mouse Ren1d-null background, restoring granulation in juxtaglomerular cells. Correct processing of human renin in dense core granules was confirmed by immunogold labeling. After stimulation of the renin-angiotensin system, juxtaglomerular cells contained rhomboid protogranules with paracrystalline contents, dilated rough endoplasmic reticulum, and electron-lucent granular structures. However, complementation of Ren1d(-/-) mice with human renin was unable to rescue the abnormality seen in macula densa structure. The juxtaglomerular apparatus was still able to respond to tubuloglomerular feedback in isolated perfused juxtaglomerular apparatus preparations, although minor differences in glomerular tuft contractility and macula densa cell calcium handling were observed. This study reveals that the human renin protein is able to complement the mouse Ren1d(-/-) non-granulated defect and suggests that granulopoiesis requires a structural motif that is conserved between the mouse Ren1d and human renin proteins. It also suggests that the altered macula densa phenotype is related to the activity of the renin-1d enzyme in a local juxtaglomerular renin-angiotensin system.	[Buckley, Charlotte; Nelson, Robert J.; Mullins, Linda J.; Sharp, Matthew G. F.; Kenyon, Christopher J.; Semprini, Sabrina; Mullins, John J.] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Fleming, Stewart] Univ Dundee, Ninewells Hosp, Sch Med, Dundee DD1 9SY, Scotland; [Steppan, Dominik; Kurtz, Armin] Univ Regensburg, Physiol Inst, D-93053 Regensburg, Germany; [Peti-Peterdi, Janos] Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Peti-Peterdi, Janos] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Christian, Helen] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Nelson, Robert J.] Novimmune SA, 14 Chemin Aulx, CH-1228 Geneva, Switzerland	University of Edinburgh; University of Dundee; University of Regensburg; University of Southern California; University of Southern California; University of Oxford; NovImmune SA	Buckley, C (corresponding author), Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.; Mullins, JJ (corresponding author), 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	cbuckley@exseed.ed.ac.uk; J.Mullins@ed.ac.uk		Buckley, Charlotte/0000-0002-7961-4544; Christian, Helen/0000-0002-4263-5499; Mullins, Linda/0000-0002-6743-8707	British Heart Foundation Centre of Research Excellence Ph.D. studentship Award [RE/08/001/23904]; Wellcome Trust Cardiovascular Research Initiative Ph.D. studentship Award [WT052633MA]; Shared Instrument Grant from the National Institutes of Health [1 S10 OD021833]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064324] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021833] Funding Source: NIH RePORTER	British Heart Foundation Centre of Research Excellence Ph.D. studentship Award; Wellcome Trust Cardiovascular Research Initiative Ph.D. studentship Award(Wellcome Trust); Shared Instrument Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by British Heart Foundation Centre of Research Excellence 4-year Ph.D. studentship Award RE/08/001/23904 (to C. B.) and Wellcome Trust Cardiovascular Research Initiative 4-year Ph.D. studentship Award WT052633MA (to R. J. N.). This work was also supported by Shared Instrument Grant 1 S10 OD021833 from the National Institutes of Health (to J. P-P). Published abstracts from this work were presented at Experimental Biology, April 20-24, 2013, Boston, MA and the Angiotensin Gorden Conference, February 21-26, 2016, Lucca, Italy. The authors declare that they have no conflicts of interest with the contents of this article.	ABEL KJ, 1990, GENETICS, V124, P937; ABEL KJ, 1988, NUCLEIC ACIDS RES, V16, P2111, DOI 10.1093/nar/16.5.2111; Abel MH, 2013, J NEUROENDOCRINOL, V25, P863, DOI 10.1111/jne.12081; BERKA JLA, 1990, J HYPERTENS, V8, P229; BERKA JLA, 1992, CELL TISSUE RES, V268, P141, DOI 10.1007/BF00338063; Christensen TH, 2015, EXP PHYSIOL, V100, P1362, DOI 10.1113/EP085177; Clark AF, 1997, J BIOL CHEM, V272, P18185, DOI 10.1074/jbc.272.29.18185; DICKINSON DP, 1984, GENETICS, V108, P651; GOLDSTONE R, 1983, J CLIN ENDOCR METAB, V56, P264, DOI 10.1210/jcem-56-2-264; GREENBERG SG, 1993, AM J PHYSIOL, V265, pF578, DOI 10.1152/ajprenal.1993.265.4.F578; HACKENTHAL E, 1990, PHYSIOL REV, V70, P1067, DOI 10.1152/physrev.1990.70.4.1067; Huerta-Ocampo I, 2005, ENDOCRINOLOGY, V146, P5012, DOI 10.1210/en.2005-0335; Kurtz A, 2011, ANNU REV PHYSIOL, V73, P377, DOI 10.1146/annurev-physiol-012110-142238; MULLINS JJ, 1982, EMBO J, V1, P1461, DOI 10.1002/j.1460-2075.1982.tb01338.x; Mullins LJ, 2000, J BIOL CHEM, V275, P40378, DOI 10.1074/jbc.M007315200; OGAWA K, 1995, ANAT RECORD, V243, P336, DOI 10.1002/ar.1092430308; OLIVER WJ, 1966, P SOC EXP BIOL MED, V122, P923; PANTHIER JJ, 1983, EMBO J, V2, P675, DOI 10.1002/j.1460-2075.1983.tb01483.x; Peti-Peterdi J, 1999, AM J PHYSIOL-RENAL, V277, pF472, DOI 10.1152/ajprenal.1999.277.3.F472; Peti-Peterdi J, 2003, J CLIN INVEST, V112, P76, DOI 10.1172/JCI200318018; Peti-Peterdi J, 2002, AM J PHYSIOL-RENAL, V282, pF324, DOI 10.1152/ajprenal.00251.2001; Peti-Peterdi J, 2000, AM J PHYSIOL-RENAL, V278, pF452, DOI 10.1152/ajprenal.2000.278.3.F452; Peti-Peterdi J, 2006, AM J PHYSIOL-RENAL, V291, pF473, DOI 10.1152/ajprenal.00425.2005; PICCINI N, 1982, CELL, V30, P205, DOI 10.1016/0092-8674(82)90026-5; Rohrwasser A, 1999, HYPERTENSION, V34, P1265, DOI 10.1161/01.HYP.34.6.1265; Sharp MGF, 1996, HYPERTENSION, V28, P1126, DOI 10.1161/01.HYP.28.6.1126; Sinn PL, 1999, J BIOL CHEM, V274, P35785, DOI 10.1074/jbc.274.50.35785; SKOTT O, 1987, SCIENCE, V237, P1618, DOI 10.1126/science.3306925; Steppan D, 2013, KIDNEY INT, V83, P233, DOI 10.1038/ki.2012.392; TOFFELMIRE EB, 1989, J CLIN INVEST, V83, P679, DOI 10.1172/JCI113932; Yan Y, 1998, CIRC RES, V83, P1279, DOI 10.1161/01.RES.83.12.1279; Yang TX, 2000, J BIOL CHEM, V275, P37922, DOI 10.1074/jbc.M006218200	32	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1151	1162		10.1074/jbc.RA117.000160	http://dx.doi.org/10.1074/jbc.RA117.000160			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29123029	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000423515000005
J	Clerman, A; Noor, Z; Fishelevich, R; Lockatell, V; Hampton, BS; Shah, NG; Salcedo, MV; Todd, NW; Atamas, SP; Luzina, IG				Clerman, Andrew; Noor, Zahid; Fishelevich, Rita; Lockatell, Virginia; Hampton, Brian S.; Shah, Nirav G.; Salcedo, Mariah V.; Todd, Nevins W.; Atamas, Sergei P.; Luzina, Irina G.			The full-length interleukin-33 (FLIL33)-importin-5 interaction does not regulate nuclear localization of FLIL33 but controls its intracellular degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; nuclear translocation; proteasome; protein degradation; protein-protein interaction; interleukin-33	EPITHELIAL PROGENITOR CELLS; IMPORTIN-BETA; CYTOKINE IL-33; LUNG-DISEASE; IN-VIVO; INFLAMMATION; FAMILY; TRANSCRIPTION; EXPRESSION; CHROMATIN	Human mature IL-33 is a member of the IL-1 family and a potent regulator of immunity through its pro-T helper cell 2 activity. Its precursor form, full-length interleukin-33 (FLIL33), is an intranuclear protein in many cell types, including fibroblasts, and its intracellular levels can change in response to stimuli. However, the mechanisms controlling the nuclear localization of FLIL33 or its stability in cells are not understood. Here, we identified importin-5 (IPO5), a member of the importin family of nuclear transport proteins, as an intracellular binding partner of FLIL33. By overexpressing various FLIL33 protein segments and variants in primary human lung fibroblasts and HEK293T cells, we show that FLIL33, but not mature interleukin-33, physically interacts with IPO5 and that this interaction localizes to a cluster of charged amino acids (positions 46-56) but not to an adjacent segment (positions 61-67) in the FLIL33 N-terminal region. siRNA-mediated IPO5 knockdown in cell culture did not affect nuclear localization of FLIL33. However, the IPO5 knockdown significantly decreased the intracellular levels of overexpressed FLIL33, reversed by treatment with the 20S proteasome inhibitor bortezomib. Furthermore, FLIL33 variants deficient in IPO5 binding remained intranuclear and exhibited decreased levels, which were also restored by the bortezomib treatment. These results indicate that the interaction between FLIL33 and IPO5 is localized to a specific segment of the FLIL33 protein, is not required for nuclear localization of FLIL33, and protects FLIL33 from proteasome-dependent degradation.	[Clerman, Andrew; Noor, Zahid; Fishelevich, Rita; Lockatell, Virginia; Shah, Nirav G.; Salcedo, Mariah V.; Todd, Nevins W.; Atamas, Sergei P.; Luzina, Irina G.] Univ Maryland, Sch Med, Dept Med, 10 S Pine St,MSTF 8-34, Baltimore, MD 21201 USA; [Hampton, Brian S.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 10 S Pine St,MSTF 8-34, Baltimore, MD 21201 USA; [Hampton, Brian S.] Univ Maryland, Sch Med, Ctr Innovat Biomed Resources, 10 S Pine St,MSTF 8-34, Baltimore, MD 21201 USA; [Todd, Nevins W.; Atamas, Sergei P.; Luzina, Irina G.] Baltimore Vet Affairs Med Ctr, Res Serv, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Atamas, SP (corresponding author), Univ Maryland, Sch Med, Dept Med, 10 S Pine St,MSTF 8-34, Baltimore, MD 21201 USA.	satamas@umaryland.edu	Hampton, Brian/G-8427-2015	Hampton, Brian/0000-0003-4650-2869	NHLBI, National Institutes of Health [R01HL126897]; Veterans Affairs Merit Awards [I01CX000101, I01BX002499]; Scleroderma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126897] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000101, I01BX002499] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs Merit Awards(US Department of Veterans Affairs); Scleroderma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant R01HL126897 (to S. P. A.). This work was also supported by Veterans Affairs Merit Awards I01CX000101 (to I. G. L.) and I01BX002499 (to S. P. A.) and a Scleroderma Foundation award (to S. P. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Baas R, 2016, J BIOL CHEM, V291, P24121, DOI 10.1074/jbc.M116.748582; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Bessa J, 2014, J AUTOIMMUN, V55, P33, DOI 10.1016/j.jaut.2014.02.012; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Chung KM, 2008, MOL CELLS, V26, P291; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De la Fuente M, 2015, CYTOKINE GROWTH F R, V26, P615, DOI 10.1016/j.cytogfr.2015.07.017; Deane R, 1997, MOL CELL BIOL, V17, P5087, DOI 10.1128/MCB.17.9.5087; Gordon ED, 2016, P NATL ACAD SCI USA, V113, P8765, DOI 10.1073/pnas.1601914113; Holtzman Michael J, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS287, DOI 10.1513/AnnalsATS.201402-056AW; Huber FM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14354; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kobayashi J, 2013, J MOL BIOL, V425, P1852, DOI 10.1016/j.jmb.2013.02.035; Kopach P., J BIOL CHEM, V289; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111/j.1476-5381.2009.00331.x; Luzina IG, 2015, CYTOKINE, V74, P88, DOI 10.1016/j.cyto.2014.11.008; Luzina IG, 2013, AM J RESP CELL MOL, V49, P999, DOI 10.1165/rcmb.2013-0093OC; Luzina IG, 2012, J IMMUNOL, V189, P403, DOI 10.4049/jimmunol.1200259; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Murphy GEJ, 2010, ANN RHEUM DIS, V69, P43, DOI 10.1136/ard.2009.120113; Ni YM, 2015, INT J MOL SCI, V16, P27956, DOI 10.3390/ijms161126063; Ohta S, 2016, CELL SIGNAL, V28, P1025, DOI 10.1016/j.cellsig.2016.04.013; Oshio T, 2017, J DERMATOL SCI, V85, P106, DOI 10.1016/j.jdermsci.2016.10.008; Pei C, 2014, IMMUNOLOGY, V141, P9, DOI 10.1111/imm.12174; Ross AE, 2003, MOL CELL BIOL, V23, P5308, DOI 10.1128/MCB.23.15.5308-5319.2003; Roussel L, 2008, EMBO REP, V9, P1006, DOI 10.1038/embor.2008.145; Shan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151701; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Tao LQ, 2014, INT J CLIN EXP PATHO, V7, P4930; Wischnewski J, 2000, MECH DEVELOP, V95, P245, DOI 10.1016/S0925-4773(00)00337-3; Zhong YW, 2011, J BIOL CHEM, V286, P33921, DOI 10.1074/jbc.M111.272906	40	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21653	21661		10.1074/jbc.M117.807636	http://dx.doi.org/10.1074/jbc.M117.807636			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29127199	hybrid, Green Published			2022-12-26	WOS:000419013000039
J	Hodgens, C; Nimchuk, ZL; Kieber, JJ				Hodgens, Charles; Nimchuk, Zachary L.; Kieber, Joseph J.			indCAPS: A tool for designing screening primers for CRISPR/Cas9 mutagenesis events	PLOS ONE			English	Article							HISTIDINE PHOSPHOTRANSFER PROTEINS; B RESPONSE REGULATORS; CYTOKININ RECEPTORS; ARABIDOPSIS; STABILITY; DNA; LOCALIZATION; AHK4	Genetic manipulation of organisms using CRISPR/Cas9 technology generally produces small insertions/deletions (indels) that can be difficult to detect. Here, we describe a technique to easily and rapidly identify such indels. Sequence-identified mutations that alter a restriction enzyme recognition site can be readily distinguished from wild-type alleles using a cleaved amplified polymorphic sequence (CAPS) technique. If a restriction site is created or altered by the mutation such that only one allele contains the restriction site, a polymerase chain reaction (PCR) followed by a restriction digest can be used to distinguish the two alleles. However, in the case of most CRISPR-induced alleles, no such restriction sites are present in the target sequences. In this case, a derived CAPS (dCAPS) approach can be used in which mismatches are purposefully introduced in the oligonucleotide primers to create a restriction site in one, but not both, of the amplified templates. Web-based tools exist to aid dCAPS primer design, but when supplied sequences that include indels, the current tools often fail to suggest appropriate primers. Here, we report the development of a Python-based, species-agnostic web tool, called indCAPS, suitable for the design of PCR primers used in dCAPS assays that is compatible with indels. This tool should have wide utility for screening editing events following CRISPR/Cas9 mutagenesis as well as for identifying specific editing events in a pool of CRISPR-mediated mutagenesis events. This tool was field-tested in a CRISPR mutagenesis experiment targeting a cytokinin receptor (AHK3) in Arabidopsis thaliana. The tool suggested primers that successfully distinguished between wild-type and edited alleles of a target locus and facilitated the isolation of two novel ahk3 null alleles. Users can access indCAPS and design PCR primers to employ dCAPS to identify CRISPR/Cas9 alleles at http://indcaps.kieber.cloudapps.unc.edu/.	[Hodgens, Charles; Nimchuk, Zachary L.; Kieber, Joseph J.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Nimchuk, Zachary L.; Kieber, Joseph J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kieber, JJ (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.; Kieber, JJ (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC USA.	jkieber@unc.edu	Kieber, Joseph/GLN-6328-2022	Kieber, Joseph/0000-0002-5766-812X; Hodgens, Charles/0000-0002-0384-4458	National Science Foundation [IOS-1238051, IOS-1455607]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation (IOS-1238051 and IOS-1455607) https://www.nsf.gov/div/index.jsp?div=IOS. The funder had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.; We would like to thank G. Eric Schaller, Brian Nalley, Christian Burr, Amala John, Joanna Polko, Lauren Ross, and Ariel Aldrette for helping with the visual design of the website and the figures for this paper and Jamie Winshell for technical support. This work was supported by grants from the National Science Foundation (IOS-1238051 and IOS-1455607).	Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Caesar K, 2011, J EXP BOT, V62, P5571, DOI 10.1093/jxb/err238; Cheng CY, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23393; Cheng CY, 2013, PLANT J, V73, P929, DOI 10.1111/tpj.12084; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Farboud B, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.287; Housden Benjamin E, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top086843; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Karkute SG, 2017, FRONT PLANT SCI, V8; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kieber Joseph J, 2014, Arabidopsis Book, V12, pe0168, DOI 10.1199/tab.0168; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Peterson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162169; Punwani JA, 2010, PLANT SIGNAL BEHAV, V5, P896, DOI 10.4161/psb.5.7.12094; Punwani JA, 2010, PLANT J, V62, P473, DOI 10.1111/j.1365-313X.2010.04165.x; Simsek M, 2000, J Sci Res Med Sci, V2, P11; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; Tandon P, 2017, DEV BIOL, V426, P325, DOI 10.1016/j.ydbio.2016.04.009; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Wulfetange K, 2011, PLANT PHYSIOL, V156, P1808, DOI 10.1104/pp.111.180539; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127	31	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188406	10.1371/journal.pone.0188406	http://dx.doi.org/10.1371/journal.pone.0188406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141013	Green Submitted, Green Published, gold			2022-12-26	WOS:000415260400074
J	Ortiz, AB; Garcia, D; Vicente, Y; Palka, M; Bellas, C; Martin, P				Ortiz, Angela B.; Garcia, Diego; Vicente, Yolanda; Palka, Magda; Bellas, Carmen; Martin, Paloma			Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; ESTROGEN-RECEPTOR; CELL-CYCLE; CCND1 AMPLIFICATION; CANCER PATIENTS; POOR-PROGNOSIS; OVEREXPRESSION; ACTIVATION; REGULATORS; PHENOTYPE	The oncogenic capacity of cyclin D1 has long been established in breast cancer. CCND1 amplification has been identified in a subset of patients with poor prognosis, but there are conflicting data regarding the predictive value of cyclin D1 protein overexpression. This study was designed to analyze the expression of cyclin D1 and its correlation with CCND1 amplification and their prognostic implications in invasive breast cancer. By using the tissue microarray technique, we performed an immunohistochemical study of ER, PR, HER2, p53, cyclin D1, Ki67 and p16 in 179 invasive breast carcinoma cases. The FISH method was performed to detect HER2/Neu and CCND1 amplification. High cyclin D1 expression was identified in 94/179 (52%) of invasive breast cancers. Cyclin D1 overexpression and CCND1 amplification were significantly associated (p = 0.010). Overexpression of cyclin D1 correlated with ER expression, PR expression and Luminal subtypes (p < 0.001), with a favorable impact on overall survival in the whole series. However, in the Luminal A group, high expression of cyclin D1 correlated with shorter disease-free survival, suggesting that the prognostic role of cyclin D1 depends on the molecular subtype. CCND1 gene amplification was detected in 17 cases (9%) and correlated significantly with high tumor grade (p = 0.038), high Ki-67 protein expression (p = 0.002), and the Luminal B subtype (p = 0.002). Patients with tumors with high amplification of CCND1 had an increased risk of recurrence (HR = 2.5; 95% CI, 1.2-4.9, p = 0.01). These findings suggest that CCND1 amplification could be useful for predicting recurrence in invasive breast cancer.	[Ortiz, Angela B.; Garcia, Diego; Vicente, Yolanda; Bellas, Carmen; Martin, Paloma] Inst Invest Sanitaria Puerta Hierro Majadahonda I, Pathol Dept, Madrid, Spain; [Palka, Magda] Inst Invest Sanitaria Puerta Hierro Majadahonda I, Med Oncol Dept, Madrid, Spain; [Bellas, Carmen; Martin, Paloma] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC	Martin, P (corresponding author), Inst Invest Sanitaria Puerta Hierro Majadahonda I, Pathol Dept, Madrid, Spain.; Martin, P (corresponding author), Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain.	pmartin@idiphim.org	Acosta, Paloma Martin/AAF-7998-2021	Acosta, Paloma Martin/0000-0002-3274-4595	Fundacion Mutua Madrilena; Instituto Salud Carlos III (FEDER) - Fondosde Investigacion Sanitaria [JR14/0018]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Instituto Salud Carlos III (FEDER) - Fondosde Investigacion Sanitaria	This work was supported by grant from the Fundacion Mutua Madrilena. PM is supported by a Juan Rodes contract (JR14/0018) from Instituto Salud Carlos III (FEDER) - Fondosde Investigacion Sanitaria. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen K, 2009, BREAST CANCER RES TR, V113, P75, DOI 10.1007/s10549-008-9908-5; Ahlin C, 2017, BREAST CANCER RES TR, V164, P667, DOI 10.1007/s10549-017-4294-5; Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Cho EY, 2008, PATHOL INT, V58, P17, DOI 10.1111/j.1440-1827.2007.02183.x; Chung J, 2014, J BREAST CANCER, V17, P47, DOI 10.4048/jbc.2014.17.1.47; Cianfrocca M, 2009, CA-CANCER J CLIN, V59, P303, DOI 10.3322/caac.20029; Gillett C, 1996, INT J CANCER, V69, P92, DOI 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.3.CO;2-I; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; HAN EKH, 1995, ONCOGENE, V10, P953; Han SW, 2001, BREAST CANCER RES TR, V70, P205, DOI 10.1023/A:1013047413895; Holm K, 2012, BREAST CANCER RES TR, V133, P583, DOI 10.1007/s10549-011-1817-3; Hwang TS, 2003, PATHOL INT, V53, P74, DOI 10.1046/j.1440-1827.2003.01441.x; Kenny FS, 1999, CLIN CANCER RES, V5, P2069; Lamb R, 2013, CELL CYCLE, V12, P2384, DOI 10.4161/cc.25403; Li ZS, 2016, AM J TRANSL RES, V8, P142; Lundgren K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3161; Malvezzi M, 2013, ANN ONCOL, V24, P792, DOI 10.1093/annonc/mdt010; MARTINEZ JC, 1995, J PATHOL, V177, P27, DOI 10.1002/path.1711770106; MCINTOSH GG, 1995, ONCOGENE, V11, P885; Milde-Langosch K, 2001, BREAST CANCER RES TR, V67, P61, DOI 10.1023/A:1010623308275; Mu K, 2011, HISTOPATHOLOGY, V58, P601, DOI 10.1111/j.1365-2559.2011.03780.x; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Mylona E, 2013, HISTOPATHOLOGY, V62, P472, DOI 10.1111/his.12013; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Peurala E, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3376; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Reis JS, 2006, MODERN PATHOL, V19, P999, DOI 10.1038/modpathol.3800621; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Roy PG, 2010, INT J CANCER, V127, P355, DOI 10.1002/ijc.25034; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sugianto J, 2014, HUM PATHOL, V45, P802, DOI 10.1016/j.humpath.2013.11.013; Sutherland RL, 2002, BREAST CANCER RES, V4, P14, DOI 10.1186/bcr411; vanDiest PJ, 1997, AM J PATHOL, V150, P705; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	37	50	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188068	10.1371/journal.pone.0188068	http://dx.doi.org/10.1371/journal.pone.0188068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140993	Green Submitted, Green Published, gold			2022-12-26	WOS:000415260400053
J	Thorngren, L; Holthuis, TD; Lindegarth, S; Lindegarth, M				Thorngren, Linnea; Holthuis, Thomas Duner; Lindegarth, Susanne; Lindegarth, Mats			Developing methods for assessing abundance and distribution of European oysters (Ostrea edulis) using towed video	PLOS ONE			English	Article							MARINE PROTECTED AREA; UNDERWATER VIDEO; CRASSOSTREA-GIGAS; BENTHIC HABITATS; MULTIBEAM SONAR; REEFS; SEA; ECOSYSTEM; BIODIVERSITY; RESTORATION	Due to large-scale habitat losses and increasing pressures, benthic habitats in general, and perhaps oyster beds in particular, are commonly in decline and severely threatened on regional and global scales. Appropriate and cost-efficient methods for mapping and monitoring of the distribution, abundance and quality of remaining oyster populations are fundamental for sustainable management and conservation of these habitats and their associated values. Towed video has emerged as a promising method for surveying benthic communities in a both non-destructive and cost-efficient way. Here we examine its use as a tool for quantification and monitoring of oyster populations by (i) analysing how well abundances can be estimated and how living Ostrea edulis individuals can be distinguished from dead ones, (ii) estimating the variability within and among observers as well as the spatial variability at a number of scales, and finally (iii) evaluating the precision of estimated abundances under different scenarios for monitoring. Overall, the results show that the can be used to quantify abundance and occurrence of Ostrea edulis in heterogeneous environments. There was a strong correlation between abundances determined in the field and abundances estimated by video-analyses (r(2) = 0.93), even though video analyses underestimated the total abundance of living oysters by 20%. Additionally, the method was largely repeatable within and among observers and revealed no evident bias in identification of living and dead oysters. We also concluded that the spatial variability was an order of magnitude larger than that due to observer errors. Subsequent modelling of precision showed that the total area sampled was the main determinant of precision and provided general method for determining precision. This study provides a thorough validation of the application of towed video on quantitative estimations of live oysters. The results suggest that the method can indeed be very useful for this purpose and we therefor recommend it for future monitoring of oysters and other threatened habitats and species.	[Thorngren, Linnea; Holthuis, Thomas Duner] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Lindegarth, Susanne; Lindegarth, Mats] Univ Gothenburg, Dept Marine Sci Tjarno, Stromstad, Sweden	University of Gothenburg; University of Gothenburg	Thorngren, L (corresponding author), Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.	linnea.thorngren@marine.gu.se	Lindegarth, Mats Å/U-2665-2017	Lindegarth, Mats Å/0000-0001-5361-5437; Thorngren, Linnea/0000-0002-0735-5344	County Administrative board [29947-2013-1]; Radman och fru Ernst Collianders stiftelse for valgorande andamal	County Administrative board; Radman och fru Ernst Collianders stiftelse for valgorande andamal	This research was funded by The County Administrative board, Grant number 29947-2013-1, http://www.lansstyrelsen.se/VastraGotaland/En/Pages/default.aspx, and by Radman och fru Ernst Collianders stiftelse for valgorande andamal.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Allen YC, 2005, ESTUARIES, V28, P435, DOI 10.1007/BF02693925; Alleway HK, 2015, CONSERV BIOL, V29, P795, DOI 10.1111/cobi.12452; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; ANDREW NL, 1987, OCEANOGR MAR BIOL, V25, P39; Bates D, 2012, LME4 LINEAR MIXED EF; Beaman RJ, 2005, CONT SHELF RES, V25, P1657, DOI 10.1016/j.csr.2005.04.013; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Beck MW, 2009, NATURE CONSERVANCY; BenedettiCecchi L, 1996, MAR ECOL PROG SER, V138, P93, DOI 10.3354/meps138093; Bernard ATF, 2013, J EXP MAR BIOL ECOL, V443, P75, DOI 10.1016/j.jembe.2013.02.039; Boman EM, 2016, J SHELLFISH RES, V35, P493, DOI 10.2983/035.035.0222; Bucas M, 2007, ESTUAR COAST SHELF S, V75, P308, DOI 10.1016/j.ecss.2007.04.038; Buhl-Mortensen L, 2012, HYDROBIOLOGIA, V685, P191, DOI 10.1007/s10750-011-0988-6; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cano J, 1996, AQUACULT INT, V4, P67; CARLETON JH, 1995, CORAL REEFS, V14, P35, DOI 10.1007/BF00304070; Carstensen J, 2016, ECOL INDIC, V67, P306, DOI 10.1016/j.ecolind.2016.03.002; Chust G, 2010, ESTUAR COAST SHELF S, V89, P200, DOI 10.1016/j.ecss.2010.07.002; Cochran WG., 1963, SAMPLING TECHNIQUES; Coen L. D, 2016, ENCY ESTUARIES, P89; Coen LD, 1999, AM FISHERIES SOC S; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Cognie B, 2006, AQUACULTURE, V259, P249, DOI 10.1016/j.aquaculture.2006.05.037; Commission O, 2008, BIODIVERSITY SERIES, V358, P1; Costa BM, 2009, REMOTE SENS ENVIRON, V113, P1082, DOI 10.1016/j.rse.2009.01.015; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; Cranfield HJ, 1999, AQUAT CONSERV, V9, P461, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<461::AID-AQC353>3.0.CO;2-Z; Edwards E, 1997, TECHNICAL REPORT; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Francis FTY, 2014, MAR BIOL, V161, P1375, DOI 10.1007/s00227-014-2425-7; GIGUERE M, 1994, J SHELLFISH RES, V13, P25; Gillies C., 2015, SHELLF REEF HAB SYN; Grabowski JH, 2012, BIOSCIENCE, V62, P900, DOI 10.1525/bio.2012.62.10.10; Greco M., 2008, NATURAL OYSTER GROUN; Grizzle RE, 2008, J COASTAL RES, V24, P103, DOI 10.2112/06-0672.1; Grizzle RE, 2003, MAPPING CHARACTERIZI; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harris PT, 2012, ELSEV INSIGHT, P1; He KS, 2015, REMOTE SENS ECOL CON, V1, P4, DOI 10.1002/rse2.7; HELCOM, 2013, RED LIST BALT SEA UN; Herbert RJH, 2016, BIODIVERS CONSERV, V25, P2835, DOI 10.1007/s10531-016-1209-4; Holmes KW, 2008, CONT SHELF RES, V28, P1800, DOI 10.1016/j.csr.2008.04.016; Ierodiaconou D, 2011, CONT SHELF RES, V31, pS28, DOI 10.1016/j.csr.2010.01.012; Kellogg ML, 2014, ESTUAR COAST SHELF S, V151, P156, DOI 10.1016/j.ecss.2014.09.025; Kennedy R, 1999, BIOL ENV P ROYAL IRI; Kenny AJ, 2003, ICES J MAR SCI, V60, P411, DOI 10.1016/S1054-3139(03)00006-7; Kostylev VE, 2001, MAR ECOL PROG SER, V219, P121, DOI 10.3354/meps219121; Laing I, 2005, FEASIBILITY STUDY NA; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le Bris A, 2016, ESTUAR COAST SHELF S, V172, P1, DOI 10.1016/j.ecss.2016.01.039; Letessier TB, 2015, BIOL REV; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Lindegarth M, 2014, OSTRON OSTREA EDULIS, P43; Lirman D, 2007, ENVIRON MONIT ASSESS, V125, P59, DOI 10.1007/s10661-006-9239-0; Loo LO, 1888, OSTRON BLIR ALLMER S; Mallet D, 2014, FISH RES, V154, P44, DOI 10.1016/j.fishres.2014.01.019; Mann R, 2004, J SHELLFISH RES, V23, P387; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Nadon MO, 2006, CORAL REEFS, V25, P177, DOI 10.1007/s00338-005-0074-5; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Nieuwhof S, 2015, REMOTE SENS-BASEL, V7, P3710, DOI 10.3390/rs70403710; Ninio R, 2003, ESTIMATING COVER BEN; OSPAR, 2010, QUAL STAT REP 2010; Piazza BP, 2005, RESTOR ECOL, V13, P499, DOI 10.1111/j.1526-100X.2005.00062.x; Powell EN, 2006, ESTUAR COAST SHELF S, V69, P531, DOI 10.1016/j.ecss.2006.05.014; Roberts D.A., 2007, MAPPING SEAFLOOR HAB, P71; Rodney WS, 2006, J EXP MAR BIOL ECOL, V335, P39, DOI 10.1016/j.jembe.2006.02.017; Ross P., 2009, POPULATION ASSESSMEN; Schubert PR, 2015, MAR ECOL PROG SER, V522, P79, DOI 10.3354/meps11133; Sheehan EV, 2016, METHODS ECOL EVOL, V7, P843, DOI 10.1111/2041-210X.12540; Sheehan EV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014461; Smaal A., 2015, FEASIBILITY FLAT OYS; Smith J, 2015, ESTUAR COAST SHELF S, V164, P520, DOI 10.1016/j.ecss.2015.07.036; Soniat TM, 2014, J SHELLFISH RES, V33, P381, DOI 10.2983/035.033.0207; Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233; Stevens TF, 2014, MAR POLICY, V45, P310, DOI 10.1016/j.marpol.2013.09.006; Stokesbury KDE, 2004, J SHELLFISH RES, V23, P33; Stunz GW, 2010, MAR ECOL PROG SER, V406, P147, DOI 10.3354/meps08556; Tarnowski M, 2005, MARYLAND OYSTER POPU; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Team RC, 2016, R LANG ENV STAT COMP; Team RC, 2014, R LANG ENV STAT COMP; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Tyne JA, 2010, MAR FRESHWATER RES, V61, P1023, DOI 10.1071/MF09240; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; van Rein H, 2012, J MAR BIOL ASSOC UK, V92, P49, DOI 10.1017/S0025315411000233; Van Rein HB, 2009, UNDERWATER TECHNOL, V28, P99, DOI 10.3723/ut.28.099; Ventura D, 2016, ESTUAR COAST SHELF S, V171, P85, DOI 10.1016/j.ecss.2016.01.030; Waldbusser GG, 2011, J SHELLFISH RES, V30, P659, DOI 10.2983/035.030.0308; Wolff WJ, 2005, HELGOLAND MAR RES, V59, P31, DOI 10.1007/s10152-004-0204-4; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Zanini JM, 2000, CORAL REEFS, V19, P83, DOI 10.1007/s003380050231	93	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187870	10.1371/journal.pone.0187870	http://dx.doi.org/10.1371/journal.pone.0187870			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141028	gold, Green Submitted, Green Published			2022-12-26	WOS:000415260400035
J	Tonosu, J; Oka, H; Higashikawa, A; Okazaki, H; Tanaka, S; Matsudaira, K				Tonosu, Juichi; Oka, Hiroyuki; Higashikawa, Akiro; Okazaki, Hiroshi; Tanaka, Sakae; Matsudaira, Ko			The associations between magnetic resonance imaging findings and low back pain: A 10-year longitudinal analysis	PLOS ONE			English	Article							HIGH-INTENSITY ZONE; LUMBAR SPINE; DISC DEGENERATION; MRI FINDINGS; PREVALENCE; DISABILITY; DISEASE; ADULTS; RISK	Purpose To conduct a 10-year longitudinal analysis of the relationship between magnetic resonance imaging (MRI) findings and low back pain (LBP). Materials and methods Ninety-one volunteers with a history of LBP, but without current LBP were recruited between 2005 and 2006. Participants' baseline demographics and MRI findings were recorded. All volunteers were invited for a follow-up MRI in 2016; of these, 49 volunteers (53.8%) participated in the follow-up. We enquired whether they had LBP history during the 10 years between the baseline and follow-up examinations. Sagittal T1 and T2-weighted MRI were used to assess the intervertebral space from T12/L1 to L5/S1. We evaluated the presence of disc degeneration by Pfirrmann's grading system, disc bulging, high intensity zone (HIZ), spondylolisthesis, and any type of Modic changes in the follow-up MRIs. We compared the follow-up MRI findings with the baseline findings; the progress of each finding over the 10 years were also compared between the groups with (n = 36) and without (n = 13) LBP. Results Average age of the study participants at follow-up was 44.8 years; 25 were female and 24 were male. Average age, sex, body mass index, and smoking habits of those who did and did not participate in the follow-up study, as well as the demographic characteristics of those who did and did not have LBP history during the 10 years, were not significantly different. Compared with the group without LBP history, the group that had LBP history during the 10 years did not have a significantly increased prevalence of disc degeneration, disc bulging, and HIZ in the follow-up and baseline MRIs. Spondylolisthesis and any type of Modic changes were also not associated with LBP history during the 10 years. Conclusions Follow-up MRI findings consistent with Pfirrmann grading >= 4, disc bulging, HIZ, spondylolisthesis, and any type of Modic changes were not associated with LBP history during the 10 years between the baseline and follow-up study. The progresses of these findings were also not associated with the LBP history. In addition, baseline MRI findings were not associated with LBP history during the 10 years; therefore, our data suggest that baseline MRI findings cannot predict future LBP.	[Tonosu, Juichi; Higashikawa, Akiro; Okazaki, Hiroshi] Kanto Rosai Hosp, Dept Orthoped Surg, Kawasaki, Kanagawa, Japan; [Oka, Hiroyuki; Matsudaira, Ko] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Fac Med, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo, Dept Orthoped Surg, Fac Med, Tokyo, Japan	University of Tokyo; University of Tokyo	Oka, H (corresponding author), Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Fac Med, Tokyo, Japan.	okah-tky@umin.ac.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	Industrial Disease Clinical Research Grants [14020301]	Industrial Disease Clinical Research Grants	This work was supported by the Industrial Disease Clinical Research Grants No. 14020301 (URL:http://www.mhiw.go.jp/ seisakunitsuite/bunya/koyou_roudou/roudoukijun/ rousai/hojokin/0000051021.html) to KM and this fund is managed by Japanese public agencies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri A, 2013, J NEUROSURG SCI, V57, P103; APRILL C, 1992, BRIT J RADIOL, V65, P361, DOI 10.1259/0007-1285-65-773-361; Berg L, 2013, SKELETAL RADIOL, V42, P1593, DOI 10.1007/s00256-013-1700-x; Borenstein DG, 2001, J BONE JOINT SURG AM, V83A, P1306, DOI 10.2106/00004623-200109000-00002; Brinjikji W, 2015, AM J NEURORADIOL, V36, P2394, DOI 10.3174/ajnr.A4498; Brinjikji W, 2015, AM J NEURORADIOL, V36, P811, DOI 10.3174/ajnr.A4173; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Dongfeng Ren, 2011, Spine (Phila Pa 1976), V36, pE429, DOI 10.1097/BRS.0b013e3181dfce9e; Endean A, 2011, SPINE, V36, P160, DOI 10.1097/BRS.0b013e3181cd9adb; Fardon DF, 2014, SPINE J, V14, P2525, DOI 10.1016/j.spinee.2014.04.022; Fujii T, 2013, EUR SPINE J, V22, P432, DOI 10.1007/s00586-012-2439-0; Goldberg MS, 2000, SPINE, V25, P995, DOI 10.1097/00007632-200004150-00016; Jarvik JJ, 2001, SPINE, V26, P1158, DOI 10.1097/00007632-200105150-00014; Jarvinen J, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0540-3; Kalichman L, 2009, SPINE, V34, P199, DOI 10.1097/BRS.0b013e31818edcfd; Kjaer P, 2005, SPINE, V30, P1173, DOI 10.1097/01.brs.0000162396.97739.76; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Maatta JH, 2015, SPINE, V40, P1187, DOI 10.1097/BRS.0000000000000937; McGregor A H, 1997, Eur Spine J, V6, P308, DOI 10.1007/BF01142676; McNee P, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-234; Mikkone P, 2016, EUR SPINE J, V25, P635, DOI 10.1007/s00586-015-4065-0; Mitra D, 2004, CLIN RADIOL, V59, P1002, DOI 10.1016/j.crad.2004.06.001; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Mok FPS, 2016, SPINE J, V16, P32, DOI 10.1016/j.spinee.2015.09.060; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Schellhas KP, 1996, SPINE, V21, P79, DOI 10.1097/00007632-199601010-00018; Shiri Rahman, 2010, Am J Med, V123, DOI 10.1016/j.amjmed.2009.05.028; Stadnik TW, 1998, RADIOLOGY, V206, P49, DOI 10.1148/radiology.206.1.9423651; Steffens D, 2014, EUR J PAIN, V18, P755, DOI 10.1002/j.1532-2149.2013.00427.x; Suri P, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-152; Tamcan O, 2010, PAIN, V150, P451, DOI 10.1016/j.pain.2010.05.019; Tonosu J, 2017, J PAIN RES, V10, P47, DOI 10.2147/JPR.S122380; Videman T, 2003, SPINE, V28, P582, DOI 10.1097/00007632-200303150-00013; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Weishaupt D, 1998, RADIOLOGY, V209, P661, DOI 10.1148/radiology.209.3.9844656	36	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188057	10.1371/journal.pone.0188057	http://dx.doi.org/10.1371/journal.pone.0188057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141001	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400049
J	Acuna, SM; Aoki, JI; Laranjeira-Silva, MF; Zampieri, RA; Fernandes, JCR; Muxel, SM; Floeter-Winter, LM				Acuna, Stephanie Maia; Aoki, Juliana Ide; Laranjeira-Silva, Maria Fernanda; Zampieri, Ricardo Andrade; Ribeiro Fernandes, Juliane Cristina; Muxel, Sandra Marcia; Floeter-Winter, Lucile Maria			Arginase expression modulates nitric oxide production in Leishmania (Leishmania) amazonensis	PLOS ONE			English	Article							MAJOR AMASTIGOTES; COMPLEX I; PARASITE; NITRATION; OXIDOREDUCTASE; PROMASTIGOTES; MECHANISMS; SYNTHASE; GENE; CONSEQUENCES	Background Arginase is an enzyme that converts L-arginine to urea and L-ornithine, an essential substrate for the polyamine pathway supporting Leishmania (Leishmania) amazonensis replication and its survival in the mammalian host. L-arginine is also the substrate of macrophage nitric oxide synthase 2 (NOS2) to produce nitric oxide (NO) that kills the parasite. This competition can define the fate of Leishmania infection. Methodology/Principal findings The transcriptomic profiling identified a family of oxidoreductases in L. (L.) amazonensis wild-type (La-WT) and L. (L.) amazonensis arginase knockout (La-arg(-)) promastigotes and axenic amastigotes. We highlighted the identification of an oxidoreductase that could act as nitric oxide synthase-like (NOS-like), due to the following evidences: conserved domain composition, the participation of NO production during the time course of promastigotes growth and during the axenic amastigotes differentiation, regulation dependence on arginase activity, as well as reduction of NO amount through the NOS activity inhibition. NO quantification was measured by DAF-FM labeling analysis in a flow cytometry. Conclusions/Significance We described an arginase-dependent NOS-like activity in L. (L.) amazonensis and its role in the parasite growth. The increased detection of NO production in the mid-stationary and late-stationary growth phases of La-WT promastigotes could suggest that this production is an important factor to metacyclogenesis triggering. On the other hand, La-arg(-) showed an earlier increase in NO production compared to La-WT, suggesting that NO production can be arginase-dependent. Interestingly, La-WT and La-arg(-) axenic amastigotes produced higher levels of NO than those observed in promastigotes. As a conclusion, our work suggested that NOS-like is expressed in Leishmania in the stationary growth phase promastigotes and amastigotes, and could be correlated to metacyclogenesis and amastigotes growth in a dependent way to the internal pool of L-arginine and arginase activity.	[Acuna, Stephanie Maia; Aoki, Juliana Ide; Laranjeira-Silva, Maria Fernanda; Zampieri, Ricardo Andrade; Ribeiro Fernandes, Juliane Cristina; Muxel, Sandra Marcia; Floeter-Winter, Lucile Maria] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Muxel, SM; Floeter-Winter, LM (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil.	sandrammuxel@usp.br; lucile@usp.br	Aoki, Juliana Ide/K-7927-2018; Laranjeira-Silva, Maria Fernanda/H-9056-2012; Floeter-Winter, Lucile Maria/AAE-7629-2019; Zampieri, Ricardo/D-3706-2018; Floeter-Winter, Lucile Maria/K-2618-2012; Muxel, Sandra/F-7464-2012; Maia Acuna, Stephanie/T-1571-2017; Fernandes, Juliane/R-6016-2017	Aoki, Juliana Ide/0000-0002-1745-0310; Laranjeira-Silva, Maria Fernanda/0000-0002-7128-6208; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Muxel, Sandra/0000-0003-0118-5361; Maia Acuna, Stephanie/0000-0001-6074-4077; Fernandes, Juliane/0000-0001-7754-3925	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [307587/2014-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/50717-1, 2016/19815-2]; FAPESP [2015/25942-4]; CNPq [307587/2014-2, 103563/2013-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br 307587/2014-2.) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, www. fapesp.br 2014/50717-1, 2016/19815-2). SMA received a fellowship from FAPESP (2015/25942-4) and CNPq (103563/2013-0), and LMFW received a research fellowship from CNPq (307587/2014-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Adhuna A, 2000, IMMUNOL LETT, V71, P171, DOI 10.1016/S0165-2478(00)00158-9; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Aoki JI, 2017, PLOS NEGL TROP DIS, V11; Aoki JI, 2017, PLOS NEGL TROP DIS; Balafanova Z, 2002, J BIOL CHEM, V277, P15021, DOI 10.1074/jbc.M112451200; Basu NK, 1997, FEMS MICROBIOL LETT, V156, P43, DOI 10.1016/S0378-1097(97)00401-1; Bogdan C, 2008, CELL MICROBIOL, V10, P1221, DOI 10.1111/j.1462-5822.2008.01146.x; Boitz JM, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00554-16; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Castilho-Martins EA, 2015, ELECTROPHORESIS; Castilho-Martins EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027818; Cysne-Finkelstein L, 1998, EXP PARASITOL, V89, P58, DOI 10.1006/expr.1998.4276; da Silva ER, 2002, INT J PARASITOL, V32, P727, DOI 10.1016/S0020-7519(02)00002-4; da Silva Maria Fernanda Laranjeira, 2014, Subcell Biochem, V74, P103, DOI 10.1007/978-94-007-7305-9_4; Darlyuk I, 2009, J BIOL CHEM, V284, P19800, DOI 10.1074/jbc.M901066200; Fiebig M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005186; Fieschi F, 1995, J BIOL CHEM, V270, P30392, DOI 10.1074/jbc.270.51.30392; FONTECAVE M, 1994, BIOMETALS, V7, P3; Gaur U, 2007, J IMMUNOL, V179, P8446, DOI 10.4049/jimmunol.179.12.8446; Genestra M, 2006, ARCH MED RES, V37, P328, DOI 10.1016/j.arcmed.2005.07.011; Genestra M, 2003, MED MICROBIOL IMMUN, V192, P217, DOI 10.1007/s00430-003-0176-z; Genestra M, 2006, ARCH MICROBIOL, V185, P348, DOI 10.1007/s00203-006-0105-9; Goldman-Pinkovich A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005494; GREEN SJ, 1990, J IMMUNOL, V145, P4290; GREEN SJ, 1990, J IMMUNOL, V144, P278; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; HANUKOGLU I, 1993, ARCH BIOCHEM BIOPHYS, V305, P489, DOI 10.1006/abbi.1993.1452; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hodgkinson VH, 1996, EXP PARASITOL, V83, P94, DOI 10.1006/expr.1996.0053; Holzmuller P, 2006, INFECT GENET EVOL, V6, P187, DOI 10.1016/j.meegid.2005.03.003; Ji YB, 2006, J BIOL CHEM, V281, P1986, DOI 10.1074/jbc.M509480200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; da Silva MFL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034022; Laranjeira-Silva MF, 2015, J PINEAL RES; Lemire BD, 2015, BBA-BIOENERGETICS, V1847, P451, DOI 10.1016/j.bbabio.2015.01.014; Liese J, 2008, IMMUNOBIOLOGY, V213, P377, DOI 10.1016/j.imbio.2007.12.005; LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Mauel J, 1997, EXP PARASITOL, V87, P98, DOI 10.1006/expr.1997.4205; May SW, 1999, CURR OPIN BIOTECH, V10, P370, DOI 10.1016/S0958-1669(99)80067-6; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Morina K, 2011, J BIOL CHEM, V286, P34627, DOI 10.1074/jbc.M111.274571; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muleme HM, 2009, J IMMUNOL, V183, P8068, DOI 10.4049/jimmunol.0803979; Muxel SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44141; Nakagawa H, 2007, BIOL PHARM BULL, V30, P15, DOI 10.1248/bpb.30.15; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PAVETO C, 1995, J BIOL CHEM, V270, P16576, DOI 10.1074/jbc.270.28.16576; Pereira M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003683; Piacenza L, 2001, P NATL ACAD SCI USA, V98, P7301, DOI 10.1073/pnas.121520398; Planchet E, 2006, PLANT SIGNAL BEHAV, V1, P46, DOI 10.4161/psb.1.2.2435; Reguera RM, 2009, MOL BIOCHEM PARASIT, V165, P48, DOI 10.1016/j.molbiopara.2009.01.001; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Salvati L, 2001, BBA-PROTEIN STRUCT M, V1545, P357, DOI 10.1016/S0167-4838(00)00297-1; Sarkar A, 2011, CYTOM PART A, V79A, P35, DOI 10.1002/cyto.a.21001; Sarkar A, 2009, EXP PARASITOL, V122, P299, DOI 10.1016/j.exppara.2009.04.012; Seguin O, 2016, CELL IMMUNOL, V309, P1, DOI 10.1016/j.cellimm.2016.08.004; Souza JM, 2000, ARCH BIOCHEM BIOPHYS, V380, P360, DOI 10.1006/abbi.2000.1940; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Teixeira DE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003594; Temporal RM, 2005, J ENZYM INHIB MED CH, V20, P13, DOI 10.1080/14756360400015207; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wanasen N, 2008, IMMUNOL RES, V41, P15, DOI 10.1007/s12026-007-8012-y; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550	74	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187186	10.1371/journal.pone.0187186	http://dx.doi.org/10.1371/journal.pone.0187186			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135983	gold, Green Published, Green Submitted			2022-12-26	WOS:000415121200014
J	Garcia-Jimenez, A; Teruel-Puche, JA; Garcia-Ruiz, PA; Saura-Sanmartin, A; Berna, J; Garcia-Canovas, F; Rodriguez-Lopez, JN				Garcia-Jimenez, Antonio; Teruel-Puche, Jose Antonio; Garcia-Ruiz, Pedro Antonio; Saura-Sanmartin, Adrian; Berna, Jose; Garcia-Canovas, Francisco; Rodriguez-Lopez, Jose Neptuno			Structural and kinetic considerations on the catalysis of deoxyarbutin by tyrosinase	PLOS ONE			English	Article							CONSUMER SAFETY SCCS; MUSHROOM TYROSINASE; SCIENTIFIC COMMITTEE; DEPIGMENTING AGENT; COSMETIC PRODUCTS; CRYSTAL-STRUCTURE; CATECHOL OXIDASE; DIPHENOLASE ACTIVITIES; BIOSYNTHESIS PATHWAY; MICHAELIS CONSTANTS	Deoxyarbutin, a potent inhibitor of tyrosinase, could act as substrate of the enzyme. Oxytyrosinase is able to hydroxylate deoxyarbutin and finishes the catalytic cycle by oxidizing the formed o-diphenol to quinone, while the enzyme becomes deoxytyrosinase, which evolves to oxytyrosinase in the presence of oxygen. This compound is the only one described that does not release o-diphenol after the hydroxylation step. Oxytyrosinase hydroxylates the deoxyarbutin in ortho position of the phenolic hydroxyl group by means of an aromatic electrophilic substitution. As the oxygen orbitals and the copper atoms are not coplanar, but in axial/equatorial position, the concerted oxidation/reduction cannot occur and the release of a copper atom to bind again in coplanar position, enabling the oxidation/reduction or release of the o-diphenol from the active site to the medium. In the case of deoxyarbutin, the o-diphenol formed is repulsed by the water due to its hydrophobicity, and so can bind correctly and be oxidized to a quinone before being released. Deoxyarbutin has been characterized with:(kD-Arb)(cat) = 1.95 +/- 0.06 s(-1) and K-M(D-Arb) = 33 +/- 4 mu M. Computational simulations of the interaction of beta-arbutin, deoxyarbutin and their o-diphenol products with tyrosinase show how these ligands bind at the copper centre of tyrosinase. The presence of an energy barrier in the release of the o-diphenol product of deoxyarbutin, which is not present in the case of beta-arbutin, together with the differences in polarity and, consequently differences in their interaction with water help understand the differences in the kinetic behaviour of both compounds. Therefore, it is proposed that the release of the o-diphenol product of deoxyarbutin from the active site might be slower than in the case of beta-arbutin, contributing to its oxidation to a quinone before being released from the protein into the water phase.	[Garcia-Jimenez, Antonio; Garcia-Canovas, Francisco; Rodriguez-Lopez, Jose Neptuno] Univ Murcia, GENZ Grp Res Enzymol, Dept Biochem & Mol Biol A, Reg Campus Int Excellence,Campus Mare Nostrum, Murcia, Spain; [Teruel-Puche, Jose Antonio] Univ Murcia, Grp Mol Interact Membranes, Dept Biochem & Mol Biol A, Murcia, Spain; [Garcia-Ruiz, Pedro Antonio] Univ Murcia, Fac Vet, Dept Organ Chem, Grp Chem Carbohydrates Ind Polymers & Addit, Murcia, Spain; [Saura-Sanmartin, Adrian; Berna, Jose] Univ Murcia, Fac Chem, Dept Organ Chem, Grp Synthet Organ Chem, Murcia, Spain	University of Murcia; University of Murcia; University of Murcia; University of Murcia	Garcia-Canovas, F (corresponding author), Univ Murcia, GENZ Grp Res Enzymol, Dept Biochem & Mol Biol A, Reg Campus Int Excellence,Campus Mare Nostrum, Murcia, Spain.	canovasf@um.es	Saura-Sanmartín, Adrián/B-6971-2017; Puche, José Antonio Teruel/R-4137-2018; Berna, Jose/C-9334-2011; Garcia-Canovas, Francisco/M-1290-2014	Saura-Sanmartín, Adrián/0000-0002-9099-3450; Puche, José Antonio Teruel/0000-0003-2256-3368; Berna, Jose/0000-0001-7775-3703; Garcia-Canovas, Francisco/0000-0002-8869-067X; Rodriguez-Lopez, Jose Neptuno/0000-0001-6863-1173	Fundacion Seneca (CARM, Murcia, Spain) [19545/PI/14, 19304/PI/14, 19240/PI/14]; MINECO [SAF2016-77241-R, CTQ2014-56887-P]; Fondos FEDER; University of Murcia (Murcia) [UMU15452, UMU17766]; FPU fellowship from the University of Murcia	Fundacion Seneca (CARM, Murcia, Spain)(Fundacion Seneca); MINECO(Spanish Government); Fondos FEDER(European Commission); University of Murcia (Murcia); FPU fellowship from the University of Murcia	This work was supported by the Fundacion Seneca (CARM, Murcia, Spain) under Projects 19545/PI/14, 19304/PI/14 and 19240/PI/14; MINECO under Projects SAF2016-77241-R and CTQ2014-56887-P (Co-financing with Fondos FEDER); and University of Murcia (Murcia) under Projects UMU15452 and UMU17766. A. Garcia-Jimenez has a FPU fellowship from the University of Murcia.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Alvarez-Parrilla E, 2007, FOOD CHEM, V101, P1346, DOI 10.1016/j.foodchem.2006.03.040; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boissy RE, 2005, EXP DERMATOL, V14, P601, DOI 10.1111/j.0906-6705.2005.00337.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chawla S, 2008, BRIT J DERMATOL, V159, P1267, DOI 10.1111/j.1365-2133.2008.08864.x; Cheng TJ, 2007, J CHEM INF MODEL, V47, P2140, DOI 10.1021/ci700257y; Degen GH, 2016, REGUL TOXICOL PHARM, V74, P77, DOI 10.1016/j.yrtph.2015.11.007; Degen GH, 2016, REGUL TOXICOL PHARM, V74, P75, DOI 10.1016/j.yrtph.2015.11.008; Degen GH, 2015, REGUL TOXICOL PHARM, V73, P866, DOI 10.1016/j.yrtph.2015.10.008; Garcia-Molina MD, 2014, REACT KINET MECH CAT, V112, P305, DOI 10.1007/s11144-014-0723-1; Garcia-Molina MD, 2014, BIOORGAN MED CHEM, V22, P3360, DOI 10.1016/j.bmc.2014.04.048; Deri B, 2016, SCI REP-UK, V6, DOI 10.1038/srep34993; Devece C, 1999, J AGR FOOD CHEM, V47, P4506, DOI 10.1021/jf981398+; Espin JC, 1998, J AGR FOOD CHEM, V46, P2968, DOI 10.1021/jf971045v; Espin JC, 2000, EUR J BIOCHEM, V267, P1270, DOI 10.1046/j.1432-1327.2000.01013.x; Espin JC, 1996, J FOOD SCI, V61, P1177, DOI 10.1111/j.1365-2621.1996.tb10955.x; Fenoll LG, 2002, INT J BIOCHEM CELL B, V34, P332, DOI 10.1016/S1357-2725(01)00133-9; Fenoll LG, 2002, INT J BIOCHEM CELL B, V34, P1594, DOI 10.1016/S1357-2725(02)00076-6; Fenoll LG, 2001, BBA-PROTEIN STRUCT M, V1548, P1, DOI 10.1016/S0167-4838(01)00207-2; Garcia-Jimenez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177330; Garcia-Jimenez A, 2017, REACT KINET MECH CAT, V120, P1, DOI 10.1007/s11144-016-1106-6; Garcia-Jimenez A, 2017, INT J BIOL MACROMOL, V98, P622, DOI 10.1016/j.ijbiomac.2017.02.032; Garcia-Jimenez A, 2016, BIOORGAN MED CHEM, V24, P4434, DOI 10.1016/j.bmc.2016.07.048; Garcia-Jimenez A, 2016, IUBMB LIFE, V68, P663, DOI 10.1002/iub.1528; Garcia-Molina F, 2007, J AGR FOOD CHEM, V55, P9739, DOI 10.1021/jf0712301; Garcia-Molina F, 2005, J AGR FOOD CHEM, V53, P3702, DOI 10.1021/jf048340h; Garcia-Sevilla F, 2000, BIOSYSTEMS, V54, P151, DOI 10.1016/S0303-2647(99)00071-4; Gerald C.F., 1978, APPL NUMERICAL ANAL; Goldfeder M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5505; Hamed SH, 2006, J COSMET SCI, V57, P291; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hu ZM, 2009, J DERMATOL SCI, V55, P179, DOI 10.1016/j.jdermsci.2009.06.003; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t; Ito S, 2007, CHEM MELANINS PIGMEN, P282; JACKMAN MP, 1992, BIOCHEM J, V282, P915, DOI 10.1042/bj2820915; Joseph P, 1998, BRIT J CANCER, V78, P312, DOI 10.1038/bjc.1998.492; Kanteev M, 2015, PROTEIN SCI, V24, P1360, DOI 10.1002/pro.2734; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; Kolbe L, 2013, J EUR ACAD DERMATOL, V27, P19, DOI 10.1111/jdv.12051; Koziara KB, 2014, J COMPUT AID MOL DES, V28, P221, DOI 10.1007/s10822-014-9713-7; Lee S, 2016, EURASIP J IMAGE VIDE, DOI 10.1186/s13640-016-0104-y; LERCH K, 1981, MET IONS BIOL SYST, V13, P143; Levin C Y, 2001, Am J Clin Dermatol, V2, P213, DOI 10.2165/00128071-200102040-00002; Li YC, 2009, P NATL ACAD SCI USA, V106, P17002, DOI 10.1073/pnas.0906095106; Lin CC, 2011, INT J MOL SCI, V12, P5946, DOI 10.3390/ijms12095946; Madera Core, 2006, J SCI; Mary Sea Garcia-Molina, 2013, BIOSCI BIOTECH BIOCH, V77, P2383, DOI 10.1271/bbb.130500; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; MCEVILY AJ, 1992, CRIT REV FOOD SCI, V32, P253, DOI 10.1080/10408399209527599; Mendes E, 2014, EXPERT OPIN DRUG DIS, V9, P533, DOI 10.1517/17460441.2014.907789; Miao F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165338; Munoz JL, 2006, ANAL BIOCHEM, V351, P128, DOI 10.1016/j.ab.2006.01.011; Nokinsee D, 2015, ENZYME RES, V2015, DOI 10.1155/; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Park KL, 2017, ARCH PHARM RES, V40, P57, DOI 10.1007/s12272-016-0866-x; Pillaiyar T, 2015, EXPERT OPIN THER PAT, V25, P775, DOI 10.1517/13543776.2015.1039985; Rodriguez-Lopez JN, 2001, BBA-PROTEIN STRUCT M, V1548, P238, DOI 10.1016/S0167-4838(01)00237-0; Rodriguez-Lopez JN, 2000, BIOCHEMISTRY-US, V39, P10497, DOI 10.1021/bi000539+; RODRIGUEZLOPEZ JN, 1993, BIOCHEM J, V293, P859, DOI 10.1042/bj2930859; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Sardana K, 2015, EXPERT REV CLIN PHAR, V8, P123, DOI 10.1586/17512433.2015.977255; Schrodinger L., 2020, PYMOL; Si YX, 2011, INT J BIOL MACROMOL, V48, P700, DOI 10.1016/j.ijbiomac.2011.02.015; Solem E, 2016, ANGEW CHEM INT EDIT, V55, P2884, DOI 10.1002/anie.201508534; Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Tofani RP, 2016, SCI PHARM, V84, P634, DOI 10.3390/scipharm84040634; Urabe K, 1998, MIXED EPIDERMAL DERM; Ortiz-Ruiz CV, 2016, J DERMATOL SCI, V82, P115, DOI 10.1016/j.jdermsci.2016.02.004; Ortiz-Ruiz CV, 2015, IUBMB LIFE, V67, P828, DOI 10.1002/iub.1439; Ortiz-Ruiz CV, 2015, J AGR FOOD CHEM, V63, P7032, DOI 10.1021/acs.jafc.5b02523; Wang ZJ, 2013, INT J BIOL MACROMOL, V55, P15, DOI 10.1016/j.ijbiomac.2012.12.040; Washington C, 2015, ARCH BIOCHEM BIOPHYS, V577, P24, DOI 10.1016/j.abb.2015.04.007; WEI CI, 1991, TOXICOL LETT, V59, P213, DOI 10.1016/0378-4274(91)90074-G; Won YK, 2014, ARCH DERMATOL RES, V306, P455, DOI 10.1007/s00403-014-1439-9; Wu Z, 2010, J PHYS CHEM B, V114, P10524, DOI 10.1021/jp1019763; Yang CH, 2013, BIOSCI BIOTECH BIOCH, V77, P1127, DOI 10.1271/bbb.130042; Yang CH, 2010, INT J MOL SCI, V11, P3977, DOI 10.3390/ijms11103977; Yoshimura M, 2005, BIOSCI BIOTECH BIOCH, V69, P2368, DOI 10.1271/bbb.69.2368; Zheng ZP, 2011, FOOD FUNCT, V2, P259, DOI 10.1039/c1fo10033e; Zhou HF, 2009, MOL PHARMACOL, V76, P579, DOI 10.1124/mol.109.057323	85	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187845	10.1371/journal.pone.0187845	http://dx.doi.org/10.1371/journal.pone.0187845			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136639	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200035
J	Liu, F; Zeng, ZY; Jiang, R				Liu, Fei; Zeng, Zhiyuan; Jiang, Rong			A video-based real-time adaptive vehicle-counting system for urban roads	PLOS ONE			English	Article								In developing nations, many expanding cities are facing challenges that result from the overwhelming numbers of people and vehicles. Collecting real-time, reliable and precise traffic flow information is crucial for urban traffic management. The main purpose of this paper is to develop an adaptive model that can assess the real-time vehicle counts on urban roads using computer vision technologies. This paper proposes an automatic real-time background update algorithm for vehicle detection and an adaptive pattern for vehicle counting based on the virtual loop and detection line methods. In addition, a new robust detection method is introduced to monitor the real-time traffic congestion state of road section. A prototype system has been developed and installed on an urban road for testing. The results show that the system is robust, with a real-time counting accuracy exceeding 99% in most field scenarios.	[Liu, Fei; Zeng, Zhiyuan] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Hubei, Peoples R China; [Jiang, Rong] Huawei Corp, Shenzhen, Peoples R China	Huazhong University of Science & Technology; Huawei Technologies	Zeng, ZY (corresponding author), Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Hubei, Peoples R China.	chengru2003@hust.edu.cn						Al-Gami SM, 2006, PROC WRLD ACAD SCI E, V18, P180; Chen T.H., 2007, 2 INT C INN COMP INF, P238; Chen TH, 2007, 2007 THIRD INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING, VOL II, PROCEEDINGS, P519; Coifman B, 1998, TRANSPORT RES C-EMER, V6, P271, DOI 10.1016/S0968-090X(98)00019-9; Cucchiara R, 2002, VIDEO-BASED SURVEILLANCE SYSTEMS: COMPUTER VISION AND DISTRIBUTED PROCESSING, P145; Cucchiara R, 2001, 2001 IEEE INTELLIGENT TRANSPORTATION SYSTEMS - PROCEEDINGS, P334, DOI 10.1109/ITSC.2001.948679; Gajda J, 2001, IEEE IMTC P, P460, DOI 10.1109/IMTC.2001.928860; Hu XS, 2016, ENERGY, V111, P971, DOI 10.1016/j.energy.2016.06.037; Hu XS, 2016, IEEE T CONTR SYST T, V24, P1036, DOI 10.1109/TCST.2015.2476799; Hu XS, 2016, IEEE T IND ELECTRON, V63, P2645, DOI 10.1109/TIE.2015.2461523; Hu XS, 2015, IEEE T IND ELECTRON, V62, P7847, DOI 10.1109/TIE.2015.2463770; HUSSAIN TM, 1995, IEEE T VEH TECHNOL, V44, P683, DOI 10.1109/25.406637; Kim SE, 1998, P 5 WORLD C INT TRAN; Lei M, 2008, SITIS 2008: 4TH INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGY AND INTERNET BASED SYSTEMS, PROCEEDINGS, P523, DOI 10.1109/SITIS.2008.91; Li SG, 2014, IET INTELL TRANSP SY, V8, P164, DOI 10.1049/iet-its.2012.0099; Li ZX, 2006, J TRANSP ENG, V132, P565, DOI 10.1061/(ASCE)0733-947X(2006)132:7(565); Mimbela L.E.Y., 2007, SUMMARY VEHICLE DETE; Mohana HS, 2009, INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER CONTROL : ICACC 2009 - PROCEEDINGS, P791, DOI 10.1109/ICACC.2009.149; Pornpanomchai C, 2008, INT C WAVEL ANAL PAT, P356, DOI 10.1109/ICWAPR.2008.4635804; Qi L, 2008, 2008 WORKSHOP ON POWER ELECTRONICS AND INTELLIGENT TRANSPORTATION SYSTEM, PROCEEDINGS, P529, DOI 10.1109/PEITS.2008.124; Robert K., 2009, P 2009 12 INT IEEE C, P1, DOI [10.1109/ITSC.2009.5309837, DOI 10.1109/ITSC.2009.5309837]; Rodriguez T, 2010, MACH VISION APPL, V21, P555, DOI 10.1007/s00138-009-0185-z; SUZUKI S, 1985, COMPUT VISION GRAPH, V30, P32, DOI 10.1016/0734-189X(85)90016-7; Watanabe A., 1999, IJCNN'99. International Joint Conference on Neural Networks. Proceedings (Cat. No.99CH36339), P3170, DOI 10.1109/IJCNN.1999.836160; Yan XP, 2012, 2012 11TH INTERNATIONAL SYMPOSIUM ON DISTRIBUTED COMPUTING AND APPLICATIONS TO BUSINESS, ENGINEERING & SCIENCE (DCABES), P321, DOI 10.1109/DCABES.2012.107; Zhang L, 2015, J POWER SOURCES, V287, P129, DOI 10.1016/j.jpowsour.2015.04.043	26	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0186098	10.1371/journal.pone.0186098	http://dx.doi.org/10.1371/journal.pone.0186098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135984	Green Submitted, Green Published, gold			2022-12-26	WOS:000415121200004
J	Witkowski, AM; Ludzik, J; Arginelli, F; Bassoli, S; Benati, E; Casari, A; De Carvalho, N; De Pace, B; Farnetani, F; Losi, A; Manfredini, M; Reggiani, C; Malvehy, J; Pellacani, G				Witkowski, A. M.; Ludzik, J.; Arginelli, F.; Bassoli, S.; Benati, E.; Casari, A.; De Carvalho, N.; De Pace, B.; Farnetani, F.; Losi, A.; Manfredini, M.; Reggiani, C.; Malvehy, J.; Pellacani, G.			Improving diagnostic sensitivity of combined dermoscopy and reflectance confocal microscopy imaging through double reader concordance evaluation in telemedicine settings: A retrospective study of 1000 equivocal cases	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; OPTICAL COHERENCE TOMOGRAPHY; SKIN-CANCER DIAGNOSIS; TIME RAMAN-SPECTROSCOPY; IN-VIVO; MELANOCYTIC LESIONS; MELANOMA DETECTION; LENTIGINOUS MELANOMA; ACTINIC KERATOSIS; CLINICAL-PRACTICE	Background Reflectance confocal microscopy (RCM) is an imaging device that permits non-invasive visualization of cellular morphology and has been shown to improve diagnostic accuracy of dermoscopically equivocal cutaneous lesions. The application of double reader concordance evaluation of dermoscopy-RCM image sets in retrospective settings and its potential application to telemedicine evaluation has not been tested in a large study population. Objective To improve diagnostic sensitivity of RCM image diagnosis using a double reader concordance evaluation approach; to reduce mismanagement of equivocal cutaneous lesions in retrospective consultation and telemedicine settings. Methods 1000 combined dermoscopy-RCM image sets were evaluated in blind by 10 readers with advanced training and internship in dermoscopy and RCM evaluation. We compared sensitivity and specificity of single reader evaluation versus double reader concordance evaluation as well as the effect of diagnostic confidence on lesion management in a retrospective setting. Results Single reader evaluation resulted in an overall sensitivity of 95.2% and specificity of 76.3%, with misdiagnosis of 8 melanomas, 4 basal cell carcinomas and 2 squamous cell carcinomas. Combined double reader evaluation resulted in an overall sensitivity of 98.3% and specificity of 65.5%, with misdiagnosis of 1 in-situ melanoma and 2 basal cell carcinomas. Conclusion Evaluation of dermoscopy-RCM image sets of cutaneous lesions by single reader evaluation in retrospective settings is limited by sensitivity levels that may result in potential mismanagement of malignant lesions. Double reader blind concordance evaluation may improve the sensitivity of diagnosis and management safety. The use of a second check can be implemented in telemedicine settings where expert consultation and second opinions may be required.	[Witkowski, A. M.; Ludzik, J.; Arginelli, F.; Bassoli, S.; Benati, E.; Casari, A.; De Carvalho, N.; De Pace, B.; Farnetani, F.; Losi, A.; Manfredini, M.; Reggiani, C.] Univ Modena & Reggio Emilia, Dept Dermatol, Modena, Italy; [Ludzik, J.] Jagiellonian Univ, Dept Biostat & Telemed, Coll Med, Krakow, Poland; [Malvehy, J.] Dept Dermatol, Melanoma Unit, Barcelona, Spain	Universita di Modena e Reggio Emilia; Jagiellonian University; Collegium Medicum Jagiellonian University	Witkowski, AM (corresponding author), Univ Modena & Reggio Emilia, Dept Dermatol, Modena, Italy.	alexander.witkowski@unimore.it	de Carvalho, N./AAZ-9154-2021; Pellacani, Giovanni/E-8573-2011	de Carvalho, N./0000-0002-0823-5731; Pellacani, Giovanni/0000-0002-7222-2951; Manfredini, Marco/0000-0003-3601-655X				Alarcon I, 2014, BRIT J DERMATOL, V170, P802, DOI 10.1111/bjd.12678; Argenziano G, 2014, GIORN ITAL DERMAT V, V149, P161; Argenziano G, 2012, J AM ACAD DERMATOL, V67, P54, DOI 10.1016/j.jaad.2011.07.019; Arzberger E, 2016, ACTA DERM VENEREOL; Borsari S, 2016, JAMA DERMATOL, V152, P1093, DOI 10.1001/jamadermatol.2016.1188; Dimitrow E, 2009, J INVEST DERMATOL, V129, P1752, DOI 10.1038/jid.2008.439; Edwards SJ, 2017, CLIN EXP DERMATOL; Farnetani F, 2015, JAMA DERMATOL, V151, P1075, DOI 10.1001/jamadermatol.2015.0810; Ferrari B, 2015, J EUR ACAD DERMATOL, V29, P1135, DOI 10.1111/jdv.12769; Gambichler T, 2015, J EUR ACAD DERMATOL, V29, P537, DOI 10.1111/jdv.12621; Giambrone D, 2015, J AM ACAD DERMATOL, V73, P317, DOI 10.1016/j.jaad.2015.03.052; Gill M, 2014, J EUR ACAD DERMATOL, V28, P1069, DOI 10.1111/jdv.12285; Guida S, 2016, BRIT J DERMATOL, V174, P610, DOI 10.1111/bjd.14286; Guitera P, 2016, BRIT J DERMATOL, V175, P1311, DOI 10.1111/bjd.14749; Guitera P, 2012, J INVEST DERMATOL, V132, P2386, DOI 10.1038/jid.2012.172; Guitera P, 2010, J INVEST DERMATOL, V130, P2080, DOI 10.1038/jid.2010.84; Guitera P, 2009, J INVEST DERMATOL, V129, P131, DOI 10.1038/jid.2008.193; Kadouch DJ, 2015, J EUR ACAD DERMATOL, V29, P1890, DOI 10.1111/jdv.13224; King R, 2011, ARCH PATHOL LAB MED, V135, P337, DOI 10.1043/2009-0538-RA.1; Kittler H, 2002, LANCET ONCOL, V3, P159, DOI 10.1016/S1470-2045(02)00679-4; Langley RGB, 2007, DERMATOLOGY, V215, P365, DOI 10.1159/000109087; Longo C, 2013, BRIT J DERMATOL, V169, P58, DOI 10.1111/bjd.12259; Lovatto L, 2015, J EUR ACAD DERMATOL, V29, P1918, DOI 10.1111/jdv.13067; Ludzik J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162495; Lui H, 2012, CANCER RES, V72, P2491, DOI 10.1158/0008-5472.CAN-11-4061; Maher NG, 2016, BR J DERMATOL; Manfredini M, 2013, SKIN RES TECHNOL, V19; Monheit G, 2011, ARCH DERMATOL, V147, P188, DOI 10.1001/archdermatol.2010.302; Mooi WJ, 2014, ADV ANAT PATHOL, V21, P181, DOI 10.1097/PAP.0000000000000013; Olsen J, 2016, PHOTODIAGN PHOTODYN, V16, P44, DOI 10.1016/j.pdpdt.2016.08.004; Pellacani G, 2016, J EUR ACAD DERMATOL, V30, P413, DOI 10.1111/jdv.13408; Pellacani G, 2014, BRIT J DERMATOL, V171, P1044, DOI 10.1111/bjd.13148; Pellacani G, 2007, J INVEST DERMATOL, V127, P2759, DOI 10.1038/sj.jid.5700993; Pellacani G, 2012, J AM ACAD DERMATOL, V66, pE109, DOI 10.1016/j.jaad.2011.05.017; Pellacani G, 2009, J AM ACAD DERMATOL, V60, P236, DOI 10.1016/j.jaad.2008.07.061; Pellicani G, 2005, J AM ACAD DERMATOL, V53, P979, DOI 10.1016/j.jaad.2005.08.022; Peppelman M, 2015, J EUR ACAD DERMATOL, V29, P1302, DOI 10.1111/jdv.12806; Piccolo D, 2000, J TELEMED TELECARE, V6, P132, DOI 10.1258/1357633001935202; Rao BK, 2013, J AM ACAD DERMATOL, V69, pE295, DOI 10.1016/j.jaad.2013.07.022; Segura S, 2009, J AM ACAD DERMATOL, V61, P216, DOI 10.1016/j.jaad.2009.02.014; Seidenari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070682; Song E, 2016, J AM ACAD DERMATOL, V75, P1187, DOI 10.1016/j.jaad.2016.07.022; Stanganelli I, 2015, BRIT J DERMATOL, V172, P365, DOI 10.1111/bjd.13373; Ulrich M, 2015, BRIT J DERMATOL, V173, P428, DOI 10.1111/bjd.13853; Vestergaard ME, 2008, BRIT J DERMATOL, V159, P669, DOI 10.1111/j.1365-2133.2008.08713.x; Witkowski AM, 2016, SKIN RES TECHNOL, V22, P230, DOI 10.1111/srt.12254; Witkowski A, 2016, DERMATOL CLIN, V34, P505, DOI 10.1016/j.det.2016.05.013; Xiong YQ, 2017, J CANC RES CLIN ONCO; Zhao JH, 2015, ANAL BIOANAL CHEM, V407, P8373, DOI 10.1007/s00216-015-8914-9	49	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187748	10.1371/journal.pone.0187748	http://dx.doi.org/10.1371/journal.pone.0187748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121636	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900071
J	Yanagawa, A; Neyen, C; Lemaitre, B; Marion-Poll, F				Yanagawa, Aya; Neyen, Claudine; Lemaitre, Bruno; Marion-Poll, Frederic			The gram-negative sensing receptor PGRP-LC contributes to grooming induction in Drosophila	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; IMMUNE-RESPONSE; FUNGAL-INFECTIONS; GENE-EXPRESSION; LE; MELANOGASTER; BEHAVIOR; DEFENSE; CHEMORECEPTORS; BACTERIAL	Behavioral resistance protects insects from microbial infection. However, signals inducing insect hygiene behavior are still relatively unexplored. Our previous study demonstrated that olfactory signals from microbes enhance insect hygiene behavior, and gustatory signals even induce the behavior. In this paper, we postulated a cross-talk between behavioral resistance and innate immunity. To examine this hypothesis, we employed a previously validated behavioral test to examine the function of taste signals in inducing a grooming reflex in decapitated flies. Microbes, which activate different pattern recognition systems upstream of immune pathways, were applied to see if there was any correlation between microbial perception and grooming reflex. To narrow down candidate elicitors, the grooming induction tests were conducted with highly purified bacterial components. Lastly, the role of DAP-type peptidoglycan in grooming induction was confirmed. Our results demonstrate that cleaning behavior can be triggered through recognition of DAP-type PGN by its receptor PGRP-LC.	[Yanagawa, Aya] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Neyen, Claudine; Lemaitre, Bruno] Swiss Fed Inst Technol, Global Hlth Inst, Sch Life Sci, Lausanne, Switzerland; [Marion-Poll, Frederic] Univ Paris Sud, Univ Paris Saclay, CNRS, Evolut Genomes Comportement & Ecol,IRD, Gif Sur Yvette, France; [Marion-Poll, Frederic] AgroParisTech, Dept Sci Vie & Sante, Paris, France; [Neyen, Claudine] Univ Basel, Language Ctr, Basel, Switzerland	Kyoto University; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; University of Basel	Marion-Poll, F (corresponding author), Univ Paris Sud, Univ Paris Saclay, CNRS, Evolut Genomes Comportement & Ecol,IRD, Gif Sur Yvette, France.; Marion-Poll, F (corresponding author), AgroParisTech, Dept Sci Vie & Sante, Paris, France.	frederic.marion-poll@agroparisitech.fr	Frederic, Marion-Poll/I-1358-2019; Lemaitre, Bruno/T-8146-2019	Frederic, Marion-Poll/0000-0001-6824-0180; Lemaitre, Bruno/0000-0001-7970-1667; Neyen, Claudine/0000-0002-9870-5548	Itochu research foundation; Research Institute of Sustainable Humanosphere, Kyoto University [2016-5-1-5]	Itochu research foundation; Research Institute of Sustainable Humanosphere, Kyoto University	This research is supported by Itochu research foundation and the Research Institute of Sustainable Humanosphere, Kyoto University (grant no. 2016-5-1-5), http://www.rish.kyoto-u.ac.jp/mission_e/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; E. coli strain of TOP 10 was kindly supplied by Dr. E. Jacquin-Joly (INRA, France) and A.aceti was kindly supplied by Dr. T. Imai (Kyoto University, Japan). PGN was from Dr. D. Mengin-Lecreulx (University of Orsay, Orsay, France). This research is supported by Itochu research foundation and the Research Institute of Sustainable Humanosphere, Kyoto University (grant no. 2016-5-1-5).	Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Ashton K, 2001, GENETICS, V157, P283; Bartholomay LC, 2004, INFECT IMMUN, V72, P4114, DOI 10.1128/IAI.72.7.4114-4126.2004; Boroczky K, 2013, P NATL ACAD SCI USA, V110, P3615, DOI 10.1073/pnas.1212466110; Bosco-Drayon V, 2012, CELL HOST MICROBE, V12, P153, DOI 10.1016/j.chom.2012.06.002; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; BURG MG, 1993, J NEUROBIOL, V24, P803, DOI 10.1002/neu.480240608; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; CORFAS G, 1989, J NEUROSCI, V9, P56; DeGrandi-Hoffman G, 2015, CURR OPIN INSECT SCI, V10, P170, DOI 10.1016/j.cois.2015.05.007; Fernando E, 2011, INSECT PATHOLOGY; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gendrin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000694; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Girardin SE, 2006, IMMUNITY, V24, P363, DOI 10.1016/j.immuni.2006.04.001; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Guan RJ, 2007, TRENDS MICROBIOL, V15, P127, DOI 10.1016/j.tim.2007.01.006; Hughes WOH, 2002, P ROY SOC B-BIOL SCI, V269, P1811, DOI 10.1098/rspb.2002.2113; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kapsetaki SE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5401; Kurata S, 2010, INT IMMUNOL, V22, P143, DOI 10.1093/intimm/dxp128; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Newland PL, 1998, J COMP PHYSIOL A, V183, P313, DOI 10.1007/s003590050258; Neyen C, 2012, J IMMUNOL, V189, P1886, DOI 10.4049/jimmunol.1201022; NOTTEBOHM E, 1994, NEURON, V12, P25, DOI 10.1016/0896-6273(94)90149-X; Page KL, 2004, J EXP BIOL, V207, P2691, DOI 10.1242/jeb.01096; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; PHILLIS RW, 1993, GENETICS, V133, P581; Raad H, 2016, CELL REP, V15, P1442, DOI 10.1016/j.celrep.2016.04.040; Rieger D, 2007, J BIOL RHYTHM, V22, P387, DOI 10.1177/0748730407306198; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; Seeds AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02951; Soldano A, 2016, ELIFE, V5, DOI 10.7554/eLife.13133; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; VANDERVORST P, 1980, NATURE, V286, P65, DOI 10.1038/286065a0; Yanagawa A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00254; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zhukovskaya Marianna, 2013, Insects, V4, P609, DOI 10.3390/insects4040609	44	8	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0185370	10.1371/journal.pone.0185370	http://dx.doi.org/10.1371/journal.pone.0185370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121087	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900007
J	Gahring, LC; Myers, EJ; Dunn, DM; Weise, RB; Rogers, SW				Gahring, Lorise C.; Myers, Elizabeth J.; Dunn, Diane M.; Weise, Robert B.; Rogers, Scott W.			Lung epithelial response to cigarette smoke and modulation by the nicotinic alpha 7 receptor	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; TRANSCRIPTION FACTORS; CATHEPSIN-D; IN-VIVO; MICE; INFLAMMATION; CANCER; CELLS; DYSFUNCTION; EXPOSURE	Cigarette smoking (CS) is a principal contributor to a spectrum of devastating lung diseases whose occurrence and severity may vary between individuals and not appear for decades after prolonged use. One explanation for the variability and delay in disease onset is that nicotine, the addictive component of CS, acts through the ionotropic nicotinic acetylcholine receptor (nAChR) alpha? (alpha 7) to modulate anti-inflammatory protection. In this study we measured the impact alpha 7 signaling has on the mouse distal lung response to side-stream CS exposure for mice of the control genotype (alpha 7(G)) and those in which the alpha 7-receptor signaling mechanisms are restricted by point mutation (alpha 7(E260A:G)). Flow cytometry results show that after CS there is an increase in a subset of CD11c (CD11chi) alveolar macrophages (AMs) and histology reveals an increase in these cells within the alveolar space in both genotypes although the alpha 7(E260A:G) AMs tend to accumulate into large aggregates rather than more widely distributed solitary cells common to the alpha 7G lung after CS. Changes to lung morphology with CS in both genotypes included increased tissue cavitation due to alveolar expansion and bronchial epithelium dysplasia in part associated with altered club cell morphology. RNA-Seq analysis revealed changes in epithelium gene expression after CS are largely independent of the alpha 7-genotype. However, the alpha 7(E260A:G) genotype did reveal some unique variations to transcript expression of gene sets associated with immune responsiveness and macrophage recruitment, hypoxia, genes encoding mitochondrial respiration complex I and extracellular fibrillary matrix proteins (including alterations to fibrotic deposits in the alpha 7(G) proximal airway bronchioles after CS). These results suggest alpha 7 has a central role in modulating the response to chronic CS that could include altering susceptibility to associated lung diseases including fibrosis and cancer.	[Gahring, Lorise C.; Rogers, Scott W.] Salt Lake City Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA; [Gahring, Lorise C.; Myers, Elizabeth J.] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA; [Dunn, Diane M.; Weise, Robert B.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Rogers, Scott W.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Gahring, LC; Rogers, SW (corresponding author), Salt Lake City Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA.; Gahring, LC (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA.; Rogers, SW (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	Lorise.Gahring@hsc.utah.edu; Scott.Rogers@hsc.utah.edu			Veterans Administration (VA Merit grant); NIH [R01 HL135610]; NCI [5P01CA098262]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135610] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001798] Funding Source: NIH RePORTER	Veterans Administration (VA Merit grant)(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the Veterans Administration (VA Merit grant to LCG), NIH (R01 HL135610 to LCG and SWR), and NCI (5P01CA098262 to RBW). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Boffetta P, 2011, CANCER CAUSE CONTROL, V22, P73, DOI 10.1007/s10552-010-9676-5; Corbiere V, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-15; Cunningham AC, 1997, IMMUNOLOGY, V91, P458, DOI 10.1046/j.1365-2567.1997.d01-2249.x; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Enioutina EY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121128; Fox C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20101; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175367; Gahring LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057481; Gilley SK, 2014, AM J PHYSIOL-LUNG C, V306, pL162, DOI 10.1152/ajplung.00095.2013; Goette A, 2007, HEART, V93, P1056, DOI 10.1136/hrt.2005.087171; Gundavarapu S, 2012, J ALLERGY CLIN IMMUN, V130, P770, DOI 10.1016/j.jaci.2012.04.002; Hahn FF, 2007, INT J TOXICOL, V26, P307, DOI 10.1080/10915810701483450; HARRIS JO, 1970, J CLIN INVEST, V49, P2086, DOI 10.1172/JCI106426; Karampitsakos T, 2017, PULM PHARMACOL THER, V45, P1, DOI 10.1016/j.pupt.2017.03.016; Kraetzel K, 2008, EUR RESPIR J, V32, P563, DOI 10.1183/09031936.00096407; Leonard MO, 2008, AM J RESP CRIT CARE, V178, P977, DOI 10.1164/rccm.200712-1890OC; Liu JL, 2016, INT J MOL MED, V38, P1257, DOI 10.3892/ijmm.2016.2709; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Mancardi D, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-12; Maouche K, 2013, P NATL ACAD SCI USA, V110, P4099, DOI 10.1073/pnas.1216939110; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1; Papke RL, 2014, BIOCHEM PHARMACOL, V89, P1, DOI 10.1016/j.bcp.2014.01.029; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Rogers SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036467; Rogers SW, 2012, AM J MED GENET A, V158A, P1135, DOI 10.1002/ajmg.a.35372; Roider HG, 2009, BIOINFORMATICS, V25, P435, DOI 10.1093/bioinformatics/btn627; Roos-Engstrand E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-128; Sato A, 2007, P NATL ACAD SCI USA, V104, P2361, DOI 10.1073/pnas.0607882104; Schuliga M, 2015, BIOMOLECULES, V5, P1266, DOI 10.3390/biom5031266; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Suki B, 2002, AM J RESP CRIT CARE, V166, P133, DOI 10.1164/rccm.200202-152PP; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thaikoottathil JV, 2012, AM J RESP CELL MOL, V47, P253, DOI 10.1165/rcmb.2012-0064OC; Tuveson DA, 1999, ONCOGENE, V18, P5318, DOI 10.1038/sj.onc.1203107; Uteshev VV, 2012, ADV EXP MED BIOL, V740, P603, DOI 10.1007/978-94-007-2888-2_27; Vicary GW, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0596-8; Wang FZ, 2010, PAIN, V148, P275, DOI 10.1016/j.pain.2009.11.011; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Yang Z, 2007, MUTAT RES-FUND MOL M, V621, P61, DOI 10.1016/j.mrfmmm.2007.02.010; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	48	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187773	10.1371/journal.pone.0187773	http://dx.doi.org/10.1371/journal.pone.0187773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117258	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600075
J	Maserati, A; Fink, RC; Lourenco, A; Julius, ML; Diez-Gonzalez, F				Maserati, Alice; Fink, Ryan C.; Lourenco, Antonio; Julius, Matthew L.; Diez-Gonzalez, Francisco			General response of Salmonella enterica serovar Typhimurium to desiccation: A new role for the virulence factors sopD and sseD in survival	PLOS ONE			English	Article							III SECRETION SYSTEM; ESCHERICHIA-COLI-CELLS; LOW-WATER ACTIVITY; PATHOGENICITY ISLAND-2; HEAT-RESISTANCE; TRANSPORT-SYSTEM; HOST-CELLS; COMPATIBLE SOLUTES; EFFECTOR PROTEINS; ROD SHAPE	Salmonella can survive for long periods under extreme desiccation conditions. This stress tolerance poses a risk for food safety, but relatively little is known about the molecular and cellular regulation of this adaptation mechanism. To determine the genetic components involved in Salmonella's cellular response to desiccation, we performed a global transcriptomic analysis comparing S. enterica serovar Typhimurium cells equilibrated to low water activity (a(w) 0.11) and cells equilibrated to high water activity (a(w) 1.0). The analysis revealed that 719 genes were differentially regulated between the two conditions, of which 290 genes were up-regulated at a(w) 0.11. Most of these genes were involved in metabolic pathways, transporter regulation, DNA replication/repair, transcription and translation, and, more importantly, virulence genes. Among these, we decided to focus on the role of sopD and sseD. Deletion mutants were created and their ability to survive desiccation and exposure to aw 0.11 was compared to the wild-type strain and to an E. coliO157:H7 strain. The sopD and sseD mutants exhibited significant cell viability reductions of 2.5 and 1.3 Log (CFU/g), respectively, compared to the wild-type after desiccation for 4 days on glass beads. Additional viability differences of the mutants were observed after exposure to aw 0.11 for 7 days. E. coli O157:H7 lost viability similarly to the mutants. Scanning electron microscopy showed that both mutants displayed a different morphology compared to the wild-type and differences in production of the extracellular matrix under the same conditions. These findings suggested that sopD and sseD are required for Salmonella's survival during desiccation.	[Maserati, Alice; Fink, Ryan C.; Lourenco, Antonio; Diez-Gonzalez, Francisco] Univ Minnesota, Dept Food Sci & Nutr, Minneapolis, MN 55455 USA; [Fink, Ryan C.; Julius, Matthew L.] St Cloud State Univ, Dept Biol, St Cloud, MN 56301 USA; [Diez-Gonzalez, Francisco] Univ Georgia, Ctr Food Safety, Griffin, GA USA	University of Minnesota System; University of Minnesota Twin Cities; Minnesota State Colleges & Universities; Saint Cloud State University; University System of Georgia; University of Georgia	Fink, RC (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, Minneapolis, MN 55455 USA.; Fink, RC (corresponding author), St Cloud State Univ, Dept Biol, St Cloud, MN 56301 USA.	rcfink@stcloudstate.edu	Julius, Matthew L/M-1302-2014; Lourenco, Antonio Afonso/AAH-7149-2019; Diez-Gonzalez, Francisco/AAA-8401-2022; Fink, Ryan/B-8097-2008	Julius, Matthew L/0000-0003-1693-4644; Lourenco, Antonio Afonso/0000-0003-0277-458X; Fink, Ryan/0000-0002-9827-5090; Diez-Gonzalez, Francisco/0000-0002-8644-1397	United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative [2012-67005-19613]; University of Minnesota MnDRIVE Global Food Supply Initiative scholarship	United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative(United States Department of Agriculture (USDA)); University of Minnesota MnDRIVE Global Food Supply Initiative scholarship	This work was supported by grant #2012-67005-19613, provided by the United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative, received by RCF and FDG (https://nita.usda.gov/program/agriculture-and-tood-research-inifiative-afri). AM salary was partially supported by the University of Minnesota MnDRIVE Global Food Supply Initiative scholarship (https://mndrive.umn.edu/foocl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdogan H, 1999, INT J FOOD SCI TECH, V34, P195, DOI 10.1046/j.1365-2621.1999.00256.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Archer J, 1998, J FOOD PROTECT, V61, P969, DOI 10.4315/0362-028X-61.8.969; Aviles B, 2013, INT J FOOD MICROBIOL, V162, P252, DOI 10.1016/j.ijfoodmicro.2013.01.026; BAIRDPARKER AC, 1970, J APPL BACTERIOL, V33, P515, DOI 10.1111/j.1365-2672.1970.tb02228.x; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; Beuchat LR, 2013, J FOOD PROTECT, V76, P150, DOI 10.4315/0362-028X.JFP-12-211; Billi D, 2002, RES MICROBIOL, V153, P7, DOI 10.1016/S0923-2508(01)01279-7; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Bulmer DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002500; CAIRNEY J, 1985, J BACTERIOL, V164, P1218, DOI 10.1128/JB.164.3.1218-1223.1985; CAIRNEY J, 1985, J BACTERIOL, V164, P1224, DOI 10.1128/JB.164.3.1224-1232.1985; CARSIOTIS M, 1989, INFECT IMMUN, V57, P3276, DOI 10.1128/IAI.57.11.3276-3280.1989; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Colgan AM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006258; Coombes BK, 2003, MICROBES INFECT, V5, P561, DOI 10.1016/S1286-4579(03)00094-7; Cooper CA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-221; CRUMRINE MH, 1971, APPL MICROBIOL, V22, P578, DOI 10.1128/AEM.22.4.578-580.1971; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Cytryn EJ, 2007, J BACTERIOL, V189, P6751, DOI 10.1128/JB.00533-07; da Costa M. S., 1998, V61, P117; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Rezende CLE, 2001, J IND MICROBIOL BIOT, V26, P222, DOI 10.1038/sj.jim.7000116; Deng XY, 2012, FOOD MICROBIOL, V30, P311, DOI 10.1016/j.fm.2011.11.001; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; Earnshaw RG, 1995, INT J FOOD MICROBIOL, V28, P197, DOI 10.1016/0168-1605(95)00057-7; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Empadinhas N, 2008, INT MICROBIOL, V11, P151, DOI 10.2436/20.1501.01.55; Finn S, 2013, APPL ENVIRON MICROB, V79, P4376, DOI 10.1128/AEM.00515-13; Fontana A.J., 2007, WATER ACTIVITY FOODS, P405, DOI [10.1002/9781118765982.app4, DOI 10.1002/9781118765982.APP4, 10.1002/9780470376454.app4, DOI 10.1002/9780470376454.APP4]; FOSTER JW, 1995, ANNU REV MICROBIOL, V49, P145, DOI 10.1146/annurev.micro.49.1.145; Frossard SM, 2012, J BACTERIOL, V194, P3861, DOI 10.1128/JB.00495-12; Garmiri P, 2008, FEMS MICROBIOL LETT, V281, P155, DOI 10.1111/j.1574-6968.2008.01093.x; Gharzouli R, 2013, APPL ENVIRON MICROB, V79, P1764, DOI 10.1128/AEM.02903-12; Gruzdev N, 2012, APPL ENVIRON MICROB, V78, P7866, DOI 10.1128/AEM.01822-12; Gruzdev N, 2012, FOOD MICROBIOL, V32, P415, DOI 10.1016/j.fm.2012.08.003; Gruzdev N, 2011, APPL ENVIRON MICROB, V77, P1667, DOI 10.1128/AEM.02156-10; Gunzel D, 2006, J BACTERIOL, V188, P5586, DOI 10.1128/JB.00296-06; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hiramatsu R, 2005, APPL ENVIRON MICROB, V71, P6657, DOI 10.1128/AEM.71.11.6657-6663.2005; Humann JL, 2015, BIOLOGICAL NITROGEN FIXATION, VOLS 1 AND 2, P397; Iibuchi R, 2010, J FOOD PROTECT, V73, P1506, DOI 10.4315/0362-028X-73.8.1506; Inoue A, 2008, J BACTERIOL, V190, P7298, DOI 10.1128/JB.00551-08; Jiang XJ, 2004, MOL MICROBIOL, V54, P1186, DOI 10.1111/j.1365-2958.2004.04344.x; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Jones MA, 1998, INFECT IMMUN, V66, P5799, DOI 10.1128/IAI.66.12.5799-5804.1998; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlinsey JE, 2007, METHOD ENZYMOL, V421, P199, DOI 10.1016/S0076-6879(06)21016-4; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kieboom J, 2006, J FOOD PROTECT, V69, P2681, DOI 10.4315/0362-028X-69.11.2681; KIRBY RM, 1990, J APPL BACTERIOL, V68, P241, DOI 10.1111/j.1365-2672.1990.tb02570.x; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; LAZINSKY D, 1979, MICRON, V10, P49, DOI 10.1016/0047-7206(79)90026-8; Li HP, 2012, FOODBORNE PATHOG DIS, V9, P1143, DOI 10.1089/fpd.2012.1254; Mattick KL, 2000, APPL ENVIRON MICROB, V66, P1274, DOI 10.1128/AEM.66.4.1274-1279.2000; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; MCDONOUG.FE, 1968, J DAIRY SCI, V51, P1587, DOI 10.3168/jds.S0022-0302(68)87236-4; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Nikolaus T, 2001, J BACTERIOL, V183, P6036, DOI 10.1128/JB.183.20.6036-6045.2001; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; OPHIR T, 1994, APPL ENVIRON MICROB, V60, P740, DOI 10.1128/AEM.60.2.740-745.1994; Podolak R, 2010, J FOOD PROTECT, V73, P1919, DOI 10.4315/0362-028X-73.10.1919; Poolman B, 2002, MOL MICROBIOL, V44, P889, DOI 10.1046/j.1365-2958.2002.02894.x; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Ramachandran VK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-25; ROBERSON EB, 1992, APPL ENVIRON MICROB, V58, P1284, DOI 10.1128/AEM.58.4.1284-1291.1992; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Ruiz-Albert J, 2003, MICROBIOL-SGM, V149, P1103, DOI 10.1099/mic.0.26190-0; Saini A, 2010, BIOCHEMISTRY-US, V49, P9402, DOI 10.1021/bi1011546; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Smirnov A, 2016, P NATL ACAD SCI USA, V113, P11591, DOI 10.1073/pnas.1609981113; STIRLING DA, 1989, MOL MICROBIOL, V3, P1025, DOI 10.1111/j.1365-2958.1989.tb00253.x; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; Su AAH, 2013, NUCLEIC ACIDS RES, V41, P6250, DOI 10.1093/nar/gkt317; Szeto J, 2009, INFECT IMMUN, V77, P996, DOI 10.1128/IAI.01275-08; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; TANEJA S, 1994, BIOCHEM J, V303, P147, DOI 10.1042/bj3030147; Troller J. A., 1978, WATER ACTIVITY FOOD; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; WACHI M, 1989, J BACTERIOL, V171, P6511, DOI 10.1128/jb.171.12.6511-6516.1989; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Wood JM, 2007, METHOD ENZYMOL, V428, P77, DOI 10.1016/S0076-6879(07)28005-X; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zurawski DV, 2003, MOL MICROBIOL, V47, P1341, DOI 10.1046/j.1365-2958.2003.03373.x	95	26	27	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187692	10.1371/journal.pone.0187692	http://dx.doi.org/10.1371/journal.pone.0187692			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117268	Green Submitted, Green Published, gold			2022-12-26	WOS:000414659600066
J	Passlick, S; Kramer, PF; Richers, MT; Williams, JT; Ellis-Davies, GCR				Passlick, Stefan; Kramer, Paul F.; Richers, Matthew T.; Williams, John T.; Ellis-Davies, Graham C. R.			Two-color, one-photon uncaging of glutamate and GABA	PLOS ONE			English	Article							WAVELENGTH-SELECTIVE CLEAVAGE; NEUROTRANSMITTERS IN-VITRO; RAT BARREL CORTEX; DENDRITIC SPINES; ORTHOGONAL PHOTOLYSIS; PROTECTING GROUPS; CAGED COMPOUNDS; PHOTOSTIMULATION; NEURONS; INHIBITION	Neuronal cells receive a variety of excitatory and inhibitory signals which they process to generate an output signal. In order to study the interaction between excitatory and inhibitory receptors with exogenously applied transmitters in the same preparation, two caging chromophores attached to glutamate and GABA were developed that were selectively photolyzed by different wavelengths of light. This technique has the advantage that the biologically inactive caged compound can be applied at equilibrium prior to the near instantaneous release of the transmitters. This method therefore mimics the kinetics of endogenously released transmitters that is otherwise not possible in brain slice preparations. Repeated photolysis with either of the two wavelengths resulted in GABA- or glutamate-induced activation of both ionotropic and metabotropic receptors to evoke reproducible currents. With these compounds, the interaction between inhibitory and excitatory receptors was examined using whole field photolysis.	[Passlick, Stefan; Richers, Matthew T.; Ellis-Davies, Graham C. R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Kramer, Paul F.; Williams, John T.] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA	Icahn School of Medicine at Mount Sinai; Oregon Health & Science University	Ellis-Davies, GCR (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.; Williams, JT (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	williamj@ohsu.edu; graham.davies@mssm.edu		Kramer, Paul/0000-0002-0095-3712; Richers, Matthew/0000-0002-2036-8262	National Institutes of health [GM53395 NS60720]; German Research Foundation; NIH (USA); Research Fellowship (Deutsche Forschungsgemeinschaft (DFG, Germany); NATIONAL EYE INSTITUTE [R21EY026702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004523] Funding Source: NIH RePORTER	National Institutes of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NIH (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Fellowship (Deutsche Forschungsgemeinschaft (DFG, Germany); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of health GM53395 NS60720 and German Research Foundation.; This work was supported by the NIH (USA). Stefan Passlick was supported by a Research Fellowship (Deutsche Forschungsgemeinschaft (DFG, Germany).	Amatrudo JM, 2015, EUR J NEUROSCI, V41, P5, DOI 10.1111/ejn.12785; Amatrudo JM, 2014, ACS CHEM NEUROSCI, V5, P64, DOI 10.1021/cn400185r; Bochet CG, 2000, TETRAHEDRON LETT, V41, P6341, DOI 10.1016/S0040-4039(00)01050-9; Bochet CG, 2001, ANGEW CHEM INT EDIT, V40, P2071, DOI 10.1002/1521-3773(20010601)40:11<2071::AID-ANIE2071>3.0.CO;2-9; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Deng RK, 2017, CELL REP, V19, P1141, DOI 10.1016/j.celrep.2017.04.044; Eder M, 2004, REV NEUROSCIENCE, V15, P167, DOI 10.1515/REVNEURO.2004.15.3.167; Ellis-Davies GCR, 2008, CHEM REV, V108, P1603, DOI 10.1021/cr078210i; Fournier L, 2013, CHEM-EUR J, V19, P17494, DOI 10.1002/chem.201302630; Goguen BN, 2011, J AM CHEM SOC, V133, P11038, DOI 10.1021/ja2028074; Hansen MJ, 2015, CHEM SOC REV, V44, P3358, DOI 10.1039/c5cs00118h; Hara K, 2003, J PHYS CHEM B, V107, P597, DOI 10.1021/jp026963x; Hayama T, 2013, NAT NEUROSCI, V16, P1409, DOI 10.1038/nn.3496; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Jishkariani D, 2015, J AM CHEM SOC, V137, P10728, DOI 10.1021/jacs.5b06306; Kantevari S, 2016, CHEMBIOCHEM, V17, P953, DOI 10.1002/cbic.201600019; Kantevari S, 2010, NAT METHODS, V7, P123, DOI [10.1038/NMETH.1413, 10.1038/nmeth.1413]; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Olson JP, 2013, J AM CHEM SOC, V135, P15948, DOI 10.1021/ja408225k; Olson JP, 2013, J AM CHEM SOC, V135, P5954, DOI 10.1021/ja4019379; Priestman MA, 2011, ACS CHEM BIOL, V6, P377, DOI 10.1021/cb100398e; Richers MT, 2017, ANGEW CHEM INT EDIT, V56, P193, DOI 10.1002/anie.201609269; Scott TF, 2009, SCIENCE, V324, P913, DOI 10.1126/science.1167610; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Shepherd Gordon M G, 2012, Cold Spring Harb Protoc, V2012, P998, DOI 10.1101/pdb.prot070664; Stanton-Humphreys MN, 2012, CHEM COMMUN, V48, P657, DOI 10.1039/c1cc15135e; Xu XM, 2016, J NEUROPHYSIOL, V115, P3204, DOI 10.1152/jn.01148.2015; Xu XM, 2010, J NEUROPHYSIOL, V103, P2301, DOI 10.1152/jn.00992.2009	32	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187732	10.1371/journal.pone.0187732	http://dx.doi.org/10.1371/journal.pone.0187732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117230	gold, Green Published, Green Submitted			2022-12-26	WOS:000414659600070
J	Salmier, A; Tirera, S; de Thoisy, B; Franc, A; Darcissac, E; Donato, D; Bouchier, C; Lacoste, V; Lavergne, A				Salmier, Arielle; Tirera, Sourakhata; de Thoisy, Benoit; Franc, Alain; Darcissac, Edith; Donato, Damien; Bouchier, Christiane; Lacoste, Vincent; Lavergne, Anne			Virome analysis of two sympatric bat species (Desmodus rotundus and Molossus molossus) in French Guiana	PLOS ONE			English	Article							SIMIAN FOAMY VIRUS; COMMON VAMPIRE BAT; GENOMIC CHARACTERIZATION; METAGENOMIC ANALYSIS; SOCIAL-ORGANIZATION; ISSYK-KUL; DIVERSITY; HOST; IDENTIFICATION; TRANSMISSION	Environmental disturbances in the Neotropics (e.g., deforestation, agriculture intensification, urbanization) contribute to an increasing risk of cross-species transmission of microorganisms and to disease outbreaks due to changing ecosystems of reservoir hosts. Although Amazonia encompasses the greatest diversity of reservoir species, the outsized viral population diversity (virome) has yet to be investigated. Here, through a metagenomic approach, we identified 10,991 viral sequences in the saliva and feces of two bat species, Desmodus rotundus (hematophagous), trapped in two different caves surrounded by primary lowland forest, and Molossus molossus (insectivorous), trapped in forest and urban habitats. These sequences are related to 51 viral families known to infect a wide range of hosts (i.e., bacteria, plants, insects and vertebrates). Most viruses detected reflected the diet of bat species, with a high proportion of plant and insect-related viral families for M. molossus and a high proportion of vertebrate-related viral families for D. rotundus, highlighting its influence in shaping the viral diversity of bats. Lastly, we reconstructed the phylogenetic relationships for five vertebrate-related viral families (Nairoviridae, Circoviridae, Retroviridae, Herpesviridae, Papillomaviridae). The results showed highly supported clustering with other viral sequences of the same viral family hosted by other bat species, highlighting the potential association of viral diversity with the host's diet. These findings provide significant insight into viral bat diversity in French Guiana belonging to the Amazonian biome and emphasize that habitats and the host's dietary ecology may drive the viral diversity in the bat communities investigated.	[Salmier, Arielle; Tirera, Sourakhata; de Thoisy, Benoit; Darcissac, Edith; Donato, Damien; Lacoste, Vincent; Lavergne, Anne] Inst Pasteur, Lab Interact Virus Hotes, Cayenne, French Guiana; [Franc, Alain] INRA, UMR BIOGECO, Cestas, France; [Bouchier, Christiane] Inst Pasteur, Plateforme Genom Pole Biom, Paris, France	INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lavergne, A (corresponding author), Inst Pasteur, Lab Interact Virus Hotes, Cayenne, French Guiana.	alavergne@pasteur_cayenne.fr	LACOSTE, Vincent/V-2321-2019	LACOSTE, Vincent/0000-0002-3173-4053; Lavergne, Anne/0000-0002-5304-5574; de thoisy, benoit/0000-0002-8420-5112; TIRERA, Sourakhata/0000-0001-9311-7889	European funds; Agence Nationale de la Recherche (CEBA) [ANR-10LABEX-25-01]; European funds (ERDF/FEDER); European Commission [REGPOT-CT-2011-285837STRonGer];  [ANR-10-LABEX-25-01]	European funds; Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR)); European funds (ERDF/FEDER); European Commission(European CommissionEuropean Commission Joint Research Centre); 	A. Salmier was funded by a grant from European funds (PO FSE 2007-2013) and "Investissement d'Avenir managed by Agence Nationale de la Recherche (CEBA, Ref. ANR-10LABEX-25-01). This study was conducted within the CAROLIA program supported by European funds (ERDF/FEDER) and assistance from Region Guyane and Direction Regionale pour la Recherche et la Technologie. It also received a European Com mission "REGPOT-CT-2011-285837STRonGer" grant within the FP7 and "Investissement d'Avenir" grants managed by the Agence Nationale de la Recherche (CEBA, Ref. ANR-10-LABEX-25-01). The Genomics Platform is a member of the France Genomique consortium (ANR10-INBS-09-08). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; [Anonymous], TRACER V1 6; Baker KS, 2013, VIROLOGY, V441, P95, DOI 10.1016/j.virol.2013.03.014; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; Blackwood JC, 2013, P NATL ACAD SCI USA, V110, P20837, DOI 10.1073/pnas.1308817110; Blasse A, 2013, J VIROL, V87, P5193, DOI 10.1128/JVI.02743-12; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brook CE, 2015, TRENDS MICROBIOL, V23, P172, DOI 10.1016/j.tim.2014.12.004; Brosset A, 1996, CAN J ZOOL, V74, P1974, DOI 10.1139/z96-224; Brown C. T., 2012, ARXIV12034802QBICOGN, V1203, P4802; Calisher C. H., 2015, BATS VIRUSES NEW FRO, P23; Canuti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029140; Carrillo-Araujo M, 2015, FRONT MICROBIOL, V6, P447; Catzeflis F., 2015, LISTE MAMMIFERES GUY; Cibulski SP, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01028-14; Crusoe Michael R, 2015, F1000Res, V4, P900, DOI 10.12688/f1000research.6924.1; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de S Lima FE, 2015, PLOS ONE, V10; de S Lima FE, 2015, GENOME ANNOUNCEMENTS, V3; Lima FED, 2015, ARCH VIROL, V160, P1831, DOI 10.1007/s00705-015-2447-6; Lima FED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118070; de Thoisy B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004378; Dechmann DKN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009012; Delaval M, 2006, REV ECOL-TERRE VIE, V61, P343; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Drexler JF, 2012, J VIROL, V86, P9134, DOI 10.1128/JVI.00800-12; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Duboscq J, 2015, PATHOGENES PARASITES, P343; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Garcia-Perez R, 2014, GENOME BIOL EVOL, V6, P94, DOI 10.1093/gbe/evt211; Gay Noellie, 2014, International Journal for Parasitology Parasites and Wildlife, V3, P161, DOI 10.1016/j.ijppaw.2014.06.003; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Ge XY, 2011, J GEN VIROL, V92, P2646, DOI 10.1099/vir.0.034108-0; He B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061950; Host KM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00016-16; Hu D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11384-w; Ishii A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6651; Johnson N, 2014, VIRUSES-BASEL, V6, P1911, DOI 10.3390/v6051911; Jung Kirsten, 2016, P13; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Liu WM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000097; Luis AD, 2015, ECOL LETT, V18, P1153, DOI 10.1111/ele.12491; LVOV DK, 1973, ARCH GES VIRUSFORSCH, V42, P207, DOI 10.1007/BF01270841; Molnar V, 2008, ACTA VET HUNG, V56, P529, DOI 10.1556/AVet.56.2008.4.10; Moratelli R, 2015, MEM I OSWALDO CRUZ, V110, P1, DOI 10.1590/0074-02760150048; Mouinga-Ondeme A, 2012, J VIROL, V86, P1255, DOI 10.1128/JVI.06016-11; Muller MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26637; Muniz CP, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0217-x; Murray SM, 2006, J MED PRIMATOL, V35, P225, DOI 10.1111/j.1600-0684.2006.00171.x; Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975; Olival KJ, 2015, BATS AND VIRUSES, P281; Phillips CD, 2012, MOL ECOL, V21, P2617, DOI 10.1111/j.1365-294X.2012.05568.x; Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124; Prescott LM, 2010, VIRUS INTRO CARACTER; Razafindratsimandresy R, 2009, J GEN VIROL, V90, P44, DOI 10.1099/vir.0.006825-0; Sano K, 2015, VIRUS GENES, V51, P136, DOI 10.1007/s11262-015-1197-6; Schneeberger Karin, 2016, P263; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043986; Turmelle AS, 2009, ECOHEALTH, V6, P522, DOI 10.1007/s10393-009-0263-8; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Voevodin AF, 2009, SIMIAN VIROLOGY, P217; Walker PJ, 2015, AM J TROP MED HYG, V93, P1041, DOI 10.4269/ajtmh.15-0344; Watanabe S, 2009, VIRUS GENES, V39, P90, DOI 10.1007/s11262-009-0368-8; Wibbelt G, 2007, J GEN VIROL, V88, P2651, DOI 10.1099/vir.0.83045-0; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P123; Wu ZQ, 2016, ISME J, V10, P609, DOI 10.1038/ismej.2015.138; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng XY, 2016, ARCH VIROL, V161, P135, DOI 10.1007/s00705-015-2614-9	77	26	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0186943	10.1371/Journal.pone.0186943	http://dx.doi.org/10.1371/Journal.pone.0186943			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117243	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600019
J	Ali, AS; Gronberg, M; Federspiel, B; Scoazec, JY; Hjortland, GO; Gronbaek, H; Ladekarl, M; Langer, SW; Welin, S; Vestermark, LW; Arola, J; Osterlund, P; Knigge, U; Sorbye, H; Grimelius, L; Janson, ET				Ali, Abir Salwa; Gronberg, Malin; Federspiel, Birgitte; Scoazec, Jean-Yves; Hjortland, Geir Olav; Gronbaek, Henning; Ladekarl, Morten; Langer, Seppo W.; Welin, Staffan; Vestermark, Lene Weber; Arola, Johanna; Osterlund, Pia; Knigge, Ulrich; Sorbye, Halfdan; Grimelius, Lars; Janson, Eva Tiensuu			Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma	PLOS ONE			English	Article							CONSENSUS GUIDELINES; ENDOCRINE TUMORS; CANCER; PROGRESSION; MUTATIONS; NEOPLASMS; DIAGNOSIS; PANCREAS; TRACT; NEC	Background Gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs) are aggressive, rapidly proliferating tumors. Therapeutic response to current chemotherapy regimens is usually short lasting. The aim of this study was to examine the expression and potential clinical importance of immunoreactive p53 protein in GEP-NEC. Materials and methods Tumor tissues from 124 GEP-NEC patients with locally advanced or metastatic disease treated with platinum-based chemotherapy were collected from Nordic centers and clinical data were obtained from the Nordic NEC register. Tumor proliferation rate and differentiation were re-evaluated. All specimens were immunostained for p53 protein using a commercially available monoclonal antibody. Kaplan-Meier curves and cox regression analyses were used to assess progression-free survival (PFS) and overall survival (OS). Results All tumor tissues were immunoreactive for either one or both neuroendocrine biomarkers (chromogranin A and synaptophysin) and Ki67 index was >20% in all cases. p53 immunoreactivity was only shown in 39% of the cases and was not found to be a prognostic marker for the whole cohort. However, p53 immunoreactivity was correlated with shorter PFS in patients with colorectal tumors (HR = 2.1, p = 0.03) in a univariate analysis as well as to poorer PFS (HR = 2.6, p = 0.03) and OS (HR = 3.4, p = 0.02) in patients with colorectal tumors with distant metastases, a correlation which remained significant in the multivariate analyses. Conclusion In this cohort of GEP-NEC patients, p53 expression could not be correlated with clinical outcome. However, in patients with colorectal NECs, p53 expression was correlated with shorter PFS and OS. Further studies are needed to establish the role of immunoreactive p53 as a prognostic marker for GEP-NEC patients.	[Ali, Abir Salwa; Gronberg, Malin; Welin, Staffan; Janson, Eva Tiensuu] Uppsala Univ, Sect Endocrine Oncol, Dept Med Sci, Uppsala, Sweden; [Federspiel, Birgitte] Rigshosp, Copenhagen Univ Hosp, Dept Pathol, Copenhagen, Denmark; [Scoazec, Jean-Yves] Inst Gustave Roussy, Dept Biopathol, Villejuif, France; [Hjortland, Geir Olav] Univ Oslo, Dept Oncol, Oslo, Norway; [Gronbaek, Henning] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark; [Ladekarl, Morten] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark; [Langer, Seppo W.] Rigshosp, Copenhagen Univ Hosp, Dept Oncol, Copenhagen, Denmark; [Vestermark, Lene Weber] Odense Univ Hosp, Dept Oncol, Odense, Denmark; [Arola, Johanna] Univ Helsinki, HUSLAB, Pathol, Helsinki, Finland; [Arola, Johanna] Helsinki Univ Hosp, Helsinki, Finland; [Osterlund, Pia] Helsinki Univ Hosp, Dept Oncol, Helsinki, Finland; [Osterlund, Pia] Univ Helsinki, Helsinki, Finland; [Osterlund, Pia] Tampere Univ Hosp, Dept Oncol, Tampere, Finland; [Knigge, Ulrich] Univ Copenhagen, Dept Surg & Endocrinol PE C, Fac Hlth Sci, Rigshosp, Copenhagen, Denmark; [Sorbye, Halfdan] Haukeland Hosp, Dept Oncol, Bergen, Norway; [Sorbye, Halfdan] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Grimelius, Lars] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University; Rigshospitalet; University of Copenhagen; UNICANCER; Gustave Roussy; University of Oslo; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Tampere University; Tampere University Hospital; Rigshospitalet; University of Copenhagen; University of Bergen; Haukeland University Hospital; University of Bergen; Uppsala University	Janson, ET (corresponding author), Uppsala Univ, Sect Endocrine Oncol, Dept Med Sci, Uppsala, Sweden.	eva.tiensuu_janson@medsci.uu.se	Ladekarl, Morten/AAD-5654-2020; Gronbaek, Henning/AAJ-3202-2020; Ladekarl, Morten/AAQ-1702-2020; Grönberg, Malin/A-9331-2010	Ladekarl, Morten/0000-0002-0182-1228; Gronbaek, Henning/0000-0001-8998-7910; Gronberg, Malin/0000-0003-4001-0572; Osterlund, Pia/0000-0002-7124-3515; /0000-0001-9732-9192; Ali, Abir/0000-0001-9881-769X	Lion's Cancer foundation; Swedish Cancer Society [CAN558/2014]; Selanders foundation; foundation for International Studies at the Faculty of Health Science, University of Copenhagen (UK); Novo Nordisk Fonden [NNF10OC1013267] Funding Source: researchfish	Lion's Cancer foundation; Swedish Cancer Society(Swedish Cancer Society); Selanders foundation; foundation for International Studies at the Faculty of Health Science, University of Copenhagen (UK); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Lion's Cancer foundation (www.Icff.se, ETJ), the Swedish Cancer Society (www.cancerfenden.se, ETJ CAN558/2014), the Selanders foundation (ETJ) and the foundation for International Studies at the Faculty of Health Science, University of Copenhagen (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeno N, 2015, ONCOGENE, V34, P589, DOI 10.1038/onc.2013.589; Ando K, 2015, CANCER MED-US, V4, P75, DOI 10.1002/cam4.346; Bian YS, 2001, MODERN PATHOL, V14, P397, DOI 10.1038/modpathol.3880324; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Furlan D, 2004, CLIN CANCER RES, V10, P947, DOI 10.1158/1078-0432.CCR-1068-3; Garcia-Carbonero R, 2016, NEUROENDOCRINOLOGY, V103, P186, DOI 10.1159/000443172; Glenn ST, 2014, ONCOGENE, V33, P5706, DOI 10.1038/onc.2013.514; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Haugvik SP, 2016, ANN SURG ONCOL, V23, P1721, DOI 10.1245/s10434-015-5013-2; Ilett EE, 2015, DIAGNOSTICS, V5, P119, DOI 10.3390/diagnostics5020119; Janson ET, 2014, ACTA ONCOL, V53, P1284, DOI 10.3109/0284186X.2014.941999; La Rosa Stefano, 2012, Cancers (Basel), V4, P11, DOI 10.3390/cancers4010011; Li AFY, 2006, AM J CLIN PATHOL, V126, P856, DOI 10.1309/5X6WBYJ3U94EEKNN; Lomo L, 2008, MODERN PATHOL, V21, P937, DOI 10.1038/modpathol.2008.97; Milione M, 2017, NEUROENDOCRINOLOGY, V104, P85, DOI 10.1159/000445165; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Paik KH, 2006, J KOREAN MED SCI, V21, P35, DOI 10.3346/jkms.2006.21.1.35; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Sorbye H, 2013, ANN ONCOL, V24, P152, DOI 10.1093/annonc/mds276; Sorbye H, 2014, CANCER-AM CANCER SOC, V120, P2814, DOI 10.1002/cncr.28721; Strosberg JR, 2010, PANCREAS, V39, P799, DOI 10.1097/MPA.0b013e3181ebb56f; Tang LH, 2016, AM J SURG PATHOL, V40, P1192, DOI 10.1097/PAS.0000000000000662; Velayoudom-Cephise FL, 2013, ENDOCR-RELAT CANCER, V20, P649, DOI 10.1530/ERC-13-0027; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85	24	24	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187667	10.1371/journal.pone.0187667	http://dx.doi.org/10.1371/journal.pone.0187667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112960	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100031
J	Stritih, N; Kosi, AZ				Stritih, Natasa; Kosi, Alenka Zunic			Olfactory signaling of aggressive intent in male-male contests of cave crickets (Troglophilus neglectus; Orthoptera: Rhaphidophoridae)	PLOS ONE			English	Article							THREAT DISPLAYS; AGONISTIC INTERACTIONS; ASSESSMENT STRATEGY; SCENT MARKING; URINE; COMMUNICATION; EVOLUTION; IDENTITY; PHEROMONES; MOTIVATION	In animal contests, communicating aggressive motivation is most often mediated by visual or acoustic signals, while chemical signals are not expected to serve such a function since they are less able to be modulated by the sender during the changing behavioral context. We describe a rare example of ephemeral olfactory signals in terrestrial animals, signals that are emitted via protrusive scent glands in male cave crickets Troglophilus neglectus (Orthoptera, Rhaphidophoridae) to reflect the state of the signaler's aggression. We correlate the intensity of behaviorally expressed aggression of the individuals in dyadic contests with the frequency and extent of their gland tissue protrusion, the latter serving as an indication of the amount of released odor. We detected large amounts of odor release during brief gland protrusions, and the absence of its release during gland retraction. Males protruded the glands during and after encountering a rival, with the degree of protrusion increasing with the intensity of the signalers' aggression. During the encounters, the degree of gland protrusion increased most strongly with the occurrence of the elevated body posture, directly preceding the attack. This degree was significantly higher in encounter winners than in losers displaying such posture, suggesting the highly important role of the released odor for contest resolution. After the encounters, glands were protruded almost exclusively by winners, apparently announcing victory. We tested for the function of the olfactory signals also directly, by preventing gland tissue protrusion in symmetric and asymmetric treatments of the contestants. Treating only the dominant individuals decreased the percentage of encounters they won by over 60%, while treating both contestants elicited a significant increase in the frequency and duration of fights. During contests, the olfactory signals of T. neglectus apparently function as a highly effective threat, which prevents maximal contest escalation and decreases the conflict-related costs.	[Stritih, Natasa; Kosi, Alenka Zunic] Natl Inst Biol, Dept Organisms & Ecosyst Res, Ljubljana, Slovenia	National Institute of Biology - Slovenia	Stritih, N (corresponding author), Natl Inst Biol, Dept Organisms & Ecosyst Res, Ljubljana, Slovenia.	natasa.stritih@nib.si	Peljhan, Natasa Stritih/M-5369-2019	Zunic Kosi, Alenka/0000-0003-4774-6902	Slovenian Research Agency [P1-0255]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency (htto://www.arrs.gov.si), research core funding P1-0255.	Akcay C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2517; ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; [Anonymous], 1981, CHEM DEFENSES ARTHRO; [Anonymous], 2003, ANIMAL SIGNALS; Arakawa H, 2008, NEUROSCI BIOBEHAV R, V32, P1236, DOI 10.1016/j.neubiorev.2008.05.012; Atema Jelle, 2007, P115; Barata EN, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-54; BARTOS L, 1983, AGGRESSIVE BEHAV, V9, P59, DOI 10.1002/1098-2337(1983)9:1<59::AID-AB2480090108>3.0.CO;2-F; Bertram SM, 2010, BEHAVIOUR, V147, P1249, DOI 10.1163/000579510X514535; Biernaskie JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0876; Blank DA, 2014, FOLIA ZOOL, V63, P127; Bower John L., 2006, P114; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Breithaupt T, 2002, J EXP BIOL, V205, P1221; Breithaupt T, 2000, BEHAV ECOL SOCIOBIOL, V49, P67, DOI 10.1007/s002650000271; Breithaupt T, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P257, DOI 10.1007/978-0-387-77101-4_13; Briffa M, 2007, FUNCT ECOL, V21, P627, DOI 10.1111/j.1365-2435.2006.01188.x; Briffa M, 2015, ANIMAL SIGNALING AND FUNCTION: AN INTEGRATIVE APPROACH, P141; Briffa M, 2013, ANIMAL CONTESTS, P86; Brown WD, 2006, ANIM BEHAV, V72, P225, DOI 10.1016/j.anbehav.2006.01.012; Burgener N, 2009, ANIM BEHAV, V77, P707, DOI 10.1016/j.anbehav.2008.11.022; Chung HY, 2000, J AGR FOOD CHEM, V48, P1803, DOI 10.1021/jf991272s; Counet C, 2002, J AGR FOOD CHEM, V50, P2385, DOI 10.1021/jf0114177; De Souza LR, 2011, BEHAVIOUR, V148, P341, DOI 10.1163/000579511X559418; Di Russo C, 1998, ENCY BIOSPEOLOGICA, VII, P979; Eisner T., 2007, SECRET WEAPONS DEFEN; Field Laurence H., 2001, P333, DOI 10.1079/9780851994086.0333; Fowler-Finn KD, 2006, J ARACHNOL, V34, P62, DOI 10.1636/S04-104.1; Gabor CR, 2010, ENCY ANIMAL BEHAV, P35; Gogala M, 1964, THESIS; Goubault M, 2008, BIOL J LINN SOC, V94, P837, DOI 10.1111/j.1095-8312.2008.01022.x; Goubault M, 2006, P ROY SOC B-BIOL SCI, V273, P2853, DOI 10.1098/rspb.2006.3655; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; GRAY DR, 1989, CAN J ZOOL, V67, P1134, DOI 10.1139/z89-163; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; Hollister-Smith JA, 2008, ANIM BEHAV, V76, P1829, DOI 10.1016/j.anbehav.2008.05.033; Huber R, 1997, BRAIN BEHAV EVOLUT, V50, P60, DOI 10.1159/000113355; Hurd PL, 2006, J THEOR BIOL, V241, P639, DOI 10.1016/j.jtbi.2006.01.001; Hurd PL, 2005, ANIM BEHAV, V70, P1155, DOI 10.1016/j.anbehav.2005.02.014; Hurd PL, 2004, AGGRESSIVE BEHAV, V30, P326, DOI 10.1002/ab.20020; Judge KA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003980; Karaman I, 2011, ZOOL J LINN SOC-LOND, V163, P1035, DOI 10.1111/j.1096-3642.2011.00738.x; Kelly CD, 2006, ANIM BEHAV, V72, P727, DOI 10.1016/j.anbehav.2006.02.007; Kemp DJ, 2006, BIOL J LINN SOC, V88, P565, DOI 10.1111/j.1095-8312.2006.00643.x; Laidre ME, 2008, BEHAV ECOL SOCIOBIOL, V62, P1207, DOI 10.1007/s00265-007-0539-3; Ligon RA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1873; Logue DM, 2010, P ROY SOC B-BIOL SCI, V277, P2571, DOI 10.1098/rspb.2010.0421; Martin J, 2007, FUNCT ECOL, V21, P568, DOI 10.1111/j.1365-2435.2007.01262.x; Martin SB, 2005, HERPETOLOGICA, V61, P29, DOI 10.1655/04-13; Martinovic-Weigelt D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046579; Maruska KP, 2012, J EXP BIOL, V215, P68, DOI 10.1242/jeb.062794; Moore PJ, 1997, NATURE, V389, P25, DOI 10.1038/37888; Moretz JA, 2006, AM NAT, V168, P336, DOI 10.1086/506920; Mouterde SC, 2012, ANIM BEHAV, V83, P605, DOI 10.1016/j.anbehav.2011.11.032; Novak T, 1983, MEM BIOSPEOL, V10, P183; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Rajagopal T, 2010, BEHAV PROCESS, V85, P58, DOI 10.1016/j.beproc.2010.06.007; Rasmussen LEL, 1999, PHYSIOL BEHAV, V67, P539, DOI 10.1016/S0031-9384(99)00114-6; Raspotnig G, 1998, J INSECT PHYSIOL, V44, P413, DOI 10.1016/S0022-1910(98)00044-4; Rillich J, 2007, ANIM BEHAV, V74, P823, DOI 10.1016/j.anbehav.2006.11.022; Santer RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022473; Scheel D, 2016, CURR BIOL, V26, P377, DOI 10.1016/j.cub.2015.12.033; SEARCY WA, 2005, MG BEH ECOL, P1; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; Seliskar A., 1923, Zoologischer Anzeiger Leipzig, V57, P253; Stritih N, 2015, MITT DEUT GES ALLGEM, V20, P333; Stritih N, 2014, J INSECT BEHAV, V27, P317, DOI 10.1007/s10905-013-9429-x; Szamado S, 2003, J THEOR BIOL, V221, P327, DOI 10.1006/jtbi.2003.3176; Szamado S, 2008, ANIM BEHAV, V76, P1455, DOI 10.1016/j.anbehav.2008.07.010; Umbers KDL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049600; Vehrencamp S. L., 2000, ANIMAL SIGNALS SIGNA, P277; WAAS JR, 1991, BEHAV ECOL SOCIOBIOL, V29, P139, DOI 10.1007/BF00166489; Walther FR, 1983, GAZELLES THEIR RELAT; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1; Wyatt TD, 2010, J COMP PHYSIOL A, V196, P685, DOI 10.1007/s00359-010-0564-y; 2013, ANIMAL CONTESTS, P1	76	4	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187512	10.1371/journal.pone.0187512	http://dx.doi.org/10.1371/journal.pone.0187512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL9KF	29112984	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100020
J	Pahlavan, S; Tousi, MS; Ayyari, M; Alirezalu, A; Ansari, H; Saric, T; Baharvand, H				Pahlavan, Sara; Tousi, Marziyeh Shalchi; Ayyari, Mahdi; Alirezalu, Abolfazl; Ansari, Hassan; Saric, Tomo; Baharvand, Hossein			Effects of hawthorn (Crataegus pentagyna) leaf extract on electrophysiologic properties of cardiomyocytes derived from human cardiac arrhythmia-specific induced pluripotent stem cells	FASEB JOURNAL			English	Article						nutraceuticals; in vitro drug testing; CPVT1; LQTS2	POLYMORPHIC VENTRICULAR-TACHYCARDIA; HEART-FAILURE; RAT MODEL; OXYACANTHA; PATIENT; DIFFERENTIATION; COMPLEMENTARY; PHARMACOLOGY; PROGRESSION; GENERATION	Cardiac arrhythmias are major life-threatening conditions. The landmark discovery of induced pluripotent stem cells has provided a promising in vitro system for modeling hereditary cardiac arrhythmias as well as drug development and toxicity testing. Nowadays, nutraceuticals are frequently used as supplements for cardiovascular therapy. Here we studied the cardiac effects of hawthorn (Crataegus pentagyna) leaf extract using cardiomyocytes (CMs) differentiated from healthy human embryonic stem cells, long QT syndrome type 2 (LQTS2), and catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) patient-specific induced pluripotent stem cells. The hydroalcoholic extract resulted in a dose-dependent negative chronotropic effect in all CM preparations leading to a significant reduction at 1000 mu g/ml. This was accompanied by prolongation of field potential durations, although with different magnitudes in CMs from different human embryonic stem cell and iPSC lines. Hawthorn further prolonged field potential durations in LQTS2 CMs but reduced the beating frequencies and occurrence of immature field potentials triggered by beta(1)-adrenergic stimulation in CPVT1 CMs at 300 and 1000 mu g/ml. Furthermore, isoquercetin and vitexin flavonoids significantly slowed down isoproterenol (5 mu M)-induced beating frequencies at 3 and 10 mu g/ml. Therefore, C. pentagyna leaf extract and its isoquercetin and vitexin flavonoids may be introduced as a novel nutraceutical with antiarrhythmic potential for CPVT1 patients.	[Pahlavan, Sara; Tousi, Marziyeh Shalchi; Ayyari, Mahdi; Ansari, Hassan; Baharvand, Hossein] Acad Ctr Educ Culture & Res, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran, Iran; [Ayyari, Mahdi] TMU, Dept Hort Sci, Tehran, Iran; [Alirezalu, Abolfazl] Urmia Univ, Dept Hort Sci, Fac Agr, Orumiyeh, Iran; [Saric, Tomo] Univ Cologne, Inst Neurophysiol, Med Fac, Ctr Physiol & Pathophysiol, Cologne, Germany; [Baharvand, Hossein] Univ Sci & Culture, Dept Dev Biol, Tehran, Iran	Academic Center for Education, Culture & Research (ACECR); Urmia University; University of Cologne	Baharvand, H (corresponding author), Royan Inst, Banihashem Sq,Banihashem St,POB 16635-148, Tehran 1665659911, Iran.	baharvand@royaninstitute.org	Alirezalu, Abolfazl/U-7964-2019	Alirezalu, Abolfazl/0000-0002-5882-8981; Pahlavan, Sara/0000-0002-8854-2626	Royan Institute; Iranian Council of Herbal Medicine; Iran National Science Foundation (INSF) [96001316]; Iran Science Elites Federation; EBiSC project; European Commission	Royan Institute; Iranian Council of Herbal Medicine; Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); Iran Science Elites Federation; EBiSC project; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Royan Institute, the Iranian Council of Herbal Medicine, the Iran National Science Foundation (INSF; Grant 96001316), and the Iran Science Elites Federation to H.B. The banking of CPVT1 and LQTS2 iPSC lines was supported by the EBiSC project (to T.S. and J.H.). EBiSC is supported as a multinational public-private Innovative Medicines Initiative (http://www.imi.europa.eu/) funded by the European Commission and in-kind contributions from Pfizer Ltd., H. Lundbeck A/S, Janssen Pharmaceutica NV, Novo Nordisk A/S, AstraZeneca A/B, UCB Pharma SA, and Bayer Pharma AG and Lilly (joining after the Hot Start). The authors declare no conflicts of interest.	Al Makdessi S, 1999, BASIC RES CARDIOL, V94, P71, DOI 10.1007/s003950050128; Alp H, 2015, ANATOL J CARDIOL, V15, P970, DOI 10.5152/akd.2014.5869; AMMON HPT, 1981, PLANTA MED, V43, P209, DOI 10.1055/s-2007-971502; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x; Brenyo A, 2014, AM J CARDIOL, V113, P897, DOI 10.1016/j.amjcard.2013.11.044; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Chang WT, 2005, AM J CHINESE MED, V33, P1, DOI 10.1142/S0192415X05002606; Chen ZY, 1998, LIFE SCI, V63, P1983, DOI 10.1016/S0024-3205(98)00476-7; Dahmer S, 2010, AM FAM PHYSICIAN, V81, P465; Diane A, 2016, FOOD FUNCT, V7, P3943, DOI [10.1039/c6fo01023g, 10.1039/C6FO01023G]; Dong LY, 2008, AM J CHINESE MED, V36, P385, DOI 10.1142/S0192415X08005849; Edwards JE, 2012, PHYTOCHEMISTRY, V79, P5, DOI 10.1016/j.phytochem.2012.04.006; Fatima A, 2016, STEM CELL RES, V16, P304, DOI 10.1016/j.scr.2015.12.039; Fatima A, 2011, CELL PHYSIOL BIOCHEM, V28, P579, DOI 10.1159/000335753; Flattery Maureen, 2008, Prog Cardiovasc Nurs, V23, P187, DOI 10.1111/j.1751-7117.2008.00014.x; Fonoudi H, 2016, JOVE-J VIS EXP, DOI 10.3791/54276; Fonoudi H, 2015, STEM CELL TRANSL MED, V4, P1482, DOI 10.5966/sctm.2014-0275; Ganji F, 2015, CELL J, V16, P426; Garjani A, 2000, PHYTOTHER RES, V14, P428, DOI 10.1002/1099-1573(200009)14:6&lt;428::AID-PTR618&gt;3.0.CO;2-L; Halbach MD, 2003, CELL PHYSIOL BIOCHEM, V13, P271, DOI 10.1159/000074542; Harris K, 2015, CURR PROTOC PHARM, V71, P11181; Harvey RD, 2003, BRIT J PHARMACOL, V139, P1074, DOI 10.1038/sj.bjp.0705338; Herron TJ, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.113.003638; Holubarsch CJF, 2008, EUR J HEART FAIL, V10, P1255, DOI 10.1016/j.ejheart.2008.10.004; Hwang HS, 2009, PHARMACOTHERAPY, V29, P639, DOI 10.1592/phco.29.6.639; Itzhaki I, 2012, J AM COLL CARDIOL, V60, P990, DOI 10.1016/j.jacc.2012.02.066; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; Koch E, 2011, PLANTA MED, V77, P1123, DOI 10.1055/s-0030-1270849; Larijani MR, 2011, STEM CELLS DEV, V20, P1911, DOI 10.1089/scd.2010.0517; Li XM, 2015, MOL MED REP, V12, P5423, DOI 10.3892/mmr.2015.4080; Long SR, 2006, PHYTOMEDICINE, V13, P643, DOI 10.1016/j.phymed.2006.01.005; Lu CC, 2013, N-S ARCH PHARMACOL, V386, P747, DOI 10.1007/s00210-013-0873-0; Muller A, 1996, PHYTOMEDICINE, V3, P257, DOI 10.1016/S0944-7113(96)80063-8; Muller A, 1999, PLANTA MED, V65, P335, DOI 10.1055/s-1999-13997; Nishizawa H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007069; Novak A, 2012, J CELL MOL MED, V16, P468, DOI 10.1111/j.1582-4934.2011.01476.x; Pittler MH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005312.pub2; Rigelsky JM, 2002, AM J HEALTH-SYST PH, V59, P417, DOI 10.1093/ajhp/59.5.417; Salehi S, 2009, J NAT MED-TOKYO, V63, P1, DOI 10.1007/s11418-008-0278-4; SCHUSSLER M, 1995, ARZNEIMITTEL-FORSCH, V45-2, P842; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Veveris M, 2004, LIFE SCI, V74, P1945, DOI 10.1016/j.lfs.2003.09.050; Vijayan NA, 2012, MOL CELL BIOCHEM, V367, P1, DOI 10.1007/s11010-012-1251-9; Vitale AM, 2011, INT J BIOCHEM CELL B, V43, P843, DOI 10.1016/j.biocel.2011.03.013; Zhang XH, 2013, CELL CALCIUM, V54, P57, DOI 10.1016/j.ceca.2013.04.004; Zick SM, 2005, J CARD FAIL, V11, P586, DOI 10.1016/j.cardfail.2005.06.427; Zick SM, 2008, EUR J HEART FAIL, V10, P587, DOI 10.1016/j.ejheart.2008.04.008; Zick SM, 2009, EUR J HEART FAIL, V11, P990, DOI 10.1093/eurjhf/hfp116; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	49	13	14	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1440	1451		10.1096/fj.201700494RR	http://dx.doi.org/10.1096/fj.201700494RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29133340				2022-12-26	WOS:000427246000026
J	Li, DJ; Fan, ZY; Tang, WKS				Li, Doujie; Fan, Zhongyan; Tang, Wallace K. S.			Domain learning naming game for color categorization	PLOS ONE			English	Article							NETWORKS; LANGUAGE; UNIVERSALS; EMERGENCE; MEMORY	Naming game simulates the evolution of vocabulary in a population of agents. Through pairwise interactions in the games, agents acquire a set of vocabulary in their memory for object naming. The existing model confines to a one-to-one mapping between a name and an object. Focus is usually put onto name consensus in the population rather than knowledge learning in agents, and hence simple learning model is usually adopted. However, the cognition system of human being is much more complex and knowledge is usually presented in a complicated form. Therefore, in this work, we extend the agent learning model and design a new game to incorporate domain learning, which is essential for more complicated form of knowledge. In particular, we demonstrate the evolution of color categorization and naming in a population of agents. We incorporate the human perceptive model into the agents and introduce two new concepts, namely subjective perception and subliminal stimulation, in domain learning. Simulation results show that, even without any supervision or pre-requisition, a consensus of a color naming system can be reached in a population solely via the interactions. Our work confirms the importance of society interactions in color categorization, which is a long debate topic in human cognition. Moreover, our work also demonstrates the possibility of cognitive system development in autonomous intelligent agents.	[Li, Doujie; Fan, Zhongyan; Tang, Wallace K. S.] City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China	City University of Hong Kong	Tang, WKS (corresponding author), City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China.	eekstang@cityu.edu.hk		Tang, Wallace K.S./0000-0002-5786-418X				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baronchelli A, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/06/P06014; Baronchelli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125019; Barrat A, 2007, CHAOS, V17, DOI 10.1063/1.2734403; Berlin B., 1991, BASIC COLOR TERMS TH; Beuls K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058960; Bhattacherjee B, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062808; Bleys J., 2012, EXPT CULTURAL LANGUA, P61; Dall'Asta L, 2006, EUROPHYS LETT, V73, P969, DOI 10.1209/epl/i2005-10481-7; Dall'Asta L, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036105; Fu G, 2017, AM CONTR C ACC 2017; Hao J, 2012, ADV COMP INT ICACI 2; HEIDER ER, 1972, COGNITIVE PSYCHOL, V3, P337, DOI 10.1016/0010-0285(72)90011-4; HEIDER ER, 1972, J EXP PSYCHOL, V93, P10, DOI 10.1037/h0032606; HUNTER RS, 1958, J OPT SOC AM, V48, P985, DOI 10.1364/JOSA.48.000985; Jameson K, 1997, COLOR CATEGORIES THO, V295; Kay P, 2003, P NATL ACAD SCI USA, V100, P9085, DOI 10.1073/pnas.1532837100; KAY P, 1978, LANGUAGE, V54, P610, DOI 10.2307/412789; Ke J, 2008, COMMUN COMPUT PHYS, V3, P935; Lei CA, 2010, PHYSICA A, V389, P5628, DOI 10.1016/j.physa.2010.08.039; Li B, 2013, COMMUN NONLINEAR SCI, V18, P1214, DOI 10.1016/j.cnsns.2012.09.022; LOFTUS EF, 1992, AM PSYCHOL, V47, P761, DOI 10.1037/0003-066X.47.6.761; Lou Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12191; Luo MR, 2001, COLOR RES APPL, V26, P340, DOI 10.1002/col.1049; MacLaury R., 1997, COLOR COGNITION MESO; MCCONNELL JV, 1958, AM PSYCHOL, V13, P229, DOI 10.1037/h0042953; Mukherjee A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016677; Paravina Rade D, 2005, Odontology, V93, P46, DOI 10.1007/s10266-005-0048-7; Puglisi A, 2008, P NATL ACAD SCI USA, V105, P7936, DOI 10.1073/pnas.0802485105; Regier T, 2005, P NATL ACAD SCI USA, V102, P8386, DOI 10.1073/pnas.0503281102; Roberson D, 2005, COGNITIVE PSYCHOL, V50, P378, DOI 10.1016/j.cogpsych.2004.10.001; Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369; Schuessler Zachary, 2015, ANN GITHUB; Steels L, 2005, BEHAV BRAIN SCI, V28, P469, DOI 10.1017/S0140525X05000087; Steels L., 2012, EXPT CULTURAL LANGUA; Treitman Y, 2013, NETW SCI WORKSH NSW; Tria F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120771; Webster MA, 2007, INDIVIDUAL POPULATIO; Witzel C, 2013, J VISION, V13, DOI 10.1167/13.7.1; Wu CW, 2011, CIRC SYST ISCAS 2011; Xie J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033215	42	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188164	10.1371/journal.pone.0188164	http://dx.doi.org/10.1371/journal.pone.0188164			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136661	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200073
J	Patel, S; Paulsen, C; Heffernan, C; Saunders, D; Sharma, M; King, M; Hoeppner, V; Orr, P; Kunimoto, D; Menzies, D; Christianson, S; Wolfe, J; Boffa, J; McMullin, K; Lopez-Hille, C; Senthilselvan, A; Long, R				Patel, Smit; Paulsen, Catherine; Heffernan, Courtney; Saunders, Duncan; Sharma, Meenu; King, Malcolm; Hoeppner, Vernon; Orr, Pamela; Kunimoto, Dennis; Menzies, Dick; Christianson, Sara; Wolfe, Joyce; Boffa, Jody; McMullin, Kathleen; Lopez-Hille, Carmen; Senthilselvan, Ambikaipakan; Long, Richard			Tuberculosis transmission in the Indigenous peoples of the Canadian prairies	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; EPIDEMIOLOGY; ELIMINATION; COMMUNITIES; DYNAMICS; OUTCOMES; HISTORY; DISEASE	Setting The prairie provinces of Canada. Objective To characterize tuberculosis (TB) transmission among the Indigenous and non-Indigenous Canadian-born peoples of the prairie provinces of Canada. Design A prospective epidemiologic study of consecutively diagnosed adult (age >= 14 years) Canadian-born culture-positive pulmonary TB cases on the prairies, hereafter termed "potential transmitters," and the transmission events generated by them. "Transmission events" included new positive tuberculin skin tests (TSTs), TST conversions, and secondary cases among contacts. Results In the years 2007 and 2008, 222 potential transmitters were diagnosed on the prairies. Of these, the vast majority (198; 89.2%) were Indigenous peoples who resided in either an Indigenous community (135; 68.2%) or a major metropolitan area (44; 22.2%). Over the 4.5year period between July 1 st, 2006 and December 31 st 2010, 1085 transmission events occurred in connection with these potential transmitters. Most of these transmission events were attributable to potential transmitters who identified as Indigenous (94.5%). With a few notable exceptions most transmitters and their infected contacts resided in the same community type. In multivariate models positive smear status and a higher number of close contacts were associated with increased transmission; adjusted odds ratios (ORs) and 95% confidence intervals (CIs), 4.30 [1.88, 9.84] and 2.88 [1.31, 6.34], respectively. Among infected contacts, being Indigenous was associated with disease progression; OR and 95% CI, 3.59 [1.27, 10.14] and 6.89 [2.04, 23.25] depending upon Indigenous group, while being an infected casual contact was less likely than being a close contact to be associated with disease progression, 0.66 [0.44, 1.00]. Conclusion In the prairie provinces of Canada and among Canadian-born persons, Indigenous peoples account for the vast majority of cases with the potential to transmit as well as the vast majority of infected contacts. Active case finding and preventative therapy measures need to focus on high-incidence Indigenous communities.	[Patel, Smit; Paulsen, Catherine; Heffernan, Courtney; Kunimoto, Dennis; Boffa, Jody; Long, Richard] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada; [Patel, Smit; Saunders, Duncan; Senthilselvan, Ambikaipakan; Long, Richard] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Sharma, Meenu] Natl Microbiol Lab, Natl Reference Ctr Mycobacteriol, Winnipeg, MB, Canada; [Sharma, Meenu] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [King, Malcolm] Canadian Inst Hlth Res, Inst Aboriginal Peoples Hlth, Sudbury, ON, Canada; [Hoeppner, Vernon; McMullin, Kathleen] Univ Saskatchewan, Dept Med, Coll Med, Saskatoon, SK, Canada; [Orr, Pamela; Lopez-Hille, Carmen] Univ Manitoba, Dept Med, Max Rady Coll Med, Winnipeg, MB, Canada; [Menzies, Dick] McGill Univ, Dept Med, Montreal, PQ, Canada; [Christianson, Sara] Natl Microbiol Lab, Enter Dis, Winnipeg, MB, Canada; [Wolfe, Joyce] Natl Microbiol Lab, Div Bacterial Dis, Winnipeg, MB, Canada	University of Alberta; University of Alberta; University of Manitoba; Institute for Work & Health; University of Saskatchewan; University of Manitoba; McGill University	Long, R (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada.; Long, R (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	richard.long@ualberta.ca	Heffernan, Courtney E/G-5296-2016; Sharma, Meenu/AAE-2536-2022; Sharma, Meenu/GWM-5030-2022; Paulsen, Catherine/AAP-4665-2021	Sharma, Meenu/0000-0002-6020-9995; Kunimoto, Dennis/0000-0002-7691-5448; Boffa, Jody/0000-0002-8183-6461	Canadian Institute of Health Research [151631]; Health Canada	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Health Canada	Funding for this study was provided by the Canadian Institute of Health Research (Grant #151631) and Health Canada (http://www.cihr-irsc.gc.ca./e/193html; http://www.hc-sc.gc.ca/index-eng.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GG, 2014, PLOS ONE; Andrews JR, 2015, INT J TUBERC LUNG D, V19, P375, DOI 10.5588/ijtld.14.0423; [Anonymous], 2007, CAN TUB STAND; [Anonymous], 1982, CANADIAN CHARTER RIG; Aspler A, 2010, CAN J PUBLIC HEALTH, V101, P205, DOI 10.1007/BF03404391; Blackwood KS, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-18; Boffa J, 2011, SOC SCI MED, V72, P733, DOI 10.1016/j.socscimed.2010.10.033; Brancker A, 1992, Health Rep, V4, P103; Cegielski JP, 2014, AM J PUBLIC HEALTH, V104, pS225, DOI [10.2105/AJPH.2012.300781, 10.2105/AJPH.2012.300781r]; Clark M, 2002, INT J EPIDEMIOL, V31, P940, DOI 10.1093/ije/31.5.940; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Eisenbeis L, 2016, CAN J PUBLIC HEALTH, V107, pE106, DOI [10.17269/cjph.107.5255, 10.17269/CJPH.107.5255]; ENARSON DA, 1986, CAN MED ASSOC J, V134, P1149; Farmer P., 1999, INFECT INEQUALITIES; Ferebee SH, 1969, ADV TUBERC RES, V17, P29; Frost WH, 1937, AM J PUBLIC HEALTH N, V27, P759, DOI 10.2105/AJPH.27.8.759; GALTUNG J, 1969, J PEACE RES, P167; Greenwood CMT, 2000, AM J HUM GENET, V67, P405, DOI 10.1086/303012; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Koethe JR, 2016, INT J TUBERC LUNG D, V20, P857, DOI 10.5588/ijtld.15.0936; Larcombe L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049872; Lau A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154032; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Long R, 2016, INT J TUBERC LUNG D, V20, P1285, DOI 10.5588/ijtld.16.0447; Long R, 2013, CAN RESPIR J, V20, P223, DOI 10.1155/2013/429496; O'Neil JD, 1998, HUM ORGAN, V57, P230, DOI 10.17730/humo.57.2.b7628vwvg7q127m8; Ortblad KF, 2015, LANCET, V386, P2354, DOI 10.1016/S0140-6736(15)00324-4; Parhar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117036; Pepperell C, 2011, INT J TUBERC LUNG D, V15, P899, DOI 10.5588/ijtld.10.0556; Rosner B., 2015, FUNDAMENTALS BIOSTAT; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; The Canadian Tuberculosis Committee of the Centre for Infectious Disease Prevention and Control, 2007, CCDR, V33, p1 ; Tian Y, 2013, HEALTH EDUC BEHAV, V40, p98S, DOI 10.1177/1090198113493910; Tuite Ar, 2017, BMC PUBLIC HLTH; VEEN J, 1992, TUBERCLE LUNG DIS, V73, P73, DOI 10.1016/0962-8479(92)90058-R; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Wherrett George J., 1977, MIRACLE EMPTY BEDS H; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Ziv E, 2001, AM J EPIDEMIOL, V153, P381, DOI 10.1093/aje/153.4.381	44	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188189	10.1371/journal.pone.0188189	http://dx.doi.org/10.1371/journal.pone.0188189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136652	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200076
J	Horbowy, J; Tomczak, MT				Horbowy, Jan; Tomczak, Maciej T.			Extension of biomass estimates to pre-assessment periods using density dependent surplus production approach	PLOS ONE			English	Article							STOCK REDUCTION ANALYSIS; CLIMATE-CHANGE; FISH POPULATIONS; CATCH; MODEL; FISHERIES; DYNAMICS; WHALES	Biomass reconstructions to pre-assessment periods for commercially important and exploitable fish species are important tools for understanding long-term processes and fluctuation on stock and ecosystem level. For some stocks only fisheries statistics and fishery dependent data are available, for periods before surveys were conducted. The methods for the backward extension of the analytical assessment of biomass for years for which only total catch volumes are available were developed and tested in this paper. Two of the approaches developed apply the concept of the surplus production rate (SPR), which is shown to be stock density dependent if stock dynamics is governed by classical stock-production models. The other approach used a modified form of the Schaefer production model that allows for backward biomass estimation. The performance of the methods was tested on the Arctic cod and North Sea herring stocks, for which analytical biomass estimates extend back to the late 1940s. Next, the methods were applied to extend biomass estimates of the North-east Atlantic mackerel from the 1970s (analytical biomass estimates available) to the 1950s, for which only total catch volumes were available. For comparison with other methods which employs a constant SPR estimated as an average of the observed values, was also applied. The analyses showed that the performance of the methods is stock and data specific; the methods that work well for one stock may fail for the others. The constant SPR method is not recommended in those cases when the SPR is relatively high and the catch volumes in the reconstructed period are low.	[Horbowy, Jan] Natl Marine Fisheries Res Inst, Gdynia, Poland; [Tomczak, Maciej T.] Stockholm Univ, Baltic Sea Ctr, Stockholm, Sweden	National Marine Fisheries Research Institute; Stockholm University	Tomczak, MT (corresponding author), Stockholm Univ, Baltic Sea Ctr, Stockholm, Sweden.	maciej.tomczak@su.se			European Commission EURO-BASIN (European Basin Scale Analysis, Synthesis, and Integration) [264 933]; MareFame (Co-creating Ecosystem-based Fisheries Management Solutions) [613571]; Polish Ministry of Science and Higher Education; History of Marine Animal Populations (HMAP) project	European Commission EURO-BASIN (European Basin Scale Analysis, Synthesis, and Integration); MareFame (Co-creating Ecosystem-based Fisheries Management Solutions); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); History of Marine Animal Populations (HMAP) project	This work was supported by European Commission FP7 EURO-BASIN (European Basin Scale Analysis, Synthesis, and Integration, Grant Agreement 264 933), www.euro-basin.eu/; MareFame (Co-creating Ecosystem-based Fisheries Management Solutions, grant agreement no.613571), http://mareframe.mapix.com/; and the Polish Ministry of Science and Higher Education has also participated in the financing of this research. The History of Marine Animal Populations (HMAP) project are acknowledged for supporting this publication.	Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Cardinale M, 2012, J APPL ICHTHYOL, V28, P200, DOI 10.1111/j.1439-0426.2012.01937.x; Carlton JT, 1998, CONSERV BIOL, V12, P1165, DOI 10.1046/j.1523-1739.1998.0120061165.x; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; DERISO RB, 1980, CAN J FISH AQUAT SCI, V37, P268, DOI 10.1139/f80-034; Eero M, 2012, ICES J MAR SCI, V69, P1010, DOI 10.1093/icesjms/fss051; Eero M, 2011, MAR ECOL PROG SER, V440, P191, DOI 10.3354/meps09346; Eero M, 2011, ECOL APPL, V21, P214, DOI 10.1890/09-1879.1; FLETCHER RI, 1978, FISH B-NOAA, V76, P515; FOX WW, 1970, T AM FISH SOC, V99, P80, DOI 10.1577/1548-8659(1970)99<80:AESMFO>2.0.CO;2; ICES, 2012, ICES ADV 2012 BOOK 9, V9; ICES, 2012, ICES ADV 2012 BOOK 3, V3; ICES, 2012, ICES ADV 2012 BOOK 6, V6; Jackson ST, 2009, SCIENCE, V325, P567, DOI 10.1126/science.1172977; KIMURA DK, 1982, CAN J FISH AQUAT SCI, V39, P1467, DOI 10.1139/f82-198; KIMURA DK, 1984, CAN J FISH AQUAT SCI, V41, P1325, DOI 10.1139/f84-162; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Mackenzie BR, 2007, GLOBAL CHANGE BIOL, V13, P1348, DOI 10.1111/j.1365-2486.2007.01369.x; MacKenzie BR, 2011, MAR POLICY, V35, P266, DOI 10.1016/j.marpol.2010.10.004; Marandel F, 2016, AQUAT LIVING RESOUR, V29, DOI 10.1051/alr/2016020; Nielsen A, 2014, FISH RES, V158, P96, DOI 10.1016/j.fishres.2014.01.014; Patterson KR, 1998, 58 SCOTT FISH RES; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pella J.J., 1969, INTERAMERICAN TROP T, V13, P416; Pope J.G., 1972, INT COMMISSION NW AT, V9, P65; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Roberts CM, 2003, ORYX, V37, P166, DOI 10.1017/S0030605303000358; Rose GA, 2004, CAN J FISH AQUAT SCI, V61, P1553, DOI 10.1139/F04-173; Schaefer MB., 1954, B IATTC BOL CIAT, V1, P23; Shepherd JG, 1999, ICES J MAR SCI, V56, P584, DOI 10.1006/jmsc.1999.0498; ter Hofstede R, 2011, ICES J MAR SCI, V68, P1189, DOI 10.1093/icesjms/fsr053; UN, 1992, LAND USE POLICY, V9, P300; United Nations, 2002, WORLD SUMMIT SUSTAIN; Witting L, 2013, POPUL ECOL, V55, P377, DOI 10.1007/s10144-013-0370-9; Witting Lars, 2003, Journal of Cetacean Research and Management, V5, P45	35	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0186830	10.1371/journal.pone.0186830	http://dx.doi.org/10.1371/journal.pone.0186830			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131850	Green Published, gold, Green Submitted			2022-12-26	WOS:000414997800005
J	Mahdavimehr, M; Meratan, AA; Ghobeh, M; Ghasemi, A; Saboury, AA; Nemat-Gorgani, M				Mahdavimehr, Mohsen; Meratan, Ali Akbar; Ghobeh, Maryam; Ghasemi, Atiyeh; Saboury, Ali Akbar; Nemat-Gorgani, Mohsen			Inhibition of HEWL fibril formation by taxifolin: Mechanism of action	PLOS ONE			English	Article							EGG-WHITE LYSOZYME; AMYLOID FIBRILLATION; PROTEIN INTERACTIONS; ALZHEIMERS-DISEASE; ALPHA-LACTALBUMIN; BETA AGGREGATION; CORE STRUCTURE; HEN LYSOZYME; IN-VITRO; POLYPHENOLS	Among therapeutic approaches for amyloid-related diseases, attention has recently turned to the use of natural products as effective anti-aggregation compounds. Although a wealth of in vitro and in vivo evidence indicates some common inhibitory activity of these compounds, they don't generally suggest the same mechanism of action. Here, we show that taxifolin, a ubiquitous bioactive constituent of foods and herbs, inhibits formation of HEWL amyloid fibrils and their related toxicity by causing formation of very large globular, chain-like aggregates. A range of amyloid-specific techniques were employed to characterize this process. We found that taxifolin exerts its effect by binding to HEWL prefibrillar species, rather than by stabilizing the molecule in its native-like state. Furthermore, it's binding results in diverting the amyloid pathway toward formation of very large globular, chain-like aggregates with low beta-sheet content and reduced solvent-exposed hydrophobic patches. ThT fluorescence measurements show that the binding capacity of taxifolin is significantly reduced, upon generation of large protofibrillar aggregates at the end of growth phase. We believe these results may help design promising inhibitors of protein aggregation for amyloid-related diseases.	[Mahdavimehr, Mohsen; Meratan, Ali Akbar] IASBS, Dept Biol Sci, Zanjan, Iran; [Ghobeh, Maryam] Islamic Azad Univ, Dept Biol, Sci & Res Branch, Tehran, Iran; [Ghasemi, Atiyeh; Saboury, Ali Akbar] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Nemat-Gorgani, Mohsen] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	Institute for Advanced Studies in Basic Sciences (IASBS); Islamic Azad University; University of Tehran; Stanford University	Meratan, AA (corresponding author), IASBS, Dept Biol Sci, Zanjan, Iran.	a.meratan@iasbs.ac.ir	Saboury, Ali Akbar/L-6136-2019; Meratan, Ali Akbar/L-1413-2017	Saboury, Ali Akbar/0000-0003-0604-9465; Meratan, Ali Akbar/0000-0002-1428-3254	Research Council of the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran	Research Council of the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran	This work was supported by grants from the Research Council of the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran.	Alam P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26759; Bartolini M, 2010, CHEMBIOCHEM, V11, P1018, DOI 10.1002/cbic.200900666; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; BOOTH AN, 1958, J AM PHARM ASSOC, V47, P183, DOI 10.1002/jps.3030470310; Borana MS, 2014, BBA-PROTEINS PROTEOM, V1844, P670, DOI 10.1016/j.bbapap.2014.01.009; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10256; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chong XY, 2017, INT J BIOL MACROMOL, V101, P321, DOI 10.1016/j.ijbiomac.2017.03.107; De Felice FG, 2002, CELL MOL NEUROBIOL, V22, P545, DOI 10.1023/A:1021832302524; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Frare E, 2004, J MOL BIOL, V340, P1153, DOI 10.1016/j.jmb.2004.05.056; Frare E, 2006, J MOL BIOL, V361, P551, DOI 10.1016/j.jmb.2006.06.055; Gazit E, 2005, FEBS J, V272, P5971, DOI 10.1111/j.1742-4658.2005.05022.x; Gazova Z, 2013, PROTEINS, V81, P994, DOI 10.1002/prot.24250; Ghobeh M, 2014, BIOPOLYMERS, V102, P473, DOI 10.1002/bip.22572; Ghosh S, 2013, INT J BIOL MACROMOL, V54, P90, DOI 10.1016/j.ijbiomac.2012.11.031; Goers J, 2002, BIOCHEMISTRY-US, V41, P12546, DOI 10.1021/bi0262698; GOLDBERG ME, 1991, BIOCHEMISTRY-US, V30, P2790, DOI 10.1021/bi00225a008; He JW, 2014, J AGR FOOD CHEM, V62, P9442, DOI 10.1021/jf5025449; Hirohata M, 2012, BBA-MOL BASIS DIS, V1822, P1316, DOI 10.1016/j.bbadis.2012.05.006; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Ladiwala AR, 2001, J BIOL CHEM, V286, P3209; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Marcinko TM, 2017, J BIOL CHEM; Marino L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12052; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Meratan AA, 2011, J MOL BIOL, V409, P826, DOI 10.1016/j.jmb.2011.04.045; Mishra R, 2009, CHEMBIOCHEM, V10, P445, DOI 10.1002/cbic.200800762; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nigen M, 2009, BBA-PROTEINS PROTEOM, V1794, P709, DOI 10.1016/j.bbapap.2008.12.017; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Roqanian S, 2017, INT J BIOL MACROMOL, V103, P709, DOI 10.1016/j.ijbiomac.2017.05.130; Saito S, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0429-5; Sato M, 2013, J BIOL CHEM, V288, P23212, DOI 10.1074/jbc.M113.464222; Sato M, 2013, BIOSCI BIOTECH BIOCH, V77, P1100, DOI 10.1271/bbb.120925; Shariatizi S, 2015, INT J BIOL MACROMOL, V80, P95, DOI 10.1016/j.ijbiomac.2015.06.030; Shoval H, 2007, AMYLOID, V14, P73, DOI 10.1080/13506120601116674; Siebert KJ, 1996, J AGR FOOD CHEM, V44, P80, DOI 10.1021/jf9502459; Soares S, 2007, J AGR FOOD CHEM, V55, P6726, DOI 10.1021/jf070905x; Soto C, 1999, MOL MED TODAY, V5, P343, DOI 10.1016/S1357-4310(99)01508-7; Stefani M, 2013, INT J MOL SCI, V14, P12411, DOI 10.3390/ijms140612411; Sun X, 2014, FOOD CHEM TOXICOL, V63, P221, DOI 10.1016/j.fct.2013.11.013; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tokunaga Y, 2013, INT J BIOL SCI, V9, P219, DOI 10.7150/ijbs.5380; Wang JB, 2011, BIOCHEM BIOPH RES CO, V415, P675, DOI 10.1016/j.bbrc.2011.10.135; Wang N, 2015, J AGR FOOD CHEM, V63, P1347, DOI 10.1021/jf505277e; Wang SSS, 2006, J MOL CATAL B-ENZYM, V43, P49, DOI 10.1016/j.molcatb.2006.06.006; Wang SSS, 2011, BBA-MOL CELL BIOL L, V1811, P301, DOI 10.1016/j.bbalip.2011.02.003; Weidmann AE, 2012, EUR J PHARMACOL, V684, P19, DOI 10.1016/j.ejphar.2012.03.035; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yan YL, 2003, CURR OPIN CHEM BIOL, V7, P635, DOI 10.1016/j.cbpa.2003.08.017; YOUNG ACM, 1994, J MOL BIOL, V235, P302, DOI 10.1016/S0022-2836(05)80034-8; Zhai J, 2012, BIOCHEMISTRY-US, V51, P1070, DOI 10.1021/bi201871r	63	36	38	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187841	10.1371/journal.pone.0187841	http://dx.doi.org/10.1371/journal.pone.0187841			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131828	Green Submitted, Green Published, gold			2022-12-26	WOS:000414997800027
J	Herzmann, C; Ernst, M; Lange, C; Stenger, S; Kaufmann, SHE; Reiling, N; Schaberg, T; van der Merwe, L; Maertzdorf, J				Herzmann, Christian; Ernst, Martin; Lange, Christoph; Stenger, Steffen; Kaufmann, Stefan H. E.; Reiling, Norbert; Schaberg, Tom; van der Merwe, Lize; Maertzdorf, Jeroen		Tb Not Tb Consortium	Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals	PLOS ONE			English	Article							GAMMA-RELEASE ASSAYS; LATENT TUBERCULOSIS; DIAGNOSTIC-ACCURACY; ACTIVE PULMONARY; IFN-GAMMA; CELLS; INFECTION; LUNG; RECRUITMENT; INTERFERON	Background Blood based Interferon-(IFN)-gamma release assays (IGRAs) have a poor predictive value for the development of tuberculosis. This study aimed to investigate the correlation between IGRAs and pulmonary immune responses in tuberculosis contacts in Germany. Methods IGRAs were performed on bronchoalveolar lavage (BAL) cells and peripheral blood from close healthy contacts of patients with culturally confirmed tuberculosis. Cellular BAL composition was determined by flow cytometry. BAL cells were co-cultured with three strains of Mycobacterium tuberculosis (Mtb) and Mtb derived antigens including Purified Protein Derivative (PPD), 6 kD Early Secretory Antigenic Target (ESAT-6) and 10 kD Culture Filtrate Protein (CFP-10). Levels of 29 cytokines and chemokines were analyzed in the supernatants by multiplex assay. Associations and effects were examined using linear mixed-effects models. Results There were wide variations of inter-individual cytokine levels in BAL cell culture supernatants. Mycobacterial infection and stimulation with PPD showed a clear induction of several macrophage and lymphocyte associated cytokines, reflecting activation of these cell types. No robust correlation between cytokine patterns and blood IGRA status of the donor was observed, except for slightly higher Interleukin-2 (IL-2) responses in BAL cells from IGRA-positive donors upon mycobacterial infection compared to cells from IGRA-negative donors. Stronger correlations were observed when cytokine patterns were stratified according to BAL IGRA status. BAL cells from donors with BAL IGRA-positive responses produced significantly more IFN-gamma and IL-2 upon PPD stimulation and mycobacterial infection than cells from BAL IGRA-negative individuals. Correlations between BAL composition and basal cytokine release from unstimulated cells were suggestive of pre-activated lymphocytes but impaired macrophage activity in BAL IGRA-positive donors, in contrast to BAL IGRA-negative donors. Conclusions In vitro BAL cell cytokine responses to M. tuberculosis antigens or infection do not reflect blood IGRA status but do correlate with stronger cellular responses in BAL IGRA-positive donors. The cytokine patterns observed suggest a pre-activated state of lymphocytes and suppressed macrophage responsiveness in BAL cells from BAL IGRA-positive individuals.	[Herzmann, Christian; van der Merwe, Lize] Res Ctr Borstel, Ctr Clin Studies, Borstel, Germany; [Ernst, Martin] Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany; [Lange, Christoph] German Ctr Infect Res DZIF, Clin TB Unit, Borstel, Germany; [Lange, Christoph] Univ Lubeck, Int Hlth Infect Dis, Lubeck, Germany; [Lange, Christoph] Karolinska Inst, Dept Med, Stockholm, Sweden; [Stenger, Steffen] Univ Hosp Ulm, Inst Med Microbiol & Hyg, Ulm, Germany; [Kaufmann, Stefan H. E.; Maertzdorf, Jeroen] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Reiling, Norbert] Res Ctr Borstel, Div Microbial Interface Biol, Borstel, Germany; [Schaberg, Tom] Agaples Deaconess Hosp Rotenburg, Ctr Pneumol, Rotenburg, Germany; [van der Merwe, Lize] LizeStats Consulting, Overstrand, Western Cape, South Africa	Forschungszentrum Borstel; Forschungszentrum Borstel; German Center for Infection Research; University of Lubeck; Karolinska Institutet; Ulm University; Max Planck Society; Forschungszentrum Borstel	Herzmann, C (corresponding author), Res Ctr Borstel, Ctr Clin Studies, Borstel, Germany.	cherzmann@fz-borstel.de	Lange, Christoph/J-6289-2012; Reiling, Norbert/D-6796-2013	Lange, Christoph/0000-0002-9691-4741; Reiling, Norbert/0000-0001-6673-4291	German Ministry of Education and Research (BMBF) [01KI0784]; German Ministry of Education and Research [01EY1103]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This observational, multicentre, prospective study was carried out by the research consortium on "Pulmonary Tuberculosis Host and Pathogen Determinants of Resistance and Disease Progression- (TB or not TB)", funded by the German Ministry of Education and Research (BMBF, reference 01KI0784). The funder provided support in the form of salaries for one author [CH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. LvdM is the sole employee and owner of the statistics consulting company LizeStats Consulting. LizeStats Consulting provides a salary to LvdM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; For technical and logistic support, the authors are grateful to F. Daduna, J. Dahling, J. Hofmeister, K. Gaede, A. Glaewe, L. Krabbe (Research Center Borstel), D. Mayer (Department of Medical Microbiology and Hygiene, University of Ulm), S. Jaletzky (Klinik Dr. Hancken, Stade), D. Kraus-Leonhauser, C. Skrybeck (both Municipal Health Authority, Frankfurt), K. Meywaldt-Walter, G. Reinke (both Municipal Health Authority Hamburg), D. Lehnert (Evanglische Lungenklinik, Berlin), N. Vorreiter (Lungenfachklinik, Immenhausen), J. Paepke (Helios Klinikum Emil von Behring, Berlin), J. Reppe and L. Tittmann (Biobank PopGen, Kiel). PopGen is a member of the popgen 2.0 network (P2N) which is supported by a grant from the German Ministry of Education and Research (reference 01EY1103).	Arko-Mensah J, 2009, CLIN MICROBIOL INFEC, V15, P777, DOI 10.1111/j.1469-0691.2009.02734.x; Barry SM, 2003, J INFECT DIS, V187, P243, DOI 10.1086/346112; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brace PT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006367; Breen RAM, 2006, AIDS, V20, P1330, DOI 10.1097/01.aids.0000232243.51286.32; Cellestis, 2006, QUANTIFERON TB GOLD; Chavez-Galan L, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4048235; Cobben NAM, 1999, EUR RESPIR J, V14, P496, DOI 10.1034/j.1399-3003.1999.14c04.x; Dorhoi A, 2014, EUR J IMMUNOL, V44, P2380, DOI 10.1002/eji.201344219; du Plessis N, 2013, AM J RESP CRIT CARE, V188, P724, DOI 10.1164/rccm.201302-0249OC; Ferrara G, 2009, INT J IMMUNOPATH PH, V22, P669, DOI 10.1177/039463200902200312; Fournier A, 2012, REV MAL RESPIR, V29, P1079, DOI 10.1016/j.rmr.2012.06.005; Fox, 2003, J STAT SOFTW, V8, DOI 10.18637/jss.v008.i15; Haussinger K, 2004, Pneumologie, V58, P344; Herzmann C, 2012, EUR RESP J; Herzmann C, 2016, INFECTION; Herzmann C, 2014, EUR RESPIR J, V44, P1087, DOI 10.1183/09031936.00086514; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Jambo KC, 2014, AM J RESP CRIT CARE, V190, P938, DOI 10.1164/rccm.201405-0864OC; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; Krishnan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023870; Kupli E, 2008, RESPIRATION, V75, P73, DOI 10.1159/000110744; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mamishi S, 2014, EUR J CLIN MICROBIOL, V33, P2111, DOI 10.1007/s10096-014-2190-z; Murrell P., 2011, R GRAPHICS; Nolan A, 2013, INT J TUBERC LUNG D, V17, P922, DOI 10.5588/ijtld.12.0610; Nolan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059461; Oxford Immunotec, 2009, T SPOT TB PACK INS; Prabhakar S, 2003, INFECT IMMUN, V71, P2487, DOI 10.1128/IAI.71.5.2487-2497.2003; Raju B, 2008, TUBERCULOSIS, V88, P39, DOI 10.1016/j.tube.2007.07.003; Reiling N, 2013, MBIO, V4, DOI 10.1128/mBio.00250-13; Saha PK, 2013, CYTOKINE, V63, P43, DOI 10.1016/j.cyto.2013.04.001; Sahu SK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006410; Schwander S, 2011, AM J RESP CRIT CARE, V183, P696, DOI 10.1164/rccm.201006-0963PP; Semple PL, 2013, AM J RESP CRIT CARE, V187, P1249, DOI 10.1164/rccm.201210-1934OC; Silver RF, 2003, AM J RESP CELL MOL, V29, P117, DOI 10.1165/rcmb.4840; Thillai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038083; Walrath E, 2005, AM J RESP CELL MOL, V33, P48, DOI 10.1165/rcmb.2005-0060OC; White AD, 2013, CLIN VACCINE IMMUNOL, V20, P663, DOI 10.1128/CVI.00690-12; Wilson FA, 2016, PUBLIC HEALTH REP, V131, P303, DOI 10.1177/003335491613100214; Zellweger JP, 2015, AM J RESP CRIT CARE, V191, P1176, DOI 10.1164/rccm.201502-0232OC	43	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187882	10.1371/journal.pone.0187882	http://dx.doi.org/10.1371/journal.pone.0187882			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125874	gold, Green Published, Green Submitted			2022-12-26	WOS:000414866000029
J	Lenihan, JA; Saha, O; Young, PW				Lenihan, Joan A.; Saha, Orthis; Young, Paul W.			Proteomic analysis reveals novel ligands and substrates for LNX1 E3 ubiquitin ligase	PLOS ONE			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; MAMMALIAN NUMB; PROTEIN; FAMILY; DIFFERENTIATION; IDENTIFICATION; UBIQUITYLATION; SPECIFICITY; CELLS; TIGHT	Ligand of Numb protein X1 (LNX1) is an E3 ubiquitin ligase that contains a catalytic RING (Really Interesting New Gene) domain and four PDZ (PSD-95, DlgA, ZO-1) domains. LNX1 can ubiquitinate Numb, as well as a number of other ligands. However, the physiological relevance of these interactions in vivo remain unclear. To gain functional insights into the LNX family, we have characterised the LNX1 interactome using affinity purification and mass spectrometry. This approach identified a large number of novel LNX1-interacting proteins, as well as confirming known interactions with NUMB and ERC2. Many of the novel interactions mapped to the LNX PDZ domains, particularly PDZ2, and many showed specificity for LNX1 over the closely related LNX2. We show that PPFIA1 (liprin-alpha 1), KLHL11, KIF7 and ERC2 are substrates for ubiquitination by LNX1. LNX1 ubiquitination of liprin-a1 is dependent on a PDZ binding motif containing a carboxyl terminal cysteine that binds LNX1 PDZ2. Surprisingly, the neuronally-expressed LNX1p70 isoform, that lacks the RING domain, was found to promote ubiquitination of PPFIA1 and KLHL11, albeit to a lesser extent than the longer RING-containing LNX1p80 isoform. Of several E3-ligases identified in the LNX1 interactome we confirm interactions of LNX1 with MID2/TRIM1 and TRIM27. On this basis we propose a model whereby LNX1p70, despite lacking a catalytic RING domain, may function as a scaffold to promote ubiquitination of its ligands through recruitment of other E3-ligases. These findings provide functional insights into the LNX protein family, particularly the neuronal LNX1p70 isoform.	[Lenihan, Joan A.; Saha, Orthis; Young, Paul W.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Saha, Orthis] Ecole Normale Super, Inst Biol, Paris, France	University College Cork; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Young, PW (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland.	p.young@ucc.ie	Young, Paul/A-4874-2015	Young, Paul/0000-0002-1307-0249	Science Foundation Ireland Research Frontiers Programme [08/RFP/NSC1382]; Irish Research Council EMBARK	Science Foundation Ireland Research Frontiers Programme(Science Foundation Ireland); Irish Research Council EMBARK(Irish Research Council for Science, Engineering and Technology)	This work was supported by Science Foundation Ireland Research Frontiers Programme (08/RFP/NSC1382); Irish Research Council EMBARK Postgraduate Research Scholarship.	Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Camps J, 2013, CANCER RES, V73, P2003, DOI 10.1158/0008-5472.CAN-12-3159; D'Agostino M, 2011, J CELL SCI, V124, P3545, DOI 10.1242/jcs.081224; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Flynn M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-235; Foley KS, 2013, BIOCHEM J, V452, P477, DOI 10.1042/BJ20121824; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Guo ZG, 2012, J PROTEOME RES, V11, P4847, DOI 10.1021/pr300674c; Higa S, 2007, BIOCHEM BIOPH RES CO, V354, P686, DOI 10.1016/j.bbrc.2007.01.036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim JYH, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-2; Lenihan JA, 2016, MOL NEUROBIOL, P1; Lenihan JA, 2014, GENE, V552, P39, DOI 10.1016/j.gene.2014.09.011; Liu YLC, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005608; Murphy ACH, 2016, FEBS LETT, V590, P685, DOI 10.1002/1873-3468.12101; Nie J, 2004, J BIOL CHEM, V279, P20807, DOI 10.1074/jbc.M311396200; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Rice DS, 2001, MOL CELL NEUROSCI, V18, P525, DOI 10.1006/mcne.2001.1024; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Spangler SA, 2007, BIOCHEM SOC T, V35, P1278, DOI 10.1042/BST0351278; Suzuki M, 2010, DEVELOPMENT, V137, P2329, DOI 10.1242/dev.048769; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Wang H, 2014, CELL REP, V8, P1093, DOI 10.1016/j.celrep.2014.07.006; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Weiss A, 2007, FEBS LETT, V581, P5131, DOI 10.1016/j.febslet.2007.09.062; Wolting CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026248; Won MH, 2015, P NATL ACAD SCI USA, V112, P12426, DOI 10.1073/pnas.1517033112; Yin FT, 2015, STEM CELLS DEV, V24, P640, DOI 10.1089/scd.2014.0261; Young P, 2005, MOL CELL NEUROSCI, V30, P238, DOI 10.1016/j.mcn.2005.07.015; Zhou J, 2015, CALCIFIED TISSUE INT, V96, P465, DOI 10.1007/s00223-015-9967-7	35	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187352	10.1371/journal.pone.0187352	http://dx.doi.org/10.1371/journal.pone.0187352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121065	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900030
J	Li, SW; Takahara, T; Fujino, M; Fukuhara, Y; Sugiyama, T; Li, XK; Takahara, S				Li, Shaowei; Takahara, Terumi; Fujino, Masayuki; Fukuhara, Yasuyuki; Sugiyama, Toshiro; Li, Xiao-Kang; Takahara, Shiro			Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice	PLOS ONE			English	Article							HEPATIC ISCHEMIA/REPERFUSION INJURY; REDUCED-SIZE LIVER; INDUCED APOPTOSIS; OXIDATIVE STRESS; FATTY LIVER; ANTIOXIDANT ACTIVITY; KUPFFER CELLS; RAT-LIVER; IN-VIVO; PATHWAY	Steatosis has a low tolerance against ischemia-reperfusion injury (IRI). To prevent IRI in the steatotic liver, we attempted to elucidate the protective effect of astaxanthin (ASTX) in the steatotic liver model by giving mice a methionine and choline-deficient high fat (MCDHF) diet. Levels of lipid peroxidation and apoptosis, the expression of inflammatory cytokines and heme oxygenase (HO)-1, in the liver were assessed. Reactive oxygen species (ROS), inflammatory cytokines, apoptosis-related proteins and members of the signaling pathway were also examined in isolated Kupffer cells and/or hepatocytes from the steatotic liver. ASTX decreased serum ALT and AST levels, the amount of TUNEL, F4/80, or 4HNE-positive cells and the mRNA levels of inflammatory cytokines in MCDHF mice by IRI. Moreover, HO-1 and HIF-1a, phosphorylation of Akt and mTOR expressions were increased by ASTX. The inflammatory cytokines produced by Kupffer, which were subjected to hypoxia and reoxygenation (HR), were inhibited by ASTX. Expressions of Bcl-2, HO-1 and Nrf2 in hepatocytes by HR were increased, whereas Caspases activation, Bax and phosphorylation of ERK, MAPK, and JNK were suppressed by ASTX. Pretreatment with ASTX has a protective effect and is a safe therapeutic treatment for IRI, including for liver transplantation of the steatotic liver.	[Li, Shaowei; Fujino, Masayuki; Li, Xiao-Kang] Natl Res Inst Child Hlth & Dev, Div Transplantat Immunol, Tokyo, Japan; [Li, Shaowei; Takahara, Shiro] Osaka Univ, Dept Adv Technol Transplantat, Grad Sch Med, Osaka, Japan; [Li, Shaowei] Inner Mongolia Med Univ, Sch Basic Med Sci, Res Ctr Mol Biol, Hohhot, Inner Mongolia, Peoples R China; [Li, Shaowei] Inner Mongolia Med Univ, Affiliated Hosp, Clin Med Res Ctr, Hohhot, Inner Mongolia, Peoples R China; [Takahara, Terumi; Sugiyama, Toshiro] Univ Toyama, Dept Internal Med 3, Toyama, Japan; [Fujino, Masayuki] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Fukuhara, Yasuyuki] Natl Ctr Child Hlth & Dev, Div Med Genet, Tokyo, Japan	National Center for Child Health & Development - Japan; Osaka University; Inner Mongolia Medical University; Inner Mongolia Medical University; University of Toyama; National Institute of Infectious Diseases (NIID); National Center for Child Health & Development - Japan	Li, XK (corresponding author), Natl Res Inst Child Hlth & Dev, Div Transplantat Immunol, Tokyo, Japan.; Takahara, T (corresponding author), Univ Toyama, Dept Internal Med 3, Toyama, Japan.	terutaka-tym@unim.ac.jp; ri-k@ncchd.go.jp	Li, Shaowei/ABC-1102-2020		Ministry of Education, Culture, Sports, Science, and Technology of Japan [17H04277, 15K10043, 17K09411]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. (17H04277, 15K10043, 17K09411) https://www.jsps.go.jp/engIish/index.html.	Ambati RR, 2014, MAR DRUGS, V12, P128, DOI 10.3390/md12010128; Bilzer M, 2000, J HEPATOL, V32, P508, DOI 10.1016/S0168-8278(00)80404-3; Camera E, 2009, EXP DERMATOL, V18, P222, DOI 10.1111/j.1600-0625.2008.00790.x; Cao L, 2006, TRANSPL P, V38, P2207, DOI 10.1016/j.transproceed.2006.06.014; Chu MJJ, 2015, HPB, V17, P1, DOI 10.1111/hpb.12258; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Crenesse D, 2003, EUR J PHARMACOL, V473, P177, DOI 10.1016/S0014-2999(03)01977-0; Curek GD, 2010, TOXICOLOGY, V267, P147, DOI 10.1016/j.tox.2009.11.003; Durand F, 2008, LIVER TRANSPLANT, V14, P1694, DOI 10.1002/lt.21668; Gujral JS, 2001, HEPATOLOGY, V33, P397, DOI 10.1053/jhep.2001.22002; Haddad JJ, 2007, PROTEIN PEPTIDE LETT, V14, P361, DOI 10.2174/092986607780363925; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Harada H, 2001, J APPL PHYSIOL, V91, P2816, DOI 10.1152/jappl.2001.91.6.2816; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355; Kale J, 2012, CELL, V151, P1179, DOI 10.1016/j.cell.2012.11.013; Kamath BS, 2008, EUR J PHARMACOL, V590, P387, DOI 10.1016/j.ejphar.2008.06.042; Khan RS, 2016, METABOLISM; Kim YJ, 2009, J AGR FOOD CHEM, V57, P8793, DOI 10.1021/jf9019745; King LA, 2009, J HEPATO-BILIARY-PAN, V16, P763, DOI 10.1007/s00534-009-0155-x; Lai YS, 2015, J AGR FOOD CHEM, V63, P7873, DOI 10.1021/acs.jafc.5b02830; Li JJ, 2015, MAR DRUGS, V13, P3368, DOI 10.3390/md13063368; Li S, 2016, BIOCHEM BIOPH RES CO, V470, P900, DOI 10.1016/j.bbrc.2016.01.136; Lin WY, 2013, STROKE, V44, P162, DOI 10.1161/STROKEAHA.112.677617; Liu XB, 2007, BIOCHEM BIOPH RES CO, V357, P187, DOI 10.1016/j.bbrc.2007.03.120; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; McCormack L, 2011, J HEPATOL, V54, P1055, DOI 10.1016/j.jhep.2010.11.004; Naito Y, 2004, BIOFACTORS, V20, P49, DOI 10.1002/biof.5520200105; Ni YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17192; Otsuka T, 2016, CURR EYE RES, V41, P1465, DOI 10.3109/02713683.2015.1127392; Park GB, 2014, INT J ONCOL, V44, P977, DOI 10.3892/ijo.2014.2252; Park GB, 2011, CANCER LETT, V313, P235, DOI 10.1016/j.canlet.2011.09.011; Qiu XF, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0388-1; Rao AR, 2013, FOOD RES INT, V54, P711, DOI 10.1016/j.foodres.2013.07.067; RYMSA B, 1991, AM J PHYSIOL, V261, pG602, DOI 10.1152/ajpgi.1991.261.4.G602; Saw CLL, 2013, FOOD CHEM TOXICOL, V62, P869, DOI 10.1016/j.fct.2013.10.023; Seki E, 2001, J IMMUNOL, V166, P2651, DOI 10.4049/jimmunol.166.4.2651; Shen H, 2009, FASEB J, V23, P1958, DOI 10.1096/fj.08-123281; Tang T, 2013, AFR J TRADIT COMPLEM, V10, P12, DOI 10.4314/ajtcam.v10i4.3; Tang ZY, 2006, TRANSPLANTATION, V82, P1518, DOI 10.1097/01.tp.0000243381.41777.c7; Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007; Tripathi DN, 2010, MUTAT RES-GEN TOX EN, V696, P69, DOI 10.1016/j.mrgentox.2009.12.014; van Golen RF, 2013, J GASTROEN HEPATOL, V28, P394, DOI 10.1111/jgh.12072; Vilatoba M, 2005, TRANSPL P, V37, P399, DOI 10.1016/j.transproceed.2004.12.053; Wang H, 2013, INT J MOL MED, V32, P187, DOI 10.3892/ijmm.2013.1379; Xiao Q, 2017, CRYOBIOLOGY, V75, P100, DOI 10.1016/j.cryobiol.2017.01.005; Xu Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081179; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zetzmann CP, 2010, OCHSNER J, V10, P250; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhou GF, 2009, AM J PHYSIOL-LUNG C, V297, pL1120, DOI 10.1152/ajplung.00007.2009	50	33	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187810	10.1371/journal.pone.0187810	http://dx.doi.org/10.1371/journal.pone.0187810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121675	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900079
J	Richtig, G; Aigelsreiter, A; Schwarzenbacher, D; Ress, AL; Adiprasito, JB; Stiegelbauer, V; Hoefler, G; Schauer, S; Kiesslich, T; Kornprat, P; Winder, T; Eisner, F; Gerger, A; Stoeger, H; Stauber, R; Lackner, C; Pichler, M				Richtig, Georg; Aigelsreiter, Ariane; Schwarzenbacher, Daniela; Ress, Anna Lena; Adiprasito, Jan Basri; Stiegelbauer, Verena; Hoefler, Gerald; Schauer, Silvia; Kiesslich, Tobias; Kornprat, Peter; Winder, Thomas; Eisner, Florian; Gerger, Armin; Stoeger, Herbert; Stauber, Rudolf; Lackner, Carolin; Pichler, Martin			SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types	PLOS ONE			English	Article							POOR-PROGNOSIS; EXPRESSION; SPINOPHILIN; SORAFENIB; SLUG	SOX9 has been previously shown to be involved in hepatocellular carcinoma (HCC) and other types of cancer. However, prognostic studies so far involved rather small cohorts or lack external validation and experimental data. In this study, we firstly determined the histological expression pattern of SOX9 in human HCC by immunohistochemistry (n = 84) and evaluated its prognostic value. External cohorts of publicly available datasets were used to validate its prognostic relevance in HCC (n = 359) and other types of cancer including breast (n = 3951), ovarian (n = 1306), lung (n = 1926) and gastric cancer (n = 876). Functional SOX9 knock-down studies using siRNA and cancer stem cell models were generated in a panel of liver and breast cancer cell lines. High level of SOX9 was associated with poor survival even after adjustment for other prognostic factors in multivariate analysis (HR = 2.103, 95% CI = 1.064 to 4.156, p = 0.021). SOX9 prevailed a poor prognostic factor in all cancer validation cohorts (p<0.05). Reduced SOX9 expression by siRNA decreased the growth of liver cancer cells (p<0.05). SOX9 expression was associated with stem cell features in all tested cell lines (p<0.05). In conclusion, this study demonstrated in a large number of patients from multiple cohorts that high levels of SOX9 are a consistent negative prognostic factor.	[Richtig, Georg] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria; [Aigelsreiter, Ariane; Hoefler, Gerald; Schauer, Silvia; Lackner, Carolin] Med Univ Graz, Inst Pathol, Graz, Austria; [Schwarzenbacher, Daniela; Ress, Anna Lena; Adiprasito, Jan Basri; Stiegelbauer, Verena; Eisner, Florian; Gerger, Armin; Stoeger, Herbert; Pichler, Martin] Med Univ Graz, Div Oncol, Dept Internal Med, Graz, Austria; [Schwarzenbacher, Daniela; Ress, Anna Lena; Adiprasito, Jan Basri; Stiegelbauer, Verena; Pichler, Martin] Med Univ Graz, Res Unit Noncoding RNAs & Genome Editing Canc, Graz, Austria; [Kiesslich, Tobias] Paracelsus Med Univ, Salzburger Landeskliniken, Dept Internal Med, Salzburg, Austria; [Kiesslich, Tobias] Paracelsus Med Univ, Inst Physiol & Pathophysiol, Lab Tumour Biol & Expt Therapies TREAT, Salzburg, Austria; [Kornprat, Peter] Med Univ Graz, Div Visceral Surg, Dept Surg, Graz, Austria; [Winder, Thomas] Univ Hosp Zurich, Dept Oncol, Zurich, Switzerland; [Stauber, Rudolf] Med Univ Graz, Div Gastroenterol & Hepatol, Dept Internal Med, Graz, Austria; [Pichler, Martin] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Paracelsus Private Medical University; Paracelsus Private Medical University; Medical University of Graz; University of Zurich; University Zurich Hospital; Medical University of Graz; University of Texas System; UTMD Anderson Cancer Center	Pichler, M (corresponding author), Med Univ Graz, Div Oncol, Dept Internal Med, Graz, Austria.; Pichler, M (corresponding author), Med Univ Graz, Res Unit Noncoding RNAs & Genome Editing Canc, Graz, Austria.; Pichler, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	martin.pichler@medunigraz.at	, Kornprat/AAH-6353-2019; Hoefler, Gerald/H-1796-2016	Richtig, Georg/0000-0002-4437-4413; Pichler, Martin/0000-0002-8701-9462; Hoefler, Gerald/0000-0002-9056-3063; Kiesslich, Tobias/0000-0001-5403-9478	OSTERREICHISCHE KREBSHILFE STEIERMARK; Hans and Blanca Moser Stiftung	OSTERREICHISCHE KREBSHILFE STEIERMARK; Hans and Blanca Moser Stiftung	This research project was supported by a grant of the OSTERREICHISCHE KREBSHILFE STEIERMARK (to Martin Pichler) and by a grant of the Hans and Blanca Moser Stiftung (to Florian Eisner). Both funding bodies had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigelsreiter A, 2013, BRIT J CANCER, V108, P1830, DOI 10.1038/bjc.2013.165; Aigelsreiter A, 2016, LIVER INT; Aigelsreiter A, 2012, HUM PATHOL, V43, P1012, DOI 10.1016/j.humpath.2011.08.009; Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Cheng PF, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0594-4; Coon JT, 2008, BRIT J CANCER, V98, P1166, DOI 10.1038/sj.bjc.6604301; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Guo XD, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-44; Hong Y, 2015, ONCOTARGET, V10, P18632, DOI DOI 10.18632/0NC0TARGET.5160; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Jiang SS, 2010, CLIN CANCER RES, V16, P4363, DOI 10.1158/1078-0432.CCR-10-0138; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kawai T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30489; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lamarca A, 2015, CRIT REV ONCOL HEMAT; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Leung CO-N, 2016, ONCOTARGET; Liu CG, 2016, HEPATOLOGY, V64, P117, DOI 10.1002/hep.28509; Liu ZL, 2015, MOL ENDOCRINOL, V29, P1006, DOI 10.1210/me.2015-1103; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Luanpitpong S, 2016, ONCOGENE, V35, P2824, DOI 10.1038/onc.2015.351; Matsushima H, 2015, DIGEST LIVER DIS, V47, P1067, DOI 10.1016/j.dld.2015.08.003; Merle P, 2005, J HEPATOL, V43, P854, DOI 10.1016/j.jhep.2005.05.018; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Raspaglio G, 2014, GENE, V542, P173, DOI 10.1016/j.gene.2014.03.037; Santos JC, 2016, CANCER RES, V76, P6735, DOI 10.1158/0008-5472.CAN-16-1120; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Schwarzenbacher D, 2015, ONCOTARGET, V6, P11191, DOI 10.18632/oncotarget.3586; Sobin L, 2009, TNM CLASSIFICATION M; Stotz M, 2015, ANTICANCER RES, V35, P5737; Sun MH, 2012, VIRCHOWS ARCH, V460, P271, DOI 10.1007/s00428-012-1201-7; Szasz AM, 2014, ONCOTARGET; Wang XY, 2015, ONCOL LETT, V10, P990, DOI 10.3892/ol.2015.3303; Xue TC, 2015, DIGEST DIS SCI, V60, P427, DOI 10.1007/s10620-014-3377-y; Zhou CJ, 2011, DIAGN CYTOPATHOL, V39, P105, DOI 10.1002/dc.21348; Zhou CH, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-18	41	40	43	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187814	10.1371/journal.pone.0187814	http://dx.doi.org/10.1371/journal.pone.0187814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121666	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900080
J	Yang, ZY; Jia, MM; Liu, GJ; Hao, HN; Chen, L; Li, GH; Liu, SX; Li, YW; Wu, CI; Lu, XM; Wang, SD				Yang, Zuyu; Jia, Mingming; Liu, Guojing; Hao, Huaining; Chen, Li; Li, Guanghao; Liu, Sixue; Li, Yawei; Wu, Chung-I; Lu, Xuemei; Wang, Shengdian			Genomic sequencing identifies a few mutations driving the independent origin of primary liver tumors in a chronic hepatitis murine model	PLOS ONE			English	Article							MYELOID-LEUKEMIA GENOME; HEPATOCELLULAR-CARCINOMA; COPY-NUMBER; SOMATIC MUTATIONS; CLONAL EVOLUTION; TRANSGENIC MICE; CANCER; GENES; EXPRESSION; MEDULLOBLASTOMA	With the development of high-throughput genomic analysis, sequencing a mouse primary cancer model provides a new opportunity to understand fundamental mechanisms of tumorigenesis and progression. Here, we characterized the genomic variations in a hepatitis related primary hepatocellular carcinoma (HCC) mouse model. A total of 12 tumor sections and four adjacent non-tumor tissues from four mice were used for whole exome and/or whole genome sequencing and validation of genotyping. The functions of the mutated genes in tumorigenesis were studied by analyzing their mutation frequency and expression in clinical HCC samples. A total of 46 single nucleotide variations (SNVs) were detected within coding regions. All SNVs were only validated in the sequencing samples, except the Hras mutation, which was shared by three tumors in the M1 mouse. However, the mutated allele frequency varied from high (0.4) to low (0.1), and low frequency (0.1-0.2) mutations existed in almost every tumor. Together with a diploid karyotype and an equal distribution pattern of these SNVs within the tumor, these results suggest the existence of subclones within tumors. A total of 26 mutated genes were mapped to 17 terms describing different molecular and cellular functions. All 41 human homologs of the mutated genes were mutated in the clinical samples, and some mutations were associated with clinical outcomes, suggesting a high probability of cancer driver genes in the spontaneous tumors of the mouse model. Genomic sequencing shows that a few mutations can drive the independent origin of primary liver tumors and reveals high heterogeneity among tumors in the early stage of hepatitis-related primary hepatocellular carcinoma.	[Yang, Zuyu; Liu, Guojing; Hao, Huaining; Li, Guanghao; Liu, Sixue; Li, Yawei; Wu, Chung-I; Lu, Xuemei] Chinese Acad Sci, Beijing Inst Genom, China Gastrointestinal Canc Res Ctr, CAS Key Lab Genom & Precis Med, Beijing, Peoples R China; [Jia, Mingming; Chen, Li; Wang, Shengdian] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing, Peoples R China; [Jia, Mingming; Chen, Li; Wang, Shengdian] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wu, Chung-I] Sun Yat Sen Univ, Coll Ecol & Evolut, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Wu, Chung-I] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sun Yat Sen University; University of Chicago	Lu, XM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, China Gastrointestinal Canc Res Ctr, CAS Key Lab Genom & Precis Med, Beijing, Peoples R China.; Wang, SD (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing, Peoples R China.; Wang, SD (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	luxm@big.ac.cn; sdwang@moon.ibp.ac.cn	Li, Yawei/AAT-8732-2021	Li, Yawei/0000-0001-9699-5118; yang, zuyu/0000-0002-0651-848X	National Science Foundation of China [91231204, 31301036, 912311022]; National Key Basic Research Program of China [2014C6542006]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Science Foundation of China (http://www.nsfc.gov.cni) (91231204 to S.W., and 31301036, 912311022 to Z.Y.) and the National Key Basic Research Program of China (Grant No. 2014C6542006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cheon DJ, 2011, ANNU REV PATHOL-MECH, V6, P95, DOI 10.1146/annurev.pathol.3.121806.154244; CHISARI FV, 1986, J VIROL, V60, P880, DOI 10.1128/JVI.60.3.880-887.1986; Choi YJ, 2014, PATHOL ONCOL RES, V20, P517, DOI 10.1007/s12253-013-9722-1; Cleary SP, 2013, HEPATOLOGY, V58, P1693, DOI 10.1002/hep.26540; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Herceg Z, 2011, MUTAT RES-REV MUTAT, V727, P55, DOI 10.1016/j.mrrev.2011.04.001; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Jhunjhunwala S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0436-9; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Ling SP, 2015, P NATL ACAD SCI USA, V112, pE6496, DOI 10.1073/pnas.1519556112; Lu JG, 2015, MOL MED REP, V12, P4678, DOI 10.3892/mmr.2015.3952; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nault JC, 2014, BEST PRACT RES CL GA, V28, P937, DOI 10.1016/j.bpg.2014.08.006; Ni SB, 2013, CANCER SCI, V104, P817, DOI 10.1111/cas.12157; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; NIKZAINAL S, 2012, CELL, V149; Noda T, 2012, LIVER INT, V32, P110, DOI 10.1111/j.1478-3231.2011.02619.x; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Schulze Kornelius N J-C, 2016, J HEPATOLOGY; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; Tao Yong H Z, 2015, FURTHER GENETIC DIVE; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Wang J, 2010, J IMMUNOL, V185, P7654, DOI 10.4049/jimmunol.1000927; Wartman LD, 2011, J CLIN INVEST, V121, P1445, DOI 10.1172/JCI45284; Weinberg RA, 2007, BIOL CANC; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Xue RD, 2016, GASTROENTEROLOGY, V150, P998, DOI 10.1053/j.gastro.2015.12.033	50	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187551	10.1371/journal.pone.0187551	http://dx.doi.org/10.1371/journal.pone.0187551			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117265	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600045
J	Zammit, AR; Ezzati, A; Katz, MJ; Zimmerman, ME; Lipton, ML; Sliwinski, MJ; Lipton, RB				Zammit, Andrea R.; Ezzati, Ali; Katz, Mindy J.; Zimmerman, Molly E.; Lipton, Michael L.; Sliwinski, Martin J.; Lipton, Richard B.			The association of visual memory with hippocampal volume	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; TEMPORAL-LOBE EPILEPSY; COMPLEX FIGURE TEST; ALZHEIMERS-DISEASE; SPATIAL MEMORY; OLDER-ADULTS; EPISODIC MEMORY; OBJECT-LOCATION; STRUCTURAL MRI; DEMENTIA	Background In this study we investigated the role of hippocampal volume (HV) in visual memory. Methods Participants were a subsample of older adults (> = 70 years) from the Einstein Aging Study. Visual performance was measured using the Complex Figure (CF) copy and delayed recall tasks from the Repeatable Battery for the Assessment of Neuropsychological Status. Linear regressions were fitted to study associations between HV and visual tasks. Results Participants' (n = 113, mean age = 78.9 years) average scores on the CF copy and delayed recall were 17.4 and 11.6, respectively. CF delayed recall was associated with total (beta = .031, p = 0.001) and left (beta = 0.031, p = 0.001) and right HVs (beta =0.24, p = 0.012). CF delayed recall remained significantly associated with left HV even after we also included right HV (beta = 0.27, p = 0.025) and the CF copy task (beta = 0.30, p = 0.009) in the model. CF copy did not show any significant associations with HV. Conclusion Our results suggest that left HV contributes in retrieval of visual memory in older adults.	[Zammit, Andrea R.; Katz, Mindy J.; Zimmerman, Molly E.; Lipton, Richard B.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Zammit, Andrea R.; Ezzati, Ali; Katz, Mindy J.; Zimmerman, Molly E.; Lipton, Michael L.; Sliwinski, Martin J.; Lipton, Richard B.] Albert Einstein Coll Med, Einstein Aging Study, Bronx, NY 10467 USA; [Ezzati, Ali] Montefiore Med Ctr, Dept Neurol, 111 E 210th St, Bronx, NY 10467 USA; [Zimmerman, Molly E.] Fordham Univ, Dept Psychol, Bronx, NY 10458 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Behav Sci, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Lipton, Michael L.] Montefiore Med Ctr, Dept Radiol, 111 E 210th St, Bronx, NY 10467 USA; [Sliwinski, Martin J.] Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA; [Lipton, Richard B.] Yeshiva Univ, Dept Epidemiol & Populat Hlth, Albert Einstein Coll Med, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Fordham University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Yeshiva University; Albert Einstein College of Medicine	Zammit, AR (corresponding author), Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA.; Zammit, AR (corresponding author), Albert Einstein Coll Med, Einstein Aging Study, Bronx, NY 10467 USA.	andrea.zammit@einstein.yu.edu	Ezzati, Ali/H-7600-2019; Lipton, Richard B/B-5060-2011; Lipton, Richard Bruce/AAY-2818-2021; Sliwinski, Martin/HGC-5907-2022	Zammit, Andrea/0000-0002-2749-1239; Ezzati, Ali/0000-0003-1307-4589	National Institute On Aging of the National Institutes of Health [K01AG054700]; Einstein Aging Study from the National Institutes on Aging program [P01 AG03949]; National Institutes of Health CTSA from the National Center for Advancing Translational Sciences (NCATS) [1UL1TR001073]; Sylvia and Leonard Marx Foundation; Czap Foundation; NATIONAL INSTITUTE ON AGING [K01AG054700] Funding Source: NIH RePORTER	National Institute On Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Einstein Aging Study from the National Institutes on Aging program; National Institutes of Health CTSA from the National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Sylvia and Leonard Marx Foundation; Czap Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute On Aging of the National Institutes of Health under Award Number K01AG054700; by the Einstein Aging Study (P01 AG03949) from the National Institutes on Aging program; the National Institutes of Health CTSA (1UL1TR001073) from the National Center for Advancing Translational Sciences (NCATS), the Sylvia and Leonard Marx Foundation, and the Czap Foundation. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, NEUROLOGY, V44, pA141; Battery AIT, 1944, MANUAL DIRECTIONS SC; Bonner-Jackson A, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0147-9; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cruz-Gomez AJ, 2016, REV NEUROLOGIA, V62, P6, DOI 10.33588/rn.6201.2015216; de Toledo-Morrell L, 2000, HIPPOCAMPUS, V10, P136, DOI 10.1002/(SICI)1098-1063(2000)10:2<136::AID-HIPO2>3.0.CO;2-J; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; England HB, 2014, ARCH CLIN NEUROPSYCH, V29, P322, DOI 10.1093/arclin/acu012; ESLINGER PJ, 1985, JAMA-J AM MED ASSOC, V253, P670, DOI 10.1001/jama.253.5.670; Ezzati A., 2015, BRAIN IMAGING BEHAV; Ezzati A, 2016, NEUROPSYCHOLOGIA, V93, P380, DOI 10.1016/j.neuropsychologia.2016.08.016; Ezzati A, 2014, BRAIN RES, V1573, P54, DOI 10.1016/j.brainres.2014.05.025; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Hagemeier J, 2016, PSYCHIAT RES-NEUROIM, V255, P87, DOI 10.1016/j.pscychresns.2016.08.003; Hayes SM, 2004, BEHAV NEUROSCI, V118, P885, DOI 10.1037/0735-7044.118.5.885; Johnson DK, 2009, ARCH NEUROL-CHICAGO, V66, P1254, DOI 10.1001/archneurol.2009.158; Kasai M, 2006, PSYCHIAT CLIN NEUROS, V60, P139, DOI 10.1111/j.1440-1819.2006.01478.x; Katz MJ, 2012, ALZ DIS ASSOC DIS, V26, P335, DOI 10.1097/WAD.0b013e31823dbcfc; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Kawas CH, 2003, NEUROLOGY, V60, P1089, DOI 10.1212/01.WNL.0000055813.36504.BF; Kessels RPC, 2010, J INT NEUROPSYCH SOC, V16, P200, DOI 10.1017/S1355617709990944; Kohler S, 1998, NEUROPSYCHOLOGIA, V36, P901, DOI 10.1016/S0028-3932(98)00017-7; Kohler S, 1998, NEUROPSYCHOLOGIA, V36, P129, DOI 10.1016/S0028-3932(97)00098-5; Kramer JH, 2007, NEUROPSYCHOLOGY, V21, P412, DOI 10.1037/0894-4105.21.4.412; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; McConley R, 2008, EPILEPSY BEHAV, V13, P174, DOI 10.1016/j.yebeh.2008.03.003; Mecklinger A, 1998, MEM COGNITION, V26, P1068, DOI 10.3758/BF03201184; Nedelska Z, 2012, P NATL ACAD SCI USA, V109, P2590, DOI 10.1073/pnas.1121588109; Nemmi F, 2013, NEUROPSYCHOLOGIA, V51, P1561, DOI 10.1016/j.neuropsychologia.2013.03.031; Persson J, 2013, BEHAV BRAIN RES, V256, P219, DOI 10.1016/j.bbr.2013.07.050; Randolph C., 1998, REPEATABLE BATTERY A; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Siedlecki KL, 2014, PSYCHON B REV, V21, P721, DOI 10.3758/s13423-013-0523-z; Tales A, 2005, NEUROCASE, V11, P85, DOI 10.1080/13554790490896983; Travis SG, 2014, NEUROPSYCHOLOGIA, V53, P233, DOI 10.1016/j.neuropsychologia.2013.11.016; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1997, ADULT INTELLIGENCE S, V21; Wisniewski I, 2012, EPILEPSY BEHAV, V23, P254, DOI 10.1016/j.yebeh.2011.12.006; Witt JA, 2014, HIPPOCAMPUS, V24, P446, DOI 10.1002/hipo.22238; Zelinski EM, 2003, PSYCHOL AGING, V18, P727, DOI 10.1037/0882-7974.18.4.727; ZONDERMAN AB, 1995, ARCH CLIN NEUROPSYCH, V10, P111, DOI 10.1016/0887-6177(94)00040-9	45	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187851	10.1371/journal.pone.0187851	http://dx.doi.org/10.1371/journal.pone.0187851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM0ME	29117260	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600082
J	Law, BA; Liao, XH; Moore, KS; Southard, A; Roddy, P; Ji, RP; Szulc, Z; Bielawska, A; Schulze, PC; Cowart, LA				Law, Brittany A.; Liao, Xianghai; Moore, Kelsey S.; Southard, Abigail; Roddy, Patrick; Ji, Ruiping; Szulc, Zdzislaw; Bielawska, Ala; Schulze, P. Christian; Cowart, L. Ashley			Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes	FASEB JOURNAL			English	Article						mitophagy; sphingolipid; diabetic cardiomyopathy; cardiovascular disease	IDIOPATHIC DILATED CARDIOMYOPATHY; RADIATION-INDUCED APOPTOSIS; HEART-FAILURE SUBSEQUENT; INSULIN-RESISTANCE; DIABETIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; HEMODYNAMIC STRESS; RESPIRATORY-CHAIN; SYNTHASE ACTIVITY; MOUSE MODEL	Accumulating data support a role for bioactive lipids as mediators of lipotixicity in cardiomyocytes. One class of these, the ceramides, constitutes a family of molecules that differ in structure and are synthesized by distinct enzymes, ceramide synthase(CerS) 1-CerS6. Data support that specific ceramides and the enzymes that catalyze their formation play distinct roles in cell function. In a mouse model of diabetic cardiomyopathy, sphingolipid profiling revealed increases in not only the CerS5-derived ceramides but also in very long chain (VLC) ceramides derived from CerS2. Overexpression of CerS2 elevated VLC ceramides caused insulin resistance, oxidative stress, mitochondrial dysfunction, and mitophagy. Palmitate induced CerS2 and oxidative stress, mitophagy, and apoptosis, which were prevented by depletion of CerS2. Neither overexpression nor knockdown of CerS5 had any function in these processes, suggesting a chain-length dependent impact of ceramides on mitochondrial function. This concept was also supported by the observation that synthetic mitochondria-targeted ceramides led to mitophagy in a manner proportional to N-acyl chain length. Finally, blocking mitophagy exacerbated cell death. Taken together, our results support a model by which CerS2 and VLC ceramides have a distinct role in lipotoxicity, leading to mitochondrial damage, which results in subsequent adaptive mitophagy. Our data reveal a novel lipotoxic pathway through CerS2.	[Law, Brittany A.] Duke Univ, Med Ctr, Dept Med Cardiol, Durham, NC USA; [Liao, Xianghai; Ji, Ruiping; Schulze, P. Christian] Columbia Univ, Dept Med, Med Ctr, Div Cardiol, New York, NY USA; [Moore, Kelsey S.; Southard, Abigail; Roddy, Patrick; Szulc, Zdzislaw; Bielawska, Ala; Cowart, L. Ashley] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Schulze, P. Christian] Univ Jena, Friedrich Schiller Univ Jena, Div Cardiol Angiol Pneumol & Intens Med Care, Dept Internal Med 1, Jena, Germany; [Cowart, L. Ashley] Dept Vet Affairs, Charleston, SC USA	Duke University; Columbia University; Medical University of South Carolina; Friedrich Schiller University of Jena	Cowart, LA (corresponding author), MUSC, 173 Ashley Ave,Room BSB 512E, Charleston, SC 29425 USA.	lauren.cowart@vcuhealth.org	Schulze, Christian/AGJ-7744-2022	Schulze, Christian/0000-0001-9442-7141; Elliott, Brittany/0000-0001-5907-1231	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [1R01HL117233]; U.S. Department of Veteran's Affairs; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117233] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000200] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Department of Veteran's Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grant 1R01HL117233), the U.S. Department of Veteran's Affairs, and the American Heart Association. The authors declare no conflicts of interest.	Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Banerjee D, 2013, CIRC-HEART FAIL, V6, P364, DOI 10.1161/CIRCHEARTFAILURE.112.000022; Basu R, 2009, AM J PHYSIOL-HEART C, V297, pH2096, DOI 10.1152/ajpheart.00452.2009; BELCH JJF, 1991, BRIT HEART J, V65, P245; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Campolo J, 2007, J CARDIOVASC MED, V8, P1024, DOI 10.2459/JCM.0b013e3281053a63; Canton M, 2011, J AM COLL CARDIOL, V57, P300, DOI 10.1016/j.jacc.2010.06.058; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Chokshi A, 2012, CIRCULATION, V125, P2844, DOI 10.1161/CIRCULATIONAHA.111.060889; COUGHLIN SS, 1994, EPIDEMIOLOGY, V5, P449, DOI 10.1097/00001648-199407000-00012; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Di Paola M, 2004, J BIOENERG BIOMEMBR, V36, P165, DOI 10.1023/B:JOBB.0000023619.97392.0c; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; FranceLanord V, 1997, J NEUROCHEM, V69, P1612; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hartmann D, 2012, INT J BIOCHEM CELL B, V44, P620, DOI 10.1016/j.biocel.2011.12.019; Hill MF, 1996, AM J PATHOL, V148, P291; Hill MF, 1997, CIRCULATION, V96, P2414; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308; Jaishy B, 2015, J LIPID RES, V56, P546, DOI 10.1194/jlr.M055152; Kim HJ, 2012, J LIPID RES, V53, P1701, DOI 10.1194/jlr.D025627; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; KUO TH, 1983, DIABETES, V32, P781, DOI 10.2337/diabetes.32.9.781; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liu L, 2009, J BIOL CHEM, V284, P36312, DOI 10.1074/jbc.M109.049817; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Miyata S, 2006, AM J PATHOL, V168, P386, DOI 10.2353/ajpath.2006.050137; Muriel MP, 2000, J COMP NEUROL, V426, P297, DOI 10.1002/1096-9861(20001016)426:2<297::AID-CNE10>3.0.CO;2-O; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Narula J, 2000, CURR OPIN CARDIOL, V15, P183, DOI 10.1097/00001573-200005000-00011; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Novgorodov SA, 2016, J LIPID RES, V57, P546, DOI 10.1194/jlr.M060061; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Russell LK, 2005, J MOL CELL CARDIOL, V38, P81, DOI 10.1016/j.yjmcc.2004.10.010; Russo SB, 2013, J BIOL CHEM, V288, P13397, DOI 10.1074/jbc.M112.428185; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shimomura H, 2001, JPN CIRC J, V65, P965, DOI 10.1253/jcj.65.965; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Stratford S, 2001, BIOCHEM J, V354, P359, DOI 10.1042/0264-6021:3540359; Szulc ZM, 2008, BIOORGAN MED CHEM, V16, P1015, DOI 10.1016/j.bmc.2007.08.033; Szulc ZM, 2006, BIOORGAN MED CHEM, V14, P7083, DOI 10.1016/j.bmc.2006.07.016; Watanabe E, 2006, J CARD FAIL, V12, P527, DOI 10.1016/j.cardfail.2006.05.011; Watanabe T, 2014, EXP CELL RES, V323, P314, DOI 10.1016/j.yexcr.2014.02.027; Westermeier F, 2015, BBA-MOL CELL RES, V1853, P1113, DOI 10.1016/j.bbamcr.2015.02.005; Witteles RM, 2004, J AM COLL CARDIOL, V44, P78, DOI 10.1016/j.jacc.2004.03.037; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Yamamoto S, 2000, J MOL CELL CARDIOL, V32, P161, DOI 10.1006/jmcc.1999.1064; Yaoita H, 2008, HEART FAIL REV, V13, P181, DOI 10.1007/s10741-007-9074-6; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	71	99	105	4	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1403	1416		10.1096/fj.201700300R	http://dx.doi.org/10.1096/fj.201700300R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127192	Green Published			2022-12-26	WOS:000427246000023
J	Senechal, F; Habrylo, O; Hocq, L; Domon, JM; Marcelo, P; Lefebvre, V; Pelloux, J; Mercadante, D				Senechal, Fabien; Habrylo, Olivier; Hocq, Ludivine; Domon, Jean-Marc; Marcelo, Paulo; Lefebvre, Valerie; Pelloux, Jerome; Mercadante, Davide			Structural and dynamical characterization of the pH-dependence of the pectin methylesterase-pectin methylesterase inhibitor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pH regulation; protein-protein interaction; plant biochemistry; molecular dynamics; molecular modeling; plant cell wall; plant physiology	PLANT-CELL-WALL; IMAGE-ANALYSIS; ARABIDOPSIS-THALIANA; MOLECULAR-DYNAMICS; METHYL ESTERASE; PROTEIN; EXPRESSION; METHYLESTERIFICATION; INVERTASE; INSIGHTS	Pectin methylesterases (PMEs) catalyze the demethylesterification of pectin, one of the main polysaccharides in the plant cell wall, and are of critical importance in plant development. PME activity generates highly negatively charged pectin and mutates the physiochemical properties of the plant cell wall such that remodeling of the plant cell can occur. PMEs are therefore tightly regulated by proteinaceous inhibitors (PMEIs), some of which become active upon changes in cellular pH. Nevertheless, a detailed picture of how this pH-dependent inhibition of PME occurs at the molecular level is missing. Herein, using an interdisciplinary approach that included homology modeling, MD simulations, and biophysical and biochemical characterizations, we investigated the molecular basis of PME3 inhibition by PMEI7 in Arabidopsis thaliana. Our complementary approach uncovered how changes in the protonation of amino acids at the complex interface shift the network of interacting residues between intermolecular and intramolecular. These shifts ultimately regulate the stability of the PME3-PMEI7 complex and the inhibition of the PME as a function of the pH. These findings suggest a general model of how pH-dependent proteinaceous inhibitors function. Moreover, they enhance our understanding of how PMEs may be regulated by pH and provide new insights into how this regulation may control the physical properties and structure of the plant cell wall.	[Senechal, Fabien; Habrylo, Olivier; Hocq, Ludivine; Domon, Jean-Marc; Lefebvre, Valerie; Pelloux, Jerome] Univ Picardie, BIOPI Biol Plantes & Innovat EA3900, SFR Condorcet FR CNRS 3417, 33 Rue St Leu, F-80039 Amiens, France; [Marcelo, Paulo] Univ Picardie Jules Verne, Plateforme ICAP, Ctr Univ Rech Sante, F-80054 Amiens, France; [Mercadante, Davide] Heidelberg HITS, Heidelberg Inst Theoret Studies, D-16920 Heidelberg, Germany; [Mercadante, Davide] Heidelberg Univ, IWR Interdisciplinary Ctr Sci Comp, D-69120 Heidelberg, Germany	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Heidelberg Institute for Theoretical Studies; Ruprecht Karls University Heidelberg	Pelloux, J (corresponding author), Univ Picardie, BIOPI Biol Plantes & Innovat EA3900, SFR Condorcet FR CNRS 3417, 33 Rue St Leu, F-80039 Amiens, France.; Mercadante, D (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jerome.pelloux@u-picardie.fr; d.mercadante@bioc.uzh.ch	Sénéchal, Fabien/AAR-8411-2021	Pelloux, Jerome/0000-0002-9371-1711; Mercadante, Davide/0000-0001-6792-7706; Fabien, Senechal/0000-0002-4145-7205; Marcelo, Paulo/0000-0002-2586-8119	Agence Nationale de la Recherche [ANR-12-BSV5-0001 GALAPAGOS, ANR-14-CE34-0010-03 PECTOSIGN]; Conseil Regional de Picardie; Institut Universitaire de France	Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil Regional de Picardie(Region Hauts-de-France); Institut Universitaire de France	This work was supported by Agence Nationale de la Recherche Projects ANR-12-BSV5-0001 GALAPAGOS and ANR-14-CE34-0010-03 PECTOSIGN and by grants from the Conseil Regional de Picardie (to F. S.) and the Institut Universitaire de France (to J. P.). The authors declare that they have no conflicts of interest with the contents of this article.	AMREIN KE, 1993, P NATL ACAD SCI USA, V90, P10285, DOI 10.1073/pnas.90.21.10285; Anderson CT, 2016, J EXP BOT, V67, P495, DOI 10.1093/jxb/erv501; Andre T., 2013, DNA DNA INTERACTION; Baldwin L, 2014, PHYTOCHEMISTRY, V104, P37, DOI 10.1016/j.phytochem.2014.04.011; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bonavita A, 2016, J AGR FOOD CHEM, V64, P5866, DOI 10.1021/acs.jafc.6b01718; Bourgault R, 2002, ANAL BIOCHEM, V300, P87, DOI 10.1006/abio.2001.5450; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Degraeve P, 2003, J FOOD SCI, V68, P716, DOI 10.1111/j.1365-2621.2003.tb05738.x; Demir N, 2001, J FOOD ENG, V47, P275, DOI 10.1016/S0260-8774(00)00127-8; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Fries M, 2007, EMBO J, V26, P3879, DOI 10.1038/sj.emboj.7601816; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Griesbach J., 2013, PROTEIN SMALL MOL IN; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; Hamann T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00077; Hocq L, 2017, PLANT PHYSIOL, V173, P1075, DOI 10.1104/pp.16.01790; Hothorn M, 2004, PLANT CELL, V16, P3437, DOI 10.1105/tpc.104.025684; Hothorn M, 2010, P NATL ACAD SCI USA, V107, P17427, DOI 10.1073/pnas.1004481107; Houston K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00984; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jayani RS, 2005, PROCESS BIOCHEM, V40, P2931, DOI 10.1016/j.procbio.2005.03.026; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Johansson K, 2002, FEBS LETT, V514, P243, DOI 10.1016/S0014-5793(02)02372-4; Kashyap DR, 2001, BIORESOURCE TECHNOL, V77, P215, DOI 10.1016/S0960-8524(00)00118-8; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Levesque-Tremblay G, 2015, PLANTA, V242, P791, DOI 10.1007/s00425-015-2358-5; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Louvet R, 2006, PLANTA, V224, P782, DOI 10.1007/s00425-006-0261-9; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pelletier S, 2010, NEW PHYTOL, V188, P726, DOI 10.1111/j.1469-8137.2010.03409.x; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pilling J, 2000, PLANTA, V210, P391, DOI 10.1007/PL00008147; Ren CW, 2000, PLANT PHYSIOL, V124, P231, DOI 10.1104/pp.124.1.231; Routledge KE, 2009, J MOL BIOL, V389, P776, DOI 10.1016/j.jmb.2009.04.042; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scognamiglio MA, 2003, J PROTEIN CHEM, V22, P363, DOI 10.1023/A:1025342207831; Senechal F, 2015, J BIOL CHEM, V290, P23320, DOI 10.1074/jbc.M115.639534; Senechal F, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.983351; Senechal F, 2014, J EXP BOT, V65, P5125, DOI 10.1093/jxb/eru272; Sexton TR, 2012, PLANT PHYSIOL, V158, P531, DOI 10.1104/pp.111.181602; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Sun CL, 2016, J EXP BOT, V67, P979, DOI 10.1093/jxb/erv514; Tucker MR, 2014, CURR OPIN PLANT BIOL, V17, P137, DOI 10.1016/j.pbi.2013.11.015; Weber M, 2013, PLANT J, V76, P151, DOI 10.1111/tpj.12279; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Zhao CZ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0582-6	55	7	8	3	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21538	21547		10.1074/jbc.RA117.000197	http://dx.doi.org/10.1074/jbc.RA117.000197			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29109147	Green Published, hybrid			2022-12-26	WOS:000419013000028
J	Liu, S; Waqas, MA; Wang, SH; Xiong, XY; Wan, YF				Liu, Shuo; Waqas, Muhammad Ahmed; Wang, Song-he; Xiong, Xiang-yang; Wan, Yun-fan			Effects of increased levels of atmospheric CO2 and high temperatures on rice growth and quality	PLOS ONE			English	Article								The increased atmospheric temperatures resulting from the increased concentration of atmospheric carbon dioxide (CO2) have had a profound influence on global rice production. China serves as an important area for producing and consuming rice. Therefore, exploring the effects of the simultaneously rising levels of atmospheric CO2 and temperatures on rice growth and quality in the future is very important. The present study was designed to measure the most important aspects of variation for rice-related physiological, ecological and quality indices in different growing periods under a simultaneous increase of CO2 and temperature, through simulation experiments in climate-controlled growth chambers, with southern rice as the study object. The results indicated that the ecological indices, rice phenology, and leaf area would decrease under a simultaneous increase of CO2 and temperature. For the physiological indices, Malondialdehyde (MDA) levels increased significantly in the seedling period. However, it showed the trend of increase and subsequent decrease in the heading and filling periods. In addition, the decomposition of soluble protein (SP) and soluble sugar (SS) accelerated in filling period. The rice quality index of the Head Rice Rate showed the decreasing trend and subsequent increase, but the Chalky Rice Rate and Protein Content indices gradually decreased while the Gel Consistency gradually increased.	[Liu, Shuo; Waqas, Muhammad Ahmed; Wan, Yun-fan] Chinese Acad Agr Sci, Key Lab Agr Environm, Inst Environm & Sustainable Dev Agr, Beijing, Peoples R China; [Wang, Song-he; Xiong, Xiang-yang] Yangtze Univ, Dept Agr, Jingzhou, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Yangtze University	Liu, S (corresponding author), Chinese Acad Agr Sci, Key Lab Agr Environm, Inst Environm & Sustainable Dev Agr, Beijing, Peoples R China.	liushuo@caas.cn			Special funds for basic research and operation expenses of central level public welfare research institutes [BSRF201501, BSRF201713]; National Key Research and Development Program [2017YFD0300400]	Special funds for basic research and operation expenses of central level public welfare research institutes; National Key Research and Development Program	The study is funded by the project of "Special funds for basic research and operation expenses of central level public welfare research institutes (BSRF201501)", "Special funds for basic research and operation expenses of central level public welfare research institutes (BSRF201713)" and "National Key Research and Development Program (2017YFD0300400)". There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], THESIS; [包云轩 Bao Yunxuan], 2012, [中国农业气象, Chinese Journal of Agrometeorology], V33, P289; [蔡威威 Cai Weiwei], 2015, [中国农业气象, Chinese Journal of Agrometeorology], V36, P717; Chen N., 2012, THESIS; El-Sharkawy MA, 2014, PHOTOSYNTHETICA, V52, P161, DOI 10.1007/s11099-014-0028-7; HE S., 2014, THESIS; Ko JongHan, 2014, Journal of Crop Science and Biotechnology, V17, P117, DOI 10.1007/s12892-013-0110-x; Lai Shang-kun, 2015, Shengtaixue Zazhi, V34, P1253; Lee KyuJong, 2014, Journal of Crop Science and Biotechnology, V17, P53, DOI 10.1007/s12892-014-0032-2; Li HS, 2007, BIOCH EXPT PRINCIPLE; [李健陵 Li JianLing], 2013, [中国农业气象, Chinese Journal of Agrometeorology], V34, P23; Li WC, 2013, RELATIONSHIPS PHYSL, V29, P5; [李中阳 Li Zhongyang], 2013, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V19, P20; Liu HZ, 2006, FUJIAN J AGR SCI, V21, P168; Liu J. Y., 2010, THESIS; [刘书仁 LIU Shuren], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P127; [刘媛媛 LIU Yuanyuan], 2008, [西南大学学报. 自然科学版, Journal of Southwest University. Natural Science Edition], V30, P59; [刘玉洁 Liu Yujie], 2013, [地理科学进展, Progress in Geography], V32, P416; Ma TC, 2015, CHINESE AGR SCI B, V31, P25; Melloy P, 2014, EUR J PLANT PATHOL, V140, P19, DOI 10.1007/s10658-014-0441-6; Na HY, 2008, THESIS; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Solomon S., 2007, ANTARCT RES SER, V9, P123; Sun CM., 2009, ENV SUSTAIN DEV, V34, P45; Wang H., 2014, THESIS; Wang Hongmei, 2008, Chinese Journal of Applied and Environmental Biology, V14, P757, DOI 10.3724/SP.J.1145.2008.00757; [王连喜 Wang Lianxi], 2014, [中国农业气象, Chinese Journal of Agrometeorology], V35, P206; [谢立勇 XIE Liyong], 2009, [东北农业大学学报, Journal of Northeast Agricultural University], V40, P1; [谢晓金 Xie Xiaojin], 2012, [中国农业气象, Chinese Journal of Agrometeorology], V33, P457; [张立极 Zhang Liji], 2015, [土壤, Soils], V47, P26; [赵贵林 ZHAO Guilin], 2011, [干旱地区农业研究, Agricultural Research in the Arid Areas], V29, P80	31	17	18	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187724	10.1371/journal.pone.0187724	http://dx.doi.org/10.1371/journal.pone.0187724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145420	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800027
J	Eberhardt, M; Stueber, T; de la Roche, J; Herzog, C; Leffler, A; Reeh, PW; Kistner, K				Eberhardt, Mirjam; Stueber, Thomas; de la Roche, Jeanne; Herzog, Christine; Leffler, Andreas; Reeh, Peter W.; Kistner, Katrin			TRPA1 and TRPV1 are required for lidocaine-evoked calcium influx and neuropeptide release but not cytotoxicity in mouse sensory neurons	PLOS ONE			English	Article							HYPERBARIC 5-PERCENT LIDOCAINE; TRANSIENT NEUROLOGIC TOXICITY; LOCAL-ANESTHETICS; IN-VITRO; NEUROGENIC INFLAMMATION; SUBARACHNOID ANESTHESIA; MECHANISMS; NERVE; PAIN; ACTIVATION	Background Local anaesthetics (LA) reduce neuronal excitability by inhibiting voltage-gated Na+ channels. When applied at high concentrations in the direct vicinity of nerves, LAs can also induce relevant irritation and neurotoxicity via mechanisms involving an increase of intracellular Ca2+. In the present study we explored the role of the Ca2+-permeable ion channels TRPA1 and TRPV1 for lidocaine-induced Ca2+-influx, neuropeptide release and neurotoxicity in mouse sensory neurons. Methods Cultured dorsal root ganglion (DRG) neurons from wildtype and mutant mice lacking TRPV1, TRPA1 or both channels were explored by means of calcium imaging, whole-cell patch clamp recordings and trypan blue staining for cell death. Release of calcitonin gene-related peptide (CGRP) from isolated mouse peripheral nerves was determined with ELISA. Results Lidocaine up to 10 mM induced a concentration-dependent reversible increase in intracellular Ca2+ in DRG neurons from wildtype and mutant mice lacking one of the two receptors, but not in neurons lacking both TRPA1 and TRPV1. 30 mM lidocaine also released Ca2+ from intracellular stores, presumably from the endoplasmic reticulum. While 10 mM lidocaine evoked an axonal CGRP release requiring expression of either TRPA1 or TRPV1, CGRP release induced by 30 mM lidocaine again mobilized internal Ca2+ stores. Lidocaine-evoked cell death required neither TRPV1 nor TRPA1. Summary Depending on the concentration, lidocaine employs TRPV1, TRPA1 and intracellular Ca2+ stores to induce a Ca2+-dependent release of the neuropeptide CGRP. Lidocaine-evoked cell death does not seem to require Ca2+ influx through TRPV1 or TRPV1.	[Eberhardt, Mirjam; Reeh, Peter W.; Kistner, Katrin] Friedrich Alexander Univ Erlangen Nuernberg, Inst Physiol & Pathophysiol, Erlangen, Germany; [Eberhardt, Mirjam; Stueber, Thomas; de la Roche, Jeanne; Herzog, Christine; Leffler, Andreas] Hannover Med Sch, Dept Anaesthesia & Crit Care Med, Hannover, Germany; [de la Roche, Jeanne] Hannover Med Sch, Inst Neurophysiol, Hannover, Germany	University of Erlangen Nuremberg; Hannover Medical School; Hannover Medical School	Kistner, K (corresponding author), Friedrich Alexander Univ Erlangen Nuernberg, Inst Physiol & Pathophysiol, Erlangen, Germany.	katrin.kistner@physiologie1.med.uni-erlangen.de	Reeh, Peter W./J-8981-2012	Reeh, Peter W./0000-0002-4367-094X	Wilhelm Sander-Stiftung [2014.068.1]	Wilhelm Sander-Stiftung	This work was supported by grant number 2014.068.1, URL www.sanst.de, Wilhelm Sander-Stiftung (P.W.R. K.K.).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN WE, 1993, ANESTH ANALG, V77, P1306, DOI 10.1213/00000539-199312000-00044; Anand P, 2011, BRIT J ANAESTH, V107, P490, DOI 10.1093/bja/aer260; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bird GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-31; Butterworth JF, 2010, REGION ANESTH PAIN M, V35, P167, DOI 10.1097/AAP.0b013e3181d231b9; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; de la Roche J, 2013, J BIOL CHEM, V288, P20280, DOI 10.1074/jbc.M113.479337; Doan LV, 2014, ANESTHESIOLOGY, V120, P50, DOI 10.1097/ALN.0b013e3182a2a561; Docherty RJ, 2013, PAIN, V154, P1569, DOI 10.1016/j.pain.2013.04.030; Geppetti P, 2008, BJU INT, V101, P2, DOI 10.1111/j.1464-410X.2008.07493.x; Gold MS, 1998, J PHARMACOL EXP THER, V285, P413; Hamilton NB, 2016, NATURE, V529, P523, DOI 10.1038/nature16519; Johnson ME, 2004, ANESTHESIOLOGY, V101, P1184, DOI 10.1097/00000542-200411000-00019; Johnson ME, 2002, ANESTHESIOLOGY, V97, P1466, DOI 10.1097/00000542-200212000-00019; Kim SR, 2006, J IMMUNOL, V177, P4322, DOI 10.4049/jimmunol.177.7.4322; Kitagawa N, 2004, ANESTHESIOLOGY, V100, P962, DOI 10.1097/00000542-200404000-00029; LAMBERT LA, 1994, ANESTHESIOLOGY, V80, P1082, DOI 10.1097/00000542-199405000-00017; Leffler A, 2008, J CLIN INVEST, V118, P763, DOI 10.1172/JCI32751; Leffler A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-62; MYERS RR, 1989, ANESTHESIOLOGY, V71, P757, DOI 10.1097/00000542-198911000-00021; Piao LH, 2009, BIOCHEM BIOPH RES CO, V379, P980, DOI 10.1016/j.bbrc.2008.12.183; Pollock JE, 2002, REGION ANESTH PAIN M, V27, P581, DOI 10.1053/rapm.2002.36457; Pollock Julia E, 2003, Best Pract Res Clin Anaesthesiol, V17, P471, DOI 10.1016/S1521-6896(02)00113-1; REEH PW, 1986, BRAIN RES, V384, P42, DOI 10.1016/0006-8993(86)91217-5; RIGLER ML, 1991, ANESTH ANALG, V72, P275; Saghy E, 2016, GLIA, V64, P2166, DOI 10.1002/glia.23051; SAKURA S, 1995, ANESTH ANALG, V81, P338, DOI 10.1097/00000539-199508000-00023; SCHNEIDER MC, 1994, ANESTH ANALG, V79, P610, DOI 10.1213/00000539-199409000-00053; Scholz A, 2002, BRIT J ANAESTH, V89, P52, DOI 10.1093/bja/aef163; Stenger B, 2015, ARCH TOXICOL, V89, P1631, DOI 10.1007/s00204-014-1414-4; Stueber T, 2016, ANESTHESIOLOGY, V124, P1153, DOI 10.1097/ALN.0000000000001050; Tomohiro D, 2013, LIFE SCI, V92, P368, DOI 10.1016/j.lfs.2013.01.011; van der Wal SEI, 2016, EUR J PAIN, V20, P655, DOI 10.1002/ejp.794; Verlinde M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030339; Wehrfritz A, 2011, EUR J PAIN, V15, P907, DOI 10.1016/j.ejpain.2011.03.011; Werdehausen R, 2015, PAIN, V156, P1647, DOI 10.1097/j.pain.0000000000000206; Werdehausen R, 2011, REGION ANESTH PAIN M, V36, P436, DOI 10.1097/AAP.0b013e318226ba62	38	10	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188008	10.1371/journal.pone.0188008	http://dx.doi.org/10.1371/journal.pone.0188008			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141003	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400044
J	Famuyide, AO; Laughlin-Tommaso, SK; Shazly, SA; Long, KH; Breitkopf, DM; Weaver, AL; McGree, ME; El-Nashar, SA; Lemens, MA; Hopkins, MR				Famuyide, Abimbola O.; Laughlin-Tommaso, Shannon K.; Shazly, Sherif A.; Long, Kirsten Hall; Breitkopf, Daniel M.; Weaver, Amy L.; McGree, Michaela E.; El-Nashar, Sherif A.; Lemens, Maureen A.; Hopkins, Matthew R.			Medical therapy versus radiofrequency endometrial ablation in the initial treatment of heavy menstrual bleeding (iTOM Trial): A clinical and economic analysis	PLOS ONE			English	Article							LEVONORGESTREL INTRAUTERINE SYSTEM; THERMAL BALLOON ABLATION; TRANSCERVICAL RESECTION; RANDOMIZED-TRIAL; BLOOD-LOSS; FOLLOW-UP; WOMEN; MANAGEMENT	Background Radiofrequency endometrial ablation (REA) is currently a second line treatment in women with heavy menstrual bleeding (MHB) if medical therapy (MTP) is contraindicated or unsatisfactory. Our objective is to compare the effectiveness and cost burden of MTP and REA in the initial treatment of HMB. Methods We performed a randomized trial at Mayo Clinic Rochester, Minnesota. The planned sample size was 60 patients per arm. A total of 67 women with HMB were randomly allocated to receive oral contraceptive pills (Nordette (R)) or Naproxen (Naprosyn (R)) (n = 33) or REA (n = 34). Primary 12-month outcome measures included menstrual blood loss using pictorial blood loss assessment chart (PBLAC), patients' satisfaction, and Menorrhagia Multi-Attribute Scale (MMAS). Secondary outcomes were total costs including direct medical and indirect costs associated with healthcare use, patient out-of-pocket costs, and lost work days and activity limitations over 12 months. Results Compared to MTP arm, women who received REA had a significantly lower PBLAC score (median [Interquartile range, IQR]: 0 [0-4] vs. 15 [0-131], p = 0.003), higher satisfaction rates (96.8% vs. 63.2%, p = 0.003) and higher MMAS (median [IQR]: 100 [100-100] vs. 100 [87-100], p = 0.12) at 12 months. Direct medical costs were higher for REA ($5,331vs. $2,901, 95% confidence interval (CI) of mean difference:$727,$4,852), however, when indirect costs are included, the difference did not reach statistical significance ($5,469 vs. $3,869, 95% CI of mean difference:-$339, $4,089). Conclusion For women with heavy menstrual bleeding, initial radiofrequency endometrial ablation compared to medical therapy offered superior reduction in menstrual blood loss and improvement in quality of life without significant differences in total costs of care.	[Famuyide, Abimbola O.; Laughlin-Tommaso, Shannon K.; Shazly, Sherif A.; Breitkopf, Daniel M.; Lemens, Maureen A.; Hopkins, Matthew R.] Mayo Clin, Minimally Invas Gynecol Surg, Dept Obstet & Gynecol, Rochester, MN 55905 USA; [Long, Kirsten Hall] K Long Hlth Econ Consulting LLC, St Paul, MN USA; [Weaver, Amy L.; McGree, Michaela E.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [El-Nashar, Sherif A.] Univ Hosp, Div Female Pelv Med & Reconstruct Surg, Cleveland, OH USA	Mayo Clinic; Mayo Clinic; University Hospitals of Cleveland	Famuyide, AO (corresponding author), Mayo Clin, Minimally Invas Gynecol Surg, Dept Obstet & Gynecol, Rochester, MN 55905 USA.	famuyide.abimbola@mayo.edu	Breitkopf, Daniel M./Z-1535-2019; El-Nashar, Sherif/H-3656-2019	Breitkopf, Daniel M./0000-0002-9161-0829; El-Nashar, Sherif/0000-0002-8905-1458; Famuyide, Abimbola/0000-0003-3667-2717	Hologic Inc.	Hologic Inc.	The study was funded by an unrestricted grant from Hologic Inc. Hologic Inc. has supported authors AOF in the form of honoraria for consultancy and speaking engagements. Hologic Inc. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. K. Long Health Economics Consulting LLC is a private consulting firm owned by author KHL, and supported KHL in the form of salary. KHL was involved in data analysis and preparation of the manuscript.	Abbott J, 2003, FERTIL STERIL, V80, P203, DOI 10.1016/S0015-0282(03)00549-1; [Anonymous], 2010, Obstet Gynecol, V115, P206, DOI 10.1097/AOG.0b013e3181cb50b5; [Anonymous], 2007, OBSTET GYNECOL, V109, P1233, DOI DOI 10.1097/01.AOG.0000263898.22544.CD; Barrington JW, 2003, EUR J OBSTET GYN R B, V108, P72, DOI 10.1016/S0301-2115(02)00408-6; Briggs A, 1998, J Health Serv Res Policy, V3, P233; Cooper KG, 1999, BRIT J OBSTET GYNAEC, V106, P258, DOI 10.1111/j.1471-0528.1999.tb08240.x; Cooper KG, 1997, BRIT J OBSTET GYNAEC, V104, P1360, DOI 10.1111/j.1471-0528.1997.tb11004.x; Cooper KG, 1999, LANCET, V354, P1859, DOI 10.1016/S0140-6736(99)04101-X; Cooper KG, 2001, BRIT J OBSTET GYNAEC, V108, P1222, DOI 10.1016/S0306-5456(01)00275-3; Cote I, 2003, AM J OBSTET GYNECOL, V188, P343, DOI 10.1067/mob.2003.92; Cote I, 2002, OBSTET GYNECOL, V100, P683, DOI 10.1016/S0029-7844(02)02094-X; Cravello L, 2004, Gynecol Obstet Fertil, V32, P825, DOI 10.1016/j.gyobfe.2004.08.007; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Duleba AJ, 2003, J AM ASSOC GYN LAP, V10, P17, DOI 10.1016/S1074-3804(05)60229-0; El-Nashar SA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.032; El-Nashar SA, 2009, OBSTET GYNECOL, V113, P97, DOI 10.1097/AOG.0b013e31818f5a8d; ELNASHAR SA, 2015, GYNECOLOGICAL SURG, P1; EPHRON B, 1998, MONOGRAPHS STAT APPL; Famuyide AO, 2014, J MINIM INVAS GYN, V21, P782, DOI 10.1016/j.jmig.2014.03.004; Fraser IS, 2012, CONTRACEPTION, V86, P96, DOI 10.1016/j.contraception.2011.11.011; FRASER IS, 1990, AUST NZ J OBSTET GYN, V30, P353, DOI 10.1111/j.1479-828X.1990.tb02028.x; FRASER IS, 1991, AUST NZ J OBSTET GYN, V31, P66, DOI 10.1111/j.1479-828X.1991.tb02769.x; Gervaise A, 1999, HUM REPROD, V14, P2743, DOI 10.1093/humrep/14.11.2743; HIGHAM JM, 1990, BRIT J OBSTET GYNAEC, V97, P734, DOI 10.1111/j.1471-0528.1990.tb16249.x; Lethaby A, 2008, CYCLICAL PROGESTOGEN; Lethaby A, 2009, ENDOMETRIAL RESECTIO; Miller L, 2001, OBSTET GYNECOL, V98, P771, DOI 10.1016/S0029-7844(01)01555-1; PINION SB, 1994, BRIT MED J, V309, P979, DOI 10.1136/bmj.309.6960.979; Provera DS, 2013, 104 PACKAGE INSERT; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Reid PC, 2005, BJOG-INT J OBSTET GY, V112, P1121, DOI 10.1111/j.1471-0528.2005.00642.x; SHAW RW, 1994, BRIT J OBSTET GYNAEC, V101, P15, DOI 10.1111/j.1471-0528.1994.tb13690.x; Tjarks M, 2000, OBSTET GYNECOL, V96, P886, DOI 10.1016/S0029-7844(00)01059-0; Weber A M, 1998, Medscape Womens Health, V3, P3; Wells GA., 2015, NEWCASTLE OTTAWA SCA	35	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188176	10.1371/journal.pone.0188176	http://dx.doi.org/10.1371/journal.pone.0188176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141040	gold, Green Published, Green Submitted			2022-12-26	WOS:000415260400068
J	Sarnataro, S; Chiariello, AM; Esposito, A; Prisco, A; Nicodemi, M				Sarnataro, Sergio; Chiariello, Andrea M.; Esposito, Andrea; Prisco, Antonella; Nicodemi, Mario			Structure of the human chromosome interaction network	PLOS ONE			English	Article							SPATIAL-ORGANIZATION; GENOME ARCHITECTURE; GENE-EXPRESSION; GRANULAR MEDIA; CONTACT MAPS; CELL-NUCLEUS; 3D GENOME; SEGREGATION; DYNAMICS; DOMAINS	New Hi-C technologies have revealed that chromosomes have a complex network of spatial contacts in the cell nucleus of higher organisms, whose organisation is only partially understood. Here, we investigate the structure of such a network in human GM12878 cells, to derive a large scale picture of nuclear architecture. We find that the intensity of intra-chromosomal interactions is power-law distributed. Inter-chromosomal interactions are two orders of magnitude weaker and exponentially distributed, yet they are not randomly arranged along the genomic sequence. Intra-chromosomal contacts broadly occur between epigenomically homologous regions, whereas inter-chromosomal contacts are especially associated with regions rich in highly expressed genes. Overall, genomic contacts in the nucleus appear to be structured as a network of networks where a set of strongly individual chromosomal units, as envisaged in the 'chromosomal territory' scenario derived from microscopy, interact with each other via on average weaker, yet far from random and functionally important interactions.	[Sarnataro, Sergio] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Chiariello, Andrea M.; Esposito, Andrea; Nicodemi, Mario] Univ Naples Federico II, Dipartimento Fis, I-80126 Naples, Italy; [Chiariello, Andrea M.; Esposito, Andrea; Nicodemi, Mario] Complesso Univ Monte St Angelo, CNR SPIN, INFN Napoli, I-80126 Naples, Italy; [Prisco, Antonella] CNR IGB, Via Pietro Castellino 111, Naples, Italy; [Esposito, Andrea] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Berlin, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Superconduttori, Materiali e Dispositivi Innovativi (SPIN-CNR); Istituto Nazionale di Fisica Nucleare (INFN); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sarnataro, S (corresponding author), Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.; Chiariello, AM (corresponding author), Univ Naples Federico II, Dipartimento Fis, I-80126 Naples, Italy.; Chiariello, AM (corresponding author), Complesso Univ Monte St Angelo, CNR SPIN, INFN Napoli, I-80126 Naples, Italy.	sarnatas@igbmc.fr; chiariello@na.infn.it	Prisco, Antonella/X-5749-2019; Esposito, Andrea/CAJ-1360-2022; Chiariello, Andrea Maria/AAA-1544-2020; Nicodemi, Mario/K-1815-2015	Esposito, Andrea/0000-0002-5903-8439; Chiariello, Andrea Maria/0000-0002-6112-0167; Nicodemi, Mario/0000-0002-8416-6416; Prisco, Antonella/0000-0001-8061-0068; Sarnataro, Sergio/0000-0002-6001-9892				Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Annunziatella C, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.042402; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barbieri M, 2013, SOFT MATTER, V9, P8631, DOI 10.1039/c3sm51436f; Barbieri M, 2017, NAT STRUCT MOL BIOL, V24, P515, DOI 10.1038/nsmb.3402; Barbieri Mariano, 2013, Frontiers in Genetics, V4, P113, DOI 10.3389/fgene.2013.00113; Bianco S, 2017, CHROMOSOME RES, P1; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Brackley CA, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0909-0; Brackley CA, 2013, P NATL ACAD SCI USA, V110, pE3605, DOI 10.1073/pnas.1302950110; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Caglioti E, 1998, EUROPHYS LETT, V43, P591, DOI 10.1209/epl/i1998-00402-x; CATAUDELLA V, 1994, PHYS REV LETT, V72, P1541, DOI 10.1103/PhysRevLett.72.1541; Chiariello AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29775; Chiariello AM, 2015, MOD PHYS LETT B, V29, DOI 10.1142/S0217984915300033; Ciamarra MP, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058001; Coniglio A, 2000, J PHYS-CONDENS MAT, V12, P6601, DOI 10.1088/0953-8984/12/29/331; D'Agostino G, 2014, UNDERST COMPLEX SYST, pVII; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorogovtsev S. N., 2013, EVOLUTION NETWORKS B; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gilarranz LJ, 2017, SCIENCE, V357, P199, DOI 10.1126/science.aal4122; Goloborodko A, 2016, BIOPHYS J, V110, P2162, DOI 10.1016/j.bpj.2016.02.041; Grebenkov DS, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.078001; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Jost D, 2014, NUCLEIC ACIDS RES, V42, P9553, DOI 10.1093/nar/gku698; Kaufmann S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126125; Knight PA, 2013, IMA J NUMER ANAL, V33, P1029, DOI 10.1093/imanum/drs019; Kruse K, 2013, NUCLEIC ACIDS RES, V41, P701, DOI 10.1093/nar/gks1096; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Manning CD, 2009, INTRO INFORM RETRIEV; Morlot JB, 2016, EPJ NONLINEAR BIOMED, V4, DOI 10.1140/epjnbp/s40366-016-0029-5; Nicodemi M, 1998, PHYS REV LETT, V80, P1340, DOI 10.1103/PhysRevLett.80.1340; Nicodemi M, 1998, PHYS REV E, V57, pR39, DOI 10.1103/PhysRevE.57.R39; Nicodemi M, 2002, EUROPHYS LETT, V60, P684, DOI 10.1209/epl/i2002-00363-0; Nicodemi M, 2001, PHYS REV LETT, V86, P4378, DOI 10.1103/PhysRevLett.86.4378; Nicodemi M, 2008, GENETICS, V179, P717, DOI 10.1534/genetics.107.083154; Nicodemi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108104; Nicodemi M, 2014, CURR OPIN CELL BIOL, V28, P90, DOI 10.1016/j.ceb.2014.04.004; Nicodemi M, 2009, BIOPHYS J, V96, P2168, DOI 10.1016/j.bpj.2008.12.3919; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Scialdone A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002229; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tanay A, 2013, CURR OPIN GENET DEV, V23, P197, DOI 10.1016/j.gde.2012.12.009; Tarzia M, 2004, EUROPHYS LETT, V66, P531, DOI 10.1209/epl/i2004-10015-y; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Valverde S, 2002, EUROPHYS LETT, V60, P512, DOI 10.1209/epl/i2002-00248-2	52	16	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188201	10.1371/journal.pone.0188201	http://dx.doi.org/10.1371/journal.pone.0188201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141034	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000415260400070
J	Han, KN; Kim, HK; Choi, YH				Han, Kook Nam; Kim, Hyun Koo; Choi, Young Ho			Midterm outcomes of single port thoracoscopic surgery for major pulmonary resection	PLOS ONE			English	Article							ASSISTED THORACIC-SURGERY; LUNG-CANCER; UNIPORTAL VATS; LOBECTOMY; THORACOTOMY; COMPLICATIONS; EXPERIENCE	Introduction Single-port thoracoscopic surgery has widened the current minimally invasive surgical techniques toward more less invasive procedures in terms of reducing the number of incisions. However, the current status of oncologic outcome with this technique is not well known for lung cancer surgery. The purpose of this study is to evaluate the oncologic outcomes in early stage lung cancer for impact of the survival outcomes with our experience of conversion to a single-port approach from the conventional three-port approach. Materials and methods Retrospective data of patients who underwent thoracoscopic major lung resection for non-small cell lung cancer between January 2006 and June 2015 were analyzed. Patients characteristics, perioperative outcomes, pathologic result, and postoperative follow-up data of thoracoscopic surgery were reviewed and surgical outcomes were compared between conventional three-port (n = 168), two-port (n = 68), and single-port thoracoscopic surgery (n = 203). Results Of the 203 single-port thoracoscopic surgeries, we performed 167 single-port thoracoscopic lobectomy and mediastinal lymph node dissections. During the learning period of each thoracoscopic approach, the mean operation time for single-port thoracoscopic surgery (189 +/- 62 min) was not significantly different from those of two-port (175 +/- 46 min) and three-port (195 +/- 75 min) thoracoscopic lobectomy (p = 0.165). Perioperative outcomes including drain indwelling time (p <0.001), complication (p = 0.185) and conversion event (p = 0.911) were not worsened during learning period with two-port. Midterm survival (p = 0.753) and recurrence free survival (p = 0.656) of single port thoracoscopic lobectomy showed acceptable results compared with two- and three-port approach. Conclusions Single-port thoracoscopic surgery is safe and a feasible option for major lung resection in lung malignancy and this approach following experiences of two-port approach may yield similar oncologic results to those of conventional multi-port approach during thoracoscopic lobectomy.	[Han, Kook Nam; Kim, Hyun Koo; Choi, Young Ho] Korea Univ, Guro Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Han, Kook Nam; Kim, Hyun Koo; Choi, Young Ho] Korea Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, HK (corresponding author), Korea Univ, Guro Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.; Kim, HK (corresponding author), Korea Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.	kimhyunkoo@korea.ac.kr	Han, Kook Nam/D-6036-2012; Han, Kook Nam/GSJ-1109-2022; Han, Kooknam/AAB-6677-2020	Han, Kook Nam/0000-0002-1508-0125; Han, Kooknam/0000-0002-1508-0125; Kim, Hyun Koo/0000-0001-7604-4729	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A121074]; National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology [NRF2015R1A2A2A04005760, 2015R1A2A2A04005760 [A1]]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology	This work was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (No: A121074), http://www.mohw.go.kr/eng/index. isp; and a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (No: NRF2015R1A2A2A04005760), http://english.moe.go kr/main.do?s=english.; This work was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A121074) and the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (2015R1A2A2A04005760 [A1]).	Bertolaccini L, 2013, J THORAC DIS, V5, pS214, DOI 10.3978/j.issn.2072-1439.2013.04.06; Cattaneo SM, 2008, ANN THORAC SURG, V85, P231, DOI 10.1016/j.athoracsur.2007.07.080; Chen PR, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-58; Flores RM, 2011, J THORAC CARDIOV SUR, V142, P1412, DOI 10.1016/j.jtcvs.2011.09.028; Gonzalez-Rivas D, 2014, J THORAC DIS, V6, pS674, DOI 10.3978/j.issn.2072-1439.2014.09.17; Gonzalez-Rivas D, 2013, J THORAC CARDIOV SUR, V145, P1676, DOI 10.1016/j.jtcvs.2013.02.052; Gonzalez-Rivas D, 2013, ANN THORAC SURG, V95, P426, DOI 10.1016/j.athoracsur.2012.10.070; Gonzalez-Rivas D, 2012, J THORAC CARDIOV SUR, V143, P745, DOI 10.1016/j.jtcvs.2011.07.049; Han KN, 2016, J THORAC DIS, V8, pS279, DOI 10.3978/j.issn.2072-1439.2016.02.31; Han KN, 2016, EUR J CARDIO-THORAC, V49, P42, DOI 10.1093/ejcts/ezv406; Handy JR, 2010, EUR J CARDIO-THORAC, V37, P451, DOI 10.1016/j.ejcts.2009.07.037; Harris CG, 2016, ANN CARDIOTHORAC SUR, V5, P76, DOI [10.21037/acs.2016.03.17, 10.3978/j.issn.2225-319X.2015.12.04]; Kim HK, 2015, INTERACT CARDIOV TH, V20, P310, DOI 10.1093/icvts/ivu405; Kim HK, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-88; Lau R, 2014, CHEST, V145; McKenna Robert J Jr, 2008, Thorac Surg Clin, V18, P275, DOI 10.1016/j.thorsurg.2008.04.004; Ng CSH, 2007, EUR J CARDIO-THORAC, V31, P83, DOI 10.1016/j.ejcts.2006.10.019; Ng CSH, 2016, THORAC CARDIOV SURG, V64, P348, DOI 10.1055/s-0034-1396789; Ng CSH, 2016, WORLD J SURG, V40, P484, DOI 10.1007/s00268-015-3248-5; Nomori H, 2001, ANN THORAC SURG, V72, P879, DOI 10.1016/S0003-4975(01)02891-0; Nwogu CE, 2015, ANN THORAC SURG, V99, P399, DOI 10.1016/j.athoracsur.2014.09.018; Perna V, 2016, EUR J CARDIO-THORAC, V50, P411, DOI 10.1093/ejcts/ezw161; Rocco G, 2004, ANN THORAC SURG, V77, P726, DOI 10.1016/S0003-4975(03)01219-0; Rocco Gaetano, 2006, Interact Cardiovasc Thorac Surg, V5, P430, DOI 10.1510/icvts.2006.128603; Seely AJE, 2010, ANN THORAC SURG, V90, P936, DOI 10.1016/j.athoracsur.2010.05.014; Sihoe ADL, 2016, J THORAC DIS, V8, pS333, DOI 10.3978/j.issn.2072-1439.2016.02.41; Tamura M, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-153; Whitson BA, 2008, ANN THORAC SURG, V86, P2008, DOI 10.1016/j.athoracsur.2008.07.009; Yim APC, 2002, ANN THORAC SURG, V74, P615, DOI 10.1016/S0003-4975(02)03579-8	29	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0186857	10.1371/journal.pone.0186857	http://dx.doi.org/10.1371/journal.pone.0186857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136038	gold, Green Published, Green Submitted			2022-12-26	WOS:000415121200008
J	Pires, MEL; Clarke, SR; Marcondes, S; Gibbins, JM				Pires, Maria E. Lopes; Clarke, Simon R.; Marcondes, Sisi; Gibbins, Jonathan M.			Lipopolysaccharide potentiates platelet responses via toll-like receptor 4-stimulated Akt-Erk-PLA(2) signalling	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; REACTIVE-OXYGEN; PATHOGEN RECOGNITION; PHOSPHOLIPASE A(2); BINDING-PROTEIN; INNATE IMMUNITY; KINASE CASCADES; ACTIVATION; AGGREGATION; LPS	Lipopolysaccharide (LPS) from the cell envelope of Gram-negative bacteria is a principal cause of the symptoms of sepsis. LPS has been reported to modulate the function of platelets although the underlying mechanisms of LPS action in these cells remain unclear. Platelets express the Toll-like receptor 4 (TLR4) which serves as a receptor for LPS, although the potential role of TLR4 and associated cell signalling in controlling platelet responses to LPS has not been extensively explored. In this study, we therefore investigated the actions of LPS prepared from different strains of Escherichia coli on platelet function, the underlying signalling mechanisms, and the potential role of TLR4 in orchestrating these. We report that LPS increased the aggregation of washed platelets stimulated by thromboxane (U46619) or GPVI collagen receptor agonists, effects that were prevented by a TLR4 antagonist. Associated with this, LPS enhanced fibrinogen binding, P-selectin exposure and reactive oxygen species (ROS) release. Increase of ROS was found to be important for the actions of LPS on platelets, since these were inhibited in the presence of superoxide dismutase or catalase. The effects of LPS were associated with phosphorylation of Akt, ERK1/2 and PLA2 in stimulated platelets, and inhibitors of PI3-kinase, Akt and ERK1/2 reduced significantly LPS enhanced platelet function and associated ROS production. Furthermore, inhibition of platelet cyclooxygenase or the thromboxane receptor, revealed an important role for thromboxane A2. We therefore conclude that LPS increases human platelet activation through a TLR4-PI3K-Akt-ERK1/2-PLA2 -dependent pathway that is dependent on ROS and TXA2 formation.	[Pires, Maria E. Lopes; Clarke, Simon R.; Gibbins, Jonathan M.] Univ Reading, Inst Cardiovasc & Metab Res, Sch Biol Sci, Reading, Berks, England; [Marcondes, Sisi] Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil	University of Reading; Universidade Estadual de Campinas	Gibbins, JM (corresponding author), Univ Reading, Inst Cardiovasc & Metab Res, Sch Biol Sci, Reading, Berks, England.	j.m.gibbins@reading.ac.uk			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Brazil; British Heart Foundation [RG/15/2/31224]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); British Heart Foundation(British Heart Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MELP received grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Brazil. Jonathan Gibbins received grants from British Heart Foundation: Programme Grant RG/15/2/31224. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) Brazil and by British Heart Foundation (RG/15/2/31224).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Bakdash N, 2008, FREE RADICAL BIO MED, V45, P158, DOI 10.1016/j.freeradbiomed.2008.03.021; Boffa JJ, 2004, J AM SOC NEPHROL, V15, P2358, DOI 10.1097/01.ASN.0000136300.72480.86; Brooks AC, 2007, INFLAMM RES, V56, P154, DOI 10.1007/s00011-006-6151-6; Brown GT, 2011, J IMMUNOL, V186, P5489, DOI 10.4049/jimmunol.1001623; Burkholder TJ, 2009, BIOCHEM BIOPH RES CO, V386, P60, DOI 10.1016/j.bbrc.2009.05.150; Casarin AL, 2011, LIFE SCI, V89, P773, DOI 10.1016/j.lfs.2011.09.004; Cognasse F, 2005, IMMUNOL CELL BIOL, V83, P196, DOI 10.1111/j.1440-1711.2005.01314.x; Cognasse F, 2008, BRIT J HAEMATOL, V141, P84, DOI 10.1111/j.1365-2141.2008.06999.x; Cognasse F, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00083; Davis MR, 2012, JOVE-J VIS EXP, DOI 10.3791/3916; Dong HP, 2010, KAOHSIUNG J MED SCI, V26, P584, DOI 10.1016/S1607-551X(10)70090-5; El-Achkar TM, 2007, AM J PHYSIOL-RENAL, V293, pF1187, DOI 10.1152/ajprenal.00217.2007; Lopes-Pires ME, 2012, PLATELETS, V23, P195, DOI 10.3109/09537104.2011.603065; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Gangloff SC, 1999, CLIN INFECT DIS, V28, P491, DOI 10.1086/515176; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; Iba T, 2016, BLOOD REV, V30, P149, DOI 10.1016/j.blre.2015.10.002; Ikezoe T, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-014-0050-7; Kaiser WJ, 2009, J PROTEOME RES, V8, P2903, DOI 10.1021/pr900027j; Kalvegren H, 2003, ARTERIOSCL THROM VAS, V23, P1677, DOI 10.1161/01.ATV.0000084810.52464.D5; Kassouf N, 2015, CELL SIGNAL, V27, P1488, DOI 10.1016/j.cellsig.2015.03.008; Katagiri H, 2004, HEPATOLOGY, V39, P139, DOI 10.1002/hep.20000; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; KEEN RR, 1991, CRIT CARE MED, V19, P1114, DOI 10.1097/00003246-199109000-00004; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Krotz F, 2002, BLOOD, V100, P917, DOI 10.1182/blood.V100.3.917; Lee GL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091394; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; Li X, 2015, IMMUNOBIOLOGY, V220, P399, DOI 10.1016/j.imbio.2014.10.008; Li ZY, 2011, THROMB RES, V127, P184, DOI 10.1016/j.thromres.2010.10.010; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Mathiak G, 2003, INT J MOL MED, V11, P41; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Morganti RP, 2010, PLATELETS, V21, P260, DOI 10.3109/09537101003637240; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Nakae H, 1996, RES COMMUN MOL PATH, V92, P131; Nocella C, 2017, THROMB HAEMOSTASIS, V117, P1558, DOI 10.1160/TH16-11-0857; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Phillips DR, 2001, THROMB HAEMOSTASIS, V86, P246; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Quach ND, 2014, BIOCHEM PHARMACOL, V90, P338, DOI 10.1016/j.bcp.2014.05.022; Ren QS, 2008, CURR OPIN HEMATOL, V15, P537, DOI 10.1097/MOH.0b013e328309ec74; Rivadeneyra L, 2014, THROMB RES, V133, P235, DOI 10.1016/j.thromres.2013.11.028; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Saponaro C, 2012, IMMUNOPHARM IMMUNOT, V34, P858, DOI 10.3109/08923973.2012.665461; SIESS W, 1989, PHYSIOL REV, V69, P58, DOI 10.1152/physrev.1989.69.1.58; Soromou LW, 2012, MOLECULES, V17, P3574, DOI 10.3390/molecules17033574; Tavener SA, 2004, CIRC RES, V95, P700, DOI 10.1161/01.RES.0000144175.70140.8c; Woulfe DS, 2010, EXPERT REV HEMATOL, V3, P81, DOI 10.1586/EHM.09.75; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yin H, 2013, ARTERIOSCL THROM VAS, V33, P2529, DOI 10.1161/ATVBAHA.113.302339; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; ZHOU PH, 2016, MEDIAT INFLAMM, V2016, DOI DOI 10.1155/2016/720549	61	35	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0186981	10.1371/journal.pone.0186981	http://dx.doi.org/10.1371/journal.pone.0186981			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136006	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000415121200010
J	Irace, C; Messiniti, V; Tassone, B; Cortese, C; Barrett, EJ; Gnasso, A				Irace, Concetta; Messiniti, Valentina; Tassone, Bruno; Cortese, Claudio; Barrett, Eugene J.; Gnasso, Agostino			Evidence for congruent impairment in micro and macrovascular function in type 1 diabetes	PLOS ONE			English	Article							CONTRAST-ENHANCED ULTRASOUND; SKELETAL-MUSCLE MICROCIRCULATION; PERIPHERAL ARTERIAL-DISEASE; BLOOD-FLOW; MICROVASCULAR RECRUITMENT; INSULIN; VASODILATION; INCREASES; EXERCISE; MELLITUS	Diabetes affects large and small vessels through mechanisms only partially known. In the present study, we evaluated the function of capillaries and large arteries in subjects with type 1 diabetes mellitus (T1DM) to study the effect of chronic hyperglycemia in the absence of other cardiovascular risk factors. Twenty-five subjects with T1DM and 12 healthy age-matched controls were enrolled. Nine patients had mild or moderate retinopathy. Contrast enhanced ultrasound was used to measure perfusion of the deep forearm flexor muscle of the non-dominant arm at rest (baseline) and after an ischemic stimulus (reactive hyperemia). Perfusion was expressed as Video Intensity (VI) in arbitrary unit (a.u.)/mm(2). The time to reach peak VI after ischemia was also recorded. The function of large arteries was evaluated using flow-mediated vasodilation (FMD). VI was significantly lower in T1DM compared to control subjects both at baseline (0.22 +/- 0.16 vs 0.44 +/- 0.35 a. u./mm(2), p < 0.05), and after ischemia (0.33 +/- 0.24 vs 0.68 +/- 0.46 a.u./mm(2), p < 0.05). The time to reach peak VI after ischemia was markedly longer in T1DM (5.6 +/- 2.2 vs 4.0 +/- 1.7 seconds, p < 0.02). These differences were more marked in T1DM subjects with retinopathy. FMD was lower in TIDM patients compared to controls (5.4 +/- 6.4 vs 10.7 +/- 4.5%, p < 0.01). The present findings demonstrate that T1DM patients have defective peripheral skeletal muscle perfusion both at rest and after ischemia compared with control subjects. Low muscle perfusion associates with low FMD of the brachial artery. Furthermore, T1DM subjects with retinopathy have the least muscle perfusion and blunted response to hyperemia compared to T1DM without retinopathy.	[Irace, Concetta] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Messiniti, Valentina; Tassone, Bruno; Gnasso, Agostino] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Cortese, Claudio] Tor Vergata Univ, Dept Expt Med & Surg, Rome, Italy; [Barrett, Eugene J.] Univ Virginia, Sch Med, Dept Med, Div Endocrinol, Charlottesville, VA 22908 USA	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; University of Rome Tor Vergata; University of Virginia	Gnasso, A (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	gnasso@unicz.it	Irace, Concetta/AAC-7796-2022					Amarteifio E, 2012, EUR J RADIOL, V81, P3332, DOI 10.1016/j.ejrad.2011.12.030; Amarteifio E, 2013, DIABETES VASC DIS RE, V10, P468, DOI 10.1177/1479164113484165; Amarteifio E, 2011, INVEST RADIOL, V46, P504, DOI 10.1097/RLI.0b013e3182183a77; Clark MG, 2003, AM J PHYSIOL-ENDOC M, V284, pE241, DOI 10.1152/ajpendo.00408.2002; Clerk LH, 2006, DIABETES, V55, P1436, DOI 10.2337/db05-1373; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Dawson D, 2002, AM J PHYSIOL-ENDOC M, V282, pE714, DOI 10.1152/ajpendo.00373.2001; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; GILL RW, 1985, ULTRASOUND MED BIOL, V11, P625, DOI 10.1016/0301-5629(85)90035-3; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; Inyard AC, 2007, DIABETES, V56, P2194, DOI 10.2337/db07-0020; Irace C, 2008, ATHEROSCLEROSIS, V200, P439, DOI 10.1016/j.atherosclerosis.2007.12.036; Irace C, 2016, J ATHEROSCLER THROMB, V23, P355, DOI 10.5551/jat.32060; Irace C, 2014, EUR J CLIN INVEST, V44, P549, DOI 10.1111/eci.12268; Irace C, 2013, EUR J CLIN INVEST, V43, P49, DOI 10.1111/eci.12016; Jahn LA, 2016, J CLIN ENDOCR METAB, V101, P1198, DOI 10.1210/jc.2015-3293; Krix M, 2009, ULTRASOUND MED BIOL, V35, P1587, DOI 10.1016/j.ultrasmedbio.2009.05.006; MENEILLY GS, 1995, J CLIN ENDOCR METAB, V80, P1899, DOI 10.1210/jc.80.6.1899; Quaia E., 2005, CONTRAST MEDIA ULTRA; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Solomon TPJ, 2011, J CLIN ENDOCR METAB, V96, P1377, DOI 10.1210/jc.2010-2069; UTRIAINEN T, 1995, DIABETOLOGIA, V38, P555, DOI 10.1007/s001250050319; Vincent MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE123, DOI 10.1152/ajpendo.00021.2003; Vincent MA, 2002, DIABETES, V51, P42, DOI 10.2337/diabetes.51.1.42; Womack L, 2009, J AM COLL CARDIOL, V53, P2175, DOI 10.1016/j.jacc.2009.02.042; Zheng C, 2015, TRENDS ENDOCRIN MET, V26, P297, DOI 10.1016/j.tem.2015.02.002	28	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187525	10.1371/journal.pone.0187525	http://dx.doi.org/10.1371/journal.pone.0187525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131837	gold, Green Published, Green Submitted			2022-12-26	WOS:000414997800017
J	Khare, D; Goldschmidt, N; Bardugo, A; Gur-Wahnon, D; Ben-Dov, IZ; Avni, B				Khare, Drirh; Goldschmidt, Neta; Bardugo, Aya; Gur-Wahnon, Devorah; Ben-Dov, Iddo Z.; Avni, Batia			Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance	PLOS ONE			English	Article							CELL LYMPHOMA; NON-HODGKIN; PI3K/AKT PATHWAY; CDNA LIBRARIES; EXPRESSION; CLUSTER; RECOMMENDATIONS; PATHOGENESIS; ASSOCIATION; SERUM	Early detection of relapsed lymphoma improves response and survival. Current tools lack power for detection of early relapse, while being cumbersome and expensive. We searched for sensitive biomarkers that precede clinical relapse, and serve for further studies on therapy response and relapse. We recruited 20 healthy adults, 14 diffuse large B-cell lymphoma (DLBCL) patients and 11 Hodgkin lymphoma (HL) patients at diagnosis. Using small-RNA sequencing we identified in DLBCL patients increased plasma levels of miR-124 and miR-532-5p, and decreased levels of miR-425, miR-141, miR-145, miR-197, miR-345, miR-424, miR-128 and miR-122. In the HL group, we identified miR-25, miR-30a/d, miR-26b, miR-182, miR-186, miR-140* and miR-125a to be up-regulated, while miR-23a, miR-122, miR-93 and miR-144 were down-regulated. Pathway analysis of potential mRNAs targets of these miRNA revealed in the DLBCL group potential up-regulation of STAT3, IL8, p13k/AKT and TGF-B signaling, and potential down-regulation of the PTEN and p53 pathways; while in the HL group we have found the cAMP-mediated pathway and p53 pathway to be potentially down-regulated. Survival analyses revealed that plasma levels of miR-20a/b, miR-93 and miR-106a/b were associated with higher mortality. In conclusion, we identified sets of dysregulated circulating miRNA that might serve as reliable biomarkers for relapsed lymphoma.	[Khare, Drirh; Goldschmidt, Neta; Bardugo, Aya; Avni, Batia] Hadassah Hebrew Univ, Med Ctr, Dept Hematol & Bone Marrow Transplantat & Canc Im, Jerusalem, Israel; [Gur-Wahnon, Devorah; Ben-Dov, Iddo Z.] Hadassah Hebrew Univ, Lab Med Transcript, Nephrol & Hypertens Serv, Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Avni, B (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Hematol & Bone Marrow Transplantat & Canc Im, Jerusalem, Israel.	Batiaa@hadassah.org.il	Ben-Dov, Iddo/F-3282-2010; KHARE, DRIRH/CAF-5301-2022	Ben-Dov, Iddo/0000-0002-9180-3604; Avni, Batia/0000-0001-8516-2751	I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41/11]; City of Hope, CA, USA	I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); City of Hope, CA, USA	IZB-D is supported by the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation under grant number 41/11. This research was partly supported by a Nesvig Grant, City of Hope, CA, USA, awarded to BA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; IZB-D is supported by the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation under grant number 41/11.; This research was partly supported by a Nesvig Grant, City of Hope, CA, USA, awarded to BA.	Alencar AJ, 2011, CLIN CANCER RES, V17, P4125, DOI 10.1158/1078-0432.CCR-11-0224; Battistella M, 2015, J INVEST DERMATOL, V135, P1659, DOI 10.1038/jid.2015.27; Ben-Dov IZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147249; Blachly JS, 2014, BRIT J HAEMATOL, V167, P19, DOI 10.1111/bjh.13065; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Chiappella A, 2016, HEMATOL ONCOL CLIN N, V30, P1147, DOI 10.1016/j.hoc.2016.07.002; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cui Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111942; Danielson KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0164644; Di Lisio L, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.1; Duletic-Nacinovic A, 2008, TUMORI J, V94, P511; El-Galaly TC, 2014, AM J HEMATOL, V89, P575, DOI 10.1002/ajh.23688; Fang C, 2012, ANN HEMATOL, V91, P553, DOI 10.1007/s00277-011-1350-9; Farazi TA, 2012, METHODS, V58, P171, DOI 10.1016/j.ymeth.2012.07.020; Fassina A, 2012, LAB INVEST, V92, P1574, DOI 10.1038/labinvest.2012.129; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iqbal J, 2015, BLOOD, V125, P1137, DOI 10.1182/blood-2014-04-566778; Jones K, 2014, CLIN CANCER RES, V20, P253, DOI 10.1158/1078-0432.CCR-13-1024; Khana J, 2017, CLIN CHEM LAB MED, V55, P608, DOI 10.1515/cclm-2016-0471; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Li CM, 2017, J CANCER, V8, P870, DOI 10.7150/jca.17958; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matsuzaki J., 2017, INT J CLIN ONCOL; Max KEA, 2017, PLASMA SERUM EXRNA R; Mazan-Mamczarz K, 2013, LEUKEMIA RES, V37, P1420, DOI 10.1016/j.leukres.2013.08.020; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Musilova K, 2015, LEUKEMIA, V29, P1004, DOI 10.1038/leu.2014.351; Navarro A, 2009, CANCER RES, V69, P7071, DOI 10.1158/0008-5472.CAN-09-1095; Paydas S, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0749-5; Pimentel F, 2015, JALA-J LAB AUTOM, V20, P574, DOI 10.1177/2211068214561788; Rao E, 2012, LEUKEMIA, V26, P1064, DOI 10.1038/leu.2011.305; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Skrabek P, 2013, TRANSFUS APHER SCI, V49, P133, DOI 10.1016/j.transci.2013.07.014; Tagawa H, 2013, CANCER SCI, V104, P801, DOI 10.1111/cas.12160; Teras LR, 2016, CA CANC J CLIN, V2016; Thapa DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020781; Therneau T.M., 2000, MODELING SURVIVAL DA; Tibshirani R., 2011, SAMR SAM SIGNIFICANC; Tonge DP, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0057-9; Vaknin-Dembinsky A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0648-x; van Eijndhoven MAJ, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89631; Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Yuan WX, 2016, ONCOL LETT, V11, P423, DOI 10.3892/ol.2015.3866	49	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187722	10.1371/journal.pone.0187722	http://dx.doi.org/10.1371/journal.pone.0187722			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131834	Green Published, gold, Green Submitted			2022-12-26	WOS:000414997800022
J	Wang, ZG; Tang, K; Zhang, DY; Wan, YZ; Wen, Y; Lu, QY; Wang, L				Wang, Zegang; Tang, Kai; Zhang, Dayong; Wan, Yizhen; Wen, Yan; Lu, Quanyou; Wang, Lei			High-throughput m(6)A-seq reveals RNA m(6)A methylation patterns in the chloroplast and mitochondria transcriptomes of Arabidopsis thaliana	PLOS ONE			English	Article							MESSENGER-RNA; MALE-STERILITY; N-6-METHYLADENOSINE; NUCLEAR; N6-METHYLADENOSINE; METABOLISM; RESOLUTION; PROGRAM; M6A	This study is the first to comprehensively characterize m(6)A patterns in the Arabidopsis chloroplast and mitochondria transcriptomes based on our open accessible data deposited in NCBI's Gene Expression Omnibus with GEO Series accession number of GSE72706. Over 86% of the transcripts were methylated by m(6)A in the two organelles. Over 550 and 350 m(6)A sites were mapped, with similar to 5.6 to similar to 5.8 and similar to 4.6 to similar to 4.9 m(6)A sites per transcript, to the chloroplast and mitochondria genome, respectively. The overall m(6)A methylation extent in the two organelles was greatly higher than that in the nucleus. The m(6)A motif sequences in the transcriptome of two organelles were similar to the nuclear motifs, suggesting that selection of the m(6)A motifs for RNA methylation was conserved between the nucleus and organelle transcriptomes. The m(6)A patterns of rRNAs and tRNAs in the organelle were similar to those in the nucleus. However, the m(6)A patterns in coding RNAs were distinct between the nucleus and the organelle, suggesting that that regulation of the m(6)A methylation patterns may be different between the nuclei and the organelles. The extensively methylated transcripts in the two organelles were mainly associated with rRNA, ribosomal proteins, photosystem reaction proteins, tRNA, NADH dehydrogenase and redox. On average, 64% and 79% of the transcripts in the two organelles showed differential m(6)A methylation across three organs of the leaves, flowers and roots. The m(6)A methylation extent in the chloroplast was higher than that in the mitochondria. This study provides deep insights into the m(6)A methylation topology and differentiation in the plant organelle transcriptomes.	[Wang, Zegang] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Jiangsu, Peoples R China; [Wang, Zegang; Tang, Kai; Wan, Yizhen; Wen, Yan; Lu, Quanyou; Wang, Lei] Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Peoples R China; [Tang, Kai; Wan, Yizhen] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Zhang, Dayong] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China; [Wen, Yan; Lu, Quanyou; Wang, Lei] Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang, Peoples R China; [Zhang, Dayong] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Yangzhou University; Jiangsu University of Science & Technology; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Jiangsu Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Nanjing Agricultural University	Wan, YZ (corresponding author), Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Peoples R China.; Wan, YZ (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	wyz689@hotmail.com			Shaanxi Province Fund for Returnees Scientists from Foreign Study [A289021201]; China Scholarship Council [22861057]; Jiangsu University of Science and Technology, USA NIH [R01GM070795, R01GM059138]; National Science Foundation of China [31101166]	Shaanxi Province Fund for Returnees Scientists from Foreign Study; China Scholarship Council(China Scholarship Council); Jiangsu University of Science and Technology, USA NIH; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the 2012 Shaanxi Province Fund for Returnees Scientists from Foreign Study (A289021201), China Scholarship Council Project (22861057), Initiation Grant to Dr. Yizhen Wan as the Emeritus Professor by Jiangsu University of Science and Technology, USA NIH grants (R01GM070795 and R01GM059138) to Kai Tang, and National Science Foundation of China (31101166) to Dayong Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bodi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132090; Bodi Z, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00048; Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266; Bongaarts J, 1983, FERTILITY BIOL BEHAV; Bruley C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00205; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Chen T, 2015, CELL STEM CELL, V16, P289, DOI 10.1016/j.stem.2015.01.016; COUVET D, 1986, HEREDITY, V57, P325, DOI 10.1038/hdy.1986.130; CSEPANY T, 1990, J BIOL CHEM, V265, P20117; DeHaan AA, 1997, HEREDITY, V79, P453, DOI 10.1038/hdy.1997.184; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; FINKEL D, 1983, VIROLOGY, V131, P409, DOI 10.1016/0042-6822(83)90508-1; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Globisch D, 2011, ANGEW CHEM INT EDIT, V50, P9739, DOI 10.1002/anie.201103229; Grosjean H., 2005, FINE TUNING RNA FUNC; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee M, 2014, CELL, V158, P980, DOI 10.1016/j.cell.2014.08.005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YL, 2014, RNA BIOL, V11, P1180, DOI 10.4161/rna.36281; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu J, 2014, J GENET GENOMICS, V41, P21, DOI 10.1016/j.jgg.2013.10.002; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Luo GZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6630; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mitra SK, 2007, J PROTEOME RES, V6, P1933, DOI 10.1021/pr060525b; Nakayama T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-35; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Pan T, 2013, TRENDS BIOCHEM SCI, V38, P204, DOI 10.1016/j.tibs.2012.12.006; Peltier JB, 2004, J BIOL CHEM, V279, P49367, DOI 10.1074/jbc.M406763200; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; RAO MK, 1990, PLANT BREEDING, V105, P1, DOI 10.1111/j.1439-0523.1990.tb00447.x; Richards A.J., 1986, PLANT BREEDING SYSTE; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Spremulli L, 2000, BIOCH MOL BIOL PLANT; Stover J, 1998, STUD FAMILY PLANN, V29, P255, DOI 10.2307/172272; Sugiura M, 2005, BIOCH MOL BIOL PLANT, P676; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wan YZ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0839-2; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Wise Robert R., 2006, V23, P3; Zhao BS, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0609-1; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	61	22	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0185612	10.1371/journal.pone.0185612	http://dx.doi.org/10.1371/journal.pone.0185612			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131848	Green Submitted, Green Published, gold			2022-12-26	WOS:000414997800002
J	Jafari, M; Mehrnejad, F; Doustdar, F				Jafari, Majid; Mehrnejad, Faramarz; Doustdar, Farahnoosh			Insight into the interactions, residue snorkeling, and membrane disordering potency of a single antimicrobial peptide into different lipid bilayers	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; AMYLOID BETA-PEPTIDE; SOLID-STATE NMR; PORE FORMATION; BACTERIAL-MEMBRANES; PARDAXIN; MECHANISM; ELECTROSTATICS; ORIENTATION; INSERTION	Pardaxin, with a bend-helix-bend-helix structure, is a membrane-active antimicrobial peptide that its membrane activity depends on the lipid bilayer composition. Herein, all-atom molecular dynamics (MD) simulations were performed to provide further molecular insight into the interactions, structural dynamics, orientation behavior, and cationic residues snorkeling of pardaxin in the DMPC, DPPC, POPC, POPG, POPG/POPE (3:1), and POPG/POPE (1: 3) lipid bilayers. The results showed that the C-terminal helix of the peptide was maintained in all six types of the model-bilayers and pardaxin was tilted into the DMPC, DPPC, and POPG/POPE mixed bilayers more than the POPC and POPG bilayers. As well as, the structure of zwitterionic membranes was more affected by the peptide than the anionic bilayers. Taken together, the study demonstrated that the cationic residues of pardaxin snorkeled toward the interface of lipid bilayers and all phenylalanine residues of the peptide played important roles in the peptide-membrane interactions. We hope that this work will provide a better understanding of the interactions of antimicrobial peptides with the membranes.	[Jafari, Majid; Mehrnejad, Faramarz] Univ Tehran, Fac New Sci & Technol, Dept Life Sci Engn, Tehran, Iran; [Doustdar, Farahnoosh] Shahid Beheshti Univ Med Sci, Dept Microbiol, Fac Med, Tehran, Iran	University of Tehran; Shahid Beheshti University Medical Sciences	Mehrnejad, F (corresponding author), Univ Tehran, Fac New Sci & Technol, Dept Life Sci Engn, Tehran, Iran.; Doustdar, F (corresponding author), Shahid Beheshti Univ Med Sci, Dept Microbiol, Fac Med, Tehran, Iran.	Mehrnejad@ut.ac.ir; F_doustdar@sbum.ac.ir	Doustdar, Farahnoosh/AAX-1121-2021; Jafari, Majid/AAA-8934-2020; Mehrnejad, Faramarz/AAU-1526-2020	Mehrnejad, Faramarz/0000-0002-2991-3079; Jafari, Majid/0000-0001-5233-6882				Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Almeida PF, 2009, BIOCHEMISTRY-US, V48, P8083, DOI 10.1021/bi900914g; Arrighi RBG, 2002, ANTIMICROB AGENTS CH, V46, P2104, DOI 10.1128/AAC.46.7.2104-2110.2002; Bachar M, 2000, BIOPHYS J, V78, P1359, DOI 10.1016/S0006-3495(00)76690-2; BAKER MA, 1993, CANCER RES, V53, P3052; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barany-Wallje E, 2005, BIOPHYS J, V89, P2513, DOI 10.1529/biophysj.105.067694; Belohorcova K, 1997, BIOPHYS J, P73; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bonhenry D, 2013, J CHEM THEORY COMPUT, V9, P5675, DOI 10.1021/ct400576e; Both C., 1980, EUR J BIOCHEM, V16, P7; Caudle AS, 2011, NATURE, V150, P137; Chem JB, 2000, J BIOL CHEM, V275, P33464; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Domanski J., 2010, J MEMBRANE BIOL; Fleming PJ, 2012, BBA-BIOMEMBRANES, V1818, P126, DOI 10.1016/j.bbamem.2011.07.016; Gleason NJ, 2013, P NATL ACAD SCI USA, V110, P1692, DOI 10.1073/pnas.1215400110; Gumbart J, 2012, BIOPHYS J, V102, P795, DOI 10.1016/j.bpj.2012.01.021; Guo C, 2014, BIOCHIMIE, V105, P192, DOI 10.1016/j.biochi.2014.07.013; Hallbrink M, 2001, BBA-BIOMEMBRANES, V1515, P101, DOI 10.1016/S0005-2736(01)00398-4; Hallock KJ, 2002, BIOPHYS J, V83, P1004, DOI 10.1016/S0006-3495(02)75226-0; Harrison PL, 2016, TOXICON, V117, P30, DOI 10.1016/j.toxicon.2016.03.014; Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hsu JC, 2011, PEPTIDES, V32, P1110, DOI 10.1016/j.peptides.2011.04.024; Huang HW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198304; Jafari M, 2017, J CHEM INF MODEL, V57, P929, DOI 10.1021/acs.jcim.6b00693; Johansson ACV, 2009, P NATL ACAD SCI USA, V106, P15684, DOI 10.1073/pnas.0905394106; King JD, 2012, PEPTIDES, V33, P35, DOI 10.1016/j.peptides.2011.11.015; Kolusheva S, 2008, PEPTIDES, V29, P1620, DOI 10.1016/j.peptides.2008.05.012; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lazarovici P, 2002, J TOXICOL-TOXIN REV, V21, P391, DOI 10.1081/TXR-120014410; Lazarovici P, 2003, CEL MOL MEC TOX ACT, V5, P178; LAZAROVICI P, 1986, J BIOL CHEM, V261, P6704; Lee BL, 2016, J CHEM PHYS; Lee J, 2016, LANGMUIR, V32, P1782, DOI 10.1021/acs.langmuir.5b04113; Lemkul JA, 2013, BIOCHEMISTRY; Lemkul JA, 2009, FEBS J, V276, P3060, DOI 10.1111/j.1742-4658.2009.07024.x; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; MacCallum JL, 2011, TRENDS BIOCHEM SCI, V36, P653, DOI 10.1016/j.tibs.2011.08.003; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Matsuzaki K, 1997, BIOCHEMISTRY-US, V36, P2104, DOI 10.1021/bi961870p; Mishra B., 2015, ACS MED CHEM LETT; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; Mukherjee S, 2017, PHYS CHEM CHEM PHYS, V19, P19289, DOI 10.1039/c7cp01941f; Nie Y, 2012, PEPTIDES, V38, P389, DOI 10.1016/j.peptides.2012.09.012; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Oren Z, 1996, EUR J BIOCHEM, V237, P303, DOI 10.1111/j.1432-1033.1996.0303n.x; Park SI, 2015, DEV COMP IMMUNOL, V52, P98, DOI 10.1016/j.dci.2015.04.018; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peng KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050263; Porcelli F, 2004, J BIOL CHEM, V279, P45815, DOI 10.1074/jbc.M405454200; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; RAPAPORT D, 1992, J BIOL CHEM, V267, P6502; Rapaport D, 1996, BIOPHYS J, V70, P2502, DOI 10.1016/S0006-3495(96)79822-3; Robert H., 1989, TRANSPORT THROUGH ME, P369; Sankararamakrishnan R, 2000, BIOPHYS J, V79, P2331, DOI 10.1016/S0006-3495(00)76479-4; Schow EV, 2011, J MEMBRANE BIOL, V239, P35, DOI 10.1007/s00232-010-9330-x; SHAI Y, 1990, J BIOL CHEM, V265, P20202; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shen LY, 1997, BIOPHYS J, V73, P3, DOI 10.1016/S0006-3495(97)78042-1; Toraya S, 2010, BIOPHYS J, V99, P3282, DOI 10.1016/j.bpj.2010.09.060; Uezono T, 2005, J MOL STRUCT, V749, P13, DOI 10.1016/j.molstruc.2005.02.037; Vad BS, 2010, BIOPHYS J, V98, P576, DOI 10.1016/j.bpj.2009.08.063; Vorobyov I, 2010, BIOPHYS J, V98, P2904, DOI 10.1016/j.bpj.2010.03.046; Wang GS, 2014, ACS CHEM BIOL, V9, P1997, DOI 10.1021/cb500475y; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zhao W, 2008, BIOCHIMIE, V90, P930, DOI 10.1016/j.biochi.2008.02.025; Zhao W, 2007, BIOPHYS J, V92, P1114, DOI 10.1529/biophysj.106.086272	77	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187216	10.1371/journal.pone.0187216	http://dx.doi.org/10.1371/journal.pone.0187216			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125878	Green Submitted, Green Published, gold			2022-12-26	WOS:000414866000008
J	Ambavane, A; Lindahl, B; Giannitis, E; Rolz, J; Mendivil, J; Frankenstein, L; Body, R; Christ, M; Bingisser, R; Alquezar, A; Mueller, C				Ambavane, Apoorva; Lindahl, Bertil; Giannitis, Evangelos; Rolz, Julie; Mendivil, Joan; Frankenstein, Lutz; Body, Richard; Christ, Michael; Bingisser, Roland; Alquezar, Aitor; Mueller, Christian		TRAPID-AMI Investigators	Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department	PLOS ONE			English	Article							CHEST-PAIN; EARLY-DIAGNOSIS	Background The 1-hour (h) algorithm triages patients presenting with suspected acute myocardial infarction (AMI) to the emergency department (ED) towards "rule-out," "rule-in," or "observation," depending on baseline and 1-h levels of high-sensitivity cardiac troponin (hs-cTn). The economic consequences of applying the accelerated 1-h algorithm are unknown. Methods and findings We performed a post-hoc economic analysis in a large, diagnostic, multicenter study of hs-cTnT using central adjudication of the final diagnosis by two independent cardiologists. Length of stay (LoS), resource utilization (RU), and predicted diagnostic accuracy of the 1-h algorithm compared to standard of care (SoC) in the ED were estimated. The ED LoS, RU, and accuracy of the 1-h algorithm was compared to that achieved by the SoC at ED discharge. Expert opinion was sought to characterize clinical implementation of the 1-h algorithm, which required blood draws at ED presentation and 1h, after which "rule-in" patients were transferred for coronary angiography, "rule-out" patients underwent outpatient stress testing, and "observation" patients received SoC. Unit costs were for the United Kingdom, Switzerland, and Germany. The sensitivity and specificity for the 1-h algorithm were 87% and 96%, respectively, compared to 69% and 98% for SoC. The mean ED LoS for the 1-h algorithm was 4.3h D it was 6.5h for SoC, which is a reduction of 33%. The 1-h algorithm was associated with reductions in RU, driven largely by the shorter LoS in the ED for patients with a diagnosis other than AMI. The estimated total costs per patient were 2,480 pound for the 1-h algorithm compared to 4,561 pound for SoC, a reduction of up to 46%. Conclusions The analysis shows that the use of 1-h algorithm is associated with reduction in overall AMI diagnostic costs, provided it is carefully implemented in clinical practice. These results need to be prospectively validated in the future.	[Ambavane, Apoorva; Rolz, Julie] Evidera, Modeling & Simulat, London, England; [Lindahl, Bertil] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lindahl, Bertil] Uppsala Clin Res Ctr, Uppsala, Sweden; [Giannitis, Evangelos] Heidelberg Univ, Med Klin 3, Heidelberg, Germany; [Mendivil, Joan] Roche Diagnost Int Ltd, Market Access, Rotkreuz, Switzerland; [Frankenstein, Lutz] Univ Hosp Heidelberg, Dept Cardiol, Angiol, Pulmonol, Heidelberg, Germany; [Body, Richard] Cent Manchester Univ Hosp NHS Fdn Trust, Emergency Dept, Manchester, Lancs, England; [Christ, Michael] Paracelsus Med Univ, Nuremberg Gen Hosp, Dept Emergency & Crit Care Med, Nurnberg, Germany; [Bingisser, Roland] Univ Basel, Univ Hosp, Emergency Dept, Basel, Switzerland; [Alquezar, Aitor] Hosp Santa Creu & Sant Pau, Serv Urgencies, Barcelona, Spain; [Mueller, Christian] Univ Hosp Basel, Dept Cardiol, Basel, Switzerland; [Mueller, Christian] Univ Hosp Basel, Cardiovasc Res Inst Basel, Basel, Switzerland; [Mendivil, Joan] Shire Int GmbH, Global Hlth Econ Outcomes & Epidemiol, Zug, Switzerland	Evidera; Uppsala University; Uppsala University; Ruprecht Karls University Heidelberg; Roche Holding; Ruprecht Karls University Heidelberg; University of Manchester; University of Basel; Hospital of Santa Creu i Sant Pau; University of Basel; University of Basel	Ambavane, A (corresponding author), Evidera, Modeling & Simulat, London, England.	apoorva.ambavane@evidera.com	Müller, Christian/AAB-4783-2022; Body, Richard/C-2736-2010; Christ, Michael/AAQ-8121-2020; Ambavane, Apoorva/AAW-4834-2020	Müller, Christian/0000-0002-1120-6405; Body, Richard/0000-0001-9089-8130; Christ, Michael/0000-0001-7977-0195; Mendivil, Joan/0000-0003-1139-0078	Roche Diagnostic; National Institute for Health Research [PDF-2012-05-193] Funding Source: researchfish	Roche Diagnostic; National Institute for Health Research(National Institute for Health Research (NIHR))	Joan Mendivil was employed by Roche Diagnostic Ltd. Apoorva Ambavane and Julie Roiz are employed by Evidera, Inc., which received research funding from Roche Diagnostic to conduct the analysis. Apoorva Ambavane and Julie Roiz did not receive direct reimbursement from Roche for the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other authors (Bertil Lindahl, Evangelos Giannitis, Lutz Frankenstein, Richard Body, Michael Christ, Roland Bingisser, Aitor Alquezar, and Christian Mueller) did not receive any compensation for their role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassand JP, 2007, EUR HEART J, V161, P1093; Body R, 2011, J AM COLL CARDIOL, V58, P1333, DOI 10.1016/j.jacc.2011.06.026; Cheng QL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009746; Cowling TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066699; Forberg JL, 2006, BMC EMERG MED, V6, DOI 10.1186/1471-227X-6-6; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Julicher P, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013653; Kaambwa B, 2017, INT J CARDIOL, V238, P144, DOI 10.1016/j.ijcard.2017.02.141; Kassenarztliche Bundesvereinigung (KBV), ONL VERS EBM; Keller T, 2011, JAMA-J AM MED ASSOC, V306, P2684, DOI 10.1001/jama.2011.1896; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; MacRae AR, 2006, CLIN CHEM, V52, P812, DOI 10.1373/clinchem.2005.059550; Mokhtari A, 2016, J AM COLL CARDIOL, V67, P1531, DOI 10.1016/j.jacc.2016.01.059; Mueller C, 2016, ANN EMERG MED, V68, P76, DOI 10.1016/j.annemergmed.2015.11.013; National Institute for Health and Care Excellence, 2014, MYOC INF AC EARL RUL; Nawar EW, 2005, ADV DATA, V2007, P1; Niska R, 2007, NATL HLTH STAT REPOR, V2010, P1; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Reichlin T, 2012, ARCH INTERN MED, V172, P1211, DOI 10.1001/archinternmed.2012.3698; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Shortt C, 2017, CLIN CHEM, V63, P593, DOI 10.1373/clinchem.2016.261776; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2010, EUR HEART J, V31, P2197, DOI 10.1093/eurheartj/ehq251; Twerenbold R, 2016, EUROPEAN HEART J; Vaidya A, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-77	27	38	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187662	10.1371/journal.pone.0187662	http://dx.doi.org/10.1371/journal.pone.0187662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121105	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900062
J	Ishikawa, S; Noma, T; Fu, HY; Matsuzaki, T; Ishizawa, M; Ishikawa, K; Murakami, K; Nishimoto, N; Nishiyama, A; Minamino, T				Ishikawa, Shohei; Noma, Takahisa; Fu, Hai Ying; Matsuzaki, Takashi; Ishizawa, Makoto; Ishikawa, Kaori; Murakami, Kazushi; Nishimoto, Naoki; Nishiyama, Akira; Minamino, Tetsuo			Apoptosis inhibitor of macrophage depletion decreased M1 macrophage accumulation and the incidence of cardiac rupture after myocardial infarction in mice	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; MEDIATED APOPTOSIS; GENE-TRANSFER; AIM; SURVIVAL; THERAPY; REPAIR; TISSUE; HEART; EXPRESSION	Background Cardiac rupture is an important cause of death in the acute phase after myocardial infarction (MI). Macrophages play a pivotal role in cardiac remodeling after MI. Apoptosis inhibitor of macrophage (AIM) is secreted specifically by macrophages and contributes to macrophage accumulation in inflamed tissue by maintaining survival and recruiting macrophages. In this study, we evaluated the role of AIM in macrophage accumulation in the infarcted myocardium and cardiac rupture after MI. Methods and results Wild-type (WT) and AIM(-/-) mice underwent permanent left coronary artery ligation and were followed-up for 7 days. Macrophage accumulation and phenotypes (M1 pro-inflammatory macrophage or M2 anti-inflammatory macrophage) were evaluated by immunohistological analysis and RT-PCR. Matrix metalloproteinase (MMP) activity levels were measured by gelatin zymography. The survival rate was significantly higher (81.1% vs. 48.2%, P<0.05), and the cardiac rupture rate was significantly lower in AIM(-/-) mice than in WT mice (10.8% vs. 31.5%, P<0.05). The number of M1 macrophages and the expression levels of M1 markers (iNOS and IL-6) in the infarcted myocardium were significantly lower in AIM(-/-) mice than in WT mice. In contrast, there was no difference in the number of M2 macrophages and the expression of M2 markers (Arg-1, CD206 and TGF-beta 1) between the two groups. The ratio of apoptotic macrophages in the total macrophages was significantly higher in AIM(-/-) mice than in WT mice, although MCP-1 expression did not differ between the two groups. MMP-2 and 9 activity levels in the infarcted myocardium were significantly lower in AIM(-/-) mice than in WT mice. Conclusions These findings suggest that AIM depletion decreases the levels of M1 macrophages, which are a potent source of MMP-2 and 9, in the infarcted myocardium in the acute phase after MI by promoting macrophage apoptosis, and leads to a decrease in the incidence of cardiac rupture and improvements in survival rates.	[Ishikawa, Shohei; Noma, Takahisa; Matsuzaki, Takashi; Ishizawa, Makoto; Ishikawa, Kaori; Murakami, Kazushi; Minamino, Tetsuo] Kagawa Univ, Dept Cardiorenal & Cerebrovasc Med, Fac Med, Kagawa, Japan; [Fu, Hai Ying] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka, Japan; [Nishimoto, Naoki] Kagawa Univ Hosp, Clin Res Support Ctr, Kagawa, Japan; [Nishiyama, Akira] Kagawa Univ, Dept Pharmacol, Fac Med, Kagawa, Japan	Kagawa University; Osaka University; Kagawa University; Kagawa University	Minamino, T (corresponding author), Kagawa Univ, Dept Cardiorenal & Cerebrovasc Med, Fac Med, Kagawa, Japan.	minamino@med.kagawa-u.ac.jp		Nishiyama, Akira/0000-0001-5971-820X	Core Research for Evolutional Medical Science and Technology - Agency for Medical Research and Development (AMED-CREST); Ministry of Education, Culture, Sports, Science and Technology, Japan	Core Research for Evolutional Medical Science and Technology - Agency for Medical Research and Development (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Core Research for Evolutional Medical Science and Technology grant funded by the Agency for Medical Research and Development (AMED-CREST) (to Akira Nishiyama) and Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to Tetsuo Minamino).; We thank Toru Miyazaki and Satoko Arai (Laboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, University of Tokyo, Tockyo, Japan), Daisuke Nakano (Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan), Yoshio Kushida and Toru Matsunaga (Department of Diagnostic Pathology, Kagawa University Hospital, Kagawa, Japan) for helpful advice. We also thank Teruyo Oka and Yoshiko Fujita (Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan) for her excellent technical assistance. This research was supported by a Core Research for Evolutional Medical Science and Technology grant funded by the Agency for Medical Research and Development (AMED-CREST) (to Akira Nishiyama) and Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to Tetsuo Minamino).	Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Arslan F, 2011, CIRC RES, V108, P582, DOI 10.1161/CIRCRESAHA.110.224428; Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; Chen JQ, 2005, CIRCULATION, V111, P1800, DOI 10.1161/01.CIR.0000160936.91849.9F; CHRISTENSEN DJ, 1977, CHEST, V72, P618, DOI 10.1378/chest.72.5.618; Dutta P, 2015, ARTERIOSCL THROM VAS, V35, P1066, DOI 10.1161/ATVBAHA.114.304652; Everaert BR, 2011, PLOS ONE, V6; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Foster CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083513; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Fujiu K, 2014, CARDIOVASC RES, V102, P232, DOI 10.1093/cvr/cvu059; Haruta I, 2001, J BIOL CHEM, V276, P22910, DOI 10.1074/jbc.M100324200; Hayashidani S, 2003, CIRCULATION, V108, P2134, DOI 10.1161/01.CIR.0000092890.29552.22; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Honda S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000984; Kurokawa J, 2011, P NATL ACAD SCI USA, V108, P12072, DOI 10.1073/pnas.1101841108; Kuwata K, 2003, AM J PATHOL, V162, P837, DOI 10.1016/S0002-9440(10)63880-1; Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059; Li GH, 2009, CIRC RES, V104, P896, DOI 10.1161/CIRCRESAHA.108.172882; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; Nagai T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000839; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Nishikido T, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002863; Okada H, 2009, AM J PHYSIOL-HEART C, V296, pH616, DOI 10.1152/ajpheart.01147.2008; Oshima E, 2013, BRAIN PATHOL, V23, P633, DOI 10.1111/bpa.12059; Reed GW, 2016, LANCET, V16, P30677; Shiraishi M, 2016, J CLIN INVEST, V126, P2151, DOI 10.1172/JCI85782; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Takii T, 2010, CIRC J, V74, P93, DOI 10.1253/circj.CJ-09-0619; Tao ZY, 2004, LIFE SCI, V74, P1561, DOI 10.1016/j.lfs.2003.09.042; ter Horst EN, 2015, INT J MOL SCI, V16, P29583, DOI 10.3390/ijms161226187; Tomura S, 2014, J VET MED SCI, V76, P1641, DOI 10.1292/jvms.14-0166; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Van Craeyveld E, 2012, GENE THER, V19, P860, DOI 10.1038/gt.2011.147; van den Bome SWM, 2009, CARDIOVASC PATHOL, V18, P37, DOI 10.1016/j.carpath.2007.12.012; Vanhoutte D, 2006, CARDIOVASC RES, V69, P604, DOI 10.1016/j.cardiores.2005.10.002; Weinberger T, 2015, FRONTIERS PHYSL; White DA, 2014, J MOL CELL CARDIOL, V69, P32, DOI 10.1016/j.yjmcc.2014.01.015; Yip HK, 2003, CHEST, V124, P565, DOI 10.1378/chest.124.2.565; Zhou LS, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0053-8	43	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187894	10.1371/journal.pone.0187894	http://dx.doi.org/10.1371/journal.pone.0187894			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121663	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900089
J	Lahiri, S; Nghe, P; Tans, SJ; Rosinberg, ML; Lacoste, D				Lahiri, Sourabh; Nghe, Philippe; Tans, Sander J.; Rosinberg, Martin Luc; Lacoste, David			Information-theoretic analysis of the directional influence between cellular processes	PLOS ONE			English	Article								Inferring the directionality of interactions between cellular processes is a major challenge in systems biology. Time-lagged correlations allow to discriminate between alternative models, but they still rely on assumed underlying interactions. Here, we use the transfer entropy (TE), an information-theoretic quantity that quantifies the directional influence between fluctuating variables in a model-free way. We present a theoretical approach to compute the transfer entropy, even when the noise has an extrinsic component or in the presence of feedback. We re-analyze the experimental data from Kiviet et al. (2014) where fluctuations in gene expression of metabolic enzymes and growth rate have been measured in single cells of E. coli. We confirm the formerly detected modes between growth and gene expression, while prescribing more stringent conditions on the structure of noise sources. We furthermore point out practical requirements in terms of length of time series and sampling time which must be satisfied in order to infer optimally transfer entropy from times series of fluctuations.	[Lahiri, Sourabh; Lacoste, David] PSL Res Univ, ESPCI, Gulliver Lab, 10 Rue Vauquelin, F-75231 Paris 05, France; [Nghe, Philippe] PSL Res Univ, ESPCI, Lab Biochem, 10 Rue Vauquelin, F-75231 Paris 05, France; [Tans, Sander J.] FOM Inst AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands; [Rosinberg, Martin Luc] Univ Paris 06, CNRS, UMR 7600, Lab Phys Theor Matiere Condensee, 4 Pl Jussieu, F-75252 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); AMOLF; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Lacoste, D (corresponding author), PSL Res Univ, ESPCI, Gulliver Lab, 10 Rue Vauquelin, F-75231 Paris 05, France.	david.lacoste@espci.fr	Nghe, Philippe/AAB-3575-2019; Lacoste, David/AAD-6426-2021; Tans, Sander/AAS-2901-2020; Lahiri, Sourabh/AAB-3132-2019; Lacoste, David/L-4920-2016	Nghe, Philippe/0000-0003-3690-4610; Lacoste, David/0000-0002-5735-4657	Institute of Complex Systems (ISC-PIF); Region Ile-de-France; Labex CelTisPhyBio part of the IDEX PSL [ANR-10-LBX-0038, ANR-10-IDEX-0001-02 PSL]	Institute of Complex Systems (ISC-PIF); Region Ile-de-France(Region Ile-de-France); Labex CelTisPhyBio part of the IDEX PSL	S.L. thanks the Institute of Complex Systems (ISC-PIF), the Region Ile-de-France, and the Labex CelTisPhyBio (No. ANR-10-LBX-0038) part of the IDEX PSL (No. ANR-10-IDEX-0001-02 PSL) for financial support (to DL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge J. Lizier for many insightful comments regarding the numerical evaluation of transfer entropies, and L. Peliti for stimulating discussions. S.L. thanks the Institute of Complex Systems (ISC-PIF), the Region Ile-de-France, and the Labex CelTisPhyBio (No. ANR-10-LBX-0038) part of the IDEX PSL (No. ANR-10-IDEX-0001-02 PSL) for financial support.	Affeldt S, 2016, BMC BIOINFORMATICS, V17; Allahverdyan AE, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/P09011; Barnett L, 2017, J NEUROSCI METH, V275, P93, DOI 10.1016/j.jneumeth.2016.10.016; Bowsher CG, 2012, P NATL ACAD SCI USA, V109, pE1320, DOI 10.1073/pnas.1119407109; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hartich D, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/02/P02016; Hartich D, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.022116; Horowitz JM, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/12/125007; Horowitz JM, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031015; Ito S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8498; Kim KH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.120602; Kiviet DJ, 2014, NATURE, V514, P376, DOI 10.1038/nature13582; Kobayashi TJ, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.238102; Lassig M, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0077; Lizier JT, 2010, EUR PHYS J B, V73, P605, DOI 10.1140/epjb/e2010-00034-5; Lizier JT, 2014, FRONT ROBOT AI, DOI 10.3389/frobt.2014.00011; Monteoliva D, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.012403; Munakata T, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/06/P06014; Pahle J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-139; Parrondo JMR, 2015, NAT PHYS, V11, P131, DOI 10.1038/NPHYS3230; Prill RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125777; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Sauer T, 2013, WIRES COMPUT STAT, V5, P362, DOI 10.1002/wics.1272; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tishby Naftali, 2000, P 37 ANN ALL C COMM, Patent No. [physics/0004057, 0004057]; Tostevin F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218101; Tusch S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.180604; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809	32	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187431	10.1371/journal.pone.0187431	http://dx.doi.org/10.1371/journal.pone.0187431			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121044	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900037
J	Muqaddasi, QH; Pillen, K; Plieske, J; Ganal, MW; Roder, MS				Muqaddasi, Quddoos H.; Pillen, Klaus; Plieske, Joerg; Ganal, Martin W.; Roeder, Marion S.			Genetic and physical mapping of anther extrusion in elite European winter wheat	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; DWARFING GENES; BREAD WHEAT; GIBBERELLIN; ASSOCIATION; ARCHITECTURE; INHERITANCE; SUPPRESSION; POLLINATION; TRAITS	The production and cultivation of hybrid wheat is a possible strategy to close the yield gap in wheat. Efficient hybrid wheat seed production largely depends on high rates of cross-pollination which can be ensured through high anther extrusion (AE) by male parental lines. Here, we report the AE capacity and elucidate its genetics in 514 elite European winter wheat varieties via genome-wide association studies (GWAS). We observed a wide range of variation among genotypes and a high heritability (0.80) for AE. The whole panel was genotyped with the 35k Affymetrix and 90k iSELECT single nucleotide polymorphism (SNP) arrays plus Ppd-D1, Rht-B1 and Rht-D1 candidate markers. GWAS revealed 51 marker-trait associations (MTAs) on chromosomes 1A, 1B, 2A, 4D and 5B, with Rht-D1 (4D) being the most significant marker. Division of whole panel according to the Rht-D1 genotype resulted in 212 and 294 varieties harboring Rht-D1a and Rht-D1b allele, respectively. The presence of Rht-D1a compared to Rht-D1b (mutant) allele had a large phenotypic influence on AE resulting in its similar to 17% increase. GWAS performed on the sub-panels detected novel MTAs on chromosomes 2D, 3B and 6A with increased phenotypic variance imparted by individual markers. Our study shows that AE is a highly quantitative trait and wild type Rht-D1a allele greatly improves AE. Moreover, demarcating the quantitative trait loci regions based on intra-chromosomal linkage disequilibrium revealed AE's candidate genes/genomic regions. Understanding the genetics of AE in elite European wheat and utilizing the linked markers in breeding programs can help to enhance cross-pollination for better exploitation of heterosis.	[Muqaddasi, Quddoos H.; Roeder, Marion S.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Stadt Seeland Ot Gatersl, Germany; [Pillen, Klaus] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutrit Sci, Halle, Germany; [Plieske, Joerg; Ganal, Martin W.] TraitGenet GmbH, Stadt Seeland Ot Gatersl, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Martin Luther University Halle Wittenberg	Muqaddasi, QH (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Stadt Seeland Ot Gatersl, Germany.	muqaddasi@ipk-gatersleben.de	Pillen, Klaus/I-6511-2012	Pillen, Klaus/0000-0003-4646-6351; Roder, Marion/0000-0002-9313-0650; Muqaddasi, Quddoos/0000-0001-5961-7273	BMBF [0315947]; program Grants4Traits from Bayer Crop Science (BCS)	BMBF(Federal Ministry of Education & Research (BMBF)); program Grants4Traits from Bayer Crop Science (BCS)	The genotyping data were generated in the project VALID funded by BMBF (project number 0315947). This research is supported by the program Grants4Traits from Bayer Crop Science (BCS). Both funders provided support in the form of contributions to salaries (BMBF for JP; BCS for QHM) and research materials, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen AM, 2017, PLANT BIOTECHNOL J, V15, P390, DOI 10.1111/pbi.12635; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Boeven PHG, 2016, THEOR APPL GENET, V129, P2343, DOI 10.1007/s00122-016-2771-6; Borrill P, 2016, PLANT PHYSIOL, V170, P2172, DOI 10.1104/pp.15.01667; Buerstmayr M, 2015, THEOR APPL GENET, V128, P1519, DOI 10.1007/s00122-015-2527-8; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Chhun T, 2007, PLANT CELL, V19, P3876, DOI 10.1105/tpc.107.054759; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; DEVRIES AP, 1973, EUPHYTICA, V22, P445, DOI 10.1007/BF00036640; DEVRIES AP, 1971, EUPHYTICA, V20, P152, DOI 10.1007/BF00056076; DSOUZA L, 1970, Z PFLANZENZUCHTUNG, V63, P246; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; Frichot E, 2015, METHODS ECOL EVOL, V6, P925, DOI 10.1111/2041-210X.12382; Frichot E, 2014, GENETICS, V196, P973, DOI 10.1534/genetics.113.160572; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Kempe K, 2011, MOL BREEDING, V27, P417, DOI 10.1007/s11032-011-9555-0; Langer SM, 2014, PLANT BREEDING, V133, P433, DOI 10.1111/pbr.12192; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu W, 2013, HEREDITY, V110, P71, DOI 10.1038/hdy.2012.63; Longin CFH, 2012, THEOR APPL GENET, V125, P1087, DOI 10.1007/s00122-012-1967-7; Lu QX, 2013, THEOR APPL GENET, V126, P317, DOI 10.1007/s00122-012-1981-9; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Muqaddasi QH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00754; Muqaddasi QH, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1863-y; Muqaddasi QH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155494; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; Ning SZ, 2013, BREEDING SCI, V63, P255, DOI 10.1270/jsbbs.63.255; Ning SZ, 2013, THEOR APPL GENET, V126, P1273, DOI 10.1007/s00122-013-2052-6; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pickett A.A., 1993, HYBRID WHEAT RESULTS; R Core Team, 2021, R LANGUAGE ENV STAT; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SAGE GCM, 1974, THEOR APPL GENET, V45, P126, DOI 10.1007/BF00291142; Schnable PS, 2013, ANNU REV PLANT BIOL, V64, P71, DOI 10.1146/annurev-arplant-042110-103827; Skinnes H, 2010, PLANT BREEDING, V129, P149, DOI 10.1111/j.1439-0523.2009.01731.x; Spannagl M, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-35; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Waines JG, 2003, CROP SCI, V43, P451, DOI 10.2135/cropsci2003.0451; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Weir BS, 1996, GENETIC DATA ANAL, P73; Whitford R, 2013, J EXP BOT, V64, P5411, DOI 10.1093/jxb/ert333; Wu MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154501; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Youssef HM, 2017, NAT GENET, V49, P157, DOI 10.1038/ng.3717; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	55	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187744	10.1371/journal.pone.0187744	http://dx.doi.org/10.1371/journal.pone.0187744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121111	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900070
J	Stagegaard, J; Kurth, A; Stern, D; Dabrowski, PW; Pocknell, A; Nitsche, A; Schrick, L				Stagegaard, Julia; Kurth, Andreas; Stern, Daniel; Dabrowski, Piotr Wojciech; Pocknell, Ann; Nitsche, Andreas; Schrick, Livia			Seasonal recurrence of cowpox virus outbreaks in captive cheetahs (Acinonyx jubatus)	PLOS ONE			English	Article							MONGOOSES MUNGOS-MUNGO; FELINE COWPOX; INFECTION; ORTHOPOXVIRUS; ALGORITHMS; ALIGNMENT; RESERVOIR; DISEASE; GERMANY	Cowpox virus infections in captive cheetahs (Acinonyx jubatus) with high morbidity and mortality have already been reported in the UK and Russia in the 1970s. However, most of the reported cases have been singular events. Here, we report a total of five cowpox virus outbreaks in cheetahs in the same safari park in Denmark between 2010 and 2014. Nine cheetahs showed varying severity of clinical disease; two of them died (22%). All episodes occurred between August and October of the respective year. No other carnivores kept at the same institution nor the keepers taking care of the animals were clinically affected. The clinical picture of cowpox was confirmed by extensive laboratory investigations including histopathological and molecular analyses as well as cell culture isolation of a cowpox virus. High anti-orthopoxvirus antibody titers were detected in all 9 diseased cheetahs compared to seven contact cheetahs without clinical signs and 13 cheetahs not in direct contact. Additionally, whole genome sequencing from one sample of each cluster with subsequent phylogenetic analysis showed that the viruses from different outbreaks have individual sequences but clearly form a clade distinct from other cowpox viruses. However, the intra-clade distances are still larger than those usually observed within clades of one event. These findings indicate multiple and separate introductions of cowpox virus, probably from wild rodent populations, where the virus keeps circulating naturally and is only sporadically introduced into the cheetahs. Sero-positivity of voles (Arvicola amphibious) caught in zoo grounds strengthens this hypothesis. As a consequence, recommendations are given for medical and physical management of diseased cheetahs, for hygienic measures as well as for pre-shipment isolation before cheetah export from zoo grounds.	[Stagegaard, Julia] Ree Pk Safari, Ebeltoft, Denmark; [Kurth, Andreas; Stern, Daniel; Nitsche, Andreas; Schrick, Livia] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany; [Kurth, Andreas; Nitsche, Andreas; Schrick, Livia] Robert Koch Inst, German Consultant Lab Poxviruses, Berlin, Germany; [Dabrowski, Piotr Wojciech] Robert Koch Inst, Methodol & Res Infrastruct, Berlin, Germany; [Pocknell, Ann] Finn Pathologists, Norfolk, England	Robert Koch Institute; Robert Koch Institute; Robert Koch Institute	Nitsche, A (corresponding author), Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany.; Nitsche, A (corresponding author), Robert Koch Inst, German Consultant Lab Poxviruses, Berlin, Germany.	NitscheA@rki.de	Stern, Daniel/AAF-6280-2020; Dabrowski, Piotr Wojtek/L-1423-2015	Stern, Daniel/0000-0001-9057-4283; Dabrowski, Piotr Wojtek/0000-0003-4893-805X; Nitsche, Andreas/0000-0001-8185-3176				Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; BAXBY D, 1982, J HYG-CAMBRIDGE, V89, P365, DOI 10.1017/S0022172400070935; BAXBY D, 1994, ENCY VIROLOGY, P261; BENNETT M, 1986, VET REC, V118, P387, DOI 10.1136/vr.118.14.387; BENNETT M, 2008, ENCY VIROLOGY, P574; Boulanger D, 1996, VET REC, V138, P247, DOI 10.1136/vr.138.11.247; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423; Drake GJ, 2012, P AAZV C, P224; Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x; Feore SM, 1997, P ROY SOC B-BIOL SCI, V264, P1457, DOI 10.1098/rspb.1997.0202; Gavrilova EV, 2010, J CLIN VIROL, V49, P37, DOI 10.1016/j.jcv.2010.06.003; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hazel SM, 2000, EPIDEMIOL INFECT, V124, P551, DOI 10.1017/S0950268899003799; HEENEY JL, 1990, J VIROL, V64, P1964, DOI 10.1128/JVI.64.5.1964-1972.1990; Juncker-Voss M, 2004, BERL MUNCH TIERARZTL, V117, P404; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kaysser P, 2010, VET MICROBIOL, V141, P282, DOI 10.1016/j.vetmic.2009.09.029; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kurth A, 2011, FOWLERS ZOO WILD ANI, V7, P32; Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817; Kurth A, 2007, FUTURE VIROL, V2, P467, DOI 10.2217/17460794.2.5.467; Kurth A, 2011, METHODS MOL BIOL, V665, P257, DOI 10.1007/978-1-60761-817-1_15; Kurth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006883; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; MARENNIKOVA SS, 1977, J INFECT DIS, V135, P358, DOI 10.1093/infdis/135.3.358; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; Pfeffer M, 2002, VET REC, V150, P50, DOI 10.1136/vr.150.2.50; Schmiedeknecht G, 2010, VET PATHOL, V47, P547, DOI 10.1177/0300985810363703; Stern D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150110; Tausch SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137896; Wolters M, 2008, TRANSMISSIBLE DIS HD, P3; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	34	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187089	10.1371/journal.pone.0187089	http://dx.doi.org/10.1371/journal.pone.0187089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121668	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900018
J	Yang, C; Liu, JB; Wu, XY; Bao, PJ; Long, RJ; Guo, X; Ding, XZ; Yan, P				Yang, Chao; Liu, Jianbin; Wu, Xiaoyun; Bao, Pengjia; Long, Ruijun; Guo, Xian; Ding, Xuezhi; Yan, Ping			The response of gene expression associated with lipid metabolism, fat deposition and fatty acid profile in the longissimus dorsi muscle of Gannan yaks to different energy levels of diets	PLOS ONE			English	Article							RUMEN-PROTECTED FAT; BINDING PROTEIN; ADIPOSE-TISSUE; PPAR-ALPHA; BEEF; MEAT; BULLS; PERFORMANCE; ACTIVATION; CARCASS	The energy available from the diet, which affects fat deposition in vivo, is a major factor in the expression of genes regulating fat deposition in the longissimus dorsi muscle. Providing high-energy diets to yaks might increase intramuscular fat deposition and fatty acid concentrations under a traditional grazing system in cold seasons. A total of fifteen adult castrated male yaks with an initial body weight 274.3 +/- 3.14 kg were analyzed for intramuscular adipose deposition and fatty acid composition. The animals were divided into three groups and fed low-energy (LE: 5.5 MJ/kg), medium-energy (ME: 6.2 MJ/kg) and high-energy (HE: 6.9 MJ/kg) diets, respectively. All animals were fed ad libitum twice daily at 08:00-09:00 am and 17:00-18:00 pm and with free access to water for 74 days, including a 14-d period to adapt to the diets and the environment. Intramuscular fat (IMF) content, fatty acid profile and mRNA levels of genes involved in fatty acid synthesis were determined. The energy levels of the diets significantly (P < 0.05) affected the content of IMF, total SFA, total MUFA and total PUFA. C16:0, C18:0 and C18:1n9c account for a large proportion of total fatty acids. Relative expression of acetyl-CoA carboxylase (ACACA), fatty acid synthase (FASN), stearoyl-CoA desaturase (SCD), sterol regulatory element-binding protein-1c (SREBP-1c), peroxisome proliferator-activated receptor. (PPAR.) and fatty acid-binding protein 4 (FABP4) was greater in HE than in LE yaks (P < 0.05). Moreover, ME yaks had higher (P < 0.05) mRNA expression levels of PPAR., ACACA, FASN, SCD and FABP4 than did the LE yaks. The results demonstrate that the higher energy level of the diets increased IMF deposition and fatty acid content as well as increased intramuscular lipogenic gene expression during the experimental period.	[Yang, Chao; Liu, Jianbin; Wu, Xiaoyun; Bao, Pengjia; Guo, Xian; Ding, Xuezhi; Yan, Ping] Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Key Lab Yak Breeding Engn, Lanzhou, Gansu, Peoples R China; [Yang, Chao] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Pastoral Agr Ecosyst, Lanzhou, Gansu, Peoples R China; [Yang, Chao; Long, Ruijun] Lanzhou Univ, Int Ctr Tibetan Plateau Ecosyst Management, Lanzhou, Gansu, Peoples R China; [Long, Ruijun] Lanzhou Univ, Sch Life Sci, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; Lanzhou University; Lanzhou University; Lanzhou University	Guo, X; Ding, XZ; Yan, P (corresponding author), Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Key Lab Yak Breeding Engn, Lanzhou, Gansu, Peoples R China.; Long, RJ (corresponding author), Lanzhou Univ, Int Ctr Tibetan Plateau Ecosyst Management, Lanzhou, Gansu, Peoples R China.; Long, RJ (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou, Gansu, Peoples R China.	longrj@lzu.edu.cn; guoxian@caas.cn; dingxuezhi@caas.cn; pingyanlz@163.com			National Natural Science Foundation of China [314691143020]; International cooperation projects in Gansu province [1504WKCA053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International cooperation projects in Gansu province	This work is supported by the International cooperation and exchange program of the National Natural Science Foundation of China (NO.314691143020) and International cooperation projects in Gansu province (No.1504WKCA053) to XD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, BIOCHEM GENET, V47, P397, DOI 10.1007/s10528-009-9235-5; [Anonymous], [No title captured]; Beam TM, 2000, J DAIRY SCI, V83, P2564, DOI 10.3168/jds.S0022-0302(00)75149-6; Bednarova A, 2013, CHEM PAP, V67, P274, DOI 10.2478/s11696-012-0179-6; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Boone C, 2000, REPROD NUTR DEV, V40, P325, DOI 10.1051/rnd:2000103; CABEZAS MT, 1965, J ANIM SCI, V24, P57, DOI 10.2527/jas1965.24157x; da Costa N, 2004, J NUTR, V134, P2191, DOI 10.1093/jn/134.9.2191; De Smet S, 2000, MEAT SCI, V56, P73, DOI 10.1016/S0309-1740(00)00023-1; Di Luccia A, 2003, MEAT SCI, V65, P1379, DOI 10.1016/S0309-1740(03)00060-3; Ding ST, 2003, NUTR RES, V23, P1059, DOI 10.1016/S0271-5317(03)00081-2; Ding XZ, 2012, LIVEST SCI, V143, P29, DOI 10.1016/j.livsci.2011.08.004; Enser M, 1996, MEAT SCI, V42, P443, DOI 10.1016/0309-1740(95)00037-2; Fernandez X, 1999, MEAT SCI, V53, P59, DOI 10.1016/S0309-1740(99)00037-6; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gerbens F, 2001, J ANIM SCI, V79, P347; Gilbert CD, 2003, J ANIM SCI, V81, P2457; Gondret F, 2002, J ANIM SCI, V80, P3184; Graugnard DE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-142; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hausman GJ, 2009, J ANIM SCI, V87, P1218, DOI 10.2527/jas.2008-1427; JENKINS TC, 1993, J DAIRY SCI, V76, P3851, DOI 10.3168/jds.S0022-0302(93)77727-9; Jeong J, 2012, J ANIM SCI, V90, P2044, DOI 10.2527/jas.2011-4753; Jeukendrup AE, 2002, ANN NY ACAD SCI, V967, P217; Jurie C, 2007, J ANIM SCI, V85, P2660, DOI 10.2527/jas.2006-837; Kadegowda AKG, 2009, J DAIRY SCI, V92, P4276, DOI 10.3168/jds.2008-1932; Katsumata Masaya, 2005, Animal Science Journal, V76, P237, DOI 10.1111/j.1740-0929.2005.00261.x; Konig B, 2009, EUR J PHARMACOL, V605, P23, DOI 10.1016/j.ejphar.2009.01.009; Ladeira MM, 2014, MEAT SCI, V96, P597, DOI 10.1016/j.meatsci.2013.04.062; Li C, 2012, ANIM GENET, V43, P93, DOI 10.1111/j.1365-2052.2011.02217.x; Lim D, INT J BIOL; Lo Fiego DP, 2005, MEAT SCI, V69, P107, DOI 10.1016/j.meatsci.2004.06.010; Long RJ, 2008, RANGELAND J, V30, P241, DOI 10.1071/RJ08012; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Mandell IB, 1998, J ANIM SCI, V76, P2619; Matsumoto H, 2012, MOL BIOL REP, V39, P8637, DOI 10.1007/s11033-012-1718-5; McManus S, 2016, J LIPID RES, V57, P1720, DOI 10.1194/jlr.M067801; Montgomery SP, 2008, J ANIM SCI, V86, P640, DOI 10.2527/jas.2006-812; Oliveira DM, 2014, J ANIM SCI, V92, P5426, DOI 10.2527/jas.2014-7855; Oliveira DM, 2011, J ANIM SCI, V89, P2546, DOI 10.2527/jas.2010-3553; Peng QH, 2012, J FOOD AGRIC ENVIRON, V10, P404; Pfeuffer M, 2016, ADV NUTR, V7, P730, DOI 10.3945/an.115.011387; Pol KJV, 2009, J ANIM SCI, V87, P639, DOI 10.2527/jas.2008-1036; Qin W, 2015, GENET MOL RES, V14, P14469, DOI 10.4238/2015.November.18.9; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Renaville B, 2006, BRIT J NUTR, V95, P688, DOI 10.1079/BJN20061717; Ribeiro RG, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-124; Rosa HJD, 2014, J ANIM SCI, V92, P3701, DOI 10.2527/jas.2013-6982; Scheeder MRL, 2001, MEAT SCI, V58, P321, DOI 10.1016/S0309-1740(01)00037-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Takahashi Nobuyuki, 2005, Nihon Rinsho, V63, P557; Taniguchi M, 2008, BIOCHEM BIOPH RES CO, V366, P54, DOI 10.1016/j.bbrc.2007.11.110; VERNON R G, 1980, Progress in Lipid Research, V19, P23, DOI 10.1016/0163-7827(80)90007-7; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Wang JF, 2012, SPAT STAT-NETH, V2, P1, DOI [10.1016/j.spasta.2012.08.001, 10.1155/2012/279560]; WESTERLING DB, 1979, J ANIM SCI, V48, P1343, DOI 10.2527/jas1979.4861343x; Xu J, 2001, J BIOL CHEM, V276, P9800, DOI 10.1074/jbc.M008973200; Yao D, 2016, J CELL PHYSL; Zhang H, 2015, ANIM SCI J; Zhang HB, 2016, ANIM SCI J, V87, P517, DOI 10.1111/asj.12447; Zhang HB, 2015, ANIM SCI J, V86, P392, DOI 10.1111/asj.12316; Zhang S, 2007, J ANIM SCI, V85, P583, DOI 10.2527/jas.2006-239; Zhong CL, 2016, ANIM PROD SCI	65	15	16	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187604	10.1371/journal.pone.0187604	http://dx.doi.org/10.1371/journal.pone.0187604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121115	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900055
J	Sera, F; Griffiths, LJ; Dezateux, C; Geraci, M; Cortina-Borja, M				Sera, Francesco; Griffiths, Lucy J.; Dezateux, Carol; Geraci, Marco; Cortina-Borja, Mario			Using functional data analysis to understand daily activity levels and patterns in primary school-aged children: Cross-sectional analysis of a UK-wide study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; TIME; DETERMINANTS; PEOPLE; MODELS	Background Temporal characterisation of physical activity in children is required for effective strategies to increase physical activity (PA). Evidence regarding determinants of physical activity in childhood and their time-dependent patterns remain inconclusive. We used functional data analysis (FDA) to model temporal profiles of daily activity, measured objectively using accelerometers, to identify diurnal and seasonal PA patterns in a nationally representative sample of primary school-aged UK children. We hypothesised that PA levels would be lower in girls than boys at play times and after school, higher in children participating in social forms of exercise (such as sport or play), and lower among those not walking to school. Methods Children participating in the UK-wide Millennium Cohort Study wore an Actigraph GT1 M accelerometer for seven consecutive days during waking hours. We modelled 6,497 daily PA profiles from singleton children (3,176 boys; mean age: 7.5 years) by means of splines, and used functional analysis of variance to examine the cross-sectional relation of time and place of measurement, demographic and behavioural characteristics to smoothed PA profiles. Results Diurnal and time-specific patterns of activity showed significant variation by sex, ethnicity, UK country and season of measurement; girls were markedly less active than boys during school break times than boys, and children of Indian ethnicity were significantly less active during school hours (9:30-12:00). Social activities such as sport clubs, playing with friends were associated with higher level of PA in afternoon (15:00-17:30) and early evenings (17:30-19:30). Lower PA levels between 8:30-9:30 and 17:30-19:30 were associated with mode of travel to and from school, and number of cars in regular use in the household. Conclusion Diminished PA in primary school aged children is temporally patterned and related to modifiable behavioural factors. FDA can be used to inform and evaluate public health policies to promote childhood PA.	[Sera, Francesco] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London, England; [Griffiths, Lucy J.; Dezateux, Carol; Cortina-Borja, Mario] UCL Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London, England; [Geraci, Marco] Univ South Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of South Carolina System; University of South Carolina Columbia	Cortina-Borja, M (corresponding author), UCL Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London, England.	m.cortina@ucl.ac.uk	Borja, Mario Cortina/A-3847-2009; Geraci, Marco/B-9588-2009	Borja, Mario Cortina/0000-0003-0627-2624; Geraci, Marco/0000-0002-6311-8685; Griffiths, Lucy/0000-0001-9230-624X; Dezateux, Carol/0000-0001-9787-6276; Sera, Francesco/0000-0002-8890-6848	Economic and Social Research Council; Wellcome Trust [084686/Z/08/A]; Medical Research Council [G0400546]; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; National Institute of Child Health and Human Development - National Institutes of Health [1 R03 HD084807-01A1]; MRC [G0400546] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); National Institute of Child Health and Human Development - National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Millennium Cohort Study is funded by grants to former and current directors of the study from the Economic and Social Research Council (Professors Joshi, Platt and Fitzsimons). The physical activity study was funded by the Wellcome Trust (principal investigator Carol Dezateux; grant 084686/Z/08/A), and was supported in part by the Medical Research Council through funding for the former MRC Centre of Epidemiology for Child Health (principal investigator Carol Dezateux; grant G0400546). Research at the UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children receives a proportion of the funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. Marco Geraci was supported by funding received from the National Institute of Child Health and Human Development - National Institutes of Health (Grant Number: 1 R03 HD084807-01A1).	[Anonymous], 2014, R LANG ENV STAT COMP; Arvidsson D, 2012, MED SCI SPORTS EXERC; Atkin AJ, 2016, PREV MED, V87, P167, DOI 10.1016/j.ypmed.2016.02.040; Atkin AJ, 2016, MED SCI SPORT EXER, V48, P449, DOI 10.1249/MSS.0000000000000786; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Brooke Hannah L, 2016, Prev Med Rep, V4, P585; Brooke HL, 2014, SPORTS MED, V44, P1427, DOI 10.1007/s40279-014-0215-5; Condello G, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0510-2; Cooper AR, 2005, AM J PREV MED, V29, P179, DOI 10.1016/j.amepre.2005.05.009; Cooper AR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0274-5; De Baere S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2093-7; Department of Health, 2011, START ACT STAY ACT R; Esliger D.W., 2007, CANADIAN J PUBLIC S2, V98, P195; Fan Ruzong, 2015, Journal of Circadian Rhythms, V13, P3, DOI 10.5334/jcr.ac; Geraci M, 2012, TECHNICAL REPORT ACC; Geraci M., PAWACC PHYS ACTIVITY; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Goldsmith J, 2016, MED SCI SPORT EXER, V48, P1723, DOI 10.1249/MSS.0000000000000968; Griffiths LR, 2013, TECHNICAL REPORT ENH; Griffiths LJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002893; Hansen K., 2014, MILLENNIUM COHORT ST; Hesketh KR, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-1; HM Government, CHILDH OB PLAN ACT; Hubbard K, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0358-x; Li X, 2017, J EPIDEMIOL COMMUNIT; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; McCullagh P, 1989, GEN LINEAR MODELS; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; Morris JS, 2006, J AM STAT ASSOC, V101, P1352, DOI 10.1198/016214506000000465; Mota J, 2005, J SPORT SCI, V23, P269, DOI 10.1080/02640410410001730124; Page A, 2005, INT J OBESITY, V29, P1070, DOI 10.1038/sj.ijo.0802993; Plewis I., 2007, MILLENNIUM COHORT ST; Ramsay J. O., 2002, APPL FUNCTIONAL DATA, DOI 10.1111/j.1467-985x.2004.t01-5-.x; Ramsay JO, 2014, FUNCTIONAL DATA ANAL; Ramsay JO, 2017, PACKAGE FDA FUNCTION; Rich C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085134; Rich C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067206; Rich C, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-49; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Smith Kate, 2002, Popul Trends, P30; Sorensen H, 2013, STAT MED, V32, P5222, DOI 10.1002/sim.5989; Stanley RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096460; Stanley RM, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-50; Uijtdewilligen L, 2011, BRIT J SPORT MED, V45, P896, DOI 10.1136/bjsports-2011-090197; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Wood S.N., 2017, GEN ADDITIVE MODELS	48	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187677	10.1371/journal.pone.0187677	http://dx.doi.org/10.1371/journal.pone.0187677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117203	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000414659600060
J	Straub, J; Paula, H; Mayr, M; Kasper, D; Assadian, O; Berger, A; Rittenschober-Bohm, J				Straub, Julia; Paula, Helga; Mayr, Michaels; Kasper, David; Assadian, Ojan; Berger, Angelika; Rittenschober-Boehm, Judith			Diagnostic accuracy of the ROCHE Septifast PCR system for the rapid detection of blood pathogens in neonatal sepsis-A prospective clinical trial	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; LATE-ONSET SEPSIS; REAL-TIME PCR; STREAM INFECTIONS; SUSPECTED SEPSIS; SURVEILLANCE SYSTEM; MOLECULAR-DETECTION; RESEARCH NETWORK; MULTIPLEX PCR; CULTURE	Introduction Diagnosis of neonatal sepsis remains a major challenge in neonatology. Most molecular based methods are not customized for neonatal requirements. The aim of the present study was to assess the diagnostic accuracy of a modified multiplex PCR protocol for the detection of neonatal sepsis using small blood volumes. Methods 212 episodes of suspected neonatal late onset sepsis were analyzed prospectively using the Roche SeptiFast MGRADE PCR with a modified DNA extraction protocol and software-handling tool. Results were compared to blood culture, laboratory biomarkers and clinical signs of sepsis. Results Of 212 episodes, 85 (40.1%) were categorized as "not infected". Among these episodes, 1 was false positive by blood culture (1.2%) and 23 were false positive by PCR (27.1%). Of 51 (24.1%) episodes diagnosed as "culture proven sepsis", the same pathogen was detected by blood culture and PCR in 39 episodes (76.5%). In 8 episodes, more pathogens were detected by PCR compared to blood culture, and in 4 episodes the pathogen detected by blood culture was not found by PCR. One of these episodes was caused by Bacillus cereus, a pathogen not included in the PCR panel. In 76/212 (35.8%) episodes, clinical sepsis was diagnosed. Among these, PCR yielded positive results in 39.5% of episodes (30/76 episodes). For culture-positive sepsis, PCR showed a sensitivity of 90.2% (95%CI 86.2-94.2%) and a specificity of 72.9% (95%CI 67.0-79.0%). Conclusion The Roche SeptiFast (R) MGRADE PCR using a modified DNA extraction protocol showed acceptable results for rapid detection of neonatal sepsis in addition to conventional blood culture. The benefit of rapid pathogen detection has to be balanced against the considerable risk of contamination, loss of information on antibiotic sensitivity pattern and increased costs.	[Straub, Julia; Mayr, Michaels; Berger, Angelika; Rittenschober-Boehm, Judith] Med Univ Vienna, Div Neonatol Pediat Intens Care & Neuropediat, Dept Pediat & Adolescent Med, Vienna, Austria; [Paula, Helga; Assadian, Ojan] Med Univ Vienna, Dept Hosp Epidemiol & Infect Control, Vienna, Austria; [Kasper, David] Med Univ Vienna, Dept Pediat & Adolescent Med, Res Core Unit Pediat Biochem & Analyt, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Rittenschober-Bohm, J (corresponding author), Med Univ Vienna, Div Neonatol Pediat Intens Care & Neuropediat, Dept Pediat & Adolescent Med, Vienna, Austria.	Judith.rittenschober-boehm@meduniwien.ac.at		Rittenschober-Bohm, Judith/0000-0003-2361-7196; Berger, Angelika/0000-0001-8775-2405	Oesterreichische Nationalbank (OeNB) Anniversary Fund [14277]	Oesterreichische Nationalbank (OeNB) Anniversary Fund	AB received a Grant of the Oesterreichische Nationalbank (OeNB, www.oenb.at) Anniversary Fund (Nr. 14277). Roche Diagnostics Vienna, Austria, provided equipment and reagents for PCR analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron E.J., 1999, MANUAL CLIN MICROBIO, V7th; Benjamin Daniel K, 2004, J Perinatol, V24, P175, DOI 10.1038/sj.jp.7211068; Boghossian NS, 2013, J PEDIATR-US, V162, P1120, DOI 10.1016/j.jpeds.2012.11.089; Chang SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062323; Chiesa C, 2004, CLIN CHEM, V50, P279, DOI 10.1373/clinchem.2003.025171; Cotten C Michael, 2005, J Perinatol, V25, P650; Dark P, 2015, INTENS CARE MED, V41, P21, DOI 10.1007/s00134-014-3553-8; Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126; Geffers C, 2008, J HOSP INFECT, V68, P214, DOI 10.1016/j.jhin.2008.01.016; Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1; Idelevich E, 2015, MED MICROBIOL IMMUN, V204, P585, DOI 10.1007/s00430-014-0385-7; Kasper DC, 2013, NEONATOLOGY, V103, P268, DOI 10.1159/000346365; Kaufman D, 2004, CLIN MICROBIOL REV, V17, P638, DOI 10.1128/CMR.17.3.638-680.2004; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Liu CL, 2014, ARCH PEDIATRIE, V21, P162, DOI 10.1016/j.arcped.2013.11.015; Lucignano B, 2011, J CLIN MICROBIOL, V49, P2252, DOI 10.1128/JCM.02460-10; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; Mussap M, 2007, J Chemother, V19 Suppl 2, P31; Perlman SE, 2007, AM J INFECT CONTROL, V35, P177, DOI 10.1016/j.ajic.2006.01.002; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Polin RA, 2014, PEDIATRICS, V133, P1122, DOI 10.1542/peds.2014-0360; Reier-Nilsen T, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-5; Schwab F, 2007, J HOSP INFECT, V65, P319, DOI 10.1016/j.jhin.2006.12.020; Shane AL, 2014, J INFECTION, V68, pS24, DOI 10.1016/j.jinf.2013.09.011; SONG JH, 1993, J CLIN MICROBIOL, V31, P1439, DOI 10.1128/JCM.31.6.1439-1443.1993; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Troger B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159821; Troger B, 2014, PEDIATR INFECT DIS J, V33, P238, DOI 10.1097/INF.0000000000000031; Tsai MH, 2014, PEDIATR INFECT DIS J, V33, pE7, DOI 10.1097/INF.0b013e3182a72ee0; Tschiedel E, 2012, KLIN PADIATR, V224, P12, DOI 10.1055/s-0031-1285878; van den Anker JN, 2014, EARLY HUM DEV, V90, pS10, DOI 10.1016/S0378-3782(14)70004-0; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Wynn JL, 2016, CURR OPIN PEDIATR, V28, P135, DOI 10.1097/MOP.0000000000000315	34	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187688	10.1371/journal.pone.0187688	http://dx.doi.org/10.1371/journal.pone.0187688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117261	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600065
J	Silva, T; Gislason, A; Astthorsson, OS; Marteinsdottir, G				Silva, Teresa; Gislason, Astthor; Astthorsson, Olafur S.; Marteinsdottir, Gudrun			Distribution, maturity and population structure of Meganyctiphanes norvegica and Thysanoessa inermis around Iceland in spring	PLOS ONE			English	Article							LONG-TERM CHANGES; ARCTIC WATERS NORTH; ZOOPLANKTON COMMUNITIES; REPRODUCTION STRATEGIES; OVARIAN DEVELOPMENT; EGG-PRODUCTION; IRMINGER SEA; GROWTH-RATES; KRILL; EUPHAUSIIDS	This study aims to explain the distribution, maturity and population structure of Meganyctiphanes norvegica and Thysanoessa inermis in springtime in relation to main hydrographic regions around Iceland: Atlantic in the southwest, Atlantic-Arctic mixture in the north and Arctic in the east. Krill were collected 14-29 May 2013 using a macrozooplankton trawl. Biomass of both species combined was significantly higher in the southwest than in north and east. M. norvegica clearly dominated in Atlantic waters, whereas T. inermis was more evenly distributed around the island, while the highest values were also observed in the southwest for this species. Simple linear regressions showed that the abundance of M. norvegica was positively related to temperature, salinity and phytoplankton concentration, while the abundance of T. inermis was negatively related to bathymetry. Multiple linear regression analyses did not add to this information of a positive relationship between abundance and temperature for M. norvegica, while T. inermis was shown to be negatively related to both temperature and bathymetry. During the latter half of May, the main spawning of both species was confined to the regions off the southwest coast. Sex ratio (males/females) of M. norvegica was higher in the southwest than in the north and east, whereas T. inermis showed a similar sex ratio all around the island. In all regions, M. norvegica appears to have a lifespan of 2 years while T. inermis of 1 year in the southwest and possibly 2 years in north and east.	[Silva, Teresa; Gislason, Astthor] Marine & Freshwater Res Inst, Pelag Div, Skulagata 4, Reykjavik, Iceland; [Silva, Teresa; Marteinsdottir, Gudrun] Univ Iceland, Inst Biol, Sturlugata 7, Reykjavik, Iceland; [Astthorsson, Olafur S.] Marine & Freshwater Res Inst, Environm Div, Skulagata 4, Reykjavik, Iceland	Marine & Freshwater Research Institute (MFRI); University of Iceland; Marine & Freshwater Research Institute (MFRI)	Silva, T (corresponding author), Marine & Freshwater Res Inst, Pelag Div, Skulagata 4, Reykjavik, Iceland.; Silva, T (corresponding author), Univ Iceland, Inst Biol, Sturlugata 7, Reykjavik, Iceland.	teresa.silva@hafogvatn.is		Marteinsdottir, Gudrun/0000-0001-6939-2434; Silva, Teresa Sofia Giesta da/0000-0003-2724-1288	Marine and Freshwater Research Institute [15.19]; research programme EURO-BASIN - European Union Basin-scale Analysis, Synthesis, and Integration [264933]	Marine and Freshwater Research Institute; research programme EURO-BASIN - European Union Basin-scale Analysis, Synthesis, and Integration	This work was supported by the Marine and Freshwater Research Institute (project number 15.19) and by the research programme EURO-BASIN - European Union Basin-scale Analysis, Synthesis, and Integration (FP7 contract no. 264933).	Agersted MD, 2014, MAR ECOL PROG SER, V516, P139, DOI 10.3354/meps11055; [Anonymous], 2014, HAFRANNSOKNIR, V175, P5; Astthorsson OS, 2007, DEEP-SEA RES PT II, V54, P2456, DOI 10.1016/j.dsr2.2007.07.030; ASTTHORSSON OS, 1987, MAR BIOL, V96, P327, DOI 10.1007/BF00412513; ASTTHORSSON OS, 1995, ICES J MAR SCI, V52, P657, DOI 10.1016/1054-3139(95)80079-4; ASTTHORSSON OS, 1990, MAR BIOL, V107, P147, DOI 10.1007/BF01313252; Astthorsson OS, 1997, MAR BIOL, V129, P319, DOI 10.1007/s002270050172; Astthorsson OS, 1997, SARSIA, V82, P81, DOI 10.1080/00364827.1997.10413641; Beare DJ, 2000, ICES J MAR SCI, V57, P1545, DOI 10.1006/jmsc.2000.0973; Benaglia T, 2009, J STAT SOFTW, V32, P1; BHATTACHARYA CG, 1967, BIOMETRICS, V23, P115, DOI 10.2307/2528285; Cuzin-Roudy J, 1999, MAR BIOL, V133, P267, DOI 10.1007/s002270050466; CUZINROUDY J, 1991, J CRUSTACEAN BIOL, V11, P236, DOI 10.2307/1548361; DALPADADO P, 1991, POLAR RES, V10, P443, DOI 10.1111/j.1751-8369.1991.tb00665.x; Dalpadado P, 1996, MAR ECOL PROG SER, V144, P175, DOI 10.3354/meps144175; DALPADADO P, 1989, J PLANKTON RES, V11, P133, DOI 10.1093/plankt/11.1.133; Dalpadado P, 2006, POLAR BIOL, V29, P849, DOI 10.1007/s00300-006-0123-8; Dalpadado P, 2008, DEEP-SEA RES PT II, V55, P2257, DOI 10.1016/j.dsr2.2008.05.015; Dommasnes A, 2004, ICES J MAR SCI, V61, P739, DOI 10.1016/j.icesjms.2004.04.001; Einarsson H., 1945, NO ATLANTIC SPECIES; Falk-Petersen S, 2000, CAN J FISH AQUAT SCI, V57, P178, DOI 10.1139/cjfas-57-S3-178; FALK-PETERSEN S, 1981, Journal of Plankton Research, V3, P177, DOI 10.1093/plankt/3.2.177; Gayanilo F. C., 2005, FAO ICLARM STOCK ASS; GISLASON A, 1995, J PLANKTON RES, V17, P1959, DOI 10.1093/plankt/17.10.1959; Gislason A, 2004, SARSIA, V89, P467, DOI 10.1080/00364820410009256; Gislason A, 2005, MAR ECOL PROG SER, V286, P177, DOI 10.3354/meps286177; Gudmundsson K, 1998, ICES J MAR SCI, V55, P635, DOI 10.1006/jmsc.1998.0391; Hansen B, 2000, PROG OCEANOGR, V45, P109, DOI 10.1016/S0079-6611(99)00052-X; Jaworski A, 2006, ICES J MAR SCI, V63, P1682, DOI 10.1016/j.icesjms.2006.07.003; Jonsson S, 2005, ICES J MAR SCI, V62, P1350, DOI 10.1016/j.icesjms.2005.05.003; Jonsson S, 2007, PROG OCEANOGR, V73, P231, DOI 10.1016/j.pocean.2006.11.003; Krag LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102168; Letessier TB, 2011, J PLANKTON RES, V33, P1510, DOI 10.1093/plankt/fbr056; LINDLEY JA, 1980, MAR BIOL, V57, P79, DOI 10.1007/BF00387373; LINDLEY JA, 1982, MAR BIOL, V66, P37, DOI 10.1007/BF00397252; Logemann K, 2013, OCEAN SCI DISCUSS, V10, P763, DOI [10.5194/osd-10-763-2013, DOI 10.5194/OSD-10-763-2013]; MALMBERG SA, 1992, ICES MAR SC, V195, P76; Mauchline J., 1980, ADV MAR BIOL, V18, P373; MAUCHLINE J., 1969, BIOL EUPHAUSIIDS; MOTODA SIGERU, 1959, MEM FAC FISH HOKKAIDO UNIV, V7, P73; Palsson OK, 2011, ICES J MAR SCI, V68, P1488, DOI 10.1093/icesjms/fsr057; Paulsen O., 1909, MEDDELELSER KOMMISSI, V1, P1; Petursdottir H, 2012, ICES J MAR SCI, V69, P1277, DOI 10.1093/icesjms/fss125; Pinchuk AI, 2006, J EXP MAR BIOL ECOL, V332, P206, DOI 10.1016/j.jembe.2005.11.019; Raynisson Pall, 2015, Hafrannsoknastofnun Fjolrit, V181, P26; Saunders RA, 2007, PROG OCEANOGR, V72, P313, DOI 10.1016/j.pocean.2006.09.005; Saunders RA, 2013, J MAR BIOL ASSOC UK, V93, P1287, DOI 10.1017/S0025315412001385; Schmidt K, 2010, ADV MAR BIOL, V57, P127, DOI 10.1016/S0065-2881(10)57005-6; Sigurjonsson Johann, 1997, Journal of Northwest Atlantic Fishery Science, V22, P271; Silva T, 2016, MAR BIOL RES; Silva T, 2014, J PLANKTON RES, V36, P1262, DOI 10.1093/plankt/fbu050; Stefansson U, 1962, RIT FISKIDEILDAR, V3, P1; Stephensen K, 1938, ZOOLOGY ICELAND, V3, P1; Tarling GA, 2010, ADV MAR BIOL, V57, P59, DOI 10.1016/S0065-2881(10)57003-2; Valdimarsson H, 1999, RIT FISKIDEILDAR, V16, P23; Valdimarsson H, 2012, ICES J MAR SCI, V69, P816, DOI 10.1093/icesjms/fss027; Zuur Alain F., 2009, P1	57	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187360	10.1371/journal.pone.0187360	http://dx.doi.org/10.1371/journal.pone.0187360			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112989	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100013
J	Ewanchuk, BW; Allan, ERO; Warren, AL; Ramachandran, R; Yates, RM				Ewanchuk, Benjamin W.; Allan, Euan R. O.; Warren, Amy L.; Ramachandran, Rithwik; Yates, Robin M.			The cooling compound icilin attenuates autoimmune neuroinflammation through modulation of the T-cell response	FASEB JOURNAL			English	Article						inflammation; T lymphocytes; neuropharmacology; multiple sclerosis	GENE-RELATED PEPTIDE; CYTOKINE GM-CSF; MULTIPLE-SCLEROSIS; TRPM8 ACTIVATION; CALCIUM-CHANNEL; ION-CHANNEL; COLD; MENTHOL; ENCEPHALOMYELITIS; EXPRESSION	The synthetic supercooling drug, icilin, and its primary receptor target, the cation channel transient receptor potential (TRP) melastatin-8 (TRPM8), have been described as potent negative regulators of inflammation in the colon. The aim of this study was to determine whether the anti-inflammatory action of icilin could potentially be used to treat autoimmune neuroinflammatory disorders, such as multiple sclerosis (MS). During experimental autoimmune encephalomyelitis (EAE)-a CD4+ T cell-driven murine model of MS-we found that both wild-type (WT) and TRPM8-deficient EAE mice were protected from disease progression during icilin treatment, as evidenced by delays in clinical onset and reductions in neuroinflammation. In vitro, icilin potently inhibited the proliferation of murine and human CD4+ T cells, with the peripheral expansion of autoantigen-restricted T cells similarly diminished by the administration of icilin in mice. Attenuation of both TRPM8(-/-) and TRP ankyrin-1(-/-) T-cell proliferation by icilin was consistent with the WT phenotype, which suggests a mechanism that is independent of these channels. In addition, icilin treatment altered the expressional profile of activated CD4+ T cells to one that was indicative of restricted effector function and limited neuroinflammatory potential. These findings identify a potent anti-inflammatory role for icilin in lymphocyte-mediated neuroinflammation and highlight clear pleiotropic effects of the compound beyond classic TRP channel activation.-Ewanchuk, B.W., Allan, E.R.O., Warren, A.L., Ramachandran, R., Yates, R. M. The cooling compound icilin attenuates autoimmune neuroinflammation through modulation of the T-cell response.	[Ewanchuk, Benjamin W.; Yates, Robin M.] Univ Calgary, Fac Vet Med, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Allan, Euan R. O.; Yates, Robin M.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Warren, Amy L.] Univ Calgary, Fac Vet Med, Dept Vet Clin & Diagnost Sci, Calgary, AB, Canada; [Ramachandran, Rithwik] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	University of Calgary; University of Calgary; University of Calgary; Western University (University of Western Ontario)	Yates, RM (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, 3330 Hosp Dr NW,HRIC 4AA10, Calgary, AB T2N 4N1, Canada.	rmyates@ucalgary.ca	Ramachandran, Rithwik/N-7815-2015	Ramachandran, Rithwik/0000-0001-9557-9905; Ewanchuk, Benjamin/0000-0001-6197-9222	Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research	Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Multiple Sclerosis Society of Canada and the Canadian Institutes of Health Research. Graduate student support was generously provided by the endMS Research and Training Network, Alberta Innovates-Health Solutions, and the Snyder Institute for Chronic Diseases (Calgary, AB, Canada). The authors declare no conflicts of interest.	Agrawal SM, 2011, J NEUROSCI, V31, P669, DOI 10.1523/JNEUROSCI.3659-10.2011; Allan ERO, 2014, J IMMUNOL, V192, P4989, DOI 10.4049/jimmunol.1302896; Badou A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00243; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Becher B, 2017, NAT REV IMMUNOL, V17, P49, DOI 10.1038/nri.2016.123; Belmaati MS, 2014, INFLAMM BOWEL DIS, V20, P1004, DOI 10.1097/MIB.0000000000000039; Bertin S, 2017, GUT, V66, P1584, DOI 10.1136/gutjnl-2015-310710; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cohen JA, 2012, LANCET, V380, P1819, DOI 10.1016/S0140-6736(12)61769-3; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Jong PR, 2015, MUCOSAL IMMUNOL, V8, P491, DOI 10.1038/mi.2014.82; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Du J, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hagenacker T, 2014, BRAIN RES, V1557, P171, DOI 10.1016/j.brainres.2014.02.022; Harrington AM, 2011, PAIN, V152, P1459, DOI 10.1016/j.pain.2011.01.027; Hartung HP, 2002, LANCET, V360, P2018, DOI 10.1016/S0140-6736(02)12023-X; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson CD, 2009, AM J PHYSIOL-HEART C, V296, pH1868, DOI 10.1152/ajpheart.01112.2008; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Khalil M, 2016, MUCOSAL IMMUNOL, V9, P1500, DOI 10.1038/mi.2016.16; Kim CS, 2003, CELL SIGNAL, V15, P299, DOI 10.1016/S0898-6568(02)00086-4; Kim SH, 2011, BIOCHEM BIOPH RES CO, V406, P30, DOI 10.1016/j.bbrc.2011.01.094; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee S, 2013, BIOCHEM BIOPH RES CO, V441, P1005, DOI 10.1016/j.bbrc.2013.11.015; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ma ST, 2009, AM J PHYSIOL-HEART C, V297, pH887, DOI 10.1152/ajpheart.00460.2009; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Melanaphy D, 2016, AM J PHYSIOL-HEART C, V311, pH1416, DOI 10.1152/ajpheart.00222.2015; Melzer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047617; Mikami N, 2012, INT IMMUNOL, V24, P681, DOI 10.1093/intimm/dxs075; NORONHA A, 1993, J NEUROIMMUNOL, V46, P145, DOI 10.1016/0165-5728(93)90244-S; Omilusik K, 2011, IMMUNITY, V35, P349, DOI 10.1016/j.immuni.2011.07.011; Paltser G, 2013, MOL MED, V19, P149, DOI 10.2119/molmed.2012.00329; Parenti A, 2016, BRIT J PHARMACOL, V173, P953, DOI 10.1111/bph.13392; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; RACKE MK, 1995, J IMMUNOL, V154, P450; Ramachandran R, 2013, P NATL ACAD SCI USA, V110, P7476, DOI 10.1073/pnas.1217431110; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Sardi C, 2014, J NEUROIMMUNOL, V271, P18, DOI 10.1016/j.jneuroim.2014.03.008; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; TRAUGOTT U, 1983, SCIENCE, V219, P308, DOI 10.1126/science.6217550; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valero MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029760; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; WEI ET, 1983, J PHARM PHARMACOL, V35, P110, DOI 10.1111/j.2042-7158.1983.tb04279.x; Zhang L, 2016, LUNG, V194, P595, DOI 10.1007/s00408-016-9901-4; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	64	2	2	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1236	1249		10.1096/fj.201700552R	http://dx.doi.org/10.1096/fj.201700552R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29114087				2022-12-26	WOS:000427246000011
J	Best, A; Holt, B; Troy, K; Hamill, J				Best, Andrew; Holt, Brigitte; Troy, Karen; Hamill, Joseph			Trabecular bone in the calcaneus of runners	PLOS ONE			English	Article							CANCELLOUS BONE; ARCHITECTURE; ADAPTATION; PATTERNS; HOMO; MICROARCHITECTURE; MICROSTRUCTURE; BIOMECHANICS; ANISOTROPY; STIFFNESS	Trabecular bone of the human calcaneus is subjected to extreme repetitive forces during endurance running and should adapt in response to this strain. To assess possible bone functional adaptation in the posterior region of the calcaneus, we recruited forefoot-striking runners (n = 6), rearfoot-striking runners (n = 6), and non-runners (n = 6), all males aged 20-41 for this institutionally approved study. Foot strike pattern was confirmed for each runner using a motion capture system. We obtained high resolution peripheral computed tomography scans of the posterior calcaneus for both runners and non-runners. No statistically significant differences were found between runners and nonrunners or forefoot strikers and rearfoot strikers. Mean trabecular thickness and mineral density were greatest in forefoot runners with strong effect sizes (<0.80). Trabecular thickness was positively correlated with weekly running distance (r(2) = 0.417, p<0.05) and years running (r(2) = 0.339, p<0.05) and negatively correlated with age at onset of running (r(2) = 0.515, p<0.01) Trabecular thickness, mineral density and bone volume ratio of nonrunners were highly correlated with body mass (r(2) = 0.824, p<0.05) and nonrunners were significantly heavier than runners (p<0.05). Adjusting for body mass revealed significantly thicker trabeculae in the posterior calcaneus of forefoot strikers, likely an artifact of greater running volume and earlier onset of running in this subgroup; thus, individuals with the greatest summative loading stimulus had, after body mass adjustment, the thickest trabeculae. Further study with larger sample sizes is necessary to elucidate the role of footstrike on calcaneal trabecular structure. To our knowledge, intraspecific body mass correlations with measures of trabecular robusticity have not been reported elsewhere. We hypothesize that early adoption of running and years of sustained moderate volume running stimulate bone modeling in trabeculae of the posterior calcaneus.	[Best, Andrew; Holt, Brigitte] Univ Massachusetts, Dept Anthropol, Amherst, MA 01003 USA; [Troy, Karen] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Hamill, Joseph] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; Worcester Polytechnic Institute; University of Massachusetts System; University of Massachusetts Amherst	Best, A (corresponding author), Univ Massachusetts, Dept Anthropol, Amherst, MA 01003 USA.	abest@umass.edu	Troy, Karen L/AAH-1184-2019	Troy, Karen L/0000-0002-8135-0066; Best, Andrew/0000-0003-1561-2272	WPI	WPI	Joseph Hamill provided funding for participant transportation to and from WPI.	Barak MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077687; Barak MM, 2011, BONE, V49, P1141, DOI 10.1016/j.bone.2011.08.020; Biewener AA, 1996, BONE, V19, P1, DOI 10.1016/8756-3282(96)00116-0; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chirchir H, 2015, P NATL ACAD SCI USA, V112, P366, DOI 10.1073/pnas.1411696112; Cohen J.E., 1988, STAT POWER ANAL BEHA; COWIN SC, 1985, MECH MATER, V4, P137, DOI 10.1016/0167-6636(85)90012-2; DeSilva JM, 2012, J HUM EVOL, V63, P536, DOI 10.1016/j.jhevol.2012.06.006; Diederichs G, 2009, BONE, V44, P976, DOI 10.1016/j.bone.2009.01.372; Doube M, 2011, P ROY SOC B-BIOL SCI, V278, P3067, DOI 10.1098/rspb.2011.0069; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Fajardo RJ, 2013, ANAT REC, V296, P210, DOI 10.1002/ar.22632; Feldman S, 2012, MED SCI SPORT EXER, V44, P1580, DOI 10.1249/MSS.0b013e31824e10b6; GALANTE J, 1970, CALC TISS RES, V5, P236, DOI 10.1007/BF02017552; Giddings VL, 2000, MED SCI SPORT EXER, V32, P627, DOI 10.1097/00005768-200003000-00012; Griffin NL, 2010, J HUM EVOL, V59, P202, DOI 10.1016/j.jhevol.2010.06.006; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hsu A., 1989, THESIS U SO CALIFORN, P1; Huiskes R, 2000, J ANAT, V197, P145, DOI 10.1046/j.1469-7580.2000.19720145.x; Joo YI, 2003, BONE, V33, P485, DOI 10.1016/S8756-3282(03)00212-6; Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307; Khosla S, 2006, J BONE MINER RES, V21, P124, DOI 10.1359/JBMR.050916; Kulmala JP, 2013, MED SCI SPORT EXER, V45, P2306, DOI 10.1249/MSS.0b013e31829efcf7; Laib A, 1998, Technol Health Care, V6, P329; Laib A, 1999, COMPUT MED IMAG GRAP, V23, P69, DOI 10.1016/S0895-6111(98)00071-8; Lara B, 2016, EUR J APPL PHYSIOL, V116, P327, DOI 10.1007/s00421-015-3285-7; Lieberman DE, 2004, AM J PHYS ANTHROPOL, V123, P156, DOI 10.1002/ajpa.10316; Lin JC, 1998, OSTEOPOROSIS INT, V8, P16, DOI 10.1007/s001980050043; Lockhart RD, 1959, ANATOMY HUMAN BODY; MacNeil JA, 2007, MED ENG PHYS, V29, P1096, DOI 10.1016/j.medengphy.2006.11.002; Mullender MG, 1996, J ORTHOPAED RES, V14, P972, DOI 10.1002/jor.1100140618; Odgaard A, 1997, J BIOMECH, V30, P487, DOI 10.1016/S0021-9290(96)00177-7; OXNARD CE, 1993, J BIOMECH, V26, P63, DOI 10.1016/0021-9290(93)90080-X; Pontzer H, 2006, J EXP BIOL, V209, P57, DOI 10.1242/jeb.01971; PUGH JW, 1973, J BIOMECH, V6, P475, DOI 10.1016/0021-9290(73)90006-7; RAUX P, 1975, J BIOMECH, V8, P1, DOI 10.1016/0021-9290(75)90037-8; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ryan TM, 2015, P NATL ACAD SCI USA, V112, P372, DOI 10.1073/pnas.1418646112; Ryan TM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0172; Shaw CN, 2013, J HUM EVOL, V64, P242, DOI 10.1016/j.jhevol.2013.01.004; Shaw CN, 2012, AM J PHYS ANTHROPOL, V147, P187, DOI 10.1002/ajpa.21635; Stephens NB, 2016, AM J PHYS ANTHROPOL, V161, P603, DOI 10.1002/ajpa.23061; Su A, 2013, J HUM EVOL, V64, P667, DOI 10.1016/j.jhevol.2013.03.003; Swartz SM, 1998, J EXP BIOL, V201, P573; TOWNSEND PR, 1975, J BIOMECH, V8, P363, DOI 10.1016/0021-9290(75)90071-8; van der Meulen MCH, 2006, BONE, V38, P871, DOI 10.1016/j.bone.2005.11.026; WEAVER JK, 1966, J BONE JOINT SURG AM, VA 48, P289, DOI 10.2106/00004623-196648020-00007; Wilks DC, 2009, BONE, V45, P91, DOI 10.1016/j.bone.2009.03.660; Wolff J, 1892, GESETZ TRANSFORMATIO; WRONSKI TJ, 1987, CALCIFIED TISSUE INT, V40, P155, DOI 10.1007/BF02555700; Zeininger A, 2016, J HUM EVOL, V97, P145, DOI 10.1016/j.jhevol.2016.05.009	52	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188200	10.1371/journal.pone.0188200	http://dx.doi.org/10.1371/journal.pone.0188200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29141022	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400069
J	Butler, WE; Agarwalla, PK; Codd, P				Butler, William E.; Agarwalla, Pankaj K.; Codd, Patrick			CSF in the ventricles of the brain behaves as a relay medium for arteriovenous pulse wave phase coupling	PLOS ONE			English	Article							INTRACRANIAL-PRESSURE; PULSATION ABSORBER; ULTRASOUND; TRANSFORM	The ventricles of the brain remain perhaps the largest anatomic structure in the human body without established primary purpose, even though their existence has been known at least since described by Aristotle. We hypothesize that the ventricles help match a stroke volume of arterial blood that arrives into the rigid cranium with an equivalent volume of ejected venous blood by spatially configuring cerebrospinal fluid (CSF) to act as a low viscosity relay medium for arteriovenous pulse wave (PW) phase coupling. We probe the hypothesis by comparing the spatiotemporal behavior of vascular PW about the ventricular surfaces in piglets to internal observations of ventricle wall motions and adjacent CSF pressure variations in humans. With wavelet brain angiography data obtained from piglets, we map the travel relative to brain pulse motion of arterial and venous PWs over the ventricle surfaces. We find that arterial PWs differ in CF phase from venous PWs over the surfaces of the ventricles consistent with arteriovenous PW phase coupling. We find a spatiotemporal difference in vascular PW phase between the ventral and dorsal ventricular surfaces, with the PWs arriving slightly sooner to the ventral surfaces. In humans undergoing neuroendoscopic surgery for hydrocephalus, we measure directly ventricle wall motions and the adjacent internal CSF pressure variations. We find that CSF pressure peaks slightly earlier in the ventral Third Ventricle than the dorsal Lateral Ventricle. When matched anatomically, the peri-ventricular vascular PW phase distribution in piglets complements the endo-ventricular CSF PW phase distribution in humans. This is consistent with a role for the ventricles in arteriovenous PW coupling and may add a framework for understanding hydrocephalus and other disturbances of intracranial pressure.	[Butler, William E.; Agarwalla, Pankaj K.] Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA; [Codd, Patrick] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27710 USA	Harvard University; Massachusetts General Hospital; Duke University	Butler, WE (corresponding author), Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA.	wbutler@mgh.harvard.edu		Butler, William/0000-0002-4249-565X				Abramovich F, 2000, J ROY STAT SOC D-STA, V49, P1, DOI 10.1111/1467-9884.00216; Aristotle, HIST ANIMALIUM; Butler WE, PLOS ONE; Faubel R, 2016, SCIENCE, V353, P176, DOI 10.1126/science.aae0450; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Jalalvand E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10002; Kulkarni AV, 2009, J PEDIATR-US, V155, P254, DOI 10.1016/j.jpeds.2009.02.048; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Meairs S, 2007, PROG BIOPHYS MOL BIO, V93, P354, DOI 10.1016/j.pbiomolbio.2006.07.019; Ohata S, 2015, J NEUROSCI, V35, P11153, DOI 10.1523/JNEUROSCI.0686-15.2015; Park EH, 2010, J NEUROSURG-PEDIATR, V6, P159, DOI 10.3171/2010.5.PEDS09142; Persson EK, 2005, ACTA PAEDIATR, V94, P726, DOI 10.1080/08035250510027336; Pewsey A, 2013, CIRCULAR STAT R, P25; Pewsey A, 2013, CIRCULAR STAT R, P144; Pewsey A, 2013, CIRCULAR STAT R, P134; Pewsey A, 2013, CIRCULAR STAT R, P132; Provost J, 2014, PHYS MED BIOL, V59, pL1, DOI 10.1088/0031-9155/59/19/L1; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vo A, 2011, SIGNAL PROCESS, V91, P114, DOI 10.1016/j.sigpro.2010.06.014; Wagshul ME, 2009, J NEUROSURG-PEDIATR, V3, P354, DOI 10.3171/2009.1.PEDS08109; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Zhao XY, 2011, ULTRASOUND MED BIOL, V37, P1292, DOI 10.1016/j.ultrasmedbio.2011.05.003; Zou R, 2008, J NEUROS-PEDIATR, V2, P83, DOI 10.3171/PED/2008/2/7/083	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0181025	10.1371/journal.pone.0181025	http://dx.doi.org/10.1371/journal.pone.0181025			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141045	gold, Green Published, Green Submitted			2022-12-26	WOS:000415260400001
J	Chen, I; Kelkar, YD; Gu, Y; Zhou, J; Qiu, X; Wu, HL				Chen, Iris; Kelkar, Yogeshwar D.; Gu, Yu; Zhou, Jie; Qiu, Xing; Wu, Hulin			High-dimensional linear state space models for dynamic microbial interaction networks	PLOS ONE			English	Article							VECTOR AUTOREGRESSIVE PROCESSES; SUBSET-SELECTION; ADAPTIVE LASSO; DIVERSITY; ODES	Medical researchers are increasingly interested in knowing how the complex community of micro-organisms living on human body impacts human health. Key to this is to understand how the microbes interact with each other. Time-course studies on human microbiome indicate that the composition of microbiome changes over short time periods, primarily as a consequence of synergistic and antagonistic interactions of the members of the microbiome with each other and with the environment. Knowledge of the abundance of bacteria-which are the predominant members of the human microbiome-in such time-course studies along with appropriate mathematical models will allow us to identify key dynamic interaction networks within the microbiome. However, the high-dimensional nature of these data poses significant challenges to the development of such mathematical models. We propose a high-dimensional linear State Space Model (SSM) with a new Expectation-Regularization-Maximization (ERM) algorithm to construct a dynamic (M) under bar icrobial (I) under bar nteraction (N) under bar etwork (MIN). System noise and measurement noise can be separately specified through SSMs. In order to deal with the problem of high-dimensional parameter space in the SSMs, the proposed new ERM algorithm employs the idea of the adaptive LASSO-based variable selection method so that the sparsity property of MINs can be preserved. We performed simulation studies to evaluate the proposed ERM algorithm for variable selection. The proposed method is applied to identify the dynamic MIN from a time-course vaginal microbiome study of women. This method is amenable to future developments, which may include interactions between microbes and the environment.	[Chen, Iris; Gu, Yu; Qiu, Xing; Wu, Hulin] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Kelkar, Yogeshwar D.] Univ Rochester, Dept Biol, 601 Elmwood Ave, Rochester, NY 14642 USA; [Zhou, Jie] Xidian Univ, Dept Stat, Xian 71007, Shanxi, Peoples R China; [Chen, Iris] Amgen Inc, Global Biostat Sci, Thousand Oaks, CA 91320 USA; [Wu, Hulin] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA	University of Rochester; University of Rochester; Xidian University; Amgen; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Qiu, X; Wu, HL (corresponding author), Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14642 USA.; Wu, HL (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA.	xing_qiu@urmc.rochester.edu; Hulin.Wu@uth.tmc.edu		Kelkar, Yogeshwar/0000-0002-4440-0191	National Institutes of Health [5 P30 AI078498-08, AI087135, 5 T32AI083206-05]; National Institutes of Health / National Center for Advancing Translational Sciences [UL1 TR002001]; National Institutes of Health / National Institute of Allergy and Infectious Diseases [HHSN272201200005C]; NIH [5 P30 AI078498-08, AI087135, 5 T32AI083206-05]; NIH/NCATS [UL1 TR002001]; NIH/NIAID [HHSN272201200005C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498, T32AI083206, R01AI087135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health / National Center for Advancing Translational Sciences; National Institutes of Health / National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by 5 P30 AI078498-08, granting institute: National Institutes of Health (URL: https://www.nih.gov/), recipient: HW; AI087135, granting institute: National Institutes of Health (URL: https://www.nih.gov/), recipient: HW; UL1 TR002001, granting institute: National Institutes of Health / National Center for Advancing Translational Sciences (URL: https://ncats.nih.gov), recipient: HW; 5 T32AI083206-05, granting institute: National Institutes of Health (URL: https://www.nih.gov/), recipient: HW; and HHSN272201200005C, granting institute: National Institutes of Health / National Institute of Allergy and Infectious Diseases (URL: https://www.niaid.nih.gov/), recipient: HW.; This research was supported in part by NIH 5 P30 AI078498-08, NIH AI087135, NIH 5 T32AI083206-05, NIH/NCATS UL1 TR002001, and NIH/NIAID HHSN272201200005C.	Antonio MAD, 2009, J INFECT DIS, V199, P1506, DOI 10.1086/598686; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219; Biswas S, 2015, LECT N BIOINFORMAT, V9029, P32, DOI 10.1007/978-3-319-16706-0_6; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Danielsson D, 2011, ANN NY ACAD SCI, V1230, P48, DOI 10.1111/j.1749-6632.2011.06041.x; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; Durbin J, 2012, TIME SERIES ANAL STA, V38; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Fisher CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102451; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Harvey AC, 1990, FORECASTING STRUCTUR; Hsu NJ, 2008, COMPUT STAT DATA AN, V52, P3645, DOI 10.1016/j.csda.2007.12.004; Huang J, 2008, STAT SINICA, V18, P1603; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kojima K, 2009, GENOME INFORM, V22, P56; Lu T, 2011, J AM STAT ASSOC, V106, P1242, DOI 10.1198/jasa.2011.ap10194; Marino S, 2014, P NATL ACAD SCI USA, V111, P439, DOI 10.1073/pnas.1311322111; Paine RT, 1995, JSTOR; Quach M, 2007, BIOINFORMATICS, V23, P3209, DOI 10.1093/bioinformatics/btm510; Rangel C, 2004, BIOINFORMATICS, V20, P1361, DOI 10.1093/bioinformatics/bth093; Ravel J, 2013, STUDIES, V19, P20; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Ren YW, 2010, STAT PROBABIL LETT, V80, P1705, DOI 10.1016/j.spl.2010.07.013; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Shumway R. H., 1982, Journal of Time Series Analysis, V3, P253, DOI 10.1111/j.1467-9892.1982.tb00349.x; Stapleton AE, 2011, CLIN INFECT DIS, V52, P1212, DOI 10.1093/cid/cir183; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Steinway SN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004338; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; West M, 1997, HDB ECONOMETRICS; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	42	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187822	10.1371/journal.pone.0187822	http://dx.doi.org/10.1371/journal.pone.0187822			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141044	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400032
J	Van de Wouw, AP; Elliott, VL; Chang, S; Lopez-Ruiz, FJ; Marcroft, SJ; Idnurm, A				Van de Wouw, Angela P.; Elliott, Vicki L.; Chang, Steven; Lopez-Ruiz, Francisco J.; Marcroft, Steven J.; Idnurm, Alexander			Identification of isolates of the plant pathogen Leptosphaeria maculans with resistance to the triazole fungicide fluquinconazole using a novel In Planta assay	PLOS ONE			English	Article							MAJOR GENE RESISTANCE; RAPE BRASSICA-NAPUS; PHOMA STEM CANKER; OILSEED RAPE; STEROL 14-ALPHA-DEMETHYLASE; STROBILURIN FUNGICIDES; AZOLE FUNGICIDES; MATING-TYPE; AUSTRALIA; CYP51	Leptosphaeria maculans is the major pathogen of canola (oilseed rape, Brassica napus) worldwide. In Australia, the use of azole fungicides has contributed to the 50-fold increase in canola production in the last 25 years. However, extensive application of fungicides sets the stage for the selection of fungal populations with resistance. A high-throughput in planta assay was developed to allow screening of thousands of isolates from multiple populations. Using this screen, isolates were identified with decreased sensitivity to the fungicide fluquinconazole when applied at field rates as a protective seed dressing: these isolates cause significantly larger lesions on cotyledons and true leaves and increased disease severity at plant maturity. This increased in planta resistance was specific to fluquinconazole, with no cross resistance to flutriafol or tebuconazole/prothioconazole. In a limited set of 22 progeny from a cross between resistant and susceptible parents, resistance segregated in a 1:1 ratio, suggesting a single gene is responsible. A survey of 200 populations from across canola growing regions of Australia revealed fungicide resistance was present in 15% of the populations. Although in vitro analysis of the fungicide resistant isolates showed a significant shift in the average EC50 compared to the sensitive isolates, this was not as evident as the in planta assays. The development of this novel, high-throughput in planta assay has led to the identification of the first fungicide resistant L. maculans isolates, which may pose a threat to the productivity of the Australian canola industry.	[Van de Wouw, Angela P.; Idnurm, Alexander] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia; [Elliott, Vicki L.; Marcroft, Steven J.] Marcroft Grains Pathol, Grains Innovat Pk, Horsham, Australia; [Chang, Steven; Lopez-Ruiz, Francisco J.] Curtin Univ, Dept Environm & Agr, Ctr Crop & Dis Management, Bentley, WA, Australia	University of Melbourne; Curtin University	Van de Wouw, AP (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.	apvdw2@unimelb.edu.au	Idnurm, Alexander/GPX-9055-2022; Van de Wouw, Angela/AAY-1163-2021; Idnurm, Alexander/AAC-9614-2019; Idnurm, Alexander/K-8558-2013	Idnurm, Alexander/0000-0001-5995-7040; Van de Wouw, Angela/0000-0001-5147-0393; Idnurm, Alexander/0000-0001-5995-7040; Marcroft, Steve/0000-0002-1339-2694	Australian Grains Research and Development Corporation; Grains Research and Development Corporation [UM00051, CUR00023]	Australian Grains Research and Development Corporation(Grains R&D Corp); Grains Research and Development Corporation(Grains R&D Corp)	All research was funded by the Grains Research and Development Corporation through UM00051 to Alexander Idnurm and CUR00023 to Francisco J Lopez-Ruiz. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Australian Grains Research and Development Corporation for funding this research and the agronomists, farmers and researchers that contributed stubble for screening in the large-scale survey.	Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520; Call AD, 2013, HORTSCIENCE, V48, P53, DOI 10.21273/HORTSCI.48.1.53; Canas-Gutierrez GP, 2009, PEST MANAG SCI, V65, P892, DOI 10.1002/ps.1770; Carter HE, 2014, MOL PLANT PATHOL, V15, P513, DOI 10.1111/mpp.12106; Cools HJ, 2002, J PHYTOPATHOL, V150, P444, DOI 10.1046/j.1439-0434.2002.00776.x; Cools HJ, 2013, PEST MANAG SCI, V69, P105; Cozijnsen AJ, 2003, CURR GENET, V43, P351, DOI 10.1007/s00294-003-0391-6; Cozijnsen AJ, 2000, MOL PLANT PATHOL, V1, P293, DOI 10.1046/j.1364-3703.2000.00033.x; Delourme R, 2006, EUR J PLANT PATHOL, V114, P41, DOI 10.1007/s10658-005-2108-9; Eckert MR, 2010, PEST MANAG SCI, V66, P396, DOI 10.1002/ps.1890; Elliott VL, 2016, PLANT BREEDING, V135, P200, DOI 10.1111/pbr.12343; Fitt BDL, 2006, EUR J PLANT PATHOL, V114, P3, DOI 10.1007/s10658-005-2233-5; Fraaije BA, 2007, MOL PLANT PATHOL, V8, P245, DOI [10.1111/j.1364-3703.2007.00388.x, 10.1111/j.1364-3703.2007.00388.X]; Fraser M, 2017, CAN J PLANT SCI, V97, P83, DOI 10.1139/cjps-2015-0382; Griffiths KM, 2002, FEMS MICROBIOL LETT, V217, P81, DOI 10.1016/S0378-1097(02)01038-8; Hollomon DW, 2015, PLANT PROTECT SCI, V51, P170, DOI 10.17221/42/2015-PPS; JosephHorne T, 1997, FEMS MICROBIOL LETT, V149, P141, DOI 10.1111/j.1574-6968.1997.tb10321.x; Kirui KR, 2016, ADV PLANTS AGR RES, V5; KOCH E, 1991, MOL PLANT MICROBE IN, V4, P341, DOI 10.1094/MPMI-4-341; Leadbeater A, 2015, PLANT PROTECT SCI, V51, P163, DOI 10.17221/83/2015-PPS; Liu C, 2013, CAN J PLANT PATHOL, V35, P119; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcroft SJ, 2012, PLANT PATHOL, V61, P934, DOI 10.1111/j.1365-3059.2011.02580.x; Marcroft SJ, 2004, AUST J EXP AGR, V44, P601, DOI 10.1071/EA03087; Marcroft SJ, 2012, CROP PASTURE SCI, V63, P338, DOI 10.1071/CP11341; Morzfeld J, 2004, Z PFLANZENK PFLANZEN, V111, P105; Price CL, 2015, PEST MANAG SCI, V71, P1054, DOI 10.1002/ps.4029; Sexton AC, 2000, MOL GEN GENET, V263, P463, DOI 10.1007/s004380051190; Sierotzki H, 2013, PHYTOPATHOLOGY, V103, P880, DOI 10.1094/PHYTO-01-13-0009-RVW; Sprague SJ, 2006, PLANT DIS, V90, P190, DOI 10.1094/PD-90-0190; Sprague SJ, 2006, EUR J PLANT PATHOL, V114, P33, DOI 10.1007/s10658-005-3683-5; TINLINE R. D., 1960, CANADIAN JOUR BOT, V38, P275, DOI 10.1139/b60-028; Van De Wouw AP, 2016, CROP PASTURE SCI, V67, P273, DOI 10.1071/CP15221; Van de Wouw AP, 2014, FIELD CROP RES, V166, P144, DOI 10.1016/j.fcr.2014.06.023; Van de Wouw AP, 2017, CROP PASTUR IN PRESS; Yan LY, 2009, CROP PROT, V28, P376, DOI 10.1016/j.cropro.2008.12.011	36	23	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188106	10.1371/journal.pone.0188106	http://dx.doi.org/10.1371/journal.pone.0188106			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141039	Green Published, gold			2022-12-26	WOS:000415260400057
J	Vergara, J; Acosta, LE; Gonzalez-Ittig, RE; Vaschetto, LM; Gardenal, CN				Vergara, Julia; Acosta, Luis E.; Gonzalez-Ittig, Raul E.; Vaschetto, Luis M.; Gardenal, Cristina N.			The disjunct pattern of the Neotropical harvestman Discocyrtus dilatatus (Gonyleptidae) explained by climate-driven range shifts in the Quaternary: Paleodistributional and molecular evidence	PLOS ONE			English	Article							MESOPOTAMIAN-YUNGAS DISJUNCTION; DRY TROPICAL FORESTS; DISTRIBUTION MODELS; SEA-LEVEL; SPECIES DISTRIBUTIONS; ENVELOPE MODELS; SOUTH-AMERICA; RAIN-FOREST; OPILIONES; NICHE	The disjunct distribution of the harvestman Discocyrtus dilatatus (Opiliones, Gonyleptidae) is used as a case study to test the hypothesis of a trans-Chaco Pleistocene paleobridge during range expansion stages. This would have temporarily connected humid regions ('Mesopotamia' in northeastern Argentina, and the 'Yungas' in the northwest, NWA) in the subtropical and temperate South American lowlands. The present study combines two independent approaches: paleodistributional reconstruction, using the Species Distribution Modeling method MaxEnt and projection onto Quaternary paleoclimates (6 kya, 21 kya, 130 kya), and phylogeographic analyses based on the cytochrome oxidase subunit I molecular marker. Models predict a maximal shrinkage during the warm Last Interglacial (130 kya), and the rise of the hypothesized paleobridge in the Last Glacial Maximum (21 kya), revealing that cold-dry stages (not warm-humid ones, as supposed) enabled the range expansion of this species. The disjunction was formed in the mid-Holocene (6 kya) and is intensified under current conditions. The median-joining network shows that NWA haplotypes are peripherally related to different Mesopotamian lineages; haplotypes from Santa Fe and Cordoba Provinces consistently occupy central positions in the network. According to the dated phylogeny, Mesopotamia-NWA expansion events would have occurred in the last glacial period, in many cases closely associated to the Last Glacial Maximum, with most divergence events occurring shortly thereafter. Only two (out of nine) NWA haplotypes are shared with Mesopotamian localities. A single, presumably relictual NWA haplotype was found to have diverged much earlier, suggesting an ancient expansion event not recoverable by the paleodistributional models. Different measures of sequence statistics, genetic diversity, population structure and history of demographic changes are provided. This research offers the first available evidence for the historical origin of NWA disjunct populations of a Mesopotamian harvestman.	[Vergara, Julia; Acosta, Luis E.; Gonzalez-Ittig, Raul E.; Vaschetto, Luis M.; Gardenal, Cristina N.] Univ Nacl Cordoba, CONICET, IDEA, Cordoba, Argentina; [Vergara, Julia; Acosta, Luis E.; Vaschetto, Luis M.] UNC, Fac Ciencias Exactas Fis & Nat, Catedra Diversidad Anim 1, Cordoba, Argentina; [Gonzalez-Ittig, Raul E.; Gardenal, Cristina N.] UNC, Fac Ciencias Exactas Fis & Nat, Catedra Genet Poblac & Evoluc, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; National University of Cordoba	Vergara, J; Acosta, LE (corresponding author), Univ Nacl Cordoba, CONICET, IDEA, Cordoba, Argentina.; Vergara, J; Acosta, LE (corresponding author), UNC, Fac Ciencias Exactas Fis & Nat, Catedra Diversidad Anim 1, Cordoba, Argentina.	juliavofi@gmail.com; luis.acosta@unc.edu.ar	Vaschetto, Luis Maria/L-4151-2019	Vaschetto, Luis Maria/0000-0002-9290-4335; Gonzalez-Ittig, Raul/0000-0001-6761-3379	Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP) [918/10]; Agencia Nacional de Promocion Cientifica y Teconologica [FONCYT PICT 1296/07]; SECYT - Universidad Nacional de Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Teconologica; SECYT - Universidad Nacional de Cordoba, Argentina(Secretaria de Ciencia y Tecnologia (SECYT))	This work received partial funding from Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP Res. 918/10), Agencia Nacional de Promocion Cientifica y Teconologica (FONCYT PICT 1296/07), and SECYT - Universidad Nacional de Cordoba, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta LE, 2017, J NAT HIST, V51, P17, DOI 10.1080/00222933.2016.1245450; Acosta LE, 2014, ZOOTAXA, V3821, P301, DOI 10.11646/zootaxa.3821.3.1; Acosta LE, 2013, ZOOTAXA, V 3736, P143, DOI 10.11646/zootaxa.3736.2.3; Acosta Luis E., 2002, Revista Iberica de Aracnologia, V6, P69; Acosta LE, 2008, J ARACHNOL, V36, P574, DOI 10.1636/T07-36.1; Acosta Luis Eduardo, 1995, Revue Arachnologique, V10, P207; Adamoli J., 2005, MISCELANEA, V14, P245; AVISE JC, 2001, PHYLOGEOGRAPHY HIST; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behling H, 1998, REV PALAEOBOT PALYNO, V99, P143, DOI 10.1016/S0034-6667(97)00044-4; Behling H, 2002, PALAEOGEOGR PALAEOCL, V177, P19, DOI 10.1016/S0031-0182(01)00349-2; Behling H, 2001, QUATERNARY RES, V56, P383, DOI 10.1006/qres.2001.2264; Boyer SL, 2007, MOL ECOL, V16, P4999, DOI 10.1111/j.1365-294X.2007.03555.x; Bragagnolo C, 2015, INVERTEBR SYST, V29, P386, DOI 10.1071/IS15009; Caetano S, 2008, MOL ECOL, V17, P3147, DOI 10.1111/j.1365-294X.2008.03817.x; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Clouse RM, 2016, ORG DIVERS EVOL, V16, P167, DOI 10.1007/s13127-015-0233-7; Collevatti RG, 2013, J BIOGEOGR, V40, P345, DOI 10.1111/jbi.12005; Collevatti RG, 2012, MOL ECOL, V21, P5845, DOI 10.1111/mec.12071; COLTRINARI L, 1993, GLOBAL PLANET CHANGE, V7, P11, DOI 10.1016/0921-8181(93)90037-O; Curtis David J., 2007, P280; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Bartoleti LFD, 2017, J BIOGEOGR, V44, P2007, DOI 10.1111/jbi.12998; DELSAL G, 1989, BIOTECHNIQUES, V7, P514; Derkarabetian S, 2011, MOL PHYLOGENET EVOL, V61, P844, DOI 10.1016/j.ympev.2011.08.004; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dutton A, 2012, SCIENCE, V337, P216, DOI 10.1126/science.1205749; Edgecombe GD, 2002, SYST ENTOMOL, V27, P31, DOI 10.1046/j.0307-6970.2001.00163.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAIRBRIDGE RW, 1960, SCI AM, V202, P70, DOI 10.1038/scientificamerican0560-70; Flantua SGA, 2015, REV PALAEOBOT PALYNO, V223, P104, DOI 10.1016/j.revpalbo.2015.09.008; Franklin J, 2009, MAPPING SPECIES DIST; Fu YX, 1997, GENETICS, V147, P915; Ginzburg R., 2006, SITUACION AMBIENTAL, P103; Fernandez MJG, 2016, GENETICA, V144, P711, DOI 10.1007/s10709-016-9937-7; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hearty PJ, 2007, QUATERNARY SCI REV, V26, P2090, DOI 10.1016/j.quascirev.2007.06.019; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Iriondo Martin H., 2007, P7, DOI 10.1007/978-3-540-70624-3_1; Katinas L, 2008, J BIOGEOGR, V35, P1374, DOI 10.1111/j.1365-2699.2007.01874.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krohling DM, 1999, QUATERN INT, V57-8, P149, DOI 10.1016/S1040-6182(98)00056-1; Kukla GJ, 2002, QUATERNARY RES, V58, P2, DOI 10.1006/qres.2001.2316; Ledru MP, 1998, REV PALAEOBOT PALYNO, V99, P131, DOI 10.1016/S0034-6667(97)00049-3; LEDRU MP, 1993, QUATERNARY RES, V39, P90, DOI 10.1006/qres.1993.1011; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowe JJ, 2007, ENCY QUATERNARY SCI, P28; Luoto M, 2005, GLOBAL ECOL BIOGEOGR, V14, P575, DOI 10.1111/j.1466-822x.2005.00186.x; Martínez Olga G, 2013, Darwiniana, nueva serie, V1, P279, DOI 10.14522/darwiniana.2013.12.536; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Morales NS, 2017, PEERJ, V5, DOI 10.7717/peerj.3093; Nei M., 1987, MOL EVOLUTIONARY GEN; Nores M, 2004, GLOBAL ECOL BIOGEOGR, V13, P149, DOI 10.1111/j.1466-882X.2004.00076.x; NORES M, 1992, AUK, V109, P346, DOI 10.2307/4088203; Nores M., 1989, THESIS; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Popolizio E, 2006, PARANA RIO HIST GEOM, V1, P1; Prado D. E., 2000, Edinburgh Journal of Botany, V57, P437, DOI 10.1017/S096042860000041X; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Ringuelet R. A., 1959, Revista del Museo Argentino de las Ciencias Naturales Zool, V5, P127; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos Flavio H., 2007, P473; Schreve D, 2010, PROG PHYS GEOG, V34, P845, DOI 10.1177/0309133310386869; Shcheglovitova M, 2013, ECOL MODEL, V269, P9, DOI 10.1016/j.ecolmodel.2013.08.011; Siddall M, 2007, DEV QUATER SCI, V7, P75, DOI 10.1016/S1571-0866(07)80032-7; Silva JMC, 1994, AUK, V111, P495, DOI DOI 10.2307/4088618; Sobral-Souza T, 2015, EVOL ECOL, V29, P643, DOI 10.1007/s10682-015-9780-9; Speranza PR, 2007, J BIOGEOGR, V34, P427, DOI 10.1111/j.1365-2699.2006.01622.x; Stevaux JC, 2000, QUATERN INT, V72, P73, DOI 10.1016/S1040-6182(00)00023-9; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tajima F, 1996, GENETICS, V143, P1457; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Thomas SM, 2008, MOL PHYLOGENET EVOL, V46, P645, DOI 10.1016/j.ympev.2007.10.013; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trujillo-Arias N, 2017, MOL PHYLOGENET EVOL, V112, P107, DOI 10.1016/j.ympev.2017.03.025; Vaschetto LM, 2015, J ZOOL SYST EVOL RES, V53, P211, DOI 10.1111/jzs.12093; Vergara J, 2015, ZOOLOGIA-CURITIBA, V32, P445, DOI [10.1590/S1984-46702015000600003, 10.1590/s1984-46702015000600003]; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Waltari E, 2009, J BIOGEOGR, V36, P148, DOI 10.1111/j.1365-2699.2008.01959.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Werneck FP, 2012, J BIOGEOGR, V39, P1695, DOI 10.1111/j.1365-2699.2012.02715.x; Werneck FP, 2011, GLOBAL ECOL BIOGEOGR, V20, P272, DOI 10.1111/j.1466-8238.2010.00596.x; Whitney BS, 2014, VEG HIST ARCHAEOBOT, V23, P1, DOI 10.1007/s00334-013-0395-1; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120056	103	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187983	10.1371/journal.pone.0187983	http://dx.doi.org/10.1371/journal.pone.0187983			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141036	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400040
J	Garriga, C; Manzanares-Laya, S; de Olalla, PG; Gorrindo, P; Lens, S; Sola, R; Martinez-Rebollar, M; Laguno, M; Navarro, J; Torras, X; Gurgui, M; Barbera, MJ; Quer, J; Masdeu, E; Simon, P; Ros, M; de Andres, A; Cayla, JA				Garriga, Cesar; Manzanares-Laya, Sandra; Garcia de Olalla, Patricia; Gorrindo, Pilar; Lens, Sabela; Sola, Ricard; Martinez-Rebollar, Maria; Laguno, Montserrat; Navarro, Jordi; Torras, Xavier; Gurgui, Merce; Barbera, Maria-Jesus; Quer, Josep; Masdeu, Eva; Simon, Pere; Ros, Miriam; de Andres, Anna; Cayla, Joan A.			Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns	PLOS ONE			English	Article							HIV-POSITIVE MEN; SEXUAL TRANSMISSION; DRUG INJECTORS; SPAIN; HCV; PREVALENCE; EPIDEMIOLOGY; BARCELONA; BEHAVIOR; COUPLES	The aims of this study were to describe the evolution of acute hepatitis C virus (HCV) infections since 2004 and to determine its associated factors. Acute HCV infections diagnosed in Barcelona from 2004 to 2015 were included. Incidence ratios (IR) were then estimated for sex and age groups. Cases were grouped between 2004-2005, 2006-2011 and 2012-2015, and their incidence rate ratios (IRR) were calculated. In addition, risk factors for acute HCV infection were identified using multinomial logistic regression for complete, available and multiple imputed data. 204 new HCV cases were identified. Two peaks of higher IR of acute HCV infection in 2005 and 2013 were observed. Men and those aged 35-54 had higher IR. IRR for men was 2.9 times greater than in women (95% confidence intervals (CI): 1.8 - 4.7). Factors related to the period 2012-2015 (versus 2006-2011) were: a) sexual risk factor for transmission versus nosocomial (relative-risk ratio (RRR): 13.0; 95% CI: 2.3 - 72.1), b) higher educated versus lower (RRR: 5.4; 95% CI: 1.6 -18.7), and c) HIV coinfected versus not HIV-infected (RRR: 53.1; 95% CI: 5.7 - 492.6). This is one of the few studies showing IR and RRRs of acute HCV infections and the first focused on a large city in Spain. Sexual risk for transmission between men, higher educational level and HIV co-infection are important factors for understanding current HCV epidemic. There has been a partial shift in the pattern of the risk factor for transmission from nosocomial to sexual.	[Garriga, Cesar; Manzanares-Laya, Sandra; Garcia de Olalla, Patricia; Gorrindo, Pilar; Masdeu, Eva; Simon, Pere; Ros, Miriam; de Andres, Anna; Cayla, Joan A.] Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain; [Garriga, Cesar] Inst Salud Carlos III, Natl Ctr Epidemiol, Spanish Field Epidemiol Training Programme FETP P, Madrid, Spain; [Manzanares-Laya, Sandra; Garcia de Olalla, Patricia; Cayla, Joan A.] CIBERESP, Madrid, Spain; [Lens, Sabela] Barcelona IDIBAPS, Hosp Clin, Liver Unit, Barcelona, Spain; [Lens, Sabela; Torras, Xavier] CIBER Hepat & Digest Dis CIBERehd, Madrid, Spain; [Sola, Ricard] Hosp del Mar, Internal Med Infect Dis, Barcelona, Spain; [Martinez-Rebollar, Maria; Laguno, Montserrat] Univ Barcelona, Hosp Clin, August Pi & Sunyer Biomed Res Inst, Barcelona, Spain; [Navarro, Jordi] Univ Autonoma Barcelona, Hosp Vall Hebron, Infect Dis, Barcelona, Spain; [Torras, Xavier] Hosp Santa Creu & Sant Pau, Dept Gastroenterol, CIBERehd, Barcelona, Spain; [Gurgui, Merce] Univ Autonoma Barcelona, Hosp Santa Creu & Sant Pau, Infect Dis Unit, Barcelona, Spain; [Barbera, Maria-Jesus] Univ Autonoma Barcelona, Hosp Vall Hebron, Sexually Transmitted Infect Unit, Barcelona, Spain; [Quer, Josep] Univ Autonoma Barcelona, Lab Malalties Hepat, Liver Unit, Internal Med,VHIR,HUVH, Barcelona, Spain; [Garriga, Cesar] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, Oxon, England	Public Health Agency of Barcelona; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Oxford	Garriga, C; Manzanares-Laya, S (corresponding author), Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain.; Garriga, C (corresponding author), Inst Salud Carlos III, Natl Ctr Epidemiol, Spanish Field Epidemiol Training Programme FETP P, Madrid, Spain.; Manzanares-Laya, S (corresponding author), CIBERESP, Madrid, Spain.; Garriga, C (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, Oxon, England.	cesar.garriga-fuentes@ndorms.ox.ac.uk; smanzana@aspb.cat	Navarro, Jordi/N-5499-2015; Quer, Josep/A-6741-2012; Navarro, Jordi/AGO-2330-2022; Garriga, Cesar/AEV-9080-2022; Lens, Sabela/L-4750-2018	Navarro, Jordi/0000-0002-7187-0367; Quer, Josep/0000-0003-0014-084X; Navarro, Jordi/0000-0002-7187-0367; Garriga, Cesar/0000-0001-7073-3611; Lens, Sabela/0000-0003-4900-411X; Laguno Centeno, Montserrat/0000-0002-7798-6352	Spanish Field Epidemiology Training Programme (FETP) [12/PEAC-06]	Spanish Field Epidemiology Training Programme (FETP)	Cesar Garriga developed the present study as part of his fellowship in the Spanish Field Epidemiology Training Programme (FETP) (file number: 12/PEAC-06; see https://goo.gl/RXhCX3 and Official Gazette number 167 of Friday July 13th 2012, pp. 50417, act 9361 in https://goo.gl/3q2c4h). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, INF CUEST ACT PREV V; [Anonymous], 2005, INF CUEST ACT PREV V; Barcelona council technical programming office, 2014, DISTR TERR REND FAM; Barrio G, 2012, ADDICTION, V107, P1111, DOI 10.1111/j.1360-0443.2011.03759.x; Bottieau E, 2010, EUROSURVEILLANCE, V15, P19673; Bravo MJ, 2008, GAC SANIT, V22, P128, DOI 10.1157/13119320; Bruguera M, 2006, MED CLIN-BARCELONA, V127, P113, DOI 10.1157/13090276; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Carvalho C, 2013, HIV MED, V14, P15, DOI 10.1111/hiv.12058; Castilla J, 2000, MED CLIN-BARCELONA, V115, P85, DOI 10.1016/S0025-7753(00)71473-4; Coll M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022591; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; Danta M, 2011, CURR OPIN HIV AIDS, V6, P451, DOI 10.1097/COH.0b013e32834b4974; Daskalopoulou M, 2014, LANCET HIV, V1, pE22, DOI 10.1016/S2352-3018(14)70001-3; Ponde RAD, 2011, MED MICROBIOL IMMUN, V200, P7, DOI 10.1007/s00430-010-0159-9; Declaration of Helsiki, 2013, ETH PRINC MED RES IN; Diaz A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1093; Dietze P, 2012, INT J DRUG POLICY, V23, P257, DOI 10.1016/j.drugpo.2012.02.006; European Centre for Disease Prevention and Control, 2015, HEP C SURV EUR 2013, P9; Folch C, 2016, SUBST USE MISUSE, V51, P250, DOI 10.3109/10826084.2015.1092991; Gambotti L, 2005, Euro Surveill, V10, P115, DOI 10.2807/esm.10.05.00535-en; Garg S, 2013, CLIN INFECT DIS, V56, P1480, DOI 10.1093/cid/cit054; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Heymann DL, 2008, CONTROL COMMUNICABLE; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hygiene NYCDoHaM, 2014, HEP B C ANN REP; Jin FY, 2010, SEX TRANSM INFECT, V86, P25, DOI 10.1136/sti.2009.038182; Klevens RM, 2014, AM J PUBLIC HEALTH, V104, P482, DOI 10.2105/AJPH.2013.301601; Martinez-Rebollar M, 2015, ENFERM INFEC MICR CL, V33, P3, DOI 10.1016/j.eimc.2014.05.013; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Omland Lars Haukali, 2013, Clin Epidemiol, V5, P163, DOI 10.2147/CLEP.S43926; Owen G, 2008, CULT HEALTH SEX, V10, P601, DOI 10.1080/13691050802061673; Panella H, 2008, EMERG INFECT DIS, V14, P333, DOI 10.3201/eid1402.060763; Panneer N, 2014, CLIN INFECT DIS, V59, P875, DOI 10.1093/cid/ciu396; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; de la Hoya PS, 2011, EUR J CLIN MICROBIOL, V30, P857, DOI 10.1007/s10096-011-1166-5; Sanchez C, 2013, LIVER INT, V33, P1357, DOI 10.1111/liv.12212; Sanchez-Niubo A, 2009, ADDICTION, V104, P248, DOI 10.1111/j.1360-0443.2008.02451.x; Statistics department, STAT YB BARC CIT; Terrault NA, 2013, HEPATOLOGY, V57, P881, DOI 10.1002/hep.26164; Vallejo F, 2006, 24 REUN CIENT AN SOC; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566	44	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187893	10.1371/journal.pone.0187893	http://dx.doi.org/10.1371/journal.pone.0187893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29135988	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200042
J	Shiferaw, S; Spigt, M; Seme, A; Amogne, A; Skrovseth, S; Desta, S; Radloff, S; Tsui, A; GeertJan, D				Shiferaw, Solomon; Spigt, Mark; Seme, Assefa; Amogne, Ayanaw; Skrovseth, Stein; Desta, Selamawit; Radloff, Scott; Tsui, Amy; GeertJan, Dinant			Does proximity of women to facilities with better choice of contraceptives affect their contraceptive utilization in rural Ethiopia?	PLOS ONE			English	Article							SERVICES; QUALITY; IMPACT; CARE	Background There is limited evidence of the linkage between contraceptive use, the range of methods available and level of contraceptive stocks at health facilities and distance to facility in developing countries. The present analysis aims at examining the influence of contraceptive method availability and distance to the nearby facilities on modern contraceptive utilization among married women in rural areas in Ethiopia using geo-referenced data. Methods We used data from the first round of surveys of the Performance Monitoring & Accountability 2020 project in Ethiopia (PMA2020/Ethiopia-2014). The survey was conducted in a sample of 200 enumeration areas (EAs) where for each EA, 35 households and up to 3 public or private health service delivery points (SDPs) were selected. The main outcome variable was individual use of a contraceptive method for married women in rural Ethiopia. Correlates of interest include distance to nearby health facilities, range of contraceptives available in facilities, household wealth index, and the woman's educational status, age, and parity and whether she recently visited a health facility. This analysis primarily focuses on stock provision at public SDPs. Results Overall complete information was collected from 1763 married rural women ages 15-49 years and 198 SDPs in rural areas (97.1% public). Most rural women (93.9%) live within 5 kilometers of their nearest health post while a much lower proportion (52.2%) live within the same distance to the nearest health centers and hospital (0.8%), respectively. The main sources of modern contraceptive methods for married rural women were health posts (48.8%) and health centers (39.0%). The mean number of the types of contraceptive methods offered by hospitals, health centers and health posts was 6.2, 5.4 and 3.7 respectively. Modern contraceptive use (mCPR) among rural married women was 27.3% (95% CI: 25.3, 29.5). The percentage of rural married women who use modern contraceptives decreased as distance from the nearest SDP increased; 41.2%, 27.5%, 22.0%, and 22.6% of women living less than 2 kilometers, 2 to 3.9 kilometers, 4 to 5.9 kilometers and 6 or more kilometers, respectively (p-value<0.01). Additionally, women who live close to facilities that offer a wider range of contraceptive methods were significantly more likely to use modern contraceptives. The mCPR ranged from 42.3% among women who live within 2 kilometers of facilities offering 3 or more methods to 22.5% among women living more than 6 kilometers away from the nearest facility with the same number (3 or more methods) available after adjusting for observed covariates. Conclusions Although the majority of the Ethiopian population lives within a relatively close distance to lower level facilities (health posts), the number and range of methods available (method choice) and proximity are independently associated with contraceptive utilization. By demonstrating the extent to which objective measures of distance (of relatively small magnitude) explain variation in contraceptive use among rural women, the study fills an important planning gap for family planning programs operating in resource limited settings.	[Shiferaw, Solomon; Seme, Assefa] Addis Ababa Univ, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Coll Hlth Sci, Addis Ababa, Ethiopia; [Spigt, Mark] Maastricht Univ Netherlands, Dept Family Med, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Amogne, Ayanaw] Mela Res Plc, Addis Ababa, Ethiopia; [Skrovseth, Stein; GeertJan, Dinant] UiT Arctic Univ Norway, Dept Math & Stat, Tromso, Norway; [Skrovseth, Stein; GeertJan, Dinant] Univ Hosp North Norway, Norwegian Ctr Hlth Res E, Tromso, Norway; [Desta, Selamawit; Radloff, Scott; Tsui, Amy] Johns Hopkins Univ, Bill & Melinda Gates Inst Populat & Reprod Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Addis Ababa University; Maastricht University; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Bill & Melinda Gates Foundation; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Shiferaw, S (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Coll Hlth Sci, Addis Ababa, Ethiopia.	solomonshiferaw@gmail.com	Dangal, Ganesh/O-1989-2017	Dangal, Ganesh/0000-0002-5834-5525	Bill and Melinda Gates Foundation through Bill and Melinda Gates Institute at the Bloomberg School of Public Health, Johns Hopkins University	Bill and Melinda Gates Foundation through Bill and Melinda Gates Institute at the Bloomberg School of Public Health, Johns Hopkins University	The project was made possible by generous support from the Bill and Melinda Gates Foundation through the Bill and Melinda Gates Institute at the Bloomberg School of Public Health, Johns Hopkins University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ayanaw Amogne is affiliated to Mela Research Plc. Mela Research did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of author salaries.; The authors would like to thank survey respondents and the field staff, including the regional coordinators, field supervisors, resident enumerators, and other personnel of Addis AbabaUniversity for their dedicated effort. The project was made possible by generous support from the Bill and Melinda Gates Foundation through the Bill and Melinda Gates Institute for Population and Reproductive Health at the Bloomberg School of Public Health, Johns Hopkins University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Local support was provided by the Ethiopia Federal Ministry of Health and the respective Regional Health Bureaus and the Central Statistics Agency.	Agadjanian Victor, 2015, Int J Gynaecol Obstet, V130 Suppl 3, pE47, DOI 10.1016/j.ijgo.2015.03.019; [Anonymous], 2017, CENTRAL STAT AGENCY; Ayele HI Wondimu, TRENDS DETERMINANTS; Blanc AK, 2002, STUD FAMILY PLANN, V33, P127, DOI 10.1111/j.1728-4465.2002.00127.x; Chen S, 2003, STUD FAMILY PLANN, V34, P263, DOI 10.1111/j.1728-4465.2003.00263.x; Entwisle B, 1997, DEMOGRAPHY, V34, P171, DOI 10.2307/2061697; Ettarh Remare R, 2012, Afr J Reprod Health, V16, P48; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR; Federal democratic republic of Ethiopia Ministry of Health, 2015, HLTH SECT TRANSF PLA; Federal Ministry of Health, 2010, IMPL HLTH CAR FIN RE; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Guilkey SCaDK, 2002, EFFECT FACILITY CHAR; Jones SG, 2010, HEALTH SERV RES, V45, P316, DOI 10.1111/j.1475-6773.2009.01044.x; Karim AM, 2005, SESS 102 ACC F UNPUB; KEY FAMILY PLANNING INDICATORS, 2016, KEY FAMILY PLANNING; Lewis T, B WHO, V90, P332; Magnani RJ, 1999, STUD FAMILY PLANN, V30, P120, DOI 10.1111/j.1728-4465.1999.00120.x; [MEASURE DHS IGF Macro CSA], 2016, ETH DEM HLTH SURV 20; Mensch B, 1996, STUD FAMILY PLANN, V27, P59, DOI 10.2307/2138134; Skiles MP, 2015, INT PERSPECT SEX R H, V41, P20, DOI 10.1363/4102015; Skiles MP, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-14; Stephenson R, 2008, INT FAM PLAN PERSPEC, V34, P62, DOI 10.1363/ifpp.34.062.08; Tsui AO, 2002, WORKING PAPER SERIES, V60	23	26	26	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187311	10.1371/journal.pone.0187311	http://dx.doi.org/10.1371/journal.pone.0187311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM4OL	29131860	gold, Green Published, Green Submitted			2022-12-26	WOS:000414997800009
J	Dunlap, SS; Aziz, MA; Ziermann, JM				Dunlap, Samuel S.; Aziz, M. Ashraf; Ziermann, Janine M.			Anatomical variations of the deep head of Cruveilhier of the flexor pollicis brevis and its significance for the evolution of the precision grip	PLOS ONE			English	Article							LUMBRICAL MUSCLES; HUMAN HAND; HYPOTHENAR MUSCLES; INTRINSIC MUSCLES; MEDIAN NERVE; PRIMATE HAND; TOOL USE; THUMB; THENAR; INNERVATION	Cruveilhier described in 1834 the human flexor pollicis brevis (FPB), a muscle of the thenar compartment, as having a superficial and a deep head, respectively, inserted onto the radial and ulnar sesamoids of the thumb. Since then, Cruveilhier's deep head has been controversially discussed. Often this deep head is confused with Henle's "interosseous palmaris volaris" or said to be a slip of the oblique adductor pollicis. In the 1960s, Day and Napier described anatomical variations of the insertions of Cruveilhier's deep head, including its absence, and hypothesized, that the shift of the deep head's insertion from ulnar to radial facilitated "true opposability" in anthropoids. Their general thesis for muscular arrangements underlying the power and precision grip is sound, but they did not delineate their deep head from Henle's muscle or the adductor pollicis, and their description of the attachments of Cruveilhier's deep head were too vague and not supported by a significant portion of the anatomical literature. Here, we reinvestigated Cruveilhier's deep head to resolve the controversy about it and because many newer anatomy textbooks do not describe this muscle, while it is often an obvious functionally (writing, texting, precision grip) and clinically significant thenar muscle. For the first time, we empirically delineated Cruveilhier's deep head from neighboring muscles with which it was previously confused. We observed 100% occurrence of the uncontested deep head in 80 human hands, displaying a similar variability of insertions as Day and Napier, but in significantly different numbers. Furthermore, we found variability in the origin and included as important landmarks the trapezoid and the ligamentum carpi radiatum. We tested the assertion regarding the evolutionary morphology and its role in the improvements in thumb movements during various precision grips. Our overall conclusions differ with respect to the developmental and evolutionary origin of the FPB heads.	[Aziz, M. Ashraf; Ziermann, Janine M.] Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA	Howard University	Ziermann, JM (corresponding author), Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA.	musciebonedarwin@gmail.com; jziermann@yahoo.de	Ziermann, Janine M./C-7155-2014	Ziermann, Janine M./0000-0002-1264-9240				ABRAMOWITZ I, 1955, S AFR J SCI, V51, P270; Ajmani ML, 1996, J ANAT, V189, P145; AKIYAMA K., 1960, OKAJIMAS FOLIA ANAT JAPON, V34, P641; Albinus BS, 1749, TABLES SKELETON MUSC; Anson BJ., 1966, MORRIS HUMAN ANATOMY, P482; AZIZ MA, 1986, PRIMATES, V27, P293, DOI 10.1007/BF02382073; Aziz MA, 2017, MED RES ARCH, V5, P1; BASU SS, 1960, ANAT REC, V136, P501, DOI 10.1002/ar.1091360409; Bello-Hellegouarch G, 2013, J MORPHOL, V274, P275, DOI 10.1002/jmor.20090; Bischoff, 1870, ABH BAYER AKAD WISS, V10, P197; Brooks H S, 1887, J Anat Physiol, V22, P78; Brooks H S, 1886, J Anat Physiol, V20, P641; Brooks HSJ., 1886, J ANAT, V20, P645; Bunnell S, 1938, J BONE JOINT SURG, V20, P269; Cihak R, 1977, Birth Defects Orig Artic Ser, V13, P97; Cihak R., 1972, ADV ANAT EMBRYOL CEL, V46, P1; Clemente CD., 1985, ANATOMY HUMAN BODY H; Cozzi EP., 1992, ATLAS SURG ANATOMY H; Cruveilhier J, 1834, TRAITE ANATOMIE DESC, V1re; Cruveilhier J., 1843, TRAITE DANATOMIE DES; Cunningham D J, 1878, J Anat Physiol, V12, P434; Cunningham D J, 1890, J Anat Physiol, V25, P31; Cunningham DJ., 1882, ZOOL CHALLENG EXPED, V16, P1; Cunningham DJ, 1887, ANAT ANZEIGER, V2, P186; DAY M. H., 1963, FOLIA PRIMATOLOGICA [BASEL], V1, P122, DOI 10.1159/000165787; DAY MH, 1961, J ANAT, V95, P123; Diogo R, 2011, J ANAT, V219, P273, DOI 10.1111/j.1469-7580.2011.01403.x; Diogo R., 2012, COMP ANATOMY PHYLOGE; Diogo R., 2013, PHOTOGRAPHIC DESCRIP; Diogo R., 2012, PHOTOGRAPHIC DESCRIP; Diogo R., 2010, PHOTOGRAPHIC DESCRIP; Diogo R, 2010, MUSCLES VERTEBRATES; Diogo R, 2016, DEVELOPMENTAL APPROACHES TO HUMAN EVOLUTION, P167; Diogo R, 2012, J HUM EVOL, V63, P64, DOI 10.1016/j.jhevol.2012.04.001; Duchenne G, 1867, PHYSL MOUVEMENTS; DUNLAP SS, 1985, AM J PHYS ANTHROPOL, V68, P499, DOI 10.1002/ajpa.1330680406; Dunlap SS, 2012, INTRINSIC HAND MUSCL; Dunlap SS, 2013, INTEROSSEOUS PALMARI; Fahrer M., 1981, HAND, P399; FALCONER D, 1985, CLIN ORTHOP RELAT R, P83; Ferner H., 1964, PERNKOPFS ATLAS TOPO; Flemming W., 1887, ANAT ANZ 2, P269; Flemming W., 1887, ANAT ANZ 2, P68; Furbinger M., 1888, UNTERSUCHUNGEN MOPHO; Gardner E., 1969, ANATOMY REGIONAL STU; Haines RW, 1935, J ANAT, V70, P33; Haines RW, 1944, J ANAT, V78, P44; HARNESS D, 1971, J ANAT, V109, P461; Henkel-Kopleck A, 2000, Handchir Mikrochir Plast Chir, V32, P223, DOI 10.1055/s-2000-10932; Henle J., 1855, HDB SYSTEMATISCHEN A; Henle J., 1841, S THOMAS SOMMERRING, P363; Hepburn D, 1892, J Anat Physiol, V26, P149; Hollinshead WH., 1958, ANATOMY SURG, V3; Hollinshead WH, 1969, ANATOMY SURG, V3; HOMMA T, 1992, ACTA ANAT, V145, P44; Hou JX, 2014, INJURY EXTRA, V45, P41; Huber GC, 1930, PIERSOLS HUMAN ANATO; IKEBUCHI Y, 1988, ACTA MED OKAYAMA, V42, P327; JAN SVS, 1994, ANAT RECORD, V238, P131, DOI 10.1002/ar.1092380115; Jones F.W., 1920, PRINCIPLES ANATOMY S; Kaplan E B, 1966, Bull Hosp Joint Dis, V27, P39; Kaplan EB, 1965, FUNCTIONAL SURG ANAT; KIMURA K, 1970, Primates, V11, P145, DOI 10.1007/BF01731140; KING RB, 1951, J NEUROSURG, V8, P528, DOI 10.3171/jns.1951.8.5.0528; Kuhlmann J N, 1985, Bull Assoc Anat (Nancy), V69, P29; Landsmeer J. M., 1976, ATLAS ANATOMY HAND; Lewis O.J., 1989, FUNCTIONAL MORPHOLOG; LEWIS OJ, 1965, ANAT REC, V153, P275, DOI 10.1002/ar.1091530307; MARINACCI A A, 1964, Bull Los Angel Neuro Soc, V29, P133; MARINACCI A A, 1964, Electromyography, V4, P85; MARZKE MW, 1986, J HUM EVOL, V15, P439, DOI 10.1016/S0047-2484(86)80027-6; MARZKE MW, 1992, HAND CLIN, V8, P1; MCFARLANE RM, 1962, J BONE JOINT SURG AM, V44, P1073, DOI 10.2106/00004623-196244060-00004; McMurrich JP, 1903, AM J ANAT, V2, P463, DOI 10.1002/aja.1000020405; Morrison PE, 2011, CLIN ANAT, V24, P978, DOI 10.1002/ca.21253; MUMFORD J, 1987, J HAND SURG-AM, V12A, P361, DOI 10.1016/S0363-5023(87)80004-7; NAPIER J, 1962, SCI AM, V207, P56, DOI 10.1038/scientificamerican1262-56; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Neto JQL, 2015, ACTA ORTOP BRAS, V23, P16, DOI 10.1590/1413-78522015230101026; OLAVE E, 1995, J ANAT, V186, P441; ORahilly R., 1977, BASIC HUMAN ANATOMY; Perkins R.E., 1993, CLIN ANAT, V6, P226; Robinson A., 1923, CUNNINGHAMS TXB ANAT; Robinson A., 1931, CUNNINGHAMS TXB ANAT; Romanes GJ., 1966, CUNNINGHAMS MANUAL P, V1; Ross LM, 2006, THIEME ATLAS ANATOMY; ROWNTREE T, 1949, J BONE JOINT SURG BR, V31, P505, DOI 10.1302/0301-620X.31B4.505; Russell KF, 1938, J ANAT, V72, P306; Schafer EA, 1894, QUAINS ELEMENTS AN 2, V2; Schmidt H.M., 2004, SURG ANATOMY HAND; Schultz M., 1984, OSTEOLOGY MYOLOGY UP; Stern Jr JT, 1988, ESSENTIALS GROSS ANA; STRAUS WL, 1946, BIOL BULL, V91, P233; STRAUS WL, 1946, BIOL REV, V21, P75, DOI 10.1111/j.1469-185X.1946.tb00454.x; SUSMAN RL, 1994, SCIENCE, V265, P1570, DOI 10.1126/science.8079169; Thomson A, 1882, QUAINS ELEMENTS ANAT; Toldt C., 1904, ATLAS HUMAN ANATOMY, V6; Tubiana, 1981, HAND, P244; TUBIANA R, 1968, SURG CLIN N AM, V48, P967; Tubiana R., 1981, HAND; Valentine P., 1981, HAND, VI, P237; Warwick R, 1973, GRAYS ANATOMY; WILSON FR, 1999, HAND; Witthaut J, 1999, Handchir Mikrochir Plast Chir, V31, P66, DOI 10.1055/s-1999-13496; Wolf-Heidegger G., 1962, ATLAS SYSTEMATIC HUM; Woodburne RT, 1988, ESSENTIALS HUMAN ANA; Young A H, 1880, J Anat Physiol, V14, P149	107	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187402	10.1371/journal.pone.0187402	http://dx.doi.org/10.1371/journal.pone.0187402			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121048	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900034
J	Manineng, CM; MacLaren, D; Baigry, M; Trowalle, E; Muller, R; Vallely, A; Gesch, P; Hombhanje, F; McBride, WJ				Manineng, Clement Morris; MacLaren, David; Baigry, Maggie; Trowalle, Emil; Muller, Reinhold; Vallely, Andrew; Gesch, Patrick; Hombhanje, Francis; McBride, William John			Re-establishing safer medical-circumcision integrated initiation ceremonies for HIV prevention in a rural setting in Papua New Guinea. A multi-method acceptability study	PLOS ONE			English	Article							PREVALENCE; COMMUNITY; BLOOD	Background Efforts to stem the spread of Human Immunodeficiency Virus (HIV) in Papua New Guinea (PNG) are hampered by multiple interrelated factors including limited health services, extreme diversities in culture and language and highly prevalent gender inequity, domestic violence and poverty. In the rural district of Yangoru-Saussia, a revival of previously ceased male initiation ceremonies (MICs) is being considered for a comprehensive approach to HIV prevention. In this study, we explore the local acceptability of this undertaking including replacing traditional penile cutting practices with medical male circumcision (MMC). Methods A multi-method study comprising three phases. Phase one, focus group discussions with male elders to explore locally appropriate approaches to HIV prevention; Phase two, interviews and a cross-sectional survey with community men and women to assess views on MICs that include MMC for HIV prevention; Phase three, interviews with cultural leaders and a cross sectional survey to assess the acceptability of replacing traditional penile bleeding with MMC. Results Cultural leaders expressed that re-establishing MICs was locally appropriate for HIV prevention given the focus on character building and cultural preservation. Most surveyed participants (81.5%) supported re-establishing MICs and 92.2% supported adapting MICs with MMC. Changes to penile bleeding emerged as a contentious and contested issue given its cultural significance in symbolizing initiates' transition from childhood to adulthood. Participants were concerned about potential clash with modern education, introduced religious beliefs and limited government support in leadership and funding. Conclusions Most people in this study in Yangoru-Saussia support re-establishing MICs and replacing traditional penile bleeding with MMC. This culturally-sensitive alignment of MMC (and HIV prevention) with revived MICs responds to a national health priority in PNG and acts as an example of providing culturally-sensitive male circumcision for HIV prevention recommended by WHO/UNAIDS. However, the implementation of this undertaking will require considerable effort, especially when modern pursuits in education and religion must be factored and when there is expectation for local authorities to lead and provide funding.	[Manineng, Clement Morris; MacLaren, David; Muller, Reinhold; McBride, William John] James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia; [Manineng, Clement Morris; Baigry, Maggie; Gesch, Patrick; Hombhanje, Francis] Divine Word Univ, Fac Med & Hlth Sci, Madang, Papua N Guinea; [Trowalle, Emil] East Sepik Prov AIDS Comm, Wewak, Papua N Guinea; [Vallely, Andrew] Papua New Guinea Inst Med Res, Sexual & Reprod Hlth Unit, Goroka, Papua N Guinea	James Cook University; PNG Institute Of Medical Research	Manineng, CM (corresponding author), James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia.; Manineng, CM (corresponding author), Divine Word Univ, Fac Med & Hlth Sci, Madang, Papua N Guinea.	clement.manineng@my.jcu.edu.au	McBride, William John Hannan/B-9145-2008; McBride, William/GQY-9084-2022	McBride, William John Hannan/0000-0001-8894-533X; McBride, William/0000-0001-8894-533X; Vallely, Andrew/0000-0003-1558-4822; Manineng, Clement/0000-0003-3055-0276; Baigry, Maggie/0000-0002-2689-7202	Papua New Guinea National AIDS Council Secretariat grant [RES10 026]; Australia Awards (PNG)	Papua New Guinea National AIDS Council Secretariat grant; Australia Awards (PNG)	This study was endorsed and supported by the Papua New Guinea National AIDS Council Secretariat grant RES10 026. CM is supported by a scholarship from Australia Awards (PNG) and by a staff-support initiative from Divine Word University. The grant, scholarship and support providers had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew EVW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093025; [Anonymous], 2006, HLTH SOCIOLOGY REV, DOI DOI 10.5172/HESR.2006.15.3.293; [Anonymous], 2015, WORLD REP PAP NEW GU; [Anonymous], 2017, PAP NEW GUIN COUNTR; [Anonymous], 2013, PAP NEW GUIN HIV PRE; [Anonymous], 2010, COUNTR COOP STRAT PA; [Anonymous], 2009, PAP NEW GUIN NAT DEV; [Anonymous], 2003, GLOBALIZATION CULTUR; [Anonymous], ADV UROLOGY; [Anonymous], 2016, 7 DAY ADV CHURCH BEL; [Anonymous], PAP NEW GUIN ED CAL; [Anonymous], 2014, INT GLOB AIDS RESP P; Aria KI, 2012, MALE INITIATION OROK; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643; Bauze AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037861; Blades J., 2017, HIV REMAINS CRITICAL; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buttner P, 2010, INTRO PRACTICAL BIOS; Buttner P, 2011, EPIDEMIOLOGY; CHIEN S, 1967, SCIENCE, V157, P827, DOI 10.1126/science.157.3790.827; Connell J., 1997, PAPUA NEW GUINEA STR; Creswell J. W., 2013, QUALITATIVE INQUIRY; Garrett J, 2017, ABC NEWS PACIFI 0427; Gerwertz D, 1991, TWISTED HIST ALTERED; Gesch P, 1985, INITIATIVE INITIATIO; Godelier Maurice., 1991, BIG MEN GREAT MEN; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Green EC, 2009, AJAR-AFR J AIDS RES, V8, P389, DOI 10.2989/AJAR.2009.8.4.3.1040; Herdt G., 1982, RITUALS MANHOOD MALE; Hill PS, 2012, AIDS CARE, V24, P77, DOI 10.1080/09540121.2011.592812; Houschyar KS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-54; Hwaimani DKJ, 1974, CULTURAL READER; Jayathunge PHM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123429; Jenkins C., 2007, CULTURE CONTEXTS MAT; Kelly A, 2013, QUAL HEALTH RES, V23, P180, DOI 10.1177/1049732312467234; Kelly A, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-10; Kelly A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-67; Kelly-Hanku A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1108; Kempf W, 2002, OCEANIA, V73, P56, DOI 10.1002/j.1834-4461.2002.tb02806.x; Knauft B., 2002, EXCHANGING RAINFORES; Lewis Ione, 2009, CATALYST, V39, P29; Lutkehaus Nancy, 1990, SEPIK HERITAGE TRADI; MacLaren D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-818; MacLaren DJ, 2015, SEX TRANSM INFECT, V91, P502, DOI 10.1136/sextrans-2014-051970; Manineng C, 2014, MED J AUSTRALIA, V201, P610, DOI 10.5694/mja14.00230; McDowell N, 1998, GENDER RITUALS FEMAL, P259; Meyers L. S., 2013, PERFORMING DATA ANAL; Millan J., 2010, HIV AUSTR, V8, P9; Morris BJ, 2012, AIDS CARE, V24, P1565, DOI 10.1080/09540121.2012.661836; Morris BJ, 2011, ADV UROL, V2011, DOI 10.1155/2011/812368; Redman-MacLaren ML, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-552; Rifkin SB, 2009, INT HEALTH, V1, P31, DOI 10.1016/j.inhe.2009.02.001; Roscoe P, 1990, SEPIK HERITAGE TRADI, P402; Roscoe P, 1996, ENCY WORLD CULTURES; Roscoe Paul, 1995, GENDER RITUALS FEMAL; ROSCOE PB, 1986, ETHNOLOGY, V25, P181, DOI 10.2307/3773582; Roscoe PB, 1990, SEPIK HERITAGE TRADI, P414; Rowley KG, 2000, AUST NZ J PUBL HEAL, V24, P136, DOI 10.1111/j.1467-842X.2000.tb00133.x; Salonen JT, 1998, AM J EPIDEMIOL, V148, P445; Smith Michael French, 2002, VILLAGE EDGE CHANGIN; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Tommbe R, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-44; Tuzin Donald F., 1980, VOICE TAMBARAN TRUTH; Tynan A, 2011, PAPUA NEW GUINEA MED, V54, P109; Tynan A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-749; Tynan A, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-7; Tynan A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-299; United Nations Educational Scientific and Cultural Organization and United Nations Program for HIV/AIDS, 2002, CULT APPR HIV AIDS P; Vallely A, 2011, PAPUA NEW GUINEA MED, V54, P91; Vallely AJ, 2017, J INT AIDS SOC, P20; Waigeno D, 2016, BOIMSARA LOCALS REVI; World Health Organization and United Nations Program for HIV/AIDS, 2010, TRAD MAL CIRC CONT H; Zocca F., 2010, CATALYST, V40, P192	74	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187577	10.1371/journal.pone.0187577	http://dx.doi.org/10.1371/journal.pone.0187577			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM0ME	29117244	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000414659600048
J	Secondi, J; Dupont, V; Davranche, A; Mondy, N; Lengagne, T; Thery, M				Secondi, Jean; Dupont, Valentin; Davranche, Aurelie; Mondy, Nathalie; Lengagne, Thierry; Thery, Marc			Variability of surface and underwater nocturnal spectral irradiance with the presence of clouds in urban and peri-urban wetlands	PLOS ONE			English	Article							ECOLOGICAL LIGHT POLLUTION; ARTIFICIAL-LIGHT; SPATIAL-DISTRIBUTION; NIGHT; RHYTHMS; POND; BIODIVERSITY; VULGARIS; IMPACTS; QUALITY	Artificial light at night (ALAN) is an increasing phenomenon worldwide. It causes a wealth of biological and ecological effects that may eventually affect populations and ecosystems. Despite the growing concern about ALAN, little is known about the light levels species are exposed to at night, especially for wetlands and underwater habitats. We determined nocturnal irradiance in urban and peri-urban wetlands above and under water, and assessed the effect of cloud cover on the variability of ALAN across the urban gradient. Even in aquatic habitats, cloud cover could increase irradiance beyond values observed during clear full moon nights. We report a negative relationship between baseline irradiance and the increase in irradiance during overcast nights. According to this result and previous studies, we propose that the change in the variation regime of ALAN between the urban center and rural land at its periphery is a usual feature. We discuss the ecological and evolutionary implications of this spatial variation in the urban and peri-urban environment.	[Secondi, Jean; Mondy, Nathalie; Lengagne, Thierry] Univ Lyon 1, CNRS, ENTPE, UMR 5023,Ecol Hydrosyst Nat & Anthropises, Villeurbanne, France; [Secondi, Jean; Dupont, Valentin] Univ Angers, GECCO, Angers, France; [Davranche, Aurelie] Univ Angers, CNRS, LETG, UMR 6554,LEESA, Angers, France; [Thery, Marc] CNRS, MNHN, UMR 7179, Mecanismes Adaptatifs & Evolut, Brunoy, France; [Secondi, Jean] LTSER France, Zone Atelier, Loire, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Secondi, J (corresponding author), Univ Lyon 1, CNRS, ENTPE, UMR 5023,Ecol Hydrosyst Nat & Anthropises, Villeurbanne, France.; Secondi, J (corresponding author), Univ Angers, GECCO, Angers, France.; Secondi, J (corresponding author), LTSER France, Zone Atelier, Loire, France.	jean.secondi@univ-angers.fr	Davranche, Aurélie/AAR-1125-2020	Secondi, Jean/0000-0001-8130-1195; Mondy, Nathalie/0000-0002-4479-7053				Aube M, 2016, J QUANT SPECTROSC RA, V181, P11, DOI 10.1016/j.jqsrt.2016.01.032; Bennie J, 2017, J APPL ECOL; Bennie J, 2015, REMOTE SENS-BASEL, V7, P2715, DOI 10.3390/rs70302715; Bennie J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0131; Bergstrom J. C., 1990, Ecological Economics, V2, P129, DOI 10.1016/0921-8009(90)90004-E; BERNINGER UG, 1986, J PROTOZOOL, V33, P557, DOI 10.1111/j.1550-7408.1986.tb05662.x; Bloch G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0019; BOAG DA, 1984, CAN J ZOOL, V62, P1485, DOI 10.1139/z84-215; Bruning A, 2015, SCI TOTAL ENVIRON, V511, P516, DOI 10.1016/j.scitotenv.2014.12.094; Buchanan Bryant W., 2006, P192; Cathey H. M., 1975, Journal of Arboriculture, V1, P181; Chester ET, 2013, BIOL CONSERV, V166, P64, DOI 10.1016/j.biocon.2013.06.016; Davies B, 2008, AGR ECOSYST ENVIRON, V125, P1, DOI 10.1016/j.agee.2007.10.006; Davies TW, 2013, GLOBAL CHANGE BIOL, V19, P1417, DOI 10.1111/gcb.12166; de Jong M, 2016, PHYSIOL BEHAV, V155, P172, DOI 10.1016/j.physbeh.2015.12.012; Deeming DC, 2008, HERPETOL J, V18, P171; Dominoni DM, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-60; Duriscoe DM, 2016, J QUANT SPECTROSC RA, V181, P33, DOI 10.1016/j.jqsrt.2016.02.022; Falchi F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600377; Ffrench-Constant RH, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0813; FIRTH BT, 1991, NEUROSCI LETT, V121, P139, DOI 10.1016/0304-3940(91)90669-K; Fonken LK, 2012, CHRONOBIOL INT, V29, P26, DOI 10.3109/07420528.2011.635831; Gaston KJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0133; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Gaston KJ, 2012, J APPL ECOL, V49, P1256, DOI 10.1111/j.1365-2664.2012.02212.x; Grant R, 2013, BEHAV ECOL, V24, P53, DOI 10.1093/beheco/ars135; GRIFFITHS RA, 1987, J ANIM ECOL, V56, P441, DOI 10.2307/5059; Hampton SE, 2002, HYDROBIOLOGIA, V477, P171, DOI 10.1023/A:1021059108674; Holker F, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0130; Holker F, 2010, ECOL SOC, V15; Huovinen PS, 2003, CHEMOSPHERE, V51, P205, DOI 10.1016/S0045-6535(02)00634-3; Jechow A., 2017, INT J SUSTAIN LIGHT, V36, P15, DOI [10.26607/ijsl.v19i1.62, DOI 10.26607/IJSL.V19I1.62, DOI 10.26607/ijsl.v19i1.62]; Jechow A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06998-z; Jechow A, 2016, J QUANT SPECTROSC RA, V181, P24, DOI 10.1016/j.jqsrt.2016.02.005; Joshi BN, 2003, BMC PHYSL, V6, p1 ; Kelber A, 2010, P ROY SOC B-BIOL SCI, V277, P1617, DOI 10.1098/rspb.2009.2118; Knop E, 2017, NATURE, V548, P206, DOI 10.1038/nature23288; Kyba CCM, 2012, MON NOT R ASTRON SOC, V425, P701, DOI 10.1111/j.1365-2966.2012.21559.x; KYBA CCM, 2015, SCI REP UK, V5; Kyba CCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017307; LARSEN L O, 1982, Amphibia-Reptilia, V2, P321; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; Luginbuhl CB, 2009, PUBL ASTRON SOC PAC, V121, P204, DOI 10.1086/597626; Lytle DA, 2003, TRENDS ECOL EVOL; Meyer LA, 2013, ECOL APPL, V23, P1322, DOI 10.1890/12-2007.1; Moore Marianne V., 2006, P365; Moore MV, 2000, VERH INT VER LIMNOL, V27, P779, DOI DOI 10.1080/03680770.1998.11901341; Newman RC, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov051; Nightingale Barbara, 2006, P257; Perkin EK, 2014, FRESHWATER BIOL, V59, P2235, DOI 10.1111/fwb.12426; Perkin EK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00241.1; Perry Gad, 2008, P239; Pun CSJ, 2012, ENVIRON MONIT ASSESS, V184, P2537, DOI 10.1007/s10661-011-2136-1; Raap T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35626; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Rich C., 2006, ECOLOGICAL CONSEQUEN; Ruokolainen L, 2009, TRENDS ECOL EVOL, V24, P555, DOI 10.1016/j.tree.2009.04.009; Secondi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030391; Spoelstra H, 2014, J QUANT SPECTROSC RA, V139, P82, DOI 10.1016/j.jqsrt.2014.01.001; Swaddle JP, 2015, TRENDS ECOL EVOL, V9, p555 ; Tamir R, 2017, SCI REP-UK, V7, DOI 10.1038/srep42329; Verhoeven JTA, 2006, TRENDS ECOL EVOL, V21, P96, DOI 10.1016/j.tree.2005.11.015; Wise Sharon E., 2006, P221; Zedler JB, 2003, FRONT ECOL ENVIRON, V1, P65, DOI 10.1890/1540-9295(2003)001[0065:WAYSRI]2.0.CO;2	64	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0186808	10.1371/Journal.pone.0186808	http://dx.doi.org/10.1371/Journal.pone.0186808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117235	gold, Green Published, Green Submitted			2022-12-26	WOS:000414659600016
J	Pedroza, M; Welschhans, RL; Agarwal, SK				Pedroza, Mesias; Welschhans, Robert L.; Agarwal, Sandeep K.			Targeting of cadherin-11 decreases skin fibrosis in the tight skin-1 mouse model	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; ANIMAL-MODEL; DERMAL FIBROSIS; OB-CADHERIN; SCLERODERMA; CELL; EXPRESSION; ADHESION; CLONING; CANCER	Objective Systemic sclerosis (SSc) is an autoimmune disease clinically manifesting as progressive fibrosis of the skin and internal organs. Cadherin-11 (CDH11) expression is increased in fibrotic skin and lung tissue. Targeting CDH11 may be an effective approach to treating fibrosis. We hypothesize that targeting CDH11 will decrease fibrosis in the tight skin-1 (Tsk-1) mouse model. Methods CDH11 expression was determined in the Tsk-1 mouse model using quantitative real time PCR and immunofluorescence (IF). Inhibitory anti-CDH11 monoclonal antibodies were tested in Tsk-1 mice for their ability to decrease hypodermal fibrosis. Results Expression of CDH11 was increased in fibrotic skin from Tsk-1 mice compared to pallid controls. IF staining demonstrated that CDH11 expression localized to fibroblasts within the hypodermis of fibrotic skin. Treatment with inhibitory anti-CDH11 monoclonal antibodies decreased hypodermal thickness and fibrotic mediators in Tsk-1 mice compared to control antibodies. Conclusions These data demonstrate an important role for CDH11 in the development of skin fibrosis in Tsk-1 mice. These data add to the growing evidence for the important role of CDH11 in tissue fibrosis and fibrotic disease such as systemic sclerosis.	[Pedroza, Mesias; Welschhans, Robert L.; Agarwal, Sandeep K.] Baylor Coll Med, Dept Med, Biol Inflammat Ctr, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA	Baylor College of Medicine	Agarwal, SK (corresponding author), Baylor Coll Med, Dept Med, Biol Inflammat Ctr, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA.	skagarwa@bcm.edu			NIH/NIAMS [R01AR062056-01A1]; NIH [2T32AI053831-11A1]	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH/NIAMS R01AR062056-01A1 (SKA), NIH 2T32AI053831-11A1 (MP).	Abraham DJ, 2005, TRENDS IMMUNOL, V26, P587, DOI 10.1016/j.it.2005.09.004; Artlett CM, 2010, CURR OPIN RHEUMATOL, V22, P677, DOI 10.1097/BOR.0b013e32833e307b; Baxter RM, 2005, LAB INVEST, V85, P1199, DOI 10.1038/labinvest.3700331; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; GREEN MC, 1976, AM J PATHOL, V82, P493; Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386; HOFFMANN I, 1995, DEV BIOL, V169, P337, DOI 10.1006/dbio.1995.1148; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; OKAZAKI M, 1994, J BIOL CHEM, V269, P12092; Pablos JL, 2004, CLIN EXP RHEUMATOL, V22, pS81; Pishvaian MJ, 1999, CANCER RES, V59, P947; Pittet P, 2008, J CELL SCI, V121, P877, DOI 10.1242/jcs.024877; Row S, 2016, J CELL SCI, V129, P2950, DOI 10.1242/jcs.183772; Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098; Shibata T, 1996, CANCER LETT, V99, P147, DOI 10.1016/0304-3835(95)04047-1; Valencia X, 2004, J EXP MED, V200, P1673, DOI 10.1084/jem.20041545; Wei J, 2011, ARTHRITIS RHEUM-US, V63, P1707, DOI 10.1002/art.30312; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wu MH, 2014, ARTHRITIS RHEUMATOL, V66, P1010, DOI 10.1002/art.38275; Wu MH, 2012, J INVEST DERMATOL, V132, P1605, DOI 10.1038/jid.2012.32; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Yamamoto T, 2010, J DERMATOL, V37, P26, DOI 10.1111/j.1346-8138.2009.00764.x	23	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187109	10.1371/journal.pone.0187109	http://dx.doi.org/10.1371/journal.pone.0187109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112946	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100008
J	Lee, JH; Wen, XL; Cho, H; Koo, SH				Lee, Ji-Hyun; Wen, Xianlan; Cho, Hana; Koo, Seung-Hoi			CREB/CRTC2 controls GLP-1-dependent regulation of glucose homeostasis	FASEB JOURNAL			English	Article						cAMP signaling; transcriptional activator; glucose metabolism; intestinal L cells	GLUCAGON-LIKE PEPTIDE-1; PROGLUCAGON GENE-EXPRESSION; CREB COACTIVATOR TORC2; INSULIN-SECRETION; INCRETIN HORMONES; KEY REGULATOR; PREPROGLUCAGON; PANCREAS; PROTEIN; CELLS	Glucagon-like peptide 1 (GLP-1) is a major incretin that controls glucose homeostasis. The secretion of mature GLP-1 is regulated via GPCRs, including bile acid receptor G protein-coupled bile acid receptor 1, which uses cAMP signaling to enhance the exocytosis of GLP-1-containing vesicles. However, the role of cAMP-mediated transcription has not been clearly demonstrated to date. In this study, we explored the role of cAMP response element-binding protein/CREB-regulated transcription coactivator 2 (CREB/CRTC2)-dependent transcription on GLP-1 secretion in the L cells. We found that the reduced CREB/CRTC2 activity impaired the cAMP-dependent increase in GLP-1 secretion, whereas expression of constitutively active CRTC2 increased GLP-1 exocytosis from the L cells. Close investigation revealed that expression of not only proglucagon but also PC1/3, an endopeptidase for GLP-1 maturation, is transcriptionally regulated by CREB/CRTC2. Furthermore, expression of peroxisome proliferator-activating receptor coactivator 1 a is also reduced upon depletion of CRTC2, leading to the decreased expression of oxidative phosphorylation (OxPhos) genes, reduced ATP levels, and calcium concentrations in the L cells. Finally, we observed that intestine-specific CRTC2 knockout mice displayed reduced GLP-1 expression, leading to the lower plasma GLP-1 levels, impaired glucose tolerance, and decreased insulin-containing beta cells in pancreatic islets. Our data show that the CREB/CRTC2-dependent transcriptional pathway is critical for regulating glucose homeostasis by controlling production of GLP-1 from the L cells at the level of transcription, maturation, and exocytosis.	[Lee, Ji-Hyun; Koo, Seung-Hoi] Korea Univ, Div Life Sci, 145 Anam Rd, Seoul 02841, South Korea; [Wen, Xianlan; Cho, Hana] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Physiol, Suwon, South Korea	Korea University; Sungkyunkwan University (SKKU)	Koo, SH (corresponding author), Korea Univ, Div Life Sci, 145 Anam Rd, Seoul 02841, South Korea.	koohoi@korea.ac.kr		Cho, Hana/0000-0002-9394-8671	National Research Foundation of Korea [NRF-2015R1A2A1A01006687, NRF-2012M3A9B6055345, NRF-2015R1A5A1009024, NRF-2017M3A9D5A01052447]; Ministry of Science and ICT, Korea; Korea University	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science and ICT, Korea; Korea University	The authors thank Prof. Daniel Drucker (University of Toronto, Toronto, ON, Canada) and Prof. Toru Hira (Hokkaido University, Sapporo, Hokkaido, Japan) for kindly providing us the GLUTag L cells and Prof. Minsun Kim (Asan Medical Center, Seoul, Korea) for kindly providing us with the villin-Cre transgenic mice. The authors thank members of the Koo Laboratory for critical review of this manuscript. This work was supported by the National Research Foundation of Korea (Grants NRF-2015R1A2A1A01006687, NRF-2012M3A9B6055345, NRF-2015R1A5A1009024, and NRF-2017M3A9D5A01052447), funded by the Ministry of Science and ICT, Korea, and a grant from Korea University. The authors declare no conflicts of interests.	Baggio L, 2000, ENDOCRINOLOGY, V141, P3703, DOI 10.1210/en.141.10.3703; BELL GI, 1983, NATURE, V304, P368, DOI 10.1038/304368a0; Cani PD, 2007, MOL CELL ENDOCRINOL, V276, P18, DOI 10.1016/j.mce.2007.06.003; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deacon CF, 2006, INT J BIOCHEM CELL B, V38, P831, DOI 10.1016/j.biocel.2005.09.011; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dyer J, 2003, EUR J BIOCHEM, V270, P3377, DOI 10.1046/j.1432-1033.2003.03721.x; Eberhard CE, 2013, ENDOCRINOLOGY, V154, P2308, DOI 10.1210/en.2012-2088; El-Ouaghlidi A, 2007, J CLIN ENDOCR METAB, V92, P4165, DOI 10.1210/jc.2006-1932; Espinosa VP, 2008, NEUROSCIENCE, V156, P788, DOI 10.1016/j.neuroscience.2008.07.063; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gevrey JC, 2004, DIABETOLOGIA, V47, P926, DOI 10.1007/s00125-004-1380-0; Han JB, 2015, NATURE, V524, P243, DOI 10.1038/nature14557; Harach T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00430; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Henriksen DB, 2003, J BONE MINER RES, V18, P2180, DOI 10.1359/jbmr.2003.18.12.2180; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kim MJ, 2015, DIABETES, V64, P3189, DOI 10.2337/db14-1240; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lotfi S, 2006, ENDOCRINOLOGY, V147, P3727, DOI 10.1210/en.2006-0056; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; NOVAK U, 1987, EUR J BIOCHEM, V164, P553, DOI 10.1111/j.1432-1033.1987.tb11162.x; Ogata H, 2014, J ENDOCRINOL, V222, P191, DOI 10.1530/JOE-14-0161; ORSKOV C, 1988, ENDOCRINOLOGY, V123, P2009, DOI 10.1210/endo-123-4-2009; Orskov C, 1996, SCAND J GASTROENTERO, V31, P665, DOI 10.3109/00365529609009147; Parker HE, 2012, DIABETOLOGIA, V55, P2445, DOI 10.1007/s00125-012-2585-2; Reimann F, 2002, DIABETES, V51, P2757, DOI 10.2337/diabetes.51.9.2757; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; ROUILLE Y, 1994, P NATL ACAD SCI USA, V91, P3242, DOI 10.1073/pnas.91.8.3242; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Ugleholdt R, 2004, ENDOCRINOLOGY, V145, P1349, DOI 10.1210/en.2003-0801; Villareal DT, 2010, DIABETES, V59, P479, DOI 10.2337/db09-1169; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wettergren A, 1998, PEPTIDES, V19, P877, DOI 10.1016/S0196-9781(98)00020-5; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Yoon YS, 2010, P NATL ACAD SCI USA, V107, P17704, DOI 10.1073/pnas.1012665107	43	20	21	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1566	1578		10.1096/fj.201700845R	http://dx.doi.org/10.1096/fj.201700845R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29118086				2022-12-26	WOS:000427246000035
J	Pan, I; Roitenberg, N; Cohen, E				Pan, Ieshita; Roitenberg, Noa; Cohen, Ehud			Vesicle-mediated secretion of misfolded prion protein molecules from cyclosporin A-treated cells	FASEB JOURNAL			English	Article						proteotoxicity; neurodegeneration; exosome; PrP	UNCONVENTIONAL SECRETION; NEUROBLASTOMA-CELLS; STRAUSSLER-SYNDROME; CULTURED-CELLS; EXOSOMES; AGGRESOMES; MICROVESICLES; COMPARTMENTS; AGGREGATION; HEPATOCYTES	Loss of protein homeostasis is a hazardous situation that jeopardizes cellular functionality and viability. Cells have developed mechanisms that supervise protein integrity and direct misfolded molecules for degradation. Nevertheless, subsets of aggregation-prone proteins escape degradation and form aggregates that can underlie the development of neurodegenerative disorders. In some cases, cells deposit hazardous protein aggregates in designated sites, like aggresomes, or secrete them with vesicles. The prion protein (PrP) is an aggregation-prone, membrane-anchored glycoprotein, whose aggregation causes familial and sporadic, fatal, neurodegenerative diseases. The proper maturation of PrP is assisted by cyclophilin B, an endoplasmic reticulum-resident foldase. Accordingly, the inhibition of cyclophilins by the drug cyclosporin A (CsA) leads to the accumulation of aggregated PrP and to its deposition in aggresomes. In this study, we asked whether secretion is an alternative strategy that cells adopt to get rid of misfolded PrP molecules and found that, upon treatment with CsA, cells secrete PrP by exosomes, a subtype of secretion vesicles, and by additional types of vesicles. CsA-induced, PrP-containing exosomes originate from the endoplasmic reticulum in a Golgi-independent manner. These findings divulge a new cellular response that is activated upon CsA treatment to secrete misfolded PrP species from the cell and may underlie the spreading of toxic prions among cells and across tissues.	[Pan, Ieshita; Roitenberg, Noa; Cohen, Ehud] Hebrew Univ Jerusalem, Sch Med, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Cohen, E (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.	ehudc@ekmd.huji.ac.il	Pan, Ieshita/ABD-1807-2021	Cohen, Ehud/0000-0001-5552-7086; PAN, IESHITA/0000-0003-3434-2845	E-Rare Net (The Israeli Ministry of Health and Research) [3-0000-44710]; Israel Science Foundation [ISF 981/16]	E-Rare Net (The Israeli Ministry of Health and Research); Israel Science Foundation(Israel Science Foundation)	The authors thank Tatyana Dubnikov (Hebrew University School of Medicine) for critical reading of the manuscript. This work was generously supported by the E-Rare Net (The Israeli Ministry of Health and Research, Grant 3-0000-44710) and the Israel Science Foundation (Grant ISF 981/16). The authors declare no conflicts of interest.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Ben-Gedalya T, 2015, EMBO J, V34, P2820, DOI 10.15252/embj.201592042; Ben-Gedalya T, 2011, J CELL SCI, V124, P1891, DOI 10.1242/jcs.077693; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Cohen E, 2003, EMBO J, V22, P404, DOI 10.1093/emboj/cdg045; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Dubnikov T, 2016, J CELL SCI, V129, P3635, DOI 10.1242/jcs.186981; Falker C, 2016, J NEUROCHEM, V137, P88, DOI 10.1111/jnc.13514; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Hartmann A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00194; Hosseini-Beheshti E, 2012, MOL CELL PROTEOMICS, V11, P863, DOI 10.1074/mcp.M111.014845; Howitt J, 2016, J BIOL CHEM, V291, P26589, DOI 10.1074/jbc.R116.757955; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Laulagnier K, 2017, METHODS MOL BIOL, V1545, P129, DOI 10.1007/978-1-4939-6728-5_9; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Lipatova Z, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005390; Marques FC, 2015, ANNU REV PATHOL-MECH, V10, P1, DOI 10.1146/annurev-pathol-012414-040508; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Momen-Heravi F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09991; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802; Ruhlmann A, 1997, IMMUNOBIOLOGY, V198, P192; Sassone J, 2006, EUR J HISTOCHEM, V50, P109; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Volkmar N, 2016, NAT CELL BIOL, V18, P724, DOI 10.1038/ncb3381; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; Willms E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22519; Xia D, 2016, GENE, V583, P64, DOI 10.1016/j.gene.2016.02.042; Yamazaki M, 1999, ACTA NEUROPATHOL, V98, P506, DOI 10.1007/s004010051116; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740	42	6	6	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1479	1492		10.1096/fj.201700598RRR	http://dx.doi.org/10.1096/fj.201700598RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127190				2022-12-26	WOS:000427246000029
J	Pogribny, IP; Dreval, K; Kindrat, I; Melnyk, S; Jimenez, L; de Conti, A; Tryndyak, V; Pogribna, M; Ortega, JF; James, SJ; Rusyn, I; Beland, FA				Pogribny, Igor P.; Dreval, Kostiantyn; Kindrat, Iryna; Melnyk, Stepan; Jimenez, Leandro; de Conti, Aline; Tryndyak, Volodymyr; Pogribna, Marta; Ortega, Juliana Festa; James, S. Jill; Rusyn, Ivan; Beland, Frederick A.			Epigenetically mediated inhibition of S-adenosylhomocysteine hydrolase and the associated dysregulation of 1-carbon metabolism in nonalcoholic steatohepatitis and hepatocellular carcinoma	FASEB JOURNAL			English	Article						hepatocarcinogenesis; mouse; epigenetics	FATTY LIVER-DISEASE; ONE-CARBON METABOLISM; COULOMETRIC ELECTROCHEMICAL DETECTION; FOLATE-DEFICIENT DIET; HEPATIC ONE-CARBON; LIPID-METABOLISM; BETAINE SUPPLEMENTATION; INTERSTRAIN DIFFERENCES; METHIONINE METABOLISM; PLASMA HOMOCYSTEINE	The substantial rise in the prevalence of nonalcoholic steatohepatitis (NASH), an advanced form of nonalcoholic fatty liver disease, and the strong association between NASH and the development of hepatocellular carcinoma indicate the urgent need for a better understanding of the underlying mechanisms. In the present study, by using the Stelic animal model of NASH and NASH-derived liver carcinogenesis, we investigated the role of the folate-dependent 1-carbon metabolism in the pathogenesis of NASH. We demonstrated that advanced NASH and NASH-related liver carcinogenesis are characterized by a significant dysregulation of 1-carbon homeostasis, with diminished expression of key 1-carbon metabolism genes, especially a marked inhibition of the S-adenosylhomocysteine hydrolase (Ahcy) gene and an increased level of S-adenosyl-L-homocysteine (SAH). The reduction in Ahcy expression was associated with gene-specific cytosine DNA hypermethylation and enrichment of the gene promoter by trimethylated histone H3 lysine 27 and deacetylated histone H4 lysine 16, 2 main transcription-inhibiting markers. These results indicate that epigenetically mediated inhibition of Ahcy expression may be a driving force in causing SAH elevation and subsequent downstream disturbances in transsulfuration and transmethylation pathways during the development and progression of NASH.	[Pogribny, Igor P.; Dreval, Kostiantyn; Kindrat, Iryna; de Conti, Aline; Tryndyak, Volodymyr; Pogribna, Marta; Ortega, Juliana Festa; Beland, Frederick A.] Natl Ctr Toxicol Res, Div Biochem Toxicol, Jefferson, AR 72079 USA; [Melnyk, Stepan; James, S. Jill] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Jimenez, Leandro] Hosp Sirio Libanes, Mol Oncol Ctr, Sao Paulo, Brazil; [Ortega, Juliana Festa] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Food & Expt Nutr, Sao Paulo, Brazil; [Rusyn, Ivan] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	US Food & Drug Administration (FDA); University of Arkansas System; University of Arkansas Medical Sciences; Hospital Sirio Libanes; Universidade de Sao Paulo; Texas A&M University System; Texas A&M University College Station	Pogribny, IP (corresponding author), NCTR, Div Biochem Toxicol, 3900 NCTR Rd, Jefferson, AR 72079 USA.	igor.pogribny@fda.hhs.gov	Kindrat, Iryna/AAA-7824-2020	Dreval, Kostiantyn/0000-0002-6214-2843; Rusyn, Ivan/0000-0001-9340-7384; Kindrat, Iryna/0000-0003-3960-0495; Tryndyak, Volodymyr/0000-0002-8319-2954	NIEHS NIH HHS [P30 ES023512] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023512] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aissa AF, 2014, MOL NUTR FOOD RES, V58, P1502, DOI 10.1002/mnfr.201300726; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Barroso M, 2016, BBA-MOL BASIS DIS, V1862, P82, DOI 10.1016/j.bbadis.2015.10.019; Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buist NRM, 2006, J INHERIT METAB DIS, V29, P538, DOI 10.1007/s10545-006-0240-0; Cheung O, 2008, SEMIN LIVER DIS, V28, P351, DOI 10.1055/s-0028-1091979; Dai HJ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0221-6; de Conti A, 2017, MOL CANCER RES, V15, P1163, DOI 10.1158/1541-7786.MCR-17-0109; Deminice R, 2015, AMINO ACIDS, V47, P839, DOI 10.1007/s00726-014-1913-x; Doycheva I, 2017, HEPATOLOGY, V65, P2100, DOI 10.1002/hep.29068; Frau M, 2013, J HEPATOL, V59, P830, DOI 10.1016/j.jhep.2013.04.031; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Goldberg D, 2017, GASTROENTEROLOGY, V152, P1090, DOI 10.1053/j.gastro.2017.01.003; Gupta S, 2016, J INHERIT METAB DIS, V39, P39, DOI 10.1007/s10545-015-9883-z; Kakehashi A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020434; Leach NV, 2014, EUR J INTERN MED, V25, P762, DOI 10.1016/j.ejim.2014.09.007; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Maher JJ, 2011, ANTIOXID REDOX SIGN, V15, P535, DOI 10.1089/ars.2010.3749; Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832; Matthews RP, 2009, DEVELOPMENT, V136, P865, DOI 10.1242/dev.027565; Medici V, 2010, J HEPATOL, V53, P551, DOI 10.1016/j.jhep.2010.03.029; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Melnyk S, 2000, CLIN CHEM, V46, P265; Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047; Neuschwander-Tetri BA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0806-8; Pacana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136822; Pastore A, 2014, INT J MOL SCI, V15, P21202, DOI 10.3390/ijms151121202; Pogribny IP, 2013, FASEB J, V27, P2233, DOI 10.1096/fj.12-227116; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Ratziu V, 2015, J HEPATOL, V62, pS65, DOI 10.1016/j.jhep.2015.02.041; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rubio-Aliaga I, 2011, PHYSIOL GENOMICS, V43, P408, DOI 10.1152/physiolgenomics.00179.2010; Saito K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12466; Satapathy SK, 2015, SEMIN LIVER DIS, V35, P221, DOI 10.1055/s-0035-1562943; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwahn BC, 2004, BIOCHEM J, V382, P831, DOI 10.1042/BJ20030822; Stender S, 2015, MOL GENET METAB, V116, P269, DOI 10.1016/j.ymgme.2015.10.009; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Teng YW, 2012, J NUTR, V142, P1964, DOI 10.3945/jn.112.166835; Tryndyak V, 2012, FASEB J, V26, P4592, DOI 10.1096/fj.12-209569; Tryndyak VP, 2011, MOL NUTR FOOD RES, V55, P411, DOI 10.1002/mnfr.201000300; Tsuchiya M, 2012, HEPATOLOGY, V56, P130, DOI 10.1002/hep.25641; Turner MA, 2000, CELL BIOCHEM BIOPHYS, V33, P101, DOI 10.1385/CBB:33:2:101; Uehara T, 2013, TOXICOL SCI, V132, P53, DOI 10.1093/toxsci/kfs342; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	51	18	18	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1591	1601		10.1096/fj.201700866R	http://dx.doi.org/10.1096/fj.201700866R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127188	Green Published, Bronze			2022-12-26	WOS:000427246000037
J	Bowden, CFM; Chan, ACK; Li, EJW; Arrieta, AL; Eltis, LD; Murphy, MEP				Bowden, Catherine F. M.; Chan, Anson C. K.; Li, Emily J. W.; Arrieta, Angele L.; Eltis, Lindsay D.; Murphy, Michael E. P.			Structure-function analyses reveal key features in Staphylococcus aureus IsdB-associated unfolding of the heme-binding pocket of human hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HAPTOGLOBIN; SURFACE PROTEIN; NEAT DOMAIN; IRON; RECEPTOR; DETERMINANTS; COMPLEX; SYSTEM; IDENTIFICATION; OXYHEMOGLOBIN	IsdB is a receptor on the surface of the bacterial pathogen Staphylococcus aureus that extracts heme from hemoglobin (Hb) to enable growth on Hb as a sole iron source. IsdB is critically important both for in vitro growth on Hb and in infection models and is also highly up-regulated in blood, serum, and tissue infection models, indicating a key role of this receptor in bacterial virulence. However, structural information for IsdB is limited. We present here a crystal structure of a complex between human Hb and IsdB. In this complex, the alpha subunits of Hb are refolded with the heme displaced to the interface with IsdB. We also observe that atypical residues of Hb, His58 and His89 of alpha Hb, coordinate to the heme iron, which is poised for transfer into the heme-binding pocket of IsdB. Moreover, the porphyrin ring interacts with IsdB residues Tyr440 and Tyr444. Previously, Tyr440 was observed to coordinate heme iron in an IsdB.heme complex structure. A Y440F/ Y444F IsdB variant we produced was defective in hemetransferyetformedastablecomplexwithHb(K-d = 6 +/- 2 mu M) in solution with spectroscopic features of the bis-His species observed in the crystal structure. Haptoglobin binds to a distinct site onHbto inhibit heme transfer to IsdB and growth of S. aureus, and a ternary complex of IsdB.Hb.Hp was observed. We propose a model for IsdB heme transfer from Hb that involves unfolding of Hb and heme iron ligand exchange.	[Bowden, Catherine F. M.; Chan, Anson C. K.; Li, Emily J. W.; Arrieta, Angele L.; Eltis, Lindsay D.; Murphy, Michael E. P.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Murphy, MEP (corresponding author), Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	Michael.Murphy@ubc.ca		Chan, Anson/0000-0001-6625-8942	Canadian Institutes of Health Research [MOP-49597]; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship - Doctoral scholarship; Canada Foundation for Innovation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship - Doctoral scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Canadian Institutes of Health Research Grant MOP-49597 (to M. E. P. M.) and a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship - Doctoral scholarship (to C. F. M. B.). Support for laboratory infrastructure was provided by the Canada Foundation for Innovation (to M. E. P. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allard M, 2006, MICROBES INFECT, V8, P1679, DOI 10.1016/j.micinf.2006.01.022; Andrade MA, 2002, GENOME BIOL, V3; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bowden CFM, 2014, BIOCHEMISTRY-US, V53, P2286, DOI 10.1021/bi500230f; BUNN HF, 1968, J BIOL CHEM, V243, P465; Cheng TM, 2007, CLIN BIOCHEM, V40, P1045, DOI 10.1016/j.clinbiochem.2007.04.018; Wobeto VPD, 2008, GENET MOL BIOL, V31, P602, DOI 10.1590/S1415-47572008000400002; Dickson CF, 2015, ACTA CRYSTALLOGR D, V71, P1295, DOI 10.1107/S1399004715005817; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; EATON JW, 1982, SCIENCE, V215, P691, DOI 10.1126/science.7036344; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Etz H, 2002, P NATL ACAD SCI USA, V99, P6573, DOI 10.1073/pnas.092569199; Fonner BA, 2014, BIOCHEMISTRY-US, V53, P3922, DOI 10.1021/bi5005188; FRANCIS RT, 1985, INT J BIOCHEM, V17, P767, DOI 10.1016/0020-711X(85)90262-9; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; HWANG PK, 1980, J BIOL CHEM, V255, P3038; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; MANSOURI A, 1973, BIOCHEMISTRY-US, V12, P4946, DOI 10.1021/bi00748a020; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nielsen MJ, 2013, J BIOL CHEM, V288, P18834, DOI 10.1074/jbc.M113.471060; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pishchany G, 2013, JOVE-J VIS EXP, DOI 10.3791/50072; Pishchany G, 2014, J INFECT DIS, V209, P1764, DOI 10.1093/infdis/jit817; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Robinson VL, 2003, BIOCHEMISTRY-US, V42, P10113, DOI 10.1021/bi030059t; Saederup KL, 2016, J BIOL CHEM, V291, P23989, DOI 10.1074/jbc.M116.755934; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Tsuruga M, 1998, J BIOL CHEM, V273, P8607, DOI 10.1074/jbc.273.15.8607; Waness A, 2010, J GLOB INFECT DIS, V2, P49, DOI 10.4103/0974-777X.59251; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	54	29	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					177	190		10.1074/jbc.M117.806562	http://dx.doi.org/10.1074/jbc.M117.806562			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29109153	Green Published, hybrid			2022-12-26	WOS:000419453200016
J	Shizu, R; Min, J; Sobhany, M; Pedersen, LC; Mutoh, S; Negishi, M				Shizu, Ryota; Min, Jungki; Sobhany, Mack; Pedersen, Lars C.; Mutoh, Shingo; Negishi, Masahiko			Interaction of the phosphorylated DNA-binding domain in nuclear receptor CAR with its ligand-binding domain regulates CAR activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dimerization; nuclear receptor; nuclear translocation; phosphorylation; protein-protein interaction; CAR; DNA-binding domain; ligand-binding domain; heterodimer; homodimer	CONSTITUTIVE ACTIVE/ANDROSTANE RECEPTOR; GLUCOCORTICOID-RECEPTOR; ANDROSTANE RECEPTOR; PROGESTERONE-RECEPTOR; CYP2B GENE; LIVER; DIMERIZATION; HETERODIMER; CYTOPLASM; TRANSLOCATION	The nuclear protein constitutive active/androstane receptor (CAR or NR1I3) regulates several liver functions such as drug and energy metabolism and cell growth or death, which are often involved in the development of diseases such as diabetes and hepatocellular carcinoma. CAR undergoes a conversion from inactive homodimers to active heterodimers with retinoid X receptor (RXR), and phosphorylation of the DNA-binding domain (DBD) at Thr-38 in CAR regulates this conversion. Here, we uncovered the molecular mechanism by which this phosphorylation regulates the intramolecular interaction between CAR's DBD and ligand-binding domain (LBD), enabling the homodimer-heterodimer conversion. Phosphomimetic substitution of Thr-38 with Asp increased co-immunoprecipitation of the CAR DBD with CAR LBD in Huh-7 cells. Isothermal titration calorimetry assays also revealed that recombinant CAR DBD-T38D, but not nonphosphorylated CAR DBD, bound the CAR LBD peptide. This DBD-LBD interaction masked CAR's dimer interface, preventing CAR homodimer formation. Of note, EGF signaling weakened the interaction of CAR DBD T38D with CAR LBD, converting CAR to the homodimer form. The DBD-T38D-LBD interaction also prevented CAR from forming a heterodimer with RXR. However, this interaction opened up a CAR surface, allowing interaction with protein phosphatase 2A. Thr-38 dephosphorylation then dissociated the DBD-LBD interaction, allowing CAR heterodimer formation with RXR. We conclude that the intramolecular interaction of phosphorylated DBD with the LBD enables CAR to adapt a transient monomer configuration that can be converted to either the inactive homodimer or the active heterodimer.	[Shizu, Ryota; Mutoh, Shingo; Negishi, Masahiko] NIEHS, Dept Pharmacogenet, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Min, Jungki; Pedersen, Lars C.] NIEHS, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Sobhany, Mack] NIEHS, Dept Nucl Integr, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Dept Pharmacogenet, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	Negishi@niehs.nih.gov	Shizu, Ryota/ACP-9957-2022; Pedersen, Lars/C-6173-2019; Negishi, Masahiko/F-7805-2019	Pedersen, Lars/0000-0002-4488-4077; Negishi, Masahiko/0000-0002-2076-8928; Shizu, Ryota/0000-0002-0465-5077; Min, Jungki/0000-0003-1860-3064	National Institutes of Health Intramural Research program [Z01ES1005-01, ZIA ES102645]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102645, ZIAES080040, ZIAES102645] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Intramural Research program Grants Z01ES1005-01 and ZIA ES102645. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; DAHLMANWRIGHT K, 1991, J BIOL CHEM, V266, P3107; Dong BN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6944; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Gao J, 2009, J BIOL CHEM, V284, P25984, DOI 10.1074/jbc.M109.016808; Grimm SL, 2016, J MOL BIOL, V428, P3831, DOI 10.1016/j.jmb.2016.06.020; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Helsen C, 2014, MOL CELL ENDOCRINOL, V382, P97, DOI 10.1016/j.mce.2013.09.009; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Kanno Y, 2005, BBA-MOL CELL RES, V1745, P215, DOI 10.1016/j.bbamcr.2005.06.012; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; Lou XH, 2014, NAT STRUCT MOL BIOL, V21, P277, DOI 10.1038/nsmb.2778; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108; Nadal M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14388; Orlov I, 2012, EMBO J, V31, P291, DOI 10.1038/emboj.2011.445; Osabe M, 2011, J BIOL CHEM, V286, P35763, DOI 10.1074/jbc.M111.284596; Putcha BDK, 2009, J BIOL CHEM, V284, P22517, DOI 10.1074/jbc.M109.026682; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Sberna AL, 2011, J HEPATOL, V55, P154, DOI 10.1016/j.jhep.2010.10.029; Shizu R, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00649-16; Sobhany M, 2012, J BIOL CHEM, V287, P36022, DOI 10.1074/jbc.M112.375873; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Takimoto GS, 2003, J STEROID BIOCHEM, V85, P209, DOI 10.1016/S0960-0760(03)00197-3; Tetel MJ, 1997, MOL ENDOCRINOL, V11, P1114, DOI 10.1210/me.11.8.1114; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yasujima T, 2016, J PHARMACOL EXP THER, V357, P367, DOI 10.1124/jpet.116.232140; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001	36	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					333	344		10.1074/jbc.M117.806604	http://dx.doi.org/10.1074/jbc.M117.806604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29133527	Green Published, hybrid			2022-12-26	WOS:000419453200028
J	Chen, M; Qiu, L; Shen, S; Wang, F; Zhang, J; Zhang, CC; Liu, SR				Chen, Meng; Qiu, Lin; Shen, Si; Wang, Fei; Zhang, Jing; Zhang, Cici; Liu, Sirun			The influences of walking, running and stair activity on knee articular cartilage: Quantitative MRI using T1 rho and T2 mapping	PLOS ONE			English	Article							IN-VIVO; HEALTHY-SUBJECTS; RELAXATION-TIMES; OSTEOARTHRITIS; JOINT; T1RHO; T-2; STRESS; SLOPE	Objective To explore the different influences of walking, running and stair activity on knee articular cartilage with T1 rho and T2 mapping sequences. Materials and methods MRI (3.0-T) scans of the right knee were performed in twenty-three young healthy adults immediately after 30 minutes of rest, walking, running and stair activity respectively. Articular cartilage was quantitatively assessed based on T1 rho and T2 relaxation times. Analysis of variance for random block design data, bonferroni test and paired samples t tests were performed to estimate the different influences of physiological activities on articular cartilage. Results T1 rho and T2 values had reductions after physiological activities in all regions of articular cartilage. T1 rho and T2 values were decreased more after running than walking. T1 rho and T2 values were decreased more after stair activity than running, except for femoral cartilage. The superficial layer of patella cartilage had higher reduction rates than the deep layer. The T1 rho and T2 values of articular cartilage were reduced in the following order: patellofemoral cartilage> medial tibiofemoral cartilage> lateral tibiofemoral cartilage. Patellofemoral cartilage experienced reductions in the following order: lateral part> middle part> medial part. Tibiofemoral cartilage had reductions in the following order: posterior part> middle part> anterior part. Conclusions T1 rho and T2 mapping sequences can quantitatively reflect the different influences of physiological activities on knee articular cartilage. Fluid shifts, collagen fiber deformation, spatial heterogeneity, inherent differences in material properties and tissue stiffness have close relationship with cartilage loading characteristics.	[Chen, Meng; Qiu, Lin; Shen, Si; Wang, Fei; Zhang, Jing; Zhang, Cici; Liu, Sirun] Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Meng] Soochow Univ, Affiliated Hosp 1, Radiol Dept, Suzhou, Jiangsu, Peoples R China; [Zhang, Jing] Guangzhou Med Univ, Affiliated Hosp 3, Radiol Dept, Guangzhou, Guangdong, Peoples R China; [Zhang, Cici] Guangzhou Red Cross Hosp, Radiol Dept, Guangzhou, Guangdong, Peoples R China	Jinan University; Soochow University - China; Guangzhou Medical University	Liu, SR (corresponding author), Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China.	tlsr@jnu.edu.cn						Akbarshahi M, 2014, MED ENG PHYS, V36, P1122, DOI 10.1016/j.medengphy.2014.06.009; Akella SVS, 2001, MAGNET RESON MED, V46, P419, DOI 10.1002/mrm.1208; Besier TF, 2005, MED SCI SPORT EXER, V37, P1924, DOI 10.1249/01.mss.0000176686.18683.64; Brechter JH, 2002, GAIT POSTURE, V16, P115, DOI 10.1016/S0966-6362(02)00090-5; Buckley MR, 2010, J BIOMECH, V43, P796, DOI 10.1016/j.jbiomech.2009.10.012; Buckwalter JA, 2004, CURR OPIN RHEUMATOL, V16, P634, DOI 10.1097/01.bor.0000132647.55056.a9; Chinkulprasert C, 2011, J ORTHOP SPORT PHYS, V41, P241, DOI 10.2519/jospt.2011.3408; Cymet TC, 2006, J AM OSTEOPATH ASSOC, V106, P342; Eckstein F, 2005, ANN RHEUM DIS, V64, P291, DOI 10.1136/ard.2004.022400; Erdil M, 2016, ACTA CHIR ORTHOP TR, V83, P43; Goudakos IG, 2009, J BIOMECH, V42, P2590, DOI 10.1016/j.jbiomech.2009.07.007; Haddad B, 2012, ACTA ORTHOP BELG, V78, P757; Jackson BD, 2004, J SCI MED SPORT, V7, P347, DOI 10.1016/S1440-2440(04)80030-6; Kessler MA, 2008, AM J SPORT MED, V36, P966, DOI 10.1177/0363546507313093; Kim Keong-Hwan, 2012, Knee Surg Relat Res, V24, P158, DOI 10.5792/ksrr.2012.24.3.158; Lane NE, 1998, J RHEUMATOL, V25, P334; LANE NE, 1993, J RHEUMATOL, V20, P461; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; Luke AC, 2010, AM J SPORT MED, V38, P2273, DOI 10.1177/0363546510372799; Mosher TJ, 2005, RADIOLOGY, V234, P245, DOI 10.1148/radiol.2341040041; Rauscher I, 2008, RADIOLOGY, V249, P591, DOI 10.1148/radiol.2492071870; Silverberg JL, 2014, BIOPHYS J, V107, P1721, DOI 10.1016/j.bpj.2014.08.011; Silverberg JL, 2013, J ORTHOP RES, V31, P686, DOI 10.1002/jor.22303; Souza RB, 2010, OSTEOARTHR CARTILAGE, V18, P1557, DOI 10.1016/j.joca.2010.10.001; Stahl R, 2009, EUR RADIOL, V19, P132, DOI 10.1007/s00330-008-1107-6; Subburaj K, 2012, AM J SPORT MED, V40, P2134, DOI 10.1177/0363546512449816; Temple MM, 2007, OSTEOARTHR CARTILAGE, V15, P1042, DOI 10.1016/j.joca.2007.03.005; Virayavanich W, 2013, ARTHRIT CARE RES, V65, P1441, DOI 10.1002/acr.22017; Wang LG, 2015, J MAGN RESON IMAGING, V41, P586, DOI 10.1002/jmri.24677; Wang LG, 2014, ACAD RADIOL, V21, P463, DOI 10.1016/j.acra.2013.12.010; Zarins ZA, 2010, OSTEOARTHR CARTILAGE, V18, P1408, DOI 10.1016/j.joca.2010.07.012; Zhang WG, 2009, J TRANDITIONAL CHINE, V21, P15; Zhang Y, 2014, KNEE, V21, P694, DOI 10.1016/j.knee.2014.01.008	33	20	26	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187008	10.1371/journal.pone.0187008	http://dx.doi.org/10.1371/journal.pone.0187008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136015	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200011
J	Lay, P; An, S; Soeung, S; Srey, PS; Thai, S; Lynen, L; van Griensven, J				Lay, Phirum; An, Sokkab; Soeung, Sunpiseth; Srey, Pich Sovannary; Thai, Sopheak; Lynen, Lutgarde; van Griensven, Johan			Ten year experience with antiretroviral treatment in Cambodia: Trends in patient characteristics and treatment outcomes	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SCALE-UP; SOUTH-AFRICA; THERAPY; FAILURE; PROGRAM; EXPANSION; CARE	Background Although HIV disease stage at ART initiation critically determines ART outcomes, few reports have longitudinally monitored this within Asia. Using prospectively collected data from a large ART program at Sihanouk Hospital Center of Hope in Cambodia, we report on the change in patient characteristics and outcomes over a ten-year period. Methods We conducted a retrospective analysis including all adults (>= 18 years old) starting ART from March 2003-March 2013 in a non-governmental hospital in Phnom Penh, Cambodia. The cumulative incidence of death, lost to follow-up (LTFU), attrition (death or LTFU) and first line treatment failure were calculated using Kaplan-Meier methods. Independent risk factors for these outcomes were determined using Cox regression modeling. Results Over the ten-year period, 3581 patients initiated ART with a median follow-up time of 4.8 years (IQR 2.87.2). The median age was 35 years (IQR 3041), 54% were female. The median CD4 count at ART initiation increased from 22 cells/mu L (IQR 4129) in 2003 to 218 (IQR 57302) in 2013. Over the 10 year period, a total of 282 (7.9%) individuals died and 433 (12.1%) were defined LTFU. Program attrition (died or LTFU) was 11.1% (95% CI: 10.1%- 12.4%) at one year, 16.3% (95% CI: 15.1%-17.6%) at three years, 19.8% (95% CI: 18.5%-21.2%) at five years and 23.3% (95% CI: 21.625.1) at ten years. Male sex and low baseline body mass index (BMI) were associated with increased attrition. Factors independently associated with mortality included a low baseline CD4 count, older age, male sex, low baseline BMI and hepatitis B co-infection. Individuals aged above 40 years old had an increased risk of mortality but were less likely to LTFU. There were a total of 137 individuals with first line ART failure starting second line treatment. The probability of first line failure was estimated at 2.8% (95% CI: 2.3%-3.4%) at 3 years, 4.6% (95% CI: 3.9%-5.5%) at 5 years and 7.8% (95% CI 4.8%-12.5%) at ten years of ART. The probability was particularly high in the first few program years. A lower risk was observed among individuals starting ART during the 20062008 period. Factors independently associated with an increased risk of treatment failure included ART-experience, NVP-based ART and a baseline CD4 count below 200 cells/mu L. Conclusions Overall program outcomes were fair, and generally compare well to other reports from the region. Despite gradually earlier initiation of ART over the ten year period, ART is still initiated at too low CD4 count levels, warranting increased efforts for early HIV diagnosis and enrolment/retention into HIV care. Tailored strategies for poor prognostic groups (older age, male, low BMI) should be designed and evaluated.	[Lay, Phirum; An, Sokkab; Soeung, Sunpiseth; Srey, Pich Sovannary; Thai, Sopheak] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [Lynen, Lutgarde; van Griensven, Johan] Inst Trop Med, Antwerp, Belgium	Institute of Tropical Medicine (ITM)	Lay, P (corresponding author), Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia.	phirumlay@sihosp.org	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895	Belgian Directorate General of Development Cooperation; Global Fund to fight AIDS, Tuberculosis and Malaria; Hope World Wide	Belgian Directorate General of Development Cooperation; Global Fund to fight AIDS, Tuberculosis and Malaria; Hope World Wide	The HIV program was supported by the Belgian Directorate General of Development Cooperation, the Global Fund to fight AIDS, Tuberculosis and Malaria, and Hope World Wide.	Alave J, 2013, REV CHIL INFECTOL, V30, P42, DOI 10.4067/S0716-10182013000100006; [Anonymous], 2010, CONS GUID US ANT DRU; Authority TNA, 2014, CAMB COUNTR PROGR RE; Boulle A, 2010, S AFRICA AIDS, V24, P563; Castilho JL, 2014, AIDS RES HUM RETROV, V30, P446, DOI [10.1089/aid.2013.0208, 10.1089/AID.2013.0208]; Chasombat S, 2009, JAIDS-J ACQ IMM DEF, V50, P506, DOI 10.1097/QAI.0b013e3181967602; Chim B PS, 2013, J AIDS CLIN RES, V4, P6; Choun K, 2013, B WORLD HEALTH ORGAN, V91, P195, DOI 10.2471/BLT.12.111153; Farahani M, 2014, LANCET GLOB HEALTH, V2, pE44, DOI 10.1016/S2214-109X(13)70149-9; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Fitzgerald M, 2010, AIDS CARE, V22, P355, DOI 10.1080/09540120903111536; Grimsrud A, 2014, JAIDS-J ACQ IMM DEF, V67, pE55, DOI 10.1097/QAI.0000000000000268; Guy R, 2013, AIDS PATIENT CARE ST, V27, P681, DOI 10.1089/apc.2012.0439; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jourdain G, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001494; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lynen L, 2009, JAIDS-J ACQ IMM DEF, V52, P40, DOI 10.1097/QAI.0b013e3181af6705; Madec Y, 2007, AIDS, V21, P351, DOI 10.1097/QAD.0b013e328012c54f; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Mills EJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001167; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Pe R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143320; Phan V, 2013, JAIDS-J ACQ IMM DEF, V62, P509, DOI 10.1097/QAI.0b013e318285d28c; Phan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030647; Pillay P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068995; Pujades-Rodriguez M, 2011, TROP MED INT HEALTH, V16, P205, DOI 10.1111/j.1365-3156.2010.02689.x; Thai S, 2009, TROP MED INT HEALTH, V14, P1048, DOI 10.1111/j.1365-3156.2009.02334.x; UNAIDS, 2016, UNAIDS REP GLOB AIDS; van Griensven J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088552; van Griensven J, 2011, T ROY SOC TROP MED H, V105, P694, DOI 10.1016/j.trstmh.2011.08.007; WHO, 2016, CONGUID UANT DRU; WHO, 2006, REC PUBL HLTH APPR 2; World Health Organization, 2003, SCAL ANT THER RES LI; Zhou J, 2007, HIV MED, V8, P8, DOI 10.1111/j.1468-1293.2007.00417.x	35	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0185348	10.1371/journal.pone.0185348	http://dx.doi.org/10.1371/journal.pone.0185348			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136011	Green Submitted, Green Published, gold			2022-12-26	WOS:000415121200001
J	Lin, TC; Hwang, DK; Hsu, CC; Peng, CH; Wang, ML; Chiou, SH; Chen, SJ				Lin, Tai-Chi; Hwang, De-Kuang; Hsu, Chih-Chien; Peng, Chi-Hsien; Wang, Mong-Lien; Chiou, Shih-Hwa; Chen, Shih-Jen			Protective effect of metformin against retinal vein occlusions in diabetes mellitus - A nationwide population-based study	PLOS ONE			English	Article							RISK-FACTORS; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; GLUCOSE CONTROL; MORTALITY; THERAPY; PATHOPHYSIOLOGY; COMPLICATIONS; RANIBIZUMAB; ASSOCIATION	Previous studies have found that metformin can reduce cardiovascular risk, but its association with retinal vein occlusion (RVO) is unknown. In this population-based cohort study using the Taiwan National Health Insurance Research Database (NHIRD), we demonstrated the protective effect of metformin against RVO in diabetes mellitus (DM) and explored the incidence rate and factors associated with RVO development in general and diabetic populations. One million patients were randomly selected from the registry files of the NHIRD, and all their claims data were collected for the 1996-2011 period. Patients with a new diagnosis of central or branch RVO were identified using International Classification of Disease codes. DM was defined for patients with diagnoses and treatments. Factors associated with RVO development in the non-DM and DM cohorts were explored using Cox proportional regression models. In total, 1,018 RVO patients were identified from the database. The average incidence of RVO was 9.93 and 53.5 cases per 100,000 person-years in the non-DM and DM cohorts, respectively. Older age, DM, hypertension, and glaucoma were significant risk factors for RVO, whereas the prescription of anticoagulants was a significant protective factor. In the DM cohort, older age, hypertension, and diabetic retinopathy were significant risk factors for RVO, whereas metformin treatment was a significant protective factor. These results confirmed the risk factors for RVO and demonstrated the protective effect of metformin against RVO in DM patients. Prescribing metformin for DM patients may be beneficial for reducing the incidence of RVO, along with its hypoglycemic action.	[Lin, Tai-Chi; Hsu, Chih-Chien; Chiou, Shih-Hwa] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Lin, Tai-Chi; Hwang, De-Kuang; Hsu, Chih-Chien; Chiou, Shih-Hwa; Chen, Shih-Jen] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Hwang, De-Kuang] Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan; [Hwang, De-Kuang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Hwang, De-Kuang; Peng, Chi-Hsien; Chen, Shih-Jen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Peng, Chi-Hsien] Shin Kong Wu Ho Su Mem Hosp, Dept Ophthalmol, Taipei, Taiwan; [Peng, Chi-Hsien] Fu Jen Catholic Univ, Taipei, Taiwan; [Wang, Mong-Lien; Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chiou, Shih-Hwa] Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Chen, SJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	sjchen@vghtpe.gov.tw	Hwang, DK De-Kuang/J-3931-2016	Hwang, DK De-Kuang/0000-0001-6346-8485				Aboonabi A, 2016, BIOMED PHARMACOTHER, V83, P277, DOI 10.1016/j.biopha.2016.06.044; Angiolillo DJ, 2009, DIABETES CARE, V32, P531, DOI 10.2337/dc08-2064; Boyer D, 2010, OPHTHALMOLOGY, V117, P1860, DOI 10.1016/j.ophtha.2010.02.022; Braithwaite T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007325.pub2; Brown DM, 2013, AM J OPHTHALMOL, V155, P429, DOI 10.1016/j.ajo.2012.09.026; Brynskov T, 2014, RETINA-J RET VIT DIS, V34, P1637, DOI 10.1097/IAE.0000000000000111; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Chang SH, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0123-x; Cheng YY, 2014, J STROKE CEREBROVASC, V23, pE99, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.001; Coch RW, 2016, CURRENT CARDIOVASCUL; COLLIER A, 1989, DIABETES METAB, V15, P420; Cugati S, 2006, ARCH OPHTHALMOL-CHIC, P124; Derosa G, 2003, DIABETES RES CLIN PR, V60, P161, DOI 10.1016/S0168-8227(03)00057-3; Dodson P M, 1993, Eur J Ophthalmol, V3, P109; DODSON PM, 1992, EYE, V6, P66, DOI 10.1038/eye.1992.13; Dolasik I, 2013, PLATELETS, V24, P118, DOI 10.3109/09537104.2012.674165; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Ferrannini E, 2015, EUR HEART J, V36, P2288, DOI 10.1093/eurheartj/ehv239; FORD I, 1991, DIABETIC MED, V8, P322, DOI 10.1111/j.1464-5491.1991.tb01604.x; Formoso G, 2008, DIABETES-METAB RES, V24, P231, DOI 10.1002/dmrr.794; Fuller JH, 2001, DIABETOLOGIA, V44, pS54, DOI 10.1007/PL00002940; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Hayreh SS, 2011, OPHTHALMOLOGY, V118, P1603, DOI 10.1016/j.ophtha.2011.04.036; Hayreh SS, 2003, OPHTHALMOLOGICA, V217, P167, DOI 10.1159/000068980; Khan Z, 2013, CAN J OPHTHALMOL, V48, P40, DOI 10.1016/j.jcjo.2012.08.017; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P513, DOI 10.1001/archopht.126.4.513; Koh V, 2016, OPHTHAL EPIDEMIOL, V23, P6, DOI 10.3109/09286586.2015.1082604; Krentz AJ, 2007, DIABETES OBES METAB, V9, P781, DOI 10.1111/j.1463-1326.2007.00670.x; Lehto S, 1997, DIABETES, V46, P1354, DOI 10.2337/diabetes.46.8.1354; Martinez F, 2014, INT J CLIN PRACT, V68, P871, DOI 10.1111/ijcp.12390; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; MUGGEO M, 1995, DIABETOLOGIA, V38, P672, DOI 10.1007/s001250050336; Natarajan A, 2008, DIABETES VASC DIS RE, V5, P138, DOI 10.3132/dvdr.2008.023; Nghiem-Buffet S, 2009, J FR OPHTALMOL, V32, P679, DOI 10.1016/j.jfo.2009.10.002; Papazafiropoulou A, 2015, J DIABETES COMPLICAT, V29, P846, DOI 10.1016/j.jdiacomp.2015.04.005; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Rahman S, 2007, DIABETES OBES METAB, V9, P767, DOI 10.1111/j.1463-1326.2006.00655.x; RATH EZ, 1992, OPHTHALMOLOGY, V99, P509; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Roussel R, 2010, ARCH INTERN MED, V170, P1892, DOI 10.1001/archinternmed.2010.409; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; TREMOLI E, 1982, ATHEROSCLEROSIS, V41, P53, DOI 10.1016/0021-9150(82)90069-7; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Zhong CK, 2016, ATHEROSCLEROSIS, V247, P170, DOI 10.1016/j.atherosclerosis.2016.02.024; Zhou JQ, 2013, OPHTHALMOLOGY, V120, P803, DOI 10.1016/j.ophtha.2012.09.033	47	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188136	10.1371/journal.pone.0188136	http://dx.doi.org/10.1371/journal.pone.0188136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136662	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200069
J	Hai, NK; Lawpoolsri, S; Jittamala, P; Huong, PTT; Kaewkungwal, J				Nguyen Khac Hai; Lawpoolsri, Saranath; Jittamala, Podjanee; Phan Thi Thu Huong; Kaewkungwal, Jaranit			Practices in security and confidentiality of HIV/AIDS patients' information: A national survey among staff at HIV outpatient clinics in Vietnam	PLOS ONE			English	Article							ELECTRONIC HEALTH RECORDS; STIGMA; DISCLOSURE; ATTITUDES; PERCEPTIONS; CARE	Introduction Breach of confidentiality or invasion of privacy from the collection and use of medical records, particularly those of patients with HIV/AIDS or other diseases sensitive to stigmatization, should be prevented by all related stakeholders in healthcare settings. The main focus of this study was to assess practices regarding security and confidentiality of HIV-related information among staff at HIV outpatient clinics (HIV-OPCs) in Vietnam. Methods A descriptive cross-sectional study was conducted at all 312 HIV-OPCs across the country using an online survey technique. Results In general, the staff practices for securing and protecting patient information were at acceptable levels. Most staff had proper measures and practices for maintaining data security; however, the protection of patient confidentiality, particularly for data access, sharing, and transfer still required improvement. Most HIV-OPC staff had good or moderate knowledge and positive perceptions towards security and confidentiality issues. Staff who were not trained in the practice of security measures differed significantly from those who were trained (OR: 3.74; 95% CI: 1.44-9.67); staff needing improved knowledge levels differed significantly from those with good (OR: 5.20; 95% CI: 2.39-11.32) and moderate knowledge levels (OR: 5.10; 95% CI: 2.36-11.00); and staff needing improved perception levels differed significantly from those with good (i. e., with 100% proper practices) and moderate perception levels (OR: 5.67; 95% CI: 2.93-10.95). Staff who were not trained in the protection of data confidentiality differed significantly from those who were trained (OR: 2.18; 95% CI: 1.29-3.65). Conclusions Training is an important factor to help raise the levels of proper practices regarding confidentiality and security, to improve knowledge and raise awareness about change among staff. The operation and management of HIV treatment and care in Vietnam are currently transitioning from separate healthcare clinics (HIV-OPC) into units integrated into general hospitals/healthcare facilities. The findings of this study highlight topics that could be used for improving management and operation of information system and revising guidelines and regulations on protection measures/strategies for data security and confidentiality of HIV/AIDS patients by Vietnam health authorities or other countries facing similar situations. Secure infrastructure and secure measures for data access and use are very important, worthwhile investments. The provision of continuous training and active enforcement and monitoring of the practices of healthcare personnel might lead to an improved understanding and acknowledegement of the importance of national policies/guidelines regarding HIV-related patient information.	[Nguyen Khac Hai] Hanoi Med Univ, Hanoi, Vietnam; [Lawpoolsri, Saranath; Jittamala, Podjanee; Kaewkungwal, Jaranit] Mahidol Univ, Dept Trop Hyg, Bangkok, Thailand; [Phan Thi Thu Huong] Minist Hlth, Vietnam Author HIV AIDS Control, Hanoi, Vietnam	Hanoi Medical University; Mahidol University	Kaewkungwal, J (corresponding author), Mahidol Univ, Dept Trop Hyg, Bangkok, Thailand.	jaranit.kae@mahidol.ac.th		Lawpoolsri, Saranath/0000-0003-4841-7924	Rockefeller Foundation; Faculty of Tropical Medicine, Mahidol University; Faculty of Tropical Medicine, Mahidol University, Thailand	Rockefeller Foundation; Faculty of Tropical Medicine, Mahidol University; Faculty of Tropical Medicine, Mahidol University, Thailand	This project was funded by a grant from the Rockefeller Foundation(no grant number, www.rockefellerfoundation.org) and the Faculty of Tropical Medicine, Mahidol University (no grant number, www.tm.mahidol.ac.th). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by a grant from the Rockefeller Foundation and the Faculty of Tropical Medicine, Mahidol University, Thailand. The authors would like to extend their thanks to the funders for supporting the graduate students in the Biomedical and Health Informatics program at Mahidol University. Sincere appreciation goes to all heads of the HIV-OPCs and the staff at all of the clinics in Vietnam, the key groups participating in the study, for their time and willingness to respond.	Ali MG, 2015, INT J RES MED SCI, V3, P3080, DOI 10.18203/2320-6012.ijrms201511406; Allen AL, 2008, FACULTY SCHOLARSHIP, P186; [Anonymous], 2017, NEWS VN; [Anonymous], 2007, NGHI DINH QUY DINH C; [Anonymous], 2016, HIV SEC CONF POL; Beck EJ, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.32089; Beck EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-6; Brito-Mutunayagam SL, 2013, J MED INTERNET RES, V15, P294, DOI 10.2196/jmir.2650; Bureau of AIDS Tuberculosis and Sexually Transmitted Infections Department of Disease Control Ministry of Public Health, 2019, THAIL NAT GUID HIV A; CDC, 2014, VIETN FACTSH; Centers for Disease Control and Prevention, 2006, TECHN GUID HIV AIDS; Chandra PS, 2003, AIDS CARE, V15, P207, DOI 10.1080/0954012031000068353; Church K, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17981; Cohen J, 2013, HEALTH HUM RIGHTS, V15, P7; Connecticut Department of Public Health, 2017, HIV STD TB HEP SURV; Cross S, 2000, J MED ETHICS, V26, P447, DOI 10.1136/jme.26.6.447; Farzandipour M, 2010, J MED SYST, V34, P629, DOI 10.1007/s10916-009-9276-7; Fernando J, 2008, ELECTRON J HEALTH IN, V3; Fernando JI, 2009, INT J MED INFORM, V78, P815, DOI 10.1016/j.ijmedinf.2009.08.006; Gostin L O, 1995, Health Matrix Clevel, V5, P1; Grossman CI, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18881; Hagey JM, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20123; Holt R, 1998, AIDS CARE, V10, P49, DOI 10.1080/09540129850124578; Ives Erickson Jeanette, 2005, Online J Issues Nurs, V10, P2; Kato caNHL Masaya, 2014, ENHANCING BENEFITS A; Kurtz Gary, 2003, J Healthc Inf Manag, V17, P41; Loutfy M, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19835; Fernandez-Aleman JL, 2013, J BIOMED INFORM, V46, P541, DOI 10.1016/j.jbi.2012.12.003; Maiorana A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-34; Naing CM, 2010, SE ASIAN J TROP MED, V41, P952; Nixon SA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18806; Nyblade L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18718; Oosterhoff P, 2008, AIDS CARE, V20, P654, DOI 10.1080/09540120701687026; Risher K, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18715; Tarkang E.E., 2015, CENT AFRICAN J PUBLI, V1, P1, DOI [10.11648/j.cajph.20150101.11., DOI 10.11648/J.CAJPH.20150101.11]; Tesic V, 2006, COLLEGIUM ANTROPOL, V30, P89; The Office of the National Coordinator for Health Information Technology, 2015, GUID PRIV SEC EL HLT; Torres C G, 1991, Am J Public Health, V81, P210, DOI 10.2105/AJPH.81.2.210; UNAIDS, 2015, FACT SHEET HIV AIDS; UNAIDS, VIET NAM IS 1 COUNTR; UNAIDS, 2015, AIDS BY THE NUMB; UNAIDS GNP+ IPPF ICWG, 2011, PEOPL LIV HIV STIGM; UNAIDS/PEPFAR, 2007, INT GUID PROT CONF S; VanderMolen J, 2015, ED PERSPECTIVES  FAL; Varga CA, 2006, AIDS CARE, V18, P952, DOI 10.1080/09540120500356906; Vietnam Authority of HIV/AIDS Control, 2014, OPT VIET NAMS HIV RE; Vietnam Authority of HIV/ AIDS Control, 2015, NAT HIV AIDS PREV CO; Vietnam Authority of HIV/AIDS Control, 2014, VIETN AIDS RESP PROG; Vietnam Ministry of Health, 2014, QUYETDNH BANH QUY D; Vietnam National Network of People Living With HIV, 2012, VIET NAM STIGM IND; Vietnam National Network of People Living With HIV, 2014, PEOPL LIV HIV STIGM; Vietnamese National Assembly, 2006, LAW HIV AIDS PREV CO; Wiljer D, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1061	53	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188160	10.1371/journal.pone.0188160	http://dx.doi.org/10.1371/journal.pone.0188160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136017	Green Submitted, Green Published, gold			2022-12-26	WOS:000415121200072
J	Kocheshkova, AA; Kroupin, PY; Bazhenov, MS; Karlov, GI; Pochtovyy, AA; Upelniek, VP; Belov, VI; Divashuk, MG				Kocheshkova, A. A.; Kroupin, P. Yu.; Bazhenov, M. S.; Karlov, G. I.; Pochtovyy, A. A.; Upelniek, V. P.; Belov, V. I.; Divashuk, M. G.			Pre-harvest sprouting resistance and haplotype variation of ThVp-1 gene in the collection of wheat-wheatgrass hybrids	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; CONTROLLING SEED DORMANCY; VIVIPAROUS-1 GENE; BREAD-WHEAT; GRAIN DORMANCY; MAPPING QTLS; THINOPYRUM-PONTICUM; PARTIAL AMPHIPLOIDS; PERENNIAL CEREAL; CHINESE WHEATS	The germplasm collection of 87 wheat-wheatgrass hybrids developed in Tsitisin Main Botanical Garden (Russia, Moscow) was evaluated for resistance to pre-harvest sprouting (PHS) by spike sprouting (SS) and germination index (GI) assays as well as for spike and grain features. The PHS resistance variation and haplotype polymorphism of the wheat-grass ThVp-1 and wheat TaVp-1B genes orthologues of Vp-1 was revealed in the studied collection. Four haplotypes of ThVp-1 were revealed: ThVp-1a (41% of the entries), ThVp-1b (13%), ThVp-1c (29%), and ThVp-1d (15%). The association between the allelic state of ThVp-1 and PHS resistance in the wheat-wheatgrass hybrids was shown: haplotype ThVp-1d of the wheatgrass Vp-1 gene is significantly associated with reduced PHS in the wheat-wheatgrass hybrids (mean SS 0.33, mean GI 0.64). The resistant entries may be perspective as a source of PHS resistance in the development of commercial cultivars of perennial wheat.	[Kocheshkova, A. A.; Kroupin, P. Yu.; Bazhenov, M. S.; Karlov, G. I.; Pochtovyy, A. A.; Divashuk, M. G.] Russian State Agrarian Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Moscow, Russia; [Kroupin, P. Yu.; Karlov, G. I.; Divashuk, M. G.] All Russia Res Inst Agr Biotechnol, Moscow, Russia; [Upelniek, V. P.; Belov, V. I.] Russian Acad Sci, NV Tsitsin Main Bot Garden, Dept Distant Hybridizat, Moscow, Russia	Russian State Agrarian University - Moscow Timiryazev Agricultural Academy; All-Russia Research Institute of Agricultural Biotechnology; Russian Academy of Sciences; Tsytsin Main Moscow Botanical Garden of the Russian Academy of Sciences	Divashuk, MG (corresponding author), Russian State Agrarian Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Moscow, Russia.; Divashuk, MG (corresponding author), All Russia Res Inst Agr Biotechnol, Moscow, Russia.	divashuk@gmail.com	Karlov, Gennady/F-7403-2013; Divashuk, Mikhail/T-7621-2019; Bazhenov, Mikhail/N-4721-2016; Kocheshkova, Alina/AAO-6441-2020; Kroupin, Pavel Yu./D-8515-2014	Karlov, Gennady/0000-0002-9016-103X; Divashuk, Mikhail/0000-0001-6221-3659; Bazhenov, Mikhail/0000-0002-7301-1363; Kroupin, Pavel Yu./0000-0001-6858-3941; Kocheshkova, Alina/0000-0003-1924-6708	Russian Science Foundation, Russia [16-16-00097]; Russian Science Foundation [16-16-00097] Funding Source: Russian Science Foundation	Russian Science Foundation, Russia(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	Financial support from the Russian Science Foundation, Russia, Project Number 16-16-00097 is gratefully acknowledged.	Adebiyi J, 2016, RENEW AGR FOOD SYST, V31, P101, DOI 10.1017/S1742170515000150; Bailey PC, 1999, THEOR APPL GENET, V98, P281, DOI 10.1007/s001220051069; BANKS PM, 1993, GENOME, V36, P207, DOI 10.1139/g93-029; Bell LW, 2010, CROP PASTURE SCI, V61, P679, DOI 10.1071/CP10064; Cabral AL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0340-1; Cao LZ, 2016, BREEDING SCI, V66, P260, DOI 10.1270/jsbbs.66.260; Chang C, 2010, MOL BREEDING, V25, P517, DOI 10.1007/s11032-009-9350-3; Chang C, 2010, MOL BREEDING, V25, P481, DOI 10.1007/s11032-009-9346-z; Chang C, 2011, EUPHYTICA, V179, P343, DOI 10.1007/s10681-011-0348-7; Chao SM, 2010, CROP SCI, V50, P1180, DOI 10.2135/cropsci2009.10.0589; Chen CX, 2008, MOL BREEDING, V21, P351, DOI 10.1007/s11032-007-9135-5; Cox TS, 2010, CROP PASTURE SCI, V61, P513, DOI 10.1071/CP09201; Craig F, 1988, CEREAL CHEM, V65, P404; Divashuk M., 2012, OPEN J GEN, V2, P51, DOI [10.4236/ojgen.2012.21006, DOI 10.4236/OJGEN.2012.21006]; Divashuk M. G., 2011, Sel'skokhozyaistvennaya Biologiya, P40; Fakthongphan J, 2016, CROP SCI, V56, P1025, DOI 10.2135/cropsci2015.08.0490; Fedak G, 2005, CYTOGENET GENOME RES, V109, P360, DOI 10.1159/000082420; Flintham J, 2002, EUPHYTICA, V126, P39, DOI 10.1023/A:1019632008244; Flintham JE, 2000, SEED SCI RES, V10, P43, DOI 10.1017/S0960258500000052; Fofana B, 2009, EUPHYTICA, V165, P509, DOI 10.1007/s10681-008-9766-6; Gale M.D., 1987, ASPECTS APPLIED BIOL, V15, P115; Gao X, 2013, J ANIM PLANT SCI, V23, P556; Gazza L, 2016, GENET RESOUR CROP EV, V63, P209, DOI 10.1007/s10722-015-0240-8; Groos C, 2002, THEOR APPL GENET, V104, P39, DOI 10.1007/s001220200004; Hayes RC, 2012, FIELD CROP RES, V133, P68, DOI 10.1016/j.fcr.2012.03.014; Himi E, 2005, EUPHYTICA, V143, P239, DOI 10.1007/s10681-005-7854-4; Himi E, 2002, J EXP BOT, V53, P1569, DOI 10.1093/jxb/erf005; Humphreys DG, 2002, EUPHYTICA, V126, P61, DOI 10.1023/A:1019671622356; Imtiaz M, 2008, GENETICS, V178, P1725, DOI 10.1534/genetics.107.084939; Jones HD, 1997, PLANT J, V12, P911, DOI 10.1046/j.1365-313X.1997.12040911.x; Kato K, 2001, THEOR APPL GENET, V102, P980, DOI 10.1007/s001220000494; Kato T, 2002, J AGR FOOD CHEM, V50, P6307, DOI 10.1021/jf0204755; King RW, 2000, EUPHYTICA, V112, P157, DOI 10.1023/A:1003832031695; Knox RE, 2012, EUPHYTICA, V186, P193, DOI 10.1007/s10681-011-0557-0; Kocheshkova A. A., 2014, Izvestiya Timiryazevskoi Sel'skokhozyaistvennoi Akademii, P5; Kong LG, 2008, PLANT GROWTH REGUL, V56, P275, DOI 10.1007/s10725-008-9307-2; Kottearachchi NS, 2006, EUPHYTICA, V152, P421, DOI 10.1007/s10681-006-9231-3; Kroupin PY, 2011, RUSS J GENET+, V47, P432, DOI 10.1134/S1022795411040077; Krupnova OV., 2012, RUSS J GENET APPL RE, V2, P467; Kruppa K, 2016, COMP CYTOGENET, V10, P283, DOI 10.3897/CompCytogen.v10i2.7305; Kulwal PL, 2005, THEOR APPL GENET, V111, P1052, DOI 10.1007/s00122-005-0021-4; Kumar A, 2009, PLANT SCI, V177, P114, DOI 10.1016/j.plantsci.2009.04.004; Lee HY, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0452-8; Li HJ, 2009, J GENET GENOMICS, V36, P557, DOI 10.1016/S1673-8527(08)60147-2; Lin M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3148-6; Liu SB, 2013, GENETICS, V195, P263, DOI 10.1534/genetics.113.152330; Liu SB, 2010, THEOR APPL GENET, V121, P1395, DOI 10.1007/s00122-010-1396-4; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Lloyd S., 2015, PERENNIAL WHEAT; Lohwasser U, 2005, EUPHYTICA, V143, P247, DOI 10.1007/s10681-005-7858-0; Mares D, 2005, THEOR APPL GENET, V111, P1357, DOI 10.1007/s00122-005-0065-5; Mares D, 2009, EUPHYTICA, V168, P311, DOI 10.1007/s10681-009-9927-2; Marquardt K, 2016, AGROECOL SUST FOOD, V40, P432, DOI 10.1080/21683565.2016.1141146; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; McKibbin RS, 2002, P NATL ACAD SCI USA, V99, P10203, DOI 10.1073/pnas.152318599; Mohan A, 2009, EUPHYTICA, V168, P319, DOI 10.1007/s10681-009-9935-2; Mori M, 2005, THEOR APPL GENET, V110, P1315, DOI 10.1007/s00122-005-1972-1; Munkvold JD, 2009, THEOR APPL GENET, V119, P1223, DOI 10.1007/s00122-009-1123-1; Murphy KM, 2010, PLANT BREEDING, V129, P480, DOI 10.1111/j.1439-0523.2009.01712.x; Nakamura S, 2001, J EXP BOT, V52, P875, DOI 10.1093/jexbot/52.357.875; NAMBARA E, 1994, PLANT CELL PHYSIOL, V35, P509; Ogbonnaya FC, 2008, THEOR APPL GENET, V116, P891, DOI 10.1007/s00122-008-0712-8; Osa M, 2003, THEOR APPL GENET, V106, P1491, DOI 10.1007/s00122-003-1208-1; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Ren XB, 2008, J APPL GENET, V49, P333; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Salina EA, 2015, EUPHYTICA, V204, P91, DOI 10.1007/s10681-014-1344-5; Shorinola O, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01555; Shorinola O, 2016, J EXP BOT, V67, P4169, DOI 10.1093/jxb/erw194; Singh MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063922; Singh M, 2012, EUPHYTICA, V188, P123, DOI 10.1007/s10681-012-0624-1; Singh R, 2010, EUPHYTICA, V174, P391, DOI 10.1007/s10681-010-0137-8; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; Sun YW, 2012, EUPHYTICA, V186, P25, DOI 10.1007/s10681-011-0482-2; Sun YongWei, 2011, Acta Agronomica Sinica, V37, P1743, DOI 10.3724/SP.J.1006.2011.01743; Tsitsin N.V., 1987, MNOGOLETNYAYA PSHENI; TSITSIN NV, 1959, AM NAT, V93, P181, DOI 10.1086/282073; Turner MK, 2013, CROP SCI, V53, P1994, DOI 10.2135/cropsci2012.10.0584; WALKERSIMMONS M, 1988, PLANT CELL ENVIRON, V11, P769, DOI 10.1111/j.1365-3040.1988.tb01161.x; WALKERSIMMONS M, 1987, PLANT PHYSIOL, V84, P61, DOI 10.1104/pp.84.1.61; Wang JR, 2011, GENES GENOM, V33, P139, DOI 10.1007/s13258-010-0125-3; Wang Y, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0573-9; Warner RL, 2000, SEED SCI RES, V10, P51, DOI 10.1017/S0960258500000064; Xia LQ, 2008, EUPHYTICA, V159, P411, DOI 10.1007/s10681-007-9576-2; Xia LQ, 2009, EUPHYTICA, V168, P385, DOI 10.1007/s10681-009-9928-1; Yang Y, 2007, THEOR APPL GENET, V115, P971, DOI 10.1007/s00122-007-0624-z; Yang Y, 2014, MOL BREEDING, V33, P75, DOI 10.1007/s11032-013-9935-8; Yang Y, 2009, CEREAL RES COMMUN, V37, P169, DOI 10.1556/CRC.37.2009.2.3; Zanetti S, 2000, CROP SCI, V40, P1406, DOI 10.2135/cropsci2000.4051406x; Zhang HaiPing, 2011, Journal of Agricultural Biotechnology, V19, P270; Zhang YJ, 2014, THEOR APPL GENET, V127, P855, DOI 10.1007/s00122-014-2262-6; Zheng J, 2012, NEW PHYTOL, V193, P605, DOI 10.1111/j.1469-8137.2011.03969.x; Zhou Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00401; Zhu Z, 2010, SHANDONG AGR SCI, V6, P19	94	8	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e188049	10.1371/journal.pone.0188049	http://dx.doi.org/10.1371/journal.pone.0188049			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131854	Green Published, gold, Green Submitted			2022-12-26	WOS:000414997800042
J	Liao, QJ; Yang, YJ; Wang, J; Pang, X; Xu, CM; Peng, CL; Lu, ZX; Liu, YH				Liao, Qiu-Ju; Yang, Ya-Jun; Wang, Jia; Pang, Xiao; Xu, Chun-Mei; Peng, Cheng-Lin; Lu, Zhong-Xian; Liu, Ying-Hong			Temperature-dependent development and reproduction of rice leaffolder, Marasmia exigua (Lepidoptera: Pyralidae)	PLOS ONE			English	Article							CNAPHALOCROCIS-MEDINALIS GUENEE; LIFE-TABLE; PEST; DEMOGRAPHY; SURVIVAL; DIAPAUSE; BEHAVIOR; INSECTS; STAGE	Marasmia exigua (Butler) (Lepidoptera: Pyralidae) is one of the major rice leaffolders negatively affecting the rice production in the world. The growth and development of M. exigua was studied at seven constant temperatures (10, 15, 20, 25, 27, 30 and 35 degrees C). The results showed that M. exigua eggs failed to hatch at 10 degrees C and the larvae could not complete development at 15 and 35 degrees C. The developmental times of each stage, survival rates of pre-adult, adult longevity, fecundities and oviposition days of M. exigua at 20, 25, 27 and 30 degrees C were investigated using age-stage, two-sex life table. The total pre-adult development time decreased with the increase in temperature decreasing from 61.58 days at 20 degrees C to 28.94 days at 30 degrees C. The highest survival rate was observed at 25 degrees C (73%). Male adult longevities were generally longer than that of females, except at 30 degrees C. The highest mean fecundity, age-stage specific fecundity and age-specific fecundity peak values were all observed at 27 degrees C. The maximum intrinsic rate of increase r and finite rate of increase. were observed at 27 degrees C, while the maximum net reproduction rate R-0 was observed at 25 degrees C. The longest mean generation time occurred at 20 degrees C and the shortest at 27 degrees C. These results provide better understanding on the development, reproduction and dynamic of M. exigua populations, their distribution, and might be utilized to forecast and manage M. exigua outbreaks in China.	[Liao, Qiu-Ju; Wang, Jia; Pang, Xiao; Liu, Ying-Hong] Southwest Univ, Inst Entomol, Coll Plant Protect, Chongqing, Peoples R China; [Yang, Ya-Jun; Lu, Zhong-Xian] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Xu, Chun-Mei; Peng, Cheng-Lin] Qianwei Plant Protect Stn, Leshan, Peoples R China	Southwest University - China; Zhejiang Academy of Agricultural Sciences	Liu, YH (corresponding author), Southwest Univ, Inst Entomol, Coll Plant Protect, Chongqing, Peoples R China.; Lu, ZX (corresponding author), Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.	luzxmh@163.com; yhliu@swu.edu.cn	LIU, YING/GZL-7252-2022; Yang, Yajun/HGC-2463-2022; liu, ying/GXF-4294-2022		China Agriculture Research System [CARS-01-17]; Fundamental Research Funds for the Central Universities, China [2362015XK04]	China Agriculture Research System; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	The present research was supported by China Agriculture Research System (CARS-01-17), and the Fundamental Research Funds for the Central Universities, China (2362015XK04). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKISSON PL, 1963, J INSECT PHYSIOL, V9, P299, DOI 10.1016/0022-1910(63)90107-0; ADKISSON PL, 1964, AM NAT, V98, P357, DOI 10.1086/282332; Andreadis SS, 2013, J PEST SCI, V86, P409, DOI 10.1007/s10340-013-0490-1; Atlihan R, 2008, J ECON ENTOMOL, V101, P325, DOI 10.1603/0022-0493(2008)101[325:TDADOS]2.0.CO;2; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Barrion A.T., 1991, Philippine Entomologist, V8, P987; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; BRAMAN SK, 1984, ANN ENTOMOL SOC AM, V77, P592, DOI 10.1093/aesa/77.5.592; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Carey JR., 1993, APPL DEMOGRAPHY BIOL; Chen Q, 2017, PLOS ONE, V12; Chi BJ, 2016, AGR FOREST ENTOMOL, V18, P189, DOI 10.1111/afe.12151; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1990, J ECON ENTOMOL, V83, P1143, DOI 10.1093/jee/83.4.1143; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Efron B., 1994, INTRO BOOTSTRAP; Esperk T, 2007, J ECON ENTOMOL, V100, P627, DOI 10.1603/0022-0493(2007)100[627:IVINOL]2.0.CO;2; FRAENKEL G, 1981, ENTOMOL EXP APPL, V29, P147, DOI 10.1111/j.1570-7458.1981.tb03054.x; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; GRAF B, 1992, J APPL ECOL, V29, P558, DOI 10.2307/2404463; Gurr GM, 2012, AGR FOREST ENTOMOL, V14, P1, DOI 10.1111/j.1461-9563.2011.00550.x; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; HARCOURT DG, 1969, ANNU REV ENTOMOL, V14, P175, DOI 10.1146/annurev.en.14.010169.001135; HINCKLEY AD, 1963, J ECON ENTOMOL, V56, P112, DOI 10.1093/jee/56.1.112; HODEK I, 1988, ENTOMOL EXP APPL, V49, P153, DOI 10.1007/BF00188248; Huang Yu-Bing, 2012, Insect Science, V19, P263, DOI 10.1111/j.1744-7917.2011.01424.x; KHAN ZR, 1988, INSECT SCI APPL, V9, P129, DOI 10.1017/S1742758400005919; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Lewis EG, 1977, BIOMATHEMATICS, V6, P221, DOI [10.1007/978-3-642-81046-6_25, DOI 10.1007/978-3-642-81046-6_25]; Li WX, 2015, J ECON ENTOMOL, V108, P126, DOI 10.1093/jee/tou011; [刘家莉 LIU Jia-Li], 2009, [生态学报, Acta Ecologica Sinica], V29, P3206; Ma L, 2017, PLOS ONE, V12; MORRIS R. F., 1963, MEM ENTOMOL SOC CANADA, V32, P16; Nylin S, 2001, AUSTRAL ECOL, V26, P507, DOI 10.1046/j.1442-9993.2001.01134.x; Pan X. X., 1984, ENTOMOL KNOWL, V3, P003; Pan XX, 1985, J NANJING AGR U CHIN, V3, P32; Punithavalli M, 2013, RICE SCI, V20, P442, DOI 10.1016/S1672-6308(13)60154-7; Regniere J, 2012, J INSECT PHYSIOL, V58, P634, DOI 10.1016/j.jinsphys.2012.01.010; WADA T, 1980, APPL ENTOMOL ZOOL, V15, P207, DOI 10.1303/aez.15.207; Wang Y, 2016, FORENSIC SCI INT, V267, P136, DOI 10.1016/j.forsciint.2016.07.019; WATT K. E. F., 1963, Memoirs of the Entomology Society of Canada, P83; Wu J. C., 1984, J NANJING AGR COLL, V4, P19; Yang YaJun, 2015, Acta Phytophylacica Sinica, V42, P691; Ye GY, 2003, CROP PROT, V22, P171, DOI 10.1016/S0261-2194(02)00142-4; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	45	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187972	10.1371/journal.pone.0187972	http://dx.doi.org/10.1371/journal.pone.0187972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125858	Green Published, Green Submitted, gold			2022-12-26	WOS:000414866000033
J	Loggi, E; Galli, S; Vitale, G; Di Donato, R; Vukotic, R; Grandini, E; Margotti, M; Guarneri, V; Furlini, G; Galli, C; Re, MC; Andreone, P				Loggi, Elisabetta; Galli, Silvia; Vitale, Giovanni; Di Donato, Roberto; Vukotic, Ranka; Grandini, Elena; Margotti, Marzia; Guarneri, Valeria; Furlini, Giuliano; Galli, Claudio; Re, Maria Carla; Andreone, Pietro			Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods	PLOS ONE			English	Article							CORE ANTIGEN QUANTIFICATION; HCV RNA; CLINICAL UTILITY; EFFICACY	Aim To evaluate the potential value of using a serological assay to quantitate the hepatitis C virus core antigen (HCV-Ag) when monitoring patients with chronic hepatitis C being treated with direct-acting antivirals (DAAs). Methods Ninety-six patients treated with DAAs, either alone (91) or in combination with PEG interferon (5), were tested for HCV-RNA and for HCV-Ag at baseline and at weeks 2, 4, 8 and 12 during treatment and 12 weeks after completion. The concordance and correlation between the viral parameters as well as the respective kinetics during and after treatment were evaluated. Results A sustained viral response (SVR) was achieved in 82 patients (91%), whereas 11 relapsed (R) and 1 showed a virological breakthrough while receiving treatment. HCV-RNA and HCV-Ag showed good concordance (kappa = 0.62) and correlation. No significant differences between SVR and R was observed in either assay at 2 and 4 weeks after the start of treatment. At 8 weeks, HCV-Ag showed higher accuracy than HCV-RNA (AUC: 0.74 vs. 0.55) and there was a significantly greater decrease from baseline in SVR than in R (4.01 vs. 3.36 log10; p<0.05). Conclusions Monitoring during treatment with DAAs by using either HCV-RNA or HCV-Ag has only a limited predictive value for SVR. Since those assays are equivalent for identifying a virological relapse, HCV-Ag may be preferred from an economical and organizational perspective.	[Loggi, Elisabetta; Vitale, Giovanni; Di Donato, Roberto; Vukotic, Ranka; Grandini, Elena; Margotti, Marzia; Guarneri, Valeria; Andreone, Pietro] Univ Bologna, Ctr Ric Studio Epatiti, Dipartimento Sci Med & Chirurg, Bologna, Italy; [Galli, Silvia; Furlini, Giuliano; Re, Maria Carla] St Orsola Marcello Malpighi Hosp, Unita Microbiol, Bologna, Italy; [Galli, Claudio] Abbott Diagnost, Med Sci Liaison, Rome, Italy; [Loggi, Elisabetta] UOC Patol Clin, ASUR Area Vasta 4, Fermo, FM, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Andreone, P (corresponding author), Univ Bologna, Ctr Ric Studio Epatiti, Dipartimento Sci Med & Chirurg, Bologna, Italy.	pietro.andreone@unibo.it	Vitale, Giovanni/K-6322-2016; Furlini, Giuliano/ABB-1290-2020; Andreone, Pietro/K-8050-2016; Vitale, Giovanni/AAP-9000-2020	Vitale, Giovanni/0000-0003-2603-8245; Andreone, Pietro/0000-0002-4794-9809; Vitale, Giovanni/0000-0003-2603-8245	Abbott Diagnostics	Abbott Diagnostics(Abbott Laboratories)	The laboratory reagents (serological determinations) have been provided by Abbott Diagnostics, free of charge. The Abbott Diagnostics partially supported the research providing the research materials, following an agreement for an Investigator Initiated Study (IIS), but did not play a role in the study design, data collection, decision to publish, or preparation of the manuscript. No Authors' salaries have been provided. The Co-Author, Dr. Claudio Galli is currently employed by Abbott Diagnostics as the Associate Director, Medical Scientific Liaison Europe contributed to data analysis, as stated in Author roles in the Author Contributions section.	Aghemo A, 2016, CLIN GASTROENTEROL H, V14, P1331, DOI 10.1016/j.cgh.2016.03.035; America TAAftSoLDatIDSo, 2017, REC TEST MAN TREAT H; Bouvier-Alias M, 2002, HEPATOLOGY, V36, P211, DOI 10.1053/jhep.2002.34130; Chevaliez S, 2016, ANTIVIRAL THERAPY; Chevaliez S, 2014, J CLIN VIROL, V61, P145, DOI [10.1016/j.jcv.2014.05.014, 10.1016/j.jcv.2014.15.014]; Chung Raymond T, 2008, Hepatology, V47, P306, DOI 10.1002/hep.22070; Craxi A, 2016, DIGESTIVE LIVER DIS; Cresswell FV, 2015, CLIN INFECT DIS, V60, P263, DOI 10.1093/cid/ciu782; EASL, 2016, J HEPATOL; Kamal SM, 2015, ALIMENT PHARM THER, V42, P307, DOI 10.1111/apt.13261; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Lens S, 2014, DIGEST LIVER DIS, V46, pS197, DOI 10.1016/j.dld.2014.10.002; Loggi E, 2013, J CLIN VIROL, V56, P207, DOI 10.1016/j.jcv.2012.11.012; Maasoumy B, 2016, J HEPATOL, V65, P473, DOI 10.1016/j.jhep.2016.04.006; Medici MC, 2011, J CLIN VIROL, V51, P260, DOI 10.1016/j.jcv.2011.05.003; Morota K, 2009, J VIROL METHODS, V157, P8, DOI 10.1016/j.jviromet.2008.12.009; Omata M, 2016, HEPATOL INT, V10, P681, DOI 10.1007/s12072-016-9736-3; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rockstroh JK, 2017, J VIROL METHODS, V245, P14, DOI 10.1016/j.jviromet.2017.03.002; Sarrazin C, 2015, J CLIN MICROBIOL, V53, P1264, DOI 10.1128/JCM.03030-14; Sarrazin C, 2015, J VIROL METHODS, V214, P29, DOI 10.1016/j.jviromet.2014.11.027; World Health Organization, 2017, GUID HEP B C TEST	23	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187755	10.1371/journal.pone.0187755	http://dx.doi.org/10.1371/journal.pone.0187755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125869	Green Published, gold, Green Submitted			2022-12-26	WOS:000414866000023
J	Min, HP; Niu, MM; Zhang, WL; Yan, J; Li, JC; Tan, XY; Li, B; Su, MX; Di, B; Yan, F				Min, Hongping; Niu, Miaomiao; Zhang, Weilin; Yan, Jia; Li, Jiachang; Tan, Xiying; Li, Bo; Su, Mengxiang; Di, Bin; Yan, Fang			Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein	PLOS ONE			English	Article							MOLECULAR DOCKING; PHILADELPHIA-CHROMOSOME; IMATINIB MESYLATE; DRUG-INTERACTIONS; K562/ADM CELLS; IN-SILICO; BINDING; TRANSPORTER; SITES; ANTHRAQUINONES	Development of multidrug resistance (MDR) is a continuous clinical challenge partially due to the overexpression of P-glycoprotein (P-gp) for chronic myelogenous leukemia (CML) patients. Herein, we evaluated the inhibitory potency of emodin, a natural anthraquinone derivative isolated from Rheum palmatum L, on P-gp in P-gp positive K562/ADM cells. Competition experiments combined with molecular docking analysis were utilized to investigate the binding modes between emodin and binding sites of P-gp. Emodin reversed adriamycin resistance in K562/ADM cells accompanied with the decrease of P-gp protein expression, further increasing the uptake of rhodamine123 in both K562/ADM and Caco-2 cells, indicating the inhibition of P-gp efflux function. Moreover, when incubated with emodin under different conditions where P-gp was inhibited, K562/ADM cells displayed increasing intracellular uptake of emodin, suggesting that emodin may be the potential substrate of P-gp. Importantly, rhodamine 123 could increase the K-intrinsic (K-i) value of emodin linearly, whereas, verapamil could not, implying that emodin competitively bound to the R site of P-gp and non-competition existed between emodin and verapamil at the M site, in a good accordance with the results of molecular docking that emodin bound to the R site of P-gp with higher affinity. Based on our results, we suggest that emodin might be used to modulate P-gp function and expression.	[Min, Hongping; Niu, Miaomiao; Zhang, Weilin; Yan, Jia; Li, Bo; Su, Mengxiang; Di, Bin; Yan, Fang] China Pharmaceut Univ, Key Lab Prot Chem & Struct Biol, Nanjing, Jiangsu, Peoples R China; [Min, Hongping; Niu, Miaomiao; Zhang, Weilin; Yan, Jia; Li, Bo; Su, Mengxiang; Di, Bin; Yan, Fang] China Pharmaceut Univ, Key Lab Drug Qual Control & Pharmacovigilance, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Li, Jiachang] China Pharmaceut Univ, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Tan, Xiying] Jiangsu Prov Hosp Chinese Tradit Med, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; Nanjing University of Chinese Medicine	Di, B; Yan, F (corresponding author), China Pharmaceut Univ, Key Lab Prot Chem & Struct Biol, Nanjing, Jiangsu, Peoples R China.; Di, B; Yan, F (corresponding author), China Pharmaceut Univ, Key Lab Drug Qual Control & Pharmacovigilance, Minist Educ, Nanjing, Jiangsu, Peoples R China.	dibin@cpu.edu.cn; cpuyanfang@hotmail.com		Di, Bin/0000-0002-1907-1736	National Nature Science Foundation of China [81202500]; Fundamental Research Funds for the Central Universities [2016ZZD008]; Jiangsu Provincial Natural Science Foundation of China [BK20141356]; National Nature Science Foundation of P.R. China [81773693]; MOE Key Laboratory of Drug Quality Control and Pharmacovigilance [DQCP2015MS05]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu Provincial Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province); National Nature Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); MOE Key Laboratory of Drug Quality Control and Pharmacovigilance	This work was funded by the National Nature Science Foundation of China (no. 81202500) (http://www.nsfc.gov.cn/) (FY), the Fundamental Research Funds for the Central Universities (no. 2016ZZD008), Jiangsu Provincial Natural Science Foundation of China (no. BK20141356) (http://www.jskjjh.gov.cn) (FY), National Nature Science Foundation of P.R. China (no. 81773693) (http://www.nsfc.gov.cn/) and the Open Project Program of MOE Key Laboratory of Drug Quality Control and Pharmacovigilance (no. DQCP2015MS05) (FY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ayesh S, 1996, BBA-MOL BASIS DIS, V1316, P8, DOI 10.1016/0925-4439(96)00008-7; Chen P, 2013, PHARM BIOL, V51, P1586, DOI 10.3109/13880209.2013.803257; Chen Ying-Yu, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P1413, DOI 10.7534/j.issn.1009-2137.2013.06.010; Choi RJ, 2013, EUR J PHARM SCI, V48, P272, DOI 10.1016/j.ejps.2012.10.027; Correa S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-303; Daddam JR, 2014, INTERDISCIP SCI, V6, P167, DOI 10.1007/s12539-012-0197-7; De Souza PS, 2011, INT J ONCOL, V39, P925, DOI 10.3892/ijo.2011.1103; Dolghih E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002083; Domicevica L, 2015, BIOCHEM SOC T, V43, P952, DOI 10.1042/BST20150125; Feng YD, 2013, EUR J PHARMACOL, V712, P53, DOI 10.1016/j.ejphar.2013.04.028; Ferreira RJ, 2013, J CHEM INF MODEL, V53, P1747, DOI 10.1021/ci400195v; Gadhe CG, 2013, ANTI-CANCER AGENT ME, V13, P1636, DOI 10.2174/18715206113139990302; Huang Q, 2007, MED RES REV, V27, P609, DOI 10.1002/med.20094; Illmer T, 2004, LEUKEMIA, V18, P401, DOI 10.1038/sj.leu.2403257; Kosztyu P, 2013, PHARMACOL RES, V67, P79, DOI 10.1016/j.phrs.2012.10.012; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Li X, 2014, TOXICOL APPL PHARM, V275, P163, DOI 10.1016/j.taap.2013.12.015; Liu DL, 2012, INT J ONCOL, V40, P1049, DOI 10.3892/ijo.2011.1285; Lu Xujin, 2016, PDA J Pharm Sci Technol, V70, P39, DOI 10.5731/pdajpst.2015.006015; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Mai LiPing, 2011, Journal of Tropical Medicine (Guangzhou), V11, P1363; Muller F, 2013, BIOCHEM PHARMACOL, V86, P808, DOI 10.1016/j.bcp.2013.07.008; NARE B, 1994, BIOCHEM PHARMACOL, V48, P2215, DOI 10.1016/0006-2952(94)00427-7; Niu MM, 2015, NEW J CHEM, V39, P1060, DOI 10.1039/c4nj01387e; Persidis A, 1999, NAT BIOTECHNOL, V17, P94, DOI 10.1038/5289; Safa Ahmad R., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P1, DOI 10.2174/1568011043482142; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7187, DOI 10.1073/pnas.85.19.7187; Shafiei-Irannejad V, 2017, CHEM BIOL DRUG DESIG; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Takahashi N, 1998, BLOOD, V92, P4758, DOI 10.1182/blood.V92.12.4758; TAMAI I, 1991, J BIOL CHEM, V266, P16796; Teng YN, 2015, J AGR FOOD CHEM, V63, P847, DOI 10.1021/jf5042307; Teng Z, 2014, BIOSCIENCE BIOTECHNO, V71, P1636; Wang DH, 2005, PHARMACOL RES, V52, P376, DOI 10.1016/j.phrs.2005.05.010; Wang RB, 2003, J CLIN PHARM THER, V28, P203, DOI 10.1046/j.1365-2710.2003.00487.x; Wang Xiang-fei, 2006, Fudan Xuebao (Yixueban), V33, P262; Wu L., 2016, ACM T INTEL SYST TEC, V7, DOI DOI 10.18632/0NC0TARGET.8489; Zeino M, 2014, INVEST NEW DRUG, V32, P618, DOI 10.1007/s10637-014-0098-1; [张艳 Zhang Yan], 2012, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V23, P286	41	23	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187971	10.1371/journal.pone.0187971	http://dx.doi.org/10.1371/journal.pone.0187971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121121	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900106
J	Srinivasula, S; Gabriel, E; Kim, I; DeGrange, P; St Claire, A; Mallow, C; Donahue, RE; Paik, C; Lane, HC; Di Mascio, M				Srinivasula, Sharat; Gabriel, Erin; Kim, Insook; DeGrange, Paula; St Claire, Alexis; Mallow, Candace; Donahue, Robert E.; Paik, Chang; Lane, H. C.; Di Mascio, Michele			CD4+levels control the odds of induction of humoral immune responses to tracer doses of therapeutic antibodies	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; INFLUENZA VACCINATION; MONOCLONAL-ANTIBODY; B-CELLS; PHARMACOKINETICS; INDIVIDUALS; INFECTION; VACCINES; TETANUS; NUMBER	Rapidly increasing number of therapeutic antibodies are being repurposed to imaging probes for noninvasive diagnosis, as well as monitoring during treatment or disease recurrence. Though antibody-based imaging involves tracer doses (similar to 3 log lower than therapeutic doses), and immune responses are severely reduced in patients with impaired immunity, formation of anti-tracer antibodies (ATA) has been observed hampering further diagnostic monitoring. Here, we explored the potential to develop humoral responses to intravenously administered tracer dose of a monoclonal antibody F(ab')(2) fragment, and associated with host related immune measures in 49 rhesus macaques categorized into healthy (uninfected controls), SIV-progressors, SIV non-progressors, or total body irradiated (TBI). Antibody fragment administered in tracer amount (similar to 100 mu g) induced immune responses with significantly lower odds in SIV-progressors or TBI macaques (P<0.005) as compared to healthy animals. Peripheral blood (PB) CD4+ cell counts, but not CD20+ cell levels, were associated with significantly higher risk of developing a humoral response (P<0.001). Doubling the PB CD4+ counts is associated with an odds ratio of developing an immune response of 1.73. Among SIV-infected animals, CD4+ cell count was a stronger predictor of immune response than plasma SIV-RNA levels. Both SIV-progressors and TBI macaques showed higher odds of responses with increasing CD4+ counts, however when compared to healthy or SIV non-progressors with similar CD4+ count, they were still functionally incompetent in generating a response (P<0.01). Moreover, presence of ATA in systemic circulation altered the in vivo biodistribution by increasing hepatic uptake and decreasing plasma radiotracer clearance, with minimal to no binding detected in targeted tissues.	[Srinivasula, Sharat; Gabriel, Erin] Leidos Biomed Res Inc, Clin Res Directorate, Clin Monitoring Res Program, NCI Campus Frederick, Frederick, MD 21704 USA; [Kim, Insook] Leidos Biomed Res Inc, Appl Dev Res Directorate, NCI Campus Frederick, Frederick, MD USA; [DeGrange, Paula] NIAID, Integrated Res Facil, NIH, Frederick, MD USA; [St Claire, Alexis; Mallow, Candace] NIAID, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Donahue, Robert E.] NHLBI, Hematol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Paik, Chang] NIH, Radiopharmaceut Lab, Nucl Med Radiol & Imaging Sci, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Lane, H. C.] NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Di Mascio, Michele] NIAID, Biostat Res Branch, Div Clin Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Srinivasula, S (corresponding author), Leidos Biomed Res Inc, Clin Res Directorate, Clin Monitoring Res Program, NCI Campus Frederick, Frederick, MD 21704 USA.	srinivasulas@mail.nih.gov			National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NIAID; NHLBI; NHLBI of National Institutes of Health; NIAID [HHSN 272201300031C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL002338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000585] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010976] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI of National Institutes of Health; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E (Authors: SS, EG and IK), and the intramural research programs of the NIAID (Authors: CP, HCL and MDM) and NHLBI (Author: RED).; This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This work was also supported by the intramural research programs of the NIAID and NHLBI of National Institutes of Health. The authors wish to thank the veterinary and animal care staff of the NIH for maintaining the non-human primates used in this study, Merck for providing Raltegravir, Gilead for providing Tenofovir and Emtricitabine, and NIH Nonhuman Primate Reagent Resource (R24 OD010976, and NIAID contract HHSN 272201300031C) for providing humanized and rhesus recombinant anti-CD4 antibodies. We thank Ludmila Krymskaya for flow cytometry support, and Keith A. Reimann of MassBiologics for critical reading of the manuscript and useful discussion of the study.	Baker Matthew P, 2010, Self Nonself, V1, P314, DOI 10.4161/self.1.4.13904; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bercovici N, 1999, EUR J IMMUNOL, V29, P345, DOI 10.1002/(SICI)1521-4141(199901)29:01<345::AID-IMMU345>3.0.CO;2-K; Bortnick A, 2012, J IMMUNOL, V188, P5389, DOI 10.4049/jimmunol.1102808; Brinks V, 2011, PHARM RES-DORDR, V28, P2379, DOI 10.1007/s11095-011-0523-5; Buss NAPS, 2012, CURR OPIN PHARMACOL, V12, P615, DOI 10.1016/j.coph.2012.08.001; Cagigi A, 2010, LANCET INFECT DIS, V10, P499, DOI 10.1016/S1473-3099(10)70117-1; CHALLACOMBE SJ, 1979, IMMUNOLOGY, V36, P331; Corcoran LM, 2016, CURR OPIN IMMUNOL, V39, P59, DOI 10.1016/j.coi.2015.12.008; Descotes J, 2008, EXPERT OPIN DRUG MET, V4, P1537, DOI 10.1517/17425250802525496 ; Di Mascio M, 2009, BLOOD, V114, P328, DOI 10.1182/blood-2008-12-192203; Donahue RE, 2015, BLOOD, V126, P2632, DOI 10.1182/blood-2015-07-657346; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Evison J, 2009, CLIN INFECT DIS, V48, P1402, DOI 10.1086/598193; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Getts DR, 2010, MABS-AUSTIN, V2, P682, DOI 10.4161/mabs.2.6.13601; Harding FA, 2010, MABS-AUSTIN, V2, P256, DOI 10.4161/mabs.2.3.11641; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; KEENAN AM, 1985, J NUCL MED, V26, P531; Keizer RJ, 2010, CLIN PHARMACOKINET, V49, P493, DOI 10.2165/11531280-000000000-00000; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; KROON FP, 1995, CLIN INFECT DIS, V21, P1197, DOI 10.1093/clinids/21.5.1197; KROON FP, 1994, AIDS, V8, P469, DOI 10.1097/00002030-199404000-00008; Kroon FP, 1998, AIDS, V12, pF217, DOI 10.1097/00002030-199817000-00002; Kroon FP, 2000, VACCINE, V18, P3040, DOI 10.1016/S0264-410X(00)00079-7; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Liblau RS, 1996, P NATL ACAD SCI USA, V93, P3031, DOI 10.1073/pnas.93.7.3031; Long JE, 2016, VACCINE, V34, P2679, DOI 10.1016/j.vaccine.2016.04.032; Machac J, 2002, SEMIN NUCL MED, V32, P276, DOI 10.1053/snuc.2002.126053; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; MIOTTI PG, 1989, JAMA-J AM MED ASSOC, V262, P779, DOI 10.1001/jama.262.6.779; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; R Core Team, 2021, R LANGUAGE ENV STAT; SAKAHARA H, 1989, J NUCL MED, V30, P1311; Tavare R, 2015, J NUCL MED, V56, P1258, DOI 10.2967/jnumed.114.153338; TORRES G, 1993, CLIN NUCL MED, V18, P477, DOI 10.1097/00003072-199306000-00003; VARDINON N, 1990, J INFECT DIS, V162, P238, DOI 10.1093/infdis/162.1.238; Vigano A, 2008, JAIDS-J ACQ IMM DEF, V48, P289, DOI 10.1097/QAI.0b013e3181632cda; Wang RE, 2013, CURR MOL MED, V13, P1523, DOI 10.2174/1566524013666131111120951; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Warram JM, 2014, CANCER METAST REV, V33, P809, DOI 10.1007/s10555-014-9505-5	43	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187912	10.1371/journal.pone.0187912	http://dx.doi.org/10.1371/journal.pone.0187912			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121114	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900092
J	Glavinic, U; Stankovic, B; Draskovic, V; Stevanovic, J; Petrovic, T; Lakic, N; Stanimirovic, Z				Glavinic, Uros; Stankovic, Biljana; Draskovic, Vladimir; Stevanovic, Jevrosima; Petrovic, Tamas; Lakic, Nada; Stanimirovic, Zoran			Dietary amino acid and vitamin complex protects honey bee from immunosuppression caused by Nosema ceranae	PLOS ONE			English	Article							POLLEN SUBSTITUTE DIETS; APIS-MELLIFERA; GENE-EXPRESSION; COLONY LOSSES; MICROSPORIDIAN PARASITE; HEMOLYMPH PROTEIN; QUANTITATIVE-PCR; 1ST DETECTION; INFECTION; NUTRITION	Microsporidium Nosema ceranae is well known for exerting a negative impact on honey bee health, including down-regulation of immunoregulatory genes. Protein nutrition has been proven to have beneficial effects on bee immunity and other aspects of bee health. Bearing this in mind, the aim of our study was to evaluate the potential of a dietary amino acid and vitamin complex "BEEWELL AminoPlus" to protect honey bees from immunosuppression induced by N. ceranae. In a laboratory experiment bees were infected with N. ceranae and treated with supplement on first, third, sixth and ninth day after emergence. The expression of genes for immune-related peptides (abaecin, apidaecin, hymenoptaecin, defensin and vitellogenin) was compared between groups. The results revealed significantly lower (p<0.01 or p<0.001) numbers of Nosema spores in supplemented groups than in the control especially on day 12 post infection. With the exception of abacein, the expression levels of immune-related peptides were significantly suppressed (p<0.01 or p<0.001) in control group on the 12th day post infection, compared to bees that received the supplement. It was supposed that N. ceranae had a negative impact on bee immunity and that the tested amino acid and vitamin complex modified the expression of immune-related genes in honey bees compromised by infection, suggesting immune-stimulation that reflects in the increase in resistance to diseases and reduced bee mortality. The supplement exerted best efficacy when applied simultaneously with Nosema infection, which can help us to assume the most suitable period for its application in the hive.	[Glavinic, Uros; Draskovic, Vladimir; Stevanovic, Jevrosima; Stanimirovic, Zoran] Univ Belgrade, Dept Biol, Fac Vet Med, Belgrade, Serbia; [Stankovic, Biljana] Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Mol Biomed, Belgrade, Serbia; [Petrovic, Tamas] Sci Vet Inst Novi Sad, Novi Sad, Serbia; [Lakic, Nada] Univ Belgrade, Dept Stat, Fac Agr, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Novi Sad; University of Belgrade	Glavinic, U (corresponding author), Univ Belgrade, Dept Biol, Fac Vet Med, Belgrade, Serbia.	uglavinic@vet.bg.ac.rs	Draskovic, Vladimir/AAE-3308-2020; Petrovic, Tamas/H-3764-2019; Glavinic, Uros/S-5451-2019; Stevanovic, Jevrosima/AAA-8089-2020	Draskovic, Vladimir/0000-0001-5159-1937; Petrovic, Tamas/0000-0002-9164-3356; Glavinic, Uros/0000-0003-2143-1611; Stevanovic, Jevrosima/0000-0003-0906-5911; Stanimirovic, Zoran/0000-0003-2657-8591; Stankovic, BIljana/0000-0002-7571-277X	Ministry of Education, Science and Technological Development of the Republic of Serbia [11146002]	Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This study was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No. 11146002), led by professor Zoran Stanimirovic.	Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Ames BN, 2001, MUTAT RES-FUND MOL M, V475, P7, DOI 10.1016/S0027-5107(01)00070-7; [Anonymous], 2004, EXP GERONTOL, V39, P767; Antunez K, 2015, MICROB ECOL, V70, P522, DOI 10.1007/s00248-015-0594-7; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Azzami K, 2012, ARCH VIROL, V157, P689, DOI 10.1007/s00705-012-1223-0; BAILEY L, 1967, Journal of Apicultural Research, V6, P121; Bailey L, 1955, ANN APPL BIOL, V43, P379, DOI 10.1111/j.1744-7348.1955.tb02488.x; Basualdo M, 2014, ENV MICROBIOL REP, V6, P396, DOI 10.1111/1758-2229.12169; Borneck R, 2010, J APICULT RES, V49, P334, DOI 10.3896/IBRA.1.49.4.06; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; CANTWELL G E, 1970, American Bee Journal, V110, P222; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; CASTEELS P, 1990, EUR J BIOCHEM, V187, P381, DOI 10.1111/j.1432-1033.1990.tb15315.x; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Chauzat MP, 2007, J APICULT RES, V46, P127, DOI 10.1080/00218839.2007.11101380; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Currie RW, 2010, J APICULT RES, V49, P104, DOI 10.3896/IBRA.1.49.1.18; Czekonska K, 2015, APIDOLOGIE, V46, P1, DOI 10.1007/s13592-014-0296-z; De Jong D, 2009, J APICULT RES, V48, P34, DOI 10.3896/IBRA.1.48.1.08; Decanini LI, 2007, J HERED, V98, P195, DOI 10.1093/jhered/esm008; DeGrandi-Hoffman G, 2000, INSECT SOC, V47, P302, DOI 10.1007/PL00001720; DeGrandi-Hoffman G, 2008, J APICULT RES, V47, P265, DOI 10.3896/IBRA.1.47.4.06; DeGrandi-Hoffman G, 2016, APIDOLOGIE, V47, P186, DOI 10.1007/s13592-015-0386-6; DeGrandi-Hoffman G, 2015, CURR OPIN INSECT SCI, V10, P170, DOI 10.1016/j.cois.2015.05.007; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Evans JD, 2005, EVOLUTION, V59, P2270, DOI 10.1111/j.0014-3820.2005.tb00935.x; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; Evison SEF, 2016, APIDOLOGIE, V47, P206, DOI 10.1007/s13592-015-0388-4; Fleming JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132014; Fries I, 2006, J APICULT RES, V45, P230; Fries I., 2013, J APICULT RES, V52, P1, DOI [10.3896/ IBRA. 1.52.1.14, DOI 10.3896/IBRA.1.52.1.14]; Gatschenberger H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066415; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Glavinic U, 2014, ACTA VET-BEOGRAD, V64, P349, DOI 10.2478/acve-2014-0033; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Grozinger CM, 2015, CURR OPIN INSECT SCI, V10, P124, DOI 10.1016/j.cois.2015.03.007; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Higes M, 2009, J APICULT RES, V48, P217, DOI 10.3896/IBRA.1.48.3.12; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Li CC, 2014, ENTOMOL EXP APPL, V151, P19, DOI 10.1111/eea.12167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maistrello L, 2008, APIDOLOGIE, V39, P436, DOI 10.1051/apido:2008022; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martin-Hernandez R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170183; Mattila HR, 2006, J ECON ENTOMOL, V99, P604, DOI 10.1603/0022-0493-99.3.604; Morais MM, 2013, J APICULT RES, V52, P119, DOI 10.3896/IBRA.1.52.3.01; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Neumann P, 2013, J APICULT RES, V52, P1, DOI [10.3896/IBRA.1.52.1.04, DOI 10.3896/IBRA.1.52.1.04]; OIE, 2013, MAN DIAGN TESTS VACC; Pajuelo AG, 2008, J APICULT RES, V47, P84, DOI 10.1080/00218839.2008.11101429; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Porrini MP, 2011, J APICULT RES, V50, P35, DOI 10.3896/IBRA.1.50.1.04; Ptaszynska AA, 2016, PARASITOL RES, V115, P397, DOI 10.1007/s00436-015-4761-z; Saffari A, 2010, J APIC SCI, V54, P63; Shi YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018808; Simeunovic P, 2014, J APICULT RES, V53, P545, DOI 10.3896/IBRA.1.53.5.09; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Stanimirovic Z, 2007, MUTAT RES-GEN TOX EN, V628, P1, DOI 10.1016/j.mrgentox.2006.09.014; Stanimirovic Z, 2017, ACTA VET-BEOGRAD, V67, P191, DOI 10.1515/acve-2017-0017; Steinmann N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129956; Stevanovic J, 2008, ENVIRON MOL MUTAGEN, V49, P594, DOI 10.1002/em.20409; Stevanovic J, 2013, APIDOLOGIE, V44, P522, DOI 10.1007/s13592-013-0203-z; Stevanovic J, 2011, APIDOLOGIE, V42, P49, DOI 10.1051/apido/2010034; Tapaszti Z, 2009, ACTA VET HUNG, V57, P383, DOI 10.1556/AVet.57.2009.3.4; van der Zee R, 2010, J APICULT RES, V49, P121, DOI 10.3896/IBRA.1.49.1.25; Wang H, 2014, APIDOLOGIE, V45, P618, DOI 10.1007/s13592-014-0276-3; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005	79	45	46	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187726	10.1371/journal.pone.0187726	http://dx.doi.org/10.1371/journal.pone.0187726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117233	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600069
J	Jing, DW; Liu, FC; Wang, MY; Ma, HL; Du, ZY; Ma, BY; Dong, YF				Jing, Da-Wei; Liu, Fang-Chun; Wang, Ming-You; Ma, Hai-Lin; Du, Zhen-Yu; Ma, Bing-Yao; Dong, Yu-Feng			Effects of root pruning on the physicochemical properties and microbial activities of poplar rhizosphere soil	PLOS ONE			English	Article							ENZYME-ACTIVITIES; N MINERALIZATION; DELICIOUS APPLE; LOESS PLATEAU; KARST REGION; SHOOT GROWTH; CHINESE FIR; BIOMASS; CARBON; MICROORGANISMS	This study aimed to determine the effects of root pruning on the physicochemical characteristics and microbial activities of poplar rhizosphere soil. The root systems of 5-year-old poplar (Populusxeuramericana cv. 'Neva') trees were manually pruned at 6, 8, or 10 times diameter at breast height (DBH) from the trunk (severe, moderate, and light, respectively) along both inter-row sides. Moderate root pruning significantly increased the concentrations of amino acids, organic acids, and total sugars in the root exudates and decreased the pH of rhizosphere soil. This treatment also increased the contents of available nitrogen, phosphorus, potassium, and total organic carbon as well as high-, medium-, and low-activity organic carbon in rhizosphere soil. Moreover, moderate pruning increased the contents of microbial biomass carbon and nitrogen, and enhanced basal respiration, in addition to decreasing the metabolic quotients in rhizosphere soil by 8.9%, 5.0%, and 11.4% compared with control, light, and severe root pruning treatments, respectively. Moderate pruning increased the growth rates of DBH, tree height, and volume to the highest levels. Furthermore, these indices were not significantly different between the light root pruning and control groups, but varied significantly between severe and moderate root-pruning treatments. Thus, root pruning, depending on the distance from the trunk, significantly influences the physicochemical properties and microbial activities in poplar rhizosphere soil.	[Jing, Da-Wei] Dezhou Univ, Coll Resources Environm & Planning, Dezhou, Peoples R China; [Liu, Fang-Chun; Ma, Hai-Lin; Du, Zhen-Yu; Ma, Bing-Yao; Dong, Yu-Feng] Shandong Acad Forestry, Inst Resource & Environm, Jinan, Shandong, Peoples R China; [Wang, Ming-You] Dezhou Univ, Coll Ecol & Garden Architecture, Dezhou, Peoples R China	Dezhou University; Dezhou University	Liu, FC (corresponding author), Shandong Acad Forestry, Inst Resource & Environm, Jinan, Shandong, Peoples R China.	fehliu007@163.com			National Natural Science Foundation of China [31500513, 31570614]; Key Agricultural Application Technology Innovation Program of Shandong Province; Shandong Provincial Doctoral Foundation [BS2015NY013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Agricultural Application Technology Innovation Program of Shandong Province; Shandong Provincial Doctoral Foundation	The present study was funded by the National Natural Science Foundation of China (Grant Nos. 31500513 and 31570614), the Key Agricultural Application Technology Innovation Program of Shandong Province, and Shandong Provincial Doctoral Foundation (BS2015NY013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TH, 1989, SOIL BIOL BIOCHEM, V21, P471, DOI 10.1016/0038-0717(89)90117-X; ANDERSON TH, 1990, SOIL BIOL BIOCHEM, V22, P251, DOI 10.1016/0038-0717(90)90094-G; Asin L, 2007, SCI HORTIC-AMSTERDAM, V113, P142, DOI 10.1016/j.scienta.2007.02.008; Balota EL, 2004, SOIL TILL RES, V77, P137, DOI 10.1016/j.still.2003.12.003; Bertin C, 2003, PLANT SOIL, V256, P67, DOI 10.1023/A:1026290508166; Bragg DC, 2008, SOUTH J APPL FOR, V32, P38, DOI 10.1093/sjaf/32.1.38; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Chen J, 2016, EUR J SOIL SCI, V67, P857, DOI 10.1111/ejss.12388; DesRochers A, 2009, FOREST ECOL MANAG, V258, P2062, DOI 10.1016/j.foreco.2009.07.059; Du ZY, 2012, FOREST SYST, V21, P236, DOI 10.5424/fs/2012212-02634; Fang SZ, 1999, BIOMASS BIOENERG, V17, P415, DOI 10.1016/S0961-9534(99)00060-4; Fang Y, 2010, EUR J AGRON, V33, P257, DOI 10.1016/j.eja.2010.07.001; [冯志敏 Feng zhimin], 2008, [水土保持学报, Journal of Soil and Water Conservation], P145; Ferree DC, 1997, HORTSCIENCE, V32, P645, DOI 10.21273/HORTSCI.32.4.645; Glenn DM, 2011, SCI HORTIC-AMSTERDAM, V129, P889, DOI 10.1016/j.scienta.2011.04.023; Hu N, 2016, EUR J SOIL BIOL, V73, P77, DOI 10.1016/j.ejsobi.2016.01.007; Hu YL, 2006, PLANT SOIL, V282, P379, DOI 10.1007/s11104-006-0004-5; INSAM H, 1991, SOIL BIOL BIOCHEM, V23, P459, DOI 10.1016/0038-0717(91)90010-H; INSAM H, 1989, SOIL BIOL BIOCHEM, V21, P211, DOI 10.1016/0038-0717(89)90097-7; Kaschuk G, 2010, SOIL BIOL BIOCHEM, V42, P1, DOI 10.1016/j.soilbio.2009.08.020; KLEIN DA, 1988, PLANT SOIL, V110, P19, DOI 10.1007/BF02143534; Kuroda H, 2006, J JPN SOC HORTIC SCI, V75, P91, DOI 10.2503/jjshs.75.91; Laudicina VA, 2011, BIOL FERT SOILS, V47, P63, DOI 10.1007/s00374-010-0502-8; Laudicina VA, 2009, BIOL FERT SOILS, V45, P691, DOI 10.1007/s00374-009-0380-0; Li LJ, 2010, BIOL FERT SOILS, V46, P653, DOI 10.1007/s00374-010-0463-y; [李夏 Li Xia], 2014, [水土保持通报, Bulletin of Soil and Water Conservation], V34, P202; Liu C. S., 1996, AGR CHEM ANAL; Liu FC, 2013, APPL MICROBIOL BIOT, V97, P4617, DOI 10.1007/s00253-012-4255-1; Lu R., 1999, ANAL METHODS SOIL AG, P18; Makarov MI, 2016, EURASIAN SOIL SCI+, V49, P685, DOI 10.1134/S1064229316060053; MCARTNEY SJ, 1992, NEW ZEAL J CROP HORT, V20, P383, DOI 10.1080/01140671.1992.10418054; Meng XY, 1996, FOREST MEASUREMENT, P158; Miller S. S., 2003, PGRSA Quarterly, V31, P8; Myers S. C., 1992, Acta Horticulturae, P215; RICHARDS D, 1977, ANN BOT-LONDON, V41, P729, DOI 10.1093/oxfordjournals.aob.a085347; Schupp JR, 1992, HORTICULTURAL SCI, V22, P387; Tian YL, 2013, AGROFOREST SYST, V87, P1201, DOI 10.1007/s10457-013-9630-0; Tian Y, 2008, J FOREST RES-JPN, V13, P205, DOI 10.1007/s10310-008-0073-9; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang CH, 2014, GEODERMA, V213, P419, DOI 10.1016/j.geoderma.2013.08.003; Wang GB, 2011, AGROFOREST SYST, V83, P89, DOI 10.1007/s10457-011-9399-y; Wang H, 2005, AGROFOREST SYST, V64, P131, DOI 10.1007/s10457-004-0718-4; Wang XP, 1998, PLANT SOIL, V200, P13, DOI 10.1023/A:1004240315308; Wardle DA, 1995, SOIL BIOL BIOCHEM, V27, P1601, DOI 10.1016/0038-0717(95)00093-T; WILLIAMS BL, 1988, SOIL BIOL BIOCHEM, V20, P579, DOI 10.1016/0038-0717(88)90078-8; Xue D, 2006, PLANT SOIL, V288, P319, DOI 10.1007/s11104-006-9123-2; Xue Sha, 2009, Scientia Agricultura Sinica, V42, P1458; Yang S, 2010, HORTIC SCI, V37, P14, DOI 10.17221/29/2009-HORTSCI; Yang SJ, 2011, PLANT SOIL ENVIRON, V57, P493, DOI 10.17221/38/2011-PSE; ZAK DR, 1994, ECOLOGY, V75, P2333, DOI 10.2307/1940888; Zeng ZQ, 2015, J FORESTRY RES, V26, P673, DOI 10.1007/s11676-015-0060-x; Zhang C, 2012, EUR J SOIL BIOL, V50, P127, DOI 10.1016/j.ejsobi.2012.01.002; Zhao XY, 2014, NEW FOREST, V45, P21, DOI 10.1007/s11056-013-9389-1	53	14	17	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187685	10.1371/journal.pone.0187685	http://dx.doi.org/10.1371/journal.pone.0187685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117215	Green Submitted, Green Published, gold			2022-12-26	WOS:000414659600064
J	Basmaciyan, L; Azas, N; Casanova, M				Basmaciyan, Louise; Azas, Nadine; Casanova, Magali			Calcein plus /PI- as an early apoptotic feature in Leishmania	PLOS ONE			English	Article							CELL-DEATH; DONOVANI PROMASTIGOTES; ANNEXIN-V; THERAPY; MARKERS; AM	Although leishmaniases are responsible for high morbidity and mortality all over the world, no really satisfying treatment exists. Furthermore, the corresponding parasite Leishmania undergoes a very characteristic form of programmed cell death. Indeed, different stimuli can induce morphological and biochemical apoptotic-like features. However, the key proteins involved in mammal apoptosis, such as caspases and death receptors, are not encoded in the genome of this parasite. Currently, little is known about Leishmania apoptosis, notably owing to the lack of specific tools for programmed cell death analysis in these parasites. Furthermore, there is a need for a better understanding of Leishmania programmed cell death in order (i) to better understand the role of apoptosis in unicellular organisms, (ii) to better understand apoptosis in general through the study of an ancestral eukaryote, and (iii) to identify new therapeutic targets against leishmaniases. To advance understanding of apoptosis in Leishmania, in this study we developed a new tool based on the quantification of calcein and propidium iodide by flow cytometry. This double labeling can be employed to distinguish early apoptosis, late apoptosis and necrosis in Leishmania live cells with a very simple and rapid assay. This paper should, therefore, be of interest for people working on Leishmania and related parasites.	[Basmaciyan, Louise; Azas, Nadine; Casanova, Magali] Univ Montpellier I, Aix Marseille Univ, IRBA, IP TPT, Marseille, France; [Basmaciyan, Louise] Valmis Team, UMR PAM A, Dijon, France	UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Casanova, M (corresponding author), Univ Montpellier I, Aix Marseille Univ, IRBA, IP TPT, Marseille, France.	magali.casanova@univ-amu.fr	Casanova, Magali/P-5903-2016	Casanova, Magali/0000-0002-1439-0762				Atale N, 2014, J MICROSC-OXFORD, V255, P7, DOI 10.1111/jmi.12133; Benaim G, 2011, TROP BIOMED, V28, P471; Collins JA, 1997, J HISTOCHEM CYTOCHEM, V45, P923, DOI 10.1177/002215549704500702; Das M, 2001, J CELL SCI, V114, P2461; Das R, 2008, APOPTOSIS, V13, P867, DOI 10.1007/s10495-008-0224-7; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Essodaigui M, 1999, MOL BIOCHEM PARASIT, V100, P73, DOI 10.1016/S0166-6851(99)00036-5; Gatti R, 1998, J HISTOCHEM CYTOCHEM, V46, P895, DOI 10.1177/002215549804600804; Genes CM, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.43; Jimenez-Ruiz A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-104; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Luder CGK, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-116; Moen MD, 2009, DRUGS, V69, P361, DOI 10.2165/00003495-200969030-00010; Neri S, 2001, CLIN DIAGN LAB IMMUN, V8, P1131, DOI 10.1128/CDLI.8.6.1131-1135.2001; Nguewa PA, 2005, CHEM BIODIVERS, V2, P1387, DOI 10.1002/cbdv.200590111; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Palma PFR, 2008, BRAZ J INFECT DIS, V12, P108, DOI 10.1590/S1413-86702008000200003; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Proto WR, 2013, NAT REV MICROBIOL, V11, P58, DOI 10.1038/nrmicro2929; Weingartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042070	20	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187756	10.1371/journal.pone.0187756	http://dx.doi.org/10.1371/journal.pone.0187756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112976	Green Submitted, Green Published, gold			2022-12-26	WOS:000414572100038
J	Glidden, MD; Yang, YW; Smith, NA; Phillips, NB; Carr, K; Wickramasinghe, NP; Ismail-Beigi, F; Lawrence, MC; Smith, BJ; Weiss, MA				Glidden, Michael D.; Yang, Yanwu; Smith, Nicholas A.; Phillips, Nelson B.; Carr, Kelley; Wickramasinghe, Nalinda P.; Ismail-Beigi, Faramarz; Lawrence, Michael C.; Smith, Brian J.; Weiss, Michael A.			Solution structure of an ultra-stable single-chain insulin analog connects protein dynamics to a novel mechanism of receptor binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PICHIA-PASTORIS; GROWTH-FACTOR-I; MOLECULAR-DYNAMICS; BACKBONE DYNAMICS; CONFORMATIONAL DISORDER; DISTANCE RESTRAINTS; CRYSTAL-STRUCTURES; MODEL-FREE; NMR; STABILITY	Domain-minimized insulin receptors (IRs) have enabled crystallographic analysis of insulin-bound "micro-receptors." In such structures, the C-terminal segment of the insulin B chain inserts between conserved IR domains, unmasking an invariant receptor-binding surface that spans both insulinAand B chains. This "open" conformation not only rationalizes the inactivity of single-chain insulin (SCI) analogs (in which the A and B chains are directly linked), but also suggests that connecting (C) domains of sufficient length will bind the IR. Here, we report the high-resolution solution structure and dynamics of such an active SCI. The hormone's closed-to-open transition is foreshadowed by segmental flexibility in the native state as probed by heteronuclear NMR spectroscopy and multiple conformer simulations of crystallographic protomers as described in the companion article. We propose a model of the SCI's IR-bound state based on molecular-dynamics simulations of a micro-receptor complex. In this model, a loop defined by the SCI's B and C domains encircles the C-terminal segment of the IR beta-subunit. This binding mode predicts a conformational transition between an ultra-stable closed state (in the free hormone) and an active open state (on receptor binding). Optimization of this switch within an ultra-stable SCI promises to circumvent insulin's complex global cold chain. The analog's biphasic activity, which serendipitously resembles current premixed formulations of soluble insulin and microcrystalline suspension, may be of particular utility in the developing world.	[Glidden, Michael D.; Yang, Yanwu; Phillips, Nelson B.; Carr, Kelley; Wickramasinghe, Nalinda P.; Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Glidden, Michael D.; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Smith, Nicholas A.; Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; La Trobe University; Walter & Eliza Hall Institute; University of Melbourne	Weiss, MA (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	weissma@iu.edu	Smith, Brian J/F-8282-2011; Lawrence, Michael C/A-5357-2009; Wickramasinghe, Nalinda P/F-9465-2010; Smith, Nicholas A/I-7422-2016	Smith, Brian J/0000-0003-0498-1910; Smith, Nicholas A/0000-0001-8894-4249; Wickramasinghe, Nalinda P./0000-0002-8700-2775; Lawrence, Michael/0000-0003-1999-0801	National Institutes of Health [R01 DK040949, R01 DK069764]; Australian National Health and Medical Research Council [APP1058233]; Victorian State Government Operational Infrastructure Support; Australian NHMRC Independent Research Institutes Infrastructure Support Scheme; National Computational Infrastructure (NCI); Australian Government; Australian Government Research Training Program Scholarship; Sanofi (Germany); Medical Scientist Training Program [5T32GM007250-38]; American Diabetes Association [7-13-IN-31, 1-08-RA-149];  [1F30DK104618-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK069764, F30DK104618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian NHMRC Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); National Computational Infrastructure (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian Government(Australian GovernmentCGIAR); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Sanofi (Germany)(Sanofi-Aventis); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work, a contribution of the Cleveland Center for Membrane and Structural Biology and CWRU Institute for the Science of Origins, was supported in part by National Institutes of Health Grants R01 DK040949 and R01 DK069764 (to M. A. W.), by Australian National Health and Medical Research Council Project Grant APP1058233 (to M. C. L.), Victorian State Government Operational Infrastructure Support, Australian NHMRC Independent Research Institutes Infrastructure Support Scheme, both to his institution, and by the National Computational Infrastructure (NCI), which is supported by the Australian Government. This work was also supported by an Australian Government Research Training Program Scholarship (to N. A. S.). M. A. W. has equity in Thermalin Diabetes, LLC (Cleveland, OH), where he serves as Chief Innovation Officer; he has also been a consultant to Merck Research Laboratories and DEKA Research & Development Corp. N. B. P. and F. I.-B. are consultants to Thermalin Diabetes, LLC. Part of M.C.L.'s research is funded by Sanofi (Germany). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Pre-doctoral Fellow of the National Institutes of Health supported by Medical Scientist Training Program 5T32GM007250-38 and Fellowship 1F30DK104618-01.; Supported in part by American Diabetes Association Grants 7-13-IN-31 and 1-08-RA-149.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Angyan AF, 2013, MOLECULES, V18, P10548, DOI 10.3390/molecules180910548; BADGER J, 1992, BIOPHYS J, V61, P816, DOI 10.1016/S0006-3495(92)81886-6; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Becker RHA, 2007, DIABETES TECHNOL THE, V9, P109, DOI 10.1089/dia.2006.0035; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Binder PM, 2011, EMBO REP, V12, P495, DOI 10.1038/embor.2011.83; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; BREMS DN, 1991, J BIOL CHEM, V266, P1611; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; BURLING FT, 1994, ISRAEL J CHEM, V34, P165; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cabail MZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7406; Campbell E, 2016, NAT CHEM BIOL, V12, P944, DOI [10.1038/NCHEMBIO.2175, 10.1038/nchembio.2175]; Carr K., 2017, THESIS; Charity KW, 2016, DIABETES RES CLIN PR, V112, P37, DOI 10.1016/j.diabres.2015.11.006; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; CLORE GM, 1988, EUR J BIOCHEM, V171, P479, DOI 10.1111/j.1432-1033.1988.tb13814.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; COSMATOS A, 1978, J BIOL CHEM, V253, P6586; Croll TI, 2016, STRUCTURE, V24, P469, DOI 10.1016/j.str.2015.12.014; CUTFIELD J, 1981, H-S Z PHYSIOL CHEM, V362, P755, DOI 10.1515/bchm2.1981.362.1.755; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fushman D, 2012, METHODS MOL BIOL, V831, P485, DOI 10.1007/978-1-61779-480-3_24; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Glidden MD, 2018, J BIOL CHEM, V293, P47, DOI 10.1074/jbc.M117.808626; Goddard D., 2008, SPARKY 3; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Heise T, 1998, DIABETES CARE, V21, P800, DOI 10.2337/diacare.21.5.800; Hua QX, 2008, J BIOL CHEM, V283, P14703, DOI 10.1074/jbc.M800313200; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; HUA QX, 1993, BIOCHEMISTRY-US, V32, P1433, DOI 10.1021/bi00057a006; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Kalra S, 2013, J Assoc Physicians India, V61, P9; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kjeldsen T, 1999, BIOTECHNOL APPL BIOC, V29, P79; Laajoki LG, 2000, J BIOL CHEM, V275, P10009, DOI 10.1074/jbc.275.14.10009; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; Li QX, 2014, BBA-BIOMEMBRANES, V1838, P1313, DOI 10.1016/j.bbamem.2014.01.005; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; NAKAGAWA SH, 1989, J BIOL CHEM, V264, P272; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; OHARA T, 1989, J BIOL CHEM, V264, P20625; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Pandyarajan V, 2016, J BIOL CHEM, V291, P12978, DOI 10.1074/jbc.M115.708347; Pandyarajan V, 2014, J BIOL CHEM, V289, P23367, DOI 10.1074/jbc.M114.588277; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Rask-Madsen C, 2012, ARTERIOSCL THROM VAS, V32, P2052, DOI 10.1161/ATVBAHA.111.241919; Saker F, 1998, AM J PHYSIOL-ENDOC M, V274, pE984, DOI 10.1152/ajpendo.1998.274.6.E984; Sanbonmatsu KY, 2012, CURR OPIN STRUC BIOL, V22, P168, DOI 10.1016/j.sbi.2012.01.008; Schaffer ML, 2003, BIOCHEMISTRY-US, V42, P9324, DOI 10.1021/bi034386c; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Setter SM, 2000, ANN PHARMACOTHER, V34, P1423; Shabanpoor F, 2009, VITAM HORM, V80, P1, DOI 10.1016/S0083-6729(08)00601-8; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi LX, 2017, DIABETES THER, V8, P915, DOI 10.1007/s13300-017-0286-z; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; Sohma Y, 2010, J BIOL CHEM, V285, P5040, DOI 10.1074/jbc.M109.062992; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; STEINER DF, 1967, T NEW YORK ACAD SCI, V30, P60, DOI 10.1111/j.2164-0947.1967.tb02452.x; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; Sugiki T, 2012, METHODS MOL BIOL, V831, P19, DOI 10.1007/978-1-61779-480-3_2; TORDA AE, 1990, J MOL BIOL, V214, P223, DOI 10.1016/0022-2836(90)90157-H; TORDA AE, 1989, CHEM PHYS LETT, V157, P289, DOI 10.1016/0009-2614(89)87249-5; TORRES AM, 1995, J MOL BIOL, V248, P385, DOI 10.1006/jmbi.1995.0229; Vinther TN, 2013, PROTEIN SCI, V22, P296, DOI 10.1002/pro.2211; Wang Y, 2001, BIOTECHNOL BIOENG, V73, P74, DOI 10.1002/1097-0290(20010405)73:1<74::AID-BIT1038>3.0.CO;2-V; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weiss M., 2013, J HLTH SPEC, V1, P59, DOI DOI 10.4103/1658-600X.114683; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Xu YQ, 2007, J AM CHEM SOC, V129, P7722, DOI 10.1021/ja071442e; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; Yang YW, 2010, J BIOL CHEM, V285, P7847, DOI 10.1074/jbc.C109.084921; Zaykov AN, 2016, NAT REV DRUG DISCOV, V15, P425, DOI 10.1038/nrd.2015.36; Zhang Y. Z., 1995, THESIS	100	9	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					69	88		10.1074/jbc.M117.808667	http://dx.doi.org/10.1074/jbc.M117.808667			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29114034	Green Published, hybrid			2022-12-26	WOS:000419453200005
J	Clusa, L; Miralles, L; Basanta, A; Escot, C; Garcia-Vazquez, E				Clusa, Laura; Miralles, Laura; Basanta, Ana; Escot, Carmelo; Garcia-Vazquez, Eva			eDNA for detection of five highly invasive molluscs. A case study in urban rivers from the Iberian Peninsula	PLOS ONE			English	Article							ANODONTA-WOODIANA LEA; ENVIRONMENTAL DNA; MYTILOPSIS-LEUCOPHAEATA; CORBICULA-FLUMINEA; SPECIES RICHNESS; AQUARIUM TRADE; 1834 BIVALVIA; POPULATION; MUSSEL; INVERTEBRATES	Biological invasions are an important threat to biodiversity especially in aquatic ecosystems, and their frequency is generally higher near urban areas. Potentially invasive non-indigenous molluscs were deliberately introduced into European waters for food (Corbicula fluminea) and biocontrol (Melanoides tuberculata), and unintentionally introduced by ballast water (Mytilopsis leucophaeata, Corbicula fluminea), stock contamination (Sinanodonta woodiana), accidental escapes from aquaculture (Sinanodonta woodiana), aquarium trade releases (Melanoides tuberculata) and even attached to aquatic birds (Corbicula fluminea). Three rivers from the Iberian Peninsula were monitored near the three most populated inland cities to evaluate the presence of these invasive molluscs through PCR amplification using taxon-specific primers from eDNA. New primers were designed within 16S rRNA and cytochrome oxidase subunit I genes, tested in silico from BLAST methodology and experimentally in vitro before application in the field. C. fluminea was found in Ebro River (near Zaragoza); M. leucophaeata in Guadalquivir River (near Sevilla). M. tuberculata and S. woodiana were found from enclosed areas (lake and reservoir respectively) upstream, respectively, Zaragoza and Madrid. The new tools are ready to be used in other regions where these species are also invasive.	[Clusa, Laura; Miralles, Laura; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, Oviedo, Asturias, Spain; [Basanta, Ana; Escot, Carmelo] Metropolitan Water Supply & Sanitat Co Sevilla, EMASESA, Seville, Spain	University of Oviedo	Clusa, L (corresponding author), Univ Oviedo, Dept Funct Biol, Oviedo, Asturias, Spain.	lauraclusa@gmail.com	Garcia-Vazquez, Eva/Y-7293-2019; Escot, Carmelo/ABH-8609-2020	Escot, Carmelo/0000-0002-5589-0579; Clusa, Laura/0000-0002-3503-2331; Garcia-Vazquez, Eva/0000-0002-8429-838X; Miralles, Laura/0000-0002-7146-9776	PCTI Grant from the Asturias Regional Government [BP14-145]; Ministerio de Economia y Competitividad [MINECO-13-CGL2013-42415-R]; Asturias Regional Grant [GRUPIN-2014-093]; European Commission: EU RIA [689682-AMBER]	PCTI Grant from the Asturias Regional Government; Ministerio de Economia y Competitividad(Spanish Government); Asturias Regional Grant; European Commission: EU RIA	This work was supported by PCTI Grant from the Asturias Regional Government, referenced BP14-145: LC; Ministerio de Economia y Competitividad: MINECO-13-CGL2013-42415-R; Asturias Regional Grant: GRUPIN-2014-093; and European Commission: EU RIA Contract 689682 -AMBER.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ardura A, 2017, AQUAT CONSERV, V27, P165, DOI 10.1002/aqc.2655; Ardura A, 2015, MAR ENVIRON RES, V112, P48, DOI 10.1016/j.marenvres.2015.09.013; Beasley Colin Robert, 2003, Acta Amazonica, V33, P317; Bellard C, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1241; Bodis E, 2014, LIMNOLOGICA, V49, P1, DOI 10.1016/j.limno.2014.07.002; Boltovskoy D, 2006, BIOL INVASIONS, V8, P947, DOI 10.1007/s10530-005-5107-z; Callil CT, 2002, AMAZONIANA, V17, P153; Cambray JA, 2003, HYDROBIOLOGIA, V500, P217, DOI 10.1023/A:1024648719995; Cianfanelli Simone, 2007, V2, P103, DOI 10.1007/978-1-4020-6029-8_5; Clusa L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162899; COHEN RRH, 1984, LIMNOL OCEANOGR, V29, P170, DOI 10.4319/lo.1984.29.1.0170; de Souza LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165273; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Devloo-Delva F, 2016, MAR POLLUT BULL, V105, P23, DOI 10.1016/j.marpolbul.2016.03.008; Dostine PL, 2013, WILDLIFE RES, V40, P393, DOI 10.1071/WR13057; Douda K, 2012, BIOL INVASIONS, V14, P127, DOI 10.1007/s10530-011-9989-7; Duggan IC, 2010, BIOL INVASIONS, V12, P3757, DOI 10.1007/s10530-010-9768-x; Duggan IC, 2002, NEW ZEAL J MAR FRESH, V36, P825, DOI 10.1080/00288330.2002.9517135; Escot C., 2003, Graellsia, V59, P91; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Florin Ann-Britt, 2013, BioInvasions Records, V2, P303, DOI 10.3391/bir.2013.2.4.07; Franch N, 2008, BIOL INVASIONS, V10, P1327, DOI 10.1007/s10530-007-9207-9; Fuller PL, 2015, 5 VECTORS INVASIONS, P88; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Graells MdlP, 1846, CATALOGO MOLUSCOS TE; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Havel JE, 2015, HYDROBIOLOGIA, V750, P147, DOI 10.1007/s10750-014-2166-0; Holopainen R, 2016, BIOL INVASIONS, V18, P3015, DOI 10.1007/s10530-016-1197-z; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kennedy VS, 2011, AQUAT ECOL, V45, P163, DOI 10.1007/s10452-010-9344-6; Kraszewski Andrzej, 2007, Folia Malacologica, V15, P65; Laamrani H, 1997, J FRESHWATER ECOL, V12, P75, DOI 10.1080/02705060.1997.9663510; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Laine Ari O., 2006, Aquatic Invasions, V1, P38; Lewis JS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44152; LUDYANSKIY ML, 1993, BIOSCIENCE, V43, P533, DOI 10.2307/1311948; Maceda-Veiga A, 2013, BIOL INVASIONS, V15, P2707, DOI 10.1007/s10530-013-0485-0; MADSEN H, 1989, ACTA TROP, V46, P139, DOI 10.1016/0001-706X(89)90030-2; Martinez-Orti A, 2011, IUCN RED LIST THREAT; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Nislow KH, 2011, FRESHWATER BIOL, V56, P2135, DOI 10.1111/j.1365-2427.2011.02634.x; Oliveira P, 2015, ESTUAR COAST SHELF S, V167, P191, DOI 10.1016/j.ecss.2015.06.014; Oliver PG, 1998, J CONCHOL, V36, P13; Oscoz J, 2010, AQUAT INVASIONS, V5, P263, DOI 10.3391/ai.2010.5.3.04; Pointier JP, 2000, ACTA TROP, V77, P53, DOI 10.1016/S0001-706X(00)00123-6; Pou-Rovira Q., 2009, Graellsia, V65, P67; Prie V., 2010, IUCN RED LIST THREAT, V2010, DOI DOI 10.2305/IUCN.UK.2010-4.RLTS.T12798A3381899.EN; Quinonero-Salgado S, 2010, SPIRA, V3, P141; Reyna PB, 2013, IHERINGIA SER ZOOL, V103, P77, DOI 10.1590/S0073-47212013000200001; Soler J., 2006, Graellsia, V62, P201; Sousa R, 2008, ESTUAR COAST SHELF S, V80, P289, DOI 10.1016/j.ecss.2008.08.006; Sousa R, 2014, HYDROBIOLOGIA, V735, P233, DOI 10.1007/s10750-012-1409-1; Spear D, 2013, BIOL CONSERV, V159, P137, DOI 10.1016/j.biocon.2012.11.022; Spyra A, 2012, INT REV HYDROBIOL, V97, P12, DOI 10.1002/iroh.201111425; Stoeckle BC, 2016, AQUAT CONSERV, V26, P1120, DOI 10.1002/aqc.2611; Strayer DL, 2010, FRESHWATER BIOL, V55, P152, DOI 10.1111/j.1365-2427.2009.02380.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Vaughn CC, 2001, FRESHWATER BIOL, V46, P1431, DOI 10.1046/j.1365-2427.2001.00771.x; Verween A, 2006, BIOFOULING, V22, P221, DOI 10.1080/08927010600816401; Watters GT, 1997, VELIGER, V40, P152; Zimmermann Heike, 2014, F1000Res, V3, P109, DOI 10.12688/f1000research.3740.2	66	26	27	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188126	10.1371/journal.pone.0188126	http://dx.doi.org/10.1371/journal.pone.0188126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141037	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400060
J	Ganse, B; Pishnamaz, M; Kobbe, P; Herren, C; Gradl-Dietsch, G; Bohle, F; Johannes, B; Kim, BS; Horst, K; Knobe, M				Ganse, Bergita; Pishnamaz, Miguel; Kobbe, Philipp; Herren, Christian; Gradl-Dietsch, Gertraud; Boehle, Franziska; Johannes, Bernd; Kim, Bong-Sung; Horst, Klemens; Knobe, Matthias			Microcirculation in open vs. minimally invasive dorsal stabilization of thoracolumbar fractures	PLOS ONE			English	Article								Standard open and percutaneous minimally invasive surgical procedures co-exist in the treatment of fractures of the thoracolumbar spine. Shorter skin incisions just above the pedicles are used in minimally invasive procedures. Full-length skin incisions and invasive preparations are applied in the standard open approach. While both methods show equivalent rates of intraoperative surgical complications and comparable clinical and radiological outcomes, blood loss and operation time have shown to be decreased in minimally invasive treatment. However, no study so far has investigated differences in microcirculation. This study hypothesized less impairment of microcirculation in the minimally invasive approach compared to the open approach and an improvement of microcirculation over time. A prospective cohort study was conducted using non-invasive laser-Doppler spectrophotometry (an O2C "oxygen to see" device) for measurement of cutaneous and subcutaneous blood oxygenation (SO2), haemoglobin concentration (Hb), and blood flow at depths of 2, 8, and 15 mm at six locations on the skin. Measurements were performed before surgery, 8 and 24 h after surgery, and 2, 4, 7, 12 and 20 days after surgery, however the number of patients measured decreased towards the later time points. Forty patients were included in the study, 20 with each approach (18 females and 22 males). Pair-wise comparison of the types of surgical procedure for each measurement point revealed a significantly higher flow value in the minimally invasive group at one of the measurement points located between the incisions (P = .041). The point-wise analyses of SO2 and Hb did not show significant differences between the approaches. In conclusion, significantly albeit moderately higher flow values could be found in minimally invasive procedures compared to open operations of thoracolumbar fractures in the area of skin that is spared by the incisions.	[Ganse, Bergita; Pishnamaz, Miguel; Kobbe, Philipp; Herren, Christian; Gradl-Dietsch, Gertraud; Boehle, Franziska; Horst, Klemens; Knobe, Matthias] RWTH Aachen Univ Hosp, Dept Orthopaed Trauma, Aachen, Germany; [Gradl-Dietsch, Gertraud] Univ Duisburg Essen, LVR Hosp Essen, Essen, Germany; [Johannes, Bernd] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Kim, Bong-Sung] RWTH Aachen Univ Hosp, Dept Plast & Reconstruct Surg, Hand Surg Burn Ctr, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Duisburg Essen; Helmholtz Association; German Aerospace Centre (DLR); RWTH Aachen University; RWTH Aachen University Hospital	Knobe, M (corresponding author), RWTH Aachen Univ Hosp, Dept Orthopaed Trauma, Aachen, Germany.	mknobe@ukaachen.de	Kim, Bong-Sung/AAR-3802-2021; Knobe, Matthias/Y-3537-2019; Gradl-Dietsch, Gertraud/R-1872-2018	Knobe, Matthias/0000-0002-9166-0965; Gradl-Dietsch, Gertraud/0000-0003-3577-0227; Kim, Bong-Sung/0000-0002-0493-3196; Ganse, Bergita/0000-0002-9512-2910				Beckert S, 2004, DIABETES CARE, V27, P2863, DOI 10.2337/diacare.27.12.2863; Bentov I, 2014, ANESTHESIOLOGY, V120, P760, DOI 10.1097/ALN.0000000000000036; Djurasovic Mladen, 2016, Am J Orthop (Belle Mead NJ), V45, pE77; Farouk O, 1999, J ORTHOP TRAUMA, V13, P401, DOI 10.1097/00005131-199908000-00002; Forst Thomas, 2008, J Diabetes Sci Technol, V2, P1151; Ganse B, 2017, INT ORTHOP; Gerometta A, 2012, INT ORTHOP, V36, P457, DOI 10.1007/s00264-011-1426-0; Grossbach AJ, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.6.FOCUS13176; Langer S, 2004, Handchir Mikrochir Plast Chir, V36, P197, DOI 10.1055/s-2004-821240; Lee KH, 2012, EUR SPINE J, V21, P2265, DOI 10.1007/s00586-012-2281-4; Lindenblatt N, 2008, PLAST RECONSTR SURG, V122, P1669, DOI 10.1097/PRS.0b013e31818cbeb1; Pishnamaz M, 2015, ACTA CHIR ORTHOP TR, V82, P274; Saklad M., 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004; Sedney CL, 2016, INT J SPINE SURG, V10, DOI 10.14444/3023; Sommer B, 2013, J SPORT SCI MED, V12, P414; Sun XY, 2016, EUR SPINE J; ter Gunne AFP, 2010, SPINE, V35, P1323, DOI 10.1097/BRS.0b013e3181bcde61	17	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188115	10.1371/journal.pone.0188115	http://dx.doi.org/10.1371/journal.pone.0188115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141048	gold, Green Published, Green Submitted			2022-12-26	WOS:000415260400058
J	Kim, HT; Chase, MW				Kim, Hyoung Tae; Chase, Mark W.			Independent degradation in genes of the plastid ndh gene family in species of the orchid genus Cymbidium (Orchidaceae; Epidendroideae)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CHLOROPLAST GENOME SEQUENCE; DEHYDROGENASE-LIKE COMPLEX; CYCLIC ELECTRON FLOW; PHOTOSYSTEM-I; EVOLUTION; REDUCTION; PLANT; DNA; ORGANIZATION	In this paper, we compare ndh genes in the plastid genome of many Cymbidium species and three closely related taxa in Orchidaceae looking for evidence of ndh gene degradation. Among the 11 ndh genes, there were frequently large deletions in directly repeated or AT-rich regions. Variation in these degraded ndh genes occurs between individual plants, apparently at population levels in these Cymbidium species. It is likely that ndh gene transfers from the plastome to mitochondrial genome (chondriome) occurred independently in Orchidaceae and that ndh genes in the chondriome were also relatively recently transferred between distantly related species in Orchidaceae. Four variants of the ycf1-rpl32 region, which normally includes the ndhF genes in the plastome, were identified, and some Cymbidium species contained at least two copies of that region in their organellar genomes. The four ycf1-rpl32 variants seem to have a clear pattern of close relationships. Patterns of ndh degradation between closely related taxa and translocation of ndh genes to the chondriome in Cymbidium suggest that there have been multiple bidirectional intracellular gene transfers between two organellar genomes, which have produced different levels of ndh gene degradation among even closely related species.	[Kim, Hyoung Tae] Kyungpook Univ, Coll Agr & Life Sci, Daegu, South Korea; [Chase, Mark W.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England	Kyungpook National University; Royal Botanic Gardens, Kew	Chase, MW (corresponding author), Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England.	m.chase@kew.org		Kim, Hyoung Tae/0000-0003-1823-4369; HyoungTae, Kim/0000-0002-2482-6064	National Research Foundation of Korea (NRF) - Ministry of Education [2015R1A6A3A03020621]	National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1A6A3A03020621).; This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1A6A3A03020621).	ALDRICH J, 1988, CURR GENET, V14, P137, DOI 10.1007/BF00569337; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Barrett CF, 2014, MOL BIOL EVOL, V31, P3095, DOI 10.1093/molbev/msu252; Barrett CF, 2012, AM J BOT, V99, P1513, DOI 10.3732/ajb.1200256; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Cai J, 2015, NAT GENET, V47, P65, DOI 10.1038/ng.3149; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chase MW, 2015, BOT J LINN SOC, V177, P151, DOI 10.1111/boj.12234; Blazier J, 2011, PLANT MOL BIOL, V76, P263, DOI 10.1007/s11103-011-9753-5; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; DEPAMPHILIS CW, 1990, NATURE, V348, P337, DOI 10.1038/348337a0; Doyle J. J., 1987, PHYTOCHEM B, P11; Du Puy D., 1988, THE GENUS CYMBIDIUM; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; Forrest LL, 2011, PLANT ECOL EVOL, V144, P29, DOI 10.5091/plecevo.2011.535; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Gao L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-130; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; HABERHAUSEN G, 1994, PLANT MOL BIOL, V24, P217, DOI 10.1007/BF00040588; Jheng CF, 2012, PLANT SCI, V190, P62, DOI 10.1016/j.plantsci.2012.04.001; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142215; Kim HT, 2014, MOL CELLS, V37, P372, DOI 10.14348/molcells.2014.2296; Kim JS, 2015, PLANT MOL BIOL REP, V33, P1210, DOI 10.1007/s11105-014-0833-y; Kim KA, 2016, MITOCHONDRIAL DNA A, V27, P2963, DOI [10.3109/19401736.2015.1063121, 10.3109/19401736.2015.1060461]; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058747; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Lin CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09040; Logacheva MD, 2014, GENOME BIOL EVOL, V6, P238, DOI 10.1093/gbe/evu001; Logacheva MD, 2011, GENOME BIOL EVOL, V3, P1296, DOI 10.1093/gbe/evr102; Luo JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108185; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; Mccoy SR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-130; McNeal JR, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-57; Miller M.A., 2010, P GAT COMP ENV WORKS; Muller AE, 1999, J MOL BIOL, V291, P29, DOI 10.1006/jmbi.1999.2957; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Neyland R, 1996, PLANTA, V200, P273, DOI 10.1007/BF00208318; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Pan IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034738; Park S, 2015, NEW PHYTOL, V208, P570, DOI 10.1111/nph.13467; Peredo EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068591; Rodriguez-Moreno L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-424; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruhlman TA, 2014, METHODS MOL BIOL, V1132, P3, DOI 10.1007/978-1-62703-995-6_1; Sanderson MJ, 2015, AM J BOT, V102, P1115, DOI 10.3732/ajb.1500184; Sazanov LA, 1998, P NATL ACAD SCI USA, V95, P1319, DOI 10.1073/pnas.95.3.1319; Schelkunov MI, 2015, GENOME BIOL EVOL, V7, P1179, DOI 10.1093/gbe/evv019; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Ueda M, 2012, PLANT J, V72, P683, DOI 10.1111/j.1365-313X.2012.05115.x; van den Berg Cassio, 2002, Lindleyana, V17, P102; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Wang D, 2007, MOL BIOL EVOL, V24, P2040, DOI 10.1093/molbev/msm133; Wang S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074141, 10.1371/journal.pone.0073946]; Weng ML, 2014, MOL BIOL EVOL, V31, P645, DOI 10.1093/molbev/mst257; Wicke S, 2013, PLANT CELL, V25, P3711, DOI 10.1105/tpc.113.113373; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; Wolf PG, 2003, DNA RES, V10, P59, DOI 10.1093/dnares/10.2.59; WOLFE KH, 1992, J MOL EVOL, V35, P304, DOI 10.1007/BF00161168; Wu CS, 2011, GENOME BIOL EVOL, V3, P309, DOI 10.1093/gbe/evr026; Wu CS, 2009, MOL PHYLOGENET EVOL, V52, P115, DOI 10.1016/j.ympev.2008.12.026; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037128; Yamori W, 2015, SCI REP-UK, V5, DOI 10.1038/srep13908; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Yang P, 2016, MITOCHONDRIAL DNA A, V27, P1262, DOI 10.3109/19401736.2014.945547; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yukawa Tomohisa, 2002, Bulletin of the National Science Museum Series B (Botany), V28, P129	80	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187318	10.1371/journal.pone.0187318	http://dx.doi.org/10.1371/journal.pone.0187318			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140976	Green Submitted, gold, Green Published			2022-12-26	WOS:000415260400021
J	Pourier, VEC; van Laarhoven, CJHCM; Vergouwen, MDI; Rinkel, GJE; de Borst, GJ				Pourier, V. E. C.; van Laarhoven, C. J. H. C. M.; Vergouwen, M. D. I.; Rinkel, G. J. E.; de Borst, Gert J.			Prevalence of extracranial carotid artery aneurysms in patients with an intracranial aneurysm	PLOS ONE			English	Article								Background and purpose Aneurysms in various arterial beds have common risk-and genetic factors. Data on the correlation of extracranial carotid artery aneurysms (ECAA) with aneurysms in other vascular territories are lacking. We aimed to investigate the prevalence of ECAA in patients with an intracranial aneurysm (IA). Methods We used prospectively collected databases of consecutive patients registered at the University Medical Center Utrecht with an unruptured intracranial aneurysm (UIA) or aneurysmal Subarachnoid hemorrhage (SAH). The medical files of patients included in both databases were screened for availability of radiological reports, imaging of the brain and of the cervical carotid arteries. All available radiological images were then reviewed primarily for the presence of an ECAA and secondarily for an extradural/cavernous carotid or vertebral artery aneurysm. An ECAA was defined as a fusiform dilation >= 150% of the normal internal or common carotid artery or a saccular distention of any size. Results We screened 4465 patient records (SAH database n = 3416, UIA database n = 1049), of which 2931 had radiological images of the carotid arteries available. An ECAA was identified in 12/638 patients (1.9%; 95% CI 1.1-3.3) with completely imaged carotid arteries and in 15/2293 patients (0.7%; 95% CI 0.4-1.1) with partially depicted carotid arteries. Seven out of 27 patients had an additional extradural (cavernous or vertebral artery) aneurysm. Conclusions This comprehensive study suggests a prevalence for ECAA of approximately 2% of patients with an IA. The rarity of the disease makes screening unnecessary so far. Future registry studies should study the factors associated with IA and ECAA to estimate the prevalence of ECAA in these young patients more accurately.	[Pourier, V. E. C.; van Laarhoven, C. J. H. C. M.; de Borst, Gert J.] Univ Med Ctr Utrecht, Dept Vasc Surg, Heidelberglaan, Utrecht, Netherlands; [Vergouwen, M. D. I.; Rinkel, G. J. E.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Heidelberglaan, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Borst, GJ (corresponding author), Univ Med Ctr Utrecht, Dept Vasc Surg, Heidelberglaan, Utrecht, Netherlands.	g.j.deborst-2@umcutrecht.nl		Pourier, Vanessa/0000-0003-4766-8289				Attigah N, 2009, EUR J VASC ENDOVASC, V37, P127, DOI 10.1016/j.ejvs.2008.10.020; Barlinn K, 2011, NEUROTHERAPEUTICS, V8, P340, DOI 10.1007/s13311-011-0042-4; De Borst GJ, 2016, OXFORD TXB VASCULAR, P462; de Jong K P, 1989, Eur J Vasc Surg, V3, P557, DOI 10.1016/S0950-821X(89)80132-X; Donas KP, 2009, J VASC SURG, V49, P93, DOI 10.1016/j.jvs.2008.08.006; Norman PE, 2010, CIRCULATION, V121, P560, DOI 10.1161/CIRCULATIONAHA.109.880724; Pourier VEC, 2015, J CARDIOVASC SURG TO; Ruigrok YM, 2008, CARDIOVASC PATHOL, V17, P40, DOI 10.1016/j.carpath.2007.06.001; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; van't Hof FNG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002603; Welleweerd JC, 2015, EUR J VASC ENDOVASC, V50, P141, DOI 10.1016/j.ejvs.2015.05.002; Welleweerd JC, 2015, EUR J VASC ENDOVASC, V49, P235, DOI 10.1016/j.ejvs.2014.11.007; Welleweerd JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117915; Welleweerd JC, 2015, J CARDIOVASC SURG TO	15	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187479	10.1371/journal.pone.0187479	http://dx.doi.org/10.1371/journal.pone.0187479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131823	Green Published, Green Submitted, gold			2022-12-26	WOS:000414997800013
J	Cheng, YH; Eby, JM; LaPorte, HM; Volkman, BF; Majetschak, M				Cheng, You-Hong; Eby, Jonathan M.; LaPorte, Heather M.; Volkman, Brian F.; Majetschak, Matthias			Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; MOTIF RECEPTOR 4; PROTEASE-ACTIVATED RECEPTORS; TRAUMATIC BRAIN-INJURY; RECRUITS BETA-ARRESTIN; FACTOR-I; EXOGENOUS UBIQUITIN; CXCL12; THROMBIN; FACTOR-1-ALPHA	Recent evidence suggests that chemokine CXCL12, the cognate agonist of chemokine receptors CXCR4 and ACKR3, reduces thrombin-mediated impairment of endothelial barrier function. A detailed characterization of the effects of CXCL12 on thrombin-mediated human lung endothelial hyperpermeability is lacking and structure-function correlations are not available. Furthermore, effects of other CXCR4/ACKR3 ligands on lung endothelial barrier function are unknown. Thus, we tested the effects of a panel of CXCR4/ACKR3 ligands (CXCL12, CXCL11, ubiquitin, AMD3100, TC14012) and compared the CXCR4/ACKR3 activities of CXCL12 variants (CXCL12 alpha/beta, CXCL12(3-68), CXCL121, CXCL122, CXCL12S-S4V, CXCL12-R47E, CXCL12-K27A/R41A/R47A) with their effects on human lung endothelial barrier function in permeability assays. CXCL12 alpha enhanced human primary pulmonary artery endothelial cell (hPPAEC) barrier function, whereas CXCL11, ubiquitin, AMD3100 and TC14012 were ineffective. Pre-treatment of hPPAEC with CXCL12 alpha and ubiquitin reduced thrombin-mediated hyperpermeability. CXCL12 alpha-treatment of hPPAEC after thrombin exposure reduced barrier function impairment by 70% (EC50 0.05-0.5 mu M), which could be antagonized with AMD3100; ubiquitin (0.03-3 mu M) was ineffective. In a human lung microvascular endothelial cell line (HULEC5 alpha), CXCL12 alpha and ubiquitin posttreatment attenuated thrombin-induced hyperpermeability to a similar degree. CXCL12(3- 68) was inefficient to activate CXCR4 in Presto-Tango beta-arrestin2 recruitment assays; CXCL12-S-S4V, CXCL12-R47E and CXCL12-K27A/R41A/R47A showed significantly reduced potencies to activate CXCR4. While the potencies of all proteins in ACKR3 PrestoTango assays were comparable, the efficacy of CXCL12(3-68) to activate ACKR3 was significantly reduced. The potencies to attenuate thrombin-mediated hPPAEC barrier function impairment were: CXCL12 alpha/beta, CXCL121, CXCL12-K27A/R41A/R47A > CXCL12-S-S4V, CXCL12-R47E > CXCL122 > CXCL12(3-68). Our findings indicate that CXCR4 activation attenuates thrombin-induced lung endothelial barrier function impairment and suggest that protective effects of CXCL12 are dictated by its CXCR4 agonist activity and interactions of distinct protein moieties with heparan sulfate on the endothelial surface. These data may facilitate development of compounds with improved pharmacological properties to attenuate thrombin-induced vascular leakage in the pulmonary circulation.	[Cheng, You-Hong; Eby, Jonathan M.; LaPorte, Heather M.; Majetschak, Matthias] Loyola Univ Chicago, Stritch Sch Med, Dept Surg, Burn & Shock Trauma Res Inst, Maywood, IL 60153 USA; [Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Majetschak, Matthias] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA	Loyola University Chicago; Medical College of Wisconsin; Loyola University Chicago	Majetschak, M (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Surg, Burn & Shock Trauma Res Inst, Maywood, IL 60153 USA.; Majetschak, M (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA.	mmajetschak@luc.edu	Volkman, Brian F./ABE-7306-2020; Volkman, Brian F./ABE-7312-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Eby, Jonathan/0000-0002-0691-4044	Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program [W81XWH-15-1-0262]; National Institute of General Medical Sciences [R01GM107495]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058072, R37AI058072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107495] Funding Source: NIH RePORTER	Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program under Award No. W81XWH-15-1-0262 and by the National Institute of General Medical Sciences (Awards R01GM107495). The content is solely the responsibility of the authors. The authors declare that they have no conflict of interest.	Albee LJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006575; Alberelli MA, 2014, VASC PHARMACOL, V62, P72, DOI 10.1016/j.vph.2014.06.001; Arachiche A, 2013, J BIOL CHEM, V288, P32553, DOI 10.1074/jbc.M113.472373; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Baker TA, 2012, CRIT CARE MED, V40, P2376, DOI 10.1097/CCM.0b013e3182514ed9; Blank R, 2011, CRIT CARE CLIN, V27, P439, DOI 10.1016/j.ccc.2011.05.005; Chen TJ, 2016, CLIN CHIM ACTA, V454, P6, DOI 10.1016/j.cca.2015.12.033; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Dushianthan A, 2011, POSTGRAD MED J, V87, P612, DOI 10.1136/pgmj.2011.118398; Earle SA, 2005, SURGERY, V138, P431, DOI 10.1016/j.surg.2005.06.026; Eby JM, 2017, MOL CELL BIOCHEM, V434, P143, DOI 10.1007/s11010-017-3044-7; Ethier MF, 1996, AM J PHYSIOL-LUNG C, V270, pL199, DOI 10.1152/ajplung.1996.270.2.L199; Evans AE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060971; Franchini S, 2015, AM J EMERG MED, V33, P1802, DOI 10.1016/j.ajem.2015.08.047; Garcia-Covarrubias L, 2008, CRIT CARE MED, V36, P979, DOI 10.1097/CCM.0B013E318164E417; Gifford AN, 1999, J PHARMACOL EXP THER, V288, P478; Gonzales J.N., 2015, AUSTIN J VASC MED, V2; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Guo C.X., 2015, ECAM, V2015, P1, DOI DOI 10.2119/M0LMED.2015.00240; Guo WX, 2014, BIOCHEM BIOPH RES CO, V452, P191, DOI 10.1016/j.bbrc.2014.07.033; Gur-Cohen S, 2016, ANN NY ACAD SCI, V1370, P65, DOI 10.1111/nyas.13013; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Janssens R, 2017, BIOCHEM PHARMACOL, V132, P92, DOI 10.1016/j.bcp.2017.03.009; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kobayashi K, 2014, ARTERIOSCL THROM VAS, V34, P1716, DOI 10.1161/ATVBAHA.114.303890; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; Mihara K, 2016, MOL PHARMACOL, V89, P606, DOI 10.1124/mol.115.102723; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Nassoiy SP, 2017, CLIN EXP PHARM PHYSL; Proost P, 1998, FEBS LETT, V432, P73, DOI 10.1016/S0014-5793(98)00830-8; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Saini V, 2011, J BIOL CHEM, V286, P44145, DOI 10.1074/jbc.M111.298505; Saini V, 2011, J BIOL CHEM, V286, P33466, DOI 10.1074/jbc.M111.233742; Saini Vikas, 2010, Commun Integr Biol, V3, P608, DOI 10.4161/cib.3.6.13375; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Tripathi A, 2015, NAUNYN SCHMIEDEBERGS; Tripathi A, 2015, P NATL ACAD SCI USA, V112, pE1659, DOI 10.1073/pnas.1417564112; Tripathi A, 2013, BIOCHEMISTRY-US, V52, P4184, DOI 10.1021/bi400254f; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2016, METHOD ENZYMOL, V570, P539, DOI 10.1016/bs.mie.2015.09.031; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Verkaar F, 2014, J IMMUNOL, V192, P3908, DOI 10.4049/jimmunol.1302159; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; Zhang P, 2012, CIRCULATION, V126, P83, DOI 10.1161/CIRCULATIONAHA.112.091918; Ziarek JJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah5756; Ziarek JJ, 2013, ACS CHEM BIOL, V8, P1955, DOI 10.1021/cb400274z; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064	59	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187949	10.1371/journal.pone.0187949	http://dx.doi.org/10.1371/journal.pone.0187949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125867	gold, Green Published, Green Submitted			2022-12-26	WOS:000414866000031
J	Li, JH; Evans, JD; Li, WF; Zhao, YZ; DeGrandi-Hoffman, G; Huang, SK; Li, ZG; Hamilton, M; Chen, YP				Li, Jiang Hong; Evans, Jay D.; Li, Wen Feng; Zhao, Ya Zhou; DeGrandi-Hoffman, Gloria; Huang, Shao Kang; Li, Zhi Guo; Hamilton, Michele; Chen, Yan Ping			New evidence showing that the destruction of gut bacteria by antibiotic treatment could increase the honey bee's vulnerability to Nosema infection	PLOS ONE			English	Article							APIS-MELLIFERA; MICROBIAL COMMUNITIES; PAENIBACILLUS-LARVAE; HOST IMMUNITY; BUMBLE BEES; EARLY-LIFE; PATHOGEN; CERANAE; DIVERSITY; PARASITE	It has become increasingly clear that gut bacteria play vital roles in the development, nutrition, immunity, and overall fitness of their eukaryotic hosts. We conducted the present study to investigate the effects of gut microbiota disruption on the honey bee's immune responses to infection by the microsporidian parasite Nosema ceranae. Newly emerged adult workers were collected and divided into four groups: Group I-no treatment; Group II-inoculated with N. ceranae, Group III-antibiotic treatment, and Group IV-antibiotic treatment after inoculation with N. ceranae. Our study showed that Nosema infection did not cause obvious disruption of the gut bacterial community as there was no significant difference in the density and composition of gut bacteria between Group I and Group II. However, the elimination of gut bacteria by antibiotic (Groups III and IV) negatively impacted the functioning of the honey bees' immune system as evidenced by the expression of genes encoding antimicrobial peptides abaecin, defensin1, and hymenoptaecin that showed the following ranking: Group I > Group II > Group III > Group IV. In addition, significantly higher Nosema levels were observed in Group IV than in Group II, suggesting that eliminating gut bacteria weakened immune function and made honey bees more susceptible to Nosema infection. Based on Group IV having displayed the highest mortality rate among the four experimental groups indicates that antibiotic treatment in combination with stress, associated with Nosema infection, significantly and negatively impacts honey bee survival. The present study adds new evidence that antibiotic treatment not only leads to the complex problem of antibiotic resistance but can impact honey bee disease resistance. Further studies aimed at specific components of the gut bacterial community will provide new insights into the roles of specific bacteria and possibly new approaches to improving bee health.	[Li, Jiang Hong; Evans, Jay D.; Li, Wen Feng; Hamilton, Michele; Chen, Yan Ping] USDA ARS, Bee Res Lab, Beltsville, MD 20705 USA; [Li, Jiang Hong; Huang, Shao Kang; Li, Zhi Guo] Fujian Agr & Forestry Univ, Coll Bee Sci, Fuzhou, Fujian, Peoples R China; [Zhao, Ya Zhou] Chinese Acad Agr Sci, Inst Apicultural Res, Beijing, Peoples R China; [DeGrandi-Hoffman, Gloria] USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ USA	United States Department of Agriculture (USDA); Fujian Agriculture & Forestry University; Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; United States Department of Agriculture (USDA)	Chen, YP (corresponding author), USDA ARS, Bee Res Lab, Beltsville, MD 20705 USA.	judy.chen@ars.usda.gov	Evans, Jay/C-8408-2012	Evans, Jay/0000-0002-0036-4651; LI, WENFENG/0000-0001-8819-6009	Fujian Agriculture & Forestry University; Educational Department of Fujian Province, China; USDA-CAP grant [2014-67013-21784]	Fujian Agriculture & Forestry University; Educational Department of Fujian Province, China; USDA-CAP grant	The authors gratefully acknowledge financial support from Fujian Agriculture & Forestry University and the Educational Department of Fujian Province, China. This research was supported in part by the USDA-CAP grant (2014-67013-21784).	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alberoni D, 2016, APPL MICROBIOL BIOT, V100, P9469, DOI 10.1007/s00253-016-7870-4; Alippi AM, 2005, VET MICROBIOL, V109, P47, DOI 10.1016/j.vetmic.2005.03.008; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Baffoni L, 2016, BENEF MICROBES, V7, P45, DOI 10.3920/BM2015.0085; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Cantwell GE, STANDARD METHODS COU; Cariveau DP, 2014, ISME J, V8, P2369, DOI 10.1038/ismej.2014.68; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Engel P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004596; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Engel P, 2013, GUT MICROBES, V4, P60, DOI 10.4161/gmic.22517; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Evans JD, 2009, J APICULT RES, V48, P300, DOI 10.3896/IBRA.1.48.4.13; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Fries I., 2013, J APICULT RES, V52, P1, DOI [10.3896/ IBRA. 1.52.1.14, DOI 10.3896/IBRA.1.52.1.14]; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Glittenberg MT, 2011, DIS MODEL MECH, V4, P515, DOI 10.1242/dmm.006627; Hamilton PT, 2014, MOL ECOL, V23, P1558, DOI 10.1111/mec.12603; Hansen CHF, 2013, GUT MICROBES, V4, P241, DOI 10.4161/gmic.23999; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Holden C, 2006, SCIENCE, V314, P397, DOI 10.1126/science.314.5798.397; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hroncova Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118707; Huang WF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003185; KATZNELSON H, 1950, J BACTERIOL, V59, P471, DOI 10.1128/JB.59.4.471-479.1950; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Koch H, 2012, ECOL LETT, V15, P1095, DOI 10.1111/j.1461-0248.2012.01831.x; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kuraishi T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00375; Kwong WK, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170003; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Lee WJ, 2009, GENE DEV, V23, P2260, DOI 10.1101/gad.1858709; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li W, 2016, APPL ENVIRON MICROB, V82, P6779, DOI 10.1128/AEM.02105-16; MacDonald TT, 2000, INFLAMM BOWEL DIS, V6, P116, DOI 10.1097/00054725-200005000-00008; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Moran NA, 2015, CURR OPIN INSECT SCI, V10, P22, DOI 10.1016/j.cois.2015.04.003; Nakajima C, 1997, J VET MED SCI, V59, P765, DOI 10.1292/jvms.59.765; O'Sulliyan A, 2013, J PROTEOME RES, V12, P2833, DOI 10.1021/pr4001702; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Powell E, 2016, MOL ECOL, V25, P4461, DOI 10.1111/mec.13787; Powell JE, 2014, APPL ENVIRON MICROB, V80, P7378, DOI 10.1128/AEM.01861-14; Raymann K, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001861; Reynaldi FJ, 2008, VET MICROBIOL, V132, P119, DOI 10.1016/j.vetmic.2008.04.034; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Saraiva MA, 2015, ANTON LEEUW INT J G, V107, P921, DOI 10.1007/s10482-015-0384-8; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarz RS, 2016, P NATL ACAD SCI USA, V113, P9345, DOI 10.1073/pnas.1606631113; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Smith KM, 2013, ECOHEALTH, V10, P434, DOI 10.1007/s10393-013-0870-2; Thompson HM, 2005, FOOD ADDIT CONTAM, V22, P573, DOI 10.1080/02652030500089986; Tian BY, 2012, MBIO, V3, DOI 10.1128/mBio.00377-12; Waite R, 2003, LETT APPL MICROBIOL, V36, P20, DOI 10.1046/j.1472-765X.2003.01254.x; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zheng H, 2016, METABOLISM TOXIC SUG, V7; Zheng H, 2017, P NATL ACAD SCI USA, V114, P4775, DOI 10.1073/pnas.1701819114	68	48	54	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187505	10.1371/journal.pone.0187505	http://dx.doi.org/10.1371/journal.pone.0187505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125851	gold, Green Submitted, Green Published			2022-12-26	WOS:000414866000015
J	Delius, JD; Delius, JAM; Lee, JM				Delius, Juan D.; Delius, Julia A. M.; Lee, Jennifer M.			Symmetry recognition by pigeons: Generalized or not?	PLOS ONE			English	Article							CRITICAL-FLICKER-FUSION; COLUMBA-LIVIA; OBJECT RECOGNITION; POLARIZED-LIGHT; VISUAL-PATTERNS; DISCRIMINATION; PECKING; PERCEPTION; LIMITS; COLOR	This note looks into the reasons why earlier reports may have arrived at differing conclusions about pigeons' capacity to categorize bilaterally symmetric and asymmetric visual patterns. Attention is drawn to pigeons' comparatively superior visual flicker resolution and superior visual linear acuity by reporting results of two ad-hoc experiments. This circumstance turns out to constrain conclusions drawn by earlier symmetry-asymmetry studies that used computer-generated patterns displayed on cathode ray tube monitors as these suffered from pictorial distortions. Additionally one of the studies involved patterns of inconsistent symmetry at global and local levels. A smaller-scale experiment using slide-projected unequivocal symmetric and asymmetric patterns yielded results compatible with the supposition that pigeons are capable of a symmetry-asymmetry categorization. The possibility that an artfactual cue may have inadvertently accentuated this capability in an earlier own experiment is considered.	[Delius, Juan D.; Lee, Jennifer M.] Univ Konstanz, Allgemeine Psychol, Constance, Germany; [Delius, Julia A. M.] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Lee, Jennifer M.] Zurich Insurance Co, Zurich, Switzerland	University of Konstanz; Max Planck Society	Delius, JD (corresponding author), Univ Konstanz, Allgemeine Psychol, Constance, Germany.	juan.delius@uni-konstanz.de		Delius, Julia A. M./0000-0002-6347-310X; Delius, Juan D./0000-0003-3965-2375	Universitat Konstanz; Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft, Bonn	Universitat Konstanz; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft, Bonn(German Research Foundation (DFG))	This research was funded by the Universitat Konstanz and the Deutsche Forschungsgemeinschaft. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Mark Cleaveland, Konstanz (meanwhile Vassar College), and Dr. Joachim Ostheim, Konstanz, for useful technical hints, Ines Krug, Konstanz, for early assistance, Dr. Ursula Probst and Christian Schuppler, Applied Optical Physics Unit, Konstanz University, for a voltage-radiance calibration of the light-emitting diodes employed, Dr. Jacky Emmerton, Yorkshire (formerly at Purdue University), for critically reading and editing an earlier draft, Nadja Ruther, Konstanz, for help with the stimuli, and Jurgen Rossbach, Berlin, for assistance with the figures. Prof. Ludwig Huber, Vienna, commented helpfully on the second draft. The research was supported by a grant of the Deutsche Forschungsgemeinschaft, Bonn, to J.D.D.	Akesson S, 2014, SPR SER VIS RES, V2, P275, DOI 10.1007/978-3-642-54718-8_12; Cavoto KK, 2001, J EXP PSYCHOL-ANIM B, V27, P3, DOI 10.1037//0097-7403.27.1.3; Cesaretti G, 1997, ARCH ITAL BIOL, V135, P131; Cohen EH, 2013, J VISION, V13, DOI 10.1167/13.6.22; Cook RG, 2005, PSYCHON B REV, V12, P350, DOI 10.3758/BF03196384; Cooke Robert G., 2012, P43; Delius J. D., 1985, BEHAV ANAL CONT PSYC, P53; DELIUS JD, 1968, PSYCHON SCI, V13, P273, DOI 10.3758/BF03342520; Delius JD, 1999, CAH PSYCHOL COGN, V18, P621; DELIUS JD, 1976, J COMP PHYSIOL PSYCH, V90, P560, DOI 10.1037/h0077223; DELIUS JD, 1978, BEHAV BIOL, V22, P336, DOI 10.1016/S0091-6773(78)92411-2; DELIUS JD, 1982, PSYCHOL RES-PSYCH FO, V44, P199, DOI 10.1007/BF00308420; Emmerton J., 1983, P245; Emmerton J, 2009, ANIM COGN, V12, P511, DOI 10.1007/s10071-009-0212-5; FELLOWS BJ, 1967, PSYCHOL BULL, V67, P87, DOI 10.1037/h0024098; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; GOODALE MA, 1983, BRAIN BEHAV EVOLUT, V22, P22, DOI 10.1159/000121504; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GRAF V, 1973, VISION RES, V13, P1815, DOI 10.1016/0042-6989(73)90058-8; Green PR, 1999, BEHAV PROCESS, V46, P97, DOI 10.1016/S0376-6357(99)00022-4; Hendricks J., 1996, J EXP ANAL BEHAV, V9, P501; HERRNSTEIN RJ, 1976, J EXP PSYCHOL ANIM B, V2, P285, DOI 10.1037/0097-7403.2.4.285; HODOS W, 1990, VISION RES, V30, P653, DOI 10.1016/0042-6989(90)90091-X; Hodos W., 2012, ANIMALS SEE WORLD CO, P5; HOLLARD VD, 1982, SCIENCE, V218, P804, DOI 10.1126/science.7134976; Huber L, 2005, J EXP PSYCHOL ANIM B, V31, P237, DOI 10.1037/0097-7403.31.2.237; Huber L, 1999, Q J EXP PSYCHOL-B, V52, P351, DOI 10.1080/027249999393040; Jarvis JR, 2002, VISION RES, V42, P99, DOI 10.1016/S0042-6989(01)00268-1; KREITHEN ML, 1974, J COMP PHYSIOL, V89, P83, DOI 10.1007/BF00696165; Lazareva O, 2012, ANIMALS SEE WORLD CO, P5; Lisney TJ, 2011, VISION RES, V51, P1324, DOI 10.1016/j.visres.2011.04.009; LOHMANN A, 1988, J COMP PSYCHOL, V102, P3, DOI 10.1037/0735-7036.102.1.3; Lombardi CM, 2008, ANIM COGN, V11, P67, DOI 10.1007/s10071-007-0087-2; LOMBARDI CM, 1984, ANIM LEARN BEHAV, V12, P2, DOI 10.3758/BF03199807; Lombardi CM, 1988, INT J COMP PSYCHOL, V2, P83; Mascalzoni E, 2012, P ROY SOC B-BIOL SCI, V279, P841, DOI 10.1098/rspb.2011.1486; MENNE M, 1978, Z TIERPSYCHOL, V47, P299; MOLLER AP, 1992, NATURE, V357, P238, DOI 10.1038/357238a0; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; NUBOER JFW, 1992, BRIT POULTRY SCI, V33, P123, DOI 10.1080/00071669208417449; Ostheim J, 1997, EUR J MORPHOL, V35, P269, DOI 10.1076/ejom.35.4.269.13082; Ostheim J, 1997, NETH J ZOOL, V47, P457; Palumbo L, 2015, VISION RES, V117, P1, DOI 10.1016/j.visres.2015.10.002; POULTON EC, 1966, NATURE, V209, P1267, DOI 10.1038/2091267a0; POWELL RW, 1968, PSYCHOL REC, V18, P35, DOI 10.1007/BF03393738; POWELL RW, 1967, PSYCHOL REC, V17, P151, DOI 10.1007/BF03393699; Rajchard J, 2009, VET MED-CZECH, V54, P351, DOI 10.17221/110/2009-VETMED; Rashotte M.E., 1979, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V19, P195; Roberts JE, 2013, LIGHTING RES TECHNOL, V45, P124, DOI 10.1177/1477153512436367; Rounsley KJ, 2005, PERCEPTION, V34, P983, DOI 10.1068/p5205; Rubene D, 2009, THESIS; SAHGAL A, 1975, PSYCHOPHARMACOLOGIA, V43, P175, DOI 10.1007/BF00421021; Sawada T., 2015, OXFORD HDB COMPUTATI, P255; SCHWABL U, 1984, BIRD BEHAV, V5, P118; SIEMANN M, 1992, ETHOLOGY, V92, P29; Swaddle JP, 2008, ANIM BEHAV, V76, P487, DOI 10.1016/j.anbehav.2008.05.005; Swaddle JP, 2001, AM NAT, V158, P300, DOI 10.1086/321323; Theunissen LM, 2017, J EXP BIOL, V220, P437, DOI 10.1242/jeb.147850; Veitch J. A., 1995, Lighting Research and Technology, V27, P243; VONFERSEN L, 1991, J EXP PSYCHOL ANIM B, V17, P334, DOI 10.1037/0097-7403.17.3.334; VONFERSEN L, 1992, MARINE MAMMAL SENSORY SYSTEMS, P753; VONFERSEN L, 1989, ETHOLOGY, V82, P141; WASSERMAN EA, 1995, J EXP PSYCHOL ANIM B, V21, P248, DOI 10.1037/0097-7403.21.3.248; WILLIAMS JL, 1974, J EXP ANAL BEHAV, V21, P421, DOI 10.1901/jeab.1974.21-421; WOHLSCHLAGER A, 1993, J COMP PSYCHOL, V107, P313, DOI 10.1037/0735-7036.107.3.313; Xia L, 1996, BEHAV RES METH INSTR, V28, P49, DOI 10.3758/BF03203635; XIA L, 1991, BEHAV RES METH INSTR, V23, P72, DOI 10.3758/BF03203337; Zeigler HP, 1993, VISION BRAIN BEHAV B, P265	68	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187541	10.1371/journal.pone.0187541	http://dx.doi.org/10.1371/journal.pone.0187541			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121110	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900046
J	Hahn, T; Winter, NR; Anderl, C; Notebaert, K; Wuttke, AM; Clement, CC; Windmann, S				Hahn, Tim; Winter, Nils R.; Anderl, Christine; Notebaert, Karolien; Wuttke, Alina Marie; Clement, Celina Chantal; Windmann, Sabine			Facial width-to-height ratio differs by social rank across organizations, countries, and value systems	PLOS ONE			English	Article							STRUCTURE PREDICTS; TESTOSTERONE; FACE; COOPERATION; BEHAVIOR; TRAITS	Facial Width-to-Height Ratio (fWHR) has been linked with dominant and aggressive behavior in human males. We show here that on portrait photographs published online, chief executive officers (CEOs) of companies listed in the Dow Jones stock market index and the Deutscher Aktienindex have a higher-than-normal fWHR, which also correlates positively with their company's donations to charitable causes and environmental awareness. Furthermore, we show that leaders of the world's most influential non-governmental organizations and even the leaders of the Roman Catholic Church, the popes, have higher fWHR compared to controls on public portraits, suggesting that the relationship between displayed fWHR and leadership is not limited to profit-seeking organizations. The data speak against the simplistic view that wider-faced men achieve higher social status through antisocial tendencies and overt aggression, or the mere signaling of such dispositions. Instead they suggest that high fWHR is linked with high social rank in a more subtle fashion in both competitive as well as prosocially oriented settings.	[Hahn, Tim; Winter, Nils R.; Anderl, Christine; Notebaert, Karolien; Wuttke, Alina Marie; Clement, Celina Chantal; Windmann, Sabine] Goethe Univ Frankfurt, Dept Psychol, Cognit Psychol 2, Frankfurt, Germany; [Notebaert, Karolien] Katholieke Univ Leuven, Res Ctr Mkt & Consumer Sci, Leuven, Belgium; [Hahn, Tim] Univ Munster, Translat Psychiat, Munster, Germany; [Winter, Nils R.] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Anderl, Christine] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	Goethe University Frankfurt; KU Leuven; University of Munster; Goethe University Frankfurt; University of British Columbia	Windmann, S (corresponding author), Goethe Univ Frankfurt, Dept Psychol, Cognit Psychol 2, Frankfurt, Germany.	S.Windmann@psych.uni-frankfurt.de			Johann-Wolfgang-Goethe University Frankfurt; Research Foundation Flanders (Belgium)	Johann-Wolfgang-Goethe University Frankfurt; Research Foundation Flanders (Belgium)(FWO)	All authors have been funded by Johann-Wolfgang-Goethe University Frankfurt at the time the study was performed; KN additionally received a scholarship from the Research Foundation Flanders (Belgium) at the time of her contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to Heike Moldenhauer and Marco Barresi for rating the facial expressions. Further credit is given to the Massachusetts Institute of Technology and to the Center for Biological and Computational Learning for providing one of the databases of facial images. In addition, part of the face images used in this work has been provided by the Computer Vision Laboratory, University of Ljubljana, Slovenia. All authors have been funded by Johann-Wolfgang-Goethe University Frankfurt at the time the study was performed; KN additionally received a scholarship from the Research Foundation Flanders (Belgium) at the time of her contribution.	Alrajih S, 2014, BRIT J PSYCHOL, V105, P153, DOI 10.1111/bjop.12035; Anderl C, 2016, PERS INDIV DIFFER, V88, P99, DOI 10.1016/j.paid.2015.08.057; Boksem MAS, 2013, PSYCHOL SCI, V24, P2306, DOI 10.1177/0956797613495063; Carre JM, 2011, PSYCHONEUROENDOCRINO, V36, P935, DOI 10.1016/j.psyneuen.2011.02.001; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Ebner NC, 2010, BEHAV RES METH INS C, V42, P11; Eisenegger C, 2010, NATURE, V463, P356, DOI 10.1038/nature08711; Eisenegger C, 2011, TRENDS COGN SCI, V15, P263, DOI 10.1016/j.tics.2011.04.008; Feinberg M, 2014, PSYCHOL SCI, V25, P656, DOI 10.1177/0956797613510184; Geniole SN, 2015, EVOL HUM BEHAV, V36, P279, DOI 10.1016/j.evolhumbehav.2014.12.005; Geniole SN, 2014, J EXP PSYCHOL HUMAN, V40, P1526, DOI 10.1037/a0036732; Geniole SN, 2014, PERS INDIV DIFFER, V57, P59, DOI 10.1016/j.paid.2013.09.023; Gervais MM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2773; Gomulya D, 2017, J APPL PSYCHOL, V102, P617, DOI 10.1037/apl0000172; Haselhuhn MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122637; Haselhuhn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072259; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Haslam SA, 2011, NEW PSYCHOLOGY OF LEADERSHIP: IDENTITY, INFLUENCE, AND POWER, P1; Hehman E, 2014, PERS SOC PSYCHOL B, V40, P1624, DOI 10.1177/0146167214552791; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ho DE, 2011, J STAT SOFTW, V42; Hodges-Simeon CR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153083; Imai K, 2008, J R STAT SOC A STAT, V171, P481, DOI 10.1111/j.1467-985X.2007.00527.x; Jia YP, 2014, J ACCOUNT RES, V52, P1195, DOI 10.1111/1475-679X.12065; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Lewis GJ, 2012, PERS INDIV DIFFER, V52, P855, DOI 10.1016/j.paid.2011.12.030; Lieberz KA, 2017, AGGRESSIVE BEHAV, V43, P460, DOI 10.1002/ab.21704; Loehr J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0049; Lucey P, 2010, IEEE COMP VIS PATT R; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Slepian ML, 2016, PSYCHOL SCI, V27, P282, DOI 10.1177/0956797615594897; Spisak BR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00792; Spisak BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030399; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2012, EVOL HUM BEHAV, V33, P551, DOI 10.1016/j.evolhumbehav.2012.02.002; Stoker JI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159950; Trebicky V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149313; Tsujimura H, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0140; Valentine KA, 2014, PSYCHOL SCI, V25, P806, DOI 10.1177/0956797613511823; van Honk J, 2012, NATURE, V485, pE4, DOI 10.1038/nature11136; Verdonck A, 1999, EUR J ORTHODONT, V21, P137, DOI 10.1093/ejo/21.2.137; Weyrauch B, 2004, COMP VIS PATT REC WO; Wibral M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046774; Wong EM, 2011, PSYCHOL SCI, V22, P1478, DOI 10.1177/0956797611418838; Yildirim BO, 2012, PSYCHIAT RES, V200, P984, DOI 10.1016/j.psychres.2012.07.044	45	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187957	10.1371/journal.pone.0187957	http://dx.doi.org/10.1371/journal.pone.0187957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121113	Green Submitted, gold, Green Published			2022-12-26	WOS:000414769900104
J	Nezafat, M; Ramos, IT; Henningsson, M; Pratti, A; Basha, T; Botnar, RM				Nezafat, Maryam; Ramos, Isabel T.; Henningsson, Markus; Pratti, Andrea; Basha, Tamer; Botnar, Rene M.			Improved segmented modified Look-Locker inversion recovery T-1 mapping sequence in mice	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; LATE GADOLINIUM ENHANCEMENT; MOUSE MYOCARDIUM; MOLLI; MRI; QUANTIFICATION; HEART; T1; OPTIMIZATION; SASHA	Object To develop and evaluate a 2D modified Look-Locker (MOLLI) for high-resolution T-1 mapping in mice using a 3T MRI scanner. Materials and methods To allow high-resolution T-1 mapping in mice at high heart rates a multi-shot ECG-triggered 2D MOLLI sequence was developed. In the proposed T-1 mapping sequence the optimal number of sampling points and pause cardiac cycles following an initial adiabatic inversion pulse was investigated in a phantom. Seven native control and eight mice, 3 days post myocardial infarction (MI) after administration of gadolinium were scanned. Two experienced readers graded the visual T-1 map quality. Results In T-1 phantoms, there were no significant differences (<0.4% error) between 12, 15 and 20 pause cardiac cycles (p = 0.1, 0.2 and 0.6 respectively) for 8 acquisition cardiac cycles for 600bpm in comparison to the conventional inversion recovery spin echo T-1 mapping sequence for short T-1's (< 600 ms). Subsequently, all in-vivo scans were performed with 8 data acquisitions and 12 pause cardiac cycles to minimize scan time. The mean native T-1 value of myocardium in control animal was 820.5 +/- 52 ms. The post-contrast T-1 measured 3 days after MI in scar was 264 +/- 59 ms and in healthy myocardium was 512 +/- 62 ms. The Bland-Altman analysis revealed mean difference of only -1.06% of infarct size percentage between T-1 maps and LGE. Conclusions A multi-shot 2D MOLLI sequence has been presented that allows reliable measurement of high spatial resolution T-1 maps in mice for heart rates up to 600bpm.	[Nezafat, Maryam; Ramos, Isabel T.; Henningsson, Markus; Pratti, Andrea; Botnar, Rene M.] Kings Coll London, Div Imaging Sci & Biomed Engn, London, England; [Nezafat, Maryam] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Nezafat, Maryam] Harvard Med Sch, Boston, MA 02115 USA; [Basha, Tamer] Cairo Univ, Biomed Engn Dept, Giza, Egypt; [Botnar, Rene M.] Pontificia Univ Catolica Chile, Escuela Ingn, Santiago, Chile	University of London; King's College London; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Egyptian Knowledge Bank (EKB); Cairo University; Pontificia Universidad Catolica de Chile	Nezafat, M (corresponding author), Kings Coll London, Div Imaging Sci & Biomed Engn, London, England.; Nezafat, M (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.; Nezafat, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mnezafat@bidmc.harvard.edu	Botnar, Rene Michael/AAZ-2112-2020; Basha, Tamer/AAN-4033-2020; Henningsson, Markus/AAB-5307-2019; Botnar, Rene/E-6875-2012	Basha, Tamer/0000-0003-4431-8646; Henningsson, Markus/0000-0001-6142-3005; Botnar, Rene/0000-0003-2811-2509; Nezafat, Maryam/0000-0002-2608-9977; Botnar, Rene/0000-0002-9447-4367	British Heart Foundation [RG/12/1/29262]; Centre of Excellence in Medical Engineering - Wellcome Trust; EPSRC [WT 088641/Z/09/Z]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; Engineering and Physical Sciences Research Council [EP/P007619/1] Funding Source: researchfish; EPSRC [EP/P007619/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Centre of Excellence in Medical Engineering - Wellcome Trust(Wellcome Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; King's College Hospital NHS Foundation Trust; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors acknowledge financial support from: (1) the British Heart Foundation (RG/12/1/29262) to Rene M. Botnar, (2) the Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC (WT 088641/Z/09/Z) to Rene M. Botnar, (3) the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust to Rene M. Botnar. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Bohl S, 2009, AM J PHYSIOL-HEART C, V296, pH1200, DOI 10.1152/ajpheart.01294.2008; Coolen BF, 2011, NMR BIOMED, V24, P154, DOI 10.1002/nbm.1566; Epstein FH, 2007, NMR BIOMED, V20, P238, DOI 10.1002/nbm.1152; Freeman AJ, 1998, MAGN RESON IMAGING, V16, P765, DOI 10.1016/S0730-725X(98)00011-3; HAASE A, 1990, MAGN RESON MED, V13, P77, DOI 10.1002/mrm.1910130109; Jiang K, 2015, MAGN RESON MED, V74, P1370, DOI 10.1002/mrm.25533; Kellman P, 2014, MAGN RESON MED, V71, P1428, DOI 10.1002/mrm.24793; Kellman P, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-63; Li W, 2010, MAGN RESON MED, V64, P1296, DOI 10.1002/mrm.22544; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; Messroghli DR, 2007, J MAGN RESON IMAGING, V26, P1081, DOI 10.1002/jmri.21119; Messroghli DR, 2007, MAGN RESON MED, V58, P34, DOI 10.1002/mrm.21272; Messroghli DR, 2011, RADIOLOGY, V261, P258, DOI 10.1148/radiol.11101943; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Messroghli DR, 2003, J CARDIOV MAGN RESON, V5, P353, DOI 10.1081/JCMR-120019418; Nahrendorf M, 2006, CIRCULATION, V113, P1196, DOI 10.1161/CIRCULATIONAHA.105.602094; Protti A, 2010, J MAGN RESON IMAGING, V32, P878, DOI 10.1002/jmri.22325; Robson MD, 2013, MAGN RESON MED, V70, P664, DOI 10.1002/mrm.24867; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; Roujol S, 2014, RADIOLOGY, V272, P683, DOI 10.1148/radiol.14140296; Schneider JE, 2003, J MAGN RESON IMAGING, V18, P691, DOI 10.1002/jmri.10411; Streif JUG, 2005, MAGN RESON MED, V53, P584, DOI 10.1002/mrm.20327; Waghorn B, 2008, NMR BIOMED, V21, P1102, DOI 10.1002/nbm.1287; Zhang HS, 2014, MAGN RESON MED, V72, P737, DOI 10.1002/mrm.24988	24	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187621	10.1371/journal.pone.0187621	http://dx.doi.org/10.1371/journal.pone.0187621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121086	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900058
J	Sancho, V; Daniele, G; Lucchesi, D; Lupi, R; Ciccarone, A; Penno, G; Bianchi, C; Dardano, A; Miccoli, R; Del Prato, S				Sancho, Veronica; Daniele, Giuseppe; Lucchesi, Daniela; Lupi, Roberto; Ciccarone, Annamaria; Penno, Giuseppe; Bianchi, Cristina; Dardano, Angela; Miccoli, Roberto; Del Prato, Stefano			Metabolic regulation of GLP-1 and PC1/3 in pancreatic alpha-cell line	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ENTEROENDOCRINE CELLS; INSULIN-SECRETION; FATTY-ACIDS; BETA-CELLS; ACTIVATION; STIMULATION; MOUSE; REGENERATION; PROGLUCAGON	Background and aims An intra-islet incretin system has been recently suggested to operate through modulation of the expression and activity of proconvertase 1/3 and 2 (PC1/3, PC2) in pancreatic alpha-cell accounting for local release of GLP-1. Little is known, whether this alpha-cell activity can be affected by the metabolic alterations occurring in type 2 diabetes, such as hyperglycemia, hyperlipidemia or hyperglucagonemia. Materials and methods lphaTC1/6 cells from a mice pancreatic cell line were incubated in the presence of two glucose (G) concentration (5.5 and 16.7 mM) for 16 h with or without free fatty acid, IL6 or glucagon. GLP-1 secretion was measured by ELISA and expression of PC1/3 and PC2 by RTPCR and western blot; cell viability was determined by MTT method, Reactive Oxygen Species generation (ROS) by H2DCFDA fluorescence and apoptosis by Annexin staining and Propidium Iodine (PI) fluorescence. Results Upon 16.7G incubation, GLP-1 secretion (total and active) was significantly increased in parallel with a significant increment in PC1/3 expression, a slight increase in cell viability and ROS generation and by a decrement in PC2 expression with no change in cell apoptosis. When cells were incubated at 5.5mM glucose with FFA, also an increment in GLP-1 secretion and PC1/3 expression was observed together an increment in ROS generation, a decrement in cell viability, and a modest increment in apoptosis. When incubated with 16.7mM glucose with FFA, the increment in GLP-1 secretion was reduced to basal, accompanied by an increment in apoptosis and ROS generation. This was also observed with IL-6, but in this case, no modification in ROS generation or apoptosis was observed when compared to 16.7mM glucose. The presence of glucagon did not modify any of the parameters studied. Conclusion These data suggest that under hyperglycemic, hyperlipidemia or inflammatory conditions, alpha cells can increase expression PC1/3 and activate GLP-1 secretion, which may contribute protecting both alpha and beta-cells from glucose and lipotoxicity, while this effect seems to be lost in the presence of both pathophysiological conditions.	[Sancho, Veronica; Daniele, Giuseppe; Lucchesi, Daniela; Penno, Giuseppe; Dardano, Angela; Miccoli, Roberto; Del Prato, Stefano] Univ Pisa, Cisanello Hosp, Dept Clin & Expt Med, Sect Diabet & Metab Dis, Pisa, Italy; [Lupi, Roberto; Ciccarone, Annamaria; Bianchi, Cristina] Azienda Osped Univ Pisana, Cisanello Hosp, Sect Diabet & Metab Dis, Pisa, Italy	University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Del Prato, S (corresponding author), Univ Pisa, Cisanello Hosp, Dept Clin & Expt Med, Sect Diabet & Metab Dis, Pisa, Italy.	stefano.delprato@med.unipi.it	Bianchi, Cristina/C-2847-2018; Daniele, Giuseppe/K-9650-2016; Del+Prato, Stefano/AAC-9197-2021	Bianchi, Cristina/0000-0003-2799-2380; Daniele, Giuseppe/0000-0001-6301-9161; Sancho Bornez, Veronica/0000-0002-8563-4568				Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Brubaker PL, 1998, ENDOCRINOLOGY, V139, P4108, DOI 10.1210/en.139.10.4108; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Hamaguchi K, 2003, EXP BIOL MED, V228, P1227, DOI 10.1177/153537020322801020; Heller RS, 1995, AM J PHYSIOL-GASTR L, V269, pG852, DOI 10.1152/ajpgi.1995.269.6.G852; Hivert MF, 2009, DIABETOLOGIA, V52, P2101, DOI 10.1007/s00125-009-1455-z; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Kahles F, 2014, DIABETES, V63, P3221, DOI 10.2337/db14-0100; Kilimnik G, 2010, ISLETS, V2, P149, DOI 10.4161/isl.2.3.11396; Lim GE, 2006, DIABETES, V55, pS70, DOI 10.2337/db06-S020; Marchetti P, 2012, DIABETOLOGIA, V55, P3262, DOI 10.1007/s00125-012-2716-9; Marselli L, 2013, DIABETES OBES METAB, V15, P130, DOI 10.1111/dom.12152; O'Malley TJ, 2014, DIABETES-METAB RES, V30, P661, DOI 10.1002/dmrr.2534; Piro S, 2014, PLOS ONE, P9; Reimer RA, 2001, ENDOCRINOLOGY, V142, P4522, DOI 10.1210/en.142.10.4522; ROCCA AS, 1995, ENDOCRINOLOGY, V136, P5593, DOI 10.1210/en.136.12.5593; Sancho V, 2011, BBA-MOL CELL RES, V1813, P2145, DOI 10.1016/j.bbamcr.2011.07.007; Symonds EL, 2015, GUT, V64, P618, DOI 10.1136/gutjnl-2014-306834; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Wang L, 2011, J ENDOCRINOL, V210, P173, DOI 10.1530/JOE-11-0132; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Xiao JZ, 2001, ENDOCRINOLOGY, V142, P4777, DOI 10.1210/en.142.11.4777	25	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187836	10.1371/journal.pone.0187836	http://dx.doi.org/10.1371/journal.pone.0187836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121068	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900085
J	Stoffregen, TA; Chang, CH; Chen, FC; Zeng, WJ				Stoffregen, Thomas A.; Chang, Chih-Hui; Chen, Fu-Chen; Zeng, Wei-Jhong			Effects of decades of physical driving on body movement and motion sickness during virtual driving	PLOS ONE			English	Article							INFLUENCES POSTURAL ACTIVITY; SIMULATOR SICKNESS; INSTABILITY; SWAY	We investigated relations between experience driving physical automobiles and motion sickness during the driving of virtual automobiles. Middle-aged individuals drove a virtual automobile in a driving video game. Drivers were individuals who had possessed a driver's license for approximately 30 years, and who drove regularly, while non-drivers were individuals who had never held a driver's license, or who had not driven for more than 15 years. During virtual driving, we monitored movement of the head and torso. During virtual driving, drivers became motion sick more rapidly than non-drivers, but the incidence and severity of motion sickness did not differ as a function of driving experience. Patterns of movement during virtual driving differed as a function of driving experience. Separately, movement differed between participants who later became motion sick and those who did not. Most importantly, physical driving experience influenced patterns of postural activity that preceded motion sickness during virtual driving. The results are consistent with the postural instability theory of motion sickness, and help to illuminate relations between the control of physical and virtual vehicles.	[Stoffregen, Thomas A.] Univ Minnesota, Sch Kinesiol, Affordance Percept Act Lab, Minneapolis, MN 55455 USA; [Chang, Chih-Hui; Chen, Fu-Chen; Zeng, Wei-Jhong] Natl Kaohsiung Normal Univ, Dept Phys Educ, Kaohsiung, Taiwan	University of Minnesota System; University of Minnesota Twin Cities; National Kaohsiung Normal University	Stoffregen, TA (corresponding author), Univ Minnesota, Sch Kinesiol, Affordance Percept Act Lab, Minneapolis, MN 55455 USA.	tas@umn.edu	Stoffregen, Thomas/ABC-8710-2021					Bonnet CT, 2006, HUM MOVEMENT SCI, V25, P800, DOI 10.1016/j.humov.2006.03.001; BRAITHWAITE MG, 1990, J SOC OCCUP MED, V40, P105; Brooks J. O., 2007, J VISION, V7, P246; Brooks JO, 2010, ACCIDENT ANAL PREV, V42, P788, DOI 10.1016/j.aap.2009.04.013; Chang C.-H., 2017, AVIAT MED H IN PRESS; Chang CH, 2012, EXP BRAIN RES, V217, P299, DOI 10.1007/s00221-011-2993-4; Chen YC, 2012, ECOL PSYCHOL, V24, P279, DOI 10.1080/10407413.2012.726181; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Cohen J.E., 1988, STAT POWER ANAL BEHA; CROWLEY JS, 1987, AVIAT SPACE ENVIR MD, V58, P355; Dong X, 2011, J EXP PSYCHOL-APPL, V17, P128, DOI 10.1037/a0024097; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Koslucher FC, 2014, GAIT POSTURE, V39, P606, DOI 10.1016/j.gaitpost.2013.09.016; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Merhi O, 2007, HUM FACTORS, V49, P920, DOI 10.1518/001872007X230262; MILLER JAMES W., 1960, AEROSPACE MED, V31, P204; Murphy-Hill E, 2014, 36TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE 2014), P1, DOI 10.1145/2568225.2568226; Oman C M, 1982, Acta Otolaryngol Suppl, V392, P1; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; RICCIO G E, 1991, Ecological Psychology, V3, P195, DOI 10.1207/s15326969eco0303_2; ROLNICK A, 1991, ERGONOMICS, V34, P867, DOI 10.1080/00140139108964831; Stevens SC, 2002, MAR TECHNOL SNAME N, V39, P29; STOFFREGEN T A, 1991, Ecological Psychology, V3, P159, DOI 10.1207/s15326969eco0303_1; Stoffregen TA, 2000, HUM FACTORS, V42, P458, DOI 10.1518/001872000779698097; Stoffregen TA, 1998, BRAIN RES BULL, V47, P437, DOI 10.1016/S0361-9230(98)00102-6; Stoffregen TA, 2008, HUM FACTORS, V50, P322, DOI 10.1518/001872008X250755; Stoffregen TA, 2014, EXP BRAIN RES, V232, P1389, DOI 10.1007/s00221-014-3859-3; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; Stoffregen TA, 2010, ECOL PSYCHOL, V22, P169, DOI 10.1080/10407413.2010.496645; Villard SJ, 2008, HUM FACTORS, V50, P332, DOI 10.1518/001872008X250728; Webb CM, 2009, AVIAT SPACE ENVIR MD, V80, P541, DOI 10.3357/ASEM.2454.2009; Young L, 1984, HDB PHYSL NERVOUS SY, P1023	34	24	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187120	10.1371/journal.pone.0187120	http://dx.doi.org/10.1371/journal.pone.0187120			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121059	Green Submitted, gold, Green Published			2022-12-26	WOS:000414769900021
J	Bach, FC; Laagland, LT; Grant, MP; Creemers, LB; Ito, KT; Meij, BP; Mwale, F; Tryfonidou, MA				Bach, Frances C.; Laagland, Lisanne T.; Grant, Michael P.; Creemers, Laura B.; Ito, Keita; Meij, Bjorn P.; Mwale, Fackson; Tryfonidou, Marianna A.			Link-N: The missing link towards intervertebral disc repair is species-specific	PLOS ONE			English	Article							NUCLEUS PULPOSUS; INITIAL-CHARACTERIZATION; II RECEPTOR; BACK-PAIN; CELLS; DEGENERATION; PEPTIDE; PROTEIN; PROTEOGLYCAN; REGENERATION	Introduction Degeneration of the intervertebral disc (IVD) is a frequent cause for back pain in humans and dogs. Link-N stabilizes proteoglycan aggregates in cartilaginous tissues and exerts growth factor-like effects. The human variant of Link-N facilitates IVD regeneration in several species in vitro by inducing Smadl signaling, but it is not clear whether this is species specific. Dogs with IVD disease could possibly benefit from Link-N treatment, but Link-N has not been tested on canine IVD cells. If Link-N appears to be effective in canines, this would facilitate translation of Link-N into the clinic using the dog as an in vivo large animal model for human IVD degeneration. Materials and methods This study's objective was to determine the effect of the human and canine variant of Link-N and short (s) Link-N on canine chondrocyte-like cells (CLCs) and compare this to those on already studied species, i.e. human and bovine CLCs. Extracellular matrix (ECM) production was determined by measuring glycosaminoglycan (GAG) content and histological evaluation. Additionally, the micro-aggregates' DNA content was measured. Phosphorylated (p) Smadl and-2 levels were determined using ELISA. Results Human (s)Link-N induced GAG deposition in human and bovine CLCs, as expected. In contrast, canine (s)Link-N did not affect ECM production in human CLCs, while it mainly induced collagen type I and II deposition in bovine CLCs. In canine CLCs, both canine and human (s)Link-N induced negligible GAG deposition. Surprisingly, human and canine (s) Link-N did not induce Smad signaling in human and bovine CLCs. Human and canine (s) Link-N only mildly increased pSmadl and Smad2 levels in canine CLCs. Conclusions Human and canine (s)Link-N exerted species-specific effects on CLCs from early degenerated IVDs. Both variants, however, lacked the potency as canine IVD regeneration agent. While these studies demonstrate the challenges of translational studies in large animal models, (s)Link-N still holds a regenerative potential for humans.	[Bach, Frances C.; Laagland, Lisanne T.; Meij, Bjorn P.; Tryfonidou, Marianna A.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Grant, Michael P.; Mwale, Fackson] McGill Univ, Dept Surg, Montreal, PQ, Canada; [Grant, Michael P.] SMBD Jewish Gen Hosp, Lady Davis Inst Med Res, Orthoped Res Lab, Montreal, PQ, Canada; [Creemers, Laura B.; Ito, Keita] Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands; [Ito, Keita] Eindhoven Univ Technol, Dept Biomed Engn, Orthoped Biomech, Eindhoven, Netherlands	Utrecht University; McGill University; Lady Davis Institute; McGill University; Utrecht University; Utrecht University Medical Center; Eindhoven University of Technology	Tryfonidou, MA (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	m.a.tryfonidou@uu.nl	Ito, Keita/A-8592-2017; Creemers, Laura B/AAS-2424-2020; Tryfonidou, Marianna/O-3114-2017	Ito, Keita/0000-0002-7372-4072; Tryfonidou, Marianna/0000-0002-2333-7162; Creemers, Laura/0000-0002-1585-3052; Grant, Michael/0000-0003-3758-5009	AOSpine Research Network [109933, SRN2011_11]; Dutch Arthritis Foundation [LLP22]; ReumaFonds [LLP-12, LLP-22] Funding Source: researchfish	AOSpine Research Network; Dutch Arthritis Foundation; ReumaFonds	This work was funded by the AOSpine Research Network (SRN2011_11 and Consortium award 109933) and the Dutch Arthritis Foundation (LLP22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlGarni N, 2016, TISSUE ENG PT A, V22, P1252, DOI 10.1089/ten.tea.2016.0115; Altschul S.F., 1997, NUCLEIC ACIDS RES, V25, P3389, DOI DOI 10.1093/NAR/25.17; Antoniou J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4113; Arkesteijn ITM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0569-6; Bach FC, 2015, EUR CELLS MATER, V30, P132, DOI 10.22203/eCM.v030a10; Bach FC, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-3; Benneker L M, 2014, Eur Cell Mater, V27, P5; Bergknut N, 2013, VET J, V195, P282, DOI 10.1016/j.tvjl.2012.10.024; Bergknut N, 2012, SPINE, V37, P351, DOI 10.1097/BRS.0b013e31821e5665; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Feng G, 2013, OSTEOARTHR CARTILAGE, V21, P582, DOI 10.1016/j.joca.2013.01.001; Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396; Gawri R, 2014, J ORTHOP RES, V32, P1189, DOI 10.1002/jor.22653; Gawri R, 2013, EUR CELLS MATER, V26, P107, DOI 10.22203/eCM.v026a08; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Lee JY, 2001, SPINE, V26, P2316; Mace PD, 2006, BIOCHEM BIOPH RES CO, V351, P831, DOI 10.1016/j.bbrc.2006.10.109; MALDONADO BA, 1992, J ORTHOP RES, V10, P677, DOI 10.1002/jor.1100100510; Mwale F, 2003, J CELL BIOCHEM, V88, P1202, DOI 10.1002/jcb.10479; Mwale F, 2014, TISSUE ENG PT A, V20, P2942, DOI [10.1089/ten.tea.2013.0749, 10.1089/ten.TEA.2013.0749]; Mwale F, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3423; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; NGUYEN Q, 1993, BIOCHEM J, V295, P595, DOI 10.1042/bj2950595; Petit A, 2011, TISSUE ENG PT A, V17, P899, DOI [10.1089/ten.tea.2010.0494, 10.1089/ten.TEA.2010.0494]; Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m; Smolders LA, 2013, VET J, V195, P292, DOI 10.1016/j.tvjl.2012.10.011; Wang ZL, 2013, J BIOL CHEM, V288, P28243, DOI 10.1074/jbc.M113.451948; Willems N, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0625-2; Yang SH, 2013, SPINE J, V13, P1590, DOI 10.1016/j.spinee.2013.05.025; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	30	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187831	10.1371/journal.pone.0187831	http://dx.doi.org/10.1371/journal.pone.0187831			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117254	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600080
J	Boateng, GO; Adams, EA; Boateng, MO; Luginaah, IN; Taabazuing, MM				Boateng, Godfred O.; Adams, Ellis A.; Boateng, Mavis Odei; Luginaah, Isaac N.; Taabazuing, Mary-Margaret			Obesity and the burden of health risks among the elderly in Ghana: A population study	PLOS ONE			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; WEIGHT MANAGEMENT; OLDER-ADULTS; SOUTH-AFRICA; HYPERTENSION; DISABILITY; PREVENTION; EPIDEMIOLOGY	Background The causes and health risks associated with obesity in young people have been extensively documented, but elderly obesity is less well understood, especially in sub-Saharan Africa. This study examines the relationship between obesity and the risk of chronic diseases, cognitive impairment, and functional disability among the elderly in Ghana. It highlights the social and cultural dimensions of elderly obesity and discusses the implications of related health risks using a socio-ecological model. Methodology We used data from wave 1 of the Ghana Study on Global Ageing and Adult Health (SAGE) survey-2007/8, with a restricted sample of 2,091 for those 65 years and older. Using random effects multinomial, ordered, and binary logit models, we examined the relationship between obesity and the risk of stage 1 and stage 2 hypertension, arthritis, difficulties with recall and learning new tasks, and deficiencies with activities of daily living and instrumental activities of daily living. Findings Elderly Ghanaians who were overweight and obese had a higher risk of stage 1 and stage 2 hypertension, and were more likely to be diagnosed with arthritis and report severe deficiencies with instrumental activities of daily living. Those who were underweight were 1.71 times more likely to report severe difficulties with activities of daily living. A sub analysis using waist circumference as a measure of body fat showed elderly females with abdominal adiposity were relatively more likely to have stage 2 hypertension. Conclusions These findings call for urgent policy initiatives geared towards reducing obesity among working adults given the potentially detrimental consequences in late adulthood. Future research should explore the gendered pathways leading to health disadvantages among Ghanaian women in late adulthood.	[Boateng, Godfred O.] Northwestern Univ, Dept Anthropol & Global Hlth, Evanston, IL USA; [Adams, Ellis A.] Georgia State Univ, Global Studies Inst, Atlanta, GA 30303 USA; [Adams, Ellis A.] Georgia State Univ, Dept Geosci, Atlanta, GA 30303 USA; [Boateng, Mavis Odei] Univ Windsor, Dept Social Work, Windsor, ON, Canada; [Luginaah, Isaac N.] Western Univ, Dept Geog, London, ON, Canada; [Taabazuing, Mary-Margaret] Western Univ, Div Geriatr Med, Dept Med, London, ON, Canada; [Taabazuing, Mary-Margaret] London Hlth Sci Ctr, Dept Med, Victoria Campus, London, ON, Canada	Northwestern University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University of Windsor; Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre	Boateng, GO (corresponding author), Northwestern Univ, Dept Anthropol & Global Hlth, Evanston, IL USA.	godfred.boateng@northwestern.edu	Boateng, Godfred Odei/AAB-8341-2020	Boateng, Godfred Odei/0000-0001-5898-6966; Luginaah, Isaac/0000-0001-7858-3048; Adams, Ellis/0000-0003-3783-9005				Aboderin IAG, 2015, LANCET, V385, pE9, DOI 10.1016/S0140-6736(14)61602-0; Addo J, 2012, Ghana Med J, V46, P4; Agyemang C., 2016, METABOLIC SYNDROME C, P41, DOI [DOI 10.1007/978-3-319-11251-0_5, 10.1007/978-3-319-11251-0_5]; Amarya S, 2014, J CLIN GERONTOL GERI, V5, P63, DOI 10.1016/j.jcgg.2014.01.004; [Anonymous], 2000, WHO TECHN REP SER; Assimeng JM, 1999, SOCIAL STRUCTURE GHA; Association AH, 2011, UND BLOOD PRESS READ; Banegas JR, 2007, EUR J CARDIOV PREV R, V14, P456, DOI 10.1097/HJR.0b013e3280803f29; Barbour KE, 2017, MMWR-MORBID MORTAL W, P66; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Biritwum R, 2013, STUDY GLOBAL AGEING; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; Boateng GO, 2015, J AGING HEALTH; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Calle EE, 2005, NEW ENGL J MED, V353, P2197, DOI 10.1056/NEJM200511173532020; Cameron M., 2013, TOPICAL HERBAL THERA; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Chomistek AK, 2015, J AM COLL CARDIOL, V65, P43, DOI 10.1016/j.jacc.2014.10.024; Corica F, 2015, PHARMACOECONOMICS, V33, P655, DOI 10.1007/s40273-014-0237-8; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Daien CI, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2014-000012; Debrino G, 2010, CLIN INQUIRIES, V2010; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Dorresteijn JAN, 2012, OBES REV, V13, P17, DOI 10.1111/j.1467-789X.2011.00914.x; Duda RB, 2011, J CROSS-CULT GERONTO, V26, P299, DOI 10.1007/s10823-011-9148-8; Elias MF, 2005, NEUROBIOL AGING, V26, pS11, DOI 10.1016/j.neurobiolaging.2005.08.019; Farr SA, 2008, ENDOCRINOLOGY, V149, P2628, DOI 10.1210/en.2007-1722; Felson DT, 1997, BAILLIERE CLIN RHEUM, V11, P671, DOI 10.1016/S0950-3579(97)80003-9; Ferguson BD, 2003, ESTIMATING PERMANENT, P747; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; GALANOS AN, 1994, J AM GERIATR SOC, V42, P368, DOI 10.1111/j.1532-5415.1994.tb07483.x; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Goisser S, 2015, CLIN INTERV AGING, V10, DOI 10.2147/CIA.S82454; Gordon R.A., 2015, REGRESSION ANAL SOCI, DOI 10.4324/9781315748788; Gureje O, 2006, J AM GERIATR SOC, V54, P1784, DOI 10.1111/j.1532-5415.2006.00944.x; Han TS, 2013, BEST PRACT RES CL EN, V27, P509, DOI 10.1016/j.beem.2013.04.012; Han TS, 2011, BRIT MED BULL, V97, P169, DOI 10.1093/bmb/ldr002; Hardy SE, 2011, J GEN INTERN MED, V26, P130, DOI 10.1007/s11606-010-1543-2; Heidari B, 2011, CASP J INTERN MED, V2, P205; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kulkarni RS, 2017, INT J DIABETES DEV C, V37, P31, DOI 10.1007/s13410-015-0411-3; Kurukulasuriya LR, 2011, MED CLIN N AM, V95, P903, DOI 10.1016/j.mcna.2011.06.004; LEW EA, 1979, J CHRON DIS, V32, P563, DOI 10.1016/0021-9681(79)90119-X; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Magliano Malgorzata, 2008, Menopause Int, V14, P149, DOI 10.1258/mi.2008.008018; Marengoni A, 2009, J INTERN MED, V265, P288, DOI 10.1111/j.1365-2796.2008.02017.x; Mba CJ, 2010, J AGING RES, V2010; Miller AA, 2014, BRAIN BEHAV IMMUN, V42, P10, DOI 10.1016/j.bbi.2014.04.001; Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2; Minicuci N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.21292; Nelson MR, 2013, MED J AUSTRALIA, V198, P606, DOI 10.5694/mja12.11054; Nguyen JCD, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00375; Nukunya, 2003, TRADITION CHANGE GHA; Nunnally J, 1978, PSYCHOMETRIC METHODS; Obioha EE, 2012, ANTHROPOLOGIST, V14, P251, DOI 10.1080/09720073.2012.11891246; Ofori-Asenso R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3901-4; Ostir GV, 2001, PSYCHOSOM MED, V63, P210, DOI 10.1097/00006842-200103000-00003; Otitoola OC, 2015, S AFR J CLIN NUTR, V28, P12; Proctor DB, 2016, KINNS CLIN MED ASSIS; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rai MF, 2011, CRITICAL REV EUKARYO, V21; Robson K., 2015, MULTILEVEL MODELING; Salihu HM, 2009, MATURITAS, V63, P7, DOI 10.1016/j.maturitas.2009.02.010; Samper-Ternent R, 2012, REV CLIN GERONTOL, V22, P10, DOI 10.1017/S0959259811000190; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Solar O, 2007, CONCEPTUAL FRAMEWORK; Starr KNP, 2014, J AM MED DIR ASSOC, V15, P240, DOI 10.1016/j.jamda.2013.11.008; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Sturman MT, 2008, NEUROLOGY, V70, P360, DOI 10.1212/01.wnl.0000285081.04409.bb; Tenkorang EY, 2017, GLOB HEALTH PROMOT, V24, P14, DOI 10.1177/1757975915583636; Usenbo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133858; van Zon SKR, 2016, SOC SCI MED, V170, P26, DOI 10.1016/j.socscimed.2016.10.002; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; WHO, 2016, MENT HLTH OLD AD WHO; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 2014, NONC DIS COUNTR PROF; World Health Organization-WHO, 2014, GHAN COUNTR ASS REP; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002; Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI [10.1016/j.cger.2010.03.001, 10.1016/j.rdc.2012.10.004]	82	30	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							0186947	10.1371/journal.pone.0186947	http://dx.doi.org/10.1371/journal.pone.0186947			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM0ME	29117264	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600020
J	Habl, C; Auersperg, AMI				Habl, Cornelia; Auersperg, Alice Marie Isabel			The keybox: Shape-frame fitting during tool use in Goffin's cockatoos (Cacatua goffiniana)	PLOS ONE			English	Article							DISCRIMINATION; OBJECTS; PIGEONS; VISION; HUMANS	The ability to move an object in alignment to a surface develops early in human ontogeny. However, aligning not just your own body but also the object itself in relation to a surface with a specific shape requires using landmarks rather than the own body as a frame of reference for orientation. The ability to do so is considered important in the development of tool use behaviour in human and non-human animals. Aside from humans, with the exception of a single study on habitually tool using primates, shape-frame matching abilities remain largely unstudied. The Goffin's cockatoo is a generalist parrot, and not a specialised tool user but has shown the capacity to innovate and use different types of tools under controlled settings. We tested these parrots in a tool selection and tool use task featuring objects and their corresponding substrate grooves in a number of shapes with different levels of symmetry. Subjects had to choose the correct 'key' to insert into a box, and align its shape to fit into the corresponding 'keyhole' in the box. The parrots were able to select the correct key above chance level from early on in the experiment. Despite their lack of hands, they required fewer placement attempts than primates to insert simple object shapes into corresponding grooves. For complex shapes, they reduced their insertion effort by rotating shapes in their beak while avoiding as many protrusions as possible. Unrewarded play experience with similar object shapes was provided to some of the subjects previously to testing, but did not seem to have an effect on the number of correct choices or on insertion effort.	[Habl, Cornelia] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Auersperg, Alice Marie Isabel] Med Univ Vienna, Univ Vet Med Vienna, Univ Vienna, Messerli Res Inst, Vienna, Austria	University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Habl, C (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	cornelia.habl@gmail.com		Auersperg, Alice/0000-0001-7405-9791	Austrian Science Fund FWF [B19 J3404, P29075, P 29084]	Austrian Science Fund FWF(Austrian Science Fund (FWF))	This study was funded by the Austrian Science Fund FWF, project numbers B19 J3404; P29075 and P 29084 to Alice Auersperg. http://www.fwf.ac.at/en/.	[Anonymous], SPATIAL REPRESENTATI; Auersperg A., 2015, ANIMAL CREATIVITY IN, P45, DOI DOI 10.1016/B978-0-12-800648-1.00003-6; Auersperg AMI, 2017, ANIM BEHAV, V128, P125, DOI 10.1016/j.anbehav.2017.04.010; Auersperg AMI, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0972; Auersperg AMI, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0689; Auersperg AMI, 2015, J COMP PSYCHOL, V129, P62, DOI 10.1037/a0038314; Auersperg AMI, 2014, J COMP PSYCHOL, V128, P88, DOI 10.1037/a0033272; Auersperg AMI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068979; Auersperg AMI, 2012, CURR BIOL, V22, pR903, DOI 10.1016/j.cub.2012.09.002; Auersperg AMI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020231; Auersperg Alice Marie Isabel, 2014, Anim Behav Cogn, V1, P470; Bateson P., 2013, PLAY PLAYFULNESS INN; Bayley N., 1993, BAYLEY SCALES INFANT, Vsecond; Bernstein N, 1967, COORDINATION REGULAT; Boesch C, 2000, CHIMPANZEES TAI FORE; Burghardt GM, 2005, GENESIS OF ANIMAL PLAY: TESTING THE LIMITS, P1; Demery ZP, 2011, P ROY SOC B-BIOL SCI, V278, P3687, DOI 10.1098/rspb.2011.0374; Demery ZP, 2011, ASS STUD AN BEH SUMM; Fragaszy DM, 1998, CLIN DEV MED, P77; Fragaszy DM, 2011, AM J PRIMATOL, V73, P1012, DOI 10.1002/ajp.20966; Fragaszy DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140033; Friedman A, 2005, J EXP PSYCHOL GEN, V134, P149, DOI 10.1037/0096-3445.134.2.149; Gajdon G. K., 2014, Open Journal of Animal Sciences, V4, P51, DOI 10.4236/ojas.2014.42008; Gruber R, 2016, THESIS; Heinsohn R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602399; Lantermann W., 1999, PAPAGEIENKUNDE; Laumer IB, 2016, SCI REP-UK, V6, DOI 10.1038/srep28380; Lockman JJ, 2000, CHILD DEV, V71, P137, DOI 10.1111/1467-8624.00127; Mannu M, 2009, AM J PRIMATOL, V71, P242, DOI 10.1002/ajp.20642; O'Hara M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134894; O'Hara M, 2015, ANIM BEHAV, V101, P51, DOI 10.1016/j.anbehav.2014.12.022; Ornkloo H, 2007, DEV PSYCHOL, V43, P404, DOI 10.1037/0012-1649.43.2.404; Poti Patrizia, 2000, Animal Cognition, V3, P69, DOI 10.1007/s100710000062; Sanz CM, 2007, J HUM EVOL, V52, P420, DOI 10.1016/j.jhevol.2006.11.001; Spetch ML, 2006, COMP COGN BEHAV REV, V1, P12, DOI 10.3819/ccbr.2008.10002; Stephan C, 2014, J COMP PSYCHOL, V128, P261, DOI 10.1037/a0036874; Street SY, 2011, CHILD DEV, V82, P2083, DOI 10.1111/j.1467-8624.2011.01655.x; Szabo B, 2017, LEARN BEHAV, V45, P7, DOI 10.3758/s13420-016-0235-0; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Watanabe, 2012, LOGIC SENSIBILITY, P23	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0186859	10.1371/journal.pone.0186859	http://dx.doi.org/10.1371/journal.pone.0186859			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM0ME	29117242	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600018
J	Mavrici, D; Yambao, JC; Lee, BG; Quinones, B; He, XH				Mavrici, Daniela; Yambao, Jaszemyn C.; Lee, Bertram G.; Quinones, Beatriz; He, Xiaohua			Screening for the presence of mcr-1/mcr-2 genes in Shiga toxin-producing Escherichia coli recovered from a major produce-production region in California	PLOS ONE			English	Article							RESISTANCE GENE; LIPID-A; MCR-1; PLASMID; SALMONELLA	The rapid spreading of polymyxin E (colistin) resistance among bacterial strains through the horizontally transmissible mcr-1 and mcr-2 plasmids has become a serious concern. The emergence of these genes in Shiga toxin-producing Escherichia coli (STEC), a group of human pathogenic bacteria was even more worrisome, urging us to investigate the prevalence of mcrgenes among STEC isolates. A total of 1000 STEC isolates, recovered from livestock, wildlife, produce and other environmental sources in a major production region for leafy vegetables in California during 2006-2014, were screened by PCR for the presence of plasm id-borne mcr-1 and mcr-2. All isolates tested yielded negative results, indicating if any, the occurrence rate of mcr-11mcr-2 among STEC was very low in this agricultural region. This study provides valuable information such as sample size needed and methodologies for future surveillance programs of antimicrobial resistance.	[Mavrici, Daniela; He, Xiaohua] ARS, Foodborne Toxin Detect & Prevent Res Unit, Western Reg Res Ctr, USDA, Albany, CA 94710 USA; [Yambao, Jaszemyn C.; Lee, Bertram G.; Quinones, Beatriz] ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA 94710 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	He, XH (corresponding author), ARS, Foodborne Toxin Detect & Prevent Res Unit, Western Reg Res Ctr, USDA, Albany, CA 94710 USA.; Quinones, B (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA 94710 USA.	Beatriz.Qninones@ars.usda.gov; Xiahua.he@ars.usda.gov		Quinones, Beatriz/0000-0001-5010-9889	USDA-ARS CRIS [2030-42000-049-00D, 2030-42000-051-00D]	USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research work was supported by USDA-ARS CRIS 2030-42000-049-00D and 2030-42000-051-00D. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2016, INT J ANTIMICROB AG, V48, P445, DOI 10.1016/j.ijantimicag.2016.06.021; BRENNER SE, 1995, TRENDS GENET, V11, P330, DOI 10.1016/S0168-9525(00)89094-0; Castanheira M, 2016, ANTIMICROB AGENTS CH, V60, P5623, DOI 10.1128/AAC.01267-16; Catry B, 2015, INT J ANTIMICROB AG, V46, P297, DOI 10.1016/j.ijantimicag.2015.06.005; Chabou S., 2016, New Microbes and New Infections, V13, P71, DOI 10.1016/j.nmni.2016.06.017; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cooley MB, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00030; Cooley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065716; Di Pilato V, 2016, ANTIMICROB AGENTS CH, V60, P5612, DOI 10.1128/AAC.01075-16; Du H, 2016, LANCET INFECT DIS, V16, P287, DOI 10.1016/S1473-3099(16)00056-6; Falagas ME, 2011, FUTURE MICROBIOL, V6, P653, DOI [10.2217/fmb.11.49, 10.2217/FMB.11.49]; Gao RS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005957; Hasman H, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.49.30085; Wertheim H, 2013, J GLOB ANTIMICROB RE, V1, P131, DOI 10.1016/j.jgar.2013.03.012; Inglis GD, 2004, APPL ENVIRON MICROB, V70, P2296, DOI 10.1128/AEM.70.4.2296-2306.2004; Kline KE, 2016, MMWR-MORBID MORTAL W, V65, P977, DOI 10.15585/mmwr.mm6536e2; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; McGann P, 2016, ANTIMICROB AGENTS CH, V60, P4420, DOI 10.1128/AAC.01103-16; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mediavilla JR, 2016, MBIO, V7, DOI 10.1128/mBio.01191-16; Meinersmann RJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02244-16; Quinones B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00061; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Stojanoski V, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0303-0; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P979, DOI 10.15585/mmwr.mm6536e3; Xavier BB, 2016, EURO SURVEILL, V21; Yang D, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060576; Yang YQ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01204-16, 10.1128/AAC.01204-16]	31	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187827	10.1371/journal.pone.0187827	http://dx.doi.org/10.1371/journal.pone.0187827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117270	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600079
J	Ribeiro, D; Andersson, EM; Heath, N; Persson-Kry, A; Collins, R; Hicks, R; Dekker, N; Forslow, A				Ribeiro, Diana; Andersson, Eva-Marie; Heath, Nikki; Persson-Kry, Anette; Collins, Richard; Hicks, Ryan; Dekker, Niek; Forslow, Anna			Human pancreatic islet-derived extracellular vesicles modulate insulin expression in 3D-differentiating iPSC clusters	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; ENDOCRINE-CELLS; GENE-EXPRESSION; BETA-CELLS; DIFFERENTIATION; EXOSOMES; TRANSPLANTATION; PROGENITORS; INDUCTION	It has been suggested that extracellular vesicles (EVs) can mediate crosstalk between hormones and metabolites within pancreatic tissue. However, the possible effect of pancreatic EVs on stem cell differentiation into pancreatic lineages remains unknown. Herein, human islet-derived EVs (h-Islet-EVs) were isolated, characterized and subsequently added to human induced pluripotent stem cell (iPSC) clusters during pancreatic differentiation. The hislet-EVs had a mean size of 117+/-7 nm and showed positive expression of CD63 and CD81 EV markers as measured by ELISA. The presence of key pancreatic transcription factor mRNA, such as NGN3, MAFA and PDX1, and pancreatic hormone proteins such as C-peptide and glucagon, were confirmed in h-Islet-EVs. iPSC clusters were differentiated in suspension and at the end stages of the differentiation protocol, the mRNA expression of the main pancreatic transcription factors and pancreatic hormones was increased. H-Islet-EVs were supplemented to the iPSC clusters in the later stages of differentiation. It was observed that h-Islet-EVs were able to up-regulate the intracellular levels of C-peptide in iPSC clusters in a concentration-dependent manner. The effect of h-Islet-EVs on the differentiation of iPSC clusters cultured in 3D-collagen hydrogels was also assessed. Although increased mRNA expression for pancreatic markers was observed when culturing the iPSC clusters in 3D-collagen hydrogels, delivery of EVs did not affect the insulin or C-peptide intracellular content. Our results provide new information on the role of h-Islet-EVs in the regulation of insulin expression in differentiating iPSC clusters, and are highly relevant for pancreatic tissue engineering applications.	[Ribeiro, Diana; Persson-Kry, Anette; Hicks, Ryan; Dekker, Niek; Forslow, Anna] AstraZeneca, Discovery Sci Innovat Med & Early Dev Biotech Uni, Gothenburg, Sweden; [Ribeiro, Diana] Chalmers Univ Technol, Dept Biol & Bioengn, Gothenburg, Sweden; [Andersson, Eva-Marie] AstraZeneca, Innovat Med & Early Dev Biotech Unit, Cardiovasc & Metab Dis, Gothenburg, Sweden; [Heath, Nikki] AstraZeneca, Discovery Sci Innovat Med & Early Dev Biotech Uni, Alderley Pk, Macclesfield, Cheshire, England; [Collins, Richard] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	AstraZeneca; Chalmers University of Technology; AstraZeneca; AstraZeneca; University of Manchester	Ribeiro, D; Forslow, A (corresponding author), AstraZeneca, Discovery Sci Innovat Med & Early Dev Biotech Uni, Gothenburg, Sweden.; Ribeiro, D (corresponding author), Chalmers Univ Technol, Dept Biol & Bioengn, Gothenburg, Sweden.	diana.ribeiro@astrazeneca.com; anna.forslow@astrazeneca.com	; Ribeiro, Diana/K-7403-2013	Hicks, Ryan/0000-0002-3367-6272; Ribeiro, Diana/0000-0001-7829-6305; Salmond, Nikki/0000-0001-5126-5592	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA [607842]; AstraZeneca Postdoc program	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA; AstraZeneca Postdoc program(AstraZeneca)	DR is funded by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 (2007-2013) under REA grant agreement no [607842]. NH is funded by AstraZeneca Postdoc program. AstraZeneca provided support in the form of salaries for following authors: DR, E-MA, NH, AP-K, RH, ND and AF. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulnick AD, 2015, STEM CELL TRANSL MED, V4, P1214, DOI 10.5966/sctm.2015-0079; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442; Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Cerf ME, 2006, EUR J ENDOCRINOL, V155, P671, DOI 10.1530/eje.1.02277; Cho CHH, 2012, DIABETOLOGIA, V55, P3284, DOI 10.1007/s00125-012-2687-x; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Croon AC, 2003, TRANSPLANT P, V35, P764, DOI 10.1016/S0041-1345(03)00031-9; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dominguez-Bendala J, 2016, TRENDS ENDOCRIN MET, V27, P153, DOI 10.1016/j.tem.2015.12.003; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Eitan E, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26373; Figliolini F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102521; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Guay C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0097-7; Haga H, 2017, STEM CELL TRANSL MED, V6, P1262, DOI 10.1002/sctm.16-0226; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Huang-Doran I, 2017, TRENDS ENDOCRIN MET, V28, P3, DOI 10.1016/j.tem.2016.10.003; Ishikawa M, 2015, J TISSUE ENG REGENER; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Jun Y, 2013, BIOMATERIALS, V34, P8122, DOI 10.1016/j.biomaterials.2013.07.079; Kataoka K, 2002, J BIOL CHEM, V277, P36825, DOI 10.1074/jbc.M206756200; Lakhter AJ, 2015, MOL ENDOCRINOL, V29, P1535, DOI 10.1210/me.2015-1206; Lee BR, 2012, BIOMATERIALS, V33, P837, DOI 10.1016/j.biomaterials.2011.10.014; Li M, 2016, NAT PROTOC, V11, P1579, DOI 10.1038/nprot.2016.108; Mao GH, 2009, BIOMATERIALS, V30, P1706, DOI 10.1016/j.biomaterials.2008.12.030; Oh K, 2015, ACS NANO, V9, P11718, DOI 10.1021/acsnano.5b02997; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Quesenberry PJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0150-x; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rowley WR, 2012, POPUL HEALTH MANAG, V15, P194, DOI 10.1089/pop.2011.0053; Royo F, 2017, SCI REP-UK, V7, DOI 10.1038/srep42798; Rukstalis JM, 2009, ISLETS, V1, P177, DOI 10.4161/isl.1.3.9877; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; */* S  81, 2014, DIABETES CARE S1, V37, pS8, DOI DOI 10.2337/DC14-S081; Savina A, 2002, J CELL SCI, V115, P2505; Schneider S, 2001, BIOMATERIALS, V22, P1961, DOI 10.1016/S0142-9612(00)00380-X; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeda YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135111; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Vaca P, 2006, STEM CELLS, V24, P258, DOI 10.1634/stemcells.2005-0058; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030; Wen D, 2016, J CONTROL RELEASE, V238, P166, DOI 10.1016/j.jconrel.2016.07.044; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; World Health Organization W, 2015, GLOB REP DIAB; Yoshioka Y, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20424; Zhao M, 2010, J BIOMED MATER RES A, V94A, P667, DOI 10.1002/jbm.a.32624	57	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187665	10.1371/journal.pone.0187665	http://dx.doi.org/10.1371/journal.pone.0187665			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117231	gold, Green Published, Green Submitted			2022-12-26	WOS:000414659600059
J	Sasaki, T; Yoshimura, N; Hashizume, H; Yamada, H; Oka, H; Matsudaira, K; Iwahashi, H; Shinto, K; Ishimoto, Y; Nagata, K; Teraguchi, M; Kagotani, R; Muraki, S; Akune, T; Tanaka, S; Kawaguchi, H; Nakamura, K; Minamide, A; Nakagawa, Y; Yoshida, M				Sasaki, Takahide; Yoshimura, Noriko; Hashizume, Hiroshi; Yamada, Hiroshi; Oka, Hiroyuki; Matsudaira, Ko; Iwahashi, Hiroki; Shinto, Kazunori; Ishimoto, Yuyu; Nagata, Keiji; Teraguchi, Masatoshi; Kagotani, Ryohei; Muraki, Shigeyuki; Akune, Toru; Tanaka, Sakae; Kawaguchi, Hiroshi; Nakamura, Kozo; Minamide, Akihito; Nakagawa, Yukihiro; Yoshida, Munehito			MRI-defined paraspinal muscle morphology in Japanese population: The Wakayama Spine Study	PLOS ONE			English	Article							LOW-BACK-PAIN; RADIOGRAPHIC LUMBAR SPONDYLOSIS; GROWTH-HORMONE-SECRETION; QUALITY-OF-LIFE; FATTY INFILTRATION; BODY-COMPOSITION; AGE; PREVALENCE; SARCOPENIA; COHORT	Objective This study aimed to establish sex- and age-dependent distributions of the cross sectional area and fatty infiltration ratio of paraspinal muscles, and to examine the correlation between paraspinal muscle degeneration and low back pain in the Japanese population. Methods In this cross-sectional study, data from 796 participants (241 men, 555 women; mean age, 63.5 years) were analyzed. The measurement of the cross sectional area and fatty infiltration ratio of the erector spinae and multifidus from the level of T12/L1 to L4/5 and psoas major at the level of T12/L1 was performed using axial T2-weighted magnetic resonance imaging. Multivariate logistic regression analysis was used to estimate the association between fatty infiltration of the paraspinal muscles and the prevalence of low back pain. Results The cross sectional area was larger in men than women, and tended to decrease with age, with the exception of the erector spinae at T12/L1 and L1/2 in women. The fatty infiltration ratio was lower in men than women, except for multifidus at T12/L1 in 70-79 year-olds and psoas major in those less than 50 years-old, and tended to increase with age. Logistic regression analysis adjusted for age, sex, and body mass index showed that the fatty infiltration ratio of the erector spinae at L1/2 and L2/3 was significantly associated with low back pain (L1/2 level: odds ratio, 1.05; 95% confidence interval, 1.005-1.104; L2/3 level: odds ratio, 1.05; 95% confidence interval, 1.001-1.113). Conclusion This study measured the cross sectional area and fatty infiltration ratio of paraspinal muscles in the Japanese population using magnetic resonance imaging, and demonstrated that the fatty infiltration ratio of the erector spinae in the upper lumbar spine was significantly associated with the presence of low back pain. The measurements could be used as reference values, which are important for future comparative studies.	[Sasaki, Takahide; Hashizume, Hiroshi; Yamada, Hiroshi; Iwahashi, Hiroki; Shinto, Kazunori; Ishimoto, Yuyu; Nagata, Keiji; Teraguchi, Masatoshi; Kagotani, Ryohei; Minamide, Akihito; Nakagawa, Yukihiro; Yoshida, Munehito] Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama, Wakayama, Japan; [Yoshimura, Noriko; Muraki, Shigeyuki; Akune, Toru] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Prevent Med Locomot Organ Disorders,Bunkyo K, Tokyo, Japan; [Oka, Hiroyuki; Matsudaira, Ko] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Med Res & Management Musculoskeletal Pain,Bu, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo, Japan; [Kawaguchi, Hiroshi] Tokyo Shinjuku Med Ctr, Japan Community Hlth Care Org, Shinjuku Ku, Tokyo, Japan; [Nakamura, Kozo] Natl Rehabil Ctr Persons Disabil, Rehabil Serv Bur, 1 Namiki 4 Chome, Tokorozawa, Saitama, Japan	Wakayama Medical University; University of Tokyo; University of Tokyo; University of Tokyo	Hashizume, H (corresponding author), Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama, Wakayama, Japan.	hashizum@wakayama-med.ac.jp	Tanaka, Sakae/Y-3061-2019; Hashizume, Hiroshi/V-6888-2019	Tanaka, Sakae/0000-0001-9210-9414; Hashizume, Hiroshi/0000-0002-9064-0284	Ministry of Health, Labor and Welfare [201417014A, H23-Choujyu-002, H-25-Choujyu-007, H25-Nanchitou (Men)-005, H22-Choujyu-Wakate-007]; Japan Society for the Promotion of Science KAKENHI [B26293139, B23390172, B2629333, C20591774, C26462249, C16K10834, C25462305, B17K16699, B25860448, B26861286, B26860419, B15K20013, 15K15219, 26670307, 24659666, 25670293]; Japanese Orthopedics and Traumatology Foundation, Inc. [287]; Ministry of Education, Culture, Sports, Science and Technology in Japan; Grants-in-Aid for Scientific Research [26293331] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Orthopedics and Traumatology Foundation, Inc.; Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by: H23-Choujyu-002 (Director, Toru Akune), H-25-Choujyu-007 (Director, Noriko Yoshimura), H25-Nanchitou (Men)-005 (Director, Sakae Tanaka), 201417014A (Director, Noriko Yoshimura), and H22-Choujyu-Wakate-007 (Director, Shigeyuki Muraki) from the Ministry of Health, Labor and Welfare (http://www.mhiw.go.jp); a Grant-in-Aid for Scientific Research (B26293139, B23390172 to Noriko Yoshimura, B2629333, C20591774 to Shigeyuki Muraki, C26462249 to Hiroshi Hashizume, C16K10834, C25462305 to Hiroshi Yamada); a Grant-in-Aid for Young Researchers (B17K16699 to Takahide Sasaki, B25860448 to Yuyu Ishimoto, B26861286 to Masatoshi Teraguchi, B26860419 to Ryohei Kagotani, B15K20013 to Hiroki Iwahashi; a Grant-in-Aid for Challenging Exploratory Research (15K15219 to Noriko Yoshimura, 26670307 to Shigeyuki Muraki, 24659666 to Hiroyuki Oka, 25670293 to Toru Akune) of Japan Society for the Promotion of Science KAKENHI grant (https://www.isps.go.jp/jg rantsinaid/); a Grant from the Japanese Orthopedics and Traumatology Foundation, Inc. (http://loff.jp) (No. 287) to Masatoshi Teraguchi; and Collaborating Research with NSF 0803301100262 (Director, Noriko Yoshimura) from the Ministry of Education, Culture, Sports, Science and Technology in Japan (http://www.mext.go.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison O, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/309570; Akune T, 2014, OSTEOPOROSIS INT, V25, P1081, DOI 10.1007/s00198-013-2550-z; Ali S, 2014, GERONTOLOGY, V60, P294, DOI 10.1159/000356760; Baumgartner RN, 1999, MECH AGEING DEV, V107, P123, DOI 10.1016/S0047-6374(98)00130-4; BENEKE R, 1991, EUR J APPL PHYSIOL O, V63, P424, DOI 10.1007/BF00868073; BORKAN GA, 1983, J GERONTOL, V38, P673, DOI 10.1093/geronj/38.6.673; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Crawford RJ, 2016, AM J NEURORADIOL, V37, P742, DOI 10.3174/ajnr.A4596; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Danneels LA, 2000, EUR SPINE J, V9, P266, DOI 10.1007/s005860000190; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fortin M, 2013, PHYS THER, V93, P873, DOI 10.2522/ptj.20120457; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51; Ishimoto Y, 2013, OSTEOARTHR CARTILAGE, V21, P783, DOI 10.1016/j.joca.2013.02.656; Iwahashi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160002; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004; Lee S, 2016, EURASIP J IMAGE VIDE, DOI 10.1186/s13640-016-0104-y; Macfarlane GJ, 2012, PAIN, V153, P27, DOI 10.1016/j.pain.2011.08.005; Marzetti E, 2009, MECH AGEING DEV, V130, P272, DOI 10.1016/j.mad.2008.12.008; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Muraki S, 2012, OSTEOARTHR CARTILAGE, V20, P712, DOI 10.1016/j.joca.2012.03.009; Muraki S, 2009, ANN RHEUM DIS, V68, P1401, DOI 10.1136/ard.2007.087296; Muraki S, 2011, SPINE, V36, P1312, DOI 10.1097/BRS.0b013e3181fa60d1; Muraki S, 2010, MOD RHEUMATOL, V20, P444, DOI 10.1007/s10165-010-0307-5; Nagata K, 2014, SPINE J, V14, P2811, DOI 10.1016/j.spinee.2014.03.051; Nagata K, 2012, SPINE, V37, P1892, DOI 10.1097/BRS.0b013e31825a2619; Penna F, 2013, AM J PATHOL, V182, P1367, DOI 10.1016/j.ajpath.2012.12.023; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; ROUBENOFF R, 1993, J NUTR, V123, P469, DOI 10.1093/jn/123.suppl_2.469; RUDMAN D, 1981, J CLIN INVEST, V67, P1361, DOI 10.1172/JCI110164; Samagh SP, 2013, J ORTHOP RES, V31, P421, DOI 10.1002/jor.22233; Sions JM, 2017, J GERIATR PHYS THER, V40, P74, DOI 10.1519/JPT.0000000000000073; Takayama K, 2016, SPINE, V41, pE84, DOI 10.1097/BRS.0000000000001154; Teichtahl AJ, 2015, SPINE J, V15, P1593, DOI 10.1016/j.spinee.2015.03.039; Teraguchi M, 2014, OSTEOARTHR CARTILAGE, V22, P104, DOI 10.1016/j.joca.2013.10.019; Thompson D. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P344; Tong HC, 2005, SPINE, V30, pE499, DOI 10.1097/01.brs.0000176318.95523.12; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8	43	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187765	10.1371/journal.pone.0187765	http://dx.doi.org/10.1371/journal.pone.0187765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117256	Green Submitted, Green Published, gold			2022-12-26	WOS:000414659600073
J	Horvath, G; Meszaros, B; Urszan, TJ; Bajer, K; Molnar, O; Garamszegi, LZ; Herczeg, G				Horvath, Gergely; Meszaros, Boglarka; Urszan, Tamas Janos; Bajer, Katalin; Molnar, Orsolya; Zsolt Garamszegi, Laszlo; Herczeg, Gabor			Environment-dependence of behavioural consistency in adult male European green lizards (Lacerta viridis)	PLOS ONE			English	Article							INDIVIDUAL VARIATION; BODY CONDITION; METABOLIC-RATE; RISK-TAKING; PERSONALITY; REPEATABILITY; TEMPERATURE; PERFORMANCE; EXPOSURE; STATE	Understanding the background mechanisms affecting the emergence and maintenance of consistent between-individual variation within population in single (animal personality) or across multiple (behavioural syndrome) behaviours has key importance. State-dependence theory suggests that behaviour is 'anchored' to individual state (e.g. body condition, gender, age) and behavioural consistency emerges through behavioural-state feedbacks. A number of relevant state variables are labile (e.g. body condition, physiological performance) and expected to be affected by short-term environmental change. Yet, whether short-term environmental shifts affect behavioural consistency during adulthood remains questionable. Here, by employing a full-factorial laboratory experiment, we explored if quantity of food (low vs. high) and time available for thermoregulation (3h vs. 10h per day) had an effect on activity and risk-taking of reproductive adult male European green lizards (Lacerta viridis). We focussed on different components of behavioural variation: (i) strength of behavioural consistency (repeatability for animal personality; between-individual correlation for behavioural syndrome), (ii) behavioural type (individual mean behaviour) and (iii) behavioural predictability (within-individual behavioural variation). Activity was repeatable in all treatments. Risktaking was repeatable only in the low basking treatments. We found significant between-individual correlation only in the low food x long basking time group. The treatments did not affect behavioural type, but affected behavioural predictability. Activity predictability was higher in the short basking treatment, where it also decreased with size (approximate to age). Risk-taking predictability in the short basking treatment increased with size under food limitation, but decreased when food supply was high. We conclude that short-term environmental change can alter various components of behavioural consistency. The effect could be detected in the presence/absence patterns of animal personality and behavioural syndrome and the level of individual behavioural predictability, but not in behavioural type.	[Horvath, Gergely; Meszaros, Boglarka; Urszan, Tamas Janos; Bajer, Katalin; Molnar, Orsolya; Herczeg, Gabor] Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary; [Bajer, Katalin; Molnar, Orsolya] Univ Fed Rio Grande do Norte, Ctr Biociencias, Lab Biogeog & Macroecol, Dept Bot Ecol & Zool, Campus Univ, Natal, RN, Brazil; [Zsolt Garamszegi, Laszlo] Estn Biol Donana CSIC, Dept Evolutionary Ecol, Seville, Spain	Eotvos Lorand University; Universidade Federal do Rio Grande do Norte; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Horvath, G (corresponding author), Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary.	gergohorvath@caesar.elte.hu	Horváth, Gergely/Q-1119-2018; Herczeg, Gabor/AAZ-1661-2021; Bajer-Molnar, Orsolya/E-9684-2014; Herczeg, Gábor/AAF-9978-2020; Garamszegi, Laszlo/M-1488-2015; Meszaros, Boglarka/I-4643-2016	Horváth, Gergely/0000-0002-0485-333X; Herczeg, Gabor/0000-0003-0441-342X; Bajer-Molnar, Orsolya/0000-0002-2458-4659; Garamszegi, Laszlo/0000-0001-8920-2183; Meszaros, Boglarka/0000-0003-0005-8678	Ministry of Economy and Competitiveness (Spain) through the "Programa Estatal de Investigacion Cientifica y Tecnica de Excelencia" [CGL2015-70639-P]; National Research, Development and Innovation Office (NKFIH) [K-115970K]	Ministry of Economy and Competitiveness (Spain) through the "Programa Estatal de Investigacion Cientifica y Tecnica de Excelencia"; National Research, Development and Innovation Office (NKFIH)(National Research, Development & Innovation Office (NRDIO) - Hungary)	LZG was supported by funds from The Ministry of Economy and Competitiveness (Spain) through the "Programa Estatal de Investigacion Cientifica y Tecnica de Excelencia" (CGL2015-70639-P) (http://www.mineco.gob.es), and the National Research, Development and Innovation Office (NKFIH, K-115970K (http://nkfih.gov.hu/english). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049247; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; Bajer K, 2015, BEHAV PROCESS, V111, P67, DOI 10.1016/j.beproc.2014.11.020; Bajer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034359; Barton K., 2016, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauwens D, 1996, ECOLOGY, V77, P1818, DOI 10.2307/2265786; Beckmann C, 2013, ETHOLOGY, V119, P937, DOI 10.1111/eth.12137; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Biro PA, 2012, ANIM BEHAV, V83, P1295, DOI 10.1016/j.anbehav.2012.01.036; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; Briffa M, 2013, ANIM BEHAV, V86, P47, DOI 10.1016/j.anbehav.2013.04.009; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; Carere C., 2013, ANIMAL PERSONALITIES, P1, DOI DOI 10.7208/CHICAGO/9780226922065.003.0001; Civantos E, 2010, PHYSIOL BEHAV, V100, P332, DOI 10.1016/j.physbeh.2010.03.003; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Clarke A, 2004, FUNCT ECOL, V18, P243, DOI 10.1111/j.0269-8463.2004.00841.x; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; David M, 2012, IBIS, V154, P372, DOI 10.1111/j.1474-919X.2012.01216.x; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dingemanse NJ, 2010, PHILOS T R SOC B, V365, P3947, DOI 10.1098/rstb.2010.0221; Dingemanse NJ, 2009, P R SOC B, V276, P1285, DOI 10.1098/rspb.2008.1555; DiRienzo N, 2016, BEHAV ECOL SOCIOBIOL, V70, P1941, DOI 10.1007/s00265-016-2200-5; DiRienzo N, 2016, J ANIM ECOL, V85, P915, DOI 10.1111/1365-2656.12512; DiRienzo N, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00036; DiRienzo N, 2012, ANIM BEHAV, V84, P861, DOI 10.1016/j.anbehav.2012.07.007; Dosmann AJ, 2014, ETHOLOGY, V120, P1, DOI DOI 10.1111/ETH.12320; Engqvist L, 2015, EVOLUTION, V69, P395, DOI 10.1111/evo.12591; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Herczeg G, 2008, OECOLOGIA, V155, P1, DOI 10.1007/s00442-007-0886-9; Herczeg G, 2006, BEHAV ECOL SOCIOBIOL, V60, P405, DOI 10.1007/s00265-006-0180-6; Herczeg G, 2012, BEHAV ECOL SOCIOBIOL, V66, P161, DOI 10.1007/s00265-011-1291-2; Horvath G, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-016-2257-1; Houston AI, 1999, MODELS ADAPTIVE BEHA; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; HUEY RB, 1987, EVOLUTION, V41, P1098, DOI 10.1111/j.1558-5646.1987.tb05879.x; Kekalainen J, 2014, BEHAV ECOL SOCIOBIOL, V68, P197, DOI 10.1007/s00265-013-1634-2; Komers PE, 1997, CAN J ZOOL, V75, P161, DOI 10.1139/z97-023; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Li H, 2016, P R SOC B, P283; Lichtenstein JLL, 2016, BEHAV ECOL SOCIOBIOL, V70, P1793, DOI 10.1007/s00265-016-2184-1; Luttbeg B, 2010, PHILOS T R SOC B, V365, P3977, DOI 10.1098/rstb.2010.0207; Mathot KJ, 2015, INTEGRATIVE ORGANISMAL BIOLOGY, P55; Mathot KJ, 2015, TRENDS ECOL EVOL, V30, P199, DOI 10.1016/j.tree.2015.01.010; Mathot KJ, 2015, FUNCT ECOL, V29, P239, DOI 10.1111/1365-2435.12318; Nakayama S, 2016, BEHAV ECOL, V27, P1676, DOI 10.1093/beheco/arw090; R Core Team, 2021, R LANGUAGE ENV STAT; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; RISMILLER PD, 1991, J COMP PHYSIOL B, V161, P482; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2015, TRENDS ECOL EVOL, V30, P50, DOI 10.1016/j.tree.2014.11.004; Siviter H, 2017, ANIM COGN, V20, P109, DOI 10.1007/s10071-016-1030-1; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Stamps JA, 2016, BIOL REV, V91, P534, DOI 10.1111/brv.12186; Stamps JA, 2012, ANIM BEHAV, V83, P1325, DOI 10.1016/j.anbehav.2012.02.017; Stapley J, 2006, J THERM BIOL, V31, P362, DOI 10.1016/j.jtherbio.2006.01.008; Urszan TJ, 2015, ECOL EVOL, V5, pS847, DOI 10.1002/ece3.1804; Urszan TJ, 2015, OECOLOGIA, V178, P129, DOI 10.1007/s00442-014-3207-0; VANDAMME R, 1991, FUNCT ECOL, V5, P507; Velasque M, 2016, BEHAVIOUR, V153, P1545, DOI 10.1163/1568539X-00003371; Weinstein BG, 2015, METHODS ECOL EVOL, V6, P357, DOI 10.1111/2041-210X.12320; West-Eberhard Mary Jane, 2003, pi; Westneat DF, 2015, BIOL REV, V90, P729, DOI 10.1111/brv.12131; Westneat DF, 2013, BEHAV ECOL, V24, P598, DOI 10.1093/beheco/ars207; Wolf M, 2010, PHILOS T R SOC B, V365, P3959, DOI 10.1098/rstb.2010.0215; Garamszegi LZ, 2015, BEHAV ECOL SOCIOBIOL, V69, P2005, DOI 10.1007/s00265-015-2012-z; Garamszegi LZ, 2012, EVOL ECOL, V26, P1213, DOI 10.1007/s10682-012-9589-8	69	11	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187657	10.1371/journal.pone.0187657	http://dx.doi.org/10.1371/journal.pone.0187657			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112964	Green Published, gold			2022-12-26	WOS:000414572100030
J	Longo, JD; Simaleko, MM; Diemer, HSC; Gresenguet, G; Brucker, G; Belec, L				Longo, Jean De Dieu; Simaleko, Marcel Mbeko; Diemer, Henri Saint-Calvaire; Gresenguet, Gerard; Brucker, Gilles; Belec, Laurent			Risk factors for HIV infection among female sex workers in Bangui, Central African Republic	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; HETEROSEXUAL ANAL INTERCOURSE; BACTERIAL VAGINOSIS; HIGH PREVALENCE; HEALTH-RISKS; BURKINA-FASO; HEPATITIS-B; ALCOHOL-USE; CONDOM USE	Objective The aims of the study were i) to categorize female sex workers (FSW) according to socio-anthropologic criteria in Bangui; ii) to examine the association between a selection of demographic and risk variables with the different categories of female sex work as outcome, and iii) to investigate factors associated with HIV status. Methods A cross-sectional questionnaire survey was conducted to describe the spectrum of commercial sex work in Bangui among 345 sexually active women. After collection of social and behavioral characteristics, each woman received a physical examination and a blood sample was taken for biological analyses, including HIV testing. The relationships between sociodemographic characteristics, behavioral variables involved in high risk for HIV as well as biological results were investigated by bivariate analysis in relationship with FSW categories as main outcomes, and by bivariate analysis followed by multivariate logistic regression analysis in relationship with HIV as the main outcome. The strength of statistical associations was measured by crude and adjusted Odds ratios (OR) and their 95% confidence intervals. Results The typology of FSW comprised six different categories. Two groups were the "official" professional FSW primarily classified according to their locations of work [i) "kata"(1 8.55%) representing women working in poor neighborhoods of Bangui; ii) "pupulenge"(13.91%) working in hotels and night clubs to seek white men]. Four groups were "clandestine" nonprofessional FSW classified according to their reported main activity [i) "market and street vendors" (20.86%); ii) "schoolgirls or students" (19.13%) involved in occasional transactional sex (during holidays); iii)"housewives or unemployed women" (15.65%); iv) "civil servants" (11.88%) working as soldiers or in the public sector]. The overall prevalence of HIV-1 was 19.12% (66/345). HIV varied according to FSW categories. Thus, among professional FSW, the HIV prevalence was 6-fold higher in "kata" than "pupulenge" (39.13% versus 6.30%; P= 0.001). Among nonprofessional FSW, the "vendors" showed the highest HIV prevalence (31.91 %), which was higher than in "students" (6.10%; P= 0.001), "civil servants" (9.83%; P= 0.005), and "housewives" (13.00%; P= 0.01). In bivariate analysis, the following variables showed statistically significant association with risk for HIV infection: nationality; age of first sexual intercourse; self-assessment of HIV risk; knowledge of HIV status; anal sex practice with last clients; irregular condom use in last week; consumption of alcohol; other psycho-active substances; past history of STIs; HBs Ag; HSV-2 and bacterial vaginosis. However, the variable "sex workers categories" dichotomized into professional versus nonprofessional FSW was no longer associated with HIV. In multivariate logistical regression analysis, HIV infection was strongly associated with nationality (15.65% versus 3.77%) [adjusted OR (aOR) 3.39: 95% Cl: 1.25-9.16, P<0.05]; age of first sexual intercourse (21.10% versus 14.00%) (aOR 2.13: 95% Cl: 1.03-4.39, P< 0.05); anal sex practice with last clients (43.40% versus 11.50%) (aOR 4.31: 95% Cl: 2.28-8.33, P< 0.001); irregular condom use in past week (33.50% versus 3.00%) (aOR 5.49: 95% Cl: 1.89-15.98, P< 0.001); alcohol consumption before sex (34.70% versus 7.80%) (aOR 2.69: 95% Cl: 1.22-4.96, P< 0.05); past history of STIs (41.00% versus 10.80%) (aOR 2.46: 95% Cl: 1.22-4.97, P< 0.05) and bacterial vaginosis (29.80% versus 4.29%) (aOR 6.36: 95% Cl: 2.30-17.72, P< 0.001). Conclusion Our observations highlight the high level of vulnerability for HIV acquisition of both poor professional "kata" and nonprofessional "street vendor" FSW categories. These categories should be particularly taken into account when designing specific prevention programs for STIs/HIV control purposes.	[Longo, Jean De Dieu; Simaleko, Marcel Mbeko; Diemer, Henri Saint-Calvaire; Gresenguet, Gerard] Ctr Natl Reference Malad Sexuellement Transmissib, Bangui, Cent Afr Republ; [Longo, Jean De Dieu; Gresenguet, Gerard] Fac Sci Sante Bangui, Dept Sante Publ, Unite Rech & Intervent Malad Sexuellement Transmi, Bangui, Cent Afr Republ; [Brucker, Gilles] Univ Paris Sud, Bicetre Hosp, AP HP, Dept Sante Publ, Le Kremlin Bicetre, France; [Brucker, Gilles] AP HP, Direct Int, Paris, France; [Belec, Laurent] Hop Europeen Georges Pompidou, AP HP, Lab Microbiol, Paris, France; [Belec, Laurent] Univ Paris 05, Sorbonne Paris Cite, Fac Med Paris Descartes, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Longo, JD (corresponding author), Ctr Natl Reference Malad Sexuellement Transmissib, Bangui, Cent Afr Republ.; Longo, JD (corresponding author), Fac Sci Sante Bangui, Dept Sante Publ, Unite Rech & Intervent Malad Sexuellement Transmi, Bangui, Cent Afr Republ.	jddlongo@yahoo.fr			GIP-ESTHER, Paris, France	GIP-ESTHER, Paris, France	This project was grafted on the national reproductive health program and the fight against HIV / AIDS in Central African Republic.; Furthermore, partial funding was obtained from GIP-ESTHER, Paris, France, for biological analyses.	Aklilu M, 2001, AIDS, V15, P87, DOI 10.1097/00002030-200101050-00013; Alexander M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088858; Baganizi E, 1997, AIDS, V11, P685; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Belec L, 2012, LANCET, V380, P1993, DOI 10.1016/S0140-6736(12)62156-4; Beyrer C, 2015, LANCET, V385, P287, DOI 10.1016/S0140-6736(14)60933-8; Boily MC, 2009, SEX TRANSM INFECT, V85, P408, DOI 10.1136/sti.2009.037499; Busza J, 2016, AIDS CARE, V28, P14, DOI 10.1080/09540121.2016.1176673; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Choi SYP, 2011, SOCIOL HEALTH ILL, V33, P33, DOI 10.1111/j.1467-9566.2010.01265.x; Cwikel JG, 2008, SEX HEALTH, V5, P9, DOI 10.1071/SH07024; Das P, 2015, LANCET, V385, P3, DOI 10.1016/S0140-6736(14)61064-3; Dhana A, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-46; Ding YP, 2005, JAIDS-J ACQ IMM DEF, V38, P314; Elmes J, 2014, J INFECT DIS, V210, pS569, DOI 10.1093/infdis/jiu493; Elmore-Meegan M, 2004, REPROD HEALTH MATTER, V12, P50, DOI 10.1016/S0968-8080(04)23125-1; Ettiegne-Traore V, 1998, INT J STD AIDS, V9, P173, DOI 10.1258/0956462981921819; Forbi JC, 2008, REV INST MED TROP SP, V50, P219, DOI 10.1590/S0036-46652008000400006; Ghys PD, 2002, AIDS, V16, P251, DOI 10.1097/00002030-200201250-00015; Gmel G, 2011, ADDICTION, V106, P1051, DOI 10.1111/j.1360-0443.2011.03438.x; Gresenguet G, 2002, JAIDS-J ACQ IMM DEF, V31, P106, DOI 10.1097/00126334-200209010-00014; Gresenguet G, 1997, AIDS, V11, P101, DOI 10.1097/00002030-199701000-00015; GRESENGUET G, 1991, B SOC PATHOL EXOT, V84, P240; Halperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717; Hanenberg R, 1998, AIDS CARE, V10, P69, DOI 10.1080/713612352; Hawken MP, 2002, SEX TRANSM INFECT, V78, P271, DOI 10.1136/sti.78.4.271; Jespers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109670; Johnston CL, 2010, DRUG ALCOHOL REV, V29, P144, DOI 10.1111/j.1465-3362.2009.00091.x; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Kalichman SC, 2008, PREV SCI, V9, P55, DOI 10.1007/s11121-008-0085-x; Kalichman SC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-807; Karim SSA, 1998, AM J PUBLIC HEALTH, V88, P1265, DOI 10.2105/AJPH.88.8.1265-a; Komas NP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-226; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Laurent C, 2003, AIDS, V17, P1811, DOI 10.1097/00002030-200308150-00010; LeGoff J, 2007, AIDS, V21, P1569, DOI 10.1097/QAD.0b013e32825a69bd; Longo JDD, 2015, HLTH SCI DIS, V16; Longo JDD, SAHARA J    IN PRESS; Low A, 2015, JAIDS-J ACQ IMM DEF, V68, pS180, DOI 10.1097/QAI.0000000000000441; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; MARTIN PMV, 1992, RES VIROLOGY, V143, P205, DOI 10.1016/S0923-2516(06)80105-6; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; McClure C, 2015, LANCET, V385, P97, DOI 10.1016/S0140-6736(14)60979-X; Melhem NM, 2015, WORLD J HEPATOL, V7, P2619, DOI 10.4254/wjh.v7.i25.2619; Mirmonsef P, 2012, CURR HIV RES, V10, P202, DOI 10.2174/157016212800618165; Morojele NK, 2006, SOC SCI MED, V62, P217, DOI 10.1016/j.socscimed.2005.05.031; MOSES S, 1991, AIDS, V5, P407, DOI 10.1097/00002030-199104000-00008; Mosoko JJ, 2009, AIDS BEHAV, V13, P277, DOI 10.1007/s10461-007-9294-8; Mountain E, 2014, EXPERT REV ANTI-INFE, V12, P1203, DOI 10.1586/14787210.2014.948422; Mulanga-Kabeya C, 1999, SEX TRANSM INFECT, V75, P358, DOI 10.1136/sti.75.5.358; NAGELKERKE NJD, 1990, AIDS, V4, P743, DOI 10.1097/00002030-199008000-00005; Nagot N, 2002, J ACQ IMMUN DEF SYND, V29, P517, DOI 10.1097/00126334-200204150-00013; Ngugi EN, 2012, SAHARA J-J SOC ASP H, V9, P148, DOI 10.1080/17290376.2012.743825; Ngugi EN, 1996, J INFECT DIS, V174, pS240, DOI 10.1093/infdis/174.Supplement_2.S240; Ntumbanzondo M, 2006, AIDS CARE, V18, P777, DOI 10.1080/09540120500412824; Overs C, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18459; Passmore JAS, 2016, CURR OPIN HIV AIDS, V11, P156, DOI 10.1097/COH.0000000000000232; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; PAWLOTSKY JM, 1995, J MED VIROL, V46, P269, DOI 10.1002/jmv.1890460318; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Puradiredja DI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052858; Scheibe A, 2012, SAHARA J-J SOC ASP H, V9, P167, DOI 10.1080/17290376.2012.743809; Silverman JG, 2011, ARCH DIS CHILD, V96, P478, DOI 10.1136/adc.2009.178715; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Tucker JD, 2013, CURR OPIN INFECT DIS, V26, P73, DOI 10.1097/QCO.0b013e32835c21b0; UNICEF, 2011, CENTR AFR REP STAT; van de Wijgert JHHM, 2009, SEX TRANSM DIS, V36, P357, DOI 10.1097/OLQ.0b013e3181a4f695; Vandenhoudt HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054953; Vandepitte JM, 2007, SEX TRANSM DIS, V34, P203, DOI 10.1097/01.olq.0000233743.57334.6a; Vuylsteke B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032627; Walden VM, 1999, HEALTH EDUC RES, V14, P545, DOI 10.1093/her/14.4.545; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; WHO, 2005, ALC US SEX RISK BEH; WHO, 2015, WHO GUID PREV CAR TR; World Health Organization, 2012, IMPL COMPR HIV STI P; World Health Organization, 2001, BRIEF INTERVENTION F; Zhou C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-225	79	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187654	10.1371/journal.pone.0187654	http://dx.doi.org/10.1371/journal.pone.0187654			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL7JU	29108022	Green Submitted, gold, Green Published			2022-12-26	WOS:000414424600054
J	Kumar, RP; Morehouse, BR; Fofana, J; Trieu, MM; Zhou, DH; Lorenz, MO; Oprian, DD				Kumar, Ramasamy P.; Morehouse, Benjamin R.; Fofana, Josiane; Trieu, Melissa M.; Zhou, Daniel H.; Lorenz, Molly O.; Oprian, Daniel D.			Structure and monomer/dimer equilibrium for the guanylyl cyclase domain of the optogenetics protein RhoGC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; cyclic GMP (cGMP); disulfide; guanylate cyclase (guanylyl cyclase); optogenetics; rhodopsin; Blastocladiella emersonii; class III nucleotidyl cyclase	ADENYLYL-CYCLASE; CATALYTIC DOMAINS; CRYSTAL-STRUCTURE; FUSION PROTEIN; PURIFICATION; EXPRESSION; INTERFACE; MECHANISM; CGMP; TOOL	RhoGC is a fusion protein from the aquatic fungus Blastocladiella emersonii, combining a type I rhodopsin domain with a guanylyl cyclase domain. It has generated excitement as an optogenetics tool for the manipulation of cyclic nucleotide signaling pathways. To investigate the regulation of the cyclase activity, we isolated the guanylyl cyclase domain from Escherichia coli with (GCwCC(Rho)) and without (GC(Rho)) the coiled-coil linker. Both constructs were constitutively active but were monomeric as determined by size-exclusion chromatography and analytical ultracentrifugation, whereas other class III nucleotidyl cyclases are functional dimers. We also observed that crystals of GC(Rho) have only a monomer in an asymmetric unit. Dimers formed when crystals were grown in the presence of the non-cyclizable substrate analog 2,3-dideoxyguanosine-5-triphosphate, MnCl2, and tartrate, but their quaternary structure did not conform to the canonical pairing expected for class III enzymes. Moreover, the structure contained a disulfide bond formed with an active-site Cys residue required for activity. We consider it unlikely that the disulfide would form under intracellular reducing conditions, raising the possibility that this unusual dimer might have a biologically relevant role in the regulation of full-length RhoGC. Although we did not observe it with direct methods, a functional dimer was identified as the active state by following the dependence of activity on total enzyme concentration. The low affinity observed for GC(Rho) monomers is unusual for this enzyme class and suggests that dimer formation may contribute to light activation of the full-length protein.	[Kumar, Ramasamy P.; Morehouse, Benjamin R.; Fofana, Josiane; Trieu, Melissa M.; Zhou, Daniel H.; Lorenz, Molly O.; Oprian, Daniel D.] Brandeis Univ, Dept Biochem, 415 South St, Waltham, MA 02454 USA	Brandeis University	Oprian, DD (corresponding author), Brandeis Univ, Dept Biochem, 415 South St, Waltham, MA 02454 USA.	oprian@brandeis.edu		Ramasamy, Prem/0000-0002-6555-8289; Morehouse, Benjamin/0000-0003-3352-5463	Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [R01EY007965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596] Funding Source: NIH RePORTER	Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research used resources of the Advanced Light Source, which is a Department of Energy Office of Science User Facility under Contract No. DE-AC02-05CH11231. We are grateful to the staff at the Advanced Light Source-Berkeley Center for Structural Biology for their assistance in X-ray data collection. We thank the Adar family and friends for continued support throughout this work. We also thank Prof. Timothy Street and Jackson Halpin for sharing their HPLC and providing technical advice. We thank Prof. Bruce Foxman for helpful discussions on crystallography.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allerston CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057644; Avelar GM, 2014, CURR BIOL, V24, P1234, DOI 10.1016/j.cub.2014.04.009; Barathy D, 2014, IUCRJ, V1, P338, DOI 10.1107/S2052252514016741; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bieger B, 2001, EMBO J, V20, P433, DOI 10.1093/emboj/20.3.433; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gao SQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9046; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Lamarche LB, 2017, BIOCHEMISTRY-US, V56, P5812, DOI 10.1021/acs.biochem.7b00519; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lucas KA, 2000, PHARMACOL REV, V52, P375; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Scheib U, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0611; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; Trieu MM, 2017, J BIOL CHEM, V292, P10379, DOI 10.1074/jbc.M117.789636; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshida K, 2017, J BIOL CHEM, V292, P7531, DOI 10.1074/jbc.M117.775569; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0	34	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21578	21589		10.1074/jbc.M117.812685	http://dx.doi.org/10.1074/jbc.M117.812685			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29118188	hybrid, Green Published			2022-12-26	WOS:000419013000032
J	Intapad, S; Dasinger, JH; Fahling, JM; Backstrom, MA; Alexander, BT				Intapad, Suttira; Dasinger, John Henry; Fahling, Joel M.; Backstrom, Miles A.; Alexander, Barbara T.			Testosterone is protective against impaired glucose metabolism in male intrauterine growth-restricted offspring	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; NUTRITION EXAMINATION SURVEY; ENDOGENOUS SEX-HORMONES; 3RD NATIONAL-HEALTH; CARDIOVASCULAR EVENTS; REPLACEMENT THERAPY; INSULIN-RESISTANCE; BODY-COMPOSITION; BLOOD-PRESSURE; PROTEIN-DIET	Placental insufficiency alters the intrauterine environment leading to increased risk for chronic disease including impaired glucose metabolism in low birth weight infants. Using a rat model of low birth weight, we previously reported that placental insufficiency induces a significant increase in circulating testosterone in male intrauterine growth-restricted offspring (mIUGR) in early adulthood that is lost by 12 months of age. Numerous studies indicate testosterone has a positive effect on glucose metabolism in men. Female growthrestricted littermates exhibit glucose intolerance at 6 months of age. Thus, the aim of this paper was to determine whether mIUGR develop impaired glucose metabolism, and whether a decrease in elevated testosterone levels plays a role in its onset. Male growthrestricted offspring were studied at 6 and 12 months of age. No impairment in glucose tolerance was observed at 6 months of age when mIUGR exhibited a 2-fold higher testosterone level compared to age-matched control. Fasting blood glucose was significantly higher and glucose tolerance was impaired with a significant decrease in circulating testosterone in mIUGR at 12 compared with 6 months of age. Castration did not additionally impair fasting blood glucose or glucose tolerance in mIUGR at 12 months of age, but fasting blood glucose was significantly elevated in castrated controls. Restoration of elevated testosterone levels significantly reduced fasting blood glucose and improved glucose tolerance in mIUGR. Thus, our findings suggest that the endogenous increase in circulating testosterone in mIUGR is protective against impaired glucose homeostasis.	[Intapad, Suttira] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; [Intapad, Suttira; Dasinger, John Henry; Fahling, Joel M.; Backstrom, Miles A.; Alexander, Barbara T.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA	Tulane University; University of Mississippi; University of Mississippi Medical Center	Intapad, S (corresponding author), Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.; Intapad, S (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA.	sintapad@tulane.edu		Intapad, Suttira/0000-0003-0750-3252	National Institutes of Health Grant (NIH) [HL074927]; American Heart Grant (AHA) [GRNT19900004]; NIH [P20GM104357, HL51971, T32HL105324]; AHA [12POST11980021, 16SDG27770041, PRE24700010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	National Institutes of Health Grant (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Grant (AHA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant (NIH) HL074927 and the American Heart Grant (AHA) GRNT19900004 to B. T. Alexander. Additional funding was provided by NIH P20GM104357 and HL51971. Intapad and J. Dasinger were supported by funding from the AHA, 12POST11980021 and 16SDG27770041. J. Dasinger also received support from a NIH T32HL105324 and from the AHA PRE24700010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afiadata A, 2014, Hosp Pract (1995), V42, P69, DOI 10.3810/hp.2014.12.1160; Al Salmi I, 2008, DIABETES CARE, V31, P159, DOI 10.2337/dc07-1170; Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; Basaria S, 2013, J GERONTOL A-BIOL, V68, P153, DOI 10.1093/gerona/gls138; Bhattacharya RK, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-18; BOGARDUS C, 1984, J CLIN INVEST, V74, P1238, DOI 10.1172/JCI111533; Boyanov M A, 2003, Aging Male, V6, P1; Carlsson S, 1999, DIABETES CARE, V22, P1043, DOI 10.2337/diacare.22.7.1043; Chamson-Reig A, 2009, EXP BIOL MED, V234, P1425, DOI 10.3181/0902-RM-69; Christe N, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14216; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Dasinger JH, 2016, AM J PHYSIOL-RENAL, V311, pF312, DOI 10.1152/ajprenal.00123.2016; De Pergola G, 2000, INT J OBESITY, V24, pS59, DOI 10.1038/sj.ijo.0801280; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Eriksson M, 2004, J INTERN MED, V255, P236, DOI 10.1046/j.1365-2796.2003.01289.x; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Gatford KL, 2008, ENDOCRINOLOGY, V149, P5118, DOI 10.1210/en.2008-0233; Grossmann M, 2015, CLIN ENDOCRINOL, V83, P344, DOI 10.1111/cen.12664; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hou WW, 2015, DIABETIC MED, V32, P505, DOI 10.1111/dme.12602; Intapad S, 2016, PEDIATR RES, V79, P962, DOI 10.1038/pr.2016.14; Intapad S, 2013, HYPERTENSION, V61, P828, DOI 10.1161/HYPERTENSIONAHA.111.00645; Jahan-Mihan A, 2015, NUTRIENTS, V7, P9185, DOI 10.3390/nu7115460; Jansson T, 1999, J HYPERTENS, V17, P1239, DOI 10.1097/00004872-199917090-00002; Jones TH, 2011, DIABETES CARE, V34, P828, DOI 10.2337/dc10-1233; Jornayvaz FR, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0389-2; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Li J, 2017, J DIABETES COMPLICAT, V31, P318, DOI 10.1016/j.jdiacomp.2016.10.022; Magnussen LV, 2016, DIABETES OBES METAB, V18, P980, DOI 10.1111/dom.12701; MARIN P, 1992, INT J OBESITY, V16, P991; Mogren I, 2003, SCAND J PUBLIC HEALT, V31, P382, DOI 10.1080/14034940210165136; Oh JY, 2002, DIABETES CARE, V25, P55, DOI 10.2337/diacare.25.1.55; Ojeda NB, 2007, AM J PHYSIOL-REG I, V292, pR758, DOI 10.1152/ajpregu.00311.2006; Onasanya O, 2016, LANCET DIABETES ENDO, V4, P943, DOI 10.1016/S2213-8587(16)30215-7; Owens JA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1879, DOI 10.1152/ajpendo.00706.2006; Petry C J, 2001, Int J Exp Diabetes Res, V2, P139; Saad F, 2009, ARQ BRAS ENDOCRINOL, V53, P901, DOI 10.1590/S0004-27302009000800002; Selvin E, 2007, DIABETES CARE, V30, P234, DOI 10.2337/dc06-1579; Siebel AL, 2008, ENDOCRINOLOGY, V149, P3067, DOI 10.1210/en.2008-0128; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; Williamson JR, 1996, P NATL ACAD SCI USA, V56, P247; Yarmolinsky J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37032; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462; Zerradi M, 2014, CURR OBES REP, V3, P396, DOI 10.1007/s13679-014-0119-6; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8; Zimmermann E, 2015, DIABETES, V64, P4220, DOI 10.2337/db15-0494	49	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187843	10.1371/journal.pone.0187843	http://dx.doi.org/10.1371/journal.pone.0187843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145418	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800034
J	Perez, EC; Xander, P; Laurindo, MFL; Brito, RRNE; Vivanco, BC; Mortara, RA; Mariano, M; Lopes, JD; Keller, AC				Perez, Elizabeth Cristina; Xander, Patricia; Lucatelli Laurindo, Maria Fernanda; Novaes e Brito, Ronni Romulo; Vivanco, Bruno Camolese; Mortara, Renato Arruda; Mariano, Mario; Lopes, Jose Daniel; Keller, Alexandre Castro			The axis IL-10/claudin-10 is implicated in the modulation of aggressiveness of melanoma cells by B-1 lymphocytes	PLOS ONE			English	Article							CANCER; NORMALIZATION; METASTASIS; CROSSTALK; PRECURSOR; MICE	B-1 lymphocytes are known to increase the metastatic potential of B16F10 melanoma cells via the extracellular signal-regulated kinase (ERK) pathway. Since IL-10 is associated with B-1 cells performance, we hypothesized that IL-10 could be implicated in the progression of melanoma. In the present work, we found that the C57BL/6 mice, inoculated with B16F10 cells that were co-cultivated with B-1 lymphocytes from IL-10 knockout mice, developed fewer metastatic nodules than the ones which were injected with the melanoma cells that were cultivated in the presence of wild-type B-1 cells. The impairment of metastatic potential of the B16F10 cells was correlated with low activation of the ERK signaling pathway, supporting the idea that the production of IL-10 by B-1 cells influences the behavior of the tumor. A microarray analysis of the B-1 lymphocytes revealed that IL-10 deficiency is associated with down-regulation of the genes that code for claudin-10, a protein that is involved in cell-to-cell contact and that has been linked to lung adenocarcinoma. In order to determine the impact of claudin-10 in the cross-talk between B-1 lymphocytes and the B16F10 tumor cells, we took advantage of small interfering RNA. The silencing of claudin-10 gene in B-1 lymphocytes inhibited activation of the ERK pathway and abrogated the B-1-induced aggressive behavior of the B16F10 cells. Thus, our findings suggest that the axis IL-10/claudin-10 is a promising target for the development of therapeutic agents against aggressive melanoma.	[Perez, Elizabeth Cristina; Mariano, Mario] Univ Paulista, Environm & Expt Pathol Program, Sao Paulo, SP, Brazil; [Perez, Elizabeth Cristina; Lucatelli Laurindo, Maria Fernanda; Vivanco, Bruno Camolese; Mortara, Renato Arruda; Mariano, Mario; Lopes, Jose Daniel; Keller, Alexandre Castro] Univ Fed Sao Paulo Escola Paulista Med UNIFESP EPM, Dept Microbiol Immunol & Parasitol, Sao Paulo, SP, Brazil; [Xander, Patricia] Univ Fed Sao Paulo, Dept Pharmaceut Sci, Campus Diadema, Diadema, SP, Brazil; [Novaes e Brito, Ronni Romulo] Ctr Univ Sao Camilo, Sao Paulo, SP, Brazil; [Keller, Alexandre Castro] Univ Fed Sao Paulo Escola Paulista Med UNIFESP EPM, Nephrol Div, Dept Med, Sao Paulo, SP, Brazil	Universidade Paulista; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Centro Universitario Sao Camilo; Universidade Federal de Sao Paulo (UNIFESP)	Keller, AC (corresponding author), Univ Fed Sao Paulo Escola Paulista Med UNIFESP EPM, Dept Microbiol Immunol & Parasitol, Sao Paulo, SP, Brazil.; Keller, AC (corresponding author), Univ Fed Sao Paulo Escola Paulista Med UNIFESP EPM, Nephrol Div, Dept Med, Sao Paulo, SP, Brazil.	elicristin@hotmail.com; ackeller.unifesp@gmail.com	Keller, Alexandre C/E-4621-2012; Pérez, Elizabeth C/E-8057-2012; Xander, Patricia/E-4682-2012; Mortara, Renato A./C-1864-2012	Keller, Alexandre C/0000-0002-7827-0292; Pérez, Elizabeth C/0000-0003-3038-9902; Xander, Patricia/0000-0002-6329-6449; Mortara, Renato A./0000-0002-2311-8349	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/50256-6, 08/50632-5, 2016/02189-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472035/2011-8, 308374/2016-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; www.fapesp.br), grant numbers 11/50256-6; 08/50632-5 and 2016/02189-1; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; www.cnpq.br), grant numbers 472035/2011-8 and 308374/2016-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz M, 2015, IMMUNOL RES, V63, P153, DOI 10.1007/s12026-015-8708-3; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Choi EO, 2017, BIOMOL THER, V25, P213, DOI 10.4062/biomolther.2016.094; Eljaszewicz A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/831387; Fujimura T, 2016, J DERMATOL SCI, V83, P167, DOI 10.1016/j.jdermsci.2016.05.015; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lopes JD, 2009, AN ACAD BRAS CIENC, V81, P489, DOI 10.1590/S0001-37652009000300013; Neesse A, 2012, ARCH BIOCHEM BIOPHYS, V524, P64, DOI 10.1016/j.abb.2012.01.009; Neesse A, 2013, GUT, V62, P1034, DOI 10.1136/gutjnl-2012-302577; Popi AF, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00138; Popi AF, 2008, MICROBES INFECT, V10, P817, DOI 10.1016/j.micinf.2008.04.012; Sindhava VJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00372; Singh AB, 2017, PFLUG ARCH EUR J PHY, V469, P69, DOI 10.1007/s00424-016-1919-1; Soini Y, 2012, INT J CLIN EXP PATHO, V5, P126; Staquicini FI, 2008, CANCER RES, V68, P8419, DOI 10.1158/0008-5472.CAN-08-1242; Vigna AF, 2006, MICROBES INFECT, V8, P589, DOI 10.1016/j.micinf.2005.06.033; Xander P, 2017, J PARASITOL; Xander P, 2013, IMMUNOBIOLOGY, V218, P1293, DOI 10.1016/j.imbio.2013.04.017; Zhang ZF, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-95	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187333	10.1371/journal.pone.0187333	http://dx.doi.org/10.1371/journal.pone.0187333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145406	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800015
J	Velez, R; Clune, J				Velez, Roby; Clune, Jeff			Diffusion-based neuromodulation can eliminate catastrophic forgetting in simple neural networks	PLOS ONE			English	Article							NITRIC-OXIDE; SYNAPTIC-TRANSMISSION; GLUTAMATE SPILLOVER; DOPAMINE; CONSTRAINTS; HIPPOCAMPUS; PLASTICITY; MODULARITY; RECEPTORS; EVOLUTION	A long-term goal of AI is to produce agents that can learn a diversity of skills throughout their lifetimes and continuously improve those skills via experience. A longstanding obstacle towards that goal is catastrophic forgetting, which is when learning new information erases previously learned information. Catastrophic forgetting occurs in artificial neural networks (ANNs), which have fueled most recent advances in AI. A recent paper proposed that catastrophic forgetting in ANNs can be reduced by promoting modularity, which can limit forgetting by isolating task information to specific clusters of nodes and connections (functional modules). While the prior work did show that modular ANNs suffered less from catastrophic forgetting, it was not able to produce ANNs that possessed task-specific functional modules, thereby leaving the main theory regarding modularity and forgetting untested. We introduce diffusion-based neuromodulation, which simulates the release of diffusing, neuromodulatory chemicals within an ANN that can modulate (i.e. up or down regulate) learning in a spatial region. On the simple diagnostic problem from the prior work, diffusion-based neuromodulation 1) induces task-specific learning in groups of nodes and connections (task-specific localized learning), which 2) produces functional modules for each subtask, and 3) yields higher performance by eliminating catastrophic forgetting. Overall, our results suggest that diffusion-based neuromodulation promotes task-specific localized learning and functional modularity, which can help solve the challenging, but important problem of catastrophic forgetting.	[Velez, Roby; Clune, Jeff] Univ Wyoming, Dept Comp Sci, Laramie, WY 82071 USA; [Clune, Jeff] UberAI Labs, San Francisco, CA 94107 USA	University of Wyoming	Clune, J (corresponding author), Univ Wyoming, Dept Comp Sci, Laramie, WY 82071 USA.; Clune, J (corresponding author), UberAI Labs, San Francisco, CA 94107 USA.	jeffclune@uwyo.edu			NSF CAREER award [CAREER: 1453549]; Wyoming NASA Space Grant Consortium Grant [NNX15AI08H]; Wyoming Space Consortium Grant [NNX10A095H]	NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Wyoming NASA Space Grant Consortium Grant; Wyoming Space Consortium Grant	Jeff Clune and Roby Velez were supported by an NSF CAREER award (CAREER: 1453549). Jeff Clune was also supported by a Wyoming NASA Space Grant Consortium Grant (#NNX15AI08H) and Roby Velez was supported by a Wyoming Space Consortium Grant (#NNX10A095H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Jeff Clune and Roby Velez were supported by an NSF CAREER award (CAREER: 1453549). Jeff Clune was also supported by a Wyoming NASA Space Grant Consortium Grant (#NNX15AI08H) and Roby Velez was supported by a Wyoming Space Consortium Grant (#NNX10A095H). All experiments were conducted on the Mount Moran computing cluster at the University of Wyoming Advanced Research Computing Center (ARCC). The authors thank the ARCC staff for their support, and the members of the Evolving AI Lab at the University of Wyoming for valuable feedback on this draft, especially Joost Huizinga, Kai Ellefsen, and Nicholas Cheney. We also thank James Kirkpatrick and one anonymous reviewer for their valuable insights, which improved the manuscript.	Agnati LF, 2006, ACTA PHYSIOL, V187, P329, DOI 10.1111/j.1748-1716.2006.01579.x; Agnati LF, 2010, BRAIN RES REV, V64, P137, DOI 10.1016/j.brainresrev.2010.03.003; Alon U., 2006, INTRO SYSTEMS BIOL D; [Anonymous], 2017, P NATL ACAD SCI; [Anonymous], 1998, NEURAL NETWORKS COMP; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Baldwin CY, 2000, DESIGN RULES POWER M, V1; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Christian SF, 1990, ADV NEURAL INFORM PR, V2; Clune J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2863; DAWSON TM, 1994, J NEUROSCI, V14, P5147; De-Miguel FF, 2005, CELL MOL NEUROBIOL, V25, P297, DOI 10.1007/s10571-005-3061-z; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM, P6, DOI [10.1007/s10589-007-9053-9, DOI 10.1007/S10589-007-9053-9]; Descarries L, 1996, J COMP NEUROL, V375, P167; DESCARRIES L, 1975, BRAIN RES, V100, P563, DOI 10.1016/0006-8993(75)90158-4; Diamond JS, 2002, NAT NEUROSCI, V5, P291, DOI 10.1038/nn0402-291; Ellefsen KO, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004128; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Esplugues JV, 2002, BRIT J PHARMACOL, V135, P1079, DOI 10.1038/sj.bjp.0704569; Fine P, 2006, LECT NOTES COMPUT SC, V4095, P546; Floreano D., 2008, BIOINSPIRED ARTIFICI; French R. M., 1992, Connection Science, V4, P365, DOI 10.1080/09540099208946624; French RM, 1999, TRENDS COGN SCI, V3, P128, DOI 10.1016/S1364-6613(99)01294-2; Fuxe K, 2007, BRAIN RES REV, V55, P17, DOI 10.1016/j.brainresrev.2007.02.009; Fuxe K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00136; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Goodfellow IJ, 2013, ARXIV131262112013; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Gutstein S, 2015, 2015 INT JOINT C NEU, P1, DOI [10.1109/IJCNN.2015.7280416, DOI 10.1109/IJCNN.2015.7280416]; Haykin S., 2009, NEURAL NETWORKS LEAR; Hebb D. O., 2005, ORG BEHAV NEUROPSYCH; Hinton G.E., 1987, P 9 ANN C COGNITIVE, P177; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; Huang EP, 1998, CURR BIOL, V8, pR613, DOI 10.1016/S0960-9822(98)70389-6; Huizinga J, 2014, GECCO'14: PROCEEDINGS OF THE 2014 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P697, DOI 10.1145/2576768.2598232; Husbands P, 1998, CONNECT SCI, V10, P185, DOI 10.1080/095400998116404; Isaacson JS, 2000, CURR BIOL, V10, pR475, DOI 10.1016/S0960-9822(00)00551-0; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Klingenberg C.P., 2005, VARIATION CENTRAL CO, P1; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Levine S, 2016, J MACH LEARN RES, V17; Levitan IB, 2015, NEURON CELL MOL BIOL; Lipson Hod, 2007, Journal of Biological Physics and Chemistry, V7, P125, DOI 10.4024/40701.jbpc.07.04; Luders B, 2017, LECT NOTES COMPUT SC, V10199, P886, DOI 10.1007/978-3-319-55849-3_57; Marder E, 2002, NEURAL NETWORKS, V15, P479, DOI 10.1016/S0893-6080(02)00043-6; McHale G, 2004, FROM ANIMALS TO ANIMATS 8, P163; Mengistu H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004829; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Mouret J. -B., 2010, EV COMP CEC 2010 IEE, P1; Mouret JB, 2012, EVOLUTIONARY COMPUTA, V1; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; Risi S, 2010, LECT NOTES ARTIF INT, V6226, P533, DOI 10.1007/978-3-642-15193-4_50; Robins A., 1995, Connection Science, V7, P123, DOI 10.1080/09540099550039318; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Rusu A. A., 2016, PROGR NEURAL NETWORK; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Sem'yanov A V, 2005, Neurosci Behav Physiol, V35, P253, DOI 10.1007/s11055-005-0051-z; Soltoggio Andrea, 2008, 2008 8th International Conference on Hybrid Intelligent Systems (HIS), P637, DOI 10.1109/HIS.2008.155; Soltoggio A., 2008, ARTIFICIAL LIFE, VXI, P569; Soltoggio A, 2007, IEEE C EVOL COMPUTAT, P2471, DOI 10.1109/CEC.2007.4424781; Stanley KO, 2007, GENET PROGRAM EVOL M, V8, P131, DOI 10.1007/s10710-007-9028-8; Susswein AJ, 2004, NEUROSCIENTIST, V10, P153, DOI 10.1177/1073858403261226; Taber KH, 2014, J NEUROPSYCHIATRY CL, V26, P4, DOI [10.1176/appi.neuropsych.13110351, DOI 10.1176/APPI.NEUR0PSYCH]; Tonelli P, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1531; TRUETA C, 2012, FRONT PHYSIOL, V3; Velez R, 2016, GECCO'16: PROCEEDINGS OF THE 2016 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P181, DOI 10.1145/2908812.2908839; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; WIDROW B, 1990, P IEEE, V78, P1415, DOI 10.1109/5.58323; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; WOOD J, 1994, NEUROPHARMACOLOGY, V33, P1235, DOI 10.1016/0028-3908(94)90022-1; Yao X, 1999, P IEEE, V87, P1423, DOI 10.1109/5.784219	85	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187736	10.1371/journal.pone.0187736	http://dx.doi.org/10.1371/journal.pone.0187736			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145413	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800028
J	Xia, D; Zhou, H; Qiu, L; Jiang, HC; Zhang, QL; Gao, GJ; He, YQ				Xia, Duo; Zhou, Hao; Qiu, Lei; Jiang, Haichao; Zhang, Qinglu; Gao, Guanjun; He, Yuqing			Mapping and verification of grain shape QTLs based on an advanced backcross population in rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; NATURAL VARIATION; YIELD COMPONENTS; SIZE DIVERSITY; RARE ALLELE; MAJOR QTL; LENGTH; PROTEIN; WEIGHT; WIDTH	Grain shape is a key factor that influences both the appearance quality and grain yield of rice. To clarify the genetic basis of grain shape, an advanced backcross population was developed from the cross of a slender indica variety Jin23B and a round japonica variety QingGuAi, and a total of 10 quantitative trait loci (QTLs) for grain shape were detected over 2 years. Three QTLs, qGW1, qGS3 and qGS7 have large effects on grain shape and were detected in both years. To further validate their effects, the BC4F2 populations of the three QTLs were constructed. The alleles from QingGuAi of qGW1 and qGS7 both greatly increase grain width and the alleles from Jin23B of qGS3 greatly increase grain length. The allele variations of the three QTLs lead to the totally different grain shape of the two rice varieties. Our study provides insights into the genetic bases of grain shape and will promote the improvements of grain quality and yield in rice.	[He, Yuqing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	He, YQ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	yqhe@mail.hzau.edu.cn			National Natural Science Foundation [91435202]; National Program on R&D of Transgenic Plants [2016ZX08009003-004]; National 863 Project [2012AA10A303]; China Agriculture Research System of China [CARS-01-03]; Bill & Melinda Gates Foundation	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Program on R&D of Transgenic Plants; National 863 Project(National High Technology Research and Development Program of China); China Agriculture Research System of China; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by grants from the National Natural Science Foundation (91435202) to Yuqing He, the National Program on R&D of Transgenic Plants (2016ZX08009003-004) to Yuqing He, the National 863 Project (2012AA10A303) to Yuqing He and the earmarked fund for the China Agriculture Research System (CARS-01-03) of China to Yuqing He and and the Bill & Melinda Gates Foundation to Yuqing He. The funders did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernacchi D, 1998, THEOR APPL GENET, V97, P381, DOI 10.1007/s001220050908; Du A, 2017, MOL PLANT; Duan PG, 2017, MOL PLANT, V10, P685, DOI 10.1016/j.molp.2017.03.009; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fulton MR, 1997, OIKOS, V78, P291, DOI 10.2307/3546296; Fulton TM, 2002, EUPHYTICA, V127, P163, DOI 10.1023/A:1020209930031; Hu J, 2015, MOL PLANT, V8, P1455, DOI 10.1016/j.molp.2015.07.002; Jiang JF, 2015, RICE, V8, DOI 10.1186/s12284-015-0048-3; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lincoln S, 1992, CONSTRUCING GENETIC, V3rd; Liu JF, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.43; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Nemoto Y, 2016, PLANT J, V86, P221, DOI 10.1111/tpj.13168; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; Qiu Lei, 2014, Genomics and Applied Biology, V33, P828; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Teng B, 2012, MOL BREEDING, V30, P583, DOI 10.1007/s11032-011-9647-x; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xu Q, 2014, MOL BREEDING, V33, P813, DOI 10.1007/s11032-013-9994-x; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang DP, 2015, J EXP BOT, V66, P6371, DOI 10.1093/jxb/erv350; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110	31	7	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187553	10.1371/journal.pone.0187553	http://dx.doi.org/10.1371/journal.pone.0187553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145412	gold, Green Published, Green Submitted			2022-12-26	WOS:000415378800018
J	Ajayi, IO; Ughasoro, MD; Ogunwale, A; Odeyinka, O; Babalola, O; Sharafadeen, S; Adamu, AY; Ajumobi, O; Orimogunje, T; Nguku, P				Ajayi, IkeOluwapo O.; Ughasoro, Maduka D.; Ogunwale, Akintayo; Odeyinka, Oluwaseun; Babalola, Obafemi; Sharafadeen, Salami; Adamu, Al-Mukhtar Y.; Ajumobi, Olufemi; Orimogunje, Taiwo; Nguku, Patrick			A qualitative exploration of malaria operational research situation in Nigeria	PLOS ONE			English	Article							ELIMINATION	Background Malaria, remains one of the leading causes of high morbidity and mortality in Nigeria despite implementation of several public health interventions for its control. Operational limitations and methodological gaps have been associated with malaria control interventions and research, and these have necessitated the need for a well-tailored Malaria Operational Research (MOR) agenda. However, there is paucity of evidence-based information on relevant stakeholders' experience, awareness, perceptions and use of MOR and suggestions on setting MOR agenda. As part of a larger study to provide data for national MOR agenda setting, we assessed the MOR research situation from the perspectives of key stakeholders in Nigeria and contribution of MOR to the malaria elimination agenda Methods We conducted key informant interviews among 40 purposively selected stakeholders from the six geo-political zones in Nigeria. Data was collected using a pre-tested key informant interview guide which comprised issues related to experience, awareness, use of MOR and MOR needs, and suggestions for MOR. We conducted a detailed content analysis. Results Half of the participants had participated in MOR. Participants perceived MOR as important. Only few were aware of existing framework for MOR in Nigeria while above half expressed that MOR is yet to be used to inform policy in Nigeria. Participants identified several MOR needs such as development of improved diagnostic techniques, and interventions for promoting early diagnosis, prompt treatment and quality programmatic data. Participants opined the need for country-specific prioritised MOR agenda that cut across malaria thematic areas including malaria prevention and case management. Participants suggested the involvement of various stakeholders and multi-disciplinary approach in setting MOR. Conclusion Although some stakeholders have been involved in MOR, it is still rarely used to inform policy and several needs exist across thematic areas. A broad-based stakeholder involvement, multi-disciplinary approach to agenda setting and its wide dissemination have been suggested.	[Ajayi, IkeOluwapo O.; Babalola, Obafemi; Sharafadeen, Salami; Ajumobi, Olufemi; Nguku, Patrick] Nigeria Field Epidemiol & Lab Training Programme, Abuja, Nigeria; [Ajayi, IkeOluwapo O.; Odeyinka, Oluwaseun] Univ Ibadan, Fac Publ Hlth, Dept Epidemiol & Med Stat, Coll Med, Ibadan, Nigeria; [Ughasoro, Maduka D.] Univ Nigeria, Dept Paediat, Enugu Campus, Enugu, Nigeria; [Ogunwale, Akintayo] Univ Ibadan, Fac Publ Hlth, Dept Hlth Promot & Educ, Coll Med, Ibadan, Nigeria; [Ogunwale, Akintayo] Oyo State Coll Agr & Technol Igboora, Dept Gen Studies, Igboora, Oyo State, Nigeria; [Adamu, Al-Mukhtar Y.] Bayero Univ, Fac Clin Sci, Dept Med Microbiol & Parasitol, Kano, Nigeria; [Ajumobi, Olufemi; Nguku, Patrick] African Field Epidemiol Network, Abuja, Nigeria; [Orimogunje, Taiwo] Natl Malaria Eliminat Programme, Abuja, Nigeria	University of Ibadan; University of Nigeria; University of Ibadan; Bayero University	Ajayi, IO (corresponding author), Nigeria Field Epidemiol & Lab Training Programme, Abuja, Nigeria.; Ajayi, IO (corresponding author), Univ Ibadan, Fac Publ Hlth, Dept Epidemiol & Med Stat, Coll Med, Ibadan, Nigeria.	ikeajayi2003@yahoo.com	Babalola, Obafemi/V-6000-2018; Ajumobi, Olufemi/J-7389-2018; Orimogunje, Taiwo/HHC-8522-2022	Babalola, Obafemi/0000-0003-3468-3527; Ajumobi, Olufemi/0000-0002-2652-1205; ajayi, Ikeoluwapo/0000-0001-7719-8746	Centers for Disease Control and Prevention [(GH15-1619) U2GGH001876]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by cooperative agreement number (GH15-1619) U2GGH001876, from the Centers for Disease Control and Prevention, https://afenetnigeria.net, to PN. The funder has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Federal Ministry of Health National Malaria Elimination Programme, REP COUNTR DIAL MAL; Federal Ministry of Health National Malaria Elimination Programme, 2014, NAT MAL STRAT PLAN 2; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; President's Malaria Initiative, 2014, STRAT GUID OP RES; Ramsay A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1302-x; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Tanner M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0384-6; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.3305/NH.2010.25.2.4545; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2007, GLOB FUND 22 BOARD M; WHO, 2015, GLOB ACT FRAM RES SU; WHO, 2015, GLOB TECHN STRAT MAL; WHO, OP RES MAL CONTR; WHO, 2015, TDR POSTGR TRAIN SCH; WHO/HTM/RBM, 2003, OP RES MAL CONTR; WHO - World Health Organization, 2014, PLANN M OP RES MAL E; Zhou SS, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-473	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188128	10.1371/journal.pone.0188128	http://dx.doi.org/10.1371/journal.pone.0188128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141032	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400061
J	Baird, JR; Feng, ZP; Xiao, HD; Friedman, D; Cottam, B; Fox, BA; Kramer, G; Leidner, RS; Bell, RB; Young, KH; Crittenden, MR; Gough, MJ				Baird, Jason R.; Feng, Zipeng; Xiao, Hong D.; Friedman, David; Cottam, Ben; Fox, Bernard A.; Kramer, Gwen; Leidner, Rom S.; Bell, R. Bryan; Young, Kristina H.; Crittenden, Marka R.; Gough, Michael J.			STING expression and response to treatment with STING ligands in premalignant and malignant disease	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INTERFERON-ALPHA; MICE; CARCINOGENESIS; REGRESSION; TUMORS; ACTIVATION; IMMUNITY; HEAD	Human papilloma virus positive (HPV+) tumors represent a large proportion of anal, vulvar, vaginal, cervical and head and neck squamous carcinomas (HNSCC) and late stage invasive disease is thought to originate from a premalignant state. Cyclic dinucleotides that activate STimulator of INterferon Genes (STING) have been shown to cause rapid regression of a range of advanced tumors. We aimed to investigate STING ligands as a novel treatment for papilloma. We tested therapies in a spontaneous mouse model of papilloma of the face and anogenital region that histologically resembles human HPV-associated papilloma. We demonstrate that STING ligands cause rapid regression of papilloma, associated with T cell infiltration, and are significantly more effective than Imiquimod, a current immunotherapy for papilloma. In humans, we show that STING is expressed in the basal layer of normal skin and lost during keratinocyte differentiation. We found STING was expressed in all HPV-associated cervical and anal dysplasia and was strongly expressed in the cancer cells of HPV+ HNSCC but not in HPV-unrelated HNSCC. We found no strong association between STING expression and progressive disease in non-HPV oral dysplasia and oral pre-malignancies that are not HPV-related. These data demonstrate that STING is expressed in basal cells of the skin and is retained in HPV+ pre-malignancies and advanced cancers, but not in HPV-unrelated HNSCC. However, using a murine HNSCC model that does not express STING, we demonstrate that STING ligands are an effective therapy regardless of expression of STING by the cancer cells.	[Baird, Jason R.; Friedman, David; Cottam, Ben; Fox, Bernard A.; Kramer, Gwen; Leidner, Rom S.; Bell, R. Bryan; Young, Kristina H.; Crittenden, Marka R.; Gough, Michael J.] Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA; [Feng, Zipeng] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Xiao, Hong D.] Providence Portland Med Ctr, Pathol, Portland, OR USA; [Bell, R. Bryan] Head & Neck Surg Inst, Portland, OR USA; [Young, Kristina H.; Crittenden, Marka R.] Oregon Clin, Portland, OR USA	Providence Portland Medical Center; Oregon Health & Science University; Providence Portland Medical Center	Gough, MJ (corresponding author), Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA.	michael.gough@providence.org	Gough, Michael/AAY-3419-2020	Gough, Michael/0000-0002-5575-0074; Leidner, Rom/0000-0003-0788-7938; Friedman, David/0000-0002-1295-1562; Bell, R. Bryan/0000-0002-3775-109X	Heath Foundation; American Cancer Society; National Cancer Institute [R01CM82311, R01CA208644]; Cancer Research Animal Division; NATIONAL CANCER INSTITUTE [R01CA182311] Funding Source: NIH RePORTER	Heath Foundation; American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Animal Division; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a research grant from the Heath Foundation (JRB, RBB, MJG); a postdoctoral fellowship from the American Cancer Society (JRB); and the National Cancer Institute (MJG, MRC R01CM82311, R01CA208644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of the Cancer Research Animal Division in the execution of these studies.	Baird JR, 2017, INT J RADIAT ONCOL, V99, P362, DOI 10.1016/j.ijrobp.2017.04.014; Baird JR, 2016, CANCER RES, V76, P50, DOI 10.1158/0008-5472.CAN-14-3619; Buechner SA, 1997, J CLIN INVEST, V100, P2691, DOI 10.1172/JCI119814; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Crittenden MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069527; Einstein MH, 2009, LANCET INFECT DIS, V9, P347, DOI 10.1016/S1473-3099(09)70108-2; Elson DA, 2000, CANCER RES, V60, P1267; Gades NM, 2008, COMPARATIVE MED, V58, P271; Gostout BS, 2001, INT J GYNECOL OBSTET, V74, P207, DOI 10.1016/S0020-7292(00)00389-1; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Khurana D, 2001, HEAD NECK-J SCI SPEC, V23, P899, DOI 10.1002/hed.1130; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Moore E, 2016, CANCER IMMUNOL RES, V4, P1061, DOI 10.1158/2326-6066.CIR-16-0104; Nassar D, 2015, NAT MED, V21, P946, DOI 10.1038/nm.3878; Pachman DR, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.06.105; Riley RR, 2003, CANCER RES, V63, P4862; RODRIGUEZVILLANUEVA J, 1995, INT J CANCER, V61, P110, DOI 10.1002/ijc.2910610119; Seitz CS, 2000, J CLIN INVEST, V105, P253, DOI 10.1172/JCI7630; Strati K, 2006, P NATL ACAD SCI USA, V103, P14152, DOI 10.1073/pnas.0606698103; Tang XH, 2004, CLIN CANCER RES, V10, P301, DOI 10.1158/1078-0432.CCR-0999-3; Ulrich C, 2007, BRIT J DERMATOL, V157, P25, DOI 10.1111/j.1365-2133.2007.08269.x	22	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187532	10.1371/journal.pone.0187532	http://dx.doi.org/10.1371/journal.pone.0187532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135982	gold, Green Submitted, Green Published			2022-12-26	WOS:000415121200022
J	Ishida, M; Yamazaki, H				Ishida, Masanobu; Yamazaki, Hideo			Radioactive contamination in the Tokyo metropolitan area in the early stage of the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident and its fluctuation over five years	PLOS ONE			English	Article							CESIUM ADSORPTION; CLAY-MINERALS; SOURCE-TERM; MICROPARTICLES; RADIONUCLIDES; RADIOCESIUM; SEDIMENTS; SOIL; PREFECTURE; ATMOSPHERE	Radioactive contamination in the Tokyo metropolitan area in the immediate aftermath of the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident was analyzed via surface soil sampled during a two-month period after the accident. I-131, Cs-134, and Cs-137 were detected in these soil samples. The activity and inventory of radioactive material in the eastern part of Tokyo tended to be high. The Cs-134/Cs-137 activity ratio in soil was 0.978 +/- 0.053. The I-131/Cs-137 ratio fluctuated widely, and was 19.7 +/- 9.0 (weighted average 18.71 +/- 0.13, n = 14) in the Tokyo metropolitan area. The radioactive plume with high 131 I activity spread into the Tokyo metropolitan area and was higher than the weighted average of 6.07 +/- 0.04 (n = 26) in other areas. The radiocesium activity and inventory surveyed in soil from a garden in Chiyoda Ward in the center of Tokyo, fell approximately 85% in the four months after the accident, and subsequently tended to rise slightly while fluctuating widely. It is possible that migration and redistribution of radiocesium occurred. The behavior of radiocesium in Tokyo was analyzed via monitoring of radiocesium in sludge incineration ash. The radiocesium activity in the incineration ash was high at wastewater treatment centers that had catchment areas in eastern Tokyo and low at those with catchment areas in western Tokyo. Similar to the case of the garden soil, even in incineration ash, the radiocesium activity dropped rapidly immediately after the accident. The radiocesium activity in the incineration ash fell steadily from the tenth month after the accident until December 2016, and its half-life was about 500 days. According to frequency analysis, in central Tokyo, the cycles of fluctuation of radiocesium activity in incineration ash and rainfall conformed, clearly showing that radiocesium deposited in urban areas was resuspended and transported by rainfall run-off.	[Ishida, Masanobu; Yamazaki, Hideo] Kindai Univ, Grad Sch Sci & Engn, Higashiosaka, Osaka, Japan	Kindai University (Kinki University)	Ishida, M (corresponding author), Kindai Univ, Grad Sch Sci & Engn, Higashiosaka, Osaka, Japan.	masanobuijp1989@gmail.com			JSPS KAKENHI [24310014, 26289155, 26303004];  [15J10109]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by JSPS KAKENHI (B) Grant Numbers 24310014, 26289155, and 26303004 and Grants-in-aid for JSPS Fellow Grant Number 15J10109.; The radiocesium activity in sludge incineration ash at Tokyo's wastewater treatment centers were obtained by referring to data published on the website of the Bureau of Sewerage, Tokyo Metropolitan Government. To perform the frequency analysis of the data, we obtained advice from Associate Professor Y. Ogawa of Kindai University. Mses. W. Ishii, Y. Sakai, N. Sawada, and A. Kinsaka helped us analyze and measure the samples and process the data. This work was supported by JSPS KAKENHI (B) Grant Numbers 24310014, 26289155, and 26303004 and Grants-in-aid for JSPS Fellow Grant Number 15J10109.	Abe Y, 2014, ANAL CHEM, V86, P8521, DOI 10.1021/ac501998d; Adachi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02554; Amano H, 2012, J ENVIRON RADIOACTIV, V111, P42, DOI 10.1016/j.jenvrad.2011.10.019; [Anonymous], 2006, CHERN FOR GROUP ENV; [Anonymous], 2004, J ENVIRON RADIOACTIV, V77, P247; Aoi Y, 2014, J MINER PETROL SCI, V109, P23, DOI 10.2465/jmps.130620c; Bostick BC, 2002, ENVIRON SCI TECHNOL, V36, P2670, DOI 10.1021/es0156892; Bureau of Sewerage Tokyo Metropolitan Government, 2017, TOK METR GOV MEAS RE; Bureau of Sewerage Tokyo Metropolitan Government, 2017, LIST TOK WAT RECL CT; Chaisan K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02520; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Comans RNJ, 1998, WATER RES, V32, P2846, DOI 10.1016/S0043-1354(98)00038-4; du Bois PB, 2012, J ENVIRON RADIOACTIV, V114, P2, DOI 10.1016/j.jenvrad.2011.11.015; EVANS DW, 1983, GEOCHIM COSMOCHIM AC, V47, P1041, DOI 10.1016/0016-7037(83)90234-X; Evrard O, 2014, SCI REP-UK, V4, DOI 10.1038/srep04574; Furuki G, 2017, SCI REP-UK, V7, DOI 10.1038/srep42731; Furuta S., 2011, JAEA REV; Gallego E, 2006, J ENVIRON RADIOACTIV, V85, P247, DOI 10.1016/j.jenvrad.2004.10.017; Garcia-Sanchez L, 2009, J ENVIRON RADIOACTIV, V100, P774, DOI 10.1016/j.jenvrad.2008.08.005; Gossuin Y, 2002, J MAGN RESON, V157, P132, DOI 10.1006/jmre.2002.2581; GSI (Geospatial Information Authority of Japan), 2014, EXT SIT DISTR MAP RA; IAEA, 2004, SOIL SAMPL ENV CONT; IAEA, 2006, CHERN LEG HLTH ENV S; IAEA, 2015, FUK DAIICH ACC REP D; Investigation Committee on the accident at the Fukushima Nuclear Power Stations of Tokyo Electric Power Company, 2012, FUK NUCL POW STAT TO; Itoh S, 2014, SOIL SCI PLANT NUTR, V60, P540, DOI 10.1080/00380768.2014.907735; Izrael YA, 2007, HEALTH PHYS, V93, P410, DOI 10.1097/01.HP.0000285092.10598.41; JMA (Japan Meteorological Agency), 2017, MONTHL RAINF DAT TOK; Kaneyasu N, 2012, ENVIRON SCI TECHNOL, V46, P5720, DOI 10.1021/es204667h; Koarashi J, 2012, SCI TOTAL ENVIRON, V431, P392, DOI 10.1016/j.scitotenv.2012.05.041; Kogure T, 2012, CHEM LETT, V41, P380, DOI 10.1246/cl.2012.380; Komori M, 2013, BUNSEKI KAGAKU, V62, P475, DOI 10.2116/bunsekikagaku.62.475; Koto Ward Government, AN RES RAD ACT SOIL; MAES A, 1985, CLAY CLAY MINER, V33, P251, DOI 10.1346/CCMN.1985.0330312; Matsunaga T, 1998, J CONTAM HYDROL, V35, P101, DOI 10.1016/S0169-7722(98)00119-3; MEXT (Ministry of Education Culture Sports Science and Technology of Japan), 2012, RES SURV RES DISTR S; MEXT (Ministry of Education Culture Sports Science and Technology of Japan), 2011, CALC RES REAS INT EX; Monte L, 2004, J ENVIRON RADIOACTIV, V75, P83, DOI 10.1016/j.jenvrad.2003.11.004; Morino Y, 2013, ENVIRON SCI TECHNOL, V47, P2314, DOI 10.1021/es304620x; Motokawa R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06585; Mukai H, 2016, SCI REP-UK, V6, DOI 10.1038/srep21543; NA Independent, 2014, FUK DAIICH NUCL POW; Nagakawa Yoshiyasu, 2011, Radioisotopes, V60, P467; NDJ (The National Diet of Japan), 2012, OFF REP FUK NUCL ACC; NILU (Norwegian Institute for Air Research), RES SIM ATM TRANSP 1; NISA (Nuclear and Industrial Safety Agency), 2011, EV STAT COR UN 1 2 3; Nishizawa Y, 2016, J NUCL SCI TECHNOL, V53, P468, DOI 10.1080/00223131.2015.1071721; NSAC (Nuclear Science Advisory Committee), 1980, AN 3 MIL ISL UN 2 AC; Ohara T., 2011, Journal of the National Institute of Public Health, V60, P292; Oza RB, 2013, ANN NUCL ENERGY, V58, P95, DOI 10.1016/j.anucene.2013.03.016; Qin HB, 2012, GEOCHEM J, V46, P297, DOI 10.2343/geochemj.2.0214; SAWHNEY BL, 1972, CLAY CLAY MINER, V20, P93, DOI 10.1346/CCMN.1972.0200208; SCJ (Science Council of Japan), 2014, SECT COMM NUCL ACC R; Stohl A, 2012, ATMOS CHEM PHYS, V12, P2313, DOI 10.5194/acp-12-2313-2012; Tanaka K, 2012, GEOCHEM J, V46, P73, DOI 10.2343/geochemj.1.0137; TEPCO (Tokyo Electric Power Company), 2012, EST AMOUNT RAD MAT R; TEPCO (Tokyo Electric Power Company), 2012, INV REP FUK NUCL ACC; Tsuruta H., 2012, Chikyukagaku (Geochemistry), V46, P99; Wakiyama Y, 2014, GEOPHY RES, V16, P10185; Yamaguchi N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20548; Yasuhara M, 2005, MAR MICROPALEONTOL, V55, P63, DOI 10.1016/j.marmicro.2005.02.005; Yoshida N, 2012, SCIENCE, V336, P1115, DOI 10.1126/science.1219493; Zachara JM, 2002, GEOCHIM COSMOCHIM AC, V66, P193, DOI 10.1016/S0016-7037(01)00759-1	63	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187687	10.1371/journal.pone.0187687	http://dx.doi.org/10.1371/journal.pone.0187687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136641	gold, Green Published, Green Submitted			2022-12-26	WOS:000415121200026
J	Musumari, PM; Tangmunkongvorakul, A; Srithanavibooncha, K; Feldman, MD; Sitthi, W; Rerkasem, K; Techasrivichien, T; Suguimoto, SP; Ono-Kihara, M; Kihara, M				Musumari, Patou Masika; Tangmunkongvorakul, Arunrat; Srithanavibooncha, Kriengkrai; Feldman, Mitchell D.; Sitthi, Wathee; Rerkasem, Kittipan; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Ono-Kihara, Masako; Kihara, Masahiro			Socio-behavioral risk factors among older adults living with HIV in Thailand	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ALCOHOL-USE; INFECTED INDIVIDUALS; GENDER-DIFFERENCES; LIFE EXPECTANCY; CIGARETTE-SMOKING; SUBSTANCE USE; CESSATION; MORTALITY; DISEASE	Background There has been a global increase in HIV infection in persons 50 years of age and older. This group is at risk for development of chronic illness that may be exacerbated by socio-behavioral risk factors such as smoking, unhealthy alcohol use, and sedentary lifestyle. However, socio-behavioral risk factors in this older HIV infected population are not well described. The current study aims to describe and document factors related to alcohol use, tobacco smoking, and physical exercise in older adults living with HIV (OALHIV). Methods This cross-sectional quantitative study was conducted between August and September 2015, and enrolled HIV-infected participants aged 50 years and older from 12 community hospitals in Chiang Mai Province, Northern Thailand. Results Of the 364 participants recruited in the study, 57.1% were female, and 67.3% were between 50-59 years of age. Respectively, 15.1%, 59.1%, and 18.7% were current smokers, currently engaged in physical exercises, and reported ever drank alcohol in the past year. 22.1% of those who drank alcohol reported experience of heavy episodic drinking. Male gender was one of the strongest predictors of ever drank alcohol in the past year (AOR, 4.66; CI, 2.28-9.49; P < 0.001) and of being a current smoker (AOR, 13.41; CI, 7.23-24.87; P < 0.001). Lower household income was associated with increased odds of ever drank alcohol in the past year (household income (1 USD = 35 THB) of <= 5,000 Baht versus > 20,000 Baht: AOR, 5.34; CI, 1.28-22.25; P = 0.021). Lower educational level was associated with decreased odds of physical exercises (no education versus secondary and higher: AOR, 0.22; CI, 0.08-0.55; P = 0.001). Conclusion Smoking and alcohol use is common among OALHIV, with a substantial proportion not engaging in physical exercises. Interventions for OALHIV should particularly target males and those of lower socio-economic status to deter smoking and alcohol use and to promote physical exercises.	[Musumari, Patou Masika; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Ono-Kihara, Masako; Kihara, Masahiro] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Tangmunkongvorakul, Arunrat; Srithanavibooncha, Kriengkrai; Sitthi, Wathee; Rerkasem, Kittipan] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand; [Srithanavibooncha, Kriengkrai; Rerkasem, Kittipan] Chiang Mai Univ, Fac Med, Chiang Mai, Thailand; [Feldman, Mitchell D.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Suguimoto, S. Pilar] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto, Japan	Kyoto University; Chiang Mai University; Chiang Mai University; University of California System; University of California San Francisco; Kyoto University	Tangmunkongvorakul, A (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand.	arunrat@rihes.org	Suguimoto, S Pilar/P-6825-2018	Suguimoto, S. Pilar/0000-0002-8447-9172	Chiang Mai University Center of Excellence in HIV/AIDS Research; National Research University under Thailand's Office of the Higher Education Commission; Kyoto University	Chiang Mai University Center of Excellence in HIV/AIDS Research; National Research University under Thailand's Office of the Higher Education Commission; Kyoto University	The study was supported by the Chiang Mai University Center of Excellence in HIV/AIDS Research and the National Research University Project under Thailand's Office of the Higher Education Commission.; This study was part of the main study "Health Behaviors, Health Conditions, and Quality of Life of Older Adults Living with HIV". It was supported by the Chiang Mai University Center of Excellence in HIV/AIDS Research and the National Research University Project under Thailand's Office of the Higher Education Commission. We thank the participants who contributed to this research. We also thank the Kyoto University "Strategic Young Researcher Overseas Visit Program for Accelerating Brain Circulation Program" for supporting the collaboration between Kyoto University and the Research Institute for Health Sciences, Chiang Mai University.	Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557; Assanangkornchai S, 2010, ALCOHOL ALCOHOLISM, V45, P278, DOI 10.1093/alcalc/agq018; Babor T.F., 2001, ALCOHOL USE DISORDER; Batista Joanna d’Arc Lyra, 2013, Rev. bras. epidemiol., V16, P432, DOI 10.1590/S1415-790X2013000200018; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Blanco JR, 2010, AIDS REV, V12, P218; Brooks JT, 2012, AM J PUBLIC HEALTH, V102, P1516, DOI 10.2105/AJPH.2012.300844; Brown JL, 2013, CURR HIV-AIDS REP, V10, P356, DOI 10.1007/s11904-013-0174-8; Browning KK, 2013, CLIN CHEST MED, V34, P181, DOI 10.1016/j.ccm.2013.01.005; Calvo M, 2015, AIDS REV, V17, P47; Crombie IK, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-494; DIAZ T, 1994, AM J PREV MED, V10, P217, DOI 10.1016/S0749-3797(18)30594-4; Duncan DT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147520; Edelman EJ, 2014, CURR OPIN HIV AIDS, V9, P317, DOI 10.1097/COH.0000000000000069; Elzi L, 2006, ANTIVIR THER, V11, P787; Fiore MC, 2008, TREATING TOBACCO USE; Florindo AA, 2007, INT J STD AIDS, V18, P692, DOI 10.1258/095646207782193795; Fone DL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002337; Goar SG, 2011, AJDAS, V10; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Honjo K, 2000, TOB CONTROL, V9, P193, DOI 10.1136/tc.9.2.193; Ikeda ML, 2016, PLOS ONE, V11, P2016; Jitnarin N, 2011, ASIA-PAC J PUBLIC HE, V23, P672, DOI 10.1177/1010539509352200; Justice AC, 2016, DRUG ALCOHOL DEPEN, V161, P95, DOI 10.1016/j.drugalcdep.2016.01.017; Katz IT, 2017, LANCET HIV, V3018, P30086; Lifson Alan R, 2012, Curr HIV/AIDS Rep, V9, P223, DOI 10.1007/s11904-012-0121-0; Martinez E, 2007, HIV MED, V8, P251, DOI 10.1111/j.1468-1293.2007.00468.x; McGinnis KA, 2013, ALCOHOL CLIN EXP RES, V37, P435, DOI 10.1111/j.1530-0277.2012.01937.x; Morrow M, 2003, HEALTH PROMOT INT, V18, P373, DOI 10.1093/heapro/dag403; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; National Health Examination Survey Office, 2009, THAIL NAT HLTH EX SU; NELSON KE, 1993, JAMA-J AM MED ASSOC, V270, P955, DOI 10.1001/jama.270.8.955; NELSON KE, 1994, AIDS, V8, P951, DOI 10.1097/00002030-199407000-00012; Nguyen N, 2008, CLIN INTERV AGING, V3, P453; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Peters SAE, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005663; Petrosillo N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-16; Pratt G, 2010, AGE AGEING, V39, P289, DOI 10.1093/ageing/afq009; Rahmanian Shiva, 2011, Proc Am Thorac Soc, V8, P313, DOI 10.1513/pats.201009-058WR; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Samet JH, 2007, JAIDS-J ACQ IMM DEF, V46, P194, DOI 10.1097/QAI.0b013e318142aabb; Sankar A, 2011, AIDS CARE, V23, P1187, DOI 10.1080/09540121.2011.564115; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Siviroj Penprapa, 2013, Journal of Human Ecology, V42, P187; Somarriba G, 2010, HIV AIDS-RES PALLIAT, V2, P191, DOI 10.2147/HIV.S9069; Thai National AIDS Committee, 2014, 2014 THAIL AIDS RESP; Tsai YW, 2008, J WOMENS HEALTH, V17, P971, DOI 10.1089/jwh.2007.0621; UNAIDS, 2013, HIV AG SPEC SUPPL UN; UNAIDS, 2016, LESS THAIL INT HIV S; UNAIDS, 2014, THE GAP REP; Vidrine DJ, 2012, NICOTINE TOB RES, V14, P106, DOI 10.1093/ntr/ntr121; Vidrine DJ, 2006, AIDS, V20, P253, DOI 10.1097/01.aids.0000198094.23691.58; Wakabayashi M, 2015, BMC PUBLIC HEALTH, V15, P015; WALDRON I, 1991, SOC SCI MED, V32, P989, DOI 10.1016/0277-9536(91)90157-8; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9; Webel AR, 2015, J ASSOC NURSE AIDS C, V26, DOI 10.1016/j.jana.2014.06.004; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011; World Health Organization (WHO), 2005, ALC GEND DRINK PROBL	62	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188088	10.1371/journal.pone.0188088	http://dx.doi.org/10.1371/journal.pone.0188088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136655	gold, Green Published, Green Submitted			2022-12-26	WOS:000415121200061
J	Javanainen, M; Martinez-Seara, H; Vattulainen, I				Javanainen, Matti; Martinez-Seara, Hector; Vattulainen, Ilpo			Excessive aggregation of membrane proteins in the Martini model	PLOS ONE			English	Article							TRANSMEMBRANE DOMAIN DIMERIZATION; RESONANCE ENERGY-TRANSFER; HELIX-HELIX INTERACTIONS; HYDROPHOBIC MISMATCH; COUPLED RECEPTORS; SELF-ASSOCIATION; STRUCTURAL BASIS; GLYCOPHORIN-A; FORCE-FIELD; SIMULATIONS	The coarse-grained Martini model is employed extensively to study membrane protein oligomerization. While this approach is exceptionally promising given its computational efficiency, it is alarming that a significant fraction of these studies demonstrate unrealistic protein clusters, whose formation is essentially an irreversible process. This suggests that the protein-protein interactions are exaggerated in the Martini model. If this held true, then it would limit the applicability of Martini to study multi-protein complexes, as the rapidly clustering proteins would not be able to properly sample the correct dimerization conformations. In this work we first demonstrate the excessive protein aggregation by comparing the dimerization free energies of helical transmembrane peptides obtained with the Martini model to those determined from FRET experiments. Second, we show that the predictions provided by the Martini model for the structures of transmembrane domain dimers are in poor agreement with the corresponding structures resolved using NMR. Next, we demonstrate that the first issue can be overcome by slightly scaling down the Martini protein-protein interactions in a manner, which does not interfere with the other Martini interaction parameters. By preventing excessive, irreversible, and non-selective aggregation of membrane proteins, this approach renders the consideration of lateral dynamics and protein-lipid interactions in crowded membranes by the Martini model more realistic. However, this adjusted model does not lead to an improvement in the predicted dimer structures. This implicates that the poor agreement between the Martini model and NMR structures cannot be cured by simply uniformly reducing the interactions between all protein beads. Instead, a careful amino-acid specific adjustment of the protein-protein interactions is likely required.	[Javanainen, Matti; Martinez-Seara, Hector; Vattulainen, Ilpo] Tampere Univ Technol, Lab Phys, Tampere, Finland; [Javanainen, Matti; Vattulainen, Ilpo] Univ Helsinki, Dept Phys, Helsinki, Finland; [Martinez-Seara, Hector] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic; [Vattulainen, Ilpo] Memphys, Ctr Biomembrane Phys, Odense, Denmark	Tampere University; University of Helsinki; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Martinez-Seara, H; Vattulainen, I (corresponding author), Tampere Univ Technol, Lab Phys, Tampere, Finland.; Vattulainen, I (corresponding author), Univ Helsinki, Dept Phys, Helsinki, Finland.; Martinez-Seara, H (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic.; Vattulainen, I (corresponding author), Memphys, Ctr Biomembrane Phys, Odense, Denmark.	hseara@gmail.com; ilpo.vattulainen@helsinki.fi	Javanainen, Matti/GZA-9227-2022; Martinez-Seara, Hector/D-3734-2014; Vattulainen, Ilpo T/G-4224-2014	Javanainen, Matti/0000-0003-4858-364X; Martinez-Seara, Hector/0000-0001-9716-1713; Vattulainen, Ilpo/0000-0001-7408-3214	Academy of Finland (Centre of Excellence program) [307415]; European Research Council [290974]; Czech Science Foundation [P208/12/G016]	Academy of Finland (Centre of Excellence program)(Academy of Finland); European Research Council(European Research Council (ERC)European Commission); Czech Science Foundation(Grant Agency of the Czech Republic)	MJ, HMS, and IV thank the Academy of Finland (Centre of Excellence program (grant no. 307415)) and the European Research Council (Advanced Grant CROWDED-PRO-LIPIDS (grant no. 290974)) for financial support. HMS thanks the Czech Science Foundation (grant no. P208/12/G016).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Arnarez C, 2016, CHEM SCI, V7, P4435, DOI 10.1039/c5sc04664e; Artemenko EO, 2008, BBA-BIOMEMBRANES, V1778, P2361, DOI 10.1016/j.bbamem.2008.06.003; Ash WL, 2009, HELIX HELIX INTERACT; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bocharov EV, 2008, J BIOL CHEM, V283, P29385, DOI 10.1074/jbc.M803089200; Bocharov EV, 2016, BBA-BIOMEMBRANES, V1858, P1254, DOI 10.1016/j.bbamem.2016.02.023; Bond PJ, 2006, J AM CHEM SOC, V128, P2697, DOI 10.1021/ja0569104; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Castillo N, 2013, CHEM PHYS LIPIDS, V169, P95, DOI 10.1016/j.chemphyslip.2013.02.001; Casuso I, 2012, NAT NANOTECHNOL, V7, P525, DOI [10.1038/nnano.2012.109, 10.1038/NNANO.2012.109]; Chavent M, 2014, BIOCHEMISTRY-US, V53, P6641, DOI 10.1021/bi500800x; Chavent M, 2014, FARADAY DISCUSS, V169, P455, DOI 10.1039/c3fd00145h; Chen LR, 2010, J AM CHEM SOC, V132, P3628, DOI 10.1021/ja910692u; Chen LR, 2009, BIOPHYS J, V96, P4622, DOI 10.1016/j.bpj.2009.03.004; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; de Jong DH, 2016, COMPUT PHYS COMMUN, V199, P1, DOI 10.1016/j.cpc.2015.09.014; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Domanski J, 2017, J PHYS CHEM B, V121, P3364, DOI 10.1021/acs.jpcb.6b08445; Dunton TA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003417; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Finger C, 2006, J MOL BIOL, V358, P1221, DOI 10.1016/j.jmb.2006.02.065; Ghosh A, 2014, COMPUT BIOL CHEM, V48, P29, DOI 10.1016/j.compbiolchem.2013.11.002; Gomes I, 2016, ANNU REV PHARMACOL, V56, P403, DOI 10.1146/annurev-pharmtox-011613-135952; Gonzalez R, 2016, SCI REP, V6; Goose JE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003033; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hong H, 2010, P NATL ACAD SCI USA, V107, P19802, DOI 10.1073/pnas.1010348107; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Janosi L, 2010, BIOPHYS J, V99, P284, DOI 10.1016/j.bpj.2010.04.005; Javanainen M, 2016, BBA-BIOMEMBRANES, V1858, P2468, DOI 10.1016/j.bbamem.2016.02.036; Javanainen M, 2013, FARADAY DISCUSS, V161, P397, DOI 10.1039/c2fd20085f; Jeon JH, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.021006; Johnston JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090694; Johnston JM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002649; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; Koldso H, 2015, J AM CHEM SOC, V137, P14694, DOI 10.1021/jacs.5b08048; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lelimousin M, 2016, J AM CHEM SOC, V138, P10611, DOI 10.1021/jacs.6b05602; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li E, 2005, BIOCHEMISTRY-US, V44, P352, DOI 10.1021/bi048480k; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Merzlyakov M, 2007, J MEMBRANE BIOL, V215, P93, DOI 10.1007/s00232-007-9009-0; Michalowsky J, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4974833; Mondal S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02909; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nash A, 2015, BBA-BIOMEMBRANES, V1848, P1248, DOI 10.1016/j.bbamem.2015.02.020; Nishizawa M, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4891932; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Parton DL, 2011, BIOPHYS J, V101, P691, DOI 10.1016/j.bpj.2011.06.048; Periole X, 2007, J AM CHEM SOC, V129, P10126, DOI 10.1021/ja0706246; Periole X, 2017, CHEM REV, V117, P156, DOI 10.1021/acs.chemrev.6b00344; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Prakash A, 2010, BIOPHYS J, V99, P3657, DOI 10.1016/j.bpj.2010.10.023; Prasanna X, 2014, BIOPHYS J, V106, P1290, DOI 10.1016/j.bpj.2014.02.002; Provasi D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004148; Provasi D, 2010, BIOCHEMISTRY-US, V49, P6771, DOI 10.1021/bi100686t; Qi YF, 2015, J CHEM THEORY COMPUT, V11, P4486, DOI 10.1021/acs.jctc.5b00513; Rassam P, 2015, NATURE, V523, P333, DOI 10.1038/nature14461; Reddy T, 2015, STRUCTURE, V23, P584, DOI 10.1016/j.str.2014.12.019; Sarabipour S, 2013, BBA-BIOMEMBRANES, V1828, P1829, DOI 10.1016/j.bbamem.2013.03.022; Schafer LV, 2011, P NATL ACAD SCI USA, V108, P1343, DOI 10.1073/pnas.1009362108; Sengupta D, 2010, PHYS CHEM CHEM PHYS, V12, P12987, DOI 10.1039/c0cp00101e; Stansfeld PJ, 2015, STRUCTURE, V23, P1350, DOI 10.1016/j.str.2015.05.006; Stark AC, 2013, J CHEM THEORY COMPUT, V9, P4176, DOI 10.1021/ct400008p; Sulistijo ES, 2009, BIOCHEMISTRY-US, V48, P5106, DOI 10.1021/bi802245u; Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2278, DOI 10.1021/ct5010092; Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2144, DOI 10.1021/acs.jctc.5b00209; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; Yano Y, 2006, BIOCHEMISTRY-US, V45, P3370, DOI 10.1021/bi0522854; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; You M, 2006, BIOCHEMISTRY-US, V45, P5551, DOI 10.1021/bi060113g; You M, 2005, ANAL BIOCHEM, V340, P154, DOI 10.1016/j.ab.2005.01.035	77	95	95	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187936	10.1371/journal.pone.0187936	http://dx.doi.org/10.1371/journal.pone.0187936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131844	Green Published, gold			2022-12-26	WOS:000414997800031
J	Marcelino, PRF; da Silva, VL; Philippini, RR; Von Zuben, CJ; Contiero, J; dos Santos, JC; da Silva, SS				Franco Marcelino, Paulo Ricardo; da Silva, Vinicius Luiz; Philippini, Rafael Rodrigues; Von Zuben, Claudio Jose; Contiero, Jonas; dos Santos, Julio Cesar; da Silva, Silvio Silverio			Biosurfactants produced by Scheffersomyces stipitis cultured in sugarcane bagasse hydrolysate as new green larvicides for the control of Aedes aegypti, a vector of neglected tropical diseases	PLOS ONE			English	Article							POTENTIAL APPLICATIONS; BACILLUS-SUBTILIS; CELLOBIOSE LIPIDS; ACCUMULATION; SOPHOROLIPIDS; MOSQUITO; STRAIN	Biosurfactants are microbial metabolites with possible applications in various industrial sectors that are considered ecofriendly molecules. In recent years, some studies identified these compounds as alternatives for the elimination of vectors of tropical diseases, such as Aedes aegypti. The major bottlenecks of biosurfactant industrial production have been the use of conventional raw materials that increase production costs as well as opportunistic or pathogenic bacteria, which restrict the application of these biomolecules. The present study shows the potential of hemicellulosic sugarcane bagasse hydrolysate as a raw material for the production of a crystalline glycolipidic BS by Scheffersomyces stipitis NRRL Y-7124, which resulted in an emulsifying index (EI24) of 70 +/- 3.4% and a superficial tension of 52 +/- 2.9 mN.m(-1). Additionally, a possible new application of these compounds as biolarvicides, mainly against A. aegypti, was evaluated. At a concentration of 800 mg.L-1, the produced biosurfactant caused destruction to the larval exoskeletons 12 h after application and presented an letal concentration (LC50) of 660 mg.L-1. Thus, a new alternative for biosurfactant production using vegetal biomass as raw material within the concept of biorefineries was proposed, and the potential of the crystalline glycolipidic biosurfactant in larvicidal formulations against neglected tropical disease vectors was demonstrated.	[Franco Marcelino, Paulo Ricardo; Philippini, Rafael Rodrigues; dos Santos, Julio Cesar; da Silva, Silvio Silverio] Univ Sao Paulo, Engn Sch Lorena, Dept Biotechnol, Lorena, Brazil; [da Silva, Vinicius Luiz; Contiero, Jonas] Sao Paulo State Univ, Dept Biochem & Microbiol, Biosci Inst, Campus Rio Claro, Rio Claro, Brazil; [Von Zuben, Claudio Jose] Sao Paulo State Univ, Dept Zool, Biosci Inst, Campus Rio Claro, Rio Claro, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista	Marcelino, PRF (corresponding author), Univ Sao Paulo, Engn Sch Lorena, Dept Biotechnol, Lorena, Brazil.	paulorfm1@hotmail.com	Philippini, Rafael R/V-1125-2018; da Silva, Silvio Silvério/H-8960-2012; CUNHA, JOEL/E-6916-2015; Contiero, Jonas/AAM-1711-2020; Santos, Júlio C/H-4777-2013; Contiero, Jonas/C-4474-2012	da Silva, Silvio Silvério/0000-0003-0669-2784; CUNHA, JOEL/0000-0001-9880-6974; Santos, Júlio C/0000-0001-6192-6155; Franco Marcelino, Paulo Ricardo/0000-0002-9792-4810; Philippini, Rafael/0000-0003-0526-6839; Contiero, Jonas/0000-0003-1215-6400	FAPESP (Sao Paulo Research Foundation) [2015/06238-4, 2016/14852-7]; CNPq (National Council for Scientific and Technological Development); CAPES (Coordination for the Improvement of Higher Education Personnel)	FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors acknowledge the FAPESP (Sao Paulo Research Foundation) (2015/06238-4 and 2016/14852-7) and CNPq (National Council for Scientific and Technological Development) for financial support and CAPES (Coordination for the Improvement of Higher Education Personnel) for the provision of scholarships.	Abdel-Mawgoud AM, 2009, APPL BIOCHEM BIOTECH, V157, P329, DOI 10.1007/s12010-008-8285-1; Alves LA, 1998, APPL BIOCHEM BIOTECH, V70-2, P89, DOI 10.1007/BF02920126; [Anonymous], 2017, B EP SECR VIG SAUD, V48, P10; Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035; Attard TM, 2008, INTRO CHEM BIOMASS, P31; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braga I.A, 2007, EPIDEMIOL SERVI OS S, V16, P113, DOI [10.5123/S1679-49742007000200006, DOI 10.5123/S1679-49742007000200006, DOI 10.5123/S1679-49742007000400007]; Chandel AK, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-63; Christophers SR, 1960, SDF; Colegate S. M., 1993, BIOACTIVE NATURAL PR; COOPER DG, 1987, APPL ENVIRON MICROB, V53, P224, DOI 10.1128/AEM.53.2.224-229.1987; Cortez DV, 2010, BIORESOURCE TECHNOL, V101, P1858, DOI 10.1016/j.biortech.2009.09.072; Daud RD, 2012, BIOASSAY, V7, P1; Daverey A, 2009, APPL BIOCHEM BIOTECH, V158, P663, DOI 10.1007/s12010-008-8449-z; Domonguez-Robles J, 2017, INT J MOL SCI, V327, P1; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eraqi Walaa A, 2016, Biotechnol Res Int, V2016, P3464509, DOI 10.1155/2016/3464509; Fontes GC, 2012, BRAZ J CHEM ENG, V29, P483, DOI 10.1590/S0104-66322012000300005; Fontes GC, 2005, QUIM NOVA, V31, P2091; Geetha I, 2012, PEST MANAG SCI, V68, P1447, DOI 10.1002/ps.3324; Gudina EJ, 2013, TRENDS PHARMACOL SCI, V34, P667, DOI 10.1016/j.tips.2013.10.002; Hu YM, 2001, J BIOTECHNOL, V87, P263, DOI 10.1016/S0168-1656(01)00248-6; Izard J, 2003, J MICROBIOL METH, V55, P411, DOI 10.1016/S0167-7012(03)00193-3; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Kamal A, 2012, J MICROBIOL BIOTECHN, V22, P69, DOI 10.4014/jmb.1105.05008; Kamiabi Fatemeh, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P767, DOI 10.1016/S2221-1691(13)60153-7; Katemai W, 2008, J GEN APPL MICROBIOL, V54, P79, DOI 10.2323/jgam.54.79; Kim SK, 2011, J AGR FOOD CHEM, V59, P934, DOI 10.1021/jf104027x; KITAMOTO D, 1990, AGR BIOL CHEM TOKYO, V54, P31, DOI 10.1080/00021369.1990.10869918; Kulakovskaya TV, 2010, MYCOPATHOLOGIA, V169, P117, DOI 10.1007/s11046-009-9236-2; Lau KW, 2015, J MED ENTOMOL, V52, P199, DOI 10.1093/jme/tju019; Leitermann Frank, 2008, J Biol Eng, V2, P13, DOI 10.1186/1754-1611-2-13; Liu JF, 2015, INT J MOL SCI, V16, P4814, DOI 10.3390/ijms16034814; Mendki MJ, 2000, CURR SCI INDIA, V78, P1295; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mnif I, 2016, J SCI FOOD AGR, V96, P4310, DOI 10.1002/jsfa.7759; Morita T, 2013, FEMS YEAST RES, V13, P44, DOI 10.1111/1567-1364.12005; Morita T, 2009, APPL MICROBIOL BIOT, V83, P1017, DOI 10.1007/s00253-009-1945-4; Pinzon NM, 2009, APPL MICROBIOL BIOT, V82, P975, DOI 10.1007/s00253-009-1896-9; PIZZI M, 1950, Hum Biol, V22, P151; Poomtien J, 2013, BIOSCI BIOTECH BIOCH, V77, P2362, DOI 10.1271/bbb.130434; Pruszynski CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170079; Sekhon Randhawa Kamaljeet K, 2014, Front Microbiol, V5, P454, DOI 10.3389/fmicb.2014.00454; Silva AS, 2016, CHEM ENGINEER TRANS, V49, P367, DOI 10.3303/CET1649062; Silva VL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00088; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Sun DB, 2014, J AM MOSQUITO CONTR, V30, P99, DOI 10.2987/13-6394.1; Uzoigwe C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00245; van de Beek D, 2017, NAT REV NEUROL, V13, P69, DOI 10.1038/nrneurol.2016.202; Wadekar SD, 2010, PREP BIOCHEM BIOTECH, V42, P125; ZAVALAMORENO A, 2014, ADV MICROBIOL, V4, P934, DOI DOI 10.4236/aim.2014.413104; Zini E, 2008, MACROMOLECULES, V41, P7463, DOI 10.1021/ma800496f	53	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187125	10.1371/journal.pone.0187125	http://dx.doi.org/10.1371/journal.pone.0187125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125845	Green Published, gold, Green Submitted			2022-12-26	WOS:000414866000006
J	Saunders, MI; Atkinson, S; Klein, CJ; Weber, T; Possingham, HP				Saunders, Megan Irene; Atkinson, Scott; Klein, Carissa Joy; Weber, Tony; Possingham, Hugh P.			Increased sediment loads cause non-linear decreases in seagrass suitable habitat extent	PLOS ONE			English	Article							GREAT-BARRIER-REEF; 3RD-GENERATION WAVE MODEL; WATER-QUALITY; MORETON BAY; MARINE ECOSYSTEMS; COASTAL REGIONS; IMAGE-ANALYSIS; CORAL; COVER; QUEENSLAND	Land-based activities, including deforestation, agriculture, and urbanisation, cause increased erosion, reduced inland and coastal water quality, and subsequent loss or degradation of downstream coastal marine ecosystems. Quantitative approaches to link sediment loads from catchments to metrics of downstream marine ecosystem state are required to calculate the cost effectiveness of taking conservation actions on land to benefits accrued in the ocean. Here we quantify the relationship between sediment loads derived from landscapes to habitat suitability of seagrass meadows in Moreton Bay, Queensland, Australia. We use the following approach: (1) a catchment hydrological model generates sediment loads; (2) a statistical model links sediment loads to water clarity at monthly time-steps; (3) a species distribution model (SDM) factors in water clarity, bathymetry, wave height, and substrate suitability to predict seagrass habitat suitability at monthly time-steps; and (4) a statistical model quantifies the effect of sediment loads on area of seagrass suitable habitat in a given year. The relationship between sediment loads and seagrass suitable habitat is non-linear: large increases in sediment have a disproportionately large negative impact on availability of seagrass suitable habitat. Varying the temporal scale of analysis (monthly vs. yearly), or varying the threshold value used to delineate predicted seagrass presence vs. absence, both affect the magnitude, but not the overall shape, of the relationship between sediment loads and seagrass suitable habitat area. Quantifying the link between sediment produced from catchments and extent of downstream marine ecosystems allows assessment of the relative costs and benefits of taking conservation actions on land or in the ocean, respectively, to marine ecosystems.	[Saunders, Megan Irene; Atkinson, Scott; Klein, Carissa Joy; Possingham, Hugh P.] Univ Queensland, Ctr Biodivers & Conservat Sci, St Lucia, Qld, Australia; [Saunders, Megan Irene; Atkinson, Scott; Klein, Carissa Joy; Possingham, Hugh P.] Univ Queensland, Australian Res Council, Ctr Excellence Environm Decis, St Lucia, Qld, Australia; [Saunders, Megan Irene; Klein, Carissa Joy] Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld, Australia; [Saunders, Megan Irene] Univ Queensland, Sch Chem Engn, St Lucia, Qld, Australia; [Weber, Tony] Alluvium Consulting Australia, Fortitude Valley, Qld, Australia; [Possingham, Hugh P.] Nature Conservancy, 1815 N Lynn St, Arlington, VA USA	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Nature Conservancy	Saunders, MI (corresponding author), Univ Queensland, Ctr Biodivers & Conservat Sci, St Lucia, Qld, Australia.; Saunders, MI (corresponding author), Univ Queensland, Australian Res Council, Ctr Excellence Environm Decis, St Lucia, Qld, Australia.; Saunders, MI (corresponding author), Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld, Australia.; Saunders, MI (corresponding author), Univ Queensland, Sch Chem Engn, St Lucia, Qld, Australia.	m.saunders1@uq.edu.au	POSSINGHAM, HUGH/R-8310-2019; Klein, Carissa J/F-1632-2011; Atkinson, Scott Consaul/F-8406-2016; Possingham, Hugh/B-1337-2008; Saunders, Megan/I-7731-2012; Coleman, Ross/B-1314-2008	POSSINGHAM, HUGH/0000-0001-7755-996X; Klein, Carissa J/0000-0002-6299-6451; Atkinson, Scott Consaul/0000-0001-5995-0199; Possingham, Hugh/0000-0001-7755-996X; Saunders, Megan/0000-0002-8549-5609; Coleman, Ross/0000-0003-4136-5914; Weber, Tony/0000-0002-2781-7585	Australian Research Council; University of Queensland; University of Queensland [UQFEL1717597]; Science for Nature and People Partnership, a collaboration of The Nature Conservancy; Wildlife Conservation Society; National Center for Ecological Analysis and Synthesis (NCEAS)	Australian Research Council(Australian Research Council); University of Queensland(University of Queensland); University of Queensland(University of Queensland); Science for Nature and People Partnership, a collaboration of The Nature Conservancy; Wildlife Conservation Society; National Center for Ecological Analysis and Synthesis (NCEAS)	Funding for the workshop, MIS, SA and HPP, was provided by an ARC Laureate Grant from the Australian Research Council (http://www.arc.gov.au/) to HPP. CJK was supported by a University of Queensland (http://www.uq.edu.au/) Postdoctoral Research Fellowship. Funding for MIS was supported by a University of Queensland Development Fellowship UQFEL1717597 (http:// www.uq.edu.au/) and by a grant from the Science for Nature and People Partnership (http:// snappartnership.net/), a collaboration of The Nature Conservancy, the Wildlife Conservation Society and the National Center for Ecological Analysis and Synthesis (NCEAS), to CJK and HPP. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alluvium Consulting Australia provided support in the form of salaries for authors [TW], but did not received funding or monetary recompense for any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All time provided for this project was pro bono publico. The specific roles of these authors are articulated in the 'author contributions' section.	Abal EG, 1996, MAR FRESHWATER RES, V47, P763, DOI 10.1071/MF9960763; Adams MP, 2016, AQUAT CONSERV, V26, P639, DOI 10.1002/aqc.2573; Alvarez-Romero JG, 2014, J ENVIRON MANAGE, V146, P164, DOI 10.1016/j.jenvman.2014.07.007; [Anonymous], 2016, QUEENSLAND WATERWAYS; Argent RM, 2009, ENVIRON MODELL SOFTW, V24, P809, DOI 10.1016/j.envsoft.2008.12.010; Bach SS, 1998, MAR ECOL PROG SER, V174, P247, DOI 10.3354/meps174247; Baird ME, 2016, ENVIRON MODELL SOFTW, V78, P79, DOI 10.1016/j.envsoft.2015.11.025; Beaman RJ, 2010, 3D GBR HIGH RESOLUTI; Beher J, 2016, ENVIRON SCI POLICY, V59, P35, DOI 10.1016/j.envsci.2016.02.005; Blandon A, 2014, ESTUAR COAST SHELF S, V141, P1, DOI 10.1016/j.ecss.2014.01.009; Booij N, 1999, J GEOPHYS RES-OCEANS, V104, P7649, DOI 10.1029/98JC02622; Brodie J., 2013, 2013 SCI CONSENSUS S; Brodie J, 2016, ESTUAR COAST SHELF S, V183, P438, DOI 10.1016/j.ecss.2016.05.008; Brown CJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05031-7; Callaghan DP, 2015, ESTUAR COAST SHELF S, V153, P108, DOI 10.1016/j.ecss.2014.12.016; Chartrand KM, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00106; Chiew F. H. S., 2002, Mathematical models of small watershed hydrology and applications, P335; Croke J, 2013, EARTH SURF PROC LAND, V38, P1444, DOI 10.1002/esp.3430; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; Dennison W C, 1999, MORETON BAY STUDY SC, P245; DENNISON WC, 1987, AQUAT BOT, V27, P15, DOI 10.1016/0304-3770(87)90083-0; DSITIA, 2014, LAND US SUMM S EAST; Duarte CM, 2007, ESTUAR COAST, V30, P652, DOI 10.1007/BF02841962; Duarte CM, 2013, NAT CLIM CHANGE, V3, P961, DOI [10.1038/nclimate1970, 10.1038/NCLIMATE1970]; DUARTE CM, 1991, AQUAT BOT, V40, P363, DOI 10.1016/0304-3770(91)90081-F; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Freeman EA, 2008, J STAT SOFTW, V23, P1; GBRMPA, 2014, ANN REV ECOLOGY EVOL; GIESEN WBJT, 1990, AQUAT BOT, V37, P71, DOI 10.1016/0304-3770(90)90065-S; Gorman D, 2013, MAR BIOL, V160, P309, DOI 10.1007/s00227-012-2089-0; Graham MH, 2007, P NATL ACAD SCI USA, V104, P16576, DOI 10.1073/pnas.0704778104; Green E.P., 2003, WORLD ATLAS SEAGRASS; Green L, 2015, AQUAT BOT, V124, P45, DOI 10.1016/j.aquabot.2015.03.005; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2006, J APPL ECOL, V43, P386, DOI 10.1111/j.1365-2664.2006.01164.x; Hall JW, 2014, SCIENCE, V346, P429, DOI 10.1126/science.1257890; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Halpern BS, 2009, CONSERV LETT, V2, P189, DOI 10.1111/j.1755-263X.2009.00060.x; Hamel P, 2015, SCI TOTAL ENVIRON, V524, P166, DOI 10.1016/j.scitotenv.2015.04.027; Hanington P, 2015, AQUAT BOT, V120, P244, DOI 10.1016/j.aquabot.2014.09.002; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Hughes AO, 2009, GEOMORPHOLOGY, V104, P262, DOI 10.1016/j.geomorph.2008.09.003; Ivarez-Romero JG, 2016, PLOS ONE, V10; Jeffrey SJ, 2001, ENVIRON MODELL SOFTW, V16, P309, DOI 10.1016/S1364-8152(01)00008-1; Jerlov N.G., 1970, MARINE ECOLOGY ENV F, V1, P95; Kemp J, 2015, ANTHROPOCENE, V11, P48, DOI 10.1016/j.ancene.2015.11.006; Kilminster K, 2015, SCI TOTAL ENVIRON, V534, P97, DOI 10.1016/j.scitotenv.2015.04.061; Klein CJ, 2014, MAR POLICY, V44, P360, DOI 10.1016/j.marpol.2013.10.001; Klein CJ, 2012, ECOL APPL, V22, P1246, DOI 10.1890/11-1718.1; Klein CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012431; Kroon FJ, 2016, GLOBAL CHANGE BIOL, V22, P1985, DOI 10.1111/gcb.13262; Lopez-Merino L, 2015, GLOBAL PLANET CHANGE, V133, P87, DOI 10.1016/j.gloplacha.2015.08.004; Lyons M, 2015, MAR ECOL PROG SER, V530, P1, DOI 10.3354/meps11321; Lyons MB, 2012, ISPRS J PHOTOGRAMM, V71, P34, DOI 10.1016/j.isprsjprs.2012.05.002; Maxwell PS, 2014, J ECOL, V102, P54, DOI 10.1111/1365-2745.12167; Milliman J.D., 2013, RIVER DISCHARGE COAS; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Naylor LA, 2017, EARTH SURF PROC LAND, V42, P166, DOI 10.1002/esp.4062; Neil DT, 2002, MAR FRESHWATER RES, V53, P733, DOI 10.1071/MF00151; O'Brien AG, 2011, MODELLING SIMULATION; Ollerton J, 2005, PRACTICAL POLLINATIO, P1; Olley J, 2015, HYDROL PROCESS, V29, P2290, DOI 10.1002/hyp.10369; Ondiviela B, 2014, COAST ENG, V87, P158, DOI 10.1016/j.coastaleng.2013.11.005; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; PETUS C, 2016, REMOTE SENSING, V8; Phinn SR, 2005, MAR POLLUT BULL, V51, P459, DOI 10.1016/j.marpolbul.2004.10.031; POOLE H. H., 1929, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V16, P297; PREEN A, 1995, WILDLIFE RES, V22, P507, DOI 10.1071/WR9950507; Queensland Land Use Mapping Program, 2014, LAND US MAPP; Ramos-Scharron CE, 2014, EARTH SURF PROC LAND, V39, P1764, DOI 10.1002/esp.3558; Ris RC, 1999, J GEOPHYS RES-OCEANS, V104, P7667, DOI 10.1029/1998JC900123; Roelfsema CM, 2009, J SPAT SCI, V54, P45, DOI 10.1080/14498596.2009.9635166; Roelfsema C, 2013, ESTUAR COAST SHELF S, V133, P161, DOI 10.1016/j.ecss.2013.08.026; Roelfsema CM, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.40; Roelfsema CM, 2014, REMOTE SENS ENVIRON, V150, P172, DOI 10.1016/j.rse.2014.05.001; Roelfsema CM, 2004, HABITAT MAP SEAGRASS; Romero E, 2013, BIOGEOCHEMISTRY, V113, P481, DOI 10.1007/s10533-012-9778-0; Rude J, 2016, AQUAT CONSERV, V26, P251, DOI 10.1002/aqc.2548; Saunders MI, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001886; Saunders MI, 2014, NAT CLIM CHANGE, V4, P724, DOI 10.1038/NCLIMATE2274; Saunders MI, 2013, GLOBAL CHANGE BIOL, V19, P2569, DOI 10.1111/gcb.12218; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Stoms DM, 2005, FRONT ECOL ENVIRON, V3, P429, DOI 10.1890/1540-9295(2005)003[0429:ICRPMT]2.0.CO;2; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P1117, DOI 10.1130/0016-7606(1952)63[1117:HAAOET]2.0.CO;2; Tallis H, 2008, CONSERV BIOL, V22, P120, DOI 10.1111/j.1523-1739.2007.00861.x; Tozer CR, 2012, HYDROL EARTH SYST SC, V16, P1481, DOI 10.5194/hess-16-1481-2012; Tulloch VJD, 2016, BIOL CONSERV, V203, P43, DOI 10.1016/j.biocon.2016.08.013; van den Honert RC, 2011, WATER-SUI, V3, P1149, DOI 10.3390/w3041149; Venables WN., 2002, MODERN APPL STAT S 4; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	94	18	18	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187284	10.1371/journal.pone.0187284	http://dx.doi.org/10.1371/journal.pone.0187284			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125843	gold, Green Published, Green Submitted			2022-12-26	WOS:000414866000010
J	Conway, A; Brady, N; Misra, K				Conway, Aisling; Brady, Nuala; Misra, Karuna			Holistic word processing in dyslexia	PLOS ONE			English	Article							RECOGNITION; SUPERIORITY; INVERSION; LANGUAGE; SKILLS; LEVEL; MODEL; PARTS; READ	People with dyslexia have difficulty learning to read and many lack fluent word recognition as adults. In a novel task that borrows elements of the 'word superiority' and 'word inversion' paradigms, we investigate whether holistic word recognition is impaired in dyslexia. In Experiment 1 students with dyslexia and controls judged the similarity of pairs of 6-and 7-letter words or pairs of words whose letters had been partially jumbled. The stimuli were presented in both upright and inverted form with orthographic regularity and orientation randomized from trial to trial. While both groups showed sensitivity to orthographic regularity, both word inversion and letter jumbling were more detrimental to skilled than dyslexic readers supporting the idea that the latter may read in a more analytic fashion. Experiment 2 employed the same task but using shorter, 4-and 5-letter words and a design where orthographic regularity and stimuli orientation was held constant within experimental blocks to encourage the use of either holistic or analytic processing. While there was no difference in reaction time between the dyslexic and control groups for inverted stimuli, the students with dyslexia were significantly slower than controls for upright stimuli. These findings suggest that holistic word recognition, which is largely based on the detection of orthographic regularity, is impaired in dyslexia.	[Conway, Aisling; Brady, Nuala; Misra, Karuna] Univ Coll Dublin, Sch Psychol, Dublin, Ireland	University College Dublin	Brady, N (corresponding author), Univ Coll Dublin, Sch Psychol, Dublin, Ireland.	nuala.brady@ucd.ie		Brady, Nuala/0000-0002-9725-1441				Ahissar M, 2015, TRENDS COGN SCI; ALLEN PA, 1990, J EXP PSYCHOL HUMAN, V16, P48, DOI 10.1037/0096-1523.16.1.48; ALLEN PA, 1991, J EXP PSYCHOL HUMAN, V17, P489, DOI 10.1037/0096-1523.17.2.489; Allen PA, 2009, ATTEN PERCEPT PSYCHO, V71, P281, DOI 10.3758/APP.71.2.281; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1989, J EXP PSYCHOL HUMAN; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; BARON J, 1973, COGNITIVE PSYCHOL, V4, P207, DOI 10.1016/0010-0285(73)90012-1; Bijeljac-Babic R., 2004, READ WRIT, V17, P411, DOI [https://doi.org/10.1023/B:READ.0000032664.20755.af, DOI 10.1023/B:READ.0000032664.20755.AF]; Bjornstrom LE, 2014, PERCEPTION, V43, P438, DOI 10.1068/p7698; BRUCK M, 1990, DEV PSYCHOL, V26, P439, DOI 10.1037/0012-1649.26.3.439; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Callens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038081; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Coltheart M, 2006, LOND REV EDUC, V4, P5, DOI 10.1080/13603110600574322; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Farah MJ., 1992, CURR DIR PSYCHOL SCI, V1, P164, DOI [10.1111/1467, DOI 10.1111/1467-8721.EP11510333]; Glezer LS, 2015, J NEUROSCI, V35, P4965, DOI 10.1523/JNEUROSCI.4031-14.2015; Glezer LS, 2009, NEURON, V62, P199, DOI 10.1016/j.neuron.2009.03.017; Grainger J, 2004, TRENDS COGN SCI, V8, P58, DOI 10.1016/j.tics.2003.11.006; Grainger J, 2003, BRAIN LANG, V87, P432, DOI 10.1016/S0093-934X(03)00145-7; Houpt JW, 2014, ACTA PSYCHOL, V145, P118, DOI 10.1016/j.actpsy.2013.10.013; Jordan TR, 1999, PERCEPTION, V28, P1413, DOI 10.1068/p2919; Kao CH, 2010, CORTEX, V46, P217, DOI 10.1016/j.cortex.2009.04.003; Kleinschmidt A, 2006, CURR OPIN NEUROL, V19, P386, DOI 10.1097/01.wco.0000236619.89710.ee; KORIAT A, 1985, J EXP PSYCHOL HUMAN, V11, P490, DOI 10.1037/0096-1523.11.4.490; Kucera H., 1967, COMPUTATIONAL ANAL P; Kwok RKW, 2015, Q J EXP PSYCHOL, V68, P326, DOI 10.1080/17470218.2014.944549; Lewis MB, 2001, PERCEPTION, V30, P769, DOI 10.1068/p3174; Macmillan NA, 2005, DETECTION THEORY USE; New B, 2006, PSYCHON B REV, V13, P45, DOI 10.3758/BF03193811; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Pelli DG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000680; Pelli DG, 2003, NATURE, V423, P752, DOI 10.1038/nature01516; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; Polk TA, 2002, J EXP PSYCHOL GEN, V131, P65, DOI 10.1037//0096-3445.131.1.65; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; REICHER GM, 1969, J EXP PSYCHOL, V81, P275, DOI 10.1037/h0027768; Reilhac C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00154; Richler JJ, 2008, J EXP PSYCHOL LEARN, V34, P1356, DOI 10.1037/a0013080; Samuels S., 2002, WHAT RES HAS SAY REA, P166; SHAFRIR U, 1994, J LEARN DISABIL, V27, P583, DOI 10.1177/002221949402700907; Shaywitz BA, 2007, ANN NEUROL, V61, P363, DOI 10.1002/ana.21093; SHAYWITZ SE, 1992, NEW ENGL J MED, V326, P145, DOI 10.1056/NEJM199201163260301; Shaywitz SE, 1996, SCI AM, V275, P98, DOI 10.1038/scientificamerican1196-98; SIEGEL LS, 1995, PSYCHOL SCI, V6, P250, DOI 10.1111/j.1467-9280.1995.tb00601.x; Szwed M, 2011, NEUROIMAGE, V56, P330, DOI 10.1016/j.neuroimage.2011.01.073; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; Van Belle G, 2010, J VISION, V10, DOI 10.1167/10.5.10; Van der Mark S, 2009, NEUROIMAGE, V47, P1940, DOI 10.1016/j.neuroimage.2009.05.021; Wong ACN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020753; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	57	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187326	10.1371/journal.pone.0187326	http://dx.doi.org/10.1371/journal.pone.0187326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121046	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900028
J	Lewis, JS; Logan, KA; Alldredge, MW; Carver, S; Bevins, SN; Lappin, M; VandeWoude, S; Crooks, KR				Lewis, Jesse S.; Logan, Kenneth A.; Alldredge, Mat W.; Carver, Scott; Bevins, Sarah N.; Lappin, Michael; VandeWoude, Sue; Crooks, Kevin R.			The effects of demographic, social, and environmental characteristics on pathogen prevalence in wild felids across a gradient of urbanization	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; HOME-RANGE OVERLAP; WEST-NILE-VIRUS; TOXOPLASMA-GONDII; LYME-DISEASE; IMMUNODEFICIENCY VIRUS; BARTONELLA INFECTION; HABITAT SUITABILITY; SPATIAL-DISTRIBUTION; IXODES-SCAPULARIS	Transmission of pathogens among animals is influenced by demographic, social, and environmental factors. Anthropogenic alteration of landscapes can impact patterns of disease dynamics in wildlife populations, increasing the potential for spillover and spread of emerging infectious diseases in wildlife, human, and domestic animal populations. We evaluated the effects of multiple ecological mechanisms on patterns of pathogen exposure in animal populations. Specifically, we evaluated how ecological factors affected the prevalence of Toxoplasma gondii (Toxoplasma), Bartonella spp. (Bartonella), feline immunodeficiency virus (FIV), and feline calicivirus (FCV) in bobcat and puma populations across wildland-urban interface (WUI), low-density exurban development, and wildland habitat on the Western Slope (WS) and Front Range (FR) of Colorado during 2009-2011. Samples were collected from 37 bobcats and 29 pumas on the WS and FR. As predicted, age appeared to be positively related to the exposure to pathogens that are both environmentally transmitted (Toxoplasma) and directly transmitted between animals (FIV). In addition, WS bobcats appeared more likely to be exposed to Toxoplasma with increasing intraspecific space-use overlap. However, counter to our predictions, exposure to directly-transmitted pathogens (FCV and FIV) was more likely with decreasing space-use overlap (FCV: WS bobcats) and potential intraspecific contacts (FIV: FR pumas). Environmental factors, including urbanization and landscape covariates, were generally unsupported in our models. This study is an approximation of how pathogens can be evaluated in relation to demographic, social, and environmental factors to understand pathogen exposure in wild animal populations.	[Lewis, Jesse S.; Crooks, Kevin R.] Colorado State Univ, Grad Degree Program Ecol, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Logan, Kenneth A.] Mammals Res Colorado Pk & Wildlife, Montrose, CO USA; [Alldredge, Mat W.] Mammals Res Colorado Pk & Wildlife, Ft Collins, CO USA; [Carver, Scott] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Bevins, Sarah N.] USDA APHIS Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Lappin, Michael] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA; [VandeWoude, Sue] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University; University of Tasmania; United States Department of Agriculture (USDA); Colorado State University; Colorado State University	Lewis, JS (corresponding author), Colorado State Univ, Grad Degree Program Ecol, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.	jslewis.research@gmail.com	Carver, Scott/J-7654-2014	Carver, Scott/0000-0002-3579-7588	Colorado State University; Open Space, Boulder City Open Space and Mountain Parks; Bureau of Land Management; National Science Foundation-Ecology of Infectious Diseases Program [NSF EF-0723676, EF-1413925]; Colorado Parks and Wildlife (CPW); Boulder County Parks; US Forest Service	Colorado State University; Open Space, Boulder City Open Space and Mountain Parks; Bureau of Land Management; National Science Foundation-Ecology of Infectious Diseases Program(National Science Foundation (NSF)); Colorado Parks and Wildlife (CPW); Boulder County Parks; US Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	Funding and support were provided by Colorado State University, Colorado Parks and Wildlife (CPW), Boulder County Parks and Open Space, Boulder City Open Space and Mountain Parks, the Bureau of Land Management, US Forest Service, and a grant from the National Science Foundation-Ecology of Infectious Diseases Program (NSF EF-0723676; EF-1413925).; Funding and support were provided by Colorado State University, Colorado Parks and Wildlife (CPW), Boulder County Parks and Open Space, Boulder City Open Space and Mountain Parks, the Bureau of Land Management, US Forest Service, Arizona State University, and a grant from the National Science Foundation-Ecology of Infectious Diseases Program (NSF EF-0723676; EF-1413925). We greatly thank R. Alonso, B. Dunne, M. Durant, D. Morin, and L. Sweanor for their invaluable assistance in the field. In addition, we thank the numerous landowners who allowed us access to their properties for our research. We greatly appreciate the discussions and commentary about our project and manuscript provided by D. Theobald, as well as insight from anonymous reviewers that improved the paper.	Afonso E, 2010, EPIDEMIOL INFECT, V138, P1105, DOI 10.1017/S0950268809991270; Afonso E, 2008, INT J PARASITOL, V38, P1017, DOI 10.1016/j.ijpara.2008.01.004; Afonso Eve, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P278, DOI 10.1016/j.ijppaw.2013.09.006; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 2014, R LANG ENV STAT COMP; Berger A, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0595-2; Bevins SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031403; Biek R, 2006, SCIENCE, V311, P538, DOI 10.1126/science.1121360; Biek R, 2006, J WILDLIFE DIS, V42, P606, DOI 10.7589/0090-3558-42.3.606; Bradley CA, 2008, ECOL APPL, V18, P1083, DOI 10.1890/07-0822.1; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; Breitschwerdt EB, 2000, CLIN MICROBIOL REV, V13, P428, DOI 10.1128/CMR.13.3.428-438.2000; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carver S, 2016, ECOL APPL, V26, P367, DOI [10.1890/15-0445.1, 10.1890/15-0445]; Carver S, 2012, J CLIN MICROBIOL, V50, P3080, DOI 10.1128/JCM.01558-12; Chomel BB, 2004, VET RES, V35, P233, DOI 10.1051/vetres:2004001; Chomel BB, 2006, ANN NY ACAD SCI, V1078, P410, DOI 10.1196/annals.1374.080; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Craft ME, 2009, P ROYAL SOC B; Crooks Kevin R., 2010, P185; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Deplazes P, 2011, VET PARASITOL, V182, P41, DOI 10.1016/j.vetpar.2011.07.014; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Dybas CL, 2009, BIOSCIENCE, V59, P8, DOI 10.1525/bio.2009.59.1.3; Eisen L, 2006, J MED ENTOMOL, V43, P415, DOI 10.1603/0022-2585(2006)043[0415:GDPAHS]2.0.CO;2; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; Eisen RJ, 2006, AM J TROP MED HYG, V75, P669, DOI 10.4269/ajtmh.2006.75.669; Eisen RJ, 2003, ENVIRON ENTOMOL, V32, P1010, DOI 10.1603/0046-225X-32.5.1010; Estrada-Pena A, 2002, ENVIRON HEALTH PERSP, V110, P635, DOI 10.1289/ehp.02110635; Estrada-Pena A, 2001, VET PARASITOL, V98, P111, DOI 10.1016/S0304-4017(01)00426-5; Farine DR, 2012, ANIM BEHAV, V84, P1271, DOI 10.1016/j.anbehav.2012.08.008; Farnsworth ML, 2005, ECOL APPL, V15, P119, DOI 10.1890/04-0194; Fenton A, 2002, J ANIM ECOL, V71, P893, DOI 10.1046/j.1365-2656.2002.00656.x; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Flegr J, 2013, TRENDS PARASITOL, V29, P156, DOI 10.1016/j.pt.2013.01.007; Foley JE, 2013, J WILDLIFE DIS, V49, P279, DOI 10.7589/2012-08-206; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Franklin SP, 2007, J VIROL, V81, P10961, DOI 10.1128/JVI.00997-07; Franklin SP, 2007, J WILDLIFE DIS, V43, P700, DOI 10.7589/0090-3558-43.4.700; FRANTI CE, 1976, J AM VET MED ASSOC, V169, P901; FRENCH JB, 1995, J MED ENTOMOL, V32, P876, DOI 10.1093/jmedent/32.6.876; Gilot-Fromont E, 2012, TOXOPLASMOSIS RECENT, V10, P2845; Godfrey SS, 2010, INT J PARASITOL, V40, P1575, DOI 10.1016/j.ijpara.2010.06.002; Gorman ML, 1998, NATURE, V391, P479, DOI 10.1038/35131; Gotteland C, 2014, PARASITOLOGY, V141, P259, DOI 10.1017/S0031182013001522; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; Gurnell J, 2006, BIOL CONSERV, V131, P287, DOI 10.1016/j.biocon.2006.04.009; Hegglin D, 2007, FUNCT ECOL, V21, P552, DOI 10.1111/j.1365-2435.2007.01257.x; Horne JS, 2006, J WILDLIFE MANAGE, V70, P641, DOI 10.2193/0022-541X(2006)70[641:LCVLSC]2.0.CO;2; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hudson P. J., 1995, P144, DOI 10.1017/CBO9780511629396.006; HUGHJONES M, 1992, REMOTE SENS ENVIRON, V40, P43, DOI 10.1016/0034-4257(92)90125-4; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kikuchi Y, 2004, VET PARASITOL, V120, P1, DOI 10.1016/j.vetpar.2004.01.002; Krasnov BR, 2008, PARASITOLOGY, V135, P229, DOI 10.1017/S003118200700368X; Kreeger TJ, 2002, HDB WILDLIFE CHEM IM; Lagana DM, 2013, J WILDLIFE DIS, V49, P718, DOI 10.7589/2012-10-243; Langlois JP, 2001, LANDSCAPE ECOL, V16, P255, DOI 10.1023/A:1011148316537; Lee J, 2017, J VIROL, V91, DOI [10.1128/JVI.02134-16, 10.1128/jvi.02134-16]; Lelu M, 2010, THEOR POPUL BIOL, V78, P139, DOI 10.1016/j.tpb.2010.05.005; Levi T, 2012, P NATL ACAD SCI USA, V109, P10942, DOI 10.1073/pnas.1204536109; Lewis JS, 2015, ECOL EVOL, V5, pS946, DOI 10.1002/ece3.1812; Lewis JS, 2015, ECOL APPL, V25, P1880, DOI 10.1890/14-1664.1; Lewis JS, 2011, LANDSCAPE URBAN PLAN, V101, P99, DOI 10.1016/j.landurbplan.2011.01.008; Lewis JS, CONTACT NET IN PRESS; LINDSTEDT SL, 1986, ECOLOGY, V67, P413, DOI 10.2307/1938584; McCallum Hamish, 2008, P100; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; McMichael AJ, 2004, PHILOS T ROY SOC B, V359, P1049, DOI 10.1098/rstb.2004.1480; Merkle JA, 2009, CAN J ZOOL, V87, P56, DOI 10.1139/Z08-136; Mize EL, 2011, J VECTOR ECOL, V36, P308, DOI 10.1111/j.1948-7134.2011.00171.x; Monello RJ, 2009, J PARASITOL, V95, P56, DOI 10.1645/GE-1643.1; MORSE DH, 1974, AM NAT, V108, P818, DOI 10.1086/282957; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Murray DL, 1999, ANIM CONSERV, V2, P241, DOI 10.1111/j.1469-1795.1999.tb00070.x; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Page LK, 2008, J WILDLIFE DIS, V44, P594, DOI 10.7589/0090-3558-44.3.594; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; PAULMURPHY J, 1994, J WILDLIFE DIS, V30, P205, DOI 10.7589/0090-3558-30.2.205; Pecon-Slattery J, 2008, VET IMMUNOL IMMUNOP, V123, P32, DOI 10.1016/j.vetimm.2008.01.010; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Rachlow J.L., 2009, ANIMAL SPACE USE 13; Radford AD, 2007, VET RES, V38, P319, DOI 10.1051/vetres:2006056; Ramsey D, 2002, J APPL ECOL, V39, P806, DOI 10.1046/j.1365-2664.2002.00760.x; Reperant LA, 2009, PARASITOLOGY, V136, P329, DOI 10.1017/S0031182008005428; Reperant LA, 2007, PARASITOL RES, V101, P605, DOI 10.1007/s00436-007-0520-0; Riley SPD, 2004, J WILDLIFE DIS, V40, P11, DOI 10.7589/0090-3558-40.1.11; Robert K, 2012, J WILDLIFE MANAGE, V76, P1670, DOI 10.1002/jwmg.435; ROELKE ME, 1993, J WILDLIFE DIS, V29, P36, DOI 10.7589/0090-3558-29.1.36; Rushton SP, 2000, J APPL ECOL, V37, P997, DOI 10.1046/j.1365-2664.2000.00553.x; Russell CA, 2004, P ROY SOC B-BIOL SCI, V271, P21, DOI 10.1098/rspb.2003.2559; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Saura S., 2011, ECOLOGICAL INDICATOR, V11, P407, DOI DOI 10.1016/J.EC0LIND.2010.06.011; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Seidensticker J.C. IV., 1973, Wildlife Monogr, VNo. 35, P1; Seimon TA, 2013, MBIO, V4, DOI 10.1128/mBio.00410-13; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Skelly David K., 2006, P153; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Sunquist ME, 2002, WILD CATS WORLD; Theobald DM, 2005, ECOL SOC, V10; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Totton SC, 2002, J WILDLIFE DIS, V38, P313, DOI 10.7589/0090-3558-38.2.313; Tracey JA, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00376.1; Troyer JL, 2008, VET IMMUNOL IMMUNOP, V123, P159, DOI 10.1016/j.vetimm.2008.01.023; Troyer JL, 2005, J VIROL, V79, P8282, DOI 10.1128/JVI.79.13.8282-8294.2005; Vander Wal E, 2014, BEHAV ECOL SOCIOBIOL, V68, P383, DOI 10.1007/s00265-013-1652-0; VanderWaal KL, 2014, BEHAV ECOL, V25, P17, DOI 10.1093/beheco/art061; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06; Vanwambeke SO, 2007, ECOHEALTH, V4, P37, DOI 10.1007/s10393-007-0085-5; Vanwambeke SO, 2007, J MED ENTOMOL, V44, P133, DOI 10.1603/0022-2585(2007)44[133:LALCFI]2.0.CO;2; Walker BL, 2007, AVIAN DIS, V51, P691, DOI 10.1637/0005-2086(2007)51[691:WNVAGS]2.0.CO;2; Walter WD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1203; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Wheeler DC, 2010, SPAT SPATIO-TEMPORAL, V1, P151, DOI 10.1016/j.sste.2010.03.009; Wilcox Bruce A., 2005, Environmental Health and Preventive Medicine, V10, P263, DOI 10.1007/BF02897701; Wilson K., 2002, P6; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Yamamoto K, 1998, J WILDLIFE DIS, V34, P56, DOI 10.7589/0090-3558-34.1.56; Young HS, 2014, P NATL ACAD SCI USA, V111, P7036, DOI 10.1073/pnas.1404958111; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	131	6	6	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187035	10.1371/journal.pone.0187035	http://dx.doi.org/10.1371/journal.pone.0187035			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121060	Green Published, gold, Green Accepted			2022-12-26	WOS:000414769900017
J	Braig, M; Leupold, J; Menza, M; Russe, M; Ko, CW; Hennig, J; von Elverteldt, D				Braig, Moritz; Leupold, Jochen; Menza, Marius; Russe, Maximilian; Ko, Cheng-Wen; Hennig, Juergen; von Elverteldt, Dominik			Preclinical 4D-flow magnetic resonance phase contrast imaging of the murine aortic arch	PLOS ONE			English	Article							FLOW MRI	Purpose Cardiovascular diseases remain the number one death cause worldwide. Preclinical 4D flow phase contrast magnetic resonance imaging can provide substantial insights in the analysis of aortic pathophysiologies in various animal models. These insights may allow a better understanding of pathophysiologies, therapy monitoring, and can possibly be translated to humans. This study provides a framework to acquire the velocity field within the aortic arch. It analyses important flow values at different locations within the aortic arch. Imaging parameters with high temporal and spatial resolution are provided, that still allow combining this time-consuming method with other necessary imaging-protocols. Methods A new setup was established where a prospectively gated 4D phase contrast sequence is combined with a highly sensitive cryogenic coil on a preclinical magnetic resonance scanner. The sequence was redesigned to maintain a close to steady state condition of the longitudinal magnetization and hence to overcome steady state artifacts. Imaging parameters were optimized to provide high spatial and temporal resolution. Pathline visualizations were generated from the acquired velocity data in order to display complex flow patterns. Results Our setup allows data acquisition with at least two times the rate than that of previous publications based on Cartesian encoding, at an improved image quality. The "steady state" sequence reduces observed artifacts and provides uniform image intensity over the heart cycle. This made possible quantification of blood speed and wall shear stress (WSS) within the aorta and its branches. The highest velocities were observed in the ascending aorta with 137.5 8 cm/s. Peak velocity values in the Brachiocephalic trunk were 57 12 cm/s. Quantification showed that the peak flow occurs around 20 ms post R-wave in the ascending aorta. The highest mean axial wall shear stress was observed in the analysis plane between the left common carotid artery (LCCA) and the left subclavian artery. A stable image quality allows visualizing complex flow patterns by means of streamlines and for the first time, to the best of our knowledge, pathline visualizations from 4D flow MRI in mice. Conclusion The described setup allows analyzing pathophysiologies in mouse models of cardiovascular diseases in the aorta and its branches with better image quality and higher spatial and temporal resolution than previous Cartesian publications. Pathlines provide an advanced analysis of complex flow patterns in the murine aorta. An imaging protocol is provided that offers the possibility to acquire the aortic arch at sufficiently high resolution in less than one hour. This allows the combination of the flow assessment with other multifunctional imaging protocols.	[Braig, Moritz; Leupold, Jochen; Menza, Marius; Hennig, Juergen; von Elverteldt, Dominik] Univ Freiburg, Fac Med, Med Ctr, Dept Radiol,Med Phys, Freiburg, Germany; [Russe, Maximilian] Univ Freiburg, Fac Med, Med Ctr, Dept Radiol,Radiol, Freiburg, Germany; [Ko, Cheng-Wen] Natl Sun Yat Sen Univ, Dept Comp Sci & Engn, Kaohsiung, Taiwan	University of Freiburg; University of Freiburg; National Sun Yat Sen University	Braig, M (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Radiol,Med Phys, Freiburg, Germany.	Moritz.braig@uniklinik-freiburg.de	Hennig, Jürgen/F-2424-2010; Leupold, Jochen/AAH-9118-2021	Hennig, Jürgen/0000-0002-2273-3497; von Elverfeldt, Dominik/0000-0002-6219-3528; Leupold, Jochen/0000-0002-2582-9451	German research council (DFG) [EL 534/6-1]	German research council (DFG)(German Research Foundation (DFG))	This work was funded by the German research council (DFG): EL 534/6-1 (http://www. dfg.de/) granted to DvE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock J, 2007, P 15 ANN MEET ISMRM, V15, P3138; Bovenkamp PR, 2014, MAGMA N Y N; Braig M, 2015, P 18 ANN M GERM CHAP; Cassidy PJ, 2004, J MAGN RESON IMAGING, V19, P229, DOI 10.1002/jmri.10454; Casteleyn C, 2010, J ANAT, V216, P563, DOI 10.1111/j.1469-7580.2010.01220.x; Dyverfeldt P, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0174-5; Espe EKS, 2012, MAGN RESON MED; Guo X, 2002, AM J PHYSIOL-HEART C, V283, pH1829, DOI 10.1152/ajpheart.00224.2002; Herold V, 2009, MAGN RESON MED, V61, P1293, DOI 10.1002/mrm.21957; Janiczek RL, 2011, MAGN RESON MED, V66, P1382, DOI 10.1002/mrm.22937; Markl M, 2012, J MAGN RESON IMAGING, V36, P1015, DOI 10.1002/jmri.23632; Markl M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-7; Sigfridsson A, 2012, MAGN RESON MED, V68, P1065, DOI 10.1002/mrm.23297; Stalder AF, 2008, MAGN RESON MED, V60, P1218, DOI 10.1002/mrm.21778; Wagenhaus B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042383; Wahlin A, 2012, J MAGN RESON IMAGING, V35, P1055, DOI 10.1002/jmri.23527; Winter P, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-88	17	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187596	10.1371/journal.pone.0187596	http://dx.doi.org/10.1371/journal.pone.0187596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117252	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600050
J	Guo, JL; Zhang, Q; Li, J; Llu, YS; Hou, ZY; Chen, W; Jin, L; Tian, Y; Ju, LL; Liu, B; Dong, TH; Zhang, F; Zhang, YZ				Guo, Jialiang; Zhang, Qi; Li, Jia; Llu, Yansong; Hou, Zhiyong; Chen, Wei; Jin, Lin; Tian, Ye; Ju, Linlin; Liu, Bo; Dong, Tianhua; Zhang, Fei; Zhang, Yingze			Local application of an ibandronate/collagen sponge improves femoral fracture healing in ovariectomized rats	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; COLLAGEN SPONGE; ZOLEDRONIC ACID; BISPHOSPHONATES; STRENGTH; DELIVERY; PROLIFERATION; OSTEOPOROSIS; OSTEOBLASTS; INHIBITION	Non-union is a major clinical problem in the healing of fractures, especially in patients with osteoporosis. The systemic administration of drugs is time consuming and large doses are demanding and act slowly, whereas local release acts rapidly, increases the quality and quantity of the bone tissue. We hypothesize that local delivery demonstrates better therapeutic effects on an osteoporotic fracture. The aim of this paper is to investigate the effect of the local application of ibandronate loaded with a collagen sponge on regulating bone formation and remodeling in an osteoporotic rat model of fracture healing. We found that the local delivery of ibandronate exhibited excellent effects on improving the bone microarchitecture and suppressed effects on bone remodeling. At 4 weeks, more callus formation and improvement of mechanical character and microstructure were observed in a local delivery via mu CT, mechanical test, histological research and serum analysis. The suppression of bone remodeling was compared with a systemic treatment at 12 weeks, and the structural mechanical properties and microarchitecture were also improved with local delivery. This research identifies an earlier, safer and integrated approach for local delivery of ibandronate with collagen and provides a better strategy for the treatment of osteoporotic fracture in rats.	[Guo, Jialiang; Zhang, Qi; Li, Jia; Hou, Zhiyong; Chen, Wei; Jin, Lin; Tian, Ye; Ju, Linlin; Liu, Bo; Dong, Tianhua; Zhang, Fei; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Wuhan, Hubei, Peoples R China; [Guo, Jialiang; Zhang, Qi; Li, Jia; Hou, Zhiyong; Chen, Wei; Jin, Lin; Tian, Ye; Ju, Linlin; Liu, Bo; Dong, Tianhua; Zhang, Fei; Zhang, Yingze] Key Lab Orthopaed Biomech Hebei Prov, Shijiazhuang, Hebei, Peoples R China; [Guo, Jialiang; Zhang, Qi; Li, Jia; Chen, Wei; Jin, Lin; Tian, Ye; Ju, Linlin; Liu, Bo; Dong, Tianhua; Zhang, Fei; Zhang, Yingze] Orthopaed Res Inst Hebei Prov, Shijiazhuang, Hebei, Peoples R China; [Llu, Yansong] VSD Med Sci & Technol Co Ltd, Shijiazhuang, Hubei, Peoples R China	Hebei Medical University	Zhang, YZ (corresponding author), Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Wuhan, Hubei, Peoples R China.; Zhang, YZ (corresponding author), Key Lab Orthopaed Biomech Hebei Prov, Shijiazhuang, Hebei, Peoples R China.; Zhang, YZ (corresponding author), Orthopaed Res Inst Hebei Prov, Shijiazhuang, Hebei, Peoples R China.	dryzzhang@126.com	Chen, Wei/GRX-2231-2022	Zhang, YIngze/0000-0001-8042-6105; Hou, Zhiyong/0000-0001-5838-4025	Hebei Provincial 333 Talent Projection Foundation of China [A2016015062]; VSD Medical Science & Technology Co., Ltd	Hebei Provincial 333 Talent Projection Foundation of China; VSD Medical Science & Technology Co., Ltd	The authors acknowledge the support from Hebei Provincial 333 Talent Projection Foundation of China (No. A2016015062) (QZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author YL was employed by VSD Medical Science & Technology Co., Ltd, during the course of the study. The commercial company VSD Medical Science & Technology Co., Ltd had no direct relation with this experiment. The author from VSD is a senior fellow apprentice of the first author who focused on basal experiment in his doctor research, and he guided the procedure of ovariectomy before conducting this experiment. He has left the company now, and has a job in another company. The author did not play a role in the process of the experiment. VSD Medical Science & Technology Co., Ltd, provided support in the form of salary for author YL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Abrahamsen B, 2010, CALCIFIED TISSUE INT, V86, P421, DOI 10.1007/s00223-010-9364-1; Alvarez GS, 2015, CURR PHARM BIOTECHNO, V16, P661, DOI 10.2174/138920101607150427113355; Amanat N, 2005, J ORTHOP RES, V23, P1029, DOI 10.1016/j.orthres.2005.03.004; Amanat N, 2007, J BONE MINER RES, V22, P867, DOI 10.1359/JBMR.070318; Aya-Ay J, 2007, J BONE MINER RES, V22, P93, DOI 10.1359/JBMR.060817; Barrett J, 2004, J CLIN PHARMACOL, V44, P951, DOI 10.1177/0091270004267594; Bauss F, 2002, J RHEUMATOL, V29, P990; Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063; Chen DC, 2007, J BIOMED MATER RES A, V80A, P399, DOI 10.1002/jbm.a.30932; Coxon FP, 2000, J BONE MINER RES, V15, P1467, DOI 10.1359/jbmr.2000.15.8.1467; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Fromigue O, 2002, J ENDOCRINOL INVEST, V25, P539, DOI 10.1007/BF03345497; Gallagher JC, 2010, MATURITAS, V65, P301, DOI 10.1016/j.maturitas.2010.01.002; Gao Y, 2009, BIOMATERIALS, V30, P1790, DOI 10.1016/j.biomaterials.2008.12.025; Gao Y, 2009, BONE, V44, P225, DOI 10.1016/j.bone.2008.10.054; Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1; Gleeson JP, 2010, EUR CELLS MATER, V20, P218; Goodship A E, 1994, Ann Oncol, V5 Suppl 7, pS53; Guo CL, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/912631; Habermann B, 2010, CALCIFIED TISSUE INT, V86, P82, DOI 10.1007/s00223-009-9317-8; Hao Y, 2015, BONE, V81, P702, DOI 10.1016/j.bone.2015.09.018; HORISAKA Y, 1994, J BIOMED MATER RES, V28, P97, DOI 10.1002/jbm.820280113; HUGHES DE, 1989, J CLIN INVEST, V83, P1930, DOI 10.1172/JCI114100; Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024; Jackix ED, 2010, J MED FOOD, V13, P1385, DOI 10.1089/jmf.2009.0256; Jing D, 2016, SCI REP-UK, V6, DOI 10.1038/srep28537; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kim BS, 2013, J BIOMED MATER RES A, V101, P2661, DOI 10.1002/jbm.a.34567; Koo KH, 2014, ARTIF ORGANS, V38, P893, DOI 10.1111/aor.12249; Kumar D, 2006, J ORTHOP SCI, V11, P512, DOI 10.1007/s00776-006-1046-5; Li BJ, 2011, J CELL BIOCHEM, V112, P1229, DOI 10.1002/jcb.23049; Little DG, 2007, J BONE JOINT SURG BR, V89B, P425, DOI 10.1302/0301-620X.89B4.18301; Madsen JE, 1998, ACTA ORTHOP SCAND, V69, P532, DOI 10.3109/17453679808997793; Manabe T, 2012, CALCIFIED TISSUE INT, V90, P193, DOI 10.1007/s00223-011-9563-4; O'Neal JM, 2010, BONE, V47, P241, DOI 10.1016/j.bone.2010.05.016; Odvina CV, 2006, J INVEST MED, V54, P114, DOI 10.2310/6650.2006.05037; Paglia DN, 2014, J ORTHOP RES, V32, P727, DOI 10.1002/jor.22570; Peter B, 2006, J BIOMED MATER RES A, V76A, P133, DOI 10.1002/jbm.a.30456; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.3.CO;2-C; Sadeghi AR, 2016, MAT SCI ENG C-MATER, V66, P130, DOI 10.1016/j.msec.2016.04.073; Sakai S, 2015, BONE, V81, P449, DOI 10.1016/j.bone.2015.08.004; Santos TD, 2015, J APPL ORAL SCI, V23, P623, DOI 10.1590/1678-775720150374; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sekine T, 2000, J THORAC CARDIOV SUR, V119, P1162, DOI 10.1067/mtc.2000.106652; Senn C, 2014, OSTEOPOROSIS INT, V25, P1945, DOI 10.1007/s00198-014-2703-8; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Stadelmann VA, 2008, EUR CELLS MATER, V16, P10, DOI 10.22203/eCM.v016a02; Toosi S, 2016, J BIOMED MATER RES A, V104, P2020, DOI 10.1002/jbm.a.35736; Tsai CH, 2002, J BIOMED MATER RES, V63, P65, DOI 10.1002/jbm.10089; Walter C, 2011, ORAL DIS, V17, P194, DOI 10.1111/j.1601-0825.2010.01720.x; Wang LP, 2015, J BONE MINER RES, V30, P1896, DOI 10.1002/jbmr.2540; Wong E, 2013, J BONE JOINT SURG AM, V95A, P454, DOI 10.2106/JBJS.L.00275; Woolfson DN, 2006, CURR OPIN CHEM BIOL, V10, P559, DOI 10.1016/j.cbpa.2006.09.019; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yang ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125807	55	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187683	10.1371/journal.pone.0187683	http://dx.doi.org/10.1371/journal.pone.0187683			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108027	gold, Green Published, Green Submitted			2022-12-26	WOS:000414424600058
J	Ji, XR; Cheng, KC; Chen, YR; Lin, TY; Cheung, CHA; Wu, CL; Chiang, HC				Ji, Xuan-Ru; Cheng, Kuan-Chung; Chen, Yu-Ru; Lin, Tzu-Yu; Cheung, Chun Hei Antonio; Wu, Chia-Lin; Chiang, Hsueh-Cheng			Dysfunction of different cellular degradation pathways contributes to specific beta-amyloid42-induced pathologies	FASEB JOURNAL			English	Article						Alzheimer's disease; autophagy; proteasome; lysosome	AMYLOID PRECURSOR PROTEIN; ENDOPLASMIC-RETICULUM STRESS; SPORADIC ALZHEIMERS-DISEASE; UBIQUITIN-PROTEASOME SYSTEM; DROSOPHILA-MELANOGASTER; AUTOPHAGIC VACUOLES; SECRETORY PATHWAY; BETA-PROTEIN; ENDOCYTIC TRAFFICKING; PRESENILIN-MUTATIONS	The endosomal-lysosomal system (ELS), autophagy, and ubiquitin-proteasome system (UPS) are cellular degradation pathways that each play a critical role in the removal of misfolded proteins and the prevention of the accumulation of abnormal proteins. Recent studies on Alzheimer's disease (AD) pathogenesis have suggested that accumulation of aggregated beta-amyloid (A beta) peptides in the AD brain results from a dysfunction in these cellular clearance systems. However, the specific roles of these pathways in the removal of A beta peptides and the pathogenesis underlying AD are unclear. Our in vitro and in vivo genetic approaches revealed that ELS mainly removed monomeric beta-amyloid42 (A beta 42), while autophagy and UPS clear oligomeric A beta 42. Although overproduction of phosphatidylinositol 4-phosphate-5 increased A beta 42 clearance, it reduced the life span of A beta 42 transgenic flies. Our behavioral studies further demonstrated impaired autophagy and UPS-enhanced A beta 42-induced learning and memory deficits, but there was no effect on A beta 42-induced reduction in life span. Results from genetic fluorescence imaging showed that these pathways were damaged in the following order: UPS, autophagy, and finally ELS. The results of our study demonstrate that different degradation pathways play distinct roles in the removal of A beta 42 aggregates and in disease progression. These findings also suggest that pharmacologic treatments that are designed to stimulate cellular degradation pathways in patients with AD should be used with caution.	[Ji, Xuan-Ru; Cheng, Kuan-Chung; Chen, Yu-Ru; Lin, Tzu-Yu; Cheung, Chun Hei Antonio; Chiang, Hsueh-Cheng] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan, Taiwan; [Cheng, Kuan-Chung; Cheung, Chun Hei Antonio; Chiang, Hsueh-Cheng] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan, Taiwan; [Wu, Chia-Lin] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan	National Cheng Kung University; National Cheng Kung University; Chang Gung University	Chiang, HC (corresponding author), Natl Cheng Kung Univ, 1 Univ Rd, Tainan 701, Taiwan.	chianghc@mail.ncku.edu.tw		Cheung, Chun Hei Antonio/0000-0003-4181-1435; Lin, Tzu Yu/0000-0003-1678-7779; Wu, Chia-Lin/0000-0002-7906-2364	Ministry of Science and Technology, Taiwan [MOST 104-2320-B-006-037-MY3, MOST 103-2320-B-006-051]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors thank Y. Zhong, G. C. Chen, C. C. Jang, U. B. Pandey, Y. W. Liu, P. Raghu, R. Regazzi, T. F. J. Martin, and S. H. Yang, as well as the Bloomington Drosophila Stock Center, Kyoto Stock Center, Vienna Drosophila RNAi Center (VDRC), and FlyORF for providing experimental materials, and L. Wang, Y.-C. Shuai, and K.-S. Hsu for constructive comments on early drafts of the article. The authors also thank the technical services from the Bio-image Core Facility of the National Core Facility Program for Biotechnology, Ministry of Science and Technology, Taiwan. This work was supported by the Ministry of Science and Technology, Taiwan (MOST 104-2320-B-006-037-MY3 to H.-C.C., MOST 103-2320-B-006-051 to H.-C.C.). The authors declare no conflicts of interest.	Abe N, 2008, J CELL SCI, V121, P1488, DOI 10.1242/jcs.020792; Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; Belote JM, 2002, GENESIS, V34, P80, DOI 10.1002/gene.10131; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Cescato R, 2000, J NEUROCHEM, V74, P1131; Chakrabarti P, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004948; Chen GC, 2008, AUTOPHAGY, V4, P37, DOI 10.4161/auto.5141; Chin YH, 2015, HUM MOL GENET, V24, P5542, DOI 10.1093/hmg/ddv285; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; DECAMILLI P, 1995, CURR OPIN NEUROBIOL, V5, P559, DOI 10.1016/0959-4388(95)80059-X; Dias BD, 2014, SCI REP-UK, V4, DOI 10.1038/srep05556; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Gadhave K, 2016, J CELL MOL MED, V20, P1392, DOI 10.1111/jcmm.12817; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gong B, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00004; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; Guglielmotto M, 2014, AUTOPHAGY, V10, P1827, DOI 10.4161/auto.30001; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jang SK, 2015, EUR J PHARMACOL, V758, P1, DOI 10.1016/j.ejphar.2015.03.071; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Lilienbaum Alain, 2013, Int J Biochem Mol Biol, V4, P1; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Maiese K, 2016, BRIT J CLIN PHARMACO, V82, P1245, DOI 10.1111/bcp.12804; Mizushima N, 2005, J CELL BIOL, V171, P15, DOI 10.1083/jcb.200508097; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; PERRY G, 1989, J NEUROCHEM, V52, P1523, DOI 10.1111/j.1471-4159.1989.tb09203.x; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Salon ML, 2003, EXP NEUROL, V180, P131, DOI 10.1016/S0014-4886(02)00060-2; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Soejima N, 2013, CURR ALZHEIMER RES, V10, P11; Song MS, 2011, NEUROSCIENCE, V178, P181, DOI 10.1016/j.neuroscience.2010.12.055; Thal DR, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00025; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Tung YT, 2012, J BIOSCIENCES, V37, P157, DOI 10.1007/s12038-011-9176-0; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Urushitani M, 2008, FASEB J, V22, P2476, DOI 10.1096/fj.07-092783; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Viswanathan J, 2011, TRAFFIC, V12, P330, DOI 10.1111/j.1600-0854.2010.01149.x; WANG GP, 1991, BRAIN RES, V566, P146, DOI 10.1016/0006-8993(91)91692-T; Wang L, 2012, P NATL ACAD SCI USA, V109, P16743, DOI 10.1073/pnas.1208011109; Wang R, 2012, CURR ALZHEIMER RES, V9, P606, DOI 10.2174/156720512800618026; Wilson CA, 2002, NAT NEUROSCI, V5, P849, DOI 10.1038/nn898; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; Zhou FF, 2011, PROTEIN CELL, V2, P377, DOI 10.1007/s13238-011-1047-9	67	9	9	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1375	1387		10.1096/fj.201700199RR	http://dx.doi.org/10.1096/fj.201700199RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127191				2022-12-26	WOS:000427246000021
J	Zhao, B; Xu, ST; Dong, XC; Lu, CF; Springer, TA				Zhao, Bo; Xu, Shutong; Dong, Xianchi; Lu, Chafen; Springer, Timothy A.			Prodomain-growth factor swapping in the structure of pro-TGF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						activin; bone morphogenetic protein (BMP); crystal structure; dimerization; transforming growth factor beta (TGF-); heterodimer; prodomain; proprotein convertase; swapping; Arg-Gly-Asp-Leu-any-any-Leu; Ile (RGDLXX(L; I)); latent TGF--binding proteins (LTBPs); glycoprotein-A repetitions predominant protein (GARP); latency-associated peptide (LAP); growth factor (GF); Protein Data Bank (PDB)	LATENT TGF-BETA; MORPHOGENETIC PROTEIN HETERODIMERS; MACROMOLECULAR STRUCTURE; MESODERM INDUCTION; BMP2/7 HETERODIMER; IN-VITRO; SECRETION; ACTIVATION; GARP; FACTOR-BETA-1	TGF- is synthesized as a proprotein that dimerizes in the endoplasmic reticulum. After processing in the Golgi to cleave the N-terminal prodomain from the C-terminal growth factor (GF) domain in each monomer, pro-TGF- is secreted and stored in latent complexes. It is unclear which prodomain and GF monomer are linked before proprotein convertase cleavage and how much conformational change occurs following cleavage. We have determined a structure of pro-TGF-1 with the proprotein convertase cleavage site mutated to mimic the structure of the TGF-1 proprotein. Structure, mutation, and model building demonstrate that the prodomain arm domain in one monomer is linked to the GF that interacts with the arm domain in the other monomer in the dimeric structure (i.e. the prodomain arm domain and GF domain in each monomer are swapped). Swapping has important implications for the mechanism of biosynthesis in the TGF- family and is relevant to the mechanism for preferential formation of heterodimers over homodimers for some members of the TGF- family. Our structure, together with two previous ones, also provides insights into which regions of the prodomain-GF complex are highly structurally conserved and which are perturbed by crystal lattice contacts.	[Zhao, Bo; Dong, Xianchi; Lu, Chafen; Springer, Timothy A.] Childrens Hosp Boston, 3 Blackfan Circle, Boston, MA 02115 USA; [Zhao, Bo; Dong, Xianchi; Lu, Chafen; Springer, Timothy A.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 3 Blackfan Circle, Boston, MA 02115 USA; [Xu, Shutong] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Xu, Shutong; Springer, Timothy A.] Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Springer, TA (corresponding author), Childrens Hosp Boston, 3 Blackfan Circle, Boston, MA 02115 USA.; Springer, TA (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 3 Blackfan Circle, Boston, MA 02115 USA.	springer_lab@crystal.harvard.edu	Zhao, Bo/GVT-7665-2022	Zhao, Bo/0000-0002-2163-6484	National Institutes of Health [R01 AR067288]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant R01 AR067288. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Belville C, 2004, MOL ENDOCRINOL, V18, P708, DOI 10.1210/me.2003-0358; Buijs JT, 2012, ONCOGENE, V31, P2164, DOI 10.1038/onc.2011.400; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dong XC, 2014, NAT STRUCT MOL BIOL, V21, P1091, DOI 10.1038/nsmb.2905; GENTRY LE, 1987, MOL CELL BIOL, V7, P3418, DOI 10.1128/MCB.7.10.3418; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Hinck A. P., 2016, COLD SPRING HARB PER, V8, DOI [10.1101/cshperspect.a022103, DOI 10.1101/CSHPERSPECT.A022103]; HSUEH AJW, 1987, P NATL ACAD SCI USA, V84, P5082, DOI 10.1073/pnas.84.14.5082; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nishimatsu S, 1998, MECH DEVELOP, V74, P75, DOI 10.1016/S0925-4773(98)00070-7; Robertson IB, 2013, CYTOKINE GROWTH F R, V24, P355, DOI 10.1016/j.cytogfr.2013.06.003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang XC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12469; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Zheng YN, 2012, TISSUE ENG PT A, V18, P621, DOI [10.1089/ten.tea.2011.0366, 10.1089/ten.TEA.2011.0366]	37	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1579	1589		10.1074/jbc.M117.809657	http://dx.doi.org/10.1074/jbc.M117.809657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29109152	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000424201700011
J	Vigil, JM; Stith, SS; Adams, IM; Reeve, AP				Vigil, Jacob M.; Stith, Sarah S.; Adams, Ian M.; Reeve, Anthony P.			Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study	PLOS ONE			English	Article							MARIJUANA LAWS; BACK-PAIN; PREVALENCE; SUBSTANCES; RISK	Background Current levels and dangers of opioid use in the U.S. warrant the investigation of harm-reducing treatment alternatives. Purpose A preliminary, historical, cohort study was used to examine the association between enroll-ment in the New Mexico Medical Cannabis Program (MCP) and opioid prescription use. \ Methods Thirty-seven habitual opioid using, chronic pain patients (mean age = 54 years; 54% male; 86% chronic back pain) enrolled in the MCP between 4/1/2010 and 10/3/2015 were compared to 29 non-enrolled patients (mean age = 60 years; 69% male; 100% chronic back pain). We used Prescription Monitoring Program opioid records over a 21 month period (first three months prior to enrollment for the MCP patients) to measure cessation (defined as the absence of opioid prescriptions activity during the last three months of observation) and reduction (calculated in average daily intravenous [IV] morphine dosages). MCP patient-reported benefits and side effects of using cannabis one year after enrollment were also collected. Results By the end of the 21 month observation period, MCP enrollment was associated with 17.27 higher age-and gender-adjusted odds of ceasing opioid prescriptions (CI 1.89 to 157.36, p = 0.012), 5.12 higher odds of reducing daily prescription opioid dosages (CI 1.56 to 16.88, p = 0.007), and a 47 percentage point reduction in daily opioid dosages relative to a mean change of positive 10.4 percentage points in the comparison group (CI -90.68 to -3.59, p = 0.034). The monthly trend in opioid prescriptions over time was negative among MCP patients (-0.64mg IV morphine, CI -1.10 to -0.18, p = 0.008), but not statistically different from zero in the comparison group (0.18mg IV morphine, CI -0.02 to 0.39, p = 0.081). Survey responses indicated improvements in pain reduction, quality of life, social life, activity levels, and concentration, and few side effects from using cannabis one year after enrollment in the MCP (ps<0.001). Conclusions The clinically and statistically significant evidence of an association between MCP enrollment and opioid prescription cessation and reductions and improved quality of life warrants further investigations on cannabis as a potential alternative to prescription opioids for treating chronic pain.	[Vigil, Jacob M.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Stith, Sarah S.] Univ New Mexico, Dept Econ, Albuquerque, NM 87131 USA; [Adams, Ian M.; Reeve, Anthony P.] Ind Rehabil Clin, Albuquerque, NM USA	University of New Mexico; University of New Mexico	Vigil, JM (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	vigilj@unm.edu	Adams, Ian Marshall/GQB-5002-2022		University of New Mexico Medical Cannabis Research Fund	University of New Mexico Medical Cannabis Research Fund	This research was funded in part by the University of New Mexico Medical Cannabis Research Fund.; This research was funded in part by the University of New Mexico Medical Cannabis Research Fund. All authors had access to the data in the study and take responsibility for the integrity of the data and the accuracy of the data analyses. We thank J. Alcock for comments on an earlier draft.	Abrams DI, 2016, CURR ONCOL, V23, pS8, DOI 10.3747/co.23.3099; Ashton CH, 2001, BRIT J PSYCHIAT, V178, P101, DOI 10.1192/bjp.178.2.101; Bachhuber MA, 2014, JAMA INTERN MED, V174, P1668, DOI 10.1001/jamainternmed.2014.4005; Bonn-Miller MO, 2011, PSYCHOL ADDICT BEHAV, V25, P485, DOI 10.1037/a0021945; Bradford AC, 2016, HEALTH AFFAIR, V35, P1230, DOI 10.1377/hlthaff.2015.1661; Calabria B, 2010, DRUG ALCOHOL REV, V29, P318, DOI 10.1111/j.1465-3362.2009.00149.x; CDC, 2016, WID RANG ONL DAT EP; Chey WD, 2014, NEW ENGL J MED, V370, P2387, DOI 10.1056/NEJMoa1310246; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Crane EH, EMERGENCY DEP VISITS; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; Deyo RA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g6380; Friedman D, 2015, NEW ENGL J MED, V373, P1048, DOI 10.1056/NEJMra1407304; Fuster D, J ADDICTION MED; Garcia-Portilla M. P., 2012, BRIT J CLIN PHARMACO, V77, P272; Globalrph. com, 2016, OP NARC AN CONV; Haroutounian S, 2016, CLIN J PAIN, V32, P1036, DOI 10.1097/AJP.0000000000000364; Hill KP, 2016, JAMA-J AM MED ASSOC, V315, P2338, DOI 10.1001/jama.2016.5181; Hurd YL, TRENDS IN NEUROSCIEN; Kim JH, 2016, AM J PUBLIC HEALTH, V106, P2032, DOI 10.2105/AJPH.2016.303426; Lucas P, 2017, INT J DRUG POLICY, V42, P30, DOI 10.1016/j.drugpo.2017.01.011; Lucas P, 2016, DRUG ALCOHOL REV, V35, P326, DOI 10.1111/dar.12323; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; National Academies of Sciences Engineering and Medicine, 2017, HLTH EFF CANN CANN C; Reiman A, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-35; Rubin R., 2017, JAMA; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Schuckit MA, 2016, NEW ENGL J MED, V375, P357, DOI 10.1056/NEJMra1604339; Shaheed CA, 2016, JAMA INTERN MED, V176, P958, DOI 10.1001/jamainternmed.2016.1251; Stith SS, 2016, SCIENCE, V352, P1182, DOI 10.1126/science.aaf7450; Tashkin Donald P, 2013, Ann Am Thorac Soc, V10, P239, DOI 10.1513/AnnalsATS.201212-127FR; Trescot A, 2008, PAIN PHYSICIAN, V11, pS181; Volkow ND, 2016, NEW ENGL J MED, V374, P1253, DOI 10.1056/NEJMra1507771; Wang T, 2008, CAN MED ASSOC J, V178, P1669, DOI 10.1503/cmaj.071178; Ware MA, 2015, J PAIN, V16, P1233, DOI 10.1016/j.jpain.2015.07.014; Whiting PF, 2016, JAMA-J AM MED ASSOC, V3913, P2456; Wilkie G, 2016, JAMA ONCOL, V2, P670, DOI 10.1001/jamaoncol.2016.0155	37	73	72	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187795	10.1371/journal.pone.0187795	http://dx.doi.org/10.1371/journal.pone.0187795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145417	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800030
J	Siegerstetter, SC; Schmitz-Esser, S; Magowan, E; Wetzels, SU; Zebeli, Q; Lawlor, PG; O'Connell, NE; Metzler-Zebeli, BU				Siegerstetter, Sina-Catherine; Schmitz-Esser, Stephan; Magowan, Elizabeth; Wetzels, Stefanie Urimare; Zebeli, Qendrim; Lawlor, Peadar G.; O'Connell, Niamh E.; Metzler-Zebeli, Barbara U.			Intestinal microbiota profiles associated with low and high residual feed intake in chickens across two geographical locations	PLOS ONE			English	Article							IMMUNE-RESPONSES; FECAL MICROBIOTA; CECAL MICROBIOTA; EFFICIENCY; PERFORMANCE; IDENTIFICATION; DIVERSITY; SELECTION; FCR	Intestinal microbe-host interactions can affect the feed efficiency (FE) of chickens. As inconsistent findings for FE-associated bacterial taxa were reported across studies, the present objective was to identify whether bacterial profiles and predicted metabolic functions that were associated with residual feed intake (RFI) and performance traits in female and male chickens were consistent across two different geographical locations. At six weeks of life, the microbiota in ileal, cecal and fecal samples of low (n = 34) and high (n = 35) RFI chickens were investigated by sequencing the V3-5 region of the 16S rRNA gene. Location-associated differences in alpha-diversity and relative abundances of several phyla and genera were detected. RFI-associated bacterial abundances were found at the phylum and genus level, but differed among the three intestinal sites and between males and females. Correlation analysis confirmed that, of the taxonomically classifiable bacteria, Lactobacillus (5% relative abundance) and two Lactobacillus crispatus-OTUs in feces were indicative for high RFI in females (P < 0.05). In males, Ruminococcus in cecal digesta (3.1% relative abundance) and Dorea in feces (< 0.1% relative abundance) were best indicative for low RFI, whereas Acinetobacter in feces (< 1.5% relative abundance) related to high RFI (P < 0.05). Predicted metabolic functions in feces of males confirmed compositional relationships as functions related to amino acid, fatty acid and vitamin metabolism correlated with low RFI, whereas an increasing abundance of bacterial signaling and interaction (i.e. cellular antigens) genes correlated with high RFI (P < 0.05). In conclusion, RFI-associated bacterial profiles could be identified across different geographical locations. Results indicated that consortia of low-abundance taxa in the ileum, ceca and feces may play a role for FE in chickens, whereby only bacterial FE-associations found in ileal and cecal digesta may serve as useful targets for dietary strategies.	[Siegerstetter, Sina-Catherine; Wetzels, Stefanie Urimare; Zebeli, Qendrim; Metzler-Zebeli, Barbara U.] Univ Vet Med, Inst Anim Nutr & Funct Plant Cpds, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Siegerstetter, Sina-Catherine; Schmitz-Esser, Stephan; Wetzels, Stefanie Urimare; Zebeli, Qendrim; Metzler-Zebeli, Barbara U.] Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Res Cluster Anim Gut Hlth, Vienna, Austria; [Schmitz-Esser, Stephan; Wetzels, Stefanie Urimare] Univ Vet Med, Inst Milk Hyg Milk Technol & Food Sci, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Magowan, Elizabeth] Agrifood & Biosci Inst, Agr Branch, Large Pk, Hillsborough, North Ireland; [Lawlor, Peadar G.] Anim & Grassland Res & Innovat Ctr, Teagasc Pig Dev Dept, Fermoy, Cork, Ireland; [O'Connell, Niamh E.] Queens Univ Belfast, Inst Global Food Secur, Univ Rd Belfast, Belfast, Antrim, North Ireland; [Schmitz-Esser, Stephan] Iowa State Univ, Coll Agr & Life Sci, Dept Anim Sci, Ames, IA USA	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Agri-Food & Biosciences Institute; Teagasc; Queens University Belfast; Iowa State University	Metzler-Zebeli, BU (corresponding author), Univ Vet Med, Inst Anim Nutr & Funct Plant Cpds, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.; Metzler-Zebeli, BU (corresponding author), Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Res Cluster Anim Gut Hlth, Vienna, Austria.	barbara.metzler@vetmeduni.ac.at	Schmitz-Esser, Stephan/AAA-7287-2019	Schmitz-Esser, Stephan/0000-0002-1907-0709; O'Connell, Niamh/0000-0001-6831-2041	European Union's Seventh Framework Programme for research, technological development and demonstration [311794]	European Union's Seventh Framework Programme for research, technological development and demonstration	This project (ECO-FCE) has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration (grant no. 311794) to Barbara U Metzler-Zebeli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apajalahti J, 2016, ANIM FEED SCI TECH, V221, P323, DOI 10.1016/j.anifeedsci.2016.05.004; Ben Shabat SK, 2016, ISME J, V10, P2958, DOI 10.1038/ismej.2016.62; Berry DP, 2012, J ANIM SCI, V90, P109, DOI 10.2527/jas.2011-4245; Bottje WG, 2009, J ANIM SCI, V87, pE48, DOI 10.2527/jas.2008-1379; Brisbin Jennifer T., 2008, Animal Health Research Reviews, V9, P101, DOI 10.1017/S146625230800145X; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Crisol-Martinez E, 2017, PEERJ, V5, DOI 10.7717/peerj.3071; D'Amore R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2194-9; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Hausmann A, 2016, ENVIRON CONSERV, V43, P117, DOI 10.1017/S0376892915000314; Hwang IY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15028; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Konsak BM, 2013, ANIM PROD SCI, V53, P1269, DOI 10.1071/AN12426; Korver DR, 1997, J NUTR, V127, P2039, DOI 10.1093/jn/127.10.2039; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Ludvigsen J, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00016; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McKay DM, 1999, GUT, V44, P283, DOI 10.1136/gut.44.2.283; Metzler-Zebeli BU, 2016, J ANIM SCI, V94, P2890, DOI 10.2527/jas.2016-0375; Metzler-Zebeli BU, 2016, ANIMALS-BASEL, V6, DOI 10.3390/ani6030018; Metzler-Zebeli BU, 2015, APPL ENVIRON MICROB, V81, P8489, DOI 10.1128/AEM.02756-15; Mignon-Grasteau S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135488; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Rubio LA, 2015, J ANIM PHYSIOL AN N, V99, P418, DOI 10.1111/jpn.12256; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schokker D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1646-6; Sekelja M, 2012, APPL ENVIRON MICROB, V78, P2941, DOI 10.1128/AEM.05391-11; Singh KM, 2014, J APPL GENET, V55, P145, DOI 10.1007/s13353-013-0179-4; Singh KM, 2012, MOL BIOL REP, V39, P10595, DOI 10.1007/s11033-012-1947-7; Stanley D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00187; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Stanley D, 2013, VET MICROBIOL, V164, P85, DOI 10.1016/j.vetmic.2013.01.030; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Van Eerden E, 2004, POULTRY SCI, V83, P1602, DOI 10.1093/ps/83.9.1602; Vigors S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148145; Willems OW, 2013, WORLD POULTRY SCI J, V69, P77, DOI 10.1017/S004393391300007X; Yan W, 2017, SCI REP-UK, V7, DOI 10.1038/srep45308	45	59	60	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187766	10.1371/journal.pone.0187766	http://dx.doi.org/10.1371/journal.pone.0187766			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141016	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000415260400028
J	Alva-Urcia, C; Aguilar-Luis, MA; Palomares-Reyes, C; Silva-Caso, W; Suarez-Ognio, L; Weilg, P; Manrique, C; Vasquez-Achaya, F; del Valle, LJ; del Valle-Mendoza, J				Alva-Urcia, Carlos; Angel Aguilar-Luis, Miguel; Palomares-Reyes, Carlos; Silva-Caso, Wilmer; Suarez-Ognio, Luis; Weilg, Pablo; Manrique, Carlos; Vasquez-Achaya, Fernando; del Valle, Luis J.; del Valle-Mendoza, Juana			Emerging and reemerging arboviruses: A new threat in Eastern Peru	PLOS ONE			English	Article							MAYARO VIRUS-INFECTION; ZIKA VIRUS; AMAZON BASIN; DENGUE; PCR; EPIDEMIOLOGY; DIAGNOSIS; DISEASES; AMERICA	Background Arboviral diseases are one of the most common causes of acute febrile illness (AFI) and a significant health problem in South America. In Peru, laboratory etiologic identification of these infections occurs in less than 50% of cases, leading to underdiagnoses of important emerging arboviruses. Aim To assess the prevalence of the Dengue (DENV), Oropouche (OROV), Chikungunya (CHIKV), Mayaro (MAYV) and Zika (ZIKV) viruses in patients with acute febrile illness from Puerto Maldonado (Peru). Methodology Serum samples were obtained from patients with AFI during January 2016 to March 2016. A total of 139 specimens were analyzed for the presence of DENV, OROV, CHIKV, MAYV, and ZIKV using polymerase chain reaction (PCR). Results CHIKV in 9.4% and OROV in 8.6% were the most prevalent arboviruses, followed by DENV and ZIKV, with a prevalence of 6.5% and 5%, respectively. Among all patients, the most common symptoms accompanying fever were headaches 79.9%, muscle pain 65.5% and joint pain 63.3%. Conclusions During this short 3-month period, 4 arboviruses were detected by PCR, CHIKV and OROV being the most common arboviruses in Puerto Maldonado (Peru). Thus, it is crucial to include OROV detection in the national health surveillance. Furthermore, the etiologic clinical diagnosis of arboviral infections is not possible due to the low specificity of symptoms; therefore an increase of cases confirmed by molecular diagnostic methods will enhance arboviral surveillance in Peru.	[Alva-Urcia, Carlos; Angel Aguilar-Luis, Miguel; Palomares-Reyes, Carlos; Silva-Caso, Wilmer; Suarez-Ognio, Luis; Vasquez-Achaya, Fernando; del Valle-Mendoza, Juana] Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Sch Med, Lima, Peru; [Angel Aguilar-Luis, Miguel; Palomares-Reyes, Carlos; Silva-Caso, Wilmer; Weilg, Pablo; Vasquez-Achaya, Fernando; del Valle-Mendoza, Juana] Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Res & Innovat Ctr, Lima, Peru; [Angel Aguilar-Luis, Miguel; Silva-Caso, Wilmer; del Valle-Mendoza, Juana] IIN, Lab Mol Biol, Lima, Peru; [Manrique, Carlos] Direcc Reg Salud Madre De Dios DIRESA Madre De D, Madre De Dios, Peru; [del Valle, Luis J.] UPC, Barcelona Res Ctr Multiscale Sci & Engn, Dept Engn Quim, EEBE,Barcelona Tech, Barcelona, Spain	Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Peruana de Ciencias Aplicadas (UPC); Universitat Politecnica de Catalunya	Aguilar-Luis, MA; del Valle-Mendoza, J (corresponding author), Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Sch Med, Lima, Peru.; Aguilar-Luis, MA; del Valle-Mendoza, J (corresponding author), Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Res & Innovat Ctr, Lima, Peru.; Aguilar-Luis, MA; del Valle-Mendoza, J (corresponding author), IIN, Lab Mol Biol, Lima, Peru.	ma23aguilar@gmail.com; jdelvall@upc.edu.pe	Palomares Reyes, Carlos Cesar/Q-1255-2018; del Valle Mendoza, Juana/C-9805-2018; Vasquez Achaya, Fernando/I-6380-2017; Aguilar-Luis, Miguel Angel/C-8686-2018; Silva, Wilmer Gianfranco/D-2699-2018; Del Valle, Luis J./I-1342-2015	Palomares Reyes, Carlos Cesar/0000-0002-7027-1952; del Valle Mendoza, Juana/0000-0002-6011-5040; Vasquez Achaya, Fernando/0000-0003-3627-7688; Aguilar-Luis, Miguel Angel/0000-0001-7023-3190; Silva, Wilmer Gianfranco/0000-0003-1086-8084; Del Valle, Luis J./0000-0001-9916-1741; Weilg Espejo, Pablo Renato/0000-0002-9711-2193; Suarez-Ognio, Luis/0000-0002-9627-799X	Programa Nacional de Innovacion para la Competitividad y Productividad (Innovate Peru) [116-PNICP-PIAP-2015]	Programa Nacional de Innovacion para la Competitividad y Productividad (Innovate Peru)	This project was supported by "Programa Nacional de Innovacion para la Competitividad y Productividad (Innovate Peru)-contract 116-PNICP-PIAP-2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315; Aguilar-Leon Pool, 2016, Infez Med, V24, P172; Baisley KJ, 1998, AM J TROP MED HYG, V59, P710, DOI 10.4269/ajtmh.1998.59.710; Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301; Chavez R, 1992, REV FARMACOL TERAP L, V2, P12; Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500; Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787; García María P, 2016, Rev. perú. med. exp. salud publica, V33, P380, DOI 10.17843/rpmesp.2016.332.2098; Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013; Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777; Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010; Levy-Blitchtein S, 2016, ASIAN PAC J TROP MED, V9, P997, DOI 10.1016/j.apjtm.2016.07.030; Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013; Lorenzi OD, 2013, AM J TROP MED HYG, V88, P472, DOI 10.4269/ajtmh.12-0373; Ministerio de Salud del Peru (MINSA), 2016, B EP 03, V03; Ministerio de Salud (MINSA), 2016, MINS EM AL EP ANT CI; Ministerio de Salud (MINSA), 2016, RES MIN; Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122; Naing C, 2012, T ROY SOC TROP MED H, V106, P331, DOI 10.1016/j.trstmh.2012.03.003; Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717; Peyrefitte CN, 2005, EMERG INFECT DIS, V11, P757, DOI 10.3201/eid1105.040959; Red Nacional de Epidemiologia (RENACE), 2016, VIG SINDR FEBR AR AL; Red Nacional de Epidemiologia (RENACE), 2016, CAS DENG DEP PER 201; Salmon-Mulanovich G, 2015, AM J TROP MED HYG, V93, P684, DOI 10.4269/ajtmh.14-0755; Simmons M, 2016, J CLIN MICROBIOL, V54, P1766, DOI 10.1128/JCM.00299-16; Tam PYI, 2016, J PEDIAT INF DIS SOC, V5, P190, DOI 10.1093/jpids/piw016; Tantalean-Yepez D, 2016, ASIAN PAC J TROP MED, V9, P819, DOI 10.1016/j.apjtm.2016.06.018; Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952; World Health Organization, 2017, DIS OUTBREAK NE 0208; Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108	32	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187897	10.1371/journal.pone.0187897	http://dx.doi.org/10.1371/journal.pone.0187897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136650	Green Submitted, Green Published, gold			2022-12-26	WOS:000415121200043
J	Carling, CJ; Lacome, M; Flanagan, E; O'Doherty, P; Piscione, J				Carling, Christopher J.; Lacome, Mathieu; Flanagan, Eamon; O'Doherty, Pearse; Piscione, Julien			Exposure time, running and skill-related performance in international u20 rugby union players during an intensified tournament	PLOS ONE			English	Article							STATISTICS; MATCH	Purpose This study investigated exposure time, running and skill-related performance in two international u20 rugby union teams during an intensified tournament: the 2015 Junior World Rugby Championship. Method Both teams played 5 matches in 19 days. Analyses were conducted using global positioning system (GPS) tracking (Viper 2 T, Statsports Technologies Ltd) and event coding (Opta Pro (R)). Results Of the 62 players monitored, 36 (57.1%) participated in 4 matches and 23 (36.5%) in all 5 matches while player availability for selection was 88%. Analyses of team running output (all players completing > 60-min play) showed that the total and peak 5-minute high metabolic load distances covered were likely-to-very likely moderately higher in the final match compared to matches 1 and 2 in back and forward players. In individual players with the highest match-play exposure (participation in > 75% of total competition playing time and > 75-min in each of the final 3 matches), comparisons of performance in matches 4 and 5 versus match 3 (three most important matches) reported moderate-to-large decreases in total and high metabolic load distance in backs while similar magnitude reductions occurred in high-speed distance in forwards. In contrast, skill-related performance was unchanged, albeit with trivial and unclear changes, while there were no alterations in either total or high-speed running distance covered at the end of matches. Conclusions These findings suggest that despite high availability for selection, players were not overexposed to match-play during an intensified u20 international tournament. They also imply that the teams coped with the running and skill-related demands. Similarly, individual players with the highest exposure to match-play were also able to maintain skill-related performance and end-match running output (despite an overall reduction in the latter). These results support the need for player rotation and monitoring of performance, recovery and intervention strategies during intensified tournaments.	[Carling, Christopher J.] Univ Cent Lancashire, Inst Coaching & Performance, Preston, Lancs, England; [Carling, Christopher J.; Lacome, Mathieu; Piscione, Julien] French Rugby Union, Res Dept, Marcoussis, France; [Flanagan, Eamon] Irish Rugby Football Union, Fitness Dept, Dublin, Ireland; [O'Doherty, Pearse] Statsports Technol, Newry, North Ireland	University of Central Lancashire	Lacome, M (corresponding author), French Rugby Union, Res Dept, Marcoussis, France.	mathlacome@gmail.com						[Anonymous], J STRENGTH CONDITION; [Anonymous], EUROPEAN J SPORT SCI; [Anonymous], S AFRICAN J SPORTS M; Austin D, 2011, J SPORT SCI, V29, P1105, DOI 10.1080/02640414.2011.582508; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Carling C, 2012, INT J SPORTS MED, V33, P36, DOI 10.1055/s-0031-1283190; Carling C, 2015, J SPORT SCI, V33, P2116, DOI 10.1080/02640414.2015.1091492; Cunniffe B, 2010, EUR J APPL PHYSIOL, V108, P113, DOI 10.1007/s00421-009-1200-9; Cunningham D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153275; Dellal A, 2015, BRIT J SPORT MED, V49, P390, DOI 10.1136/bjsports-2012-091290; Duthie G, 2003, SPORTS MED, V33, P973, DOI 10.2165/00007256-200333130-00003; Elloumi M, 2003, EUR J APPL PHYSIOL, V90, P23, DOI 10.1007/s00421-003-0868-5; Higgins TR, 2013, J STRENGTH COND RES, V27, P954, DOI 10.1519/JSC.0b013e318260ed9b; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Johnston RD, 2015, J SCI MED SPORT, V18, P209, DOI 10.1016/j.jsams.2014.01.009; Johnston RD, 2013, J SCI MED SPORT, V16, P460, DOI 10.1016/j.jsams.2012.10.009; Jones MR, 2015, EUR J SPORT SCI, V15, P488, DOI 10.1080/17461391.2015.1010106; Jones MR, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-38; Lacome M, 2014, J SPORT SCI, V32, P290, DOI 10.1080/02640414.2013.823225; Lindsay A, 2015, EUR J SPORT SCI, V15, P480, DOI 10.1080/17461391.2015.1025858; Liu HY, 2013, INT J PERF ANAL SPOR, V13, P803, DOI 10.1080/24748668.2013.11868690; McLean BD, 2010, INT J SPORT PHYSIOL, V5, P367, DOI 10.1123/ijspp.5.3.367; Montgomery PG, 2008, J SPORT SCI, V26, P1135, DOI 10.1080/02640410802104912; Osgnach C, 2010, MED SCI SPORT EXER, V42, P170, DOI 10.1249/MSS.0b013e3181ae5cfd; Quarrie KL, 2017, BRIT J SPORT MED, V51, P421, DOI 10.1136/bjsports-2016-096191; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Smart DJ, 2008, BRIT J SPORT MED, V42, P198, DOI 10.1136/bjsm.2007.040162; Takarada Y, 2003, BRIT J SPORT MED, V37, P416, DOI 10.1136/bjsm.37.5.416; Waldron M, 2014, SPORTS MED, V44, P1645, DOI 10.1007/s40279-014-0230-6; West DJ, 2014, J STRENGTH COND RES, V28, P194, DOI 10.1519/JSC.0b013e318291b726; Winter EM, 2014, J SPORT SCI, V32, P901, DOI 10.1080/02640414.2014.895118; Winter EM, 2009, J SPORT SCI, V27, P985, DOI 10.1080/02640410903178344	32	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0186874	10.1371/journal.pone.0186874	http://dx.doi.org/10.1371/journal.pone.0186874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136039	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000415121200009
J	Komalavilas, P; Luo, WF; Guth, CM; Jolayemi, O; Bartelson, RI; Cheung-Flynn, J; Brophy, CM				Komalavilas, Padmini; Luo, Weifeng; Guth, Christy M.; Jolayemi, Olukemi; Bartelson, Rachel I.; Cheung-Flynn, Joyce; Brophy, Colleen M.			Vascular surgical stretch injury leads to activation of P2X7 receptors and impaired endothelial function	PLOS ONE			English	Article							BRILLIANT BLUE FCF; P2X(7) PURINERGIC RECEPTOR; VEIN GRAFT MARKING; EXTRACELLULAR ATP; RHEUMATOID-ARTHRITIS; CELLULAR VIABILITY; SMOOTH-MUSCLE; UP-REGULATION; L-ARGININE; ANTAGONIST	A viable vascular endothelial layer prevents vasomotor dysfunction, thrombosis, inflammation, and intimal hyperplasia. Injury to the endothelium occurs during harvest and "back table" preparation of human saphenous vein prior to implantation as an arterial bypass conduit. A subfailure overstretch model of rat aorta was used to show that subfailure stretch injury of vascular tissue leads to impaired endothelial-dependent relaxation. Stretch-induced impaired relaxation was mitigated by treatment with purinergic P2X7 receptor (P2X7R) inhibitors, brilliant blue FCF (FCF) and A740003, or apyrase, an enzyme that catalyzes the hydrolysis of ATP. Alternatively, treatment of rat aorta with exogenous ATP or 2'(3')-O-(4-Benzoyl benzoyl)-ATP (BzATP) also impaired endothelial-dependent relaxation. Treatment of human saphenous vein endothelial cells (HSVEC) with exogenous ATP led to reduced nitric oxide production which was associated with increased phosphorylation of the stress activated protein kinase, p38 MAPK. ATP-stimulated p38 MAPK phosphorylation of HSVEC was inhibited by FCF and SB203580. Moreover, ATP inhibition of nitric oxide production in HSVEC was prevented by FCF, SB203580, L-arginine supplementation and arginase inhibition. Finally, L-arginine supplementation and arginase inhibition restored endothelial dependent relaxation after stretch injury of rat aorta. These results suggest that vascular stretch injury leads to ATP release, activation of P2X7R and p38 MAPK resulting in endothelial dysfunction due to arginase activation. Endothelial function can be restored in both ATP treated HSVEC and intact stretch injured rat aorta by P2X7 receptor inhibition with FCF or L-arginine supplementation, implicating straightforward therapeutic options for treatment of surgical vascular injury.	[Komalavilas, Padmini; Luo, Weifeng; Guth, Christy M.; Jolayemi, Olukemi; Bartelson, Rachel I.; Cheung-Flynn, Joyce; Brophy, Colleen M.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [Komalavilas, Padmini; Brophy, Colleen M.] VA Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Komalavilas, P (corresponding author), Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA.; Komalavilas, P (corresponding author), VA Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA.	padmini.komalavilas@vanderbilt.edu	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Institute of Health grant [R01HL105731-01, R01HL70715]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105731, R01HL070715] Funding Source: NIH RePORTER	National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported in part by a National Institute of Health grant R01HL105731-01 to J Cheung-Flynn, R01HL70715 to CM Brophy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446; Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Avanzato D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32602; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Brophy C, 2015, FED REGISTER, V80, P46485; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; BUSSE R, 1985, BASIC RES CARDIOL, V80, P475, DOI 10.1007/BF01907912; Chen S, 2013, CRIT CARE MED, V41, pE466, DOI 10.1097/CCM.0b013e31829a8246; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; CREAGER MA, 1992, J CLIN INVEST, V90, P1248, DOI 10.1172/JCI115987; De Ita M, 2016, LIFE SCI, V145, P85, DOI 10.1016/j.lfs.2015.12.013; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Eagle S, 2011, AM SURGEON, V77, P922; Feng L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0409-2; Ferrari D, 1997, J IMMUNOL, V159, P1451; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Flynn CR, 2005, J APPL PHYSIOL, V98, P1836, DOI 10.1152/japplphysiol.01043.2004; Franke H, 2004, J NEUROPATH EXP NEUR, V63, P686, DOI 10.1093/jnen/63.7.686; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Guth CM, 2017, J SURG RES, V216, P80, DOI 10.1016/j.jss.2017.03.025; Hess CN, 2014, SAPHENOUS VEIN GRAFT; Hocking KM, 2016, J VASC SURG, V64, P210, DOI 10.1016/j.jvs.2014.12.059; Hocking KM, 2011, J VASC SURG, V53, P454, DOI 10.1016/j.jvs.2010.09.010; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Jacques-Silva MC, 2004, BRIT J PHARMACOL, V141, P1106, DOI 10.1038/sj.bjp.0705685; Jespersen B, 2015, JOVE-J VIS EXP, DOI 10.3791/52324; Jun DJ, 2007, J BIOL CHEM, V282, P37350, DOI 10.1074/jbc.M707915200; Keystone EC, 2012, ANN RHEUM DIS, V71, P1630, DOI 10.1136/annrheumdis-2011-143578; Li FD, 2014, JAMA SURG, V149, P655, DOI 10.1001/jamasurg.2013.5067; Lombardi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05137-y; Luo W, 2017, PURINERG SIGNAL; Luo WF, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00075; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Okumura H, 2008, BIOCHEM BIOPH RES CO, V372, P486, DOI 10.1016/j.bbrc.2008.05.066; Osgood MJ, 2016, J VASC SURG, V64, P471, DOI 10.1016/j.jvs.2015.02.028; Osgood MJ, 2014, J VASC SURG, V60, P202, DOI 10.1016/j.jvs.2013.06.004; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Papp L, 2007, BIOCHEM BIOPH RES CO, V355, P568, DOI 10.1016/j.bbrc.2007.02.014; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Pernow J, 2015, BRIT J PHARMACOL, V172, P4684, DOI 10.1111/bph.13242; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Sathanoori R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125111; Shatanawi A, 2015, EUR J PHARMACOL, V746, P106, DOI 10.1016/j.ejphar.2014.10.042; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Steppan J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00278; Stock TC, 2012, J RHEUMATOL, V39, P720, DOI 10.3899/jrheum.110874; Tousoulis D, 2002, VASC MED, V7, P203, DOI 10.1191/1358863x02vm434ra; Vanhoutte PM, 2017, ACTA PHYSIOL, V219, P22, DOI 10.1111/apha.12646; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Voskresensky IV, 2014, JAMA SURG, V149, P1176, DOI 10.1001/jamasurg.2014.2029; Winkler B, 2016, INTERACT CARDIOV TH, V23, P300, DOI 10.1093/icvts/ivw056; Wise ES, 2016, VASC MED, V21, P413, DOI 10.1177/1358863X16649040; Wise ES, 2015, AM SURGEON, V81, pE274; Wise ES, 2015, SURGERY, V158, P537, DOI 10.1016/j.surg.2015.03.036; Yamamoto K, 2000, AM J PHYSIOL-HEART C, V279, pH285, DOI 10.1152/ajpheart.2000.279.1.H285; Yan Y, 2015, AM J PHYSL CELL PHYS; Yu Y, 2009, NEUROREPORT, V20, P393, DOI 10.1097/WNR.0b013e328324ede7; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661	59	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188069	10.1371/journal.pone.0188069	http://dx.doi.org/10.1371/journal.pone.0188069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136654	gold, Green Published, Green Submitted			2022-12-26	WOS:000415121200059
J	Ramadasan-Nair, R; Hui, J; Zimin, PI; Itsara, LS; Morgan, PG; Sedensky, MM				Ramadasan-Nair, Renjini; Hui, Jessica; Zimin, Pavel I.; Itsara, Leslie S.; Morgan, Philip G.; Sedensky, Margaret M.			Regional knockdown of NDUFS4 implicates a thalamocortical circuit mediating anesthetic sensitivity	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX-I; POSITRON-EMISSION-TOMOGRAPHY; SPINAL MOTOR-NEURONS; CEREBRAL-BLOOD-FLOW; CAENORHABDITIS-ELEGANS; VOLATILE-ANESTHETICS; PROPOFOL ANESTHESIA; FEEDFORWARD INHIBITION; LEIGH-SYNDROME; DEFAULT MODE	Knockout of the mitochondrial complex I protein, NDUFS4, profoundly increases sensitivity of mice to volatile anesthetics. In mice carrying an Ndufs4(lox/lox) gene, adeno-associated virus expressing Cre recombinase was injected into regions of the brain postulated to affect sensitivity to volatile anesthetics. These injections generated otherwise phenotypically wild type mice with region-specific, postnatal inactivation of Ndufs4, minimizing developmental effects of gene loss. Sensitivities to the volatile anesthetics isoflurane and halothane were measured using loss of righting reflex (LORR) and movement in response to tail clamp (TC) as endpoints. Knockdown (KD) of Ndufs4 in the vestibular nucleus produced resistance to both anesthetics for movement in response to TC. Ndufs4 loss in the central and dorsal medial thalami and in the parietal association cortex increased anesthetic sensitivity to both TC and LORR. Knockdown of Ndufs4 only in the parietal association cortex produced striking hypersensitivity for both endpoints, and accounted for half the total change seen in the global KO (Ndufs4(KO)). Excitatory synaptic transmission in the parietal association cortex in slices from Ndufs4(KO) animals was hypersensitive to isoflurane compared to control slices. We identified a direct neural circuit between the parietal association cortex and the central thalamus, consistent with a model in which isoflurane sensitivity is mediated by a thalamic signal relayed through excitatory synapses to the parietal association cortex. We postulate that the thalamocortical circuit is crucial for maintenance of consciousness and is disrupted by the inhibitory effects of isoflurane/halothane on mitochondria.	[Ramadasan-Nair, Renjini; Hui, Jessica; Zimin, Pavel I.; Itsara, Leslie S.; Morgan, Philip G.; Sedensky, Margaret M.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, 1900 Ninth Ave, Seattle, WA 98101 USA; [Zimin, Pavel I.; Morgan, Philip G.; Sedensky, Margaret M.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle	Ramadasan-Nair, R (corresponding author), Seattle Childrens Res Inst, Ctr Integrat Brain Res, 1900 Ninth Ave, Seattle, WA 98101 USA.	renjini.ramadasannair@seattlechildrens.org	Core, Vector/CAF-4832-2022	Morgan, Phil/0000-0003-4857-2756	R01 grant from National Institute of Health [NIH R01 GM105696]; NW Mitochondrial Research Guild; NIH [RO1 GM105696]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105696] Funding Source: NIH RePORTER	R01 grant from National Institute of Health; NW Mitochondrial Research Guild; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an R01 grant from National Institute of Health (https://grants.nih.gov/grants/funding/funding_program.htm#RSeries) - NIH R01 GM105696 to M.M.S. and the NW Mitochondrial Research Guild. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH RO1 GM105696 and the NW Mitochondrial Research Guild. We thank Dr. Albert Quintana for guidance with regional Ndufs4 KD techniques, Dr. Beatrice Predoi for technical support, Christian Woods and Dr. Ernst-Bernhard Kayser for meaningful discussions and critical advice.	Akeju O, 2014, ELIFE, V3, DOI 10.7554/eLife.04499; Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; ANTOGNINI JF, 1993, ANESTHESIOLOGY, V79, P1244, DOI 10.1097/00000542-199312000-00015; Baker R, 2014, J NEUROSCI, V34, P13326, DOI 10.1523/JNEUROSCI.1519-14.2014; BEITZ AJ, 1987, NEUROSCIENCE, V20, P409, DOI 10.1016/0306-4522(87)90101-1; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Bonhomme V, 2001, J NEUROPHYSIOL, V85, P1299, DOI 10.1152/jn.2001.85.3.1299; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Carriot J, 2013, J NEUROSCI, V33, P19555, DOI 10.1523/JNEUROSCI.3051-13.2013; COHEN PJ, 1973, ANESTHESIOLOGY, V39, P153, DOI 10.1097/00000542-197308000-00007; Cunningham SI, 2017, HUM BRAIN MAPP, V38, P938, DOI 10.1002/hbm.23429; Delevich K, 2015, J NEUROSCI, V35, P5743, DOI 10.1523/JNEUROSCI.4565-14.2015; Devor M, 2001, PAIN, V94, P101, DOI 10.1016/S0304-3959(01)00345-1; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Feng D, 2015, METHODS, V73, P90, DOI 10.1016/j.ymeth.2015.01.009; Fiset P, 1999, J NEUROSCI, V19, P5506; FRANK GB, 1970, BRIT J PHARMACOL, V39, P696, DOI 10.1111/j.1476-5381.1970.tb09895.x; Frias B, 2016, MOLECULES, V21, DOI 10.3390/molecules21060797; Gupta RG, 2017, AUTON NEUROSCI-BASIC, V202, P114, DOI 10.1016/j.autneu.2016.06.007; HARRIS RA, 1971, ARCH BIOCHEM BIOPHYS, V142, P435, DOI 10.1016/0003-9861(71)90507-8; Herrera CG, 2016, NAT NEUROSCI, V19, P290, DOI 10.1038/nn.4209; Jinks SL, 2008, ANESTHESIOLOGY, V108, P1016, DOI 10.1097/ALN.0b013e3181730297; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Karunadharma PP, 2015, FASEB J, V29, P3582, DOI 10.1096/fj.15-272666; Kayser EB, 1999, ANESTHESIOLOGY, V90, P545, DOI 10.1097/00000542-199902000-00031; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Kayser EB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148219; Kayser EB, 2011, ANESTH ANALG, V112, P1321, DOI 10.1213/ANE.0b013e3182121d37; KING BS, 1994, ANESTHESIOLOGY, V81, P1484, DOI 10.1097/00000542-199412000-00024; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Lee CC, 2008, J NEUROPHYSIOL, V100, P317, DOI 10.1152/jn.90391.2008; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8; Lenaz G, 2006, BBA-BIOENERGETICS, V1757, P1406, DOI 10.1016/j.bbabio.2006.05.007; MacIver MB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00203; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; Morgan PG, 2002, ANESTHESIOLOGY, V96, P1268, DOI 10.1097/00000542-200205000-00036; MORGAN SE, 1994, ANESTHESIOLOGY, V80, P201, DOI 10.1097/00000542-199401000-00027; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Pathak D, 2015, J BIOL CHEM, V290, P22325, DOI 10.1074/jbc.M115.656405; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Quintana A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042904; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Rampil IJ, 1996, ANESTHESIOLOGY, V85, P129, DOI 10.1097/00000542-199607000-00018; Reinsel RA, 2000, INT J NEUROPSYCHOPH, V3, P117, DOI 10.1017/S1461145700001814; Ren K, 2002, PAIN, V100, P1, DOI 10.1016/S0304-3959(02)00368-8; Ries CR, 1999, J NEUROPHYSIOL, V81, P1795, DOI 10.1152/jn.1999.81.4.1795; Sherman SM, 2016, NAT NEUROSCI, V19, P533, DOI 10.1038/nn.4269; Sherrington C.S., 1906, INTEGRATIVE ACTION N, Vfirst, DOI 10.1037/13798-000; Shin TJ, 2016, NEUROSCI LETT, V627, P18, DOI 10.1016/j.neulet.2016.05.045; Shulman RG, 2009, P NATL ACAD SCI USA, V106, P11096, DOI 10.1073/pnas.0903941106; Sobieski C, 2017, J NEUROSCI, V37, P1888, DOI 10.1523/JNEUROSCI.2712-16.2017; Song LY, 2015, BRAIN RES, V1594, P82, DOI 10.1016/j.brainres.2014.11.013; Sonner JM, 2007, ANESTHESIOLOGY, V106, P107, DOI 10.1097/00000542-200701000-00019; Spangler-Bickell MG, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0242-3; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Veselis RA, 2004, ANESTH ANALG, V99, P399, DOI 10.1213/01.ANE.0000131971.92180.DF; Wang N, 2010, NEUROSCI BULL, V26, P188, DOI 10.1007/s12264-010-0150-x; Zimin PI, 2016, CURR BIOL, V26, P2194, DOI 10.1016/j.cub.2016.06.020; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028	64	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188087	10.1371/journal.pone.0188087	http://dx.doi.org/10.1371/journal.pone.0188087			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136012	Green Published, Green Submitted, gold			2022-12-26	WOS:000415121200060
J	Jiang, DY; Yu, L; Wang, F; Xie, XX; Yu, YS				Jiang, Dengying; Yu, Ling; Wang, Fei; Xie, Xiaoxia; Yu, Yongsheng			Design of the smart home system based on the optimal routing algorithm and ZigBee network	PLOS ONE			English	Article							HYBRID	To improve the traditional smart home system, its electric wiring, networking technology, information transmission and facility control are studied. In this paper, we study the electric wiring, networking technology, information transmission and facility control to improve the traditional smart home system. First, ZigBee is used to replace the traditional electric wiring. Second, a network is built to connect lots of wireless sensors and facilities, thanks to the capability of ZigBee self-organized network and Genetic Algorithm-Particle Swarm Optimization Algorithm (GA-PSOA) to search for the optimal route. Finally, when the smart home system is connected to the internet based on the remote server technology, home environment and facilities could be remote real-time controlled. The experiments show that the GA-PSOA reduce the system delay and decrease the energy consumption of the wireless system.	[Jiang, Dengying; Yu, Ling] Wuhan Univ Technol, Sch Sci, Wuhan, Hubei, Peoples R China; [Wang, Fei] Cent China Normal Univ, Phys Sci & Technol Dept, Wuhan, Hubei, Peoples R China; [Xie, Xiaoxia] Idaho State Univ, Dept Math & Stat, Pocatello, ID 83209 USA; [Yu, Yongsheng] Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan, Hubei, Peoples R China	Wuhan University of Technology; Central China Normal University; Idaho; Idaho State University; Wuhan University of Technology	Yu, YS (corresponding author), Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan, Hubei, Peoples R China.	yongshengyu@whut.edu.cn			Fundamental Research Funds for the Central Universities [201716014]; Fundamental Research Funds for the Central Universities (WUT) [2017IB014]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fundamental Research Funds for the Central Universities (WUT)	This work is supported by the Fundamental Research Funds for the Central Universities (grant number: 201716014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article is supported by the Fundamental Research Funds for the Central Universities (WUT: 2017IB014). Thanks for the support.	Ameen SY, 2013, 2013 FIRST INTERNATIONAL SCIENTIFIC CONFERENCE ON ELECTRICAL, COMMUNICATION, COMPUTER, POWER, AND CONTROL ENGINEERING (ICECCPCE'13), P130, DOI 10.1109/ICECCPCE.2013.6998748; Anvari-Moghaddam A, 2015, IEEE T SMART GRID, V6, P324, DOI 10.1109/TSG.2014.2349352; Byun J, 2012, IEEE T CONSUM ELECTR, V58, P794, DOI 10.1109/TCE.2012.6311320; Cao Jian-zhao, 2013, Journal of Northeastern University. Natural Science, V34, P1113; De Silva LC, 2012, ENG APPL ARTIF INTEL, V25, P1313, DOI 10.1016/j.engappai.2012.05.002; Gao De-min, 2010, Application Research of Computers, V27, P4226, DOI 10.3969/j.issn.1001-3695.2010.11.061; Gao L, 2016, EURASIP J AUDIO SPEE, DOI 10.1186/s13636-016-0091-z; Giovanni P, 2017, ENERGIES, V10; Guo P, 2012, J HUAZHONG U SCI TEC, V40, P61; Helal S. A., 2017, P 2017 IEEE 30 CANAD, P1, DOI DOI 10.1109/CCECE.2017.7946775; Khalil T. M., 2012, INT J MULTIDISCIP SC, V3, P1; Kim T, 2016, IEEE SENS J, V16, P5107, DOI 10.1109/JSEN.2016.2557344; Kuo RJ, 2010, DECIS SUPPORT SYST, V49, P451, DOI 10.1016/j.dss.2010.05.006; Lee JS, 2007, IEEE IND ELEC, P46; Liu YM, 2015, NEUROCOMPUTING, V151, P1237, DOI 10.1016/j.neucom.2014.03.081; [马超 Ma Chao], 2013, [计算机研究与发展, Journal of Computer Research and Development], V50, P2278; Mihajlov B., 2011, INT J COMPUT APPL, V29, P28, DOI DOI 10.5120/3704-5138; Muhammad RA, 2017, ENERGY EFFICIENCY; Pretty DG, 2014, FUSION ENG DES, V89, P731, DOI 10.1016/j.fusengdes.2014.03.025; Sun C, 2016, J POWER SOURCES, V325, P723, DOI 10.1016/j.jpowsour.2016.06.076; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; Yan X., 2014, THESIS	22	2	2	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0188026	10.1371/journal.pone.0188026	http://dx.doi.org/10.1371/journal.pone.0188026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131868	Green Published, gold, Green Submitted			2022-12-26	WOS:000414997800038
J	Al Hariri, M; Elmedawar, M; Zhu, R; Jaffa, MA; Zhao, JF; Mirzaei, P; Ahmed, A; Kobeissy, F; Ziyadeh, FN; Mechref, Y; Jaffa, AA				Al Hariri, Moustafa; Elmedawar, Mohamad; Zhu, Rui; Jaffa, Miran A.; Zhao, Jingfu; Mirzaei, Parvin; Ahmed, Adnan; Kobeissy, Firas; Ziyadeh, Fuad N.; Mechref, Yehia; Jaffa, Ayad A.			Proteome profiling in the aorta and kidney of type 1 diabetic rats	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; PLASMA PREKALLIKREIN; GENE-EXPRESSION; RISK MARKER; COMPLICATIONS; OXIDATION; MELLITUS; GLOMERULI; DISEASE; HEALTH	Diabetes is associated with a number of metabolic and cardiovascular risk factors that contribute to a high rate of microvascular and macrovascular complications. The risk factors and mechanisms that contribute to the development of micro-and macrovascular disease in diabetes are not fully explained. In this study, we employed mass spectrometric analysis using tandem LC-MS/MS to generate a proteomic profile of protein abundance and post-translational modifications (PTM) in the aorta and kidney of diabetic rats. In addition, systems biology analyses were employed to identify key protein markers that can provide insights into molecular pathways and processes that are differentially regulated in the aorta and kidney of type 1 diabetic rats. Our results indicated that 188 (111 downregulated and 77 upregulated) proteins were significantly identified in the aorta of diabetic rats compared to normal controls. A total of 223 (109 downregulated and 114 upregulated) proteins were significantly identified in the kidney of diabetic rats compared to normal controls. When the protein profiles from the kidney and aorta of diabetic and control rats were analyzed by principal component analysis, a distinct separation of the groups was observed. In addition, diabetes resulted in a significant increase in PTM (oxidation, phosphorylation, and acetylation) of proteins in the kidney and aorta and this effect was partially reversed by insulin treatment. Ingenuity pathway analysis performed on the list of differentially expressed proteins depicted mitochondrial dysfunction, oxidative phosphorylation and acute phase response signaling to be among the altered canonical pathways by diabetes in both tissues. The findings of the present study provide a global proteomics view of markers that highlight the mechanisms and putative processes that modulate renal and vascular injury in diabetes.	[Al Hariri, Moustafa; Elmedawar, Mohamad; Kobeissy, Firas; Ziyadeh, Fuad N.; Jaffa, Ayad A.] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon; [Zhu, Rui; Zhao, Jingfu; Mirzaei, Parvin; Mechref, Yehia] Texas Tech Univ, Mem Circle & Boston, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Jaffa, Miran A.] Amer Univ Beirut, Fac Hlth Sci, Epidemiol & Populat Hlth Dept, Beirut, Lebanon; [Ahmed, Adnan] Texas Tech Univ, Ctr Biotechnol & Genom, Canton & Main, Expt Sci Bldg, Lubbock, TX 79409 USA; [Ziyadeh, Fuad N.] Amer Univ Beirut, Dept Internal Med, Fac Med, Beirut, Lebanon	American University of Beirut; Texas Tech University System; Texas Tech University; American University of Beirut; Texas Tech University System; Texas Tech University; American University of Beirut	Jaffa, AA (corresponding author), Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon.	aj24@aub.edu.lb	Almedawar, Mohamad Musbah/O-7910-2019; Kobeissy, Firas/E-7042-2017; Mechref, Yehia/I-5126-2013	Almedawar, Mohamad Musbah/0000-0002-3595-4715; Kobeissy, Firas/0000-0002-5008-6944; Mechref, Yehia/0000-0002-6661-6073; Ahmed, Adnan/0000-0002-1883-7680	LCNRS [102676]; Medical Practice Plan, Faculty of Medicine, AUBMC (AAJ); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112490] Funding Source: NIH RePORTER	LCNRS; Medical Practice Plan, Faculty of Medicine, AUBMC (AAJ); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by LCNRS Award Number 102676 and a grant from the Medical Practice Plan, Faculty of Medicine, AUBMC (AAJ).; This work was supported by LCNRS Award Number 102676 and a grant from the Medical Practice Plan, Faculty of Medicine, AUBMC (AAJ).	Aurelie NDC, 2011, PEPTIDES, V32, P2141, DOI 10.1016/j.peptides.2011.09.010; Bannier K, 2015, J DIABETES COMPLICAT, V29, P1130, DOI 10.1016/j.jdiacomp.2015.08.010; Bavelloni A, 2015, IUBMB LIFE, V67, P239, DOI 10.1002/iub.1366; Brahma MK, 2017, DIABETES METAB J, V41, P1, DOI 10.4093/dmj.2017.41.1.1; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai L, 2001, Cardiovasc Toxicol, V1, P181, DOI 10.1385/CT:1:3:181; Cai L, 2002, DIABETES, V51, P1938, DOI 10.2337/diabetes.51.6.1938; Caimi G, 2013, CLIN HEMORHEOL MICRO, V54, P409, DOI 10.3233/CH-131739; Caseiro A, 2014, TRANSL RES, V163, P188, DOI 10.1016/j.trsl.2013.09.005; del Monte F, 2014, PROTEOM CLIN APPL, V8, P534, DOI 10.1002/prca.201400037; Diabetes C, 2015, DIABETES, V64, P631, DOI DOI 10.2337/DB14-0930; Ding Y, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4080364; Dong WQ, 2016, ONCOTARGET, V7, P66, DOI 10.18632/oncotarget.6384; Dwinovan J, 2017, ACTA DIABETOL, V54, P171, DOI 10.1007/s00592-016-0929-y; Fernandes JD, 2016, DIABETES RES CLIN PR, V117, P48, DOI 10.1016/j.diabres.2016.04.016; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Fokkens BT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173379; Fugmann T, 2011, KIDNEY INT, V80, P272, DOI 10.1038/ki.2011.116; Gajjala PR, 2015, NEPHROL DIAL TRANSPL, V30, P1814, DOI 10.1093/ndt/gfv048; Garcia-Campos MA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00383; Genuth SM, 2013, DIABETES, V62, P3561, DOI 10.2337/db12-0546; Geyer PE, 2016, CELL SYST, V2, P185, DOI 10.1016/j.cels.2016.02.015; Hatzirodos N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173391; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hsueh W. A., 1998, AM J MED, V105, P4, DOI DOI 10.1016/S0002-9343(98)00205-8; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Jaffa AA, 2003, DIABETES, V52, P1215, DOI 10.2337/diabetes.52.5.1215; Jaffa MA, 2016, DIABETES, V65, P498, DOI 10.2337/db15-0930; Jaffa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044714; Jenkin KA, 2016, BRIT J PHARMACOL, V173, P1128, DOI 10.1111/bph.13056; Khan SA, 2016, LAB INVEST, V96, P773, DOI 10.1038/labinvest.2016.52; Kilpatrick ES, 2012, DIABETOLOGIA, V55, P2089, DOI 10.1007/s00125-012-2610-5; Liljedahl L, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-016-9123-z; Lindsey ML, 2015, CIRCULATION, V132, P852, DOI 10.1161/CIR.0000000000000226; Liu XD, 2014, MED SCI MONITOR, V20, P2705, DOI 10.12659/MSM.893078; Lu MY, 2016, ONCOTARGET, V7, P61325, DOI 10.18632/oncotarget.11348; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Matsuyama Y, 2009, CLIN EXP NEPHROL, V13, P308, DOI 10.1007/s10157-009-0161-y; Merchant ML, 2013, KIDNEY INT, V83, P1177, DOI 10.1038/ki.2013.8; Mogensen CE, 1997, DIABETES, V46, pS104, DOI 10.2337/diab.46.2.S104; Munoz J, 2014, ANGEW CHEM INT EDIT, V53, P10864, DOI 10.1002/anie.201406545; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Patel VB, 2014, CLIN SCI, V126, P471, DOI 10.1042/CS20130344; Peng W, 2017, ELECTROPHORESIS; Roberto T, 2017, NUTRIENTS, V9; Schwammle V, 2014, MOL CELL PROTEOMICS, V13, P1855, DOI 10.1074/mcp.O113.036335; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shao BH, 2014, CIRC RES, V114, P1733, DOI 10.1161/CIRCRESAHA.114.303454; Smith LE, 2014, PROTEOM CLIN APPL, V8, P506, DOI 10.1002/prca.201400052; Stephen EA, 2014, J BIOMED MATER RES A, V102, P3255, DOI 10.1002/jbm.a.34998; Takahashi E, 2017, J DIABETES INVESTIG; Thongboonkerd Visith, 2005, Rev Diabet Stud, V2, P19, DOI 10.1900/RDS.2005.2.19; Van JAD, 2017, J AM SOC NEPHROL, V28, P1050, DOI 10.1681/ASN.2016091018; Voronova V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171781; Voss JG, 2017, NURS RES, V66, P63, DOI 10.1097/NNR.0000000000000209; Wang Y, 2006, KIDNEY INT, V70, P882, DOI 10.1038/sj.ki.5001624; Zheng H, 2017, AGING DIS, V8, P7, DOI 10.14336/AD.2016.0627	58	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187752	10.1371/journal.pone.0187752	http://dx.doi.org/10.1371/journal.pone.0187752			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121074	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900072
J	Fu, YH; Huang, CY; Sun, CT				Fu, Yu-Hsiang; Huang, Chung-Yuan; Sun, Chuen-Tsai			A community detection algorithm using network topologies and rule-based hierarchical arc-merging strategies	PLOS ONE			English	Article							LABEL PROPAGATION ALGORITHM; COMPLEX NETWORKS; SELF-SIMILARITY; MODULARITY; FRAMEWORK; FEATURES; MODEL	The authors use four criteria to examine a novel community detection algorithm: (a) effectiveness in terms of producing high values of normalized mutual information (NMI) and modularity, using well-known social networks for testing; (b) examination, meaning the ability to examine mitigating resolution limit problems using NMI values and synthetic networks; (c) correctness, meaning the ability to identify useful community structure results in terms of NMI values and Lancichinetti-Fortunato-Radicchi (LFR) benchmark networks; and (d) scalability, or the ability to produce comparable modularity values with fast execution times when working with large-scale real-world networks. In addition to describing a simple hierarchical arc-merging (HAM) algorithm that uses network topology information, we introduce rule-based arc-merging strategies for identifying community structures. Five well-studied social network datasets and eight sets of LFR benchmark networks were employed to validate the correctness of a ground-truth community, eight large-scale real-world complex networks were used to measure its efficiency, and two synthetic networks were used to determine its susceptibility to two resolution limit problems. Our experimental results indicate that the proposed HAM algorithm exhibited satisfactory performance efficiency, and that HAM-identified and ground-truth communities were comparable in terms of social and LFR benchmark networks, while mitigating resolution limit problems.	[Fu, Yu-Hsiang; Sun, Chuen-Tsai] Natl Chiao Tung Univ, Dept Comp Sci, Hsinchu, Taiwan; [Huang, Chung-Yuan] Chang Gung Univ, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Coll Engn, Taoyuan, Taiwan; [Huang, Chung-Yuan] 259 Wen Hwa Ist Rd, Taoyuan, Taiwan	National Yang Ming Chiao Tung University; Chang Gung University	Huang, CY (corresponding author), Chang Gung Univ, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Coll Engn, Taoyuan, Taiwan.; Huang, CY (corresponding author), 259 Wen Hwa Ist Rd, Taoyuan, Taiwan.	gscott@mail.cgu.edu.tw	Huang, Chung-Yuan/AAH-2330-2019; Sun, Chuen-Tsai/Q-8348-2018	Huang, Chung-Yuan/0000-0002-8680-6755; Sun, Chuen-Tsai/0000-0002-4757-9131	Republic of China National Science Council [MOST-106-2221-E-182-073]; High Speed Intelligent Communication (HSIC) Research Center of Chang Gung University, Taiwan	Republic of China National Science Council(Ministry of Science and Technology, Taiwan); High Speed Intelligent Communication (HSIC) Research Center of Chang Gung University, Taiwan	This work was supported by the Republic of China National Science Council (MOST-106-2221-E-182-073) and the High Speed Intelligent Communication (HSIC) Research Center of Chang Gung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Arenas A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053039; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barber MJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026129; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Chang HH, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P3072; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Cormen Thomas H., 2009, INTRO ALGORITHMS; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Duan XD, 2008, IEEE C EVOL COMPUTAT, P1074, DOI 10.1109/CEC.2008.4630930; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fu YH, 2016, PHYSICA A, V461, P840, DOI 10.1016/j.physa.2016.06.042; Fu YH, 2015, PHYSICA A, V433, P344, DOI 10.1016/j.physa.2015.03.042; Gallos LK, 2007, PHYSICA A, V386, P686, DOI 10.1016/j.physa.2007.07.069; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gong MG, 2012, PHYSICA A, V391, P4050, DOI 10.1016/j.physa.2012.03.021; Gong MG, 2014, IEEE T EVOLUT COMPUT, V18, P82, DOI 10.1109/TEVC.2013.2260862; Gong MG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; He TT, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1496, DOI 10.1109/CEC.2014.6900570; Huang JB, 2011, PHYSICA A, V390, P2160, DOI 10.1016/j.physa.2010.10.040; Ji JZ, 2013, PHYSICA A, V392, P3260, DOI 10.1016/j.physa.2013.04.001; Jiang YW, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/16/165101; Kumpula JM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228701; Lai DR, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066118; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066122; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Liu W, 2014, SCI REP-UK, V4, DOI 10.1038/srep05739; Liu X, 2010, PHYSICA A, V389, P1493, DOI 10.1016/j.physa.2009.12.019; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Matake N, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P861; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman M.E.J., 2010, NETWORKS INTRO; Newman M. E. J., 2004, PHYS REV, V69; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pizzuti C, 2008, LECT NOTES COMPUT SC, V5199, P1081, DOI 10.1007/978-3-540-87700-4_107; Pizzuti C, 2009, PROC INT C TOOLS ART, P379; Pizzuti C, 2012, IEEE T EVOLUT COMPUT, V16, P418, DOI 10.1109/TEVC.2011.2161090; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Ronhovde P, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016109; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Russell SJ, 2010, ARTIF INTELL; Shang RH, 2017, PHYSICA A, V469, P471, DOI 10.1016/j.physa.2016.11.066; Shang RH, 2016, INT J PATTERN RECOGN, V30, DOI 10.1142/S0218001416590242; Shang RH, 2016, PHYSICA A, V453, P203, DOI 10.1016/j.physa.2016.02.020; Shang RH, 2015, PHYSICA A, V428, P279, DOI 10.1016/j.physa.2015.02.004; Shang RH, 2013, PHYSICA A, V392, P1215, DOI 10.1016/j.physa.2012.11.003; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Sun HL, 2015, PHYSICA A, V436, P767, DOI 10.1016/j.physa.2015.05.080; Tasgin M., 2007, ARXIV07110491; Teitelbaum T, 2008, CHAOS, V18, DOI 10.1063/1.2988285; Wang XF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169355; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086085, 10.1371/journal.pone.0091856]; Wu JS, 2015, PHYSICA A, V433, P218, DOI 10.1016/j.physa.2015.03.044; Xiang J, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/03/033405; Xiang J, 2015, PHYSICA A, V432, P127, DOI 10.1016/j.physa.2015.03.006; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang SH, 2007, PHYSICA A, V374, P483, DOI 10.1016/j.physa.2006.07.023; Zhang XH, 2013, KNOWL-BASED SYST, V42, P74, DOI 10.1016/j.knosys.2013.01.017	68	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187603	10.1371/journal.pone.0187603	http://dx.doi.org/10.1371/journal.pone.0187603			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121100	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900054
J	Vandeplassche, E; Coenye, T; Crabbe, A				Vandeplassche, Eva; Coenye, Tom; Crabbe, Aurelie			Developing selective media for quantification of multispecies biofilms following antibiotic treatment	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; TRICLOSAN RESISTANCE; INFECTIONS; TOLERANCE; PATHOGENS	The lungs of cystic fibrosis (CF) patients are chronically colonized by a polymicrobial biofilm community, leading to difficult-to-treat infections. To combat these infections, CF patients are commonly treated with a variety of antibiotics. Understanding the dynamics of polymicrobial community composition in response to antibiotic therapy is essential in the search for novel therapies. Culture-dependent quantification of individual bacteria from defined multi-species biofilms is frequently carried out by plating on selective media. However, the influence of the selective agents in these media on quantitative recovery before or after antibiotic treatment is often unknown. In the present study we developed selective media for six bacterial species that are frequently co-isolated from the CF lung, i.e. Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus anginosus, Achromobacter xylosoxidans, Rothia mucilaginosa, and Gemella haemolysans. We show that certain supplementations to selective media strongly influence quantitative recovery of (un) treated biofilms. Hence, the developed media were optimized for selectivity and quantitative recovery before or after treatment with antibiotics of four major classes, i.e. ceftazidime, ciprofloxacin, colistin, or tobramycin. Finally, in a proof of concept experiment the novel selective media were applied to determine the community composition of multispecies biofilms before and after treatment with tobramycin.	[Vandeplassche, Eva; Coenye, Tom; Crabbe, Aurelie] Univ Ghent, Lab Pharmaceut Microbiol, Ghent, Belgium	Ghent University	Crabbe, A (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, Ghent, Belgium.	Aurelie.Crabbe@UGent.be	Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014	Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Crabbe, Aurelie/0000-0003-3084-4418	Research Foundation Flanders	Research Foundation Flanders(FWO)	This work was funded by an Odysseus grant from the Research Foundation Flanders (AC, TC).	Amoureux L, 2013, APPL ENVIRON MICROB, V79, P7142, DOI 10.1128/AEM.02293-13; Brayshaw DP, 1999, BRIT J BIOMED SCI, V56, P170; Caverly LJ, 2015, PEDIAT PULMONOL, V50, P31; Chuanchuen R, 2003, AM J INFECT CONTROL, V31, P124, DOI 10.1067/mic.2003.11; Ciofu O, 2015, ADV DRUG DELIVER REV, V85, P7, DOI 10.1016/j.addr.2014.11.017; Cowley ES, 2015, MBIO, V6, DOI 10.1128/mBio.00767-15; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; de Koff EM, 2016, CURR OPIN PULM MED, V22, P623, DOI 10.1097/MCP.0000000000000316; De Soyza A, 2013, MICROBIOLOGYOPEN, V2, P1010, DOI 10.1002/mbo3.141; European Comm Antimicrobial Susc, 2000, CLIN MICROBIOL INFEC, V6, P509; Filkins LM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005258; Hall CW, 2017, FEMS MICROBIOL REV, V41, P276, DOI [10.1093/femsre/fux010, 10.1093/femsre/f]; Ho P-L, 2016, J CLIN MICROBIOL, V55, P1; Hoiby N, 2017, APMIS, V125, P339, DOI 10.1111/apm.12689; Huang YJ, 2016, CLIN CHEST MED, V37, P59, DOI 10.1016/j.ccm.2015.10.003; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Kobayashi T, 2012, J MICROBIOL METH, V91, P364, DOI 10.1016/j.mimet.2012.09.011; Lopes SP, 2012, INT J ANTIMICROB AG, V40, P260, DOI 10.1016/j.ijantimicag.2012.04.020; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Magalhaes AP, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02146; Mahenthiralingam E, 2014, PAEDIATR RESPIR REV, V15, P13, DOI 10.1016/j.prrv.2014.04.006; O'Connell HA, 2006, APPL ENVIRON MICROB, V72, P5013, DOI 10.1128/AEM.02474-05; PARFENTJEV IA, 1964, J BACTERIOL, V88, P1, DOI 10.1002/path.1700880102; Rabin HR, 2012, CURR OPIN PULM MED, V18, P622, DOI 10.1097/MCP.0b013e328358d49a; Sawant AA, 2002, J DAIRY SCI, V85, P1127, DOI 10.3168/jds.S0022-0302(02)74174-X; Sibley CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022702; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Sibley CD, 2010, J MED MICROBIOL, V59, P534, DOI 10.1099/jmm.0.016592-0; Takada K, 2005, J MICROBIOL METH, V60, P189, DOI 10.1016/j.mimet.2004.09.009; Tavernier S, 2015, PEERJ, V3, DOI 10.7717/peerj.787; Van Acker H, 2016, J BIOL CHEM, V291, P12565, DOI 10.1074/jbc.R115.707257; Van den Driessche F, 2014, J MICROBIOL METH, V98, P31, DOI 10.1016/j.mimet.2013.12.011; Vandecandelaere I, 2013, PATHOG DIS, V69, P142, DOI 10.1111/2049-632X.12100; Waite RD, 2012, J CLIN MICROBIOL, V50, P1430, DOI 10.1128/JCM.06184-11; Wauven C V, 1984, J BACTERIOL, V160, P918; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	39	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187540	10.1371/journal.pone.0187540	http://dx.doi.org/10.1371/journal.pone.0187540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121069	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900045
J	Viswanathan, K; Verweij, MC; John, N; Malouli, D; Fruh, K				Viswanathan, Kasinath; Verweij, Marieke C.; John, Nessy; Malouli, Daniel; Fruh, Klaus			Quantitative membrane proteomics reveals a role for tetraspanin enriched microdomains during entry of human cytomegalovirus	PLOS ONE			English	Article							HEPATITIS-C VIRUS; PUTATIVE CELLULAR RECEPTOR; GROWTH-FACTOR RECEPTOR; IMMUNODEFICIENCY-VIRUS; GENE-EXPRESSION; TRANSMEMBRANE-4 SUPERFAMILY; SURFACE EXPRESSION; MASS-SPECTROMETRY; HEPARAN-SULFATE; DOWN-REGULATION	Human cytomegalovirus (HCMV) depends on and modulates multiple host cell membrane proteins during each stage of the viral life cycle. To gain a global view of the impact of HCMV-infection on membrane proteins, we analyzed HCMV-induced changes in the abundance of membrane proteins in fibroblasts using stable isotope labeling with amino acids (SILAC), membrane fractionation and protein identification by two-dimensional liquid chromatography and tandem mass spectrometry. This systematic approach revealed that CD81, CD44, CD98, caveolin-1 and catenin delta-1 were down-regulated during infection whereas GRP-78 was up-regulated. Since CD81 downregulation was also observed during infection with UV-inactivated virus we hypothesized that this tetraspanin is part of the viral entry process. Interestingly, additional members of the tetraspanin family, CD9 and CD151, were also downregulated during HCMV-entry. Since tetraspanin-enriched microdomains (TEM) cluster host cell membrane proteins including known CMV receptors such as integrins, we studied whether TEMs are required for viral entry. When TEMs were disrupted with the cholesterol chelator methyl-beta-cylcodextrin, viral entry was inhibited and this inhibition correlated with reduced surface levels of CD81, CD9 and CD151, whereas integrin levels remained unchanged. Furthermore, simultaneous siRNA-mediated knockdown of multiple tetraspanins inhibited viral entry whereas individual knockdown had little effect suggesting essential, but redundant roles for individual tetraspanins during entry. Taken together, our data suggest that TEM act as platforms for receptors utilized by HCMV for entry into cells.	[Viswanathan, Kasinath; Verweij, Marieke C.; John, Nessy; Malouli, Daniel; Fruh, Klaus] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Viswanathan, Kasinath] Cadila Healthcare Ltd, Mol & Cellular Biol, Zydus Res Ctr, Sarkhej Bavla NH 8A, Ahmadabad, Gujarat, India	Oregon Health & Science University; Zydus Cadila	Fruh, K (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.	fruehk@ohsu.edu	John, Nessy/AAV-7640-2021; Malouli, Daniel/AAX-1855-2021	John, Nessy/0000-0002-4114-4946; Malouli, Daniel/0000-0003-1287-7283; Frueh, Klaus/0000-0001-8014-3877				Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Baron W, 2003, CURR BIOL, V13, P151, DOI 10.1016/S0960-9822(02)01437-9; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Bartee E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015132; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bassani S, 2012, INT J BIOCHEM CELL B, V44, P703, DOI 10.1016/j.biocel.2012.01.020; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Browne EP, 2001, J VIROL, V75, P12319, DOI 10.1128/JVI.75.24.12319-12330.2001; Buchkovich NJ, 2008, J VIROL, V82, P31, DOI 10.1128/JVI.01881-07; Buchkovich NJ, 2009, J VIROL, V83, P11421, DOI 10.1128/JVI.00762-09; Byun M, 2009, CELL HOST MICROBE, V6, P422, DOI 10.1016/j.chom.2009.09.012; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Charrin S, 2003, EUR J IMMUNOL, V33, P2479, DOI 10.1002/eji.200323884; Cobbs C, 2014, ONCOTARGET, V5, P1091, DOI 10.18632/oncotarget.1787; Cobbs CS, 2007, J NEURO-ONCOL, V85, P271, DOI 10.1007/s11060-007-9423-2; COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192; Delos Santos RC, 2015, CELL SIGNAL, V27, P1963, DOI 10.1016/j.cellsig.2015.07.004; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Dumortier J, 2008, J VIROL, V82, P6524, DOI 10.1128/JVI.00502-08; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; Garrigues HJ, 2014, VIROLOGY, V464, P118, DOI 10.1016/j.virol.2014.06.035; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gui L, 2012, FISH SHELLFISH IMMUN, V32, P1008, DOI 10.1016/j.fsi.2012.02.022; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; HO M, 1990, REV INFECT DIS, V12, pS701; Ho SH, 2006, J VIROL, V80, P6487, DOI 10.1128/JVI.02539-05; Hochdorfer D, 2016, J VIROL, V90, P6430, DOI 10.1128/JVI.00145-16; Hofmann H, 2002, J VIROL, V76, P5769, DOI 10.1128/JVI.76.11.5769-5783.2002; HUANG ES, 1976, YALE J BIOL MED, V49, P93; IMAI T, 1993, J IMMUNOL, V151, P6470; IMAI T, 1995, J IMMUNOL, V155, P1229; Isaacson MK, 2007, J VIROL, V81, P6241, DOI 10.1128/JVI.00169-07; ITO M, 1995, MICROBIOL IMMUNOL, V39, P129, DOI 10.1111/j.1348-0421.1995.tb02179.x; Jeibmann A, 2015, J NEURO-ONCOL, V124, P373, DOI 10.1007/s11060-015-1864-4; Jeong Y S, 2013, INT J DISTRIB SENS N, V2013, DOI DOI 10.1016/J.IJRMMS.2009.03.007; JONES TR, 1995, J VIROL, V69, P4830, DOI 10.1128/JVI.69.8.4830-4841.1995; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Kattenhorn LM, 2004, J VIROL, V78, P11187, DOI 10.1128/JVI.78.20.11187-11197.2004; Kedhar Sanjay R, 2007, Herpes, V14, P66; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130670; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kovalenko OV, 2007, MOL CELL PROTEOMICS, V6, P1855, DOI 10.1074/mcp.M700183-MCP200; Landais I, 2013, CURR OPIN VIROL, V3, P408, DOI 10.1016/j.coviro.2013.06.002; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Loffler S, 1997, J VIROL, V71, P42; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Lukashchuk V, 2008, J VIROL, V82, P12543, DOI 10.1128/JVI.01215-08; Maidji E, 1998, J VIROL, V72, P5717, DOI 10.1128/JVI.72.7.5717-5727.1998; Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Meredith LW, 2012, REV MED VIROL, V22, P182, DOI 10.1002/rmv.723; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Moorman NJ, 2010, MOL CELL PROTEOMICS, V9, P851, DOI 10.1074/mcp.M900485-MCP200; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Oresic K, 2008, J GEN VIROL, V89, P1122, DOI 10.1099/vir.0.83516-0; Petracca R, 2000, J VIROL, V74, P4824, DOI 10.1128/JVI.74.10.4824-4830.2000; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Prager GW, 2007, J BIOL CHEM, V282, P24477, DOI 10.1074/jbc.M702877200; Reitsma JM, 2011, CELL HOST MICROBE, V9, P103, DOI 10.1016/j.chom.2011.01.006; Salsman J, 2012, J VIROL, V86, P806, DOI 10.1128/JVI.05442-11; Scheffer KD, 2013, J VIROL, V87, P3435, DOI 10.1128/JVI.02906-12; Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413, DOI 10.1099/0022-1317-81-6-1413; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Slobedman Barry, 2008, V141, P153; Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209; Spoden G, 2013, J VIROL, V87, P7765, DOI 10.1128/JVI.00370-13; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Stanton RJ, 2007, J VIROL, V81, P7860, DOI 10.1128/JVI.02247-06; Stiles KM, 2010, J VIROL, V84, P11646, DOI 10.1128/JVI.01550-10; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Stojanovic M, 2005, J BIOL CHEM, V280, P30018, DOI 10.1074/jbc.M501306200; Tandon R, 2009, J VIROL, V83, P10797, DOI 10.1128/JVI.01093-09; Tani H, 2007, J VIROL, V81, P8601, DOI 10.1128/JVI.00608-07; Todd SC, 1996, J EXP MED, V184, P2055, DOI 10.1084/jem.184.5.2055; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Veettil MV, 2008, J VIROL, V82, P12126, DOI 10.1128/JVI.01146-08; von Lindern JJ, 2003, J VIROL, V77, P3624, DOI 10.1128/JVI.77.6.3624-3633.2003; Wang A, 2011, ADV VIROL, V2011, DOI 10.1155/2011/262080; Wang W, 2009, ARCH VIROL, V154, P595, DOI 10.1007/s00705-009-0348-2; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028; WILLETT BJ, 1994, IMMUNOLOGY, V81, P228; Wu YQ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006281; YAMASHITA Y, 1993, VIROLOGY, V193, P727, DOI 10.1006/viro.1993.1181; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhang H, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.005678, 10.1074/mcp.M111.009936, 10.1186/1476-4598-10-108]; Zhu H, 1998, P NATL ACAD SCI USA, V95, P14470, DOI 10.1073/pnas.95.24.14470	104	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187899	10.1371/journal.pone.0187899	http://dx.doi.org/10.1371/journal.pone.0187899			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121670	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900090
J	Zerulla, FN; Augel, C; Zebitz, CPW				Zerulla, Florian N.; Augel, Clemens; Zebitz, Claus P. W.			Oviposition activity of Drosophila suzukii as mediated by ambient and fruit temperature	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; DIPTERA DROSOPHILIDAE; POPULATION; INVASION; EUROPE; INFESTATION; PLASTICITY; CALIFORNIA; TOLERANCE; BEHAVIOR	The invasive pest Drosophila suzukii was introduced to southern Europe in 2008 and spread throughout Central Europe in the following years. Precise reliable data on the temperature-dependent behavior of D. suzukii are scarce but will help forecasting and cultivation techniques. Depending on physico-chemical properties, surface temperature of objects may differ from ambient temperatures, determining physical activity, and affect oviposition on or into substrate, determining preimaginal development later. Therefore, the preferred ambient temperatures of D. suzukii and fruit temperature for oviposition were examined on a linear temperature gradient device. Thirty adults (15 female; 15 male) were adapted to different temperatures (10, 20, 30 degrees C) for six days and then exposed to different temperature gradients (10-25, 20-35, 25-40 degrees C). D. suzukii adapted to 10 degrees C remained in cooler regions and suffered from a significantly higher mortality at the 25-40 degrees C gradient. Animals adapted to warmer temperatures had a wider temperature preference on the gradient device. Acclimation to lower temperatures and the resulting lower temperature preferences may allow the flies to disperse better in spring to search for oviposition sites. The oviposition activity decreased continuously at a fruit temperature above 28 degrees C and below 15 degrees C, with highest oviposition activity in fruits with temperatures between 19.7 degrees C and 24.8 degrees C. The preferred fruit temperature is in accordance with the temperature optimum of reproduction biology and preimaginal development of D. suzukii reported in the literature.	[Zerulla, Florian N.; Augel, Clemens; Zebitz, Claus P. W.] Univ Hohenheim, Dept Appl Entomol, Baden, Switzerland		Zerulla, FN (corresponding author), Univ Hohenheim, Dept Appl Entomol, Baden, Switzerland.	Florian.Zerulla@uni-hohenheim.de	Zebitz, Claus/ABW-3991-2022					Arnim Frh, 1936, Z ANGEW ENTOMOL, V22, P533; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Atallah J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2840; Bathon H., 1991, World Crop Pests, V5, P283; Bergqvist J, 2001, AM J ENOL VITICULT, V52, P1; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; Cini A, 2012, B INSECTOL, V65, P149; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; Diepenbrock LM, 2017, J APPL ENTOMOL, V141, P1, DOI 10.1111/jen.12335; Dillon ME, 2009, J THERM BIOL, V34, P109, DOI 10.1016/j.jtherbio.2008.11.007; Ferguson CTJ, 2015, J EXP BIOL, V218, P3855, DOI 10.1242/jeb.125468; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Gutierrez A, 2016, BIOL INVASIONS, V18, P3647, DOI 10.1007/s10530-016-1255-6; Hamby KA, 2016, J PEST SCI, V89, P605, DOI 10.1007/s10340-016-0756-5; Haviland DR, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM11034; Jakobs R, 2015, J INSECT PHYSIOL, V79, P1, DOI 10.1016/j.jinsphys.2015.05.003; Kanzawa T, 1939, REV APPL ENTOMOLOGY, V29, p[49, 622]; Kenis M, 2016, J PEST SCI, V89, P735, DOI 10.1007/s10340-016-0755-6; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Langille AB, 2016, ECOL MODEL, V336, P70, DOI 10.1016/j.ecolmodel.2016.05.014; Lee JC, 2015, ANN ENTOMOL SOC AM, V108, P117, DOI 10.1093/aesa/sau014; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Lin QC, 2014, FLA ENTOMOL, V97, P1424, DOI 10.1653/024.097.0417; Mazzi D, 2017, INSECTS, V8, DOI 10.3390/insects8010018; Orhan A, 2016, TURK J ZOOL, V40, P290, DOI 10.3906/zoo-1412-25; Quesada-Moraga E, 2012, ENVIRON ENTOMOL, V41, P966, DOI 10.1603/EN12029; Ros G. de, 2013, IOBC/WPRS Bulletin, V91, P317; Rota-Stabelli O, 2013, CURR BIOL, V23, pR8, DOI 10.1016/j.cub.2012.11.021; Ryan GD, 2016, J ECON ENTOMOL, V109, P746, DOI 10.1093/jee/tow006; Shearer PW, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0070-3; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; Tonina L, 2016, J PEST SCI, V89, P667, DOI 10.1007/s10340-016-0730-2; Van Timmeren S, 2013, CROP PROT, V54, P126, DOI 10.1016/j.cropro.2013.08.003; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; Woolf AB, 2000, POSTHARVEST BIOL TEC, V21, P7, DOI 10.1016/S0925-5214(00)00161-7; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194	36	18	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187682	10.1371/journal.pone.0187682	http://dx.doi.org/10.1371/journal.pone.0187682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121635	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900065
J	Franklyn, AM; Eibl, JK; Gauthier, GJ; Marsh, DC				Franklyn, Alexandra M.; Eibl, Joseph K.; Gauthier, Graham J.; Marsh, David C.			The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada	PLOS ONE			English	Article							METHADONE-MAINTENANCE TREATMENT; TREATMENT OUTCOMES; DEPENDENT PATIENTS; SEX-DIFFERENCES; UNITED-STATES; SUBSTANCE USE; HEALTH; ASSOCIATION; DISORDERS; RETENTION	Background With the Canadian government legalizing cannabis in the year 2018, the potential harms to certain populations including those with opioid use disorder must be investigated. Cannabis is one of the most commonly used substances by patients who are engaged in medication-assisted treatment for opioid use disorder, the effects of which are largely unknown. In this study, we examine the impact of baseline and ongoing cannabis use, and whether these are impacted differentially by gender. Methods We conducted a retrospective cohort study using anonymized electronic medical records from 58 clinics offering opioid agonist therapy in Ontario, Canada. One-year treatment retention was the primary outcome of interest and was measured for patients who did and did not have a cannabis positive urine sample in their first month of treatment, and as a function of the proportion of cannabis-positive urine samples throughout treatment. Results Our cohort consisted of 644 patients, 328 of which were considered baseline cannabis users and 256 considered heavy users. Patients with baseline cannabis use and heavy cannabis use were at increased risk of dropout (38.9% and 48.1%, respectively). When evaluating these trends by gender, only female baseline users and male heavy users are at increased risk of premature dropout. Interpretation Both baseline and heavy cannabis use are predictive of decreased treatment retention, and differences do exist between genders. With cannabis being legalized in the near future, physicians should closely monitor cannabis-using patients and provide education surrounding the potential harms of using cannabis while receiving treatment for opioid use disorder.	[Franklyn, Alexandra M.; Eibl, Joseph K.; Gauthier, Graham J.; Marsh, David C.] Northern Ontario Sch Med, Sudbury, ON, Canada; [Marsh, David C.] Canadian Addict Treatment Ctr, Richmond Hill, ON, Canada	Northern Ontario School of Medicine	Marsh, DC (corresponding author), Northern Ontario Sch Med, Sudbury, ON, Canada.; Marsh, DC (corresponding author), Canadian Addict Treatment Ctr, Richmond Hill, ON, Canada.	dmarsh@nosm.ca	Marsh, David C./AAU-7184-2020; Fazli, Ghazal/AAE-8320-2022	Marsh, David C./0000-0002-8769-1785; 	Clinical Innovation Grant from the Northern Ontario Academic Medicine Association; CANOC Scholarship Awards Programme; Centres Grant [CIHR 711314]; Canadian Institutes of Health Research (CIHR) through a Centres Grant (Centres for HIV/AIDS Population Health and Health Services Research [CIHR 711314]; Operating Grants (HIV/AIDS Priority Announcement [CIHR 711310]; Population and Public Health [CIHR 711319]; CIHR Canadian HIV Trials Network [CTN 242]; Foundation Grant (Expansion of Antiretroviral Therapy and its Impact on Vulnerable Populations in Canada and Global Settings) [CIHR] [143342]	Clinical Innovation Grant from the Northern Ontario Academic Medicine Association; CANOC Scholarship Awards Programme; Centres Grant; Canadian Institutes of Health Research (CIHR) through a Centres Grant (Centres for HIV/AIDS Population Health and Health Services Research; Operating Grants (HIV/AIDS Priority Announcement; Population and Public Health; CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); Foundation Grant (Expansion of Antiretroviral Therapy and its Impact on Vulnerable Populations in Canada and Global Settings) [CIHR]	This study was funded by a Clinical Innovation Grant from the Northern Ontario Academic Medicine Association. JKE received funding as a successful recipient of the 2014-2015 CANOC Scholarship Awards Programme; (this programme is supported through the Centres Grant [CIHR 711314]). CANOC is funded by the Canadian Institutes of Health Research (CIHR) through a Centres Grant (Centres for HIV/AIDS Population Health and Health Services Research [CIHR 711314]); two Operating Grants (HIV/AIDS Priority Announcement [CIHR 711310]; Population and Public Health [CIHR 711319]); the CIHR Canadian HIV Trials Network [CTN 242]; and a Foundation Grant (Expansion of Antiretroviral Therapy and its Impact on Vulnerable Populations in Canada and Global Settings [CIHR # 143342]).	Bachhuber MA, 2014, JAMA INTERN MED, V174, P1668, DOI 10.1001/jamainternmed.2014.4005; Back SE, 2011, AM J DRUG ALCOHOL AB, V37, P313, DOI 10.3109/00952990.2011.596982; Bawor M, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0038-6; Benyamina Amine, 2014, Rev Prat, V64, P165; Blanco C, 2016, JAMA PSYCHIAT, V73, P388, DOI 10.1001/jamapsychiatry.2015.3229; Boehnke KF, 2016, J PAIN, V17, P739, DOI 10.1016/j.jpain.2016.03.002; Brands B, 2008, J ADDICT DIS, V27, P37, DOI 10.1080/10550880802122620; Canada H, 2015, CAN ALC DRUG US SURV; Cerda M, 2012, DRUG ALCOHOL DEPEN, V120, P22, DOI 10.1016/j.drugalcdep.2011.06.011; Davis JM, 2016, AM J PREV MED, V50, P373, DOI 10.1016/j.amepre.2015.06.034; Degenhardt L, 2001, DRUG ALCOHOL DEPEN, V64, P319, DOI 10.1016/S0376-8716(01)00130-2; Dills, 2016, DOSE REALITY EFFECT, V799; Eibl JK, 2015, J ADDICT MED, V9, P440, DOI 10.1097/ADM.0000000000000156; Epstein DH, 2015, AM J ADDICTION, V24, P323, DOI 10.1111/ajad.12183; Epstein DH, 2003, ADDICTION, V98, P269, DOI 10.1046/j.1360-0443.2003.00310.x; Evans E, 2015, DRUG ALCOHOL DEPEN, V155, P228, DOI 10.1016/j.drugalcdep.2015.07.010; Franklyn AM, 2017, INT J DRUG POLICY, V48, P1, DOI 10.1016/j.drugpo.2017.05.044; Franklyn AM, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0134-5; Haberstick BC, 2014, DRUG ALCOHOL DEPEN, V136, P158, DOI 10.1016/j.drugalcdep.2013.11.022; Hall W, 2016, ADDICTION, V111, P1764, DOI 10.1111/add.13428; Handford CKM., 2012, BUPRENORPHINE NALOXO; Hill KP, 2013, DRUG ALCOHOL DEPEN, V132, P342, DOI 10.1016/j.drugalcdep.2013.02.030; Hser YI, 2014, ADDICTION, V109, P79, DOI 10.1111/add.12333; Palamar JJ, 2014, INT J DRUG POLICY, V25, P424, DOI 10.1016/j.drugpo.2014.01.017; Peles E, 2007, J AFFECT DISORDERS, V99, P213, DOI 10.1016/j.jad.2006.09.017; Porath-Waller A BJ, 2013, CANADIAN CTR SUBSTAN, P57; Regulation. TFoMLa, 2016, LEG REG RESTR ACC MA; Roux P, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-31; Scavone JL, 2013, AM J ADDICTION, V22, P344, DOI 10.1111/j.1521-0391.2013.12044.x; Schiff M, 2007, ADDICT BEHAV, V32, P2108, DOI 10.1016/j.addbeh.2007.01.010; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Zielinski L, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0130-1	32	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187633	10.1371/journal.pone.0187633	http://dx.doi.org/10.1371/journal.pone.0187633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM0ME	29117267	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600052
J	Jing, XL; Lin, SJ; Zhang, H; Koerting, C; Yu, ZG				Jing, Xiaoli; Lin, Senjie; Zhang, Huan; Koerting, Claudia; Yu, Zhigang			Utilization of urea and expression profiles of related genes in the dinoflagellate Prorocentrum donghaiense	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; CYLINDROTHECA-FUSIFORMIS BACILLARIOPHYCEAE; AUREOCOCCUS-ANOPHAGEFFERENS; TRANSCRIPTIONAL REGULATION; PHOSPHORUS LIMITATION; PHOSPHATE LIMITATION; MARINE-PHYTOPLANKTON; AMPHIDINIUM-CARTERAE; NITRATE TRANSPORTER; ORGANIC NITROGEN	Urea has been shown to contribute more than half of total nitrogen (N) required by phyto-plankton in some estuaries and coastal waters and to provide a substantial portion of the N demand for many harmful algal blooms (HABs) of dinoflagellates. In this study, we investigated the physiological and transcriptional responses in Prorocentrum donghaiense to changes in nitrate and urea availability. We found that this species could efficiently utilize urea as sole N source and achieve comparable growth rate and photosynthesis capability as it did under nitrate. These physiological parameters were markedly lower in cultures grown under nitrate- or urea-limited conditions. P. donghaiense N content was similarly low under nitrate- or urea-limited culture condition, but was markedly higher under urea-replete condition than under nitrate- replete condition. Carbon (C) content was consistently elevated under N-limited condition. Consequently, the C: N ratio was as high as 21:1 under nitrate- or urea-limitation, but 7:1 under urea-replete condition and 9:1 to 10:1 under nitrate- replete condition. Using quantitative reverse transcription PCR, we investigated the expression pattern for four genes involved in N transport and assimilation. The results indicated that genes encoding nitrate transport, urea hydrolysis, and nickel transporter gene were sensitive to changes in general N nutrient availability whereas the urea transporter gene responded much more strongly to changes in urea concentration. Taken together, our study shows the high bioavailability of urea, its impact on C: N stoichiometry, and the sensitivity of urea transporter gene expression to urea availability.	[Jing, Xiaoli] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China; [Jing, Xiaoli; Lin, Senjie; Zhang, Huan; Koerting, Claudia] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Jing, Xiaoli; Yu, Zhigang] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Yu, Zhigang] Minist Educ, Key Lab Marine Chem Theory & Technol, Qingdao, Peoples R China	Ocean University of China; University of Connecticut; Qingdao National Laboratory for Marine Science & Technology	Lin, SJ (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011		Chinese Scholarship Council [201506330036]	Chinese Scholarship Council(China Scholarship Council)	The Chinese Scholarship Council provided an eighteen-month visiting scholarship (201506330036) for Xiaoli Jing to perform this research at University of Connecticut. The funder had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript	Alvarez-Salgado XA, 1998, MAR CHEM, V62, P325, DOI 10.1016/S0304-4203(98)00037-1; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; APHA, 2005, STANDARD METHODS EXA, V21; Bellefeuille SD, 2016, HARMFUL ALGAE, V55, P272, DOI 10.1016/j.hal.2016.03.021; Berg GM, 1997, MAR BIOL, V129, P377, DOI 10.1007/s002270050178; Berg GM, 2008, J PHYCOL, V44, P1235, DOI 10.1111/j.1529-8817.2008.00571.x; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Collos Y, 2004, J PHYCOL, V40, P96, DOI 10.1046/j.1529-8817.2004.03034.x; Dagenais-Bellefeuille S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00369; Diego-McGlone MLS, 2008, MAR POLLUT BULL, V57, P295, DOI 10.1016/j.marpolbul.2008.03.028; Dupont CL, 2008, APPL ENVIRON MICROB, V74, P23, DOI 10.1128/AEM.01007-07; Dyhrman ST, 2006, APPL ENVIRON MICROB, V72, P252, DOI 10.1128/AEM.72.1.252-260.2006; Dyhrman ST, 2003, LIMNOL OCEANOGR, V48, P647, DOI 10.4319/lo.2003.48.2.0647; ELBERRY HM, 1993, J BACTERIOL, V175, P4688, DOI 10.1128/JB.175.15.4688-4698.1993; Fan C, 2003, MAR BIOL, V142, P949, DOI 10.1007/s00227-003-1017-8; Fan CL, 2003, HARMFUL ALGAE, V2, P283, DOI 10.1016/S1568-9883(03)00047-7; FUJITA RM, 1985, J EXP MAR BIOL ECOL, V92, P283, DOI 10.1016/0022-0981(85)90100-5; Geider RJ, 1998, EUR J PHYCOL, V33, P315, DOI 10.1080/09670269810001736813; Gobler CJ, 2002, LIMNOL OCEANOGR, V47, P129, DOI 10.4319/lo.2002.47.1.0129; Guiry M.D., WORLD WIDE ELECT PUB; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Hildebrand M, 2000, J PHYCOL, V36, P702, DOI 10.1046/j.1529-8817.2000.99153.x; Hildebrand M, 2005, J PHYCOL, V41, P105, DOI 10.1111/j.1529-8817.2005.04108.x; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Hu Z, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/612823; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Kang LK, 2007, PHYCOLOGIA, V46, P521, DOI 10.2216/06-44.1; Kojima S, 2006, J MEMBRANE BIOL, V212, P83, DOI 10.1007/s00232-006-0868-6; Koper TE, 2004, APPL ENVIRON MICROB, V70, P2342, DOI 10.1128/AEM.70.4.2342-2348.2004; Kopp C, 2013, MBIO, V4, DOI 10.1128/mBio.00052-13; Kudela RM, 2000, AQUAT MICROB ECOL, V21, P31, DOI 10.3354/ame021031; Li MZ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00826; Lin SJ, 2006, J PHYCOL, V42, P646, DOI 10.1111/j.1529-8817.2006.00229.x; Lin SJ, 2015, SCIENCE, V350, P691, DOI 10.1126/science.aad0408; Lin SJ, 2011, RES MICROBIOL, V162, P551, DOI 10.1016/j.resmic.2011.04.006; Lin SJ, 1998, APPL ENVIRON MICROB, V64, P3052; Lin X, 2012, HARMFUL ALGAE, V17, P14, DOI 10.1016/j.hal.2012.02.005; Lin X, 2011, J PHYCOL, V47, P1110, DOI 10.1111/j.1529-8817.2011.01038.x; Liu ZF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00631; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomas MW, 2000, J PHYCOL, V36, P903, DOI 10.1046/j.1529-8817.2000.99029.x; Lomas MW, 2002, ESTUARIES, V25, P469, DOI 10.1007/BF02695988; Matantseva O, 2016, FRONT MICROBIOL, P7; McDonald SM, 2010, MOL BIOL EVOL, V27, P2268, DOI 10.1093/molbev/msq113; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Morel F.M.M., 2003, TREATISE GEOCHEMISTR, P113, DOI [10.1016/B0-08-043751-6/06108-9, DOI 10.1016/B0-08-043751-6/06108-9]; Morey JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-346; Oakley Kate, 2010, THESIS; OLIVEIRA L, 1986, CAN J FISH AQUAT SCI, V43, P2427, DOI 10.1139/f86-301; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Pernice M, 2015, ENVIRON MICROBIOL, V17, P3570, DOI 10.1111/1462-2920.12518; PRICE NM, 1991, LIMNOL OCEANOGR, V36, P1071, DOI 10.4319/lo.1991.36.6.1071; Puget Sound Water Quality Action Team, 1995, REC GUID MEAS MET PU, V71; REDFIELD AC, 1958, AM SCI, V46, P205; Shi XG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00555; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1137, DOI 10.4319/lo.1997.42.5_part_2.1137; Solomon CM, 2008, AQUAT MICROB ECOL, V52, P149, DOI 10.3354/ame01213; Solomon CM, 2010, AQUAT MICROB ECOL, V59, P67, DOI 10.3354/ame01390; Song B, 2007, J PHYCOL, V43, P542, DOI 10.1111/j.1529-8817.2007.00352.x; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; Wang D.-Z., 2011, IDENTIFICATION CHARA; Wurch LL, 2011, ENVIRON MICROBIOL, V13, P468, DOI 10.1111/j.1462-2920.2010.02351.x; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhuang YY, 2015, HARMFUL ALGAE, V42, P60, DOI 10.1016/j.hal.2014.12.006; Zimmermann CF, 1992, US ENV PPROTECTION A	66	20	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187837	10.1371/journal.pone.0187837	http://dx.doi.org/10.1371/journal.pone.0187837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117255	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600081
J	Koene, RJ; Norby, FL; Maheshwari, A; Rooney, MR; Soliman, EZ; Alonso, A; Chen, LY				Koene, Ryan J.; Norby, Faye L.; Maheshwari, Ankit; Rooney, Mary R.; Soliman, Elsayed Z.; Alonso, Alvaro; Chen, Lin Y.			Predictors of sudden cardiac death in atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study	PLOS ONE			English	Article							CORONARY HEART-DISEASE; SERUM-ALBUMIN; CARDIOVASCULAR-DISEASE; COMPETING-RISK; CYCLE LENGTH; ASSOCIATION; FAILURE; POPULATION; PREVALENCE; MORTALITY	We previously reported that incident atrial fibrillation (AF) is associated with an increased risk of sudden cardiac death (SCD) in the general population. We now aimed to identify predictors of SCD in persons with AF from the Atherosclerosis Risk in Communities (ARIC) study, a community-based cohort study. We included all participants who attended visit 1 (1987-89) and had no prior AF (n = 14,836). Incident AF was identified from study electrocardiograms and hospitalization discharge codes through 2012. SCD was physician-adjudicated. We used cause-specific Cox proportional hazards models, followed by stepwise selection (backwards elimination, removing all variables with p>0.10) to identify predictors of SCD in participants with AF. AF occurred in 2321 (15.6%) participants (age 45-64 years, 58% male, 18% black). Over a median of 3.3 years, SCD occurred in 110 of those with AF (4.7%). Predictors of SCD in AF included higher age, body mass index (BMI), coronary heart disease, hypertension, diabetes, current smoker, left ventricular hypertrophy, increased heart rate, and decreased albumin. Predictors associated only with SCD and not other cardiovascular (CV) death included increased BMI (HR per 5-unit increase, 1.15, 95% CI, 0.97-1.36, p = 0.10), increased heart rate (HR per SD increase, 1.18, 95% CI 0.99-1.41, p = 0.07), and low albumin (HR per SD decrease 1.23, 95% CI 1.02-1.48, p = 0.03). In the ARIC study, predictors of SCD in AF that are not associated with non-sudden CV death included increased BMI, increased heart rate, and low albumin. Further research to confirm these findings in larger community-based cohorts and to elucidate the underlying mechanisms to facilitate prevention is warranted.	[Koene, Ryan J.; Maheshwari, Ankit; Chen, Lin Y.] Univ Minnesota, Sch Med, Dept Med, Cardiovasc Div, Minneapolis, MN 55455 USA; [Norby, Faye L.; Rooney, Mary R.] Univ Minnesota, Div Epidemiol & Community Hlth, Sch Publ Hlth, Minneapolis, MN USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Epidemiol Cardiol Res Ctr EPICARE, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Internal Med Cardiol, Winston Salem, NC USA; [Alonso, Alvaro] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Wake Forest University; Emory University; Rollins School Public Health	Koene, RJ (corresponding author), Univ Minnesota, Sch Med, Dept Med, Cardiovasc Div, Minneapolis, MN 55455 USA.	koene030@umn.edu	Rooney, Mary/X-5728-2019; Norby, Faye/FNA-7255-2022; Soliman, Elsayed Z/AAD-7135-2020; Alonso, Alvaro/A-4917-2010	Norby, Faye/0000-0002-1975-0405; Soliman, Elsayed Z/0000-0001-5632-8150; Alonso, Alvaro/0000-0002-2225-8323; Chen, Lin/0000-0002-0700-814X	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; Donald W. Reynolds Foundation; American Heart Association grant [16EIA2641000]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Foundation; American Heart Association grant(American Heart Association)	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). SCD adjudication in ARIC was supported by the Donald W. Reynolds Foundation. Additional support was provided by American Heart Association grant 16EIA2641000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adabag S, 2015, HEART, V101, P215, DOI 10.1136/heartjnl-2014-306238; Al-Gobari M, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-52; Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Chao TF, 2017, SCI REP-UK, V7, DOI 10.1038/srep46445; Chen LY, 2013, JAMA INTERN MED, V173, P29, DOI 10.1001/2013.jamainternmed.744; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; DENES P, 1974, CIRCULATION, V49, P32, DOI 10.1161/01.CIR.49.1.32; DENKER S, 1984, AM J CARDIOL, V53, P508, DOI 10.1016/0002-9149(84)90022-5; Deo R, 2016, CIRCULATION, V134, P806, DOI 10.1161/CIRCULATIONAHA.116.023042; Eisen A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003735; Epstein AE, 2008, CIRCULATION, V117, P2820, DOI 10.1161/CIRCUALTIONAHA.108.189741; Fauchier L, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.06.045; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Friedman AN, 2013, AM J NEPHROL, V38, P12, DOI 10.1159/000351764; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Gopal DM, 2010, AM HEART J, V160, P279, DOI 10.1016/j.ahj.2010.05.022; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Kucharska-Newton AM, 2009, ARTERIOSCL THROM VAS, V29, P2182, DOI 10.1161/ATVBAHA.109.192740; KULLER LH, 1991, AM J EPIDEMIOL, V134, P1266, DOI 10.1093/oxfordjournals.aje.a116030; Ling LH, 2012, CIRC-HEART FAIL, V5, P786, DOI 10.1161/CIRCHEARTFAILURE.112.968321; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; Olson KA, 2011, EUR HEART J, V32, P3098, DOI 10.1093/eurheartj/ehr264; Peacock JM, 2010, AM HEART J, V160, P464, DOI 10.1016/j.ahj.2010.06.012; Piccini JP, 2014, JACC-HEART FAIL, V2, P228, DOI 10.1016/j.jchf.2014.03.004; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Soliman EZ, 2014, JAMA INTERN MED, V174, pE107, DOI 10.1001/jamainternmed.2013.11912; Soliman EZ, 2011, HEART, V97, P1597, DOI 10.1136/hrt.2010.215871; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187659	10.1371/journal.pone.0187659	http://dx.doi.org/10.1371/journal.pone.0187659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117224	gold, Green Submitted, Green Published			2022-12-26	WOS:000414659600058
J	Lagger, C; Servetto, N; Torre, L; Sahade, R				Lagger, Cristian; Servetto, Natalia; Torre, Luciana; Sahade, Ricardo			Benthic colonization in newly ice-free soft bottom areas in an Antarctic fjord	PLOS ONE			English	Article							KING GEORGE ISLAND; SOUTH SHETLAND ISLANDS; CLIMATE-CHANGE; POTTER COVE; ICEBERG DISTURBANCE; MARINE ECOSYSTEM; SHELF COLLAPSE; PENINSULA; COMMUNITIES; ASCIDIANS	Extended glacier retreat is among the main consequences of the rapid warming of the West Antarctic Peninsula. Particularly, in the inner part of Potter Cove (South Shetland Islands, Antarctica) large areas are now exposed to open sea conditions owing to the retreat of Fourcade glacier. During the 2010 austral summer, underwater photographic surveys were undertaken by SCUBA diving up to 30 m in these new ice-free areas 80 m from the glacier front. Our main aim was to investigate colonization and early succession of the benthic assemblages on soft-bottom areas. Here, we reported a total of 1,146 animals belonging to 13 taxa. Filter-feeders comprised the largest trophic group and sessile fauna showed much higher coverages and densities than mobile fauna at all depths. The most abundant groups were ascidians and bryozoans, which together comprised-90% of all taxa documented. In a region where most of marine-terminating glaciers are in retreat, these results are an important contribution to improve our knowledge on colonization in the newly ice-free areas.	[Lagger, Cristian; Servetto, Natalia; Torre, Luciana; Sahade, Ricardo] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Lab Ecol Marina, Cordoba, Argentina; [Lagger, Cristian; Servetto, Natalia; Torre, Luciana; Sahade, Ricardo] Consejo Nacl Invest Cient & Tecn CONICET, IDEA, Cordoba, Argentina	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Lagger, C (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Lab Ecol Marina, Cordoba, Argentina.; Lagger, C (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, IDEA, Cordoba, Argentina.	laggercristan@gmail.com		Sahade, Ricardo/0000-0001-5650-8135; Torre, Luciana/0000-0002-2090-1258	Institute Antartico Argentino, Alfred Wegener Institute, CONICET, FONCyT, EU (European Union) [119]; IMCONet [FP7 IRSES (International Research Staff Exchange Scheme), Action [319718]	Institute Antartico Argentino, Alfred Wegener Institute, CONICET, FONCyT, EU (European Union); IMCONet [FP7 IRSES (International Research Staff Exchange Scheme), Action	Logistic and financial support was provided by Institute Antartico Argentino, Alfred Wegener Institute, CONICET, FONCyT, EU (European Union) via grants PICTO-DNA No 119, and IMCONet [FP7 IRSES (International Research Staff Exchange Scheme), Action No. 319718]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DKA, 2008, CLIM RES, V37, P149, DOI 10.3354/cr00760; Barnes DKA, 2007, PHILOS T R SOC B, V362, P11, DOI 10.1098/rstb.2006.1951; Barnes DKA, 2016, GLOBAL CHANGE BIOL, V22, P1110, DOI 10.1111/gcb.13157; Barnes DKA, 2013, CURR BIOL, V23, pR609, DOI 10.1016/j.cub.2013.05.058; Barnes David K.A., 1996, P19; Barnes DKA, 2003, MAR ECOL PROG SER, V249, P145, DOI 10.3354/meps249145; Bowden DA, 2006, MAR ECOL PROG SER, V316, P1, DOI 10.3354/meps316001; Chen JL, 2009, NAT GEOSCI, V2, P859, DOI 10.1038/ngeo694; Clark GF, 2017, J EXP MAR BIOL ECOL, V486, P222, DOI 10.1016/j.jembe.2016.10.008; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; Cook AJ, 2014, ANTARCT SCI, V26, P614, DOI 10.1017/S0954102014000200; Dayton PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056939; DAYTON PK, 1969, SCIENCE, V163, P273, DOI 10.1126/science.163.3864.273; DAYTON PK, 1979, C INT CNRS, V291, P271; Deregibus D, 2016, POLAR BIOL, V39, P153, DOI 10.1007/s00300-015-1679-y; Domack E., 2005, EOS, V86, P269, DOI DOI 10.1029/2005EO290001; Dominguez C, 2007, KARST CRYOKARST STUD, V45, P87; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Ducklow HW, 2013, OCEANOGRAPHY, V26, P190, DOI 10.5670/oceanog.2013.62; Fillinger L, 2013, CURR BIOL, V23, P1330, DOI 10.1016/j.cub.2013.05.051; Fuentes V, 2016, SCI REP-UK, V6, DOI 10.1038/srep27234; Gorley C.K., 2006, GETTING STARTED PRIM; Grange LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077917, 10.1371/journal.pone.0084448]; Gutt J, 2001, POLAR BIOL, V24, P615, DOI 10.1007/s003000100263; Gutt J, 2007, ANTARCT SCI, V19, P165, DOI 10.1017/S0954102007000247; Gutt J, 2015, GLOBAL CHANGE BIOL, V21, P1434, DOI 10.1111/gcb.12794; Gutt J, 2011, DEEP-SEA RES PT II, V58, P74, DOI 10.1016/j.dsr2.2010.05.024; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hock R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037020; Holte B, 1998, POLAR BIOL, V19, P375, DOI 10.1007/s003000050262; Ivins ER, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007607; KLOSER H, 1994, ESTUAR COAST SHELF S, V38, P523, DOI 10.1006/ecss.1994.1036; KOPRI, 2014, ANN REP ENV MON HUM; Lagger C, 2017, ECOGRAPHY; Lambert CC, 2005, CAN J ZOOL, V83, P1, DOI 10.1139/Z04-160; Quartino ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058223; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MCCLINTOCK JB, 1991, J EXP MAR BIOL ECOL, V147, P163, DOI 10.1016/0022-0981(91)90180-5; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Moon HW, 2015, ECOL INDIC, V57, P280, DOI 10.1016/j.ecolind.2015.04.031; Nonato EF, 2000, POLAR BIOL, V23, P580, DOI 10.1007/s003000000129; Pasotti F, 2015, MAR ECOL-EVOL PERSP, V36, P716, DOI 10.1111/maec.12179; PEARSE JS, 1991, ANTARCT J US, V26, P149; Peck LS, 2010, GLOBAL CHANGE BIOL, V16, P2614, DOI 10.1111/j.1365-2486.2009.02071.x; Philipp EER, 2011, ANTARCT SCI, V23, P127, DOI 10.1017/S0954102010000970; Raes M, 2010, GLOBAL CHANGE BIOL, V16, P1618, DOI 10.1111/j.1365-2486.2009.02137.x; Rauschert M., 1991, BREMERHAVEN BER POLA, V76; Riddle MJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001327; Rimondino C, 2015, POLAR RES, V34, DOI 10.3402/polar.v34.24338; Ruckamp M, 2011, GLOBAL PLANET CHANGE, V79, P99, DOI 10.1016/j.gloplacha.2011.06.009; Sahade R, 1998, POLAR BIOL, V19, P85, DOI 10.1007/s003000050218; Sahade R, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500050; Saiz-Salinas JI, 1998, POLAR BIOL, V19, P424, DOI 10.1007/s003000050269; Scambos TA, 2000, J GLACIOL, V46, P516, DOI 10.3189/172756500781833043; Schloss IR, 1999, SCI MAR, V63, P99, DOI 10.3989/scimar.1999.63s199; Schloss IR, 2012, J MARINE SYST, V92, P53, DOI 10.1016/j.jmarsys.2011.10.006; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Segelken-Voigt A, 2016, POLAR BIOL, V39, P863, DOI 10.1007/s00300-016-1909-y; Servetto N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163152; Servetto N, 2013, POLAR RES, V32, DOI 10.3402/polar.v32i0.20040; Sicinski J, 2012, POLAR BIOL, V35, P355, DOI 10.1007/s00300-011-1081-3; Smale DA, 2008, ECOGRAPHY, V31, P289, DOI 10.1111/j.0906-7590.2008.05456.x; Smale DA, 2008, POLAR BIOL, V31, P189, DOI 10.1007/s00300-007-0346-3; Stammerjohn S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050874; StanwellSmith D, 1997, J EXP MAR BIOL ECOL, V212, P61, DOI 10.1016/S0022-0981(96)02754-2; Stark JS, 2008, MAR ECOL PROG SER, V365, P77, DOI 10.3354/meps07559; SYVITSKI JPM, 1989, ARCTIC, V42, P232; Tatian M, 1998, ANTARCT SCI, V10, P147; Teixido N, 2007, ECOSYSTEMS, V10, P142, DOI 10.1007/s10021-006-9012-9; Teixido N, 2004, MAR ECOL PROG SER, V278, P1, DOI 10.3354/meps278001; Torre L, 2014, MAR ENVIRON RES, V99, P179, DOI 10.1016/j.marenvres.2014.05.014; Torre L, 2012, POLAR BIOL, V35, P1743, DOI 10.1007/s00300-012-1208-1; Turner J, 2014, POLAR REC, V50, P237, DOI 10.1017/S0032247413000296; Wlodarska-Kowalczuk M, 2005, MAR ECOL PROG SER, V303, P31, DOI 10.3354/meps303031	74	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0186756	10.1371/Journal.pone.0186756	http://dx.doi.org/10.1371/Journal.pone.0186756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117262	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600015
J	Levan, J; Vliet-Gregg, PA; Robinson, KL; Katzenellenbogen, RA				Levan, Justine; Vliet-Gregg, Portia A.; Robinson, Kristin L.; Katzenellenbogen, Rachel A.			Human papillomavirus type 16 E6 and NFX1123 mislocalize immune signaling proteins and downregulate immune gene expression in keratinocytes	PLOS ONE			English	Article							TELOMERASE ACTIVITY; NFX1-123; BINDING; HPV; ONCOPROTEIN; E7; DIFFERENTIATION; SUPPRESSION; INFECTIONS; FACTOR-3	Human papillomavirus (HPV) is the most prevalent sexually transmitted infection, affecting an estimated 11% of the world's population. The high-risk HPV types (HR HPV) account for approximately 5% of the global burden of cancer and thus cause high morbidity and mortality. Although it is known that persistent infection with HR HPV is the greatest risk factor for developing HPV-associated cancer, and that the HPV early proteins E6 and E7 dysregulate immune detection by its host cells, the mechanisms of immune evasion by HR HPV are not well understood. Previous work in the laboratory identified the endogenous cytoplasmic host protein NFX1-123 as a binding partner of the HR HPV type 16 oncoprotein E6 (16E6). Together NFX1-123 and 16E6 affect cellular growth, differentiation, and immortalization genes and pathways. In a whole genome microarray, human foreskin keratinocytes (HFKs) stably expressing 16E6 and overexpressing NFX1-123 showed a diverse set of innate immune genes downregulated two-fold or more when compared to 16E6 cells with endogenous NFX1-123. We demonstrated that 16E6 and NFX1-123 decreased expression of pro inflammatory cytokines and interferon-stimulated genes (ISGs) in 16E6 HFKs at the mRNA and protein level. Knock down of NFX1-123 in 16E6 HFKs resulted in a derepression of innate immune genes, pointing to the requirement of NFX1-123 for immune regulation in the context of 16E6. Studies using immunofluorescent microscopy revealed that 16E6 and NFX1-123 disturbed the normal localization of signaling proteins involved in initiating the immune response. This study identifies NFX1-123 as a critical host protein partner through which 16E6 is able to subvert the immune response and in turn permit a long-lived HR HPV infection.	[Levan, Justine; Vliet-Gregg, Portia A.; Robinson, Kristin L.; Katzenellenbogen, Rachel A.] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA; [Levan, Justine; Katzenellenbogen, Rachel A.] Univ Washington, Dept Global Hlth, Pathobiol Interdisciplinary Program, Seattle, WA 98195 USA; [Katzenellenbogen, Rachel A.] Univ Washington, Dept Pediat, Div Adolescent Med, Seattle, WA 98195 USA; [Vliet-Gregg, Portia A.] Kineta Inc, Seattle, WA USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Katzenellenbogen, RA (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA.; Katzenellenbogen, RA (corresponding author), Univ Washington, Dept Global Hlth, Pathobiol Interdisciplinary Program, Seattle, WA 98195 USA.; Katzenellenbogen, RA (corresponding author), Univ Washington, Dept Pediat, Div Adolescent Med, Seattle, WA 98195 USA.	rkatzen@uw.edu		Katzenellenbogen, Rachel/0000-0002-2597-2071	National Institutes of Health [R01 CA 172742, T32 A1083203]; NATIONAL CANCER INSTITUTE [R01CA172742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI083203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health R01 CA 172742 to R.A.K and T32 A1083203 to J.L. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz SR, 1997, METHODS, V12, P337, DOI 10.1006/meth.1997.0487; Bosch FX, 2013, VACCINE, V31, pF1, DOI [10.1016/j.vaccine.2013.10.001, 10.1016/j.vaccine.2013.07.026, 10.1016/j.vaccine.2013.10.003]; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Chang YJE, 2000, J VIROL, V74, P4174, DOI 10.1128/JVI.74.9.4174-4182.2000; Chaturvedi AK, 2010, J ADOLESCENT HEALTH, V46, pS20, DOI 10.1016/j.jadohealth.2010.01.016; Cho YS, 2001, FEBS LETT, V501, P139, DOI 10.1016/S0014-5793(01)02652-7; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Georgopolous N, 2000, TRANSCRIPTIONAL REGU; Gewin L, 2004, GENE DEV, V18, P2269, DOI 10.1101/gad.1214704; Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Hong S, 2017, VIRUS RES, V231, P34, DOI 10.1016/j.virusres.2016.11.004; Hong SY, 2011, J VIROL, V85, P9486, DOI 10.1128/JVI.05007-11; Huang SM, 2002, J VIROL, V76, P8710, DOI 10.1128/JVI.76.17.8710-8721.2002; Karim R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003384; Katzenellenbogen RA, 2007, J VIROL, V81, P3786, DOI 10.1128/JVI.02007-06; Katzenellenbogen RA, 2010, J VIROL, V84, P12934, DOI 10.1128/JVI.01377-10; Katzenellenbogen RA, 2009, J VIROL, V83, P6446, DOI 10.1128/JVI.02556-08; Kleine-Lowinski K, 2003, INT J CANCER, V107, P407, DOI 10.1002/ijc.11411; Koshiol JE, 2006, INT J CANCER, V119, P1623, DOI 10.1002/ijc.22015; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Lefort K, 2004, SEMIN CANCER BIOL, V14, P374, DOI 10.1016/j.semcancer.2004.04.017; Li S, 1999, HUMAN PAPILLOMA VIRU; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maglennon GA, 2011, VIROLOGY, V414, P153, DOI 10.1016/j.virol.2011.03.019; Mantovani F, 2001, HUMAN PAPILLOMAVIRUS; Matthews K, 2003, J VIROL, V77, P8378, DOI 10.1128/JVI.77.15.8378-8385.2003; McDade SS, 2011, J CELL SCI, V124, P1635, DOI 10.1242/jcs.084723; Moscicki AB, 2004, LANCET, V364, P1678, DOI 10.1016/S0140-6736(04)17354-6; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nees M, 2001, J VIROL, V75, P4283, DOI 10.1128/JVI.75.9.4283-4296.2001; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003; Stratton KL, 2016, ONCOLOGY-NY, V30, P245; Tummers B, 2015, VIRUSES-BASEL, V7, P2485, DOI 10.3390/v7052485; Tummers B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7537; Vliet-Gregg PA, 2015, VIROLOGY, V478, P50, DOI 10.1016/j.virol.2015.02.002; Vliet-Gregg PA, 2013, J VIROL, V87, P13741, DOI 10.1128/JVI.02582-13; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557	52	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187514	10.1371/Journal.pone.0187514	http://dx.doi.org/10.1371/Journal.pone.0187514			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117186	gold, Green Published, Green Submitted			2022-12-26	WOS:000414659600042
J	Bhattacharya, D; Yu, L; Wang, MW				Bhattacharya, Dhruva; Yu, Li; Wang, Mingwu			Expression patterns of conjunctival mucin 5AC and aquaporin 5 in response to acute dry eye stress	PLOS ONE			English	Article							DIQUAFOSOL OPHTHALMIC SOLUTION; ACTIVATED PROTEIN-KINASE; OCULAR SURFACE EPITHELIA; FLUID SECRETION; WORKSHOP 2007; DEPENDENT PATHWAY; SJOGRENS-SYNDROME; P2Y(2) RECEPTOR; GOBLET CELLS; IN-VITRO	The relationship between aquaporin (AQP) 5 and mucin (MUC) 5AC in the conjunctiva was investigated in response to acute dry eye (DE) stress. A mixed-mechanism rabbit DE model, in which the main lacrimal gland, Harderian gland, and nictitating membrane were resected, was further explored in this study. Conjunctival impression cytology specimens were harvested before excision (BE) and up to 3 months after excision (AE) in 8 (16 eyes) male New Zealand White rabbits, and immunoblotting was employed to assess the expression of AQP5 and MUC5AC. It was observed that AQP5 and MUC5AC showed a positive, synchronous expression pattern with progressive upregulation at protein level up to 2 months AE. At 3 months, the expression of both proteins decreased, but was still higher than that of BE. Such a synchronous relationship was further observed in mouse conjunctiva epithelium primary cells under hyperosmotic condition. Moreover, the co-immunoprecipitation of AQP5 and MUC5AC suggested a possible physical interaction between the two molecules. Our data indicates that conjunctival AQP5 and MUC5AC act synchronously in response to acute DE stress.	[Bhattacharya, Dhruva; Wang, Mingwu] Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, Tucson, AZ USA; [Yu, Li] Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Guangdong, Peoples R China; [Yu, Li] Shenzhen Ocular Trauma & Stem Cell Differentiat S, Shenzhen, Guangdong, Peoples R China; [Yu, Li] Shenzhen Univ, Coll Optometry, Shenzhen, Guangdong, Peoples R China; [Wang, Mingwu] NeuVis Med Inst, Tucson, AZ 85716 USA	University of Arizona; Jinan University; Shenzhen University	Wang, MW (corresponding author), Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, Tucson, AZ USA.; Wang, MW (corresponding author), NeuVis Med Inst, Tucson, AZ 85716 USA.	mingwuwang@hotmail.com		Wang, Mingwu/0000-0003-0259-3607	Arizona Biomedical Research Commission Research [ADHS14-082988]; Department of Ophthalmology and Vision Science at University of Arizona	Arizona Biomedical Research Commission Research; Department of Ophthalmology and Vision Science at University of Arizona	This work was supported by Arizona Biomedical Research Commission Research (ADHS14-082988) to Dr. Mingwu Wang and the Department of Ophthalmology and Vision Science at University of Arizona. Dr. Mingwu Wang established the NeuVision Medical Institute in June of 2016 after leaving the University of Arizona Physician Practice to join a private practice while continuing his lab research at the University. NeuVision Medical Institute has not provided any salary or funding to any of the authors and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.; This work was supported by Arizona Biomedical Research Commission Research and Department of Ophthalmology and Vision Science at University of Arizona. We are thankful to the Animal Care Facility at the University of Arizona for the care of our animals throughout this study.	Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Argueso P, 2002, INVEST OPHTH VIS SCI, V43, P1004; Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Benevides L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075138; Bhattacharya D, 2015, INVEST OPHTH VIS SCI, V56, P7774, DOI 10.1167/iovs.15-17550; Blalock TD, 2008, INVEST OPHTH VIS SCI, V49, P1864, DOI 10.1167/iovs.07-1081; Caffery B, 2010, MOL VIS, V16, P1720; CHEN WYW, 1994, CURR EYE RES, V13, P765, DOI 10.3109/02713689409047012; Chen ZH, 2006, BIOCHEM BIOPH RES CO, V342, P775, DOI 10.1016/j.bbrc.2006.01.103; Contreras-Ruiz L, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/636812; Corrales RM, 2011, INVEST OPHTH VIS SCI, V52, P3492, DOI 10.1167/iovs.10-5782; Dartt DA, 2002, PROG RETIN EYE RES, V21, P555, DOI 10.1016/S1350-9462(02)00038-1; Dartt DA, 2014, CURR OPIN ALLERGY CL, V14, P464, DOI 10.1097/ACI.0000000000000098; Delporte C, 1996, J BIOL CHEM, V271, P22070, DOI 10.1074/jbc.271.36.22070; Dogru M, 2008, ALLERGY, V63, P1324, DOI 10.1111/j.1398-9995.2008.01781.x; Gipson IK, 2003, INT REV CYTOL, V231, P1, DOI 10.1016/S0074-7696(03)31001-0; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; Gipson IK, 2007, OCUL SURF, V5, P179; Gipson IK, 2011, CORNEA, V30, P1346, DOI 10.1097/ICO.0b013e31820d852a; Gong L, 2015, BR J OPHTHALMOL; Gong L, 2015, BRIT J OPHTHALMOL, V99, P903, DOI 10.1136/bjophthalmol-2014-306084; Govindarajan B, 2010, EXP EYE RES, V90, P655, DOI 10.1016/j.exer.2010.02.014; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Hoffert JD, 2000, J BIOL CHEM, V275, P9070, DOI 10.1074/jbc.275.12.9070; Jumblatt JE, 1998, EXP EYE RES, V67, P341, DOI 10.1006/exer.1998.0520; Kemp PA, 2004, AM J RESP CELL MOL, V31, P446, DOI 10.1165/rcmb.2003-0211OC; Kesimer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138988; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kinoshita S, 2012, OPHTHALMOLOGY, V119, P2471, DOI 10.1016/j.ophtha.2012.06.052; Koh S, 2014, ACTA OPHTHALMOL, V92, pe671, DOI 10.1111/aos.12443; Lemp MA, 2007, OCUL SURF, V5, P75; Levin MH, 2006, J MEMBRANE BIOL, V210, P105, DOI 10.1007/s00232-005-0849-1; Levin MH, 2004, INVEST OPHTH VIS SCI, V45, P4423, DOI 10.1167/iovs.04-0816; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Li YS, 2001, AM J PHYSIOL-CELL PH, V281, pC595, DOI 10.1152/ajpcell.2001.281.2.C595; Marko CK, 2014, INVEST OPHTH VIS SCI, V55, P291, DOI 10.1167/iovs.13-13194; Mori Y, 2014, CORNEA, V33, P659, DOI 10.1097/ICO.0000000000000136; Murakami T, 2004, OPHTHAL RES, V36, P89, DOI 10.1159/000076887; Nakamura T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10248; Nichols KK, 2004, EXPERT OPIN INV DRUG, V13, P47, DOI 10.1517/13543784.13.1.47; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Ning Y, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/3964642; Nito C, 2012, J NEUROTRAUM, V29, P2404, DOI 10.1089/neu.2012.2430; O'Sullivan NL, 2007, EXP EYE RES, V84, P323, DOI 10.1016/j.exer.2006.10.005; Oen H, 2006, EXP EYE RES, V83, P995, DOI 10.1016/j.exer.2006.04.006; Pflugfelder SC, 1997, OPHTHALMOLOGY, V104, P223, DOI 10.1016/S0161-6420(97)30330-3; Pisella PJ, 2000, OPHTHALMOLOGY, V107, P1841, DOI 10.1016/S0161-6420(00)00347-X; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Round AN, 2007, GLYCOBIOLOGY, V17, P578, DOI 10.1093/glycob/cwm027; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shatos MA, 2001, INVEST OPHTH VIS SCI, V42, P1455; Shigeyasu C, 2015, CURR EYE RES, V40, P878, DOI 10.3109/02713683.2014.967871; Sidhaye V, 2005, J BIOL CHEM, V280, P3590, DOI 10.1074/jbc.M411038200; Smith JA, 2007, OCUL SURF, V5, P93; Stephens DN, 2015, OPTOMETRY VISION SCI, V92, P931, DOI 10.1097/OPX.0000000000000664; Stern ME, 2002, INVEST OPHTH VIS SCI, V43, P2609; Takamura E, 2012, BRIT J OPHTHALMOL, V96, P1310, DOI 10.1136/bjophthalmol-2011-301448; TAM PY, 1981, NATURE, V292, P340, DOI 10.1038/292340a0; Tauber J, 2004, CORNEA, V23, P784, DOI 10.1097/01.ico.0000133993.14768.a9; Terakado K, 2014, VET J, V202, P48, DOI 10.1016/j.tvjl.2014.05.022; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Wang K, 2007, ACTA PHARMACOL SIN, V28, P1166, DOI 10.1111/j.1745-7254.2007.00608.x; Wellner RB, 2001, BIOCHEM BIOPH RES CO, V285, P1253, DOI 10.1006/bbrc.2001.5287; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yokoi N, 2014, AM J OPHTHALMOL, V157, P85, DOI 10.1016/j.ajo.2013.09.009; Zhang ZQ, 2011, ONCOL REP, V25, P1645, DOI 10.3892/or.2011.1241; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702; Zhao HC, 2001, CORNEA, V20, P873, DOI 10.1097/00003226-200111000-00019	69	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187188	10.1371/journal.pone.0187188	http://dx.doi.org/10.1371/journal.pone.0187188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112967	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100010
J	Margiotta, DPE; Basta, F; Dolcini, G; Batani, V; Navarini, L; Afeltra, A				Margiotta, Domenico Paolo Emanuele; Basta, Fabio; Dolcini, Giulio; Batani, Veronica; Navarini, Luca; Afeltra, Antonella			The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; HEALTH; ASSOCIATION; VALIDATION; DEPRESSION; OBESITY; WOMEN	Introduction Systemic Lupus Erythematosus (SLE) is associated to an increased prevalence of Metabolic Syndrome (MeS) and to a reduction of Quality of Life (QoL). The aim of this study is to evaluate the association between MeS and QoL in SLE. Methods SLE patients were consecutively enrolled in a cross sectional study. MeS was defined according to IFD definition. Therapy with glucocorticoids (GC) and antimalarial was analyzed as cumulative years of exposure. We used a cut off of 7.5 mg of prednisone to define high daily dose of GC. QoL was quantified using SF-36. We used BDI and HAM-H to assess symptoms of mood disorders. Fatigue was evaluated using Facit-Fatigue, physical activity using IPAQ, sleep quality using PSQI and alexithymia using TAS-20. Results We enrolled 100 SLE patients. MeS prevalence was 34%. Patients with MeS presented reduced scores in SF-36 MCS and PCS compared to patients without MeS (p 0.03 and p 0.004). BDI and HAM-H score were significantly higher in patients meeting MeS criteria compared to subjects without MeS (p 0.004, p 0.02). These results were confirmed after adjustment for confounders. Compared to patients without MeS, those with MeS presented higher age, lower education level, higher recent SELENA-SLEDAI, higher number of flares, increased SDI, longer cumulative exposure to high dose GC and shorter duration of antimalarial therapy. In the multiple logistic regression model, the variable associated to the Odds Ratio of having MeS were: the average of recent SELENA-SLEDAI (OR 1.15 p 0.04), the years of exposure to high dose of GC (OR 1.18 p 0.004), the years of exposure to antimalarials (OR 0.82 p 0.03) and the BDI score (OR 1.1 p 0.005). Conclusion A modern management of SLE should not miss to take all the possible measures to ensure an adequate QoL to SLE patients, with particular attention to those affected by MeS.	[Margiotta, Domenico Paolo Emanuele; Basta, Fabio; Dolcini, Giulio; Batani, Veronica; Navarini, Luca; Afeltra, Antonella] Univ Campus Biomed Roma, Unit Allergol Clin Immunol & Rheumatol, Romeu, Italy		Margiotta, DPE (corresponding author), Univ Campus Biomed Roma, Unit Allergol Clin Immunol & Rheumatol, Romeu, Italy.	d.margiotta@unicampus.it	Margiotta, Domenico Paolo Emanuele/G-5769-2018; Navarini, Luca/AAC-6635-2022; Navarini, Luca LN/A-7987-2011	Margiotta, Domenico Paolo Emanuele/0000-0002-3597-8645; Navarini, Luca/0000-0001-8537-1510; 				Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Amiri P, 2014, DIABETIC MED, V31, P854, DOI 10.1111/dme.12443; Apolone G, 1998, J CLIN EPIDEMIOL, V51, P1025, DOI 10.1016/S0895-4356(98)00094-8; Azevedo GD, 2007, ANN RHEUM DIS, V66, P1542, DOI 10.1136/ard.2007.074583; Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47; Belanoff JK, 2001, AM J PSYCHIAT, V158, P1612, DOI 10.1176/appi.ajp.158.10.1612; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bressi C, 1996, J PSYCHOSOM RES, V41, P551, DOI 10.1016/S0022-3999(96)00228-0; Bruce IN, 2003, ARTHRITIS RHEUM-US, V48, P3159, DOI 10.1002/art.11296; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Chung CP, 2007, ANN RHEUM DIS, V66, P208, DOI 10.1136/ard.2006.054973; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Curcio G, 2013, NEUROL SCI, V34, P511, DOI 10.1007/s10072-012-1085-y; El Magadmi M, 2006, J RHEUMATOL, V33, P50; Fasano S, 2017, LUPUS; Ford ES, 2008, ANN EPIDEMIOL, V18, P165, DOI 10.1016/j.annepidem.2007.10.009; Friedman KE, 2002, OBES RES, V10, P33, DOI 10.1038/oby.2002.5; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Hage MP, 2014, THER ADV ENDOCRINOL, V5, P10, DOI 10.1177/2042018813517522; Heath GW, 2009, J PHYS ACT HEALTH, V6, P403, DOI 10.1123/jpah.6.4.403; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Lalonde L, 2004, QUAL LIFE RES, V13, P793, DOI 10.1023/B:QURE.0000021695.26201.a0; Lee YJ, 2012, ANN NUTR METAB, V61, P275, DOI 10.1159/000341494; Lidfeldt J, 2003, DIABETES OBES METAB, V5, P106, DOI 10.1046/j.1463-1326.2003.00250.x; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Maloney EM, 2010, METABOLISM, V59, P1351, DOI 10.1016/j.metabol.2009.12.019; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Margiotta D, 2016, EUR REV MED PHARMACO, V20, P636; Milaneschi Y, 2009, BIOL PSYCHIAT, V65, P973, DOI 10.1016/j.biopsych.2008.11.011; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Paley MA, 2017, CURR OPIN RHEUMATOL, V29, P178, DOI 10.1097/BOR.0000000000000369; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Pancheri P, 2002, J AFFECT DISORDERS, V68, P41, DOI 10.1016/S0165-0327(00)00328-1; Park S. S., 2005, RES CLIN PRACT, V91, P381, DOI DOI 10.1016/J.DIABRES.2010.11.010; Parker B, 2011, LUPUS, V20, P1459, DOI 10.1177/0961203311416695; Parker B, 2015, ANN RHEUM DIS, V74, P1530, DOI 10.1136/annrheumdis-2013-203933; Parker B, 2013, ANN RHEUM DIS, V72, P1308, DOI 10.1136/annrheumdis-2012-202106; Pasquali R, 2000, INT J OBESITY, V24, pS47, DOI 10.1038/sj.ijo.0801277; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pinto AJ, 2016, ARTHRIT CARE RES, V68, P1780, DOI 10.1002/acr.22905; Ponticelli C, 2017, EXPERT OPIN DRUG SAF, V16, P411, DOI 10.1080/14740338.2017.1269168; Regidor E, 1999, J EPIDEMIOL COMMUN H, V53, P75, DOI 10.1136/jech.53.2.75; Ruiz-Arruza I, 2014, RHEUMATOLOGY, V53, P1470, DOI 10.1093/rheumatology/keu148; Sacco R, 2016, EUR J NEUROL, V23, P744, DOI 10.1111/ene.12932; Sada KE, 2006, J RHEUMATOL, V33, P1545; Schmeding A, 2013, BEST PRACT RES CL RH, V27, P363, DOI 10.1016/j.berh.2013.07.009; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Smarr CB, 2011, J IMMUNOL, V187, P5090, DOI 10.4049/jimmunol.1100608; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; SYMMONS DPM, 1988, Q J MED, V69, P927; Tang C, 2012, INTERN MED J, V42, P968, DOI 10.1111/j.1445-5994.2012.02886.x; Telles RW, 2010, LUPUS, V19, P803, DOI 10.1177/0961203309359781; Urowitz MB, 2007, J RHEUMATOL, V34, P70; Vadacca M, 2014, CLIN RHEUMATOL, V33, P1443, DOI 10.1007/s10067-014-2593-3; Vadacca M, 2011, CELL MOL IMMUNOL, V8, P203, DOI 10.1038/cmi.2010.75; Vadacca M, 2009, J RHEUMATOL, V36, P295, DOI 10.3899/jrheum.080503; Webster Kimberly, 2003, Health Qual Life Outcomes, V1, P79, DOI 10.1186/1477-7525-1-79	60	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187645	10.1371/journal.pone.0187645	http://dx.doi.org/10.1371/journal.pone.0187645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL9KF	29112985	Green Published, Green Submitted, gold			2022-12-26	WOS:000414572100028
J	Choi, S; Neequaye, P; French, SW; Gonzalez, FJ; Gyamfi, MA				Choi, Sora; Neequaye, Prince; French, Samuel W.; Gonzalez, Frank J.; Gyamfi, Maxwell A.			Pregnane X receptor promotes ethanol-induced hepatosteatosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOLIC LIVER-DISEASE; CONSTITUTIVE ANDROSTANE RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; INDUCED FATTY LIVER; EARLY GROWTH RESPONSE-1; DIET-INDUCED OBESITY; NUCLEAR RECEPTORS; ALDEHYDE DEHYDROGENASE; PXR GENE; INDUCED HEPATOTOXICITY	The pregnane X receptor (PXR, NR1I2) is a xenobiotic-sensing nuclear receptor that modulates the metabolic response to drugs and toxic agents. Both PXR activation and deficiency promote hepatic triglyceride accumulation, a hallmark feature of alcoholic liver disease. However, the molecular mechanism of PXR-mediated activation of ethanol (EtOH)-induced steatosis is unclear. Here, using male wildtype (WT) and Pxr-null mice, we examined PXR-mediated regulation of chronic EtOH-induced hepatic lipid accumulation and hepatotoxicity. EtOH ingestion for 8 weeks significantly (1.8-fold) up-regulated Pxr mRNA levels in WT mice. The EtOH exposure also increased mRNAs encoding hepatic constitutive androstane receptor (3-fold) and its target, Cyp2b10 (220-fold), in a PXR-dependent manner. Furthermore, WT mice had higher serum EtOH levels and developed hepatic steatosis characterized by micro-and macrovesicular lipid accumulation. Consistent with the development of steatosis, lipogenic gene induction was significantly increased in WT mice, including sterol regulatory element-binding protein 1c target gene fatty-acid synthase (3.0-fold), early growth response-1 (3.2-fold), and TNF alpha (3.0-fold), whereas the expression of peroxisome proliferator-activated receptor alpha target genes was suppressed. Of note, PXR deficiency suppressed these changes and steatosis. Protein levels, but not mRNAs levels, of EtOH-metabolizing enzymes, including alcohol dehydrogenase 1, aldehyde dehydrogenase 1A1, and catalase, as well as the microsomal triglyceride transfer protein, involved in regulating lipid output were higher in Pxr-null than in WT mice. These findings establish that PXR signaling contributes to ALD development and suggest that PXR antagonists may provide a new approach for ALD therapy.	[Choi, Sora; Neequaye, Prince; Gyamfi, Maxwell A.] North Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [French, Samuel W.] Harbor UCLA Med Ctr, Dept Pathol, Torrance, CA 90509 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of North Carolina; North Carolina Central University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gyamfi, MA (corresponding author), North Carolina Cent Univ, JLC Biomed Biotechnol Res Inst, Cardiometab Res Program, 700 George St, Durham, NC 27707 USA.	mgyamfi@nccu.edu			National Institutes of Health [U54 AA019765, 1U54MD012392, P20 MD000175, U01-021898]; NCI Intramural Research Program of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U54AA019765] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD000175, U54MD012392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Intramural Research Program of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grants U54 AA019765, 1U54MD012392, P20 MD000175, and U01-021898 and in part by the NCI Intramural Research Program of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aleynik SI, 1998, ALCOHOL CLIN EXP RES, V22, P192, DOI 10.1097/00000374-199802000-00026; ALGAR EM, 1986, INT J BIOCHEM, V18, P49, DOI 10.1016/0020-711X(86)90007-8; Bitter A, 2015, ARCH TOXICOL, V89, P2089, DOI 10.1007/s00204-014-1348-x; Blednov YA, 2015, ALCOHOL CLIN EXP RES, V39, P136, DOI 10.1111/acer.12610; Caparros-Martin JA, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0312-4; Chen XS, 2011, LAB INVEST, V91, P1136, DOI 10.1038/labinvest.2011.68; Cheng J, 2012, TOXICOL SCI, V129, P456, DOI 10.1093/toxsci/kfs211; Cheng J, 2010, J PHARMACOL EXP THER, V335, P32, DOI 10.1124/jpet.110.170225; Cheng J, 2009, DRUG METAB DISPOS, V37, P1611, DOI 10.1124/dmd.109.027565; Ciuclan L, 2010, J HEPATOL, V52, P407, DOI 10.1016/j.jhep.2009.12.003; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Cui JY, 2016, BBA-GENE REGUL MECH, V1859, P1198, DOI 10.1016/j.bbagrm.2016.04.010; Dai T, 2003, EXP MOL PATHOL, V75, P194, DOI 10.1016/S0014-4800(03)00091-1; Das BC, 2008, BIOORG MED CHEM LETT, V18, P3974, DOI 10.1016/j.bmcl.2008.06.018; Ding XS, 2005, J PHARMACOL EXP THER, V314, P120, DOI 10.1124/jpet.105.085225; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Dring MM, 2006, GASTROENTEROLOGY, V130, P341, DOI 10.1053/j.gastro.2005.12.008; Fu ZD, 2016, DRUG METAB DISPOS, V44, P842, DOI 10.1124/dmd.115.068270; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Goodwin B, 2001, MOL PHARMACOL, V60, P427; Gyamfi MA, 2008, J PHARMACOL EXP THER, V324, P443, DOI 10.1124/jpet.107.132258; Gyamfi MA, 2006, J PHARMACOL EXP THER, V319, P360, DOI 10.1124/jpet.106.108175; Gyamfi MA, 2010, EXP BIOL MED, V235, P547, DOI 10.1258/ebm.2009.009249; Gyamfi MA, 2009, TOXICOL APPL PHARM, V234, P166, DOI 10.1016/j.taap.2008.09.022; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; He JH, 2013, DIABETES, V62, P1876, DOI 10.2337/db12-1039; He P, 2006, DRUG METAB DISPOS, V34, P1198, DOI 10.1124/dmd.105.008904; Heit C, 2015, ADV EXP MED BIOL, V815, P375, DOI 10.1007/978-3-319-09614-8_22; Hoekstra M, 2009, MOL PHARMACEUT, V6, P182, DOI 10.1021/mp800131d; Imaoka S, 2004, CANCER LETT, V203, P117, DOI 10.1016/j.canlet.2003.09.009; Inoue K, 2008, J BIOL CHEM, V283, P10425, DOI 10.1074/jbc.M800729200; Inoue K, 2009, FEBS LETT, V583, P2126, DOI 10.1016/j.febslet.2009.05.031; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; Kettner NM, 2016, CANCER CELL, V30, P909, DOI 10.1016/j.ccell.2016.10.007; KHOGALI AM, 1974, TUBERCLE, V55, P231, DOI 10.1016/0041-3879(74)90050-6; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4445, DOI 10.1021/bi9521093; Koga T, 2016, J BIOL CHEM, V291, P25255, DOI 10.1074/jbc.M116.755447; Konishi T, 2003, EXP MOL PATHOL, V74, P183, DOI 10.1016/S0014-4800(03)00006-6; Kono H, 1999, AM J PHYSIOL-GASTR L, V277, pG1259, DOI 10.1152/ajpgi.1999.277.6.G1259; KOSTRUBSKY VE, 1995, ARCH BIOCHEM BIOPHYS, V322, P516, DOI 10.1006/abbi.1995.1495; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Lawrimore CJ, 2017, ALCOHOL CLIN EXP RES, V41, P939, DOI 10.1111/acer.13368; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; LIEBER CS, 1989, HEPATOLOGY, V10, P501, DOI 10.1002/hep.1840100417; Lim YP, 2015, ARCH TOXICOL, V89, P57, DOI 10.1007/s00204-014-1230-x; Lounis MA, 2016, BBA-MOL CELL BIOL L, V1861, P1662, DOI 10.1016/j.bbalip.2016.07.012; Ma YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038734; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Mandrekar P, 2016, HEPATOLOGY, V64, P1343, DOI 10.1002/hep.28530; Marek CJ, 2005, BIOCHEM J, V387, P601, DOI 10.1042/BJ20041598; Martinez A, 2007, INFLAMM BOWEL DIS, V13, P1484, DOI 10.1002/ibd.20252; McMullen MR, 2005, GASTROENTEROLOGY, V128, P2066, DOI 10.1053/j.gastro.2005.02.065; Mezey E, 2005, BIOCHEM BIOPH RES CO, V337, P1324, DOI 10.1016/j.bbrc.2005.10.003; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Nanji AA, 2004, J PHARMACOL EXP THER, V310, P417, DOI 10.1124/jpet.103.064717; Niemela O, 2000, J HEPATOL, V33, P893, DOI 10.1016/S0168-8278(00)80120-8; Pang MY, 2009, J HEPATOL, V50, P1192, DOI 10.1016/j.jhep.2009.01.021; Peng Giia-Sheun, 2009, Human Genomics, V3, P121; Planque C, 2016, ONCOTARGET, V7, P56558, DOI 10.18632/oncotarget.10646; Purohit V, 2004, ALCOHOL, V34, P3, DOI 10.1016/j.alcohol.2004.06.008; Qiao EQ, 2013, ONCOL LETT, V5, P1093, DOI 10.3892/ol.2013.1149; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG1114, DOI 10.1152/ajpgi.00528.2006; Shan WW, 2008, HEPATOLOGY, V47, P225, DOI 10.1002/hep.21925; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Sinz MW, 2013, DRUG METAB REV, V45, P3, DOI 10.3109/03602532.2012.743560; Sookoian S, 2010, PHARMACOGENET GENOM, V20, P1, DOI 10.1097/FPC.0b013e328333a1dd; Spruiell K, 2015, J PHARMACOL EXP THER, V354, P459, DOI 10.1124/jpet.115.224295; Spruiell K, 2014, BIOCHEM PHARMACOL, V89, P399, DOI 10.1016/j.bcp.2014.03.019; Spruiell K, 2014, J BIOL CHEM, V289, P3244, DOI 10.1074/jbc.M113.494575; Stagos D, 2010, DRUG METAB DISPOS, V38, P1679, DOI 10.1124/dmd.110.034678; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Sugimoto T, 2002, J HEPATOL, V36, P157, DOI 10.1016/S0168-8278(01)00263-X; Sui YP, 2011, J LIPID RES, V52, P1652, DOI 10.1194/jlr.M017376; Sun MX, 2015, DRUG METAB DISPOS, V43, P335, DOI 10.1124/dmd.114.062307; Tanaka N, 2017, PHARMACOL THERAPEUT, V179, P142, DOI 10.1016/j.pharmthera.2017.05.011; Teng S, 2007, BRIT J PHARMACOL, V151, P367, DOI 10.1038/sj.bjp.0707235; Thomes PG, 2013, INT J BIOCHEM CELL B, V45, P454, DOI 10.1016/j.biocel.2012.10.002; Tomita K, 2004, GASTROENTEROLOGY, V126, P873, DOI 10.1053/j.gastro.2003.12.008; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Venkatesh M, 2011, MOL PHARMACOL, V80, P124, DOI 10.1124/mol.111.071787; Wada S, 2008, J HEPATOL, V49, P441, DOI 10.1016/j.jhep.2008.04.026; Wan YJY, 1998, GENET TEST, V2, P79, DOI 10.1089/gte.1998.2.79; Wang HB, 2003, CURR DRUG METAB, V4, P515, DOI 10.2174/1389200033489262; Wang XY, 2017, MOL MED REP, V15, P3459, DOI 10.3892/mmr.2017.6435; Wang YM, 2014, EXPERT OPIN DRUG MET, V10, P1521, DOI 10.1517/17425255.2014.963555; Warren KR, 2013, J GASTROEN HEPATOL, V28, P4, DOI 10.1111/jgh.12246; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wu WB, 2014, BIOCHEM BIOPH RES CO, V443, P68, DOI 10.1016/j.bbrc.2013.11.057; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Yamazaki Y, 2007, GUT, V56, P565, DOI 10.1136/gut.2006.093260; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Zakhari S, 2007, HEPATOLOGY, V46, P2032, DOI 10.1002/hep.22010; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502; Zhao LY, 2017, BIOCHEM PHARMACOL, V142, P194, DOI 10.1016/j.bcp.2017.07.019; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	99	12	13	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					1	17		10.1074/jbc.M117.815217	http://dx.doi.org/10.1074/jbc.M117.815217			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29123032	Green Published, hybrid			2022-12-26	WOS:000419453200001
J	Cheng, CW; Leong, KW; Ng, YM; Kwong, YL; Tse, E				Cheng, Chi-Wai; Leong, Ka-Wai; Ng, Yiu-Ming; Kwong, Yok-Lam; Tse, Eric			The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell cycle; cyclin-dependent kinase (CDK); phosphorylation; prolyl isomerase; PIN1; immunoprecipitation; p27	HUMAN HEPATOCELLULAR-CARCINOMA; CELL-CYCLE; P27(KIP1); PROTEIN; PHOSPHORYLATION; DEGRADATION; OVEREXPRESSION; PROTEOLYSIS; ACTIVATION; COMPLEX	PIN1 is a peptidyl-prolyl isomerase that catalyzes the cis/trans isomerization of peptide bonds between proline and phosphorylated serine/threonine residues. By changing the conformation of its protein substrates, PIN1 increases the activities of key proteins that promote cell cycle progression and oncogenesis. Moreover, it has been shown that PIN1 stabilizes and increases the level of the cyclin-dependent kinase (CDK) inhibitor p27, which inhibits cell cycle progression by binding cyclin A- and cyclin E-CDK2. Notwithstanding the associated increase in the p27 level, PIN1 expression promotes rather than retards cell proliferation. To explain the paradoxical effects of PIN1 on p27 levels and cell cycle progression, we hypothesized that PIN1 relieves CDK2 inhibition by suppressing the CDK inhibitory activity of p27. Here, we confirmed that PIN1-expressing cells exhibit higher p27 levels but have increased CDK2 activities and higher proliferation rates in the S-phase compared with Pin1-null fibroblasts or PIN1-depleted hepatoma cells. Using co-immunoprecipitation and CDK kinase activity assays, we found that PIN1 binds the phosphorylated Thr(187)-Pro motif in p27 and reduces p27's interaction with cyclin A- or cyclin E-CDK2, leading to increased CDK2 kinase activity. In conclusion, our results indicate that although PIN1 increases p27 levels, it also attenuates p27's inhibitory activity on CDK2 and thereby contributes to increased G(1)-S phase transitions and cell proliferation.	[Cheng, Chi-Wai; Leong, Ka-Wai; Ng, Yiu-Ming; Kwong, Yok-Lam; Tse, Eric] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Tse, E (corresponding author), Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.	ewctse@hku.hk	Tse, Eric/ABB-4021-2020	Tse, Eric/0000-0002-8351-4722; Cheng, Timothy/0000-0002-3006-1440				Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Behrsin CD, 2007, J MOL BIOL, V365, P1143, DOI 10.1016/j.jmb.2006.10.078; Broude EV, 2007, ONCOGENE, V26, P6954, DOI 10.1038/sj.onc.1210516; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cheng CW, 2013, AM J PATHOL, V182, P765, DOI 10.1016/j.ajpath.2012.11.034; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lee J, 2009, EXP MOL MED, V41, P765, DOI 10.3858/emm.2009.41.11.102; Leong KW, 2017, ONCOTARGET, V8, P11343, DOI 10.18632/oncotarget.14526; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Mohanty AR, 2012, J BIOL CHEM, V287, P21757, DOI 10.1074/jbc.M112.346254; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pang R, 2004, ONCOGENE, V23, P4182, DOI 10.1038/sj.onc.1207493; Pang RW, 2006, J PATHOL, V210, P19, DOI 10.1002/path.2024; Pang R, 2007, GASTROENTEROLOGY, V132, P1088, DOI 10.1053/j.gastro.2006.12.030; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Reynisdottir I, 1997, GENE DEV, V11, P492, DOI 10.1101/gad.11.4.492; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Shinoda K, 2015, BRIT J CANCER, V113, P1323, DOI 10.1038/bjc.2015.272; Tian G, 2009, J BIOL CHEM, V284, P18980, DOI 10.1074/jbc.M109.003160; Tong Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.3; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Uranbileg B, 2012, J BIOL CHEM, V287, P6275, DOI 10.1074/jbc.M111.318295; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	32	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21431	21441		10.1074/jbc.M117.801373	http://dx.doi.org/10.1074/jbc.M117.801373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29118189	Green Published, hybrid			2022-12-26	WOS:000419013000019
J	Jia, QQ; Liu, SN; Wen, D; Cheng, YX; Bendena, WG; Wang, J; Li, S				Jia, Qiangqiang; Liu, Suning; Wen, Di; Cheng, Yongxu; Bendena, William G.; Wang, Jian; Li, Sheng			Juvenile hormone and 20-hydroxyecdysone coordinately control the developmental timing of matrix metalloproteinase-induced fat body cell dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; juvenile hormone (JH); matrix metalloproteinase (Mmp); signal transduction; steroid hormone; 20-hydroxyecdysone; cell dissociation; fat body	DROSOPHILA METAMORPHOSIS; KRUPPEL-HOMOLOG; INSECT METAMORPHOSIS; IN-VIVO; MELANOGASTER; LARVAL; GENE; BOMBYX; MET; BETA-FTZ-F1	Tissue remodeling is a crucial process in animal development and disease progression. Coordinately controlled by the two main insect hormones, juvenile hormone (JH) and 20-hydroxyecdysone (20E), tissues are remodeled context-specifically during insect metamorphosis. We previously discovered that two matrix metalloproteinases (Mmps) cooperatively induce fat body cell dissociation in Drosophila. However, the molecular events involved in this Mmp-mediated dissociation are unclear. Here we report that JH and 20E coordinately and precisely control the developmental timing of Mmp-induced fat body cell dissociation. We found that during the larval-prepupal transition, the anti-metamorphic factor Kr-h1 transduces JH signaling, which directly inhibited Mmp expression and activated expression of tissue inhibitor of metalloproteinases (timp) and thereby suppressed Mmp-induced fat body cell dissociation. We also noted that upon a decline in the JH titer, a prepupal peak of 20E suppresses Mmp-induced fat body cell dissociation through the 20E primary-response genes, E75 and Blimp-1, which inhibited expression of the nuclear receptor and competence factor ftz-F1. Moreover, upon a decline in the 20E titer, ftz-F1 expression was induced by the 20E early-late response gene DHR3, and then ftz-F1 directly activated Mmp expression and inhibited timp expression, causing Mmp-induced fat body cell dissociation during 6-12 h after puparium formation. In conclusion, coordinated signaling via JH and 20E finely tunes the developmental timing of Mmp-induced fat body cell dissociation. Our findings shed critical light on hormonal regulation of insect metamorphosis.	[Jia, Qiangqiang; Liu, Suning] South China Normal Univ, Guangzhou Key Lab Insect Dev Regulat & Applicat R, Inst Insect Sci & Technol, Guangzhou 510631, Guangdong, Peoples R China; [Jia, Qiangqiang; Liu, Suning] South China Normal Univ, Sch Life Sci, Guangzhou 510631, Guangdong, Peoples R China; [Wen, Di] Qiannan Normal Coll Nationalities, Dept Life Sci, Duyun 558000, Guizhou, Peoples R China; [Cheng, Yongxu] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai 201306, Peoples R China; [Bendena, William G.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Wang, Jian] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	South China Normal University; South China Normal University; Shanghai Ocean University; Queens University - Canada; University System of Maryland; University of Maryland College Park	Wang, J (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	jianwang@umd.edu; lisheng@scnu.edu.cn	Bendena, William/N-6080-2019	Jia, Qiangqiang/0000-0003-2650-7566	National Science Foundation of China [31620103917, 31560609, 31330072, 31572325]; National Key Research and Development Program of China [2016YFD0101900]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by National Science Foundation of China Grants 31620103917, 31560609, 31330072, and 31572325 and National Key Research and Development Program of China Grant 2016YFD0101900 (to S. Li and D. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Akagi K, 2016, DEVELOPMENT, V143, P2410, DOI 10.1242/dev.133595; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; Bond ND, 2011, DEV BIOL, V360, P286, DOI 10.1016/j.ydbio.2011.09.015; Bowler T, 2006, DEV BIOL, V299, P78, DOI 10.1016/j.ydbio.2006.07.007; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Gaffney J, 2015, MATRIX BIOL, V44-46, P191, DOI 10.1016/j.matbio.2015.01.012; Godenschwege TA, 2000, EUR J CELL BIOL, V79, P495, DOI 10.1078/0171-9335-00072; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Huang JH, 2011, DEVELOPMENT, V138, P2283, DOI 10.1242/dev.057687; Jia QQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07535; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kayukawa T, 2017, P NATL ACAD SCI USA, V114, P1057, DOI 10.1073/pnas.1615423114; Kayukawa T, 2016, J BIOL CHEM, V291, P1751, DOI 10.1074/jbc.M115.686121; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lam GT, 1997, DEVELOPMENT, V124, P1757; Li K, 2016, J BIOL CHEM, V291, P18163, DOI 10.1074/jbc.M116.737072; Liu HH, 2013, INSECT BIOCHEM MOLEC, V43, P1068, DOI 10.1016/j.ibmb.2013.09.001; Liu X, 2015, J BIOL CHEM, V290, P27370, DOI 10.1074/jbc.M115.687293; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Luo J, 2015, SCI CHINA LIFE SCI, V58, P379, DOI 10.1007/s11427-014-4786-z; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Nelliot A, 2006, GENESIS, V44, P396, DOI 10.1002/dvg.20229; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parvy JP, 2014, DEVELOPMENT, V141, P3955, DOI 10.1242/dev.102020; Pearson JR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005763; Pecasse F, 2000, DEV BIOL, V221, P53, DOI 10.1006/dbio.2000.9687; Qi XF, 2016, P NATL ACAD SCI USA, V113, P3803, DOI 10.1073/pnas.1523614113; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Talamillo A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003473; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Urena E, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006020; Wen D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005038; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608	41	30	33	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21504	21516		10.1074/jbc.M117.818880	http://dx.doi.org/10.1074/jbc.M117.818880			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29118190	hybrid, Green Published			2022-12-26	WOS:000419013000025
J	Nemec, AA; Howell, LA; Peterson, AK; Murray, MA; Tomko, RJ				Nemec, Antonia A.; Howell, Lauren A.; Peterson, Anna K.; Murray, Matthew A.; Tomko, Robert J., Jr.			Autophagic clearance of proteasomes in yeast requires the conserved sorting nexin Snx4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; proteasome; protein degradation; proteolysis; sorting nexin (SNX)	SELECTIVE AUTOPHAGY; SACCHAROMYCES-CEREVISIAE; RECYCLING COMPARTMENT; NITROGEN STARVATION; 26S PROTEASOMES; DEGRADATION; NUCLEAR; COMPLEXES; PROTEINS; RECEPTOR	Turnover of the 26S proteasome by autophagy is an evolutionarily conserved process that governs cellular proteolytic capacity and eliminates inactive particles. In most organisms, proteasomes are located in both the nucleus and cytoplasm. However, the specific autophagy routes for nuclear and cytoplasmic proteasomes are unclear. Here, we investigate the spatial control of autophagic proteasome turnover in budding yeast (Saccharomyces cerevisiae). We found that nitrogen starvation-induced proteasome autophagy is independent of known nucleophagy pathways but is compromised when nuclear protein export is blocked. Furthermore, via pharmacological tethering of proteasomes to chromatin or the plasma membrane, we provide evidence that nuclear proteasomes at least partially disassemble before autophagic turnover, whereas cytoplasmic proteasomes remain largely intact. A targeted screen of autophagy genes identified a requirement for the conserved sorting nexin Snx4 in the autophagic turnover of proteasomes and several other large multisubunit complexes. We demonstrate that Snx4 cooperates with sorting nexins Snx41 and Snx42 to mediate proteasome turnover and is required for the formation of cytoplasmic proteasome puncta that accumulate when autophagosome formation is blocked. Together, our results support distinct mechanistic paths in the turnover of nuclear versus cytoplasmic proteasomes and point to a critical role for Snx4 in cytoplasmic agglomeration of proteasomes en route to autophagic destruction.	[Nemec, Antonia A.; Howell, Lauren A.; Peterson, Anna K.; Murray, Matthew A.; Tomko, Robert J., Jr.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tomko, RJ (corresponding author), 1115 W Call St, Tallahassee, FL 32306 USA.	robert.tomko@med.fsu.edu		Tomko Jr., Robert/0000-0003-2515-1078	Florida State University College of Medicine; National Institutes of Health from NIGMS [1R01GM118600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118600] Funding Source: NIH RePORTER	Florida State University College of Medicine; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by start-up funds from the Florida State University College of Medicine and National Institutes of Health Grant 1R01GM118600 from NIGMS (to R. J. T., Jr.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anding AL, 2017, DEV CELL, V41, P10, DOI 10.1016/j.devcel.2017.02.016; Bean BDM, 2017, TRAFFIC, V18, P110, DOI 10.1111/tra.12459; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155; Cohen-Kaplan V, 2016, P NATL ACAD SCI USA, V113, pE7490, DOI 10.1073/pnas.1615455113; Cohen-Kaplan V, 2016, INT J BIOCHEM CELL B, V79, P403, DOI 10.1016/j.biocel.2016.07.019; Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Dambacher CM, 2016, ELIFE, V5, DOI 10.7554/eLife.13027; Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548; Elbaz-Alon Y, 2015, CELL REP, V12, P7, DOI 10.1016/j.celrep.2015.06.022; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Enenkel C, 1999, MOL BIOL REP, V26, P131, DOI 10.1023/A:1006973803960; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gallon M, 2015, BIOCHEM SOC T, V43, P33, DOI 10.1042/BST20140290; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Guthrie C, 1991, GUIDE YEAST GENETICS; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jaishy B, 2016, J LIPID RES, V57, P1619, DOI 10.1194/jlr.R067520; Kaake RM, 2010, J PROTEOME RES, V9, P2016, DOI 10.1021/pr1000175; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kramer MH, 2017, MOL CELL, V65, P761, DOI 10.1016/j.molcel.2016.12.024; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Le Fourn V, 2013, CELL MOL LIFE SCI, V70, P1985, DOI 10.1007/s00018-012-1236-6; Ma MX, 2017, TRAFFIC, V18, P134, DOI 10.1111/tra.12462; Marshall RS, 2016, CELL REP, V16, P1717, DOI 10.1016/j.celrep.2016.07.015; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; Maruzs T, 2015, TRAFFIC, V16, P1088, DOI 10.1111/tra.12309; Mijaljica D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040013; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Mueller M, 2015, ELIFE, V4, DOI 10.7554/eLife.07736; Nice DC, 2002, J BIOL CHEM, V277, P30198, DOI 10.1074/jbc.M204736200; Nilsson A, 2001, YEAST, V18, P1371, DOI 10.1002/yea.786; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Pack CG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4396; Palmer A, 1996, BIOCHEM J, V316, P401, DOI 10.1042/bj3160401; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rodkaer SV, 2014, FEMS YEAST RES, V14, P683, DOI 10.1111/1567-1364.12157; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Savulescu AF, 2011, MOL BIOL CELL, V22, P880, DOI 10.1091/mbc.E10-07-0595; Shpilka T, 2015, P NATL ACAD SCI USA, V112, P1434, DOI 10.1073/pnas.1409476112; Solis GP, 2013, MOL BIOL CELL, V24, P2689, DOI 10.1091/mbc.E12-12-0854; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; TANAKA K, 1989, J CELL PHYSIOL, V139, P34, DOI 10.1002/jcp.1041390107; Thomsson E, 2003, APPL ENVIRON MICROB, V69, P3251, DOI 10.1128/AEM.69.6.3251-3257.2003; Tomko RJ, 2014, MOL CELL, V53, P433, DOI 10.1016/j.molcel.2013.12.009; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tooze SA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018358; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Waite KA, 2016, J BIOL CHEM, V291, P3239, DOI 10.1074/jbc.M115.699124; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Wani PS, 2016, SCI REP-UK, V6, DOI 10.1038/srep27873; Welter E, 2015, EMBO J, V34, P131, DOI 10.15252/embj.201490621; Welter E, 2010, AUTOPHAGY, V6, P794, DOI 10.4161/auto.6.6.12348; Wileman T, 2013, ESSAYS BIOCHEM, V55, P153, DOI [10.1042/bse0550153, 10.1042/BSE0550153]; Zhao D, 2016, J CELL SCI, V129, P4289, DOI 10.1242/jcs.194373	70	41	41	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21466	21480		10.1074/jbc.M117.817999	http://dx.doi.org/10.1074/jbc.M117.817999			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29109144	Green Published, hybrid			2022-12-26	WOS:000419013000022
J	Lomax, S; Harris, C; Windsor, PA; White, PJ				Lomax, Sabrina; Harris, Charissa; Windsor, Peter A.; White, Peter J.			Topical anaesthesia reduces sensitivity of castration wounds in neonatal piglets	PLOS ONE			English	Article							SURGICAL CASTRATION; PAIN MANAGEMENT; RESPONSES; LAMBS; FORMULATION; ALLEVIATION; BEHAVIOR; CALVES; PIGS	The aim of this study was to do determine the efficacy of the topical anaesthetic Tri-Solfen (R) in the amelioration of the pain of castration in piglets. The trial was conducted over a three day period, and blocked across six litters with 12 piglets treated on days one and two, and 16 on day three. The piglets were randomly allocated by weight and litter to 1 of 4 treatment groups: (i) sham castration (SHAM; n = 10); (ii) surgical castration with no anaesthetic intervention (CAST; n = 10); (iii) surgical castration with post-operative topical anaesthesia (TRI; n = 10); (iv) surgical castration with a pre-operative intra-testicular lignocaine hydrochloride injection (LIG; n = 10). Wound sensitivity testing involved von Frey monofilaments of weights 4g and 300g, and an 18 gauge needle, used to stimulate the wound and surrounding skin respectively, at various pre-determined sites. Neonatal piglets receiving topical anaesthesia (Tri-Solfen (R)) spray into castration wounds had significantly lower wound sensitivity responses for up to 4h, compared to those castrated following intra-testicular lignocaine injection or those with no treatment. The use of topical anaesthetic is suggested as a practical and affordable method of improving piglet welfare during castration.	[Lomax, Sabrina; Harris, Charissa; Windsor, Peter A.] Univ Sydney, Sch Life & Environm Sci, Fac Sci, Camperdown, NSW, Australia; [White, Peter J.] Univ Sydney, Sch Vet Sci, Fac Sci, Camperdown, NSW, Australia	University of Sydney; University of Sydney	White, PJ (corresponding author), Univ Sydney, Sch Vet Sci, Fac Sci, Camperdown, NSW, Australia.	p.white@sydney.edu.au	White, Peter J/B-5208-2013	Lomax, Sabrina/0000-0002-6417-5788; White, Peter/0000-0002-9742-4939	Australian Pork Limited	Australian Pork Limited(Australian Pork Limited)	This work was funded by Australian Pork Limited with topical anaesthetic formulation supplied by Bayer Animal Health. The funder had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarpal, 2002, J VET MED A, V49, P3, DOI 10.1046/j.1439-0442.2002.00385.x; Beteg F, 2011, VET MED, V57, P217; Brofeldt B T, 1989, J Burn Care Rehabil, V10, P63, DOI 10.1097/00004630-198901000-00009; Espinoza C, 2013, J DAIRY SCI, V96, P2894, DOI 10.3168/jds.2012-5954; Hay M, 2003, APPL ANIM BEHAV SCI, V82, P201, DOI 10.1016/S0168-1591(03)00059-5; Jaggin N., 2006, ACTA VET SCAND, V48, P12; Jellish WS, 1999, ANN SURG, V229, P115, DOI 10.1097/00000658-199901000-00015; Kokinsky E, 1999, ACTA ANAESTH SCAND, V43, P225, DOI 10.1034/j.1399-6576.1999.430219.x; Lomax S, 2008, AUST VET J, V86, P159, DOI 10.1111/j.1751-0813.2008.00285.x; Lomax S, 2013, J ANIM SCI, V91, P4945, DOI 10.2527/jas.2012-5984; Lomax S, 2013, AUST VET J, V91, P160, DOI 10.1111/avj.12031; Lomax S, 2010, AUST VET J, V88, P67, DOI 10.1111/j.1751-0813.2009.00546.x; MCGLONE JJ, 1988, J ANIM SCI, V66, P3049; MCGLONE JJ, 1993, J ANIM SCI, V71, P1441, DOI 10.2527/1993.7161441x; Meyer H, 2007, J VET MED A, V54, P384, DOI 10.1111/j.1439-0442.2007.00942.x; Moya SL, 2008, APPL ANIM BEHAV SCI, V111, P133, DOI 10.1016/j.applanim.2007.05.019; Paull DR, 2007, AUST VET J, V85, P98, DOI 10.1111/j.1751-0813.2007.00115.x; Prunier A, 2006, ANIM WELFARE, V15, P277; Ren Ke, 1999, ILAR J, V40, P111; Sutherland MA, 2015, NEW ZEAL VET J, V63, P52, DOI 10.1080/00480169.2014.961990; Sutherland MA, 2010, ANIMAL, V4, P2071, DOI 10.1017/S1751731110001291; Telles FG, 2016, VET ANIM SCI, V1-2, P36, DOI 10.1016/j.vas.2016.11.003; Turton J. D., 1962, Animal Breeding Abstracts, V30, P447; US National Library of Medicine, 2010, EPH EPIN INJ SOL; WHITE RG, 1995, J ANIM SCI, V73, P381	25	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187988	10.1371/journal.pone.0187988	http://dx.doi.org/10.1371/journal.pone.0187988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140997	Green Submitted, Green Published, gold			2022-12-26	WOS:000415260400041
J	Virgone-Carlotta, A; Lemasson, M; Mertani, HC; Diaz, JJ; Monnier, S; Dehoux, T; Delanoe-Ayari, H; Riviere, C; Rieu, JP				Virgone-Carlotta, Angelique; Lemasson, Manon; Mertani, Hichem C.; Diaz, Jean-Jacques; Monnier, Sylvain; Dehoux, Thomas; Delanoe-Ayari, Helene; Riviere, Charlotte; Rieu, Jean-Paul			In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil	PLOS ONE			English	Article							CANCER CELL-LINE; COLORECTAL-CANCER; MECHANICAL-PROPERTIES; MULTIDRUG-RESISTANCE; CULTURE MODELS; DRUG; PENETRATION; TISSUE; 3-D; PROGRESSION	MultiCellular Tumor Spheroids (MCTS), which mimic the 3-Dimensional (3D) organization of a tumor, are considered as better models than conventional cultures in 2-Dimensions (2D) to study cancer cell biology and to evaluate the response to chemotherapeutic drugs. A real time and quantitative follow-up of MCTS with simple and robust readouts to evaluate drug efficacy is still missing. Here, we evaluate the chemotherapeutic drug 5-Fluorouracil (5-FU) response on the growth and integrity of MCTS two days after treatment of MCTS and for three colorectal carcinoma cell lines with different cohesive properties (HT29, HCT116 and SW480). We found different sensitivity to 5-FU for the three CRC cell lines, ranging from high (SW480), intermediate (HCT116) and low (HT29) and the same hierarchy of CRC cell lines sensitivity is conserved in 2D. We also evidence that 5-FU has a strong impact on spheroid cohesion, with the apparition of a number of single detaching cells from the spheroid in a 5-FU dose-and cell line-dependent manner. We propose an innovative methodology for the chemosensitivity evaluation in 3D MCTS that recapitulates and regionalizes the 5-FU-induced changes within MCTS over time. These robust phenotypic read-outs could be easily scalable for high-throughput drug screening that may include different types of cancer cells to take into account tumor heterogeneity and resistance to treatment.	[Virgone-Carlotta, Angelique; Lemasson, Manon; Monnier, Sylvain; Dehoux, Thomas; Delanoe-Ayari, Helene; Riviere, Charlotte; Rieu, Jean-Paul] Univ Claude Bernard Lyon 1, CNRS, Inst Lumiere Matiere, Villeurbanne, France; [Mertani, Hichem C.; Diaz, Jean-Jacques] UMR INSERM 1052 CNRS Ctr Leon Berard, Ctr Rech Cancerol Lyon, Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Rieu, JP (corresponding author), Univ Claude Bernard Lyon 1, CNRS, Inst Lumiere Matiere, Villeurbanne, France.	jean-paul.rieu@univ-lyon1.fr	DIAZ, Jean-Jacques/H-3018-2014; Delanoe-ayari, Helene/A-2085-2013; MERTANI, Hichem-Claude/AAR-6415-2020; DIAZ, Jean-Jacques/AAT-3846-2021	DIAZ, Jean-Jacques/0000-0002-7914-4319; Delanoe-ayari, Helene/0000-0002-8658-3942; DIAZ, Jean-Jacques/0000-0002-7914-4319; dehoux, thomas/0000-0003-0808-4037; Riviere, Charlotte/0000-0002-5048-5662; Monnier, Sylvain/0000-0003-1087-0459	ITMO Cancer [PC201507]	ITMO Cancer	This study was supported by the ITMO Cancer within the frame of the Programme Plan Cancer 2014-2019 (No. PC201507) and was initiated by Labexi MUST (2012-2013).	Adcock AF, 2015, J ANAL BIOANAL TECH, V6; Arul M, 2017, IN VITRO CELL DEV-AN, V53, P435, DOI 10.1007/s11626-016-0126-x; Bash-Imam Z, 2017, ONCOTARGET; CARLSSON J, 1989, EUR J CANCER CLIN ON, V25, P1127, DOI 10.1016/0277-5379(89)90404-5; Charoen KM, 2014, BIOMATERIALS, V35, P2264, DOI 10.1016/j.biomaterials.2013.11.038; Choi MS, 2011, ONCOL REP, V25, P863, DOI 10.3892/or.2011.1138; Ciasca G, 2016, WORLD J GASTROENTERO, V22, P7203, DOI 10.3748/wjg.v22.i32.7203; Daster S, 2017, ONCOTARGET, V8, P1725, DOI 10.18632/oncotarget.13857; De Angelis PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-20; Deng YC, 2001, WORLD J GASTROENTERO, V7, P93; El-Bahrawy M, 2004, INT J EXP PATHOL, V85, P65, DOI 10.1111/j.0959-9673.2004.0371.x; ERLICHMAN C, 1991, ANTICANCER RES, V11, P671; Fan XL, 2011, INT J COLORECTAL DIS, V26, P1279, DOI 10.1007/s00384-011-1248-y; Focaccetti C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115686; Foty RA, 2013, FUTURE ONCOL, V9, P1121, DOI [10.2217/FON.13.66, 10.2217/fon.13.66]; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Friedrich J, 2007, J BIOMOL SCREEN, V12, P925, DOI 10.1177/1087057107306839; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; GLIMELIUS B, 1988, APMIS, V96, P433, DOI 10.1111/j.1699-0463.1988.tb05327.x; Grantab R, 2006, CANCER RES, V66, P1033, DOI 10.1158/0008-5472.CAN-05-3077; Green SK, 2004, MOL CANCER THER, V3, P149; Hewitt RE, 2000, J PATHOL, V192, P446; Hoffmann OI, 2015, J BIOTECHNOL, V205, P14, DOI 10.1016/j.jbiotec.2015.02.029; Kalashnikova I., 2016, DRUG DELIVERY PRINCI, P131; Karlsson H, 2012, EXP CELL RES, V318, P1577, DOI 10.1016/j.yexcr.2012.03.026; Katt ME, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00012; KunzSchughart LA, 1997, IN VITRO CELL DEV-AN, V33, P73; Laurent J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-73; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lowthers EL, 2003, IN VITRO CELL DEV-AN, V39, P340; Lu CL, 2016, TUMOR BIOL, V37, P1319, DOI 10.1007/s13277-015-3873-5; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Mhaidat NM, 2014, ONCOL LETT, V8, P699, DOI 10.3892/ol.2014.2211; NEDERMAN T, 1984, CANCER CHEMOTH PHARM, V13, P131; Pachenari M, 2014, J BIOMECH, V47, P373, DOI 10.1016/j.jbiomech.2013.11.020; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Qureshi-Baig K, 2016, PLOS ONE, V11; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sagara A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164250; Santo VE, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600505; Schmidmaier R, 2008, CURR MED CHEM, V15, P978, DOI 10.2174/092986708784049667; Senkowski W, 2015, MOL CANCER THER, V14, P1504, DOI 10.1158/1535-7163.MCT-14-0792; Shi WB, 2014, J PHARM SCI-US, V103, P1064, DOI 10.1002/jps.23860; Spill F, 2016, CURR OPIN BIOTECHNOL, V40; SUTHERLAND RM, 1971, JNCI-J NATL CANCER I, V46, P113; SUTHERLAND RM, 1970, INT J RADIAT BIOL RE, V18, P491, DOI 10.1080/09553007014551401; Thakuri PS, 2016, MOL PHARMACEUT, V13, P3724, DOI 10.1021/acs.molpharmaceut.6b00527; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Yue XS, 2016, J PROTEOME RES, V15, P4265, DOI 10.1021/acs.jproteome.6b00342	50	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188100	10.1371/journal.pone.0188100	http://dx.doi.org/10.1371/journal.pone.0188100			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141026	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400056
J	Hermansen, SK; Sorensen, MD; Hansen, A; Knudsen, S; Alvarado, AG; Lathia, JD; Kristensen, BW				Hermansen, Simon K.; Sorensen, Mia D.; Hansen, Anker; Knudsen, Steen; Alvarado, Alvaro G.; Lathia, Justin D.; Kristensen, Bjarne W.			A 4-miRNA signature to predict survival in glioblastomas	PLOS ONE			English	Article							MICRORNA EXPRESSION; ADJUVANT TEMOZOLOMIDE; MIR-21 EXPRESSION; PROBE LEVEL; GLIOMA; PATHWAYS; CELLS; RADIOTHERAPY; CLASSIFICATION; CONCOMITANT	Glioblastomas are among the most lethal cancers; however, recent advances in survival have increased the need for better prognostic markers. microRNAs (miRNAs) hold great prognostic potential being deregulated in glioblastomas and highly stable in stored tissue specimens. Moreover, miRNAs control multiple genes representing an additional level of gene regulation possibly more prognostically powerful than a single gene. The aim of the study was to identify a novel miRNA signature with the ability to separate patients into prognostic subgroups. Samples from 40 glioblastoma patients were included retrospectively; patients were comparable on all clinical aspects except overall survival enabling patients to be categorized as short-term or long-term survivors based on median survival. A miRNome screening was employed, and a prognostic profile was developed using leave-one-out cross-validation. We found that expression patterns of miRNAs; particularly the four miRNAs: hsa-miR-107_st, hsa-miR-548x_st, hsa-miR-3125_st and hsa-miR-331-3p_st could determine short- and long-term survival with a predicted accuracy of 78%. Heatmap dendrograms dichotomized glioblastomas into prognostic subgroups with a significant association to survival in univariate (HR 8.50; 95% CI 3.0623.62; p<0.001) and multivariate analysis (HR 9.84; 95% CI 2.9333.06; p<0.001). Similar tendency was seen in The Cancer Genome Atlas (TCGA) using a 2-miRNA signature of miR-107 and miR-331 (miR sum score), which were the only miRNAs available in TCGA. In TCGA, patients with O6-methylguanine-DNA-methyltransferase (MGMT) unmethylated tumors and low miR sum score had the shortest survival. Adjusting for age and MGMT status, low miR sum score was associated with a poorer prognosis (HR 0.66; 95% CI 0.450.97; p = 0.033). A Kyoto Encyclopedia of Genes and Genomes analysis predicted the identified miRNAs to regulate genes involved in cell cycle regulation and survival. In conclusion, the biology of miRNAs is complex, but the identified 4-miRNA expression pattern could comprise promising biomarkers in glioblastoma stratifying patients into short- and long-term survivors.	[Hermansen, Simon K.; Sorensen, Mia D.; Kristensen, Bjarne W.] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Hermansen, Simon K.; Sorensen, Mia D.; Kristensen, Bjarne W.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Hansen, Anker; Knudsen, Steen] Med Prognosis Inst, Horsholm, Denmark; [Alvarado, Alvaro G.; Lathia, Justin D.] Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44106 USA; [Alvarado, Alvaro G.; Lathia, Justin D.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Sorensen, MD (corresponding author), Odense Univ Hosp, Dept Pathol, Odense, Denmark.; Sorensen, MD (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.	Mia.Soerensen@rsyd.dk	Kristensen, Bjarne Winther/AAX-5491-2020; Lathia, Justin/AHB-8296-2022; Kristensen, Bjarne Winther/A-6690-2012	Kristensen, Bjarne Winther/0000-0002-6352-0826; Kristensen, Bjarne Winther/0000-0002-6352-0826; Hermansen, Simon Kjaer/0000-0002-6420-8199; Sorensen, Mia Dahl/0000-0002-0105-2940	Region of Southern Denmark; Danish Council for Independent Research	Region of Southern Denmark; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	The work was supported by the Region of Southern Denmark and The Danish Council for Independent Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areeb Z, 2015, J NEURO-ONCOL, V125, P237, DOI 10.1007/s11060-015-1912-0; Barbano R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108950; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Carlsen AL, 2013, PANCREAS, V42, P1107, DOI 10.1097/MPA.0b013e318296bb34; Chen L, 2015, CELLULAR MOL NEUROBI; Chen L, 2013, CELL MOL NEUROBIOL, V33, P651, DOI 10.1007/s10571-013-9927-6; Chen L, 2013, J NEURO-ONCOL, V112, P59, DOI 10.1007/s11060-012-1037-7; Chen L, 2013, NEUROSCI LETT, V534, P327, DOI 10.1016/j.neulet.2012.11.047; Cheng W, 2015, ONCOTARGET, V6, P29285, DOI 10.18632/oncotarget.4978; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dahlrot RH, 2013, INT J CLIN EXP PATHO, V6, P31; Delgado-Lopez PD, 2016, SURVIVAL GLIOBLASTOM; Doleshal M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/jmoldx.2008.070153; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Epis MR, 2014, J NEURO-ONCOL, V116, P67, DOI 10.1007/s11060-013-1271-7; Fazi B, 2015, ONCOTARGET, V6, P22526, DOI 10.18632/oncotarget.4151; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giles KM, 2011, METHODS MOL BIOL, V676, P147, DOI 10.1007/978-1-60761-863-8_11; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; Hall JS, 2012, BRIT J CANCER, V107, P684, DOI 10.1038/bjc.2012.294; Hayes J, 2015, MOL ONCOL, V9, P704, DOI 10.1016/j.molonc.2014.11.004; Hegi ME, 2015, NEURO-ONCOLOGY, V17, P1425, DOI 10.1093/neuonc/nov198; Hermansen SK, 2013, J NEURO-ONCOL, V114, P13, DOI 10.1007/s11060-013-1155-x; Hermansen SK, 2013, J NEURO-ONCOL, V111, P71, DOI 10.1007/s11060-012-0992-3; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jensen SS, 2013, NEUROSURGERY, V73, P868, DOI 10.1227/NEU.0000000000000118; Ji YC, 2015, TUMOR BIOL, V36, P4461, DOI 10.1007/s13277-015-3086-y; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kiriakidou M, 2005, METH MOL B, V309, P295; Kloosterhof NK, 2011, LANCET ONCOL, V12, P83, DOI 10.1016/S1470-2045(10)70053-X; Knudsen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115538; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Louis, 2016, WHO CLASSIFICATION G; Niyazi M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-153; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Paravati AJ, 2011, J NEURO-ONCOL, V104, P339, DOI 10.1007/s11060-010-0499-8; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049918; Prahm KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174300; Simon JM, 2003, RADIOTHER ONCOL, V67, P45, DOI 10.1016/S0167-8140(03)00007-0; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; The WHO, 2020, CLASSIFICATION TUMOU; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Weller M, 2017, LANCET ONCOL, V18, pE315, DOI 10.1016/S1470-2045(17)30194-8; Winther M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148070; Wolter M, 2015, BRAIN PATHOLOGY ZURI; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Zhang W, 2013, CANCER-AM CANCER SOC, V119, P814, DOI 10.1002/cncr.27826; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003	57	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188090	10.1371/journal.pone.0188090	http://dx.doi.org/10.1371/journal.pone.0188090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136645	Green Published, gold			2022-12-26	WOS:000415121200062
J	Chen, CL; Xu, ML; Wang, CP; Qiao, GX; Wang, WW; Tan, ZY; Wu, TT; Zhang, ZS				Chen, Chunling; Xu, Meilong; Wang, Cuiping; Qiao, Gaixia; Wang, Wenwen; Tan, Zhaoyun; Wu, Tiantian; Zhang, Zhengsheng			Characterization of the Lycium barbarum fruit transcriptome and development of EST-SSR markers	PLOS ONE			English	Article							POLYSACCHARIDE-PROTEIN COMPLEX; DE-NOVO CHARACTERIZATION; FLAVONOID BIOSYNTHESIS; MICROSATELLITE MARKERS; LEAF TRANSCRIPTOME; TAURINE; TOXICITY; EXTRACTS; CELLS	Lycium barbarum, commonly known as goji, is important in Chinese herbal medicine and its fruit is a very important agricultural and biological product. However, the molecular mechanism of formation of its fruit and associated medicinal and nutritional components is unexplored. Moreover, this species lacks SSR markers due to lack of genomic and transcriptomic information. In this study, a total of 139,333 unigenes with average length of 1049 bp and N50 of 1579 bp are obtained by trinity assembly from Illumina sequencing reads. A total of 92,498 (66.38%) unigenes showed similarities in at least one database including Nr (46.15%), Nt (56.56%), KO (15.56%), Swiss-prot (33.34%), Pfam (33.43%), GO (33.62%) and KOG/COG (17.55%). Genes in flavonoid and taurine biosynthesis pathways were found and validated by RT-qPCR. A total of 50,093 EST-SSRs were identified from 38,922 unigenes, and 22,537 EST-SSR primer pairs were designed. Four hundred pairs of SSR markers were randomly selected to validate assembly quality, of which 352 (88%) were successful in PCR amplification of genomic DNA from 11 Lycium accessions and 210 produced polymorphisms. The polymorphic loci showed that the genetic similarity of the 11 Lycium accessions ranged from 0.50 to 0.99 and the accessions could be divided into 4 groups. These results will facilitate investigations of the molecular mechanism of formation of L. barbarum fruit and associated medicinal and nutritional components, and will be of value to novel gene discovery and functional genomic studies. The EST-SSR markers will be useful for genetic diversity evaluation, genetic mapping and marker-assisted breeding.	[Chen, Chunling; Wang, Wenwen; Tan, Zhaoyun; Wu, Tiantian; Zhang, Zhengsheng] Southwest Univ, Engn Res Ctr South Upland Agr, Minist Educ, Chongqing, Peoples R China; [Chen, Chunling; Xu, Meilong; Wang, Cuiping; Qiao, Gaixia] Ningxia Forestry Inst, State Key Lab Seedling Bioengn, Yinchuan, Peoples R China	Southwest University - China	Zhang, ZS (corresponding author), Southwest Univ, Engn Res Ctr South Upland Agr, Minist Educ, Chongqing, Peoples R China.	zhangzs@swu.edu.cn	Zhang, zs/GXN-3521-2022		Natural Science Foundation of Ningxia Province [NZ17228]	Natural Science Foundation of Ningxia Province	This work was supported by Natural Science Foundation of Ningxia Province, Award Number: NZ17228, Recipient: Chunling Chen.	Amagase H, 2009, NUTR RES, V29, P19, DOI 10.1016/j.nutres.2008.11.005; Arai Y, 2000, J NUTR, V130, P2243; Bo RN, 2016, INT J BIOL MACROMOL, V85, P294, DOI 10.1016/j.ijbiomac.2015.12.089; Cao Y., 2010, ELECTROANAL, V15, P898, DOI DOI 10.1002/ELAN,200190112; Chesney R W, 1985, Adv Pediatr, V32, P1; Davidson NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0410-6; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Gan L, 2004, INT IMMUNOPHARMACOL, V4, P563, DOI 10.1016/j.intimp.2004.01.023; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gupta PK, 2000, EUPHYTICA, V113, P163, DOI 10.1023/A:1003910819967; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; He M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042081; Ho YS, 2010, J ALZHEIMERS DIS, V19, P813, DOI 10.3233/JAD-2010-1280; Hu LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129822; Hu Z, 2016, MOL GENET GENOMICS, V291, P849, DOI 10.1007/s00438-015-1147-y; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Idury R M, 1995, J Comput Biol, V2, P291, DOI 10.1089/cmb.1995.2.291; KATAOKA H, 1986, AGR BIOL CHEM TOKYO, V50, P1887, DOI 10.1080/00021369.1986.10867664; Kwon SJ, 2009, CONSERV GENET, V10, P1557, DOI 10.1007/s10592-008-9792-x; Lam P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040465; Li CQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-552; Li RJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00801; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Long Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115805; LULIN H, 2012, PLOS ONE, V0007; Luo Q, 2004, LIFE SCI, V76, P137, DOI 10.1016/j.lfs.2004.04.056; Luo Q, 2006, LIFE SCI, V79, P613, DOI 10.1016/j.lfs.2006.02.012; Ma M, 2009, FOOD CHEM, V113, P872, DOI 10.1016/j.foodchem.2008.03.064; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Potterat O, 2010, PLANTA MED, V76, P7, DOI 10.1055/s-0029-1186218; Punyasiri PAN, 2004, ARCH BIOCHEM BIOPHYS, V431, P22, DOI 10.1016/j.abb.2004.08.003; Rai A, 2017, J NAT MED-TOKYO, V71, P1, DOI 10.1007/s11418-016-1041-x; Schijlen EGW, 2004, PHYTOCHEMISTRY, V65, P2631, DOI 10.1016/j.phytochem.2004.07.028; Shi XP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2357-8; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Song MK, 2011, BIOCHEM PHARMACOL, V82, P1209, DOI 10.1016/j.bcp.2011.07.089; Sun HP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182243; Sun XD, 2016, MOL GENET GENOMICS, V291, P647, DOI 10.1007/s00438-015-1131-6; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; THURSTON JH, 1980, LIFE SCI, V26, P1561, DOI 10.1016/0024-3205(80)90358-6; Ueki I, 2009, J NUTR, V139, P207, DOI 10.3945/jn.108.099085; Wang G, 2015, GENE, V555, P458, DOI 10.1016/j.gene.2014.10.058; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang YL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3127-y; Wu HL, 2013, PLANT MOL BIOL REP, V31, P524, DOI 10.1007/s11105-012-0519-2; Xiao J, 2014, SCI REP-UK, V4, DOI [10.1038/srep05587, 10.1038/srep03682]; Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033; Xie H, 1997, Se Pu, V15, P54; Yan CC, 1996, BIOCHEM PHARMACOL, V51, P321, DOI 10.1016/0006-2952(95)02185-X; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang KYB, 2001, PLANTA MED, V67, P379, DOI 10.1055/s-2001-14310; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915; Zhang XR, 2014, INT J BIOL MACROMOL, V65, P441, DOI 10.1016/j.ijbiomac.2014.01.020; Zhang ZS, 2005, EUPHYTICA, V144, P91, DOI 10.1007/s10681-005-4629-x; Zhao WG, 2010, CR BIOL, V333, P793, DOI 10.1016/j.crvi.2010.10.002; Zhu SS, 2016, MOL BIOL REP, V43, P1243, DOI 10.1007/s11033-016-4056-1	57	23	27	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187738	10.1371/journal.pone.0187738	http://dx.doi.org/10.1371/journal.pone.0187738			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125846	gold, Green Published, Green Submitted			2022-12-26	WOS:000414866000022
J	Kabir, M; Hameed, S; Ali, H; Bosso, L; Din, JU; Bischof, R; Redpath, S; Nawaz, MA				Kabir, Muhammad; Hameed, Shoaib; Ali, Hussain; Bosso, Luciano; Din, Jaffar Ud; Bischof, Richard; Redpath, Steve; Nawaz, Muhammad Ali			Habitat suitability and movement corridors of grey wolf (Canis lupus) in Northern Pakistan	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; LONG-DISTANCE DISPERSAL; CLIMATE-CHANGE; POTENTIAL DISTRIBUTION; POPULATION-DYNAMICS; RANGE EXPANSION; WIND FARMS; WOLVES; CONSERVATION; PREDICTION	Habitat suitability models are useful to understand species distribution and to guide management and conservation strategies. The grey wolf (Canis lupus) has been extirpated from most of its historic range in Pakistan primarily due to its impact on livestock and livelihoods. We used non-invasive survey data from camera traps and genetic sampling to develop a habitat suitability model for C. lupus in northern Pakistan and to explore the extent of connectivity among populations. We detected suitable habitat of grey wolf using a maximum entropy approach (Maxent ver. 3.4.0) and identified suitable movement corridors using the Circuitscape 4.0 tool. Our model showed high levels of predictive performances, as seen from the values of area under curve (0.971 +/- 0.002) and true skill statistics (0.886 +/- 0.021). The main predictors for habitat suitability for C. lupus were distances to road, mean temperature of the wettest quarter and distance to river. The model predicted ca. 23,129 km(2) of suitable areas for wolf in Pakistan, with much of suitable habitat in remote and inaccessible areas that appeared to be well connected through vulnerable movement corridors. These movement corridors suggest that potentially the wolf range can expand in Pakistan's Northern Areas. However, managing protected areas with stringent restrictions is challenging in northern Pakistan, in part due to heavy dependence of people on natural resources. The habitat suitability map provided by this study can inform future management strategies by helping authorities to identify key conservation areas.	[Kabir, Muhammad; Hameed, Shoaib; Ali, Hussain; Nawaz, Muhammad Ali] Quaid I Azam Univ, Dept Anim Sci, Carnivore Conservat Lab, Islamabad, Pakistan; [Bosso, Luciano] Univ Napoli Federico II, Dipartimento Agr, Wildlife Res Unit, Via Univ 100, Naples, Italy; [Din, Jaffar Ud] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Din, Jaffar Ud; Nawaz, Muhammad Ali] Snow Leopard Trust, Seattle, WA 98103 USA; [Bischof, Richard] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Redpath, Steve] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	Quaid I Azam University; University of Naples Federico II; Universiti Malaya; Norwegian University of Life Sciences; University of Aberdeen	Nawaz, MA (corresponding author), Quaid I Azam Univ, Dept Anim Sci, Carnivore Conservat Lab, Islamabad, Pakistan.; Nawaz, MA (corresponding author), Snow Leopard Trust, Seattle, WA 98103 USA.	nawazma@gmail.com	Din, Jaffar Ud/D-7748-2017; Nawaz, Muhammad Ali/AAL-9971-2020; Nawaz, Muhammad Ali/C-1125-2012; Nawaz, Muhammad Ali/GQY-8578-2022; Redpath, Stephen/B-4640-2012	Nawaz, Muhammad Ali/0000-0001-5632-9014; Nawaz, Muhammad Ali/0000-0001-5632-9014; Nawaz, Muhammad Ali/0000-0001-5632-9014; Bosso, Luciano/0000-0002-9472-3802; Redpath, Stephen/0000-0001-5399-9477	Research Council of Norway [204202/F20]; Snow Leopard Trust	Research Council of Norway(Research Council of Norway); Snow Leopard Trust	Main funding for this study came from the Research Council of Norway (Grant 204202/F20) and Snow Leopard Trust. The principal investigator were Dr. Richard Bischof and Dr. Muhammad Ali Nawaz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi M, 2013, ECOL RES, V28, P513, DOI 10.1007/s11284-013-1040-2; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Ansorge H, 4 EUR C MAMM BRNO CZ; Barja I, 2004, NATURWISSENSCHAFTEN, V91, P489, DOI 10.1007/s00114-004-0557-1; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bischof R, 2014, J ZOOL, V293, P40, DOI 10.1111/jzo.12100; Bischof R, 2014, METHODS ECOL EVOL, V5, P44, DOI 10.1111/2041-210X.12115; Booth G. D., 1994, IDENTIFYING PROXY SE; BOSSO L, 2016, HYSTRIX, V27, DOI DOI 10.4404/HYSTRIX-27.2; Bosso L, 2017, FOREST ECOL MANAG, V400, P655, DOI 10.1016/j.foreco.2017.06.044; Bosso L, 2017, ENVIRON MANAGE, V60, P304, DOI 10.1007/s00267-017-0882-8; Bosso L, 2016, BIOL INVASIONS, V18, P1759, DOI 10.1007/s10530-016-1118-1; Carroll C, 2001, LARGE MAMMAL RESTORATION: ECOLOGICAL AND SOCIOLOGICAL CHALLENGES IN THE 21ST CENTURY, P25; Carroll C, 1999, CONSERV BIOL, V13, P1344, DOI 10.1046/j.1523-1739.1999.98364.x; Ciucci P, 2003, ECOGRAPHY, V26, P223, DOI 10.1034/j.1600-0587.2003.03353.x; Ciucci P, 2009, J WILDLIFE MANAGE, V73, P1300, DOI 10.2193/2008-510; Cushman SA, 2013, BIODIVERS CONSERV, V22, P2583, DOI 10.1007/s10531-013-0541-1; Danchin Etienne, 2001, P243; Doherty TS, 2017, MAMMAL REV, V47, P83, DOI 10.1111/mam.12080; Domiguez-Vega H, 2012, J NAT CONSERV, V20, P247, DOI 10.1016/j.jnc.2012.04.003; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Enserink M, 2006, SCIENCE, V314, P746, DOI 10.1126/science.314.5800.746; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fritts Steven H., 2003, P289; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Gordon IJ, 2009, WILDLIFE BIOL, V15, P1, DOI 10.2981/06-087; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guo YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46221; Gurarie E, 2011, OECOLOGIA, V165, P891, DOI 10.1007/s00442-010-1883-y; Hanspach J, 2010, PERSPECT PLANT ECOL, V12, P219, DOI 10.1016/j.ppees.2010.04.002; Hendricks SA, 2016, BIOL CONSERV, V194, P48, DOI 10.1016/j.biocon.2015.11.027; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hilty JA., 2012, CORRIDOR ECOLOGY SCI; Hinton JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167603; Hirzel AH, 2001, ECOL MODEL, V145, P111, DOI 10.1016/S0304-3800(01)00396-9; Houle M, 2010, LANDSCAPE ECOL, V25, P419, DOI 10.1007/s10980-009-9420-2; Houts ME, 2003, USING LOGISTIC REGRE; Jacobose JP, 1993, CULTURE AREA KARAKOR, V3, P13; Jarvis AM, 1999, BIOL CONSERV, V88, P121, DOI 10.1016/S0006-3207(98)00060-3; Jedrzejewski W, 2008, ANIM CONSERV, V11, P377, DOI 10.1111/j.1469-1795.2008.00193.x; Kwon HS, 2016, CONTEMP PROBL ECOL+, V9, P515, DOI 10.1134/S1995425516050085; Latham ADM, 2009, THESIS; Lesmerises F, 2013, LANDSCAPE URBAN PLAN, V112, P18, DOI 10.1016/j.landurbplan.2012.12.011; Lindenmayer DB, 2013, HABITAT FRAGMENTATIO; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Lovari S, 2007, J ZOOL, V272, P117, DOI 10.1111/j.1469-7998.2006.00260.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McRae B., 2009, CIRCUITSCAPE USER GU; Mech D., 2003, WOLVES BEHAV ECOLOGY; Mech L. D., 1981, WOLF ECOLOGY BEHAV E; Mech LD, 2006, WILDLIFE SOC B, V34, P874, DOI 10.2193/0091-7648(2006)34[874:PFOAWL]2.0.CO;2; Mech L. David, 2003, P1; Mech LD, 2000, WILDLIFE SOC B, V28, P623; Mech SG, 2001, CONSERV BIOL, V15, P467, DOI 10.1046/j.1523-1739.2001.015002467.x; Merrill SB, 2000, AM MIDL NAT, V144, P428, DOI 10.1674/0003-0031(2000)144[0428:DOEMBM]2.0.CO;2; Mesler JI, 2015, THESIS; Milakovic B, 2011, J MAMMAL, V92, P568, DOI 10.1644/10-MAMM-A-040.1; Mooney TL., 2010, THESIS; Musiani M, 1998, ACTA THERIOL, V43, P409, DOI 10.4098/AT.arch.98-51; Newsome TM, 2016, MAMMAL REV, V46, P255, DOI 10.1111/mam.12067; Oberhauser K, 2017, ECOL ENTOMOL, V42, P51, DOI 10.1111/een.12351; Otis JA, 2017, DIVERS DISTRIB, V23, P529, DOI 10.1111/ddi.12543; Packard Jane M., 2003, P35; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Potvin F, 2005, CAN J FOREST RES, V35, P151, DOI 10.1139/X04-151; Rebelo H, 2010, J APPL ECOL, V47, P410, DOI 10.1111/j.1365-2664.2009.01765.x; Rhodes JR, 2006, CONSERV BIOL, V20, P449, DOI 10.1111/j.1523-1739.2006.00330.x; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Roberts T.J, 1997, MAMMALS PAKISTAN; Roscioni F, 2013, BIODIVERS CONSERV, V22, P1821, DOI 10.1007/s10531-013-0515-3; Roscioni F, 2014, LANDSCAPE ECOL, V29, P891, DOI 10.1007/s10980-014-0030-2; Russo D, 2015, J ZOOL, V297, P165, DOI 10.1111/jzo.12271; Saura S., 2011, ECOLOGICAL INDICATOR, V11, P407, DOI DOI 10.1016/J.EC0LIND.2010.06.011; Saura S, 2014, J APPL ECOL, V51, P171, DOI 10.1111/1365-2664.12179; Sheehan KL, 2017, ECOL EVOL, V7, P409, DOI 10.1002/ece3.2620; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Sheikh KM, 2004, STAT RED LIST PAK MA; Smeraldo S, 2017, J NAT CONSERV, V37, P12, DOI 10.1016/j.jnc.2017.02.008; Subba SA, 2017, ORYX, V51, P403, DOI 10.1017/S0030605316000296; Tang CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43822; Taylor C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169629; Theuerkauf J, 2003, J WILDLIFE MANAGE, V67, P706, DOI 10.2307/3802677; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wogan GOU, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151024; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; Zimmermann B, 2014, BEHAV ECOL, V25, P1353, DOI 10.1093/beheco/aru134	97	56	57	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187027	10.1371/journal.pone.0187027	http://dx.doi.org/10.1371/journal.pone.0187027			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121089	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900016
J	Keller-Pinter, A; Ughy, B; Domoki, M; Pettko-Szandtner, A; Letoha, T; Tovari, J; Timar, J; Szilak, L				Keller-Pinter, Aniko; Ughy, Bettina; Domoki, Monika; Pettko-Szandtner, Aladar; Letoha, Tamas; Tovari, Jozsef; Timar, Jozsef; Szilak, Laszlo			The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner	PLOS ONE			English	Article							P21-ACTIVATED KINASE; ACTIVATION; COMPLEX; GTPASE; PHOSPHORYLATION; DEGRADATION; CROSSTALK; PROTEINS; MOLECULE; ALPHA	The small GTPases of the Rho family comprising RhoA, Rac1 and Cdc42 function as molecular switches controlling several essential biochemical pathways in eukaryotic cells. Their activity is cycling between an active GTP-bound and an inactive GDP-bound conformation. The exchange of GDP to GTP is catalyzed by guanine nucleotide exchange factors (GEFs). Here we report a novel regulatory mechanism of Rac1 activity, which is controlled by a phosphomimetic (Ser179Glu) mutant of syndecan-4 (SDC4). SDC4 is a ubiquitously expressed transmembrane, heparan sulfate proteoglycan. In this study we show that the Ser179Glu mutant binds strongly Tiam1, a Rac1-GEF reducing Rac1-GTP by 3-fold in MCF-7 breast adenocarcinoma cells. Mutational analysis unravels the PDZ interaction between SDC4 and Tiam1 is indispensable for the suppression of the Rac1 activity. Neither of the SDC4 interactions is effective alone to block the Rac1 activity, on the contrary, lack of either of interactions can increase the activity of Rac1, therefore the Rac1 activity is the resultant of the inhibitory and stimulatory effects. In addition, SDC4 can bind and tether RhoGDI1 (GDP-dissociation inhibitor 1) to the membrane. Expression of the phosphomimetic SDC4 results in the accumulation of the Rac1-RhoGDI1 complex. Co-immunoprecipitation assays (co-IP-s) reveal that SDC4 can form complexes with RhoGDI1. Together, the regulation of the basal activity of Rac1 is fine tuned and SDC4 is implicated in multiple ways.	[Keller-Pinter, Aniko] Univ Szeged, Fac Gen Med, Dept Biochem, Szeged, Hungary; [Ughy, Bettina; Domoki, Monika; Pettko-Szandtner, Aladar] Hungarian Acad Sci, Inst Plant Biol, Biol Res Ctr, Szeged, Hungary; [Letoha, Tamas] Pharmacoidea Ltd, Szeged, Hungary; [Tovari, Jozsef] Natl Inst Oncol, Dept Expt Pharmacol, Budapest, Hungary; [Timar, Jozsef] Semmelweis Univ, Dept Pathol 2, MTA SE Mol Oncol Res Grp, Budapest, Hungary; [Szilak, Laszlo] Eotvos Lorand Univ, Inst Biol, Savaria Campus, Szombathely, Hungary; [Szilak, Laszlo] Szilak Labs Bioinformat & Mol Design Ltd, Szeged, Hungary	Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; National Institute of Oncology Hungary; Semmelweis University; Eotvos Lorand University	Szilak, L (corresponding author), Eotvos Lorand Univ, Inst Biol, Savaria Campus, Szombathely, Hungary.; Szilak, L (corresponding author), Szilak Labs Bioinformat & Mol Design Ltd, Szeged, Hungary.	laszlo.szilak@gmail.com	Letoha, Tamas/ABG-6348-2020; Szilak, Laszlo/T-1426-2017	Szilak, Laszlo/0000-0003-0334-272X; Keller-Pinter, Aniko/0000-0002-4105-8458	NKFIH [K116151, K116295]; TAMOP [4.2.4. A/2-11-1-2012-0001]; Innovative Medicines Initiative [115363, 115568];  [NVKP-16-1-2016-0020];  [GINOP-2.3.2-15-2016-00058];  [TET_13_IL-2-2014-0002];  [EU_BONUS_12-1-2013-0007]	NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary); TAMOP; Innovative Medicines Initiative; ; ; ; 	J.Ti. was supported by NKFIH K116151 (only research material), NVKP-16-1-2016-0020 (only research material). J.To. was supported by NKFIH K116295 (only research material), NVKP-16-1-2016-0020 (only research material). A.K.-P. was supported by TAMOP 4.2.4. A/2-11-1-2012-0001 "National Excellence Program" (only provided salary to A.K.-P.). B.U. was supported by GINOP-2.3.2-15-2016-00058 (only research material). T.L. was supported by the Innovative Medicines Initiative joint undertaking under grant agreements no 115363 and no 115568 (FP7/2007-2013) (only research material), TET_13_IL-2-2014-0002 (only research material), EU_BONUS_12-1-2013-0007 (only research material).	Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Bass MD, 2011, DEV CELL, V21, P681, DOI 10.1016/j.devcel.2011.08.007; Boissier P, 2014, CELL SIGNAL, V26, P483, DOI 10.1016/j.cellsig.2013.11.034; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Choi Y, 2010, BIOCHEM BIOPH RES CO, V391, P921, DOI 10.1016/j.bbrc.2009.11.165; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Elfenbein A, 2013, J CELL SCI, V126, P3799, DOI 10.1242/jcs.124636; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gronholm M, 2011, J IMMUNOL, V187, P3613, DOI 10.4049/jimmunol.1100704; Horowitz A, 1998, J BIOL CHEM, V273, P25548, DOI 10.1074/jbc.273.40.25548; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Ju R, 2013, CELL SIGNAL, V25, P101, DOI 10.1016/j.cellsig.2012.09.007; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Keller-Pinter A, 2010, CELL MOL LIFE SCI, V67, P1881, DOI 10.1007/s00018-010-0298-6; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Liu X, 2013, STRUCTURE, V21, P342, DOI 10.1016/j.str.2013.01.004; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Maroto B, 2008, ONCOGENE, V27, P4900, DOI 10.1038/onc.2008.131; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Mertens AEE, 2006, TRENDS CELL BIOL, V16, P308, DOI 10.1016/j.tcb.2006.04.001; Moshfegh Y, 2014, NAT CELL BIOL, V16, P571, DOI 10.1038/ncb2972; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Saoncella S, 2004, J BIOL CHEM, V279, P47172, DOI 10.1074/jbc.C400299200; Shepherd TR, 2010, J MOL BIOL, V398, P730, DOI 10.1016/j.jmb.2010.03.047; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Szilak L, 2013, THER DELIV, V4, P1479, DOI [10.4155/TDE.13.112, 10.4155/tde.13.112]; Ten Klooster JP, 2006, BIOCHEM J, V397, P39, DOI 10.1042/BJ20051957; Zhao Zhuo-Shen, 2012, Cell Logist, V2, P59	36	12	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187094	10.1371/journal.pone.0187094	http://dx.doi.org/10.1371/journal.pone.0187094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121646	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000414769900020
J	Nam, JH; Kim, DH; Yoo, JH; Hwang, JH; Chang, JD				Nam, Ji-Hoon; Kim, Dae-Hwan; Yoo, Je-Hyun; Hwang, Ji-Hyo; Chang, Jun-Dong			Does preoperative mechanical prophylaxis have additional effectiveness in preventing postoperative venous thromboembolism in elderly patients with hip fracture?-Retrospective case-control study	PLOS ONE			English	Article							INTERMITTENT PNEUMATIC COMPRESSION; PULMONARY-EMBOLISM; RISK-FACTORS; THROMBOSIS; THERAPY; THROMBOPROPHYLAXIS; POPULATION; VTE	Background Elderly patients undergoing hip fracture surgery (HFS) are at increased risk of postoperative venous thromboembolism (VTE). To reduce this risk, combined postoperative mechanical and chemical thromboprophylaxis has been routinely performed after HFS in these patients. This retrospective case-control study was conducted to evaluate the additional effectiveness of preoperative mechanical thromboprophylaxis for the prevention of VTE following HFS in elderly patients. Methods Of 539 consecutive patients aged 70 years or older undergoing HFS, 404 (control group) did not receive preoperative mechanical thromboprophylaxis, while 135 (study group) received mechanical thromboprophylaxis using an intermittent pneumatic compression device and graduated compression stockings from the time of admission until surgery. All patients received combined postoperative mechanical and chemical thromboprophylaxis following HFS in accordance with the same protocol. The incidence of symptomatic VTE confirmed based on clinical symptoms and 3-dimensional CT angiography within one month of surgery was investigated in both groups. Results The American Society of Anesthesiologists grade was higher (p = 0.016) in the study group and more patients in this group had concomitant cardiovascular and neurologic diseases (p = 0.005 and p = 0.009, respectively). In addition, more patients in the study group had received anticoagulant medication preinjury owing to comorbidities (39% vs 28%, p = 0.025). The overall incidences of symptomatic deep vein thrombosis (DVT) and pulmonary embolism (PE) were 7.4% and 3.7%, and 2.2% and 1.5% in the control and study groups, respectively. According to multiple logistic regression, symptomatic DVT significantly reduced in the study group (OR 0.28, p = 0.042), while there was no significant difference in the incidence of symptomatic PE between the two groups (p = 0.223). Conclusions Preoperative mechanical thromboprophylaxis may confer an additional benefit by preventing postoperative VTE without adding more risk of perioperative bleeding in elderly patients with hip fracture.	[Nam, Ji-Hoon; Kim, Dae-Hwan; Yoo, Je-Hyun] Hallym Univ, Sacred Heart Hosp, Dept Orthopaed Surg, Anyang, South Korea; [Hwang, Ji-Hyo] Kangnam Sacred Heart Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Chang, Jun-Dong] Dongtan Sacred Heart Hosp, Dept Orthopaed Surg, Hwasung, South Korea	Hallym University	Yoo, JH (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Orthopaed Surg, Anyang, South Korea.	oships@hallym.ac.kr		Nam, Ji Hoon/0000-0001-7079-2240	National Research Foundation of Korea [NRF-2015R1D1A1A01060157]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by a Grant from National Research Foundation of Korea (NRF-2015R1D1A1A01060157, https://ernd.nrf.re.kr)	Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Borgen PO, 2010, HIP INT, V20, P301, DOI 10.1177/112070001002000302; Comerota AJ, 1997, ANN SURG, V226, P306, DOI 10.1097/00000658-199709000-00010; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Francis CW, 2013, J THROMB THROMBOLYS, V35, P359, DOI 10.1007/s11239-013-0889-9; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Jo WL, 2016, J KOREAN MED SCI, V31, P1319, DOI 10.3346/jkms.2016.31.8.1319; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Klatsky AL, 2000, AM J CARDIOL, V85, P1334, DOI 10.1016/S0002-9149(00)00766-9; Lippi G, 2011, SEMIN THROMB HEMOST, V37, P237, DOI 10.1055/s-0031-1273088; Liu ZD, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0917-y; Mantilla CB, 2003, ANESTHESIOLOGY, V99, P552, DOI 10.1097/00000542-200309000-00009; Mehta Kinjal V, 2010, J Orthop Surg (Hong Kong), V18, P287; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; Morris RJ, 2004, ANN SURG, V239, P162, DOI 10.1097/01.sla.0000109149.77194.6c; Nam D, 2016, J ARTHROPLASTY, V31, P1299, DOI 10.1016/j.arth.2015.12.007; Nieto JA, 2010, J THROMB HAEMOST, V8, P1216, DOI 10.1111/j.1538-7836.2010.03852.x; Pedersen AB, 2010, J BONE JOINT SURG AM, V92A, P2156, DOI 10.2106/JBJS.I.00882; Perka C, 2011, THROMB J, V9, DOI 10.1186/1477-9560-9-17; Raskob GE, 2003, CHEST, V124, p379S, DOI 10.1378/chest.124.6_suppl.379S; Ricci WM, 2007, INJURY, V38, P49, DOI 10.1016/j.injury.2007.08.011; Thaler HW, 2001, J TRAUMA, V51, P518, DOI 10.1097/00005373-200109000-00015; Wein L, 2007, ARCH INTERN MED, V167, P1476, DOI 10.1001/archinte.167.14.1476; White RH, 2005, THROMB HAEMOSTASIS, V93, P298, DOI 10.1160/TH04-08-0506; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868; Zufferey P, 2003, THROMB HAEMOSTASIS, V90, P654, DOI 10.1160/TH03-02-0086	27	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187337	10.1371/journal.pone.0187337	http://dx.doi.org/10.1371/journal.pone.0187337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121664	gold, Green Published, Green Submitted			2022-12-26	WOS:000414769900029
J	Bibens-Laulan, N; St-Pierre, Y				Bibens-Laulan, Nathalie; St-Pierre, Yves			Intracellular galectin-7 expression in cancer cells results from an autocrine transcriptional mechanism and endocytosis of extracellular galectin-7	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; OVARIAN-CANCER; BREAST-CANCER; TARGETS; MITOCHONDRIA; TRAFFICKING; INHIBITORS; APOPTOSIS; PATHWAYS; LATTICE	The p-galactoside binding protein galectin-7 (gal-7) is constitutively expressed at abnormally high levels in the outside milieu and intracellular compartments of many types of epithelial cancer cells, most notably in aggressive forms of ovarian and breast cancer. It is thus of utmost importance to understand how gal-7 traffics between both intracellular and extra cellular compartments to develop novel drugs that target the protumorigenic functions of galectin-7. In the present work, we report that extracellular gal-7 plays a central role in controlling intracellular gal-7 in cells. It does so via two distinct yet complementary mechanisms: firstly by increasing the transcriptional activation of Igals7 gene transcription, and secondly via re-entry into the cells. Increased mRNA levels were dose- and time-dependent and occur in all cell lines tested, including ovarian and breast cancer cell lines. Addition of recombinant gal-7 to MDA-MB-231 transfected with a luciferase reporter vector containing response elements of the Igals7 promoter indicated that increased mRNA level of Igals7 occurs via de novo gene transcription. Re-entry of extracellular gal-7 inside cells was rapid, and reached cytosolic and mitochondrial compartments. Taken together, these findings reveal the existence of a positive self-amplification pathway that regulates intracellular gal-7 expression in breast and ovarian cancer cells.	[Bibens-Laulan, Nathalie; St-Pierre, Yves] INRS Inst Armand Frappier, 531 Boul Prairies, Laval, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	St-Pierre, Y (corresponding author), INRS Inst Armand Frappier, 531 Boul Prairies, Laval, PQ, Canada.	yves.st-pierre@iaf.inrs.ca		St-Pierre, Yves/0000-0002-1948-2041	National Science and Engineering Research Council of Canada [298215-2013]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by the National Science and Engineering Research Council of Canada (Grant No. 298215-2013 to YSP) (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat R, 2016, P NATL ACAD SCI USA, V113, pE4820, DOI 10.1073/pnas.1609135113; Borgne-Sanchez A, 2007, CELL DEATH DIFFER, V14, P422, DOI 10.1038/sj.cdd.4402018; Brewer CF, 2002, BBA-GEN SUBJECTS, V1572, P255, DOI 10.1016/S0304-4165(02)00312-4; Calore F, 2010, CELL DEATH DIFFER, V17, P1707, DOI 10.1038/cdd.2010.42; Campion CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095087; Campion CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072468; Capel V, 2016, BIOCHEM BIOPH RES CO, V477, P260, DOI 10.1016/j.bbrc.2016.06.054; Compagno D, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23565; Cumpstey I, 2005, ORG BIOMOL CHEM, V3, P1922, DOI 10.1039/b502354h; Demers M, 2009, BIOCHEM BIOPH RES CO, V387, P425, DOI 10.1016/j.bbrc.2009.07.015; Fajka-Boja R, 2008, CELL MOL LIFE SCI, V65, P2586, DOI 10.1007/s00018-008-8143-x; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Grosset AA, 2016, ONCOTARGET, V7, P18183, DOI 10.18632/oncotarget.7784; Grosset AA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-801; Kim HJ, 2013, ANTICANCER RES, V33, P1555; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Labrie M, 2014, ONCOTARGET, V5, P7705, DOI 10.18632/oncotarget.2299; Laderach DJ, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/519436; Lepur A, 2012, BBA-GEN SUBJECTS, V1820, P804, DOI 10.1016/j.bbagen.2012.02.018; Luo Z, 2013, TRANSPL P, V45, P630, DOI 10.1016/j.transproceed.2012.12.005; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mishra BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059616; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Schneider D, 2010, EUR J CELL BIOL, V89, P788, DOI 10.1016/j.ejcb.2010.07.001; Steichen AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123573; Straube T, 2013, TRAFFIC, V14, P1014, DOI 10.1111/tra.12086; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Than NG, 2015, J PATHOL TRANSL MED, V49, P181, DOI 10.4132/jptm.2015.02.25; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Villeneuve C, 2011, MOL BIOL CELL, V22, P999, DOI 10.1091/mbc.E10-06-0534; Vladoiu MC, 2014, INT J ONCOL, V44, P1001, DOI 10.3892/ijo.2014.2267; Vladoiu MC, 2015, ONCOTARGET, V6, P40970, DOI 10.18632/oncotarget.5403; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Xu J, 2014, CELL DEATH DIFFER, V21, P1229, DOI 10.1038/cdd.2014.40	36	16	17	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187194	10.1371/journal.pone.0187194	http://dx.doi.org/10.1371/journal.pone.0187194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117220	Green Published, gold, Green Submitted			2022-12-26	WOS:000414659600027
J	Curtin, P; Curtin, A; Austin, C; Gennings, C; Tammimies, K; Bolte, S; Arora, M				Curtin, Paul; Curtin, Austen; Austin, Christine; Gennings, Chris; Tammimies, Kristiina; Bolte, Sven; Arora, Manish			Recurrence quantification analysis to characterize cyclical components of environmental elemental exposures during fetal and postnatal development	PLOS ONE			English	Article							PHYSIOLOGICAL SINGULARITIES; RESPIRATORY DYNAMICS; NONLINEAR-ANALYSIS; HEART-RATE; PROTEINS; TEETH; PLOTS; TIME; TWIN	Environmental exposures to essential and toxic elements may alter health trajectories, depending on the timing, intensity, and mixture of exposures. In epidemiologic studies, these factors are typically analyzed as a function of elemental concentrations in biological matrices measured at one or more points in time. Such an approach, however, fails to account for the temporal cyclicity in the metabolism of environmental chemicals, which if perturbed may lead to adverse health outcomes. Here, we conceptualize and apply a non-linear method-recurrence quantification analysis (RQA)-to quantify cyclical components of prenatal and early postnatal exposure profiles for elements essential to normal development, including Zn, Mn, Mg, and Ca, and elements associated with deleterious health effects or narrow tolerance ranges, including Pb, As, and Cr. We found robust evidence of cyclical patterns in the metabolic profiles of nutrient elements, which we validated against randomized twin-surrogate time-series, and further found that nutrient dynamical properties differ from those of Cr, As, and Pb. Furthermore, we extended this approach to provide a novel method of quantifying dynamic interactions between two environmental exposures. To achieve this, we used cross-recurrence quantification analysis (CRQA), and found that elemental nutrient-nutrient interactions differed from those involving toxicants. These rhythmic regulatory interactions, which we characterize in two geographically distinct cohorts, have not previously been uncovered using traditional regression-based approaches, and may provide a critical unit of analysis for environmental and dietary exposures in epidemiological studies.	[Curtin, Paul; Gennings, Chris] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Curtin, Austen; Austin, Christine; Arora, Manish] Icahn Sch Med Mt Sinai, Senator Frank R Lautenberg Environm Hlth Sci Lab, Dept Environm Med & Publ Hlth, Div Environm Hlth, New York, NY 10029 USA; [Tammimies, Kristiina; Bolte, Sven] Karolinska Inst, Dept Womens & Childrens Hlth, Ctr Neurodev Disorders KIND, Stockholm, Sweden; [Tammimies, Kristiina; Bolte, Sven] Stockholm Cty Council, Ctr Psychiat Res, Stockholm, Sweden	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Karolinska Institutet; Stockholm County Council	Curtin, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA.; Arora, M (corresponding author), Icahn Sch Med Mt Sinai, Senator Frank R Lautenberg Environm Hlth Sci Lab, Dept Environm Med & Publ Hlth, Div Environm Hlth, New York, NY 10029 USA.	paul.curtin@mssm.edu; manish.arora@mssm.edu	Bölte, Sven/AAH-8675-2019	Bölte, Sven/0000-0002-4579-4970; Tammimies, Kristiina/0000-0002-8324-4697; Curtin, Paul/0000-0003-3749-3868	National Institutes of Environmental Health Sciences [DP2ES025453, R00ES019597, P30ES023515]; National Institute of Environmental Health Sciences [U2C ES026555-01]; Innovative Medicines Initiatives Joint Undertaking [115300]; European Unions Seventh Framework Programme (FP7); Swedish Research Council [523-2009-7054; 521-2013-2531]; Swedish Research Council; Swedish Research Council for Health, Working Life and Welfare; Formas; VINNOVA [259-2012-24]; Stockholm County Council [20100096, 20110602, 20120067, 20140134]; Stiftelsen Frimurare Barnhuset; Sunnerdahls; Handikappfond; Hjarnfonden; Swedish Foundation for Strategic Research; Jeanssons foundations; European Federation of Pharmaceutical Industries and Associations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD087523, R00HD087523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023515] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Innovative Medicines Initiatives Joint Undertaking; European Unions Seventh Framework Programme (FP7); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Formas(Swedish Research Council Formas); VINNOVA(Vinnova); Stockholm County Council(Stockholm County Council); Stiftelsen Frimurare Barnhuset; Sunnerdahls; Handikappfond; Hjarnfonden; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Jeanssons foundations; European Federation of Pharmaceutical Industries and Associations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	MA was supported by the National Institutes of Environmental Health Sciences research grants (DP2ES025453, R00ES019597, P30ES023515). PC and CG were supported by the National Institute of Environmental Health Sciences grant U2C ES026555-01. SB and KT were supported by the Innovative Medicines Initiatives Joint Undertaking (grant agreement number 115300), which comprises financial contribution from the European Unions Seventh Framework Programme (FP7/20072013) and in-kind contributions from companies belonging to the European Federation of Pharmaceutical Industries and Associations; the Swedish Research Council (523-2009-7054; 521-2013-2531); the Swedish Research Council, in partnership with the Swedish Research Council for Health, Working Life and Welfare, Formas and VINNOVA (cross-disciplinary research programme concerning childrens and young peoples mental health, 259-2012-24), Stockholm County Council (20100096, 20110602, 20120067, 20140134), Stiftelsen Frimurare Barnhuset, Sunnerdahls, Handikappfond, Hjarnfonden. KT is additionally financially supported by the Swedish Foundation for Strategic Research and Jeanssons foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NC, 2013, BEHAV RES METHODS, V45, P842, DOI 10.3758/s13428-012-0299-5; Andrzejak RG, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066202; Arnich N, 2003, ENVIRON POLLUT, V124, P139, DOI 10.1016/S0269-7491(02)00416-5; Arora M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15493; Arora M, 2013, CURR OPIN PEDIATR, V25, P261, DOI 10.1097/MOP.0b013e32835e9084; Austin C, 2013, NATURE, V498, P216, DOI 10.1038/nature12169; Bolte S, 2014, TWIN RES HUM GENET, V17, P164, DOI 10.1017/thg.2014.12; Bridges CC, 2005, TOXICOL APPL PHARM, V204, P274, DOI 10.1016/j.taap.2004.09.007; Coco MI, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00510; Conte E, 2004, CHAOS SOLITON FRACT, V21, P869, DOI 10.1016/j.chaos.2003.12.098; Del Santo F, 2007, EXP BRAIN RES, V178, P308, DOI 10.1007/s00221-006-0734-x; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Fraga Cesar G., 2005, Molecular Aspects of Medicine, V26, P235, DOI 10.1016/j.mam.2005.07.013; Giuliani A, 2000, PROTEIN ENG, V13, P671, DOI 10.1093/protein/13.10.671; Henn BC, 2010, EPIDEMIOLOGY, V21, P433, DOI 10.1097/EDE.0b013e3181df8e52; Labini FS, 2012, GAIT POSTURE, V35, P48, DOI 10.1016/j.gaitpost.2011.08.004; Leao RN, 2005, P ROY SOC B-BIOL SCI, V272, P2551, DOI 10.1098/rspb.2005.3258; Li XL, 2004, PHYS LETT A, V333, P164, DOI 10.1016/j.physleta.2004.10.028; Marino AA, 2002, BRAIN RES, V951, P301, DOI 10.1016/S0006-8993(02)03177-3; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; Marwan N, 2002, PHYS LETT A, V302, P299, DOI 10.1016/S0375-9601(02)01170-2; Marwan N., 2010, CROSS RECURRENCE PLO; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Marwan N, 2009, PHYS LETT A, V373, P4246, DOI 10.1016/j.physleta.2009.09.042; MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654; Naschitz JE, 2003, J HUM HYPERTENS, V17, P111, DOI 10.1038/sj.jhh.1001517; Naschitz JE, 2002, CLIN AUTON RES, V12, P264, DOI 10.1007/s10286-002-0044-8; PEEREBOOM JWC, 1985, SCI TOTAL ENVIRON, V42, P1; Peng Y, 2011, MED BIOL ENG COMPUT, V49, P25, DOI 10.1007/s11517-010-0671-5; Porrello A, 2004, PROTEINS, V55, P743, DOI 10.1002/prot.20075; Ramdani S, 2013, ANN BIOMED ENG, V41, P1713, DOI 10.1007/s10439-013-0790-x; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; SCALES WE, 1988, J APPL PHYSIOL, V65, P1840, DOI 10.1152/jappl.1988.65.4.1840; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thiel M, 2006, EUROPHYS LETT, V75, P535, DOI 10.1209/epl/i2006-10147-0; Thiel M, 2002, PHYSICA D, V171, P138, DOI 10.1016/S0167-2789(02)00586-9; Thomasson N, 2001, PHYS LETT A, V279, P94, DOI 10.1016/S0375-9601(00)00815-X; Vena A, 2004, CHAOS SOLITON FRACT, V22, P869, DOI 10.1016/j.chaos.2004.03.005; Webber CL, 2009, PHYS LETT A, V373, P3753, DOI 10.1016/j.physleta.2009.08.052; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Webber CLZ, 2005, RECURRENCE QUANTIFIC, P26; Zbilut JP, 1998, PROTEIN ENG, V11, P87, DOI 10.1093/protein/11.2.87; Zbilut JP, 2002, MED ENG PHYS, V24, P53, DOI 10.1016/S1350-4533(01)00112-6; Zbilut JP, 2002, CELL BIOCHEM BIOPHYS, V36, P67, DOI 10.1385/CBB:36:1:67; Zbilut JP, 1998, PHYS LETT A, V237, P131, DOI 10.1016/S0375-9601(97)00843-8; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M; Zbilut JP, 1998, PHYS LETT A, V246, P122, DOI 10.1016/S0375-9601(98)00457-5; Zbilut JP, 2000, PROTEIN ENG, V13, P99, DOI 10.1093/protein/13.2.99	48	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187049	10.1371/journal.pone.0187049	http://dx.doi.org/10.1371/journal.pone.0187049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112980	Green Submitted, Green Published, gold			2022-12-26	WOS:000414572100007
J	Tighilet, B; Pericat, D; Frelat, A; Cazals, Y; Rastoldo, G; Boyer, F; Dumas, O; Chabbert, C				Tighilet, Brahim; Pericat, David; Frelat, Alais; Cazals, Yves; Rastoldo, Guillaume; Boyer, Florent; Dumas, Olivier; Chabbert, Christian			Adjustment of the dynamic weight distribution as a sensitive parameter for diagnosis of postural alteration in a rodent model of vestibular deficit	PLOS ONE			English	Article							RAT MODEL; COMPENSATION; DEAFFERENTATION; RECEPTOR; NUCLEI	Vestibular disorders, by inducing significant posturo-locomotor and cognitive disorders, can significantly impair the most basic tasks of everyday life. Their precise diagnosis is essential to implement appropriate therapeutic countermeasures. Monitoring their evolution is also very important to validate or, on the contrary, to adapt the undertaken therapeutic actions. To date, the diagnosis methods of posturo-locomotor impairments are restricted to examinations that most often lack sensitivity and precision. In the present work we studied the alterations of the dynamic weight distribution in a rodent model of sudden and complete unilateral vestibular loss. We used a system of force sensors connected to a data analysis system to quantify in real time and in an automated way the weight bearing of the animal on the ground. We show here that sudden, unilateral, complete and permanent loss of the vestibular inputs causes a severe alteration of the dynamic ground weight distribution of vestibulo lesioned rodents. Characteristics of alterations in the dynamic weight distribution vary over time and follow the sequence of appearance and disappearance of the various symptoms that compose the vestibular syndrome. This study reveals for the first time that dynamic weight bearing is a very sensitive parameter for evaluating posturo-locomotor function impairment. Associated with more classical vestibular examinations, this paradigm can considerably enrich the methods for assessing and monitoring vestibular disorders. Systematic application of this type of evaluation to the dizzy or unstable patient could improve the detection of vestibular deficits and allow predicting better their impact on posture and walk. Thus it could also allow a better follow-up of the therapeutic approaches for rehabilitating gait and balance.	[Tighilet, Brahim; Pericat, David; Frelat, Alais; Cazals, Yves; Rastoldo, Guillaume; Boyer, Florent; Dumas, Olivier; Chabbert, Christian] Aix Marseille Univ, CNRS, Integrat & Adaptat Neurosci UMR 7260, Team Pathophysiol & Therapy Vestibular Disorders, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Tighilet, B; Chabbert, C (corresponding author), Aix Marseille Univ, CNRS, Integrat & Adaptat Neurosci UMR 7260, Team Pathophysiol & Therapy Vestibular Disorders, Marseille, France.	brahim.tighilet@univ-amu.fr; christian.chabbert@univ-amu.fr		CHABBERT, CHRISTIAN/0000-0003-3932-0223	Ministere de l'enseignement superieur et de la recherche; CNRS (Aix Marseille Universite) [UMR7260]	Ministere de l'enseignement superieur et de la recherche; CNRS (Aix Marseille Universite)	This research was supported by grants from the "Ministere de l'enseignement superieur et de la recherche" and "CNRS (UMR7260 Aix Marseille Universite".	Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Asher DL, 1984, HEARING DISORDERS, V2, P195; Boadas-Vaello P, 2005, TOXICOL SCI, V88, P456, DOI 10.1093/toxsci/kfi314; Desmadryl G, 2012, BRIT J PHARMACOL, V167, P905, DOI 10.1111/j.1476-5381.2012.02049.x; Dutheil S, 2016, J NEUROSCI, V36, P6199, DOI 10.1523/JNEUROSCI.0945-16.2016; Dyhrfjeld-Johnsen J, 2013, J VESTIBUL RES-EQUIL, V23, P177, DOI 10.3233/VES-130483; Gaboyard-Niay S, 2016, DIS MODEL MECH, V9, P1181, DOI 10.1242/dmm.024521; Gunther L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120891; Hall C., 1932, U CALIF PUBL PSYCHOL, V6, P1; Jones Sherri M., 2009, Seminars in Hearing, V30, P231, DOI 10.1055/s-0029-1241124; Lacour M, 1997, EXP BRAIN RES, V115, P300, DOI 10.1007/PL00005698; Lacour M, 2010, RESTOR NEUROL NEUROS, V28, P19, DOI 10.3233/RNN-2010-0509; Liberge M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-91; Luxon L. M., 1984, VERTIGO, P1; Pericat D, 2017, J NEUROSCI METH, V283, P83, DOI 10.1016/j.jneumeth.2017.04.001; Tighilet B, 2015, EUR J PHARM; XERRI C, 1983, J NEUROPHYSIOL, V50, P428, DOI 10.1152/jn.1983.50.2.428; XERRI C, 1980, ACTA OTO-LARYNGOL, V90, P414, DOI 10.3109/00016488009131743	18	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187472	10.1371/journal.pone.0187472	http://dx.doi.org/10.1371/journal.pone.0187472			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112981	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100018
J	Charley, PA; Wilusz, CJ; Wilusz, J				Charley, Phillida A.; Wilusz, Carol J.; Wilusz, Jeffrey			Identification of phlebovirus and arenavirus RNA sequences that stall and repress the exoribonuclease XRN1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBGENOMIC FLAVIVIRUS RNA; GENE-EXPRESSION; HUR PROTEIN; MOSQUITO; TRANSCRIPTION; DEGRADATION; PSEUDOKNOT; POLYADENYLATION; DEADENYLATION; INTERFERENCE	Regulated mRNA decay plays a vital role in determining both the level and quality of cellular gene expression. Viral RNAs must successfully evade this host RNA decay machinery to establish a productive infection. One way for RNA viruses to accomplish this is to target the cellular exoribonuclease XRN1, because this enzyme is accessible in the cytoplasm and plays a major role in mRNA decay. Members of the Flaviviridae use RNA structures in their 5 -or 3 -untranslated regions to stall and repress XRN1, effectively stabilizing viral RNAs while also causing significant dysregulation of host cell mRNA stability. Here, we use a series of biochemical assays to demonstrate that the 3 -terminal portion of the nucleocapsid (N) mRNA of Rift Valley fever virus, a phlebovirus of the Bunyaviridae family, also can effectively stall and repress XRN1. The region responsible for impeding XRN1 includes a G-rich portion that likely forms a G-quadruplex structure. The 3 -terminal portions of ambisense-derived transcripts of multiple arenaviruses also stalled XRN1. Therefore, we conclude thatRNAsfrom two additional families of mammalian RNA viruses stall and repress XRN1. This observation. emphasizes the importance and commonality of this viral strategy to interfere with the 5 -to-3 exoribonuclease component of the cytoplasmic RNA decay machinery	[Charley, Phillida A.; Wilusz, Carol J.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Wilusz, J (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	jeffrey.wilusz@colostate.edu	Wilusz, Carol/AAC-2901-2021		National Institutes of Health [AI123136]; College of Veterinary Medicine and Biomedical Sciences College Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Veterinary Medicine and Biomedical Sciences College Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI123136 and a grant from the College of Veterinary Medicine and Biomedical Sciences College Research Council (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963; Akiyama BM, 2016, CURR OPIN STRUC BIOL, V36, P40, DOI 10.1016/j.sbi.2015.12.006; Alkan C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004519; Balistreri G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010024; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242; Bosco-Lauth AM, 2016, EMERG INFECT DIS, V22, P2070, DOI 10.3201/eid2212.160472; Chang DC, 2016, VIROLOGY, V499, P259, DOI 10.1016/j.virol.2016.09.022; CHANG JH, 2011, MOL BIOL, V18, P270, DOI DOI 10.1038/NSMB.1984; Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897; Charley PA, 2014, CURR OPIN VIROL, V9, P14, DOI 10.1016/j.coviro.2014.09.001; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Cheng CP, 2006, J VIROL, V80, P2631, DOI 10.1128/JVI.80.6.2631-2640.2006; Cheng E, 2012, J VIROL, V86, P10173, DOI 10.1128/JVI.05560-11; Dickson AM, 2012, J BIOL CHEM, V287, P36229, DOI 10.1074/jbc.M112.371203; Flobinus A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100272; Ford LP, 1999, METHODS, V17, P21, DOI 10.1006/meth.1998.0703; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Garneau NL, 2008, J VIROL, V82, P880, DOI 10.1128/JVI.01205-07; Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16; Grande-Perez A, 2016, CURR TOP MICROBIOL, V392, P231, DOI 10.1007/82_2015_468; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hogg JR, 2016, J VIROL, V90, P7010, DOI 10.1128/JVI.00607-16; Hyde JL, 2015, VIROLOGY, V479, P66, DOI 10.1016/j.virol.2015.01.019; Ibrahim H, 2008, BBA-GENE REGUL MECH, V1779, P256, DOI 10.1016/j.bbagrm.2007.11.004; Iwakawa HO, 2008, J VIROL, V82, P10162, DOI 10.1128/JVI.01027-08; Jaag HM, 2009, VIROLOGY, V386, P344, DOI 10.1016/j.virol.2009.01.015; Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599; Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819; Lopez N, 2007, VIRUS RES, V124, P237, DOI 10.1016/j.virusres.2006.10.007; Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Molleston JM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010002; Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009; Moon SL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004708; Moon SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003762; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Nagarajan VK, 2013, BBA-GENE REGUL MECH, V1829, P590, DOI 10.1016/j.bbagrm.2013.03.005; OPYRCHAL M, 2005, MOL BIOL, V235, P1321, DOI DOI 10.1016/J.IBMB.2005.08.004; Pashler AL, 2016, BIOCHEM SOC T, V44, P1377, DOI 10.1042/BST20160107; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Raices M, 2017, CURR OPIN CELL BIOL, V46, P26, DOI 10.1016/j.ceb.2016.12.006; Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003; Stammler SN, 2011, RNA, V17, P1747, DOI 10.1261/rna.2816711; Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Ullmer W, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120335; WILUSZ J, 1988, CELL, V52, P221, DOI 10.1016/0092-8674(88)90510-7; Zust R, 2008, J VIROL, V82, P1214, DOI 10.1128/JVI.01690-07	54	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					285	295		10.1074/jbc.M117.805796	http://dx.doi.org/10.1074/jbc.M117.805796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29118186	hybrid, Green Published			2022-12-26	WOS:000419453200024
J	Oliveira, RD; Mousel, MR; Pabilonia, KL; Highland, MA; Taylor, JB; Knowles, DP; White, SN				Oliveira, Ryan D.; Mousel, Michelle R.; Pabilonia, Kristy L.; Highland, Margaret A.; Taylor, J. Bret; Knowles, Donald P.; White, Stephen N.			Domestic sheep show average Coxiella burnetii seropositivity generations after a sheep-associated human Q fever outbreak and lack detectable shedding by placental, vaginal, and fecal routes	PLOS ONE			English	Article							UNITED-STATES; INFECTION; GOATS; AIR; EPIDEMIOLOGY; CALIFORNIA; RECOVERY; EPISODE; FARMS; DNA	Coxiella burnetii is a globally distributed zoonotic bacterial pathogen that causes abortions in ruminant livestock. In humans, an influenza-like illness results with the potential for hospitalization, chronic infection, abortion, and fatal endocarditis. Ruminant livestock, particularly small ruminants, are hypothesized to be the primary transmission source to humans. A recent Netherlands outbreak from 2007-2010 traced to dairy goats resulted in over 4,100 human cases with estimated costs of more than 300 million euros. Smaller human Q fever outbreaks of small ruminant origin have occurred in the United States, and characterizing shedding is important to understand the risk of future outbreaks. In this study, we assessed bacterial shedding and seroprevalence in 100 sheep from an Idaho location associated with a 1984 human Q fever outbreak. We observed 5% seropositivity, which was not significantly different from the national average of 2.7% for the U.S. (P>0.05). Furthermore, C. burnetii was not detected by quantitative PCR from placentas, vaginal swabs, or fecal samples. Specifically, a three-target quantitative PCR of placenta identified 0.0% shedding (exact 95% confidence interval: 0.0%-2.9%). While presence of seropositive individuals demonstrates some historical C. burnetii exposure, the placental sample confidence interval suggests 2016 shedding events were rare or absent. The location maintained the flock with little or no depopulation in 1984 and without C. burnetii vaccination during or since 1984. It is not clear how a zero-shedding rate was achieved in these sheep beyond natural immunity, and more work is required to discover and assess possible factors that may contribute towards achieving zero-shedding status. We provide the first U.S. sheep placental C. burnetii shedding update in over 60 years and demonstrate potential for C. burnetii shedding to reach undetectable levels after an outbreak event even in the absence of targeted interventions, such as vaccination.	[Oliveira, Ryan D.; Knowles, Donald P.; White, Stephen N.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Mousel, Michelle R.; Highland, Margaret A.; Knowles, Donald P.; White, Stephen N.] USDA ARS Anim Dis Res, Pullman, WA 99164 USA; [Mousel, Michelle R.; Highland, Margaret A.; Knowles, Donald P.] Washington State Univ, Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Pabilonia, Kristy L.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Highland, Margaret A.] Washington State Univ, Washington Anim Dis Diagnost Lab, Pullman, WA 99164 USA; [Taylor, J. Bret] USDA ARS Range Sheep Prod Efficiency Res, Dubois, ID USA; [White, Stephen N.] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University; Washington State University; Colorado State University; Washington State University; Washington State University	White, SN (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.; White, SN (corresponding author), USDA ARS Anim Dis Res, Pullman, WA 99164 USA.; White, SN (corresponding author), Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA.	Stephen.White@ars.usda.gov	Oliveira, Ryan D/M-9254-2019; Highland, Margaret/ABF-3396-2021	White, Stephen N./0000-0001-9255-6054; Oliveira, Ryan/0000-0002-4822-3698	National Sheep Industry Improvement Center [122337_001]; USDA-ARS [2090-32000-035-00D, 2056-31000-011-00D]; Department of Veterinary Microbiology & Pathology at Washington State University; ARCS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER	National Sheep Industry Improvement Center; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Department of Veterinary Microbiology & Pathology at Washington State University; ARCS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Sheep Industry Improvement Center grant 122337_001 and by USDA-ARS 2090-32000-035-00D and USDA-ARS 2056-31000-011-00D. RDO was supported by a combined residency program fellowship from the Department of Veterinary Microbiology & Pathology at Washington State University and by an Achievement Rewards for College Scientists (ARCS) Fellowship from the ARCS Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; Anderson A, 2013, DIAGNOSIS MANAGEMENT; Arricau-Bouvery N, 2005, VACCINE, V23, P4392, DOI 10.1016/j.vaccine.2005.04.010; Ben Amara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015315; Berri M, 2007, RES VET SCI, V83, P47, DOI 10.1016/j.rvsc.2006.11.001; Berri M, 2005, VET REC, V157, P737, DOI 10.1136/vr.157.23.737; Berri M, 2002, VET MICROBIOL, V85, P55, DOI 10.1016/S0378-1135(01)00480-1; Berri M, 2001, VET REC, V148, P502, DOI 10.1136/vr.148.16.502; Brown L. D., 2001, INTERVAL ESTIMATION, P101, DOI [10.1214/ss/1009213286, DOI 10.1214/SS/1009213286]; Dahlgren FS, 2015, AM J TROP MED HYG, V92, P247, DOI 10.4269/ajtmh.14-0503; de Bruin A, 2012, APPL ENVIRON MICROB, V78, P1652, DOI 10.1128/AEM.07323-11; DELAY PD, 1950, J IMMUNOL, V65, P211; DUPONT HT, 1992, AM J MED, V93, P427, DOI 10.1016/0002-9343(92)90173-9; DUPUIS G, 1987, INT J EPIDEMIOL, V16, P282, DOI 10.1093/ije/16.2.282; Eibach R, 2012, BERLINER MUNCHENER T, V126, P3; Georgiev M, 2013, EUROSURVEILLANCE, V18, P20407; Guo HR, 1998, J OCCUP ENVIRON MED, V40, P999, DOI 10.1097/00043764-199811000-00011; Hartwell HW, 1896, PUBLIC HLTH REPORTS, V66, P1473; Hartzell JD, 2012, MIL MED, V177, P484, DOI 10.7205/MILMED-D-12-00059; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; Hilbert Angela, 2012, BMC Res Notes, V5, P152, DOI 10.1186/1756-0500-5-152; Jones RM, 2006, APPL BIOSAF, V11, P32; Kersh GJ, 2013, APPL ENVIRON MICROB, V79, P1697, DOI 10.1128/AEM.03472-12; Kersh GJ, 2010, J CLIN MICROBIOL, V48, P3428, DOI 10.1128/JCM.00758-10; Kersh GJ, 2010, APPL ENVIRON MICROB, V76, P4469, DOI 10.1128/AEM.00042-10; Kim SG, 2005, EMERG INFECT DIS, V11, P619, DOI 10.3201/eid1104.041036; Lang G. H., 1990, Q FEVER, P23; Langley JM, 2003, AM J OBSTET GYNECOL, V189, P228, DOI 10.1067/mob.2003.448; LENNETTE EH, 1951, AM J HYG, V54, P44, DOI 10.1093/oxfordjournals.aje.a119469; Loftis AD, 2006, EXP APPL ACAROL, V40, P67, DOI 10.1007/s10493-006-9025-2; Lyytikainen O, 1998, EUR J EPIDEMIOL, V14, P193, DOI 10.1023/A:1007452503863; MARMION BP, 1958, BMJ-BRIT MED J, V2, P809, DOI 10.1136/bmj.2.5100.809; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MCCAUL TF, 1981, J BACTERIOL, V147, P1063, DOI 10.1128/JB.147.3.1063-1076.1981; Mcquiston JH, 2002, VECTOR-BORNE ZOONOT, V2, P179, DOI 10.1089/15303660260613747; Monteiro L, 1997, J CLIN MICROBIOL, V35, P995, DOI 10.1128/JCM.35.4.995-998.1997; Nielsen LN, 2011, VET J, V190, P150, DOI [10.1016/j.tvjl.2010.09.016, 10.1016/j.tvjl.2010.12.021]; Norlander L, 2000, MICROBES INFECT, V2, P417, DOI 10.1016/S1286-4579(00)00325-7; O'Neill TJ., 2012, COXIELLA BURNETII SM; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Porter Sarah Rebecca, 2011, Int J Microbiol, V2011, P248418, DOI 10.1155/2011/248418; RAUCH AM, 1987, ARCH INTERN MED, V147, P341, DOI 10.1001/archinte.147.2.341; ROBBINS FC, 1946, AM J HYG, V44, P6, DOI 10.1093/oxfordjournals.aje.a119084; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Rousset E, 2009, APPL ENVIRON MICROB, V75, P428, DOI 10.1128/AEM.00690-08; Ruppanner R, 1982, ARCH ENV HLTH, V37; Sanchez J, 2006, J COMP PATHOL, V135, P108, DOI 10.1016/j.jcpa.2006.06.003; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; SINGH SB, 1985, AM J VET RES, V46, P321; STOENNER HG, 1959, AM J HYG, V69, P202, DOI 10.1093/oxfordjournals.aje.a119995; Tissot-Dupont H, 1999, AM J EPIDEMIOL, V150, P67, DOI 10.1093/oxfordjournals.aje.a009920; TOPPING NH, 1947, JAMA-J AM MED ASSOC, V133, P813, DOI 10.1001/jama.1947.02880120001001; TSELENTIS Y, 1995, CLIN INFECT DIS, V20, P1311, DOI 10.1093/clinids/20.5.1311; van Asseldonk MAPM, 2015, PREV VET MED, V121, P115, DOI 10.1016/j.prevetmed.2015.06.010; van Asseldonk MAPM, 2013, PREV VET MED, V112, P27, DOI 10.1016/j.prevetmed.2013.06.002; Van Leuken JPG, 2016, ONE HEALTH, V2, P77, DOI 10.1016/j.onehlt.2016.03.004; WELSH HH, 1951, PUBLIC HEALTH REP, V66, P1473, DOI 10.2307/4587909; WELSH HH, 1958, ANN NY ACAD SCI, V70, P528, DOI 10.1111/j.1749-6632.1958.tb35409.x; Yanase T, 1998, MICROBIOL IMMUNOL, V42, P51, DOI 10.1111/j.1348-0421.1998.tb01969.x	59	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188054	10.1371/journal.pone.0188054	http://dx.doi.org/10.1371/journal.pone.0188054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141023	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400048
J	Navarro-Quiroz, E; Pacheco-Lugo, L; Navarro-Quiroz, R; Lorenzi, H; Espana-Puccini, P; Diaz-Olmos, Y; Almendrales, L; Olave, V; Gonzalez-Torres, H; Diaz-Perez, A; Dominguez, A; Iglesias, A; Garcia, R; Aroca-Martinez, G				Navarro-Quiroz, Elkin; Pacheco-Lugo, Lisandro; Navarro-Quiroz, Roberto; Lorenzi, Hernan; Espana-Puccini, Pierine; Diaz-Olmos, Yirys; Almendrales, Lisneth; Olave, Valeria; Gonzalez-Torres, Henry; Diaz-Perez, Anderson; Dominguez, Alex; Iglesias, Antonio; Garcia, Raul; Aroca-Martinez, Gustavo			Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis	PLOS ONE			English	Article							T-CELLS; ERYTHEMATOSUS; EXPRESSION; DISEASE; PATHOGENESIS; DATABASE; TARGETS; CLASSIFICATION; MIGRATION; REVEALS	Renal involvement in Systemic Lupus Erythematous (SLE) patients is one of the leading causes of morbidity and a significant contributor to mortality. It's estimated that nearly 50% of SLE individuals develop kidney disease in the first year of the diagnosis. Class IV lupus nephritis (LN-IV) is the class of lupus nephritis most common in Colombian patients with SLE. Altered miRNAs expression levels have been reported in human autoimmune diseases including lupus. Variations in the expression pattern of peripheral blood circulating miRNAs specific for this class of lupus nephritis could be correlated with the pathophysiological status of this group of individuals. The aim of this study was to evaluate the relative abundance of circulating microRNAs in peripheral blood from Colombian patients with LN-IV. Circulating miRNAs in plasma of patients with diagnosis of LN-IV were compared with individuals without renal involvement (LNN group) and healthy individuals (CTL group). Total RNA was extracted from 10 ml of venous blood and subsequently sequenced using Illumina. The sequences were processed and these were analyzed using miRBase and Ensembl databases. Differential gene expression analysis was carried out with edgeR and functional analysis were done with DIANA-miRPath. Analysis was carried out using as variables of selection fold change (>= 2 o <=-2) and false discovery rate (0.05). We identified 24 circulating microRNAs with differential abundance between LN-IV and CTL groups, fourteen of these microRNAs are described for the first time to lupus nephritis (hsa-miR-589-3p, hsa-miR-1260b, hsa-miR-4511, hsa-miR485-5p, hsa-miR-584-5p, hsa-miR-543, hsa-miR-153-3p, hsa-miR-6087, hsa-miR-3942-5p, hsa-miR-7977, hsa-miR-323b-3p, hsa-miR-4732-3p and hsa-miR-6741-3p). These changes in the abundance of miRNAs could be interpreted as alterations in the miRNAs-mRNA regulatory network in the pathogenesis of LN, preceding the clinical onset of the disease. The findings thus contribute to understanding the disease process and are likely to pave the way towards identifying disease biomarkers for early diagnosis of LN.	[Navarro-Quiroz, Elkin; Pacheco-Lugo, Lisandro; Espana-Puccini, Pierine; Diaz-Olmos, Yirys; Almendrales, Lisneth; Olave, Valeria; Gonzalez-Torres, Henry; Diaz-Perez, Anderson; Dominguez, Alex; Aroca-Martinez, Gustavo] Univ Simon Bolivar, Grp Nefrol, Barranquilla, Colombia; [Navarro-Quiroz, Roberto] Univ Cooperat Colombia, Ctr Invest Salud Trop, Santa Marta, Colombia; [Lorenzi, Hernan] J Craig Venter Inst, Infect Dis Dept, Rockville, MD USA; [Iglesias, Antonio] Univ Nacl Colombia, Unidad Reumatol, Bogota, Colombia; [Garcia, Raul; Aroca-Martinez, Gustavo] Clin Costa, Barranquilla, Colombia	Universidad Cooperativa de Colombia; J. Craig Venter Institute; Universidad Nacional de Colombia	Navarro-Quiroz, E (corresponding author), Univ Simon Bolivar, Grp Nefrol, Barranquilla, Colombia.	enavarro26@unisimonbolivar.edu.co	Aroca Martinez, Gustavo/N-9133-2013; Aroca, Gustavo/P-9173-2016; QUIROZ, ROBERTO CARLOS NAVARRO/P-9517-2017; Domínguez-Vargas, Alex/D-4272-2019; Quiroz, Elkin Navarro/AAB-6381-2019; Aroca-Martínez, Gustavo/AAV-7952-2021; González-Torres, Henry Joseth/AAW-4602-2020; Diaz-Perez, Anderson/Q-2320-2016	Aroca Martinez, Gustavo/0000-0002-9222-3257; Aroca, Gustavo/0000-0002-9222-3257; QUIROZ, ROBERTO CARLOS NAVARRO/0000-0002-3604-3702; Domínguez-Vargas, Alex/0000-0002-3984-8653; Quiroz, Elkin Navarro/0000-0001-7567-6409; González-Torres, Henry Joseth/0000-0001-7434-4568; Lorenzi, Hernan/0000-0003-0910-7894; Diaz-Perez, Anderson/0000-0003-2448-0953; Pacheco-Lugo, Lisandro/0000-0002-9248-4596	Colciencias [125356934453]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	Research supported by Colciencias grants 125356934453.	Ajit SK, 2012, SENSORS-BASEL, V12, P3359, DOI 10.3390/s120303359; Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Arroyo C AR, 2014, REV COLOMB NEFROL, V1, P57; Balakrishnan I, 2014, STEM CELLS, V32, P662, DOI 10.1002/stem.1531; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carlsen AL, 2013, ARTHRITIS RHEUM-US, V65, P1324, DOI 10.1002/art.37890; Celhar T, 2015, P NATL ACAD SCI USA, V112, pE6195, DOI 10.1073/pnas.1507052112; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; Choi EW, 2016, SCI REP-UK, V6, DOI 10.1038/srep38237; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Contreras G, 2006, KIDNEY INT, V69, P1846, DOI 10.1038/sj.ki.5000243; Davidson A, 2016, NAT REV RHEUMATOL, V12, P143, DOI 10.1038/nrrheum.2015.159; de Souza Rocha Simonini P, 2010, CANCER RES, V70, P9175, DOI DOI 10.1158/0008-5472.CAN-10-1318; Edwards LJ, 2015, CLIN IMMUNOL, V158, P221, DOI 10.1016/j.clim.2015.04.004; Fang XY, 2014, RHEUMATOL INT, V34, P1175, DOI 10.1007/s00296-013-2873-2; Feng B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043452; GORDON C, 1989, CLIN IMMUNOL IMMUNOP, V52, P421, DOI 10.1016/0090-1229(89)90157-8; Haladyj Ewa, 2016, Reumatologia (Warsaw), V54, P61, DOI [10.5114/reum.2016.60214, 10.5114/reum.2016.06214]; Hedrich CM, 2014, P NATL ACAD SCI USA, V111, P13457, DOI 10.1073/pnas.1408023111; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Karginov FV, 2013, GENE DEV, V27, P1624, DOI 10.1101/gad.215939.113; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Lech M, 2013, J AM SOC NEPHROL, V24, P1357, DOI 10.1681/ASN.2013010026; Li Y, 2014, NUCLEIC ACIDS RES, V42, pD1070, DOI 10.1093/nar/gkt1023; Liu DM, 2016, CELL PHYSIOL BIOCHEM, V39, P303, DOI 10.1159/000445625; Liu YJ, 2014, NEPHRON CLIN PRACT, V128, P224, DOI 10.1159/000368581; Lu MC, 2013, CLIN EXP IMMUNOL, V171, P91, DOI 10.1111/j.1365-2249.2012.04676.x; Lu RJ, 2014, J CANCER RES CLIN, V140, P387, DOI 10.1007/s00432-013-1577-z; Navarro-Quiroz E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166202; Palm T, 2013, NUCLEIC ACIDS RES, V41, P3699, DOI 10.1093/nar/gkt070; Pan QJ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-67; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Prud'homme GJ, 2000, J AUTOIMMUN, V14, P23, DOI 10.1006/jaut.1999.0339; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; SAITO Y, 2012, FRONT GENET, V3; Schena FP, 2015, CLIN SCI, V128, P775, DOI 10.1042/CS20140733; Talaat RM, 2015, CYTOKINE, V72, P146, DOI 10.1016/j.cyto.2014.12.027; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13	48	43	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187973	10.1371/journal.pone.0187973	http://dx.doi.org/10.1371/journal.pone.0187973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136041	Green Published, gold			2022-12-26	WOS:000415121200052
J	Yang, HY; Sun, M; Lin, SJ; Guo, YH; Yang, YJ; Zhang, TX; Zhang, JX				Yang, Haiyan; Sun, Ming; Lin, Shuangji; Guo, Yanhong; Yang, Yongjuan; Zhang, Tengxun; Zhang, Jingxing			Transcriptome analysis of Crossostephium chinensis provides insight into the molecular basis of salinity stress responses	PLOS ONE			English	Article							ENHANCES SALT TOLERANCE; FREE POLYAMINE LEVELS; RNA-SEQ; TRANSGENIC ARABIDOPSIS; ACTIVATED EXPRESSION; SIGNAL-TRANSDUCTION; ION HOMEOSTASIS; GENE-EXPRESSION; KINASE GENE; PLANTS	Soil salinization is becoming a limitation to the utilization of ornamental plants worldwide. Crossostephium chinensis (Linnaeus) Makino is often cultivated along the southeast coast of China for its desirable ornamental qualities and high salt tolerance. However, little is known about the genomic background of the salt tolerance mechanism in C. chinensis. In the present study, we used Illumina paired-end sequencing to systematically investigate leaf transcriptomes derived from C. chinensis seedlings grown under normal conditions and under salt stress. A total of 105,473,004 bp of reads were assembled into 163,046 unigenes, of which 65,839 (40.38% of the total) and 54,342 (33.32% of the total) were aligned in Swiss-Prot and Nr protein, respectively. A total of 11,331 (6.95%) differentially expressed genes (DEGs) were identified among three comparisons, including 2,239 in 'ST3 vs ST0', 5,880 in 'ST9 vs ST3' and 9,718 in 'ST9 vs ST0', and they were generally classified into 26 Gene Ontology terms and 58 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway terms. Many genes encoding important transcription factors (e.g., WRKY, MYB, and AP2/EREBP) and proteins involved in starch and sucrose metabolism, arginine and proline metabolism, plant hormone signal transduction, amino acid biosynthesis, plant-pathogen interactions and carbohydrate metabolism, among others, were substantially up-regulated under salt stress. These genes represent important candidates for studying the salt-response mechanism and molecular biology of C. chinensis and its relatives. Our findings provide a genomic sequence resource for functional genetic assignments in C. chinensis. These transcriptome datasets will help elucidate the molecular mechanisms responsible for salt-stress tolerance in C. chinensis and facilitate the breeding of new stress-tolerant cultivars for high-saline areas using this valuable genetic resource.	[Yang, Haiyan; Sun, Ming; Lin, Shuangji; Guo, Yanhong; Yang, Yongjuan; Zhang, Tengxun; Zhang, Jingxing] Beijing Forestry Univ, Coll Landscape Architecture, Beijing, Peoples R China; [Yang, Haiyan; Sun, Ming; Lin, Shuangji; Guo, Yanhong; Yang, Yongjuan; Zhang, Tengxun; Zhang, Jingxing] Beijing Key Lab Ornamental Plant Germplasm Innova, Beijing, Peoples R China; [Yang, Haiyan; Sun, Ming; Lin, Shuangji; Guo, Yanhong; Yang, Yongjuan; Zhang, Tengxun; Zhang, Jingxing] Beijing Lab Urban & Rural Ecol Environm, Beijing, Peoples R China; [Sun, Ming] Natl Engn Res Ctr Floriculture, Beijing, Peoples R China; [Yang, Haiyan] Beijing Forestry Univ, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Sun, M (corresponding author), Beijing Forestry Univ, Coll Landscape Architecture, Beijing, Peoples R China.; Sun, M (corresponding author), Beijing Key Lab Ornamental Plant Germplasm Innova, Beijing, Peoples R China.; Sun, M (corresponding author), Beijing Lab Urban & Rural Ecol Environm, Beijing, Peoples R China.; Sun, M (corresponding author), Natl Engn Res Ctr Floriculture, Beijing, Peoples R China.	sunmingbjfu@163.com			Ministry of Science and Technology of China [2013BAD01B07, 2012BAD01B07]; National High Technology Research and Development Program of China [2013AA102706]; Fundamental Research Funds for the Central Universities [2015ZCQ-YL-03]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (grant no. 2013BAD01B07, 2012BAD01B07), the National High Technology Research and Development Program of China (grant no. 2013AA102706) and the Fundamental Research Funds for the Central Universities (no. 2015ZCQ-YL-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; !This work was supported by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (grant nos. 2013BAD01B07, 2012BAD01B07), the National High Technology Research and Development Program of China (grant no. 2013AA102706) and the Fundamental Research Funds for the Central Universities(grant no. 2015ZCQ-YL-03).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anjum NA, 2010, ASCORBATE-GLUTATHIONE PATHWAY AND STRESS TOLERANCE IN PLANTS, P1, DOI 10.1007/978-90-481-9404-9; [白雪 Bai Xue], 2015, [兰州大学学报. 自然科学版, Journal of Lanzhou University. Natural Science], V51, P397; Ashraf M, 2009, BIOTECHNOL ADV, V27, P744, DOI 10.1016/j.biotechadv.2009.05.026; Boudsocq M, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P75, DOI 10.1007/978-90-481-3112-9_4; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1583, DOI 10.1093/pcp/pcr107; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dalal M, 2009, J BIOTECHNOL, V139, P137, DOI 10.1016/j.jbiotec.2008.09.014; Deng YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044337; Fiil BK, 2009, CURR OPIN PLANT BIOL, V12, P615, DOI 10.1016/j.pbi.2009.07.017; Funck D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-70; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gorham J, 1997, NEW PHYTOL, V137, P109, DOI 10.1046/j.1469-8137.1997.00825.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gupta NK, 2013, ACTA PHYSIOL PLANT, V35, P1837, DOI 10.1007/s11738-013-1221-1; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; HEROUART D, 1993, P NATL ACAD SCI USA, V90, P3108, DOI 10.1073/pnas.90.7.3108; Huang H, 2012, PLANT SCI, V193, P18, DOI 10.1016/j.plantsci.2012.05.004; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Ito S, 2012, P NATL ACAD SCI USA, V109, P3582, DOI 10.1073/pnas.1118876109; Jiang YJ, 2012, MOL PLANT, V5, P1375, DOI 10.1093/mp/sss080; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katsuhara M, 2003, PLANT CELL PHYSIOL, V44, P1378, DOI 10.1093/pcp/pcg167; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Kishor PBK, 2014, PLANT CELL ENVIRON, V37, P300, DOI 10.1111/pce.12157; Knight H, 1998, PLANT J, V16, P681, DOI 10.1046/j.1365-313x.1998.00332.x; Lai ZB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-68; Legocka J, 2005, J PLANT PHYSIOL, V162, P662, DOI 10.1016/j.jplph.2004.08.009; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li HS, 2000, PRINCIPLES TECHNIQUE, P274; Li J, 2008, EUPHYTICA, V164, P293, DOI 10.1007/s10681-008-9734-1; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Liu QL, 2011, BIOTECHNOL LETT, V33, P2073, DOI 10.1007/s10529-011-0659-8; Liu Y, 2015, MOL BIOL EVOL, V20, P735; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu BB, 2006, J BIOCHEM MOL BIOL, V39, P607; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Mahajan S, 2008, ARCH BIOCHEM BIOPHYS, V471, P146, DOI 10.1016/j.abb.2008.01.010; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Motamayor JC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r53; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; NAOT D, 1995, PLANT MOL BIOL, V27, P619, DOI 10.1007/BF00019327; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sanchez E, 2001, J PLANT PHYSIOL, V158, P593, DOI 10.1078/0176-1617-00268; SantaCruz A, 1997, PHYSIOL PLANTARUM, V101, P341, DOI 10.1034/j.1399-3054.1997.1010213.x; Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Shan H, 2012, MOL BIOTECHNOL, V51, P160, DOI 10.1007/s12033-011-9451-1; Sharma R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126783; Shi HZ, 2002, PLANT PHYSIOL, V129, P585, DOI 10.1104/pp.001982; Tang FP, 2009, EUPHYTICA, V169, P133, DOI 10.1007/s10681-009-9956-x; Tonon G, 2004, J PLANT PHYSIOL, V161, P701, DOI 10.1078/0176-1617-01096; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang MZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0290-7; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yang YF, 2009, MOL BIOL REP, V36, P71, DOI 10.1007/s11033-007-9153-8; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	70	9	9	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187124	10.1371/journal.pone.0187124	http://dx.doi.org/10.1371/journal.pone.0187124			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131853	Green Published, Green Submitted, gold			2022-12-26	WOS:000414997800007
J	Hsu, HY; Lin, MC; Popovic, B; Lin, CR; Patankar, NA				Hsu, Hua-Yi; Lin, Ming-Chieh; Popovic, Bridget; Lin, Chii-Ruey; Patankar, Neelesh A.			A numerical investigation of the effect of surface wettability on the boiling curve	PLOS ONE			English	Article							HEAT-TRANSFER; SINGLE BUBBLE; CONTACT-ANGLE; DYNAMICS; VOLUME; FLUID; MODEL; SIMULATION; PREDICT; FLOWS	Surface wettability is recognized as playing an important role in pool boiling and the corresponding heat transfer curve. In this work, a systematic study of pool boiling heat transfer on smooth surfaces of varying wettability (contact angle range of 5 degrees - 180 degrees) has been conducted and reported. Based on numerical simulations, boiling curves are calculated and boiling dynamics in each regime are studied using a volume-of-fluid method with contact angle model. The calculated trends in critical heat flux and Leidenfrost point as functions of surface wettability are obtained and compared with prior experimental and theoretical predictions, giving good agreement. For the first time, the effect of contact angle on the complete boiling curve is shown. It is demonstrated that the simulation methodology can be used for studying pool boiling and related dynamics and providing more physical insights.	[Hsu, Hua-Yi; Lin, Chii-Ruey] Natl Taipei Univ Technol, Dept Mech Engn, Taipei, Taiwan; [Lin, Ming-Chieh] Hanyang Univ, Dept Elect & Biomed Engn, Seoul, South Korea; [Popovic, Bridget; Patankar, Neelesh A.] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA	National Taipei University of Technology; Hanyang University; Northwestern University	Hsu, HY (corresponding author), Natl Taipei Univ Technol, Dept Mech Engn, Taipei, Taiwan.; Lin, MC (corresponding author), Hanyang Univ, Dept Elect & Biomed Engn, Seoul, South Korea.	huayihsu@mail.ntut.edu.tw; mclin@hanyang.ac.kr	Patankar, Neelesh A/B-7603-2009	Hsu, Hua-Yi/0000-0002-8857-5452; Lin, Ming-Chieh/0000-0003-1653-6590	Taiwan Ministry of Science and Technology; Northwestern University; Hanyang University	Taiwan Ministry of Science and Technology; Northwestern University; Hanyang University	This study was supported by the Taiwan Ministry of Science and Technology to HYH, the McCormick Catalyst Award from Northwestern University to NAP, and by Hanyang University to MCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; H. Y. Hsu would like to acknowledge the support by Taiwan Ministry of Science and Technology, M. C. Lin would like to acknowledge the support by Hanyang University, and N. A. Patankar would like to acknowledge the support by the McCormick Catalyst Award from Northwestern University.	Ahn HS, 2006, J HEAT TRANS-T ASME, V128, P1335, DOI 10.1115/1.2349511; Ahn HS, 2012, INT J HEAT MASS TRAN, V55, P89, DOI 10.1016/j.ijheatmasstransfer.2011.08.044; Berenson P.J., 1961, J HEAT TRANS-T ASME, V83, P351, DOI DOI 10.1115/1.3682280; Bonilla CF, 1941, T AM INST CHEM ENG, V37, P0685; BRACKBILL JU, 1992, J COMPUT PHYS, V100, P335, DOI 10.1016/0021-9991(92)90240-Y; Carey V, 2007, LIQUID VAPOR PHASE C, V79, P113; Chen R, 2009, NANO LETT, V9, P548, DOI 10.1021/nl8026857; CICHELLI MT, 1945, T AM INST CHEM ENG, V41, P755; Dhir VK, 2013, J HEAT TRANS-T ASME, V135, DOI 10.1115/1.4023576; Dhir VK, 2016, PLEN TALK 2016 ASME; Dhir VK, 1999, P 5 ASME JSME JOINT; Gong S, 2015, INT J HEAT MASS TRAN, V85, P635, DOI 10.1016/j.ijheatmasstransfer.2015.02.008; Gong S, 2015, INT J HEAT MASS TRAN, V80, P206, DOI 10.1016/j.ijheatmasstransfer.2014.08.092; Guo ZL, 2000, J COMPUT PHYS, V165, P288, DOI 10.1006/jcph.2000.6616; Phan HT, 2012, INT COMMUN HEAT MASS, V39, P1500, DOI 10.1016/j.icheatmasstransfer.2012.10.019; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; Jones P, 2015, NATURE, V57, P1; Jorge PJ, 2014, THESIS; Jung S, 2014, INT J HEAT MASS TRAN, V73, P365, DOI 10.1016/j.ijheatmasstransfer.2014.02.014; Juric D, 1996, HEAT TRANSF DIV ASME, V79, P201; Juric D., 1995, ADV NUMERICAL MODELI, V234, P141; Kandlikar SG, 2001, J HEAT TRANS-T ASME, V123, P1071, DOI 10.1115/1.1409265; Kang MG, 1998, ANN NUCL ENERGY, V25, P295, DOI 10.1016/S0306-4549(97)00056-X; Kim HD, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2754644; Kim SJ, 2007, INT J HEAT MASS TRAN, V50, P4105, DOI 10.1016/j.ijheatmasstransfer.2007.02.002; Kunkelmann C, 2009, NUMER HEAT TR A-APPL, V56, P631, DOI 10.1080/10407780903423908; Kutateladze S., 1950, J TECH PHYS, V20, P1389; Kutateladze S. S., 1948, KOTLOTURBOSTROENIE, V3, P10; Lee WH, 1980, J COMPUTED PHYS, V3, P222; Li C, 2008, SMALL, V4, P1084, DOI 10.1002/smll.200700991; Li SH, 2008, ADV FUNCT MATER, V18, P2215, DOI 10.1002/adfm.200701405; Lorstad D, 2004, J COMPUT PHYS, V200, P153, DOI 10.1016/j.jcp.2004.04.001; Lorstad D, 2004, INT J NUMER METH FL, V46, P109, DOI 10.1002/fld.746; Mudawar I, 2001, IEEE T COMPON PACK T, V24, P122, DOI 10.1109/6144.926375; Mukherjee A, 2007, INT J HEAT MASS TRAN, V50, P127, DOI 10.1016/j.ijheatmasstransfer.2006.06.037; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Phan HT, 2009, CR MECANIQUE, V337, P251, DOI 10.1016/j.crme.2009.06.032; Son G, 1999, J HEAT TRANS-T ASME, V121, P623, DOI 10.1115/1.2826025; Son G, 2008, INT J HEAT MASS TRAN, V51, P2566, DOI 10.1016/j.ijheatmasstransfer.2007.07.046; Sun DL, 2014, NUMER HEAT TR B-FUND, V66, P326, DOI 10.1080/10407790.2014.915681; Thome JR, 1998, ENHANCED BOILING HEA; Ujereh S, 2007, INT J HEAT MASS TRAN, V50, P4023, DOI 10.1016/j.ijheatmasstransfer.2007.01.030; Vakarelski IU, 2012, NATURE, V489, P274, DOI 10.1038/nature11418; Wagner E., 2007, 4 INT BERL WORKSH TR; Zuber N., 1959, AECU4439 AEC, V1, P149	45	7	7	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187175	10.1371/journal.pone.0187175	http://dx.doi.org/10.1371/journal.pone.0187175			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125847	Green Submitted, Green Published, gold			2022-12-26	WOS:000414866000007
J	Linnander, E; Yuan, CT; Ahmed, S; Cherlin, E; Talbert-Slagle, K; Curry, LA				Linnander, Erika; Yuan, Christina T.; Ahmed, Shirin; Cherlin, Emily; Talbert-Slagle, Kristina; Curry, Leslie A.			Process evaluation of knowledge transfer across industries: Leveraging Coca-Cola's supply chain expertise for medicine availability in Tanzania	PLOS ONE			English	Article							QUALITATIVE RESEARCH; DRUG SHORTAGES; UNITED-STATES; HEALTH-CARE; SYSTEMS; ANTECEDENTS; REFLEXIVITY; COMMODITIES; COMPETENCE; BOUNDARIES	Persistent gaps in the availability of essential medicines have slowed the achievement of global health targets. Despite the supply chain knowledge and expertise that ministries of health might glean from other industries, limited empirical research has examined the process of knowledge transfer from other industries into global public health. We examined a partnership designed to improve the availability of medical supplies in Tanzania by transferring knowledge from The Coca-Cola system to Tanzania's Medical Stores Department (MSD). We conducted a process evaluation including in-depth interviews with 70 participants between July 2011 and May 2014, corresponding to each phase of the partnership, with focus on challenges and strategies to address them, as well as benefits perceived by partners. Partners faced challenges in (1) identifying relevant knowledge to transfer, (2) translating operational solutions from Coca-Cola to MSD, and (3) maintaining momentum between project phases. Strategies to respond to these challenges emerged through real-time problem solving and included (1) leveraging the receptivity of MSD leadership, (2) engaging a boundary spanner to identify knowledge to transfer, (3) promoting local recognition of commonalities across industries, (4) engaging external technical experts to manage translation activities, (5) developing tools with visible benefits for MSD, (6) investing in local relationships, and (7) providing time and space for the partnership model to evolve. Benefits of the partnership perceived by MSD staff included enhanced collaboration and communication, more proactive orientations in managing operations, and greater attention to performance management. Benefits perceived by Coca-Cola staff included strengthened knowledge transfer capability and enhanced job satisfaction. Linking theoretical constructs with practical experiences from the field, we highlight the challenges, emergent strategies, and perceived benefits of a partnership across industry boundaries that may be useful to others seeking to promote the transfer of knowledge to improve global health.	[Linnander, Erika; Yuan, Christina T.; Ahmed, Shirin; Cherlin, Emily; Talbert-Slagle, Kristina; Curry, Leslie A.] Yale Global Hlth Leadership Inst, New Haven, CT 06519 USA; [Linnander, Erika; Yuan, Christina T.; Ahmed, Shirin; Cherlin, Emily; Curry, Leslie A.] Yale Sch Publ Hlth, New Haven, CT 06510 USA; [Talbert-Slagle, Kristina] Yale Sch Med, New Haven, CT USA	Yale University; Yale University	Linnander, E (corresponding author), Yale Global Hlth Leadership Inst, New Haven, CT 06519 USA.; Linnander, E (corresponding author), Yale Sch Publ Hlth, New Haven, CT 06510 USA.	Erka.linnander@yale.edu	curry, leslie/AAA-6100-2022	curry, leslie/0000-0002-3419-4654; Linnander, Erika/0000-0002-3417-1049	Coca-Cola Company	Coca-Cola Company	Funding for this study was provided by the Coca-Cola Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Elizabeth H. Bradley, Dana Karen Ciccone, Ashley Fox, Michael Skonieczny, Hannah Wheatley, and Rex Wong for their assistance with data collection and analysis. The study was funded by The Coca-Cola Company. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agency or other project partners.	Aldrich H., 1977, ACAD MANAGE REV, V2, P217, DOI [10.5465/amr.1977.4409044, DOI 10.5465/AMR.1977.4409044]; [Anonymous], 2014, MIDWIFERY, V30; Argote L, 2000, ORGAN BEHAV HUM DEC, V82, P150, DOI 10.1006/obhd.2000.2893; Arney L, 2014, GLOB HEALTH-SCI PRAC, V2, P295, DOI 10.9745/GHSP-D-14-00068; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Barry CA, 1999, QUAL HEALTH RES, V9, P26, DOI 10.1177/104973299129121677; Baum JAC, 1999, ADV STRAT M, V16, P155; Bossert TJ, 2007, HEALTH POLICY PLANN, V22, P73, DOI 10.1093/heapol/czl041; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Bradley EH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000987; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Carlile PR, 2004, ORGAN SCI, V15, P555, DOI 10.1287/orsc.1040.0094; Carlile PR, 2002, ORGAN SCI, V13, P442, DOI 10.1287/orsc.13.4.442.2953; Colquhoun H, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-51; Cross R, 2004, ORGAN SCI, V15, P446, DOI 10.1287/orsc.1040.0075; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Dalberg Global Development Advisors and the MIT-Zaragoza International Logistics Program, 2008, 13 DALB GLOB DEV ADV; Easterby-Smith M, 2008, J MANAGE STUD, V45, P677, DOI 10.1111/j.1467-6486.2008.00773.x; Fooks GJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001076; Fox ER, 2014, MAYO CLIN PROC, V89, P361, DOI 10.1016/j.mayocp.2013.11.014; Gatesman ML, 2011, NEW ENGL J MED, V365, P1653, DOI 10.1056/NEJMp1109772; Glaser B.G., 1968, DISCOV GROUNDED THEO; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Green E, 2017, INT J HLTH POLICY MA, V6, P1; Griffith MM, 2012, CLIN INFECT DIS, V54, P684, DOI 10.1093/cid/cir954; Guillemin M, 2004, QUAL INQ, V10, P261, DOI 10.1177/1077800403262360; HAMEL G, 1991, STRATEGIC MANAGE J, V12, P83, DOI 10.1002/smj.4250120908; Harding R, 2014, PALLIATIVE MED, V28, P293, DOI 10.1177/0269216313498637; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, P1811, DOI 10.2146/ajhp110210; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Ko DG, 2005, MIS QUART, V29, P59; Leung NHZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156026; Levin DZ, 2004, MANAGE SCI, V50, P1477, DOI 10.1287/mnsc.1030.0136; Levina N, 2005, MIS QUART, V29, P335; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Linnan L.S.A., 2002, PROCESS EVALUATION P, V1e; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Manji I, 2016, INT J PHARM PRACT; Matowe L, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-30; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Modi SB, 2007, J OPER MANAG, V25, P42, DOI 10.1016/j.jom.2006.02.001; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pronyk PM, 2016, LANCET GLOB HEALTH, V4, pE276, DOI 10.1016/S2214-109X(16)00046-2; Reagans R, 2003, ADMIN SCI QUART, V48, P240, DOI 10.2307/3556658; Stone D, 2004, J EUR PUBLIC POLICY, V11, P545, DOI 10.1080/13501760410001694291; SUDMAN S., 1996, THINKING ANSWERS APP; Szulanski G, 1996, STRATEGIC MANAGE J, V17, P27, DOI 10.1002/smj.4250171105; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; United Nations, 2012, EV WOM EV CHILD UN C; United Nations, 2013, MILL DEV GOAL 8 GLOB; van Wijk R, 2008, J MANAGE STUD, V45, P830, DOI 10.1111/j.1467-6486.2008.00771.x; Vledder M, 1269 ROSS SCH BUS; Wagenaar BH, 2014, TROP MED INT HEALTH, V19, P791, DOI 10.1111/tmi.12314; Ward V, 2009, J HEALTH SERV RES PO, V14, P156, DOI 10.1258/jhsrp.2009.008120; Weiser TG, 2010, INT J QUAL HEALTH C, V22, P365, DOI 10.1093/intqhc/mzq039; Yale University, 2012, MED SUPPL SOL TANZ 2	58	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0186832	10.1371/journal.pone.0186832	http://dx.doi.org/10.1371/journal.pone.0186832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121051	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900013
J	Sakai, C; Ishida, M; Ohba, H; Yamashita, H; Uchida, H; Yoshizumi, M; Ishida, T				Sakai, Chiemi; Ishida, Mari; Ohba, Hideo; Yamashita, Hiromitsu; Uchida, Hitomi; Yoshizumi, Masao; Ishida, Takafumi			Fish oil omega-3 polyunsaturated fatty acids attenuate oxidative stress-induced DNA damage in vascular endothelial cells	PLOS ONE			English	Article							HEART; OMEGA-3-FATTY-ACIDS; ASSOCIATION; ANTIOXIDANT; PATHWAYS; DISEASE; REPAIR	Objective Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), likely prevent cardiovascular disease, however their mechanisms remain unclear. Recently, the role of DNA damage in atherogenesis has been receiving considerable attention. Here, we investigated the effects of EPA and DHA on DNA damage in vascular endothelial cells to clarify their antiatherogenic mechanisms. Methods and results We determined the effect of EPA and DHA on H2O2-induced DNA damage response in human aortic endothelial cells. Immunofluorescence staining showed that gamma-H(2)AX foci formation, a prominent marker of DNA damage, was significantly reduced in the cells treated with EPA and DHA (by 47% and 48%, respectively). H2O2-induced activation of ATM, a major kinase orchestrating DNA damage response, was significantly reduced with EPA and DHA treatment (by 31% and 33%, respectively). These results indicated EPA and DHA attenuated DNA damage independently of the DNA damage response. Thus the effects of EPA and DHA on a source of DNA damage were examined. EPA and DHA significantly reduced intracellular reactive oxygen species under both basal condition and H2O2 stimulation. In addition, the mRNA levels of antioxidant molecules, such as heme oxygenase-1, thioredoxin reductase 1, ferritin light chain, ferritin heavy chain and manganese superoxide dismutase, were significantly increased with EPA and DHA. Silencing nuclear factor erythroid 2-related factor 2 (NRF2) remarkably abrogated the increases in mRNA levels of antioxidant molecules and the decrease in intracellular reactive oxygen species. Furthermore, EPA and DHA significantly reduced H2O2-induced senescence-associated beta-galactosidase activity in the cells (by 31% and 22%, respectively), which was revoked by NRF2 silencing. Conclusions Our results suggested that EPA and DHA attenuate oxidative stress-induced DNA damage in vascular endothelial cells through upregulation of NRF2-mediated antioxidant response. Therefore omega-3 fatty acids likely help prevent cardiovascular disease, at least in part, by their genome protective properties.	[Sakai, Chiemi; Ishida, Mari; Ohba, Hideo; Yamashita, Hiromitsu; Uchida, Hitomi; Yoshizumi, Masao] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Hiroshima, Japan; [Ishida, Takafumi] Fukushima Med Univ, Dept Cardiovasc Med, Fukushima, Japan	Hiroshima University; Fukushima Medical University	Ishida, M (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Hiroshima, Japan.	mari@hiroshima-u.ac.jp	Ishida, Mari/L-8208-2016		Ministry of Education, Science, and Culture of Japan (KAKENHI) [22590528, 15K09122, 26461852, 17K10449]; Grants-in-Aid for Scientific Research [17K10449] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan (KAKENHI); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants in Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (KAKENHI) (No. 22590528 and No. 15K09122 to MI and No. 26461852 and No. 17K10449 to TI). https://www.jsps.go.jp/english/index.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bays HE, 2012, J CLIN LIPIDOL, V6, P565, DOI 10.1016/j.jacl.2012.07.001; BONAA KH, 1990, NEW ENGL J MED, V322, P795, DOI 10.1056/NEJM199003223221202; Brinton EA, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-100; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Ding SL, 2008, CLIN INTERV AGING, V3, P431, DOI 10.2147/CIA.S1957; DYERBERG J, 1979, HAEMOSTASIS, V8, P227; DYERBERG J, 1979, LANCET, V2, P433, DOI 10.1016/S0140-6736(79)91490-9; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Farzaneh-Far R, 2010, JAMA-J AM MED ASSOC, V303, P250, DOI 10.1001/jama.2009.2008; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gray K, 2015, CIRC RES, V116, P816, DOI 10.1161/CIRCRESAHA.116.304921; Gray K, 2011, BIOCHEM PHARMACOL, V82, P693, DOI 10.1016/j.bcp.2011.06.025; Ishida M, 1998, CIRC RES, V82, P7; Ishida M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103993; Ishida T, 2014, CIRC J, V78, P42, DOI 10.1253/circj.CJ-13-1194; Ishikado A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069415; Iwamatsu K, 2016, HYPERTENS RES, V39, P272, DOI 10.1038/hr.2015.143; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kusunoki C, 2013, BIOCHEM BIOPH RES CO, V430, P225, DOI 10.1016/j.bbrc.2012.10.115; Lee SE, 2015, SHIPS OFFSHORE STRUC, V10, P510, DOI 10.1080/17445302.2015.1022437; London B, 2007, CIRCULATION, V116, pE320, DOI 10.1161/CIRCULATIONAHA.107.712984; Mahmoudi M, 2008, CIRC RES, V103, P717, DOI 10.1161/CIRCRESAHA.108.182899; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Orino K, 2008, VET J, V178, P191, DOI 10.1016/j.tvjl.2007.07.006; Otterbein LE, 2016, CIRC RES, V118, P1940, DOI 10.1161/CIRCRESAHA.116.306588; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Rothkamm K, 2015, ENVIRON MOL MUTAGEN, V56, P491, DOI 10.1002/em.21944; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shiloh Y, 2014, EXP CELL RES, V329, P154, DOI 10.1016/j.yexcr.2014.09.002; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Wu SY, 2014, AM J CLIN NUTR, V100, P1232, DOI 10.3945/ajcn.114.088880	41	81	82	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187934	10.1371/journal.pone.0187934	http://dx.doi.org/10.1371/journal.pone.0187934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121093	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900099
J	Sato, T; Tsujino, I; Ohira, H; Oyama-Manabe, N; Ito, YM; Takashina, C; Watanabe, T; Nishimura, M				Sato, Takahiro; Tsujino, Ichizo; Ohira, Hiroshi; Oyama-Manabe, Noriko; Ito, Yoichi M.; Takashina, Chisa; Watanabe, Taku; Nishimura, Masaharu			Accuracy of echocardiographic indices for serial monitoring of right ventricular systolic function in patients with precapillary pulmonary hypertension	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; EJECTION FRACTION; PREDICTS SURVIVAL; RIGHT HEART; GUIDELINES; DIAGNOSIS; ENDARTERECTOMY; PARAMETERS; REGISTRY; THERAPY	Background Serial assessment of right ventricular ejection fraction (RVEF) predicts the clinical outcome of patients with pulmonary hypertension (PH). Cardiac magnetic resonance imaging (CMRI) enables RVEF monitoring, but its applicability is limited in clinical practice. This study aimed to examine the correlation between changes in CMRI-derived RVEF with those in echocardiographic indices in patients with precapillary PH. Methods CMRI and echocardiographic indices of RV systolic function were evaluated at baseline and follow-up in 54 consecutive patients with precapillary PH (pulmonary arterial hypertension (PAH), n = 23; non-PAH, n = 31). During follow-up, medical treatment was optimized according to the guidelines for PH. Using CMRI-derived RVEF as the gold standard, we examined the accuracy of five echocardiographic indices by correlation analysis and receiver operating characteristic (ROC) analysis and by calculating sensitivity, specificity, and positive and negative predictive values. Results After an average period of 9.5 months, CMRI-derived RVEF improved from 30.2% +/- 10.6% at baseline to 41.4% +/- 11.3% at follow-up. These changes significantly correlated with those in the five echocardiographic indices, i.e., % RV fractional shortening (r = 0.27), % RV area change (r = 0.46), tricuspid annular plane systolic excursion (TAPSE) (r = 0.84), RV myocardial performance index (RVMPI) (r = -0.72), and systolic lateral tricuspid annular motion velocity (TVlat) (r = 0.66). Of these indices, % RV area change, TAPSE, and TVlat significantly correlated with those of CMRI-derived RVEF in both PAH and non-PAH subgroups. ROC analysis showed that improvement in echocardiographic indices predicted a prespecified improvement in CMRI-derived RVEF (>2.9%), with TAPSE and TVlat showing better accuracy over the other three indices. Conclusions Echocardiographic indices modestly correlate with the changes in CMRI-derived RVEF in precapillary PH patients. Comparison among the five echocardiographic indices revealed that TAPSE and TVlat provide better accuracy than % RV fractional shortening, % RV area change, and RVMPI.	[Sato, Takahiro; Tsujino, Ichizo; Ohira, Hiroshi; Takashina, Chisa; Watanabe, Taku; Nishimura, Masaharu] Hokkaido Univ Hosp, Dept Med 1, Sapporo, Hokkaido, Japan; [Oyama-Manabe, Noriko] Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido, Japan; [Ito, Yoichi M.] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Tsujino, I (corresponding author), Hokkaido Univ Hosp, Dept Med 1, Sapporo, Hokkaido, Japan.	itsujino@med.hokudai.ac.jp	Nishimura, Masaharu/A-4062-2012	Nishimura, Masaharu/0000-0002-6456-4361; Ito, Yoichi M./0000-0001-5073-0827; Watanabe, Taku/0000-0002-3195-2413				Alfakih K, 2003, J MAGN RESON IMAGING, V18, P25, DOI 10.1002/jmri.10329; Batal O, 2015, ECHOCARDIOGR-J CARD, V32, P1471, DOI 10.1111/echo.12909; Berman M, 2014, PULM CIRC, V4, P36, DOI 10.1086/674884; Bossone E, 2013, J AM SOC ECHOCARDIOG, V26, P1, DOI 10.1016/j.echo.2012.10.009; Brown LM, 2011, CHEST, V140, P19, DOI 10.1378/chest.10-1166; Chin KM, 2008, AM J CARDIOL, V101, P1669, DOI 10.1016/j.amjcard.2008.01.055; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Farber Harrison W, 2011, Congest Heart Fail, V17, P56, DOI 10.1111/j.1751-7133.2010.00202.x; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Fukui S, 2014, EUR RESPIR J, V43, P1394, DOI 10.1183/09031936.00012914; Galie N, 2015, EUR RESPIR J, V46, P903, DOI 10.1183/13993003.01032-2015; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Grapsa J, 2010, EUR J ECHOCARDIOGR, V11, P64, DOI 10.1093/ejechocard/jep169; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Hagger D, 2009, RHEUMATOLOGY, V48, P1137, DOI 10.1093/rheumatology/kep187; Hardegree EL, 2013, AM J CARDIOL, V111, P143, DOI 10.1016/j.amjcard.2012.08.061; Hassoun PM, 2015, PULM CIRC, V5, P3, DOI 10.1086/679607; Hoeper MM, 2005, EUR RESPIR J, V26, P858, DOI 10.1183/09031936.05.00075305; Kalogeropoulos Andreas P, 2011, Congest Heart Fail, V17, P189, DOI 10.1111/j.1751-7133.2011.00234.x; KAUL S, 1984, AM HEART J, V107, P526, DOI 10.1016/0002-8703(84)90095-4; Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515; Kepez A, 2014, THORAC CARDIOV SURG, V62, P60, DOI 10.1055/s-0033-1336012; Mauritz GJ, 2012, CHEST, V141, P935, DOI 10.1378/chest.10-3277; Mauritz GJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-5; McLaughlin VV, 2013, J AM COLL CARDIOL, V62, pD73, DOI 10.1016/j.jacc.2013.10.034; McLure LER, 2009, EUR RESPIR J, V33, P1454, DOI 10.1183/09031936.00139907; Nowak J, 2008, J PHYSIOL PHARMACOL, V59, P531; Pirat B, 2006, AM J CARDIOL, V98, P699, DOI 10.1016/j.amjcard.2006.03.056; Raisinghani A, 2006, SEMIN THORAC CARDIOV, V18, P230, DOI 10.1053/j.semtcvs.2006.09.006; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; RUSHMER RF, 1953, CIRC RES, V1, P162, DOI 10.1161/01.RES.1.2.162; Sachdev A, 2011, CHEST, V139, P1299, DOI 10.1378/chest.10-2015; Sato T, 2013, INT J CARDIOVAS IMAG, V29, P1799, DOI 10.1007/s10554-013-0286-7; Sato T, 2012, J AM SOC ECHOCARDIOG, V25, P280, DOI 10.1016/j.echo.2011.12.012; Schenk P, 2000, J HEART LUNG TRANSPL, V19, P145, DOI 10.1016/S1053-2498(99)00121-7; Sebbag I, 2001, AM J CARDIOL, V88, P1060, DOI 10.1016/S0002-9149(01)01995-6; Spruijt OA, 2016, J CARDIOLOGY; Swift AJ, 2017, AM J RESP CRIT CARE; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Tonelli AR, 2013, AM J RESP CRIT CARE, V188, P365, DOI 10.1164/rccm.201209-1640OC; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; Wahl A, 2011, INT J CARDIOL, V151, P58, DOI 10.1016/j.ijcard.2010.04.089	42	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187806	10.1371/journal.pone.0187806	http://dx.doi.org/10.1371/journal.pone.0187806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121072	Green Published, gold, Green Submitted			2022-12-26	WOS:000414769900078
J	Ketosugbo, KF; Bushnell, HL; Johnson, RI				Ketosugbo, Kwami F.; Bushnell, Henry L.; Johnson, Ruth I.			A screen for E3 ubiquitination ligases that genetically interact with the adaptor protein Cindr during Drosophila eye patterning	PLOS ONE			English	Article							N-TERMINAL KINASE; CELL-DEATH; ACTIN CYTOSKELETON; SIGNALING PATHWAYS; MEMORY MUTANTS; DORSAL CLOSURE; JNK ACTIVITY; RECEPTOR; DIFFERENTIATION; MELANOGASTER	Ubiquitination is a crucial post-translational modification that can target proteins for degradation. The E3 ubiquitin ligases are responsible for recognizing substrate proteins for ubiquitination, hence providing specificity to the process of protein degradation. Here, we describe a genetic modifier screen that identified E3 ligases that modified the rough-eye phenotype generated by expression of cindrRNAl transgenes during Drosophila eye development. In total, we identified 36 E3 ligases, as well as 4 Cullins, that modified the mild cindr(RNA) mispatterning phenotype. This indicates possible roles for these E3s/Cullins in processes that require Cindr function, including cytoskeletal regulation, cell adhesion, cell signaling and cell survival. Three E3 ligases identified in our screen had previously been linked to regulating JNK signaling.	[Ketosugbo, Kwami F.; Bushnell, Henry L.; Johnson, Ruth I.] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA	Wesleyan University	Johnson, RI (corresponding author), Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA.	rijohnson@wesleyan.edu		Bushnell, Henry/0000-0003-3137-0453	National Institute of General Medical Sciences [1R15GM114729-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM114729] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences, 1R15GM114729-01A1 to Dr. Ruth I Johnson. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2000, GENETICS, V155, P1231; Akalal DBG, 2011, J NEUROSCI, V31, P5643, DOI 10.1523/JNEUROSCI.3190-10.2011; Ammeux N, 2016, P NATL ACAD SCI USA, V113, P9940, DOI 10.1073/pnas.1610432113; Ashton-Beaucage D, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002539; Ashton-Beaucage D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001809; Athanasopoulos V, 2010, FEBS J, V277, P2109, DOI 10.1111/j.1742-4658.2010.07628.x; Ayyub C, 2015, DEV BIOL, V405, P269, DOI 10.1016/j.ydbio.2015.07.019; Ayyub C, 2011, J GENET, V90, P239, DOI 10.1007/s12041-011-0062-1; Barry KC, 2011, DEVELOPMENT, V138, P1759, DOI 10.1242/dev.058420; Berger KH, 2008, ALCOHOL CLIN EXP RES, V32, P895, DOI 10.1111/j.1530-0277.2008.00659.x; Bogler O, 2000, NEURO-ONCOLOGY, V2, P6, DOI 10.1093/neuonc/2.1.6; Cagan R, 2009, CURR TOP DEV BIOL, V89, P115, DOI 10.1016/S0070-2153(09)89005-4; Capelson M, 2005, MOL CELL, V20, P105, DOI 10.1016/j.molcel.2005.08.031; Carthew RW, 2007, CURR OPIN GENET DEV, V17, P309, DOI 10.1016/j.gde.2007.05.001; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Cha GH, 2003, MOL CELL BIOL, V23, P7982, DOI 10.1128/MCB.23.22.7982-7991.2003; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Cole AJ, 2015, ENDOCR-RELAT CANCER, V22, pT19, DOI 10.1530/ERC-14-0185; Cooper SE, 2007, MECH DEVELOP, V124, P584, DOI 10.1016/j.mod.2007.04.007; Craige SM, 2016, BBA-MOL BASIS DIS, V1862, P1581, DOI 10.1016/j.bbadis.2016.05.022; Rios-Barrera LD, 2013, GENESIS, V51, P147, DOI 10.1002/dvg.22354; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Djagaeva I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007598; Domsch K, 2013, J CELL SCI, V126, P3314, DOI 10.1242/jcs.122366; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Du J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024168; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Dwane L, 2017, J BIOL CHEM, V292, P3543, DOI 10.1074/jbc.R116.755694; Erpapazoglou Zoi, 2014, Cells, V3, P1027, DOI 10.3390/cells3041027; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Gradilla AC, 2011, GENETICS, V189, P871, DOI 10.1534/genetics.111.132191; Guilgur LG, 2014, ELIFE, V3, DOI 10.7554/eLife.02181; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hotamisligil GS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a006072; Hudson AM, 2015, GENETICS, V201, P1117, DOI 10.1534/genetics.115.181289; Hudson AM, 2010, J CELL BIOL, V188, P29, DOI 10.1083/jcb.200909017; Hwang S, 2010, MOL CELLS, V29, P575, DOI 10.1007/s10059-010-0068-1; Johnson RI, 2008, J CELL BIOL, V180, P1191, DOI 10.1083/jcb.200706108; Johnson RI, 2012, DEV DYNAM, V241, P1933, DOI 10.1002/dvdy.23879; Johnson RI, 2011, MOL BIOL CELL, V22, P4513, DOI 10.1091/mbc.E11-04-0305; Johnson RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007008; Kanoh H, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005971; Kashima I, 2014, BIOCHIMIE, V106, P10, DOI 10.1016/j.biochi.2014.08.001; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; LaBeau-DiMenna EM, 2012, P NATL ACAD SCI USA, V109, P17983, DOI 10.1073/pnas.1208408109; Lehtonen S, 2000, J BIOL CHEM, V275, P32888, DOI 10.1074/jbc.M006624200; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Ma XJ, 2013, DEV BIOL, V380, P211, DOI 10.1016/j.ydbio.2013.05.013; Ma XJ, 2012, CELL RES, V22, P425, DOI 10.1038/cr.2011.135; Malartre M, 2016, CELL MOL LIFE SCI, V73, P1825, DOI 10.1007/s00018-016-2153-x; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Matsui M, 2011, GENETICS, V189, P779, DOI 10.1534/genetics.111.133819; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Mistry H, 2004, MECH DEVELOP, V121, P1495, DOI 10.1016/j.mod.2004.07.007; Morreale FE, 2016, CELL, V165, P248, DOI 10.1016/j.cell.2016.03.003; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Ou CY, 2007, DEV BIOL, V308, P106, DOI 10.1016/j.ydbio.2007.05.008; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Pai LM, 2000, CELL, V103, P51, DOI 10.1016/S0092-8674(00)00104-5; Park SY, 2008, MOL CELLS, V26, P350; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Sathyanarayana P, 2003, BBA-MOL CELL RES, V1640, P77, DOI 10.1016/S0167-4889(03)00022-3; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Secombe J, 2004, J BIOL CHEM, V279, P17126, DOI 10.1074/jbc.M310097200; Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; Tare M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.338; Treisman JE, 2013, WIRES DEV BIOL, V2, P545, DOI 10.1002/wdev.100; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Swinderen B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005989; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Wolff Tanya, 1993, P1277; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Yasin HWR, 2016, DEV BIOL, V410, P135, DOI 10.1016/j.ydbio.2016.01.003	80	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187571	10.1371/journal.pone.0187571	http://dx.doi.org/10.1371/journal.pone.0187571			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117266	Green Submitted, Green Published, gold			2022-12-26	WOS:000414659600047
J	Mora, MT; Ferrero, JM; Romero, L; Trenor, B				Mora, Maria T.; Ferrero, Jose M.; Romero, Lucia; Trenor, Beatriz			Sensitivity analysis revealing the effect of modulating ionic mechanisms on calcium dynamics in simulated human heart failure	PLOS ONE			English	Article							RAT VENTRICULAR MYOCYTES; FAILING HUMAN HEART; SARCOPLASMIC-RETICULUM; TRANSMURAL HETEROGENEITY; NA+/CA2+ EXCHANGER; SERCA ACTIVITY; SEA0400 FAILS; GENE-TRANSFER; CANINE HEART; CA2+ LEAK	Abnormal intracellular Ca2+ handling is the major contributor to the depressed cardiac contractility observed in heart failure. The electrophysiological remodeling associated with this pathology alters both the action potential and the Ca2+ dynamics, leading to a defective excitation contraction coupling that ends in mechanical dysfunction. The importance of maintaining a correct intracellular Ca2+ concentration requires a better understanding of its regulation by ionic mechanisms. To study the electrical activity and ionic homeostasis of failing myocytes, a modified version of the O'Hara et al. human action potential model was used, including electrophysiological remodeling. The impact of the main ionic transport mechanisms was analyzed using single-parameter sensitivity analyses, the first of which explored the modulation of electrophysiological characteristics related to Ca2+ exerted by the remodeled parameters. The second sensitivity analysis compared the potential consequences of modulating individual channel conductivities, as one of the main effects of potential drugs, on Ca2+ dynamic properties under both normal conditions and in heart failure. The first analysis revealed the important contribution of the sarcoplasmic reticulum Ca2+-ATPase (SERCA) dysfunction to the altered Ca2+ homeostasis, with the Na+/Ca2+ exchanger (NCX) and other Ca2+ cycling proteins also playing a significant role. Our results highlight the importance of improving the SR uptake function to increase Ca2+ content and restore Ca2+ homeostasis and contractility. The second sensitivity analysis highlights the different response of the failing myocyte versus the healthy myocyte to potential pharmacological actions on single channels. The result of modifying the conductances of the remodeled proteins such as SERCA and NCX in heart failure has less impact on Ca2+ modulation. These differences should be taken into account when designing drug therapies.	[Mora, Maria T.; Ferrero, Jose M.; Romero, Lucia; Trenor, Beatriz] Univ Politecn Valencia, Ctr Invest & Innovac Bioingn, Valencia, Spain	Universitat Politecnica de Valencia	Trenor, B (corresponding author), Univ Politecn Valencia, Ctr Invest & Innovac Bioingn, Valencia, Spain.	btrenor@eln.upv.es	Romero, Lucia/H-6815-2015; Ferrero, Jose M/I-2034-2015; Trenor, Beatriz/H-1716-2015	Romero, Lucia/0000-0003-4605-8630; Ferrero, Jose M/0000-0003-4200-9225; Trenor, Beatriz/0000-0001-9166-6112	Ministerio de Economia, lndustria y Competitividad of Spain and Fondo Europeo de Desarrollo Regional (FEDER) [DPI2016-75799-R]; Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional (FEDER) [DPI2015-69125-R]	Ministerio de Economia, lndustria y Competitividad of Spain and Fondo Europeo de Desarrollo Regional (FEDER); Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional (FEDER)	This work was partially supported by the "Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion 2013-2016" from the Ministerio de Economia, lndustria y Competitividad of Spain and Fondo Europeo de Desarrollo Regional (FEDER) DPI2016-75799-R (AEI/FEDER, UE), and by Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional (FEDER) DPI2015-69125-R (MINECO/FEDER, UE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsai K, 2016, EUR J PHARMACOL, V779, P91, DOI 10.1016/j.ejphar.2016.03.016; Alpert NR, 2000, JPN HEART J, V41, P103; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; BEUCKELMANN DJ, 1995, AM HEART J, V129, P684, DOI 10.1016/0002-8703(95)90316-X; Birinyi P, 2008, CARDIOVASC RES, V78, P476, DOI 10.1093/cvr/cvn031; Bode EF, 2011, J PHYSIOL-LONDON, V589, P4723, DOI 10.1113/jphysiol.2011.211052; Bueno-Orovio A, 2014, PFLUG ARCH EUR J PHY, V466, P183, DOI 10.1007/s00424-013-1293-1; Cai L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174834; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; Drouin E, 1998, J AM COLL CARDIOL, V32, P1063, DOI 10.1016/S0735-1097(98)00330-1; Elshrif MM, 2015, IEEE J BIOMED HEALTH, V19, P1308, DOI 10.1109/JBHI.2015.2442833; Gandhi A, 2013, CARDIOVASC THER, V31, pE115, DOI 10.1111/1755-5922.12045; Gomez JF, 2015, J MOL CELL CARDIOL, V89, P146, DOI 10.1016/j.yjmcc.2015.10.016; Gomez JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106602; Gorski PA, 2015, CELL METAB, V21, P183, DOI 10.1016/j.cmet.2015.01.005; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Greensmith DJ, 2014, CARDIOVASC RES, V103, P554, DOI 10.1093/cvr/cvu158; Hasenfuss G, 1997, BASIC RES CARDIOL, V92, P87, DOI 10.1007/BF00794072; Houser SR, 2000, TRENDS CARDIOVAS MED, V10, P101, DOI 10.1016/S1050-1738(00)00057-8; Jost N, 2013, J PHYSIOL-LONDON, V591, P4189, DOI 10.1113/jphysiol.2013.261198; Kho C, 2012, NAT REV CARDIOL, V9, P717, DOI 10.1038/nrcardio.2012.145; Kubo H, 2001, CIRCULATION, V104, P1012, DOI 10.1161/hc3401.095073; Levi AJ, 1997, J CARDIOVASC ELECTR, V8, P700, DOI 10.1111/j.1540-8167.1997.tb01834.x; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Lindner M, 1998, J MOL CELL CARDIOL, V30, P743, DOI 10.1006/jmcc.1997.0626; Lou Q, 2012, ADV EXP MED BIOL, V740, P1145, DOI 10.1007/978-94-007-2888-2_52; Lou Q, 2011, CIRCULATION, V123, P1881, DOI 10.1161/CIRCULATIONAHA.110.989707; Lyon AR, 2011, CIRC-ARRHYTHMIA ELEC, V4, P362, DOI 10.1161/CIRCEP.110.961615; Maltsev VA, 2006, CARDIOVASC RES, V69, P116, DOI 10.1016/j.cardiores.2005.08.015; Miller L, 2015, CELL CALCIUM, V58, P208, DOI 10.1016/j.ceca.2015.05.002; Morimoto S, 2014, CELL CALCIUM, V55, P17, DOI 10.1016/j.ceca.2013.10.005; Nagy ZA, 2004, BRIT J PHARMACOL, V143, P827, DOI 10.1038/sj.bjp.0706026; Njeim Mario T, 2010, Arch Cardiovasc Dis, V103, P477, DOI 10.1016/j.acvd.2010.04.004; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Ozdemir S, 2008, CIRC RES, V102, P1398, DOI 10.1161/CIRCRESAHA.108.173922; Passini E, 2016, J MOL CELL CARDIOL, V96, P72, DOI 10.1016/j.yjmcc.2015.09.003; Pieske B, 2002, CIRCULATION, V106, P447, DOI 10.1161/01.CIR.0000023042.50192.F4; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Rocchetti M, 2008, J PHARMACOL EXP THER, V326, P957, DOI 10.1124/jpet.108.138701; Roe AT, 2015, CURR PHARM DESIGN, V21, P431; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Sankaranarayanan R, 2016, J PHYSIOL-LONDON, V594, P611, DOI 10.1113/JP271473; Schmidt U, 1998, J MOL CELL CARDIOL, V30, P1929, DOI 10.1006/jmcc.1998.0748; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Szentandrassy N, 2008, N-S ARCH PHARMACOL, V378, P65, DOI 10.1007/s00210-008-0296-5; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Terracciano CMN, 2001, CARDIOVASC RES, V49, P38, DOI 10.1016/S0008-6363(00)00205-4; Teucher N, 2004, CIRCULATION, V110, P3553, DOI 10.1161/01.CIR.0000145161.48545.B3; Trenor B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032659; Undrovinas Albertas I, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS169; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; Walmsley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056359; Wang JF, 2009, AM J PHYSIOL-HEART C, V297, pH590, DOI 10.1152/ajpheart.00190.2009; Zhang Y, 2005, P ANN INT IEEE EMBS, P337; Zima AV, 2014, PFLUG ARCH EUR J PHY, V466, P1129, DOI 10.1007/s00424-014-1469-3	57	10	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187739	10.1371/journal.pone.0187739	http://dx.doi.org/10.1371/journal.pone.0187739			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117223	Green Published, gold			2022-12-26	WOS:000414659600072
J	Niikura, M; Inoue, SI; Mineo, S; Asahi, H; Kobayashi, F				Niikura, Mamoru; Inoue, Shin-Ichi; Mineo, Shoichiro; Asahi, Hiroko; Kobayashi, Fumie			IFNGR1 signaling is associated with adverse pregnancy outcomes during infection with malaria parasites	PLOS ONE			English	Article							PLASMODIUM-VIVAX MALARIA; HIGH-EFFICIENCY TRANSFECTION; INTERFERON-GAMMA RECEPTOR; NECROSIS-FACTOR-ALPHA; CHONDROITIN SULFATE; PLACENTAL MALARIA; T-CELLS; FALCIPARUM; PATHOGENESIS; GENE	Complicated/severe cases of placental pathology due to Plasmodium falciparum and P. vivax, especially adverse pregnancy outcomes during P. vivax infection, have been increasing in recent years. However, the pathogenesis of placental pathology during severe malaria is poorly understood, while responses against IFN-y are thought to be associated with adverse pregnancy outcomes. In the present study, we explored the role of IFN-gamma receptor 1 (IFNGR1) signaling in placental pathology during severe malaria using luciferase-expressing rodent malaria parasites, P. berghei NK65 (PbNK65L). We detected luciferase activities in the lung, spleen, adipose tissue, and placenta in pregnant mice, suggesting that infected erythrocytes could accumulate in various organs during infection. Importantly, we found that fetal mortality in IFNGR1-deficient mice infected with PbNK65L parasites was much less than in infected wild type (WT) mice. Placental pathology was also improved in IFNGR1deficient mice. In contrast, bioluminescence imaging showed that parasite accumulation in the placentas of IFNGR1-deficient pregnant mice was comparable to that in WT mice infected with PbNK65L. These findings suggest that IFNGR1 signaling plays a pivotal role in placental pathology and subsequent adverse pregnancy outcomes during severe malaria. Our findings may increase our understanding of how disease aggravation occurs during malaria during pregnancy.	[Niikura, Mamoru; Inoue, Shin-Ichi; Asahi, Hiroko; Kobayashi, Fumie] Kyorin Univ, Sch Med, Dept Infect Dis, Tokyo, Japan; [Mineo, Shoichiro] Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan	Kyorin University; Tokyo Medical University	Kobayashi, F (corresponding author), Kyorin Univ, Sch Med, Dept Infect Dis, Tokyo, Japan.	furnfum@ks.kyorin-u.ac.jp	niikura, mamoru/ABG-5467-2021; Inoue, Shin-Ichi/P-2911-2018	Niikura, Mamoru/0000-0002-1647-2745; Inoue, Shin-Ichi/0000-0003-1244-826X	Japan Society for the Promotion of Science [15K08451, 15K08449, 15K19085]; Japan Agency for Medical Research and Development	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by Japan Society for the Promotion of Science 15K08451 to Dr. Fumie Kobayashi; Japan Society for the Promotion of Science 15K08449 to Dr Mamoru Niikura; Japan Society for the Promotion of Science 15K19085 to Dr Shin Ichi Inoue; Japan Agency for Medical Research and Development to Dr. Fumie Kobayashi.	Barboza R, 2014, INFECT IMMUN, V82, P830, DOI 10.1128/IAI.01288-13; Blaszkowska Joanna, 2014, Annals of Parasitology, V60, P225; Brutus L, 2013, EMERG INFECT DIS, V19, P1605, DOI 10.3201/eid1910.130308; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Chaturvedi V, 2015, J CLIN INVEST, V125, P1713, DOI 10.1172/JCI78578; CHEN HL, 1994, PLACENTA, V15, P109, DOI 10.1016/S0143-4004(05)80448-5; Chene A, 2014, INFECT IMMUN, V82, P3783, DOI 10.1128/IAI.01922-14; Chotivanich K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034509; Chua CLL, 2015, INT J PARASITOL, V45, P107, DOI 10.1016/j.ijpara.2014.12.002; Costa FTM, 2012, INT J PARASITOL, V42, P1099, DOI 10.1016/j.ijpara.2012.08.007; Dos Santos E, 2007, J ENDOCRINOL, V194, P313, DOI 10.1677/JOE-06-0101; Duffy PE, 2007, PARASITOLOGY, V134, P1877, DOI 10.1017/S0031182007000170; Ecker A, 2006, MOL BIOCHEM PARASIT, V145, P265, DOI 10.1016/j.molbiopara.2005.10.006; Fonager J, 2012, J EXP MED, V209, P93, DOI 10.1084/jem.20110762; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gbedande K, 2013, INFECT IMMUN, V81, P2686, DOI 10.1128/IAI.00237-13; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kalhan SC, 2016, MOL CELL ENDOCRINOL, V435, P48, DOI 10.1016/j.mce.2016.06.006; Klein PW, 2008, GENDER MED, V5, P423, DOI 10.1016/j.genm.2008.10.001; Lacasa D, 2001, J BIOL CHEM, V276, P11512, DOI 10.1074/jbc.M008556200; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Liehl P, 2012, INT J PARASITOL, V42, P557, DOI 10.1016/j.ijpara.2012.04.006; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; Marinho CRF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005630; McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mineo S, 2013, INFECT IMMUN, V81, P3865, DOI 10.1128/IAI.00749-13; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Neres R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001608; Niikura M, 2008, J IMMUNOL, V180, P6877, DOI 10.4049/jimmunol.180.10.6877; Niikura M, 2013, BIOCHEM BIOPH RES CO, V432, P504, DOI 10.1016/j.bbrc.2013.02.004; Niikura M, 2010, INT J PARASITOL, V40, P101, DOI 10.1016/j.ijpara.2009.08.009; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; PICHYANGKUL S, 1994, AM J TROP MED HYG, V51, P430, DOI 10.4269/ajtmh.1994.51.430; Polese B, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00106; Poovassery JS, 2009, J IMMUNOL, V183, P5342, DOI 10.4049/jimmunol.0901669; Requena P, 2015, J IMMUNOL, V194, P3275, DOI 10.4049/jimmunol.1401038; Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031411; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; Rogerson SJ, 2007, PARASITOLOGY, V134, P1883, DOI 10.1017/S003118200700011X; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Ruizendaal E, 2015, BIOMARK MED, V9, P217, DOI 10.2217/bmm.14.117; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; STEVENSON MM, 1992, INFECT IMMUN, V60, P1193, DOI 10.1128/IAI.60.3.1193-1201.1992; Suzuki S, 2004, TOHOKU J EXP MED, V203, P349, DOI 10.1620/tjem.203.349; Truchet S, 2001, MOL REPROD DEV, V60, P319, DOI 10.1002/mrd.1094; VALENTE G, 1992, EUR J IMMUNOL, V22, P2403, DOI 10.1002/eji.1830220933; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; WALTER PR, 1982, AM J PATHOL, V109, P330; WHO, 2016, WORLD MAL REP 2016	56	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0185392	10.1371/journal.pone.0185392	http://dx.doi.org/10.1371/journal.pone.0185392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117241	Green Submitted, gold, Green Published			2022-12-26	WOS:000414659600002
J	Cho, SB; Baek, HJ; Ryu, KH; Il Moon, J; Choi, H; Park, SE; Bae, K; Jeon, KN; Kim, DW				Cho, Soo Buem; Baek, Hye Jin; Ryu, Kyeong Hwa; Il Moon, Jin; Choi, Bo Hwa; Park, Sung Eun; Bae, Kyungsoo; Jeon, Kyung Nyeo; Kim, Dong Wook			Initial clinical experience with dual-layer detector spectral CT in patients with acute intracerebral haemorrhage: A single-centre pilot study	PLOS ONE			English	Article							ENERGY CT; COMPUTED-TOMOGRAPHY; IODINATED CONTRAST; DIFFERENTIATION; HEAD	Purpose The purpose of this study was to investigate the clinical feasibility of spectral analyses using dual-layer detector spectral computed tomography (CT) in acute intracerebral haemorrhage (ICH). Material and methods We retrospectively reviewed patients with acute ICH who underwent CT angiography on a dual-layer detector spectral CT scanner. A spectral data analysis was performed to detect contrast enhancement in or adjacent to acute ICH by using spectral image reconstructions including monoenergetic (MonoE), virtual noncontrast (VNC), and iodine overlay fusion images. We also acquired a spectral plot to assess material differentiation within lesions. Results Among the 30 patients, the most common cause of acute ICH was chronic hypertension (18/30, 60%) followed by trauma (5/30, 16.7%), brain tumour (3/30, 10%), Moyamoya disease (2/30, 6.7%), and haemorrhagic diathesis from anticoagulation therapy (2/30, 6.7%). Of 30 patients, 13 showed suboptimal iodine suppression in the subcalvarial spaces on VNC images compared with true noncontrast images. The CT angiographic spot sign within the acute ICH was detected in four patients (4/30, 13.3%). All three tumours were metastatic and included lung cancer (n = 2) and hepatocellular carcinoma (n = 1) which showed conspicuous delineation of an enhancing tumour portion in the spectral analysis. Spectral analyses allowed the discrimination of acute haemorrhage and iodine with enhanced lesion visualization on the MonoE images obtained at lower keVs (less than 70 keV) and spectral plot. Conclusions Even though the image quality of VNC is perceived to be inferior, it is feasible to evaluate acute ICH in clinical settings using dual-layer detector spectral CT. The MonoE images taken at lower keVs were useful for depicting contrast enhancing lesion, and spectral plot might be helpful for material differentiation in patients with acute ICH.	[Cho, Soo Buem; Baek, Hye Jin; Ryu, Kyeong Hwa; Il Moon, Jin; Choi, Bo Hwa; Park, Sung Eun; Bae, Kyungsoo; Jeon, Kyung Nyeo] Gyeongsang Natl Univ, Sch Med, Dept Radiol, Chang Won, South Korea; [Cho, Soo Buem; Baek, Hye Jin; Ryu, Kyeong Hwa; Il Moon, Jin; Choi, Bo Hwa; Park, Sung Eun; Bae, Kyungsoo; Jeon, Kyung Nyeo] Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea; [Kim, Dong Wook] Inje Univ, Coll Med, Busan Paik Hosp, Dept Radiol, Busan, South Korea	Gyeongsang National University; Gyeongsang National University; Inje University	Baek, HJ (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Radiol, Chang Won, South Korea.; Baek, HJ (corresponding author), Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea.	sartre81@gmail.com	Baek, Hye Jin/T-2076-2019; Baek, Hye Jin/AAC-7595-2020; Jeon, Kyung Nyeo/ABR-3583-2022	Baek, Hye Jin/0000-0001-7349-2841; 				ALVAREZ RE, 1976, PHYS MED BIOL, V21, P733, DOI 10.1088/0031-9155/21/5/002; BARKOVICH AJ, 1988, RADIOL CLIN N AM, V26, P801; Cohnen M, 2006, AM J NEURORADIOL, V27, P1741; Duan X, 2016, MED PHYS, V43, P3836, DOI 10.1118/1.4957957; Fewel Matthew E, 2003, Neurosurg Focus, V15, pE1; FURLAN AJ, 1979, ANN NEUROL, V5, P367, DOI 10.1002/ana.410050410; Gupta R, 2010, RADIOLOGY, V257, P205, DOI 10.1148/radiol.10091806; Inamasu J, 2009, NEUROL MED-CHIR, V49, P427, DOI 10.2176/nmc.49.427; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Kim SJ, 2012, AM J NEURORADIOL, V33, P865, DOI 10.3174/ajnr.A2890; Lv PJ, 2017, EUR RADIOL, V27, P374, DOI 10.1007/s00330-016-4349-8; Ozguner O, 2016, MED PHYS, V43, P3836, DOI 10.1118/1.4957956; Phan CM, 2012, AM J NEURORADIOL, V33, P1088, DOI 10.3174/ajnr.A2909; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Shuman WP, 2016, ACAD RADIOL, V23, P611, DOI 10.1016/j.acra.2015.12.019; Thomas C, 2010, J COMPUT ASSIST TOMO, V34, P309, DOI 10.1097/RCT.0b013e3181c9b9ff	16	4	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0186024	10.1371/journal.pone.0186024	http://dx.doi.org/10.1371/journal.pone.0186024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112977	Green Published, gold, Green Submitted			2022-12-26	WOS:000414572100005
J	Zhang, CB; Zhou, YC; Xie, SS; Yin, QQ; Tang, CH; Ni, ZM; Fei, J; Zhang, YL				Zhang, Chaobao; Zhou, Yuchuan; Xie, Shengsong; Yin, Qianqian; Tang, Chunhua; Ni, Zimei; Fei, Jian; Zhang, Yonglian			CRISPR/Cas9-mediated genome editing reveals the synergistic effects of beta-defensin family members on sperm maturation in rat epididymis	FASEB JOURNAL			English	Article						male subfertility; acrosome reaction; sperm capacitation; sperm motility	GENE CLUSTERS; BETA-DEFENSIN-1; EXPRESSION	The epididymis is a male reproductive organ involved in posttesticular sperm maturation and storage, but the mechanism underlying sperm maturation remains unclear. beta-Defensins (Defbs) belong to a family of small, cysteine-rich, cationic peptides that are antimicrobial and modulate the immune response. A large number of Defb genes are expressed abundantly in the male reproductive tract, especially in the epididymis. We and other groups have shown the involvement of several Defb genes in regulation of sperm function. In this study, we found that Defb23, Defb26, and Defb42 were highly expressed in specific regions of the epididymis. Rats with CRISPR/Cas9-mediated single-gene disruption of Defb23, Defb26, or Defb42 had no obvious fertility phenotypes. Those with the deletion of Defb23/26 or Defb23/26/42 became subfertile, and sperm isolated from the epididymal cauda of multiple-mutant rats were demonstrated decreased motility. Meanwhile, the sperm showed precocious capacitation and increased spontaneous acrosome reaction. Consistent with premature capacitation and acrosome reaction, sperm from multiple-gene-knockout rats had significantly increased intracellular calcium. These results suggest that Defb family members affect sperm maturation by a synergistic pattern in the epididymis.-Zhang, C., Zhou, Y., Xie, S., Yin, Q., Tang, C., Ni, Z., Fei, J., Zhang, Y. CRISPR/Cas9-mediated genome editing reveals the synergistic effects of beta-defensin familymembers on sperm maturation in rat epididymis.	[Zhang, Chaobao; Fei, Jian] Tongji Univ, Sch Life Sci & Technol, Shanghai 20009, Peoples R China; [Zhang, Chaobao; Zhou, Yuchuan; Xie, Shengsong; Yin, Qianqian; Tang, Chunhua; Ni, Zimei; Zhang, Yonglian] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, SIBCB,Shanghai Key Lab Mol Androl,State Key Lab M, Shanghai, Peoples R China	Tongji University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fei, J (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 20009, Peoples R China.; Zhang, YL (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	jfei@tongji.edu.cn; ylzhang@sibcb.ac.cn	zhou, yuchuan/AAF-6202-2019		National Natural Science Foundation of China [31471104, 31671203]; National Basic Research Program [2014CB943103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China)	The authors thank Lianfeng Zhang and Wei Dong (Chinese Academy of Medical Sciences) for the generation of Defb23<SUP>+/-</SUP>, Defb26<SUP>+/-</SUP>, Defb42<SUP>+/-</SUP>, and Defb23/26<SUP>+/-</SUP> rats using CRISPR/Cas9 technology; Xingxu Huang (Shanghai Tech University, Shanghai, China), Jingsong Li (SIBCB) and Xiangqi Li (SIBCB) for the helpful comments; Yanfei Ru (SIBCB) for the rat epididymal tissues collection (1-19 segments); and Winnie Wai Chi Shum (Shanghai Tech University) for polishing the language. This work was supported by National Natural Science Foundation of China Grants 31471104 and 31671203, and the National Basic Research Program Grant 2014CB943103. The authors declare no conflicts of interest.	Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Bendahmane M, 2002, ARCH BIOCHEM BIOPHYS, V404, P38, DOI 10.1016/S0003-9861(02)00278-3; Bjorkgren I, 2016, MOL CELL ENDOCRINOL, V427, P143, DOI 10.1016/j.mce.2016.03.013; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Diao RY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009071; Duan SW, 2015, J CELL MOL MED, V19, P1077, DOI 10.1111/jcmm.12502; Fraire-Zamora JJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1688, DOI 10.1152/ajpcell.00141.2004; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Jelinsky SA, 2007, BIOL REPROD, V76, P561, DOI 10.1095/biolreprod.106.057323; Jrad-Lamine A, 2011, J BIOL CHEM, V286, P8030, DOI 10.1074/jbc.M110.172114; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Narmadha G, 2016, J REPROD IMMUNOL, V118, P100, DOI 10.1016/j.jri.2016.11.001; Oberlander G, 1996, J REPROD FERTIL, V106, P231, DOI 10.1530/jrf.0.1060231; OBRIEN DA, 1993, METHODS TOXICOL, V3, P246; Patil AA, 2005, PHYSIOL GENOMICS, V23, P5, DOI 10.1152/physiolgenomics.00104.2005; Robaire B, 2015, KNOBIL NEILLS PHYSL; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Skerget S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140650; Tollner TL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002289; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xin AJ, 2015, ACTA BIOCH BIOPH SIN, V47, P861, DOI 10.1093/abbs/gmv089; Zhang YL, 2011, J ANDROL, V32, P587, DOI 10.2164/jandrol.111.013060; Zhao Y, 2011, CELL MOL LIFE SCI, V68, P697, DOI 10.1007/s00018-010-0478-4; Zhou YS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003826	27	16	18	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1354	1363		10.1096/fj.201700936R	http://dx.doi.org/10.1096/fj.201700936R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29141997				2022-12-26	WOS:000427246000019
J	Kuusk, S; Bissaro, B; Kuusk, P; Forsberg, Z; Eijsink, VGH; Sorlie, M; Valjamae, P				Kuusk, Silja; Bissaro, Bastien; Kuusk, Piret; Forsberg, Zarah; Eijsink, Vincent G. H.; Sorlie, Morten; Valjamae, Priit			Kinetics of H2O2-driven degradation of chitin by a bacterial lytic polysaccharide monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper monooxygenase; enzyme inactivation; enzyme kinetics; hydrogen peroxide; polysaccharide; Serratia marcescens	BINDING PROTEIN CBP21; SERRATIA-MARCESCENS; OXIDATIVE-DEGRADATION; RECALCITRANT POLYSACCHARIDES; CELLOBIOSE DEHYDROGENASE; NEUROSPORA-CRASSA; CELLULOSE; ENZYMES; CLEAVAGE; OLIGOSACCHARIDES	Lytic polysaccharide monooxygenases (LPMOs) catalyze the oxidative cleavage of glycosidic bonds in recalcitrant polysaccharides, such as cellulose and chitin, and are of interest in biotechnological utilization of these abundant biomaterials. It has recently been shown that LPMOs can use H2O2, instead of O-2, as a cosubstrate. This peroxygenase-like reaction by a monocopper enzyme is unprecedented in nature and opens new avenues in chemistry and enzymology. Here, we provide the first detailed kinetic characterization of chitin degradation by the bacterial LPMO chitin-binding protein CBP21 using H2O2 as cosubstrate. The use of C-14-labeled chitin provided convenient and sensitive detection of the released soluble products, which enabled detailed kinetic measurements. The k(cat) for chitin oxidation found here (5.6 s(-1)) is more than an order of magnitude higher than previously reported (apparent) rate constants for reactions containing O-2 but no added H2O2. The k(cat)/K-m for H2O2-driven degradation of chitin was on the order of 10(6) m(-1) s(-1), indicating that LPMOs have catalytic efficiencies similar to those of peroxygenases. Of note, H2O2 also inactivated CBP21, but the second-order rate constant for inactivation was about 3 orders of magnitude lower than that for catalysis. In light of the observed CBP21 inactivation at higher H2O2 levels, we conclude that controlled generation of H(2)O(2)in situ seems most optimal for fueling LPMO-catalyzed oxidation of polysaccharides.	[Kuusk, Silja; Valjamae, Priit] Univ Tartu, Inst Mol & Cell Biol, Riia 23b-202, EE-51010 Tartu, Estonia; [Bissaro, Bastien; Forsberg, Zarah; Eijsink, Vincent G. H.; Sorlie, Morten] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway; [Kuusk, Piret] Univ Tartu, Inst Phys, EE-50411 Tartu, Estonia	University of Tartu; Norwegian University of Life Sciences; University of Tartu; University of Tartu Institute of Physics	Valjamae, P (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Riia 23b-202, EE-51010 Tartu, Estonia.	priit.valjamae@ut.ee	Bissaro, Bastien/AAI-6814-2020; Forsberg, Zarah/AAM-2395-2020; BISSARO, Bastien/AAL-7130-2021; Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493; Bissaro, Bastien/0000-0001-8354-3892; Forsberg, Zarah/0000-0002-8236-7986	Estonian Research Council [PUT1024]; Norwegian Financial Mechanism Grant [EMP171]	Estonian Research Council; Norwegian Financial Mechanism Grant	This work was supported by Estonian Research Council Grant PUT1024 and Norwegian Financial Mechanism Grant EMP171. The authors declare that they have no conflicts of interest with the contents of this article.	Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Cannella D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11134; Cornish-Bowden A, 1999, FUNDAMENTALS ENZYME; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Frommhagen M, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0810-4; Frommhagen M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0594-y; Garajova S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28276; Hamre AG, 2014, FEBS LETT, V588, P4620, DOI 10.1016/j.febslet.2014.10.034; Hofrichter M, 2014, CURR OPIN CHEM BIOL, V19, P116, DOI 10.1016/j.cbpa.2014.01.015; Holtmann D, 2016, CHEMBIOCHEM, V17, P1391, DOI 10.1002/cbic.201600176; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Johansen KS, 2016, BIOCHEM SOC T, V44, P143, DOI 10.1042/BST20150204; Kari J, 2017, ACS CATAL, V7, P4904, DOI 10.1021/acscatal.7b00838; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kracher D, 2016, SCIENCE, V352, P1098, DOI 10.1126/science.aaf3165; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; Ladeveze S, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0903-0; Loose JSM, 2016, PROTEIN SCI, V25, P2175, DOI 10.1002/pro.3043; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; Martinez AT, 2016, SCIENCE, V352, P1050, DOI 10.1126/science.aaf8920; Matthews S, 2017, J BIOL CHEM, V292, P5128, DOI 10.1074/jbc.M116.762336; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Nakagawa YS, 2013, J AGR FOOD CHEM, V61, P11061, DOI 10.1021/jf402743e; Ni Y, 2016, ANGEW CHEM INT EDIT, V55, P798, DOI 10.1002/anie.201507881; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Scott BR, 2016, BIOTECHNOL LETT, V38, P425, DOI 10.1007/s10529-015-1989-8; Simmons TJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01247-3; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2017, CURR OPIN STRUC BIOL, V44, P67, DOI 10.1016/j.sbi.2016.12.012; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Valderrama B, 2002, CHEM BIOL, V9, P555, DOI 10.1016/S1074-5521(02)00149-7; Walton PH, 2016, CURR OPIN CHEM BIOL, V31, P195, DOI 10.1016/j.cbpa.2016.04.001; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Yang YL, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0470-6	39	86	88	3	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					523	531		10.1074/jbc.M117.817593	http://dx.doi.org/10.1074/jbc.M117.817593			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29138240	Green Published, hybrid			2022-12-26	WOS:000419915400009
J	Chen, L; Hsi, RS; Yang, FF; Sherer, BA; Stoller, ML; Ho, SP				Chen, Ling; Hsi, Ryan S.; Yang, Feifei; Sherer, Benjamin A.; Stoller, Marshall L.; Ho, Sunita P.			Anatomically-specific intratubular and interstitial biominerals in the human renal medullo-papillary complex	PLOS ONE			English	Article							COLLOIDAL-GOLD IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVE BONE SIALOPROTEIN; MINERALIZED TISSUE PROTEINS; OSTEOCALCIN-DEFICIENT MICE; NEPHRON-SPARING SURGERY; RANDALLS PLAQUES; STONE FORMATION; AVIAN EGGSHELL; IN-VITRO; HYDROXYAPATITE FORMATION	Limited information exists on the anatomically-specific early stage events leading to clinically detectable mineral aggregates in the renal papilla. In this study, quantitative multiscale correlative maps of structural, elemental and biochemical properties of whole medullo-papillary complexes from human kidneys were developed. Correlative maps of properties specific to the uriniferous and vascular tubules using high-resolution X-ray computed tomography, scanning and transmission electron microscopy, energy dispersive X-ray spectroscopy, and immunolocalization of noncollagenous proteins (NCPs) along with their association with anatomy specific biominerals were obtained. Results illustrated that intratubular spherical aggregates primarily form at the proximal regions distant from the papillary tip while interstitial spherical and fibrillar aggregates are distally located near the papillary tip. Biominerals at the papillary tip were closely localized with 10 to 50 mu m diameter vasa recta immunolocalized for CD31 inside the medullo-papillary complex. Abundant NCPs known to regulate bone mineralization were localized within nanoparticles, forming early pathologic mineralized regions of the complex. Based on the physical association between vascular and urothelial tubules, results from light and electron microscopy techniques suggested that these NCPs could be delivered from vasculature to prompt calcification of the interstitial regions or they might be synthesized from local vascular smooth muscle cells after transdifferentiation into osteoblast-like phenotypes. In addition, results provided insights into the plausible temporal events that link the anatomically specific intratubular mineral aggregates with the interstitial biomineralization processes within the functional unit of the kidney.	[Chen, Ling; Yang, Feifei; Ho, Sunita P.] Univ Calif San Francisco, Sch Dent, Dept Prevent & Restorat Dent Sci, Div Biomat & Bioengn, San Francisco, CA 94143 USA; [Hsi, Ryan S.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN USA; [Sherer, Benjamin A.; Stoller, Marshall L.; Ho, Sunita P.] Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Vanderbilt University; University of California System; University of California San Francisco	Ho, SP (corresponding author), Univ Calif San Francisco, Sch Dent, Dept Prevent & Restorat Dent Sci, Div Biomat & Bioengn, San Francisco, CA 94143 USA.; Ho, SP (corresponding author), Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA.	sunita.ho@ucsf.edu	Ho, Sunita P/B-1084-2008	Hsi, Ryan/0000-0003-1652-694X	National Institutes of Diabetes and Digestive and Kidney Disease (NIDDK) [R21DK109912-01]; NIDDK [P20DK100863]; National Institutes of Dental and Craniofacial Research (NIDCR) [R01DE022032]	National Institutes of Diabetes and Digestive and Kidney Disease (NIDDK); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Financial support was through R21DK109912-01 to Drs. Ho (contact) and Stoller (Co-PI) from National Institutes of Diabetes and Digestive and Kidney Disease (NIDDK). Additionally, support was provided by NIDDK - P20DK100863 (to MLS) and the National Institutes of Dental and Craniofacial Research (NIDCR) - R01DE022032 (to SPH) all of which can be accessed from NIH RePORTER (https.//projectreporter.nih.gov/reporter.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Addison WN, 2010, J BONE MINER RES, V25, P1191, DOI 10.1002/jbmr.110; Arabmotlagh M, 2006, J ORTHOP RES, V24, P1336, DOI 10.1002/jor.20162; AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; Boskey AL, 1998, BONE, V23, P187, DOI 10.1016/S8756-3282(98)00092-1; Boskey AL, 2016, MATRIX BIOLOGY JOURN; Bouleftour W, 2016, MATRIX BIOL, V52-54, P60, DOI 10.1016/j.matbio.2015.12.011; CAMARDA AJ, 1987, CALCIFIED TISSUE INT, V40, P349, DOI 10.1007/BF02556698; Campbell S, 2017, THE JOURNAL OF UROLO; Chen L, 2015, BONE, V71, P7, DOI 10.1016/j.bone.2014.09.021; Chien YC, 2008, J STRUCT BIOL, V163, P84, DOI 10.1016/j.jsb.2008.04.008; Chien YC, 2009, CELLS TISSUES ORGANS, V189, P38, DOI 10.1159/000151374; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Evan A, 2006, KIDNEY INT, V69, P1313, DOI 10.1038/sj.ki.5000238; Evan AP, 2006, KIDNEY INT, V69, P2227, DOI 10.1038/sj.ki.5000268; Evan AP, 2008, SEMIN NEPHROL, V28, P111, DOI 10.1016/j.semnephrol.2008.01.004; Evan AP, 2015, ANAT REC, V298, P865, DOI 10.1002/ar.23105; Evan AP, 2015, UROLITHIASIS, V43, pS19, DOI 10.1007/s00240-014-0701-0; Evan AP, 2010, PEDIATR NEPHROL, V25, P831, DOI 10.1007/s00467-009-1116-y; Evan AP, 2003, J CLIN INVEST, V111, P607, DOI 10.1172/JCI200317038; Fassbender WJ, 2000, IN VIVO, V14, P619; Flade K, 2001, CHEM MATER, V13, P3596, DOI 10.1021/cm011063z; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; GERSTENFELD LC, 1995, ANN NY ACAD SCI, V760, P67, DOI 10.1111/j.1749-6632.1995.tb44621.x; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; GUARNER V, 1989, DIABETES, V38, P410, DOI 10.2337/diabetes.38.4.410; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; HAUSCHKA PV, 1989, ANAT REC, V224, P180, DOI 10.1002/ar.1092240208; HAUSCHKA PV, 1982, BIOCHEMISTRY-US, V21, P2538, DOI 10.1021/bi00539a038; Hincke MT, 2008, J HISTOCHEM CYTOCHEM, V56, P467, DOI 10.1369/jhc.2008.950576; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Hsi RS, 2016, BJU INT; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; Hunter GK, 1996, J DENT RES, V75, P913; Khan SR, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.8; Khan SR, 2016, ANAT REC, V299, P5, DOI 10.1002/ar.23275; Khan SR, 2015, UROLITHIASIS, V43, pS109, DOI 10.1007/s00240-014-0705-9; Khan SR, 2012, J UROLOGY, V187, P1094, DOI 10.1016/j.juro.2011.10.125; Kumar V, 2006, J INVEST MED, V54, P412, DOI 10.2310/6650.2006.06021; Kumari S, 1997, J POLYM SCI POL CHEM, V35, P927, DOI 10.1002/(SICI)1099-0518(19970415)35:5<927::AID-POLA7>3.0.CO;2-H; Kuo RL, 2003, KIDNEY INT, V64, P2150, DOI 10.1046/j.1523-1755.2003.00316.x; Li JQ, 2016, J BONE MINER METAB, V34, P367, DOI 10.1007/s00774-015-0734-7; Liu Y, 2010, AM J PHYSIOL-RENAL, V299, pF469, DOI 10.1152/ajprenal.00243.2010; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Matlaga BR, 2006, J UROLOGY, V175, P1720, DOI 10.1016/S0022-5347(05)01017-7; Matlaga BR, 2007, J UROLOGY, V177, P31, DOI 10.1016/j.juro.2006.08.088; MCKEE MD, 1993, J BONE MINER RES, V8, P485; MCKEE MD, 1995, MICROSC RES TECHNIQ, V31, P44, DOI 10.1002/jemt.1070310105; MCKEE MD, 1995, ANN NY ACAD SCI, V760, P177, DOI 10.1111/j.1749-6632.1995.tb44629.x; McKee MD, 1996, J BONE MINER RES, V11, P873; MCKEE MD, 1995, J BONE MINER RES, V10, P1913; Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278; Ogawa-Furuya N, 2013, OSTEOPOROSIS INT, V24, P2223, DOI 10.1007/s00198-013-2289-6; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Oury F, 2013, CELL, V155, P228, DOI 10.1016/j.cell.2013.08.042; Paldanius PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063036; Pallone TL, 2003, AM J PHYSIOL-REG I, V284, pR1153, DOI 10.1152/ajpregu.00657.2002; Pearle MS, 2005, J UROLOGY, V173, P848, DOI 10.1097/01.ju.0000152082.14384.d7; Raynal C, 1996, ENDOCRINOLOGY, V137, P2347, DOI 10.1210/en.137.6.2347; RITTER NM, 1992, J BONE MINER RES, V7, P877; Rowe PSN, 2006, J BONE MINER RES, V21, pS11; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Seibel MJ, 1996, J CLIN ENDOCR METAB, V81, P3289, DOI 10.1210/jc.81.9.3289; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Stoller ML, 2004, J UROLOGY, V171, P1920, DOI 10.1097/01.ju.0000120291.90839.49; Sugiyama T, 2001, J BONE MINER METAB, V19, P146, DOI 10.1007/s007740170034; Taylor ER, 2015, UROLITHIASIS, V43, pS41, DOI 10.1007/s00240-014-0718-4; Tiselius HG, 2013, UROLITHIASIS, V41, P369, DOI 10.1007/s00240-013-0602-7; Tiselius HG, 2011, UROL RES, V39, P231, DOI 10.1007/s00240-010-0349-3; Tobert CM, 2012, UROLOGY, V80, P157, DOI 10.1016/j.urology.2012.03.025; Trion A, 2004, AM HEART J, V147, P808, DOI 10.1016/j.ahj.2003.10.047; Uzzo RG, 2001, J UROLOGY, V166, P6, DOI 10.1016/S0022-5347(05)66066-1; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D; Wiener S, 2014, J ENDOUROL, V28, P807, DOI 10.1089/end.2013.0640; Williams JC, 2013, J NEPHROL, V26, P25, DOI 10.5301/jn.5000208; Xie YS, 2001, KIDNEY INT, V60, P1645, DOI 10.1046/j.1523-1755.2001.00032.x; Yamauchi M, 2010, CLIN NUTR, V29, P761, DOI 10.1016/j.clnu.2010.02.010; Yao YC, 2013, CIRC RES, V113, P495, DOI 10.1161/CIRCRESAHA.113.301792	84	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187103	10.1371/journal.pone.0187103	http://dx.doi.org/10.1371/journal.pone.0187103			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145401	Green Published, gold			2022-12-26	WOS:000415378800009
J	Mulmi, P; Masters, WA; Ghosh, S; Namirembe, G; Rajbhandary, R; Manohar, S; Shrestha, B; West, KP; Webb, P				Mulmi, Prajula; Masters, William A.; Ghosh, Shibani; Namirembe, Grace; Rajbhandary, Ruchita; Manohar, Swetha; Shrestha, Binod; West, Keith P.; Webb, Patrick			Household food production is positively associated with dietary diversity and intake of nutrient-dense foods for older preschool children in poorer families: Results from a nationally-representative survey in Nepal	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; FEEDING PRACTICES; NUTRITIONAL-STATUS; HEALTH; CONSUMPTION; INTERVENTIONS; BANGLADESH; FREQUENCY; MOTHERS; MARKETS	Background Nutrition-sensitive interventions supporting enhanced household food production have potential to improve child dietary quality. However, heterogeneity in market access may cause systematic differences in program effectiveness depending on household wealth and child age. Identifying these effect modifiers can help development agencies specify and target their interventions. Objective This study investigates mediating effects of household wealth and child age on links between farm production and child diets, as measured by production and intake of nutrient-dense food groups. Methods Two rounds (2013 and 2014) of nationally representative survey data (n = 5,978 observations) were used to measure production and children's dietary intake, as well as a household wealth index and control variables, including breastfeeding. Novel steps used include measuring production diversity in terms of both species grown and food groups grown, as well as testing for mediating effects of family wealth and age of child. Results We find significant associations between child dietary diversity and agricultural diversity in terms of diversity of food groups and of species grown, especially for older children in poorer households, and particularly for fruits and vegetables, dairy and eggs. With each additional food group produced, log-odds of meeting minimum dietary diversity score (>= 4) increase by 0.25 (p = 0.01) for children aged 24-59 months. For younger children aged 18-23 months there is a similar effect size but only in the poorest two quintiles of household wealth, and for infants 6-18 months we find no correlation between production and intake in most models. Conclusions Child dietary intake is associated with the composition of farm production, most evident among older preschool children and in poorer households. To improve the nutrition of infants, other interventions are needed; and for relatively wealthier households, own farm production may displace market purchases, which could attenuate the impact of household production on child diets.	[Mulmi, Prajula; Masters, William A.; Ghosh, Shibani; Namirembe, Grace; Webb, Patrick] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Rajbhandary, Ruchita; Manohar, Swetha; Shrestha, Binod; West, Keith P.] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Ctr Human Nutr, Baltimore, MD USA	Tufts University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Masters, WA (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	william.masters@tufts.edu	Webb, Patrick/P-3420-2017; Masters, William A./A-4796-2017	Webb, Patrick/0000-0002-9857-3354; Masters, William A./0000-0002-4546-7291	United States Agency for International Development through the Feed the Future Innovation Lab for Nutrition [USAID] [AID-OAA-L-1-00005]; Bill & Melinda Gates Foundation through the Advancing Research on Nutrition and Agriculture (ARENA) project [IFPRI] [301052.001.001.515.01.01]; Feed the Future Policy Impact Study Consortium [USDA] [TA-CA-15-008]; Logistics Management Division at the Child Health Division; UNICEF	United States Agency for International Development through the Feed the Future Innovation Lab for Nutrition [USAID](United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation through the Advancing Research on Nutrition and Agriculture (ARENA) project [IFPRI]; Feed the Future Policy Impact Study Consortium [USDA](United States Agency for International Development (USAID)); Logistics Management Division at the Child Health Division; UNICEF	This project was supported by a grant to PW and subaward to KPW from the United States Agency for International Development through the Feed the Future Innovation Lab for Nutrition [USAID grant number AID-OAA-L-1-00005], online at www.nutritioninnovationlab.org. WAM was also supported by the Bill & Melinda Gates Foundation through the Advancing Research on Nutrition and Agriculture (ARENA) project [IFPRI project no. 301052.001.001.515.01.01], online at www.ifpri. org/project/advancing-research-nutrition-and-agriculture-arena, and the Feed the Future Policy Impact Study Consortium [USDA cooperative agreement TA-CA-15-008], online at http://ru-ftf.rutgers.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all contributors to the Nutrition Innovation Lab including Liz Marino-Costello of Tufts University and Gerald Shively from Purdue University; Raman Shrestha, Abhighyna Bhattarai, Hari Krishna Shah, Dev Raj Gautam and Diplav Sapkota of the PoSHAN study team in Nepal; Deepak Thapa from the Nepal Technical Assistance Group and Hari Koirala from USAID/Nepal. We are particularly grateful for the work of more than 80 interviewers and anthropometrists, field supervisors, quality control officers, data entry and management staff and research supervisors as well as Sidhartha M Tuladhar, Executive Director of New Era (P.) Ltd., and support received from the Logistics Management Division at the Child Health Division and UNICEF. We also thank the administrative leadership of Rajkumar Pokharel, Chief, Nutrition Section, at the Child Health Division of the Department of Health Services, Ministry of Health and Population in the Government of Nepal. Ethical review in Nepal was conducted by the Nepal Health Research Council (Kathmandu).	Alaofe H, 2016, FOOD NUTR BULL, V37, P164, DOI 10.1177/0379572116639710; [Anonymous], CLIMATE IMPACTS FOOD; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Bageant E, 2016, 1515 IFPRI; Bardhan P.K., 1999, DEV MICROECONOMICS; Bellon MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162535; Bennett L., 2008, CASTE ETHNIC REGIONA; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Biehl E, 2016, FOOD NUTR BULL, V37, P247, DOI 10.1177/0379572116657267; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Block SA, 2006, OXF EC PAP, V59, P330; Byrd-Bredbenner C, 2012, WARDLAWS PERSPECTIVE; Central Bureau of Statistics, 2014, POPULATION MONOGRAPH; Darrouzet-Nardi AF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168759; Darrouzet-Nardi AF, 2016, FOOD POLICY, V61, P185, DOI 10.1016/j.foodpol.2016.03.007; DEJANVRY A, 1991, ECON J, V101, P1400, DOI 10.2307/2234892; DFID and the World Bank, 2006, UN CIT GEND CAST ETH; Dorsey JL, 2017, MATERN CHILD NUTR; ESWARAN M, 1989, J DEV ECON, V31, P37, DOI 10.1016/0304-3878(89)90030-8; Gender Bennett L., 2005, NEW FRONTIERS SOCIAL; Hjelm L, 2016, FOOD NUTR BULL, V37, P275, DOI 10.1177/0379572116653509; Islam MM, 2008, AM J CLIN NUTR, V88, P84, DOI 10.1093/ajcn/88.1.84; Lamichhane DK, 2016, PAEDIATR INT CHILD H, V36, P260, DOI 10.1080/20469047.2015.1109281; Lartey A, 2008, P NUTR SOC, V67, P105, DOI 10.1017/S0029665108006083; Lindsay AC, 2008, FOOD NUTR BULL, V29, P15, DOI 10.1177/156482650802900102; Malapit HJL, 2013, 1313 IFPRI; Manohar S., 2014, POSHAN COMMUNITY STU; MARTORELL R, 1984, AM J CLIN NUTR, V39, P74, DOI 10.1093/ajcn/39.1.74; Masters WA, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12421; Mendola Mariapia, 2007, ASIAN DEV REV, V24, P49, DOI DOI 10.2139/ssrn.661021; Miller LC, 2014, FOOD NUTR BULL, V35, P312, DOI 10.1177/156482651403500304; Ministry of Health and Population (MOHP), 2012, NEP DEM HLTH SURV 20; Mulmi P, 2016, ECON HUM BIOL, V23, P63, DOI 10.1016/j.ehb.2016.07.002; Nguyen PH, 2013, J NUTR, V143, P1176, DOI 10.3945/jn.112.172247; Osei A, 2017, FOOD NUTR BULL, V38, P49, DOI 10.1177/0379572116676427; Pandey J.P., 2013, MATERNAL CHILD HLTH; Pomeroy-Stevens A, 2016, FOOD NUTR BULL, V37, pS151, DOI 10.1177/0379572116674555; Rahman MM, 2015, OBES REV, V16, P758, DOI 10.1111/obr.12293; Rasheed S, 2011, FOOD NUTR BULL, V32, P192, DOI 10.1177/156482651103200302; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, P10657, DOI 10.1073/pnas.1510982112; Simondon KB, 2001, INT J EPIDEMIOL, V30, P476, DOI 10.1093/ije/30.3.476; Singh Inderjit, 1986, AGR HOUSEHOLD MODELS; Singh PK, 2005, J PEDIATR GASTR NUTR, V41, P422, DOI 10.1097/01.mpg.0000178443.18041.98; Taylor J. E., 2003, REV ECON HOUSEHOLD, V1, P33, DOI DOI 10.1023/A:1021847430758; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Health Organization, 2001, COMPL FEED REP GLOB	48	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0186765	10.1371/journal.pone.0186765	http://dx.doi.org/10.1371/journal.pone.0186765			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145391	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800004
J	Jiang, QL; Bao, CC; Yang, YN; Liu, A; Liu, F; Huang, HY; Ye, HH				Jiang, Qingling; Bao, Chenchang; Yang, Ya'nan; Liu, An; Liu, Fang; Huang, Huiyang; Ye, Haihui			Transcriptome profiling of claw muscle of the mud crab (Scylla paramamosain) at different fattening stages	PLOS ONE			English	Article							SKELETAL-MUSCLE; DROSOPHILA; GROWTH; SARCOSPAN; CRUSTACEAN; REVEALS; QUANTIFICATION; ANNOTATION; REGULATORS; HOMOLOG	In crustaceans, muscle growth and development is complicated, and to date substantial knowledge gaps exist. In this study, the claw muscle, hepatopancreas and nervous tissue of the mud crab (Scylla paramamosain) were collected at three fattening stages for sequence by the Illumina sequencing. A total of 127.87 Gb clean data with no less than 3.94 Gb generated for each sample and the cycleQ30 percentages were more than 86.13% for all samples. De Bruijn assembly of these clean data produced 94,853 unigenes, thereinto, 50,059 unigenes were found in claw muscle. A total of 121 differentially expressed genes (DEGs) were revealed in claw muscle from the three fattening stages with a Padj value < 0.01, including 63 genes with annotation. Functional annotation and enrichment analysis showed that the DEGs clusters represented the predominant gene catalog with roles in biochemical processes (glycolysis, phosphorylation and regulation of transcription), molecular function (ATP binding, 6-phosphofructokinase activity, and sequence-specific DNA binding) and cellular component (6-phosphofructokinase complex, plasma membrane, and integral component of membrane). qRT-PCR was employed to further validate certain DEGs. Single nucleotide polymorphism (SNP) analysis obtained 159,322, 125,963 and 166,279 potential SNPs from the muscle transcriptome at stage B, stage C and stage D, respectively. In addition, there were sixteen neuropeptide transcripts being predicted in the claw muscle. The present study provides a comprehensive transcriptome of claw muscle of S. paramamosain during fattening, providing a basis for screening the functional genes that may affect muscle growth of S. paramamosain.	[Jiang, Qingling; Bao, Chenchang; Yang, Ya'nan; Liu, An; Liu, Fang; Huang, Huiyang; Ye, Haihui] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China; [Ye, Haihui] Collaborat Innovat Ctr Dev & Utilizat Marine Biol, Xiamen, Peoples R China	Xiamen University	Ye, HH (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China.; Ye, HH (corresponding author), Collaborat Innovat Ctr Dev & Utilizat Marine Biol, Xiamen, Peoples R China.	haihuiye@xmu.edu.cn			Important Science AMP; Technology Specific Project of Zhejiang Province for Selective Breeding [2016C02055-8]; Ningbo University; Spark Plan Project in Fujian Province [2016S0055]; Xiamen Southern Oceanographic Center [14GZY56HJ26]	Important Science AMP; Technology Specific Project of Zhejiang Province for Selective Breeding; Ningbo University; Spark Plan Project in Fujian Province; Xiamen Southern Oceanographic Center	This study was supported by the Important Science & Technology Specific Project of Zhejiang Province for Selective Breeding (2016C02055-8) and K. C. Wong Magna Fund in Ningbo University, the Spark Plan Project in Fujian Province (No. 2016S0055) and the Xiamen Southern Oceanographic Center (No. 14GZY56HJ26).	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bao CC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17055; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bauer DC., 2011, NATURE PRECEDINGS; BITTNER GD, 1978, J COMP PHYSIOL, V124, P277, DOI 10.1007/BF00657059; Cohen S, 2012, J CELL BIOL, V198, P575, DOI 10.1083/jcb.201110067; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Crosbie RH, 2000, HUM MOL GENET, V9, P2019, DOI 10.1093/hmg/9.13.2019; Dreiza CM, 2010, CELL STRESS CHAPERON, V15, P1, DOI 10.1007/s12192-009-0127-8; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Duan H, 2001, DEVELOPMENT, V128, P4489; ELHAJ AJ, 1984, J CRUSTACEAN BIOL, V4, P536, DOI 10.2307/1548067; Feng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110896; Fernandes JJ, 1998, DEVELOPMENT, V125, P1769; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Ghaffari N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07081; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grimmelikhuijzen CJP, 1996, INT REV CYTOL, V167, P37, DOI 10.1016/S0074-7696(08)61345-5; Hartenstein V, 2006, J ENDOCRINOL, V190, P555, DOI 10.1677/joe.1.06964; Hayashi K, 2006, MICRON, V37, P591, DOI 10.1016/j.micron.2005.11.013; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Huang XS, 2014, GEN COMP ENDOCR, V204, P229, DOI 10.1016/j.ygcen.2014.06.002; Keenan C., 1999, ACAIR P; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lebakken CS, 2000, MOL CELL BIOL, V20, P1669, DOI 10.1128/MCB.20.5.1669-1677.2000; Liu SS, 2017, FISH SHELLFISH IMMUN, V60, P545, DOI 10.1016/j.fsi.2016.07.033; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152572; Marshall JL, 2012, HUM MOL GENET, V21, P4378, DOI 10.1093/hmg/dds271; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; MYKLES DL, 1980, J EXP BIOL, V84, P89; Navegantes LCC, 2001, AM J PHYSIOL-ENDOC M, V281, pE449, DOI 10.1152/ajpendo.2001.281.3.E449; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Piccirillo R, 2014, DEV DYNAM, V243, P201, DOI 10.1002/dvdy.24036; Portin P, 2002, HEREDITAS, V136, P89, DOI 10.1034/j.1601-5223.2002.1360201.x; Puppa MJ, 2015, HEALTHY AGEING LONG, V3, P107, DOI 10.1007/978-3-319-18326-8_5; Rembold CM, 2000, J PHYSIOL-LONDON, V524, P865, DOI 10.1111/j.1469-7793.2000.00865.x; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Shen Jie, 2011, Journal of Fisheries of China, V35, P1481; SKINNER DM, 1966, J EXP ZOOL, V163, P115, DOI 10.1002/jez.1401630202; Tagmount A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009327; Taylor MV, 2006, MOL B INT U, P169, DOI 10.1007/0-387-32963-3_14; Tiefenbock SK, 2010, EMBO J, V29, P171, DOI 10.1038/emboj.2009.330; Tinkerhess MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031633; Tixier V, 2013, P NATL ACAD SCI USA, V110, P18982, DOI 10.1073/pnas.1301262110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Waiho K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171095; Watling L, 2015, NATURAL HIST CRUSTAC; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yalin S., 1994, Naga, V17, P28; Ye HH, 2011, AQUACULT INT, V19, P313, DOI 10.1007/s10499-010-9399-3; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zhang FY, 2016, NEUROSCI BULL, V32, P205, DOI 10.1007/s12264-016-0032-y	61	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188067	10.1371/journal.pone.0188067	http://dx.doi.org/10.1371/journal.pone.0188067			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141033	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400052
J	Yu, TY; Lin, J; Zhao, J; Huang, W; Zeng, LW; Fang, ZY; Xu, N				Yu, Tingyu; Lin, Jiao; Zhao, Jin; Huang, Wei; Zeng, Lingwen; Fang, Zhiyuan; Xu, Ning			A simple in vitro tumor chemosensitivity assay based on cell penetrating peptide tagged luciferase	PLOS ONE			English	Article							ADENOSINE-TRIPHOSPHATE; ATP-BIOLUMINESCENCE; CHEMOTHERAPY; DELIVERY; REPORTER; SIRNA	The analysis of intracellular ATP can reveal the response of cells to different treatments and is important for individualized medicine. In the present study, we developed a cell penetrating peptides (CPPs) tagged luciferase (TAT-LUC) for tumor chemosensitivity assay. The activity of recombinant TAT-LUC was evaluated using ATP standard solution and tumor cells. This recombinant TAT-LUC was then used for the analysis of sensitivity index (SI) of four strains of tumor cells. The results showed that TAT-LUC could detect less than 10 nM extracellular ATP with a strong correlation between the luminescence intensity and the ATP content (R-2 = 0.994). Without cell lysis, the detection limit for intracellular ATP analysis was 40 tumor cells. Furthermore, chemosensitivity of four strains of tumor cells (Skov-3/DDP, A549/DDP, MDA-MB-231, Huh-7) was determined by this assay successfully. The cell penetration ability of TAT-LUC enables the assay not only to reflect drug resistance of tumor cells real-timely but also to minimize the test time, which can be a valuable aid for personalized cancer chemotherapy.	[Yu, Tingyu; Huang, Wei] Guangzhou Univ Chinese Med, Clin Med Coll 2, Guangzhou, Guangdong, Peoples R China; [Yu, Tingyu; Xu, Ning] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Clin Lab, Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [Lin, Jiao; Zeng, Lingwen; Fang, Zhiyuan] Chinese Acad Sci, Guangzhou Inst Biomed, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Lin, Jiao; Zeng, Lingwen; Fang, Zhiyuan] Chinese Acad Sci, Guangzhou Inst Hlth, Guangzhou, Guangdong, Peoples R China; [Zhao, Jin] Guizhou Med Univ, Dept Immunol, Tissue Engn & Stem Cells Res Ctr, Guiyang, Guizhou, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guizhou Medical University	Xu, N (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Clin Lab, Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China.; Fang, ZY (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China.; Fang, ZY (corresponding author), Chinese Acad Sci, Guangzhou Inst Hlth, Guangzhou, Guangdong, Peoples R China.	fangjnu@126.com; xu_ning@126.com		Xu, Ning/0000-0001-9707-728X; Zhao, Jin/0000-0003-1442-6873	National Natural Science Foundation of China [81602608]; National Basic Research Program of China (973 Program) [2013CB967100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by grants from the National Natural Science Foundation of China (81602608) to Zhiyuan Fang and the National Basic Research Program of China (973 Program 2013CB967100) to Lingwen Zeng.; This study was supported by grants from the National Natural Science Foundation of China (81602608) to Zhiyuan Fang and the National Basic Research Program of China (973 Program 2013CB967100) to Lingwen Zeng.	Andaloussi SEL, 2011, NUCLEIC ACIDS RES, V39, P3972, DOI 10.1093/nar/gkq1299; Ando T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002561; ASKGAARD DS, 1995, BIOLOGICALS, V23, P55, DOI 10.1016/1045-1056(95)90012-8; Balik V, 2015, SURG ONCOL, V24, P292, DOI 10.1016/j.suronc.2015.06.004; Benner NL, 2016, ACS NANO; Branchini BR, 2015, ANAL BIOCHEM, V484, P148, DOI 10.1016/j.ab.2015.05.020; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Eguchi A, 2009, TRENDS PHARMACOL SCI, V30, P341, DOI 10.1016/j.tips.2009.04.009; Eguchi A, 2009, NAT BIOTECHNOL, V27, P567, DOI 10.1038/nbt.1541; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fujita K, 1998, ANTICANCER RES, V18, P1973; Glaysher S, 2011, METHODS MOL BIOL, V731, P247, DOI 10.1007/978-1-61779-080-5_21; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Kurbacher CM, 1998, ANTI-CANCER DRUG, V9, P51, DOI 10.1097/00001813-199801000-00006; Layek B, 2015, INT J MOL SCI, V16, P28912, DOI 10.3390/ijms161226142; Ling ZQ, 2012, ACTA PHARMACOL SIN, V33, P401, DOI 10.1038/aps.2011.195; MAZZA G, 1981, J BACTERIOL, V146, P305, DOI 10.1128/JB.146.1.305-311.1981; Miyazaki R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152665; Nagourney RA, 2000, GYNECOL ONCOL, V76, P143, DOI 10.1006/gyno.1999.5672; Neubauer H, 2008, ANTICANCER RES, V28, P949; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; PRIOLI RP, 1985, TUBERCLE, V66, P99, DOI 10.1016/0041-3879(85)90074-1; Sakuma K, 2016, ONCOL LETT, V12, P4643, DOI 10.3892/ol.2016.5238; SEVIN BU, 1988, GYNECOL ONCOL, V31, P191, DOI 10.1016/0090-8258(88)90293-4; Suh JS, 2009, BIOCHEM BIOPH RES CO, V379, P669, DOI 10.1016/j.bbrc.2008.12.041; Tantama M, 2014, METHOD ENZYMOL, V547, P355, DOI 10.1016/B978-0-12-801415-8.00017-5; Tatar B, 2016, J TURK-GER GYNECOL A, V17, P35, DOI 10.5152/jtgga.2016.16017; Tonary AM, 2006, ANAL BIOCHEM, V350, P239, DOI 10.1016/j.ab.2006.01.015; Unger FT, 2015, CELL MOL LIFE SCI, V72, P729, DOI 10.1007/s00018-014-1772-3; Uruno T, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/967286; Wang L, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0071-2; Zhao Dan, 2011, Zhonghua Fu Chan Ke Za Zhi, V46, P193	32	1	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0186184	10.1371/journal.pone.0186184	http://dx.doi.org/10.1371/journal.pone.0186184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125836	Green Published, gold, Green Submitted			2022-12-26	WOS:000414866000002
J	Starosolski, Z; Bhavane, R; Ghaghada, KB; Vasudevan, SA; Kaay, A; Annapragada, A				Starosolski, Zbigniew; Bhavane, Rohan; Ghaghada, Ketan B.; Vasudevan, Sanjeev A.; Kaay, Alexander; Annapragada, Ananth			Indocyanine green fluorescence in second near-infrared (NIR-II) window	PLOS ONE			English	Article							AG2S QUANTUM DOTS; FLOW; VISUALIZATION; FLUOROPHORES; ANGIOGRAPHY; ABSORPTION; ARTERY	Indocyanine green (ICG), a FDA approved near infrared (NIR) fluorescent agent, is used in the clinic for a variety of applications including lymphangiography, intra-operative lymph node identification, tumor imaging, superficial vascular imaging, and marking ischemic tissues. These applications operate in the so-called "NIR-I" window (700-900 nm). Recently, imaging in the "NIR-II" window (1000-1700 nm) has attracted attention since, at longer wavelengths, photon absorption, and scattering effects by tissue components are reduced, making it possible to image deeper into the underlying tissue. Agents for NIR-II imaging are, however, still in pre-clinical development. In this study, we investigated ICG as a NIR-II dye. The absorbance and NIR-II fluorescence emission of ICG were measured in different media (PBS, plasma and ethanol) for a range of ICG concentrations. In vitro and in vivo testing were performed using a custom-built spectral NIR assembly to facilitate simultaneous imaging in NIR-I and NIR-II window. In vitro studies using ICG were performed using capillary tubes (as a simulation of blood vessels) embedded in Intralipid solution and tissue phantoms to evaluate depth of tissue penetration in NIR-I and NIR-II window. In vivo imaging using ICG was performed in nude mice to evaluate vascular visualization in the hind limb in the NIR-I and II windows. Contrast-to-noise ratios (CNR) were calculated for comparison of image quality in NIR-I and NIR-II window. ICG exhibited significant fluorescence emission in the NIR-II window and this emission (similar to the absorption profile) is substantially affected by the environment of the ICG molecules. In vivo imaging further confirmed the utility of ICG as a fluorescent dye in the NIR-II domain, with the CNR values being similar to 2 times those in the NIR-I window. The availability of an FDA approved imaging agent could accelerate the clinical translation of NIR-II imaging technology.	[Starosolski, Zbigniew; Bhavane, Rohan; Ghaghada, Ketan B.; Annapragada, Ananth] Texas Childrens Hosp, Edward B Singleton Dept Pediat Radiol, Houston, TX 77030 USA; [Vasudevan, Sanjeev A.] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Kaay, Alexander] Avue LLC, Santa Barbara, CA USA	Baylor College of Medicine; Baylor College of Medicine	Starosolski, Z; Bhavane, R (corresponding author), Texas Childrens Hosp, Edward B Singleton Dept Pediat Radiol, Houston, TX 77030 USA.	zastaros@texaschildrens.org; rcbhavan@texaschildrens.org	Annapragada, Ananth/GOK-1576-2022		Macy Easom Cancer Research Foundation	Macy Easom Cancer Research Foundation	This work was supported by the Macy Easom Cancer Research Foundation (SAV). There was no additional external funding received for this study. The funder provided support in the form of salaries for authors [ZS, KBG, SAV, AA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antaris AL, 2016, NAT MATER, V15, P235, DOI [10.1038/NMAT4476, 10.1038/nmat4476]; Carr Jessica A, 100768 BIORXIV; de Oliveira JG, 2008, NEUROSURGERY, V62, P1300, DOI [10.1227/01.neu.0000333795.21468.d4, 10.1227/01.NEU.0000279982.48426.A1]; Desmettre T, 2000, SURV OPHTHALMOL, V45, P15, DOI 10.1016/S0039-6257(00)00123-5; FLOWER RW, 1976, JOHNS HOPKINS MED J, V138, P33; FOX IJ, 1960, P STAFF M MAYO CLIN, V35, P732; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Fujiwara M, 2009, J PLAST RECONSTR AES, V62, pE373, DOI 10.1016/j.bjps.2007.12.074; Guan XM, 2016, J MINIM INVAS GYN, V23, P10, DOI 10.1016/j.jmig.2015.08.001; Hirata A, 2004, GRAEF ARCH CLIN EXP, V242, P527, DOI 10.1007/s00417-004-0875-1; Hong GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5206; Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995; Hong GS, 2012, ANGEW CHEM INT EDIT, V51, P9818, DOI 10.1002/anie.201206059; InternationalAA Commission onAA Non-Ionizing RadiationAA Protection, 2000, HEALTH PHYS, V79, P431; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Killory BD, 2009, NEUROSURGERY, V65, P456, DOI 10.1227/01.NEU.0000346649.48114.3A; Kraft JC, 2014, BIOCHEMISTRY-US, V53, P1275, DOI 10.1021/bi500021j; LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575, DOI 10.1152/jappl.1976.40.4.575; Li CY, 2014, BIOMATERIALS, V35, P393, DOI 10.1016/j.biomaterials.2013.10.010; Lim Yong Taik, 2003, Mol Imaging, V2, P50, DOI 10.1162/153535003765276282; Ma CY, 2009, CLIN NEUROL NEUROSUR, V111, P840, DOI 10.1016/j.clineuro.2009.08.017; Murawa D, 2009, BRIT J SURG, V96, P1289, DOI 10.1002/bjs.6721; Naczynski DJ, NATURE COMMUNICATION, V4, P1; Nairat M, 2015, PHYS CHEM CHEM PHYS, V17, P5872, DOI 10.1039/c4cp04984e; Oduor P, 2016, SPIE; Ohnishi S, 2005, MOL IMAGING; Onda N, 2016, INT J CANCER, V139, P673, DOI 10.1002/ijc.30102; Ozawa Y, 2016, ASIAN J ENDOSC SURG, V9, P340, DOI 10.1111/ases.12306; Philip R, 1996, J PHOTOCH PHOTOBIO A, V96, P137, DOI 10.1016/1010-6030(95)04292-X; Reuthebuch O, 2004, CHEST, V125, P418, DOI 10.1378/chest.125.2.418; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; Shinohara H, 1996, HEPATOLOGY, V23, P137, DOI 10.1053/jhep.1996.v23.pm0008550033; Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326; Sun Y, 2016, CHEM SCI, V7, P6203, DOI 10.1039/c6sc01561a; Takaike N, 2016, LIBR INFORM SC, P1; Tanabe N, 2017, ACTA NEUROCHIR, V159, P567, DOI 10.1007/s00701-016-3060-5; Tao ZM, 2013, ANGEW CHEM INT EDIT, V52, P13002, DOI 10.1002/anie.201307346; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Vinegoni C, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001577; Welsher K, 2011, P NATL ACAD SCI USA, V108, P8943, DOI 10.1073/pnas.1014501108; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706; Zheng XH, 2011, MOL PHARMACEUT, V8, P447, DOI 10.1021/mp100301t; Zhu B, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140547	43	114	116	5	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187563	10.1371/journal.pone.0187563	http://dx.doi.org/10.1371/journal.pone.0187563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121078	Green Submitted, gold, Green Published			2022-12-26	WOS:000414769900049
J	Chesnais, M; Lecuru, F; Mimouni, M; Ngo, C; Fauconnier, A; Huchon, C				Chesnais, Marion; Lecuru, Fabrice; Mimouni, Myriam; Ngo, Charlotte; Fauconnier, Arnaud; Huchon, Cyrille			A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer	PLOS ONE			English	Article							SUBOPTIMAL CYTOREDUCTION; LAPAROSCOPY; CARCINOMA; RESECTABILITY	Objective Postoperative residual tumor is the major prognostic factor in ovarian cancer. The feasibility of complete cytoreductive surgery is assessed by laparoscopy. Our goal was to develop a predictive score prior to laparoscopy to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer. Methods We developed a score to predict incomplete cytoreductive surgery by performing multiple logistic regressions after bootstrap procedures on data from a retrospective cohort of 247 patients with advanced ovarian cancer. This score was validated on a different population of 45 patients with ovarian cancer. Results Four criteria were independently associated with incomplete cytoreduction, confirmed by surgery: BMI > 30 kg/m(2) (adjusted odds ratio [aOR], 3.07; 95% confidence interval [95% CI], 1.0-9.6), CA125 > 100 IU/L (aOR, 3.99; 95% CI, 1.6-10.1), diaphragmatic and/or omental carcinomatosis by CT-Scan (aOR, 5.82; 95% CI, 2.6-13.1), and positive parenchymal metastases by PET/CT (aOR, 3.59; 95% CI, 1.0-12.8). The 100-point score was based on these criteria. The area-under-the-curve of the score was 0.79 (95% CI, 0.73-0.86). In the validation group, no patient ranked in the high-risk group of incomplete cytoreductive surgery had a complete upfront cytoreductive surgery (95% CI 0-16). Three of 29 patients for whom primary complete cytoreduction was not possible were classified in the group at low risk of incomplete cytoreductive surgery (12%; 95% CI 4-27). Conclusion This pre-operative score may be useful for distinguishing which patients may have complete cytoreductive surgery from those who will receive neoadjuvant chemotherapy, while avoiding unnecessary laparoscopy.	[Chesnais, Marion; Mimouni, Myriam; Fauconnier, Arnaud; Huchon, Cyrille] Univ Versailles St Quentin En Yvelines, EA Clin Risks & Safety Womens Hlth 7285, Montigny Le Bretonneux, France; [Lecuru, Fabrice; Mimouni, Myriam; Ngo, Charlotte] Hop Europeen Georges Pompidou, AP HP, Gynecol Oncol Ctr Paris Descartes, Paris, France; [Lecuru, Fabrice] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Lecuru, Fabrice] Univ Paris 05, INSERM, Fac Med, UMR S 1124, Paris, France; [Mimouni, Myriam; Ngo, Charlotte; Fauconnier, Arnaud; Huchon, Cyrille] CHI Poissy St Germain, Dept Gynecol & Obstet, Poissy, France	UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hospital Chi of Poissy Saint Germain	Chesnais, M (corresponding author), Univ Versailles St Quentin En Yvelines, EA Clin Risks & Safety Womens Hlth 7285, Montigny Le Bretonneux, France.	marion_chesnais@hotmail.com						Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Brun JL, 2008, GYNECOL ONCOL, V110, P354, DOI 10.1016/j.ygyno.2008.04.042; Byrom J, 2002, BJOG-INT J OBSTET GY, V109, P369, DOI 10.1111/j.1471-0528.2002.01216.x; Chereau E, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.856; Chi DS, 2006, GYNECOL ONCOL, V101, P224, DOI 10.1016/j.ygyno.2005.10.037; de Jong D, 2007, ONCOLOGY-BASEL, V72, P293, DOI 10.1159/000113051; Dessapt AL, SURG ONCOLOGY, V25, P326; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Fagotti A, 2005, GYNECOL ONCOL, V96, P729, DOI 10.1016/j.ygyno.2004.11.031; Fagotti A, 2006, ANN SURG ONCOL, V13, P1156, DOI 10.1245/ASO.2006.08.021; Fagotti A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.052; Gerestein CG, 2011, ANTICANCER RES, V31, P4043; Morice P, 2004, E MEM ACAD NATL CHIR, V3, p35 ; Reuss A, 2009, CANCER, V15, P1234; Gomez-Hidalgo NR, 2015, GYNECOL ONCOL, V137, P553, DOI 10.1016/j.ygyno.2015.03.049; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Rutten MJ, 2017, J CLIN ONCOL, V35, P613, DOI 10.1200/JCO.2016.69.2962; Rutten MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009786.pub2; Sugarbaker, 1996, PERITONEAL CARCINOMA, V82, P359, DOI DOI 10.1007/978-1-4613-1247-5_23; Suidan RS, 2014, GYNECOL ONCOL, V134, P455, DOI 10.1016/j.ygyno.2014.07.002; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806	21	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187245	10.1371/journal.pone.0187245	http://dx.doi.org/10.1371/journal.pone.0187245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117194	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600029
J	Risalde, MA; Rivero-Juarez, A; Romero-Palomo, F; Frias, M; Lopez-Lopez, P; Cano-Terriza, D; Garcia-Bocanegra, I; Jimenez-Ruiz, S; Camacho, A; Machuca, I; Gomez-Villamandos, JC; Rivero, A				Risalde, Maria A.; Rivero-Juarez, Antonio; Romero-Palomo, Fernando; Frias, Mario; Lopez-Lopez, Pedro; Cano-Terriza, David; Garcia-Bocanegra, Ignacio; Jimenez-Ruiz, Saul; Camacho, Angela; Machuca, Isabel; Gomez-Villamandos, Jose C.; Rivero, Antonio			Persistence of hepatitis E virus in the liver of non-viremic naturally infected wild boar	PLOS ONE			English	Article							LOCAL GROCERY STORES; KUPFFER CELLS; PIG LIVERS; ANIMAL-MODELS; SWINE; RISK; TRANSMISSION; HEV; PATHOGENESIS; PREVALENCE	Hepatitis E virus (HEV) is an emerging zoonotic pathogen with pigs and wild boar serving as reservoirs for human infection through direct contact with infected animals or the consumption of raw or undercooked pork products. The liver is considered the main target site of HEV replication in swine and an important organ in the pathogenesis of the disease. The aim of this study was to characterize the target liver cells for HEV entry in naturally infected wild boar and to evaluate the type and severity of the pathological changes in order to reach a better understanding of the hepatic pathogenic mechanisms involved in hepatitis E. In total, 58 livers from hunted wild boar were histopathologically evaluated. The presence of specific HEV antibodies in serum was determined by indirect ELISA. Immunohistochemistry was used for the detection of HEV antigen and Real time RT-PCR to detect HEV RNA in liver and serum. HEV seroprevalence in these animals was of 5.197% (Cl-95%: 1.77-14.14). By Real time RT-PCR, HEV was detected in the liver tissue of four wild boar (6.8%; Cl-95%: 2.7-16.4) and only one animal was also positive in serum (1.7%; Cl-95%: 0.3-9.1). The non-viremic animals naturally infected with HEV presented evidence of liver infection, mainly in Kupffer cells and liver sinusoidal endothelial cells, without apparent associated hepatitis lesions. This study supports the hypothesis that low viral titers may persist in the liver of non-viremic individuals, giving thus the possibility of consumption of contaminated liver of animals diagnosed as HEV-negative in serum. Further immunopathogenic studies are necessary to elucidate the mechanisms responsible for this process and to evaluate the protocols of HEV diagnosis in animals destined for human consumption.	[Risalde, Maria A.; Rivero-Juarez, Antonio; Frias, Mario; Lopez-Lopez, Pedro; Camacho, Angela; Machuca, Isabel; Rivero, Antonio] Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Unidad Enfermedades Infecciosas, Cordoba, Spain; [Romero-Palomo, Fernando; Gomez-Villamandos, Jose C.] Univ Cordoba UCO, Dept Anat & Anat Patol Vet, Fac Vet, Agrifood Excellence Int Campus CeiA3, Cordoba, Spain; [Cano-Terriza, David; Garcia-Bocanegra, Ignacio; Jimenez-Ruiz, Saul] UCO CeiA3, Dept Sanidad Anim, Fac Vet, Cordoba, Spain; [Romero-Palomo, Fernando] F Hoffmann La Roche Ltd, Pharmaceut Res & Early Dev pRED, Pharmaceut Sci, Roche Innovat Ctr Basel, Basel, Switzerland	Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; Roche Holding	Rivero, A (corresponding author), Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Unidad Enfermedades Infecciosas, Cordoba, Spain.	ariveror@gmail.com	Jiménez-Ruiz, Saúl/AAG-7110-2019; Cano-Terriza, David/AAG-4117-2021; Villamandos, Jose Carlos Gómez/AAN-2874-2021; Moya, Maria A. Risalde/AAP-8925-2021; Frias, Mario/AAL-6494-2021; Espejo, Angela Camacho/AAM-9991-2021; Rivero, Antonio/ABE-5294-2020; Lopez, Pedro Lopez/AAL-5831-2021; Bocanegra, Ignacio Garcia/G-1443-2016; Risalde, María A/M-1930-2014; Romero-Palomo, Fernando/K-9978-2014; Rivero-Juarez, Antonio/E-4528-2019; Moya, MAngeles Risalde/AAQ-2578-2021	Jiménez-Ruiz, Saúl/0000-0003-2090-9353; Cano-Terriza, David/0000-0001-5657-2567; Villamandos, Jose Carlos Gómez/0000-0001-9730-2352; Moya, Maria A. Risalde/0000-0001-6751-1305; Bocanegra, Ignacio Garcia/0000-0003-3388-2604; Risalde, María A/0000-0001-6751-1305; Rivero-Juarez, Antonio/0000-0002-5813-6889; Romero Palomo, Fernando/0000-0003-4349-6344; ABRAVANEL, Florence/0000-0002-1753-1065; Rivero, Antonio/0000-0001-5005-8268; Rivero Roman, Antonio/0000-0002-8643-4250; MACHUCA, ISABEL/0000-0003-3343-0085	Ministry of Economy and Competitiveness [RD12/0017/0012]; European Regional Development Fund; Health Research Fund from the Institute of Health Carlos III (ISCIII) [PI16/01297]; SPANISH AIDS Research Network [RD16/0025/0034]; ISCIII [CD16/00209]	Ministry of Economy and Competitiveness; European Regional Development Fund(European Commission); Health Research Fund from the Institute of Health Carlos III (ISCIII); SPANISH AIDS Research Network; ISCIII(Instituto de Salud Carlos III)	This work was supported by the Ministry of Economy and Competitiveness (RD12/0017/0012) integrated in the Nacional R+D+ i Plan and co-financed by the European Regional Development Fund, and the Health Research Fund from the Institute of Health Carlos III (ISCIII) (PI16/01297), and The SPANISH AIDS Research Network RD16/0025/0034 - ISCIII FEDER. M.A. Risalde is the recipient of a Sara Borrell postdoctoral perfection grant from ISCIII (CD16/00209).	Abravanel F, 2012, J CLIN MICROBIOL, V50, P897, DOI 10.1128/JCM.05942-11; Adlhoch C, 2009, VET MICROBIOL, V139, P270, DOI 10.1016/j.vetmic.2009.06.032; Aprea G, 2017, TRANSBOUND EMERG DIS; Arenas-Montes A, 2013, EUR J WILDLIFE RES, V59, P299, DOI 10.1007/s10344-013-0701-3; Berto Alessandra, 2012, BMC Res Notes, V5, P190, DOI 10.1186/1756-0500-5-190; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Boadella M, 2012, TRANSBOUND EMERG DIS, V59, P395, DOI 10.1111/j.1865-1682.2011.01285.x; Bouwknegt M, 2007, J FOOD PROTECT, V70, P2889, DOI 10.4315/0362-028X-70.12.2889; Bouwknegt M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-7; Cabillic F, 2006, J HEPATOL, V44, P552, DOI 10.1016/j.jhep.2005.08.010; Clemente-Casares P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9838041; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Cossaboom CM, 2016, J MED VIROL, V88, P1641, DOI 10.1002/jmv.24497; Crispe IN, 2011, J HEPATOL, V54, P357, DOI 10.1016/j.jhep.2010.10.005; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; de Deus N, 2008, VET MICROBIOL, V132, P19, DOI 10.1016/j.vetmic.2008.04.036; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; Drobeniuc J, 2013, EMERG INFECT DIS, V19, P218, DOI 10.3201/eid1902.120961; Feagins AR, 2008, INT J FOOD MICROBIOL, V123, P32, DOI 10.1016/j.ijfoodmicro.2007.11.068; Feagins AR, 2007, J GEN VIROL, V88, P912, DOI 10.1099/vir.0.82613-0; Geng YS, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.15618; Halbur PG, 2001, J CLIN MICROBIOL, V39, P918, DOI 10.1128/JCM.39.3.918-923.2001; Jori F, 2016, VIRUSES, V20, P8; Jung K, 2007, VET J, V173, P683, DOI 10.1016/j.tvjl.2006.02.016; Kasorndorkbua C, 2004, J CLIN MICROBIOL, V42, P5047, DOI 10.1128/JCM.42.11.5047-5052.2004; Khuroo MS, 2016, J VIRAL HEPATITIS, V23, P68, DOI 10.1111/jvh.12445; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Krawczynski K, 2011, VIRUS RES, V161, P78, DOI 10.1016/j.virusres.2011.03.007; Kulkarni MA, 2008, J MED VIROL, V80, P1387, DOI 10.1002/jmv.21220; Kumar S, 2013, INT J INFECT DIS, V17, pE228, DOI 10.1016/j.ijid.2012.11.026; le Coutre P, 2009, GUT, V58, P699, DOI 10.1136/gut.2008.165571; Lee YH, 2009, VET J, V179, P417, DOI 10.1016/j.tvjl.2007.10.028; Lhomme S, 2015, EMERG INFECT DIS, V21, P1224, DOI 10.3201/eid2107.141909; Martin M, 2007, VET MICROBIOL, V122, P16, DOI 10.1016/j.vetmic.2006.12.020; Masuda JI, 2005, HEPATOL RES, V31, P178, DOI 10.1016/j.hepres.2005.01.008; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Meng XJ, 2010, J VIRAL HEPATITIS, V17, P153, DOI 10.1111/j.1365-2893.2009.01257.x; Meng XJ, 2011, VIRUS RES, V161, P23, DOI 10.1016/j.virusres.2011.01.016; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Mesquita JR, 2016, TRANSBOUND EMERG DIS, V63, P574, DOI 10.1111/tbed.12297; Montagnaro S, 2015, J COMP PATHOL, V153, P1, DOI 10.1016/j.jcpa.2015.04.006; Navaneethan U, 2008, LIVER INT, V28, P1190, DOI 10.1111/j.1478-3231.2008.01840.x; Rivero-Juarez A, 2017, ZOONOSES PUBLIC HLTH, V64, P561, DOI 10.1111/zph.12343; Rivero-Juarez A, 2017, CLIN INFECT DIS, V64, P964, DOI 10.1093/cid/cix004; Rutjes SA, 2010, J VIROL METHODS, V168, P197, DOI 10.1016/j.jviromet.2010.05.014; Schlosser J, 2014, VET RES, V45, DOI 10.1186/s13567-014-0121-8; Serracca L, 2015, FOOD ENVIRON VIROL, V7, P206, DOI 10.1007/s12560-015-9201-9; Tamura A, 2007, HEPATOL RES, V37, P113, DOI 10.1111/j.1872-034X.2007.00024.x; Perez-Gracia MT, 2012, MED CLIN-BARCELONA, V139, P404, DOI 10.1016/j.medcli.2012.02.013; Vicente J, 2013, TRANSBOUND EMERG DIS, V60, P92, DOI 10.1111/tbed.12167; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Yazaki Y, 2003, J GEN VIROL, V84, P2351, DOI 10.1099/vir.0.19242-0; Yoo D, 2000, CAN J VET RES, V64, P193; Yugo DM, 2014, ILAR J, V55, P187, DOI 10.1093/ilar/ilu007	54	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0186858	10.1371/Journal.pone.0186858	http://dx.doi.org/10.1371/Journal.pone.0186858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117209	Green Submitted, Green Published, gold			2022-12-26	WOS:000414659600017
J	Menou, A; Flajolet, P; Duitman, J; Justet, A; Moog, S; Jaillet, M; Tabeze, L; Solhonne, B; Garnier, M; Mal, H; Mordant, P; Castier, Y; Cazes, A; Sallenave, JM; Mailleux, AA; Crestani, B				Menou, Awen; Flajolet, Pauline; Duitman, JanWillem; Justet, Aurelien; Moog, Sophie; Jaillet, Madeleine; Tabeze, Laure; Solhonne, Brigitte; Garnier, Marc; Mal, Herve; Mordant, Pierre; Castier, Yves; Cazes, Aurelie; Sallenave, Jean-Michel; Mailleux, Arnaud A.; Crestani, Bruno			Human airway trypsin-like protease exerts potent, antifibrotic action in pulmonary fibrosis	FASEB JOURNAL			English	Article						TMPRSS11D; bleomycin; fibroblast; protease-activated receptor 2; HAT	HEPATOCYTE GROWTH-FACTOR; PROSTAGLANDIN-E-2 INHIBITS FIBROBLAST; LUNG FIBROBLASTS; EPITHELIAL-CELLS; E-PROSTANOID-2 RECEPTOR; ACTIVATED RECEPTOR-1; SERINE PROTEASES; IN-VITRO; EXPRESSION; DISEASES	Idiopathic pulmonary fibrosis (IPF) is characterized by the deposition of excessive extracellular matrix and the destruction of lung parenchyma, resulting from an aberrant wound-healing response. Although IPF is often associated with an imbalance in protease activity, the mechanisms underlying the sustained repair mechanisms are not fully understood. Here, we addressed the role of the recently identified, membrane-anchored serine protease human airway trypsin-like protease (HAT). In the present study, we show that both HAT expression and activity were up-regulated in human IPF specimens. Next, adenoviral overexpression of HAT before bleomycin challenge attenuated lung injury as well as extracellular matrix deposition in the bleomycin-induced pulmonary fibrosis model. In vitro, HAT prevented specific fibrosis-associated responses in primary human pulmonary fibroblasts and induced the expression of mediators associated with the prostaglandin E2 pathway. Altogether, our findings suggested that HAT could have a protective role in IPF and other fibrotic lung disorders.-Menou, A., Flajolet, P., Duitmen, J., Justet, A., Moog, S., Jaillet, M., Tabeze, L., Solhonne, B., Garnier, M., Mal, H., Mordant, P., Castier, Y., Cazes, A., Sallenave, J.-M., Mailleux, A. A., Crestani, B. Human airway trypsin-like protease exerts potent, anti-fibrotic action in pulmonary fibrosis.	[Menou, Awen; Flajolet, Pauline; Duitman, JanWillem; Justet, Aurelien; Moog, Sophie; Jaillet, Madeleine; Tabeze, Laure; Solhonne, Brigitte; Garnier, Marc; Mal, Herve; Mordant, Pierre; Castier, Yves; Cazes, Aurelie; Sallenave, Jean-Michel; Mailleux, Arnaud A.; Crestani, Bruno] INSERM, Unite 1552, Paris, France; [Menou, Awen; Flajolet, Pauline; Duitman, JanWillem; Justet, Aurelien; Moog, Sophie; Jaillet, Madeleine; Tabeze, Laure; Solhonne, Brigitte; Garnier, Marc; Mal, Herve; Mordant, Pierre; Castier, Yves; Cazes, Aurelie; Sallenave, Jean-Michel; Mailleux, Arnaud A.; Crestani, Bruno] Dept Hosp Univ Fibrosis Inflammat & Remodeling Re, Paris, France; [Menou, Awen; Flajolet, Pauline; Duitman, JanWillem; Justet, Aurelien; Moog, Sophie; Jaillet, Madeleine; Tabeze, Laure; Solhonne, Brigitte; Garnier, Marc; Mal, Herve; Mordant, Pierre; Castier, Yves; Cazes, Aurelie; Sallenave, Jean-Michel; Mailleux, Arnaud A.; Crestani, Bruno] Lab Excellence Inflamex, Paris, France; [Menou, Awen; Flajolet, Pauline; Duitman, JanWillem; Justet, Aurelien; Moog, Sophie; Jaillet, Madeleine; Tabeze, Laure; Solhonne, Brigitte; Garnier, Marc; Mal, Herve; Mordant, Pierre; Castier, Yves; Cazes, Aurelie; Sallenave, Jean-Michel; Mailleux, Arnaud A.; Crestani, Bruno] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Justet, Aurelien; Tabeze, Laure; Crestani, Bruno] Hop Bichat Claude Bernard, AP HP, Serv Pneumol A, Paris, France; [Mal, Herve] Hop Bichat Claude Bernard, AP HP, Serv Pneumol & Transplantat, Paris, France; [Mordant, Pierre; Castier, Yves] Hop Bichat Claude Bernard, AP HP, Serv Chirurg Thorac & Vasc, Paris, France; [Cazes, Aurelie] Hop Bichat Claude Bernard, AP HP, Dept Anat Pathol, Paris, France; [Garnier, Marc] Hop Tenon, AP HP, Dept Anesthesie & Reanimat, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Crestani, B (corresponding author), Hop Bichat Claude Bernard, Serv Pneumol A, 46 Rue Henri Huchard, F-75018 Paris, France.	bruno.crestani@aphp.fr	Mailleux, Arnaud A/J-3576-2017; Duitman, JanWillem/AFX-7298-2022; Mailleux, Arnaud/AAH-8799-2021; Garnier, Marc/J-6438-2017	Mailleux, Arnaud A/0000-0003-4191-1778; Duitman, JanWillem/0000-0003-4254-3380; Mailleux, Arnaud/0000-0003-4191-1778; 	Agence Nationale pour la Recherche [ANR-14-CE15-0010-01]; Fondation pour la Recherche Medicale [FRM-AJE201121, FDM41320, FDM20150633109]; Laboratoire d'Excellence Inflamex; Roche; Boehringer Ingelheim; Association CARDIF-L'Assistance Respiratoire; ERS/Marie Sklodowska-Curie RESPIRE2 postdoctoral research fellowship [RESPIR2-2015-9372]; Societe de Reanimation de Langue Francaise; Societe de Pneumologie de Langue Francaise; Societe Francaise d'Anesthesieet Reanimation	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Laboratoire d'Excellence Inflamex; Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Association CARDIF-L'Assistance Respiratoire; ERS/Marie Sklodowska-Curie RESPIRE2 postdoctoral research fellowship; Societe de Reanimation de Langue Francaise; Societe de Pneumologie de Langue Francaise; Societe Francaise d'Anesthesieet Reanimation	The authors greatly acknowledge the scientific input of Keren Borensztajn (INSERM Unite de Mixte de Recherche 933, Paris, France) to this work. This work was supported by the Agence Nationale pour la Recherche (Grant ANR-14-CE15-0010-01) and the Fondation pour la Recherche Medicale (Grant FRM-AJE201121). A.M. was supported by research grants from the Laboratoire d'Excellence Inflamex, and was provided financial support from Roche and Boehringer Ingelheim. P.F. received funding from the Association CARDIF-L'Assistance Respiratoire. J.W.D. is the recipient of an ERS/Marie Sklodowska-Curie RESPIRE2 postdoctoral research fellowship (RESPIR2-2015-9372). A.J. was supported by the Fondation pour la Recherche Medicale (Grant FDM41320) and M.G. by the Fondation pour la Recherche Medicale (Grant FDM20150633109), the Societe de Reanimation de Langue Francaise, the Societe de Pneumologie de Langue Francaise (2014 Research Grant SRLF/SPLF), and the Societe Francaise d'Anesthesieet Reanimation (2016 Research Grant SFAR). The authors declare no conflicts of interest.	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Barbier D, 2012, AM J RESP CELL MOL, V47, P149, DOI 10.1165/rcmb.2011-0405OC; Bardou O, 2016, AM J RESP CRIT CARE, V193, P847, DOI 10.1164/rccm.201502-0299OC; Bauman KA, 2010, J CLIN INVEST, V120, P1950, DOI 10.1172/JCI38369; Beaufort N, 2007, AM J PHYSIOL-LUNG C, V292, pL1263, DOI 10.1152/ajplung.00191.2006; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Borensztajn K, 2010, AM J PATHOL, V177, P2753, DOI 10.2353/ajpath.2010.091107; BOROK Z, 1991, AM REV RESPIR DIS, V144, P1080, DOI 10.1164/ajrccm/144.5.1080; Chambers RC, 2008, BRIT J PHARMACOL, V153, pS367, DOI 10.1038/sj.bjp.0707603; Chaudhary NI, 2006, AM J RESP CRIT CARE, V173, P769, DOI 10.1164/rccm.200505-717OC; Chokki M, 2005, FEBS J, V272, P6387, DOI 10.1111/j.1742-4658.2005.05035.x; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; Crestani Bruno, 2012, Proc Am Thorac Soc, V9, P158, DOI 10.1513/pats.201202-018AW; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Fabre A, 2008, EUR RESPIR J, V32, P426, DOI 10.1183/09031936.00126907; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; FULMER JD, 1979, J CLIN INVEST, V63, P665, DOI 10.1172/JCI109349; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Hansen IA, 2004, ENDOCRINOLOGY, V145, P1898, DOI 10.1210/en.2003-0930; Haslam PL, 1999, EUR RESPIR J, V14, P245, DOI 10.1034/j.1399-3003.1999.14b01.x; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; Imokawa S, 1997, AM J RESP CRIT CARE, V156, P631, DOI 10.1164/ajrccm.156.2.9608094; Kato M, 2012, J BIOCHEM, V151, P179, DOI 10.1093/jb/mvr131; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Lin C, 2014, THORAX, V69, P152, DOI 10.1136/thoraxjnl-2013-203877; Madala SK, 2012, AM J RESP CELL MOL, V46, P380, DOI 10.1165/rcmb.2011-0237OC; Marchand-Adam S, 2003, AM J RESP CRIT CARE, V168, P1156, DOI 10.1164/rccm.200212-1514OC; Marchand-Adam S, 2006, AM J RESP CRIT CARE, V174, P58, DOI 10.1164/rccm.200507-1074OC; Matsushima R, 2006, AM J PHYSIOL-LUNG C, V290, pL385, DOI 10.1152/ajplung.00098.2005; McMichael JW, 2005, INFECT IMMUN, V73, P3609, DOI 10.1128/IAI.73.6.3609-3617.2005; Melboucy-Belkhir S, 2014, AM J PHYSIOL-LUNG C, V307, pL838, DOI 10.1152/ajplung.00012.2014; Menou A, 2017, AM J PHYSIOL-LUNG C, V312, P1657, DOI 10.1152/ajplung.00509.2016; Miki Mari, 2003, Journal of Medical Investigation, V50, P95; Nagataki M, 2008, CELL BIOCHEM FUNCT, V26, P279, DOI 10.1002/cbf.1434; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Sallenave JM, 1998, GENE THER, V5, P352, DOI 10.1038/sj.gt.3300610; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Simon DI, 2000, J BIOL CHEM, V275, P10228, DOI 10.1074/jbc.275.14.10228; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Sokolova E, 2005, AM J PHYSIOL-LUNG C, V288, pL793, DOI 10.1152/ajplung.00343.2004; Sokolova E, 2007, PHARMACOL THERAPEUT, V115, P70, DOI 10.1016/j.pharmthera.2007.04.002; Spagnolo P, 2015, ANN MED, V47, P15, DOI 10.3109/07853890.2014.982165; SPITERI MA, 1992, EUR RESPIR J, V5, P717; Taggart C, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01200-2015; Takahashi M, 2001, HISTOCHEM CELL BIOL, V115, P181; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wygrecka M, 2008, THROMB HAEMOSTASIS, V99, P494, DOI 10.1160/TH07-11-0666; Yamaoka K, 1998, J BIOL CHEM, V273, P11895, DOI 10.1074/jbc.273.19.11895; Yasuoka S, 1997, AM J RESP CELL MOL, V16, P300, DOI 10.1165/ajrcmb.16.3.9070615; Yoshinaga Sumiko, 1998, Journal of Medical Investigation, V45, P77	61	4	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1250	1264		10.1096/fj.201700583R	http://dx.doi.org/10.1096/fj.201700583R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29122847				2022-12-26	WOS:000427246000012
J	Swatson, WS; Katoh-Kurasawa, M; Shaulsky, G; Alexander, S				Swatson, William S.; Katoh-Kurasawa, Mariko; Shaulsky, Gad; Alexander, Stephen			Curcumin affects gene expression and reactive oxygen species via a PKA dependent mechanism in Dictyostelium discoideum	PLOS ONE			English	Article							PROTEIN-KINASE-A; ANTICANCER DRUG CISPLATIN; NF-KAPPA-B; SUPEROXIDE-DISMUTASE; TRANSCRIPTION FACTOR; CANCER CELLS; SPHINGOSINE KINASE-1; ANTIOXIDANT ENZYMES; ALZHEIMERS-DISEASE; OXIDATIVE STRESS	Botanicals are widely used as dietary supplements and for the prevention and treatment of disease. Despite a long history of use, there is generally little evidence supporting the efficacy and safety of these preparations. Curcumin has been used to treat a myriad of human diseases and is widely advertised and marketed for its ability to improve health, but there is no clear understanding how curcumin interacts with cells and affects cell physiology. D. discoideum is a simple eukaryotic lead system that allows both tractable genetic and biochemical studies. The studies reported here show novel effects of curcumin on cell proliferation and physiology, and a pleiotropic effect on gene transcription. Transcriptome analysis showed that the effect is two-phased with an early transient effect on the transcription of approximately 5% of the genome, and demonstrates that cells respond to curcumin through a variety of previously unknown molecular pathways. This is followed by later unique transcriptional changes and a protein kinase A dependent decrease in catalase A and three superoxide dismutase enzymes. Although this results in an increase in reactive oxygen species (ROS; superoxide and H2O2), the effects of curcumin on transcription do not appear to be the direct result of oxidation. This study opens the door to future explorations of the effect of curcumin on cell physiology.	[Swatson, William S.; Alexander, Stephen] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Katoh-Kurasawa, Mariko; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Missouri System; University of Missouri Columbia; Baylor College of Medicine	Alexander, S (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.; Shaulsky, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	gadi@bcm.edu; alexanderst@missouri.edu			National Institutes of Health [HD039691]; NIH IMSD [R25 GM 506901]; Department of Education GAANN [P200A201101]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH IMSD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education GAANN(US Department of Education); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported by grant number HD039691 from the National Institutes of Health, NIH IMSD grant number R25 GM 506901, and by Department of Education GAANN programs P200A201101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is in partial fulfillment of the requirements for the Ph.D. degree for WSS. The work was supported in part by grant number HD039691 from the National Institutes of Health. WSS thanks the University of Missouri for fellowship support from the NIH IMSD R25 GM 506901 to Mark Hannink and Department of Education GAANN programs P200A201101 to John David. We acknowledge the Dictyostelium Stock Center at Northwestern University (DictyBase.org) for supplying mutant strains and for maintaining the Dictyostelium database. We thank Dr. Aniruddha Belsare of the University of Idaho and Dr. Dan Alexander of Vanderbilt University for advice and help on preparing the figures and statistics. We particularly thank Professor Hannah Alexander for tireless advice and help performing experiments, and many reviews of this manuscript.	Able AJ, 1998, PLANT PHYSIOL, V117, P491, DOI 10.1104/pp.117.2.491; Aggeli IK, 2013, J EXP ZOOL PART A, V319A, P328, DOI 10.1002/jez.1797; Alexander S, 2006, BBA-GEN SUBJECTS, V1760, P301, DOI 10.1016/j.bbagen.2005.11.015; Alexander S, 2011, SEMIN CELL DEV BIOL, V22, P97, DOI 10.1016/j.semcdb.2010.10.005; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; [Anonymous], 2008, HERB MED US REV EFF; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beevers C., 2011, BOT TARGETS THER, V1, P5, DOI [10.2147/btat.s17244, DOI 10.2147/BTAT.S17244]; Bloomfield G, 2003, J CELL SCI, V116, P3387, DOI 10.1242/jcs.00649; Boeckeler K, 2006, EUR J CELL BIOL, V85, P1047, DOI 10.1016/j.ejcb.2006.04.013; Chen JP, 2015, J AGR FOOD CHEM, V63, P6440, DOI 10.1021/acs.jafc.5b01773; Chiang IT, 2015, ONCOL REP, V34, P1853, DOI 10.3892/or.2015.4159; Cine N, 2013, EXP THER MED, V5, P23, DOI 10.3892/etm.2012.754; Colacino JA, 2016, BREAST CANCER RES TR, V158, P29, DOI 10.1007/s10549-016-3854-4; CONNEY AH, 1991, ADV ENZYME REGUL, V31, P385, DOI 10.1016/0065-2571(91)90025-H; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Garcia MXU, 2000, BBA-GENE STRUCT EXPR, V1492, P295, DOI 10.1016/S0167-4781(00)00063-4; Garcia MXU, 2003, BBA-MOL CELL RES, V1641, P55, DOI 10.1016/S0167-4889(03)00064-8; Garcia MXU, 2002, MICROBIOL-SGM, V148, P333, DOI 10.1099/00221287-148-1-333; Garige M, 2015, BIOCHEM BIOPH RES CO, V467, P275, DOI 10.1016/j.bbrc.2015.09.175; Guo Y, 2017, BIOCHEM PHARMACOL, V135, P22, DOI 10.1016/j.bcp.2017.02.021; Halliwell B., 1991, FREE RADICAL BIO MED, V10, P449, DOI [10.1016/0891-5849(91)90055-8, DOI 10.1016/0891-5849(91)90055-8]; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARWOOD AJ, 1992, DEV BIOL, V149, P90, DOI 10.1016/0012-1606(92)90266-J; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Herrera E, 2001, J PHYSIOL BIOCHEM, V57, P43, DOI 10.1007/BF03179812; Huang EY, 2011, DEV BIOL, V358, P137, DOI 10.1016/j.ydbio.2011.07.017; Huminiecki L, 2017, SEMIN CANCER BIOL, V46, P107, DOI 10.1016/j.semcancer.2017.04.002; Jayaprakasha GK, 2006, FOOD CHEM, V98, P720, DOI 10.1016/j.foodchem.2005.06.037; JOE B, 1994, BBA-MOL CELL RES, V1224, P255, DOI 10.1016/0167-4889(94)90198-8; Katoh-Kurasawa M, 2016, J CELL SCI, V129, P1722, DOI 10.1242/jcs.181545; Kessin RH, 2001, DICTYOSTELIUM EVOLUT, pxiv; Khan MA, 2012, MOL CANCER THER, V11, P1873, DOI 10.1158/1535-7163.MCT-12-0141; KUNCHANDY E, 1990, INT J PHARM, V58, P237, DOI 10.1016/0378-5173(90)90201-E; KUSPA A, 1992, P NATL ACAD SCI USA, V89, P8803, DOI 10.1073/pnas.89.18.8803; Lal B, 1999, PHYTOTHER RES, V13, P318, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;318::AID-PTR445&gt;3.0.CO;2-7; LEICHTLING BH, 1984, J BIOL CHEM, V259, P662; Li CLF, 2016, GENOME RES, V26, P1268, DOI 10.1101/gr.205682.116; Li G., 2000, GENES PATHWAYS MEDIA; Li GC, 2000, MICROBIOL-SGM, V146, P2219, DOI 10.1099/00221287-146-9-2219; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu XJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2796260; Loomis WF, 1998, MICROBIOL MOL BIOL R, V62, P684, DOI 10.1128/MMBR.62.3.684-694.1998; Ludtmann MHR, 2011, SEMIN CELL DEV BIOL, V22, P105, DOI 10.1016/j.semcdb.2010.11.002; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mann SKO, 1997, DEV BIOL, V183, P208, DOI 10.1006/dbio.1996.8499; MANN SKO, 1991, MECH DEVELOP, V35, P89, DOI 10.1016/0925-4773(91)90060-J; MARTIN JP, 1987, ARCH BIOCHEM BIOPHYS, V255, P329, DOI 10.1016/0003-9861(87)90400-0; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; MCCORD JM, 1971, P NATL ACAD SCI USA, V68, P1024, DOI 10.1073/pnas.68.5.1024; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; Min JX, 2006, BIOTECHNIQUES, V41, P591, DOI 10.2144/000112260; Min JX, 2005, MOL CANCER RES, V3, P287, DOI 10.1158/1541-7786.MCR-04-0197; Min JX, 2005, EUKARYOT CELL, V4, P178, DOI 10.1128/EC.4.1.178-189.2005; Miranda ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070040; Miranda Edward Roshan, 2013, Methods Mol Biol, V983, P139, DOI 10.1007/978-1-62703-302-2_8; Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220; Moussavi M, 2006, CARCINOGENESIS, V27, P1636, DOI 10.1093/carcin/bgi371; Murata H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142438; MUTZEL R, 1987, P NATL ACAD SCI USA, V84, P6, DOI 10.1073/pnas.84.1.6; Nelson K.M., 2017, J MED CHEM; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Research Markets, 2015, RES MARK GLOB MARK S; Russ M, 2006, BIOCHEM BIOPH RES CO, V345, P516, DOI 10.1016/j.bbrc.2006.04.047; Sahoo K, 2012, INVEST NEW DRUG, V30, P558, DOI 10.1007/s10637-010-9610-4; Santhanam B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8551; SEGALL JE, 1995, J CELL BIOL, V128, P405, DOI 10.1083/jcb.128.3.405; Shakor ABA, 2014, BBA-MOL CELL BIOL L, V1841, P1672, DOI 10.1016/j.bbalip.2014.09.006; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Shaulsky G, 1998, DEVELOPMENT, V125, P691; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; SIMON MN, 1992, NATURE, V356, P171, DOI 10.1038/356171a0; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Souza GM, 1998, DEVELOPMENT, V125, P2291; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Taminato A, 2002, MOL BIOL CELL, V13, P2266, DOI 10.1091/mbc.01-11-0555; Tc-nnesen H.H., 1992, INT J PHARMACEUT, V87, P79, DOI DOI 10.1016/0378-5173(92)90230-Y; Teo R, 2010, MOL BIOL CELL, V21, P2788, DOI 10.1091/mbc.E09-10-0891; TONNESEN HH, 1985, Z LEBENSM UNTERS FOR, V180, P402, DOI 10.1007/BF01027775; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; Waheed A, 2014, BRIT J PHARMACOL, V171, P2659, DOI 10.1111/bph.12443; Wang JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep22146; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Williams RSB, 2005, PROG NEURO-PSYCHOPH, V29, P1029, DOI 10.1016/j.pnpbp.2005.03.020; Yang YL, 2012, CANCER SCI, V103, P1538, DOI 10.1111/j.1349-7006.2012.02335.x; Yoshino M, 2004, TOXICOL IN VITRO, V18, P783, DOI 10.1016/j.tiv.2004.03.009; Zhang L, 2006, J ALZHEIMERS DIS, V10, P1	92	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187562	10.1371/journal.pone.0187562	http://dx.doi.org/10.1371/journal.pone.0187562			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135990	Green Submitted, gold, Green Published			2022-12-26	WOS:000415121200023
J	Butcher, JB; Zi, T; Schmidt, M; Johnson, TE; Nover, DM; Clark, CM				Butcher, Jonathan B.; Zi, Tan; Schmidt, Michelle; Johnson, Thomas E.; Nover, Daniel M.; Clark, Christopher M.			Estimating future temperature maxima in lakes across the United States using a surrogate modeling approach	PLOS ONE			English	Article							CLIMATE-CHANGE; NORTH-AMERICAN; DISSOLVED-OXYGEN; STRATIFICATION; RESPONSES; IMPACTS	A warming climate increases thermal inputs to lakes with potential implications for water quality and aquatic ecosystems. In a previous study, we used a dynamic water column temperature and mixing simulation model to simulate chronic (7-day average) maximum temperatures under a range of potential future climate projections at selected sites representative of different U.S. regions. Here, to extend results to lakes where dynamic models have not been developed, we apply a novel machine learning approach that uses Gaussian Process regression to describe the model response surface as a function of simplified lake characteristics (depth, surface area, water clarity) and climate forcing (winter and summer air temperatures and potential evapotranspiration). We use this approach to extrapolate predictions from the simulation model to the statistical sample of U.S. lakes in the National Lakes Assessment (NLA) database. Results provide a national-scale scoping assessment of the potential thermal risk to lake water quality and ecosystems across the U.S. We suggest a small fraction of lakes will experience less risk of summer thermal stress events due to changes in stratification and mixing dynamics, but most will experience increases. The percentage of lakes in the NLA with simulated 7-day average maximum water temperatures in excess of 30 degrees C is projected to increase from less than 2% to approximately 22% by the end of the 21st century, which could significantly reduce the number of lakes that can support cold water fisheries. Site-specific analysis of the full range of factors that influence thermal profiles in individual lakes is needed to develop appropriate adaptation strategies.	[Butcher, Jonathan B.; Schmidt, Michelle] Tetra Tech Inc, Res Triangle Pk, NC 27709 USA; [Zi, Tan] Tetra Tech Inc, Fairfax, VA USA; [Johnson, Thomas E.; Clark, Christopher M.] US EPA, Off Res & Dev, Washington, DC 20460 USA; [Nover, Daniel M.] Univ Calif Merced, Sch Engn, Merced, CA USA	United States Environmental Protection Agency; University of California System; University of California Merced	Butcher, JB (corresponding author), Tetra Tech Inc, Res Triangle Pk, NC 27709 USA.	jon.butcher@tetratech.com	Butcher, Jonathan/AAE-8239-2020	Butcher, Jonathan/0000-0002-9309-6296; Johnson, Thomas E./0000-0003-4073-938X; Zi, Tan/0000-0002-8422-2537; Butcher, Jonathan/0000-0002-1894-4419	U.S. Environmental Protection Agency, Office of Research and Development [EP-C-12-060]; National Science Foundation	U.S. Environmental Protection Agency, Office of Research and Development(United States Environmental Protection Agency); National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by the U.S. Environmental Protection Agency, Office of Research and Development via Work Assignment 4-02 under Contract EP-C-12-060 to Tetra Tech, Inc. The funder provided support in the form of salaries for authors JBB, TZ, MS, who are employees of Tetra Tech, a commercial consulting company. Authors TEJ and CMC are employees of the USEPA Office of Research and Development (the funding agency) and author DMN is a former American Association for the Advancement of Science Fellow in that office. TEJ, CMC, and DMN participated in the study design, decision to publish, and preparation and editing of the manuscript.; We thank Dr. Zachary Subin (Princeton Environmental Institute) for generously sharing the LISSS model code. Dr. Seth McGinnis of the National Center for Atmospheric Research (NCAR) processed the NARCCAP output into change statistics for use in the development of future climate scenarios. NCAR is supported by the National Science Foundation. The views expressed in this paper represent those of the authors and do not necessarily reflect the views or policies of the U.S. Environmental Protection Agency.	Abatzoglou JT, 2012, INT J CLIMATOL, V32, P772, DOI 10.1002/joc.2312; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alder J.R., 2013, USGS NATL CLIMATE CH, DOI [10.5066/F7W9575T, DOI 10.5066/F7W9575T]; Allen R., 2005, ASCE STANDARDIZED RE; Antonov IA., 1979, USSR COMP MATH MATH, V19, P252, DOI DOI 10.1016/0041-5553(79)90085-5; BLANNING RW, 1975, SIMULATION, V24, P177, DOI 10.1177/003754977502400606; Brungs WA, EPA600377061; Butcher JB, 2015, CLIMATIC CHANGE; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Castle Lake Environmental Research and Education Program, 2016, CASTLE LAKE ENV RES; Coats R, 2006, CLIMATIC CHANGE, V76, P121, DOI 10.1007/s10584-005-9006-1; COUTANT CC, 1985, T AM FISH SOC, V114, P31, DOI 10.1577/1548-8659(1985)114<31:SBTADO>2.0.CO;2; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; Fang X, 2009, LIMNOL OCEANOGR, V54, P2359, DOI 10.4319/lo.2009.54.6_part_2.2359; GORHAM E, 1989, J GREAT LAKES RES, V15, P233, DOI 10.1016/S0380-1330(89)71479-9; Hao ZC, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034014; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Johnson T, 2015, J AM WATER RESOUR AS, V51, P1321, DOI 10.1111/1752-1688.12308; Kosten S, 2012, GLOBAL CHANGE BIOL, V18, P118, DOI 10.1111/j.1365-2486.2011.02488.x; Kraemer BM, 2015, GEOPHYS RES LETT, V42, P4981, DOI 10.1002/2015GL064097; Lehigh University Hargreaves B, 2014, LAKE LACAWAC LAKE TE; Livingstone DM, 2003, CLIMATIC CHANGE, V57, P205, DOI 10.1023/A:1022119503144; Lynch AJ, 2016, FISHERIES, V41, P346, DOI 10.1080/03632415.2016.1186016; McBryan TL, 2013, INTEGR COMP BIOL, V53, P648, DOI 10.1093/icb/ict066; Mearns L.O., 2009, EOS T AM GEOPHYS UN, V90, P311, DOI [10.1029/2009EO360002, DOI 10.1029/2009EO360002]; Meerhoff M, 2007, GLOBAL CHANGE BIOL, V13, P1888, DOI 10.1111/j.1365-2486.2007.01408.x; Neumann M, 2015, J MACH LEARN RES, V16, P2611; North Temperate Lakes-Long Term Ecological Research, 2016, DATA CATALOG QUERY; O'Hagan A, 2006, RELIAB ENG SYST SAFE, V91, P1290, DOI 10.1016/j.ress.2005.11.025; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Razavi S, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011527; Rempfer J, 2010, LIMNOL OCEANOGR, V55, P2170, DOI 10.4319/lo.2010.55.5.2170; Richardson DC, 2017, WATER-SUI, V9, DOI 10.3390/w9060442; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; Sobol I.M., 1967, USSR COMP MATH MATH, V7, P86, DOI [DOI 10.1016/0041-5553(67)90144-9, 10.1016/0041-5553(67)90144-9]; Strecker AL, 2004, LIMNOL OCEANOGR, V49, P1182, DOI 10.4319/lo.2004.49.4.1182; Subin ZM, 2012, J ADV MODEL EARTH SY, V4, DOI 10.1029/2011MS000072; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Toreti A, 2013, GEOPHYS RES LETT, V40, P4887, DOI 10.1002/grl.50940; United States Environmental Protection Agency (EPA), 2003, 910B03002 EPA; US Environmental Protection Agency, 2009, 841R09001 EPA; US Environmental Protection Agency, 2013, EPA600R12058F; Whitney JE, 2016, FISHERIES, V41, P332, DOI 10.1080/03632415.2016.1186656; Wismer C.A., 1987, GT LAKES FISH COMM S, P87; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Yuan LL, 2015, ENVIRON MANAGE, V55, P578, DOI 10.1007/s00267-014-0412-x	50	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0183499	10.1371/journal.pone.0183499	http://dx.doi.org/10.1371/journal.pone.0183499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM1VI	29121058	Green Published, Green Submitted, gold			2022-12-26	WOS:000414769900004
J	Charalabidis, A; Dechaume-Moncharmont, FX; Petit, S; Bohan, DA				Charalabidis, Alice; Dechaume-Moncharmont, Francois-Xavier; Petit, Sandrine; Bohan, David A.			Risk of predation makes foragers less choosy about their food	PLOS ONE			English	Article							STICKLEBACKS GASTEROSTEUS-ACULEATUS; PTEROSTICHUS-MELANARIUS COLEOPTERA; DUAL-TASK INTERFERENCE; ANTIPREDATOR BEHAVIOR; FORAGING BEHAVIOR; CARABID BEETLES; MATING PREFERENCES; SEED SELECTION; DIET SELECTION; MATE CHOICE	Animals foraging in the wild have to balance speed of decision making and accuracy of assessment of a food item's quality. If resource quality is important for maximizing fitness, then the duration of decision making may be in conflict with other crucial and time consuming tasks, such as anti-predator behaviours or competition monitoring. Individuals facing the risk of predation and/or competition should adjust the duration of decision making and, as a consequence, their level of choosiness for resources. When exposed to predation, the forager could either maintain its level of choosiness for food items but accept a reduction in the amount of food items consumed or it could reduce its level of choosiness and accept all prey items encountered. Under competition risk, individuals are expected to reduce their level of choosiness as slow decision making exposes individuals to a higher risk of opportunity costs. To test these predictions, the level of choosiness of a seed-eating carabid beetle, Harpalus affinis, was examined under 4 different experimental conditions of risk: i) predation risk; ii) intraspecific competition; iii) interspecific competition; and, iv) control. All the risks were simulated using chemical cues from individual conspecifics or beetles of different species that are predatory or granivorous. Our results show that when foraging under the risk of predation, H. affinis individuals significantly reduce their level of choosiness for seeds. Reductions in level of choosiness for food items might serve as a sensible strategy to reduce both the total duration of a foraging task and the cognitive load of the food quality assessment. No significant differences were observed when individuals were exposed to competition cues. Competition, (i.e opportunity cost) may not be perceived as risk high enough to induce changes in the level of choosiness. Our results suggest that considering the amount of items consumed, alone, would be a misleading metric when assessing individual response to a risk of predation. Foraging studies should therefore also take in account the decision making process.	[Charalabidis, Alice; Petit, Sandrine; Bohan, David A.] Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, Agroecol, Dijon, France; [Charalabidis, Alice; Dechaume-Moncharmont, Francois-Xavier] Univ Bourgogne Franche Comte, UMR CNRS Biogeosci 6282, Evolutionary Ecol Grp, Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Universite de Bourgogne	Bohan, DA (corresponding author), Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, Agroecol, Dijon, France.	David.Bohan@inra.fr	Dechaume-Moncharmont, François-Xavier/F-2394-2011; Bohan, David A/D-7992-2012; Petit, Sandrine/C-3310-2013	Dechaume-Moncharmont, François-Xavier/0000-0001-7607-8224; Bohan, David A/0000-0001-5656-775X; Petit, Sandrine/0000-0001-8781-8873; Charalabidis, Alice/0000-0002-7225-2114	Joint Programming Initiative on Agriculture, Food Security and Climate Change; European Research Area Network in the Coordinated-Integrated Pest Management in Europe Strategic Research Agenda (FACCE ERA-NET C-IPM) [00000877]; French Agence Nationale de la Recherche [ANR-12-Agro-0006, ANR-13-Agro-0001]; Institute Nationale de la Recherche Agronomique (INRA); Region of Burgundy Franche-Comte	Joint Programming Initiative on Agriculture, Food Security and Climate Change; European Research Area Network in the Coordinated-Integrated Pest Management in Europe Strategic Research Agenda (FACCE ERA-NET C-IPM); French Agence Nationale de la Recherche(French National Research Agency (ANR)); Institute Nationale de la Recherche Agronomique (INRA); Region of Burgundy Franche-Comte	This work was supported by the Joint Programming Initiative on Agriculture, Food Security and Climate Change, European Research Area Network in the Coordinated-Integrated Pest Management in Europe Strategic Research Agenda (FACCE ERA-NET C-IPM) project BioAWARE (AFB Projet 00000877, https://www.facceipi.com) and the PEERLESS (ANR-12-Agro-0006) and AGROBIOSE (ANR-13-Agro-0001) grants from the French Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/en/) to DB and SP. The PhD of Alice Charalabidis was co-funded by the Institute Nationale de la Recherche Agronomique (INRA) and the Region of Burgundy Franche-Comte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the staff of the INRA Epoisses experimental farm. We also wish to thank the staff at INRA Dijon for their technical support, and Benjamin Carbonne for his help with trapping and handling the carabids. This work was supported by the Joint Programming Initiative on Agriculture, Food Security and Climate Change, European Research Area Network in the Coordinated-Integrated Pest Management in Europe Strategic Research Agenda (FACCE ERA-NET C-IPM) project BioAWARE (AFB Projet 00000877, https://www.faccejpi.com) and the PEERLESS (ANR-12-Agro-0006) and AGROBIOSE (ANR-13-Agro-0001) grants from the French Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/en/) to DB and SP. The PhD of Alice Charalabidis was co-funded by the Institute Nationale de la Recherche Agronomique (INRA) and the Region of Burgundy Franche-Comte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JD, 2008, ANIM BEHAV, V75, P259, DOI 10.1016/j.anbehav.2007.04.033; Amita H, 2010, BIOL LETTERS, V6, P183, DOI 10.1098/rsbl.2009.0748; Armsworth CG, 2005, ANIM BEHAV, V69, P805, DOI 10.1016/j.anbehav.2004.07.009; Armsworth CG, 2005, THESIS; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Berger-Tal O, 2010, ECOL LETT, V13, P302, DOI 10.1111/j.1461-0248.2010.01447.x; Block RA, 2010, ACTA PSYCHOL, V134, P330, DOI 10.1016/j.actpsy.2010.03.006; Brown GE, 2006, BEHAV ECOL SOCIOBIOL, V61, P9, DOI 10.1007/s00265-006-0232-y; Chittka L, 2007, PLOS BIOL, V5, P2754, DOI 10.1371/journal.pbio.0050339; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Cliff N, 2003, PSYCHOLOGY; Currie CR, 1996, COLEOPTS BULL, V50, P135; David M, 2014, ANIM BEHAV, V90, P255, DOI 10.1016/j.anbehav.2014.02.009; David M, 2011, ANIM BEHAV, V82, P61, DOI 10.1016/j.anbehav.2011.03.025; Davis JM, 2011, BEHAV ECOL, V22, P730, DOI 10.1093/beheco/arr042; Davis K, 2017, OECOLOGIA, V184, P139, DOI 10.1007/s00442-017-3857-9; Dechaume-Moncharmont FX, 2016, ANIM BEHAV, V114, P249, DOI 10.1016/j.anbehav.2016.02.019; Dianne L, 2014, INT J PARASITOL, V44, P211, DOI 10.1016/j.ijpara.2013.11.001; Dougherty LR, 2015, BEHAV ECOL, V26, P311, DOI 10.1093/beheco/aru125; Dougherty LR, 2014, ANIM BEHAV, V89, P207, DOI 10.1016/j.anbehav.2014.01.005; Dukas R, 2000, BEHAV ECOL, V11, P502, DOI 10.1093/beheco/11.5.502; Edward D. A., 2014, BEHAV ECOL, P1; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Foltan P, 2004, EUR J ENTOMOL, V101, P359, DOI 10.14411/eje.2004.050; FOX LR, 1981, SCIENCE, V211, P887, DOI 10.1126/science.211.4485.887; Godin J-GJ, 1990, DIET SELECTION RISK, P739; Guy AG, 2008, ANIM BEHAV, V76, P585, DOI 10.1016/j.anbehav.2008.04.004; Hammerstein P, 2012, STRUNGMANN FORUM REP, P1; Hatteland BA, 2010, B ENTOMOL RES, V100, P559, DOI 10.1017/S0007485309990629; Helfman GS, 1997, ETHOLOGY, V103, P369; Higginson AD, 2012, AM NAT, V180, P589, DOI 10.1086/667885; Hines J, 2015, ADV ECOL RES, V53, P161, DOI 10.1016/bs.aecr.2015.09.001; Honek A, 2007, BASIC APPL ECOL, V8, P343, DOI 10.1016/j.baae.2006.07.002; Houtman R, 1998, EVOL ECOL, V12, P251, DOI 10.1023/A:1006544031697; IBRAHIM AA, 1989, BEHAVIOUR, V109, P46, DOI 10.1163/156853989X00150; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; Kromp B, 1999, AGR ECOSYST ENVIRON, V74, P187, DOI 10.1016/S0167-8809(99)00037-7; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Larrinaga AR, 2010, ACTA OECOL, V36, P141, DOI 10.1016/j.actao.2009.11.003; Law JJ, 2015, APPL SOIL ECOL, V87, P118, DOI 10.1016/j.apsoil.2014.11.015; LAWRENCE ES, 1985, ANIM BEHAV, V33, P1373, DOI 10.1016/S0003-3472(85)80206-2; Leaver LA, 2003, BEHAV PROCESS, V64, P71, DOI 10.1016/S0376-6357(03)00108-6; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1986, ANIM BEHAV, V34, P536, DOI 10.1016/S0003-3472(86)80122-1; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lindroth CH, 1974, HDB INDENTIFICATION, P98; Martel V, 2011, J INSECT BEHAV, V24, P329, DOI 10.1007/s10905-011-9257-9; McKemey AR, 2003, B ENTOMOL RES, V93, P227, DOI 10.1079/BER2003240; MCNAMARA JM, 1987, ACTA BIOTHEOR, V36, P3, DOI 10.1007/BF00159228; METCALFE NB, 1987, ANIM BEHAV, V35, P931, DOI 10.1016/S0003-3472(87)80134-3; METCALFE NB, 1987, ANIM BEHAV, V35, P901, DOI 10.1016/S0003-3472(87)80125-2; MILINSKI M, 1982, BEHAV ECOL SOCIOBIOL, V11, P109, DOI 10.1007/BF00300099; MILINSKI M, 1978, NATURE, V275, P642, DOI 10.1038/275642a0; MITCHELL WA, 1990, ECOLOGY, V71, P844, DOI 10.2307/1937356; Mohamad R, 2015, OECOLOGIA, V177, P305, DOI 10.1007/s00442-014-3124-2; Monceau K, 2017, BIOL J LINN SOC, V120, P869, DOI 10.1093/biolinnean/blw015; Moncharmont FXD, 2003, ENVIRON TOXICOL CHEM, V22, P3088, DOI 10.1897/02-578; Murray TJ, 2010, BIOL CONTROL, V52, P153, DOI 10.1016/j.biocontrol.2009.10.003; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; NAVON D, 1987, J EXP PSYCHOL HUMAN, V13, P435, DOI 10.1037/0096-1523.13.3.435; Nonacs P, 2010, EVOLUTIONARY BEHAV E; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Perea R, 2011, ANIM BEHAV, V82, P717, DOI 10.1016/j.anbehav.2011.07.001; Petit S., 2017, INTEGRATED WEED MANA; Petit S, 2014, EUR J ENTOMOL, V111, P615, DOI 10.14411/eje.2014.086; R Development Core Team, 2016, R LANG ENV STAT COMP; Raffa KF, 2002, OECOLOGIA, V133, P422, DOI 10.1007/s00442-002-1050-1; RAPPORT DJ, 1970, J THEOR BIOL, V26, P365, DOI 10.1016/0022-5193(70)90089-5; Reinhold K, 2015, J COMP PHYSIOL A, V201, P171, DOI 10.1007/s00359-014-0963-6; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Rodriguez RL, 2003, EVOLUTION, V57, P1304, DOI 10.1111/j.0014-3820.2003.tb00338.x; Rothbart MM, 2012, J COMP PHYSIOL A, V198, P817, DOI 10.1007/s00359-012-0751-0; Royaute R, 2021, ECOLOGY, DOI 10.1890/14-2424.1; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Simon J., 2015, PSCL CLASSES METHODS; Sivy KJ, 2011, ACTA OECOL, V37, P321, DOI 10.1016/j.actao.2011.03.004; Soibam B, 2012, BRAIN BEHAV, V2, P97, DOI 10.1002/brb3.36; Therneau T, 2006, PACKAGE SURVIVAL ANA; Tremmel M, 2013, BEHAV ECOL, V24, P386, DOI 10.1093/beheco/ars175; UNDERWOOD R, 1982, BEHAVIOUR, V79, P81, DOI 10.1163/156853982X00193; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; Wang MY, 2013, ANIM BEHAV, V86, P859, DOI 10.1016/j.anbehav.2013.07.029; Welti EAR, 2016, ECOL ENTOMOL, V41, P611, DOI 10.1111/een.12334; Westneat DE, 2010, EVOLUTIONARY BEHAV E, P177	85	22	23	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0187167	10.1371/journal.pone.0187167	http://dx.doi.org/10.1371/journal.pone.0187167			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121652	Green Submitted, Green Published, gold			2022-12-26	WOS:000414769900024
J	Zurovec, O; Sitaula, BK; Custovic, H; Zurovec, J; Dorsch, P				Zurovec, Ognjen; Sitaula, Bishal Kumar; Custovic, Hamid; Zurovec, Jasminka; Dorsch, Peter			Effects of tillage practice on soil structure, N2O emissions and economics in cereal production under current socio-economic conditions in central Bosnia and Herzegovina	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; NO-TILL; ORGANIC-MATTER; CLIMATE-CHANGE; CONSERVATION AGRICULTURE; SUSTAINABLE AGRICULTURE; CARBON SEQUESTRATION; FERTILIZER SOURCE; CROPPING SYSTEM; BULK-DENSITY	Conservation tillage is expected to have a positive effect on soil physical properties, soil Carbon (C) storage, while reducing fuel, labour and machinery costs. However, reduced tillage could increase soil nitrous oxide (N2O) emissions and offset the expected gains from increased C sequestration. To date, conservation tillage is barely practiced or studied in Bosnia and Herzegovina (BH). Here, we report a field study on the short-term effects of reduced (RT) and no tillage (NT) on N2O emission dynamics, yield-scaled N2O emissions, soil structure and the economics of cereal production, as compared with conventional tillage (CT). The field experiment was conducted in the Sarajevo region on a clayey loam under typical climatic conditions for humid, continental BH. N2O emissions were monitored in a Maize-Barley rotation over two cropping seasons. Soil structure was studied at the end of the second season. In the much wetter 2014, N2O emission were in the order of CT > RT > NT, while in the drier 2015, the order was RT > CT > NT. The emission factors were within or slightly above the uncertainty range of the IPCC Tier 1 factor, if taking account for the N input from the cover crop (alfalfa) preceding the first experimental year. Saturated soils in spring, formation of soil crusts and occasional droughts adversely affected yields, particularly in the second year (barley). In 2014, yield-scaled N2O emissions ranged from 83.2 to 161.7 g N Mg-1 grain (corn) but were much greater in the second year due to crop failure (barley). RT had the smallest yield-scaled N2O emission in both years. NT resulted in economically inacceptable returns, due to the increased costs of weed control and low yields in both years. The reduced number of operations in RT reduced production costs and generated positive net returns. Therefore, RT could potentially provide agronomic and environmental benefits in crop production in BH.	[Zurovec, Ognjen; Sitaula, Bishal Kumar] Norwegian Univ Life Sci NMBU, Dept Int Environm & Dev Studies, As, Norway; [Custovic, Hamid; Zurovec, Jasminka] Univ Sarajevo, Fac Agr & Food Sci, Sarajevo, Bosnia & Herceg; [Dorsch, Peter] Norwegian Univ Life Sci NMBU, Fac Environm Sci & Nat Resource Management, As, Norway	Norwegian University of Life Sciences; University of Sarajevo; Norwegian University of Life Sciences	Zurovec, O (corresponding author), Norwegian Univ Life Sci NMBU, Dept Int Environm & Dev Studies, As, Norway.	ognjen.zurovec@nmbu.no	Žurovec, Ognjen/I-3082-2019; Sitaula, Bishal K/F-7086-2017; Dörsch, Peter/U-2572-2018	Žurovec, Ognjen/0000-0002-5155-6274; Dörsch, Peter/0000-0002-4916-1839	project "Agricultural Adaptation to Climate Change Networking, Education, Research, and Extension in the West Balkans" - HERD; Programme for Higher Education, Research and Development	project "Agricultural Adaptation to Climate Change Networking, Education, Research, and Extension in the West Balkans" - HERD; Programme for Higher Education, Research and Development	This study was supported by the project "Agricultural Adaptation to Climate Change Networking, Education, Research, and Extension in the West Balkans", funded by HERD, the Programme for Higher Education, Research and Development 2010-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Statistics of Bosnia and Herzegovina (BHAS), 2016, PURCH DIR SAL REAL A; Agency for Statistics of Bosnia and Herzegovina (BHAS), 2015, PURCH DIR SAL REAL A; [Anonymous], 1986, AGRONOMY-BASEL, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C28; Baggs EM, 2003, PLANT SOIL, V254, P361, DOI 10.1023/A:1025593121839; Balesdent J, 2000, SOIL TILL RES, V53, P215, DOI 10.1016/S0167-1987(99)00107-5; Ball BC, 1999, SOIL TILL RES, V53, P29, DOI 10.1016/S0167-1987(99)00074-4; Basche AD, 2014, J SOIL WATER CONSERV, V69, P471, DOI 10.2489/jswc.69.6.471; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Burzaco JP, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035031; Chapuis-Lardy L, 2007, GLOBAL CHANGE BIOL, V13, P1, DOI 10.1111/j.1365-2486.2006.01280.x; Chatskikh D, 2007, SOIL TILL RES, V97, P5, DOI 10.1016/j.still.2007.08.004; Ciarlo E, 2007, BIOL FERT SOILS, V43, P675, DOI 10.1007/s00374-006-0147-9; Dam RF, 2005, SOIL TILL RES, V84, P41, DOI 10.1016/j.still.2004.08.006; Diaz-Zorita M, 2004, AGRON J, V96, P1651, DOI 10.2134/agronj2004.1651; Dobbie KE, 2003, GLOBAL CHANGE BIOL, V9, P204, DOI 10.1046/j.1365-2486.2003.00563.x; Duvnjak V, 2004, ENERGY EFFICIENCY AG; EHLERS W, 1983, SOIL TILL RES, V3, P261, DOI 10.1016/0167-1987(83)90027-2; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P197, DOI 10.1016/S0167-1987(02)00027-2; Gagnon B, 2011, SOIL SCI SOC AM J, V75, P595, DOI 10.2136/sssaj2010.0212; Gregorich EG, 2008, CAN J SOIL SCI, V88, P153, DOI 10.4141/CJSS06041; GROFFMAN PM, 1988, SOIL SCI SOC AM J, V52, P1626, DOI 10.2136/sssaj1988.03615995005200060022x; Guardia G, 2016, BIOGEOSCIENCES, V13, P5245, DOI 10.5194/bg-13-5245-2016; Guo YL, 2013, SOIL SCI PLANT NUTR, V59, P392, DOI 10.1080/00380768.2013.775006; Halvorson AD, 2010, J ENVIRON QUAL, V39, P1554, DOI 10.2134/jeq2010.0041; Hobbs PR, 2007, J AGR SCI-CAMBRIDGE, V145, P127, DOI 10.1017/S0021859607006892; Hobbs PR, 2008, PHILOS T R SOC B, V363, P543, DOI 10.1098/rstb.2007.2169; Holland JM, 2004, AGR ECOSYST ENVIRON, V103, P1, DOI 10.1016/j.agee.2003.12.018; IFC, 2013, WORK SMALLH HDB FIRM; IPCC, 2006, IPCC GUIDELINES NATL, V5; Johnston AE, 2009, ADV AGRON, V101, P1, DOI 10.1016/S0065-2113(08)00801-8; Jug D., 2006, Poljoprivreda, V12, P5; Junuzovic D., 2005, WORKS FACULTY AGR U, VL, P61; Kassam, 2017, SUSTAINABLE DEV ORGA, P53; Keeney DR, 1982, AGRONOMY MONOGRAPH, P711; Kelner DJ, 1997, AGR ECOSYST ENVIRON, V64, P1, DOI 10.1016/S0167-8809(97)00019-4; Kim DG, 2012, BIOGEOSCIENCES, V9, P2459, DOI 10.5194/bg-9-2459-2012; Kisic Ivica, 2002, Agriculturae Conspectus Scientificus, V67, P81; Komljenovic I, 2013, P SCI TECHN C ENV PR, P401; LAL R, 1994, SOIL SCI SOC AM J, V58, P517, DOI 10.2136/sssaj1994.03615995005800020038x; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Logsdon SD, 2004, SOIL TILL RES, V78, P143, DOI 10.1016/j.still.2004.02.003; Maag M, 1996, APPL SOIL ECOL, V4, P5, DOI 10.1016/0929-1393(96)00106-0; Minasny B, 2017, GEODERMA, V292, P59, DOI 10.1016/j.geoderma.2017.01.002; Ministry of Agriculture Water Management and Forestry of the Federation of BiH, 2015, SREDNJ STRAT RAZV PO; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; Myhre G., 2013, CLIMATE CHANGE; Nadeem S, 2015, BIOL FERT SOILS, V51, P353, DOI 10.1007/s00374-014-0979-7; Pagliai M, 2004, SOIL TILL RES, V79, P131, DOI 10.1016/j.still.2004.07.002; Pittelkow CM, 2015, FIELD CROP RES, V183, P156, DOI 10.1016/j.fcr.2015.07.020; Powlson DS, 2011, EUR J SOIL SCI, V62, P42, DOI 10.1111/j.1365-2389.2010.01342.x; Raper RL, 2000, APPL ENG AGRIC, V16, P379; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Ribera LA, 2004, AGRON J, V96, P415, DOI 10.2134/agronj2004.4150; Rochette P, 2008, SOIL TILL RES, V101, P97, DOI 10.1016/j.still.2008.07.011; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Shaver TM, 2002, SOIL SCI SOC AM J, V66, P1296, DOI 10.2136/sssaj2002.1296; Shurpali NJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25739; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Skiba U., 2000, CHEMOSPHERE GLOBAL C, V2, P379, DOI DOI 10.1016/S1465-9972(00)00016-7; Smith P, 2007, CLIMATE CHANGE 2007; Soane BD, 2012, SOIL TILL RES, V118, P66, DOI 10.1016/j.still.2011.10.015; Soane B.D., 2013, SOIL COMPACTION CROP; Stonehouse DP, 1997, SOIL TILL RES, V43, P109, DOI 10.1016/S0167-1987(97)00037-8; Syakila A., 2011, GREENH GAS MEAS MANA, V4, P17, DOI DOI 10.3763/GHGMM.2010.0007; Tebrugge F, 2003, CONSERVATION AGRICULTURE: ENVIRONMENT, FARMERS EXPERIENCES, INNOVATIONS, SOCIO-ECONOMY, POLICY, P327; Tian HQ, 2016, NATURE, V531, P225, DOI 10.1038/nature16946; Van den Putte A, 2010, EUR J AGRON, V33, P231, DOI 10.1016/j.eja.2010.05.008; Van Groenigen JW, 2010, EUR J SOIL SCI, V61, P903, DOI 10.1111/j.1365-2389.2009.01217.x; van Kessel C, 2013, GLOBAL CHANGE BIOL, V19, P33, DOI 10.1111/j.1365-2486.2012.02779.x; Venterea RT, 2011, J ENVIRON QUAL, V40, P1521, DOI 10.2134/jeq2011.0039; Wall PC, 2007, J CROP IMPROV, V19, P137, DOI 10.1300/J411v19n01_07; Ward BB, 2011, NITRIFICATION, P1; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Zurovec O, 2015, AGRICULTURE-BASEL, V5, P245, DOI 10.3390/agriculture5020245	74	15	16	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187681	10.1371/journal.pone.0187681	http://dx.doi.org/10.1371/journal.pone.0187681			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117229	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000414659600062
J	Smith, MP; Standl, M; Heinrich, J; Schulz, H				Smith, Maia P.; Standl, Marie; Heinrich, Joachim; Schulz, Holger			Accelerometric estimates of physical activity vary unstably with data handling	PLOS ONE			English	Article							VALIDATION; TRACKING; CHILDREN	Background Because of unreliable self-report, accelerometry is increasingly used to objectively monitor physical activity (PA). However, results of accelerometric studies vary depending on the chosen cutpoints between activity intensities. Population-specific activity patterns likely affect the size of these differences. To establish their size and stability we apply three sets of cutpoints, including two calibrated to a single reference, to our accelerometric data and compare PA estimates. Methods 1402 German adolescents from the GINIplus and LISAplus cohorts wore triaxial accelerometers (Actigraph GT3x) for one week (mean 6.23 days, 14.7 hours per day) at the hip. After validation of wear, we applied three sets of cutpoints for youth, including the most common standard (Freedson, 2005) and two calibrated to a single reference, (Romanzini uni- and triaxial, from Romanzini, 2014) to these data, estimating daily sedentary, light, moderate, vigorous and moderate-to-vigorous PA (MPA, VPA, MVPA). Stability of differences was assessed by comparing Romanzini's two sets of cutpoints. Results Relative agreement between cutpoints was closer for activity of lower intensities (largest difference for sedentary behaviour 9%) but increased for higher intensities (largest difference for light activity 40%, MPA 102%, VPA 88%; all p<0.01). Romanzini's uniaxial and triaxial cutpoints agreed no more closely with each other than with Freedson's. Conclusions Estimated PA differed significantly between different sets of cutpoints, even when those cutpoints agreed perfectly on another dataset (i.e. Romanzini's.) This suggests that the detected differences in estimated PA depend on population-specific activity patterns, which cannot be easily corrected for: converting activity estimates from one set of cutpoints to another may require access to raw data. This limits the utility of accelerometry for comparing populations in place and time. We suggest that accelerometric research adopt a standard for data processing, and apply and present the results of this standard in addition to those from any other method.	[Smith, Maia P.; Standl, Marie; Heinrich, Joachim; Schulz, Holger] Helmholtz Zentrum Munchen, Inst Epidemiol 1, German Res Ctr Environm Hlth, Neuherberg, Germany; [Smith, Maia P.] St Georges Univ, Sch Med, Dept Publ Hlth, True Blue, Grenada; [Heinrich, Joachim] Univ Hosp Munich LMU, Inst & Outpatient Clin Occupat Social & Environm, Inner City Clin, Munich, Germany; [Schulz, Holger] German Ctr Lung Res, CPC Munich, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Smith, MP (corresponding author), Helmholtz Zentrum Munchen, Inst Epidemiol 1, German Res Ctr Environm Hlth, Neuherberg, Germany.; Smith, MP (corresponding author), St Georges Univ, Sch Med, Dept Publ Hlth, True Blue, Grenada.	maia.phillips.smith@gmail.com	Heinrich, Joachim/N-1720-2013	Heinrich, Joachim/0000-0002-9620-1629; Smith, Maia Phillips/0000-0002-1154-1158; Standl, Marie/0000-0002-5345-2049	Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Federal Ministry for Environment (IUF Dusseldorf) [FKZ 20462296]; Helmholtz Centre for Environmental Research - UFZ, Leipzig, Research Institute at Marien Hospital Wesel, Pediatric Practice, Bad Honnef; Commission of the European Communities; Mead Johnson Company; Nestle Company; Comprehensive Pneumology Center Munich (CPCM); 7th Framework Program: MeDALL project	Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Federal Ministry for Environment (IUF Dusseldorf); Helmholtz Centre for Environmental Research - UFZ, Leipzig, Research Institute at Marien Hospital Wesel, Pediatric Practice, Bad Honnef; Commission of the European Communities(European Commission); Mead Johnson Company; Nestle Company(Nestle SA); Comprehensive Pneumology Center Munich (CPCM); 7th Framework Program: MeDALL project	The GINIplus study was mainly supported for the first 3 years of the Federal Ministry for Education, Science, Research and Technology (interventional arm) and Helmholtz Zentrum Munich (former GSF) (observational arm). The 4 year, 6 year, 10 year and 15 year follow-up examinations of the GINIplus study were covered from the respective budgets of the 5 study centres (Helmholtz Zentrum Munich (former GSF), Research Institute at Marien-Hospital Wesel, LMU Munich, TU Munich and from 6 years onwards also from IUF-Leibniz-Research-Institute for Environmental Medicine at the University of Dusseldorf) and a grant from the Federal Ministry for Environment (IUF Dusseldorf, FKZ 20462296). The LISAplus study was mainly supported by grants from the Federal Ministry for Education, Science, Research and Technology and in addition from Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research - UFZ, Leipzig, Research Institute at Marien Hospital Wesel, Pediatric Practice, Bad Honnef for the first 2 years. The 4 year, 6 year, 10 year and 15 year follow-up examinations of the LISAplus study were covered from the respective budgets of the involved partners (Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research - UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef, IUF-Leibniz-Research Institute for Environmental Medicine at the University of Dusseldorf) and in addition by a grant from the Federal Ministry for Environment (IUF Dusseldorf, FKZ 20462296). Further, the 15 year follow-up examination of the GINIplus and LISAplus studies was supported by the Commission of the European Communities, the 7th Framework Program: MeDALL project. The 15 year follow-up examination of the GINIplus study was additionally supported by the Mead Johnson and Nestle companies. Accelerometry measurements at the 15-year examination were funded by Helmholtz Zentrum Munich. This work was supported by the Comprehensive Pneumology Center Munich (CPCM) as member of the German Center for Lung Research.	Banda JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150534; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Cain KL, 2013, J PHYS ACT HEALTH, V10, P437, DOI 10.1123/jpah.10.3.437; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Coote JH, 2010, EXP PHYSIOL, V95, P431, DOI 10.1113/expphysiol.2009.047548; Direito A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1968-y; Donaire-Gonzalez D, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2470; Gao Y., 2016, P CHI C EXT ABSTR HU, P3255, DOI DOI 10.1145/2851581.2892426; Guinhouya BC, 2013, PUBLIC HEALTH, V127, P301, DOI 10.1016/j.puhe.2013.01.020; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; Hekler EB, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3505; Hislop JF, 2012, PEDIATR EXERC SCI, V24, P450, DOI 10.1123/pes.24.3.450; Kozey SL, 2010, MED SCI SPORT EXER, V42, P1776, DOI 10.1249/MSS.0b013e3181d479f2; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Nandakumar R, 2015, CONTACTLESS SYSTEM R; National Cancer Institute, 2012, SAS PROGR AN NHANES; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Pfitzner R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065192; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Robertson W, 2011, J OBES, V2011, DOI 10.1155/2011/398918; Romanzini M, 2014, EUR J SPORT SCI, V14, P91, DOI 10.1080/17461391.2012.732614; Smith M. P., 2016, EUROPEAN RESP J, V47; Smith M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135630; Smith MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152217; Smith MP, 2015, EUR C EP HLTH LIV 20; Smith MP, PHYS ACTIVITY LEVELS; Spruijt-Metz D, 2015, CURR OBES REP, V4, P510, DOI 10.1007/s13679-015-0183-6; Troiano RP, 2007, MED SCI SPORT EXER, V39, P1501, DOI 10.1097/mss.0b013e318150d42e; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Van Cauwenberghe E, 2011, INT J PEDIATR OBES, V6, pE582, DOI 10.3109/17477166.2010.526223; Vanhelst J, 2009, ARCH PUBLIC HLTH S1, V67; Vanhelst J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-26; von Berg A, 2010, CLIN EXP ALLERGY, V40, P627, DOI 10.1111/j.1365-2222.2009.03444.x; Wong TC, 1984, IEEE T BIOMED ENG, V28; Wyatt ID, 2006, OCCUPATIONAL CHANGES, P35	37	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187706	10.1371/journal.pone.0187706	http://dx.doi.org/10.1371/journal.pone.0187706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108029	gold, Green Published, Green Submitted			2022-12-26	WOS:000414424600062
J	Figiel, M; Krepl, M; Park, S; Poznanski, J; Skowronek, K; Golab, A; Ha, T; Sponer, J; Nowotny, M				Figiel, Malgorzata; Krepl, Miroslav; Park, Sangwoo; Poznanski, Jaroslaw; Skowronek, Krzysztof; Golab, Agnieszka; Ha, Taekjip; Sponer, Jiri; Nowotny, Marcin			Mechanism of polypurine tract primer generation by HIV-1 reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STRAND DNA-SYNTHESIS; RETROVIRAL RNASES-H; RNA/DNA HYBRID; TYPE-1; CLEAVAGE; SEQUENCE; SPECIFICITY; INITIATION; TEMPLATE	HIV-1 reverse transcriptase (RT) possesses both DNA polymerase activity and RNase H activity that act in concert to convert single-stranded RNA of the viral genome to double-stranded DNA that is then integrated into the DNA of the infected cell. Reverse transcriptase-catalyzed reverse transcription critically relies on the proper generation of a polypurine tract (PPT) primer. However, the mechanism of PPT primer generation and the features of the PPT sequence that are critical for its recognition by HIV-1 RT remain unclear. Here, we used a chemical cross-linking method together with molecular dynamics simulations and single-molecule assays to study the mechanism of PPT primer generation. We found that the PPT was specifically and properly recognized within covalently tethered HIV-1 RT-nucleic acid complexes. These findings indicated that recognition of the PPT occurs within a stable catalytic complex after its formation. We found that this unique recognition is based on two complementary elements that rely on the PPT sequence: RNase H sequence preference and incompatibility of the poly(rA/dT) tract of the PPT with the nucleic acid conformation that is required for RNase H cleavage. The latter results from rigidity of the poly(rA/dT) tract and leads to base-pair slip-page of this sequence upon deformation into a catalytically relevant geometry. In summary, our results reveal an unexpected mechanism of PPT primer generation based on specific dynamic properties of the poly(rA/dT) segment and help advance our understanding of the mechanisms in viral RNA reverse transcription.	[Figiel, Malgorzata; Golab, Agnieszka; Nowotny, Marcin] Int Inst Mol & Cell Biol, Lab Prot Struct, PL-02109 Warsaw, Poland; [Skowronek, Krzysztof] Int Inst Mol & Cell Biol, Biophys Core Facil, PL-02109 Warsaw, Poland; [Krepl, Miroslav; Sponer, Jiri] Czech Acad Sci, Inst Biophys, Brno 61265, Czech Republic; [Krepl, Miroslav; Sponer, Jiri] Palacky Univ, Fac Sci, Dept Phys Chem, Reg Ctr Adv Technol & Mat, Olomouc 77146, Czech Republic; [Park, Sangwoo; Ha, Taekjip] Johns Hopkins Univ, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Ha, Taekjip] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21205 USA; [Ha, Taekjip] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Poznanski, Jaroslaw] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Ha, Taekjip] Howard Hughes Med Inst, Baltimore, MD 21205 USA	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Palacky University Olomouc; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Howard Hughes Medical Institute	Nowotny, M (corresponding author), Int Inst Mol & Cell Biol, Lab Prot Struct, PL-02109 Warsaw, Poland.	mnowotny@iimcb.gov.pl	Sponer, Jiri/D-9467-2012; Figiel, Małgorzata/ABF-9197-2020; Ha, Taekjip/B-9506-2009; Poznanski, Jaroslaw/F-7705-2014; Skowronek, Krzysztof/G-2855-2010; Krepl, Miroslav/F-3868-2019	Ha, Taekjip/0000-0003-2195-6258; Poznanski, Jaroslaw/0000-0003-2684-1775; Skowronek, Krzysztof/0000-0001-9973-7085; Nowotny, Marcin/0000-0001-8632-0977; Krepl, Miroslav/0000-0002-9833-4281; Sponer, Jiri/0000-0001-6558-6186; Figiel, Malgorzata/0000-0002-2211-0425	Polish National Science Center [N N301 439738]; International Early Career Scientist grant from the Howard Hughes Medical Institute; Foundation for Polish Science "Ideas for Poland" award; Czech Science Foundation [P305/12/G034]; Ministry of Education, Youth and Sports of the Czech Republic Project [LO1305]; Praemium Academiae; National Institutes of Health [GM065367]; United States National Science Foundation [PHY 1430124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER; Division Of Physics [1430124] Funding Source: National Science Foundation	Polish National Science Center; International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); Foundation for Polish Science "Ideas for Poland" award; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic Project; Praemium Academiae(Czech Academy of Sciences); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was initially supported by a grant from the Polish National Science Center (Contract N N301 439738); later by an International Early Career Scientist grant from the Howard Hughes Medical Institute (both to M. N.); and by a Foundation for Polish Science "Ideas for Poland" award (to M. N.), Czech Science Foundation Grant P305/12/G034 (to J. S. and M. K.), Ministry of Education, Youth and Sports of the Czech Republic Project LO1305 (to J. S.), Praemium Academiae (to J. S.), and National Institutes of Health Grant GM065367 and United States National Science Foundation Grant PHY 1430124 (to S. P. and T. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Coppel Y, 1997, BIOCHEMISTRY-US, V36, P4817, DOI 10.1021/bi962677y; Das K, 2014, NUCLEIC ACIDS RES, V42, P8125, DOI 10.1093/nar/gku487; Dash C, 2004, J BIOL CHEM, V279, P37095, DOI 10.1074/jbc.M403306200; Dash C, 2004, NUCLEIC ACIDS RES, V32, P1539, DOI 10.1093/nar/gkh307; Delelis O, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-114; Figiel M, 2017, NUCLEIC ACIDS RES, V45, P3341, DOI 10.1093/nar/gkx004; FUENTES GM, 1995, J BIOL CHEM, V270, P28169, DOI 10.1074/jbc.270.47.28169; GOLJER I, 1995, J BIOL CHEM, V270, P22980, DOI 10.1074/jbc.270.39.22980; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; Han GW, 1997, J MOL BIOL, V269, P811, DOI 10.1006/jmbi.1997.1085; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Huang HF, 2000, CHEM BIOL, V7, P355, DOI 10.1016/S1074-5521(00)00113-7; HUBER HE, 1990, J BIOL CHEM, V265, P10565; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kvaratskhelia M, 2002, J BIOL CHEM, V277, P16689, DOI 10.1074/jbc.M109914200; Lapkouski M, 2013, NAT STRUCT MOL BIOL, V20, P230, DOI 10.1038/nsmb.2485; Le Grice SFJ, 2014, NUCLEIC ACIDS MOL BI, V30, P189, DOI 10.1007/978-3-642-39796-7_8; Li A, 2016, J BIOL CHEM, V291, P26566, DOI 10.1074/jbc.M116.753160; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; MARQUET R, 1995, BIOCHIMIE, V77, P113, DOI 10.1016/0300-9084(96)88114-4; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Palaniappan C, 1998, J BIOL CHEM, V273, P3808, DOI 10.1074/jbc.273.7.3808; Powell MD, 1996, J VIROL, V70, P5288, DOI 10.1128/JVI.70.8.5288-5296.1996; PULLEN KA, 1993, J BIOL CHEM, V268, P6221; PULLEN KA, 1990, J VIROL, V64, P6274, DOI 10.1128/JVI.64.12.6274-6277.1990; Rausch JW, 2007, NUCLEIC ACIDS RES, V35, P256, DOI 10.1093/nar/gkl909; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; Rausch JW, 2003, P NATL ACAD SCI USA, V100, P11279, DOI 10.1073/pnas.1932546100; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Schultz SJ, 2008, VIRUS RES, V134, P86, DOI 10.1016/j.virusres.2007.12.007; Schultz SJ, 2010, J MOL BIOL, V397, P161, DOI 10.1016/j.jmb.2010.01.059; Schultz SJ, 2009, J BIOL CHEM, V284, P32225, DOI 10.1074/jbc.M109.043158; Schultz SJ, 2006, J BIOL CHEM, V281, P1943, DOI 10.1074/jbc.M510504200; Schultz SJ, 2004, J MOL BIOL, V344, P635, DOI 10.1016/j.jmb.2004.09.081; Telesnitsky A., 1997, P121; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; Yi-Brunozzi HY, 2005, J BIOL CHEM, V280, P20154, DOI 10.1074/jbc.M411228200; Yi-Brunozzi HY, 2008, CHEM BIOL, V15, P254, DOI 10.1016/j.chembiol.2008.01.012; Zhan XY, 1997, J BIOL CHEM, V272, P22023, DOI 10.1074/jbc.272.35.22023	41	13	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					191	202		10.1074/jbc.M117.798256	http://dx.doi.org/10.1074/jbc.M117.798256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29122886	Green Published, hybrid			2022-12-26	WOS:000419453200017
J	Liu, TH; Chung, RH; Wang, SC; Fang, CP; Tsou, HH; Shih, CL; Kuo, HW; Wang, Y; Liu, YL				Liu, Tung-Hsia; Chung, Ren-Hua; Wang, Sheng-Chang; Fang, Chiu-Ping; Tsou, Hsiao-Hui; Shih, Chia-Lung; Kuo, Hsiang-Wei; Wang, Yun; Liu, Yu-Li			Missense mutation at CLDN8 associated with a high plasma interferon gamma-inducible protein 10 level in methadone-maintained patients with urine test positive for morphine	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MAINTENANCE PATIENTS; ENDOTHELIAL-CELLS; IP-10; CLAUDINS; DISEASE; GENE; CHEMOATTRACTANT; CXCL10/IP-10; INVOLVEMENT	We previously reported a high plasma chemokine interferon gamma-inducible protein 10 (IP-10) level and prolonged electrocardiography QT-interval in methadone maintenance treatment (MMT) patients with HIV or HCV infection. The purpose of this study was to evaluate the genetic association of high plasma IP-10 level in the MMT patients. The gene-based and pathway-based association analyses were conducted using a genome-wide association study dataset in 344 MMT patients for identifying genes and pathways associated with plasma IP-10 level. We found that plasma IP-10 level was significantly associated with a pathway in the tight junction (P = 1.01x10(-5)), where the claudin 8 (CLDN8) gene had the most significant association (P = 6.8x10(-5)). A functional single nucleotide polymorphism (SNP) rs686364 at exon 1 of CLDN8 showed strong association with plasma IP-10 levels, in the MMT subjects with positive urine test for morphine (dominant model, P = 0.00004). The minor allele type carriers had higher plasma IP-10 levels than the major allele type carriers. Our data support that the tight junction protein claudin 8 exon 1 is a predictor for the plasma levels of IP-10 in MMT patients with urine test positive for morphine.	[Liu, Tung-Hsia; Wang, Sheng-Chang; Fang, Chiu-Ping; Shih, Chia-Lung; Kuo, Hsiang-Wei; Wang, Yun; Liu, Yu-Li] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan; [Chung, Ren-Hua; Tsou, Hsiao-Hui] Natl Hlth Res Inst, Div Biostat & Bioinformat, Inst Populat Hlth Sci, Miaoli, Taiwan; [Tsou, Hsiao-Hui] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung, Taiwan; [Liu, Yu-Li] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Liu, YL (corresponding author), Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan.; Liu, YL (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.	ylliou@nhri.org.tw	Chung, Ren-Hua/AAB-8364-2019	Liu, Yu-Li/0000-0001-7519-2965	National Research Program for Genomic Medicine [NSC 100-3112-B-400-015]; National Science Council [NSC 100-2314-B-400-002-MY3]; National Health Research Institutes, Taiwan [NP-105-PP-04, NP-106-PP-06, NP-105-SP-04, NP-106-SP-04]; National Heath Research Institutes and Central Government ST Grant [106-1901-01-10-02]; Ministry of Science and Technology of Taiwan [MOST 106-2320-B-400-012]; National Health Research Institutes, and Central Government S & T grant, Taiwan; National Research Program for Genomic Medicine and Ministry of Science and Technology	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Heath Research Institutes and Central Government ST Grant; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, and Central Government S & T grant, Taiwan; National Research Program for Genomic Medicine and Ministry of Science and Technology	This study was provided by the National Research Program for Genomic Medicine [NSC 100-3112-B-400-015 to YLL], National Science Council [NSC 100-2314-B-400-002-MY3 to YLL] and the National Health Research Institutes, Taiwan [NP-105-PP-04, NP-106-PP-06, NP-105-SP-04 and NP-106-SP-04 to YLL]. This study was also supported in part by the National Heath Research Institutes and Central Government S&T Grant 106-1901-01-10-02 to YW and Ministry of Science and Technology of Taiwan MOST 106-2320-B-400-012 to YLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge staff at the National Center for Genomic Medicine at Academia Sinica for their assistance in genotyping. We also thank staff in the Clinical Trial Information Management System (CTIMeS) at the National Health Research Institutes for data collection and management. This study was supported by National Health Research Institutes, and Central Government S & T grant, Taiwan; National Research Program for Genomic Medicine and Ministry of Science and Technology. All study subjects and research nurses are also appreciated.	Alinejad S, 2015, EXCLI J, V14, P577, DOI 10.17179/excli2015-553; Angelow S, 2007, J MEMBRANE BIOL, V215, P147, DOI 10.1007/s00232-007-9014-3; Balkovetz DF, 2009, BBA-BIOMEMBRANES, V1788, P858, DOI 10.1016/j.bbamem.2008.07.004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bart G, 2012, J ADDICT DIS, V31, P207, DOI 10.1080/10550887.2012.694598; Chen YH, 2009, ANN NY ACAD SCI, V1165, P126, DOI 10.1111/j.1749-6632.2009.04031.x; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Fonseca F, 2009, DRUG ALCOHOL DEPEN, V99, P327, DOI 10.1016/j.drugalcdep.2008.06.018; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Guan MJ, 2016, HUM GENET, V135, P1251, DOI 10.1007/s00439-016-1714-2; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Huey CL, 2004, AM J NEPHROL, V24, P483, DOI 10.1159/000080672; Iwaki N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42316; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Ko TM, 2015, CIRC RES, V116, P876, DOI 10.1161/CIRCRESAHA.116.305834; Kreek MJ, 2010, J ADDICT DIS, V29, P200, DOI 10.1080/10550881003684798; Li MX, 2012, AM J HUM GENET, V91, P478, DOI 10.1016/j.ajhg.2012.08.004; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Liu SW, 2015, INT J CARDIOL, V194, P36, DOI 10.1016/j.ijcard.2015.05.055; Odler B, 2017, LUPUS, V26, P572, DOI 10.1177/0961203316668418; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sajadi SMA, 2013, CLIN LAB, V59, P133, DOI 10.7754/Clin.Lab.2012.120225; Shrestha A, 2013, MBIO, V4, DOI 10.1128/mBio.00594-12; Simmons RP, 2013, AIDS, V27, P2505, DOI 10.1097/01.aids.0000432455.06476.bc; Stumpf C, 2011, HYPERTENS RES, V34, P484, DOI 10.1038/hr.2010.258; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Wu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069310; Yang HZ, 2016, SCAND ACTUAR J, P1, DOI 10.1080/03461238.2014.884017; You CR, 2011, GUT LIVER, V5, P506, DOI 10.5009/gnl.2011.5.4.506	31	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187639	10.1371/journal.pone.0187639	http://dx.doi.org/10.1371/journal.pone.0187639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145422	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800025
J	Bupathi, M; Hays, JL; Chen, JL				Bupathi, Manojkumar; Hays, John L.; Chen, James L.			Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series	PLOS ONE			English	Article							ADVANCED SOFT-TISSUE; PHASE-II TRIAL; DOXORUBICIN; GLIOBLASTOMA; CHEMOTHERAPY; BEVACIZUMAB; GEMCITABINE; IFOSFAMIDE; DOCETAXEL; THERAPY	Background Sarcomas are rare, heterogeneous tumors for which prognosis remains dismal in patients with advanced disease. Pazopanib, a vascular endothelial growth factor receptor inhibitor, has shown modest efficacy in patients with soft tissue sarcoma who fail cytotoxic chemotherapy. The cytotoxic agent temozolomide has also demonstrated activity in patients with advanced sarcoma. Objective We performed a retrospective case series to evaluate the feasibility of adding temozolomide to pazopanib in advanced sarcoma patients following single-agent pazopanib failure. Patients and methods Patients with recurrent, metastatic sarcomas who had progressed on single-agent pazopanib and continued on pazopanib with the addition of temozolomide were included in this retrospective analysis to examine the tolerability and responses associated with the treatment combination. Results Nine patients with a range of sarcoma subtypes were identified (55% female; median age, 48 years; median number of therapies prior to pazopanib, 3). All patients received combination therapy. One patient was recently started on therapy and was excluded from the analysis (n = 8 evaluable patients). Median PFS for single-agent pazopanib was 7.5 months (range 2-19). For the eight evaluable patients (63% female), best response at 4 months with pazopanib plus temozolomide was partial response (n = 1), stable disease (n = 3) and progressive disease (n = 4), with a median PFS of 3.5 months (range 0-15). Median PFS with combination treatment in patients with stable disease or response was 8 months (range 5-15). All four patients who achieved clinical benefit remain on therapy and are tolerating the combination therapy with expected but manageable side effects. Conclusions In heavily pretreated patients with advanced sarcoma, the addition of temozolomide to pazopanib was found to be tolerable. Future prospective trials are required to deduce whether temozolomide extends the clinical benefit of pazopanib.	[Bupathi, Manojkumar; Chen, James L.] Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA; [Hays, John L.] Ohio State Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Columbus, OH 43210 USA; [Hays, John L.; Chen, James L.] Ohio State Univ, Dept Biomed Informat, Div Bioinformat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chen, JL (corresponding author), Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA.; Chen, JL (corresponding author), Ohio State Univ, Dept Biomed Informat, Div Bioinformat, Columbus, OH 43210 USA.	James.chen@osumc.edu	Chen, James/A-9964-2016	Chen, James/0000-0002-4095-5202	Novartis Pharmaceuticals; Novartis Pharmaceuticals Corporation	Novartis Pharmaceuticals(Novartis); Novartis Pharmaceuticals Corporation(Novartis)	This study was funded by Novartis Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Editorial assistance was provided by ApotheCom (Yardley, PA), supported by Novartis Pharmaceuticals Corporation.; Editorial assistance was provided by ApotheCom (Yardley, PA) supported by Novartis Pharmaceuticals Corporation.	[Anonymous], 2017, LARTR PRESCR INF; [Anonymous], 2016, AV PRESCR INF; [Anonymous], 2017, VOTR PRESCR INF; ANTMAN K, 1993, J CLIN ONCOL, V11, P1276, DOI 10.1200/JCO.1993.11.7.1276; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; del Muro XG, 2005, CANCER, V104, P1706, DOI 10.1002/cncr.21384; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Drappatz J, 2010, INT J RADIAT ONCOL, V78, P85, DOI 10.1016/j.ijrobp.2009.07.1741; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; EDMONSON JH, 1993, J CLIN ONCOL, V11, P1269, DOI 10.1200/JCO.1993.11.7.1269; Garcia-del-Muro X, 2011, J CLIN ONCOL, V29, P2528, DOI 10.1200/JCO.2010.33.6107; Gerstner ER, 2011, J NEURO-ONCOL, V103, P325, DOI 10.1007/s11060-010-0390-7; Gril B, 2011, CLIN CANCER RES, V17, P142, DOI 10.1158/1078-0432.CCR-10-1603; Grossman R, 2014, J NEURO-ONCOL, V116, P59, DOI 10.1007/s11060-013-1268-2; Hosaka S, 2012, J ORTHOP RES, V30, P1493, DOI 10.1002/jor.22091; Italiano A, 2013, ANN ONCOL, V24, P2916, DOI 10.1093/annonc/mdt374; Kusabe Y, 2015, ONCOL LETT, V10, P2511, DOI 10.3892/ol.2015.3506; Leahy M, 2012, ANN ONCOL, V23, P2763, DOI 10.1093/annonc/mds070; Maki RG, 2007, J CLIN ONCOL, V25, P2755, DOI 10.1200/JCO.2006.10.4117; Maki RG, 2007, ONCOLOGIST, V12, P999, DOI 10.1634/theoncologist.12-8-999; National Comprehensive Cancer Network, 2021, NCCN CLIN PRACTICE G; Pang A, 2016, JAMA ONCOL, V2, P941, DOI 10.1001/jamaoncol.2016.0241; Paoluzzi L, 2016, CLIN SARCOMA RES, V6, DOI 10.1186/s13569-016-0064-0; Park MS, 2011, CANCER-AM CANCER SOC, V117, P4939, DOI 10.1002/cncr.26098; Penel N, 2008, J CLIN ONCOL, V26, P5269, DOI 10.1200/JCO.2008.17.3146; Sleijfer S, 2010, EUR J CANCER, V46, P72, DOI 10.1016/j.ejca.2009.09.022; Stacchiotti S, 2014, EUR J CANCER, V50, P1657, DOI 10.1016/j.ejca.2014.03.013; Stacchiotti S, 2013, CLIN SARCOMA RES, V3, DOI 10.1186/2045-3329-3-16; Talbot SM, 2003, CANCER-AM CANCER SOC, V98, P1942, DOI 10.1002/cncr.11730; Tap WD, 2016, LANCET, V388, P488, DOI 10.1016/S0140-6736(16)30587-6; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Wachsberger PR, 2011, J NEURO-ONCOL, V105, P181, DOI 10.1007/s11060-011-0580-y; Woll PJ, 1999, EUR J CANCER, V35, P410, DOI 10.1016/S0959-8049(98)00403-1	34	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188116	10.1371/journal.pone.0188116	http://dx.doi.org/10.1371/journal.pone.0188116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141017	Green Submitted, gold, Green Published			2022-12-26	WOS:000415260400059
J	Lai, K; Harwood, CA; Purdie, KJ; Proby, CM; Leigh, IM; Ravi, N; Mully, TW; Brooks, L; Sandoval, PM; Rosenblum, MD; Arron, ST				Lai, Kevin; Harwood, Catherine A.; Purdie, Karin J.; Proby, Charlotte M.; Leigh, Irene M.; Ravi, Namita; Mully, Thaddeus W.; Brooks, Lionel; Sandoval, Priscilla M.; Rosenblum, Michael D.; Arron, Sarah T.			Genomic analysis of atypical fibroxanthoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-ASSOCIATED MACROPHAGES; MUTATIONAL LANDSCAPE; SOMATIC MUTATIONS; SEQUENCING DATA; CANCER; EXPRESSION; GENES; SKIN	Atypical fibroxanthoma (AFX), is a rare type of skin cancer affecting older individuals with sun damaged skin. Since there is limited genomic information about AFX, our study seeks to improve the understanding of AFX through whole-exome and RNA sequencing of 8 matched tumor-normal samples. AFX is a highly mutated malignancy with recurrent mutations in a number of genes, including COL11A1, ERBB4, CSMD3, and FAT1. The majority of mutations identified were UV signature (C>T in dipyrimidines). We observed deletion of chromosomal segments on chr9p and chr13q, including tumor suppressor genes such as KANK1 and CDKN2A, but no gene fusions were found. Gene expression profiling revealed several biological pathways that are upregulated in AFX, including tumor associated macrophage response, GPCR signaling, and epithelial to mesenchymal transition (EMT). To further investigate the presence of EMT in AFX, we conducted a gene expression meta-analysis that incorporated RNA-seq data from dermal fibroblasts and keratinocytes. Ours is the first study to employ high throughput sequencing for molecular profiling of AFX. These data provide valuable insights to inform models of carcinogenesis and additional research towards tumor-directed therapy.	[Lai, Kevin; Ravi, Namita; Mully, Thaddeus W.; Brooks, Lionel; Sandoval, Priscilla M.; Rosenblum, Michael D.; Arron, Sarah T.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Harwood, Catherine A.; Purdie, Karin J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Cutaneous Res & Cell Biol, London, England; [Proby, Charlotte M.; Leigh, Irene M.] Univ Dundee, Sch Med, Div Canc Res, Dundee, Scotland; [Arron, Sarah T.] Vet Adm Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of London; Queen Mary University London; University of Dundee; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Arron, ST (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.; Arron, ST (corresponding author), Vet Adm Med Ctr, San Francisco, CA 94121 USA.	Sarah.Arron@ucsf.edu		Arron, Sarah/0000-0001-5669-0627; Harwood, Catherine/0000-0002-1375-0965	Cancer Research UK programme; UCSF Department of Dermatology	Cancer Research UK programme(Cancer Research UK); UCSF Department of Dermatology	This work was funded by Cancer Research UK programme grant to Prof. Irene Leigh and UCSF Department of Dermatology funding to Dr Sarah Arron.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson HL, 2007, DERMATOL SURG, V33, P693, DOI 10.1111/j.1524-4725.2007.33145.x; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Cheng FX, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004497; Chin L, 1998, TRENDS BIOCHEM SCI, V23, P291, DOI 10.1016/S0968-0004(98)01236-5; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Goh G, 2016, ONCOTARGET, V7, P3393, DOI 10.18632/oncotarget.6494; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Griewank KG, 2014, MODERN PATHOL, V27, P502, DOI 10.1038/modpathol.2013.168; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Jia WL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r12; JIANG N, 1993, BIOCHEMISTRY-US, V32, P472, DOI 10.1021/bi00053a011; Kahlert UD, 2017, MOL ONCOL, V11, P860, DOI 10.1002/1878-0261.12085; Knuchel S, 2015, ONCOTARGET, V6, P14300, DOI 10.18632/oncotarget.3883; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krasinskas AM, 2010, MODERN PATHOL, V23, P531, DOI 10.1038/modpathol.2009.186; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mihic-Probst D, 2004, ANTICANCER RES, V24, P19; Mirza Basit, 2005, Australas J Dermatol, V46, P235, DOI 10.1111/j.1440-0960.2005.00190.x; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Nakamura M, 2010, J EUR ACAD DERMATOL, V24, P1365, DOI 10.1111/j.1468-3083.2010.03659.x; Pacifico A, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/43418; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Polcz MM, 2017, AUSTRALAS J DERMATOL; Quatromoni JG, 2012, AM J TRANSL RES, V4, P376; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; Sannino G, 2017, CANCER RES, V77, P4556, DOI 10.1158/0008-5472.CAN-17-0032; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schmalbach CE, 2004, ARCH OTOLARYNGOL, V130, P295, DOI 10.1001/archotol.130.3.295; Scolnick JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128916; Shyr C, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0064-y; Simon MP, 1997, NAT GENET, V15, P95, DOI 10.1038/ng0197-95; South AP, 2014, J INVEST DERMATOL, V134, P2630, DOI 10.1038/jid.2014.154; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talevich E, 2014, BIORXIV; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; TOS APD, 1994, AM J PATHOL, V145, P11; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang QG, 2013, GENOME MED, V5, DOI 10.1186/gm495; Wieland CN, 2011, J CUTAN PATHOL, V38, P884, DOI 10.1111/j.1600-0560.2011.01768.x; Wu YH, 2014, ONCOGENE, V33, P3432, DOI 10.1038/onc.2013.307; Zhang Y, 2015, CANCER METAST REV, V34, P249, DOI 10.1007/s10555-015-9558-0; Ziemer M, 2012, J DTSCH DERMATOL GES, V10, P537, DOI 10.1111/j.1610-0387.2012.07980.x	54	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188272	10.1371/journal.pone.0188272	http://dx.doi.org/10.1371/journal.pone.0188272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141020	gold, Green Published, Green Submitted			2022-12-26	WOS:000415260400073
J	Stack, JR; Madigan, A; Helbert, L; Dunne, E; Gardiner, EE; Andrews, RK; Finan, R; Smyth, E; Kenny, D; McCarthy, GM				Stack, John R.; Madigan, Anne; Helbert, Laura; Dunne, Eimear; Gardiner, Elizabeth E.; Andrews, Robert K.; Finan, Roisin; Smyth, Elizabeth; Kenny, Dermot; McCarthy, Geraldine M.			Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis	PLOS ONE			English	Article							IMMUNE THROMBOCYTOPENIC PURPURA; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; INFLAMMATION; PATIENT; ANTIBODIES; MORTALITY; RECEPTOR; GPVI	Objectives Anti-citrullinated protein antibodies (ACPA) have been shown to cause platelet activation in vitro, through the low-affinity immunoglobulin G (IgG) receptor (Fc gamma RIIa) on platelets. Platelet activation via engagement of Fc gamma RIIa results in proteolytic cleavage and shedding of platelet specific glycoprotein VI (GPVI) which can be detected in the plasma as soluble GPVI (sGPVI). We hypothesized that plasma levels of sGPVI would be increased among patients with seropositive RA as a consequence of antibody-induced platelet activation and GPVI shedding. Methods Samples from 84 patients with RA (65 seropositive and 19 seronegative) and 67 healthy controls were collected prospectively and analysed for sGPVI using a standardised ELISA. Results Patients with seropositive RA had significantly higher levels of sGPVI compared to seronegative RA and controls. Median (IQR) sGPVI levels were 4.2 ng/ml (3.2, 8.0) in seropositve RA, 2.2 ng/ml (1.5, 3.5) in seronegative RA and 2.2 ng/ml (1.6, 3.4) in controls (p<0.0001). sGPVI levels correlated with ACPA titres (r = 0.32, p = 0.0026) and with RF titres (r = 0.48, p<0.0001). Conclusion Plasma sGPVI, a specific marker of platelet activation is increased among patients with seropositive RA.	[Stack, John R.; Madigan, Anne; Helbert, Laura; McCarthy, Geraldine M.] Mater Misericordiae Univ Hosp, Eccles St, Dublin, Ireland; [Dunne, Eimear; Finan, Roisin; Smyth, Elizabeth; Kenny, Dermot] Royal Coll Surgeons Ireland, RCSI Mol & Cellular Therapeut MCT, Dublin, Ireland; [Gardiner, Elizabeth E.] Australian Natl Univ, John Curtin Sch Med Res, ACRF Dept Canc Biol & Therapeut, Canberra, ACT, Australia; [Andrews, Robert K.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia	Mater Misericordiae University Hospital; University College Dublin; Royal College of Surgeons - Ireland; Australian National University; John Curtin School of Medical Research; Monash University	Stack, JR (corresponding author), Mater Misericordiae Univ Hosp, Eccles St, Dublin, Ireland.	stack.johnr@gmail.com	Kenny, Dermot/C-3898-2012; Dunne, Eimear/AGX-1949-2022; Dunne, Eimear/C-6785-2012; Smyth, Elizabeth/N-6541-2019; McCarthy, Geraldine/AFQ-5733-2022; Gardiner, Elizabeth/P-8716-2019	Kenny, Dermot/0000-0001-5548-3263; Dunne, Eimear/0000-0001-9862-1398; Dunne, Eimear/0000-0001-9862-1398; Gardiner, Elizabeth/0000-0001-9453-9688; Stack, John/0000-0003-1615-5317; Andrews, Robert Keith/0000-0001-9577-8082; McCarthy, Geraldine/0000-0003-4078-8499				Al-Tamimi M, 2012, THROMB HAEMOSTASIS, V107, P648, DOI 10.1160/TH11-10-0745; Al-Tamimi M, 2011, STROKE, V42, P498, DOI 10.1161/STROKEAHA.110.602532; Andrews RK, 2014, J BLOOD MED, V5, P59, DOI 10.2147/JBM.S39220; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Connolly-Andersen AM, 2015, J INFECT DIS, V212, P1061, DOI 10.1093/infdis/jiv161; Duffau P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001001; Dunne E, 2011, J THROMB HAEMOST S2, P1; Ertenli I, 1998, J RHEUMATOL, V25, P1054; Gardiner EE, 2008, J THROMB HAEMOST, V6, P1175, DOI 10.1111/j.1538-7836.2008.03016.x; Gardiner EE, 2008, BLOOD, V111, P165, DOI 10.1182/blood-2007-04-086983; Gardiner EE, 2010, BRIT J HAEMATOL, V149, P625, DOI 10.1111/j.1365-2141.2010.08092.x; Goetzl EJ, 2016, FASEB J, V30, P2058, DOI 10.1096/fj.201500150R; Goodson NJ, 2002, ARTHRITIS RHEUM-US, V46, P2010, DOI 10.1002/art.10419; Habets KLL, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0665-7; Hjeltnes G, 2011, SCAND J RHEUMATOL, V40, P422, DOI 10.3109/03009742.2011.585350; Lopez-Longo FJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P419, DOI 10.1002/art.24390; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Mason JC, 2015, EUR HEART J, V36, P482, DOI 10.1093/eurheartj/ehu403; Nurden P, 2009, J THROMB HAEMOST, V7, P1541, DOI 10.1111/j.1538-7836.2009.03537.x; O'Halloran JA, 2015, HIV MED, V16, P608, DOI 10.1111/hiv.12270; Pignatelli P, 2005, BLOOD, V106, P1992, DOI 10.1182/blood-2005-03-1247; Thomas MR, 2015, THROMB HAEMOSTASIS, V114, P449, DOI 10.1160/TH14-12-1067; Tomasson G, 2010, ANN RHEUM DIS, V69, P1649, DOI 10.1136/ard.2009.110536	24	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188027	10.1371/journal.pone.0188027	http://dx.doi.org/10.1371/journal.pone.0188027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141000	Green Published, Green Submitted, gold			2022-12-26	WOS:000415260400045
J	Venugopal, G; Mueller, M; Hartmann, S; Steinfelder, S				Venugopal, Gopinath; Mueller, Marion; Hartmann, Susanne; Steinfelder, Svenja			Differential immunomodulation in human monocytes versus macrophages by filarial cystatin	PLOS ONE			English	Article							CYSTEINE PROTEASE INHIBITOR; GROWTH-FACTOR-BETA; BRUGIA-MALAYI; HELMINTH INFECTIONS; NEMATODE; EXPRESSION; INDUCTION; RESPONSES; IMMUNITY; CELLS	Parasitic nematodes have evolved powerful immunomodulatory molecules to enable their survival in immunocompetent hosts by subverting immune responses and minimizing pathological processes. One filarial molecule known to counteract host immune responses by inducing IL-10 and regulatory macrophages in mice is filarial cystatin. During a patent filarial infection monocytes encounter microfilariae in the blood, an event that occurs in asymptomatically infected filariasis patients that are immunologically hyporeactive. The microfilarial larval stage was formerly shown to induce human regulatory monocytes and macrophages. Thus, here we aim was to determine how filarial cystatin of the human pathogenic filaria Brugia malayi (BmCPI-2) contributes to immune hyporesponsiveness in human monocytes and macrophages elicited by microfilaria. For this purpose, filarial cystatin was depleted from microfilarial lysate (Mf). Detecting the immunomodulatory potential of cystatin-depleted Mf revealed that IL-10, but not IL-8 and IL-6 induction in monocytes and macrophages is dependent on the presence of cystatin. In addition, the Mf-induced expression of the regulatory surface markers PD-L1 and PD-L2 in human monocytes, but not in macrophages, is dependent on cystatin. While Mf-treated monocytes result in decreased CD4(+) T-cell proliferation in a co-culture assay, stimulation of T-cells with human monocytes treated with cystatin-depleted Mf lead to a restoration of CD4(+) T-cell proliferation. Moreover, IL-10 induction by cystatin within Mf was dependent on p38 and ERK in macrophages, but independent of the ERK pathway in monocytes. These findings indicate that filarial nematodes differentially trigger and exploit various signaling pathways to induce immunomodulation in different myeloid cell subsets.	[Venugopal, Gopinath; Mueller, Marion; Hartmann, Susanne; Steinfelder, Svenja] Free Univ Berlin, Inst Immunol, Ctr Infect Med, Berlin, Germany	Free University of Berlin	Hartmann, S (corresponding author), Free Univ Berlin, Inst Immunol, Ctr Infect Med, Berlin, Germany.	susanne.hartmann@fu-berlin.de		Venugopal, Gopinath/0000-0001-9363-0711	German Research Foundation (DFG - International Research Training Group 1673); Sonnenfeld Foundation, Berlin, Germany	German Research Foundation (DFG - International Research Training Group 1673); Sonnenfeld Foundation, Berlin, Germany	This work was supported by the German Research Foundation (DFG - International Research Training Group 1673) and Sonnenfeld Foundation, Berlin, Germany. The funders had no role in study design, data analysis, decision to publish or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; [Anonymous], 2016, DEATHS CAUS AG SEX C; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Araujo MIAS, 2004, J INFECT DIS, V190, P1797, DOI 10.1086/425017; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Babu S, 2005, J IMMUNOL, V175, P1170, DOI 10.4049/jimmunol.175.2.1170; Babu S, 2005, J INFECT DIS, V191, P1018, DOI 10.1086/427658; Babu S, 2014, PARASITE IMMUNOL, V36, P338, DOI 10.1111/pim.12081; Babu S, 2009, J INFECT DIS, V199, P1827, DOI 10.1086/599090; Behrendt P, 2016, NEUROIMMUNOMODULAT, V23, P109, DOI 10.1159/000444756; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Boyd A, 2013, INFECT IMMUN, V81, P1420, DOI 10.1128/IAI.01301-12; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Coronado S, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12425; Dainichi T, 2001, INFECT IMMUN, V69, P7380, DOI 10.1128/IAI.69.12.7380-7386.2001; Fenwick A, 2012, PUBLIC HEALTH, V126, P233, DOI 10.1016/j.puhe.2011.11.015; Figueiredo CA, 2010, INFECT IMMUN, V78, P3160, DOI 10.1128/IAI.01228-09; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gomez-Escobar N, 1998, EXP PARASITOL, V88, P200, DOI 10.1006/expr.1998.4248; Gomez-Escobar N, 2000, INFECT IMMUN, V68, P6402, DOI 10.1128/IAI.68.11.6402-6410.2000; Goodridge HS, 2003, IMMUNOLOGY, V109, P415, DOI 10.1046/j.1365-2567.2003.01689.x; Goodrigde HS, 2005, CELL SIGNAL, V17, P11, DOI 10.1016/j.cellsig.2004.05.014; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Gregory WF, 2008, INT J BIOCHEM CELL B, V40, P1389, DOI 10.1016/j.biocel.2007.11.012; Grzonka Z, 2001, ACTA BIOCHIM POL, V48, P1; Harnett W, 2005, PARASITOLOGY, V130, pS63, DOI 10.1017/S0031182005008164; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Hartmann S, 1997, EUR J IMMUNOL, V27, P2253, DOI 10.1002/eji.1830270920; Hartmann S, 2002, CYSTATINS FILARIAL N, P253; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Johnston KL, 2014, J BIOMOL SCREEN, V19, P335, DOI 10.1177/1087057113511270; Klotz C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001248; Kopitar-Jerala N, 2012, CURR PROTEIN PEPT SC, V13, P767, DOI 10.2174/138920312804871102; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Manoury B, 2001, CURR BIOL, V11, P447, DOI 10.1016/S0960-9822(01)00118-X; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; O'Regan NL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003206; Pfaff AW, 2002, INT J PARASITOL, V32, P171, DOI 10.1016/S0020-7519(01)00350-2; Rzychon M, 2004, ACTA BIOCHIM POL, V51, P861; Sabotic J, 2012, APPL MICROBIOL BIOT, V93, P1351, DOI 10.1007/s00253-011-3834-x; Satapathy AK, 2006, MICROBES INFECT, V8, P2414, DOI 10.1016/j.micinf.2006.05.003; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Schonemeyer A, 2001, J IMMUNOL, V167, P3207, DOI 10.4049/jimmunol.167.6.3207; Schroeder JH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001914; Schuit M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148476; Semnani RT, 2006, INFECT IMMUN, V74, P4409, DOI 10.1128/IAI.01106-05; Semnani RT, 2004, J IMMUNOL, V172, P6229, DOI 10.4049/jimmunol.172.10.6229; Semnani RT, 2003, J IMMUNOL, V171, P1950, DOI 10.4049/jimmunol.171.4.1950; Specht S, 2012, EXP PARASITOL, V132, P90, DOI 10.1016/j.exppara.2011.09.003; Turner JD, 2008, J INFECT DIS, V197, P1204, DOI 10.1086/586717; Turner JD, 2009, J BIOL CHEM, V284, P22364, DOI 10.1074/jbc.M901528200; Weinkopff T, 2014, PLOS NEGL TROP DIS, V8; Wilcox RA, 2009, BLOOD, V114, P2149, DOI 10.1182/blood-2009-04-216671; Zang XX, 2002, J BIOL CHEM, V277, P44261, DOI 10.1074/jbc.M204655200	55	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188138	10.1371/journal.pone.0188138	http://dx.doi.org/10.1371/journal.pone.0188138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141050	Green Submitted, Green Published, gold			2022-12-26	WOS:000415260400063
J	Yuan, M; Wang, SJ; Yu, LJ; Qu, B; Xu, LM; Liu, LN; Sun, HX; Li, CX; Shi, YJ; Liu, HX				Yuan, Min; Wang, Shujun; Yu, Lijie; Qu, Bo; Xu, Liming; Liu, Lining; Sun, Huanxia; Li, Chunxian; Shi, Yanjun; Liu, Huaxiang			Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis	PLOS ONE			English	Article							CYSTIC-FIBROSIS; CELLS; IMMUNOPATHOGENESIS; IDENTIFICATION; PROTEINS; CFTR	Long noncoding RNAs (lncRNAs) have recently emerged as important biological regulators, and the aberrant expression of lncRNAs has been reported in numerous diseases. However, the expression of lncRNAs in peripheral blood mononuclear cells (PBMCs) in rheumatoid arthritis (RA) has not been well documented. We applied a microarray analysis to profile the lncRNA and mRNA expression in 3 pairs of samples. Each sample was mixed with equivalent PBMCs from 9 female RA patients and 9 corresponding healthy controls, and the data were validated via qPCR using another cohort that comprised 36 RA patients and 24 healthy controls. A bioinformatic analysis was performed to investigate the potential functions of differentially expressed genes. Overall, 2,099 lncRNAs and 2,307 mRNAs were differentially expressed between the RA patients and healthy controls. The bioinformatic analysis indicated that the differentially expressed lncRNAs regulated the abnormally expressed mRNAs, which were involved in the pathogenesis of RA through several different pathways. The qPCR results showed that the expression levels of ENST00000456270 and NR_002838 were significantly increased in the RA patients, whereas the expression levels of NR_026812 and uc001zwf. 1 were significantly decreased. Furthermore, the expression level of ENST00000456270 was strongly associated with the serum levels of IL-6 and TNF-a and the Simplified Disease Activity Index (SDAI) of the RA patients. Our data provided comprehensive evidence regarding the differential expression of lncRNAs in PBMCs of RA patients, which shed light on the understanding of the molecular mechanisms of lncRNAs in the pathogenesis of RA.	[Yuan, Min; Wang, Shujun; Yu, Lijie; Liu, Huaxiang] Shandong Univ, Qilu Hosp, Dept Rheumatol, Jinan, Shandong, Peoples R China; [Yuan, Min; Xu, Liming; Liu, Lining; Sun, Huanxia; Li, Chunxian; Shi, Yanjun] Liaocheng Peoples Hosp, Dept Rheumatol, Liaocheng, Peoples R China; [Wang, Shujun] Cent Hosp Zibo, Dept Rheumatol, Zibo, Peoples R China; [Yu, Lijie] Donge Peoples Hosp, Dept Rheumatol, Liaocheng, Peoples R China; [Qu, Bo] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai Inst Rheumatol,Dept Rheumatol, Shanghai, Peoples R China	Shandong University; Shanghai Jiao Tong University	Liu, HX (corresponding author), Shandong Univ, Qilu Hosp, Dept Rheumatol, Jinan, Shandong, Peoples R China.	huaxiangliu@hotmail.com	liu, lining/GXM-5412-2022; Qu, Bo/V-6675-2019		National Natural Science Foundation of China [81371929]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number: 81371929), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Arase H, 2016, ADV IMMUNOL, V129, P1, DOI 10.1016/bs.ai.2015.09.005; Atianand MK, 2017, ANNU REV IMMUNOL, V35, P177, DOI 10.1146/annurev-immunol-041015-055459; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Brisslert M, 2013, IMMUNOLOGY, V140, P9; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hambardzumyan K, 2016, ARTHRITIS RHEUMATOL; Hambardzumyan K, 2015, ANN RHEUM DIS, V74, P1102, DOI 10.1136/annrheumdis-2013-204986; Jiang CM, 2016, INT J BIOCHEM CELL B, V72, P118, DOI 10.1016/j.biocel.2016.01.011; Kotlarz A, 2013, CELL STRESS CHAPERON, V18, P653, DOI 10.1007/s12192-013-0407-1; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lai NS, 2017, CLIN EXP IMMUNOL, V187, P327, DOI 10.1111/cei.12903; Lee A, 2013, ARTHRITIS RHEUM-US, V65, P928, DOI 10.1002/art.37853; Li Z, 2014, PANS, V111, P6; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Lu MC, 2016, IMMUNOL RES, V64, P576, DOI 10.1007/s12026-015-8756-8; Manara M, 2015, RMD OPEN, P1; Meng X, 2017, CELL MOL LIFE SCI, V74, P23, DOI 10.1007/s00018-016-2386-8; Moskowitz SM, 2008, GENET MED, V10, P851, DOI 10.1097/GIM.0b013e31818e55a2; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Petri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138236; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Satpathy AT, 2015, IMMUNITY, V42, P792, DOI 10.1016/j.immuni.2015.05.004; Seiler J, 2017, NUCLEIC ACIDS RES, V45, P5458, DOI 10.1093/nar/gkx076; Shi H, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1005-2; Sigdel KR, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/848790; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Spurlock CF, 2014, ARTHRITIS RHEUMATOL, V66, P2947, DOI 10.1002/art.38805; Taneja V, 2000, ARTHRITIS RES THER, V2, P3; Tong WX, 2017, ONCOTARGETS THER, V10, P1227, DOI 10.2147/OTT.S125185; Tsukuda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040136; Wang P, 2015, LUNG CANCER, V88, P147, DOI 10.1016/j.lungcan.2015.02.009; Xia F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101588; Xin JX, 2017, ONCOTARGETS THER, V10, P1, DOI 10.2147/OTT.S124201; Yang KY, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/631737; Zhang FF, 2016, J AUTOIMMUN, V75, P96, DOI 10.1016/j.jaut.2016.07.012; Zhang Y, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1129-4	43	42	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186795	10.1371/journal.pone.0186795	http://dx.doi.org/10.1371/journal.pone.0186795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140972	Green Published, gold, Green Submitted			2022-12-26	WOS:000415260400010
J	Akter, A; Biella, P; Klecka, J				Akter, Asma; Biella, Paolo; Klecka, Jan			Effects of small-scale clustering of flowers on pollinator foraging behaviour and flower visitation rate	PLOS ONE			English	Article							FLORAL DISPLAY SIZE; PROPORTIONALLY FEWER FLOWERS; PARTIAL PREY CONSUMPTION; INFLORESCENCE SIZE; SEED SET; REPRODUCTIVE SUCCESS; INSECT VISITATION; PLANT-DENSITY; PATCH SIZE; RESOURCES	Plants often grow in clusters of various sizes and have a variable number of flowers per inflorescence. This small-scale spatial clustering affects insect foraging strategies and plant reproductive success. In our study, we aimed to determine how visitation rate and foraging behaviour of pollinators depend on the number of flowers per plant and on the size of clusters of multiple plants using Dracocephalum moldavica (Lamiaceae) as a target species. We measured flower visitation rate by observations of insects visiting single plants and clusters of plants with different numbers of flowers. Detailed data on foraging behaviour within clusters of different sizes were gathered for honeybees, Apis mellifera, the most abundant visitor of Dracocephalum in the experiments. We found that the total number of flower visitors increased with the increasing number of flowers on individual plants and in larger clusters, but less then proportionally. Although individual honeybees visited more flowers in larger clusters, they visited a smaller proportion of flowers, as has been previously observed. Consequently, visitation rate per flower and unit time peaked in clusters with an intermediate number of flowers. These patterns do not conform to expectations based on optimal foraging theory and the ideal free distribution model. We attribute this discrepancy to incomplete information about the distribution of resources. Detailed observations and video recordings of individual honeybees also showed that the number of flowers had no effect on handling time of flowers by honeybees. We evaluated the implications of these patterns for insect foraging biology and plant reproduction.	[Akter, Asma; Biella, Paolo; Klecka, Jan] Czech Acad Sci, Biol Ctr, Inst Entomol, Ceske Budejovice, Czech Republic; [Akter, Asma; Biella, Paolo] Univ South Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Klecka, J (corresponding author), Czech Acad Sci, Biol Ctr, Inst Entomol, Ceske Budejovice, Czech Republic.	jan.klecka@entu.cas.cz	Akter, Asma/AAE-2499-2021; Biella, Paolo/AAZ-5886-2020; Klecka, Jan/H-7874-2014	Akter, Asma/0000-0002-6336-2768; Biella, Paolo/0000-0003-2297-006X; Klecka, Jan/0000-0003-0633-3896	Czech Science Foundation [GP14-10035P, GJ17-24795Y]; University of South Bohemia [GA JU 152/2016/P]	Czech Science Foundation(Grant Agency of the Czech Republic); University of South Bohemia	This project was supported by the Czech Science Foundation (projects GP14-10035P and GJ17-24795Y awarded to JK). AA and PB were also supported by a grant GA JU 152/2016/P provided by the University of South Bohemia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS MV, 1986, BEHAV ECOL SOCIOBIOL, V19, P409, DOI 10.1007/BF00300543; ANDERSSON S, 1991, HOLARCTIC ECOL, V14, P186; Anic V, 2015, PLANT BIOLOGY, V17, P720, DOI 10.1111/plb.12293; ASTROM M, 1990, J ANIM ECOL, V59, P287, DOI 10.2307/5173; BERNSTEIN C, 1988, J ANIM ECOL, V57, P1007, DOI 10.2307/5108; Blaauw BR, 2014, BASIC APPL ECOL, V15, P701, DOI 10.1016/j.baae.2014.10.001; Brody AK, 1997, OECOLOGIA, V110, P86, DOI 10.1007/s004420050136; Brunet J, 2015, INT J PLANT SCI, V176, P811, DOI 10.1086/683339; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Conner JK, 1996, OECOLOGIA, V105, P509, DOI 10.1007/BF00330014; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Danderson CA, 2010, AM MIDL NAT, V163, P234, DOI 10.1674/0003-0031-163.1.234; DEJONG TJ, 1992, OECOLOGIA, V89, P310, DOI 10.1007/BF00317407; DREISIG H, 1995, OIKOS, V72, P161, DOI 10.2307/3546218; Eliassen S, 2007, OIKOS, V116, P513, DOI 10.1111/j.2006.0030-1299.15462.x; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Garbuzov M, 2015, ACTA OECOL, V62, P53, DOI 10.1016/j.actao.2014.12.002; Garcia-Meneses PM, 2012, BASIC APPL ECOL, V13, P516, DOI 10.1016/j.baae.2012.08.011; Gende SM, 2001, OECOLOGIA, V127, P372, DOI 10.1007/s004420000590; GILLER PS, 1980, J ANIM ECOL, V49, P699, DOI 10.2307/4222; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Giurfa M, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P61, DOI 10.1017/CBO9780511542268.005; Goulson D, 1998, OECOLOGIA, V113, P502, DOI 10.1007/s004420050402; Goulson D, 2000, OIKOS, V91, P485, DOI 10.1034/j.1600-0706.2000.910309.x; Grindeland JM, 2005, FUNCT ECOL, V19, P383, DOI 10.1111/j.1365-2435.2005.00988.x; HASSELL MP, 1976, J ANIM ECOL, V45, P135, DOI 10.2307/3772; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; Hegland SJ, 2014, FUNCT ECOL, V28, P561, DOI 10.1111/1365-2435.12223; Ishihama F, 2007, PLANT SPEC BIOL, V22, P167, DOI 10.1111/j.1442-1984.2007.00189.x; JENNERSTEN O, 1993, OIKOS, V68, P283, DOI 10.2307/3544841; Jha S, 2009, OIKOS, V118, P1174, DOI 10.1111/j.1600-0706.2009.17523.x; Krushelnycky PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088948; Kunin WE, 1997, J ECOL, V85, P225, DOI 10.2307/2960653; LUCAS JR, 1985, ANIM BEHAV, V33, P945, DOI 10.1016/S0003-3472(85)80029-4; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Milberg P, 1997, FLORA, V192, P361; Mitchell RJ, 2004, FUNCT ECOL, V18, P116, DOI 10.1111/j.1365-2435.2004.00812.x; OHARA M, 1994, OECOLOGIA, V98, P25, DOI 10.1007/BF00326086; Ohashi K, 2002, FUNCT ECOL, V16, P492, DOI 10.1046/j.1365-2435.2002.00644.x; Ohashi K, 1998, AM J BOT, V85, P219, DOI 10.2307/2446309; Olsson O, 2006, OIKOS, V112, P260, DOI 10.1111/j.0030-1299.2006.13548.x; PATON DC, 1993, BIOSCIENCE, V43, P95, DOI 10.2307/1311970; PYKE GH, 1978, THEOR POPUL BIOL, V13, P72, DOI 10.1016/0040-5809(78)90036-9; R Core Team, 2021, R LANGUAGE ENV STAT; Ruane LG, 2014, ANN BOT-LONDON, V113, P887, DOI 10.1093/aob/mcu007; Schmid B, 2016, ECOGRAPHY, V39, P619, DOI 10.1111/ecog.01621; SCHMITT J, 1983, OECOLOGIA, V60, P97, DOI 10.1007/BF00379326; SEELEY TD, 1986, BEHAV ECOL SOCIOBIOL, V19, P343, DOI 10.1007/BF00295707; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Stephens David W., 1993, P195; Stoffel MA, METHODS ECO IN PRESS; Thomson JD, 1988, EVOL ECOL, V2, P65, DOI 10.1007/BF02071589; Vaughton G, 1998, OECOLOGIA, V115, P93, DOI 10.1007/s004420050495; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; ZIMMERMAN M, 1980, ECOLOGY, V61, P497, DOI 10.2307/1937414	56	21	21	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187976	10.1371/journal.pone.0187976	http://dx.doi.org/10.1371/journal.pone.0187976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136042	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200053
J	Bakopoulos, A; Kapelouzou, A; Tsilimigras, DI; Katsimpoulas, M; Schizas, D; Aravanis, C; Balafas, E; Mavroidis, M; Pavlakis, K; Machairas, A; Liakakos, T				Bakopoulos, Anargyros; Kapelouzou, Alkistis; Tsilimigras, Diamantis I.; Katsimpoulas, Michalis; Schizas, Dimitrios; Aravanis, Chrysostomos; Balafas, Evaggelos; Mavroidis, Manolis; Pavlakis, Kitty; Machairas, Anastasios; Liakakos, Theodore			Expression of Toll-like receptors (TLRs) in the lungs of an experimental sepsis mouse model	PLOS ONE			English	Article							CECAL LIGATION; MOLECULAR-MECHANISMS; UNITED-STATES; EPIDEMIOLOGY; MORTALITY; PUNCTURE	Background Sepsis is a condition characterized by high mortality rates and often accompanied by multiple-organ dysfunction. During sepsis, respiratory system may be affected and possibly result in acute respiratory distress syndrome (ARDS). Toll-like receptors (TLRs), as a first line defense against invading pathogens, seem to be highly expressed in septic states. Therefore, expression of TLRs in the lungs of a sepsis animal model could indicate the involvement of the respiratory system and appear as a severity index of the clinical course. Materials and methods A total of 72 C57BL/6J mice, aged 12-14 weeks, were studied. The animals were divided into 3 sepsis (S) groups (24h, 48h and 72h) and 3 control (C) groups (24h, 48h and 72h), each consisting of 12 mice. The S-groups were subjected to cecal ligation and puncture (CLP) while the C-groups had a sham operation performed. Blood samples were drawn from all groups. Total blood count analysis was performed along with the measurement of certain biochemical markers. Additionally, lung tissues were harvested and the expression of TLRs, namely TLR 2, TLR 3, TLR 4 and TLR 7 were evaluated by means of immunofluorescence (IF) and qRT-PCR (quantitative-Polymerase Chain Reaction). Statistical analysis was performed by using one-way ANOVA followed by student t-test. Results were considered statistically significant when p<0.05. Results WBCs and lymphocytes were decreased in all S-groups compared to the corresponding C-groups (p<0.05), while RBCs showed a gradual decline in S-groups with the lowest levelsappearing in the S72 group. Only, monocytes were higher in S-groups, especially between S48-C48 (p<0.05) and S72-C72 (p<0.05). Creatinine, IL-10 and IL-6 levels were significantly increased in the S-groups compared to the corresponding C-groups (S24 vs C24, S48 vs C48 and S72 vs C72, p<0.05). IF showed that expression of TLRs 2, 3, 4 and 7 was increased in all S-groups compared to the time-adjusted C-groups (p<0.05). Similarly, qRT-PCR revealed that expression of all TLRs was higher in all S-groups compared to their respective C-groups in both lungs and intestine (p<0.05). Comparing lung and intestinal tissues from S-groups, TLRs 2 and 4 were found increased in the lung at 24, 48 and 72 hours (p<0.05), whereas TLR 3 was higher in the intestine at all time points examined (p<0.05). Finally, TLR 7 levels were significantly higher in the intestinal tissues at 24 hours (p<0.0001), while lungs predominated at 48 hours (p<0.0001). Conclusion TLRs seem to be highly expressed in the lungs of septic mice, therefore suggesting a potential role in the pathogenesis of ARDS during sepsis. While more studies need to be conducted in order to completely understand the underlying mechanisms, TLRs may represent a promising target for establishing novel therapeutic strategies in the treatment of sepsis.	[Bakopoulos, Anargyros; Machairas, Anastasios] Natl & Kapodistrian Univ Athens, Sch Med, Attikon Gen Hosp, Dept Surg 3, Athens, Greece; [Kapelouzou, Alkistis; Katsimpoulas, Michalis; Aravanis, Chrysostomos] Acad Athens, Biomed Res Fdn, Ctr Clin Expt Surg & Translat Res, Athens, Greece; [Tsilimigras, Diamantis I.] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece; [Schizas, Dimitrios; Liakakos, Theodore] Natl & Kapodistrian Univ Athens, Sch Med, Laikon Gen Hosp, Dept Surg 1, Athens, Greece; [Balafas, Evaggelos] Acad Athens, Lab Anim Facil, Biomed Res Fdn, Athens, Greece; [Mavroidis, Manolis] Acad Athens, Biomed Res Fdn, Basic Res, Athens, Greece; [Pavlakis, Kitty] Univ Athens, Sch Med, Dept Pathol, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Academy of Athens; Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens	Kapelouzou, A (corresponding author), Acad Athens, Biomed Res Fdn, Ctr Clin Expt Surg & Translat Res, Athens, Greece.	akapel@bioacademy.gr	Liakakos, Theodore/A-2779-2011; SCHIZAS, DIMITRIOS/Z-3323-2019; Liakakos, Theodore/AAD-7480-2019; Kapelouzou, Alkistis/AAB-5087-2021	Katsimpoulas, Michalis/0000-0001-8083-3878; Kapelouzou, Alkistis/0000-0002-7637-8152; Mavroidis, Manolis/0000-0002-3870-3954; Liakakos, Theodore/0000-0003-2289-6242; Tsilimigras, Diamantis I./0000-0002-3676-9263				[Anonymous], CRIT CARE MED; Balibrea JL, 2003, WORLD J SURG, V27, P1275, DOI 10.1007/s00268-003-7258-3; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Brightbill HD, 2000, IMMUNOLOGY, V101, P1, DOI 10.1046/j.1365-2567.2000.00093.x; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2003, CRIT CARE MED, V31, P946, DOI 10.1097/01.CCM.0000057403.73299.A6; Dickson RP, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.113, 10.1038/NMICROBIOL.2016.113]; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Foley NM, 2015, MILITARY MED RES, V2, pCP10, DOI 10.1186/s40779-014-0029-7; Goyette RE, 2004, SEMIN RESP CRIT CARE, V25, P645, DOI 10.1055/s-2004-860979; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Inger MD, 2016, METHODS MOL BIOL, V1491, P69, DOI 10.1007/978-1-4939-3581-9_6; Knapp S, 2010, WIEN MED WOCHENSCHR, V160, P107, DOI 10.1007/s10354-010-0765-6; Lafferty EI, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-57; Linde-Zwirble WT, 2004, CRIT CARE, V8, P222, DOI 10.1186/cc2917; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Medina E, 2010, METHODS MOL BIOL, V602, P411, DOI 10.1007/978-1-60761-058-8_23; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Singleton KD, 2003, EUR SURG RES, V35, P486, DOI 10.1159/000073387; Slotwinski R, 2011, ARCH IMMUNOL THER EX, V59, P139, DOI 10.1007/s00005-011-0117-2; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; Zanotti-Cavazzoni SL, 2009, CRIT CARE CLIN, V25, P703, DOI 10.1016/j.ccc.2009.08.005	29	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188050	10.1371/journal.pone.0188050	http://dx.doi.org/10.1371/journal.pone.0188050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136027	Green Submitted, Green Published, gold			2022-12-26	WOS:000415121200057
J	Kaky, E; Gilbert, F				Kaky, Emad; Gilbert, Francis			Predicting the distributions of Egypt's medicinal plants and their potential shifts under future climate change	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; LAND-USE CHANGE; PROTECTED AREAS; HABITAT SUITABILITY; RANGE SHIFTS; CONSERVATION; BIODIVERSITY; DIVERSITY; RICHNESS; EXTINCTION	Climate change is one of the most difficult of challenges to conserving biodiversity, especially for countries with few data on the distributions of their taxa. Species distribution modelling is a modern approach to the assessment of the potential effects of climate change on biodiversity, with the great advantage of being robust to small amounts of data. Taking advantage of a recently validated dataset, we use the medicinal plants of Egypt to identify hotspots of diversity now and in the future by predicting the effect of climate change on the pattern of species richness using species distribution modelling. Then we assess how Egypt's current Protected Area network is likely to perform in protecting plants under climate change. The patterns of species richness show that in most cases the A2a 'business as usual' scenario was more harmful than the B2a 'moderate mitigation' scenario. Predicted species richness inside Protected Areas was higher than outside under all scenarios, indicating that Egypt's PAs are well placed to help conserve medicinal plants.	[Kaky, Emad; Gilbert, Francis] Univ Nottingham, Sch Life Sci, Nottingham, England; [Kaky, Emad] Sulaimani Polytech Univ, Kalar Tech Inst, Sulaymaniyah, Iraq	University of Nottingham	Kaky, E (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham, England.; Kaky, E (corresponding author), Sulaimani Polytech Univ, Kalar Tech Inst, Sulaymaniyah, Iraq.	plxedk@nottingham.ac.uk	Kaky, Emad/M-8786-2019; Kaky, Emad Dawood/A-1869-2018	Kaky, Emad/0000-0002-2354-3572; Kaky, Emad Dawood/0000-0002-2354-3572; Gilbert, Francis/0000-0002-2727-4103	Higher Committee for Education Development in Iraq (HCED); Italian Cooperation (Debt Swap)	Higher Committee for Education Development in Iraq (HCED); Italian Cooperation (Debt Swap)	We thank the Higher Committee for Education Development in Iraq (HCED) for funding this work, Italian Cooperation (Debt Swap) for funding the BioMAP Project. BioMap for sharing the data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Italian Cooperation (Debt Swap) for funding the BioMAP Project; Ahmed El-Gabbas, Tim Newbold and Katie Leach for advice; and Ahmed Dhahir Athab for GIS advice. We thank two anonymous referees for their very helpful comments on earlier drafts.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson RP, 2006, SOUTHWEST NAT, V51, P471, DOI 10.1894/0038-4909(2006)51[471:VMPAVT]2.0.CO;2; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Barbet-Massin M, 2014, DIVERS DISTRIB, V20, P1285, DOI 10.1111/ddi.12229; Basuony M. I., 2010, MAMMALS EGYPT ATLAS; Beaumont LJ, 2016, ECOL MODEL, V342, P135, DOI 10.1016/j.ecolmodel.2016.10.004; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Boulos L, 1999, FLORA EGYPT; Bradley BA, 2008, J BIOGEOGR, V35, P1158, DOI 10.1111/j.1365-2699.2008.01928.x; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Carrara R, 2010, ECOGRAPHY, V33, P942, DOI 10.1111/j.1600-0587.2009.05756.x; CBD, 2010, DEC AD C PART CONV B; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chen SL, 2016, CHIN MED-UK, V11, DOI 10.1186/s13020-016-0108-7; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coops NC, 2009, REMOTE SENS ENVIRON, V113, P668, DOI 10.1016/j.rse.2008.11.012; Crimmins SM, 2013, ECOL MODEL, V266, P126, DOI 10.1016/j.ecolmodel.2013.07.006; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; El-Gabbas A, 2016, J ARID ENVIRON, V127, P211, DOI 10.1016/j.jaridenv.2015.12.007; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Fois M, 2016, J NAT CONSERV, V33, P1, DOI 10.1016/j.jnc.2016.06.001; Franklin J, 2009, MAPPING SPECIES DIST; Garcia-Callejas D, 2016, ECOL MODEL, V326, P4, DOI 10.1016/j.ecolmodel.2015.06.002; Gilbert F., 2008, BUTTERFLIES EGYPT AT; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Golicher DJ, 2012, BIOTROPICA, V44, P284, DOI 10.1111/j.1744-7429.2011.00815.x; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Hamann A, 2013, DIVERS DISTRIB, V19, P268, DOI 10.1111/j.1472-4642.2012.00945.x; Hamilton A., 2004, MED PLANTS CONSERVAT; Hannah L, 2011, CLIMATE CHANGE BIOLOGY, P1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huang HW, 2011, BOT J LINN SOC, V166, P282, DOI 10.1111/j.1095-8339.2011.01157.x; Ihlow F, 2012, GLOBAL CHANGE BIOL, V18, P1520, DOI 10.1111/j.1365-2486.2011.02623.x; Jarnevich CS, 2011, BIOL INVASIONS, V13, P153, DOI 10.1007/s10530-010-9798-4; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kaky E, 2016, J ARID ENVIRON, V135, P140, DOI 10.1016/j.jaridenv.2016.09.001; KERSHAW M, 1995, CONSERV BIOL, V9, P324, DOI 10.1046/j.1523-1739.1995.9020324.x; Klein JA, 2008, ECOSYSTEMS, V11, P775, DOI 10.1007/s10021-008-9160-1; Leach K, 2013, BIOL CONSERV, V159, P490, DOI 10.1016/j.biocon.2012.11.025; Lee TM, 2007, ECOL APPL, V17, P1727, DOI 10.1890/06-1256.1; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; Naimi B, 2016, ECOGRAPHY, V39, P368, DOI 10.1111/ecog.01881; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; Newbold T, 2009, J BIOGEOGR, V36, P2085, DOI 10.1111/j.1365-2699.2009.02140.x; Okigbo R. N., 2008, Biotechnology and Molecular Biology Reviews, V3, P127; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pawar S, 2007, BIOL CONSERV, V136, P346, DOI 10.1016/j.biocon.2006.12.012; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearson RG, 2007, SYNTH AM MUS NAT HIS, V50; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Rafieian-Kopae M., 2013, J HERBMED PLARMACOL, V1, P1; Regos A, 2015, J ORNITHOL, V156, pS275, DOI 10.1007/s10336-015-1174-9; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saupe EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017731; Schippmann U, 2002, IMPACT CULTIVATION G; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Soultan AA, 2011, THESIS; Ten Kate K, 1999, COMMERCIAL USE BIODI; Teodoro AC, 2013, PROC SPIE, V8887, DOI 10.1117/12.2028502; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Traba J, 2007, BIODIVERS CONSERV, V16, P3255, DOI 10.1007/s10531-006-9138-2; UNEP-WCMC and IUCN, 2016, PROTECTED PLANET REP; Uprety Y, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-7; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; World Health Organization, 2002, WHO TRADITIONAL MED, P1; Wright AN, 2016, CLIMATIC CHANGE, V134, P579, DOI 10.1007/s10584-015-1552-6; Zhang MG, 2014, DIVERS DISTRIB, V20, P405, DOI 10.1111/ddi.12165	87	18	18	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187714	10.1371/journal.pone.0187714	http://dx.doi.org/10.1371/journal.pone.0187714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136659	Green Published, gold, Green Submitted			2022-12-26	WOS:000415121200029
J	Caljouw, SR; de Vries, R; Withagen, R				Caljouw, Simone R.; de Vries, Rutger; Withagen, Rob			RAAAF's office landscape The End of Sitting: Energy expenditure and temporary comfort when working in non-sitting postures	PLOS ONE			English	Article							SEDENTARY BEHAVIORS; PHYSICAL-ACTIVITY; TIME SPENT; MORTALITY; ADULTS; ASSOCIATIONS; OBESITY; DISEASE; RISK	An earlier study suggested that the activity-inviting office landscape called "The End of Sitting", designed by Rietveld Architecture Art Affordances (RAAAF), should be considered as an alternative working environment to prevent sedentary behavior. The End of Sitting lacks chairs and tables but consists instead of a myriad of sloped surfaces at different heights that afford workers to stand, lean or recline at different locations. In this study, we assessed the impact of four of its workspaces on physical intensity, temporary comfort and productivity of office work and compared the outcomes with sitting and standing behind a desk. Twenty-four participants worked for 10 minutes in each of the six test conditions. Energy expenditure, measured by indirect calorimetry, and heart rate were recorded. Questionnaires were used to assess the perceived comfort. The number of words found in the word search test was counted as a measure of productivity. The majority of The End of Sitting workspaces led to a significant increase in energy expenditure compared with sitting behind a desk (ps < .05). Average MET values ranged from 1.40 to 1.58 which is a modest rise in energy expenditure compared to sitting (1.32 METs) and not significantly different from standing (1.47 METs). The scores on the general comfort scale indicated that some workspaces were less comfortable than sitting (ps < .05), but the vast majority of participants reported that at least one of The End of Sitting workspaces was equally or more comfortable than sitting. No differences in productivity between the test conditions were found. Further long-term studies are required to assess the behavioral adaptations, productivity and the level of comfort when using The End of Sitting as a permanent office.	[Caljouw, Simone R.; de Vries, Rutger; Withagen, Rob] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, A Deusinglaan 1, Groningen, Netherlands	University of Groningen	Caljouw, SR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, A Deusinglaan 1, Groningen, Netherlands.	s.r.caljouw@umcg.nl		Caljouw, Simone R./0000-0002-3004-9900				Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bennie JA, 2015, AUST NZ J PUBL HEAL, V39, P237, DOI 10.1111/1753-6405.12293; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Botter J, 2016, ERGONOMICS, V59, P449, DOI 10.1080/00140139.2015.1080861; Buckley JP, 2014, OCCUP ENVIRON MED, V71, P109, DOI 10.1136/oemed-2013-101823; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Corlett E.Nigel., 1990, EVALUATION HUMAN WOR, P542; GARBY L, 1987, ACTA PHYSIOL SCAND, V129, P443, DOI 10.1111/j.1365-201X.1987.tb10613.x; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Howe CCF, 2014, J SPORT SCI, V32, P157, DOI 10.1080/02640414.2013.812231; Kazi A, 2014, OCCUP MED-OXFORD, V64, P497, DOI 10.1093/occmed/kqu099; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Reiff C, 2012, J PHYS ACT HEALTH, V9, P1009, DOI 10.1123/jpah.9.7.1009; Rietveld E., 2015, HARV DES MAG, V40, P180; Rietveld E., 2016, SPORT MED, P1; SHACKEL B, 1969, ERGONOMICS, V12, P269, DOI 10.1080/00140136908931053; Shrestha Nipun, 2016, Cochrane Database Syst Rev, V3, pCD010912, DOI 10.1002/14651858.CD010912.pub3; Torbeyns T, 2014, SPORTS MED, V44, P1261, DOI 10.1007/s40279-014-0202-x; Tudor-Locke C, 2014, INT J OBESITY, V38, P755, DOI 10.1038/ijo.2013.223; Tudor-Locke C, 2011, J OCCUP ENVIRON MED, V53, P1382, DOI 10.1097/JOM.0b013e31823c1402; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Wallmann-Sperlich B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1259; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Withagen R, 2016, SPORTS MED, V46, P1019, DOI 10.1007/s40279-015-0448-y	28	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187529	10.1371/journal.pone.0187529	http://dx.doi.org/10.1371/journal.pone.0187529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125854	Green Submitted, Green Published, gold			2022-12-26	WOS:000414866000017
J	Langote, A; Hiremath, S; Ruzicka, M; McCormick, BB				Langote, Amit; Hiremath, Swapnil; Ruzicka, Marcel; McCormick, Brendan B.			Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients	PLOS ONE			English	Article							ANGIOTENSIN-ALDOSTERONE SYSTEM; LOW-DOSE SPIRONOLACTONE; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; SERUM POTASSIUM; BLOOD-PRESSURE; DOUBLE-BLIND; MORTALITY; EFFICACY; SAFETY	Background Hypokalemia is common in peritoneal dialysis (PD) patients and is associated with increased cardiovascular and all-cause mortality. The management approach for such patients routinely includes spironolactone at our centre. We undertook this study to assess the efficacy of spironolactone for the treatment of hypokalemia in PD patients. Methods Retrospective chart review of PD patients at a single centre. Serum potassium was compared prior to initiation of spironolactone and two months afterwards. Indication for spironolactone and changes in blood pressure (BP), weight, and serum creatinine were also recorded. Results The chart review identified 53 patients who fit our selection criteria. The mean age was 64 +/- 15 years and the majority was treated with continuous cyclic peritoneal dialysis. Serum potassium rose from 3.7 +/- 0.5 to 4.2+/- 0.5 mmol/L (P<0.0001) after 2 months with a mean dose of spironolactone of 28.5 +/- 15.2 mg (median dose 25 mg). A significant reduction in systolic BP was observed from 150+/- 18 to 137 +/-24 (P = 0.002); a non-significant reduction in diastolic BP was also observed. The rise in potassium was constant in the range of 0.4 to 0.5 mmol/L regardless of whether spironolactone was initiated for hypokalemia, diuresis, or as an antihypertensive. There was no change in serum creatinine or body weight two months after introduction of spironolactone. Conclusions Spironolactone is safe and effective in treating hypokalemia in PD patients. It is also an effective antihypertensive agent and merits further study in the PD population.	[Langote, Amit] Apollo Hosp Enterprise Ltd, Div Nephrol, Dept Med, Bombay, Maharashtra, India; [Hiremath, Swapnil; Ruzicka, Marcel; McCormick, Brendan B.] Ottawa Hosp, Div Nephrol, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute	McCormick, BB (corresponding author), Ottawa Hosp, Div Nephrol, Dept Med, Ottawa, ON, Canada.	bmccormick@ottawahospital.on.ca	Hiremath, Swapnil/H-3492-2019	Hiremath, Swapnil/0000-0003-0010-3416				Bergstrom J, 1983, Kidney Int Suppl, V16, pS153; BLUMENKRANTZ MJ, 1982, KIDNEY INT, V21, P849, DOI 10.1038/ki.1982.109; Chuang YW, 2009, NEPHROL DIAL TRANSPL, V24, P1603, DOI 10.1093/ndt/gfn709; Dolson GM, 1997, INT J ARTIF ORGANS, V20, P134, DOI 10.1177/039139889702000302; Fulop T, 2017, PERITON DIALYSIS INT, V37, P63, DOI 10.3747/pdi.2016.00022; Gao HB, 1999, AM J NEPHROL, V19, P7, DOI 10.1159/000013418; Gross E, 2005, AM J KIDNEY DIS, V46, P94, DOI 10.1053/j.ajkd.2005.03.005; GUERRANT RL, 1972, GUT, V13, P197, DOI 10.1136/gut.13.3.197; Ito Y, 2014, J AM SOC NEPHROL, V25, P1094, DOI 10.1681/ASN.2013030273; Khan AN, 1996, PERITON DIALYSIS INT, V16, P652; Kwok JS-S, HONG KONG J NEPHROLO, V9, p36 ; Lin CT, 2016, J CLIN HYPERTENS, V18, P121, DOI 10.1111/jch.12628; Mathialahan T, 2005, J PATHOL, V206, P46, DOI 10.1002/path.1750; Matsumoto Y, 2014, J AM COLL CARDIOL, V63, P529, DOI 10.1016/j.jacc.2013.09.056; Matsumoto Y, 2009, CARDIOLOGY, V114, P32, DOI 10.1159/000210553; OREOPOULOS DG, 1982, NEPHRON, V30, P293, DOI 10.1159/000182504; Preston RA, 2009, HYPERTENSION, V53, P754, DOI 10.1161/HYPERTENSIONAHA.108.125252; Quach K, 2016, AM J KIDNEY DIS, V68, P591, DOI 10.1053/j.ajkd.2016.04.011; SANDLE GI, 1987, CLIN SCI, V73, P247, DOI 10.1042/cs0730247; Shavit L, 2011, CLIN NEPHROL, V76, P388, DOI 10.5414/CN106973; SPITAL A, 1985, AM J KIDNEY DIS, V6, P173, DOI 10.1016/S0272-6386(85)80022-6; Szeto CC, 2005, AM J KIDNEY DIS, V46, P128, DOI 10.1053/j.ajkd.2005.03.015; Taheri S, 2012, SAUDI J KIDNEY DIS T, V23, P507; Torlen K, 2012, CLIN J AM SOC NEPHRO, V7, P1272, DOI 10.2215/CJN.00960112; Tziviskou Effie, 2003, International Urology and Nephrology, V35, P429, DOI 10.1023/B:UROL.0000022867.93739.03; Unwin RJ, 2011, NAT REV NEPHROL, V7, P75, DOI 10.1038/nrneph.2010.175; Yongsiri S, 2015, THER APHER DIAL, V19, P81, DOI 10.1111/1744-9987.12219	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187269	10.1371/journal.pone.0187269	http://dx.doi.org/10.1371/journal.pone.0187269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	29125879	Green Published, Green Submitted, gold			2022-12-26	WOS:000414866000009
J	van Leeuwen, PM; de Groot, S; Happee, R; de Winter, JCF				van Leeuwen, Peter M.; de Groot, Stefan; Happee, Riender; de Winter, Joost C. F.			Differences between racing and non-racing drivers: A simulator study using eye-tracking	PLOS ONE			English	Article							VISUAL-SEARCH; EXPERIENCED DRIVERS; EXPERT PERFORMANCE; DRIVING SIMULATOR; GAZE BEHAVIOR; OPTICAL-FLOW; MOTOR SPORTS; MODEL; ANTICIPATION; ACQUISITION	Motorsport has developed into a professional international competition. However, limited research is available on the perceptual and cognitive skills of racing drivers. By means of a racing simulator, we compared the driving performance of seven racing drivers with ten non-racing drivers. Participants were tasked to drive the fastest possible lap time. Additionally, both groups completed a choice reaction time task and a tracking task. Results from the simulator showed faster lap times, higher steering activity, and a more optimal racing line for the racing drivers than for the non-racing drivers. The non-racing drivers' gaze behavior corresponded to the tangent point model, whereas racing drivers showed a more variable gaze behavior combined with larger head rotations while cornering. Results from the choice reaction time task and tracking task showed no statistically significant difference between the two groups. Our results are consistent with the current consensus in sports sciences in that task-specific differences exist between experts and novices while there are no major differences in general cognitive and motor abilities.	[van Leeuwen, Peter M.; de Groot, Stefan; Happee, Riender; de Winter, Joost C. F.] Delft Univ Technol, Dept Biomech Engn, Fac Mech Maritime & Mat Engn, Mekelweg 2, Delft, Netherlands	Delft University of Technology	van Leeuwen, PM (corresponding author), Delft Univ Technol, Dept Biomech Engn, Fac Mech Maritime & Mat Engn, Mekelweg 2, Delft, Netherlands.	P.M.vanLeeuwen@TUDelft.nl	Happee, Riender/A-2621-2011	Happee, Riender/0000-0001-5878-3472	Dutch Ministry of Economic affairs [HTASI09004-DrivObs, RAAK PRO 3-08 ADVICE]; Dutch Technology Foundation (STW), applied science division of the Netherlands Organisation for Scientific Research (NWO)	Dutch Ministry of Economic affairs(Ministry of Economic Affairs, Netherlands); Dutch Technology Foundation (STW), applied science division of the Netherlands Organisation for Scientific Research (NWO)	The research was supported by the Dutch Ministry of Economic affairs through the projects "Driver Observation in Car Simulators" (HTASI09004-DrivObs), "Advanced Driver Vehicle Interface in a Complex Environment" (RAAK PRO 3-08 & ADVICE) and by the Dutch Technology Foundation (STW), applied science division of the Netherlands Organisation for Scientific Research (NWO) contributing to the employment of the first author at TU Delft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1990, PERCEPTION, V19, P63, DOI 10.1068/p190063; Abernethy B, 1992, ASSESSMENT EFFECTIVE; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Aversa P, 2015, IND CORP CHANGE, V24, P655, DOI 10.1093/icc/dtv012; Backman J, 2005, J STRENGTH COND RES, V19, P777; Baldisserri L, 2014, MOTORSPORT DRIVER WO, P56; Baur H, 2006, BRIT J SPORT MED, V40, P906, DOI 10.1136/bjsm.2006.025783; Bell A, 2016, J QUANT ANAL SPORTS, V12, P99, DOI 10.1515/jqas-2015-0050; Bernabo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071192; Bernardi G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00888; Braghin F, 2008, COMPUT STRUCT, V86, P1503, DOI 10.1016/j.compstruc.2007.04.028; Brayshaw DL, 2005, P I MECH ENG D-J AUT, V219, P725, DOI 10.1243/095440705X11211; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Crundall DE, 1998, ERGONOMICS, V41, P448, DOI 10.1080/001401398186937; De Groot S, 2009, P DSC 2009 MON; de Winter JCF, 2012, J SPORT SCI, V30, P1747, DOI 10.1080/02640414.2012.713978; De Winter JCF, 2009, P 37 ANN C EUR SOC E; Deary IJ, 2011, BEHAV RES METHODS, V43, P258, DOI 10.3758/s13428-010-0024-1; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Falkmer T, 2005, OPTOMETRY VISION SCI, V82, P732, DOI 10.1097/01.opx.0000175560.45715.5b; Filho E, 2015, J SPORT SCI, V33, P945, DOI 10.1080/02640414.2014.977940; Gegenfurtner A, 2011, EDUC PSYCHOL REV, V23, P523, DOI 10.1007/s10648-011-9174-7; Gordon S, 1975, DOTHS801758; HART S G, 1988, P139; Klarica AJ, 2001, BRIT J SPORT MED, V35, P290, DOI 10.1136/bjsm.35.5.290; Land MF, 2001, CURR BIOL, V11, P1215, DOI 10.1016/S0960-9822(01)00351-7; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Lappi O, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00635; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Memmert D, 2009, PSYCHOL SPORT EXERC, V10, P146, DOI 10.1016/j.psychsport.2008.06.002; METZ D, 1989, AUTOMATICA, V25, P841, DOI 10.1016/0005-1098(89)90052-6; Michon J. A., 1985, HUMAN BEHAV TRAFFIC, P485, DOI DOI 10.1007/978-1-4613-2173-6_19; MILLIKEN W, 1995, RACE CAR VEHICLE DYN; MOURANT RR, 1972, HUM FACTORS, V14, P325, DOI 10.1177/001872087201400405; Owen N, 2015, PROCEDIA ENGINEER, V112, P344, DOI 10.1016/j.proeng.2015.07.260; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Potkanowicz ES, 2013, SPORTS MED, V43, P565, DOI 10.1007/s40279-013-0040-2; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Rendon-Velez E, 2016, TRANSPORT RES F-TRAF, V41, P150, DOI 10.1016/j.trf.2016.06.013; Reymond G, 2001, HUM FACTORS, V43, P483, DOI 10.1518/001872001775898188; Rodrigues ST, 2002, J SPORT SCI, V20, P187, DOI 10.1080/026404102317284754; Salvucci DD, 2004, PERCEPTION, V33, P1233, DOI 10.1068/p5343; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; Sharp RS, 2009, VEHICLE SYST DYN, V47, P613, DOI 10.1080/00423110802331567; Summala H, 1996, HUM FACTORS, V38, P442, DOI 10.1518/001872096778701944; Theodosis P. A., 2011, ASME 2011 DYN SYST C, P853; Underwood G, 2002, ERGONOMICS, V45, P1, DOI 10.1080/00140130110110610; van Leeuwen PM, 2015, PROCEDIA MANUF, V3, P3325, DOI 10.1016/j.promfg.2015.07.422; van Leeuwen PM, 2014, TRANSPORT RES F-TRAF, V24, P169, DOI 10.1016/j.trf.2014.04.010; van Leeuwen PM, 2015, ERGONOMICS, V58, P1347, DOI 10.1080/00140139.2015.1005172; Wann JP, 2000, NAT NEUROSCI, V3, P647, DOI 10.1038/76602; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1991, J EXP PSYCHOL HUMAN, V17, P28, DOI 10.1037/0096-1523.17.1.28; Wilkie RM, 2003, J VISION, V3, P677, DOI 10.1167/3.11.3	56	29	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2017	12	11							e0186871	10.1371/journal.pone.0186871	http://dx.doi.org/10.1371/journal.pone.0186871			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM1VI	29121090	gold, Green Submitted, Green Published			2022-12-26	WOS:000414769900014
J	Jung, ES; Park, HM; Hyun, SM; Shon, JC; Singh, D; Liu, KH; Whon, TW; Bae, JW; Hwang, JS; Lee, CH				Jung, Eun Sung; Park, Hye Min; Hyun, Seung Min; Shon, Jong Cheol; Singh, Digar; Liu, Kwang-Hyeon; Whon, Tae Woong; Bae, Jin-Woo; Hwang, Jae Sung; Lee, Choong Hwan			The green tea modulates large intestinal microbiome and exo/endogenous metabolome altered through chronic UVB-exposure	PLOS ONE			English	Article							GUT MICROBIOTA; BILE-ACID; HAIRLESS MICE; SKIN; HEALTH; RATS; IDENTIFICATION; DISEASE; DIET; TRANSPORTER	The attenuating effects of green tea supplements (GTS) against the ultraviolet (UV) radiation induced skin damages are distinguished. However, the concomitant effects of GTS on the large intestinal microbiomes and associated metabolomes are largely unclear. Herein, we performed an integrated microbiome-metabolome analysis to uncover the esoteric links between gut microbiome and exo/endogenous metabolome maneuvered in the large intestine of UVB-exposed mice subjected to dietary GTS. In UVB-exposed mice groups (UVB), class Bacilli and order Bifidobacteriales were observed as discriminant taxa with decreased lysophospholipid levels compared to the unexposed mice groups subjected to normal diet (NOR). Conversely, in GTS fed UVB-exposed mice (U+GTS), the gut-microbiome diversity was greatly enhanced with enrichment in the classes, Clostridia and Erysipelotrichia, as well as genera, Allobaculum and Lachnoclostridium. Additionally, the gut endogenous metabolomes changed with an increase in amino acids, fatty acids, lipids, and bile acids contents coupled with a decrease in nucleobases and carbohydrate levels. The altered metabolomes exhibited high correlations with GTS enriched intestinal microflora. Intriguingly, the various conjugates of green tea catechins viz., sulfated, glucuronided, and methylated ones including their exogenous derivatives were detected from large intestinal contents and liver samples. Hence, we conjecture that the metabolic conversions for the molecular components in GTS strongly influenced the gut micro-environment in UVB-exposed mice groups, ergo modulate their gut-microbiome as well as exo/endogenous metabolomes.	[Jung, Eun Sung; Park, Hye Min; Singh, Digar; Lee, Choong Hwan] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Hyun, Seung Min; Hwang, Jae Sung] Kyung Hee Univ, Dept Genet Engn, Yongin, South Korea; [Hyun, Seung Min; Hwang, Jae Sung] Kyung Hee Univ, Grad Sch Biotechnol, Yongin, South Korea; [Shon, Jong Cheol; Liu, Kwang-Hyeon] Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea; [Shon, Jong Cheol; Liu, Kwang-Hyeon] Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea; [Whon, Tae Woong; Bae, Jin-Woo] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea; [Whon, Tae Woong; Bae, Jin-Woo] Kyung Hee Univ, Dept Biol, Seoul, South Korea	Konkuk University; Kyung Hee University; Kyung Hee University; Kyungpook National University; Kyungpook National University; Kyung Hee University; Kyung Hee University	Lee, CH (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.; Hwang, JS (corresponding author), Kyung Hee Univ, Dept Genet Engn, Yongin, South Korea.; Hwang, JS (corresponding author), Kyung Hee Univ, Grad Sch Biotechnol, Yongin, South Korea.	jshwang@khu.ac.kr; chlee123@konkuk.ac.kr	Bae, Jin-Woo/S-1955-2017	Shon, Jong Cheol/0000-0002-1994-9465	Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [916005-2]; Bio & Medical Technology Development Program of the National Research Foundation - Korean government, MSIP [2016M3A9A5923160]	Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Bio & Medical Technology Development Program of the National Research Foundation - Korean government, MSIP	This study was funded by the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea (as part of the (multi-ministerial) Genome Technology to Business Translation Program) (Grant No.: 916005-2) to CHL, and by the Bio & Medical Technology Development Program of the National Research Foundation funded by the Korean government, MSIP (2016M3A9A5923160) to CHL.	Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058; Annaba F, 2010, AM J PHYSIOL-GASTR L, V298, pG467, DOI 10.1152/ajpgi.00360.2009; Ashraf R, 2014, CRIT REV FOOD SCI, V54, P938, DOI 10.1080/10408398.2011.619671; Basu-Modak S, 2003, FREE RADICAL BIO MED, V35, P910, DOI 10.1016/S0891-5849(03)00436-2; Brown EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8806; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Chen Wendy W, 2012, Drug Metab Lett, V6, P73; Clydesdale GJ, 2001, IMMUNOL CELL BIOL, V79, P547, DOI 10.1046/j.1440-1711.2001.01047.x; Cueva C, 2010, RES MICROBIOL, V161, P372, DOI 10.1016/j.resmic.2010.04.006; Devaraj S, 2013, CLIN CHEM, V59, P617, DOI 10.1373/clinchem.2012.187617; Donovan JL, 2001, J NUTR, V131, P1753, DOI 10.1093/jn/131.6.1753; Henning SM, 2008, J NUTR, V138, P1529; Hiramoto K, 2009, ARCH DERMATOL RES, V301, P239, DOI 10.1007/s00403-008-0926-2; Hong KB, 2015, INT J FOOD SCI NUTR, V66, P923, DOI 10.3109/09637486.2015.1088823; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Jones ML, 2014, EXPERT OPIN BIOL TH, V14, P467, DOI 10.1517/14712598.2014.880420; Jung ES, 2015, METABOLOMICS, V11, P861, DOI 10.1007/s11306-014-0743-x; Karlsson PC, 2005, J NUTR, V135, P2343; Kimoto-Nira H, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.22; Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832; Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; Lee JS, 2005, RAPID COMMUN MASS SP, V19, P3539, DOI 10.1002/rcm.2230; Liang J, 2014, BIOMED CHROMATOGR, V28, P401, DOI 10.1002/bmc.3034; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Park H., 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113811; Priebe MG, 2002, EUR J NUTR, V41, p1/2; Rebel H, 2015, INT J CANCER, V136, P271, DOI 10.1002/ijc.29002; Satoh T, 2015, BENEF MICROBES, V6, P497, DOI 10.3920/BM2014.0134; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shah NP, 2007, INT DAIRY J, V17, P1262, DOI 10.1016/j.idairyj.2007.01.014; Suh DH, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600895; Svobodova AR, 2011, BIOL PHARM BULL, V34, P471; Trauner M, 2010, DIGEST DIS, V28, P220, DOI 10.1159/000282091; Turnbaugh PJ, 2008, CELL, V134, P708, DOI 10.1016/j.cell.2008.08.025; WHO (World Health Organization), 2002, GLOB SOL UV IND PRAC; Ye T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119543; Zhang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep14405; Zou LL, 2014, ANAL METHODS-UK, V6, P4312, DOI 10.1039/c4ay00219a	45	18	18	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0187154	10.1371/journal.pone.0187154	http://dx.doi.org/10.1371/journal.pone.0187154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117187	Green Published, Green Submitted, gold			2022-12-26	WOS:000414659600025
J	Newton, EJ; Patterson, BR; Anderson, ML; Rodgers, AR; Vander Vennen, LM; Fryxell, JM				Newton, Erica J.; Patterson, Brent R.; Anderson, Morgan L.; Rodgers, Arthur R.; Vander Vennen, Lucas M.; Fryxell, John M.			Compensatory selection for roads over natural linear features by wolves in northern Ontario: Implications for caribou conservation	PLOS ONE			English	Article							RANGIFER-TARANDUS-CARIBOU; WHITE-TAILED DEER; RESOURCE SELECTION; HABITAT SELECTION; WOODLAND CARIBOU; CANIS-LUPUS; PREDATION; MOOSE; RESPONSES; MOVEMENT	Woodland caribou (Rangifertarandus caribou) in Ontario are a threatened species that have experienced a substantial retraction of their historic range. Part of their decline has been attributed to increasing densities of anthropogenic linear features such as trails, roads, railways, and hydro lines. These features have been shown to increase the search efficiency and kill rate of wolves. However, it is unclear whether selection for anthropogenic linear features is additive or compensatory to selection for natural (water) linear features which may also be used for travel. We studied the selection of water and anthropogenic linear features by 52 resident wolves (Canis lupusx lycaon) over four years across three study areas in northern Ontario that varied in degrees of forestry activity and human disturbance. We used Euclidean distance -based resource selection functions (mixed -effects logistic regression) at the seasonal range scale with random coefficients for distance to water linear features, primary/secondary roads/railways, and hydro lines, and tertiary roads to estimate the strength of selection for each linear feature and for several habitat types, while accounting for availability of each feature. Next, we investigated the trade-off between selection for anthropogenic and water linear features. Wolves selected both anthropogenic and water linear features; selection for anthropogenic features was stronger than for water during the rendezvous season. Selection for anthropogenic linear features increased with increasing density of these features on the landscape, while selection for natural linear features declined, indicating compensatory selection of anthropogenic linear features. These results have implications for woodland caribou conservation. Prey encounter rates between wolves and caribou seem to be strongly influenced by increasing linear feature densities. This behavioral mechanism a compensatory functional response to anthropogenic linear feature density resulting in decreased use of natural travel corridors has negative consequences for the viability of woodland caribou.	[Newton, Erica J.; Patterson, Brent R.] Trent Univ, Ontario Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, DNA Bldg, Peterborough, ON, Canada; [Anderson, Morgan L.; Fryxell, John M.] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada; [Rodgers, Arthur R.] Ontario Minist Nat Resources & Forestry, Ctr Northern Forest Ecosyst Res, Thunder Bay, ON, Canada; [Vander Vennen, Lucas M.] Alberta Environm & Parks, Peace River, AB, Canada	Ministry of Natural Resources & Forestry; Trent University; University of Guelph; Ministry of Natural Resources & Forestry	Newton, EJ (corresponding author), Trent Univ, Ontario Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, DNA Bldg, Peterborough, ON, Canada.	erica.newton@ontario.ca		Newton, Erica/0000-0002-6532-9478	Forest Ecosystem Science Co-operative Inc.; Natural Sciences and Engineering Research Council of Canada Collaborative Research and Development Grants program [CRDPJ 394902 - 09]; Canadian Forest Service; Wildlife Research and Monitoring Section; Centre for Northern Forest Ecosystem Research of the Ontario Ministry of Natural Resources and Forestry	Forest Ecosystem Science Co-operative Inc.; Natural Sciences and Engineering Research Council of Canada Collaborative Research and Development Grants program; Canadian Forest Service(Natural Resources CanadaCanadian Forest Service); Wildlife Research and Monitoring Section; Centre for Northern Forest Ecosystem Research of the Ontario Ministry of Natural Resources and Forestry	Financial support was provided by the Forest Ecosystem Science Co-operative Inc., Natural Sciences and Engineering Research Council of Canada Collaborative Research and Development Grants program (CRDPJ 394902 - 09), Canadian Forest Service, and the Wildlife Research and Monitoring Section and the Centre for Northern Forest Ecosystem Research of the Ontario Ministry of Natural Resources and Forestry. Several of the primary investigators involved in this study worked for organizations providing funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basille M, 2013, ECOGRAPHY, V36, P220, DOI 10.1111/j.1600-0587.2011.07367.x; Bastille-Rousseau G, 2011, ECOGRAPHY, V34, P588, DOI 10.1111/j.1600-0587.2010.06517.x; Benson JF, 2015, WILDLIFE SOC B, V39, P31, DOI 10.1002/wsb.506; Benson JF, 2015, BIOL CONSERV, V182, P223, DOI 10.1016/j.biocon.2014.12.010; Benson JF, 2014, ECOLOGY, V95, P254, DOI 10.1890/13-0698.1; Boisjoly D, 2010, J WILDLIFE MANAGE, V74, P3, DOI 10.2193/2008-149; Bolger DT, 2008, ECOL LETT, V11, P63; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Browne CL, 2007, BIOL CONSERV, V138, P421, DOI 10.1016/j.biocon.2007.05.008; BURGER LD, 1994, J WILDLIFE MANAGE, V58, P249, DOI 10.2307/3809387; Committee on the Status of Endangered Wildlife in Canada, 2014, COSEWIC ASS STAT REP; Conner L. Mike, 2001, P275, DOI 10.1016/B978-012497781-5/50011-6; Conner LM, 2003, ECOLOGY, V84, P526, DOI 10.1890/0012-9658(2003)084[0526:ACODBA]2.0.CO;2; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Courbin N, 2014, ECOL MONOGR, V84, P265, DOI 10.1890/12-2118.1; Courtois Rehaume, 2002, Alces, V38, P177; Crins WJ., 2009, TR01 SIB TER IMA; DeCesare NJ, 2012, ECOL APPL, V22, P1068, DOI 10.1890/11-1610.1; Dickie M, 2017, J APPL ECOL, V54, P253, DOI 10.1111/1365-2664.12732; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Droghini A, 2017, CAN J ZOOL IN PRESS; Environment Canada, 2012, SPECIES RISK ACT REC, DOI [10.2307/3796292, DOI 10.2307/3796292]; Environment Canada, 2011, SCI ASS INF ID CRIT; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Fisher JT, 2005, MAMMAL REV, V35, P51, DOI 10.1111/j.1365-2907.2005.00053.x; Fondell TF, 2008, J WILDLIFE MANAGE, V72, P1614, DOI 10.2193/2007-480; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Fortin M, 2013, CAN J FOREST RES, V43, P129, DOI 10.1139/cjfr-2012-0268; Found R, 2017, CAN FIELD N IN PRESS; Fritts S. H., 1981, WILDLIFE MONOGR, V80, P79, DOI DOI 10.2307/3830611; FULLER TK, 1989, WILDLIFE MONOGR, P1; FULLER TK, 1991, CAN J ZOOL, V69, P821, DOI 10.1139/z91-123; Gelman A., 2007, DATA ANAL USING REGR; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; GESE EM, 1991, CAN J ZOOL, V69, P2946, DOI 10.1139/z91-415; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Hervieux D, 2014, CAN J ZOOL, V92, P1029, DOI 10.1139/cjz-2014-0142; Hjartarson J, 2014, BENEATH SURFACE UNCO; Hogg AR, 2014, FAR N LAND COVER VER; Holloway J, 2009, THESIS; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Hornseth ML, 2016, CAN J ZOOL, V94, P79, DOI 10.1139/cjz-2015-0101; Houle M, 2010, LANDSCAPE ECOL, V25, P419, DOI 10.1007/s10980-009-9420-2; HUGGARD DJ, 1993, J WILDLIFE MANAGE, V57, P382, DOI 10.2307/3809437; James ARC, 2000, J WILDLIFE MANAGE, V64, P154, DOI 10.2307/3802985; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kie J.G., 2013, ANIM BIOTELEM, V1, P13, DOI [10.1186/2050-3385-1-13, DOI 10.1186/2050-3385-1-13]; Kittle AM, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1783; Kittle AM, 2015, J ANIM ECOL, V84, P1177, DOI 10.1111/1365-2656.12366; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Kuznetsova A., 2015, LMER TEST TESTS LINE; Laforge MP, 2016, LANDSCAPE ECOL, V31, P855, DOI 10.1007/s10980-015-0298-x; Latham ADM, 2013, ECOGRAPHY, V36, P1276, DOI 10.1111/j.1600-0587.2013.00035.x; Latham ADM, 2011, ECOL APPL, V21, P2854, DOI 10.1890/11-0666.1; Latham ADM, 2011, J WILDLIFE MANAGE, V75, P204, DOI 10.1002/jwmg.28; Latham ADM, 2009, THESIS; LAVER P. N., 2005, ABODE KERNEL HOME RA; Leblond M, 2016, J APPL ECOL, V53, P1078, DOI 10.1111/1365-2664.12658; Leblond M, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0079-4; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; Lesmerises F, 2012, FOREST ECOL MANAG, V276, P125, DOI 10.1016/j.foreco.2012.03.025; MacNulty DR, 2007, J MAMMAL, V88, P595, DOI 10.1644/06-MAMM-A-119R1.1; Maier JAK, 2005, CAN J FOREST RES, V35, P2233, DOI 10.1139/X05-123; Manly B.F.J., 2002, RESOURCE SELECTION A; McGreer MT, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00174.1; McKenzie HW, 2012, INTERFACE FOCUS, V2, P205, DOI 10.1098/rsfs.2011.0086; McLoughlin PD, 2003, J WILDLIFE MANAGE, V67, P755, DOI 10.2307/3802682; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; Mech L. David, 2003, P1; MESSIER F, 1985, CAN J ZOOL, V63, P1068, DOI 10.1139/z85-160; Metz MC, 2012, J ANIM ECOL, V81, P553, DOI 10.1111/j.1365-2656.2011.01945.x; Moffatt S., 2012, THESIS; Moreau G, 2012, J APPL ECOL, V49, P611, DOI 10.1111/j.1365-2664.2012.02134.x; Musiani M, 1998, ACTA THERIOL, V43, P409, DOI 10.4098/AT.arch.98-51; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Obbard ME, 2010, CAN J ZOOL, V88, P1063, DOI 10.1139/Z10-072; Ontario Ministry of Natural Resources, 2005, STRAT WOLF CONS ONT; Ontario Ministry of Natural Resources (OMNR), 2013, FAR N LAND COV DAT S; PETERSON RO, 1984, SCIENCE, V224, P1350, DOI 10.1126/science.224.4655.1350; POTVIN F, 1988, CAN J ZOOL, V66, P1266, DOI 10.1139/z88-185; R Core Team, 2014, R LANG ENV STAT COMP; Rempel RS, 1997, J WILDLIFE MANAGE, V61, P517, DOI 10.2307/3802610; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; Schneider MF, 2001, J APPL ECOL, V38, P720, DOI 10.1046/j.1365-2664.2001.00642.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Serrouya R, 2015, AM NAT, V185, P665, DOI 10.1086/680510; Serrouya R, 2011, J APPL ECOL, V48, P935, DOI 10.1111/j.1365-2664.2011.01998.x; Street GM, 2015, CAN J ZOOL, V93, P813, DOI 10.1139/cjz-2015-0005; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; Tsunoda H, 2009, J ETHOL, V27, P185, DOI 10.1007/s10164-008-0106-z; Vennen LMV, 2016, FUNCT ECOL, V30, P1568, DOI 10.1111/1365-2435.12642; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Whittington J, 2011, J APPL ECOL, V48, P1535, DOI 10.1111/j.1365-2664.2011.02043.x; Wittmer HU, 2007, J ANIM ECOL, V76, P568, DOI 10.1111/j.1365-2656.2007.01220.x; Zimmermann B, 2014, BEHAV ECOL, V25, P1353, DOI 10.1093/beheco/aru134; Zuur A. F., 2009, STAT BIOL HEAL	100	21	21	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2017	12	11							e0186525	10.1371/journal.pone.0186525	http://dx.doi.org/10.1371/journal.pone.0186525			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM0ME	29117234	gold, Green Published, Green Submitted			2022-12-26	WOS:000414659600009
J	Cagle, LA; Franzi, LM; Linderholm, AL; Last, JA; Adams, JY; Harper, RW; Kenyon, NJ				Cagle, Laura A.; Franzi, Lisa M.; Linderholm, Angela L.; Last, Jerold A.; Adams, Jason Y.; Harper, Richart W.; Kenyon, Nicholas J.			Effects of positive end-expiratory pressure and recruitment maneuvers in a ventilator-induced injury mouse model	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; TIDAL-VOLUME VENTILATION; RANDOMIZED CONTROLLED-TRIAL; INDIVIDUAL PATIENT DATA; MECHANICAL VENTILATION; PULMONARY COMPLICATIONS; DEEP INFLATION; PEEP LEVELS; CYTOKINES	Background Positive-pressure mechanical ventilation is an essential therapeutic intervention, yet it causes the clinical syndrome known as ventilator-induced lung injury. Various lung protective mechanical ventilation strategies have attempted to reduce or prevent ventilator-induced lung injury but few modalities have proven effective. A model that isolates the contribution of mechanical ventilation on the development of acute lung injury is needed to better understand biologic mechanisms that lead to ventilator-induced lung injury. Objectives To evaluate the effects of positive end-expiratory pressure and recruitment maneuvers in reducing lung injury in a ventilator-induced lung injury murine model in short-and longer-term ventilation. Methods 5-12 week-old female BALB/c mice (n = 85) were anesthetized, placed on mechanical ventilation for either 2 hrs or 4 hrs with either low tidal volume (8 ml/kg) or high tidal volume (15 ml/kg) with or without positive end-expiratory pressure and recruitment maneuvers. Results Alteration of the alveolar-capillary barrier was noted at 2 hrs of high tidal volume ventilation. Standardized histology scores, influx of bronchoalveolar lavage albumin, proinflammatory cytokines, and absolute neutrophils were significantly higher in the high-tidal volume ventilation group at 4 hours of ventilation. Application of positive end-expiratory pressure resulted in significantly decreased standardized histology scores and bronchoalveolar absolute neutrophil counts at low- and high-tidal volume ventilation, respectively. Recruitment maneuvers were essential to maintain pulmonary compliance at both 2 and 4 hrs of ventilation. Conclusions Signs of ventilator-induced lung injury are evident soon after high tidal volume ventilation (as early as 2 hours) and lung injury worsens with longer-term ventilation (4 hrs). Application of positive end-expiratory pressure and recruitment maneuvers are protective against worsening VILI across all time points. Dynamic compliance can be used guide the frequency of recruitment maneuvers to help ameloriate ventilator-induced lung injury.	[Cagle, Laura A.; Franzi, Lisa M.; Linderholm, Angela L.; Last, Jerold A.; Harper, Richart W.; Kenyon, Nicholas J.] Univ Calif Davis, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA; [Adams, Jason Y.; Harper, Richart W.; Kenyon, Nicholas J.] Univ Calif Davis, Sch Med, Div Pulm Crit Care & Sleep Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Cagle, LA (corresponding author), Univ Calif Davis, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA.	lacagle@ucdavis.edu			NIH [R01 HL105573, T32 HL007013]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by: NIH R01 HL105573 and T32 HL007013.	Albaiceta GM, 2011, CRIT CARE, V15, DOI 10.1186/cc10052; Allen G, 2004, J APPL PHYSIOL, V96, P293, DOI 10.1152/japplphysiol.00270.2003; Allen GB, 2006, AM J PHYSIOL-LUNG C, V291, pL710, DOI 10.1152/ajplung.00532.2005; Badet M, 2009, RESP CARE, V54, P847, DOI 10.4187/002013209793800448; Borges JB, 2006, AM J RESP CRIT CARE, V174, P268, DOI 10.1164/rccm.200506-976OC; Brederlau J, 2007, J TRAUMA, V62, P336, DOI 10.1097/01.ta.0000221667.32598.71; Cannizzaro V, 2009, RESP PHYSIOL NEUROBI, V169, P243, DOI 10.1016/j.resp.2009.09.012; Checkley W, 2008, AM J RESP CRIT CARE, V177, P1215, DOI 10.1164/rccm.200709-1424OC; Chess PR, 2010, EXP LUNG RES, V36, P331, DOI 10.3109/01902141003632332; Chiumello D, 1999, AM J RESP CRIT CARE, V160, P109, DOI 10.1164/ajrccm.160.1.9803046; Crotti S, 2001, AM J RESP CRIT CARE, V164, P131, DOI 10.1164/ajrccm.164.1.2007011; Curley GF, 2016, CHEST, V150, P1109, DOI 10.1016/j.chest.2016.07.019; Dessap AM, 2012, AM J RESP CELL MOL, V46, P541, DOI 10.1165/rcmb.2011-0306OC; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Duggan M, 2003, AM J RESP CRIT CARE, V167, P1633, DOI 10.1164/rccm.200210-1215OC; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; Fan E, 2008, AM J RESP CRIT CARE, V178, P1156, DOI 10.1164/rccm.200802-335OC; Finigan JH, 2009, AM J PHYSIOL-LUNG C, V296, pL1002, DOI 10.1152/ajplung.90555.2008; Frank JA, 2005, CRIT CARE MED, V33, P181, DOI 10.1097/01.CCM.0000150663.45778.C4; GATTINONI L, 1995, AM J RESP CRIT CARE, V151, P1807, DOI 10.1164/ajrccm.151.6.7767524; Gattinoni L, 2010, CRIT CARE MED, V38, pS539, DOI 10.1097/CCM.0b013e3181f1fcf7; Grasso S, 2002, ANESTHESIOLOGY, V96, P795, DOI 10.1097/00000542-200204000-00005; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Guay J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011151.pub2; Hodgson C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006667.pub3; Hol J, 2010, J LEUKOCYTE BIOL, V87, P501, DOI 10.1189/jlb.0809532; Johannigman JA, 2003, J TRAUMA, V54, P320, DOI 10.1097/01.TA.0000043923.19107.B6; Ko SC, 2008, ACTA ANAESTH SCAND, V52, P514, DOI 10.1111/j.1399-6576.2008.01581.x; Lapinsky SE, 2003, CRIT CARE, V7, P9, DOI 10.1186/cc1857; Li LF, 2005, CRIT CARE MED, V33, P1913, DOI 10.1097/01.CCM.0000178179.48050.BC; Lim SC, 2004, CRIT CARE MED, V32, P2378, DOI 10.1097/01.CCM.0000147444.58070.72; Malhotra A, 2007, NEW ENGL J MED, V357, P1113, DOI 10.1056/NEJMct074213; Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Meade MO, 2008, RESP CARE, V53, P1441; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Needham DM, 2015, AM J RESP CRIT CARE, V191, P177, DOI 10.1164/rccm.201409-1598OC; Neto AS, 2016, LANCET RESP MED, V4, P272, DOI 10.1016/S2213-2600(16)00057-6; Neto AS, 2015, CRIT CARE MED, V43, P2155, DOI 10.1097/CCM.0000000000001189; Nielsen J, 2006, INTENS CARE MED, V32, P585, DOI 10.1007/s00134-006-0082-0; Odenstedt H, 2005, INTENS CARE MED, V31, P112, DOI 10.1007/s00134-004-2496-x; Pedreira PR, 2008, AM J PHYSIOL-LUNG C, V295, pL820, DOI 10.1152/ajplung.90211.2008; Pelosi P, 2001, AM J RESP CRIT CARE, V164, P122, DOI 10.1164/ajrccm.164.1.2007010; Peltekova V, 2010, INTENS CARE MED, V36, P869, DOI 10.1007/s00134-010-1787-7; Petrucci N, 2013, COCHRANE DB SYST REV, V28, P2, DOI DOI 10.1002/14651858.CD003844.PUB4; Protti Alessandro, 2015, Intensive Care Med Exp, V3, P34, DOI 10.1186/s40635-015-0070-1; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Reiss LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024527; Ronchi CF, 2012, J PULMON RESP MED S, V12; Cruz RS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009098.pub2; Sinclair SE, 2004, CRIT CARE MED, V32, P2496, DOI 10.1097/01.CCM.0000148231.04642.8D; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Vaporidi K, 2008, CRIT CARE MED, V36, P1277, DOI 10.1097/CCM.0b013e318169f30e; Wang LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154754; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; Weiss CH, 2016, CRIT CARE MED, V44, P1515, DOI 10.1097/CCM.0000000000001710; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Wilson MR, 2009, AM J RESP CRIT CARE, V179, P914, DOI 10.1164/rccm.200806-877OC; Wilson MR, 2003, J APPL PHYSIOL, V95, P1385, DOI 10.1152/japplphysiol.00213.2003; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Wrigge H, 2004, ANESTH ANALG, V98, P775; Wrigge H, 2000, ANESTHESIOLOGY, V93, P1413, DOI 10.1097/00000542-200012000-00012; Zosky GR, 2008, J APPL PHYSIOL, V105, P685, DOI 10.1152/japplphysiol.90328.2008	64	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2017	12	11							e0187419	10.1371/journal.pone.0187419	http://dx.doi.org/10.1371/journal.pone.0187419			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL9KF	29112971	Green Published, gold			2022-12-26	WOS:000414572100016
J	Jeon, H; Youn, H; Kim, JS; Nam, J; Lee, J; Lee, J; Park, D; Kim, W; Ki, Y; Kim, D				Jeon, Hosang; Youn, Hanbean; Kim, Jin Sung; Nam, Jiho; Lee, Jayoung; Lee, Juhye; Park, Dahl; Kim, Wontaek; Ki, Yongkan; Kim, Donghyun			Generation of polychromatic projection for dedicated breast computed tomography simulation using anthropomorphic numerical phantom	PLOS ONE			English	Article							SPATIAL-RESOLUTION; CT; ALGORITHMS; SPECTRA; IMAGES; OPENCL; KV	Numerical simulations are fundamental to the development of medical imaging systems because they can save time and effort in research and development. In this study, we developed a method of creating the virtual projection images that are necessary to study dedicated breast computed tomography (BCT) systems. Anthropomorphic software breast phantoms of the conventional compression type were synthesized and redesigned to meet the requirements of dedicated BCT systems. The internal structure of the breast was randomly constructed to develop the proposed phantom, enabling the internal structure of a naturally distributed real breast to be simulated. When using the existing monochromatic photon incidence assumption for projection-image generation, it is not possible to simulate various artifacts caused by the X-ray spectrum, such as the beam hardening effect. Consequently, the system performance could be overestimated. Therefore, we considered the polychromatic spectrum in the projection image generation process and verified the results. The proposed method is expected to be useful for the development and optimization of BCT systems.	[Jeon, Hosang; Youn, Hanbean; Nam, Jiho; Lee, Jayoung; Lee, Juhye] Pusan Natl Univ, Yangsan Hosp, Dept Radiat Oncol, Gyeongsangnam Do, South Korea; [Jeon, Hosang; Youn, Hanbean; Nam, Jiho; Lee, Jayoung; Lee, Juhye] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Gyeongsangnam Do, South Korea; [Kim, Jin Sung] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea; [Park, Dahl; Kim, Wontaek; Ki, Yongkan; Kim, Donghyun] Pusan Natl Univ Hosp, Dept Radiat Oncol, Busan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Yonsei University; Yonsei University Health System; Pusan National University; Pusan National University Hospital	Youn, H; Nam, J (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Radiat Oncol, Gyeongsangnam Do, South Korea.	hanbean.youn@pnuyh.co.kr; jihonam@hotmail.net	Ki, Yongkan/ABF-3519-2021	Ki, Yongkan/0000-0003-0757-8211; Kim, Jin Sung/0000-0003-1415-6471	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2016R1C101010527]; Ministry of Science, ICT and Future Planning [2015M3A9E2067002]; Pusan National University Yangsan Hospital	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Pusan National University Yangsan Hospital(Pusan National University)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2016R1C101010527) and Ministry of Science, ICT and Future Planning (2015M3A9E2067002). This research also funded by the year 2016 clinical research grant from Pusan National University Yangsan Hospital.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science andTechnology (NRF-2016R1C1B1010527) and Ministry of Science CT and Future Planning (2015M3A9E2067002)	Bakic PR, 2011, MED PHYS, V38, P3165, DOI 10.1118/1.3590357; Bliznakova K, 2003, PHYS MED BIOL, V48, P3699, DOI 10.1088/0031-9155/48/22/006; Boone JM, 2003, AIP CONF PROC, V682, P3, DOI 10.1063/1.1615091; Boone JM, 1997, MED PHYS, V24, P1863, DOI 10.1118/1.598100; Boone JM, 1997, MED PHYS, V24, P1661, DOI 10.1118/1.597953; De Man B, 2004, PHYS MED BIOL, V49, P2463, DOI 10.1088/0031-9155/49/11/024; Dhaene J, 2015, NUCL INSTRUM METH B, V342, P170, DOI 10.1016/j.nimb.2014.09.033; Engstrom E, 2009, MED PHYS, V36, P1753, DOI 10.1118/1.3116774; Gao H, 2012, MED PHYS, V39, P7110, DOI 10.1118/1.4761867; Gazi PM, 2015, MED PHYS, V42, P1973, DOI 10.1118/1.4915079; Hsieh J., 2003, COMPUTED TOMOGRAPHY; Jacobs F., 1998, Journal of Computing and Information Technology - CIT, V6, P89; Jeon Hosang, 2013, [PROGRESS in MEDICAL PHYSICS, 의학물리], V24, P303, DOI 10.14316/pmp.2013.24.4.303; Jeon H, 2015, MED PHYS, V42, P4654, DOI 10.1118/1.4926552; Kak A, 1988, PRINCIPLES OF COMPUT; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Lau BA, 2012, MED PHYS, V39, P3375, DOI 10.1118/1.4718576; Li CM, 2009, MED PHYS, V36, P3122, DOI 10.1118/1.3140588; Nuyts J, 2013, PHYS MED BIOL, V51, P1877; O'Connell AM, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.93274; PETERS TM, 1981, IEEE T NUCL SCI, V28, P3641, DOI 10.1109/TNS.1981.4331812; Samani A, 2001, IEEE T MED IMAGING, V20, P271, DOI 10.1109/42.921476; Sarno A, 2015, MED PHYS, V42, P2786, DOI 10.1118/1.4919441; Seger O, 2005, DEMONSTRATION OF BEA; SIDDON RL, 1985, MED PHYS, V12, P252, DOI 10.1118/1.595715; Sisniega A, 2014, MED PHYS, V41, DOI 10.1118/1.4837220; Stone JE, 2010, COMPUT SCI ENG, V12, P66, DOI 10.1109/MCSE.2010.69; SWANK RK, 1973, J APPL PHYS, V44, P4199, DOI 10.1063/1.1662918; Vedantham S, 2012, THE SECOND INTERNATI; Vedantham S, 2013, PHYS MED BIOL, V58, P4099, DOI 10.1088/0031-9155/58/12/4099; Vedantham S, 2012, MED PHYS, V39, P7317, DOI 10.1118/1.4765050; Yang K, 2007, MED PHYS, V34, P2059, DOI 10.1118/1.2737263; Youn H, 2016, J INSTRUM, V11, DOI 10.1088/1748-0221/11/01/C01085; Youn H, 2011, NUCL INSTRUM METH A, V652, P810, DOI 10.1016/j.nima.2010.09.088; Zastrow E, 2008, IEEE T BIO-MED ENG, V55, P2792, DOI 10.1109/TBME.2008.2002130; Zhao H, 2003, IEEE NUCL SCI S, V4, P2808; Zhou LL, 2012, MED PHYS, V39, P6745, DOI 10.1118/1.4758062; ZHUANG W, 1994, IEEE T NUCL SCI, V41, P1660, DOI 10.1109/23.322963	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187242	10.1371/journal.pone.0187242	http://dx.doi.org/10.1371/journal.pone.0187242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108024	Green Published, gold, Green Submitted			2022-12-26	WOS:000414424600021
